Secretory	Secretory	JJ	B-NP	O
immunoglobulin	immunoglobulin	NN	I-NP	O
A	A	NN	I-NP	O
(	(	(	O	O
SIgA	SIgA	NN	B-NP	O
)	)	)	O	O
antibodies	antibody	NNS	B-NP	O
reactive	reactive	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
pioneer	pioneer	NN	I-NP	O
oral	oral	JJ	I-NP	O
streptococci	streptococci	NNS	I-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
mitis	mitis	NN	I-NP	O
biovar	biovar	NN	I-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
oralis	oralis	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
late	late	JJ	I-NP	O
oral	oral	JJ	I-NP	O
colonizer	colonizer	NN	I-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
mutans	mutan	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
pioneer	pioneer	NN	I-NP	O
enteric	enteric	JJ	I-NP	O
bacterium	bacterium	NN	I-NP	O
Enterococcus	Enterococcus	NN	I-NP	O
faecalis	faecalis	NN	I-NP	O
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
10	10	CD	B-NP	O
human	human	JJ	I-NP	O
infants	infant	NNS	I-NP	O
from	from	IN	B-PP	O
birth	birth	NN	B-NP	O
to	to	TO	B-PP	O
age	age	NN	B-NP	O
2	2	CD	B-NP	O
years	year	NNS	I-NP	O
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
.	.	.	O	O

Low	Low	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
salivary	salivary	JJ	B-NP	B-protein
SIgA1	SIgA1	NN	I-NP	I-protein
and	and	CC	I-NP	O
SIgA2	SIgA2	NN	I-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
reactive	reactive	JJ	B-ADJP	O
with	with	IN	B-PP	O
whole	whole	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
all	all	DT	B-NP	O
four	four	CD	I-NP	O
species	specie	NNS	I-NP	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
month	month	NN	I-NP	O
after	after	IN	B-PP	O
birth	birth	NN	B-NP	O
,	,	,	O	O
even	even	RB	B-SBAR	O
though	though	IN	I-SBAR	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
and	and	CC	O	O
E.	E.	NNP	B-NP	O
faecalis	faecalis	NNP	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
recovered	recover	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
mouths	mouth	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
infants	infant	NNS	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
period	period	NN	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
fivefold	fivefold	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
SIgA	SIgA	NN	B-NP	B-protein
between	between	IN	B-PP	O
birth	birth	NN	B-NP	O
and	and	CC	I-NP	O
age	age	NN	I-NP	O
2	2	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
differences	difference	NNS	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
SIgA1	SIgA1	NN	B-NP	B-protein
and	and	CC	I-NP	O
SIgA2	SIgA2	NN	I-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
reactive	reactive	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
four	four	CD	I-NP	O
species	specie	NNS	I-NP	O
over	over	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
period	period	NN	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
the	the	DT	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
SIgA1	SIgA1	NN	B-NP	B-protein
and	and	CC	I-NP	O
SIgA2	SIgA2	NN	I-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
reactive	reactive	JJ	B-ADJP	O
with	with	IN	B-PP	O
all	all	DT	B-NP	O
four	four	CD	I-NP	O
species	specie	NNS	I-NP	O
were	be	VBD	B-VP	O
normalized	normalize	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
SIgA1	SIgA1	NN	B-NP	B-protein
and	and	CC	I-NP	O
SIgA2	SIgA2	NN	I-NP	B-protein
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
,	,	,	I-NP	O
SIgA1	SIgA1	NN	I-NP	B-protein
and	and	CC	I-NP	O
SIgA2	SIgA2	NN	I-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
reactive	reactive	JJ	B-ADJP	O
with	with	IN	B-PP	O
these	these	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
from	from	IN	B-PP	O
birth	birth	NN	B-NP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
years	year	NNS	I-NP	O
of	of	IN	B-PP	O
age	age	NN	B-NP	O
.	.	.	O	O

Adsorption	Adsorption	NN	B-NP	O
of	of	IN	B-PP	O
each	each	DT	B-NP	O
infant	infant	NN	I-NP	O
's	's	POS	B-NP	O
saliva	saliva	NN	I-NP	O
with	with	IN	B-PP	O
cells	cell	NNS	B-NP	O
of	of	IN	B-PP	O
one	one	CD	B-NP	O
species	specie	NNS	I-NP	O
produced	produce	VBD	B-VP	O
a	a	DT	B-NP	O
dramatic	dramatic	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
of	of	IN	B-PP	O
antibodies	antibody	NNS	B-NP	B-protein
recognizing	recognize	VBG	B-VP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
three	three	CD	I-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

Sequential	Sequential	JJ	B-NP	O
adsorption	adsorption	NN	I-NP	O
of	of	IN	B-PP	O
saliva	saliva	NN	B-NP	O
samples	sample	NNS	I-NP	O
removed	remove	VBD	B-VP	O
all	all	DT	B-NP	O
SIgA	SIgA	NN	I-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
to	to	TO	B-PP	O
the	the	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
SIgA	SIgA	NN	I-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
directed	direct	VBN	I-VP	O
to	to	TO	B-PP	O
antigens	antigen	NNS	B-NP	O
shared	share	VBN	B-VP	O
by	by	IN	B-PP	O
all	all	DT	B-NP	O
four	four	CD	I-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
induction	induction	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
host	host	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
limited	limited	JJ	I-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
common	common	JJ	B-NP	B-protein
antigens	antigen	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
likely	likely	RB	I-VP	O
not	not	RB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
adherence	adherence	NN	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
that	that	WDT	B-NP	O
commensal	commensal	JJ	B-NP	O
streptococci	streptococci	NNS	I-NP	O
employ	employ	VBP	B-VP	O
to	to	TO	I-VP	O
persist	persist	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

Human	Human	JJ	B-NP	B-protein
salivary	salivary	JJ	I-NP	I-protein
mucin	mucin	NN	I-NP	I-protein
MG2	MG2	NN	I-NP	I-protein
was	be	VBD	B-VP	O
purified	purify	VBN	I-VP	O
from	from	IN	B-PP	O
submandibular/sublingual	submandibular/sublingual	JJ	B-NP	O
gland	gland	NN	I-NP	O
secretion	secretion	NN	I-NP	O
by	by	IN	B-PP	O
ultrafiltration	ultrafiltration	NN	B-NP	O
and	and	CC	O	O
sequential	sequential	JJ	B-NP	O
gel	gel	NN	I-NP	O
filtration	filtration	NN	I-NP	O
chromatography	chromatography	NN	I-NP	O
on	on	IN	B-PP	O
Sephadex	Sephadex	NN	B-NP	O
G-200	G-200	NN	I-NP	O
,	,	,	O	O
Superose	Superose	VBD	B-VP	O
6	6	CD	B-NP	O
(	(	(	O	O
prepgrade	prepgrade	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
Superose	Superose	VBD	B-VP	O
6	6	CD	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
method	method	NN	I-NP	O
differs	differ	VBZ	B-VP	O
from	from	IN	B-PP	O
earlier	early	JJR	B-NP	O
procedures	procedure	NNS	I-NP	O
in	in	IN	B-PP	O
that	that	IN	B-SBAR	O
all	all	DT	B-NP	O
steps	step	NNS	I-NP	O
are	be	VBP	B-VP	O
performed	perform	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
4	4	CD	B-NP	O
M	M	NN	I-NP	O
guanidine	guanidine	NN	I-NP	O
hydrochloride	hydrochloride	NN	I-NP	O
and	and	CC	O	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
involve	involve	VB	I-VP	O
covalent	covalent	JJ	B-NP	O
modification	modification	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mucin	mucin	NN	I-NP	B-protein
molecule	molecule	NN	I-NP	I-protein
.	.	.	O	O

Electrophoretic	Electrophoretic	JJ	B-NP	O
analyses	analysis	NNS	I-NP	O
and	and	CC	O	O
Western	Western	JJ	B-NP	O
blotting	blotting	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
purified	purify	VBN	B-NP	O
MG2	MG2	NN	I-NP	B-protein
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
contain	contain	VB	I-VP	O
detectable	detectable	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
salivary	salivary	JJ	I-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
.	.	.	O	O

Amino	Amino	NN	B-NP	O
acid	acid	NN	I-NP	O
analysis	analysis	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
composition	composition	NN	I-NP	O
of	of	IN	B-PP	O
purified	purify	VBN	B-NP	O
MG2	MG2	NN	I-NP	B-protein
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
excellent	excellent	JJ	B-NP	O
agreement	agreement	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
deduced	deduce	VBN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
MG2	MG2	NN	B-NP	O
apomucin	apomucin	NN	I-NP	O
encoded	encode	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
MUC7	MUC7	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
yield	yield	NN	I-NP	O
of	of	IN	B-PP	O
purified	purify	VBN	B-NP	O
MG2	MG2	NN	I-NP	B-protein
was	be	VBD	B-VP	O
10-15	10-15	CD	B-NP	O
mg	mg	NN	I-NP	O
from	from	IN	B-PP	O
750	750	CD	B-NP	O
ml	ml	NN	I-NP	O
of	of	IN	B-PP	O
salivary	salivary	JJ	B-NP	O
secretion	secretion	NN	I-NP	O
.	.	.	O	O

Binding	Binding	NN	B-NP	O
of	of	IN	B-PP	O
purified	purify	VBN	B-NP	O
MG2	MG2	NN	I-NP	B-protein
to	to	TO	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
significantly	significantly	RB	I-VP	O
affected	affect	VBN	I-VP	O
by	by	IN	B-PP	O
reductive	reductive	JJ	B-NP	O
methylation	methylation	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
nearly	nearly	RB	I-VP	O
abolished	abolish	VBN	I-VP	O
by	by	IN	B-PP	O
reduction	reduction	NN	B-NP	O
and	and	CC	I-NP	O
alkylation	alkylation	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
identified	identify	VBD	B-VP	O
a	a	DT	B-NP	O
functional	functional	JJ	I-NP	O
determinant	determinant	NN	I-NP	O
for	for	IN	B-PP	O
mucin-bacterial	mucin-bacterial	JJ	B-NP	O
interactions	interaction	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
N-terminal	N-terminal	JJ	I-NP	B-protein
region	region	NN	I-NP	I-protein
where	where	WRB	B-ADVP	O
the	the	DT	B-NP	O
only	only	JJ	I-NP	O
two	two	CD	I-NP	O
cysteines	cysteine	NNS	I-NP	O
(	(	(	O	O
Cys45	Cys45	NN	B-NP	B-protein
and	and	CC	O	O
Cys50	Cys50	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
MG2	MG2	NN	I-NP	O
apomucin	apomucin	NN	I-NP	O
occur	occur	VBP	B-VP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
purified	purify	VBN	B-NP	O
MG2	MG2	NN	I-NP	B-protein
bound	bind	VBD	B-VP	O
to	to	TO	B-PP	O
four	four	CD	B-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
Streptococci	Streptococci	NNS	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
complexing	complexe	VBG	B-VP	O
with	with	IN	B-PP	O
other	other	JJ	B-NP	O
salivary	salivary	JJ	I-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
secretory	secretory	JJ	B-NP	O
immunoglobulin	immunoglobulin	NN	I-NP	O
A	A	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
purification	purification	NN	I-NP	O
procedure	procedure	NN	I-NP	O
described	describe	VBN	B-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
work	work	NN	I-NP	O
will	will	MD	B-VP	O
facilitate	facilitate	VB	I-VP	O
investigation	investigation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
MG2	MG2	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
environment	environment	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
magnesium	magnesium	NN	I-NP	O
monoperoxyphthalate	monoperoxyphthalate	NN	I-NP	O
(	(	(	O	O
MMPP	MMPP	NN	B-NP	B-protein
)	)	)	O	O
mouth-rinse	mouth-rinse	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
or	or	CC	B-PP	O
without	without	IN	B-PP	O
sodium	sodium	NN	B-NP	O
lauryl	lauryl	NN	I-NP	O
sulphate	sulphate	NN	I-NP	O
(	(	(	O	O
SLS	SLS	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
MMPP	MMPP	NN	I-NP	O
dentifrice	dentifrice	NN	I-NP	O

,	,	,	O	O
on	on	IN	B-PP	O
salivary	salivary	JJ	B-NP	O
counts	count	NNS	I-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
flora	flora	NN	I-NP	O
and	and	CC	I-NP	O
yeasts	yeast	NNS	I-NP	O
,	,	,	B-PP	O
and	and	CC	I-PP	O
on	on	IN	B-PP	O
supragingival	supragingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
scores	score	NNS	I-NP	O
were	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
in	in	IN	B-PP	O
131	131	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
oral	oral	JJ	I-NP	O
candida	candida	NN	I-NP	O
carriers	carrier	NNS	I-NP	O
over	over	IN	B-PP	O
a	a	DT	B-NP	O
9	9	CD	I-NP	O
week	week	NN	I-NP	O
double	double	JJ	I-NP	O
blind	blind	JJ	I-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
salivary	salivary	JJ	I-NP	O
counts	count	NNS	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
studied	study	VBN	B-VP	O
(	(	(	O	O
anaerobes	anaerobe	NNS	B-NP	O
,	,	,	O	O
streptococci	streptococci	NNS	B-NP	O
,	,	,	O	O
fusobacteria	fusobacteria	NNS	B-NP	O
,	,	,	O	O
Actinomyces	Actinomyces	NNP	B-NP	O
,	,	,	O	O
Viellonella	Viellonella	NNP	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
test	test	NN	I-NP	O
or	or	CC	I-NP	O
placebo	placebo	NN	I-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
significant	significant	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
salivary	salivary	JJ	B-NP	O
candida	candida	NN	I-NP	O
counts	count	NNS	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
subjects	subject	NNS	B-NP	O
using	use	VBG	B-VP	O
an	an	DT	B-NP	O
MMPP	MMPP	NN	I-NP	O
rinse	rinse	NN	I-NP	O
and	and	CC	I-NP	O
dentifrice	dentifrice	NN	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
placebo	placebo	NN	B-NP	O
subjects	subject	NNS	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
phenomenon	phenomenon	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
influenced	influence	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
SLS	SLS	NN	B-NP	B-protein
.	.	.	O	O

A	A	DT	B-NP	O
significant	significant	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
plaque	plaque	NN	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
subjects	subject	NNS	B-NP	O
using	use	VBG	B-VP	O
an	an	DT	B-NP	O
MMPP	MMPP	NN	I-NP	O
rinse	rinse	NN	I-NP	O
and	and	CC	I-NP	O
dentifrice	dentifrice	NN	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
placebo	placebo	NN	B-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O

Frank	Frank	NNP	B-NP	O
candidosis	candidosis	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
only	only	RB	B-NP	O
2	2	CD	I-NP	O
subjects	subject	NNS	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
placebo	placebo	NN	I-NP	O
rinse	rinse	NN	I-NP	O
group	group	NN	I-NP	O

and	and	CC	O	O
1	1	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
MMPP	MMPP	NN	I-NP	O
dentifrice	dentifrice	NN	I-NP	O
group	group	NN	I-NP	O
)	)	)	O	O
but	but	CC	O	O
erythematous	erythematous	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
subjective	subjective	JJ	B-NP	O
reports	report	NNS	I-NP	O
of	of	IN	B-PP	O
soreness	soreness	NN	B-NP	O
,	,	,	O	O
dryness	dryness	NN	B-NP	O
or	or	CC	O	O
burning	burn	VBG	B-VP	O
sensation	sensation	NN	B-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
recorded	record	VBN	I-VP	O
and	and	CC	O	O
observed	observe	VBN	B-VP	O
more	more	RBR	B-ADVP	O
frequently	frequently	RB	I-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
experimental	experimental	JJ	I-NP	O
groups	group	NNS	I-NP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
placebos	placebo	NNS	I-NP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
in	in	IN	B-PP	O
those	those	DT	B-NP	O
also	also	RB	B-ADVP	O
using	use	VBG	B-VP	O
SLS	SLS	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
substantial	substantial	JJ	I-NP	O
plaque	plaque	NN	I-NP	O
reduction	reduction	NN	I-NP	O
achieved	achieve	VBN	B-VP	O
with	with	IN	B-PP	O
MMPP	MMPP	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
tooth	tooth	JJ	B-NP	O
staining	staining	NN	I-NP	O
but	but	CC	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
salivary	salivary	JJ	B-NP	O
Candida	Candida	NNP	I-NP	O
counts	count	NNS	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
further	further	JJ	B-NP	O
studies	study	NNS	I-NP	O
of	of	IN	B-PP	O
MMPP	MMPP	NN	B-NP	B-protein
are	be	VBP	B-VP	O
warranted	warrant	VBN	I-VP	O
.	.	.	O	O

Bacteroides	Bacteroide	NNS	B-NP	O
forsythus	forsythus	RB	B-ADVP	O
strains	strain	NNS	B-NP	O
recovered	recover	VBN	B-VP	O
from	from	IN	B-PP	O
cat	cat	NN	B-NP	B-protein
and	and	CC	I-NP	O
dog	dog	NN	I-NP	O
bite	bite	NN	I-NP	O
wound	wound	NN	I-NP	O
infections	infection	NNS	I-NP	O
in	in	IN	B-PP	O
humans	human	NNS	B-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
3	3	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
monkey	monkey	NN	B-NP	O
oral	oral	JJ	I-NP	O
strains	strain	NNS	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
3	3	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
oral	oral	JJ	I-NP	O
ATCC	ATCC	NN	I-NP	O
43037	43037	CD	I-NP	O
type	type	NN	I-NP	O
strain	strain	NN	I-NP	O
were	be	VBD	B-VP	O
characterized	characterize	VBN	I-VP	O
by	by	IN	B-PP	O
using	use	VBG	B-VP	O
phenotypic	phenotypic	JJ	B-NP	O
characteristics	characteristic	NNS	I-NP	O
,	,	,	O	O
enzymatic	enzymatic	JJ	B-NP	O
tests	test	NNS	I-NP	O
,	,	,	O	O
whole	whole	JJ	B-NP	O
cell	cell	NN	I-NP	O
fatty	fatty	JJ	I-NP	O
acid	acid	NN	I-NP	O
analysis	analysis	NN	I-NP	O
,	,	,	O	O
sodium	sodium	NN	B-NP	O
dodecyl	dodecyl	NN	I-NP	O
sulfate-polyacrylamide	sulfate-polyacrylamide	NN	I-NP	O
gel	gel	NN	I-NP	O
electrophoresis	electrophoresis	NN	I-NP	O
(	(	(	O	O
SDS-PAGE	SDS-PAGE	NN	B-NP	O
)	)	)	O	O
analysis	analysis	NN	B-NP	O
,	,	,	O	O
PCR	PCR	NN	B-NP	O
fingerprinting	fingerprinting	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
16S	16S	NN	B-NP	B-DNA
rDNA	rDNA	NN	I-NP	I-DNA
(	(	(	O	O
genes	gene	NNS	B-NP	O
coding	cod	VBG	B-VP	O
for	for	IN	B-PP	O
rRNA	rRNA	NN	B-NP	B-RNA
)	)	)	O	O
sequencing	sequencing	NN	B-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
three	three	CD	I-NP	O
bite	bite	NN	I-NP	O
wound	wound	NN	I-NP	O
isolates	isolate	NNS	I-NP	O
grew	grow	VBD	B-VP	O
on	on	IN	B-PP	O
brucella	brucella	NN	B-NP	O
agar	agar	NN	I-NP	O
supplemented	supplement	VBN	B-VP	O
with	with	IN	B-PP	O
5	5	CD	B-NP	O
%	%	NN	I-NP	O
sheep	sheep	NN	I-NP	O
blood	blood	NN	I-NP	O
,	,	,	O	O
vitamin	vitamin	NN	B-NP	O
K1	K1	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
hemin	hemin	NN	B-NP	B-protein
.	.	.	O	O

These	These	DT	B-NP	O
strains	strain	NNS	I-NP	O
,	,	,	O	O
unlike	unlike	IN	B-PP	O
the	the	DT	B-NP	O
ATCC	ATCC	NN	I-NP	O
strain	strain	NN	I-NP	O
and	and	CC	O	O
previously	previously	RB	B-NP	O
described	describe	VBN	I-NP	O
monkey	monkey	NN	I-NP	O
oral	oral	JJ	I-NP	O
and	and	CC	I-NP	O
human	human	JJ	I-NP	O
clinical	clinical	JJ	I-NP	O
strains	strain	NNS	I-NP	O
,	,	,	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
require	require	VB	I-VP	O
N-acetylmuramic	N-acetylmuramic	JJ	B-NP	O
acid	acid	NN	I-NP	O
supplementation	supplementation	NN	I-NP	O
for	for	IN	B-PP	O
growth	growth	NN	B-NP	O
as	as	IN	B-PP	O
pure	pure	JJ	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
their	their	PRP$	B-NP	O
phenotypic	phenotypic	JJ	I-NP	O
characteristics	characteristic	NNS	I-NP	O
,	,	,	O	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
catalase	catalase	NN	B-NP	B-protein
production	production	NN	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
previously	previously	RB	B-NP	O
identified	identify	VBN	I-NP	O
strains	strain	NNS	I-NP	O
.	.	.	O	O

PCR	PCR	NN	B-NP	O
fingerprinting	fingerprinting	NN	I-NP	O
analysis	analysis	NN	I-NP	O
showed	show	VBD	B-VP	O
differences	difference	NNS	B-NP	O
in	in	IN	B-PP	O
band	band	NN	B-NP	O
patterns	pattern	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
ATCC	ATCC	NN	I-NP	O
strain	strain	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
SDS-PAGE	SDS-PAGE	NN	B-NP	O
and	and	CC	O	O
whole	whole	JJ	B-NP	O
cell	cell	NN	I-NP	O
fatty	fatty	JJ	I-NP	O
acid	acid	NN	I-NP	O
analysis	analysis	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
dog	dog	NN	I-NP	O
and	and	CC	I-NP	O
cat	cat	NN	I-NP	B-protein
bite	bite	NN	I-NP	I-protein
wound	wound	NN	I-NP	I-protein
strains	strain	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
but	but	CC	O	O
not	not	RB	B-ADJP	O
identical	identical	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
B.	B.	NNP	I-NP	O
forsythus	forsythus	RB	B-ADVP	O
ATCC	ATCC	NN	B-NP	O
43037	43037	CD	I-NP	O
type	type	NN	I-NP	O
strain	strain	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
monkey	monkey	NN	I-NP	O
oral	oral	JJ	I-NP	O
strains	strain	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
rDNA	rDNA	NN	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
analysis	analysis	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
bite	bite	NN	I-NP	O
wound	wound	NN	I-NP	O
isolates	isolate	NNS	I-NP	O
had	have	VBD	B-VP	O
99.93	99.93	CD	B-NP	O
%	%	NN	I-NP	O
homology	homology	NN	I-NP	O
with	with	IN	B-PP	O
each	each	DT	B-NP	O
other	other	JJ	I-NP	O
and	and	CC	O	O
98.9	98.9	CD	B-NP	O
and	and	CC	I-NP	O
99.22	99.22	CD	I-NP	O
%	%	NN	I-NP	O
homology	homology	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
ATCC	ATCC	NN	I-NP	O
43037	43037	CD	I-NP	O
and	and	CC	O	O
monkey	monkey	NN	B-NP	O
oral	oral	JJ	I-NP	O
strains	strain	NNS	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
are	be	VBP	B-VP	O
host-specific	host-specific	JJ	B-NP	O
variations	variation	NNS	I-NP	O
within	within	IN	B-PP	O
each	each	DT	B-NP	O
group	group	NN	I-NP	O
.	.	.	O	O

Information	Information	NN	B-NP	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
samples	sample	NNS	I-NP	O
contributes	contribute	VBZ	B-VP	O
to	to	TO	B-PP	O
assessment	assessment	NN	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
individual	individual	NN	I-NP	O
's	's	POS	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
contracting	contract	VBG	B-VP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
or	or	CC	O	O
developing	develop	VBG	B-VP	O
periodontitis	periodontitis	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
prediction	prediction	NN	I-NP	O
of	of	IN	B-PP	O
that	that	DT	B-NP	O
individual	individual	NN	I-NP	O
's	's	POS	B-NP	O
clinical	clinical	JJ	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

Since	Since	IN	B-PP	O
existing	exist	VBG	B-NP	O
techniques	technique	NNS	I-NP	O
are	be	VBP	B-VP	O
often	often	RB	B-ADVP	O
time-consuming	time-consuming	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
expensive	expensive	JJ	I-ADJP	O
,	,	,	O	O
it	it	PRP	B-NP	O
seemed	seem	VBD	B-VP	O
attractive	attractive	JJ	B-ADJP	O
to	to	TO	B-VP	O
look	look	VB	I-VP	O
for	for	IN	B-PP	O
alternative	alternative	JJ	B-NP	O
methods	method	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
quantification	quantification	NN	I-NP	O
of	of	IN	B-PP	O
eubacteria	eubacteria	NNS	B-NP	O
.	.	.	O	O

With	With	IN	B-PP	O
their	their	PRP$	B-NP	O
high	high	JJ	I-NP	O
specificity	specificity	NN	I-NP	O
and	and	CC	O	O
sensitivity	sensitivity	NN	B-NP	O
,	,	,	O	O
polymerase	polymerase	NN	B-NP	O
chain-reaction	chain-reaction	NN	I-NP	O
(	(	(	O	O
PCR	PCR	NN	B-NP	O
)	)	)	O	O
techniques	technique	NNS	B-NP	O
have	have	VBP	B-VP	O
the	the	DT	B-NP	O
potential	potential	NN	I-NP	O
of	of	IN	B-PP	O
supplying	supply	VBG	B-VP	O
fast	fast	JJ	B-NP	O
and	and	CC	I-NP	O
reliable	reliable	JJ	I-NP	O
results	result	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
method	method	NN	I-NP	O
of	of	IN	B-PP	O
competitive	competitive	JJ	B-NP	O
PCR	PCR	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
quantification	quantification	NN	I-NP	O
of	of	IN	B-PP	O
eubacteria	eubacteria	NNS	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
designed	design	VBD	B-VP	O
forward	forward	RB	B-ADVP	O
and	and	CC	O	O
reverse	reverse	JJ	B-NP	O
PCR	PCR	NN	I-NP	O
primers	primer	NNS	I-NP	O
which	which	WDT	B-NP	O
bind	bind	VBP	B-VP	O
to	to	TO	B-PP	O
highly	highly	RB	B-NP	O
conserved	conserved	JJ	I-NP	O
sequences	sequence	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	B-DNA
16S	16S	NN	I-NP	I-DNA
rRNA	rRNA	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O

A	A	DT	B-NP	O
homologous	homologous	JJ	I-NP	O
competitor	competitor	NN	I-NP	O
was	be	VBD	B-VP	O
synthesized	synthesize	VBN	I-VP	O
with	with	IN	B-PP	O
Escherichia	Escherichia	FW	B-NP	B-DNA
coli	coli	FW	I-NP	I-DNA
16S	16S	NN	I-NP	I-DNA
rDNA	rDNA	NN	I-NP	I-DNA
as	as	IN	B-PP	O
a	a	DT	B-NP	O
template	template	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
reverse	reverse	JJ	I-NP	O
primer	primer	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
hybrid	hybrid	NN	I-NP	O
primer	primer	NN	I-NP	O
which	which	WDT	B-NP	O
binds	bind	VBZ	B-VP	O
67	67	CD	B-NP	O
bases	base	NNS	I-NP	O
downstream	downstream	RB	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
forward	forward	JJ	I-NP	O
primer	primer	NN	I-NP	O
and	and	CC	O	O
carries	carry	VBZ	B-VP	O
the	the	DT	B-NP	O
forward	forward	JJ	I-NP	B-DNA
primer	primer	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
at	at	IN	B-PP	O
its	its	PRP$	B-NP	O
5	5	CD	I-NP	B-DNA
'	'	SYM	I-NP	I-DNA
end	end	NN	I-NP	I-DNA
.	.	.	O	O

Specificity	Specificity	NN	B-NP	O
controls	control	NNS	I-NP	O
with	with	IN	B-PP	O
30	30	CD	B-NP	O
different	different	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
5	5	CD	B-NP	O
Archaea	Archaea	NNP	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
fungi	fungus	NNS	I-NP	O
,	,	,	O	O
human	human	JJ	B-NP	B-cell_type
astrocytoma	astrocytoma	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
and	and	CC	O	O
rat	rat	NN	B-NP	B-cell_line
hepatoblastoma	hepatoblastoma	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
carried	carry	VBN	I-VP	O
out	out	RP	B-PRT	O
.	.	.	O	O

Results	Result	NNS	B-NP	O
were	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
all	all	DT	B-NP	O
eubacteria	eubacteria	NNS	I-NP	O
and	and	CC	O	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
all	all	DT	B-NP	O
other	other	JJ	I-NP	O
cells	cell	NNS	I-NP	O
tested	test	VBN	B-VP	O
.	.	.	O	O

Calibration	Calibration	NN	B-NP	O
curves	curve	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
by	by	IN	B-PP	O
co-amplification	co-amplification	NN	B-NP	O
of	of	IN	B-PP	O
known	know	VBN	B-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
E.	E.	FW	B-NP	B-cell_type
coli	coli	FW	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
the	the	DT	I-PP	O
presence	presence	NN	I-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
homologous	homologous	JJ	I-NP	O
competitor	competitor	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
developed	develop	VBN	I-NP	O
method	method	NN	I-NP	O
was	be	VBD	B-VP	O
successfully	successfully	RB	I-VP	O
applied	apply	VBN	I-VP	O
to	to	TO	B-PP	O
assessment	assessment	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
accumulation	accumulation	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
during	during	IN	B-PP	O
an	an	DT	B-NP	O
oral	oral	JJ	I-NP	O
hygiene	hygiene	NN	I-NP	O
cessation	cessation	NN	I-NP	O
experiment	experiment	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
competitive	competitive	JJ	I-NP	O
PCR	PCR	NN	I-NP	O
method	method	NN	I-NP	O
proved	prove	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
reliable	reliable	JJ	I-NP	O
and	and	CC	I-NP	O
fast	fast	JJ	I-NP	O
method	method	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
quantification	quantification	NN	I-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
and	and	CC	O	O
cultured	culture	VBN	B-NP	O
eubacteria	eubacteria	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
in	in	IN	B-PP	O
biological	biological	JJ	B-NP	O
samples	sample	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
may	may	MD	B-VP	O
find	find	VB	I-VP	O
further	further	JJ	B-NP	O
applications	application	NNS	I-NP	O
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
in	in	IN	B-PP	O
periodontology	periodontology	NN	B-NP	O
and	and	CC	I-NP	O
cariology	cariology	NN	I-NP	O
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
in	in	IN	B-PP	O
other	other	JJ	B-NP	O
fields	field	NNS	I-NP	O
of	of	IN	B-PP	O
medical	medical	JJ	B-NP	O
microbiology	microbiology	NN	I-NP	O
.	.	.	O	O

Several	Several	JJ	B-NP	O
publications	publication	NNS	I-NP	O
have	have	VBP	B-VP	O
reported	report	VBN	I-VP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
susceptibility	susceptibility	NN	I-NP	O
for	for	IN	B-PP	O
root	root	NN	B-NP	O
caries	cary	NNS	I-NP	O
after	after	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
suggested	suggest	VBN	I-VP	O
that	that	IN	B-SBAR	O
newly	newly	RB	B-NP	O
exposed	expose	VBN	I-NP	O
roots	root	NNS	I-NP	O
were	be	VBD	B-VP	O
less	less	RBR	B-ADJP	O
resistant	resistant	JJ	I-ADJP	O
to	to	TO	B-PP	O
cariogenic	cariogenic	JJ	B-NP	B-protein
species	specie	NNS	I-NP	I-protein
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
increased	increase	VBN	I-NP	O
susceptibility	susceptibility	NN	I-NP	O
could	could	MD	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
intra-oral	intra-oral	JJ	I-NP	O
microbial	microbial	JJ	I-NP	O
shift	shift	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
periodontal	periodontal	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
perio-pathogenic	perio-pathogenic	JJ	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
more	more	RBR	I-NP	O
cariogenic	cariogenic	JJ	I-NP	O
flora	flora	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
were	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
for	for	IN	B-PP	O
8	8	CD	B-NP	O
months	month	NNS	I-NP	O
after	after	IN	B-SBAR	O
thorough	thorough	JJ	B-NP	O
scaling	scaling	NN	I-NP	O
and	and	CC	I-NP	O
root	root	NN	I-NP	O
planing	planing	NN	I-NP	O
in	in	IN	B-PP	O
combination	combination	NN	B-NP	O
with	with	IN	B-PP	O
optimal	optimal	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
and	and	CC	O	O
after	after	IN	B-PP	O
4	4	CD	B-NP	O
and	and	CC	I-NP	O
8	8	CD	I-NP	O
months	month	NNS	I-NP	O
,	,	,	O	O
samples	sample	NNS	B-NP	O
were	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
saliva	saliva	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
tongue	tongue	NN	I-NP	O
dorsum	dorsum	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
supragingival	supragingival	JJ	I-NP	O
interdental	interdental	JJ	I-NP	O
spaces	space	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
cultured	culture	VBN	I-VP	O
both	both	CC	O	O
aerobically	aerobically	RB	B-ADVP	O
and	and	CC	I-ADVP	O
anaerobically	anaerobically	RB	I-ADVP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
colony	colony	NN	B-NP	B-protein
forming	form	VBG	B-VP	I-protein
units	unit	NNS	B-NP	I-protein
(	(	(	O	O
CFU	CFU	NN	B-NP	O
)	)	)	O	O
per	per	IN	B-PP	O
sample	sample	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
CFU	CFU	NNP	B-NP	O
of	of	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
and	and	CC	O	O
Lactobacillus	Lactobacillus	NN	B-NP	B-protein
species	specie	NNS	I-NP	I-protein
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
hygiene	hygiene	NN	I-NP	O
parameters	parameter	NNS	I-NP	O
were	be	VBD	B-VP	O
recorded	record	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
visits	visit	NNS	I-NP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
and	and	CC	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
8	8	CD	I-NP	O
months	month	NNS	I-NP	O
follow-up	follow-up	JJ	B-ADJP	O
,	,	,	O	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
caries	cary	NNS	B-NP	O
activity	activity	NN	I-NP	O
and	and	CC	O	O
periodontal	periodontal	JJ	B-NP	O
health	health	NN	I-NP	O
were	be	VBD	B-VP	O
registered	register	VBN	I-VP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
aerobic	aerobic	JJ	B-NP	O
and	and	CC	I-NP	O
anaerobic	anaerobic	JJ	I-NP	O
CFU	CFU	NN	I-NP	O
in	in	IN	B-PP	O
samples	sample	NNS	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
tongue	tongue	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
saliva	saliva	NN	I-NP	O
remained	remain	VBD	B-VP	O
nearly	nearly	RB	B-ADJP	O
constant	constant	JJ	I-ADJP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	O
observation	observation	NN	I-NP	O
period	period	NN	I-NP	O
(	(	(	O	O
variations	variation	NNS	B-NP	O
within	within	IN	B-PP	O
0.5	0.5	CD	B-NP	O
log	log	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
significant	significant	JJ	B-ADJP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	B-VP	O
or	or	CC	O	O
=0.05	=0.05	CD	B-NP	O
)	)	)	O	O
increases	increase	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
detected	detect	VBN	I-VP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
at	at	IN	B-PP	O
month	month	NN	B-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
significant	significant	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
CFU	CFU	NN	I-NP	O
in	in	IN	B-PP	O
samples	sample	NNS	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
teeth	teeth	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
that	that	IN	I-SBAR	O
also	also	RB	B-ADVP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
niche	niche	NN	I-NP	O
the	the	DT	B-NP	O
relative	relative	JJ	I-NP	O
proportion	proportion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
latter	latter	JJ	I-NP	O
increased	increase	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
lactobacilli	lactobacilli	JJ	B-NP	B-protein
species	specie	NNS	I-NP	I-protein
for	for	IN	B-PP	O
the	the	DT	B-NP	O
different	different	JJ	I-NP	O
niches	niche	NNS	I-NP	O
showed	show	VBD	B-VP	O
only	only	RB	B-NP	O
negligible	negligible	JJ	I-NP	O
changes	change	NNS	I-NP	O
(	(	(	O	O
within	within	IN	B-PP	O
0.5	0.5	CD	B-NP	O
log	log	NN	I-NP	O
values	value	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
samples	sample	NNS	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
teeth	teeth	NN	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
log	log	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
but	but	CC	O	O
statistically	statistically	RB	B-ADJP	O
significant	significant	JJ	I-ADJP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.01	0.01	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
reduction	reduction	NN	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
detected	detect	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
periodontal	periodontal	JJ	I-NP	O
conditions	condition	NNS	I-NP	O
improved	improve	VBN	B-VP	O
for	for	IN	B-PP	O
all	all	DT	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
caries	cary	NNS	I-NP	O
activity	activity	NN	I-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
arrested	arrest	VBN	I-VP	O
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
seem	seem	VBP	B-VP	O
to	to	TO	I-VP	O
indicate	indicate	VB	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
increased	increase	VBN	I-NP	O
caries	cary	NNS	I-NP	O
susceptibility	susceptibility	NN	I-NP	O
after	after	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
might	might	MD	B-VP	O
partially	partially	RB	I-VP	O
be	be	VB	I-VP	O
explained	explain	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
ecological	ecological	JJ	B-NP	O
changes	change	NNS	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
consequence	consequence	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
observation	observation	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
to	to	TO	B-VP	O
advocate	advocate	VB	I-VP	O
a	a	DT	B-NP	O
more	more	RBR	I-NP	O
strict	strict	JJ	I-NP	O
caries	cary	NNS	I-NP	O
preventive	preventive	JJ	B-NP	O
program	program	NN	I-NP	O
during	during	IN	B-PP	O
initial	initial	JJ	B-NP	O
periodontal	periodontal	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
many	many	JJ	I-NP	O
viruses	virus	NNS	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
Pagetic	Pagetic	JJ	B-NP	B-cell_type
osteoclasts	osteoclast	NNS	I-NP	I-cell_type
could	could	MD	B-VP	O
be	be	VB	I-VP	O
opportunistic	opportunistic	JJ	B-ADJP	O
rather	rather	RB	B-PP	O
than	than	IN	I-PP	O
causative	causative	JJ	B-ADJP	O
.	.	.	O	O

Some	Some	DT	B-NP	O
mouth	mouth	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
can	can	MD	B-VP	O
lyse	lyse	VB	I-VP	O
bone	bone	NN	B-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
(	(	(	O	O
Actinobacillus	Actinobacillus	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
)	)	)	O	O
can	can	MD	B-VP	O
grow	grow	VB	I-VP	O
and	and	CC	O	O
even	even	RB	B-ADJP	O
multiply	multiply	JJ	I-ADJP	O
inside	inside	IN	B-PP	O
human	human	JJ	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
in	in	IN	B-PP	O
culture	culture	NN	B-NP	O
,	,	,	O	O
producing	produce	VBG	B-VP	O
osteolytic	osteolytic	JJ	B-NP	O
materials	material	NNS	I-NP	O
--	--	:	O	O
one	one	CD	B-NP	O
62	62	CD	I-NP	B-protein
kDa	kDa	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
having	have	VBG	B-VP	O
a	a	DT	B-NP	O
potency	potency	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
picomolar	picomolar	JJ	I-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
small	small	JJ	I-NP	O
focus	focus	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
,	,	,	O	O
or	or	CC	O	O
of	of	IN	B-PP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
periodontitis-causing	periodontitis-causing	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
bone	bone	NN	I-NP	O
might	might	MD	B-VP	O
gradually	gradually	RB	I-VP	O
spread	spread	VB	I-VP	O
its	its	PRP$	B-NP	O
influence	influence	NN	I-NP	O
to	to	TO	B-VP	O
activate	activate	VB	I-VP	O
osteoclasts	osteoclast	NNS	B-NP	B-cell_type
--	--	:	O	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
stage	stage	NN	I-NP	O
in	in	IN	B-PP	O
Paget	Paget	NNP	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
focus	focus	NN	I-NP	O
in	in	IN	B-PP	O
each	each	DT	B-NP	O
bone	bone	NN	I-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
small	small	JJ	B-ADJP	O
and	and	CC	O	O
easily	easily	RB	B-VP	O
overlooked	overlook	VBN	I-VP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
other	other	JJ	B-NP	O
intracellular	intracellular	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
reduced	reduce	VBN	I-NP	O
susceptibility	susceptibility	NN	I-NP	O
to	to	TO	B-PP	O
phagocytosis	phagocytosis	NN	B-NP	O
found	find	VBN	B-VP	O
among	among	IN	B-PP	O
some	some	DT	B-NP	O
periodontopathogenic	periodontopathogenic	JJ	I-NP	O
anaerobes	anaerobe	NNS	I-NP	O
may	may	MD	B-VP	O
account	account	VB	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
differences	difference	NNS	I-NP	O
between	between	IN	B-PP	O
invasive	invasive	JJ	B-NP	O
and	and	CC	I-NP	O
non-invasive	non-invasive	JJ	I-NP	O
strains	strain	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
applied	apply	VBD	B-VP	O
flow	flow	NN	B-NP	O
cytometry	cytometry	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
powerful	powerful	JJ	I-NP	O
tool	tool	NN	I-NP	O
to	to	TO	B-VP	O
analyze	analyze	VB	I-VP	O
and	and	CC	I-VP	O
quantify	quantify	VB	I-VP	O
phagocytosis	phagocytosis	NN	B-NP	O
using	use	VBG	B-VP	O
standardized	standardized	JJ	B-NP	O
cultures	culture	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
anaerobes	anaerobe	NNS	I-NP	O
(	(	(	O	O
Porphyromonas	Porphyromonas	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
Prevotella	Prevotella	NNP	B-NP	O
intermedia	intermedia	NNS	I-NP	O
,	,	,	O	O
P.	P.	NNP	B-NP	O
nigrescens	nigrescens	NNP	I-NP	O
,	,	,	O	O
Capnocytophaga	Capnocytophaga	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
C.	C.	NNP	B-NP	O
ochracea	ochracea	NNP	I-NP	O
,	,	,	O	O
C.	C.	NNP	B-NP	O
sputigena	sputigena	NNP	I-NP	O
,	,	,	O	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
and	and	CC	O	O
Peptostreptococcus	Peptostreptococcus	NNP	B-NP	O
micros	micro	NNS	I-NP	O
)	)	)	O	O
and	and	CC	O	O
heparinized	heparinize	VBN	B-VP	O
whole	whole	JJ	B-NP	O
blood	blood	NN	I-NP	O
.	.	.	O	O

Bacteria	Bacteria	NNS	B-NP	O
were	be	VBD	B-VP	O
labeled	label	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
fluorescein-methylester	fluorescein-methylester	NN	I-NP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
esterase	esterase	NN	I-NP	B-protein
activity	activity	NN	I-NP	O
,	,	,	O	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
green	green	JJ	B-NP	O
fluorescence	fluorescence	NN	I-NP	O
.	.	.	O	O

Ingested	Ingest	VBN	B-NP	O
bacteria	bacteria	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
detected	detect	VBN	I-VP	O
easily	easily	RB	B-ADVP	O
and	and	CC	O	O
quantified	quantify	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
shift	shift	NN	I-NP	O
towards	towards	IN	B-PP	O
green	green	JJ	B-NP	O
fluorescence	fluorescence	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
PMNL	PMNL	NN	I-NP	B-cell_type
population	population	NN	I-NP	I-cell_type
involved	involve	VBN	B-VP	O
and	and	CC	O	O
a	a	DT	B-NP	O
concomitant	concomitant	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	B-cell_type
population	population	NN	I-NP	I-cell_type
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
oxidative	oxidative	JJ	I-NP	O
burst	burst	NN	I-NP	O
of	of	IN	B-PP	O
PMNLs	PMNL	NNS	B-NP	B-cell_type
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
parallel	parallel	JJ	B-NP	O
assays	assay	NNS	I-NP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
dye	dye	NN	I-NP	O
DHR123	DHR123	NN	I-NP	O
which	which	WDT	B-NP	O
becomes	become	VBZ	B-VP	O
fluorescent	fluorescent	JJ	B-ADJP	O
upon	upon	IN	B-PP	O
oxidation	oxidation	NN	B-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
oxidative	oxidative	JJ	I-NP	O
burst	burst	NN	I-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
a	a	DT	B-NP	O
great	great	JJ	I-NP	O
diversity	diversity	NN	I-NP	O
in	in	IN	B-PP	O
phagocytosis	phagocytosis	NN	B-NP	O
susceptibility	susceptibility	NN	I-NP	O
determined	determine	VBN	B-VP	O
by	by	IN	B-PP	O
estimating	estimate	VBG	B-VP	O
the	the	DT	B-NP	O
portion	portion	NN	I-NP	O
of	of	IN	B-PP	O
phagocytosing	phagocytose	VBG	B-VP	O
PMNLs	PMNL	NNS	B-NP	B-cell_type
,	,	,	O	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
10.6	10.6	CD	B-NP	O
%	%	NN	I-NP	O
(	(	(	O	O
strain	strain	NN	B-NP	O
W83	W83	NN	I-NP	O
)	)	)	O	O
to	to	TO	B-PP	O
>	>	SYM	B-NP	O
99.4	99.4	CD	B-NP	O
%	%	NN	I-NP	O
(	(	(	O	O
e.g	e.g	NN	B-NP	O
.	.	.	O	O

ATCC	ATCC	NN	B-NP	O
33277T	33277T	NN	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
and	and	CC	B-PP	O
from	from	IN	B-PP	O
15.9	15.9	CD	B-NP	O
%	%	NN	I-NP	O
(	(	(	O	O
strain	strain	NN	B-NP	O
MH5	MH5	NN	I-NP	O
)	)	)	O	O
to	to	TO	B-PP	O
>	>	SYM	B-NP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
(	(	(	O	O
ATCC	ATCC	NN	B-NP	O
33563T	33563T	NN	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
P.	P.	NNP	B-NP	O
nigrescens	nigrescens	NNP	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
almost	almost	RB	B-NP	O
all	all	DT	I-NP	O
P.	P.	NNP	I-NP	O
intermedia	intermedia	NN	I-NP	O
strains	strain	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
representatives	representative	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
anaerobic	anaerobic	JJ	I-NP	O
,	,	,	I-NP	O
putative	putative	JJ	I-NP	O
periodontopathic	periodontopathic	JJ	I-NP	O
species	specie	NNS	I-NP	O
tested	test	VBN	B-VP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
or	or	CC	I-NP	O
only	only	RB	I-NP	O
moderate	moderate	JJ	I-NP	O
resistance	resistance	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
phagocytosis	phagocytosis	NN	I-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

Comparison	Comparison	NN	B-NP	O
of	of	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
data	datum	NNS	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
extent	extent	NN	I-NP	O
of	of	IN	B-PP	O
phagocytosis	phagocytosis	NN	B-NP	O
resistance	resistance	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
corresponding	correspond	VBG	I-NP	O
P.	P.	NNP	I-NP	O
gingivalis	gingivalis	NNP	I-NP	O
strains	strain	NNS	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
virulence	virulence	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
may	may	MD	B-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
outcome	outcome	NN	I-NP	O
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
studies	study	NNS	I-NP	O
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
benefits	benefit	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
one	one	CD	I-NP	O
stage	stage	NN	I-NP	O
full-mouth	full-mouth	JJ	I-NP	O
disinfection	disinfection	NN	I-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
worldwide	worldwide	JJ	I-NP	O
standard	standard	JJ	I-NP	O
treatmen	treatmen	NN	I-NP	O
strategy	strategy	NN	I-NP	O
of	of	IN	B-PP	O
consecutive	consecutive	JJ	B-NP	O
root	root	NN	I-NP	O
planings	planing	NNS	I-NP	O
per	per	IN	B-PP	O
quadrant	quadrant	NN	B-NP	O
without	without	IN	B-PP	O
proper	proper	JJ	B-NP	O
disinfection	disinfection	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
remaining	remain	VBG	I-NP	O
intraoral	intraoral	JJ	I-NP	O
niches	niche	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
purpose	purpose	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
microbiological	microbiological	JJ	I-NP	O
benefits	benefit	NNS	I-NP	O
of	of	IN	B-PP	O
such	such	PDT	B-NP	O
a	a	DT	I-NP	O
one	one	CD	I-NP	O
stage	stage	NN	I-NP	O
full-mouth	full-mouth	JJ	I-NP	O
disinfectio	disinfectio	NN	I-NP	O
with	with	IN	B-PP	O
special	special	JJ	B-NP	O
attention	attention	NN	I-NP	O
to	to	TO	B-PP	O
all	all	DT	B-NP	O
intraoral	intraoral	JJ	I-NP	O
niches	niche	NNS	I-NP	O
for	for	IN	B-PP	O
periodontopathogens	periodontopathogen	NNS	B-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
perception	perception	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
new	new	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
strategy	strategy	NN	I-NP	O
.	.	.	O	O

Sixteen	Sixteen	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
early-onset	early-onset	JJ	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
and	and	CC	O	O
24	24	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
adult	adult	JJ	I-NP	O
periodontitis	periodontitis	NN	I-NP	O
were	be	VBD	B-VP	O
randomly	randomly	RB	I-VP	O
assigned	assign	VBN	I-VP	O
to	to	TO	B-PP	O
test	test	NN	B-NP	O
and	and	CC	I-NP	O
control	control	NN	I-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
was	be	VBD	B-VP	O
scaled	scale	VBN	I-VP	O
and	and	CC	O	O
root	root	NN	B-NP	O
planed	plan	VBD	B-VP	O
,	,	,	O	O
per	per	IN	B-PP	O
quadrant	quadrant	NN	B-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
2-week	2-week	JJ	B-NP	O
intervals	interval	NNS	I-NP	O
and	and	CC	O	O
given	give	VBN	B-VP	O
oral	oral	JJ	B-NP	O
hygiene	hygiene	NN	I-NP	O
instructions	instruction	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
test	test	NN	I-NP	O
group	group	NN	I-NP	O
received	receive	VBD	B-VP	O
the	the	DT	B-NP	O
one	one	CD	I-NP	O
stage	stage	NN	I-NP	O
full-mouth	full-mouth	JJ	I-NP	O
disinfection	disinfection	NN	I-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
and	and	CC	O	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	I-NP	O
2	2	CD	I-NP	O
,	,	,	I-NP	O
4	4	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
8	8	CD	B-NP	O
months	month	NNS	I-NP	O
,	,	,	O	O
microbiological	microbiological	JJ	B-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
from	from	IN	B-PP	O
all	all	DT	B-NP	O
niches	niche	NNS	I-NP	O
(	(	(	O	O
tongue	tongue	NN	B-NP	O
,	,	,	O	O
mucosa	mucosa	NN	B-NP	O
,	,	,	O	O
saliva	saliva	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
pooled	pool	VBD	B-VP	O
samples	sample	NNS	B-NP	O
from	from	IN	B-PP	O
single-	single-	JJ	B-NP	O
and	and	CC	I-NP	O
multi-rooted	multi-rooted	JJ	I-NP	O
teeth	tooth	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
cultured	culture	VBN	I-VP	O
on	on	IN	B-PP	O
selective	selective	JJ	B-NP	O
and	and	CC	I-NP	O
non-selective	non-selective	JJ	I-NP	O
media	medium	NNS	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
perception	perception	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
questionnaire	questionnaire	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
comparison	comparison	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
standard	standard	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
one	one	CD	I-NP	O
stage	stage	NN	I-NP	O
full-mouth	full-mouth	JJ	I-NP	O
disinfection	disinfection	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
significant	significant	JJ	B-NP	O
additional	additional	JJ	I-NP	O
microbial	microbial	JJ	I-NP	O
improvements	improvement	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
test	test	NN	I-NP	O
group	group	NN	I-NP	O
showed	show	VBD	B-VP	O
larger	large	JJR	B-NP	O
reductions	reduction	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
proportions	proportion	NNS	I-NP	O
of	of	IN	B-PP	O
spirochetes	spirochete	NNS	B-NP	O
and	and	CC	O	O
motile	motile	NN	B-NP	O
organisms	organism	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
subgingival	subgingival	JJ	I-NP	O
flora	flora	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
more	more	RBR	B-NP	O
significant	significant	JJ	I-NP	O
reductions	reduction	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
density	density	NN	I-NP	O
of	of	IN	B-PP	O
key	key	JJ	B-NP	O
pathogens	pathogen	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
even	even	RB	B-NP	O
the	the	DT	I-NP	O
eradication	eradication	NN	I-NP	O
of	of	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
beneficial	beneficial	JJ	I-NP	O
effects	effect	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
niches	niche	NNS	I-NP	O
were	be	VBD	B-VP	O
primarily	primarily	RB	B-ADJP	O
restricted	restricted	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
colony-forming	colony-forming	JJ	B-NP	O
units/ml	units/ml	NNS	I-NP	O
of	of	IN	B-PP	O
black-pigmented	black-pigmented	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
mucosa	mucosa	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
saliva	saliva	NN	I-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
lesser	less	JJR	I-NP	O
extent	extent	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
tongue	tongue	NN	I-NP	O
.	.	.	O	O

Both	Both	DT	B-NP	O
treatments	treatment	NNS	I-NP	O
were	be	VBD	B-VP	O
well	well	RB	I-VP	O
tolerated	tolerate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
overall	overall	JJ	I-NP	O
severity	severity	NN	I-NP	O
rating	rating	NN	I-NP	O
for	for	IN	B-PP	O
both	both	DT	B-NP	O
therapies	therapy	NNS	I-NP	O
was	be	VBD	B-VP	O
comparable	comparable	JJ	B-ADJP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
4	4	CD	B-NP	O
quadrants	quadrant	NNS	I-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
within	within	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
test	test	NN	I-NP	O
group	group	NN	I-NP	O
versus	versus	IN	B-PP	O
only	only	RB	B-NP	O
1	1	CD	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
full-mouth	full-mouth	JJ	I-NP	O
disinfection	disinfection	NN	I-NP	O
approach	approach	NN	I-NP	O
resulted	result	VBD	B-VP	O
more	more	RBR	B-ADVP	O
frequently	frequently	RB	I-ADVP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
slight	slight	JJ	I-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
body	body	NN	B-NP	O
temperature	temperature	NN	I-NP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
after	after	IN	B-SBAR	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
support	support	VBP	B-VP	O
the	the	DT	B-NP	O
benefit	benefit	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
one	one	CD	I-NP	O
stage	stage	NN	I-NP	O
full-mouth	full-mouth	JJ	I-NP	O
disinfection	disinfection	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
either	either	CC	O	O
chronic	chronic	JJ	B-NP	O
adult	adult	JJ	I-NP	O
or	or	CC	I-NP	O
early-onset	early-onset	JJ	I-NP	O
periodontitis	periodontitis	NN	I-NP	O
.	.	.	O	O

Ninety-one	Ninety-one	CD	B-NP	O
isolates	isolate	NNS	I-NP	O
of	of	IN	B-PP	O
nutritionally	nutritionally	RB	B-NP	O
variant	variant	JJ	I-NP	O
streptococci	streptococci	NNS	I-NP	O
(	(	(	O	O
NVS	NVS	NN	B-NP	B-protein
)	)	)	O	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
previously	previously	RB	I-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
mouth	mouth	NN	I-NP	O
were	be	VBD	B-VP	O
regarded	regard	VBN	I-VP	O
as	as	IN	B-PP	O
consisting	consist	VBG	B-VP	O
of	of	IN	B-PP	O
7	7	CD	B-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
defectivus	defectivus	NN	I-NP	O
isolates	isolate	NNS	I-NP	O
,	,	,	O	O
78	78	CD	B-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
adjacens	adjacens	NNP	I-NP	O
isolates	isolate	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
6	6	CD	B-NP	O
Gemella	Gemella	NN	I-NP	O
morbillorum	morbillorum	NN	I-NP	O
isolates	isolate	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
recent	recent	JJ	B-NP	O
references	reference	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
taxonomic	taxonomic	JJ	I-NP	O
reclassification	reclassification	NN	I-NP	O
of	of	IN	B-PP	O
NVS	NVS	NN	B-NP	B-protein
,	,	,	O	O
from	from	IN	B-PP	O
S.	S.	NNP	B-NP	O
defectivus	defectivus	NN	I-NP	O
to	to	TO	B-PP	O
Abiotrophia	Abiotrophia	NNP	B-NP	O
defectiva	defectiva	NN	I-NP	O
and	and	CC	B-PP	O
from	from	IN	B-PP	O
S.	S.	NNP	B-NP	O
adjacens	adjacen	NNS	I-NP	O
to	to	TO	B-PP	O
Abiotrophia	Abiotrophia	NNP	B-NP	O
adiacens	adiacen	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
newly	newly	RB	I-NP	O
introduced	introduce	VBN	I-NP	O
species	specie	NNS	I-NP	O
Abiotrophia	Abiotrophia	NNP	I-NP	O
elegans	elegan	NNS	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
third	third	JJ	I-NP	O
Abiotrophia	Abiotrophia	NNP	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
emphasize	emphasize	VBP	B-VP	O
the	the	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
genetic	genetic	JJ	B-NP	O
analyses	analysis	NNS	I-NP	O
for	for	IN	B-PP	O
identification	identification	NN	B-NP	O
of	of	IN	B-PP	O
NVS	NVS	NN	B-NP	B-protein
.	.	.	O	O

When	When	WRB	B-ADVP	O
PCR-restriction	PCR-restriction	NN	B-NP	B-DNA
fragment	fragment	NN	I-NP	I-DNA
length	length	NN	I-NP	I-DNA
polymorphism	polymorphism	NN	I-NP	I-DNA
(	(	(	O	O
RFLP	RFLP	NN	B-NP	B-DNA
)	)	)	O	O
and	and	CC	O	O
phylogenetic	phylogenetic	JJ	B-NP	O
distances	distance	NNS	I-NP	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
16S	16S	NN	B-NP	B-DNA
rRNA	rRNA	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
,	,	,	O	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
7	7	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
91	91	CD	I-NP	O
NVS	NVS	NN	I-NP	O
isolates	isolate	NNS	I-NP	O
were	be	VBD	B-VP	O
closely	closely	RB	B-ADJP	O
related	related	JJ	I-ADJP	O
to	to	TO	B-PP	O
A.	A.	NN	B-NP	O
elegans	elegan	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
seven	seven	CD	I-NP	O
isolates	isolate	NNS	I-NP	O
consisted	consist	VBD	B-VP	O
of	of	IN	B-PP	O
four	four	CD	B-NP	O
isolates	isolate	NNS	I-NP	O
previously	previously	RB	B-VP	O
identified	identify	VBN	I-VP	O
as	as	IN	B-PP	O
G.	G.	NNP	B-NP	O
morbillorum	morbillorum	NN	I-NP	O
and	and	CC	O	O
three	three	CD	B-NP	O
isolates	isolate	NNS	I-NP	O
previously	previously	RB	B-VP	O
identified	identify	VBN	I-VP	O
as	as	IN	B-PP	O
S.	S.	NNP	B-NP	O
adjacens	adjacens	NNP	I-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
isolates	isolate	NNS	I-NP	O
previously	previously	RB	B-VP	O
identified	identify	VBN	I-VP	O
as	as	IN	B-PP	O
G.	G.	NNP	B-NP	O
morbillorum	morbillorum	NN	I-NP	O
were	be	VBD	B-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
A.	A.	NN	B-NP	O
adiacens	adiacen	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
biochemical	biochemical	JJ	B-NP	O
tests	test	NNS	I-NP	O
,	,	,	O	O
A.	A.	NN	B-NP	O
elegans	elegan	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
seven	seven	CD	I-NP	O
isolates	isolate	NNS	I-NP	O
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
it	it	PRP	B-NP	O
possessed	possess	VBD	B-VP	O
arginine	arginine	NN	B-NP	B-protein
dihydrolase	dihydrolase	NN	I-NP	I-protein
(	(	(	O	O
ADH	ADH	NN	B-NP	O
)	)	)	O	O
activity	activity	NN	B-NP	O
but	but	CC	O	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
Abiotrophia	Abiotrophia	NNP	I-NP	O
species	specie	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	O	O
.	.	.	O	O

As	As	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
,	,	,	O	O
A.	A.	NN	B-NP	O
elegans	elegan	NNS	I-NP	O
strains	strain	NNS	I-NP	O
comprised	comprise	VBD	B-VP	O
8	8	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
91	91	CD	I-NP	O
NVS	NVS	NN	I-NP	O
isolates	isolate	NNS	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
findings	finding	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
A.	A.	NN	B-NP	O
elegans	elegan	NNS	I-NP	O
,	,	,	O	O
A.	A.	NN	B-NP	O
adiacens	adiacen	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
A.	A.	NN	B-NP	O
defectiva	defectiva	NN	I-NP	O
exist	exist	VBP	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
mouth	mouth	NN	I-NP	O
in	in	IN	B-PP	O
proportions	proportion	NNS	B-NP	O
of	of	IN	B-PP	O
about	about	IN	B-NP	O
1:11:1	1:11:1	CD	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
A.	A.	NN	B-NP	O
elegans	elegan	NNS	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
genetically	genetically	RB	I-VP	O
distinguished	distinguish	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
two	two	CD	I-NP	O
Abiotrophia	Abiotrophia	NNP	I-NP	O
species	specie	NNS	I-NP	O
by	by	IN	B-PP	O
PCR-RFLP	PCR-RFLP	NN	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
16S	16S	NN	B-NP	B-DNA
rRNA	rRNA	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
and	and	CC	O	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
biochemically	biochemically	RB	I-VP	O
distinguished	distinguish	VBN	I-VP	O
by	by	IN	B-PP	O
ADH	ADH	NN	B-NP	B-protein
activity	activity	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
generally	generally	RB	I-VP	O
assumed	assume	VBN	I-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
decreased	decrease	VBN	I-NP	O
salivary	salivary	JJ	I-NP	O
secretion	secretion	NN	I-NP	O
rate	rate	NN	I-NP	O
will	will	MD	B-VP	O
promote	promote	VB	I-VP	O
plaque	plaque	NN	B-NP	O
accumulation	accumulation	NN	I-NP	O
and	and	CC	O	O
increase	increase	VB	B-VP	O
the	the	DT	B-NP	O
risk	risk	NN	I-NP	O
for	for	IN	B-PP	O
caries	cary	NNS	B-NP	O
,	,	,	O	O
gingival	gingival	JJ	B-NP	O
inflammation	inflammation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
mucosal	mucosal	JJ	B-NP	O
infections	infection	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
hyposalivation	hyposalivation	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microflora	microflora	NN	I-NP	O
was	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
following	follow	VBG	I-NP	O
micro-organisms	micro-organism	NNS	I-NP	O
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
in	in	IN	B-PP	O
rinsing	rinse	VBG	B-VP	O
samples	sample	NNS	B-NP	O
from	from	IN	B-PP	O
14	14	CD	B-NP	O
subjects	subject	NNS	I-NP	O
with	with	IN	B-PP	O
hyposalivation	hyposalivation	NN	B-NP	O
:	:	:	O	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
anaerobically	anaerobically	RB	B-NP	O
growing	grow	VBG	I-NP	O
micro-organisms	micro-organism	NNS	I-NP	O
,	,	,	O	O
alpha-hemolytic	alpha-hemolytic	JJ	B-NP	B-protein
streptococci	streptococci	NNS	I-NP	I-protein
,	,	,	O	O
mutans	mutan	NNS	B-NP	O
streptococci	streptococci	NNS	I-NP	O
,	,	,	O	O
lactobacilli	lactobacilli	NN	B-NP	O
,	,	,	O	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
,	,	,	O	O
Prevotella	Prevotella	NNP	B-NP	O
intermedia/Prevotella	intermedia/Prevotella	NNP	I-NP	O
nigrescens	nigrescens	NNP	I-NP	O
,	,	,	O	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
aureus	aureus	NNP	I-NP	O
,	,	,	O	O
Candida	Candida	NNP	B-NP	O
albicans	albicans	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
enterics	enteric	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
study	study	NN	I-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
age	age	NN	B-NP	O
53	53	CD	I-NP	O
+/-	+/-	CC	I-NP	O
7	7	CD	I-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
radiation	radiation	NN	B-NP	O
therapy	therapy	NN	I-NP	O
and	and	CC	O	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
inflammation	inflammation	NN	B-NP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
salivary	salivary	JJ	I-NP	O
glands	gland	NNS	I-NP	O
on	on	IN	B-PP	O
biopsy	biopsy	NN	B-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
were	be	VBD	B-VP	O
dentate	dentate	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
mean	mean	NN	I-NP	O
of	of	IN	B-PP	O
24	24	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
3	3	CD	I-NP	O
teeth	tooth	NNS	I-NP	O
.	.	.	O	O

Their	Their	PRP$	B-NP	O
salivary	salivary	JJ	I-NP	O
secretion	secretion	NN	I-NP	O
rates	rate	NNS	I-NP	O
were	be	VBD	B-VP	O
0.03	0.03	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
0.02	0.02	CD	I-NP	O
mL/min	mL/min	NN	I-NP	O
(	(	(	O	O
unstimulated	unstimulated	JJ	B-ADJP	O
)	)	)	O	O
and	and	CC	O	O
0.84	0.84	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
0.65	0.65	CD	I-NP	O
mL/min	mL/min	NN	I-NP	O
(	(	(	O	O
stimulated	stimulate	VBN	B-VP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
was	be	VBD	B-VP	O
matched	match	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hyposalivation	hyposalivation	NN	I-NP	O
group	group	NN	I-NP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
age	age	NN	B-NP	O
,	,	,	O	O
sex	sex	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
number	number	NN	B-NP	O
of	of	IN	B-PP	O
teeth	tooth	NNS	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
significantly	significantly	RB	I-NP	O
increased	increase	VBN	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
lactobacilli	lactobacilli	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
tendency	tendency	NN	I-NP	O
,	,	,	O	O
not	not	RB	O	O
statistically	statistically	RB	B-ADJP	O
significant	significant	JJ	I-ADJP	O
and	and	CC	O	O
with	with	IN	B-PP	O
large	large	JJ	B-NP	O
variations	variation	NNS	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
toward	toward	IN	B-PP	O
a	a	DT	B-NP	O
higher	high	JJR	I-NP	O
proportion	proportion	NN	I-NP	O
of	of	IN	B-PP	O
mutans	mutan	NNS	B-NP	O
streptococci	streptococci	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
lower	low	JJR	I-NP	O
proportion	proportion	NN	I-NP	O
of	of	IN	B-PP	O
alpha-hemolytic	alpha-hemolytic	JJ	B-NP	B-protein
streptococci	streptococci	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hyposalivation	hyposalivation	NN	I-NP	O
group	group	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
micro-organisms	micro-organism	NNS	B-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
gingival	gingival	JJ	B-NP	O
inflammation	inflammation	NN	I-NP	O
and	and	CC	O	O
mucosal	mucosal	JJ	B-NP	O
infections	infection	NNS	I-NP	O
was	be	VBD	B-VP	O
comparable	comparable	JJ	B-ADJP	O
with	with	IN	B-PP	O
that	that	DT	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
healthy	healthy	JJ	I-NP	O
controls	control	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
salivary	salivary	JJ	I-NP	O
secretion	secretion	NN	I-NP	O
rate	rate	NN	I-NP	O
mainly	mainly	RB	B-ADVP	O
promotes	promote	VBZ	B-VP	O
a	a	DT	B-NP	O
flora	flora	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
caries	cary	NNS	B-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
association	association	NN	I-NP	O
between	between	IN	B-PP	O
oral	oral	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
several	several	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
conditions	condition	NNS	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O

For	For	IN	B-PP	O
example	example	NN	B-NP	O
,	,	,	O	O
recent	recent	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
has	have	VBZ	B-VP	O
suggested	suggest	VBN	I-VP	O
a	a	DT	B-NP	O
central	central	JJ	I-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
process	process	NN	I-NP	O
of	of	IN	B-PP	O
respiratory	respiratory	JJ	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
periodontopathic	periodontopathic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
aspirated	aspirate	VBN	I-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
lung	lung	NN	I-NP	O
to	to	TO	B-VP	O
cause	cause	VB	I-VP	O
aspiration	aspiration	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
teeth	tooth	NNS	I-NP	O
may	may	MD	B-VP	O
also	also	RB	I-VP	O
serve	serve	VB	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
reservoir	reservoir	NN	I-NP	O
for	for	IN	B-PP	O
respiratory	respiratory	JJ	B-NP	O
pathogen	pathogen	NN	I-NP	O
colonization	colonization	NN	I-NP	O
and	and	CC	O	O
subsequent	subsequent	JJ	B-NP	O
nosocomial	nosocomial	JJ	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

Typical	Typical	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
colonize	colonize	VB	I-VP	O
the	the	DT	B-NP	O
dental	dental	JJ	I-NP	O
plaque	plaque	NN	I-NP	O
of	of	IN	B-PP	O
hospitalized	hospitalize	VBN	B-NP	O
intensive	intensive	JJ	I-NP	O
care	care	NN	I-NP	O
and	and	CC	I-NP	O
nursing	nursing	NN	I-NP	O
home	home	NN	I-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

Once	Once	RB	O	O
established	establish	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
,	,	,	O	O
these	these	DT	B-NP	O
pathogens	pathogen	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
aspirated	aspirate	VBN	I-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
lung	lung	NN	I-NP	O
to	to	TO	B-VP	O
cause	cause	VB	I-VP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

Other	Other	JJ	B-NP	O
epidemiologic	epidemiologic	JJ	I-NP	O
studies	study	NNS	I-NP	O
have	have	VBP	B-VP	O
noted	note	VBN	I-VP	O
a	a	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
poor	poor	JJ	B-NP	O
oral	oral	JJ	I-NP	O
hygiene	hygiene	NN	I-NP	O
or	or	CC	O	O
periodontal	periodontal	JJ	B-NP	O
bone	bone	NN	I-NP	O
loss	loss	NN	I-NP	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Several	Several	JJ	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
are	be	VBP	B-VP	O
proposed	propose	VBN	I-VP	O
to	to	TO	I-VP	O
explain	explain	VB	I-VP	O
the	the	DT	B-NP	O
potential	potential	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
respiratory	respiratory	JJ	B-NP	O
infection	infection	NN	I-NP	O
:	:	:	O	O
1.	1.	LS	B-NP	O
aspiration	aspiration	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
pathogens	pathogen	NNS	I-NP	O
(	(	(	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
,	,	,	O	O
Actinobacillus	Actinobacillus	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
,	,	,	O	O
etc	etc	FW	B-NP	O
.	.	.	O	O
)	)	)	O	O

into	into	IN	B-PP	O
the	the	DT	B-NP	O
lung	lung	NN	I-NP	O
to	to	TO	B-VP	O
cause	cause	VB	I-VP	O
infection	infection	NN	B-NP	O
;	;	:	O	O
2.	2.	LS	B-LST	O
periodontal	periodontal	JJ	B-NP	B-protein
disease-associated	disease-associated	JJ	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
may	may	MD	B-VP	O
modify	modify	VB	I-VP	O
mucosal	mucosal	JJ	B-NP	O
surfaces	surface	NNS	I-NP	O
to	to	TO	B-VP	O
promote	promote	VB	I-VP	O
adhesion	adhesion	NN	B-NP	O
and	and	CC	I-NP	O
colonization	colonization	NN	I-NP	O
by	by	IN	B-PP	O
respiratory	respiratory	JJ	B-NP	O
pathogens	pathogen	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
then	then	RB	I-VP	O
aspirated	aspirate	VBN	I-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
lung	lung	NN	I-NP	O
;	;	:	O	O
3.	3.	LS	B-LST	O
periodontal	periodontal	JJ	B-NP	B-protein
disease-associated	disease-associated	JJ	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
may	may	MD	B-VP	O
destroy	destroy	VB	I-VP	O
salivary	salivary	JJ	B-NP	O
pellicles	pellicle	NNS	I-NP	O
on	on	IN	B-PP	O
pathogenic	pathogenic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
to	to	TO	B-VP	O
hinder	hinder	VB	I-VP	O
their	their	PRP$	B-NP	O
clearance	clearance	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
mucosal	mucosal	JJ	I-NP	O
surface	surface	NN	I-NP	O
;	;	:	O	O
and	and	CC	O	O
4.	4.	LS	B-NP	O
cytokines	cytokine	NNS	I-NP	B-protein
originating	originate	VBG	B-VP	O
from	from	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
tissues	tissue	NNS	I-NP	O
may	may	MD	B-VP	O
alter	alter	VB	I-VP	O
respiratory	respiratory	JJ	B-NP	O
epithelium	epithelium	NN	I-NP	O
to	to	TO	B-VP	O
promote	promote	VB	I-VP	O
infection	infection	NN	B-NP	O
by	by	IN	B-PP	O
respiratory	respiratory	JJ	B-NP	O
pathogens	pathogen	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
majority	majority	NN	I-NP	O
of	of	IN	B-PP	O
cases	case	NNS	B-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
malodour	malodour	NN	I-NP	O
are	be	VBP	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
bacterial	bacterial	JJ	B-NP	O
activities	activity	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
many	many	JJ	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
responsible	responsible	JJ	B-ADJP	O
have	have	VBP	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
.	.	.	O	O

Volatile	Volatile	JJ	B-NP	O
sulphide	sulphide	NN	I-NP	O
compounds	compound	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
proposed	propose	VBN	I-VP	O
as	as	IN	B-PP	O
constituents	constituent	NNS	B-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
malodour	malodour	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
relation	relation	NN	I-NP	O
between	between	IN	B-PP	O
intensity	intensity	NN	B-NP	O
of	of	IN	B-PP	O
odour	odour	NN	B-NP	O
and	and	CC	I-NP	O
numbers	number	NNS	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
sulphide-producing	sulphide-producing	JJ	B-ADJP	O
from	from	IN	B-PP	O
sulphate	sulphate	NN	B-NP	O
was	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
.	.	.	O	O

Numbers	Number	NNS	B-NP	O
of	of	IN	B-PP	O
such	such	JJ	B-NP	O
dissimilatory	dissimilatory	JJ	I-NP	O
sulphate-reducing	sulphate-reducing	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
(	(	(	O	O
SRB	SRB	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
sulphide	sulphide	NN	B-NP	O
reduction	reduction	NN	I-NP	O
rates	rate	NNS	I-NP	O
were	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
in	in	IN	B-PP	O
samples	sample	NNS	B-NP	O
from	from	IN	B-PP	O
different	different	JJ	B-NP	O
oral	oral	JJ	I-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
relation	relation	NN	B-NP	O
to	to	TO	B-PP	O
measures	measure	NNS	B-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
malodour	malodour	NN	I-NP	O
.	.	.	O	O

Results	Result	NNS	B-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
sulphate-reducing	sulphate-reducing	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
numbers	number	NNS	I-NP	O
and	and	CC	I-NP	O
activities	activity	NNS	I-NP	O
were	be	VBD	B-VP	O
negatively	negatively	RB	I-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
malodour	malodour	NN	B-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
determined	determine	VBN	B-VP	O
by	by	IN	B-PP	O
organoleptic	organoleptic	JJ	B-NP	O
assessment	assessment	NN	I-NP	O
and	and	CC	I-NP	O
measurement	measurement	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
sulphide-monitoring	sulphide-monitoring	JJ	I-NP	O
instrument	instrument	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
Halimeter	Halimeter	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
data	datum	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
sulphide	sulphide	NN	B-NP	O
produced	produce	VBN	B-VP	O
by	by	IN	B-PP	O
oral	oral	JJ	B-NP	O
SRB	SRB	NN	I-NP	B-protein
may	may	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
contributor	contributor	NN	I-NP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
malodour	malodour	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
rather	rather	RB	I-NP	O
poor	poor	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
between	between	IN	B-PP	O
Halimetric	Halimetric	JJ	B-NP	O
and	and	CC	I-NP	O
organoleptic	organoleptic	JJ	I-NP	O
values	value	NNS	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
methods	method	NNS	I-NP	O
may	may	MD	B-VP	O
measure	measure	VB	I-VP	O
different	different	JJ	B-NP	O
aspects	aspect	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
malodour	malodour	NN	I-NP	O
intensity	intensity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	I-VP	O
monitor	monitor	VB	I-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
sulfate-reducing	sulfate-reducing	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
(	(	(	O	O
SRB	SRB	NN	B-NP	B-protein
)	)	)	O	O
at	at	IN	B-PP	O
different	different	JJ	B-NP	O
sites	site	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mouths	mouth	NNS	I-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
healthy	healthy	JJ	B-NP	O
individuals	individual	NNS	I-NP	O
and	and	CC	O	O
periodontitis	periodontitis	NN	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
20	20	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
and	and	CC	O	O
21	21	CD	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
samples	sample	NNS	B-NP	O
were	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
palate	palate	NN	I-NP	O
,	,	,	O	O
vestibulum	vestibulum	NN	B-NP	O
,	,	,	O	O
dorsum	dorsum	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tongue	tongue	NN	I-NP	O
,	,	,	O	O
supragingival	supragingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
periodontal	periodontal	JJ	B-NP	O
pockets	pocket	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
demonstrate	demonstrate	VB	I-VP	O
growth	growth	NN	B-NP	O
of	of	IN	B-PP	O
SRB	SRB	NN	B-NP	B-protein
,	,	,	O	O
samples	sample	NNS	B-NP	O
were	be	VBD	B-VP	O
incubated	incubate	VBN	I-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
anoxic	anoxic	JJ	I-NP	O
chamber	chamber	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
reduced	reduce	VBN	I-NP	O
growth-medium	growth-medium	NN	I-NP	O
for	for	IN	B-PP	O
SRB	SRB	NN	B-NP	B-protein
,	,	,	O	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
iron-indicator	iron-indicator	NN	I-NP	O
for	for	IN	B-PP	O
sulfide	sulfide	NN	B-NP	O
production	production	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
SRB	SRB	NN	I-NP	B-protein
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
mucosa	mucosa	NN	I-NP	O
in	in	IN	B-PP	O
10	10	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
both	both	DT	B-NP	O
healthy	healthy	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
and	and	CC	O	O
periodontitis	periodontitis	NN	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
tongue	tongue	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
supragingival	supragingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
detection	detection	NN	B-NP	O
was	be	VBD	B-VP	O
slightly	slightly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
(	(	(	O	O
22	22	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
subjects	subject	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
86	86	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
patients	patient	NNS	I-NP	O
harbored	harbor	VBD	B-VP	O
SRB	SRB	NN	B-NP	B-protein
in	in	IN	B-PP	O
one	one	CD	B-NP	O
or	or	CC	I-NP	O
more	more	JJR	I-NP	O
pockets	pocket	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
1/3	1/3	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
SRB	SRB	NN	B-NP	B-protein
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
3	3	CD	I-NP	O
pockets	pocket	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
sampled	sample	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
data	datum	NNS	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
SRB	SRB	NN	B-NP	B-protein
belong	belong	VBP	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
oral	oral	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
preference	preference	NN	I-NP	O
for	for	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
pockets	pocket	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
examined	examine	VBD	B-VP	O
and	and	CC	O	O
compared	compare	VBN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
salivary	salivary	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
which	which	WDT	B-NP	O
produced	produce	VBD	B-VP	O
volatile	volatile	JJ	B-NP	O
sulfur	sulfur	NN	I-NP	O
compounds	compound	NNS	I-NP	O
(	(	(	O	O
VSC	VSC	NNS	B-NP	B-cell_type
)	)	)	O	O
in	in	IN	B-PP	O
young	young	JJ	B-NP	O
children	child	NNS	I-NP	O
with	with	IN	B-PP	O
and	and	CC	I-PP	O
without	without	IN	I-PP	O
oral	oral	JJ	B-NP	O
malodor	malodor	NN	I-NP	O
.	.	.	O	O

Clinic	Clinic	JJ	B-NP	O
populations	population	NNS	I-NP	O
of	of	IN	B-PP	O
children	child	NNS	B-NP	O
aged	age	VBN	B-ADJP	O
two	two	CD	B-NP	O
to	to	TO	I-NP	O
seven	seven	CD	I-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
whose	whose	WP$	B-NP	O
parents	parent	NNS	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
unsolicited	unsolicited	JJ	I-NP	O
major	major	JJ	I-NP	O
complaint	complaint	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
malodor	malodor	NN	I-NP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
child	child	NN	I-NP	O
(	(	(	O	O
OM+	OM+	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
or	or	CC	O	O
aged-matched	aged-matched	JJ	B-NP	O
controls	control	NNS	I-NP	O
in	in	IN	B-PP	O
whom	whom	WP	B-NP	O
oral	oral	JJ	B-NP	O
malodor	malodor	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
detected	detect	VBN	I-VP	O
by	by	IN	B-PP	O
parents	parent	NNS	B-NP	O
(	(	(	O	O
OM-	OM-	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
were	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
.	.	.	O	O

Saliva	Saliva	NNP	B-NP	O
specimens	specimen	NNS	I-NP	O
were	be	VBD	B-VP	O
cultured	culture	VBN	I-VP	O
anaerobically	anaerobically	RB	B-ADVP	O
on	on	IN	B-PP	O
media	medium	NNS	B-NP	O
that	that	WDT	B-NP	O
differentiated	differentiate	VBD	B-VP	O
VSC+	VSC+	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
were	be	VBD	B-VP	O
quantified	quantify	VBN	I-VP	O
and	and	CC	I-VP	O
identified	identify	VBN	I-VP	O
.	.	.	O	O

Levels	Level	NNS	B-NP	O
in	in	IN	B-PP	O
OM+	OM+	JJ	B-NP	O
and	and	CC	I-NP	O
OM-	OM-	JJ	I-NP	O
children	child	NNS	I-NP	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
and	and	CC	O	O
statistically	statistically	RB	B-VP	O
analyzed	analyze	VBN	I-VP	O
.	.	.	O	O

OM+	OM+	JJ	B-NP	O
children	child	NNS	I-NP	O
harbored	harbor	VBD	B-VP	O
significantly	significantly	RB	B-NP	O
higher	high	JJR	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
VSC+	VSC+	JJ	B-NP	O
isolates	isolate	NNS	I-NP	O
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
than	than	IN	B-PP	O
OM-	OM-	JJ	B-NP	O
children	child	NNS	I-NP	O
(	(	(	O	O
OM+	OM+	NN	B-NP	O
=	=	SYM	B-VP	O
44	44	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
total	total	JJ	B-NP	O
viable	viable	JJ	I-NP	O
counts	count	NNS	I-NP	O
,	,	,	O	O
TVC	TVC	NN	B-NP	O
;	;	:	O	O
OM-	OM-	NN	B-NP	O
=	=	SYM	B-VP	O
24	24	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
TVC	TVC	NN	B-NP	O
;	;	:	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
0.0083	0.0083	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Types	Type	NNS	B-NP	O
of	of	IN	B-PP	O
recovered	recover	VBN	B-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
differ	differ	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
Prevotella	Prevotella	NN	B-NP	O
oralis	oralis	NN	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
in	in	IN	B-PP	O
OM+	OM+	JJ	B-NP	O
children	child	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
0.0001	0.0001	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Veillonella	Veillonella	NN	B-NP	O
species	specie	NNS	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
P.	P.	NNP	B-NP	O
oralis	orali	NNPS	I-NP	O
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
predominant	predominant	JJ	I-NP	O
VSC+	VSC+	JJ	I-NP	O
isolates	isolate	NNS	I-NP	O
recovered	recover	VBN	B-VP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
populations	population	NNS	I-NP	O
.	.	.	O	O

VSC+	VSC+	JJ	B-NP	O
salivary	salivary	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
may	may	MD	B-VP	O
differ	differ	VB	I-VP	O
both	both	CC	O	O
in	in	IN	B-PP	O
type	type	NN	B-NP	O
and	and	CC	I-NP	O
quantity	quantity	NN	I-NP	O
in	in	IN	B-PP	O
young	young	JJ	B-NP	O
children	child	NNS	I-NP	O
with	with	IN	B-PP	O
and	and	CC	I-PP	O
without	without	IN	I-PP	O
parent-perceived	parent-perceived	JJ	B-NP	O
oral	oral	JJ	I-NP	O
malodor	malodor	NN	I-NP	O
.	.	.	O	O

Peptides	Peptide	NNS	B-NP	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
N-terminal	N-terminal	JJ	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
that	that	WDT	B-NP	O
comprises	comprise	VBZ	B-VP	O
an	an	DT	B-NP	O
amphipathic	amphipathic	JJ	I-NP	O
alpha-helix	alpha-helix	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
lactoferrin	lactoferrin	NN	I-NP	O
(	(	(	O	O
LFh	LFh	NN	B-NP	O
18-31	18-31	CD	I-NP	O
and	and	CC	O	O
LFh	LFh	NN	B-NP	O
20-38	20-38	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
bovine	bovine	JJ	B-NP	B-protein
lactoferrin	lactoferrin	NN	I-NP	I-protein
(	(	(	O	O
LFb	LFb	NN	B-NP	O
17-30	17-30	CD	I-NP	O
and	and	CC	O	O
LFb	LFb	NN	B-NP	O
19-37	19-37	CD	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
chemically	chemically	RB	I-VP	O
synthesised	synthesise	VBN	I-VP	O
.	.	.	O	O

Since	Since	IN	B-SBAR	O
many	many	JJ	B-NP	O
positively	positively	RB	I-NP	O
charged	charge	VBN	I-NP	O
amphipathic	amphipathic	JJ	I-NP	O
alpha-helices	alpha-helice	NNS	I-NP	B-protein
contain	contain	VBP	B-VP	O
antimicrobial	antimicrobial	JJ	B-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
peptides	peptide	NNS	I-NP	O
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
for	for	IN	B-PP	O
their	their	PRP$	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
activity	activity	NN	I-NP	O
against	against	IN	B-PP	O
various	various	JJ	B-NP	O
oral	oral	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
.	.	.	O	O

Both	Both	DT	B-NP	O
peptides	peptide	NNS	I-NP	O
from	from	IN	B-PP	O
bovine	bovine	JJ	B-NP	B-protein
lactoferrin	lactoferrin	NN	I-NP	I-protein
had	have	VBD	B-VP	O
more	more	RBR	B-NP	O
potent	potent	JJ	I-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
activities	activity	NNS	I-NP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-protein
equivalent	equivalent	NN	I-NP	I-protein
.	.	.	O	O

Peptide	Peptide	NNP	B-NP	O
LFb	LFb	NNP	I-NP	O
17-30	17-30	CD	I-NP	O
,	,	,	O	O
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
largest	large	JJS	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
positively	positively	RB	B-NP	O
charged	charge	VBN	I-NP	O
amino	amino	JJ	I-NP	O
acids	acid	NNS	I-NP	O
,	,	,	O	O
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
highest	high	JJS	I-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
activity	activity	NN	I-NP	O
to	to	TO	B-PP	O
both	both	CC	O	O
Gram-positive	Gram-positive	JJ	B-NP	O
and	and	CC	I-NP	O
Gram-negative	Gram-negative	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

Since	Since	IN	B-SBAR	O
native	native	JJ	B-NP	B-protein
lactoferrin	lactoferrin	NN	I-NP	I-protein
molecules	molecule	NNS	I-NP	I-protein
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
killing	killing	NN	I-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
release	release	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
peptides	peptide	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
native	native	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
should	should	MD	B-VP	O
be	be	VB	I-VP	O
investigated	investigate	VBN	I-VP	O
to	to	TO	B-VP	O
explore	explore	VB	I-VP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
care	care	NN	I-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

Thirty	Thirty	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
oral	oral	JJ	B-NP	O
mucosal	mucosal	JJ	I-NP	O
cancer	cancer	NN	I-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
relation	relation	NN	B-NP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
mucosal	mucosal	JJ	I-NP	O
damage	damage	NN	I-NP	O
and	and	CC	O	O
bacterial	bacterial	JJ	B-NP	O
translocation	translocation	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
regional	regional	JJ	I-NP	O
lymph	lymph	NN	I-NP	O
nodes	node	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
neck	neck	NN	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
30	30	CD	I-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
gingiva	gingiva	NN	B-NP	O
11	11	CD	I-NP	O
,	,	,	O	O
tongue	tongue	NN	B-NP	O
13	13	CD	I-NP	O
,	,	,	O	O
cheek	cheek	NN	B-NP	O
mucosa	mucosa	NN	I-NP	O
four	four	CD	I-NP	O
,	,	,	I-NP	O
oral	oral	JJ	I-NP	O
floor	floor	NN	I-NP	O
two	two	CD	I-NP	O
)	)	)	O	O
underwent	undergo	VBD	B-VP	O
extensive	extensive	JJ	B-NP	O
,	,	,	I-NP	O
clean-contaminated	clean-contaminated	JJ	I-NP	O
,	,	,	I-NP	O
head-and-neck	head-and-neck	NN	I-NP	O
surgery	surgery	NN	I-NP	O
(	(	(	O	O
including	include	VBG	B-PP	O
neck	neck	NN	B-NP	O
dissection	dissection	NN	I-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
free	free	JJ	B-NP	O
flap	flap	NN	I-NP	O
reconstruction	reconstruction	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
153	153	CD	B-NP	O
lymph	lymph	NN	I-NP	O
nodes	node	NNS	I-NP	O
was	be	VBD	B-VP	O
harvested	harvest	VBN	I-VP	O
for	for	IN	B-PP	O
microbial	microbial	JJ	B-NP	O
and	and	CC	I-NP	O
histological	histological	JJ	I-NP	O
examination	examination	NN	I-NP	O
.	.	.	O	O

Viable	Viable	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
70	70	CD	B-NP	O
lymph	lymph	NN	I-NP	O
nodes	node	NNS	I-NP	O
(	(	(	O	O
45.8	45.8	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
from	from	IN	B-PP	O
25	25	CD	B-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
83.3	83.3	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Bacterial	Bacterial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
the	the	DT	B-NP	O
nodes	node	NNS	I-NP	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
by	by	IN	B-PP	O
scanning	scan	VBG	B-VP	O
electron	electron	NN	B-NP	O
microscopy	microscopy	NN	I-NP	O
.	.	.	O	O

Bacterial	Bacterial	JJ	B-NP	O
translocation	translocation	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
more	more	RBR	B-ADVP	O
often	often	RB	I-ADVP	O
in	in	IN	B-PP	O
metastatic	metastatic	JJ	B-NP	O
nodes	node	NNS	I-NP	O
(	(	(	O	O
75.0	75.0	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
uninvolved	uninvolved	JJ	B-NP	O
nodes	node	NNS	I-NP	O
(	(	(	O	O
40.3	40.3	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
(	(	(	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
0.015	0.015	CD	B-NP	O
;	;	:	O	O
chi2	chi2	NN	B-NP	O
test	test	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Gingival	Gingival	JJ	B-NP	O
carcinoma	carcinoma	NN	I-NP	O
yielded	yield	VBD	B-VP	O
56.4	56.4	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
growth	growth	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
regional	regional	JJ	I-NP	O
lymph	lymph	NN	I-NP	O
nodes	node	NNS	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	I-VP	O
tongue	tongue	VB	I-VP	O
(	(	(	O	O
40.3	40.3	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
oral	oral	JJ	B-NP	O
floor	floor	NN	I-NP	O
(	(	(	O	O
40.0	40.0	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
cheek	cheek	NN	B-NP	O
mucosa	mucosa	NN	I-NP	O
(	(	(	O	O
37.5	37.5	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

As	As	IN	B-SBAR	O
the	the	DT	B-NP	O
gingival	gingival	JJ	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
group	group	NN	I-NP	O
includes	include	VBZ	B-VP	O
more	more	JJR	B-NP	O
T4	T4	NN	I-NP	O
cases	case	NNS	I-NP	O
(	(	(	O	O
11/11	11/11	CD	B-NP	O
;	;	:	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
three	three	CD	I-NP	O
groups	group	NNS	I-NP	O
(	(	(	O	O
7/19	7/19	CD	B-NP	O
;	;	:	O	O
36.8	36.8	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
bacterial	bacterial	JJ	B-NP	O
translocation	translocation	NN	I-NP	O
in	in	IN	B-PP	O
uninvolved	uninvolved	JJ	B-NP	O
nodes	node	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
caused	cause	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
size	size	NN	I-NP	O
and	and	CC	I-NP	O
invasion	invasion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
oral	oral	JJ	I-NP	O
tumor	tumor	NN	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
streptococci	streptococci	NNS	I-NP	O
(	(	(	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
intermedius	intermedius	NNP	I-NP	O
,	,	,	O	O
Strep	Strep	NNP	B-NP	O
.	.	.	O	O

constellatus	constellatus	NN	B-NP	O
,	,	,	O	O
Strep	Strep	NNP	B-NP	O
.	.	.	O	O

oralis	oralis	RB	B-ADVP	O
,	,	,	O	O
Strep	Strep	NNP	B-NP	O
.	.	.	O	O

mitis	mitis	NN	B-NP	O
,	,	,	O	O
Strep	Strep	NNP	B-NP	O
.	.	.	O	O

sanguis	sanguis	RB	B-ADVP	O
,	,	,	O	O
Strep	Strep	NNP	B-NP	O
.	.	.	O	O

salivarius	salivarius	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
common	common	JJ	I-NP	O
isolates	isolate	NNS	I-NP	O
.	.	.	O	O

Aerobic	Aerobic	JJ	B-NP	O
enteric	enteric	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
(	(	(	O	O
Enterococcus	Enterococcus	NNP	B-NP	O
,	,	,	O	O
Escherichia	Escherichia	NNP	B-NP	O
,	,	,	O	O
Klebsiella	Klebsiella	NNP	B-NP	O
etc	etc	FW	I-NP	O
.	.	.	O	O
)	)	)	O	O

were	be	VBD	B-VP	O
also	also	RB	I-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lymph	lymph	NN	I-NP	O
nodes	node	NNS	I-NP	O
.	.	.	O	O

Among	Among	IN	B-PP	O
the	the	DT	B-NP	O
anaerobic	anaerobic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
Peptostreptococcus	Peptostreptococcus	NNP	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
12	12	CD	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

Damaged	Damage	VBN	B-NP	O
oral	oral	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
oral	oral	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
might	might	MD	B-VP	O
allow	allow	VB	I-VP	O
the	the	DT	B-NP	O
new	new	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
colonization	colonization	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
surface	surface	NN	I-NP	O
and	and	CC	O	O
subsequently	subsequently	RB	B-VP	O
drain	drain	VB	I-VP	O
the	the	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
regional	regional	JJ	I-NP	O
lymph	lymph	NN	I-NP	O
nodes	node	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
general	general	JJ	I-NP	O
circulation	circulation	NN	I-NP	O
.	.	.	O	O

Anaerobes	Anaerobe	NNS	B-NP	O
constitute	constitute	VBP	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
part	part	NN	I-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
communities	community	NNS	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
mouths	mouth	NNS	I-NP	I-cell_type
.	.	.	O	O

Their	Their	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
colonize	colonize	VB	I-VP	O
and	and	CC	I-VP	O
survive	survive	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
environment	environment	NN	I-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
remarkable	remarkable	JJ	B-NP	O
changes	change	NNS	I-NP	O
occur	occur	VBP	B-VP	O
during	during	IN	B-PP	O
early	early	JJ	B-NP	O
childhood	childhood	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
fundamental	fundamental	JJ	B-ADJP	O
for	for	IN	B-PP	O
oral	oral	JJ	B-NP	O
homeostasis	homeostasis	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
relatively	relatively	RB	B-NP	O
little	little	JJ	I-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
colonization	colonization	NN	B-NP	O
and	and	CC	I-NP	O
succession	succession	NN	I-NP	O
of	of	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
species	specie	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
article	article	NN	I-NP	O
presents	present	VBZ	B-VP	O
an	an	DT	B-NP	O
up-to-date	up-to-date	JJ	I-NP	O
review	review	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
anaerobic	anaerobic	JJ	I-NP	O
microflora	microflora	NN	I-NP	O
in	in	IN	B-PP	O
respect	respect	NN	B-NP	O
to	to	TO	B-PP	O
age	age	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
considers	consider	VBZ	B-VP	O
some	some	DT	B-NP	O
aspects	aspect	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
anaerobes	anaerobe	NNS	I-NP	O
in	in	IN	B-PP	O
health	health	NN	B-NP	O
and	and	CC	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Behcet	Behcet	NNP	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
multisystem	multisystem	JJ	I-NP	O
disorder	disorder	NN	I-NP	O
of	of	IN	B-PP	O
unknown	unknown	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
predominantly	predominantly	RB	B-ADVP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
,	,	,	O	O
skin	skin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
eyes	eye	NNS	B-NP	O
.	.	.	O	O

Recurrent	Recurrent	JJ	B-NP	O
and	and	CC	I-NP	O
painful	painful	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
ulcerations	ulceration	NNS	I-NP	O
interfere	interfere	VBP	B-VP	O
with	with	IN	B-PP	O
regular	regular	JJ	B-NP	O
oral	oral	JJ	I-NP	O
hygiene	hygiene	NN	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
rapid	rapid	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
plaque	plaque	NN	I-NP	O
accumulation	accumulation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aims	aim	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
were	be	VBD	B-VP	O
to	to	TO	I-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
periodontal	periodontal	JJ	I-NP	O
status	status	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
Behcet	Behcet	NNP	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
determine	determine	NN	B-NP	O
serum	serum	NN	I-NP	O
antibody	antibody	NN	I-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-PP	O
selected	select	VBN	B-NP	O
oral	oral	JJ	I-NP	O
microorganisms	microorganism	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
major	major	JJ	B-NP	O
periodontopathogens	periodontopathogen	NNS	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

Thirty-three	Thirty-three	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
Behcet	Behcet	NNP	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
15	15	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
were	be	VBD	B-VP	O
included	include	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

Plaque	Plaque	NN	B-NP	O
,	,	,	O	O
sulcular	sulcular	JJ	B-NP	O
bleeding	bleeding	NN	I-NP	O
,	,	,	O	O
periodontal	periodontal	JJ	B-NP	O
index	index	NN	I-NP	O
scores	score	NNS	I-NP	O
,	,	,	O	O
probing	probing	NN	B-NP	O
depths	depth	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
total	total	JJ	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
teeth	tooth	NNS	B-NP	O
were	be	VBD	B-VP	O
recorded	record	VBN	I-VP	O
.	.	.	O	O

Serum	Serum	NN	B-NP	B-protein
IgG	IgG	NN	I-NP	I-protein
antibody	antibody	NN	I-NP	I-protein
levels	level	NNS	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
panel	panel	NN	I-NP	O
of	of	IN	B-PP	O
13	13	CD	B-NP	O
oral	oral	JJ	I-NP	O
microorganisms	microorganism	NNS	I-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
.	.	.	O	O

Significantly	Significantly	RB	B-NP	O
higher	high	JJR	I-NP	O
values	value	NNS	I-NP	O
for	for	IN	B-PP	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
measures	measure	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
Behcet	Behcet	NNP	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
healthy	healthy	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
0.0001	0.0001	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Antibody	Antibody	NN	B-NP	O
levels	level	NNS	I-NP	O
to	to	TO	B-PP	O
selected	select	VBN	B-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
plaque	plaque	NN	B-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
Actinomyces	Actinomyces	NNP	B-NP	O
viscosus	viscosus	NNP	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
sanguis	sanguis	NNP	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
oralis	oralis	NNP	I-NP	O
,	,	,	O	O
Eikenella	Eikenella	NNP	B-NP	O
corrodens	corroden	VBZ	B-VP	O
,	,	,	O	O
Campylobacter	Campylobacter	NNP	B-NP	O
rectus	rectus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Prevotella	Prevotella	NN	B-NP	O
intermedia	intermedia	NNS	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
Behcet	Behcet	NNP	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
controls	control	NNS	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	JJR	B-NP	O
0.001-0.05	0.001-0.05	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
these	these	DT	B-NP	O
patients	patient	NNS	I-NP	O
exhibited	exhibit	VBD	B-VP	O
significantly	significantly	RB	B-NP	O
elevated	elevated	JJ	I-NP	O
antibody	antibody	NN	I-NP	O
levels	level	NNS	I-NP	O
to	to	TO	B-PP	O
Actinobacillus	Actinobacillus	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
Y4	Y4	NN	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
controls	control	NNS	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
0.01	0.01	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
data	datum	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
Behcet	Behcet	NNP	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
generally	generally	RB	B-ADVP	O
exhibit	exhibit	VBP	B-VP	O
clinical	clinical	JJ	B-NP	O
findings	finding	NNS	I-NP	O
of	of	IN	B-PP	O
established	establish	VBN	B-NP	O
periodontal	periodontal	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Decreased	Decrease	VBN	B-NP	O
antibody	antibody	NN	I-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-PP	O
early	early	JJ	B-NP	O
colonizers	colonizer	NNS	I-NP	O
of	of	IN	B-PP	O
both	both	CC	B-NP	O
supra-	supra-	JJ	I-NP	O
and	and	CC	I-NP	O
subgingival	subgingival	JJ	I-NP	O
plaque	plaque	NN	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
along	along	IN	B-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
elevation	elevation	NN	I-NP	O
in	in	IN	B-PP	O
antibody	antibody	NN	B-NP	O
levels	level	NNS	I-NP	O
to	to	TO	B-PP	O
A.	A.	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
plaque	plaque	NN	I-NP	O
ecology	ecology	NN	I-NP	O
and/or	and/or	CC	O	O
immune	immune	JJ	B-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-PP	O
these	these	DT	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
affected	affect	VBN	I-VP	O
in	in	IN	B-PP	O
Behcet	Behcet	NNP	B-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
which	which	WDT	B-NP	O
could	could	MD	B-VP	O
lead	lead	VB	I-VP	O
to	to	TO	B-PP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

MG2	MG2	NN	B-NP	B-protein
(	(	(	O	O
the	the	DT	B-NP	O
MUC7	MUC7	NN	I-NP	B-protein
gene	gene	NN	I-NP	I-protein
product	product	NN	I-NP	I-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
low-molecular-mass	low-molecular-mass	JJ	I-NP	B-protein
mucin	mucin	NN	I-NP	I-protein
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
submandibular/sublingual	submandibular/sublingual	JJ	I-NP	O
secretions	secretion	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
mucin	mucin	NN	I-NP	O
is	be	VBZ	B-VP	O
believed	believe	VBN	I-VP	O
to	to	TO	I-VP	O
agglutinate	agglutinate	VB	I-VP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
microbes	microbe	NNS	B-NP	O
and	and	CC	O	O
thus	thus	RB	B-ADVP	O
is	be	VBZ	B-VP	O
considered	consider	VBN	I-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
non-immune	non-immune	JJ	I-NP	O
host	host	NN	I-NP	O
defence	defence	NN	I-NP	O
system	system	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
MUC7	MUC7	NN	B-NP	B-protein
can	can	MD	B-VP	O
bind	bind	VB	I-VP	O
to	to	TO	B-PP	O
cariogenic	cariogenic	JJ	B-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
binding	binding	NN	I-NP	O
requires	require	VBZ	B-VP	O
a	a	DT	B-NP	O
structural	structural	JJ	I-NP	O
determinant	determinant	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
N-terminal	N-terminal	JJ	I-NP	B-protein
region	region	NN	I-NP	I-protein
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
an	an	DT	B-NP	O
expression	expression	NN	I-NP	O
construct	construct	NN	I-NP	O
,	,	,	O	O
pNMuc7	pNMuc7	NN	B-NP	B-protein
,	,	,	O	O
encoding	encode	VBG	B-VP	O
the	the	DT	B-NP	O
N-terminal	N-terminal	JJ	I-NP	B-protein
144	144	CD	I-NP	I-protein
amino	amino	NN	I-NP	I-protein
acids	acid	NNS	I-NP	I-protein
of	of	IN	B-PP	O
MUC7	MUC7	NN	B-NP	B-protein
was	be	VBD	B-VP	O
generated	generate	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
recombinant	recombinant	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
rNMUC7	rNMUC7	NN	I-NP	O
was	be	VBD	B-VP	O
expressed	express	VBN	I-VP	O
in	in	IN	B-PP	O
Escherichia	Escherichia	NNP	B-NP	O
coli	coli	NNP	I-NP	O
.	.	.	O	O

Purified	Purify	VBN	B-NP	O
rNMUC7	rNMUC7	NN	I-NP	O
was	be	VBD	B-VP	O
characterized	characterize	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
protein	protein	NN	I-NP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
was	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
established	established	JJ	I-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
recombinant	recombinant	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
bound	bind	VBN	B-VP	O
to	to	TO	B-PP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
ATCC	ATCC	NN	I-NP	O
25175	25175	CD	I-NP	O
and	and	CC	O	O
ATCC	ATCC	NN	B-NP	O
33402	33402	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
alkylation	alkylation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
cysteine	cysteine	NN	I-NP	O
residues	residue	NNS	I-NP	O
(	(	(	O	O
Cys	Cys	NN	B-NP	O
(	(	(	O	O
45	45	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
Cys	Cys	NN	B-NP	O
(	(	(	O	O
50	50	CD	B-NP	O
)	)	)	O	O
)	)	)	O	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
complete	complete	JJ	I-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
binding	binding	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
binding	binding	NN	B-NP	O
of	of	IN	B-PP	O
MUC7	MUC7	NN	B-NP	B-protein
to	to	TO	B-PP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
occurs	occur	VBZ	B-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
N-terminal	N-terminal	JJ	I-NP	B-protein
region	region	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mucin	mucin	NN	I-NP	B-protein
molecule	molecule	NN	I-NP	I-protein
and	and	CC	O	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
surface	surface	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
interaction	interaction	NN	I-NP	O
is	be	VBZ	B-VP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
cysteine-containing	cysteine-containing	JJ	I-NP	B-protein
domain	domain	NN	I-NP	I-protein
within	within	IN	B-PP	O
this	this	DT	B-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
MUC7	MUC7	NN	B-NP	B-protein
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
killing	killing	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
rNMUC7	rNMUC7	NN	B-NP	B-protein
was	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
with	with	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
candidacidal	candidacidal	JJ	I-NP	B-protein
salivary	salivary	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
histatin	histatin	NN	I-NP	O
5	5	CD	I-NP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
established	establish	VBN	I-NP	O
Candida	Candida	NNP	I-NP	O
albicans	albicans	NNP	I-NP	O
(	(	(	O	O
ATCC	ATCC	NN	B-NP	O
44505	44505	CD	I-NP	O
)	)	)	O	O
blastoconidia	blastoconidia	NN	B-NP	O
killing	killing	NN	I-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
LD	LD	NN	I-NP	O
(	(	(	O	O
50	50	CD	B-NP	O
)	)	)	O	O
values	value	NNS	B-NP	O
of	of	IN	B-PP	O
rNMUC7	rNMUC7	NN	B-NP	B-protein
and	and	CC	O	O
histatin	histatin	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
were	be	VBD	B-VP	O
comparable	comparable	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
recombinant	recombinant	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
displayed	display	VBD	B-VP	O
significant	significant	JJ	B-NP	O
killing	killing	NN	I-NP	O
activity	activity	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
physiological	physiological	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
MUC7	MUC7	NN	B-NP	B-protein
in	in	IN	B-PP	O
whole	whole	JJ	B-NP	O
saliva	saliva	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
to	to	TO	B-VP	O
show	show	VB	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
N-terminal	N-terminal	JJ	I-NP	B-protein
region	region	NN	I-NP	I-protein
of	of	IN	B-PP	O
MUC7	MUC7	NN	B-NP	B-protein
contains	contain	VBZ	B-VP	O
a	a	DT	B-NP	O
structural	structural	JJ	I-NP	O
determinant	determinant	NN	I-NP	O
for	for	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
binding	binding	NN	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
region	region	NN	I-NP	O
exhibits	exhibit	VBZ	B-VP	O
candidacidal	candidacidal	NN	B-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
establish	establish	VB	I-VP	O
defined-species	defined-species	JJ	B-NP	O
consortium	consortium	NN	I-NP	O
plaque	plaque	NN	I-NP	O
biofilms	biofilm	NNS	I-NP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
enamel	enamel	NN	B-NP	O
and	and	CC	I-NP	O
root	root	NN	I-NP	O
caries	cary	NNS	I-NP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
artificial	artificial	JJ	I-NP	O
mouth	mouth	NN	I-NP	O
.	.	.	O	O

Strains	Strain	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
putative	putative	JJ	I-NP	O
enamel	enamel	NN	I-NP	O
and	and	CC	I-NP	O
root	root	NN	I-NP	O
caries	cary	NNS	I-NP	O
pathogens	pathogen	NNS	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
,	,	,	O	O
Strep	Strep	NNP	B-NP	O
.	.	.	O	O

sobrinus	sobrinus	RB	B-ADVP	O
,	,	,	O	O
Actinomyces	Actinomyce	NNS	B-NP	O
naeslundii	naeslundii	NN	I-NP	O
and	and	CC	I-NP	O
Lactobacillus	Lactobacillus	NN	I-NP	O
rhamnosus	rhamnosus	NN	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
screened	screen	VBN	I-VP	O
in	in	IN	B-PP	O
batch	batch	NN	B-NP	O
culture	culture	NN	I-NP	O
for	for	IN	B-PP	O
potential	potential	JJ	B-NP	O
cariogenic	cariogenic	JJ	I-NP	O
properties	property	NNS	I-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
terminal	terminal	JJ	I-NP	O
pH	pH	NN	I-NP	O
,	,	,	O	O
ability	ability	NN	B-NP	O
to	to	TO	B-VP	O
aggregate	aggregate	VB	I-VP	O
,	,	,	O	O
and	and	CC	O	O
catabolic	catabolic	JJ	B-NP	O
diversity	diversity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
strains	strain	NNS	I-NP	O
selected	select	VBN	B-VP	O
were	be	VBD	B-VP	O
grown	grow	VBN	I-VP	O
as	as	IN	B-PP	O
monoculture	monoculture	NN	B-NP	O
biofilms	biofilm	NNS	I-NP	O
and	and	CC	B-PP	O
as	as	IN	B-PP	O
consortium	consortium	NN	B-NP	O
plaque	plaque	NN	I-NP	O
biofilms	biofilm	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
multiplaque	multiplaque	JJ	I-NP	O
artificial	artificial	JJ	I-NP	O
mouth	mouth	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
biofilms	biofilm	NNS	I-NP	O
were	be	VBD	B-VP	O
supplied	supply	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
constant	constant	JJ	I-NP	O
flow	flow	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
simulated	simulated	JJ	I-NP	O
oral	oral	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
given	give	VBN	I-VP	O
periodic	periodic	JJ	B-NP	O
sucrose	sucrose	NN	I-NP	O
(	(	(	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
some	some	DT	B-NP	O
instances	instance	NNS	I-NP	O
glucose	glucose	NN	I-NP	O
)	)	)	O	O
to	to	TO	B-VP	O
simulate	simulate	VB	I-VP	O
meals	meal	NNS	B-NP	O
.	.	.	O	O

All	All	PDT	B-NP	O
the	the	DT	I-NP	O
bacteria	bacteria	NNS	I-NP	O
except	except	IN	B-PP	O
L.	L.	NNP	B-NP	O
rhamnosus	rhamnosus	NN	I-NP	O
formed	form	VBD	B-VP	O
large	large	JJ	B-NP	O
,	,	,	I-NP	O
monospecies	monospecy	NNS	I-NP	O
biofilms	biofilm	NNS	I-NP	O
with	with	IN	B-PP	O
resting	rest	VBG	B-NP	O
pH	pH	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
range	range	NN	I-NP	B-cell_line
5.3-5.8	5.3-5.8	CD	I-NP	I-cell_line
.	.	.	O	O

The	The	DT	B-NP	O
consortia	consortia	NN	I-NP	O
biofilms	biofilm	NNS	I-NP	O
were	be	VBD	B-VP	O
larger	large	JJR	B-ADJP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
resting	resting	JJ	I-NP	O
pH	pH	NN	I-NP	O
of	of	IN	B-PP	O
4.9-5.3	4.9-5.3	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
consortia	consortia	NN	I-NP	O
biofilms	biofilm	NNS	I-NP	O
supplied	supply	VBN	B-VP	O
with	with	IN	B-PP	O
8-hourly	8-hourly	JJ	B-NP	O
carbohydrate	carbohydrate	NN	I-NP	O
comprised	comprise	VBN	B-VP	O
mainly	mainly	RB	B-ADVP	O
'mutans	'mutan	VBZ	B-VP	O
'	'	POS	B-NP	O
streptococci	streptococci	NNS	I-NP	O
(	(	(	O	O
58	58	CD	B-NP	O
,	,	,	O	O
SD	SD	NNP	B-NP	O
5.5	5.5	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
L.	L.	NN	B-NP	O
rhamnosus	rhamnosus	NN	I-NP	O
(	(	(	O	O
42	42	CD	B-NP	O
,	,	,	O	O
SD	SD	NNP	B-NP	O
5.7	5.7	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

A.	A.	NN	B-NP	O
naeslundii	naeslundii	NNS	I-NP	O
characteristically	characteristically	RB	B-ADVP	O
was	be	VBD	B-VP	O
absent	absent	JJ	B-ADJP	O
or	or	CC	O	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
percentage	percentage	NN	I-NP	O
(	(	(	O	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
4	4	CD	I-NP	O
%	%	NN	I-NP	O
colony-forming	colony-forming	JJ	I-NP	O
units	unit	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O

All	All	DT	B-NP	O
biofilms	biofilm	NNS	I-NP	O
demineralized	demineralize	VBD	B-VP	O
polished	polish	VBN	I-VP	O
bovine	bovine	JJ	B-NP	O
enamel	enamel	NN	I-NP	O
and	and	CC	I-NP	O
dentine	dentine	NN	I-NP	O
blocks	block	NNS	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
assessed	assess	VBN	B-VP	O
by	by	IN	B-PP	O
microradiography	microradiography	NN	B-NP	O
and	and	CC	I-NP	O
enamel-surface	enamel-surface	NN	I-NP	O
microhardness	microhardness	NN	I-NP	O
measurement	measurement	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
consortia	consortia	NN	I-NP	O
also	also	RB	B-ADVP	O
demineralized	demineralize	VBD	B-VP	O
intact	intact	JJ	B-NP	O
enamel	enamel	NN	I-NP	O
and	and	CC	O	O
tooth	tooth	JJ	B-NP	O
roots	root	NNS	I-NP	O
;	;	:	O	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
cariogenic	cariogenic	JJ	I-ADJP	O
to	to	TO	B-VP	O
enamel	enamel	VB	I-VP	O
than	than	IN	B-PP	O
any	any	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
monoculture	monoculture	NN	I-NP	O
biofilms	biofilm	NNS	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
measured	measure	VBN	B-VP	O
by	by	IN	B-PP	O
enamel-surface	enamel-surface	NN	B-NP	O
softening	softening	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
variation	variation	NN	B-NP	O
in	in	IN	B-PP	O
lesion	lesion	NN	B-NP	O
depth	depth	NN	I-NP	O
was	be	VBD	B-VP	O
proportional	proportional	JJ	B-ADJP	O
to	to	TO	B-VP	O
biofilm	biofilm	VB	I-VP	O
wet	wet	JJ	B-NP	O
weight	weight	NN	I-NP	O
irrespective	irrespective	JJ	B-ADJP	O
of	of	IN	B-PP	O
acidogen	acidogen	NN	B-NP	O
composition	composition	NN	I-NP	O
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
0.93	0.93	CD	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
<	<	SYM	B-NP	O
0.05	0.05	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

Enamel	Enamel	NN	B-NP	O
lesions	lesion	NNS	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
well-mineralized	well-mineralized	JJ	I-NP	O
intact	intact	JJ	I-NP	O
surface	surface	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
zone	zone	NN	I-NP	O
of	of	IN	B-PP	O
subsurface	subsurface	NN	B-NP	O
demineralization	demineralization	NN	I-NP	O
,	,	,	O	O
typical	typical	JJ	B-ADJP	O
of	of	IN	B-PP	O
early	early	JJ	B-NP	O
natural	natural	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

Dentine	Dentine	NN	B-NP	O
and	and	CC	I-NP	O
root	root	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
showed	show	VBD	B-VP	O
extensive	extensive	JJ	B-NP	O
demineralization	demineralization	NN	I-NP	O
but	but	CC	O	O
lacked	lack	VBD	B-VP	O
a	a	DT	B-NP	O
pronounced	pronounced	JJ	I-NP	O
surface	surface	NN	I-NP	O
mineralized	mineralize	VBD	B-VP	O
zone	zone	NN	B-NP	O
.	.	.	O	O

Substitution	Substitution	NN	B-NP	O
of	of	IN	B-PP	O
glucose	glucose	NN	B-NP	O
for	for	IN	B-PP	O
sucrose	sucrose	NN	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
cariogenicity	cariogenicity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
consortium	consortium	NN	I-NP	O
to	to	TO	B-PP	O
bovine	bovine	JJ	B-NP	O
enamel	enamel	NN	I-NP	O
or	or	CC	O	O
human	human	JJ	B-NP	O
roots	root	NNS	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
major	major	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
plaque	plaque	NN	I-NP	O
composition	composition	NN	I-NP	O
.	.	.	O	O

Continuously	Continuously	RB	B-NP	O
supplied	supply	VBN	I-NP	O
fluoride	fluoride	NN	I-NP	O
(	(	(	O	O
19	19	CD	B-NP	O
parts/10	parts/10	NN	I-NP	O
(	(	(	O	O
6	6	CD	B-NP	O
)	)	)	O	O
)	)	)	O	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
substantially	substantially	RB	I-NP	O
reduced	reduce	VBN	I-NP	O
enamel	enamel	NN	I-NP	O
surface	surface	NN	I-NP	O
softening	softening	NN	I-NP	O
and	and	CC	I-NP	O
subsurface	subsurface	NN	I-NP	O
demineralization	demineralization	NN	I-NP	O
of	of	IN	B-PP	O
intact	intact	JJ	B-NP	O
roots	root	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
consortia	consortia	NN	B-NP	O
biofilms	biofilm	NNS	I-NP	O
of	of	IN	B-PP	O
selected	select	VBN	B-NP	O
caries	cary	NNS	I-NP	O
pathogens	pathogen	NNS	I-NP	O
generate	generate	VBP	B-VP	O
realistic	realistic	JJ	B-NP	O
caries	cary	NNS	I-NP	O
lesions	lesion	NNS	I-NP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
tooth	tooth	JJ	I-NP	O
hard	hard	JJ	I-NP	O
tissues	tissue	NNS	I-NP	O
under	under	IN	B-PP	O
controlled	control	VBN	B-NP	O
growth	growth	NN	I-NP	O
conditions	condition	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
artificial	artificial	JJ	I-NP	O
mouth	mouth	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
caries	cary	NNS	I-NP	O
experimental	experimental	JJ	B-NP	O
model	model	NN	I-NP	O
may	may	MD	B-VP	O
prove	prove	VB	I-VP	O
useful	useful	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
interrelations	interrelation	NNS	B-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
plaque	plaque	NN	I-NP	O
biofilm	biofilm	NN	I-NP	O
,	,	,	O	O
tooth	tooth	JJ	B-NP	O
tissues	tissue	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
environment	environment	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
procedures	procedure	NNS	B-NP	O
to	to	TO	B-VP	O
modify	modify	VB	I-VP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
caries	cary	NNS	B-NP	O
development	development	NN	I-NP	O
.	.	.	O	O

intimate	intimate	JJ	B-NP	O
relationship	relationship	NN	I-NP	O
with	with	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
fundamental	fundamental	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
health	health	NN	I-NP	O
status	status	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
individual	individual	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
birth	birth	NN	B-NP	O
infants	infant	NNS	I-NP	O
are	be	VBP	B-VP	O
exposed	expose	VBN	I-VP	O
to	to	TO	B-PP	O
continuous	continuous	JJ	B-NP	O
person-to-person	person-to-person	NN	I-NP	O
and	and	CC	O	O
environmental	environmental	JJ	B-NP	O
contacts	contact	NNS	I-NP	O
with	with	IN	B-PP	O
microbes	microbe	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
indigenous	indigenous	JJ	I-NP	O
microflora	microflora	NN	I-NP	O
begins	begin	VBZ	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
surfaces	surface	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
body	body	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
a	a	DT	B-NP	O
developing	develop	VBG	I-NP	O
ecosystem	ecosystem	NN	I-NP	O
microbial	microbial	JJ	I-NP	O
colonization	colonization	NN	I-NP	O
may	may	MD	B-VP	O
easily	easily	RB	I-VP	O
occur	occur	VB	I-VP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
still	still	RB	I-NP	O
inadequate	inadequate	JJ	I-NP	O
host	host	NN	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

Adhesion	Adhesion	NN	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
event	event	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
colonization	colonization	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
,	,	,	O	O
only	only	RB	B-NP	O
mucosal	mucosal	JJ	I-NP	O
surfaces	surface	NNS	I-NP	O
are	be	VBP	B-VP	O
available	available	JJ	B-ADJP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
months	month	NNS	I-NP	O
of	of	IN	B-PP	O
life	life	NN	B-NP	O
.	.	.	O	O

After	After	IN	B-SBAR	O
teeth	tooth	NNS	B-NP	O
emerge	emerge	VBP	B-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
attachment	attachment	NN	B-NP	O
sites	site	NNS	I-NP	O
and	and	CC	O	O
potential	potential	JJ	B-NP	O
niches	niche	NNS	I-NP	O
increases	increase	VBZ	B-VP	O
significantly	significantly	RB	B-ADVP	O
.	.	.	O	O

Bacteria	Bacteria	NNS	B-NP	O
adhere	adhere	VBP	B-VP	O
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
surfaces	surface	NNS	I-NP	O
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
to	to	TO	B-PP	O
each	each	DT	B-NP	O
other	other	JJ	I-NP	O
,	,	,	O	O
forming	form	VBG	B-VP	O
multigeneric	multigeneric	JJ	B-NP	O
communities	community	NNS	I-NP	O
where	where	WRB	B-ADVP	O
specific	specific	JJ	B-NP	O
partner	partner	NN	I-NP	O
relationships	relationship	NNS	I-NP	O
influence	influence	VBP	B-VP	O
their	their	PRP$	B-NP	O
composition	composition	NN	I-NP	O
and	and	CC	I-NP	O
stability	stability	NN	I-NP	O
.	.	.	O	O

Viridans	Viridan	NNS	B-NP	O
streptococci	streptococci	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
strictly	strictly	RB	I-NP	O
anaerobic	anaerobic	JJ	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
,	,	,	O	O
are	be	VBP	B-VP	O
of	of	IN	B-PP	O
interest	interest	NN	B-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
context	context	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
oral	oral	JJ	I-NP	O
colonization	colonization	NN	I-NP	O
pattern	pattern	NN	I-NP	O
differs	differ	VBZ	B-VP	O
between	between	IN	B-PP	O
individuals	individual	NNS	B-NP	O
already	already	RB	B-ADVP	O
in	in	IN	B-PP	O
infancy	infancy	NN	B-NP	O
;	;	:	O	O
variable	variable	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
load	load	NN	I-NP	O
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
of	of	IN	B-PP	O
attendants	attendant	NNS	B-NP	O
and	and	CC	O	O
other	other	JJ	B-NP	O
close	close	JJ	I-NP	O
contacts	contact	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
exposure	exposure	NN	I-NP	O
may	may	MD	B-VP	O
partly	partly	RB	I-VP	O
account	account	VB	I-VP	O
for	for	IN	B-PP	O
individual	individual	JJ	B-NP	O
differences	difference	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
exposure	exposure	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
infant	infant	NN	I-NP	O
to	to	TO	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
affects	affect	VBZ	B-VP	O
the	the	DT	B-NP	O
quality	quality	NN	I-NP	O
of	of	IN	B-PP	O
colonizing	colonize	VBG	B-VP	O
bacteria	bacteria	NNS	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
article	article	NN	I-NP	O
presents	present	VBZ	B-VP	O
an	an	DT	B-NP	O
overview	overview	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
age-related	age-related	JJ	I-NP	O
acquisition	acquisition	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
indigenous	indigenous	JJ	I-NP	O
oral	oral	JJ	I-NP	O
microflora	microflora	NN	I-NP	O
in	in	IN	B-PP	O
health	health	NN	B-NP	O
and	and	CC	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Bacteria	Bacteria	NNS	B-NP	O
are	be	VBP	B-VP	O
causative	causative	JJ	B-NP	O
agents	agent	NNS	I-NP	O
of	of	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

Interactions	Interaction	NNS	B-NP	O
between	between	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
gingival	gingival	JJ	B-NP	B-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
are	be	VBP	B-VP	O
essential	essential	JJ	B-NP	O
aspects	aspect	NNS	I-NP	O
of	of	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
infections	infection	NNS	I-NP	O
.	.	.	O	O

Using	Use	VBG	B-VP	O
an	an	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
tissue	tissue	NN	I-NP	O
culture	culture	NN	I-NP	O
model	model	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
selected	select	VBN	I-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
gram-negative	gram-negative	JJ	B-NP	O
anaerobic	anaerobic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
frequently	frequently	RB	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
Bacteroides	Bacteroide	NNS	B-NP	O
forsythus	forsythus	RB	B-ADVP	O
,	,	,	O	O
Campylobacter	Campylobacter	NNP	B-NP	O
curvus	curvus	NN	I-NP	O
,	,	,	O	O
Eikenella	Eikenella	NNP	B-NP	O
corrodens	corroden	VBZ	B-VP	O
,	,	,	O	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
,	,	,	O	O
Porphyromonas	Porphyromonas	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Prevotella	Prevotella	NNP	B-NP	O
intermedia	intermedia	NNS	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
for	for	IN	B-PP	O
their	their	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
adhere	adhere	VB	I-VP	O
to	to	TO	B-PP	O
and	and	CC	O	O
invade	invade	VB	B-VP	O
primary	primary	JJ	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
gingival	gingival	JJ	I-NP	I-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
HGEC	HGEC	NNS	B-NP	B-cell_type
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
interleukin-8	interleukin-8	NN	B-NP	B-protein
(	(	(	O	O
IL-8	IL-8	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
proinflammatory	proinflammatory	JJ	I-NP	B-protein
chemokine	chemokine	NN	I-NP	I-protein
,	,	,	O	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
measured	measure	VBN	I-VP	O
.	.	.	O	O

These	These	DT	B-NP	O
studies	study	NNS	I-NP	O
provided	provide	VBD	B-VP	O
an	an	DT	B-NP	O
initial	initial	JJ	I-NP	O
demonstration	demonstration	NN	I-NP	O
that	that	IN	B-NP	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
adhered	adhere	VBD	B-VP	O
to	to	TO	B-PP	O
and	and	CC	O	O
invaded	invaded	JJ	B-NP	O
HGEC	HGEC	NN	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
accompanied	accompany	VBN	I-VP	O
by	by	IN	B-PP	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
IL-8	IL-8	NN	B-NP	B-protein
secretion	secretion	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
epithelial	epithelial	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
attachment	attachment	NN	I-NP	O
and	and	CC	I-NP	O
invasion	invasion	NN	I-NP	O
characteristics	characteristic	NNS	I-NP	O
of	of	IN	B-PP	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
tested	test	VBN	I-VP	O
using	use	VBG	B-VP	O
KB	KB	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
an	an	DT	B-NP	O
oral	oral	JJ	I-NP	B-cell_line
epithelial	epithelial	JJ	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

The	The	DT	B-NP	O
invasion	invasion	NN	I-NP	O
was	be	VBD	B-VP	O
verified	verify	VBN	I-VP	O
by	by	IN	B-PP	O
transmission	transmission	NN	B-NP	O
electron	electron	NN	I-NP	O
microscopy	microscopy	NN	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
metabolic	metabolic	JJ	B-NP	O
inhibitors	inhibitor	NNS	I-NP	O
.	.	.	O	O

Invasion	Invasion	NN	B-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
occur	occur	VB	I-VP	O
via	via	IN	B-PP	O
a	a	DT	B-NP	O
``	``	``	I-NP	O
zipping	zipping	NN	I-NP	O
''	''	''	I-NP	O
mechanism	mechanism	NN	I-NP	O
and	and	CC	O	O
required	require	VBD	B-VP	O
the	the	DT	B-NP	O
involvement	involvement	NN	I-NP	O
of	of	IN	B-PP	O
actins	actin	NNS	B-NP	B-protein
,	,	,	O	O
microtubules	microtubule	NNS	B-NP	B-protein
,	,	,	O	O
signal	signal	NN	B-NP	O
transduction	transduction	NN	I-NP	O
,	,	,	O	O
protein	protein	NN	B-NP	O
synthesis	synthesis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
energy	energy	NN	B-NP	O
metabolism	metabolism	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
epithelial	epithelial	JJ	I-NP	B-cell_type
cell	cell	NN	I-NP	I-cell_type
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
protein	protein	NN	B-NP	O
synthesis	synthesis	NN	I-NP	O
by	by	IN	B-PP	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
spontaneous	spontaneous	JJ	I-NP	O
mutant	mutant	NN	I-NP	O
,	,	,	O	O
lam	lam	NN	B-NP	B-protein
,	,	,	O	O
of	of	IN	B-PP	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
,	,	,	O	O
isolated	isolate	VBN	B-VP	O
as	as	IN	B-PP	O
defective	defective	JJ	B-ADJP	O
in	in	IN	B-PP	O
autoagglutination	autoagglutination	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
attach	attach	VB	I-VP	O
to	to	TO	B-PP	O
or	or	CC	O	O
invade	invade	JJ	B-NP	O
HGEC	HGEC	NN	I-NP	O
or	or	CC	I-NP	O
KB	KB	NN	I-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
further	further	RB	B-ADVP	O
indicating	indicate	VBG	B-VP	O
the	the	DT	B-NP	O
requirement	requirement	NN	I-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	B-protein
components	component	NNS	I-NP	I-protein
in	in	IN	B-PP	O
these	these	DT	B-NP	O
processes	process	NNS	I-NP	O
.	.	.	O	O

Sugar	Sugar	NN	B-NP	O
inhibition	inhibition	NN	I-NP	O
assays	assay	NNS	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
lectin-like	lectin-like	JJ	B-NP	O
interactions	interaction	NNS	I-NP	O
were	be	VBD	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
attachment	attachment	NN	I-NP	O
of	of	IN	B-PP	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
to	to	TO	B-PP	O
KB	KB	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Investigation	Investigation	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
new	new	JJ	I-NP	O
virulence	virulence	NN	I-NP	O
phenotypes	phenotype	NNS	I-NP	O
should	should	MD	B-VP	O
improve	improve	VB	I-VP	O
our	our	PRP$	B-NP	O
understanding	understanding	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
in	in	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
infections	infection	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
heterogeneous	heterogeneous	JJ	I-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
sanguinis	sanguinis	NN	I-NP	O
(	(	(	O	O
sanguis	sanguis	NN	B-NP	O
)	)	)	O	O
streptococci	streptococci	NNS	B-NP	O
comprise	comprise	VBP	B-VP	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
indigenous	indigenous	JJ	I-NP	O
biota	biota	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
the	the	DT	B-NP	O
association	association	NN	I-NP	O
of	of	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
sanguinis	sanguinis	NNP	I-NP	O
with	with	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
endocarditis	endocarditis	NN	I-NP	O
is	be	VBZ	B-VP	O
well	well	RB	I-VP	O
described	describe	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
literature	literature	NN	I-NP	O
,	,	,	O	O
S.	S.	NNP	B-NP	O
sanguinis	sanguinis	NNP	I-NP	O
is	be	VBZ	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
benign	benign	JJ	I-NP	O
,	,	,	O	O
if	if	IN	B-CONJP	O
not	not	RB	I-CONJP	O
a	a	DT	B-NP	O
beneficial	beneficial	JJ	I-NP	O
,	,	,	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

Little	Little	JJ	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
natural	natural	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
sanguinis	sanguinis	NNP	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
specific	specific	JJ	I-NP	O
relationship	relationship	NN	I-NP	O
with	with	IN	B-PP	O
other	other	JJ	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
part	part	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
longitudinal	longitudinal	JJ	I-NP	O
study	study	NN	I-NP	O
concerning	concern	VBG	B-VP	O
the	the	DT	B-NP	O
transmission	transmission	NN	I-NP	O
and	and	CC	I-NP	O
acquisition	acquisition	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
within	within	IN	B-PP	O
mother-infant	mother-infant	JJ	B-NP	O
pairs	pair	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
acquisition	acquisition	NN	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
sanguinis	sanguinis	NNP	I-NP	O
and	and	CC	O	O
described	describe	VBD	B-VP	O
its	its	PRP$	B-NP	O
colonization	colonization	NN	I-NP	O
relative	relative	JJ	B-ADVP	O
to	to	TO	B-VP	O
tooth	tooth	VB	I-VP	O
emergence	emergence	NN	B-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
proportions	proportion	NNS	I-NP	O
in	in	IN	B-PP	O
plaque	plaque	NN	B-NP	O
and	and	CC	I-NP	O
saliva	saliva	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
biological	biological	JJ	I-NP	O
events	event	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
subsequent	subsequent	JJ	B-NP	O
colonization	colonization	NN	I-NP	O
with	with	IN	B-PP	O
mutans	mutan	NNS	B-NP	O
streptococci	streptococci	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
second	second	JJ	I-NP	O
cohort	cohort	NN	I-NP	O
of	of	IN	B-PP	O
infants	infant	NNS	B-NP	O
was	be	VBD	B-VP	O
recruited	recruit	VBN	I-VP	O
to	to	TO	I-VP	O
define	define	VB	I-VP	O
the	the	DT	B-NP	O
taxonomic	taxonomic	JJ	I-NP	O
affiliation	affiliation	NN	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
sanguinis	sanguinis	NNP	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
colonization	colonization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
S.	S.	NNP	I-NP	O
sanguinis	sanguinis	NN	I-NP	O
occurs	occur	VBZ	B-VP	O
during	during	IN	B-PP	O
a	a	DT	B-NP	O
discrete	discrete	JJ	I-NP	O
``	``	``	I-NP	O
window	window	NN	I-NP	O
of	of	IN	B-PP	O
infectivity	infectivity	NN	B-NP	O
''	''	''	O	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
median	median	JJ	I-NP	O
age	age	NN	I-NP	O
of	of	IN	B-PP	O
9	9	CD	B-NP	O
months	month	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
infants	infant	NNS	I-NP	O
.	.	.	O	O

Its	Its	PRP$	B-NP	O
colonization	colonization	NN	I-NP	O
is	be	VBZ	B-VP	O
tooth	tooth	RB	B-ADJP	O
dependent	dependent	JJ	I-ADJP	O
and	and	CC	O	O
correlated	correlate	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
tooth	tooth	JJ	B-NP	O
emergence	emergence	NN	I-NP	O
;	;	:	O	O
its	its	PRP$	B-NP	O
proportions	proportion	NNS	I-NP	O
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
increase	increase	NN	I-NP	O
as	as	IN	B-SBAR	O
new	new	JJ	B-NP	O
teeth	tooth	NNS	I-NP	O
emerge	emerge	VBP	B-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
early	early	JJ	B-NP	O
colonization	colonization	NN	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
sanguinis	sanguinis	NNP	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
elevated	elevated	JJ	I-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
were	be	VBD	B-VP	O
correlated	correlate	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
delay	delay	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
colonization	colonization	NN	I-NP	O
of	of	IN	B-PP	O
mutans	mutan	NNS	B-NP	O
streptococci	streptococci	NNS	I-NP	O
.	.	.	O	O

Underpinning	Underpin	VBG	B-VP	O
this	this	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
antagonism	antagonism	NN	I-NP	O
between	between	IN	B-PP	O
S.	S.	NNP	B-NP	O
sanguinis	sanguinis	NNP	I-NP	O
and	and	CC	O	O
mutans	mutan	NNS	B-NP	O
streptococci	streptococci	NNS	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
observation	observation	NN	I-NP	O
that	that	IN	B-NP	O
after	after	IN	B-PP	O
mutans	mutan	NNS	B-NP	O
streptococci	streptococci	NNS	I-NP	O
colonize	colonize	VBP	B-VP	O
the	the	DT	B-NP	O
infant	infant	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
sanguinis	sanguinis	NNP	I-NP	O
decrease	decrease	NN	I-NP	O
.	.	.	O	O

Children	Child	NNS	B-NP	O
who	who	WP	B-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
harbor	harbor	VB	I-VP	O
detectable	detectable	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
mutans	mutan	NNS	B-NP	O
streptococci	streptococci	NNS	I-NP	O
have	have	VBP	B-VP	O
significantly	significantly	RB	B-NP	O
higher	high	JJR	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
sanguinis	sanguinis	NNP	I-NP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
saliva	saliva	NN	I-NP	O
than	than	IN	B-SBAR	O
do	do	VBP	O	O
children	child	NNS	B-NP	O
colonized	colonize	VBN	B-VP	O
with	with	IN	B-PP	O
mutans	mutan	NNS	B-NP	O
streptococci	streptococci	NNS	I-NP	O
.	.	.	O	O

Collectively	Collectively	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
findings	finding	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
colonization	colonization	NN	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
sanguinis	sanguinis	NNP	I-NP	O
may	may	MD	B-VP	O
influence	influence	VB	I-VP	O
the	the	DT	B-NP	O
subsequent	subsequent	JJ	I-NP	O
colonization	colonization	NN	I-NP	O
of	of	IN	B-PP	O
mutans	mutan	NNS	B-NP	O
streptococci	streptococci	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
in	in	IN	B-PP	O
turn	turn	NN	B-NP	O
may	may	MD	B-VP	O
suggest	suggest	VB	I-VP	O
several	several	JJ	B-NP	O
ecological	ecological	JJ	I-NP	O
approaches	approach	NNS	I-NP	O
toward	toward	IN	B-PP	O
controlling	control	VBG	B-VP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
novel	novel	JJ	I-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
spirochaetes	spirochaete	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
specifically	specifically	RB	I-VP	O
labeled	label	VBN	I-VP	O
by	by	IN	B-PP	O
H9-2	H9-2	NN	B-NP	B-DNA
,	,	,	O	O
a	a	DT	B-NP	O
monoclonal	monoclonal	JJ	I-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
against	against	IN	B-PP	O
the	the	DT	B-NP	O
37-kDa	37-kDa	JJ	I-NP	B-protein
endoflagellar	endoflagellar	JJ	I-NP	I-protein
sheath	sheath	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
of	of	IN	B-PP	O
Treponema	Treponema	NN	B-NP	O
pallidum	pallidum	NN	I-NP	O
,	,	,	O	O
have	have	VBP	B-VP	O
earlier	earlier	RBR	I-VP	O
been	be	VBN	I-VP	O
demonstrated	demonstrate	VBN	I-VP	O
in	in	IN	B-PP	O
periodontitis-associated	periodontitis-associated	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
samples	sample	NNS	I-NP	O
;	;	:	O	O
two	two	CD	B-NP	O
cultivable	cultivable	JJ	I-NP	O
oral	oral	JJ	I-NP	O
spirochaetes	spirochaete	NNS	I-NP	O
T.	T.	FW	B-ADVP	O
vincentii	vincentii	FW	I-ADVP	O
and	and	CC	O	O
T.	T.	NNP	B-NP	O
medium	medium	NN	I-NP	O
displayed	display	VBD	B-VP	O
cross-reactivity	cross-reactivity	NN	B-NP	O
with	with	IN	B-PP	O
that	that	DT	O	O
monoclonal	monoclonal	JJ	O	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
basis	basis	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
cross-reactivity	cross-reactivity	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
yet	yet	RB	I-VP	O
defined	define	VBN	I-VP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
flaA-1	flaA-1	NN	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
which	which	WDT	B-NP	O
encode	encode	VBP	B-VP	O
the	the	DT	B-NP	O
37-kDa	37-kDa	JJ	I-NP	B-protein
sheath	sheath	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
from	from	IN	B-PP	O
T.	T.	NNP	B-NP	O
vincentii	vincentii	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
spirochaetes	spirochaete	NNS	I-NP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
samples	sample	NNS	B-NP	O
from	from	IN	B-PP	O
advanced	advance	VBN	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
856	856	CD	I-NP	B-DNA
bp	bp	NN	I-NP	I-DNA
fragment	fragment	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
flaA-1	flaA-1	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
amplified	amplify	VBN	I-VP	O
in	in	IN	B-PP	O
T.	T.	FW	B-NP	O
pallidum	pallidum	FW	I-NP	O
and	and	CC	O	O
T.	T.	NNP	B-NP	O
vincentii	vincentii	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
same-size	same-size	JJ	I-NP	B-DNA
polymerase	polymerase	NN	I-NP	I-DNA
chain	chain	NN	I-NP	I-DNA
reaction	reaction	NN	I-NP	I-DNA
fragments	fragment	NNS	I-NP	I-DNA
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
amplified	amplify	VBN	I-VP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
clinical	clinical	JJ	I-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
advanced	advance	VBN	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
but	but	CC	B-PP	O
not	not	RB	I-PP	O
from	from	IN	B-PP	O
samples	sample	NNS	B-NP	O
of	of	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
sequences	sequence	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
flaA-1	flaA-1	NN	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
spirochaetes	spirochaete	NNS	I-NP	O
detected	detect	VBN	B-VP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
periodontal	periodontal	JJ	I-NP	O
plaque	plaque	NN	I-NP	O
were	be	VBD	B-VP	O
closely	closely	RB	B-ADJP	O
similar	similar	JJ	I-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
T.	T.	FW	B-NP	O
pallidum	pallidum	FW	I-NP	O
and	and	CC	O	O
T.	T.	NNP	B-NP	O
vincentii	vincentii	NNP	I-NP	O
,	,	,	O	O
but	but	CC	O	O
neither	neither	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
two	two	CD	I-NP	O
organisms	organism	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
samples	sample	NNS	I-NP	O
using	use	VBG	B-VP	O
rRNA-specific	rRNA-specific	JJ	B-NP	B-protein
primers	primer	NNS	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
identity	identity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
flaA-1	flaA-1	NN	I-NP	O
positive	positive	JJ	I-NP	O
spirochaetes	spirochaete	NNS	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
periodontitis	periodontitis	NN	B-NP	O
remains	remain	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
determined	determine	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
antibacterial	antibacterial	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
Coptidis	Coptidis	NN	B-NP	O
Rhizoma	Rhizoma	NN	I-NP	O
(	(	(	O	O
CR	CR	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
traditional	traditional	JJ	I-NP	O
medicinal	medicinal	JJ	I-NP	O
plant	plant	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

CR	CR	JJ	B-NP	O
extract	extract	NN	I-NP	O
was	be	VBD	B-VP	O
prepared	prepare	VBN	I-VP	O
by	by	IN	B-PP	O
boiling	boil	VBG	B-VP	O
CR	CR	NN	B-NP	O
in	in	IN	B-PP	O
water	water	NN	B-NP	O
for	for	IN	B-PP	O
2	2	CD	B-NP	O
h.	h.	NN	I-NP	O
Alkaloids	Alkaloid	NNS	I-NP	O
contained	contain	VBN	B-VP	O
in	in	IN	B-PP	O
CR	CR	JJ	B-NP	O
extract	extract	NN	I-NP	O
were	be	VBD	B-VP	O
assayed	assay	VBN	I-VP	O
by	by	IN	B-PP	O
high	high	JJ	B-NP	O
performance	performance	NN	I-NP	O
liquid	liquid	NN	I-NP	O
chromatography	chromatography	NN	I-NP	O
(	(	(	O	O
HPLC	HPLC	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

Antibacterial	Antibacterial	JJ	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
CR	CR	JJ	B-NP	O
extract	extract	NN	I-NP	O
was	be	VBD	B-VP	O
estimated	estimate	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
lowest	low	JJS	I-NP	O
concentration	concentration	NN	I-NP	O
that	that	WDT	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
permit	permit	VB	I-VP	O
bacterial	bacterial	JJ	B-NP	O
growth	growth	NN	I-NP	O
(	(	(	O	O
minimum	minimum	JJ	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
,	,	,	O	O
MIC	MIC	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
concentrations	concentration	NNS	I-NP	O
that	that	WDT	B-NP	O
inhibited	inhibit	VBD	B-VP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
proteolytic	proteolytic	JJ	I-NP	O
activity	activity	NN	I-NP	O
(	(	(	O	O
IC50	IC50	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

CR	CR	JJ	B-NP	O
extract	extract	NN	I-NP	O
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
Actinomyces	Actinomyces	NNP	B-NP	O
naeslundii	naeslundii	NNP	I-NP	O
,	,	,	O	O
Porphyromonas	Porphyromonas	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
Prevotella	Prevotella	NNP	B-NP	O
intermedia	intermedia	NNS	I-NP	O
,	,	,	O	O
Prevotella	Prevotella	NNP	B-NP	O
nigrescens	nigrescens	NNP	I-NP	O
and	and	CC	I-NP	O
Actinobacillus	Actinobacillus	NNP	I-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
at	at	IN	B-PP	O
MIC	MIC	NN	B-NP	O
of	of	IN	B-PP	O
0.031-0.25	0.031-0.25	CD	B-NP	O
mg	mg	NN	I-NP	O
ml	ml	NN	I-NP	O
(	(	(	O	O
-1	-1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
whereas	whereas	IN	O	O
it	it	PRP	B-NP	O
had	have	VBD	B-VP	O
less	less	RBR	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effect	effect	NN	I-NP	O
(	(	(	O	O
MIC	MIC	NN	B-NP	O
:	:	:	O	O
0.5-2	0.5-2	CD	B-NP	O
mg	mg	NN	I-NP	O
ml	ml	NN	I-NP	O
(	(	(	O	O
-1	-1	CD	B-NP	O
)	)	)	O	O
)	)	)	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
and	and	CC	I-NP	O
Lactobacillus	Lactobacillus	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
major	major	JJ	I-NP	O
active	active	JJ	I-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
CR	CR	JJ	B-NP	O
extract	extract	NN	I-NP	O
was	be	VBD	B-VP	O
berberine	berberine	NN	B-NP	O
(	(	(	O	O
Ber	Ber	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
an	an	DT	B-NP	O
alkaloid	alkaloid	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
inhibiting	inhibit	VBG	I-NP	O
specificity	specificity	NN	I-NP	O
to	to	TO	B-PP	O
bacterial	bacterial	JJ	B-NP	O
growth	growth	NN	I-NP	O
was	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
CR	CR	JJ	B-NP	O
extract	extract	NN	I-NP	O
.	.	.	O	O

CR	CR	JJ	B-NP	O
extract	extract	NN	I-NP	O
and	and	CC	I-NP	O
Ber	Ber	NN	I-NP	B-protein
were	be	VBD	B-VP	O
bacteriostatic	bacteriostatic	JJ	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
MICs	MIC	NNS	I-NP	O
against	against	IN	B-PP	O
most	most	JJS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
bacteriocidal	bacteriocidal	JJ	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
concentrations	concentration	NNS	I-NP	O
higher	high	JJR	B-ADJP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
MICs	MIC	NNS	I-NP	B-cell_type
.	.	.	O	O

Ber	Ber	NNP	B-NP	O
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
collagenase	collagenase	NN	B-NP	B-protein
from	from	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
and	and	CC	I-NP	O
A.	A.	NN	I-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
.	.	.	O	O

CR	CR	JJ	B-NP	O
extract	extract	NN	I-NP	O
and	and	CC	O	O
Ber	Ber	NNP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
periodontopathogenic	periodontopathogenic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
clinical	clinical	JJ	I-NP	O
application	application	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

Lymphocytes	Lymphocyte	NNS	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
experimental	experimental	JJ	I-NP	O
model	model	NN	I-NP	O
to	to	TO	B-VP	O
get	get	VB	I-VP	O
a	a	DT	B-NP	O
deeper	deep	JJR	I-NP	O
insight	insight	NN	I-NP	O
into	into	IN	B-PP	O
immune	immune	JJ	B-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
periapical	periapical	JJ	B-NP	B-cell_type
granulomas	granuloma	NNS	I-NP	I-cell_type
.	.	.	O	O

Lymphocytes	Lymphocyte	NNS	B-NP	B-cell_type
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
leucocyte	leucocyte	NN	B-NP	O
concentrate	concentrate	NN	I-NP	O
were	be	VBD	B-VP	O
in	in	IN	B-PP	O
lymphocyte	lymphocyte	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
stimulated	stimulate	VBN	B-VP	O
by	by	IN	B-PP	O
antigen	antigen	NN	B-NP	O
preparations	preparation	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

Lymphocyte	Lymphocyte	NN	B-NP	B-cell_type
subsets	subset	NNS	I-NP	I-cell_type
that	that	WDT	B-NP	O
have	have	VBP	B-VP	O
developed	develop	VBN	I-VP	O
in	in	IN	B-PP	O
lymphocyte	lymphocyte	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
after	after	IN	B-PP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
of	of	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
were	be	VBD	B-VP	O
analysed	analyse	VBN	I-VP	O
by	by	IN	B-PP	O
flow	flow	NN	B-NP	O
cytometry	cytometry	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
significant	significant	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
INF-gamma	INF-gamma	NN	B-NP	B-protein
molecules	molecule	NNS	I-NP	I-protein
in	in	IN	B-PP	O
CD3+	CD3+	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
stimulated	stimulate	VBN	B-VP	O
by	by	IN	B-PP	O
antigen	antigen	NN	B-NP	O
preparations	preparation	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
streptococci	streptococci	NNS	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
,	,	,	O	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
negative	negative	JJ	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
hand	hand	NN	I-NP	O
we	we	PRP	B-NP	O
observed	observe	VBD	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
IL-4	IL-4	NN	B-NP	B-protein
in	in	IN	B-PP	O
CD3+	CD3+	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
stimulated	stimulate	VBN	B-VP	O
by	by	IN	B-PP	O
antigens	antigen	NNS	B-NP	O
of	of	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
negative	negative	JJ	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
antigens	antigen	NNS	B-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
streptococci	streptococci	NNS	I-NP	O
in	in	IN	B-PP	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
lymphocyte	lymphocyte	NN	I-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
induce	induce	VBP	B-VP	O
the	the	DT	B-NP	O
differentiation	differentiation	NN	I-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
helper	helper	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
into	into	IN	B-PP	O
Th2	Th2	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
that	that	IN	B-SBAR	O
antigen	antigen	NN	B-NP	O
preparations	preparation	NNS	I-NP	O
of	of	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
induce	induce	VBP	B-VP	O
the	the	DT	B-NP	O
differentiation	differentiation	NN	I-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	B-cell_type
helper	helper	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
into	into	IN	B-PP	O
Th1	Th1	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
HLA-DR	HLA-DR	NN	B-NP	B-protein
molecules	molecule	NNS	I-NP	I-protein
on	on	IN	B-PP	O
CD8+	CD8+	JJ	B-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
stimulated	stimulate	VBN	B-VP	O
by	by	IN	B-PP	O
antigens	antigen	NNS	B-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
streptococci	streptococci	NNS	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
,	,	,	O	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
negative	negative	JJ	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

Many	Many	JJ	B-NP	O
epidemiological	epidemiological	JJ	I-NP	O
studies	study	NNS	I-NP	O
have	have	VBP	B-VP	O
identified	identify	VBN	I-VP	O
chronic	chronic	JJ	B-NP	O
alcohol	alcohol	NN	I-NP	O
consumption	consumption	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
risk	risk	NN	I-NP	O
factor	factor	NN	I-NP	O
for	for	IN	B-PP	O
cancer	cancer	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
aerodigestive	aerodigestive	JJ	I-NP	O
tract	tract	NN	I-NP	O
(	(	(	O	O
UAT	UAT	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
human	human	NN	B-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
acetaldehyde	acetaldehyde	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
metabolite	metabolite	NN	I-NP	O
from	from	IN	B-PP	O
ethanol	ethanol	NN	B-NP	O
by	by	IN	B-PP	O
alcohol	alcohol	NN	B-NP	B-protein
dehydrogenase	dehydrogenase	NN	I-NP	I-protein
(	(	(	O	O
ADH	ADH	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
is	be	VBZ	B-VP	O
regarded	regard	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
carcinogen	carcinogen	NN	I-NP	O
,	,	,	O	O
how	how	WRB	B-ADVP	O
systemic	systemic	JJ	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
acetaldehyde	acetaldehyde	NN	B-NP	O
particularly	particularly	RB	B-ADVP	O
affects	affect	VBZ	B-VP	O
the	the	DT	B-NP	O
UAT	UAT	NNP	I-NP	O
remains	remain	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
.	.	.	O	O

In	In	IN	B-PP	O
our	our	PRP$	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
searched	search	VBD	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
regional	regional	JJ	I-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
acetaldehyde	acetaldehyde	NN	B-NP	O
in	in	IN	B-PP	O
UAT	UAT	NNP	B-NP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
the	the	DT	B-NP	O
involvement	involvement	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
normal	normal	JJ	I-NP	O
oral	oral	JJ	I-NP	O
microflora	microflora	NN	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
,	,	,	O	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
identified	identify	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
,	,	,	O	O
genus	genus	NN	B-NP	O
Neisseria	Neisseria	NNP	B-NP	O
had	have	VBD	B-VP	O
extremely	extremely	RB	B-NP	O
high	high	JJ	I-NP	O
ADH	ADH	NN	I-NP	O
activity	activity	NN	I-NP	O
and	and	CC	O	O
produced	produce	VBD	B-VP	O
significant	significant	JJ	B-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
acetaldehyde	acetaldehyde	NN	B-NP	O
when	when	WRB	B-ADVP	O
cultured	culture	VBN	B-VP	O
with	with	IN	B-PP	O
medium	medium	NN	B-NP	O
containing	contain	VBG	B-VP	O
ethanol	ethanol	NN	B-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
produce	produce	VB	I-VP	O
acetaldehyde	acetaldehyde	NN	B-NP	O
was	be	VBD	B-VP	O
more	more	JJR	B-ADJP	O
than	than	IN	B-PP	O
100-fold	100-fold	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
produced	produce	VBN	B-VP	O
by	by	IN	B-PP	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
genera	genera	NN	I-NP	O
we	we	PRP	B-NP	O
studied	study	VBD	B-VP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
alcohol	alcohol	NN	B-NP	O
ingestion	ingestion	NN	I-NP	O
influences	influence	VBZ	B-VP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
composition	composition	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microflora	microflora	NN	I-NP	O
,	,	,	O	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
proportion	proportion	NN	I-NP	O
of	of	IN	B-PP	O
Neisseria	Neisseria	NNP	B-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
Neisseria	Neisseria	NNP	B-NP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
oral	oral	JJ	I-NP	O
microflora	microflora	NN	I-NP	O
is	be	VBZ	B-VP	O
generally	generally	RB	B-ADVP	O
non-pathogenic	non-pathogenic	JJ	B-ADJP	O
,	,	,	O	O
these	these	DT	B-NP	O
findings	finding	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
microbe	microbe	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
regional	regional	JJ	I-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
carcinogenic	carcinogenic	JJ	B-NP	O
acetaldehyde	acetaldehyde	NN	I-NP	O
and	and	CC	O	O
thus	thus	RB	B-VP	O
potentially	potentially	RB	I-VP	O
play	play	VB	I-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
alcohol-related	alcohol-related	JJ	B-NP	O
carcinogenesis	carcinogenesis	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
UAT	UAT	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aims	aim	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
were	be	VBD	B-VP	O
to	to	TO	I-VP	O
screen	screen	VB	I-VP	O
and	and	CC	O	O
characterize	characterize	VB	B-VP	O
the	the	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
lactic	lactic	JJ	I-NP	O
acid	acid	NN	I-NP	O
bacteria	bacteria	NNS	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
oral	oral	JJ	I-NP	O
cavities	cavity	NNS	I-NP	O
of	of	IN	B-PP	O
Thai	Thai	JJ	B-NP	O
volunteers	volunteer	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
to	to	TO	B-VP	O
characterize	characterize	VB	I-VP	O
their	their	PRP$	B-NP	O
inhibiting	inhibit	VBG	I-NP	O
substances	substance	NNS	I-NP	O
.	.	.	O	O

Among	Among	IN	B-PP	O
3790	3790	CD	B-NP	O
isolates	isolate	NNS	I-NP	O
(	(	(	O	O
suspected	suspect	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
lactic	lactic	JJ	B-NP	O
acid	acid	NN	I-NP	O
bacteria	bacteria	NNS	I-NP	O
)	)	)	O	O
from	from	IN	B-PP	O
130	130	CD	B-NP	O
volunteers	volunteer	NNS	I-NP	O
,	,	,	O	O
five	five	CD	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
appreciable	appreciable	JJ	I-NP	O
effect	effect	NN	I-NP	O
against	against	IN	B-PP	O
Sarcina	Sarcina	NNP	B-NP	O
lutea	lutea	NNP	I-NP	O
ATCC	ATCC	NNP	I-NP	O
9341	9341	CD	I-NP	O
,	,	,	O	O
Bacillus	Bacillus	CC	O	O
cereus	cereus	NN	B-NP	O
ATCC	ATCC	NN	I-NP	O
11778	11778	CD	B-NP	O
,	,	,	O	O
Escherichia	Escherichia	FW	B-NP	O
coli	coli	FW	I-NP	O
ATCC	ATCC	NN	I-NP	O
25922	25922	CD	I-NP	O
,	,	,	O	O
Staphylococcus	Staphylococcus	FW	B-NP	O
aureus	aureus	FW	I-NP	O
ATCC	ATCC	NN	I-NP	O
6538	6538	CD	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
DTMU	DTMU	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
Strep	Strep	NNP	B-NP	O
.	.	.	O	O

salivarius	salivarius	NN	B-NP	O
DTMU	DTMU	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
Strep	Strep	NNP	B-NP	O
.	.	.	O	O

sanguis	sanguis	NN	B-NP	O
DTMU	DTMU	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
Candida	Candida	NNP	B-NP	O
albicans	albicans	NNP	I-NP	O
ATCC	ATCC	NN	I-NP	O
13803	13803	CD	I-NP	O
and	and	CC	O	O
C.	C.	FW	B-NP	O
albicans	albicans	FW	I-NP	O
DTMU	DTMU	NN	I-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
isolates	isolate	NNS	I-NP	O
included	include	VBD	B-VP	O
L17	L17	NN	B-NP	B-protein
and	and	CC	I-NP	O
N14	N14	NN	I-NP	B-protein
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
antibacterial	antibacterial	JJ	I-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
D14	D14	NN	B-NP	B-protein
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
anticandidal	anticandidal	JJ	I-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
D6	D6	NN	B-NP	O
and	and	CC	I-NP	O
N8	N8	NN	I-NP	B-protein
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
both	both	CC	O	O
the	the	DT	B-NP	O
antibacterial	antibacterial	JJ	I-NP	O
and	and	CC	I-NP	O
anticandidal	anticandidal	JJ	I-NP	O
activities	activity	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
isolates	isolate	NNS	I-NP	O
were	be	VBD	B-VP	O
later	later	RB	I-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
facultative	facultative	JJ	B-NP	O
anaerobic	anaerobic	JJ	I-NP	O
,	,	,	I-NP	O
Gram-positive	Gram-positive	JJ	I-NP	O
,	,	,	I-NP	O
non-spore-forming	non-spore-forming	JJ	I-NP	O
,	,	,	I-NP	O
non-capsule-forming	non-capsule-forming	JJ	I-NP	O
and	and	CC	I-NP	O
catalase-negative	catalase-negative	JJ	I-NP	B-protein
bacilli	bacilli	NNS	I-NP	I-protein
.	.	.	O	O

They	They	PRP	B-NP	O
could	could	MD	B-VP	O
utilize	utilize	VB	I-VP	O
casein	casein	NN	B-NP	O
but	but	CC	O	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
hydrolyse	hydrolyse	VB	I-VP	O
starch	starch	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
they	they	PRP	B-NP	O
produced	produce	VBD	B-VP	O
hydrogen	hydrogen	NN	B-NP	O
peroxide	peroxide	NN	I-NP	O
and	and	CC	I-NP	O
bacteriocins	bacteriocin	NNS	I-NP	O
.	.	.	O	O

Their	Their	PRP$	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
potentials	potential	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
affected	affect	VBN	I-VP	O
by	by	IN	B-PP	O
pH	pH	NN	B-NP	O
,	,	,	O	O
catalase	catalase	NN	B-NP	B-protein
,	,	,	O	O
proteolytic	proteolytic	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
and	and	CC	O	O
temperature	temperature	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
partially	partially	RB	I-VP	O
inactivated	inactivate	VBN	I-VP	O
after	after	IN	B-PP	O
catalase	catalase	NN	B-NP	B-protein
treatment	treatment	NN	I-NP	O
,	,	,	O	O
significantly	significantly	RB	B-VP	O
declined	decline	VBD	I-VP	O
at	at	IN	B-PP	O
pH	pH	NN	B-NP	B-DNA
>	>	SYM	B-NP	I-DNA
or	or	CC	O	O
=9.0	=9.0	CD	B-NP	O
or	or	CC	O	O
after	after	IN	B-SBAR	O
trypsin	trypsin	NN	B-NP	B-protein
and	and	CC	I-NP	O
pepsin	pepsin	NN	I-NP	O
treatments	treatment	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
also	also	RB	B-VP	O
reduced	reduce	VBN	I-VP	O
after	after	IN	B-PP	O
heating	heat	VBG	B-VP	O
at	at	IN	B-PP	O
>	>	JJR	B-ADJP	O
or	or	CC	O	O
=100	=100	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C.	C.	NNP	B-NP	O
However	However	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
five	five	CD	I-NP	O
isolates	isolate	NNS	I-NP	O
was	be	VBD	B-VP	O
somewhat	somewhat	RB	B-ADJP	O
resistant	resistant	JJ	I-ADJP	O
to	to	TO	B-PP	O
heat	heat	NN	B-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
the	the	DT	B-NP	O
isolates	isolate	NNS	I-NP	O
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
for	for	IN	B-PP	O
their	their	PRP$	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
sensitivity	sensitivity	NN	I-NP	O
,	,	,	O	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
antimicrobial	antimicrobial	JJ	B-NP	O
agents	agent	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
final	final	JJ	I-NP	O
identification	identification	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
D6	D6	NN	B-NP	B-protein
,	,	,	I-NP	O
D14	D14	NN	I-NP	B-protein
and	and	CC	I-NP	O
N14	N14	NN	I-NP	B-protein
were	be	VBD	B-VP	O
Lactobacillus	Lactobacillus	JJ	B-NP	O
paracasei	paracasei	NN	I-NP	O
subsp	subsp	NN	I-NP	O
.	.	.	O	O

paracasei	paracasei	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
L17	L17	NN	B-NP	B-protein
and	and	CC	I-NP	O
N8	N8	NN	I-NP	B-protein
were	be	VBD	B-VP	O
Lact	Lact	NNP	B-NP	O
.	.	.	O	O

rhamnosus	rhamnosus	NN	B-NP	O
.	.	.	O	O

Beta-galactosyllactose	Beta-galactosyllactose	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
trisaccharide	trisaccharide	NN	I-NP	O
containing	contain	VBG	B-VP	O
the	the	DT	B-NP	O
beta-galactosidic	beta-galactosidic	JJ	I-NP	O
linkage	linkage	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
nonreducing	nonreducing	JJ	I-NP	O
end	end	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
purpose	purpose	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
certain	certain	JJ	B-NP	O
oral	oral	JJ	I-NP	O
streptococci	streptococci	NNS	I-NP	O
could	could	MD	B-VP	O
utilize	utilize	VB	I-VP	O
four	four	CD	B-NP	O
kinds	kind	NNS	I-NP	O
of	of	IN	B-PP	O
beta-galactosyllactoses	beta-galactosyllactos	NNS	B-NP	B-protein
.	.	.	O	O

Three	Three	CD	B-NP	O
of	of	IN	B-PP	O
four	four	CD	B-NP	O
beta-galactosyllactoses	beta-galactosyllactos	NNS	I-NP	O
were	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
support	support	VB	I-VP	O
growth	growth	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
streptococci	streptococci	NNS	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
substrate	substrate	NN	I-NP	O
for	for	IN	B-PP	O
producing	produce	VBG	B-VP	O
acid	acid	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
suspensions	suspension	NNS	I-NP	O
and	and	CC	O	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
.	.	.	O	O

4'-beta-Galactosyllactose	4'-beta-Galactosyllactose	JJ	B-NP	O
supported	support	VBN	I-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
sanguis	sanguis	NNP	I-NP	O
ATCC	ATCC	NNP	I-NP	O
35105	35105	CD	I-NP	O
,	,	,	O	O
ATCC	ATCC	NN	B-NP	O
49298	49298	CD	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mitis	mitis	NNP	I-NP	O
ATCC	ATCC	NNP	I-NP	O
15914	15914	CD	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
oralis	oralis	NNP	I-NP	O
ATCC	ATCC	NNP	I-NP	O
35037	35037	CD	I-NP	O
,	,	,	O	O
ATCC	ATCC	NN	B-NP	O
10557	10557	CD	I-NP	O
and	and	CC	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
milleri	milleri	NNP	I-NP	O
10707	10707	CD	I-NP	O
and	and	CC	O	O
produced	produce	VBD	B-VP	O
acid	acid	NN	B-NP	O
from	from	IN	B-PP	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
beta-galactosidase	beta-galactosidase	NN	B-NP	B-protein
activities	activity	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
strains	strain	NNS	I-NP	O
,	,	,	O	O
4'-beta-galactosyllactose	4'-beta-galactosyllactose	NN	B-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
carbon	carbon	NN	I-NP	O
source	source	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
mutans	mutan	NNS	B-NP	O
streptococci	streptococci	NNS	I-NP	O
.	.	.	O	O

Enzymes	Enzyme	NNS	B-NP	B-protein
metabolizing	metabolize	VBG	B-VP	O
4'-beta-galactosyllactose	4'-beta-galactosyllactose	NN	B-NP	O
were	be	VBD	B-VP	O
induced	induce	VBN	I-VP	O
when	when	WRB	B-ADVP	O
S.	S.	NNP	B-NP	O
oralis	oralis	CC	O	O
ATCC	ATCC	NN	B-NP	O
10557	10557	CD	I-NP	O
was	be	VBD	B-VP	O
cultured	culture	VBN	I-VP	O
in	in	IN	B-PP	O
medium	medium	NN	B-NP	O
containing	contain	VBG	B-VP	O
galactose	galactose	NN	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggested	suggest	VBD	B-VP	O
that	that	IN	B-SBAR	O
4'-beta-galactosyllactose	4'-beta-galactosyllactose	NN	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
as	as	RB	B-ADJP	O
cariogenic	cariogenic	JJ	I-ADJP	O
as	as	IN	B-PP	O
lactose	lactose	NN	B-NP	O
if	if	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
consumed	consume	VBN	I-VP	O
frequently	frequently	RB	B-ADVP	O
and	and	CC	O	O
retained	retain	VBN	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
period	period	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
purpose	purpose	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
adsorption	adsorption	NN	I-NP	O
of	of	IN	B-PP	O
[	[	(	B-NP	O
3H	3H	NN	I-NP	O
]	]	)	I-NP	O
-thymidine	-thymidine	JJ	I-NP	O
labeled	label	VBN	I-NP	O
oral	oral	JJ	I-NP	O
microorganisms	microorganism	NNS	I-NP	O
to	to	TO	B-PP	O
porous	porous	JJ	B-NP	O
type	type	NN	I-NP	O
calcium	calcium	NN	I-NP	O
carbonate	carbonate	NN	I-NP	O
(	(	(	O	O
PCC	PCC	NN	B-NP	O
)	)	)	O	O
beads	bead	VBZ	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
buffer	buffer	NN	I-NP	O
containing	contain	VBG	B-VP	O
human	human	JJ	B-NP	O
parotid	parotid	NN	I-NP	O
saliva	saliva	NN	I-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
PCC	PCC	NN	B-NP	B-protein
combined	combine	VBN	B-VP	O
chewing	chew	VBG	B-VP	O
gum	gum	NN	B-NP	O
sheets	sheet	NNS	I-NP	O
.	.	.	O	O

Adsorption	Adsorption	NN	B-NP	O
rates	rate	NNS	I-NP	O
of	of	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
sobrinus	sobrinus	NNP	I-NP	O
B13	B13	NN	I-NP	B-protein
and	and	CC	O	O
6715	6715	CD	B-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
MT8148R	MT8148R	NN	I-NP	B-protein
and	and	CC	O	O
Actinomyces	Actinomyce	VBZ	B-VP	O
naeslundii	naeslundii	NN	B-NP	O
T14V	T14V	NN	I-NP	O
with	with	IN	B-PP	O
PCC	PCC	NN	B-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
than	than	IN	B-PP	O
those	those	DT	B-NP	O
with	with	IN	B-PP	O
calcium	calcium	NN	B-NP	O
carbonate	carbonate	NN	I-NP	O
(	(	(	O	O
CC	CC	NN	B-NP	O
)	)	)	O	O
beads	bead	NNS	B-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.01	0.01	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Adsorption	Adsorption	NN	B-NP	O
rates	rate	NNS	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
sobrinus	sobrinus	NNP	I-NP	O
,	,	,	O	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
and	and	CC	O	O
A.	A.	NN	B-NP	O
naeslundii	naeslundii	NN	I-NP	O
with	with	IN	B-PP	O
PCC	PCC	NN	B-NP	O
combined	combine	VBN	B-VP	O
chewing	chew	VBG	B-NP	O
gum	gum	NN	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
than	than	IN	B-PP	O
those	those	DT	B-NP	O
with	with	IN	B-PP	O
CC	CC	NN	B-NP	O
combined	combine	VBN	B-VP	O
chewing	chew	VBG	B-VP	O
gum	gum	NN	B-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.01	0.01	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
present	present	JJ	I-NP	O
results	result	NNS	I-NP	O
suggested	suggest	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
chewing	chew	VBG	I-NP	O
gum	gum	NN	I-NP	O
containing	contain	VBG	B-VP	O
PCC	PCC	NN	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
exclude	exclude	VB	I-VP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
cariogenic	cariogenic	JJ	B-NP	O
and	and	CC	I-NP	O
periodontopathic	periodontopathic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
prevention	prevention	NN	B-NP	O
of	of	IN	B-PP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
and	and	CC	O	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
promising	promising	JJ	I-NP	O
way	way	NN	I-NP	O
of	of	IN	B-PP	O
reducing	reduce	VBG	B-VP	O
caries	cary	NNS	B-NP	O
is	be	VBZ	B-VP	O
by	by	IN	B-PP	O
using	use	VBG	B-VP	O
sucrose	sucrose	NN	B-NP	O
substitutes	substitute	NNS	I-NP	O
in	in	IN	B-PP	O
food	food	NN	B-NP	O
,	,	,	O	O
e.g.	e.g.	FW	B-NP	O
,	,	,	I-NP	O
palatinose	palatinose	NN	I-NP	O
or	or	CC	I-NP	O
leucrose	leucrose	NN	I-NP	O
.	.	.	O	O

Previous	Previous	JJ	B-NP	O
experiments	experiment	NNS	I-NP	O
addressing	address	VBG	B-VP	O
cariogenic	cariogenic	JJ	B-NP	O
potential	potential	NN	I-NP	O
of	of	IN	B-PP	O
sucrose	sucrose	NN	B-NP	O
substitutes	substitute	NNS	I-NP	O
have	have	VBP	B-VP	O
focused	focus	VBN	I-VP	O
mainly	mainly	RB	B-ADVP	O
on	on	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
many	many	JJ	I-NP	O
other	other	JJ	I-NP	O
micro-organisms	micro-organism	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
compared	compare	VBD	B-VP	O
the	the	DT	B-NP	O
acid	acid	NN	I-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
100	100	CD	B-NP	O
bacterial	bacterial	JJ	I-NP	O
strains	strain	NNS	I-NP	O
representing	represent	VBG	B-VP	O
44	44	CD	B-NP	O
different	different	JJ	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
batch	batch	NN	B-NP	O
fermentation	fermentation	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
test	test	NN	I-NP	O
tube	tube	NN	I-NP	O
containing	contain	VBG	B-VP	O
,	,	,	O	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
sole	sole	JJ	I-NP	O
carbohydrate	carbohydrate	NN	I-NP	O
source	source	NN	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
,	,	,	O	O
sucrose	sucrose	NN	B-NP	O
,	,	,	O	O
palatinose	palatinose	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
leucrose	leucrose	NN	B-NP	O
.	.	.	O	O

Selected	Select	VBN	B-NP	O
strains	strain	NNS	I-NP	O
were	be	VBD	B-VP	O
further	further	RB	I-VP	O
analyzed	analyze	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
fermenter	fermenter	NN	I-NP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
30	30	CD	B-NP	O
yeast	yeast	NN	I-NP	O
strains	strain	NNS	I-NP	O
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
auxanographic	auxanographic	JJ	I-NP	O
sugar	sugar	NN	I-NP	O
assimilation	assimilation	NN	I-NP	O
test	test	NN	I-NP	O
.	.	.	O	O

Only	Only	RB	B-NP	O
Lactobacillus	Lactobacillus	NN	I-NP	O
spp.	spp.	NN	I-NP	O
,	,	,	O	O
Stomatococcus	Stomatococcus	NNP	B-NP	O
mucilaginosus	mucilaginosus	NN	I-NP	O
,	,	,	O	O
Leuconostoc	Leuconostoc	NN	B-NP	O
mesenteroides	mesenteroide	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Weissella	Weissella	NN	B-NP	O
paramesenteroides	paramesenteroide	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
yeasts	yeast	NNS	I-NP	O
studied-i.e.	studied-i.e.	NN	I-NP	O
,	,	,	O	O
Candida	Candida	NNP	B-NP	O
albicans	albicans	NNP	I-NP	O
,	,	,	O	O
C.	C.	NNP	B-NP	O
tropicalis	tropicalis	NNP	I-NP	O
,	,	,	O	O
C.	C.	NNP	B-NP	O
parapsilosis	parapsilosis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Saccharomyces	Saccharomyce	VBZ	B-VP	O
cerevisiae-utilized	cerevisiae-utilized	JJ	B-NP	O
leucrose	leucrose	NN	I-NP	O
and/or	and/or	CC	I-NP	O
palatinose	palatinose	NN	I-NP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

Strikingly	Strikingly	RB	B-ADVP	O
,	,	,	O	O
Stomatococcus	Stomatococcus	NNP	B-NP	O
mucilaginosus	mucilaginosus	NN	I-NP	O
produced	produce	VBD	B-VP	O
water-insoluble	water-insoluble	JJ	B-NP	O
polysaccharides	polysaccharide	NNS	I-NP	O
by	by	IN	B-PP	O
fermentation	fermentation	NN	B-NP	O
of	of	IN	B-PP	O
leucrose	leucrose	NN	B-NP	O
and	and	CC	I-NP	O
palatinose	palatinose	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
fermenter	fermenter	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
respective	respective	JJ	I-NP	O
sucrose	sucrose	NN	I-NP	O
substitutes	substitute	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
only	only	RB	I-VP	O
cleaved	cleave	VBD	I-VP	O
but	but	CC	O	O
also	also	RB	B-ADVP	O
utilized	utilize	VBN	B-VP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
extracellular	extracellular	JJ	B-NP	O
cleavage	cleavage	NN	I-NP	O
by	by	IN	B-PP	O
autochthonous	autochthonous	JJ	B-NP	O
micro-organisms	micro-organism	NNS	I-NP	O
may	may	MD	B-VP	O
produce	produce	VB	I-VP	O
cariogenic	cariogenic	JJ	B-NP	B-protein
cleavage	cleavage	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
(	(	(	O	O
glucose	glucose	NN	B-NP	O
,	,	,	I-NP	O
fructose	fructose	NN	I-NP	O
)	)	)	O	O
that	that	WDT	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
by	by	IN	B-PP	O
other	other	JJ	B-NP	O
well-characterized	well-characterized	JJ	I-NP	O
cariogenic	cariogenic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
flora	flora	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
anticariogenic	anticariogenic	JJ	I-NP	O
potential	potential	NN	I-NP	O
of	of	IN	B-PP	O
sucrose	sucrose	NN	B-NP	O
substitutes	substitute	NNS	I-NP	O
in	in	IN	B-PP	O
food	food	NN	B-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
limited	limit	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
susceptibility	susceptibility	NN	I-NP	O
(	(	(	O	O
MIC	MIC	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
44	44	CD	B-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
and	and	CC	O	O
3	3	CD	B-NP	O
standard	standard	JJ	I-NP	O
strains	strain	NNS	I-NP	O
to	to	TO	B-PP	O
statherin	statherin	NN	B-NP	B-protein
and	and	CC	O	O
its	its	PRP$	B-NP	O
C-terminal	C-terminal	JJ	I-NP	B-protein
fragments	fragment	NNS	I-NP	I-protein
with	with	IN	B-PP	O
sequences	sequence	NNS	B-NP	O
QYQQYTF	QYQQYTF	NN	I-NP	B-protein
,	,	,	O	O
YQQYTF	YQQYTF	NN	B-NP	B-protein
,	,	,	O	O
QQYTF	QQYTF	NN	B-NP	B-protein
,	,	,	O	O
QYTF	QYTF	NN	B-NP	B-protein
and	and	CC	I-NP	O
YTF	YTF	NN	I-NP	B-protein
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
by	by	IN	B-PP	O
means	mean	NNS	B-NP	O
of	of	IN	B-PP	O
plate	plate	NN	B-NP	O
dilution	dilution	NN	I-NP	O
technique	technique	NN	I-NP	O
in	in	IN	B-PP	O
Brucella	Brucella	NNP	B-NP	O
agar	agar	NN	I-NP	O
with	with	IN	B-PP	O
5	5	CD	B-NP	O
%	%	NN	I-NP	O
content	content	NN	I-NP	O
of	of	IN	B-PP	O
defibrinated	defibrinate	VBN	B-NP	O
sheep's	sheep's	POS	I-NP	O
blood	blood	NN	I-NP	O
,	,	,	I-NP	O
menadione	menadione	NN	I-NP	O
and	and	CC	I-NP	O
hemin	hemin	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
culture	culture	NN	I-NP	O
was	be	VBD	B-VP	O
anaerobic	anaerobic	JJ	B-ADJP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
shown	show	VBN	B-VP	O
,	,	,	O	O
at	at	IN	B-PP	O
concentrations	concentration	NNS	B-NP	O
from	from	IN	B-PP	O
12.5	12.5	CD	B-NP	O
to	to	TO	I-NP	O
100	100	CD	I-NP	O
microg/ml	microg/ml	NN	I-NP	O
statherin	statherin	NN	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
C-terminal	C-terminal	JJ	I-NP	B-protein
fragments	fragment	NNS	I-NP	I-protein
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

Peptostreptococcus	Peptostreptococcus	NN	B-NP	O
strains	strain	NNS	I-NP	O
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
susceptible	susceptible	JJ	I-NP	O
to	to	TO	B-PP	O
statherin	statherin	NN	B-NP	O
and	and	CC	I-NP	O
YTF	YTF	NN	I-NP	B-protein
(	(	(	O	O
MIC	MIC	NN	B-NP	O
<	<	SYM	B-VP	O
or	or	CC	O	O
=	=	SYM	B-VP	O
12.5	12.5	CD	B-NP	O
mg/ml	mg/ml	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
susceptible	susceptible	JJ	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
peptides	peptide	NNS	I-NP	O
investigated	investigate	VBN	B-VP	O
were	be	VBD	B-VP	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
necrogenes	necrogene	NNS	I-NP	O
and	and	CC	O	O
Fusobacterium	Fusobacterium	NN	B-NP	O
necrophorum	necrophorum	NN	I-NP	O
strains	strain	NNS	I-NP	O
:	:	:	O	O
QYQQYTF	QYQQYTF	NN	B-NP	B-protein
,	,	,	O	O
YQQYTF	YQQYTF	NN	B-NP	B-protein
,	,	,	O	O
QQYTF	QQYTF	NN	B-NP	B-protein
,	,	,	O	O
QYTF	QYTF	NN	B-NP	B-protein
(	(	(	O	O
MIC	MIC	NN	B-NP	O
<	<	SYM	B-VP	O
or	or	CC	O	O
=	=	SYM	B-VP	O
12.5	12.5	CD	B-NP	O
microg/ml	microg/ml	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Prevotella	Prevotella	NNP	B-NP	O
oralis	oralis	NN	I-NP	O
,	,	,	O	O
Bacteroides	Bacteroide	NNS	B-NP	O
forsythus	forsythus	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
Bacteroides	Bacteroides	NNP	B-NP	O
ureolyticus	ureolyticus	NN	I-NP	O
,	,	,	O	O
strains	strain	NNS	B-NP	O
exhibited	exhibit	VBD	B-VP	O
the	the	DT	B-NP	O
lowest	low	JJS	I-NP	O
susceptibility	susceptibility	NN	I-NP	O
(	(	(	O	O
MIC	MIC	NN	B-NP	O
>	>	SYM	O	O
100	100	CD	B-NP	O
microg/ml	microg/ml	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
analysing	analyse	VBG	B-VP	O
the	the	DT	B-NP	O
bacteriostatic	bacteriostatic	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
statherin	statherin	NN	B-NP	O
it	it	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
pointed	point	VBN	I-VP	O
out	out	RP	B-PRT	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
peptide	peptide	NN	I-NP	O
used	use	VBN	B-VP	O
in	in	IN	B-PP	O
microbiological	microbiological	JJ	B-NP	O
investigations	investigation	NNS	I-NP	O
are	be	VBP	B-VP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
physiological	physiological	JJ	B-NP	O
concentrations	concentration	NNS	I-NP	O
determined	determine	VBN	B-VP	O
for	for	IN	B-PP	O
whole	whole	JJ	B-NP	O
saliva	saliva	NN	I-NP	O
when	when	WRB	B-ADVP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
and	and	CC	O	O
stimulated	stimulate	VBN	B-VP	O
in	in	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
donors	donor	NNS	I-NP	O
of	of	IN	B-PP	O
19-25	19-25	CD	B-NP	O
years	year	NNS	I-NP	O
of	of	IN	B-PP	O
age	age	NN	B-NP	O
.	.	.	O	O

Since	Since	IN	B-SBAR	O
the	the	DT	B-NP	O
anaerobes	anaerobe	NNS	I-NP	O
investigated	investigate	VBN	B-VP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
diseases	disease	NNS	I-NP	O
of	of	IN	B-PP	O
periodontum	periodontum	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
presented	present	VBN	B-VP	O
seem	seem	VBP	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
also	also	RB	B-ADVP	O
a	a	DT	B-NP	O
practical	practical	JJ	I-NP	O
aspect	aspect	NN	I-NP	O
,	,	,	O	O
i.e	i.e	NN	B-NP	O
.	.	.	O	O

a	a	DT	B-NP	O
possibility	possibility	NN	I-NP	O
to	to	TO	B-VP	O
apply	apply	VB	I-VP	O
the	the	DT	B-NP	O
C-terminal	C-terminal	JJ	I-NP	B-protein
fragments	fragment	NNS	I-NP	I-protein
of	of	IN	B-PP	O
statherin	statherin	NN	B-NP	B-protein
as	as	IN	B-PP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
therapeutic	therapeutic	JJ	I-NP	O
agent	agent	NN	I-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
favourably	favourably	RB	B-ADVP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

Escherichia	Escherichia	FW	B-NP	O
coli	coli	FW	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
common	common	JJ	I-NP	O
gut	gut	NN	I-NP	O
inhabitant	inhabitant	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
usually	usually	RB	B-ADVP	O
out	out	RB	B-ADVP	O
numbered	number	VBN	B-VP	O
by	by	IN	B-PP	O
strictly	strictly	RB	B-NP	O
anaerobic	anaerobic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
fecal	fecal	JJ	B-NP	O
material	material	NN	I-NP	O
is	be	VBZ	B-VP	O
exposed	expose	VBN	I-VP	O
to	to	TO	B-PP	O
oxygen	oxygen	NN	B-NP	O
,	,	,	O	O
fermentation	fermentation	NN	B-NP	O
acids	acid	NNS	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
respired	respire	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
numbers	number	NNS	I-NP	O
increase	increase	VBP	B-VP	O
.	.	.	O	O

E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
can	can	MD	B-VP	O
survive	survive	VB	I-VP	O
for	for	IN	B-PP	O
long	long	JJ	B-NP	O
periods	period	NNS	I-NP	O
of	of	IN	B-PP	O
time	time	NN	B-NP	O
in	in	IN	B-PP	O
feces	fece	NNS	B-NP	O
,	,	,	O	O
but	but	CC	O	O
subsequent	subsequent	JJ	B-NP	O
proliferation	proliferation	NN	I-NP	O
is	be	VBZ	B-VP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
its	its	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
re-enter	re-enter	VB	I-VP	O
the	the	DT	B-NP	O
gastrointestinal	gastrointestinal	JJ	I-NP	O
tract	tract	NN	I-NP	O
via	via	IN	B-PP	O
contaminated	contaminate	VBN	B-NP	O
water	water	NN	I-NP	O
and	and	CC	I-NP	O
food	food	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
oral-fecal	oral-fecal	JJ	I-NP	O
lifestyle	lifestyle	NN	I-NP	O
of	of	IN	B-PP	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
is	be	VBZ	B-VP	O
facilitated	facilitate	VBN	I-VP	O
by	by	IN	B-PP	O
its	its	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
survive	survive	VB	I-VP	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
pH	pH	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
gastric	gastric	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Most	Most	JJS	B-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
cause	cause	VB	I-VP	O
human	human	JJ	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
some	some	DT	B-NP	O
strains	strain	NNS	I-NP	O
produce	produce	VBP	B-VP	O
toxins	toxin	NNS	B-NP	O
and	and	CC	O	O
other	other	JJ	B-NP	O
virulence	virulence	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
.	.	.	O	O

Mature	Mature	JJ	B-NP	O
cattle	cattle	NNS	I-NP	O
carry	carry	VBP	B-VP	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
O157	O157	NN	I-NP	O
:	:	:	O	O
H7	H7	NN	B-NP	O
without	without	IN	B-PP	O
showing	show	VBG	B-VP	O
signs	sign	NNS	B-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
beef	beef	NN	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
contaminated	contaminate	VBN	I-VP	O
with	with	IN	B-PP	O
cattle	cattle	NNS	B-NP	O
feces	fece	NNS	I-NP	O
at	at	IN	B-PP	O
slaughter	slaughter	NN	B-NP	O
.	.	.	O	O

Cattle	Cattle	NN	B-NP	O
manure	manure	NN	I-NP	O
is	be	VBZ	B-VP	O
often	often	RB	I-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
fertilizer	fertilizer	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
vegetable	vegetable	JJ	I-NP	O
industry	industry	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
from	from	IN	B-PP	O
manure	manure	NN	B-NP	O
can	can	MD	B-VP	O
migrate	migrate	VB	I-VP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
soil	soil	NN	I-NP	O
into	into	IN	B-PP	O
water	water	NN	B-NP	O
supplies	supply	NNS	I-NP	O
.	.	.	O	O

Sanitation	Sanitation	NN	B-NP	O
,	,	,	I-NP	O
cooking	cooking	NN	I-NP	O
and	and	CC	I-NP	O
chlorination	chlorination	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
combat	combat	VB	I-VP	O
fecal	fecal	JJ	B-NP	O
E.	E.	NNP	I-NP	O
coli	coli	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
these	these	DT	B-NP	O
methods	method	NNS	I-NP	O
are	be	VBP	B-VP	O
not	not	RB	O	O
always	always	RB	B-ADVP	O
effective	effective	JJ	B-ADJP	O
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
work	work	NN	I-NP	O
indicates	indicate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
cattle	cattle	NNS	B-NP	O
diets	diet	NNS	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
modified	modify	VBN	I-VP	O
overcome	overcome	VB	B-VP	O
the	the	DT	B-NP	O
extreme	extreme	JJ	I-NP	O
acid	acid	NN	I-NP	O
resistance	resistance	NN	I-NP	O
of	of	IN	B-PP	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
cattle	cattle	NNS	B-NP	O
were	be	VBD	B-VP	O
fed	feed	VBN	I-VP	O
have	have	VBP	B-VP	O
for	for	IN	B-PP	O
only	only	RB	B-NP	O
a	a	DT	I-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
colonic	colonic	JJ	B-NP	O
volatile	volatile	JJ	I-NP	O
fatty	fatty	JJ	I-NP	O
acid	acid	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
declined	decline	VBD	B-VP	O
,	,	,	O	O
pH	pH	NN	B-NP	O
increased	increase	VBD	B-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
E.	E.	FW	I-NP	O
coli	coli	FW	I-NP	O
were	be	VBD	B-VP	O
no	no	RB	B-ADJP	O
longer	longer	RB	I-ADJP	O
able	able	JJ	I-ADJP	O
to	to	TO	B-VP	O
survive	survive	VB	I-VP	O
a	a	DT	B-NP	O
pH	pH	NN	I-NP	O
shock	shock	NN	I-NP	O
that	that	WDT	B-NP	O
mimicked	mimic	VBD	B-VP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
gastric	gastric	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

E.	E.	FW	B-ADVP	O
coli	coli	FW	I-ADVP	O
in	in	IN	B-PP	O
stored	store	VBN	B-NP	O
cattle	cattle	NNS	I-NP	O
manure	manure	VBP	B-VP	O
eventually	eventually	RB	I-VP	O
become	become	VB	I-VP	O
highly	highly	RB	B-ADJP	O
acid	acid	NN	I-ADJP	O
resistant	resistant	JJ	I-ADJP	O
even	even	RB	B-SBAR	O
if	if	IN	I-SBAR	O
the	the	DT	B-NP	O
cattle	cattle	NNS	I-NP	O
were	be	VBD	B-VP	O
fed	feed	VBN	I-VP	O
hay	hay	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
these	these	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
killed	kill	VBN	I-VP	O
by	by	IN	B-PP	O
sodium	sodium	NN	B-NP	O
carbonate	carbonate	NN	I-NP	O
(	(	(	O	O
150	150	CD	B-NP	O
mM	mM	NN	I-NP	O
,	,	,	O	O
pH	pH	NN	B-NP	O
8.5	8.5	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

Because	Because	IN	B-SBAR	O
the	the	DT	B-NP	O
diet	diet	NN	I-NP	O
manipulations	manipulation	NNS	I-NP	O
and	and	CC	O	O
carbonate	carbonate	NN	B-NP	O
treatments	treatment	NNS	I-NP	O
affected	affect	VBD	B-VP	O
E.	E.	FW	B-ADVP	O
coli	coli	FW	I-ADVP	O
in	in	IN	B-PP	O
general	general	JJ	B-ADJP	O
rather	rather	RB	B-PP	O
than	than	IN	I-PP	O
specific	specific	JJ	B-NP	O
serotypes	serotype	NNS	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
likelihood	likelihood	NN	I-NP	O
of	of	IN	B-PP	O
successful	successful	JJ	B-NP	O
field	field	NN	I-NP	O
application	application	NN	I-NP	O
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
studies	study	NNS	I-NP	O
reported	report	VBD	B-VP	O
significant	significant	JJ	B-NP	O
,	,	,	I-NP	O
additional	additional	JJ	I-NP	O
clinical	clinical	JJ	I-NP	O
and	and	CC	I-NP	O
microbiological	microbiological	JJ	I-NP	O
improvements	improvement	NNS	I-NP	O
when	when	WRB	B-ADVP	O
severe	severe	JJ	B-NP	O
adult	adult	JJ	I-NP	O
periodontitis	periodontitis	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
via	via	IN	B-PP	O
the	the	DT	B-NP	O
one-stage	one-stage	JJ	I-NP	O
full-mouth	full-mouth	JJ	I-NP	O
(	(	(	O	O
OSFM	OSFM	JJ	B-ADJP	O
)	)	)	O	O
disinfection	disinfection	NN	B-NP	O
approach	approach	NN	I-NP	O
,	,	,	O	O
instead	instead	RB	B-PP	O
of	of	IN	I-PP	O
a	a	DT	B-NP	O
standard	standard	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
scheme	scheme	NN	I-NP	O
with	with	IN	B-PP	O
staged	stag	VBN	B-NP	O
instrumentation	instrumentation	NN	I-NP	O
per	per	IN	B-PP	O
quadrant	quadrant	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
OSFM	OSFM	NNP	I-NP	O
disinfection	disinfection	NN	I-NP	O
involves	involve	VBZ	B-VP	O
dealing	deal	VBG	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
remaining	remain	VBG	I-NP	O
oropharyngeal	oropharyngeal	JJ	I-NP	O
niches	niche	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
tonsils	tonsil	NNS	B-NP	O
,	,	,	O	O
saliva	saliva	NN	B-NP	O
,	,	,	O	O
tongue	tongue	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
mucosa	mucosa	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
OSFM	OSFM	NNP	I-NP	O
disinfection	disinfection	NN	I-NP	O
procedure	procedure	NN	I-NP	O
involves	involve	VBZ	B-VP	O
scaling	scaling	NN	B-NP	O
and	and	CC	I-NP	O
root	root	NN	I-NP	O
planing	planing	NN	I-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
pockets	pocket	NNS	I-NP	O
within	within	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
in	in	IN	B-PP	O
combination	combination	NN	B-NP	O
with	with	IN	B-PP	O
chlorhexidine	chlorhexidine	NN	B-NP	O
application	application	NN	I-NP	O
to	to	TO	B-PP	O
all	all	DT	B-NP	O
oropharyngeal	oropharyngeal	JJ	I-NP	O
niches	niche	NNS	I-NP	O
(	(	(	O	O
chairside	chairside	NN	B-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
for	for	IN	B-PP	O
2	2	CD	B-NP	O
months	month	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
aimed	aim	VBD	B-VP	O
to	to	TO	I-VP	O
compare	compare	VB	I-VP	O
the	the	DT	B-NP	O
microbiological	microbiological	JJ	I-NP	O
shifts	shift	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
OSFM	OSFM	NNP	I-NP	O
approach	approach	NN	I-NP	O
versus	versus	IN	B-PP	O
standard	standard	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

Nineteen	Nineteen	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
advanced	advance	VBN	B-NP	O
chronic	chronic	JJ	I-NP	O
periodontitis	periodontitis	NN	I-NP	O
(	(	(	O	O
AP	AP	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
12	12	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
early-onset	early-onset	JJ	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
(	(	(	O	O
EOP	EOP	NN	B-NP	B-protein
)	)	)	O	O
were	be	VBD	B-VP	O
randomly	randomly	RB	I-VP	O
assigned	assign	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
test	test	NN	I-NP	O
and	and	CC	I-NP	O
control	control	NN	I-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
(	(	(	O	O
9	9	CD	B-NP	O
AP	AP	NN	I-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
6	6	CD	B-NP	O
EOP	EOP	NN	I-NP	O
patients	patient	NNS	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
scaled	scale	VBN	I-VP	O
and	and	CC	O	O
root	root	NN	B-NP	O
planed	plan	VBD	B-VP	O
,	,	,	O	O
per	per	IN	B-PP	O
quadrant	quadrant	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
2-week	2-week	JJ	B-NP	O
intervals	interval	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
test	test	NN	I-NP	O
group	group	NN	I-NP	O
(	(	(	O	O
10	10	CD	B-NP	O
AP	AP	NN	I-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	O	O
6	6	CD	B-NP	O
EOP	EOP	NN	I-NP	O
patients	patient	NNS	I-NP	O
)	)	)	O	O
underwent	undergo	VBD	B-VP	O
OSFM	OSFM	NN	B-NP	O
disinfection	disinfection	NN	I-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
and	and	CC	O	O
after	after	IN	B-PP	O
2	2	CD	B-NP	O
,	,	,	I-NP	O
4	4	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
8	8	CD	B-NP	O
months	month	NNS	I-NP	O
,	,	,	O	O
pooled	pool	VBD	B-VP	O
subgingival	subgingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
from	from	IN	B-PP	O
single-	single-	JJ	B-NP	O
and	and	CC	I-NP	O
multi-rooted	multi-rooted	JJ	I-NP	O
teeth	tooth	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
presence	presence	NN	I-NP	O
and	and	CC	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
subgingival	subgingival	JJ	I-NP	O
taxa	taxa	NN	I-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
using	use	VBG	B-VP	O
whole	whole	JJ	B-NP	O
genomic	genomic	JJ	I-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
probes	probe	NNS	I-NP	I-DNA
and	and	CC	O	O
checkerboard	checkerboard	NN	B-NP	O
DNA-DNA	DNA-DNA	NN	I-NP	O
hybridization	hybridization	NN	I-NP	O
.	.	.	O	O

Both	Both	DT	B-NP	O
treatments	treatment	NNS	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
important	important	JJ	B-NP	O
reductions	reduction	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pathogenic	pathogenic	JJ	I-NP	O
species	specie	NNS	I-NP	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
8	8	CD	I-NP	O
months	month	NNS	I-NP	O
after	after	IN	B-PP	O
therapy	therapy	NN	B-NP	O
,	,	,	O	O
both	both	DT	B-PP	O
for	for	IN	I-PP	O
their	their	PRP$	B-NP	O
detection	detection	NN	I-NP	O
level	level	NN	I-NP	O
and	and	CC	I-NP	O
frequency	frequency	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
OSFM	OSFM	NNP	I-NP	O
disinfection	disinfection	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
improvement	improvement	NN	I-NP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
AP	AP	NN	I-NP	O
group	group	NN	I-NP	O
.	.	.	O	O

P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
and	and	CC	O	O
B.	B.	NNP	B-NP	O
forsythus	forsythus	RB	B-ADVP	O
were	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
below	below	IN	B-PP	O
detection	detection	NN	B-NP	O
level	level	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
beneficial	beneficial	JJ	B-NP	O
species	specie	NNS	I-NP	O
remained	remain	VBD	B-VP	O
nearly	nearly	RB	B-ADJP	O
unchanged	unchanged	JJ	I-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
OSFM	OSFM	NNP	I-NP	O
disinfection	disinfection	NN	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
supplementary	supplementary	JJ	B-NP	O
reductions	reduction	NNS	I-NP	O
of	of	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
pathogens	pathogen	NNS	I-NP	O
even	even	RB	B-SBAR	O
after	after	IN	I-SBAR	O
8	8	CD	B-NP	O
months	month	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
advanced	advanced	JJ	B-NP	O
or	or	CC	I-NP	O
early-onset	early-onset	JJ	I-NP	O
periodontitis	periodontitis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
carriage	carriage	NN	B-NP	O
of	of	IN	B-PP	O
antibiotic-resistant	antibiotic-resistant	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
7-	7-	JJ	I-NP	O
and	and	CC	I-NP	O
8-year-old	8-year-old	JJ	I-NP	O
children	child	NNS	I-NP	O
in	in	IN	B-PP	O
Bristol	Bristol	NNP	B-NP	O
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
.	.	.	O	O

Children	Child	NNS	B-NP	O
born	bear	VBN	B-VP	O
in	in	IN	B-PP	O
Avon	Avon	NNP	B-NP	O
between	between	IN	B-PP	O
1	1	CD	B-NP	O
April	April	NNP	I-NP	O
1991	1991	CD	I-NP	O
and	and	CC	I-NP	O
31	31	CD	I-NP	O
December	December	NNP	I-NP	O
1992	1992	CD	I-NP	O
,	,	,	O	O
attending	attend	VBG	B-VP	O
the	the	DT	B-NP	O
Avon	Avon	NNP	I-NP	O
Longitudinal	Longitudinal	NNP	I-NP	O
Study	Study	NNP	I-NP	O
of	of	IN	B-PP	O
Pregnancy	Pregnancy	NNP	B-NP	O
and	and	CC	I-NP	O
Childhood	Childhood	NNP	I-NP	O
(	(	(	O	O
ALSPAC	ALSPAC	NN	B-NP	O
)	)	)	O	O
7	7	CD	B-NP	O
year	year	NN	I-NP	O
follow-up	follow-up	JJ	I-NP	O
clinic	clinic	NN	I-NP	O
,	,	,	O	O
formed	form	VBD	B-VP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
population	population	NN	I-NP	O
.	.	.	O	O

Carriage	Carriage	NN	B-NP	O
was	be	VBD	B-VP	O
estimated	estimate	VBN	I-VP	O
using	use	VBG	B-VP	O
mouth	mouth	NN	B-NP	O
and	and	CC	I-NP	O
stool	stool	NN	I-NP	O
samples	sample	NNS	I-NP	O
.	.	.	O	O

None	None	NN	B-NP	O
of	of	IN	B-PP	O
105	105	CD	B-NP	O
children	child	NNS	I-NP	O
on	on	IN	B-PP	O
whom	whom	WP	B-NP	O
information	information	NN	B-NP	O
was	be	VBD	B-VP	O
available	available	JJ	B-ADJP	O
had	have	VBD	B-VP	O
received	receive	VBN	I-VP	O
tetracycline	tetracycline	NN	B-NP	O
,	,	,	O	O
chloramphenicol	chloramphenicol	NN	B-NP	O
,	,	,	O	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
or	or	CC	O	O
an	an	DT	B-NP	O
extended-spectrum	extended-spectrum	JJ	I-NP	O
cephalosporin	cephalosporin	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
previous	previous	JJ	I-NP	O
year	year	NN	I-NP	O
.	.	.	O	O

Staphylococcus	Staphylococcus	FW	B-ADVP	O
aureus	aureus	FW	I-ADVP	O
was	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
mouthwashes	mouthwash	NNS	B-NP	O
from	from	IN	B-PP	O
200	200	CD	B-NP	O
(	(	(	O	O
37.1	37.1	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
539	539	CD	B-NP	O
children	child	NNS	I-NP	O
sampled	sample	VBN	B-VP	O
.	.	.	O	O

Six	Six	CD	B-NP	O
(	(	(	O	O
3	3	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
isolates	isolate	NNS	I-NP	O
were	be	VBD	B-VP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
chloramphenicol	chloramphenicol	NN	B-NP	O
or	or	CC	I-NP	O
tetracycline	tetracycline	NN	I-NP	O
and	and	CC	O	O
four	four	CD	B-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
methicillin	methicillin	NN	B-ADJP	O
resistant	resistant	JJ	I-ADJP	O
.	.	.	O	O

Haemophilus	Haemophilus	NN	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
369	369	CD	B-NP	O
(	(	(	O	O
72	72	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
513	513	CD	B-NP	O
samples	sample	NNS	I-NP	O
and	and	CC	O	O
63	63	CD	B-NP	O
(	(	(	O	O
17	17	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
ampicillin	ampicillin	NN	B-NP	O
resistant	resistant	JJ	B-ADJP	O
,	,	,	O	O
49	49	CD	B-NP	O
(	(	(	O	O
13.3	13.3	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
erythromycin	erythromycin	NN	B-ADJP	O
resistant	resistant	JJ	I-ADJP	O
and	and	CC	O	O
seven	seven	CD	B-NP	O
(	(	(	O	O
1.9	1.9	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
tetracycline	tetracycline	NN	B-ADJP	O
resistant	resistant	JJ	I-ADJP	O
.	.	.	O	O

Branhamella	Branhamella	NN	B-NP	O
catarrhalis	catarrhalis	NN	I-NP	O
was	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
333	333	CD	B-NP	O
(	(	(	O	O
74	74	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
450	450	CD	B-NP	O
samples	sample	NNS	I-NP	O
.	.	.	O	O

Twenty-eight	Twenty-eight	CD	B-NP	O
(	(	(	O	O
8.4	8.4	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
erythromycin	erythromycin	NN	B-ADJP	O
resistant	resistant	JJ	I-ADJP	O
and	and	CC	O	O
14	14	CD	B-NP	O
(	(	(	O	O
4.2	4.2	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
strains	strain	NNS	B-NP	O
were	be	VBD	B-VP	O
tetracycline	tetracycline	NN	B-ADJP	O
resistant	resistant	JJ	I-ADJP	O
.	.	.	O	O

Group	Group	VB	B-VP	O
A	A	DT	B-NP	O
beta-haemolytic	beta-haemolytic	JJ	I-NP	O
streptococci	streptococci	NNS	I-NP	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
17	17	CD	B-NP	O
of	of	IN	B-PP	O
507	507	CD	B-NP	O
children	child	NNS	I-NP	O
sampled	sample	VBN	B-VP	O
.	.	.	O	O

One	One	CD	B-NP	O
(	(	(	O	O
5.9	5.9	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
tetracycline	tetracycline	NN	B-ADJP	O
resistant	resistant	JJ	I-ADJP	O
.	.	.	O	O

Stool	Stool	NN	B-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
returned	return	VBN	I-VP	O
from	from	IN	B-PP	O
335	335	CD	B-NP	O
(	(	(	O	O
62	62	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
539	539	CD	B-NP	O
children	child	NNS	I-NP	O
from	from	IN	B-PP	O
whom	whom	WP	B-NP	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
requested	request	VBN	I-VP	O
.	.	.	O	O

Eleven	Eleven	CD	B-NP	O
per	per	IN	B-PP	O
cent	cent	NN	B-NP	O
of	of	IN	B-PP	O
samples	sample	NNS	B-NP	O
yielded	yield	VBD	B-VP	O
Gram-negative	Gram-negative	JJ	B-NP	O
bacilli	bacilli	NNS	I-NP	O
with	with	IN	B-PP	O
high-level	high-level	JJ	B-NP	O
resistance	resistance	NN	I-NP	O
to	to	TO	B-PP	O
chloramphenicol	chloramphenicol	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
frequently	frequently	RB	I-VP	O
linked	link	VBN	I-VP	O
to	to	TO	B-PP	O
resistance	resistance	NN	B-NP	O
to	to	TO	B-PP	O
ampicillin	ampicillin	NN	B-NP	O
,	,	,	I-NP	O
spectinomycin	spectinomycin	NN	I-NP	O
and	and	CC	I-NP	O
streptomycin	streptomycin	NN	I-NP	O
.	.	.	O	O

Isolates	Isolate	NNS	B-NP	O
demonstrating	demonstrate	VBG	B-VP	O
resistance	resistance	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
third-generation	third-generation	JJ	I-NP	O
cephalosporin	cephalosporin	NN	I-NP	O
ceftazidime	ceftazidime	NN	I-NP	O
were	be	VBD	B-VP	O
recovered	recover	VBN	I-VP	O
from	from	IN	B-PP	O
17	17	CD	B-NP	O
subjects	subject	NNS	I-NP	O
(	(	(	O	O
3.2	3.2	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Six	Six	CD	B-NP	O
(	(	(	O	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
17	17	CD	B-NP	B-protein
isolates	isolate	NNS	I-NP	I-protein
possessed	possess	VBD	B-VP	I-protein
extended-spectrum	extended-spectrum	JJ	B-NP	I-protein
beta-lactamases	beta-lactamas	NNS	I-NP	I-protein
.	.	.	O	O

Healthy	Healthy	JJ	B-NP	O
children	child	NNS	I-NP	O
carry	carry	VBP	B-VP	O
bacteria	bacteria	NNS	B-NP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
to	to	TO	B-PP	O
which	which	WDT	B-NP	O
children	child	NNS	B-NP	O
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
usually	usually	RB	I-VP	O
exposed	expose	VBN	I-VP	O
.	.	.	O	O

Resistance	Resistance	NN	B-NP	O
to	to	TO	B-PP	O
ceftazidime	ceftazidime	NN	B-NP	O
,	,	,	I-NP	O
chloramphenicol	chloramphenicol	NN	I-NP	O
and	and	CC	I-NP	O
tetracycline	tetracycline	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
co-selected	co-selecte	VBN	I-VP	O
by	by	IN	B-PP	O
exposure	exposure	NN	B-NP	O
to	to	TO	B-PP	O
other	other	JJ	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
used	use	VBN	B-VP	O
in	in	IN	B-PP	O
children	child	NNS	B-NP	O
or	or	CC	O	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
acquired	acquire	VBN	I-VP	O
from	from	IN	B-PP	O
family	family	NN	B-NP	O
members	member	NNS	I-NP	O
,	,	,	O	O
pets	pet	NNS	B-NP	O
,	,	,	O	O
other	other	JJ	B-NP	O
children	child	NNS	I-NP	O
or	or	CC	O	O
food	food	NN	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
antibiotic-resistant	antibiotic-resistant	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
are	be	VBP	B-VP	O
widely	widely	RB	I-VP	O
disseminated	disseminate	VBN	I-VP	O
and	and	CC	O	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
acquired	acquire	VBN	I-VP	O
by	by	IN	B-PP	O
children	child	NNS	B-NP	O
before	before	IN	B-PP	O
exposure	exposure	NN	B-NP	O
to	to	TO	B-PP	O
specific	specific	JJ	B-NP	O
selection	selection	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
eight	eight	CD	B-NP	O
bacterial	bacterial	JJ	I-NP	O
isolates	isolate	NNS	I-NP	O
belonging	belong	VBG	B-VP	O
to	to	TO	B-PP	O
six	six	CD	B-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
select	select	JJ	I-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
12	12	CD	B-NP	O
oral	oral	JJ	I-NP	O
Candida	Candida	NN	I-NP	O
albicans	albican	NNS	I-NP	O
isolates	isolate	NNS	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
study	study	VB	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
on	on	IN	B-PP	O
germ-tube	germ-tube	NN	B-NP	O
formation	formation	NN	I-NP	O
.	.	.	O	O

Briefly	Briefly	NNP	B-NP	O
,	,	,	O	O
each	each	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
suspension	suspension	NN	I-NP	O
(	(	(	O	O
10	10	CD	B-NP	O
(	(	(	O	O
5-6	5-6	CD	B-NP	O
)	)	)	O	O
cells/ml	cells/ml	NNS	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
mixed	mix	VBN	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
C.	C.	FW	I-NP	O
albicans	albicans	FW	I-NP	O
suspension	suspension	NN	I-NP	O
(	(	(	O	O
10	10	CD	B-NP	O
(	(	(	O	O
7	7	CD	B-NP	O
)	)	)	O	O
cells/ml	cells/ml	NNS	B-NP	O
)	)	)	O	O
and	and	CC	O	O
incubated	incubate	VBN	B-VP	O
at	at	IN	B-PP	O
37	37	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
for	for	IN	B-PP	O
90	90	CD	B-NP	O
min	min	NN	I-NP	O
with	with	IN	B-PP	O
bovine	bovine	JJ	B-NP	O
serum	serum	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
percentage	percentage	NN	I-NP	B-cell_line
germ-tube-positive	germ-tube-positive	JJ	I-NP	I-cell_line
Candida	Candida	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
was	be	VBD	B-VP	O
quantified	quantify	VBN	I-VP	O
using	use	VBG	I-VP	O
a	a	DT	B-NP	O
haemocytometer	haemocytometer	NN	I-NP	O
,	,	,	O	O
under	under	IN	B-PP	O
light	light	JJ	B-NP	O
microscopy	microscopy	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
general	general	JJ	B-NP	O
,	,	,	O	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
eight	eight	CD	B-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
sanguis	sanguis	NNP	I-NP	O
SK21A	SK21A	NN	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
salivarius	salivarius	NN	I-NP	O
SK56	SK56	NN	I-NP	O
,	,	,	O	O
Escherichia	Escherichia	FW	B-NP	O
coli	coli	FW	I-NP	O
ATCC	ATCC	NN	I-NP	O
25922	25922	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
S.	S.	NNP	B-NP	O
salivarius	salivarius	NN	I-NP	O
OBU3	OBU3	NN	I-NP	O
suppressed	suppress	VBD	B-VP	O
germ-tube	germ-tube	NN	B-NP	O
formation	formation	NN	I-NP	O
to	to	TO	B-PP	O
varying	vary	VBG	B-NP	O
degrees	degree	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
different	different	JJ	B-NP	O
C	C	NN	I-NP	O
albicans	albican	NNS	I-NP	O
isolates	isolate	NNS	I-NP	O
.	.	.	O	O

Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
Pg	Pg	NN	I-NP	O
50	50	CD	I-NP	O
,	,	,	O	O
Lactobacillus	Lactobacillus	NN	B-NP	O
casei	casei	NN	I-NP	O
ATCC	ATCC	NN	I-NP	O
7469	7469	CD	I-NP	O
and	and	CC	I-NP	O
Prevotella	Prevotella	NN	I-NP	O
intermedia	intermedia	NN	I-NP	O
OBU4	OBU4	NN	I-NP	O
elicited	elicit	VBD	B-VP	O
significant	significant	JJ	B-NP	O
enhancement	enhancement	NN	I-NP	O
of	of	IN	B-PP	O
germ-tube	germ-tube	NN	B-NP	O
formation	formation	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
S.	S.	NNP	B-NP	O
sanguis	sanguis	NNP	I-NP	O
OBU	OBU	NN	I-NP	B-protein
2	2	CD	I-NP	I-protein
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
ATCC	ATCC	NN	I-NP	O
25922	25922	CD	I-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
only	only	JJ	I-NP	O
organism	organism	NN	I-NP	O
to	to	TO	B-VP	O
show	show	VB	I-VP	O
statistically	statistically	RB	B-NP	O
significant	significant	JJ	I-NP	O
suppression	suppression	NN	I-NP	O
of	of	IN	B-PP	O
germ-tube	germ-tube	NN	B-NP	O
formation	formation	NN	I-NP	O
(	(	(	O	O
p=0.0312	p=0.0312	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

A	A	DT	B-NP	O
significant	significant	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
germ	germ	NN	I-NP	O
tube	tube	NN	I-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
C.	C.	NNP	B-NP	O
albicans	albicans	NNP	I-NP	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
HIV-infected	HIV-infected	JJ	B-ADJP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
HIV-free	HIV-free	JJ	B-NP	O
individuals	individual	NNS	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
current	current	JJ	I-NP	O
results	result	NNS	I-NP	O
tend	tend	VBP	B-VP	O
to	to	TO	I-VP	O
suggest	suggest	VB	I-VP	O
that	that	IN	B-SBAR	O
commensal	commensal	JJ	B-NP	O
and	and	CC	I-NP	O
transient	transient	JJ	I-NP	O
oral	oral	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
populations	population	NNS	I-NP	O
may	may	MD	B-VP	O
selectively	selectively	RB	I-VP	O
influence	influence	VB	I-VP	O
the	the	DT	B-NP	O
differential	differential	JJ	I-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
germ-tube-forming	germ-tube-forming	JJ	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
C.	C.	NNP	B-NP	O
albicans	albicans	NNP	I-NP	O
isolates	isolate	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
species	species	NN	I-NP	O
of	of	IN	B-PP	O
sulfate-reducing	sulfate-reducing	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
that	that	WDT	B-NP	O
prevail	prevail	VBP	B-VP	O
in	in	IN	B-PP	O
sites	site	NNS	B-NP	O
affected	affect	VBN	B-VP	O
by	by	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
different	different	JJ	B-ADJP	O
from	from	IN	B-PP	O
those	those	DT	B-NP	O
commonly	commonly	RB	B-VP	O
occurring	occur	VBG	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
digestive	digestive	JJ	I-NP	O
tracts	tract	NNS	I-NP	O
of	of	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
individuals	individual	NNS	I-NP	O
.	.	.	O	O

Ten	Ten	CD	B-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
mesophilic	mesophilic	JJ	B-NP	O
sulfate-reducing	sulfate-reducing	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
(	(	(	O	O
SRB	SRB	NN	B-NP	B-protein
)	)	)	O	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
subgingival	subgingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
in	in	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
of	of	IN	B-PP	O
ten	ten	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
periodontitis	periodontitis	NN	B-NP	O
.	.	.	O	O

Characterization	Characterization	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
morphological	morphological	JJ	B-NP	O
,	,	,	I-NP	O
physiological	physiological	JJ	I-NP	O
and	and	CC	I-NP	O
phylogenetic	phylogenetic	JJ	I-NP	O
properties	property	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
two	two	CD	B-NP	O
distinct	distinct	JJ	I-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
SRB	SRB	NN	I-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
strain	strain	NN	I-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
curved	curve	VBN	I-NP	O
rod	rod	NN	I-NP	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
motility	motility	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
dissimilatory	dissimilatory	JJ	B-NP	O
sulfate	sulfate	NN	I-NP	O
reduction	reduction	NN	I-NP	O
,	,	,	O	O
lactate	lactate	NN	B-NP	O
or	or	CC	I-NP	O
pyruvate	pyruvate	NN	I-NP	O
was	be	VBD	B-VP	O
oxidized	oxidize	VBN	I-VP	O
incompletely	incompletely	RB	B-ADVP	O
to	to	TO	B-PP	O
equimolar	equimolar	JJ	B-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
acetate	acetate	NN	B-NP	O
.	.	.	O	O

Desulfoviridin	Desulfoviridin	NN	B-NP	O
and	and	CC	I-NP	O
cytochrome	cytochrome	NN	I-NP	B-protein
c3	c3	NN	I-NP	I-protein
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
mesophilic	mesophilic	JJ	I-NP	O
vibrio	vibrio	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
cellular	cellular	JJ	I-NP	O
lipid	lipid	NN	I-NP	O
profile	profile	NN	I-NP	O
was	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
from	from	IN	B-PP	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
genus	genus	NN	I-NP	O
Desulfovibrio	Desulfovibrio	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
16S	16S	NN	I-NP	B-DNA
rDNA	rDNA	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proposed	propose	VBN	I-NP	O
'Desulfovibrio	'Desulfovibrio	NNP	I-NP	O
fairfieldensis	fairfieldensis	NN	I-NP	O
'	'	''	O	O
.	.	.	O	O

Cells	Cell	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nine	nine	CD	I-NP	O
other	other	JJ	I-NP	O
strains	strain	NNS	I-NP	O
were	be	VBD	B-VP	O
straight	straight	JJ	B-ADJP	O
,	,	,	O	O
rod-shaped	rod-shaped	JJ	B-ADJP	O
,	,	,	O	O
exhibited	exhibit	VBD	B-VP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
growth	growth	NN	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
oxidized	oxidize	VBN	B-NP	O
substrates	substrate	NNS	I-NP	O
incompletely	incompletely	RB	B-ADVP	O
to	to	TO	B-PP	O
acetate	acetate	NN	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
SRB	SRB	NN	I-NP	B-protein
,	,	,	O	O
like	like	IN	B-PP	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
genus	genus	NN	I-NP	O
Desulfomicrobium	Desulfomicrobium	NN	I-NP	O
,	,	,	O	O
lacked	lack	VBD	B-VP	O
desulfoviridin	desulfoviridin	NN	B-NP	O
.	.	.	O	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
16S	16S	NN	I-NP	B-DNA
rDNA	rDNA	NN	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
of	of	IN	B-PP	O
seven	seven	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nine	nine	CD	I-NP	O
isolates	isolate	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
similarity	similarity	NN	B-NP	O
among	among	IN	B-PP	O
these	these	DT	B-NP	O
oral	oral	JJ	I-NP	O
strains	strain	NNS	I-NP	O
,	,	,	O	O
forming	form	VBG	B-VP	O
a	a	DT	B-NP	O
distinct	distinct	JJ	I-NP	O
lineage	lineage	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
genus	genus	NN	I-NP	O
Desulfomicrobium	Desulfomicrobium	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
cellular	cellular	JJ	I-NP	O
lipid	lipid	NN	I-NP	O
profile	profile	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
representative	representative	JJ	I-NP	O
oral	oral	JJ	I-NP	O
strain	strain	NN	I-NP	O
,	,	,	O	O
NY678T	NY678T	NN	B-NP	B-protein
,	,	,	O	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
accordance	accordance	NN	B-NP	O
with	with	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
Desulfomicrobium	Desulfomicrobium	NNP	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
also	also	RB	B-ADVP	O
showed	show	VBD	B-VP	O
dissimilar	dissimilar	JJ	B-NP	O
features	feature	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
phenotypic	phenotypic	JJ	I-NP	O
and	and	CC	I-NP	O
phylogenetic	phylogenetic	JJ	I-NP	O
analyses	analysis	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
rod-shaped	rod-shaped	JJ	I-NP	O
SRB	SRB	NN	I-NP	B-protein
from	from	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
regarded	regard	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
designation	designation	NN	I-NP	O
Desulfomicrobium	Desulfomicrobium	NN	I-NP	O
orale	orale	JJ	I-NP	O
sp	sp	NN	I-NP	O
.	.	.	O	O

nov.	nov.	LS	B-LST	O
is	be	VBZ	B-VP	O
proposed	propose	VBN	I-VP	O
.	.	.	O	O

Transformation	Transformation	NN	B-NP	O
of	of	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
gordonii	gordonii	NNP	I-NP	O
DL1	DL1	NN	I-NP	O
by	by	IN	B-PP	O
free	free	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
saliva	saliva	NN	I-NP	O
.	.	.	O	O

Competent	Competent	NNP	B-NP	O
S.	S.	NNP	I-NP	O
gordonii	gordonii	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
transformed	transform	VBN	I-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
with	with	IN	B-PP	O
plasmid	plasmid	NN	B-NP	O
DNA	DNA	NN	I-NP	O
that	that	WDT	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
taken	take	VBN	I-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
mouth	mouth	NN	I-NP	O
.	.	.	O	O

Transformation	Transformation	NN	B-NP	O
also	also	RB	B-ADVP	O
occurred	occur	VBD	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
plasmid	plasmid	NN	I-NP	B-DNA
that	that	WDT	B-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
replicate	replicate	VB	I-VP	O
in	in	IN	B-PP	O
S.	S.	NNP	B-NP	O
gordonii	gordonii	NNP	I-NP	O
,	,	,	O	O
but	but	CC	O	O
that	that	DT	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
chromosomal	chromosomal	JJ	B-NP	O
homology	homology	NN	I-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
integration	integration	NN	B-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	B-DNA
chromosome	chromosome	NN	I-NP	I-DNA
,	,	,	O	O
although	although	IN	B-SBAR	O
linearised	linearised	JJ	B-NP	O
plasmid	plasmid	NN	I-NP	O
DNA	DNA	NN	I-NP	O
gave	give	VBD	B-VP	O
no	no	DT	B-NP	O
transformants	transformant	NNS	I-NP	O
.	.	.	O	O

Linear	Linear	JJ	B-NP	B-DNA
chromosomal	chromosomal	JJ	I-NP	I-DNA
DNA	DNA	NN	I-NP	I-DNA
fragments	fragment	NNS	I-NP	I-DNA
did	do	VBD	B-VP	O
however	however	RB	I-VP	O
transform	transform	VB	I-VP	O
S.	S.	NNP	B-NP	O
gordonii/Tn916	gordonii/Tn916	NN	I-NP	O
efficiently	efficiently	RB	B-ADVP	O
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
when	when	WRB	B-ADVP	O
regions	region	NNS	B-NP	O
of	of	IN	B-PP	O
homology	homology	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
recipient	recipient	NN	I-NP	B-DNA
chromosome	chromosome	NN	I-NP	I-DNA
flanked	flank	VBD	B-VP	O
the	the	DT	B-NP	O
marker	marker	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
are	be	VBP	B-VP	O
discussed	discuss	VBN	I-VP	O
in	in	IN	B-PP	O
relation	relation	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
potential	potential	NN	I-NP	O
for	for	IN	B-PP	O
acquisition	acquisition	NN	B-NP	O
of	of	IN	B-PP	O
DNA	DNA	NN	B-NP	B-DNA
sequences	sequence	NNS	I-NP	I-DNA
,	,	,	O	O
including	include	VBG	B-PP	O
genetically	genetically	RB	B-NP	O
modified	modify	VBN	I-NP	O
DNA	DNA	NN	I-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
gut	gut	NN	B-NP	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
develop	develop	VB	I-VP	O
a	a	DT	B-NP	O
simple	simple	JJ	I-NP	O
and	and	CC	I-NP	O
flexible	flexible	JJ	I-NP	O
novel	novel	NN	I-NP	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
model	model	NN	I-NP	O
system	system	NN	I-NP	O
to	to	TO	B-VP	O
grow	grow	VB	I-VP	O
films	film	NNS	B-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
that	that	WDT	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
study	study	VB	I-VP	O
aspects	aspect	NNS	B-NP	O
of	of	IN	B-PP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
.	.	.	O	O

Standardized	Standardized	JJ	B-NP	O
suspensions	suspension	NNS	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
were	be	VBD	B-VP	O
inoculated	inoculate	VBN	I-VP	O
into	into	IN	B-PP	O
Ultrafree-CL	Ultrafree-CL	NN	B-NP	B-DNA
(	(	(	O	I-DNA
Millipore	Millipore	NN	B-NP	I-DNA
)	)	)	O	I-DNA
ultrafiltration	ultrafiltration	NN	B-NP	I-DNA
units	unit	NNS	I-NP	I-DNA
at	at	IN	B-PP	O
various	various	JJ	B-NP	O
densities	density	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
were	be	VBD	B-VP	O
incubated	incubate	VBN	I-VP	O
for	for	IN	B-PP	O
varying	vary	VBG	B-VP	O
time	time	NN	B-NP	O
intervals	interval	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
carbon	carbon	NN	B-NP	O
sources	source	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
films	film	NNS	I-NP	O
reproducibly	reproducibly	RB	B-VP	O
achieved	achieve	VBN	I-VP	O
between	between	IN	B-PP	O
107	107	CD	B-NP	O
and	and	CC	I-NP	O
108	108	CD	I-NP	O
cfu	cfu	NN	I-NP	O
cm-2	cm-2	NN	I-NP	O
,	,	,	O	O
irrespective	irrespective	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
inoculated	inoculate	VBN	B-VP	O
and	and	CC	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
changes	change	NNS	I-NP	O
for	for	IN	B-PP	O
14	14	CD	B-NP	O
d.	d.	NN	I-NP	O
However	However	RB	B-ADVP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
grew	grow	VBD	B-VP	O
through	through	IN	B-PP	O
membranes	membrane	NNS	B-NP	O
with	with	IN	B-PP	O
pores	pore	NNS	B-NP	O
of	of	IN	B-PP	O
diameter	diameter	NN	B-NP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
0.1	0.1	CD	I-NP	O
microm	microm	NN	I-NP	O
after	after	IN	B-PP	O
6	6	CD	B-NP	O
d.	d.	NN	I-NP	O
Culture	Culture	NN	I-NP	O
of	of	IN	B-PP	O
films	film	NNS	B-NP	O
in	in	IN	B-PP	O
sucrose	sucrose	NN	B-NP	O
or	or	CC	I-NP	O
water	water	NN	I-NP	O
for	for	IN	B-PP	O
6	6	CD	B-NP	O
d	d	NN	I-NP	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
decreased	decrease	VBN	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
colony-forming	colony-forming	JJ	B-NP	B-protein
units	unit	NNS	I-NP	I-protein
,	,	,	O	O
but	but	CC	O	O
returning	return	VBG	B-VP	O
them	them	PRP	B-NP	O
to	to	TO	B-PP	O
broth	broth	NN	B-NP	O
reversed	reverse	VBD	B-VP	O
this	this	DT	B-NP	O
.	.	.	O	O

Reproducible	Reproducible	JJ	B-NP	O
films	film	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
cultured	culture	VBN	I-VP	O
in	in	IN	B-PP	O
Ultrafree-CL	Ultrafree-CL	NN	B-NP	B-cell_line
units	unit	NNS	I-NP	I-cell_line
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
has	have	VBZ	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
Ultrafree-CL	Ultrafree-CL	NN	B-NP	B-protein
units	unit	NNS	I-NP	I-protein
can	can	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
simple	simple	JJ	I-NP	O
model	model	NN	I-NP	O
system	system	NN	I-NP	O
to	to	TO	B-VP	O
grow	grow	VB	I-VP	O
biofilms	biofilm	NNS	B-NP	O
that	that	WDT	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
for	for	IN	B-PP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
research	research	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
compare	compare	VB	I-VP	O
the	the	DT	B-NP	O
resistance	resistance	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
corrosion	corrosion	NN	I-NP	O
of	of	IN	B-PP	O
dental	dental	JJ	B-NP	O
alloys	alloy	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
solution	solution	NN	I-NP	O
containing	contain	VBG	B-VP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
named	name	VBN	B-VP	O
Actinomyces	Actinomyce	NNS	B-NP	O
viscosus	viscosus	NN	B-NP	O
(	(	(	O	O
ATCC19246	ATCC19246	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
paper	paper	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
explain	explain	VBP	B-VP	O
the	the	DT	B-NP	O
choice	choice	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
precise	precise	JJ	I-NP	O
species	specie	NNS	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
specify	specify	VB	B-VP	O
its	its	PRP$	B-NP	O
culture	culture	NN	I-NP	O
in	in	IN	B-PP	O
artificial	artificial	JJ	B-NP	O
saliva	saliva	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
experimental	experimental	JJ	I-NP	O
precautions	precaution	NNS	I-NP	O
needed	need	VBN	B-VP	O
to	to	TO	B-VP	O
avoid	avoid	VB	I-VP	O
the	the	DT	B-NP	O
pollution	pollution	NN	I-NP	O
by	by	IN	B-PP	O
other	other	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
electrochemical	electrochemical	JJ	I-NP	O
behaviour	behaviour	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
dental	dental	JJ	I-NP	O
alloys	alloy	NNS	I-NP	O
(	(	(	O	O
Ni-Cr	Ni-Cr	JJ	B-NP	O
alloy	alloy	NN	I-NP	O
and	and	CC	O	O
gold-based	gold-based	JJ	B-NP	O
alloy	alloy	NN	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
by	by	IN	B-PP	O
electrochemical	electrochemical	JJ	B-NP	O
means	mean	NNS	I-NP	O
in	in	IN	B-PP	O
sterile	sterile	JJ	B-NP	O
Fusayama	Fusayama	NNP	I-NP	O
artificial	artificial	JJ	I-NP	O
saliva	saliva	NN	I-NP	O
(	(	(	O	O
AS	AS	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
AS	AS	JJ	B-ADJP	O
enriched	enrich	VBN	B-VP	O
with	with	IN	B-PP	O
sterile	sterile	JJ	B-NP	O
yeast	yeast	NN	I-NP	O
extract	extract	NN	I-NP	O
(	(	(	O	O
YE	YE	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
YE	YE	NN	B-NP	O
modified	modify	VBN	B-VP	O
by	by	IN	B-PP	O
introducing	introduce	VBG	B-VP	O
bacteria	bacteria	NNS	B-NP	O
(	(	(	O	O
AV	AV	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Open-circuit	Open-circuit	JJ	B-NP	O
potentials	potential	NNS	I-NP	O
,	,	,	O	O
potentiodynamic	potentiodynamic	JJ	B-NP	O
curves	curve	NNS	I-NP	O
,	,	,	O	O
polarization	polarization	NN	B-NP	O
resistance	resistance	NN	I-NP	O
and	and	CC	O	O
impedance	impedance	NN	B-NP	O
spectroscopy	spectroscopy	NN	I-NP	O
are	be	VBP	B-VP	O
the	the	DT	B-NP	O
electrochemical	electrochemical	JJ	I-NP	O
procedures	procedure	NNS	I-NP	O
selected	select	VBN	B-VP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
work	work	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
has	have	VBZ	B-VP	O
thus	thus	RB	I-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
open-circuit	open-circuit	JJ	I-NP	O
potential	potential	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
non-precious	non-precious	JJ	I-NP	O
alloy	alloy	NN	I-NP	O
is	be	VBZ	B-VP	O
always	always	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gold	gold	NN	I-NP	O
precious	precious	JJ	I-NP	O
alloy	alloy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
colonization	colonization	NN	I-NP	O
of	of	IN	B-PP	O
metal	metal	NN	B-NP	O
surface	surface	NN	I-NP	O
by	by	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
caused	cause	VBD	B-VP	O
a	a	DT	B-NP	O
drop	drop	NN	I-NP	O
in	in	IN	B-PP	O
open	open	JJ	B-NP	O
circuit	circuit	NN	I-NP	O
potential	potential	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
electrochemical	electrochemical	JJ	I-NP	O
impedance	impedance	NN	I-NP	O
spectroscopy	spectroscopy	NN	I-NP	O
results	result	NNS	I-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
electrolyte	electrolyte	NN	I-NP	O
resistance	resistance	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
AS	AS	NN	I-NP	O
,	,	,	I-NP	O
YE	YE	NN	I-NP	O
and	and	CC	I-NP	O
AV	AV	NN	I-NP	O
milieu	milieu	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
a	a	DT	B-NP	O
slight	slight	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
polarization	polarization	NN	B-NP	O
resistance	resistance	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
precious	precious	JJ	I-NP	O
alloy	alloy	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
non-precious	non-precious	JJ	I-NP	O
alloy	alloy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
drop	drop	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
electrolyte	electrolyte	NN	I-NP	O
resistance	resistance	NN	I-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
explain	explain	VB	I-VP	O
the	the	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
polarization	polarization	NN	B-NP	O
resistance	resistance	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
influence	influence	NN	I-NP	O
of	of	IN	B-PP	O
Actinomyces	Actinomyces	NNP	B-NP	O
viscosus	viscosus	NN	I-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
essentially	essentially	RB	B-ADVP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
consumption	consumption	NN	I-NP	O
of	of	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
metal/electrolyte	metal/electrolyte	NN	I-NP	O
interface	interface	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
specimen	specimen	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
the	the	DT	B-NP	O
non-precious	non-precious	JJ	I-NP	O
alloy	alloy	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
(	(	(	O	O
instigator	instigator	NN	B-NP	O
of	of	IN	B-PP	O
corrosion	corrosion	NN	B-NP	O
)	)	)	O	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
polarization	polarization	NN	B-NP	O
resistance	resistance	NN	I-NP	O
whereas	whereas	IN	B-PP	O
the	the	DT	B-NP	O
slight	slight	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
precious	precious	JJ	I-NP	O
alloys	alloy	NNS	I-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
justified	justify	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
organic	organic	JJ	I-NP	O
and	and	CC	I-NP	O
inorganic	inorganic	JJ	I-NP	O
metabolites	metabolite	NNS	I-NP	O
released	release	VBN	B-VP	O
by	by	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
in	in	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
electrolyte	electrolyte	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
scanning	scanning	NN	I-NP	O
electron	electron	NN	I-NP	O
micrography	micrography	NN	I-NP	O
after	after	IN	B-PP	O
electrochemical	electrochemical	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
,	,	,	O	O
confirmed	confirm	VBD	B-VP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
contaminants	contaminant	NNS	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
preliminary	preliminary	JJ	I-NP	O
results	result	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
the	the	DT	B-NP	O
unquestionable	unquestionable	JJ	I-NP	O
influence	influence	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
corrosion	corrosion	NN	I-NP	O
behaviour	behaviour	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
alloys	alloy	NNS	I-NP	O
studied	study	VBN	B-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
further	further	JJ	B-NP	O
studies	study	NNS	I-NP	O
are	be	VBP	B-VP	O
necessary	necessary	JJ	B-ADJP	O
.	.	.	O	O

Dental	Dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
and	and	CC	I-NP	O
periodontitis	periodontitis	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
generally	generally	RB	B-ADVP	O
not	not	RB	O	O
life	life	NN	B-NP	O
threatening	threatening	NN	I-NP	O
,	,	,	O	O
are	be	VBP	B-VP	O
nevertheless	nevertheless	RB	B-ADVP	O
of	of	IN	B-PP	O
significant	significant	JJ	B-NP	O
importance	importance	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
understanding	understanding	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
nature	nature	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
diseases	disease	NNS	I-NP	O
could	could	MD	B-VP	O
aid	aid	VB	I-VP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
novel	novel	JJ	B-NP	O
methods	method	NNS	I-NP	O
of	of	IN	B-PP	O
prevention	prevention	NN	B-NP	O
and	and	CC	I-NP	O
control	control	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
increase	increase	VB	B-VP	O
our	our	PRP$	B-NP	O
knowledge	knowledge	NN	I-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
etiology	etiology	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
identification	identification	NN	I-NP	O
of	of	IN	B-PP	O
virulence	virulence	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
could	could	MD	B-VP	O
lead	lead	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
vaccines	vaccine	NNS	B-NP	O
directed	direct	VBN	B-VP	O
against	against	IN	B-PP	O
these	these	DT	B-NP	O
organisms	organism	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
design	design	NN	I-NP	O
of	of	IN	B-PP	O
inhibitors	inhibitor	NNS	B-NP	O
of	of	IN	B-PP	O
biofilm	biofilm	NN	B-NP	O
formation	formation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
replacement	replacement	NN	B-NP	O
therapy	therapy	NN	I-NP	O
strategies	strategy	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
oral	oral	JJ	I-NP	O
streptococci	streptococci	NNS	I-NP	O
are	be	VBP	B-VP	O
normally	normally	RB	B-ADVP	O
non-pathogenic	non-pathogenic	JJ	B-NP	O
residents	resident	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
microflora	microflora	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
substantial	substantial	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
can	can	MD	B-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
act	act	VBP	B-VP	O
as	as	IN	B-PP	O
``	``	``	O	O
genetic	genetic	JJ	B-NP	O
reservoirs	reservoir	NNS	I-NP	O
''	''	''	O	O
and	and	CC	O	O
transfer	transfer	VB	B-VP	O
genetic	genetic	JJ	B-NP	O
information	information	NN	I-NP	O
to	to	TO	B-PP	O
transient	transient	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
as	as	IN	B-SBAR	O
they	they	PRP	B-NP	O
make	make	VBP	B-VP	O
their	their	PRP$	B-NP	O
way	way	NN	I-NP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
principal	principal	JJ	I-NP	O
entry	entry	NN	I-NP	O
point	point	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
wide	wide	JJ	I-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
.	.	.	O	O

Examples	Example	NNS	B-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
of	of	IN	B-PP	O
particular	particular	JJ	B-NP	O
concern	concern	NN	I-NP	O
include	include	VBP	B-VP	O
the	the	DT	B-NP	O
transfer	transfer	NN	I-NP	O
of	of	IN	B-PP	O
antibiotic	antibiotic	JJ	B-NP	O
resistance	resistance	NN	I-NP	O
from	from	IN	B-PP	O
oral	oral	JJ	B-NP	O
streptococci	streptococci	NNS	I-NP	O
to	to	TO	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
pneumoniae	pneumoniae	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
used	use	VBN	I-VP	O
by	by	IN	B-PP	O
oral	oral	JJ	B-NP	O
streptococci	streptococci	NNS	I-NP	O
to	to	TO	B-VP	O
exchange	exchange	VB	I-VP	O
genetic	genetic	JJ	B-NP	O
information	information	NN	I-NP	O
are	be	VBP	B-VP	O
not	not	RB	O	O
well-understood	well-understood	JJ	B-ADJP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
several	several	JJ	B-NP	O
species	specie	NNS	I-NP	O
are	be	VBP	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
enter	enter	VB	I-VP	O
a	a	DT	B-NP	O
physiological	physiological	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
genetic	genetic	JJ	B-NP	O
competence	competence	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
state	state	NN	I-NP	O
permits	permit	VBZ	B-VP	O
them	them	PRP	B-NP	O
to	to	TO	B-VP	O
become	become	VB	I-VP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
natural	natural	JJ	B-NP	O
genetic	genetic	JJ	I-NP	O
transformation	transformation	NN	I-NP	O
,	,	,	O	O
facilitating	facilitate	VBG	B-VP	O
the	the	DT	B-NP	O
acquisition	acquisition	NN	I-NP	O
of	of	IN	B-PP	O
foreign	foreign	JJ	B-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
from	from	IN	B-PP	O
the	the	DT	B-NP	O
external	external	JJ	I-NP	O
environment	environment	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
oral	oral	JJ	I-NP	O
streptococci	streptococci	NNS	I-NP	O
share	share	VBP	B-VP	O
many	many	JJ	B-NP	O
similarities	similarity	NNS	I-NP	O
with	with	IN	B-PP	O
two	two	CD	B-NP	O
closely	closely	RB	I-NP	O
related	related	JJ	I-NP	O
Gram-positive	Gram-positive	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
S.	S.	NNP	B-NP	O
pneumoniae	pneumoniae	NNP	I-NP	O
and	and	CC	I-NP	O
Bacillus	Bacillus	NNP	I-NP	O
subtilis	subtili	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
these	these	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
of	of	IN	B-PP	O
quorum-sensing	quorum-sensing	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
competence	competence	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
DNA	DNA	NN	B-NP	O
uptake	uptake	NN	I-NP	O
and	and	CC	O	O
integration	integration	NN	B-NP	O
are	be	VBP	B-VP	O
well-characterized	well-characterized	JJ	B-ADJP	O
.	.	.	O	O

Using	Use	VBG	B-VP	O
this	this	DT	B-NP	O
knowledge	knowledge	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
data	datum	NNS	I-NP	O
available	available	JJ	B-ADJP	O
in	in	IN	B-PP	O
genome	genome	NN	B-NP	O
databases	database	NNS	I-NP	O
allowed	allow	VBD	B-VP	O
us	us	PRP	B-NP	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
putative	putative	JJ	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
processes	process	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
organism	organism	NN	I-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
mutans	mutan	NNS	I-NP	O
.	.	.	O	O

Models	Model	NNS	B-NP	O
of	of	IN	B-PP	O
competence	competence	NN	B-NP	O
development	development	NN	I-NP	O
and	and	CC	O	O
genetic	genetic	JJ	B-NP	O
transformation	transformation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
streptococci	streptococci	NNS	I-NP	O
and	and	CC	I-NP	O
strategies	strategy	NNS	I-NP	O
to	to	TO	B-VP	O
confirm	confirm	VB	I-VP	O
these	these	DT	B-NP	O
models	model	NNS	I-NP	O
are	be	VBP	B-VP	O
discussed	discuss	VBN	I-VP	O
.	.	.	O	O

Future	Future	JJ	B-NP	O
studies	study	NNS	I-NP	O
of	of	IN	B-PP	O
competence	competence	NN	B-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
biofilms	biofilm	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
natural	natural	JJ	I-NP	O
environment	environment	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
streptococci	streptococci	NNS	I-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discussed	discuss	VBN	I-VP	O
.	.	.	O	O

Nested	Nest	VBN	B-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
(	(	(	O	O
PCR	PCR	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
to	to	TO	I-VP	O
detect	detect	VB	I-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
Helicobacter	Helicobacter	NN	B-NP	O
pylori	pylori	NN	I-NP	O
in	in	IN	B-PP	O
tongue	tongue	NN	B-NP	O
mucosa	mucosa	NN	I-NP	O
in	in	IN	B-PP	O
268	268	CD	B-NP	O
patients	patient	NNS	I-NP	O
divided	divide	VBN	B-VP	O
into	into	IN	B-PP	O
four	four	CD	B-NP	O
groups	group	NNS	I-NP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
their	their	PRP$	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
:	:	:	O	O
87	87	CD	B-NP	O
with	with	IN	B-PP	O
atrophic	atrophic	JJ	B-NP	O
glossitis	glossitis	NN	I-NP	O
,	,	,	O	O
37	37	CD	B-NP	O
with	with	IN	B-PP	O
benign	benign	JJ	B-NP	O
migratory	migratory	JJ	I-NP	O
glossitis	glossitis	NN	I-NP	O
and	and	CC	O	O
144	144	CD	B-NP	O
with	with	IN	B-PP	O
burning	burn	VBG	B-VP	O
mouth	mouth	NN	B-NP	O
syndrome	syndrome	NN	I-NP	O
(	(	(	O	O
BMS	BMS	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
latter	latter	JJ	I-NP	O
group	group	NN	I-NP	O
was	be	VBD	B-VP	O
subdivided	subdivide	VBN	I-VP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
anatomic	anatomic	JJ	B-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
burning	burn	VBG	B-VP	O
sensation	sensation	NN	B-NP	O
:	:	:	O	O
subgroup	subgroup	NN	B-NP	O
A	A	NN	I-NP	O
(	(	(	O	O
54	54	CD	B-NP	O
patients	patient	NNS	I-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
complaints	complaint	NNS	B-NP	O
limited	limit	VBN	B-VP	O
to	to	TO	B-PP	O
tongue	tongue	NN	B-NP	O
and	and	CC	I-NP	O
subgroup	subgroup	NN	I-NP	O
B	B	NN	I-NP	O
(	(	(	O	O
90	90	CD	B-NP	O
patients	patient	NNS	I-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
burning	burn	VBG	B-VP	O
sensations	sensation	NNS	B-NP	O
in	in	IN	B-PP	O
other	other	JJ	B-NP	O
parts	part	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
mucosa	mucosa	NN	I-NP	O
.	.	.	O	O

H.	H.	NN	B-NP	O
pylori	pylori	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
43	43	CD	B-NP	O
samples	sample	NNS	I-NP	O
(	(	(	O	O
16	16	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Bacteria	Bacteria	NNS	B-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
less	less	RBR	I-ADJP	O
present	present	JJ	I-ADJP	O
in	in	IN	B-PP	O
tongue	tongue	NN	B-NP	O
mucosa	mucosa	NN	I-NP	O
affected	affect	VBN	B-VP	O
with	with	IN	B-PP	O
benign	benign	JJ	B-NP	O
migratory	migratory	JJ	I-NP	O
glossitis	glossitis	NN	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
atrophic	atrophic	JJ	B-NP	O
glossitis	glossitis	NN	I-NP	O
and	and	CC	O	O
BMS	BMS	NN	B-NP	B-protein
(	(	(	O	O
P=0.025	P=0.025	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

This	This	DT	B-NP	O
difference	difference	NN	I-NP	O
was	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
obvious	obvious	JJ	I-ADJP	O
when	when	WRB	B-ADVP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
atrophic	atrophic	JJ	B-NP	O
glossitis	glossitis	NN	I-NP	O
only	only	RB	B-ADVP	O
(	(	(	O	O
P=0.006	P=0.006	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Mucosal	Mucosal	JJ	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
conditions	condition	NNS	I-NP	O
might	might	MD	B-VP	O
make	make	VB	I-VP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
environment	environment	NN	I-NP	O
more	more	RBR	B-ADJP	O
acceptable	acceptable	JJ	I-ADJP	O
for	for	IN	B-PP	O
H.	H.	NN	B-NP	O
pylori	pylori	NN	I-NP	O
colonization	colonization	NN	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
mucosa	mucosa	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
may	may	MD	B-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
its	its	PRP$	B-NP	O
oro-oral	oro-oral	JJ	I-NP	O
transmission	transmission	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
growing	grow	VBG	I-NP	O
body	body	NN	I-NP	O
of	of	IN	B-PP	O
information	information	NN	B-NP	O
has	have	VBZ	B-VP	O
provided	provide	VBN	I-VP	O
insights	insight	NNS	B-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
streptococci	streptococci	NNS	I-NP	O
maintain	maintain	VBP	B-VP	O
their	their	PRP$	B-NP	O
niches	niche	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
mouth	mouth	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
one	one	CD	I-NP	O
case	case	NN	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
organism	organism	NN	I-NP	O
apparently	apparently	RB	B-ADVP	O
uses	use	VBZ	B-VP	O
a	a	DT	B-NP	O
panel	panel	NN	I-NP	O
of	of	IN	B-PP	O
proteins	protein	NNS	B-NP	O
to	to	TO	B-VP	O
survive	survive	VB	I-VP	O
in	in	IN	B-PP	O
acidic	acidic	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
while	while	IN	B-SBAR	O
it	it	PRP	B-NP	O
promotes	promote	VBZ	B-VP	O
the	the	DT	B-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
streptococci	streptococci	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
not	not	RB	O	O
as	as	RB	B-ADJP	O
inherently	inherently	RB	I-ADJP	O
resistant	resistant	JJ	I-ADJP	O
to	to	TO	B-PP	O
acidification	acidification	NN	B-NP	O
,	,	,	O	O
use	use	VBP	B-VP	O
protective	protective	JJ	B-NP	O
schemes	scheme	NNS	I-NP	O
to	to	TO	B-VP	O
ameliorate	ameliorate	VB	I-VP	O
acidic	acidic	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
pH	pH	NN	I-NP	O
values	value	NNS	I-NP	O
.	.	.	O	O

Existing	Exist	VBG	B-VP	O
information	information	NN	B-NP	O
clearly	clearly	RB	B-VP	O
shows	show	VBZ	I-VP	O
that	that	IN	B-SBAR	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
streptococci	streptococci	NNS	I-NP	O
are	be	VBP	B-VP	O
highly	highly	RB	B-ADJP	O
related	relate	VBN	I-ADJP	O
,	,	,	O	O
very	very	RB	B-NP	O
different	different	JJ	I-NP	O
strategies	strategy	NNS	I-NP	O
have	have	VBP	B-VP	O
evolved	evolve	VBN	I-VP	O
for	for	IN	B-SBAR	O
them	them	PRP	B-NP	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
advantage	advantage	NN	B-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
particular	particular	JJ	I-NP	O
location	location	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
picture	picture	NN	I-NP	O
that	that	WDT	B-NP	O
emerges	emerge	VBZ	B-VP	O
is	be	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
acid-adaptive	acid-adaptive	JJ	I-NP	O
regulatory	regulatory	JJ	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
streptococci	streptococci	NNS	I-NP	O
differ	differ	VBP	B-VP	O
markedly	markedly	RB	B-ADVP	O
from	from	IN	B-PP	O
those	those	DT	B-NP	O
used	use	VBN	B-VP	O
by	by	IN	B-PP	O
Gram-negative	Gram-negative	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

What	What	WP	B-NP	O
future	future	JJ	B-NP	O
research	research	NN	I-NP	O
must	must	MD	B-VP	O
determine	determine	VB	I-VP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
extent	extent	NN	I-NP	O
and	and	CC	I-NP	O
complexity	complexity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
acid-adaptive	acid-adaptive	JJ	I-NP	O
systems	system	NNS	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
organisms	organism	NNS	I-NP	O
and	and	CC	O	O
how	how	WRB	B-ADVP	O
they	they	PRP	B-NP	O
permit	permit	VBP	B-VP	O
the	the	DT	B-NP	O
organisms	organism	NNS	I-NP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
themselves	themselves	PRP	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
face	face	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
low-pH	low-pH	JJ	I-NP	O
environment	environment	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
microbial	microbial	JJ	I-NP	O
competition	competition	NN	I-NP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
respective	respective	JJ	I-NP	O
niches	niche	NNS	I-NP	O
.	.	.	O	O

Whilst	Whilst	IN	B-PP	O
the	the	DT	B-NP	O
diversity	diversity	NN	I-NP	O
of	of	IN	B-PP	O
organisms	organism	NNS	B-NP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
is	be	VBZ	B-VP	O
well	well	RB	I-VP	O
accepted	accept	VBN	I-VP	O
,	,	,	O	O
there	there	EX	B-NP	O
remains	remain	VBZ	B-VP	O
considerable	considerable	JJ	B-NP	O
controversy	controversy	NN	I-NP	O
as	as	IN	B-PP	O
to	to	TO	B-PP	O
whether	whether	IN	B-SBAR	O
Staphylococcus	Staphylococcus	NN	B-NP	B-protein
spp	spp	NN	I-NP	I-protein
.	.	.	O	O

play	play	VB	B-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ecology	ecology	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
oral	oral	JJ	I-NP	O
flora	flora	NN	I-NP	O
.	.	.	O	O

Surprisingly	Surprisingly	RB	B-NP	O
little	little	JJ	I-NP	O
detailed	detailed	JJ	I-NP	O
work	work	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
performed	perform	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
quantitative	quantitative	JJ	I-NP	O
and	and	CC	I-NP	O
qualitative	qualitative	JJ	I-NP	O
aspects	aspect	NNS	I-NP	O
of	of	IN	B-PP	O
colonisation	colonisation	NN	B-NP	O
or	or	CC	I-NP	O
infection	infection	NN	I-NP	O
either	either	CC	O	O
by	by	IN	B-PP	O
coagulase-negative	coagulase-negative	JJ	B-NP	O
staphylococci	staphylococci	NNS	I-NP	O
(	(	(	O	O
CNS	CNS	NNS	B-NP	B-protein
)	)	)	O	O
or	or	CC	O	O
S.	S.	NNP	B-NP	O
aureus	aureus	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
latter	latter	JJ	I-NP	O
is	be	VBZ	B-VP	O
especially	especially	RB	B-ADJP	O
interesting	interesting	JJ	I-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
light	light	NN	I-NP	O
of	of	IN	B-PP	O
present	present	JJ	B-NP	O
difficulties	difficulty	NNS	I-NP	O
in	in	IN	B-PP	O
eradicating	eradicate	VBG	B-VP	O
carriage	carriage	NN	B-NP	O
of	of	IN	B-PP	O
methicillin-resistant	methicillin-resistant	JJ	B-NP	O
S.	S.	FW	I-NP	O
aureus	aureus	FW	I-NP	O
(	(	(	O	O
MRSA	MRSA	NN	B-NP	O
)	)	)	O	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
oropharynx	oropharynx	NN	I-NP	O
in	in	IN	B-PP	O
affected	affect	VBN	B-NP	O
individuals	individual	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
paper	paper	NN	I-NP	O
reviews	review	VBZ	B-VP	O
the	the	DT	B-NP	O
current	current	JJ	I-NP	O
knowledge	knowledge	NN	I-NP	O
of	of	IN	B-PP	O
staphylococcal	staphylococcal	JJ	B-NP	O
colonisation	colonisation	NN	I-NP	O
and	and	CC	I-NP	O
infection	infection	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
in	in	IN	B-PP	O
health	health	NN	B-NP	O
and	and	CC	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

S.	S.	NNP	B-NP	O
aureus	aureus	NNP	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
wide	wide	JJ	I-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
infective	infective	JJ	B-NP	O
oral	oral	JJ	I-NP	O
conditions	condition	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
angular	angular	JJ	B-NP	O
cheilitis	cheilitis	NN	I-NP	O
and	and	CC	I-NP	O
parotitis	parotitis	NN	I-NP	O
.	.	.	O	O

More	More	RBR	B-ADVP	O
recently	recently	RB	I-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
condition	condition	NN	I-NP	O
classified	classify	VBN	B-VP	O
as	as	IN	B-PP	O
staphylococcal	staphylococcal	JJ	B-NP	O
mucositis	mucositis	NN	I-NP	O
has	have	VBZ	B-VP	O
emerged	emerge	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
problem	problem	NN	I-NP	O
in	in	IN	B-PP	O
many	many	JJ	B-NP	O
debilitated	debilitate	VBN	I-NP	O
elderly	elderly	JJ	I-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	O	O
those	those	DT	B-NP	O
with	with	IN	B-PP	O
oral	oral	JJ	B-NP	O
Crohn	Crohn	NN	I-NP	O
's	's	POS	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Higher	High	JJR	B-NP	O
carriage	carriage	NN	I-NP	O
rates	rate	NNS	I-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
CNS	CNS	NN	B-NP	B-protein
or	or	CC	O	O
S.	S.	NNP	B-NP	O
aureus	aureus	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
both	both	DT	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
prone	prone	JJ	B-ADJP	O
to	to	TO	B-PP	O
joint	joint	JJ	B-NP	O
infections	infection	NNS	I-NP	O
raises	raise	VBZ	B-VP	O
the	the	DT	B-NP	O
interesting	interesting	JJ	I-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
serving	serve	VBG	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
source	source	NN	I-NP	O
for	for	IN	B-PP	O
bacteraemic	bacteraemic	JJ	B-NP	O
spread	spread	NN	I-NP	O
to	to	TO	B-PP	O
compromised	compromise	VBN	B-NP	O
joint	joint	JJ	I-NP	O
spaces	space	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
conclusion	conclusion	NN	B-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
surprising	surprising	JJ	I-NP	O
paucity	paucity	NN	I-NP	O
of	of	IN	B-PP	O
knowledge	knowledge	NN	B-NP	O
regarding	regard	VBG	B-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
staphylococci	staphylococci	NNS	I-NP	O
in	in	IN	B-PP	O
both	both	CC	O	O
health	health	NN	B-NP	O
and	and	CC	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Further	Further	JJ	B-NP	O
work	work	NN	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
area	area	NN	I-NP	O
may	may	MD	B-VP	O
lead	lead	VB	I-VP	O
to	to	TO	B-PP	O
benefits	benefit	NNS	B-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
improved	improve	VBN	B-NP	O
decolonisation	decolonisation	NN	I-NP	O
regimens	regimen	NNS	I-NP	O
for	for	IN	B-PP	O
eradication	eradication	NN	B-NP	O
of	of	IN	B-PP	O
MRSA	MRSA	NN	B-NP	B-protein
and	and	CC	I-NP	O
acknowledgement	acknowledgement	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
bacteraemic	bacteraemic	JJ	B-NP	O
staphylococci	staphylococci	NNS	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
study	study	VB	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
Triclosan-containing	Triclosan-containing	JJ	I-NP	O
mouthrinse	mouthrinse	NN	I-NP	O
--	--	:	O	O
LIBO	LIBO	NN	B-NP	O
Anti-plaque	Anti-plaque	JJ	I-NP	O
mouth	mouth	NN	I-NP	O
rinse	rinse	NN	I-NP	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

Before	Before	IN	B-PP	O
and	and	CC	I-PP	O
after	after	IN	I-PP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
triclosan	triclosan	NN	B-NP	O
mouthrinse	mouthrinse	NN	I-NP	O
:	:	:	O	O
the	the	DT	B-NP	O
gingival	gingival	NN	I-NP	O
data	datum	NNS	I-NP	O
were	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
and	and	CC	O	O
secorded	secorde	VBN	B-VP	O
;	;	:	O	O
plaque	plaque	NN	B-NP	O
sausples	sausple	NNS	I-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
,	,	,	O	O
cultured	culture	VBN	B-VP	O
in	in	IN	B-PP	O
selective	selective	JJ	B-NP	O
and	and	CC	I-NP	O
non-selective	non-selective	JJ	I-NP	O
media	medium	NNS	I-NP	O
,	,	,	O	O
bacteria	bacteria	NNS	B-NP	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
,	,	,	O	O
sounted	sounte	VBN	B-VP	O
,	,	,	O	O
and	and	CC	O	O
compased	compase	VBN	B-VP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

With	With	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
and	and	CC	O	O
P.	P.	NNP	B-NP	O
Gingivalis	Gingivalis	NNP	I-NP	O
as	as	IN	B-PP	O
experimental	experimental	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
triclosan	triclosan	NN	B-NP	O
and	and	CC	O	O
chlorhexidine	chlorhexidine	NN	B-NP	O
(	(	(	O	O
CHX	CHX	NN	B-NP	O
)	)	)	O	O
mouthrinses	mouthrinse	VBZ	B-VP	O
anti-bacterium	anti-bacterium	JJ	B-NP	O
substance	substance	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
minimum	minimum	JJ	I-NP	O
inhibitory	inhibitory	JJ	I-NP	O
concentrations	concentration	NNS	I-NP	O
(	(	(	O	O
MICs	MIC	NNS	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
rinses	rinse	NNS	I-NP	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Smooth	Smooth	JJ	B-NP	O
plates	plate	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
film	film	NN	I-NP	O
of	of	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
C	C	NN	I-NP	O
were	be	VBD	B-VP	O
set	set	VBN	I-VP	O
in	in	IN	B-PP	O
different	different	JJ	B-NP	O
mouthrinses	mouthrins	NNS	I-NP	O
and	and	CC	O	O
water	water	NN	B-NP	O
.	.	.	O	O

Observing	Observe	VBG	B-VP	O
the	the	DT	B-NP	O
exfoliation	exfoliation	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
film	film	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
plates	plate	NNS	I-NP	O
in	in	IN	B-PP	O
three	three	CD	B-NP	O
agents	agent	NNS	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

Triclosan	Triclosan	NN	B-NP	O
mouthrinse	mouthrinse	NN	I-NP	O
was	be	VBD	B-VP	O
effective	effective	JJ	B-ADJP	O
to	to	TO	B-VP	O
decrease	decrease	VB	I-VP	O
the	the	DT	B-NP	O
plaque	plaque	NN	I-NP	O
index	index	NN	I-NP	O
(	(	(	O	O
PLI	PLI	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
supragingival	supragingival	JJ	B-NP	O
bleeding	bleed	VBG	I-NP	O
index	index	NN	I-NP	O
(	(	(	O	O
SBI	SBI	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
count	count	NN	I-NP	O
obtained	obtain	VBN	B-VP	O
after	after	IN	B-PP	O
use	use	NN	B-NP	O
of	of	IN	B-PP	O
triclosan	triclosan	NN	B-NP	O
mouthrinse	mouthrinse	NN	I-NP	O
was	be	VBD	B-VP	O
lower	low	JJR	B-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
before	before	IN	B-PP	O
using	use	VBG	B-VP	O
it	it	PRP	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
minimum	minimum	JJ	I-NP	O
inhibitory	inhibitory	JJ	I-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
triclosan	triclosan	NN	B-NP	O
mouthrinse	mouthrinse	NN	I-NP	O
against	against	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
C	C	NN	I-NP	O
was	be	VBD	B-VP	O
much	much	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
chlorhexidine	chlorhexidine	NN	B-NP	O
mouthrinse	mouthrinse	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

In	In	IN	B-PP	O
triclosan	triclosan	NN	B-NP	O
mouthrinse	mouthrinse	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
films	film	NNS	I-NP	O
were	be	VBD	B-VP	O
most	most	RBS	I-VP	O
easily	easily	RB	I-VP	O
exfoliated	exfoliate	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
plate	plate	NN	I-NP	O
.	.	.	O	O

Triclosan	Triclosan	NN	B-NP	O
mouthrinse	mouthrinse	NN	I-NP	O
has	have	VBZ	B-VP	O
strongest	strong	JJS	B-NP	O
anti-adhesion	anti-adhesion	JJ	I-NP	O
effect	effect	NN	I-NP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
tested	test	VBN	I-NP	O
agents	agent	NNS	I-NP	O
.	.	.	O	O

Triclosan	Triclosan	NN	B-NP	O
mouthrinse	mouthrinse	NN	I-NP	O
has	have	VBZ	B-VP	O
continuous	continuous	JJ	B-NP	O
disinfecting	disinfect	VBG	I-NP	O
effect	effect	NN	I-NP	O
and	and	CC	I-NP	O
help	help	NN	I-NP	O
control	control	VBP	B-VP	O
the	the	DT	B-NP	O
formation	formation	NN	I-NP	O
and	and	CC	I-NP	O
adhesion	adhesion	NN	I-NP	O
of	of	IN	B-PP	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
.	.	.	O	O

Actinobacillus	Actinobacillus	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
is	be	VBZ	B-VP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
colonizing	colonize	VBG	B-VP	O
mucosa	mucosa	NN	B-NP	O
and	and	CC	O	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
and	and	CC	O	O
plays	play	VBZ	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
young	young	JJ	B-NP	O
peoples	people	NNS	I-NP	O
and	and	CC	O	O
adult	adult	JJ	B-ADJP	O
.	.	.	O	O

Adherence	Adherence	NN	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
on	on	IN	B-PP	O
epithelial	epithelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
tooth	tooth	JJ	B-NP	O
or	or	CC	I-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
gingival	gingival	JJ	B-NP	O
invasion	invasion	NN	I-NP	O
probably	probably	RB	B-ADVP	O
are	be	VBP	B-VP	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
steps	step	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
gingivitis	gingivitis	NN	B-NP	O
or	or	CC	I-NP	O
periodontitis	periodontitis	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
adherence	adherence	NN	I-NP	O
of	of	IN	B-PP	O
A.	A.	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	B-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
following	follow	VBG	B-PP	O
subculturing	subculturing	NN	B-NP	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
adherence	adherence	NN	I-NP	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	B-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
showed	show	VBD	B-VP	O
high	high	RB	B-ADVP	O
in	in	IN	B-PP	O
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
isolates	isolate	NNS	I-NP	O
values	value	NNS	I-NP	O
but	but	CC	B-PP	O
with	with	IN	B-PP	O
differences	difference	NNS	B-NP	O
among	among	IN	B-PP	O
them	them	PRP	B-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
each	each	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
subculturing	subculturing	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
adherence	adherence	NN	I-NP	O
of	of	IN	B-PP	O
A.	A.	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	VBZ	B-VP	O
FDC	FDC	NN	B-NP	B-cell_type
Y4	Y4	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
in	in	IN	B-PP	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
subcultures	subculture	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
adhesion	adhesion	NN	B-NP	O
values	value	NNS	I-NP	O
of	of	IN	B-PP	O
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
tested	test	VBN	I-NP	O
isolates	isolate	NNS	I-NP	O
were	be	VBD	B-VP	O
different	different	JJ	B-ADJP	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
strains	strain	NNS	B-NP	O
#	#	#	B-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
#	#	#	B-NP	O
38	38	CD	I-NP	O
and	and	CC	O	O
Y4	Y4	NN	B-NP	B-protein
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
a	a	DT	B-NP	O
heterogenicity	heterogenicity	NN	I-NP	O
within	within	IN	B-PP	O
this	this	DT	B-NP	O
microbial	microbial	JJ	I-NP	O
group	group	NN	I-NP	O
.	.	.	O	O

Morphologic	Morphologic	JJ	B-NP	O
variations	variation	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
extracellular	extracellular	JJ	B-NP	O
structures	structure	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
A.	A.	NN	I-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
tested	test	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
adhesion	adhesion	NN	I-NP	O
process	process	NN	I-NP	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	B-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
this	this	DT	B-NP	O
organism	organism	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
influenced	influence	VBN	I-VP	O
by	by	IN	B-PP	O
subcultures	subculture	NNS	B-NP	O
,	,	,	O	O
but	but	CC	O	O
additional	additional	JJ	B-NP	O
studies	study	NNS	I-NP	O
are	be	VBP	B-VP	O
necessary	necessary	JJ	B-ADJP	O
to	to	TO	B-VP	O
verify	verify	VB	I-VP	O
the	the	DT	B-NP	O
influence	influence	NN	I-NP	O
of	of	IN	B-PP	O
subculturing	subculture	VBG	B-VP	O
on	on	IN	B-PP	O
adherence	adherence	NN	B-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
virulence	virulence	NN	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
.	.	.	O	O

AIMS	AIMS	NNS	B-NP	O
AND	AND	CC	O	O
Currently	Currently	NNP	B-NP	O
,	,	,	O	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
preventive	preventive	JJ	I-NP	O
measure	measure	NN	I-NP	O
against	against	IN	B-PP	O
air	air	NN	B-NP	O
contamination	contamination	NN	I-NP	O
caused	cause	VBN	B-VP	O
by	by	IN	B-PP	O
dental	dental	JJ	B-NP	O
procedures	procedure	NNS	I-NP	O
,	,	,	O	O
dust-collecting	dust-collecting	JJ	B-NP	O
aspirators	aspirator	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
an	an	DT	B-NP	O
extra-oral	extra-oral	JJ	I-NP	O
vacuum	vacuum	NN	I-NP	O
aspirator	aspirator	NN	I-NP	O
(	(	(	O	O
EOVA	EOVA	NN	B-NP	B-protein
)	)	)	O	O
are	be	VBP	B-VP	O
coming	come	VBG	I-VP	O
into	into	IN	B-PP	O
general	general	JJ	B-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
tested	test	VBD	B-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
modified	modify	VBN	I-NP	O
EOVA	EOVA	NN	I-NP	B-protein
that	that	WDT	B-NP	O
uses	use	VBZ	B-VP	O
a	a	DT	B-NP	O
household	household	NN	I-NP	O
vacuum	vacuum	NN	I-NP	O
machine	machine	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
conducted	conduct	VBN	I-VP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
parts	part	NNS	I-NP	O
.	.	.	O	O

First	First	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
modified	modify	VBN	I-NP	O
EOVA	EOVA	NN	I-NP	B-protein
was	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
for	for	IN	B-PP	O
its	its	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
eliminate	eliminate	VB	I-VP	O
an	an	DT	B-NP	O
Escherichia	Escherichia	FW	I-NP	O
coli	coli	FW	I-NP	O
aerosol	aerosol	NN	I-NP	O
generated	generate	VBN	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
manikin	manikin	NN	I-NP	O
.	.	.	O	O

Second	Second	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
device	device	NN	I-NP	O
was	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
for	for	IN	B-PP	O
its	its	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
remove	remove	VB	I-VP	O
the	the	DT	B-NP	O
aerosol	aerosol	NN	I-NP	O
generated	generate	VBN	B-VP	O
by	by	IN	B-PP	O
dental	dental	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
procedures	procedure	NNS	I-NP	O
,	,	,	O	O
scaling	scale	VBG	B-VP	O
and	and	CC	I-VP	O
drilling	drill	VBG	I-VP	O
a	a	DT	B-NP	O
tooth	tooth	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
human	human	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
statistically	statistically	RB	I-NP	O
significant	significant	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
E.	E.	FW	I-NP	O
coli	coli	FW	I-NP	O
aerosol	aerosol	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
aerosol	aerosol	NN	I-NP	O
during	during	IN	B-PP	O
dental	dental	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
procedures	procedure	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
modified	modify	VBN	I-NP	O
EOVA	EOVA	NN	I-NP	O
machine	machine	NN	I-NP	O
is	be	VBZ	B-VP	O
highly	highly	RB	B-ADJP	O
effective	effective	JJ	I-ADJP	O
in	in	IN	B-PP	O
preventing	prevent	VBG	B-VP	O
air	air	NN	B-NP	O
contamination	contamination	NN	I-NP	O
by	by	IN	B-PP	O
dental	dental	JJ	B-NP	O
procedures	procedure	NNS	I-NP	O
.	.	.	O	O

Its	Its	PRP$	B-NP	O
main	main	JJ	I-NP	O
advantages	advantage	NNS	I-NP	O
are	be	VBP	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
can	can	MD	B-VP	O
easily	easily	RB	I-VP	O
be	be	VB	I-VP	O
modified	modify	VBN	I-VP	O
for	for	IN	B-PP	O
use	use	NN	B-NP	O
with	with	IN	B-PP	O
any	any	DT	B-NP	O
dental	dental	JJ	I-NP	O
unit	unit	NN	I-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
relatively	relatively	RB	B-ADJP	O
inexpensive	inexpensive	JJ	I-ADJP	O
.	.	.	O	O

Black-pigmented	Black-pigmented	JJ	B-NP	O
anaerobic	anaerobic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
and	and	CC	O	O
Prevotella	Prevotella	NNP	B-NP	O
intermedia	intermedia	NNS	I-NP	O
,	,	,	O	O
are	be	VBP	B-VP	O
amongst	amongst	IN	B-PP	O
the	the	DT	B-NP	O
predominant	predominant	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
pockets	pocket	NNS	I-NP	O
and	and	CC	O	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
implicated	implicate	VBN	I-VP	O
in	in	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
elucidate	elucidate	VB	I-VP	O
the	the	DT	B-NP	O
roles	role	NNS	I-NP	O
of	of	IN	B-PP	O
gingival	gingival	JJ	B-NP	B-cell_type
keratinocytes	keratinocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
cells	cell	NNS	I-NP	O
encountered	encounter	VBN	B-VP	O
by	by	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
,	,	,	O	O
human	human	JJ	B-NP	B-cell_type
gingival	gingival	JJ	I-NP	I-cell_type
keratinocytes	keratinocyte	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
primary	primary	JJ	B-NP	B-cell_line
culture	culture	NN	I-NP	I-cell_line
were	be	VBD	B-VP	O
stimulated	stimulate	VBN	I-VP	O
with	with	IN	B-PP	O
cell-surface	cell-surface	JJ	B-NP	B-protein
components	component	NNS	I-NP	I-protein
of	of	IN	B-PP	O
P	P	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
and	and	CC	I-NP	O
Pr	Pr	NN	I-NP	B-protein
.	.	.	O	O

intermedia	intermedia	NNS	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
glycoprotein	glycoprotein	NN	I-NP	O
fraction	fraction	NN	I-NP	O
from	from	IN	B-PP	O
Pr	Pr	NNP	B-NP	B-protein
.	.	.	O	O

intermedia	intermedia	NNS	B-NP	O
(	(	(	O	O
PGP	PGP	NN	B-NP	O
)	)	)	O	O
clearly	clearly	RB	B-ADVP	O
augmented	augment	VBD	B-VP	O
the	the	DT	B-NP	O
release	release	NN	I-NP	O
of	of	IN	B-PP	O
interleukin-8	interleukin-8	NN	B-NP	B-protein
,	,	,	O	O
granulocyte	granulocyte	NN	B-NP	B-protein
colony-stimulating	colony-stimulating	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
and	and	CC	O	O
granulocyte-macrophage	granulocyte-macrophage	JJ	B-NP	B-protein
colony-stimulating	colony-stimulating	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
,	,	,	O	O
as	as	IN	B-SBAR	O
determined	determine	VBN	B-VP	O
by	by	IN	B-PP	O
enzyme-linked	enzyme-linked	JJ	B-NP	O
immunosorbent	immunosorbent	JJ	I-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
PGP	PGP	NN	I-NP	B-protein
also	also	RB	B-ADVP	O
induced	induce	VBD	B-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
intercellular	intercellular	JJ	B-NP	B-protein
adhesion	adhesion	NN	I-NP	I-protein
molecule-1	molecule-1	NN	I-NP	I-protein
(	(	(	O	O
ICAM-1	ICAM-1	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
as	as	IN	B-SBAR	O
determined	determine	VBN	B-VP	O
by	by	IN	B-PP	O
flow	flow	NN	B-NP	O
cytometry	cytometry	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
augmentation	augmentation	NN	I-NP	O
of	of	IN	B-PP	O
mRNA	mRNA	NN	B-NP	B-RNA
expression	expression	NN	I-NP	O
for	for	IN	B-PP	O
these	these	DT	B-NP	O
molecules	molecule	NNS	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
confirmed	confirm	VBN	I-VP	O
by	by	IN	B-PP	O
reverse	reverse	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
PCR	PCR	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
lipopolysaccharide	lipopolysaccharide	NN	B-NP	O
(	(	(	O	O
LPS	LPS	NN	B-NP	O
)	)	)	O	O
from	from	IN	B-PP	O
Pr	Pr	NN	B-NP	B-protein
.	.	.	O	O

intermedia	intermedia	NNS	B-NP	O
and	and	CC	O	O
Escherichia	Escherichia	FW	B-NP	O
coli	coli	FW	I-NP	O
was	be	VBD	B-VP	O
completely	completely	RB	B-ADJP	O
inactive	inactive	JJ	I-ADJP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
assays	assay	NNS	I-NP	O
.	.	.	O	O

LPS	LPS	NN	B-NP	O
fraction	fraction	NN	I-NP	O
and	and	CC	O	O
purified	purify	VBN	B-NP	O
fimbriae	fimbria	NNS	I-NP	O
from	from	IN	B-PP	O
P	P	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
exhibited	exhibit	VBD	B-VP	O
weak	weak	JJ	B-NP	O
activities	activity	NNS	I-NP	O
.	.	.	O	O

Cytokine	Cytokine	NN	B-NP	B-protein
production	production	NN	I-NP	O
and	and	CC	O	O
ICAM-1	ICAM-1	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
by	by	IN	B-PP	O
gingival	gingival	JJ	B-NP	B-cell_type
keratinocytes	keratinocyte	NNS	I-NP	I-cell_type
might	might	MD	B-VP	O
cause	cause	VB	I-VP	O
accumulation	accumulation	NN	B-NP	O
and	and	CC	I-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
neutrophils	neutrophil	NNS	B-NP	B-cell_type
in	in	IN	B-PP	O
the	the	DT	B-NP	O
epithelium	epithelium	NN	I-NP	O
and	and	CC	O	O
,	,	,	O	O
therefore	therefore	RB	B-ADVP	O
,	,	,	O	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
initiation	initiation	NN	I-NP	O
and	and	CC	I-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
inflammation	inflammation	NN	B-NP	O
in	in	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
tissues	tissue	NNS	I-NP	O
.	.	.	O	O

Novel	Novel	JJ	B-NP	O
isolates	isolate	NNS	I-NP	O
,	,	,	O	O
strains	strain	NNS	B-NP	O
HM-7	HM-7	NN	I-NP	B-protein
,	,	,	O	O
HM-6	HM-6	NN	B-NP	B-protein
,	,	,	O	O
HH-31	HH-31	NN	B-NP	B-protein
,	,	,	O	O
P9a-hT	P9a-hT	NN	B-NP	O
and	and	CC	I-NP	O
UJB13-d	UJB13-d	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
tongue	tongue	NN	B-NP	O
plaque	plaque	NN	I-NP	O
and	and	CC	O	O
necrotic	necrotic	JJ	B-NP	O
dental	dental	JJ	I-NP	O
pulp	pulp	NN	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
taxonomically	taxonomically	RB	B-ADVP	O
and	and	CC	I-ADVP	O
phylogenetically	phylogenetically	RB	I-ADVP	O
.	.	.	O	O

These	These	DT	B-NP	O
organisms	organism	NNS	I-NP	O
were	be	VBD	B-VP	O
anaerobic	anaerobic	JJ	B-NP	O
,	,	,	I-NP	O
non-spore-forming	non-spore-forming	JJ	I-NP	O
,	,	,	I-NP	O
gram-positive	gram-positive	JJ	I-NP	O
,	,	,	I-NP	O
rod-shaped	rod-shaped	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
inert	inert	JJ	B-ADJP	O
in	in	IN	B-PP	O
most	most	JJS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
conventional	conventional	JJ	I-NP	O
biochemical	biochemical	JJ	I-NP	O
tests	test	NNS	I-NP	O
and	and	CC	O	O
phenotypically	phenotypically	RB	B-NP	O
resemble	resemble	JJ	I-NP	O
Mogibacterium	Mogibacterium	NNP	I-NP	O
species	specie	NNS	I-NP	O
or	or	CC	O	O
asaccharolytic	asaccharolytic	JJ	B-NP	O
Eubacterium	Eubacterium	NNP	I-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
G+C	G+C	NN	I-NP	O
contents	content	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
DNAs	DNA	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
novel	novel	JJ	I-NP	O
isolates	isolate	NNS	I-NP	O
ranged	range	VBD	B-VP	O
from	from	IN	B-PP	O
41	41	CD	B-NP	O
to	to	TO	I-NP	O
42	42	CD	I-NP	O
mol	mol	NN	I-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

DNA-DNA	DNA-DNA	JJ	B-NP	O
hybridization	hybridization	NN	I-NP	O
studies	study	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
strains	strain	NNS	I-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
assigned	assign	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
genus	genus	NN	I-NP	O
Mogibacterium	Mogibacterium	NN	I-NP	O
but	but	CC	B-PP	O
not	not	RB	B-PP	O
to	to	TO	I-PP	O
the	the	DT	B-NP	O
previously	previously	RB	I-NP	O
described	describe	VBN	I-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
apparent	apparent	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
strain	strain	NN	B-NP	O
HM-7	HM-7	NN	I-NP	O
belonged	belong	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
species	specie	NNS	I-NP	O
as	as	IN	B-PP	O
strains	strain	NNS	B-NP	O
HM-6	HM-6	NN	I-NP	B-protein
and	and	CC	I-NP	O
HH-31	HH-31	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
strains	strain	NNS	B-NP	O
P9a-hT	P9a-hT	NN	I-NP	O
and	and	CC	I-NP	O
UJB13-d	UJB13-d	NN	I-NP	O
belonged	belong	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
second	second	JJ	I-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
DNA-DNA	DNA-DNA	JJ	B-NP	O
relatedness	relatedness	NN	I-NP	O
to	to	TO	B-PP	O
asaccharolytic	asaccharolytic	JJ	B-NP	O
Eubacterium	Eubacterium	NNP	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
Eubacterium	Eubacterium	NNP	B-NP	O
brachy	brachy	NNP	I-NP	O
,	,	,	O	O
Eubacterium	Eubacterium	NNP	B-NP	O
nodatum	nodatum	NNP	I-NP	O
,	,	,	O	O
Eubacterium	Eubacterium	NNP	B-NP	O
saphenum	saphenum	NN	I-NP	O
and	and	CC	O	O
the	the	DT	O	O
more	more	RBR	B-ADVP	O
recently	recently	RB	I-ADVP	O
proposed	propose	VBN	B-NP	O
Eubacterium	Eubacterium	NN	I-NP	O
minutum	minutum	NN	I-NP	O
and	and	CC	I-NP	O
Eubacterium	Eubacterium	NN	I-NP	O
exiguum	exiguum	NN	I-NP	O
(	(	(	O	O
reclassified	reclassifie	VBN	B-VP	O
as	as	IN	B-PP	O
Slackia	Slackia	NNP	B-NP	O
exigua	exigua	NNP	I-NP	O
)	)	)	O	O
,	,	,	O	O
are	be	VBP	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
2	2	CD	I-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
16S	16S	NN	B-NP	O
rDNA	rDNA	NN	I-NP	O
sequence	sequence	NN	I-NP	O
comparisons	comparison	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
organisms	organism	NNS	I-NP	O
represent	represent	VBP	B-VP	O
novel	novel	JJ	B-NP	O
lineages	lineage	NNS	I-NP	O
distinct	distinct	JJ	B-ADJP	O
from	from	IN	B-PP	O
all	all	DT	B-NP	O
previously	previously	RB	I-NP	O
described	describe	VBN	I-NP	O
species	specie	NNS	I-NP	O
of	of	IN	B-PP	O
gram-positive	gram-positive	JJ	B-NP	O
,	,	,	I-NP	O
rod-shaped	rod-shaped	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
phenotypic	phenotypic	JJ	B-NP	O
characteristics	characteristic	NNS	I-NP	O
,	,	,	O	O
DNA-DNA	DNA-DNA	NN	B-NP	O
hybridization	hybridization	NN	I-NP	O
data	datum	NNS	I-NP	O
and	and	CC	O	O
phylogenetic	phylogenetic	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
with	with	IN	B-PP	O
16S	16S	NN	B-NP	O
rRNA	rRNA	NN	I-NP	O
gene	gene	NN	I-NP	O
sequence	sequence	NN	I-NP	O
data	datum	NNS	I-NP	O
,	,	,	O	O
new	new	JJ	B-NP	O
species	specie	NNS	I-NP	O
are	be	VBP	B-VP	O
proposed	propose	VBN	I-VP	O
,	,	,	O	O
namely	namely	RB	B-NP	O
Mogibacterium	Mogibacterium	NN	I-NP	O
diversum	diversum	NN	I-NP	O
(	(	(	O	O
for	for	IN	B-PP	O
strains	strain	NNS	B-NP	O
HM-7	HM-7	NN	I-NP	B-protein
,	,	,	O	O
HM-6	HM-6	NN	B-NP	B-protein
and	and	CC	O	O
HH-31	HH-31	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
Mogibacterium	Mogibacterium	NN	B-NP	O
neglectum	neglectum	NN	I-NP	O
(	(	(	O	O
for	for	IN	B-PP	O
strains	strain	NNS	B-NP	O
P9a-hT	P9a-hT	NN	I-NP	O
and	and	CC	O	O
UJB13-d	UJB13-d	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

HM-7T	HM-7T	NN	B-NP	O
(	(	(	O	O
=	=	SYM	B-VP	O
ATCC	ATCC	NN	B-NP	O
700923T	700923T	NN	I-NP	O
=	=	SYM	B-VP	O
JCM	JCM	NN	B-NP	O
11205T	11205T	NN	I-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
type	type	NN	I-NP	O
strain	strain	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
former	former	JJ	I-NP	O
and	and	CC	I-NP	O
P9a-hT	P9a-hT	NN	I-NP	O
(	(	(	O	O
=	=	SYM	B-VP	O
ATCC	ATCC	NN	B-NP	O
700924T	700924T	NN	I-NP	O
=	=	SYM	B-VP	O
JCM	JCM	NN	B-NP	O
11204T	11204T	NN	I-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
type	type	NN	I-NP	O
strain	strain	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
latter	latter	JJ	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
Actinobacillus	Actinobacillus	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
to	to	TO	B-VP	O
produce	produce	VB	I-VP	O
bacteriocin	bacteriocin	NN	B-NP	O
has	have	VBZ	B-VP	O
rarely	rarely	RB	I-VP	O
been	be	VBN	I-VP	O
reported	report	VBN	I-VP	O
.	.	.	O	O

antagonistic	antagonistic	JJ	B-NP	O
substance	substance	NN	I-NP	O
production	production	NN	I-NP	O
may	may	MD	B-VP	O
confer	confer	VB	I-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
ecological	ecological	JJ	I-NP	O
advantage	advantage	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
producer	producer	NN	I-NP	O
microorganisms	microorganism	NNS	I-NP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
competitive	competitive	JJ	I-NP	O
ecosystem	ecosystem	NN	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
75	75	CD	B-NP	O
A.	A.	NN	I-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
strains	strain	NNS	I-NP	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
periodontally	periodontally	RB	B-NP	O
healthy	healthy	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
and	and	CC	I-NP	O
marmosets	marmoset	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
two	two	CD	B-NP	O
reference	reference	NN	I-NP	O
strains	strain	NNS	I-NP	O
(	(	(	O	O
A.	A.	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
ATCC	ATCC	NN	B-NP	O
29523	29523	CD	I-NP	O
and	and	CC	O	O
FDC	FDC	NN	B-NP	B-protein
Y4	Y4	NN	I-NP	I-protein
)	)	)	O	O
were	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
for	for	IN	B-PP	O
auto-	auto-	NN	B-NP	O
,	,	,	O	O
iso-	iso-	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
heteroantagonistic	heteroantagonistic	JJ	B-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

Fifty-one	Fifty-one	CD	B-NP	O
(	(	(	O	O
68.00	68.00	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
strains	strain	NNS	B-NP	O
exhibited	exhibit	VBD	B-VP	O
antagonistic	antagonistic	JJ	B-NP	O
activity	activity	NN	I-NP	O
;	;	:	O	O
heteroantagonism	heteroantagonism	NN	B-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
more	more	RBR	B-ADVP	O
often	often	RB	I-ADVP	O
than	than	IN	B-PP	O
isoantagonism	isoantagonism	NN	B-NP	O
.	.	.	O	O

Isolated	Isolate	VBN	B-NP	O
strains	strain	NNS	I-NP	O
antagonized	antagonize	VBD	B-VP	O
17	17	CD	B-NP	O
different	different	JJ	I-NP	O
species	specie	NNS	I-NP	O
of	of	IN	B-PP	O
gram-positive	gram-positive	JJ	B-NP	O
and	and	CC	I-NP	O
gram-negative	gram-negative	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
and	and	CC	I-NP	O
nonoral	nonoral	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
.	.	.	O	O

Sensitivity	Sensitivity	NN	B-NP	O
to	to	TO	B-PP	O
heat	heat	NN	B-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
proteolytic	proteolytic	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
constituted	constitute	VBD	B-VP	O
strong	strong	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
antagonistic	antagonistic	JJ	I-NP	O
substance	substance	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
proteic	proteic	JJ	I-NP	O
nature	nature	NN	I-NP	O
.	.	.	O	O

Taken	Take	VBN	B-VP	O
together	together	RB	B-ADVP	O
,	,	,	O	O
our	our	PRP$	B-NP	O
data	datum	NNS	I-NP	O
enabled	enable	VBD	B-VP	O
us	us	PRP	B-NP	O
to	to	TO	B-VP	O
confirm	confirm	VB	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
antagonistic	antagonistic	JJ	I-NP	O
substance	substance	NN	I-NP	O
detected	detect	VBN	B-VP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
bacteriocin	bacteriocin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
wide	wide	JJ	I-NP	O
spectrum	spectrum	NN	I-NP	O
of	of	IN	B-PP	O
activity	activity	NN	B-NP	O
indicates	indicate	VBZ	B-VP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
that	that	IN	B-SBAR	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
one	one	CD	I-NP	O
antagonistic	antagonistic	JJ	I-NP	O
substance	substance	NN	I-NP	O
is	be	VBZ	B-VP	O
produced	produce	VBN	I-VP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
substances	substance	NNS	I-NP	O
play	play	VBP	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ecological	ecological	JJ	I-NP	O
balance	balance	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
ecosystem	ecosystem	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
100	100	CD	I-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
investigators	investigator	NNS	B-NP	O
have	have	VBP	B-VP	O
tried	try	VBN	I-VP	O
to	to	TO	I-VP	O
identify	identify	VB	I-VP	O
the	the	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
formation	formation	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
their	their	PRP$	B-NP	O
role	role	NN	I-NP	O
is	be	VBZ	B-VP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
specificity	specificity	NN	B-NP	O
.	.	.	O	O

Frequent	Frequent	JJ	B-NP	O
association	association	NN	I-NP	O
of	of	IN	B-PP	O
Lactobacillus	Lactobacillus	NN	B-NP	O
acidophilus	acidophilus	NN	I-NP	O
and	and	CC	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
with	with	IN	B-PP	O
caries	cary	NNS	B-NP	O
activity	activity	NN	I-NP	O
gave	give	VBD	B-VP	O
credence	credence	NN	B-NP	O
to	to	TO	B-PP	O
their	their	PRP$	B-NP	O
being	be	VBG	B-VP	O
specific	specific	JJ	B-NP	O
cariogens	cariogen	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
occurrence	occurrence	VBP	B-VP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
absence	absence	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
produce	produce	VB	I-VP	O
substantial	substantial	JJ	B-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
acid	acid	NN	B-NP	O
from	from	IN	B-PP	O
fermentable	fermentable	JJ	B-NP	O
carbohydrate	carbohydrate	NN	I-NP	O
,	,	,	O	O
provided	provide	VBN	B-NP	O
arguments	argument	NNS	I-NP	O
for	for	IN	B-PP	O
non-specificity	non-specificity	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
1940s	1940	NNS	I-NP	O
,	,	,	O	O
Stephan	Stephan	NNP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
mixed	mixed	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
produced	produce	VBD	B-VP	O
a	a	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
drop	drop	NN	I-NP	O
in	in	IN	B-PP	O
pH	pH	NN	B-NP	O
following	follow	VBG	B-PP	O
a	a	DT	B-NP	O
sugar	sugar	NN	I-NP	O
rinse	rinse	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
slow	slow	JJ	I-NP	O
pH	pH	NN	I-NP	O
return	return	NN	I-NP	O
toward	toward	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
response	response	NN	I-NP	O
became	become	VBD	B-VP	O
a	a	DT	B-NP	O
cornerstone	cornerstone	NN	I-NP	O
of	of	IN	B-PP	O
plaque	plaque	NN	B-NP	O
and	and	CC	O	O
mixed-bacterial	mixed-bacterial	JJ	B-NP	O
involvement	involvement	NN	I-NP	O
in	in	IN	B-PP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
causation	causation	NN	I-NP	O
when	when	WRB	B-ADVP	O
Stephan	Stephan	NN	B-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
pH	pH	NN	I-NP	O
decrease	decrease	NN	I-NP	O
was	be	VBD	B-VP	O
inversely	inversely	RB	B-ADVP	O
and	and	CC	O	O
clearly	clearly	RB	B-ADJP	O
related	related	JJ	I-ADJP	O
to	to	TO	B-PP	O
caries	cary	NNS	B-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

Detailed	Detailed	JJ	B-NP	O
examination	examination	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pH	pH	NN	I-NP	O
(	(	(	O	O
acid-base	acid-base	NN	B-NP	O
)	)	)	O	O
metabolisms	metabolism	NNS	B-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	B-cell_line
pure	pure	JJ	I-NP	I-cell_line
cultures	culture	NNS	I-NP	I-cell_line
,	,	,	O	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
salivary	salivary	JJ	B-NP	O
sediment	sediment	NN	I-NP	O
identified	identify	VBD	B-VP	O
the	the	DT	B-NP	O
main	main	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
metabolic	metabolic	JJ	B-NP	O
processes	process	NNS	I-NP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
pH	pH	NN	I-NP	O
metabolism	metabolism	NN	I-NP	O
of	of	IN	B-PP	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
discovered	discover	VBN	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
metabolism	metabolism	NN	I-NP	O
in	in	IN	B-PP	O
different	different	JJ	B-NP	O
individuals	individual	NNS	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
plaque	plaque	NN	B-NP	O
in	in	IN	B-PP	O
different	different	JJ	B-NP	O
dentition	dentition	NN	I-NP	O
locations	location	NNS	I-NP	O
within	within	IN	B-PP	O
individuals	individual	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
individuals	individual	NNS	B-NP	O
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
caries	cary	NNS	B-NP	O
activity	activity	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
described	describe	VBN	I-VP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
relatively	relatively	RB	I-NP	O
small	small	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
acid-base	acid-base	NN	B-NP	O
metabolic	metabolic	JJ	I-NP	O
processes	process	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
overall	overall	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
metabolic	metabolic	JJ	I-NP	O
vector	vector	NN	I-NP	O
concept	concept	NN	I-NP	O
for	for	IN	B-PP	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
helped	help	VBD	B-VP	O
unravel	unravel	VB	I-VP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
involvement	involvement	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
degradation	degradation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
carbohydrate	carbohydrate	NN	I-NP	O
and	and	CC	I-NP	O
nitrogenous	nitrogenous	JJ	I-NP	B-protein
substrates	substrate	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
produce	produce	VBP	B-VP	O
the	the	DT	B-NP	O
acids	acid	NNS	I-NP	O
and	and	CC	I-NP	O
alkali	alkali	NNS	I-NP	O
that	that	WDT	B-NP	O
affect	affect	VBP	B-VP	O
the	the	DT	B-NP	O
pH	pH	NN	I-NP	O
and	and	CC	I-NP	O
favor	favor	NN	I-NP	O
and	and	CC	O	O
inhibit	inhibit	VBP	B-VP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
production	production	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

A	A	DT	B-NP	O
central	central	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
arginolytic	arginolytic	JJ	I-NP	O
and	and	CC	I-NP	O
non-arginolytic	non-arginolytic	JJ	I-NP	O
acidogens	acidogen	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Stephan	Stephan	NN	I-NP	O
pH	pH	NN	I-NP	O
curve	curve	NN	I-NP	O
was	be	VBD	B-VP	O
discovered	discover	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
non-arginolytics	non-arginolytic	NNS	I-NP	O
could	could	MD	B-VP	O
produce	produce	VB	I-VP	O
only	only	RB	B-NP	O
the	the	DT	I-NP	O
pH	pH	NN	I-NP	O
fall	fall	NN	I-NP	O
part	part	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
curve	curve	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
arginolytics	arginolytic	NNS	I-NP	O
could	could	MD	B-VP	O
produce	produce	VB	I-VP	O
both	both	CC	O	O
the	the	DT	B-NP	O
fall	fall	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
rise	rise	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
net	net	JJ	I-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
latter	latter	JJ	I-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
less	less	RBR	I-NP	O
acidic	acidic	JJ	I-NP	O
Stephan	Stephan	NN	I-NP	O
pH	pH	NN	I-NP	O
curve	curve	NN	I-NP	O
.	.	.	O	O

Both	Both	DT	B-NP	O
kinds	kind	NNS	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
are	be	VBP	B-VP	O
numerous	numerous	JJ	B-ADJP	O
in	in	IN	B-PP	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
varying	vary	VBG	B-VP	O
their	their	PRP$	B-NP	O
ratios	ratio	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
were	be	VBD	B-VP	O
easily	easily	RB	B-ADJP	O
able	able	JJ	I-ADJP	O
to	to	TO	B-VP	O
produce	produce	VB	I-VP	O
Stephan	Stephan	NN	B-NP	O
pH	pH	NN	I-NP	O
curves	curve	NNS	I-NP	O
indicative	indicative	JJ	B-ADJP	O
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
caries	cary	NNS	B-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
and	and	CC	I-NP	O
substantial	substantial	JJ	I-NP	O
related	related	JJ	I-NP	O
metabolic	metabolic	JJ	I-NP	O
and	and	CC	I-NP	O
microbial	microbial	JJ	I-NP	O
data	datum	NNS	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
proportions	proportion	NNS	I-NP	O
and	and	CC	I-NP	O
numbers	number	NNS	I-NP	O
of	of	IN	B-PP	O
acid-base-producing	acid-base-producing	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
core	core	NN	I-NP	O
of	of	IN	B-PP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
elimination	elimination	NN	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
,	,	,	O	O
as	as	IN	B-PP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
vaccine	vaccine	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
considered	consider	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
little	little	JJ	B-NP	O
chance	chance	NN	I-NP	O
of	of	IN	B-PP	O
success	success	NN	B-NP	O
in	in	IN	B-PP	O
preventing	prevent	VBG	B-VP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
in	in	IN	B-PP	O
humans	human	NNS	B-NP	O
,	,	,	O	O
since	since	IN	B-SBAR	O
,	,	,	O	O
in	in	IN	B-PP	O
most	most	JJS	B-NP	O
cases	case	NNS	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
would	would	MD	B-VP	O
simply	simply	RB	I-VP	O
make	make	VB	I-VP	O
more	more	JJR	B-NP	O
room	room	NN	I-NP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
or	or	CC	I-NP	O
more	more	JJR	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
many	many	JJ	I-NP	O
acidogens	acidogen	NNS	I-NP	O
remaining	remain	VBG	B-VP	O
.	.	.	O	O

An	An	DT	B-NP	O
understanding	understanding	NN	I-NP	O
of	of	IN	B-PP	O
mixed-bacterial	mixed-bacterial	JJ	B-NP	O
metabolism	metabolism	NN	I-NP	O
,	,	,	O	O
knowledge	knowledge	NN	B-NP	O
of	of	IN	B-PP	O
how	how	WRB	B-ADVP	O
to	to	TO	B-VP	O
manipulate	manipulate	VB	I-VP	O
and	and	CC	O	O
work	work	VB	B-VP	O
with	with	IN	B-PP	O
mixed	mixed	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
metabolic	metabolic	JJ	I-NP	O
vector	vector	NN	I-NP	O
approach	approach	NN	I-NP	O
as	as	IN	B-SBAR	O
described	describe	VBN	B-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
article	article	NN	I-NP	O
have	have	VBP	B-VP	O
led	lead	VBN	I-VP	O
to	to	TO	B-PP	O
(	(	(	B-LST	O
1	1	LS	I-LST	O
)	)	)	O	O
a	a	DT	B-NP	O
more	more	RBR	I-NP	O
ecological	ecological	JJ	I-NP	O
focus	focus	NN	I-NP	O
for	for	IN	B-PP	O
dealing	deal	VBG	B-VP	O
with	with	IN	B-PP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
(	(	(	B-LST	O
2	2	LS	I-LST	O
)	)	)	O	O
new	new	JJ	B-NP	O
means	mean	NNS	I-NP	O
of	of	IN	B-PP	O
developing	develop	VBG	B-VP	O
and	and	CC	I-VP	O
evaluating	evaluate	VBG	I-VP	O
anti-caries	anti-cary	NNS	B-NP	O
agents	agent	NNS	I-NP	O
directed	direct	VBN	B-VP	O
toward	toward	IN	B-PP	O
microbial	microbial	JJ	B-NP	O
mixtures	mixture	NNS	I-NP	O
that	that	WDT	B-NP	O
counter	counter	VBP	B-VP	O
excess	excess	JJ	B-NP	O
acid	acid	NN	I-NP	O
accumulation	accumulation	NN	I-NP	O
and	and	CC	O	O
tooth	tooth	JJ	B-NP	O
demineralization	demineralization	NN	I-NP	O
.	.	.	O	O

Bacterial	Bacterial	JJ	B-NP	O
invasion	invasion	NN	I-NP	O
of	of	IN	B-PP	O
dentinal	dentinal	JJ	B-NP	O
tubules	tubule	NNS	I-NP	O
commonly	commonly	RB	B-ADVP	O
occurs	occur	VBZ	B-VP	O
when	when	WRB	B-ADVP	O
dentin	dentin	NN	B-NP	O
is	be	VBZ	B-VP	O
exposed	expose	VBN	I-VP	O
following	follow	VBG	B-PP	O
a	a	DT	B-NP	O
breach	breach	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
integrity	integrity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
overlying	overlie	VBG	I-NP	O
enamel	enamel	NN	I-NP	O
or	or	CC	I-NP	O
cementum	cementum	NN	I-NP	O
.	.	.	O	O

Bacterial	Bacterial	JJ	B-NP	O
products	product	NNS	I-NP	O
diffuse	diffuse	VBP	B-VP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
dentinal	dentinal	JJ	I-NP	O
tubule	tubule	NN	I-NP	O
toward	toward	IN	B-PP	O
the	the	DT	B-NP	O
pulp	pulp	NN	I-NP	O
and	and	CC	O	O
evoke	evoke	VB	B-VP	O
inflammatory	inflammatory	JJ	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pulpo-dentin	pulpo-dentin	NN	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
.	.	.	O	O

These	These	DT	B-NP	O
may	may	MD	B-VP	O
eliminate	eliminate	VB	I-VP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
insult	insult	NN	I-NP	O
and	and	CC	O	O
block	block	VB	B-VP	O
the	the	DT	B-NP	O
route	route	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

Unchecked	Unchecked	JJ	B-ADJP	O
,	,	,	O	O
invasion	invasion	NN	B-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
pulpitis	pulpitis	NN	B-NP	O
and	and	CC	O	O
pulp	pulp	NN	B-NP	O
necrosis	necrosis	NN	I-NP	O
,	,	,	O	O
infection	infection	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
root	root	NN	I-NP	O
canal	canal	NN	I-NP	O
system	system	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
periapical	periapical	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
several	several	JJ	B-NP	O
hundred	hundred	CD	I-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
are	be	VBP	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
inhabit	inhabit	VB	I-VP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
relatively	relatively	RB	I-NP	O
small	small	JJ	I-NP	O
and	and	CC	I-NP	O
select	select	JJ	I-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
is	be	VBZ	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
invasion	invasion	NN	I-NP	O
of	of	IN	B-PP	O
dentinal	dentinal	JJ	B-NP	O
tubules	tubule	NNS	I-NP	O
and	and	CC	O	O
subsequent	subsequent	JJ	B-NP	O
infection	infection	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
root	root	NN	I-NP	O
canal	canal	JJ	I-NP	O
space	space	NN	I-NP	O
.	.	.	O	O

Gram-positive	Gram-positive	JJ	B-NP	O
organisms	organism	NNS	I-NP	O
dominate	dominate	VBP	B-VP	O
the	the	DT	B-NP	O
tubule	tubule	NN	I-NP	O
microflora	microflora	NN	I-NP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
carious	carious	JJ	I-NP	O
and	and	CC	I-NP	O
non-carious	non-carious	JJ	I-NP	B-protein
dentin	dentin	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
relatively	relatively	RB	I-NP	O
high	high	JJ	I-NP	O
numbers	number	NNS	I-NP	O
of	of	IN	B-PP	O
obligate	obligate	JJ	B-NP	O
anaerobes	anaerobe	NNS	I-NP	O
present-such	present-such	JJ	B-ADJP	O
as	as	IN	B-PP	O
Eubacterium	Eubacterium	NNP	B-NP	O
spp.	spp.	NNP	I-NP	O
,	,	,	O	O
Propionibacterium	Propionibacterium	NNP	B-NP	O
spp.	spp.	NNP	I-NP	O
,	,	,	O	O
Bifidobacterium	Bifidobacterium	NNP	B-NP	O
spp.	spp.	NNP	I-NP	O
,	,	,	O	O
Peptostreptococcus	Peptostreptococcus	NNP	B-NP	O
micros	micro	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Veillonella	Veillonella	NNP	B-NP	O
spp.-suggest	spp.-suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
environment	environment	NN	I-NP	O
favors	favor	VBZ	B-VP	O
growth	growth	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

Gram-negative	Gram-negative	JJ	B-NP	O
obligate	obligate	JJ	I-NP	O
anaerobic	anaerobic	JJ	I-NP	O
rods	rod	NNS	I-NP	O
,	,	,	O	O
e.g.	e.g.	FW	B-NP	O
,	,	,	O	O
Porphyromonas	Porphyromonas	NNP	B-NP	O
spp.	spp.	NN	I-NP	O
,	,	,	O	O
are	be	VBP	B-VP	O
less	less	RBR	I-VP	O
frequently	frequently	RB	I-VP	O
recovered	recover	VBN	I-VP	O
.	.	.	O	O

Streptococci	Streptococci	NNS	B-NP	O
are	be	VBP	B-VP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
commonly	commonly	RB	I-NP	O
identified	identify	VBN	I-NP	O
bacteria	bacteria	NNS	I-NP	O
that	that	WDT	B-NP	O
invade	invade	VBP	B-VP	O
dentin	dentin	NN	B-NP	O
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
streptococci	streptococci	NNS	B-NP	O
may	may	MD	B-VP	O
recognize	recognize	VB	I-VP	O
components	component	NNS	B-NP	O
present	present	JJ	B-ADJP	O
within	within	IN	B-PP	O
dentinal	dentinal	JJ	B-NP	O
tubules	tubule	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
collagen	collagen	NN	B-NP	B-protein
type	type	NN	I-NP	I-protein
I	I	CD	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
stimulate	stimulate	VBP	B-VP	O
bacterial	bacterial	JJ	B-NP	O
adhesion	adhesion	NN	I-NP	O
and	and	CC	O	O
intra-tubular	intra-tubular	JJ	B-NP	O
growth	growth	NN	I-NP	O
.	.	.	O	O

Specific	Specific	JJ	B-NP	O
interactions	interaction	NNS	I-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
with	with	IN	B-PP	O
invading	invade	VBG	B-NP	O
streptococci	streptococci	NNS	I-NP	O
may	may	MD	B-VP	O
then	then	RB	I-VP	O
facilitate	facilitate	VB	I-VP	O
the	the	DT	B-NP	O
invasion	invasion	NN	I-NP	O
of	of	IN	B-PP	O
dentin	dentin	NN	B-NP	O
by	by	IN	B-PP	O
select	select	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
groupings	grouping	NNS	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
understanding	understand	VBG	B-VP	O
the	the	DT	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
dentinal	dentinal	JJ	B-NP	O
tubule	tubule	NN	I-NP	O
invasion	invasion	NN	I-NP	O
by	by	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
should	should	MD	B-VP	O
allow	allow	VB	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
new	new	JJ	B-NP	O
control	control	NN	I-NP	O
strategies	strategy	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
inhibitory	inhibitory	JJ	B-NP	O
compounds	compound	NNS	I-NP	O
incorporated	incorporate	VBN	B-VP	O
into	into	IN	B-PP	O
oral	oral	JJ	B-NP	B-protein
health	health	NN	I-NP	I-protein
care	care	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
or	or	CC	O	O
dental	dental	JJ	B-NP	O
materials	material	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
would	would	MD	B-VP	O
assist	assist	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
practice	practice	NN	I-NP	O
of	of	IN	B-PP	O
endodontics	endodontic	NNS	B-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
analyse	analyse	VB	I-VP	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
health	health	NN	I-NP	O
and	and	CC	I-NP	O
functional	functional	JJ	I-NP	O
status	status	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
elderly	elderly	JJ	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
species	specie	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
elderly	elderly	NNS	I-NP	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
bedridden	bedridden	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
staying	stay	VBG	B-VP	O
at	at	IN	B-PP	O
two	two	CD	B-NP	O
hospitals	hospital	NNS	I-NP	O
for	for	IN	B-PP	O
long-term	long-term	JJ	B-NP	O
(	(	(	O	O
HOBR	HOBR	NN	B-NP	B-protein
)	)	)	O	O
showed	show	VBD	B-VP	O
significantly	significantly	RB	B-NP	O
lower	low	JJR	I-NP	O
detection	detection	NN	I-NP	O
rates	rate	NNS	I-NP	O
of	of	IN	B-PP	O
commensal	commensal	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
species	specie	NNS	I-NP	O
and	and	CC	O	O
significantly	significantly	RB	B-NP	O
higher	high	JJR	I-NP	O
detection	detection	NN	I-NP	O
rates	rate	NNS	I-NP	O
of	of	IN	B-PP	O
Pseudomonas	Pseudomonas	NN	B-NP	O
aeruginosa	aeruginosa	NN	I-NP	O
,	,	,	O	O
of	of	IN	B-PP	O
methicillin-resistant	methicillin-resistant	JJ	B-NP	O
Staphylococcus	Staphylococcus	FW	I-NP	O
aureus	aureus	FW	I-NP	O
(	(	(	O	O
MRSA	MRSA	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
of	of	IN	B-PP	O
coagulase	coagulase	NN	B-NP	B-protein
(	(	(	O	O
-	-	SYM	O	O
)	)	)	O	O
Staph	Staph	NNP	B-NP	O
.	.	.	O	O

aureus	aureus	NN	B-NP	O
than	than	IN	B-PP	O
those	those	DT	B-NP	O
living	live	VBG	B-VP	O
independently	independently	RB	B-ADVP	O
(	(	(	O	O
the	the	DT	B-NP	O
independent	independent	JJ	I-NP	O
)	)	)	O	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
detection	detection	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
Haemophilus	Haemophilus	NNP	B-NP	O
parainfluenzae	parainfluenzae	NNS	I-NP	O
in	in	IN	B-PP	O
NUBR	NUBR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
discovered	discover	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
higher	high	JJR	B-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
independent	independent	JJ	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
HOBR	HOBR	NN	B-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
detection	detection	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
Ps	P	NNS	B-NP	B-DNA
.	.	.	O	O

aeruginosa	aeruginosa	NN	B-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
among	among	IN	B-PP	O
in-patients	in-patient	NNS	B-NP	O
who	who	WP	B-NP	O
required	require	VBD	B-VP	O
continual	continual	JJ	B-NP	O
care	care	NN	I-NP	O
than	than	IN	B-PP	O
those	those	DT	B-NP	O
in	in	IN	B-PP	O
need	need	NN	B-NP	O
of	of	IN	B-PP	O
partial	partial	JJ	B-NP	O
care	care	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
detection	detection	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
MRSA	MRSA	NN	B-NP	B-protein
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
among	among	IN	B-PP	O
in-patients	in-patient	NNS	B-NP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
serum	serum	NN	I-NP	B-protein
albumin	albumin	NN	I-NP	I-protein
than	than	IN	B-PP	O
those	those	DT	B-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
serum	serum	NN	I-NP	O
albumin	albumin	NN	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
examination	examination	NN	I-NP	O
analysis	analysis	NN	I-NP	O
proved	prove	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
risks	risk	NNS	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
pathogenic	pathogenic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
species	specie	NNS	I-NP	O
were	be	VBD	B-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
functional	functional	JJ	B-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
physical	physical	JJ	B-NP	O
function	function	NN	I-NP	O
and	and	CC	O	O
nutritional	nutritional	JJ	B-NP	O
state	state	NN	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
study	study	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
especially	especially	RB	B-NP	O
pathogenic	pathogenic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
influenced	influence	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
functional	functional	JJ	I-NP	O
status	status	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
elderly	elderly	JJ	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
type	type	NN	I-NP	O
and	and	CC	I-NP	O
quality	quality	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
facilities	facility	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
bedridden	bedridden	NN	I-NP	O
,	,	,	O	O
physical	physical	JJ	B-NP	O
function	function	NN	I-NP	O
and	and	CC	O	O
nutritional	nutritional	JJ	B-NP	O
state	state	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavities	cavity	NNS	I-NP	O
of	of	IN	B-PP	O
73	73	CD	B-NP	O
(	(	(	O	O
48.7	48.7	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
150	150	CD	B-NP	O
individuals	individual	NNS	I-NP	O
.	.	.	O	O

Nesterenkonia	Nesterenkonia	NNP	B-NP	O
halobia	halobia	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
frequently	frequently	RB	I-NP	O
isolated	isolate	VBN	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
20	20	CD	B-NP	O
(	(	(	O	O
27	27	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
individuals	individual	NNS	B-NP	O
,	,	,	O	O
Micrococcus	Micrococcus	NNP	B-NP	O
luteus	luteus	NN	I-NP	O
in	in	IN	B-PP	O
16	16	CD	B-NP	O
(	(	(	O	O
22	22	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Kocuria	Kocuria	NNP	B-NP	O
kristinae	kristinae	NNS	I-NP	O
in	in	IN	B-PP	O
12	12	CD	B-NP	O
(	(	(	O	O
16	16	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Kocuria	Kocuria	NNP	B-NP	O
varians	varian	NNS	I-NP	O
in	in	IN	B-PP	O
10	10	CD	B-NP	O
(	(	(	O	O
14	14	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Dermacoccus	Dermacoccus	NN	B-NP	O
sedentarius	sedentarius	NN	I-NP	O
in	in	IN	B-PP	O
9	9	CD	B-NP	O
(	(	(	O	O
12	12	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Micrococcus	Micrococcus	NNP	B-NP	O
lylae	lylae	NNS	I-NP	O
in	in	IN	B-PP	O
8	8	CD	B-NP	O
(	(	(	O	O
11	11	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
Kytococcus	Kytococcus	NNP	B-NP	O
nishinomiyaensis	nishinomiyaensis	NN	I-NP	O
in	in	IN	B-PP	O
3	3	CD	B-NP	O
(	(	(	O	O
4	4	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Mean	Mean	JJ	B-NP	O
counts	count	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
were	be	VBD	B-VP	O
relatively	relatively	RB	B-ADJP	O
low	low	JJ	I-ADJP	O
and	and	CC	O	O
amounted	amounte	VBD	B-VP	O
in	in	IN	B-PP	O
log10	log10	NN	B-NP	O
CFU/ml	CFU/ml	NN	I-NP	O
saliva	saliva	NN	I-NP	O
for	for	IN	B-PP	O
M.	M.	NNP	B-NP	O
luteus	luteus	CC	O	O
1.87	1.87	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
0.52	0.52	CD	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
M.	M.	NNP	B-NP	O
lylae	lylae	NNS	I-NP	O
2.03	2.03	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
0.39	0.39	CD	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
N.	N.	NNP	B-NP	O
halobia	halobia	NNP	I-NP	O
2.14	2.14	CD	I-NP	O
+/-	+/-	CC	I-NP	O
0.56	0.56	CD	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
K.	K.	NNP	B-NP	O
kristinae	kristinae	NNS	I-NP	O
2.20	2.20	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
0.69	0.69	CD	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
K.	K.	NNP	B-NP	O
varians	varian	NNS	I-NP	O
2.19	2.19	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
0.67	0.67	CD	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
K.	K.	NNP	B-NP	O
nishinomiyaensis	nishinomiyaensis	NN	I-NP	O
1.72	1.72	CD	I-NP	O
+/-	+/-	SYM	I-NP	O
0.39	0.39	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
for	for	IN	B-PP	O
D.	D.	NNP	B-NP	O
sedentarius	sedentarius	NN	I-NP	O
2.27	2.27	CD	I-NP	O
+/-	+/-	SYM	I-NP	O
0.55	0.55	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
factor	factor	NN	I-NP	O
limiting	limit	VBG	B-VP	O
the	the	DT	B-NP	O
population	population	NN	I-NP	O
sizes	size	VBZ	B-VP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
was	be	VBD	B-VP	O
most	most	RBS	B-ADVP	O
probably	probably	RB	I-ADVP	O
the	the	DT	B-NP	O
antagonistic	antagonistic	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
living	live	VBG	B-VP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
increasing	increase	VBG	I-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
antibiotic-resistant	antibiotic-resistant	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
emphasises	emphasise	VBZ	B-VP	O
the	the	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
new	new	JJ	B-NP	O
treatments	treatment	NNS	I-NP	O
that	that	WDT	B-NP	O
can	can	MD	B-VP	O
replace	replace	VB	I-VP	O
traditional	traditional	JJ	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
immunotherapy	immunotherapy	NN	I-NP	O
with	with	IN	B-PP	O
yolk	yolk	NN	B-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
from	from	IN	B-PP	O
hyperimmunised	hyperimmunised	JJ	B-NP	O
hens	hen	NNS	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
promising	promising	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
strategy	strategy	NN	I-NP	O
,	,	,	O	O
primarily	primarily	RB	B-ADVP	O
for	for	IN	B-PP	O
infections	infection	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
and	and	CC	I-NP	O
gastrointestinal	gastrointestinal	JJ	I-NP	O
tract	tract	NN	I-NP	O
.	.	.	O	O

Several	Several	JJ	B-NP	O
studies	study	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
bacterial	bacterial	JJ	B-NP	O
and	and	CC	I-NP	O
viral	viral	JJ	I-NP	O
infections	infection	NNS	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
prevented	prevent	VBN	I-VP	O
with	with	IN	B-PP	O
egg	egg	NN	B-NP	O
c	c	NN	I-NP	O
c	c	NN	I-NP	O
(	(	(	O	O
IgY	IgY	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
dose-dependent	dose-dependent	JJ	I-NP	O
manner	manner	NN	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
could	could	MD	B-VP	O
potentially	potentially	RB	I-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
against	against	IN	B-PP	O
many	many	JJ	B-NP	O
frequently	frequently	RB	I-NP	O
encountered	encounter	VBN	I-NP	O
diseases	disease	NNS	I-NP	O
(	(	(	O	O
e.g	e.g	NN	B-NP	O
.	.	.	O	O

common	common	JJ	B-NP	O
cold	cold	NN	I-NP	O
,	,	,	I-NP	O
tonsillitis	tonsillitis	NN	I-NP	O
and	and	CC	I-NP	O
caries	cary	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O

Healthy	Healthy	JJ	B-NP	O
volunteers	volunteer	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
studied	study	VBD	B-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
yolk	yolk	NN	B-NP	B-protein
anti-Pseudomonas	anti-Pseudomonas	JJ	I-NP	I-protein
aeruginosa	aeruginosa	NN	I-NP	I-protein
antibodies	antibody	NNS	I-NP	I-protein
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
from	from	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
volunteers	volunteer	NNS	I-NP	O
over	over	IN	B-PP	O
time	time	NN	B-NP	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
or	or	CC	I-NP	O
2	2	CD	I-NP	O
minutes	minute	NNS	I-NP	O
'	'	POS	B-NP	O
mouth	mouth	NN	I-NP	O
rinse	rinse	NN	I-NP	O
,	,	,	O	O
performed	perform	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
aqueous	aqueous	JJ	I-NP	O
IgY	IgY	NN	I-NP	O
antibody	antibody	NN	I-NP	O
preparation	preparation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
test	test	NN	I-NP	O
persons	person	NNS	I-NP	O
rinsed	rinse	VBD	B-VP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
with	with	IN	B-PP	O
8.0ml	8.0ml	NN	B-NP	O
phosphate	phosphate	NN	I-NP	O
buffered	buffer	VBD	B-VP	O
saline	saline	NN	B-NP	O
before	before	IN	B-PP	O
gargling	gargle	VBG	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
antibody	antibody	NN	I-NP	O
preparation	preparation	NN	I-NP	O
8	8	CD	B-NP	O
and	and	CC	I-NP	O
24	24	CD	I-NP	O
hours	hour	NNS	I-NP	O
later	later	RB	B-ADVP	O
.	.	.	O	O

Statistical	Statistical	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Mann-Whitney	Mann-Whitney	NNP	I-NP	O
U	U	NNP	I-NP	O
test	test	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
antibody	antibody	NN	I-NP	O
titres	titre	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
rinses	rinse	NNS	I-NP	O
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
for	for	IN	B-PP	O
their	their	PRP$	B-NP	O
specific	specific	JJ	I-NP	O
activity	activity	NN	I-NP	O
against	against	IN	B-PP	O
P.	P.	NNP	B-NP	O
aeruginosa	aeruginosa	NN	I-NP	O
by	by	IN	B-PP	O
ELISA	ELISA	NN	B-NP	O
.	.	.	O	O


The	The	DT	B-NP	O
next	next	JJ	I-NP	O
morning	morning	NN	I-NP	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
still	still	RB	B-ADVP	O
active	active	JJ	B-NP	O
antibodies	antibody	NNS	I-NP	O
detected	detect	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
saliva	saliva	NN	I-NP	O
from	from	IN	B-PP	O
18	18	CD	B-NP	O
of	of	IN	B-PP	O
19	19	CD	B-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
active	active	JJ	B-NP	O
antibodies	antibody	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
from	from	IN	B-PP	O
only	only	RB	B-NP	O
a	a	DT	I-NP	O
few	few	JJ	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
2-minute	2-minute	JJ	I-NP	O
mouth	mouth	NN	I-NP	O
rinse	rinse	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
higher	high	JJR	B-NP	O
mean	mean	JJ	I-NP	O
ELISA	ELISA	NN	I-NP	O
absorbance	absorbance	NN	I-NP	O
values	value	NNS	I-NP	O
than	than	IN	B-PP	O
a	a	DT	B-NP	O
1-minute	1-minute	JJ	I-NP	O
rinse	rinse	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
strain	strain	NN	I-NP	O
,	,	,	O	O
No	No	NNP	B-NP	O
.	.	.	O	O

90-1	90-1	CD	B-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
periodontophthy	periodontophthy	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
strain	strain	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
Gram-positive	Gram-positive	JJ	I-NP	O
,	,	,	I-NP	O
non-endospore-forming	non-endospore-forming	JJ	I-NP	O
,	,	,	I-NP	O
facultative	facultative	JJ	I-NP	O
anaerobe	anaerobe	NN	I-NP	O
with	with	IN	B-PP	O
spherical	spherical	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
0.9-1.5	0.9-1.5	CD	B-NP	O
microns	micron	NNS	I-NP	O
in	in	IN	B-PP	O
diameter	diameter	NN	B-NP	O
,	,	,	O	O
occuring	occur	VBG	B-VP	O
in	in	IN	B-PP	O
pairs	pair	NNS	B-NP	O
and	and	CC	O	O
seldom	seldom	RB	B-ADVP	O
in	in	IN	B-PP	O
short	short	JJ	B-NP	O
chains	chain	NNS	I-NP	O
of	of	IN	B-PP	O
four	four	CD	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
and	and	CC	O	O
motile	motile	NN	B-NP	O
by	by	IN	B-PP	O
one	one	CD	B-NP	O
flagellum	flagellum	NN	I-NP	O
per	per	IN	B-PP	O
cell	cell	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
optimum	optimum	JJ	I-NP	O
growing	grow	VBG	I-NP	O
temperature	temperature	NN	I-NP	O
is	be	VBZ	B-VP	O
35-37	35-37	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
;	;	:	O	O
appreciable	appreciable	JJ	B-NP	O
growth	growth	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
found	find	VBN	I-VP	O
below	below	IN	B-PP	O
10	10	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
growth	growth	NN	B-NP	O
at	at	IN	B-PP	O
53	53	CD	B-NP	O
degrees	degree	NNS	I-NP	O
and	and	CC	O	O
tolerance	tolerance	NN	B-NP	O
to	to	TO	B-PP	O
60	60	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
for	for	IN	B-PP	O
30	30	CD	B-NP	O
min	min	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
strain	strain	NN	I-NP	O
is	be	VBZ	B-VP	O
microhalophilous	microhalophilous	JJ	B-ADJP	O
and	and	CC	O	O
grows	grow	VBZ	B-VP	O
best	good	JJS	B-ADJP	O
,	,	,	O	O
well	well	RB	B-ADVP	O
and	and	CC	I-ADVP	O
poorly	poorly	RB	I-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
medium	medium	NN	I-NP	O
containing	contain	VBG	B-VP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
10	10	CD	B-NP	O
%	%	NN	I-NP	O
-15	-15	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
NaCl	NaCl	NN	I-NP	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

Catalase	Catalase	NN	B-NP	B-protein
and	and	CC	I-NP	O
urease	urease	NN	I-NP	O
are	be	VBP	B-VP	O
positive	positive	JJ	B-ADJP	O
and	and	CC	O	O
nitrate	nitrate	NN	B-NP	O
is	be	VBZ	B-VP	O
reduced	reduce	VBN	I-VP	O
.	.	.	O	O

Acid	Acid	NN	B-NP	O
is	be	VBZ	B-VP	O
produced	produce	VBN	I-VP	O
from	from	IN	B-PP	O
many	many	JJ	B-NP	O
carbohydrates	carbohydrate	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
gas	gas	NN	I-NP	B-DNA
.	.	.	O	O

Gelatin	Gelatin	NN	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
hydrolyzed	hydrolyze	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
starch	starch	NN	B-NP	O
,	,	,	I-NP	O
cellulose	cellulose	NN	I-NP	O
and	and	CC	I-NP	O
dextrin	dextrin	NN	I-NP	O
do	do	VBP	B-VP	O
not	not	RB	O	O
.	.	.	O	O

G	G	G	B-NP	O
+	+	+	I-NP	O
C	C	NN	I-NP	O
content	content	NN	I-NP	O
in	in	IN	B-PP	O
DNA	DNA	NN	B-NP	O
is	be	VBZ	B-VP	O
41.34	41.34	CD	B-NP	O
mol	mol	NN	I-NP	O
%	%	NN	I-NP	O
(	(	(	O	O
Tm	Tm	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
strain	strain	NN	I-NP	O
(	(	(	O	O
90-1	90-1	CD	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
considered	consider	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
species	specie	NNS	I-NP	O
belonging	belong	VBG	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
genus	genus	NN	I-NP	O
because	because	IN	B-SBAR	O
its	its	PRP$	B-NP	O
some	some	DT	I-NP	O
characteristics	characteristic	NNS	I-NP	O
are	be	VBP	B-VP	O
different	different	JJ	B-ADJP	O
from	from	IN	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
known	know	VBN	I-NP	O
coccus	coccus	NN	I-NP	O
genuera	genuera	NN	I-NP	O
and	and	CC	O	O
designated	designate	VBN	B-VP	O
as	as	IN	B-PP	O
Stomatostreptococcus	Stomatostreptococcus	NNP	B-NP	O
microhalophilus	microhalophilus	CC	O	O
Ping	Ping	NNP	B-NP	O
,	,	,	O	O
Zhou	Zhou	NNP	B-NP	O
,	,	,	O	O
Sun	Sun	NNP	B-NP	O
et	et	NNP	I-NP	O
Fan	Fan	NNP	I-NP	O
gen.	gen.	NNP	I-NP	O
nov.	nov.	NN	I-NP	O
sp	sp	NN	I-NP	O
.	.	.	O	O

nov.	nov.	RB	B-ADVP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
its	its	PRP$	B-NP	O
source	source	NN	I-NP	O
and	and	CC	I-NP	O
microhalophilic	microhalophilic	JJ	I-NP	O
trait	trait	NN	I-NP	O
.	.	.	O	O

Aerobic	Aerobic	JJ	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
only	only	RB	B-ADVP	O
rarely	rarely	RB	I-ADVP	O
colonize	colonize	VBP	B-VP	O
the	the	DT	B-NP	O
cleft	cleft	JJ	I-NP	O
nasal	nasal	JJ	I-NP	O
floor	floor	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
patent	patent	NN	B-NP	O
oronasal	oronasal	JJ	I-NP	O
fistula	fistula	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
no	no	DT	B-NP	O
studies	study	NNS	I-NP	O
that	that	WDT	B-NP	O
have	have	VBP	B-VP	O
investigated	investigate	VBN	I-VP	O
whether	whether	IN	B-SBAR	O
anaerobic	anaerobic	JJ	B-NP	O
oral	oral	JJ	I-NP	O
flora	flora	NN	I-NP	O
colonize	colonize	VBP	B-VP	O
this	this	DT	B-NP	O
site	site	NN	I-NP	O
and	and	CC	O	O
whether	whether	IN	B-SBAR	O
attempting	attempt	VBG	B-VP	O
to	to	TO	I-VP	O
culture	culture	VB	I-VP	O
them	them	PRP	B-NP	O
is	be	VBZ	B-VP	O
useful	useful	JJ	B-ADJP	O
for	for	IN	B-PP	O
assessing	assess	VBG	B-VP	O
the	the	DT	B-NP	O
patency	patency	NN	I-NP	O
of	of	IN	B-PP	O
oronasal	oronasal	JJ	B-NP	O
fistulae	fistula	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
clinic	clinic	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
prospective	prospective	JJ	I-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
13	13	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
cleft	cleft	NN	B-NP	O
with	with	IN	B-PP	O
patent	patent	NN	B-NP	O
unilateral	unilateral	JJ	I-NP	O
oronasal	oronasal	JJ	I-NP	O
fistulae	fistula	NNS	I-NP	O
.	.	.	O	O

Microbiological	Microbiological	JJ	B-NP	B-protein
culture	culture	NN	I-NP	I-protein
swabs	swab	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
and	and	CC	O	O
both	both	DT	B-NP	O
nasal	nasal	JJ	I-NP	O
floors	floor	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
unaffected	unaffected	JJ	I-NP	O
side	side	NN	I-NP	O
being	be	VBG	B-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

Following	Follow	VBG	B-PP	O
aerobic	aerobic	JJ	B-NP	O
and	and	CC	I-NP	O
anaerobic	anaerobic	JJ	I-NP	O
culture	culture	NN	I-NP	O
,	,	,	O	O
bacterial	bacterial	JJ	B-NP	O
isolates	isolate	NNS	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
and	and	CC	O	O
compared	compare	VBN	B-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
significant	significant	JJ	I-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
cleft	cleft	NN	I-NP	O
nasal	nasal	JJ	I-NP	O
floor	floor	NN	I-NP	O
when	when	WRB	B-ADVP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
unaffected	unaffected	JJ	I-NP	O
side	side	NN	I-NP	O
.	.	.	O	O

Aerobic	Aerobic	JJ	B-NP	O
oral	oral	JJ	I-NP	O
flora	flora	NN	I-NP	O
was	be	VBD	B-VP	O
cultured	culture	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
13	13	CD	I-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
light	light	JJ	I-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
aerobic	aerobic	JJ	B-NP	O
oral	oral	JJ	I-NP	O
flora	flora	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cleft	cleft	NN	I-NP	O
nasal	nasal	JJ	I-NP	O
floor	floor	NN	I-NP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
anaerobic	anaerobic	JJ	B-NP	O
oral	oral	JJ	I-NP	O
flora	flora	NN	I-NP	O
was	be	VBD	B-VP	O
cultured	culture	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
cleft	cleft	NN	I-NP	O
nasal	nasal	JJ	I-NP	O
floor	floor	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
two	two	CD	I-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
statistical	statistical	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
between	between	IN	B-PP	O
growth	growth	NN	B-NP	O
of	of	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
flora	flora	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
cleft	cleft	JJ	I-NP	O
nasal	nasal	JJ	I-NP	O
floor	floor	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
=.48	=.48	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

Like	Like	IN	B-PP	O
aerobic	aerobic	JJ	B-NP	O
oral	oral	JJ	I-NP	O
flora	flora	NN	I-NP	O
,	,	,	O	O
anaerobic	anaerobic	JJ	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
would	would	MD	B-VP	O
appear	appear	VB	I-VP	O
to	to	TO	B-PP	O
only	only	RB	B-ADVP	O
rarely	rarely	RB	I-ADVP	O
colonize	colonize	VBP	B-VP	O
the	the	DT	B-NP	O
cleft	cleft	JJ	I-NP	O
nasal	nasal	JJ	I-NP	O
floor	floor	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
oronasal	oronasal	JJ	B-NP	O
fistulae	fistula	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
additional	additional	JJ	I-NP	O
investigation	investigation	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
appear	appear	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
helpful	helpful	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
assessment	assessment	NN	I-NP	O
of	of	IN	B-PP	O
oronasal	oronasal	JJ	B-NP	O
fistulae	fistula	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
clinic	clinic	NN	I-NP	O
.	.	.	O	O

Five	Five	CD	B-NP	O
streptococcal	streptococcal	JJ	I-NP	O
strains	strain	NNS	I-NP	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
and	and	CC	I-NP	O
saliva	saliva	NN	I-NP	O
of	of	IN	B-PP	O
caries-free	caries-free	JJ	B-NP	O
humans	human	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
cells	cell	NNS	I-NP	O
were	be	VBD	B-VP	O
gram-positive	gram-positive	JJ	B-NP	O
,	,	,	I-NP	O
non-spore-forming	non-spore-forming	JJ	I-NP	O
,	,	,	I-NP	O
non-motile	non-motile	JJ	I-NP	O
cocci	coccus	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
arranged	arrange	VBN	I-VP	O
in	in	IN	B-PP	O
short	short	JJ	B-NP	O
chains	chain	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
strains	strain	NNS	I-NP	O
were	be	VBD	B-VP	O
catalase-negative	catalase-negative	JJ	B-ADJP	O
,	,	,	O	O
facultatively	facultatively	RB	B-ADJP	O
anaerobic	anaerobic	JJ	I-ADJP	O
and	and	CC	O	O
produced	produce	VBD	B-VP	O
lactic	lactic	JJ	B-NP	O
acid	acid	NN	I-NP	O
exclusively	exclusively	RB	B-ADVP	O
from	from	IN	B-PP	O
glucose	glucose	NN	B-NP	O
fermentation	fermentation	NN	I-NP	O
.	.	.	O	O

Biochemical	Biochemical	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
that	that	WDT	B-NP	O
used	use	VBD	B-VP	O
both	both	DT	B-NP	O
conventional	conventional	JJ	I-NP	O
methods	method	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
commercial	commercial	JJ	I-NP	O
API	API	NN	I-NP	O
20	20	CD	I-NP	O
Strep	Strep	NN	I-NP	O
system	system	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
five	five	CD	I-NP	O
strains	strain	NNS	I-NP	O
fermented	ferment	VBD	B-VP	O
only	only	RB	B-NP	O
a	a	DT	I-NP	O
few	few	JJ	I-NP	O
kinds	kind	NNS	I-NP	O
of	of	IN	B-PP	O
sugar	sugar	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
mean	mean	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
G	G	NN	I-NP	O
+	+	SYM	B-NP	O
C	C	NN	I-NP	O
content	content	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
five	five	CD	I-NP	O
novel	novel	JJ	I-NP	O
strains	strain	NNS	I-NP	O
was	be	VBD	B-VP	O
39.5	39.5	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
0.8	0.8	CD	I-NP	O
mol	mol	NN	I-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Phylogenetic	Phylogenetic	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
16S	16S	NN	B-NP	O
rDNA	rDNA	NN	I-NP	O
sequence	sequence	NN	I-NP	O
homology	homology	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
new	new	JJ	I-NP	O
isolates	isolate	NNS	I-NP	O
represented	represent	VBD	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
member	member	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mitis	mitis	NN	I-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
genus	genus	NN	I-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
,	,	,	O	O
related	relate	VBN	B-VP	O
most	most	RBS	B-ADVP	O
closely	closely	RB	I-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
recently	recently	RB	I-NP	O
described	describe	VBN	I-NP	O
species	specie	NNS	I-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
sinensis	sinensis	NNP	I-NP	O
.	.	.	O	O

DNA-DNA	DNA-DNA	JJ	B-NP	O
relatedness	relatedness	NN	I-NP	O
between	between	IN	B-PP	O
novel	novel	JJ	B-NP	O
strain	strain	NN	I-NP	O
LMG	LMG	NN	I-NP	O
21535T	21535T	NN	I-NP	O
and	and	CC	I-NP	O
type	type	NN	I-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
phylogenetically	phylogenetically	RB	B-NP	O
related	relate	VBN	I-NP	O
species	specie	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
streptococci	streptococci	NNS	I-NP	O
was	be	VBD	B-VP	O
7.1-16.4	7.1-16.4	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
oligofermentans	oligofermentan	NNS	I-NP	O
sp	sp	NN	I-NP	O
.	.	.	O	O
I-bacteria	I-bacteria	NNP	B-NP	O
nov.	nov.	NNP	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
proposed	propose	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
type	type	NN	I-NP	O
strain	strain	NN	I-NP	O
is	be	VBZ	B-VP	O
LMG	LMG	NN	B-NP	O
21535T=AS	21535T=AS	NN	I-NP	O
1.3089T	1.3089T	NN	I-NP	O
.	.	.	O	O

Previous	Previous	JJ	B-NP	O
work	work	NN	I-NP	O
has	have	VBZ	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
indigenous	indigenous	JJ	I-NP	O
gut	gut	NN	I-NP	O
microflora	microflora	NN	I-NP	O
in	in	IN	B-PP	O
mice	mouse	NNS	B-NP	O
plays	play	VBZ	B-VP	O
a	a	DT	B-NP	O
protective	protective	JJ	I-NP	O
role	role	NN	I-NP	O
against	against	IN	B-PP	O
Escherichia	Escherichia	FW	B-NP	B-protein
coli	coli	FW	I-NP	I-protein
heat-labile	heat-labile	JJ	I-NP	I-protein
enterotoxin	enterotoxin	NN	I-NP	I-protein
(	(	(	O	O
LT	LT	NN	B-NP	B-protein
)	)	)	O	O
-mediated	-mediated	JJ	B-NP	O
abrogation	abrogation	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
tolerance	tolerance	NN	I-NP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
unrelated	unrelated	JJ	I-NP	B-protein
co-ingested	co-ingested	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
.	.	.	O	O

To	To	TO	B-VP	O
assess	assess	VB	I-VP	O
potential	potential	JJ	B-NP	O
protection	protection	NN	I-NP	O
by	by	IN	B-PP	O
human	human	JJ	B-NP	O
gut	gut	NN	I-NP	O
microflora	microflora	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
studied	study	VBD	B-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-protein
gut	gut	NN	I-NP	I-protein
microflora	microflora	NN	I-NP	I-protein
in	in	IN	B-PP	O
a	a	DT	B-NP	O
murine	murine	JJ	I-NP	O
model	model	NN	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
tolerance	tolerance	NN	I-NP	O
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
adult	adult	JJ	B-NP	O
gnotobiotic	gnotobiotic	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
(	(	(	O	O
i.e	i.e	JJ	B-ADJP	O
.	.	.	O	O

ex-germ-free	ex-germ-free	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
)	)	)	O	O
colonized	colonize	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	O
human	human	JJ	I-NP	O
fecal	fecal	JJ	I-NP	O
microflora	microflora	NN	I-NP	O
and	and	CC	O	O
orally	orally	RB	B-VP	O
administered	administer	VBN	I-VP	O
once	once	RB	B-ADVP	O
with	with	IN	B-PP	O
LT	LT	NN	B-NP	B-protein
and	and	CC	I-NP	O
ovalbumin	ovalbumin	NN	I-NP	O
.	.	.	O	O

Systemic	Systemic	JJ	B-NP	O
suppression	suppression	NN	I-NP	O
of	of	IN	B-PP	O
IgG	IgG	NN	B-NP	B-protein
,	,	,	O	O
IgG1	IgG1	NN	B-NP	B-protein
,	,	,	O	O
IgG2a	IgG2a	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
IgE	IgE	NN	B-NP	B-protein
antibody	antibody	NN	I-NP	O
responses	response	NNS	I-NP	O
was	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
by	by	IN	B-PP	O
ELISA	ELISA	NN	B-NP	O
.	.	.	O	O

Both	Both	CC	O	O
specific	specific	JJ	B-NP	O
IgG	IgG	NN	I-NP	O
subclasses	subclass	NNS	I-NP	O
and	and	CC	O	O
IgE	IgE	NN	B-NP	B-protein
hyporesponsiveness	hyporesponsiveness	NN	I-NP	O
was	be	VBD	B-VP	O
induced	induce	VBN	I-VP	O
in	in	IN	B-PP	O
LT	LT	NN	B-NP	B-protein
+	+	CC	O	O
ovalbumin-fed	ovalbumin-fed	JJ	B-NP	O
gnotobiotic	gnotobiotic	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
gut	gut	NN	I-NP	O
microflora	microflora	NN	I-NP	O
can	can	MD	B-VP	O
protect	protect	VB	I-VP	O
against	against	IN	B-PP	O
the	the	DT	B-NP	O
LT-mediated	LT-mediated	JJ	I-NP	O
abrogation	abrogation	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
tolerance	tolerance	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
confirmed	confirm	VBN	B-VP	O
with	with	IN	B-PP	O
mouse	mouse	NN	B-NP	O
gut	gut	NN	I-NP	O
microflora	microflora	NN	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
protective	protective	JJ	I-NP	O
effect	effect	NN	I-NP	O
only	only	RB	B-ADVP	O
occurs	occur	VBZ	B-VP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
gut	gut	NN	I-NP	O
microflora	microflora	NN	I-NP	O
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
from	from	IN	B-PP	O
birth	birth	NN	B-NP	O
on	on	IN	B-PP	O
.	.	.	O	O

Colonization	Colonization	NN	B-NP	O
of	of	IN	B-PP	O
germ-free	germ-free	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
strain	strain	NN	I-NP	O
,	,	,	O	O
E.	E.	FW	B-ADVP	O
coli	coli	FW	I-ADVP	O
,	,	,	O	O
predominant	predominant	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
and	and	CC	I-NP	O
mouse	mouse	NN	I-NP	O
gut	gut	NN	I-NP	O
microflora	microflora	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
neonatal	neonatal	JJ	I-NP	O
period	period	NN	I-NP	O
,	,	,	O	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
strain	strain	NN	I-NP	O
alone	alone	RB	B-ADVP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
induce	induce	VB	I-VP	O
protection	protection	NN	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
supported	support	VBD	B-VP	O
the	the	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
natural	natural	JJ	I-NP	O
establishment	establishment	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gut	gut	NN	I-NP	O
microflora	microflora	NN	I-NP	O
in	in	IN	B-PP	O
neonates	neonate	NNS	B-NP	O
crucially	crucially	RB	B-ADVP	O
influenced	influence	VBD	B-VP	O
resistance	resistance	NN	B-NP	O
to	to	TO	B-PP	O
LT-mediated	LT-mediated	JJ	B-NP	O
abrogation	abrogation	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
tolerance	tolerance	NN	I-NP	O
by	by	IN	B-PP	O
reinforcing	reinforce	VBG	B-VP	O
suppression	suppression	NN	B-NP	O
of	of	IN	B-PP	O
both	both	CC	O	O
T	T	NN	B-NP	O
helper	helper	NN	I-NP	O
type	type	NN	I-NP	O
1-	1-	CD	I-NP	O
and	and	CC	I-NP	O
T	T	NN	I-NP	O
helper	helper	NN	I-NP	O
type	type	NN	I-NP	O
2-controlled	2-controlled	JJ	I-NP	O
responses	response	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
suggested	suggest	VBD	B-VP	O
that	that	IN	B-SBAR	O
sequential	sequential	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
colonization	colonization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gut	gut	NN	I-NP	O
rather	rather	RB	B-CONJP	O
than	than	IN	I-CONJP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
phenomenon	phenomenon	NN	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
long-term	long-term	JJ	I-NP	O
oral	oral	JJ	I-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
dimethylarsinic	dimethylarsinic	JJ	B-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
DMAV	DMAV	NN	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
rats	rat	NNS	B-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
three	three	CD	B-NP	O
unidentified	unidentified	JJ	I-NP	O
metabolites	metabolite	NNS	I-NP	O
,	,	,	O	O
M-1	M-1	NN	B-NP	B-cell_line
,	,	,	O	O
M-2	M-2	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
M-3	M-3	NN	B-NP	B-protein
,	,	,	O	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
urine	urine	NN	B-NP	O
and	and	CC	I-NP	O
feces	fece	NNS	I-NP	O
.	.	.	O	O

DMAV	DMAV	NN	B-NP	O
and	and	CC	I-NP	O
trimethylarsine	trimethylarsine	NN	I-NP	O
oxide	oxide	NN	I-NP	O
(	(	(	O	O
TMAO	TMAO	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
converted	convert	VBN	I-VP	O
to	to	TO	B-PP	O
M-2	M-2	NN	B-NP	O
and	and	CC	I-NP	O
M-3	M-3	NN	I-NP	O
and	and	CC	I-NP	O
M-1	M-1	NN	I-NP	O
by	by	IN	B-PP	O
Escherichia	Escherichia	FW	B-NP	O
coli	coli	FW	I-NP	O
strain	strain	NN	I-NP	O
A3-6	A3-6	NN	I-NP	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
ceca	ceca	NN	I-NP	O
of	of	IN	B-PP	O
DMAV-administered	DMAV-administered	JJ	B-NP	O
rats	rat	NNS	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
report	report	VBP	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
production	production	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
chemical	chemical	JJ	I-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
unknown	unknown	JJ	I-NP	O
metabolites	metabolite	NNS	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
conversion	conversion	NN	B-NP	O
of	of	IN	B-PP	O
DMAV	DMAV	NN	B-NP	O
or	or	CC	I-NP	O
TMAO	TMAO	NN	I-NP	B-protein
by	by	IN	B-PP	O
A3-6	A3-6	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
cysteine	cysteine	NN	B-NP	O
(	(	(	O	O
Cys	Cys	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
arsenic	arsenic	JJ	B-NP	O
metabolites	metabolite	NNS	I-NP	O
of	of	IN	B-PP	O
DMAV	DMAV	NN	B-NP	O
or	or	CC	I-NP	O
TMAO	TMAO	NN	I-NP	B-protein
in	in	IN	B-PP	O
medium	medium	NN	B-NP	O
after	after	IN	B-PP	O
incubation	incubation	NN	B-NP	O
with	with	IN	B-PP	O
A3-6	A3-6	NN	B-NP	B-protein
and	and	CC	I-NP	O
Cys	Cys	NN	I-NP	B-protein
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
by	by	IN	B-PP	O
liquid	liquid	JJ	B-NP	O
chromatography	chromatography	NN	I-NP	O
with	with	IN	B-PP	O
inductively	inductively	RB	B-NP	O
coupled	couple	VBN	I-NP	O
plasma	plasma	NN	I-NP	O
mass	mass	NN	I-NP	O
spectrometry	spectrometry	NN	I-NP	O
(	(	(	O	O
LC-ICP-MS	LC-ICP-MS	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

DMAV	DMAV	NN	B-NP	O
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
to	to	TO	B-PP	O
dimethylarsinous	dimethylarsinous	JJ	B-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
DMAIII	DMAIII	NN	B-NP	O
)	)	)	O	O
to	to	TO	B-VP	O
form	form	VB	I-VP	O
M-2	M-2	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	I-PP	O
presence	presence	NN	I-PP	O
of	of	IN	I-PP	O
Cys	Cys	NN	B-NP	B-protein
and	and	CC	I-NP	O
A3-6	A3-6	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
M-2	M-2	NN	B-NP	B-protein
was	be	VBD	B-VP	O
further	further	RB	I-VP	O
converted	convert	VBN	I-VP	O
to	to	TO	B-PP	O
M-3	M-3	NN	B-NP	B-protein
.	.	.	O	O

TMAO	TMAO	NN	B-NP	B-protein
was	be	VBD	B-VP	O
rapidly	rapidly	RB	I-VP	O
converted	convert	VBN	I-VP	O
to	to	TO	B-PP	O
M-1	M-1	NN	B-NP	O
by	by	IN	B-PP	O
A3-6	A3-6	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
cytotoxicity	cytotoxicity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
unidentified	unidentified	JJ	I-NP	O
metabolites	metabolite	NNS	I-NP	O
was	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
.	.	.	O	O

M-2	M-2	NN	B-NP	O
was	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
cytotoxic	cytotoxic	JJ	I-ADJP	O
than	than	IN	B-PP	O
DMAV	DMAV	NN	B-NP	O
,	,	,	O	O
M-1	M-1	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
M-3	M-3	NN	B-NP	O
in	in	IN	B-PP	O
V79	V79	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

The	The	DT	B-NP	O
cytotoxicity	cytotoxicity	NN	I-NP	O
of	of	IN	B-PP	O
M-2	M-2	NN	B-NP	B-protein
in	in	IN	B-PP	O
HL-60	HL-60	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
superoxide	superoxide	NN	B-NP	B-protein
dismutase	dismutase	NN	I-NP	I-protein
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
cytotoxicity	cytotoxicity	NN	I-NP	O
of	of	IN	B-PP	O
M-2	M-2	NN	B-NP	B-protein
might	might	MD	B-VP	O
be	be	VB	I-VP	O
due	due	JJ	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
reactive	reactive	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
chemical	chemical	JJ	I-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
M-2	M-2	NN	B-NP	B-protein
by	by	IN	B-PP	O
LC-ICP-MS	LC-ICP-MS	NN	B-NP	O
and	and	CC	O	O
LC-MS.	LC-MS.	JJ	B-NP	O
M-2	M-2	NN	I-NP	O
was	be	VBD	B-VP	O
oxidized	oxidize	VBN	I-VP	O
to	to	TO	B-PP	O
DMAV	DMAV	NN	B-NP	O
by	by	IN	B-PP	O
hydrogen	hydrogen	NN	B-NP	O
peroxide	peroxide	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
M-2	M-2	NN	B-NP	B-protein
may	may	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
reduced	reduce	VBN	I-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
DMAV	DMAV	NN	B-NP	B-protein
.	.	.	O	O

M-2	M-2	NN	B-NP	O
was	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
reactant	reactant	NN	I-NP	O
of	of	IN	B-PP	O
DMAV	DMAV	NN	B-NP	O
with	with	IN	B-PP	O
metabisulfite-thiosulfate	metabisulfite-thiosulfate	JJ	B-NP	O
reagent	reagent	NN	I-NP	O
but	but	CC	B-NP	O
not	not	RB	I-NP	O
DMAIII	DMAIII	NN	B-VP	O
by	by	IN	B-PP	O
analyses	analysis	NNS	B-NP	O
of	of	IN	B-PP	O
LC-ICP-MS	LC-ICP-MS	NN	B-NP	O
and	and	CC	I-NP	O
LC-MS	LC-MS	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
M-2	M-2	NN	B-NP	B-protein
was	be	VBD	B-VP	O
154	154	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
M-2	M-2	NN	B-NP	B-protein
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
sulfur-containing	sulfur-containing	JJ	I-NP	O
metabolite	metabolite	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
compared	compare	VBD	B-VP	O
removal	removal	NN	B-NP	O
of	of	IN	B-PP	O
pairs	pair	NNS	B-NP	O
of	of	IN	B-PP	O
co-adhering	co-adhering	JJ	B-NP	O
and	and	CC	I-NP	O
non-co-adhering	non-co-adhering	JJ	I-NP	O
oral	oral	JJ	I-NP	O
actinomyces	actinomyce	NNS	I-NP	O
and	and	CC	I-NP	O
streptococci	streptococci	NNS	I-NP	O
from	from	IN	B-PP	O
salivary	salivary	JJ	B-NP	O
pellicles	pellicle	NNS	I-NP	O
by	by	IN	B-PP	O
manual	manual	JJ	B-ADJP	O
,	,	,	O	O
rotating/oscillating	rotating/oscillate	VBG	B-VP	O
electric	electric	JJ	B-NP	O
and	and	CC	I-NP	O
sonic	sonic	JJ	I-NP	O
toothbrushes	toothbrush	NNS	I-NP	O
,	,	,	O	O
applying	apply	VBG	B-VP	O
weights	weight	NNS	B-NP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
240	240	CD	I-NP	O
g.	g.	NN	I-NP	O
First	First	JJ	B-ADVP	O
,	,	,	O	O
actinomyces	actinomyce	NNS	B-NP	O
were	be	VBD	B-VP	O
allowed	allow	VBN	I-VP	O
to	to	TO	I-VP	O
adhere	adhere	VB	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
pellicle	pellicle	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
parallel	parallel	JJ	I-NP	O
plate	plate	NN	I-NP	O
flow	flow	NN	I-NP	O
chamber	chamber	NN	I-NP	O
,	,	,	O	O
after	after	IN	B-PP	O
which	which	WDT	B-NP	O
streptococci	streptococci	NNS	B-NP	O
suspended	suspend	VBN	B-VP	O
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
were	be	VBD	B-VP	O
perfused	perfuse	VBN	I-VP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
chamber	chamber	NN	I-NP	O
at	at	IN	B-PP	O
33	33	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C.	C.	NNP	B-NP	O
On	On	NNP	I-NP	O
average	average	NN	I-NP	O
,	,	,	O	O
34-39	34-39	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
adhering	adhere	VBG	I-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
adhering	adhere	VBG	I-VP	O
as	as	IN	B-PP	O
single	single	JJ	B-NP	O
organisms	organism	NNS	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
co-adhering	co-adhering	NN	B-NP	O
and	and	CC	O	O
non-co-adhering	non-co-adhering	JJ	B-NP	O
pairs	pair	NNS	I-NP	O
,	,	,	O	O
33	33	CD	B-NP	O
and	and	CC	I-NP	O
10	10	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
adhering	adhere	VBG	I-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
involved	involve	VBN	I-VP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
aggregates	aggregate	NNS	B-NP	O
comprising	comprise	VBG	B-VP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
10	10	CD	I-NP	O
organisms	organism	NNS	I-NP	O
.	.	.	O	O

Brushing	Brushing	NN	B-NP	O
by	by	IN	B-PP	O
hand	hand	NN	B-NP	O
removed	remove	VBD	B-VP	O
82	82	CD	B-NP	O
%	%	NN	I-NP	O
at	at	IN	B-PP	O
low	low	JJ	B-NP	O
weight	weight	NN	I-NP	O
(	(	(	O	O
40	40	CD	B-NP	O
g	g	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
by	by	IN	B-PP	O
electric	electric	JJ	B-NP	O
(	(	(	O	O
93	93	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
or	or	CC	O	O
sonic	sonic	JJ	B-ADJP	O
(	(	(	O	O
92	92	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
brushing	brushing	NN	B-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
for	for	IN	B-PP	O
all	all	DT	B-NP	O
modes	mode	NNS	I-NP	O
of	of	IN	B-PP	O
brushing	brush	VBG	B-VP	O
bacterial	bacterial	JJ	B-NP	O
removal	removal	NN	I-NP	O
increased	increase	VBD	B-VP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-NP	O
weight	weight	NN	I-NP	O
to	to	TO	B-PP	O
95-99	95-99	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
a	a	DT	B-NP	O
non-co-adhering	non-co-adhering	JJ	I-NP	B-protein
pair	pair	NN	I-NP	I-protein
,	,	,	O	O
subsequent	subsequent	JJ	B-NP	O
exposure	exposure	NN	I-NP	O
of	of	IN	B-PP	O
brushed	brushed	JJ	B-NP	O
pellicles	pellicle	NNS	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
streptococcal	streptococcal	JJ	I-NP	O
suspension	suspension	NN	I-NP	O
yielded	yield	VBD	B-VP	O
only	only	RB	B-NP	O
2-16	2-16	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
large	large	JJ	B-NP	O
aggregates	aggregate	NNS	I-NP	O
,	,	,	O	O
regardless	regardless	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mode	mode	NN	I-NP	O
of	of	IN	B-PP	O
brushing	brush	VBG	B-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
the	the	DT	B-NP	O
co-adhering	co-adhering	JJ	I-NP	O
pair	pair	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
de	de	FW	B-NP	O
novo	novo	FW	I-NP	O
streptococcal	streptococcal	JJ	I-NP	O
adhesion	adhesion	NN	I-NP	O
to	to	TO	B-PP	O
hand-brushed	hand-brushed	JJ	B-NP	O
pellicles	pellicle	NNS	I-NP	O
yielded	yield	VBD	B-VP	O
34-57	34-57	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
large	large	JJ	B-NP	O
aggregates	aggregate	NNS	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
electric	electric	JJ	B-NP	O
and	and	CC	I-NP	O
sonic	sonic	JJ	I-NP	O
brushing	brushing	NN	I-NP	O
left	leave	VBD	B-VP	O
22-35	22-35	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
large	large	JJ	B-NP	O
aggregates	aggregate	NNS	I-NP	O
.	.	.	O	O

De	De	FW	B-NP	O
novo	novo	FW	I-NP	O
streptococcal	streptococcal	JJ	I-NP	O
adhesion	adhesion	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
co-adhering	co-adhering	JJ	I-NP	O
pair	pair	NN	I-NP	O
increased	increase	VBD	B-VP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-NP	O
weight	weight	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
electric	electric	JJ	I-NP	O
and	and	CC	I-NP	O
sonic	sonic	JJ	I-NP	O
brush	brush	NN	I-NP	O
in	in	IN	B-PP	O
contrast	contrast	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
manual	manual	JJ	I-NP	O
brush	brush	NN	I-NP	O
.	.	.	O	O

Since	Since	IN	B-PP	O
a	a	DT	B-NP	O
strong	strong	JJ	I-NP	O
influence	influence	NN	I-NP	O
of	of	IN	B-PP	O
co-adhesion	co-adhesion	NN	B-NP	O
is	be	VBZ	B-VP	O
evident	evident	JJ	B-ADJP	O
in	in	IN	B-PP	O
de	de	FW	B-NP	O
novo	novo	FW	I-NP	O
streptococcal	streptococcal	JJ	I-NP	O
adhesion	adhesion	NN	I-NP	O
,	,	,	O	O
despite	despite	IN	B-PP	O
nearly	nearly	RB	B-NP	O
complete	complete	JJ	I-NP	O
removal	removal	NN	I-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
actinomyces	actinomyce	NNS	I-NP	O
,	,	,	O	O
these	these	DT	B-NP	O
observations	observation	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
modes	mode	NNS	I-NP	O
of	of	IN	B-PP	O
brushing	brush	VBG	B-VP	O
leave	leave	NN	B-NP	O
footprints	footprint	NNS	I-NP	O
to	to	TO	B-PP	O
which	which	WDT	B-NP	O
streptococci	streptococci	NNS	B-NP	O
preferentially	preferentially	RB	B-ADVP	O
adhere	adhere	VBP	B-VP	O
.	.	.	O	O

To	To	TO	B-VP	O
examine	examine	VB	I-VP	O
the	the	DT	B-NP	O
occurrence	occurrence	NN	I-NP	O
of	of	IN	B-PP	O
specific	specific	JJ	B-NP	O
periodontal	periodontal	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
children	child	NNS	B-NP	O
and	and	CC	I-NP	O
adolescents	adolescent	NNS	I-NP	O
.	.	.	O	O

Ten	Ten	CD	B-NP	O
putative	putative	JJ	I-NP	O
periodontal	periodontal	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
longitudinally	longitudinally	RB	I-VP	O
examined	examine	VBN	I-VP	O
in	in	IN	B-PP	O
plaque	plaque	NN	B-NP	O
and	and	CC	I-NP	O
saliva	saliva	NN	I-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
119	119	CD	B-NP	O
periodontally	periodontally	RB	I-NP	O
healthy	healthy	JJ	I-NP	O
children	child	NNS	I-NP	O
(	(	(	O	O
2-15	2-15	CD	B-NP	O
years	year	NNS	I-NP	O
old	old	JJ	B-ADJP	O
)	)	)	O	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
method	method	NN	I-NP	O
.	.	.	O	O

Capnocytophaga	Capnocytophaga	NNP	B-NP	O
ochracea	ochracea	NNP	I-NP	O
,	,	,	O	O
C.	C.	NNP	B-NP	O
sputigena	sputigena	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Actinobacillus	Actinobacillus	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
were	be	VBD	B-VP	O
frequently	frequently	RB	I-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
tended	tend	VBD	B-VP	O
to	to	TO	I-VP	O
persist	persist	VB	I-VP	O
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
Porphyromonas	Porphyromonas	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
Treponema	Treponema	NNP	B-NP	O
denticola	denticola	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Prevotella	Prevotella	NN	B-NP	O
intermedia	intermedia	NNS	I-NP	O
were	be	VBD	B-VP	O
rarely	rarely	RB	I-VP	O
detected	detect	VBN	I-VP	O
.	.	.	O	O

P.	P.	NNP	B-NP	O
nigrescens	nigrescen	NNS	I-NP	O
was	be	VBD	B-VP	O
more	more	RBR	I-VP	O
frequently	frequently	RB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
plaque	plaque	NN	B-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
prevalence	prevalence	NN	I-NP	O
increased	increase	VBD	B-VP	O
with	with	IN	B-PP	O
age	age	NN	B-NP	O
.	.	.	O	O

Eikenella	Eikenella	NN	B-NP	O
corrodens	corroden	NNS	I-NP	O
and	and	CC	O	O
Campylobacter	Campylobacter	NNP	B-NP	O
rectus	rectus	NN	I-NP	O
were	be	VBD	B-VP	O
sometimes	sometimes	RB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	CC	O	O
plaque	plaque	NN	B-NP	O
and	and	CC	I-NP	O
saliva	saliva	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
Tannerella	Tannerella	NN	B-NP	O
forsythensis	forsythensis	NN	I-NP	O
was	be	VBD	B-VP	O
occasionally	occasionally	RB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
.	.	.	O	O

A.	A.	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
,	,	,	O	O
C.	C.	NNP	B-NP	O
ochracea	ochracea	NNP	I-NP	O
,	,	,	O	O
C.	C.	NNP	B-NP	O
sputigena	sputigena	NNP	I-NP	O
,	,	,	O	O
P.	P.	NNP	B-NP	O
nigrescens	nigrescens	NNP	I-NP	O
,	,	,	O	O
C.	C.	NNP	B-NP	O
rectus	rectus	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
E.	E.	NNP	B-NP	O
corrodens	corroden	NNS	I-NP	O
are	be	VBP	B-VP	O
common	common	JJ	B-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microbial	microbial	JJ	I-NP	O
flora	flora	NN	I-NP	O
of	of	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
children	child	NNS	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
P.	P.	NNP	B-NP	O
intermedia	intermedia	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
T.	T.	NN	B-NP	O
denticola	denticola	NN	I-NP	O
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
transient	transient	JJ	B-NP	O
organisms	organism	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
selectivity	selectivity	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
was	be	VBD	B-VP	O
specified	specify	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
previously	previously	RB	I-NP	O
developed	develop	VBN	I-NP	O
nutrient	nutrient	NN	I-NP	O
medium	medium	NN	I-NP	O
meant	mean	VBN	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
cultivation	cultivation	NN	I-NP	O
of	of	IN	B-PP	O
Haemophilus	Haemophilus	NN	B-NP	O
bacteria	bacteria	NNS	I-NP	O
--	--	:	O	O
CAE	CAE	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
based	base	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
acid	acid	NN	I-NP	O
hydrolysate	hydrolysate	NN	I-NP	O
of	of	IN	B-PP	O
casein	casein	NN	B-NP	O
,	,	,	O	O
enzyme	enzyme	NN	B-NP	O
hydrolysate	hydrolysate	NN	I-NP	O
of	of	IN	B-PP	O
animal	animal	NN	B-NP	O
blood	blood	NN	I-NP	O
(	(	(	O	O
aminopeptide	aminopeptide	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
extract	extract	NN	I-NP	O
of	of	IN	B-PP	O
nutrient	nutrient	JJ	B-NP	O
yeast	yeast	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
above	above	JJ	I-NP	O
nutrient	nutrient	NN	I-NP	O
medium	medium	NN	I-NP	O
containing	contain	VBG	B-VP	O
additionally	additionally	RB	B-ADVP	O
growth	growth	NN	B-NP	O
factors	factor	NNS	I-NP	O
V	V	NN	B-NP	O
and	and	CC	I-NP	O
X	X	NN	I-NP	B-DNA
,	,	,	I-NP	O
glucose	glucose	NN	I-NP	O
and	and	CC	I-NP	O
bacitracin	bacitracin	NN	I-NP	O
was	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
fit	fit	VB	I-VP	O
well	well	RB	B-ADVP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
sowing	sowing	NN	I-NP	O
of	of	IN	B-PP	O
Haemophilus	Haemophilus	NN	B-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
in	in	IN	B-PP	O
diagnostic	diagnostic	JJ	B-NP	O
examinations	examination	NNS	I-NP	O
.	.	.	O	O

Active	Active	JJ	B-NP	O
immunization	immunization	NN	I-NP	O
with	with	IN	B-PP	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
whole-cell	whole-cell	JJ	I-NP	O
preparations	preparation	NNS	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
prevent	prevent	VB	I-VP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
infection	infection	NN	I-NP	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
bone	bone	NN	I-NP	O
loss	loss	NN	I-NP	O
.	.	.	O	O

Employing	Employ	VBG	B-VP	O
passive	passive	JJ	B-NP	O
antibody	antibody	NN	I-NP	O
transfer	transfer	NN	I-NP	O
and	and	CC	I-NP	O
opsonization	opsonization	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
that	that	IN	B-SBAR	O
immunization-elicited	immunization-elicited	JJ	B-NP	O
P.	P.	NNP	I-NP	O
gingivalis-specific	gingivalis-specific	JJ	I-NP	O
immunoglobulin	immunoglobulin	NN	I-NP	O
G	G	NN	I-NP	O
facilitates	facilitate	VBZ	B-VP	O
clearance	clearance	NN	B-NP	O
of	of	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
chamber	chamber	NN	I-NP	O
model	model	NN	I-NP	O
and	and	CC	O	O
prevents	prevent	VBZ	B-VP	O
P.	P.	NNP	B-NP	O
gingivalis-elicited	gingivalis-elicited	JJ	I-NP	O
oral	oral	JJ	I-NP	O
bone	bone	NN	I-NP	O
loss	loss	NN	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
malodor	malodor	NN	I-NP	O
is	be	VBZ	B-VP	O
considered	consider	VBN	I-VP	O
to	to	TO	I-VP	O
originate	originate	VB	I-VP	O
primarily	primarily	RB	B-ADVP	O
from	from	IN	B-PP	O
tongue	tongue	NN	B-NP	B-cell_type
microbiota	microbiota	NN	I-NP	I-cell_type
populations	population	NNS	I-NP	I-cell_type
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
oral	oral	JJ	B-NP	O
malodor	malodor	NN	I-NP	O
and	and	CC	I-NP	O
tongue	tongue	NN	I-NP	O
microbiota	microbiota	NN	I-NP	O
remains	remain	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
tongue	tongue	JJ	B-NP	O
periodontal	periodontal	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
via	via	IN	B-PP	O
real-time	real-time	JJ	B-NP	O
PCR	PCR	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
association	association	NN	I-NP	O
between	between	IN	B-PP	O
oral	oral	JJ	B-NP	O
malodor	malodor	NN	I-NP	O
and	and	CC	O	O
tongue	tongue	NN	B-NP	O
periodontal	periodontal	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
Porphyromonas	Porphyromonas	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
Tannerella	Tannerella	NNP	B-NP	O
forsythia	forsythia	NNP	I-NP	O
,	,	,	O	O
Prevotella	Prevotella	NNP	B-NP	O
intermedia	intermedia	NNS	I-NP	O
,	,	,	O	O
Prevotella	Prevotella	NNP	B-NP	O
nigrescens	nigrescens	NNP	I-NP	O
and	and	CC	O	O
Treponema	Treponema	NNP	B-NP	O
denticola	denticola	NNP	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
subject	subject	NN	I-NP	O
population	population	NN	I-NP	O
consisted	consist	VBD	B-VP	O
of	of	IN	B-PP	O
29	29	CD	B-NP	O
individuals	individual	NNS	I-NP	O
with	with	IN	B-PP	O
and	and	CC	O	O
10	10	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
persons	person	NNS	I-NP	O
without	without	IN	B-PP	O
oral	oral	JJ	B-NP	O
malodor	malodor	NN	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
malodor	malodor	NN	I-NP	O
was	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
by	by	IN	B-PP	O
organoleptic	organoleptic	JJ	B-NP	O
test	test	NN	I-NP	O
and	and	CC	O	O
volatile	volatile	JJ	B-NP	O
sulfur	sulfur	NN	I-NP	O
compound	compound	NN	I-NP	O
(	(	(	O	O
VSC	VSC	NN	B-NP	O
)	)	)	O	O
levels	level	NNS	B-NP	O
as	as	IN	B-SBAR	O
measured	measure	VBN	B-VP	O
by	by	IN	B-PP	O
gas	gas	NN	B-NP	O
chromatography	chromatography	NN	I-NP	O
.	.	.	O	O

Real-time	Real-time	JJ	B-NP	O
PCR	PCR	NN	I-NP	O
was	be	VBD	B-VP	O
conducted	conduct	VBN	I-VP	O
for	for	IN	B-PP	O
anaerobes	anaerobe	NNS	B-NP	O
in	in	IN	B-PP	O
tongue	tongue	NN	B-NP	O
biofilm	biofilm	NN	I-NP	O
samples	sample	NNS	I-NP	O
employing	employ	VBG	B-VP	O
a	a	DT	B-NP	O
LightCycler	LightCycler	NNP	I-NP	O
system	system	NN	I-NP	O
;	;	:	O	O
furthermore	furthermore	RB	B-ADVP	O
,	,	,	O	O
bacterial	bacterial	JJ	B-NP	O
proportion	proportion	NN	I-NP	O
served	serve	VBD	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
quantitative	quantitative	JJ	I-NP	O
parameter	parameter	NN	I-NP	O
.	.	.	O	O

Among	Among	IN	B-PP	O
the	the	DT	B-NP	O
five	five	CD	I-NP	O
anaerobes	anaerobe	NNS	I-NP	O
,	,	,	O	O
only	only	RB	B-NP	O
T.	T.	NNP	I-NP	O
forsythia	forsythia	NN	I-NP	O
displayed	display	VBD	B-VP	O
higher	high	JJR	B-NP	O
proportions	proportion	NNS	I-NP	O
in	in	IN	B-PP	O
malodor	malodor	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
than	than	IN	B-PP	O
corresponding	correspond	VBG	B-VP	O
values	value	NNS	B-NP	O
in	in	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
controls	control	NNS	I-NP	O
.	.	.	O	O

Proportions	Proportion	NNS	B-NP	O
of	of	IN	B-PP	O
P.	P.	NNP	B-NP	O
intermedia	intermedia	NN	I-NP	O
and	and	CC	O	O
P.	P.	NNP	B-NP	O
nigrescens	nigrescens	NNP	I-NP	O
correlated	correlate	VBD	B-VP	O
strongly	strongly	RB	B-ADVP	O
with	with	IN	B-PP	O
hydrogen	hydrogen	NN	B-NP	O
sulfide	sulfide	NN	I-NP	O
concentration	concentration	NN	I-NP	O
.	.	.	O	O

Proportions	Proportion	NNS	B-NP	O
of	of	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
and	and	CC	O	O
P.	P.	NNP	B-NP	O
nigrescens	nigrescens	NNP	I-NP	O
also	also	RB	B-ADVP	O
exhibited	exhibit	VBD	B-VP	O
strong	strong	JJ	B-NP	O
correlation	correlation	NN	I-NP	O
with	with	IN	B-PP	O
methyl	methyl	NN	B-NP	O
mercaptan	mercaptan	NN	I-NP	O
concentration	concentration	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
correlation	correlation	NN	I-NP	O
coefficient	coefficient	JJ	B-ADJP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
proportion	proportion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
five	five	CD	I-NP	O
anaerobes	anaerobe	NNS	I-NP	O
and	and	CC	O	O
total	total	JJ	B-NP	O
VSC	VSC	NN	I-NP	O
level	level	NN	I-NP	O
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
0.88	0.88	CD	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
between	between	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
proportion	proportion	NN	I-NP	O
and	and	CC	O	O
organoleptic	organoleptic	JJ	B-NP	O
score	score	NN	I-NP	O
(	(	(	O	O
r	r	NN	B-NP	O
=	=	SYM	B-VP	O
0.29	0.29	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
a	a	DT	B-NP	O
linear	linear	JJ	I-NP	O
regression	regression	NN	I-NP	O
analysis	analysis	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
utilizing	utilize	VBG	I-VP	O
the	the	DT	B-NP	O
proportion	proportion	NN	I-NP	O
of	of	IN	B-PP	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
five	five	CD	I-NP	O
periodontal	periodontal	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
independent	independent	JJ	I-NP	O
variable	variable	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
explanatory	explanatory	JJ	I-NP	O
power	power	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
independent	independent	JJ	I-NP	O
variables	variable	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
81	81	CD	B-NP	O
%	%	NN	I-NP	O
for	for	IN	B-PP	O
total	total	JJ	B-NP	O
VSC	VSC	NN	I-NP	O
level	level	NN	I-NP	O
and	and	CC	O	O
16	16	CD	B-NP	O
%	%	NN	I-NP	O
for	for	IN	B-PP	O
organoleptic	organoleptic	JJ	B-NP	O
score	score	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
five	five	CD	I-NP	O
periodontal	periodontal	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
on	on	IN	B-PP	O
tongue	tongue	NN	B-NP	O
dorsa	dorsa	NN	I-NP	O
may	may	MD	B-VP	O
contribute	contribute	VB	I-VP	O
greatly	greatly	RB	B-ADVP	O
to	to	TO	B-PP	O
VSC	VSC	NN	B-NP	B-protein
production	production	NN	I-NP	O
.	.	.	O	O

Fifty-three	Fifty-three	CD	B-NP	O
beta-lactamase-producing	beta-lactamase-producing	JJ	I-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
refractory	refractory	JJ	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
in	in	IN	B-PP	O
Norway	Norway	NNP	B-NP	O
and	and	CC	I-NP	O
USA	USA	NNP	I-NP	O
were	be	VBD	B-VP	O
screened	screen	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bla	bla	NN	I-NP	O
(	(	(	O	O
TEM	TEM	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
bla	bla	NN	B-NP	O
(	(	(	O	O
SHV	SHV	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
bla	bla	NN	B-NP	O
(	(	(	O	O
OXA	OXA	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
bla	bla	NN	B-NP	O
(	(	(	O	O
ampC	ampC	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
bla	bla	NN	B-NP	O
(	(	(	O	O
cfxA	cfxA	NN	B-NP	B-DNA
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
bla	bla	NN	B-NP	B-DNA
(	(	(	O	I-DNA
cepA/cblA	cepA/cblA	NN	B-NP	I-DNA
)	)	)	O	I-DNA
genes	gene	NNS	B-NP	I-DNA
by	by	IN	B-PP	O
the	the	DT	B-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
(	(	(	O	O
PCR	PCR	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
PCR	PCR	NN	I-NP	B-DNA
products	product	NNS	I-NP	I-DNA
were	be	VBD	B-VP	O
characterized	characterize	VBN	I-VP	O
by	by	IN	B-PP	O
direct	direct	JJ	B-NP	O
sequencing	sequencing	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
amplified	amplify	VBN	I-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
.	.	.	O	O

Thirty-four	Thirty-four	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
53	53	CD	I-NP	O
enzyme-producing	enzyme-producing	JJ	I-NP	O
strains	strain	NNS	I-NP	O
(	(	(	O	O
64	64	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
PCR	PCR	NN	I-NP	O
assays	assay	NNS	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
beta-lactamase-producing	beta-lactamase-producing	JJ	I-NP	O
Prevotella	Prevotella	NNP	I-NP	O
and	and	CC	I-NP	O
Capnocytophaga	Capnocytophaga	NNP	I-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

were	be	VBD	B-VP	O
CfxA	CfxA	NN	B-ADJP	B-protein
positive	positive	JJ	I-ADJP	O
.	.	.	O	O

TEM-type	TEM-type	JJ	B-NP	B-protein
beta-lactamases	beta-lactamas	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
strain	strain	NN	I-NP	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
Escherichia	Escherichia	NNP	B-NP	O
coli	coli	NNP	I-NP	O
and	and	CC	O	O
Neisseria	Neisseria	NNP	B-NP	O
sp.	sp.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
one	one	CD	B-NP	O
strain	strain	NN	I-NP	O
of	of	IN	B-PP	O
Citrobacter	Citrobacter	NNP	B-NP	O
freundii	freundii	NNS	I-NP	O
possessed	possess	VBD	B-VP	O
an	an	DT	B-NP	O
AmpC-type	AmpC-type	JJ	I-NP	B-protein
beta-lactamase	beta-lactamase	NN	I-NP	I-protein
.	.	.	O	O

Screening	Screening	NN	B-NP	O
for	for	IN	B-PP	O
gene	gene	NN	B-NP	O
cassettes	cassette	NNS	I-NP	O
and	and	CC	O	O
genes	gene	NNS	B-NP	O
known	know	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
integrons	integron	NNS	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
reveal	reveal	VB	I-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
integrons	integron	NNS	B-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

Sequence	Sequence	NN	B-NP	O
analyses	analysis	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
most	most	JJS	B-NP	O
CfxA	CfxA	NN	I-NP	B-protein
positive	positive	JJ	I-NP	O
Prevotella	Prevotella	NNP	I-NP	O
and	and	CC	I-NP	O
Capnocytophaga	Capnocytophaga	NNP	I-NP	O
isolates	isolate	NNS	I-NP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
refractory	refractory	JJ	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
harboured	harbour	VBD	B-VP	O
variants	variant	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
CfxA2	CfxA2	NN	I-NP	O
and	and	CC	I-NP	O
CfxA3	CfxA3	NN	I-NP	B-protein
enzyme	enzyme	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
also	also	RB	B-ADVP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
many	many	JJ	B-NP	O
different	different	JJ	I-NP	O
genetic	genetic	JJ	I-NP	O
determinants	determinant	NNS	I-NP	O
of	of	IN	B-PP	O
beta-lactamase	beta-lactamase	NN	B-NP	B-protein
production	production	NN	I-NP	O
are	be	VBP	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
refractory	refractory	JJ	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
,	,	,	O	O
many	many	JJ	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
remain	remain	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
characterized	characterize	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
oral	oral	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
is	be	VBZ	B-VP	O
exposed	expose	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
density	density	NN	I-NP	O
and	and	CC	I-NP	O
diversity	diversity	NN	I-NP	O
of	of	IN	B-PP	O
gram-positive	gram-positive	JJ	B-NP	O
and	and	CC	I-NP	O
gram-negative	gram-negative	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
very	very	RB	B-ADJP	O
little	little	JJ	I-ADJP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
about	about	IN	B-PP	O
how	how	WRB	B-ADVP	O
immune	immune	JJ	B-NP	O
homeostasis	homeostasis	NN	I-NP	O
is	be	VBZ	B-VP	O
maintained	maintain	VBN	I-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
environment	environment	NN	I-NP	O
,	,	,	O	O
particularly	particularly	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
disease	disease	NN	I-NP	O
chronic	chronic	JJ	I-NP	O
periodontitis	periodontitis	NN	I-NP	O
(	(	(	O	O
CP	CP	NN	B-NP	B-DNA
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
cells	cell	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
innate	innate	JJ	I-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O
recognize	recognize	VBP	B-VP	O
bacterial	bacterial	JJ	B-NP	O
structures	structure	NNS	I-NP	O
via	via	IN	B-PP	O
the	the	DT	B-NP	O
Toll-like	Toll-like	JJ	I-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
(	(	(	O	O
TLR	TLR	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

This	This	DT	B-NP	O
activates	activate	VBZ	B-VP	O
intracellular	intracellular	JJ	B-NP	O
signaling	signaling	NN	I-NP	O
and	and	CC	I-NP	O
transcription	transcription	NN	I-NP	O
of	of	IN	B-PP	O
proteins	protein	NNS	B-NP	O
essential	essential	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
adaptive	adaptive	JJ	I-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O
;	;	:	O	O
however	however	RB	O	O
,	,	,	O	O
if	if	IN	B-SBAR	O
unregulated	unregulated	JJ	B-ADJP	O
,	,	,	O	O
it	it	PRP	B-NP	O
can	can	MD	B-VP	O
lead	lead	VB	I-VP	O
to	to	TO	B-PP	O
destructive	destructive	JJ	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
responses	response	NNS	I-NP	O
.	.	.	O	O

Using	Use	VBG	B-VP	O
single-immunoenzyme	single-immunoenzyme	NN	B-NP	O
labeling	labeling	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
oral	oral	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
(	(	(	O	O
gingiva	gingiva	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
infiltrated	infiltrate	VBN	I-VP	O
by	by	IN	B-PP	O
large	large	JJ	B-NP	O
numbers	number	NNS	I-NP	O
of	of	IN	B-PP	O
TLR2	TLR2	NN	B-NP	B-protein
(	(	(	O	O
+	+	SYM	B-NP	O
)	)	)	O	O
and	and	CC	O	O
TLR4	TLR4	NN	B-NP	B-protein
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
cells	cell	NNS	B-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
their	their	PRP$	B-NP	O
numbers	number	NNS	I-NP	O
increase	increase	VBP	B-VP	O
significantly	significantly	RB	B-ADVP	O
in	in	IN	B-PP	O
CP	CP	NN	B-NP	B-DNA
,	,	,	O	O
relative	relative	JJ	B-ADVP	O
to	to	TO	B-PP	O
health	health	NN	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
0.05	0.05	CD	B-NP	O
,	,	,	O	O
Student	Student	NNP	B-NP	O
's	's	POS	B-NP	O
t	t	NN	I-NP	O
test	test	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
numbers	number	NNS	I-NP	O
of	of	IN	B-PP	O
TLR2	TLR2	NN	B-NP	B-protein
(	(	(	O	O
+	+	SYM	B-NP	O
)	)	)	O	O
but	but	CC	B-NP	O
not	not	RB	I-NP	O
TLR4	TLR4	NN	B-NP	B-protein
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
cells	cell	NNS	B-NP	O
increase	increase	VBP	B-VP	O
linearly	linearly	RB	B-ADVP	O
with	with	IN	B-PP	O
inflammation	inflammation	NN	B-NP	O
(	(	(	O	O
r	r	NN	B-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
=	=	SYM	B-VP	O
0.33	0.33	CD	B-NP	O
,	,	,	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
0.05	0.05	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

Double-immunofluorescence	Double-immunofluorescence	NN	B-NP	O
analysis	analysis	NN	I-NP	O
confirms	confirm	VBZ	B-VP	O
that	that	IN	B-SBAR	O
TLR2	TLR2	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
coexpressed	coexpresse	VBN	I-VP	O
by	by	IN	B-PP	O
monocytes	monocyte	NNS	B-NP	B-cell_type
(	(	(	O	O
MC	MC	NN	B-NP	O
)	)	)	O	O
/macrophages	/macrophage	NNS	B-NP	B-cell_type
(	(	(	O	O
mphi	mphi	NNS	B-NP	O
)	)	)	O	O
in	in	FW	B-ADVP	O
situ	situ	FW	I-ADVP	O
.	.	.	O	O

Further	Further	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
gingival	gingival	JJ	B-NP	O
tissues	tissue	NNS	I-NP	O
by	by	IN	B-PP	O
quantitative	quantitative	JJ	B-NP	O
real-time	real-time	JJ	I-NP	O
PCR	PCR	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
indicates	indicate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
despite	despite	IN	B-PP	O
a	a	DT	B-NP	O
threefold	threefold	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
interleukin-1beta	interleukin-1beta	NN	B-NP	B-RNA
(	(	(	O	I-RNA
IL-1beta	IL-1beta	NN	B-NP	I-RNA
)	)	)	O	I-RNA
mRNA	mRNA	NN	B-NP	I-RNA
during	during	IN	B-PP	O
CP	CP	NN	B-NP	B-DNA
,	,	,	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
significant	significant	JJ	B-ADJP	O
(	(	(	O	O
30-fold	30-fold	JJ	B-ADJP	O
)	)	)	O	O
downregulation	downregulation	NN	B-NP	O
of	of	IN	B-PP	O
TLR2	TLR2	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
0.05	0.05	CD	B-NP	O
,	,	,	O	O
Student	Student	NNP	B-NP	O
's	's	POS	B-NP	O
t	t	NN	I-NP	O
test	test	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
showing	show	VBG	B-VP	O
similar	similar	JJ	B-NP	O
trends	trend	NNS	I-NP	O
are	be	VBP	B-VP	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
TLR4	TLR4	NN	B-NP	B-protein
(	(	(	O	O
ninefold	ninefold	JJ	B-NP	O
reduction	reduction	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
TLR5	TLR5	NN	B-NP	B-protein
(	(	(	O	O
twofold	twofold	JJ	B-NP	O
reduction	reduction	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
MD-2	MD-2	NN	B-NP	B-protein
(	(	(	O	O
sevenfold	sevenfold	JJ	B-NP	O
reduction	reduction	NN	I-NP	O
)	)	)	O	O
mRNA	mRNA	NN	B-NP	O
in	in	IN	B-PP	O
CP	CP	NN	B-NP	O
patients	patient	NNS	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
healthy	healthy	JJ	B-NP	O
persons	person	NNS	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
CD14	CD14	NN	B-NP	B-protein
was	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
.	.	.	O	O

In	In	FW	B-NP	O
vitro	vitro	FW	I-NP	O
studies	study	NNS	I-NP	O
with	with	IN	B-PP	O
human	human	JJ	B-NP	O
MC	MC	NN	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
MC	MC	NN	B-NP	O
respond	respond	VBP	B-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
initial	initial	JJ	I-NP	O
stimulus	stimulus	NN	I-NP	O
of	of	IN	B-PP	O
lipopolysaccharide	lipopolysaccharide	NN	B-NP	O
(	(	(	O	O
LPS	LPS	NN	B-NP	O
)	)	)	O	O
from	from	IN	B-PP	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
(	(	(	O	O
PgLPS	PgLPS	NN	B-NP	O
)	)	)	O	O
or	or	CC	O	O
Escherichia	Escherichia	FW	B-NP	O
coli	coli	FW	I-NP	O
(	(	(	O	O
EcLPS	EcLPS	NN	B-NP	O
)	)	)	O	O
by	by	IN	B-PP	O
upregulation	upregulation	NN	B-NP	O
of	of	IN	B-PP	O
TLR2	TLR2	NN	B-NP	B-protein
and	and	CC	I-NP	O
TLR4	TLR4	NN	I-NP	O
mRNA	mRNA	NN	I-NP	O
and	and	CC	I-NP	O
protein	protein	NN	I-NP	O
;	;	:	O	O
moreover	moreover	RB	B-ADVP	O
,	,	,	O	O
IL-1beta	IL-1beta	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
is	be	VBZ	B-VP	O
induced	induce	VBN	I-VP	O
and	and	CC	O	O
tumor	tumor	NN	B-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
(	(	(	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
IL-10	IL-10	NN	B-NP	B-protein
,	,	,	O	O
IL-6	IL-6	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
IL-8	IL-8	NN	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
secreted	secrete	VBN	I-VP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
restimulation	restimulation	NN	B-NP	O
of	of	IN	B-PP	O
MC	MC	NN	B-NP	B-cell_type
with	with	IN	B-PP	O
either	either	CC	O	O
PgLPS	PgLPS	NN	B-NP	O
or	or	CC	I-NP	O
EcLPS	EcLPS	NN	I-NP	B-protein
downregulates	downregulate	VBZ	B-VP	O
TLR2	TLR2	NN	B-NP	B-protein
and	and	CC	I-NP	O
TLR4	TLR4	NN	I-NP	O
mRNA	mRNA	NN	I-NP	O
and	and	CC	O	O
protein	protein	NN	B-NP	O
and	and	CC	O	O
IL-1beta	IL-1beta	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
and	and	CC	O	O
induces	induce	VBZ	B-VP	O
a	a	DT	B-NP	O
ca	ca	NN	I-NP	O
.	.	.	O	O

10-fold	10-fold	JJ	B-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
secretion	secretion	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
endotoxin	endotoxin	NN	B-NP	B-protein
tolerance	tolerance	NN	I-NP	O
by	by	IN	B-PP	O
either	either	DT	B-NP	O
LPS	LPS	NN	I-NP	O
.	.	.	O	O

Less	Less	RBR	B-ADJP	O
susceptible	susceptible	JJ	I-ADJP	O
to	to	TO	B-PP	O
tolerance	tolerance	NN	B-NP	O
than	than	IN	B-PP	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
were	be	VBD	B-VP	O
IL-6	IL-6	NN	B-NP	B-protein
,	,	,	O	O
IL-10	IL-10	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
IL-8	IL-8	NN	B-NP	B-protein
.	.	.	O	O

These	These	DT	B-NP	O
studies	study	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
certain	certain	JJ	B-NP	O
components	component	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
innate	innate	JJ	I-NP	O
oral	oral	JJ	I-NP	O
mucosal	mucosal	JJ	I-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O
,	,	,	O	O
most	most	RBS	B-ADVP	O
notably	notably	RB	I-ADVP	O
TLRs	TLR	NNS	B-NP	B-protein
and	and	CC	O	O
inflammatory	inflammatory	JJ	B-NP	B-protein
cytokines	cytokine	NNS	I-NP	I-protein
,	,	,	O	O
may	may	MD	B-VP	O
become	become	VB	I-VP	O
tolerized	tolerize	VBN	I-VP	O
during	during	IN	B-PP	O
sustained	sustained	JJ	B-NP	O
exposure	exposure	NN	I-NP	O
to	to	TO	B-PP	O
bacterial	bacterial	JJ	B-NP	O
structures	structure	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
LPS	LPS	NN	B-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
one	one	CD	B-NP	O
mechanism	mechanism	NN	I-NP	O
used	use	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
to	to	TO	B-VP	O
attempt	attempt	VB	I-VP	O
to	to	TO	I-VP	O
regulate	regulate	VB	I-VP	O
local	local	JJ	B-NP	O
immune	immune	JJ	I-NP	O
responses	response	NNS	I-NP	O
.	.	.	O	O

Clinical	Clinical	JJ	B-NP	O
research	research	NN	I-NP	O
assessing	assess	VBG	B-VP	O
different	different	JJ	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
protocols	protocol	NNS	I-NP	O
aimed	aim	VBN	B-VP	O
at	at	IN	B-PP	O
treating	treat	VBG	B-VP	O
oral	oral	JJ	B-NP	O
halitosis	halitosis	NN	I-NP	O
is	be	VBZ	B-VP	O
scarce	scarce	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
combined	combined	JJ	I-NP	O
mechanical	mechanical	JJ	I-NP	O
and	and	CC	I-NP	O
pharmacological	pharmacological	JJ	I-NP	O
approach	approach	NN	I-NP	O
to	to	TO	B-VP	O
treat	treat	VB	I-VP	O
oral	oral	JJ	B-NP	O
halitosis	halitosis	NN	I-NP	O
on	on	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
and	and	CC	I-NP	O
microbiological	microbiological	JJ	I-NP	O
outcomes	outcome	NNS	I-NP	O
on	on	IN	B-PP	O
patients	patient	NNS	B-NP	O
followed	follow	VBN	B-VP	O
for	for	IN	B-PP	O
3	3	CD	B-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

Nineteen	Nineteen	CD	B-NP	O
subjects	subject	NNS	I-NP	O
with	with	IN	B-PP	O
oral	oral	JJ	B-NP	O
malodor	malodor	NN	I-NP	O
participated	participate	VBD	B-VP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
all	all	DT	B-NP	O
subjects	subject	NNS	I-NP	O
completed	complete	VBD	B-VP	O
a	a	DT	B-NP	O
questionnaire	questionnaire	NN	I-NP	O
and	and	CC	O	O
carried	carry	VBD	B-VP	O
out	out	RP	B-PRT	O
an	an	DT	B-NP	O
examination	examination	NN	I-NP	O
including	include	VBG	B-PP	O
full-mouth	full-mouth	JJ	B-NP	O
organoleptic	organoleptic	JJ	I-NP	O
and	and	CC	I-NP	O
volatile	volatile	JJ	I-NP	O
sulfur	sulfur	NN	I-NP	O
compound	compound	NN	I-NP	O
(	(	(	O	O
VSC	VSC	NN	B-NP	O
)	)	)	O	O
levels	level	NNS	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
Winkel	Winkel	NNP	I-NP	O
tongue	tongue	NN	I-NP	O
coating	coat	VBG	B-VP	O
index	index	NN	B-NP	O
.	.	.	O	O

Standard	Standard	JJ	B-NP	O
periodontal	periodontal	JJ	I-NP	O
outcome	outcome	NN	I-NP	O
variables	variable	NNS	I-NP	O
were	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
at	at	IN	B-PP	O
six	six	CD	B-NP	O
teeth	tooth	NNS	I-NP	O
.	.	.	O	O

Standardized	Standardized	JJ	B-NP	O
microbiological	microbiological	JJ	I-NP	O
samples	sample	NNS	I-NP	O
of	of	IN	B-PP	O
subgingival	subgingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
,	,	,	O	O
unstimulated	unstimulated	JJ	B-NP	O
saliva	saliva	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
tongue	tongue	NN	B-NP	O
coating	coating	NN	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
for	for	IN	B-PP	O
culture	culture	NN	B-NP	O
analysis	analysis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
treatment	treatment	NN	I-NP	O
protocol	protocol	NN	I-NP	O
included	include	VBD	B-VP	O
supragingival	supragingival	JJ	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
;	;	:	O	O
instructions	instruction	NNS	B-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
hygiene	hygiene	NN	I-NP	O
(	(	(	O	O
toothbrushing	toothbrushing	NN	B-NP	O
,	,	,	O	O
interproximal	interproximal	JJ	B-NP	O
cleaning	cleaning	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
tongue	tongue	NN	B-NP	O
scraping	scraping	NN	I-NP	O
)	)	)	O	O
;	;	:	O	O
and	and	CC	O	O
gargling	gargle	VBG	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
mouthrinse	mouthrinse	NN	I-NP	O
containing	contain	VBG	B-VP	O
chlorhexidine	chlorhexidine	NN	B-NP	O
,	,	,	O	O
cetylpiridinium	cetylpiridinium	NN	B-NP	O
chloride	chloride	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
zinc	zinc	NN	B-NP	O
lactate	lactate	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
same	same	JJ	I-NP	O
outcome	outcome	NN	I-NP	O
variables	variable	NNS	I-NP	O
were	be	VBD	B-VP	O
registered	register	VBN	I-VP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
3	3	CD	I-NP	O
months	month	NNS	I-NP	O
after	after	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

Statistically	Statistically	RB	B-NP	O
significant	significant	JJ	I-NP	O
reductions	reduction	NNS	I-NP	O
in	in	IN	B-PP	O
organoleptic	organoleptic	JJ	B-NP	O
scores	score	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
0.001	0.001	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
VSC	VSC	NN	B-NP	B-protein
levels	level	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
tongue	tongue	NN	B-NP	O
coating	coat	VBG	B-VP	O
index	index	NN	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
0.05	0.05	CD	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
3	3	CD	I-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

Mean	Mean	NN	B-NP	O
probing	probe	VBG	B-VP	O
depth	depth	NN	B-NP	O
and	and	CC	I-NP	O
plaque	plaque	NN	I-NP	O
levels	level	NNS	I-NP	O
also	also	RB	B-ADVP	O
demonstrated	demonstrate	VBD	B-VP	O
significant	significant	JJ	B-NP	O
reductions	reduction	NNS	I-NP	O
after	after	IN	B-PP	O
3	3	CD	B-NP	O
months	month	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Total	Total	JJ	B-NP	O
anaerobic	anaerobic	JJ	I-NP	O
counts	count	NNS	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
reduced	reduce	VBN	I-VP	O
at	at	IN	B-PP	O
all	all	DT	B-NP	O
three	three	CD	I-NP	O
locations	location	NNS	I-NP	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
month	month	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
samples	sample	NNS	B-NP	O
from	from	IN	B-PP	O
tongue	tongue	NN	B-NP	O
coating	coating	NN	I-NP	O
and	and	CC	O	O
subgingival	subgingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
at	at	IN	B-PP	O
3	3	CD	B-NP	O
months	month	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Aerobic	Aerobic	JJ	B-NP	O
counts	count	NNS	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
reduced	reduce	VBN	I-VP	O
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
month	month	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
anaerobic/aerobic	anaerobic/aerobic	JJ	I-NP	O
ratio	ratio	NN	I-NP	O
significantly	significantly	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
tongue	tongue	NN	I-NP	O
samples	sample	NNS	I-NP	O
.	.	.	O	O

Among	Among	IN	B-PP	O
the	the	DT	B-NP	O
selected	select	VBN	I-NP	O
pathogens	pathogen	NNS	I-NP	O
evaluated	evaluate	VBN	B-VP	O
,	,	,	O	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
affected	affected	JJ	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
microflora	microflora	NNS	I-NP	O
evaluated	evaluate	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
evaluated	evaluate	VBN	I-NP	O
therapeutic	therapeutic	JJ	I-NP	O
approach	approach	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
its	its	PRP$	B-NP	O
efficacy	efficacy	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
halitosis	halitosis	NN	I-NP	O
,	,	,	O	O
demonstrating	demonstrate	VBG	B-VP	O
statistically	statistically	RB	B-NP	O
significant	significant	JJ	I-NP	O
improvements	improvement	NNS	I-NP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
organoleptic	organoleptic	JJ	I-NP	O
and	and	CC	I-NP	O
VSC	VSC	JJ	I-NP	O
values	value	NNS	I-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
3	3	CD	I-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
proposed	propose	VBN	I-NP	O
clinical	clinical	JJ	I-NP	O
protocol	protocol	NN	I-NP	O
significantly	significantly	RB	B-VP	O
affected	affect	VBD	I-VP	O
the	the	DT	B-NP	O
microbial	microbial	JJ	I-NP	O
composition	composition	NN	I-NP	O
in	in	IN	B-PP	O
tongue	tongue	NN	B-NP	O
coating	coating	NN	I-NP	O
,	,	,	O	O
saliva	saliva	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
subgingival	subgingival	JJ	B-NP	O
microflora	microflora	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
evaluated	evaluate	VBD	B-VP	O
the	the	DT	B-NP	O
in	in	FW	I-NP	O
vivo	vivo	FW	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
bleaching	bleach	VBG	B-NP	O
agents	agent	NNS	I-NP	O
containing	contain	VBG	B-VP	O
10	10	CD	B-NP	O
%	%	NN	I-NP	O
carbamide	carbamide	NN	I-NP	O
peroxide	peroxide	NN	I-NP	O
(	(	(	O	O
Platinum/Colgate	Platinum/Colgate	NN	B-NP	O
)	)	)	O	O
or	or	CC	O	O
7.5	7.5	CD	B-NP	O
%	%	NN	I-NP	O
hydrogen	hydrogen	NN	I-NP	O
peroxide	peroxide	NN	I-NP	O
(	(	(	O	O
Day	Day	NNP	B-NP	O
White	White	NNP	I-NP	O
2Z/Discus	2Z/Discus	NNP	I-NP	O
Dental	Dental	NNP	I-NP	O
)	)	)	O	O
on	on	IN	B-PP	O
mutans	mutan	NNS	B-NP	O
Streptococcus	Streptococcus	NNP	B-NP	O
during	during	IN	B-PP	O
dental	dental	JJ	B-NP	O
bleaching	bleaching	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
products	product	NNS	I-NP	O
were	be	VBD	B-VP	O
applied	apply	VBN	I-VP	O
on	on	IN	B-PP	O
30	30	CD	B-NP	O
volunteers	volunteer	NNS	I-NP	O
who	who	WP	B-NP	O
needed	need	VBD	B-VP	O
dental	dental	JJ	B-NP	O
bleaching	bleaching	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
each	each	DT	B-NP	O
volunteer	volunteer	NN	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
bleaching	bleaching	JJ	I-NP	O
agents	agent	NNS	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
on	on	IN	B-PP	O
both	both	CC	O	O
dental	dental	JJ	B-NP	O
arches	arch	NNS	I-NP	O
one	one	CD	B-NP	O
hour	hour	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
for	for	IN	B-PP	O
three	three	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
counts	count	NNS	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
by	by	IN	B-PP	O
collecting	collect	VBG	B-VP	O
saliva	saliva	NN	B-NP	O
before	before	IN	B-SBAR	O
(	(	(	O	O
baseline	baseline	NN	B-NP	O
values	value	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
during	during	IN	B-PP	O
(	(	NN	B-NP	O
7	7	CD	I-NP	O
and	and	CC	I-NP	O
21	21	CD	I-NP	O
days	day	NNS	I-NP	O
)	)	)	O	O
bleaching	bleach	VBG	B-NP	O
treatments	treatment	NNS	I-NP	O
and	and	CC	O	O
14	14	CD	B-NP	O
days	day	NNS	I-NP	O
posttreatment	posttreatment	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Friedman	Friedman	NNP	I-NP	O
non-parametric	non-parametric	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
(	(	(	O	O
alpha=0.05	alpha=0.05	NN	B-NP	O
)	)	)	O	O
found	find	VBD	B-VP	O
no	no	DT	B-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
microorganism	microorganism	NN	B-NP	O
counts	count	NNS	I-NP	O
at	at	IN	B-PP	O
different	different	JJ	B-NP	O
times	time	NNS	I-NP	O
for	for	IN	B-PP	O
each	each	DT	B-NP	O
group	group	NN	I-NP	O
for	for	IN	B-PP	O
both	both	DT	B-NP	O
agents	agent	NNS	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
>	>	SYM	O	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
Mann	Mann	NNP	I-NP	O
Whitney	Whitney	NNP	I-NP	O
nonparametric	nonparametric	JJ	I-NP	O
test	test	NN	I-NP	O
(	(	(	O	O
alpha=0.05	alpha=0.05	NN	B-NP	O
)	)	)	O	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
micro-organism	micro-organism	NN	B-NP	O
counts	count	NNS	I-NP	O
for	for	IN	B-PP	O
both	both	DT	B-NP	O
agents	agent	NNS	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
>	>	SYM	O	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Different	Different	JJ	B-NP	O
bleaching	bleach	VBG	I-NP	O
agents	agent	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
change	change	VB	I-VP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
mutans	mutan	NNS	I-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
counts	count	NNS	I-NP	O
.	.	.	O	O

Listeria	Listeria	NN	B-NP	B-DNA
monocytogenes	monocytogene	NNS	I-NP	I-DNA
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
food-borne	food-borne	JJ	I-NP	O
pathogen	pathogen	NN	I-NP	O
that	that	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
serious	serious	JJ	B-NP	O
listeriosis	listeriosis	NN	I-NP	O
in	in	IN	B-PP	O
humans	human	NNS	B-NP	O
.	.	.	O	O

Antimicrobial	Antimicrobial	JJ	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-protein
lactoferrin	lactoferrin	NN	I-NP	I-protein
(	(	(	O	O
hLF	hLF	NN	B-NP	B-protein
)	)	)	O	O
against	against	IN	B-PP	O
L.	L.	NNP	B-NP	O
monocytogenes	monocytogene	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
clearly	clearly	RB	I-VP	O
demonstrated	demonstrate	VBN	I-VP	O
in	in	IN	B-PP	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
studies	study	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
in	in	FW	B-NP	O
vivo	vivo	FW	I-NP	O
studies	study	NNS	I-NP	O
have	have	VBP	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
reported	report	VBN	I-VP	O
yet	yet	RB	B-ADVP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
investigated	investigate	VBD	B-VP	O
whether	whether	IN	B-SBAR	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
hLF	hLF	NN	B-NP	B-protein
could	could	MD	B-VP	O
inhibit	inhibit	VB	I-VP	O
oral	oral	JJ	B-NP	O
infection	infection	NN	I-NP	O
of	of	IN	B-PP	O
listeria	listeria	NN	B-NP	O
in	in	IN	B-PP	O
BALB/c	BALB/c	NN	B-NP	O
mice	mouse	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
MICs	MIC	NNS	I-NP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
L.	L.	NNP	B-NP	O
monocytogenes	monocytogene	NNS	I-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
sensitive	sensitive	JJ	I-NP	O
strain	strain	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
animal	animal	NN	I-NP	O
work	work	NN	I-NP	O
.	.	.	O	O

hLF	hLF	NN	B-NP	B-protein
was	be	VBD	B-VP	O
administered	administer	VBN	I-VP	O
to	to	TO	B-PP	O
BALB/c	BALB/c	NN	B-NP	O
mice	mouse	NNS	I-NP	O
for	for	IN	B-PP	O
7	7	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
commencing	commence	VBG	B-VP	O
4	4	CD	B-NP	O
days	day	NNS	I-NP	O
before	before	IN	B-PP	O
oral	oral	JJ	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
hLF	hLF	NN	B-NP	B-protein
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
by	by	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
enumeration	enumeration	NN	I-NP	O
and	and	CC	O	O
histopathological	histopathological	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
and	and	CC	I-NP	O
spleen	spleen	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
well-known	well-known	JJ	B-ADJP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
targets	target	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
listeria	listeria	NN	I-NP	O
infection	infection	NN	I-NP	O
in	in	IN	B-PP	O
mice	mouse	NNS	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
enumeration	enumeration	NN	I-NP	O
,	,	,	O	O
hLF	hLF	NN	B-NP	B-protein
decreased	decrease	VBD	B-VP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
L.	L.	NNP	B-NP	B-cell_type
monocytogenes	monocytogene	NNS	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
.	.	.	O	O

Histopathologically	Histopathologically	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
size	size	NN	I-NP	O
and	and	CC	I-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
necrotic	necrotic	JJ	B-NP	O
foci	focus	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
samples	sample	NNS	I-NP	O
decreased	decrease	VBD	B-VP	O
with	with	IN	B-PP	O
hLF	hLF	NN	B-NP	O
administration	administration	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
changes	change	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
spleen	spleen	NN	I-NP	O
samples	sample	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
mRNA	mRNA	NN	I-NP	B-RNA
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
inflammatory	inflammatory	JJ	B-NP	B-protein
cytokines	cytokine	NNS	I-NP	I-protein
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
interleukin	interleukin	NN	B-NP	B-protein
(	(	(	O	I-protein
IL	IL	NN	B-NP	I-protein
)	)	)	O	I-protein
-1beta	-1beta	NN	B-NP	I-protein
,	,	,	O	O
tumour	tumour	NN	B-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	I-protein
TNF	TNF	NN	B-NP	I-protein
)	)	)	O	I-protein
-alpha	-alpha	NN	B-NP	I-protein
and	and	CC	O	O
interferon	interferon	NN	B-NP	B-protein
(	(	(	O	I-protein
IFN	IFN	NN	B-NP	I-protein
)	)	)	O	I-protein
-gamma	-gamma	NN	B-NP	I-protein
,	,	,	O	O
decreased	decrease	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
of	of	IN	B-PP	O
mice	mouse	NNS	B-NP	O
receiving	receive	VBG	B-VP	O
hLF	hLF	NN	B-NP	B-protein
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
has	have	VBZ	B-VP	O
shown	show	VBN	I-VP	O
that	that	IN	B-SBAR	O
hLF	hLF	NN	B-NP	B-protein
decreases	decrease	VBZ	B-VP	O
the	the	DT	B-NP	O
hepatic	hepatic	JJ	I-NP	O
colonization	colonization	NN	I-NP	O
of	of	IN	B-PP	O
L.	L.	NNP	B-NP	O
monocytogenes	monocytogene	NNS	I-NP	O
,	,	,	O	O
hepatic	hepatic	JJ	B-NP	O
necrosis	necrosis	NN	I-NP	O
and	and	CC	O	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
inflammatory	inflammatory	JJ	B-NP	B-protein
cytokines	cytokine	NNS	I-NP	I-protein
.	.	.	O	O

It	It	PRP	B-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
perorally	perorally	RB	B-NP	O
given	give	VBN	I-NP	O
hLF	hLF	NN	I-NP	B-protein
could	could	MD	B-VP	O
mediate	mediate	VB	I-VP	O
antimicrobial	antimicrobial	JJ	B-NP	O
and	and	CC	I-NP	O
anti-inflammatory	anti-inflammatory	JJ	I-NP	O
activities	activity	NNS	I-NP	O
remote	remote	VBP	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
gut	gut	NN	I-NP	O
(	(	(	O	O
i.e	i.e	JJ	B-ADJP	O
.	.	.	O	O

in	in	IN	B-PP	O
the	the	DT	B-NP	O
liver	liver	NN	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
mice	mouse	NNS	B-NP	O
challenged	challenge	VBN	B-VP	O
with	with	IN	B-PP	O
L.	L.	NNP	B-NP	O
monocytogenes	monocytogene	NNS	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
microcapsules	microcapsule	NNS	B-NP	B-cell_type
containing	contain	VBG	B-VP	I-cell_type
live	live	JJ	B-NP	I-cell_type
bacterial	bacterial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
has	have	VBZ	B-VP	O
potential	potential	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
alternative	alternative	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
article	article	NN	I-NP	O
evaluates	evaluate	VBZ	B-VP	O
the	the	DT	B-NP	O
suitability	suitability	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
alginate-poly-L-lysine-alginate	alginate-poly-L-lysine-alginate	NN	I-NP	O
(	(	(	O	O
APA	APA	NN	B-NP	O
)	)	)	O	O
microcapsules	microcapsule	NNS	B-NP	O
for	for	IN	B-PP	O
oral	oral	JJ	B-NP	O
delivery	delivery	NN	I-NP	O
of	of	IN	B-PP	O
live	live	JJ	B-NP	B-cell_type
bacterial	bacterial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
in-vitro	in-vitro	FW	B-NP	O
,	,	,	O	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
dynamic	dynamic	JJ	I-NP	O
simulated	simulate	VBN	I-NP	O
human	human	JJ	I-NP	O
gastro-intestinal	gastro-intestinal	JJ	I-NP	O
(	(	(	O	O
GI	GI	NN	B-NP	O
)	)	)	O	O
model	model	NN	B-NP	O
.	.	.	O	O

Results	Result	NNS	B-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
APA	APA	NN	I-NP	O
microcapsules	microcapsule	NNS	I-NP	O
were	be	VBD	B-VP	O
morphologically	morphologically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
simulated	simulated	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
conditions	condition	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
retain	retain	VB	I-VP	O
their	their	PRP$	B-NP	O
structural	structural	JJ	I-NP	O
integrity	integrity	NN	I-NP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
3-day	3-day	JJ	I-NP	O
exposure	exposure	NN	I-NP	O
in	in	IN	B-PP	O
simulated	simulate	VBN	B-NP	O
human	human	JJ	I-NP	O
GI	GI	NN	I-NP	O
media	medium	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
microbial	microbial	JJ	I-NP	B-cell_type
populations	population	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tested	test	VBN	I-NP	O
bacterial	bacterial	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
the	the	DT	B-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tested	test	VBN	I-NP	O
enzymes	enzyme	NNS	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
simulated	simulated	JJ	I-NP	O
human	human	JJ	I-NP	O
GI	GI	NN	I-NP	O
suspension	suspension	NN	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
substantially	substantially	RB	I-VP	O
altered	alter	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
APA	APA	NN	I-NP	O
microcapsules	microcapsule	NNS	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
adverse	adverse	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
APA	APA	NN	I-NP	O
microcapsules	microcapsule	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
flora	flora	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
gastrointestinal	gastrointestinal	JJ	I-NP	O
tract	tract	NN	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
the	the	DT	B-NP	O
APA	APA	NN	I-NP	O
microcapsules	microcapsule	NNS	I-NP	O
containing	contain	VBG	B-VP	O
Lactobacillus	Lactobacillus	NN	B-NP	O
plantarum	plantarum	NN	I-NP	O
80	80	CD	I-NP	O
(	(	(	O	O
LP80	LP80	NN	B-NP	B-protein
)	)	)	O	O
were	be	VBD	B-VP	O
challenged	challenge	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
simulated	simulated	JJ	I-NP	O
gastric	gastric	JJ	I-NP	O
medium	medium	NN	I-NP	O
(	(	(	O	O
pH	pH	NN	B-NP	O
=	=	SYM	B-VP	O
2.0	2.0	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
80.0	80.0	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
encapsulated	encapsulate	VBN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
remained	remain	VBD	B-VP	O
viable	viable	JJ	B-ADJP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
5-min	5-min	NN	I-NP	O
incubation	incubation	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
viability	viability	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
considerably	considerably	RB	B-ADVP	O
(	(	(	O	O
8.3	8.3	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
after	after	IN	B-PP	O
15	15	CD	B-NP	O
min	min	NN	I-NP	O
and	and	CC	O	O
dropped	drop	VBD	B-VP	O
to	to	TO	B-PP	O
2.6	2.6	CD	B-NP	O
%	%	NN	I-NP	O
after	after	IN	B-PP	O
30	30	CD	B-NP	O
min	min	NN	I-NP	O
and	and	CC	O	O
lower	low	JJR	B-ADJP	O
than	than	IN	B-PP	O
0.2	0.2	CD	B-NP	O
%	%	NN	I-NP	O
after	after	IN	B-PP	O
60	60	CD	B-NP	O
min	min	NN	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
the	the	DT	B-NP	O
limitations	limitation	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
currently	currently	RB	I-NP	O
obtainable	obtainable	JJ	I-NP	O
APA	APA	NN	I-NP	O
membrane	membrane	NN	I-NP	O
for	for	IN	B-PP	O
oral	oral	JJ	B-NP	O
delivery	delivery	NN	I-NP	O
of	of	IN	B-PP	O
live	live	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

Further	Further	RB	B-NP	O
in-vivo	in-vivo	FW	I-NP	O
studies	study	NNS	I-NP	O
are	be	VBP	B-VP	O
required	require	VBN	I-VP	O
before	before	IN	B-PP	O
conclusions	conclusion	NNS	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
made	make	VBN	I-VP	O
concerning	concern	VBG	B-PP	O
the	the	DT	B-NP	O
inadequacy	inadequacy	NN	I-NP	O
of	of	IN	B-PP	O
APA	APA	NN	B-NP	O
microcapsules	microcapsule	NNS	I-NP	O
for	for	IN	B-PP	O
oral	oral	JJ	B-NP	O
delivery	delivery	NN	I-NP	O
of	of	IN	B-PP	O
live	live	JJ	B-NP	B-cell_type
bacterial	bacterial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
microbiota	microbiota	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
influence	influence	NN	I-NP	O
of	of	IN	B-PP	O
Helicobacter	Helicobacter	NN	B-NP	O
pylori	pylori	NN	I-NP	O
colonization	colonization	NN	I-NP	O
on	on	IN	B-PP	O
its	its	PRP$	B-NP	O
composition	composition	NN	I-NP	O
remain	remain	VBP	B-VP	O
largely	largely	RB	B-ADJP	O
unknown	unknown	JJ	I-ADJP	O
.	.	.	O	O

We	We	PRP	B-NP	O
characterized	characterize	VBD	B-VP	O
bacterial	bacterial	JJ	B-NP	O
diversity	diversity	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
gastric	gastric	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
by	by	IN	B-PP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
subunit	subunit	NN	I-NP	O
16S	16S	NN	I-NP	O
rDNA	rDNA	NN	I-NP	O
clone	clone	NN	I-NP	O
library	library	NN	I-NP	O
approach	approach	NN	I-NP	O
and	and	CC	O	O
analyzed	analyze	VBD	B-VP	O
1,833	1,833	CD	B-NP	B-DNA
sequences	sequence	NNS	I-NP	I-DNA
generated	generate	VBN	B-VP	O
by	by	IN	B-PP	O
broad-range	broad-range	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
PCR	PCR	NN	I-NP	O
from	from	IN	B-PP	O
23	23	CD	B-NP	O
gastric	gastric	JJ	I-NP	O
endoscopic	endoscopic	JJ	I-NP	O
biopsy	biopsy	NN	I-NP	O
samples	sample	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
diverse	diverse	JJ	I-NP	O
community	community	NN	I-NP	O
of	of	IN	B-PP	O
128	128	CD	B-NP	O
phylotypes	phylotype	NNS	I-NP	O
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
,	,	,	O	O
featuring	feature	VBG	B-VP	O
diversity	diversity	NN	B-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
site	site	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
previously	previously	RB	B-ADVP	O
described	describe	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
majority	majority	NN	I-NP	O
of	of	IN	B-PP	O
sequences	sequence	NNS	B-NP	O
were	be	VBD	B-VP	O
assigned	assign	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Proteobacteria	Proteobacteria	NNP	I-NP	O
,	,	,	O	O
Firmicutes	Firmicutes	NNP	B-NP	O
,	,	,	O	O
Actinobacteria	Actinobacteria	NNP	B-NP	O
,	,	,	O	O
Bacteroidetes	Bacteroidetes	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Fusobacteria	Fusobacteria	NNP	B-NP	O
phyla	phyla	NN	I-NP	O
.	.	.	O	O

Ten	Ten	CD	B-NP	O
percent	percent	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
phylotypes	phylotype	NNS	I-NP	O
were	be	VBD	B-VP	O
previously	previously	RB	B-ADJP	O
uncharacterized	uncharacterized	JJ	I-ADJP	O
,	,	,	O	O
including	include	VBG	B-PP	O
a	a	DT	B-NP	O
Deinococcus-related	Deinococcus-related	JJ	I-NP	O
organism	organism	NN	I-NP	O
,	,	,	O	O
relatives	relative	NNS	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
extreme	extreme	JJ	B-NP	O
environments	environment	NNS	I-NP	O
but	but	CC	O	O
not	not	RB	B-VP	O
reported	report	VBN	I-VP	O
before	before	RB	B-ADVP	O
in	in	IN	B-PP	O
humans	human	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
gastric	gastric	JJ	I-NP	B-DNA
clone	clone	NN	I-NP	I-DNA
libraries	library	NNS	I-NP	I-DNA
from	from	IN	B-PP	O
19	19	CD	B-NP	O
subjects	subject	NNS	I-NP	O
contained	contain	VBD	B-VP	O
H.	H.	NN	B-NP	B-DNA
pylori	pylori	NN	I-NP	I-DNA
rDNA	rDNA	NN	I-NP	I-DNA
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
only	only	RB	B-NP	O
12	12	CD	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
subjects	subject	NNS	I-NP	O
tested	test	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
H.	H.	NN	B-NP	O
pylori	pylori	NN	I-NP	O
by	by	IN	B-PP	O
conventional	conventional	JJ	B-NP	O
laboratory	laboratory	NN	I-NP	O
methods	method	NNS	I-NP	O
.	.	.	O	O

Statistical	Statistical	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
intersubject	intersubject	JJ	B-NP	O
variability	variability	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gastric	gastric	JJ	I-NP	O
ecosystem	ecosystem	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
H.	H.	NN	B-NP	O
pylori	pylori	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
affect	affect	VB	I-VP	O
the	the	DT	B-NP	O
composition	composition	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gastric	gastric	JJ	I-NP	O
community	community	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
gastric	gastric	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
rDNA	rDNA	NN	I-NP	O
data	datum	NNS	I-NP	O
set	set	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
different	different	JJ	I-ADJP	O
from	from	IN	B-PP	O
sequence	sequence	NN	B-NP	O
collections	collection	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
mouth	mouth	NN	I-NP	O
and	and	CC	I-NP	O
esophagus	esophagus	NN	I-NP	O
described	describe	VBN	B-VP	O
in	in	IN	B-PP	O
other	other	JJ	B-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
home	home	RB	B-ADVP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
distinct	distinct	JJ	I-NP	O
microbial	microbial	JJ	I-NP	O
eco-system	eco-system	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
gastric	gastric	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
may	may	MD	B-VP	O
play	play	VB	I-VP	O
important	important	JJ	B-NP	O
,	,	,	I-NP	O
as-yet-undiscovered	as-yet-undiscovered	JJ	I-NP	O
roles	role	NNS	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
health	health	NN	I-NP	O
and	and	CC	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
work	work	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
study	study	VB	I-VP	O
clinical	clinical	JJ	B-NP	O
changes	change	NNS	I-NP	O
and	and	CC	I-NP	O
microorganisms	microorganism	NNS	I-NP	O
in	in	IN	B-PP	O
mouths	mouth	NNS	B-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
patient	patient	NN	I-NP	O
groups	group	NNS	I-NP	O
:	:	:	O	O
with	with	IN	B-PP	O
congenital	congenital	JJ	B-NP	O
disorders	disorder	NNS	I-NP	O
(	(	(	O	O
Cd	Cd	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
dialyzed	dialyze	VBN	B-VP	O
(	(	(	O	O
D	D	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
control	control	NN	B-NP	O
(	(	(	O	O
C	C	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Fifty	Fifty	CD	B-NP	O
five	five	CD	I-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
to	to	TO	I-NP	O
62	62	CD	I-NP	O
years	year	NNS	I-NP	O
old	old	JJ	B-ADJP	O
were	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
.	.	.	O	O

Swabs	Swab	NNS	B-NP	O
and	and	CC	I-NP	O
samples	sample	NNS	I-NP	O
of	of	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
tissue	tissue	NN	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
for	for	IN	B-PP	O
microscopical	microscopical	JJ	B-NP	O
study	study	NN	I-NP	O
to	to	TO	B-VP	O
detect	detect	VB	I-VP	O
of	of	IN	B-PP	O
protozoans	protozoan	NNS	B-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
and	and	CC	I-NP	O
fungal	fungal	JJ	I-NP	O
cultures	culture	NNS	I-NP	O
.	.	.	O	O

E.	E.	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
and	and	CC	O	O
T.	T.	NN	B-NP	O
tenax	tenax	NN	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

Three	Three	CD	B-NP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
Cd	Cd	NN	B-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
infected	infect	VBN	I-VP	O
with	with	IN	B-PP	O
Acanthamoeba	Acanthamoeba	NN	B-NP	O
sp..	sp..	NN	I-NP	O
Fecal	Fecal	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
more	more	RBR	B-ADVP	O
often	often	RB	I-ADVP	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
D	D	NN	B-NP	O
than	than	IN	B-PP	O
Cd	Cd	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
all	all	DT	B-NP	O
30-40	30-40	CD	I-NP	O
years	year	NNS	I-NP	O
old	old	JJ	B-NP	O
D	D	NN	I-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
fecal	fecal	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
various	various	JJ	B-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
C.	C.	NNP	B-NP	O
albicans	albicans	NNP	I-NP	O
occurred	occur	VBD	B-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
systemic	systemic	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
favour	favour	VBP	B-VP	O
instabilities	instability	NNS	B-NP	O
in	in	IN	B-PP	O
mouths	mouth	NNS	B-NP	O
changing	change	VBG	B-VP	O
interrelations	interrelation	NNS	B-NP	O
between	between	IN	B-PP	O
protozoa	protozoa	NN	B-NP	O
,	,	,	O	O
bacteria	bacteria	NNS	B-NP	O
and	and	CC	I-NP	O
fungi	fungus	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
may	may	MD	B-VP	O
increase	increase	VB	I-VP	O
risk	risk	NN	B-NP	O
of	of	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
complications	complication	NNS	I-NP	O
.	.	.	O	O

Artemisia	Artemisia	NNP	B-NP	O
princeps	princep	VBZ	B-VP	O
Pampanini	Pampanini	NNP	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
called	call	VBN	I-VP	O
Ssajuarissuk	Ssajuarissuk	NNP	B-NP	O
in	in	IN	B-PP	O
Korean	Korean	JJ	B-NP	O
(	(	(	O	O
SS-1	SS-1	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
was	be	VBD	B-VP	O
fermented	ferment	VBN	I-VP	O
with	with	IN	B-PP	O
lactic	lactic	JJ	B-NP	O
acid	acid	NN	I-NP	O
bacteria	bacteria	NNS	I-NP	O
(	(	(	O	O
LAB	LAB	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
passive	passive	JJ	I-NP	O
cutaneous	cutaneous	JJ	I-NP	O
anaphylaxis	anaphylaxis	NN	I-NP	O
reaction-inhibitory	reaction-inhibitory	JJ	I-NP	O
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
these	these	DT	B-NP	O
fermented	ferment	VBN	I-NP	O
agents	agent	NNS	I-NP	O
,	,	,	O	O
SS-1	SS-1	NN	B-NP	O
extract	extract	NN	I-NP	O
fermented	ferment	VBN	B-VP	O
with	with	IN	B-PP	O
Bifidobacterium	Bifidobacterium	NN	B-NP	O
infantis	infantis	NN	I-NP	O
K-525	K-525	NN	I-NP	O
(	(	(	O	O
F-SS-1	F-SS-1	NN	B-NP	O
)	)	)	O	O
most	most	RBS	B-ADVP	O
effectively	effectively	RB	I-ADVP	O
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
release	release	NN	I-NP	O
of	of	IN	B-PP	O
P-hexosamindase	P-hexosamindase	NN	B-NP	B-protein
from	from	IN	B-PP	O
RBL-2H3	RBL-2H3	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
induced	induce	VBD	B-VP	O
IgE	IgE	NN	B-NP	B-protein
.	.	.	O	O

In	In	IN	B-PP	O
IgE-induced	IgE-induced	JJ	B-NP	B-cell_line
RBL-2H3	RBL-2H3	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
F-SS-1	F-SS-1	NN	B-NP	O
inhibited	inhibit	VBD	B-VP	O
proinflammatory	proinflammatory	JJ	B-NP	B-protein
cytokines	cytokine	NNS	I-NP	I-protein
IL-6	IL-6	NN	I-NP	B-protein
and	and	CC	I-NP	O
TNF-alpha	TNF-alpha	NN	I-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
expression	expression	NN	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
SS-1	SS-1	NN	B-NP	B-protein
and	and	CC	I-NP	O
F-SS-1	F-SS-1	NN	I-NP	O
to	to	TO	B-PP	O
mice	mouse	NNS	B-NP	O
inhibited	inhibit	VBD	B-VP	O
passive	passive	JJ	B-NP	O
cutaneous	cutaneous	JJ	I-NP	O
anaphylaxis	anaphylaxis	NN	I-NP	O
(	(	(	O	O
PCA	PCA	NN	B-NP	O
)	)	)	O	O
reaction	reaction	NN	B-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
IgE	IgE	NN	B-NP	B-protein
and	and	CC	O	O
scratching	scratch	VBG	B-VP	O
behaviors	behavior	NNS	B-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
compound	compound	NN	B-NP	O
48/80	48/80	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
F-SS-1	F-SS-1	NN	B-NP	O
against	against	IN	B-PP	O
scratching	scratch	VBG	B-NP	O
behaviors	behavior	NNS	I-NP	O
was	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
effective	effective	JJ	I-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
SS-1	SS-1	NN	B-NP	B-protein
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
fermentation	fermentation	NN	I-NP	O
of	of	IN	B-PP	O
SS-1	SS-1	NN	B-NP	B-protein
with	with	IN	B-PP	O
LAB	LAB	NN	B-NP	B-protein
can	can	MD	B-VP	O
increase	increase	VB	I-VP	O
its	its	PRP$	B-NP	O
antiallergic	antiallergic	JJ	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

Squamous	Squamous	JJ	B-NP	O
cell	cell	NN	I-NP	O
carcinomas	carcinoma	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
aerodigestive	aerodigestive	JJ	I-NP	O
tract	tract	NN	I-NP	O
are	be	VBP	B-VP	O
a	a	DT	B-NP	O
global	global	JJ	I-NP	O
health-political	health-political	JJ	I-NP	O
challenge	challenge	NN	I-NP	O
.	.	.	O	O

Accordingly	Accordingly	RB	B-ADVP	O
,	,	,	O	O
current	current	JJ	B-NP	O
research	research	NN	I-NP	O
efforts	effort	NNS	I-NP	O
are	be	VBP	B-VP	O
aimed	aim	VBN	I-VP	O
towards	towards	IN	B-PP	O
the	the	DT	B-NP	O
opportunities	opportunity	NNS	I-NP	O
for	for	IN	B-PP	O
early	early	JJ	B-NP	O
recognition	recognition	NN	I-NP	O
of	of	IN	B-PP	O
risk	risk	NN	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
recognition	recognition	NN	I-NP	O
of	of	IN	B-PP	O
risk	risk	NN	B-NP	O
factors	factor	NNS	I-NP	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
carcinogenesis	carcinogenesis	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
determined	determine	VBD	B-VP	O
the	the	DT	B-NP	O
revertant	revertant	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
variety	variety	NN	I-NP	O
Salmonella	Salmonella	NNP	I-NP	O
typhimurium	typhimurium	NNP	I-NP	O
TA	TA	NN	I-NP	B-DNA
98	98	CD	I-NP	I-DNA
and	and	CC	O	O
TA	TA	NN	B-NP	O
100	100	CD	I-NP	O
after	after	IN	B-PP	O
incubation	incubation	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
saliva	saliva	NN	B-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
100	100	CD	B-NP	O
probands	proband	NNS	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
measure	measure	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
genotoxic	genotoxic	JJ	I-NP	O
environment	environment	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
,	,	,	O	O
depending	depend	VBG	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
dental	dental	JJ	I-NP	O
status	status	NN	I-NP	O
as	as	IN	B-PP	O
measure	measure	NN	B-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
health	health	NN	I-NP	O
.	.	.	O	O

Beside	Beside	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
alcohol	alcohol	NN	I-NP	O
(	(	(	O	O
p=0.032	p=0.032	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
tobacco	tobacco	NN	B-NP	O
consumption	consumption	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.001	0.001	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
dental	dental	JJ	I-NP	O
status	status	NN	I-NP	O
displayed	display	VBN	B-VP	O
in	in	IN	B-PP	O
partial	partial	JJ	B-NP	O
aspects	aspect	NNS	I-NP	O
(	(	(	O	O
high	high	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
index	index	NN	I-NP	O
,	,	,	O	O
high	high	JJ	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
decayed	decay	VBN	B-NP	O
teeth	tooth	NNS	I-NP	O
,	,	,	O	O
prosthetically	prosthetically	RB	B-VP	O
not	not	RB	I-VP	O
rehabilitated	rehabilitate	VBN	I-VP	O
status	status	NN	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
<	<	SYM	B-VP	O
or=	or=	NN	B-NP	O
0.050	0.050	CD	I-NP	O
)	)	)	O	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
connection	connection	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
genotoxic	genotoxic	JJ	I-NP	O
salivary	salivary	JJ	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
periodontal	periodontal	JJ	I-NP	O
status	status	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
type	type	NN	I-NP	O
of	of	IN	B-PP	O
restorative	restorative	JJ	B-NP	O
filling	filling	NN	I-NP	O
material	material	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
dental	dental	JJ	B-NP	O
prostheses	prosthesis	NNS	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
important	important	JJ	I-NP	O
influence	influence	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
revertant	revertant	JJ	I-NP	O
number	number	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
>	>	SYM	O	O
or=	or=	NN	B-NP	O
0.104	0.104	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
polymicrobial	polymicrobial	JJ	I-NP	O
supragingival	supragingival	JJ	I-NP	O
plaque	plaque	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	B-protein
independent	independent	JJ	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
,	,	,	O	O
possesses	possess	VBZ	B-VP	O
a	a	DT	B-NP	O
relevant	relevant	JJ	I-NP	O
mutagenic	mutagenic	JJ	I-NP	O
interaction	interaction	NN	I-NP	O
with	with	IN	B-PP	O
saliva	saliva	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
individual	individual	JJ	B-NP	O
oral	oral	JJ	I-NP	O
health	health	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
co-factor	co-factor	NN	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
carcinomas	carcinoma	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
microbiota	microbiota	NN	I-NP	O
of	of	IN	B-PP	O
noncaries	noncary	NNS	B-NP	O
associated	associate	VBN	B-VP	O
supra-gingival	supra-gingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
(	(	(	O	O
SGP	SGP	NN	B-NP	O
)	)	)	O	O
microbiology	microbiology	NN	B-NP	O
in	in	IN	B-PP	O
Sjogren	Sjogren	NN	B-NP	O
's	's	POS	B-NP	O
syndrome	syndrome	NN	I-NP	O
(	(	(	O	O
SS	SS	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Stimulated	Stimulated	JJ	B-NP	O
whole	whole	JJ	I-NP	O
saliva	saliva	NN	I-NP	O
(	(	(	O	O
SWS	SWS	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
full-mouth	full-mouth	JJ	B-NP	O
SGP	SGP	NN	I-NP	O
on	on	IN	B-PP	O
intact	intact	JJ	B-NP	O
tooth	tooth	JJ	I-NP	O
surfaces	surface	NNS	I-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
from	from	IN	B-PP	O
26	26	CD	B-NP	O
primary	primary	JJ	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
)	)	)	O	O
SS	SS	NN	B-NP	O
,	,	,	O	O
27	27	CD	B-NP	O
secondary	secondary	JJ	I-NP	O
(	(	(	I-NP	O
s	s	JJ	I-NP	O
)	)	)	O	O
SS	SS	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
29	29	CD	B-NP	O
control	control	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
for	for	IN	B-PP	O
selective	selective	JJ	B-NP	O
culture	culture	NN	I-NP	O
of	of	IN	B-PP	O
lactobacilli	lactobacilli	NN	B-NP	O
,	,	,	O	O
mutans	mutan	NNS	B-NP	O
streptococci	streptococci	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
aerobic	aerobic	JJ	B-NP	O
and	and	CC	I-NP	O
facultatively	facultatively	RB	I-NP	O
anaerobic	anaerobic	JJ	I-NP	O
gram-negative	gram-negative	JJ	I-NP	O
rods	rod	NNS	I-NP	O
(	(	(	O	O
AGNR	AGNR	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

Predominant	Predominant	JJ	B-NP	O
cultivable	cultivable	JJ	I-NP	O
anaerobes	anaerobe	NNS	I-NP	O
from	from	IN	B-PP	O
SGP	SGP	NN	B-NP	O
of	of	IN	B-PP	O
11	11	CD	B-NP	O
randomly	randomly	RB	I-NP	O
selected	select	VBN	I-NP	O
subjects	subject	NNS	I-NP	O
from	from	IN	B-PP	O
each	each	DT	B-NP	O
group	group	NN	I-NP	O
were	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
.	.	.	O	O

Clinical	Clinical	JJ	B-NP	O
and	and	CC	I-NP	O
sialometric	sialometric	JJ	I-NP	O
data	datum	NNS	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
collected	collect	VBN	I-VP	O
.	.	.	O	O

SS	SS	NN	B-NP	O
sufferers	sufferer	NNS	I-NP	O
had	have	VBD	B-VP	O
significantly	significantly	RB	B-NP	O
lower	low	JJR	I-NP	O
SWS	SWS	NN	I-NP	O
flow	flow	NN	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
higher	high	JJR	B-NP	O
mean	mean	JJ	I-NP	O
DMFT	DMFT	NN	I-NP	O
(	(	(	O	O
decayed	decay	VBN	B-VP	O
,	,	,	O	O
missing	miss	VBG	B-VP	O
,	,	,	O	O
filled	fill	VBN	B-NP	O
teeth	tooth	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
while	while	IN	B-SBAR	O
pSS	pSS	NN	B-NP	O
subjects	subject	NNS	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
lower	low	JJR	B-NP	O
SWS	SWS	NN	I-NP	O
pH	pH	NN	I-NP	O
and	and	CC	O	O
fewer	few	JJR	B-NP	O
standing	standing	JJ	I-NP	O
teeth	tooth	NNS	I-NP	O
.	.	.	O	O

Lactobacillus	Lactobacillus	NN	B-NP	O
acidophilus	acidophilus	NN	I-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
SWS	SWS	NN	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
0.012	0.012	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
SGP	SGP	NN	B-NP	B-protein
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
0.0001	0.0001	CD	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
elevated	elevate	VBN	I-VP	O
in	in	IN	B-PP	O
pSS	pSS	NN	B-NP	O
sufferers	sufferer	NNS	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
sSS	sSS	NN	B-NP	O
individuals	individual	NNS	I-NP	O
and	and	CC	I-NP	O
controls	control	NNS	I-NP	O
.	.	.	O	O

AGNR	AGNR	NN	B-NP	O
isolation	isolation	NN	I-NP	O
was	be	VBD	B-VP	O
uncommon	uncommon	JJ	B-ADJP	O
.	.	.	O	O

SS	SS	NN	B-NP	O
sufferers	sufferer	NNS	I-NP	O
had	have	VBD	B-VP	O
significantly	significantly	RB	B-NP	O
lower	low	JJR	I-NP	O
proportion	proportion	NN	I-NP	O
of	of	IN	B-PP	O
gram-negative	gram-negative	JJ	B-NP	O
species	specie	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
0.047	0.047	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Non-oral	Non-oral	JJ	B-NP	O
species	specie	NNS	I-NP	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
in	in	IN	B-PP	O
greater	great	JJR	B-NP	O
proportions	proportion	NNS	I-NP	O
from	from	IN	B-PP	O
pSS	pSS	NN	B-NP	O
SGP	SGP	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
0.007	0.007	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Subjects	Subject	NNS	B-NP	O
with	with	IN	B-PP	O
pSS	pSS	NN	B-NP	O
harbored	harbor	VBD	B-VP	O
increased	increase	VBN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
L.	L.	NNP	B-NP	O
acidophilus	acidophilus	NN	I-NP	O
and	and	CC	O	O
non-oral	non-oral	JJ	B-NP	B-protein
species	specie	NNS	I-NP	I-protein
,	,	,	O	O
while	while	IN	B-SBAR	O
SS	SS	NN	B-NP	O
sufferers	sufferer	NNS	I-NP	O
generally	generally	RB	B-ADVP	O
had	have	VBD	B-VP	O
lower	low	JJR	B-NP	O
proportions	proportion	NNS	I-NP	O
of	of	IN	B-PP	O
gram-negative	gram-negative	JJ	B-NP	B-protein
species	specie	NNS	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
microbial	microbial	JJ	I-NP	O
composition	composition	NN	I-NP	O
of	of	IN	B-PP	O
noncaries	noncary	NNS	B-NP	O
associated	associate	VBN	B-VP	O
SGP	SGP	NN	B-NP	O
indicates	indicate	VBZ	B-VP	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
increased	increase	VBN	B-NP	O
caries	cary	NNS	I-NP	O
risk	risk	NN	I-NP	O
in	in	IN	B-PP	O
SS	SS	NN	B-NP	O
.	.	.	O	O

New	New	JJ	B-NP	O
molecules	molecule	NNS	I-NP	O
were	be	VBD	B-VP	O
designed	design	VBN	I-VP	O
for	for	IN	B-PP	O
efficient	efficient	JJ	B-NP	O
intra-oral	intra-oral	JJ	I-NP	O
delivery	delivery	NN	I-NP	O
of	of	IN	B-PP	O
antimicrobials	antimicrobial	NNS	B-NP	O
to	to	TO	B-VP	O
prevent	prevent	VB	I-VP	O
and	and	CC	I-VP	O
treat	treat	VB	I-VP	O
oral	oral	JJ	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
salivary	salivary	JJ	I-NP	B-DNA
statherin	statherin	NN	I-NP	I-DNA
fragment	fragment	NN	I-NP	I-DNA
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
high	high	JJ	B-NP	O
affinity	affinity	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
tooth	tooth	JJ	I-NP	O
enamel	enamel	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
carrier	carrier	NN	I-NP	O
peptide	peptide	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
linked	link	VBN	I-VP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
side	side	NN	I-NP	O
chain	chain	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
N-terminal	N-terminal	JJ	I-NP	B-protein
residue	residue	NN	I-NP	I-protein
to	to	TO	B-PP	O
the	the	DT	B-NP	O
C-terminus	C-terminus	NN	I-NP	B-protein
of	of	IN	B-PP	O
a	a	DT	B-NP	O
defensin-like	defensin-like	JJ	I-NP	O
12-residue	12-residue	JJ	I-NP	O
peptide	peptide	NN	I-NP	O
to	to	TO	B-VP	O
generate	generate	VB	I-VP	O
two	two	CD	B-NP	O
bifunctional	bifunctional	JJ	I-NP	O
hybrid	hybrid	NN	I-NP	O
molecules	molecule	NNS	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ester	ester	NN	I-NP	O
linkage	linkage	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
anhydride	anhydride	NN	I-NP	O
bond	bond	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
carrier	carrier	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	B-protein
components	component	NNS	I-NP	I-protein
.	.	.	O	O

They	They	PRP	B-NP	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
for	for	IN	B-PP	O
their	their	PRP$	B-NP	O
affinity	affinity	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
HAP	HAP	NN	I-NP	B-protein
(	(	(	O	O
hydroxyapatite	hydroxyapatite	NN	B-NP	O
)	)	)	O	O
surface	surface	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
extent	extent	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
release	release	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
whole	whole	JJ	I-NP	O
saliva	saliva	NN	I-NP	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
using	use	VBG	B-VP	O
13C-NMR	13C-NMR	NN	B-NP	O
spectroscopy	spectroscopy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
candidacidal	candidacidal	NN	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
molecules	molecule	NNS	I-NP	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
release	release	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
carrier	carrier	NN	I-NP	O
peptide	peptide	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
saliva	saliva	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
hybrid-adsorbed	hybrid-adsorbed	JJ	I-NP	O
HAP	HAP	NN	I-NP	O
surface	surface	NN	I-NP	O
was	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
against	against	IN	B-PP	O
Candida	Candida	NNP	B-NP	O
albicans	albicans	NNP	I-NP	O
and	and	CC	O	O
Aggregatibacter	Aggregatibacter	NNP	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
fluorescence	fluorescence	NN	I-NP	O
technique	technique	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
bifunctional	bifunctional	JJ	I-NP	B-protein
molecules	molecule	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
on	on	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
erythrocytes	erythrocyte	NNS	I-NP	I-cell_type
,	,	,	O	O
GECs	GEC	NNS	B-NP	B-cell_type
(	(	(	O	O
gingival	gingival	JJ	B-NP	B-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
)	)	)	O	O
and	and	CC	O	O
GFCs	GFC	NNS	B-NP	B-cell_type
(	(	(	O	O
gingival	gingival	JJ	B-NP	B-cell_type
fibroblast	fibroblast	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
)	)	)	O	O
for	for	IN	B-PP	O
cytotoxicity	cytotoxicity	NN	B-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
possess	possess	VB	I-VP	O
high	high	JJ	B-NP	O
affinity	affinity	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
HAP	HAP	NN	I-NP	O
mineral	mineral	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
human	human	JJ	B-NP	O
whole	whole	JJ	I-NP	O
saliva	saliva	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
sustained	sustained	JJ	I-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
release	release	NN	I-NP	O
over	over	IN	B-PP	O
a	a	DT	B-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
40-60	40-60	CD	I-NP	O
h	h	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
candidacidal	candidacidal	NN	B-NP	O
activity	activity	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
extent	extent	NN	I-NP	O
of	of	IN	B-PP	O
hybrid	hybrid	NN	B-NP	O
dissociation	dissociation	NN	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
bifunctional	bifunctional	JJ	I-NP	O
peptide-bound	peptide-bound	JJ	I-NP	O
HAP	HAP	NN	I-NP	O
surface	surface	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
exhibit	exhibit	VB	I-VP	O
antimicrobial	antimicrobial	JJ	B-NP	O
activity	activity	NN	I-NP	O
when	when	WRB	B-ADVP	O
suspended	suspend	VBN	B-VP	O
in	in	IN	B-PP	O
clarified	clarify	VBN	B-NP	O
human	human	JJ	I-NP	O
saliva	saliva	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
hybrid	hybrid	NN	I-NP	O
peptides	peptide	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
show	show	VB	I-VP	O
any	any	DT	B-NP	O
toxic	toxic	JJ	I-NP	O
influence	influence	NN	I-NP	O
on	on	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
erythrocytes	erythrocyte	NNS	I-NP	I-cell_type
,	,	,	I-NP	O
GECs	GEC	NNS	I-NP	B-cell_type
and	and	CC	I-NP	O
GFCs	GFC	NNS	I-NP	B-protein
.	.	.	O	O

These	These	DT	B-NP	O
novel	novel	JJ	I-NP	O
hybrids	hybrid	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
safely	safely	RB	I-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
deliver	deliver	VB	I-VP	O
therapeutic	therapeutic	JJ	B-NP	O
agents	agent	NNS	I-NP	O
intra-orally	intra-orally	RB	B-ADVP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
and	and	CC	I-NP	O
prevention	prevention	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
infectious	infectious	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

Human	Human	JJ	B-NP	B-protein
papillomavirus	papillomavirus	NN	I-NP	I-protein
type	type	NN	I-NP	I-protein
16	16	CD	I-NP	I-protein
L1	L1	NN	I-NP	I-protein
(	(	(	O	O
HPV16	HPV16	NN	B-NP	O
L1	L1	NN	I-NP	O
)	)	)	O	O
has	have	VBZ	B-VP	O
shown	show	VBN	I-VP	O
considerable	considerable	JJ	B-NP	O
promise	promise	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
parenteral	parenteral	JJ	I-NP	O
vaccine	vaccine	NN	I-NP	O
for	for	IN	B-PP	O
prevention	prevention	NN	B-NP	O
of	of	IN	B-PP	O
cervical	cervical	JJ	B-NP	O
cancers	cancer	NNS	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
report	report	VBP	B-VP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
vaccination	vaccination	NN	I-NP	O
for	for	IN	B-PP	O
HPV16	HPV16	NN	B-NP	O
L1	L1	NN	I-NP	O
using	use	VBG	B-VP	O
Lactococcus	Lactococcus	NN	B-NP	O
lactis	lactis	NN	I-NP	O
(	(	(	O	O
L.	L.	NNP	B-NP	O
lactis	lactis	NNP	I-NP	O
)	)	)	O	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
live	live	JJ	I-NP	O
vector	vector	NN	I-NP	O
.	.	.	O	O

L.	L.	FW	B-NP	O
lactis	lactis	FW	I-NP	O
MG1363	MG1363	NN	I-NP	O
was	be	VBD	B-VP	O
transformed	transform	VBN	I-VP	O
with	with	IN	B-PP	O
two	two	CD	B-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
HPV16	HPV16	NN	B-NP	B-DNA
L1-encoding	L1-encoding	JJ	I-NP	I-DNA
plasmids	plasmid	NNS	I-NP	I-DNA
for	for	IN	B-PP	O
intracellular	intracellular	JJ	B-NP	O
expression	expression	NN	I-NP	O
or	or	CC	I-NP	O
secretion	secretion	NN	I-NP	O
.	.	.	O	O

L.	L.	NN	B-NP	O
lactis	lactis	NN	I-NP	O
transformed	transform	VBN	B-VP	O
with	with	IN	B-PP	O
HPV16	HPV16	NN	B-NP	B-DNA
L1-encoding	L1-encoding	JJ	I-NP	I-DNA
plasmids	plasmid	NNS	I-NP	I-DNA
retained	retain	VBD	B-VP	O
biochemical	biochemical	JJ	B-NP	O
lactic	lactic	JJ	I-NP	O
acid	acid	NN	I-NP	O
production	production	NN	I-NP	O
capability	capability	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
mucosal	mucosal	JJ	I-NP	O
and	and	CC	I-NP	O
systemic	systemic	JJ	I-NP	O
immune	immune	JJ	I-NP	O
responses	response	NNS	I-NP	O
were	be	VBD	B-VP	O
affected	affect	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
cellular	cellular	JJ	I-NP	O
location	location	NN	I-NP	O
of	of	IN	B-PP	O
expressed	express	VBN	B-NP	O
HPV16	HPV16	NN	I-NP	B-protein
L1	L1	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
in	in	IN	B-PP	O
L.	L.	NNP	B-NP	O
lactis	lactis	NNP	I-NP	O
.	.	.	O	O

Serum	Serum	NN	B-NP	O
IgG	IgG	NN	I-NP	O
responses	response	NNS	I-NP	O
were	be	VBD	B-VP	O
induced	induce	VBN	I-VP	O
after	after	IN	B-PP	O
oral	oral	JJ	B-NP	O
immunizations	immunization	NNS	I-NP	O
of	of	IN	B-PP	O
L.	L.	NNP	B-NP	O
lactis	lactis	NN	I-NP	O
secreting	secrete	VBG	B-VP	O
HPV16	HPV16	NN	B-NP	O
L1	L1	NN	I-NP	O
.	.	.	O	O

Vaginal	Vaginal	JJ	B-NP	O
IgA	IgA	NN	I-NP	O
immune	immune	JJ	I-NP	O
responses	response	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
following	follow	VBG	B-PP	O
oral	oral	JJ	B-NP	O
immunization	immunization	NN	I-NP	O
with	with	IN	B-PP	O
L.	L.	NNP	B-NP	O
lactis	lactis	NN	I-NP	O
expressing	express	VBG	B-VP	O
HPV16	HPV16	NN	B-NP	O
L1	L1	NN	I-NP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
intracellular	intracellular	JJ	I-NP	O
form	form	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	B-PP	O
with	with	IN	I-PP	O
L.	L.	NNP	B-NP	O
lactis	lactis	NN	I-NP	O
secreting	secrete	VBG	B-VP	O
HPV16	HPV16	NN	B-NP	O
L1	L1	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
induction	induction	NN	B-NP	O
of	of	IN	B-PP	O
HPV16	HPV16	NN	B-NP	O
L1-specific	L1-specific	JJ	I-NP	O
mucosal	mucosal	JJ	I-NP	O
immune	immune	JJ	I-NP	O
responses	response	NNS	I-NP	O
was	be	VBD	B-VP	O
affected	affect	VBN	I-VP	O
by	by	IN	B-PP	O
immunization	immunization	NN	B-NP	O
frequency	frequency	NN	I-NP	O
.	.	.	O	O

Six	Six	CD	B-NP	O
immunizations	immunization	NNS	I-NP	O
over	over	IN	B-PP	O
5	5	CD	B-NP	O
weeks	week	NNS	I-NP	O
were	be	VBD	B-VP	O
required	require	VBN	I-VP	O
to	to	TO	I-VP	O
induce	induce	VB	I-VP	O
vaginal	vaginal	JJ	B-NP	O
immune	immune	JJ	I-NP	O
responses	response	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
HPV16	HPV16	NN	B-NP	O
L1-specific	L1-specific	JJ	I-NP	O
vaginal	vaginal	JJ	I-NP	O
IgA	IgA	NN	I-NP	B-protein
were	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
until	until	IN	B-PP	O
12	12	CD	B-NP	O
weeks	week	NNS	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
vaccination	vaccination	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
the	the	DT	B-NP	O
feasibility	feasibility	NN	I-NP	O
of	of	IN	B-PP	O
L.	L.	NNP	B-NP	O
lactis	lactis	NNP	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
oral	oral	JJ	I-NP	O
vaccine	vaccine	NN	I-NP	O
vehicle	vehicle	NN	I-NP	O
of	of	IN	B-PP	O
HPV16	HPV16	NN	B-NP	O
L1	L1	NN	I-NP	O
and	and	CC	O	O
demonstrate	demonstrate	VBP	B-VP	O
the	the	DT	B-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
cellular	cellular	JJ	B-NP	O
loci	locus	NNS	I-NP	O
of	of	IN	B-PP	O
expressed	express	VBN	B-NP	O
antigen	antigen	NN	I-NP	O
for	for	IN	B-PP	O
induction	induction	NN	B-NP	O
of	of	IN	B-PP	O
vaginal	vaginal	JJ	B-NP	O
and	and	CC	I-NP	O
systemic	systemic	JJ	I-NP	O
immune	immune	JJ	I-NP	O
responses	response	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
purpose	purpose	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
examine	examine	VB	I-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
in	in	IN	B-PP	O
synovial	synovial	JJ	B-NP	B-cell_type
fluids	fluid	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
temporomandibular	temporomandibular	JJ	B-NP	O
joint	joint	JJ	I-NP	O
disorder	disorder	NN	I-NP	O
(	(	(	O	O
TMD	TMD	NN	B-NP	O
)	)	)	O	O
by	by	IN	B-PP	O
polymerase	polymerase	NN	B-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
(	(	(	O	O
PCR	PCR	NN	B-NP	O
)	)	)	O	O
targeting	target	VBG	B-VP	O
the	the	DT	B-NP	O
16S	16S	NN	I-NP	B-DNA
ribosomal	ribosomal	JJ	I-NP	I-DNA
RNA	RNA	NN	I-NP	I-DNA
(	(	(	O	I-DNA
rRNA	rRNA	NN	B-NP	I-DNA
)	)	)	O	I-DNA
gene	gene	NN	B-NP	I-DNA
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
cloning	cloning	NN	B-NP	O
and	and	CC	I-NP	O
sequencing	sequencing	NN	I-NP	O
.	.	.	O	O

Universal	Universal	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
primers	primer	NNS	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
amplify	amplify	VB	I-VP	O
16S	16S	NN	B-NP	B-DNA
rRNA	rRNA	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
28	28	CD	B-NP	O
synovial	synovial	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
27	27	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
TMD	TMD	NN	B-NP	O
(	(	(	O	O
TMD	TMD	NN	B-NP	O
group	group	NN	I-NP	O
)	)	)	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
control	control	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
dislocation	dislocation	NN	B-NP	O
of	of	IN	B-PP	O
TMJ	TMJ	NN	B-NP	B-protein
(	(	(	O	O
non-TMD	non-TMD	JJ	B-NP	O
group	group	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Subsequently	Subsequently	RB	B-ADVP	O
,	,	,	O	O
PCR	PCR	NN	B-NP	O
amplicons	amplicon	NNS	I-NP	O
were	be	VBD	B-VP	O
purified	purify	VBN	I-VP	O
and	and	CC	O	O
cloned	clone	VBN	B-VP	O
.	.	.	O	O

Partial	Partial	JJ	B-NP	O
16S	16S	NN	I-NP	B-DNA
rRNA	rRNA	NN	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cloned	clone	VBN	I-NP	O
insert	insert	NN	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
species	species	NN	I-NP	O
identities	identity	NNS	I-NP	O
or	or	CC	O	O
closest	close	JJS	B-ADJP	O
relative	relative	JJ	I-ADJP	O
by	by	IN	B-PP	O
comparison	comparison	NN	B-NP	O
with	with	IN	B-PP	O
known	known	JJ	B-NP	O
sequences	sequence	NNS	I-NP	O
using	use	VBG	B-VP	O
GeneBank	GeneBank	NNP	B-NP	O
.	.	.	O	O

Nineteen	Nineteen	CD	B-NP	O
(	(	(	O	O
67.86	67.86	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
28	28	CD	B-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
TMD	TMD	NN	I-NP	O
group	group	NN	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
by	by	IN	B-PP	O
PCR	PCR	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
5	5	CD	I-NP	O
control	control	NN	I-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
nonTMD	nonTMD	NN	I-NP	O
group	group	NN	I-NP	O
were	be	VBD	B-VP	O
all	all	DT	O	O
negative	negative	JJ	B-ADJP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
cloning	cloning	NN	B-NP	O
and	and	CC	I-NP	O
sequencing	sequencing	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
11	11	CD	B-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
,	,	,	O	O
including	include	VBG	B-PP	O
Granulicatella	Granulicatella	NNP	B-NP	O
adiacen	adiacen	NN	I-NP	O
(	(	(	O	O
6	6	CD	B-NP	O
samples	sample	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
Pseudomonas	Pseudomonas	NN	B-NP	O
sp	sp	NN	I-NP	O
.	.	.	O	O

(	(	(	O	O
6	6	CD	B-NP	O
samples	sample	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
Methylobacterium	Methylobacterium	NN	B-NP	O
sp	sp	NN	I-NP	O
.	.	.	O	O

(	(	(	O	O
5	5	CD	B-NP	O
samples	sample	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
Beta	Beta	NN	B-NP	O
proteobacterium	proteobacterium	NN	I-NP	O
(	(	(	O	O
4	4	CD	B-NP	O
samples	sample	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O

Other	Other	JJ	B-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
Acidovorax	Acidovorax	NNP	B-NP	O
sp.	sp.	NNP	I-NP	O
,	,	,	O	O
Bradyrhizobium	Bradyrhizobium	NNP	B-NP	O
sp.	sp.	NNP	I-NP	O
,	,	,	O	O
Sphingomonas	Sphingomonas	NNP	B-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
,	,	,	O	O
Leptothrix	Leptothrix	NNP	B-NP	O
sp	sp	NN	I-NP	O
.	.	.	O	O

oral	oral	JJ	B-NP	O
clone	clone	NN	I-NP	O
,	,	,	O	O
Thiobacillus	Thiobacillus	NN	B-NP	O
denitrificans	denitrifican	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Comamonadaceae	Comamonadaceae	NNP	B-NP	O
bacterium	bacterium	NN	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
identified	identify	VBN	I-VP	O
.	.	.	O	O

Eight	Eight	CD	B-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
with	with	IN	B-PP	O
mixed	mixed	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
2-4	2-4	CD	B-NP	O
bacteria	bacteria	NNS	I-NP	O
per	per	IN	B-PP	O
sample	sample	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
fastidious	fastidious	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
Granulicatella	Granulicatella	NNP	B-NP	O
adiacen	adiacen	NN	I-NP	O
and	and	CC	O	O
mixed	mixed	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
likely	likely	JJ	I-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
older	old	JJR	B-ADJP	O
than	than	IN	B-PP	O
45	45	CD	B-NP	O
years	year	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	JJR	B-NP	O
.05	.05	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

A	A	DT	B-NP	O
wide	wide	JJ	I-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
some	some	DT	B-NP	O
not	not	RB	B-VP	O
previously	previously	RB	I-VP	O
reported	report	VBN	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
TMD	TMD	NN	B-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
synovial	synovial	JJ	I-NP	B-cell_type
fluids	fluid	NNS	I-NP	I-cell_type
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
TMD	TMD	NN	B-NP	O
.	.	.	O	O

Actinomyces	Actinomyce	NNS	B-NP	O
are	be	VBP	B-VP	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
indigenous	indigenous	JJ	I-NP	O
oral	oral	JJ	I-NP	O
microbiota	microbiota	NNS	I-NP	O
which	which	WDT	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
implicated	implicate	VBN	I-VP	O
in	in	IN	B-PP	O
root	root	NN	B-NP	O
caries	cary	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
their	their	PRP$	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
childhood	childhood	NN	B-NP	O
caries	cary	NNS	I-NP	O
initiation	initiation	NN	I-NP	O
and	and	CC	I-NP	O
progression	progression	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
well-understood	well-understood	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
distribution	distribution	NN	I-NP	O
of	of	IN	B-PP	O
Actinomyces	Actinomyce	NNS	B-NP	O
in	in	IN	B-PP	O
supragingival	supragingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
teeth	tooth	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
oral	oral	JJ	B-NP	O
Actinomyces	Actinomyce	NNS	I-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

and	and	CC	O	O
childhood	childhood	NN	B-NP	O
caries	cary	NNS	I-NP	O
primarily	primarily	RB	B-ADVP	O
were	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
.	.	.	O	O

Forty	Forty	CD	B-NP	O
children	child	NNS	I-NP	O
aged	age	VBN	B-VP	O
from	from	IN	B-PP	O
three	three	CD	B-NP	O
to	to	TO	I-NP	O
five	five	CD	I-NP	O
years	year	NNS	I-NP	O
old	old	JJ	B-ADJP	O
were	be	VBD	B-VP	O
divided	divide	VBN	I-VP	O
into	into	IN	B-PP	O
two	two	CD	B-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

Twenty	Twenty	CD	B-NP	O
children	child	NNS	I-NP	O
were	be	VBD	B-VP	O
caries-free	caries-free	JJ	B-ADJP	O
and	and	CC	O	O
twenty	twenty	CD	B-NP	O
were	be	VBD	B-VP	O
caries-susceptible	caries-susceptible	JJ	B-ADJP	O
.	.	.	O	O

Dental	Dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
different	different	JJ	B-NP	O
places	place	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
teeth	tooth	NNS	I-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
with	with	IN	B-PP	O
sterile	sterile	JJ	B-NP	O
toothpick	toothpick	NN	I-NP	O
and	and	CC	I-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
with	with	IN	B-PP	O
specific	specific	JJ	B-NP	O
primers	primer	NNS	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
designed	design	VBN	I-VP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
research	research	NN	I-NP	O
.	.	.	O	O

Actinomyces	Actinomyce	NNS	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
caries-free	caries-free	JJ	I-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
caries-susceptible	caries-susceptible	JJ	I-NP	O
group	group	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
differences	difference	NNS	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
groups	group	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
>	>	JJR	B-NP	O
0.05	0.05	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

Actinomyces	Actinomyces	NNP	B-NP	O
naeslundii	naeslundii	NNP	I-NP	O
,	,	,	O	O
Actinomyces	Actinomyces	NNP	B-NP	O
odontolyticus	odontolyticus	NNP	I-NP	O
,	,	,	O	O
Actinomyces	Actinomyces	NNP	B-NP	O
gerencseriae	gerencseriae	NNP	I-NP	O
,	,	,	O	O
Actinomyces	Actinomyces	NNP	B-NP	O
israelii	israelii	NNP	I-NP	O
and	and	CC	I-NP	O
Actinomyces	Actinomyces	NNP	I-NP	O
viscosus	viscosus	IN	B-PP	O
all	all	DT	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
Actinomyces	Actinomyces	NNP	B-NP	O
naeslundii	naeslundii	NNP	I-NP	O
,	,	,	O	O
Actinomyces	Actinomyces	NNP	B-NP	O
gerencseriae	gerencseriae	NNP	I-NP	O
and	and	CC	O	O
Actinomyces	Actinomyces	NNP	B-NP	O
odontolyticus	odontolyticus	NN	I-NP	O
were	be	VBD	B-VP	O
higher	high	JJR	B-ADJP	O
in	in	IN	B-PP	O
caries-free	caries-free	JJ	B-NP	O
group	group	NN	I-NP	O
than	than	IN	B-PP	O
those	those	DT	B-NP	O
in	in	IN	B-PP	O
caries-susceptible	caries-susceptible	JJ	B-NP	O
group	group	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
Actinomyces	Actinomyces	NNP	B-NP	O
israelii	israelii	NN	I-NP	O
and	and	CC	O	O
Actinomyces	Actinomyces	NNP	B-NP	O
viscosus	viscosus	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
difference	difference	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
groups	group	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
>	>	JJR	B-NP	O
0.05	0.05	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

Actinomyces	Actinomyce	NNS	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
main	main	JJ	I-NP	O
colonized	colonize	VBN	I-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
supragingival	supragingival	JJ	I-NP	O
plaque	plaque	NN	I-NP	O
of	of	IN	B-PP	O
children	child	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Actinomyces	Actinomyces	NNP	I-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

may	may	MD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
relationship	relationship	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
childhood	childhood	NN	I-NP	O
caries	cary	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
nothing	nothing	NN	B-NP	O
to	to	TO	B-VP	O
do	do	VB	I-VP	O
with	with	IN	B-PP	O
different	different	JJ	B-NP	O
places	place	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
teeth	tooth	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
vaccines	vaccine	NNS	B-NP	O
against	against	IN	B-PP	O
infectious	infectious	JJ	B-NP	O
microbes	microbe	NNS	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
critical	critical	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
advancement	advancement	NN	I-NP	O
of	of	IN	B-PP	O
medicine	medicine	NN	B-NP	O
.	.	.	O	O

Vaccine	Vaccine	NN	B-NP	O
strategies	strategy	NNS	I-NP	O
combined	combine	VBN	B-VP	O
with	with	IN	B-PP	O
,	,	,	O	O
or	or	CC	O	O
without	without	IN	B-PP	O
,	,	,	O	O
adjuvants	adjuvant	NNS	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
established	establish	VBN	I-VP	O
to	to	TO	I-VP	O
eradicate	eradicate	VB	I-VP	O
various	various	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
and	and	CC	I-NP	O
viral	viral	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
new	new	JJ	I-NP	O
generation	generation	NN	I-NP	O
of	of	IN	B-PP	O
vaccines	vaccine	NNS	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
developed	develop	VBN	I-VP	O
using	use	VBG	B-VP	O
specific	specific	JJ	B-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
Gram-positive	Gram-positive	JJ	B-NP	O
,	,	,	I-NP	O
lactic	lactic	JJ	I-NP	O
acid	acid	NN	I-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
,	,	,	O	O
notably	notably	RB	B-ADVP	O
,	,	,	O	O
some	some	DT	B-NP	O
probiotic	probiotic	JJ	I-NP	O
lactobacilli	lactobacilli	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
safely	safely	RB	I-VP	O
consumed	consume	VBN	I-VP	O
by	by	IN	B-PP	O
humans	human	NNS	B-NP	O
for	for	IN	B-PP	O
centuries	century	NNS	B-NP	O
in	in	IN	B-PP	O
fermented	ferment	VBN	B-NP	O
foods	food	NNS	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
they	they	PRP	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
orally	orally	RB	I-VP	O
administered	administer	VBN	I-VP	O
,	,	,	O	O
are	be	VBP	B-VP	O
well	well	RB	I-VP	O
tolerated	tolerate	VBN	I-VP	O
by	by	IN	B-PP	O
recipients	recipient	NNS	B-NP	O
and	and	CC	O	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
easily	easily	RB	B-VP	O
and	and	CC	I-VP	O
economically	economically	RB	I-VP	O
provided	provide	VBN	I-VP	O
to	to	TO	B-PP	O
large	large	JJ	B-NP	B-cell_type
populations	population	NNS	I-NP	I-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
overview	overview	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
focus	focus	VBP	B-VP	O
on	on	IN	B-PP	O
mucosal	mucosal	JJ	B-NP	O
immunity	immunity	NN	I-NP	O
and	and	CC	O	O
how	how	WRB	B-ADVP	O
its	its	PRP$	B-NP	O
cellular	cellular	JJ	I-NP	B-protein
component	component	NN	I-NP	I-protein
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
particularly	particularly	RB	B-NP	O
dendritic	dendritic	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
specifically	specifically	RB	I-VP	O
targeted	target	VBN	I-VP	O
to	to	TO	I-VP	O
deliver	deliver	VB	I-VP	O
immunogenic	immunogenic	JJ	B-NP	B-protein
subunits	subunit	NNS	I-NP	I-protein
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
the	the	DT	B-NP	O
protective	protective	JJ	I-NP	O
antigen	antigen	NN	I-NP	O
from	from	IN	B-PP	O
Bacillus	Bacillus	NN	B-NP	O
anthracis	anthracis	NN	I-NP	O
(	(	(	O	O
the	the	DT	B-NP	O
causative	causative	JJ	I-NP	O
agent	agent	NN	I-NP	O
of	of	IN	B-PP	O
anthrax	anthrax	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

An	An	DT	B-NP	O
antigen-specific	antigen-specific	JJ	I-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
elicited	elicit	VBN	I-VP	O
using	use	VBG	B-VP	O
specific	specific	JJ	B-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
Lactobacillus	Lactobacillus	NN	B-NP	O
acidophilus	acidophilus	NN	I-NP	O
expressing	express	VBG	B-VP	O
the	the	DT	B-NP	O
protective	protective	JJ	I-NP	B-protein
antigen	antigen	NN	I-NP	I-protein
.	.	.	O	O

A	A	DT	B-NP	O
mucosal	mucosal	JJ	I-NP	O
,	,	,	I-NP	O
dendritic	dendritic	JJ	I-NP	O
cell-targeted	cell-targeted	JJ	I-NP	O
approach	approach	NN	I-NP	O
increases	increase	VBZ	B-VP	O
the	the	DT	B-NP	O
bioavailability	bioavailability	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
immunogen	immunogen	NN	I-NP	O
of	of	IN	B-PP	O
interest	interest	NN	B-NP	O
when	when	WRB	B-ADVP	O
delivered	deliver	VBN	B-VP	O
orally	orally	RB	B-ADVP	O
by	by	IN	B-PP	O
L.	L.	NNP	B-NP	O
acidophilus	acidophilus	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
provides	provide	VBZ	B-VP	O
an	an	DT	B-NP	O
efficiently	efficiently	RB	I-NP	O
elegant	elegant	JJ	I-NP	O
natural	natural	JJ	I-NP	O
strategy	strategy	NN	I-NP	O
and	and	CC	O	O
serves	serve	VBZ	B-VP	O
a	a	DT	B-NP	O
dual	dual	JJ	I-NP	O
function	function	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
immune-stimulating	immune-stimulating	JJ	I-NP	O
adjuvant	adjuvant	JJ	I-NP	O
in	in	FW	I-NP	O
vivo	vivo	FW	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
analyze	analyze	VB	I-VP	O
the	the	DT	B-NP	O
localization	localization	NN	I-NP	O
of	of	IN	B-PP	O
attenuated	attenuate	VBN	B-NP	O
Salmonella	Salmonella	NNP	I-NP	O
typhimurium	typhimurium	NNP	I-NP	O
after	after	IN	B-PP	O
oral	oral	JJ	B-NP	O
immunization	immunization	NN	I-NP	O
.	.	.	O	O

Prokaryotic	Prokaryotic	JJ	B-NP	O
expression	expression	NN	I-NP	O
plasmid	plasmid	NN	I-NP	O
pYA33-DsRed	pYA33-DsRed	NN	I-NP	O
,	,	,	O	O
carrying	carry	VBG	B-VP	O
the	the	DT	B-NP	O
RFP	RFP	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
,	,	,	O	O
was	be	VBD	B-VP	O
constructed	construct	VBN	I-VP	O
and	and	CC	O	O
electro-transformed	electro-transformed	JJ	B-ADJP	O
into	into	IN	B-PP	O
an	an	DT	B-NP	O
attenuated	attenuate	VBN	I-NP	O
strain	strain	NN	I-NP	O
X4550	X4550	NN	I-NP	O
of	of	IN	B-PP	O
Salmonella	Salmonella	NNP	B-NP	O
typhimurium	typhimurium	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
recombinant	recombinant	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
named	name	VBN	I-VP	O
as	as	IN	B-PP	O
X4550	X4550	NN	B-NP	O
(	(	(	O	O
33-DsRed	33-DsRed	JJ	B-ADJP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
macrophage	macrophage	NN	I-NP	O
cell	cell	NN	I-NP	O
line	line	NN	I-NP	O
RAW264.7	RAW264.7	NN	I-NP	B-cell_line
and	and	CC	I-NP	O
bone	bone	NN	I-NP	B-cell_type
marrow	marrow	NN	I-NP	I-cell_type
dendritic	dendritic	JJ	I-NP	I-cell_type
cell	cell	NN	I-NP	I-cell_type
(	(	(	O	O
BMDC	BMDC	NN	B-NP	B-cell_type
)	)	)	O	O
were	be	VBD	B-VP	O
invaded	invade	VBN	I-VP	O
by	by	IN	B-PP	O
X4550	X4550	NN	B-NP	O
(	(	(	O	O
33-DsRed	33-DsRed	JJ	B-ADJP	O
)	)	)	O	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
BALB/c	BALB/c	NN	B-NP	O
mice	mouse	NNS	I-NP	O
were	be	VBD	B-VP	O
immunized	immunize	VBN	I-VP	O
with	with	IN	B-PP	O
recombinant	recombinant	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
orally	orally	RB	B-ADVP	O
.	.	.	O	O

RFP	RFP	NN	B-NP	B-cell_line
positive	positive	JJ	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
(	(	(	O	O
RFP+	RFP+	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
)	)	)	O	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
by	by	IN	B-PP	O
Flow	Flow	NN	B-NP	O
Cytometry	Cytometry	NN	I-NP	O
(	(	(	O	O
FCM	FCM	NN	B-NP	O
)	)	)	O	O
from	from	IN	B-PP	O
spleen	spleen	NN	B-NP	O
,	,	,	O	O
liver	liver	NN	B-NP	O
,	,	,	O	O
Mesenteric	Mesenteric	JJ	B-NP	O
lymp	lymp	NN	I-NP	O
node	node	NN	I-NP	O
(	(	(	O	O
MLN	MLN	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
Peyer's	Peyer's	POS	B-NP	O
patch	patch	NN	I-NP	O
(	(	(	O	O
PP	PP	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
Inguinal	Inguinal	JJ	B-NP	O
lymph	lymph	NN	I-NP	O
node	node	NN	I-NP	O
(	(	(	O	O
ILN	ILN	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
invasion	invasion	NN	I-NP	O
rate	rate	NN	I-NP	O
increased	increase	VBD	B-VP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
multiplicity	multiplicity	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
(	(	(	O	O
MOI	MOI	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
improved	improve	VBN	I-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
two	two	CD	I-NP	O
kinds	kind	NNS	I-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

After	After	IN	B-PP	O
oral	oral	JJ	B-NP	O
immunization	immunization	NN	I-NP	O
with	with	IN	B-PP	O
X4550	X4550	NN	B-NP	O
(	(	(	O	O
33-DsRed	33-DsRed	JJ	B-ADVP	O
)	)	)	O	O
,	,	,	O	O
RFP+	RFP+	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
by	by	IN	B-PP	O
FCM	FCM	NN	B-NP	O
on	on	IN	B-PP	O
1d	1d	NN	B-NP	O
,	,	,	O	O
2d	2d	NN	B-NP	O
,	,	,	O	O
3d	3d	NN	B-NP	O
,	,	,	O	O
5d	5d	NN	B-NP	O
,	,	,	O	O
7d	7d	NN	B-NP	O
in	in	IN	B-PP	O
spleen	spleen	NN	B-NP	O
,	,	,	O	O
liver	liver	NN	B-NP	O
,	,	,	O	O
MLN	MLN	NN	B-NP	B-protein
,	,	,	O	O
PP	PP	NN	B-NP	B-protein
,	,	,	O	O
ILN	ILN	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

The	The	DT	B-NP	O
first	first	JJ	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
RFP+	RFP+	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
MLN	MLN	NN	B-NP	O
and	and	CC	I-NP	O
PP	PP	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
PP	PP	NN	B-NP	B-protein
at	at	IN	B-PP	O
a	a	DT	B-NP	O
higher	high	JJR	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
1.4	1.4	CD	B-NP	O
%	%	NN	I-NP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
MLN	MLN	NN	B-NP	B-protein
.	.	.	O	O

0.4	0.4	CD	B-NP	O
%	%	NN	I-NP	O
RFP+	RFP+	NN	I-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
day	day	NN	I-NP	O
in	in	IN	B-PP	O
ILN	ILN	NN	B-NP	B-protein
.	.	.	O	O

On	On	IN	B-PP	O
3th	3th	JJ	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
rates	rate	NNS	I-NP	O
of	of	IN	B-PP	O
RFP+	RFP+	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
above	above	JJ	B-NP	O
tissues	tissue	NNS	I-NP	O
or	or	CC	I-NP	O
organs	organ	NNS	I-NP	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
5th	5th	JJ	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
7th	7th	JJ	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
RFP+	RFP+	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
could	could	MD	B-VP	O
n't	n't	RB	I-VP	O
be	be	VB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
tissues	tissue	NNS	I-NP	O
or	or	CC	I-NP	O
organs	organ	NNS	I-NP	O
tested	test	VBN	B-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
suggested	suggest	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
invasion	invasion	NN	I-NP	O
ability	ability	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
transfer	transfer	NN	I-NP	O
through	through	IN	B-PP	O
mucosal	mucosal	JJ	B-NP	O
pathway	pathway	NN	I-NP	O
and	and	CC	O	O
targeting	target	VBG	B-VP	O
to	to	TO	I-VP	O
recognize	recognize	VB	I-VP	O
immune	immune	JJ	B-NP	O
tissue	tissue	NN	I-NP	O
or	or	CC	I-NP	O
organs	organ	NNS	I-NP	O
are	be	VBP	B-VP	O
favor	favor	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
research	research	NN	I-NP	O
in	in	IN	B-PP	O
mucosal	mucosal	JJ	B-NP	O
vaccine	vaccine	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
vaccine	vaccine	NN	I-NP	O
efficiency	efficiency	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
evaluated	evaluate	VBD	B-VP	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
of	of	IN	B-PP	O
using	use	VBG	B-VP	O
Yersinia	Yersinia	NN	B-NP	O
pseudotuberculosis	pseudotuberculosis	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
live	live	JJ	I-NP	O
vaccine	vaccine	NN	I-NP	O
against	against	IN	B-PP	O
plague	plague	NN	B-NP	O
because	because	IN	B-SBAR	O
it	it	PRP	B-NP	O
shares	share	VBZ	B-VP	O
high	high	JJ	B-NP	O
genetic	genetic	JJ	I-NP	O
identity	identity	NN	I-NP	O
with	with	IN	B-PP	O
Y.	Y.	NNP	B-NP	O
pestis	pestis	NN	I-NP	O
while	while	IN	B-SBAR	O
being	be	VBG	B-VP	O
much	much	RB	B-ADJP	O
less	less	RBR	I-ADJP	O
virulent	virulent	JJ	I-ADJP	O
,	,	,	O	O
genetically	genetically	RB	B-ADVP	O
much	much	RB	I-ADVP	O
more	more	RBR	I-ADJP	O
stable	stable	JJ	I-ADJP	O
,	,	,	O	O
and	and	CC	O	O
deliverable	deliverable	JJ	B-ADJP	O
orally	orally	RB	B-ADVP	O
.	.	.	O	O

A	A	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
41	41	CD	B-NP	O
Y.	Y.	NNP	I-NP	O
pseudotuberculosis	pseudotuberculosis	NN	I-NP	O
strains	strain	NNS	I-NP	O
were	be	VBD	B-VP	O
screened	screen	VBN	I-VP	O
by	by	IN	B-PP	O
PCR	PCR	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
pathogenicity	pathogenicity	NN	I-NP	O
island	island	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
superantigens	superantigen	NNS	I-NP	O
YPM	YPM	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
type	type	NN	I-NP	O
IV	IV	CD	I-NP	O
pilus	pilus	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pYV	pYV	NN	I-NP	B-DNA
virulence	virulence	NN	I-NP	I-DNA
plasmid	plasmid	NN	I-NP	I-DNA
.	.	.	O	O

One	One	CD	B-NP	O
strain	strain	NN	I-NP	O
(	(	(	O	O
IP32680	IP32680	NN	B-NP	O
)	)	)	O	O
fulfilled	fulfil	VBD	B-VP	O
these	these	DT	B-NP	O
criteria	criterion	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
strain	strain	NN	I-NP	O
was	be	VBD	B-VP	O
avirulent	avirulent	JJ	B-ADJP	O
in	in	IN	B-PP	O
mice	mouse	NNS	B-NP	O
upon	upon	IN	B-PP	O
intragastric	intragastric	JJ	B-NP	O
or	or	CC	I-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
inoculation	inoculation	NN	I-NP	O
and	and	CC	O	O
persisted	persist	VBD	B-VP	O
for	for	IN	B-PP	O
2	2	CD	B-NP	O
months	month	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mouse	mouse	NN	I-NP	O
intestine	intestine	NN	I-NP	O
without	without	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
disease	disease	NN	B-NP	O
.	.	.	O	O

IP32680	IP32680	NN	B-NP	O
reached	reach	VBD	B-VP	O
the	the	DT	B-NP	O
mesenteric	mesenteric	JJ	I-NP	O
lymph	lymph	NN	I-NP	O
nodes	node	NNS	I-NP	O
,	,	,	O	O
spleen	spleen	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
liver	liver	NN	B-NP	O
without	without	IN	B-PP	O
causing	cause	VBG	B-VP	O
major	major	JJ	B-NP	O
histological	histological	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
cleared	clear	VBN	I-VP	O
after	after	IN	B-PP	O
13	13	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
antibodies	antibody	NNS	I-NP	B-protein
produced	produce	VBN	B-VP	O
in	in	IN	B-PP	O
vaccinated	vaccinate	VBN	B-NP	O
animals	animal	NNS	I-NP	O
recognized	recognize	VBD	B-VP	O
both	both	DT	O	O
Y.	Y.	NNP	B-NP	O
pseudotuberculosis	pseudotuberculosis	NN	I-NP	O
and	and	CC	O	O
Y.	Y.	NN	B-NP	B-protein
pestis	pestis	NN	I-NP	I-protein
antigens	antigen	NNS	I-NP	I-protein
efficiently	efficiently	RB	B-ADVP	O
.	.	.	O	O

After	After	IN	B-PP	O
a	a	DT	B-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
challenge	challenge	NN	I-NP	O
with	with	IN	B-PP	O
Y.	Y.	NNP	B-NP	O
pestis	pestis	NN	I-NP	O
CO92	CO92	NN	I-NP	O
,	,	,	O	O
bacteria	bacteria	NNS	B-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
low	low	JJ	B-NP	O
amounts	amount	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
organs	organ	NNS	I-NP	O
and	and	CC	O	O
rarely	rarely	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
of	of	IN	B-PP	O
vaccinated	vaccinate	VBN	B-NP	O
animals	animal	NNS	I-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
oral	oral	JJ	I-NP	O
IP32680	IP32680	NN	I-NP	O
inoculation	inoculation	NN	I-NP	O
protected	protect	VBD	B-VP	O
75	75	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mice	mouse	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
two	two	CD	B-NP	O
inoculations	inoculation	NNS	I-NP	O
induced	induce	VBD	B-VP	O
much	much	RB	B-NP	O
higher	high	JJR	I-NP	O
antibody	antibody	NN	I-NP	O
titers	titer	NNS	I-NP	O
and	and	CC	O	O
protected	protect	VBD	B-VP	O
88	88	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mice	mouse	NNS	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
thus	thus	RB	B-ADVP	O
validate	validate	VBP	B-VP	O
the	the	DT	B-NP	O
concept	concept	NN	I-NP	O
that	that	IN	B-SBAR	O
an	an	DT	B-NP	O
attenuated	attenuate	VBN	I-NP	O
Y.	Y.	NNP	I-NP	O
pseudotuberculosis	pseudotuberculosis	NN	I-NP	O
strain	strain	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
efficient	efficient	JJ	I-NP	O
,	,	,	I-NP	O
inexpensive	inexpensive	JJ	I-NP	O
,	,	,	I-NP	O
safe	safe	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
easy-to-produce	easy-to-produce	JJ	B-NP	O
live	live	JJ	I-NP	O
vaccine	vaccine	NN	I-NP	O
for	for	IN	B-PP	O
oral	oral	JJ	B-NP	O
immunization	immunization	NN	I-NP	O
against	against	IN	B-PP	O
bubonic	bubonic	JJ	B-NP	O
plague	plague	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
beta-lactamase	beta-lactamase	NN	B-NP	B-protein
producing	produce	VBG	B-VP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
childhood	childhood	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
influence	influence	NN	I-NP	O
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
parameters	parameter	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
carriage	carriage	NN	I-NP	O
of	of	IN	B-PP	O
Capnocytophaga	Capnocytophaga	NNP	B-NP	O
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
population	population	NN	I-NP	O
of	of	IN	B-PP	O
children	child	NNS	B-NP	O
with	with	IN	B-PP	O
cancer	cancer	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
examined	examine	VBN	I-NP	O
parameters	parameter	NNS	I-NP	O
included	include	VBD	B-VP	O
clinical	clinical	JJ	B-NP	O
observation	observation	NN	I-NP	O
of	of	IN	B-PP	O
oropharyngeal	oropharyngeal	JJ	B-NP	O
mucosa	mucosa	NN	I-NP	O
,	,	,	O	O
type	type	NN	B-NP	O
of	of	IN	B-PP	O
malignant	malignant	JJ	B-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
intake	intake	NN	B-NP	O
of	of	IN	B-PP	O
chemotherapy	chemotherapy	NN	B-NP	O
and	and	CC	O	O
antimicrobial	antimicrobial	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
gingival	gingival	JJ	I-NP	O
and	and	CC	I-NP	O
mucosal	mucosal	JJ	I-NP	O
status	status	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
was	be	VBD	B-VP	O
recorded	record	VBN	I-VP	O
before	before	IN	B-SBAR	O
each	each	DT	B-NP	O
sampling	sample	VBG	I-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O

Samples	Sample	NNS	B-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
by	by	IN	B-PP	O
oropharyngeal	oropharyngeal	JJ	B-NP	O
swabbing	swabbing	NN	I-NP	O
in	in	IN	B-PP	O
children	child	NNS	B-NP	O
with	with	IN	B-PP	O
leukaemia	leukaemia	NN	B-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
oncological	oncological	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
for	for	IN	B-PP	O
isolation	isolation	NN	B-NP	O
of	of	IN	B-PP	O
Capnocytophaga	Capnocytophaga	NNP	B-NP	O
strains	strain	NNS	I-NP	O
.	.	.	O	O

Capnocytophaga	Capnocytophaga	NNP	B-NP	O
strains	strain	NNS	I-NP	O
were	be	VBD	B-VP	O
more	more	RBR	I-VP	O
often	often	RB	I-VP	O
isolated	isolate	VBN	I-VP	O
in	in	IN	B-PP	O
samples	sample	NNS	B-NP	O
from	from	IN	B-PP	O
children	child	NNS	B-NP	O
with	with	IN	B-PP	O
oncological	oncological	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
(	(	(	O	O
71	71	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
other	other	JJ	B-ADJP	O
than	than	IN	B-PP	O
leukaemia	leukaemia	NN	B-NP	O
(	(	(	O	O
57	57	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Concomitant	Concomitant	JJ	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
influence	influence	NN	I-NP	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	O
Capnocytophaga	Capnocytophaga	NNP	I-NP	O
carriage	carriage	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
significant	significant	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
Capnocytophaga	Capnocytophaga	NNP	B-NP	O
strains	strain	NNS	I-NP	O
isolated	isolate	VBN	B-VP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
children	child	NNS	B-NP	O
who	who	WP	B-NP	O
received	receive	VBD	B-VP	O
antimicrobial	antimicrobial	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
within	within	IN	B-PP	O
8	8	CD	B-NP	O
days	day	NNS	I-NP	O
before	before	IN	B-PP	O
the	the	DT	B-NP	O
sampling	sampling	NN	I-NP	O
procedure	procedure	NN	I-NP	O
(	(	(	O	O
15.5	15.5	CD	B-NP	O
%	%	NN	I-NP	O
vs.	vs.	IN	B-PP	O
28	28	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

But	But	CC	O	O
,	,	,	O	O
the	the	DT	B-NP	O
incidence	incidence	NN	I-NP	O
of	of	IN	B-PP	O
beta-lactamase-producing	beta-lactamase-producing	JJ	B-NP	B-protein
strains	strain	NNS	I-NP	I-protein
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
linked	link	VBN	I-VP	O
to	to	TO	B-PP	O
previous	previous	JJ	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
treatments	treatment	NNS	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
carriage	carriage	NN	I-NP	O
of	of	IN	B-PP	O
Capnocytophaga	Capnocytophaga	NNP	B-NP	O
strains	strain	NNS	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
linked	link	VBN	I-VP	O
to	to	TO	B-PP	O
haematological	haematological	JJ	B-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
previous	previous	JJ	B-NP	O
antibiotherapy	antibiotherapy	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
results	result	NNS	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
confirm	confirm	VB	I-VP	O
that	that	IN	B-SBAR	O
beta-lactamase	beta-lactamase	NN	B-NP	O
treatments	treatment	NNS	I-NP	O
exert	exert	VBP	B-VP	O
a	a	DT	B-NP	O
selective	selective	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

Other	Other	JJ	B-NP	O
factors	factor	NNS	I-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
emerging	emerge	VBG	B-VP	O
for	for	IN	B-PP	O
oral	oral	JJ	B-NP	O
beta-lactamase-producing	beta-lactamase-producing	JJ	I-NP	O
Capnocytophaga	Capnocytophaga	NNP	I-NP	O
strains	strain	NNS	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
periodontitis	periodontitis	NN	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
innate	innate	JJ	I-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
bacterial	bacterial	JJ	B-NP	O
challenge	challenge	NN	I-NP	O
is	be	VBZ	B-VP	O
primarily	primarily	RB	I-VP	O
mediated	mediate	VBN	I-VP	O
by	by	IN	B-PP	O
neutrophils	neutrophil	NNS	B-NP	B-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
compared	compare	VBD	B-VP	O
neutrophilic	neutrophilic	JJ	B-NP	O
content	content	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
neutrophil-derived	neutrophil-derived	JJ	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
peptides	peptide	NNS	I-NP	O
in	in	IN	B-PP	O
gingival	gingival	JJ	B-NP	O
crevicular	crevicular	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
(	(	(	O	O
GCF	GCF	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
clinical	clinical	JJ	I-NP	O
forms	form	NNS	I-NP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
.	.	.	O	O

GCF	GCF	NN	B-NP	B-protein
was	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
from	from	IN	B-PP	O
14	14	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
aggressive	aggressive	JJ	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
,	,	,	O	O
17	17	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
nine	nine	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O

Samples	Sample	NNS	B-NP	O
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
for	for	IN	B-PP	O
periodontopathogen	periodontopathogen	NN	B-NP	O
load	load	NN	I-NP	O
using	use	VBG	B-VP	O
real-time	real-time	JJ	B-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reactions	reaction	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
myeloperoxidase	myeloperoxidase	NN	B-NP	B-protein
and	and	CC	I-NP	O
alpha-defensins	alpha-defensin	NNS	I-NP	B-protein
(	(	(	O	O
HNP1-3	HNP1-3	NN	B-NP	B-protein
)	)	)	O	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
by	by	IN	B-PP	O
enzyme-linked	enzyme-linked	JJ	B-NP	O
immunosorbent	immunosorbent	JJ	I-NP	O
assay	assay	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
cathelicidin	cathelicidin	NN	B-NP	B-protein
(	(	(	O	O
hCAP18/LL-37	hCAP18/LL-37	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
assayed	assay	VBN	I-VP	O
by	by	IN	B-PP	O
Western	Western	JJ	B-NP	O
blot	blot	NN	I-NP	O
.	.	.	O	O

Myeloperoxidase	Myeloperoxidase	NN	B-NP	B-protein
concentration	concentration	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
LL-37	LL-37	NN	B-NP	B-protein
and	and	CC	I-NP	O
HNP1-3	HNP1-3	NN	I-NP	B-protein
in	in	IN	B-PP	O
samples	sample	NNS	B-NP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
,	,	,	O	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
controls	control	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
HNP1-3	HNP1-3	NN	B-NP	B-protein
was	be	VBD	B-VP	O
twofold	twofold	RB	B-ADVP	O
and	and	CC	I-ADVP	O
fourfold	fourfold	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
aggressive	aggressive	JJ	B-NP	O
and	and	CC	I-NP	O
chronic	chronic	JJ	I-NP	O
periodontitis	periodontitis	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

Those	Those	DT	B-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
disease	disease	NN	I-NP	O
had	have	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
elevated	elevate	VBN	I-VP	O
amounts	amount	NNS	B-NP	O
of	of	IN	B-PP	O
mature	mature	JJ	B-NP	O
LL-37	LL-37	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
increased	increase	VBN	I-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
both	both	DT	B-NP	O
peptides	peptide	NNS	I-NP	O
in	in	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
correlated	correlate	VBD	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
load	load	NN	I-NP	O
of	of	IN	B-PP	O
Porphyromonas	Porphyromonas	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
Tannerella	Tannerella	NNP	B-NP	O
forsythia	forsythia	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Treponema	Treponema	NNP	B-NP	O
denticola	denticola	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
lack	lack	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
LL-37	LL-37	NN	B-NP	B-protein
,	,	,	O	O
HNP1-3	HNP1-3	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
myeloperoxidase	myeloperoxidase	NN	B-NP	B-protein
content	content	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
neutrophils	neutrophil	NNS	B-NP	B-cell_type
are	be	VBP	B-VP	O
not	not	RB	O	O
the	the	DT	B-NP	O
sole	sole	JJ	I-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
bactericidal	bactericidal	JJ	I-NP	O
peptides	peptide	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
GCF	GCF	NN	I-NP	B-protein
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
periodontitis	periodontitis	NN	B-NP	O
;	;	:	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
other	other	JJ	B-NP	O
cells	cell	NNS	I-NP	O
contribute	contribute	VBP	B-VP	O
to	to	TO	B-PP	O
their	their	PRP$	B-NP	O
local	local	JJ	I-NP	O
production	production	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	B-protein
proteases	protease	NNS	I-NP	I-protein
of	of	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
T.	T.	NNP	B-NP	O
forsythia	forsythia	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
T.	T.	NNP	B-NP	O
denticola	denticola	NN	I-NP	O
might	might	MD	B-VP	O
degrade	degrade	VB	I-VP	O
hCAP18/LL-37	hCAP18/LL-37	NN	B-NP	O
,	,	,	O	O
because	because	IN	B-SBAR	O
the	the	DT	B-NP	O
11-kDa	11-kDa	JJ	I-NP	B-protein
cathelicidin-derived	cathelicidin-derived	JJ	I-NP	I-protein
fragment	fragment	NN	I-NP	I-protein
was	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
GCF	GCF	NN	B-NP	B-protein
collected	collect	VBN	B-VP	O
from	from	IN	B-PP	O
pockets	pocket	NNS	B-NP	O
infected	infect	VBN	B-VP	O
with	with	IN	B-PP	O
these	these	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

Collectively	Collectively	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
appears	appear	VBZ	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
local	local	JJ	I-NP	O
deficiency	deficiency	NN	I-NP	O
in	in	IN	B-PP	O
LL-37	LL-37	NN	B-NP	B-protein
can	can	MD	B-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
supporting	supporting	JJ	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
periodontitis	periodontitis	NN	B-NP	O
.	.	.	O	O

Lipoteichoic	Lipoteichoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
LTA	LTA	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
immunostimulating	immunostimulating	JJ	I-NP	O
component	component	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
wall	wall	NN	I-NP	O
of	of	IN	B-PP	O
Gram-positive	Gram-positive	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
as	as	IN	B-PP	O
lipopolysaccharide	lipopolysaccharide	NN	B-NP	O
of	of	IN	B-PP	O
Gram-negative	Gram-negative	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
LTA	LTA	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
expressed	express	VBN	I-VP	O
on	on	IN	B-PP	O
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
pathogenic	pathogenic	JJ	B-ADJP	O
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
nonpathogenic	nonpathogenic	JJ	B-NP	O
Gram-positive	Gram-positive	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
examine	examine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
the	the	DT	B-NP	O
immunostimulating	immunostimulating	JJ	I-NP	O
potentials	potential	NNS	I-NP	O
of	of	IN	B-PP	O
Gram-positive	Gram-positive	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
are	be	VBP	B-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
their	their	PRP$	B-NP	O
LTAs	LTA	NNS	I-NP	B-protein
,	,	,	O	O
we	we	PRP	B-NP	O
prepared	prepare	VBD	B-VP	O
highly	highly	RB	B-NP	O
pure	pure	JJ	I-NP	O
LTAs	LTA	NNS	I-NP	O
from	from	IN	B-PP	O
Staphylococcus	Staphylococcus	FW	B-NP	O
aureus	aureus	FW	I-NP	O
(	(	(	O	O
pathogenic	pathogenic	JJ	B-ADVP	O
)	)	)	O	O
,	,	,	O	O
Bacillus	Bacillus	NN	B-NP	O
subtilis	subtilis	NN	I-NP	O
(	(	(	O	O
non-pathogenic	non-pathogenic	JJ	B-ADVP	O
)	)	)	O	O
,	,	,	O	O
or	or	CC	O	O
Lactobacillus	Lactobacillus	NN	B-NP	O
plantarum	plantarum	NN	I-NP	O
(	(	(	O	O
beneficial	beneficial	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
a	a	DT	B-NP	O
murine	murine	JJ	I-NP	B-cell_line
macrophage	macrophage	NN	I-NP	I-cell_line
cell-line	cell-line	NN	I-NP	I-cell_line
,	,	,	O	O
RAW	RAW	NN	B-NP	B-cell_line
264.7	264.7	CD	I-NP	I-cell_line
,	,	,	O	O
was	be	VBD	B-VP	O
stimulated	stimulate	VBN	I-VP	O
with	with	IN	B-PP	O
heat-killed	heat-killed	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
both	both	DT	B-NP	O
S.	S.	NNP	B-NP	O
aureus	aureus	NNP	I-NP	O
and	and	CC	O	O
B.	B.	NNP	B-NP	O
subtilis	subtilis	NN	I-NP	O
induced	induce	VBD	B-VP	O
nitric	nitric	JJ	B-NP	O
oxide	oxide	NN	I-NP	O
(	(	(	O	O
NO	NO	NN	B-NP	O
)	)	)	O	O
production	production	NN	B-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
dose-dependent	dose-dependent	JJ	I-NP	O
manner	manner	NN	I-NP	O
while	while	IN	B-SBAR	O
L.	L.	NNP	B-NP	O
plantarum	plantarum	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
minimal	minimal	JJ	I-NP	O
induction	induction	NN	I-NP	O
.	.	.	O	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
purified	purify	VBN	B-NP	O
LTAs	LTA	NNS	I-NP	B-protein
from	from	IN	B-PP	O
S.	S.	NNP	B-NP	O
aureus	aureus	NNP	I-NP	O
and	and	CC	O	O
B.	B.	NNP	B-NP	O
subtilis	subtilis	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
from	from	IN	B-PP	O
L.	L.	NNP	B-NP	O
plantarum	plantarum	NN	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
induce	induce	VB	I-VP	O
the	the	DT	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
NO	NO	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
differential	differential	JJ	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
potentials	potential	NNS	I-NP	O
of	of	IN	B-PP	O
LTAs	LTA	NNS	B-NP	B-protein
coincided	coincide	VBN	B-VP	O
with	with	IN	B-PP	O
their	their	PRP$	B-NP	O
abilities	ability	NNS	I-NP	O
to	to	TO	B-VP	O
activate	activate	VB	I-VP	O
Toll-like	Toll-like	JJ	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
(	(	(	O	O
TLR2	TLR2	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
recognize	recognize	VB	I-VP	O
Gram-positive	Gram-positive	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	I-NP	O
LTA	LTA	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
transcription	transcription	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
and	and	CC	O	O
AP-1	AP-1	NN	B-NP	B-protein
.	.	.	O	O

Similar	Similar	JJ	B-NP	O
results	result	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
cytokines	cytokine	NNS	B-NP	B-protein
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
inflammation	inflammation	NN	B-NP	O
by	by	IN	B-PP	O
RAW	RAW	NN	B-NP	B-cell_line
264.7	264.7	CD	I-NP	I-cell_line
and	and	CC	O	O
human	human	JJ	B-NP	B-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
LTA	LTA	NN	B-NP	B-protein
to	to	TO	B-VP	O
induce	induce	VB	I-VP	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
and	and	CC	I-NP	O
NO	NO	NN	I-NP	O
production	production	NN	I-NP	O
was	be	VBD	B-VP	O
abolished	abolish	VBN	I-VP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
LTAs	LTA	NNS	I-NP	B-protein
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
0.2	0.2	CD	B-NP	O
N	N	NN	I-NP	O
NaOH	NaOH	NN	I-NP	O
.	.	.	O	O

Collectively	Collectively	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
immunostimulating	immunostimulating	JJ	I-NP	O
potentials	potential	NNS	I-NP	O
of	of	IN	B-PP	O
Gram-positive	Gram-positive	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
differ	differ	VBP	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
their	their	PRP$	B-NP	O
LTAs	LTA	NNS	I-NP	B-protein
with	with	IN	B-PP	O
differential	differential	JJ	B-NP	O
potencies	potency	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
stimulation	stimulation	NN	I-NP	O
of	of	IN	B-PP	O
TLR2	TLR2	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
purpose	purpose	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
test	test	VB	I-VP	O
the	the	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
that	that	IN	B-SBAR	O
periodontal	periodontal	JJ	B-NP	O
pathogens	pathogen	NNS	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
aggressive	aggressive	JJ	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
persist	persist	NN	I-NP	O
in	in	IN	B-PP	O
extracrevicular	extracrevicular	JJ	B-NP	O
locations	location	NNS	I-NP	O
following	follow	VBG	B-PP	O
scaling	scaling	NN	B-NP	O
and	and	CC	I-NP	O
root	root	NN	I-NP	O
planing	planing	NN	I-NP	O
,	,	,	O	O
systemic	systemic	JJ	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
antimicrobial	antimicrobial	JJ	B-NP	O
rinses	rinse	NNS	I-NP	O
.	.	.	O	O

Eighteen	Eighteen	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
aggressive	aggressive	JJ	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
examination	examination	NN	I-NP	O
during	during	IN	B-PP	O
which	which	WDT	B-NP	O
samples	sample	NNS	B-NP	O
of	of	IN	B-PP	O
subgingival	subgingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
and	and	CC	O	O
buccal	buccal	JJ	B-NP	B-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
.	.	.	O	O

Treatment	Treatment	NN	B-NP	O
consisted	consist	VBD	B-VP	O
of	of	IN	B-PP	O
full-mouth	full-mouth	JJ	B-NP	O
root	root	NN	I-NP	O
planing	planing	NN	I-NP	O
,	,	,	O	O
systemic	systemic	JJ	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
chlorhexidine	chlorhexidine	NN	B-NP	O
rinses	rinse	NNS	I-NP	O
.	.	.	O	O

Clinical	Clinical	JJ	B-NP	O
measurements	measurement	NNS	I-NP	O
and	and	CC	I-NP	O
sampling	sampling	NN	I-NP	O
were	be	VBD	B-VP	O
repeated	repeat	VBN	I-VP	O
at	at	IN	B-PP	O
3	3	CD	B-NP	O
and	and	CC	I-NP	O
6	6	CD	I-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

Quantitative	Quantitative	JJ	B-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
determined	determine	VBD	B-VP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
Aggregatibacter	Aggregatibacter	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
(	(	(	O	O
previously	previously	RB	B-ADVP	O
Actinobacillus	Actinobacillus	CC	O	O
actinomycetemcomitans	actinomycetemcomitan	NNS	B-NP	O
)	)	)	O	O
,	,	,	O	O
Prevotella	Prevotella	NNP	B-NP	O
intermedia	intermedia	NNS	I-NP	O
,	,	,	O	O
Porphyromonas	Porphyromonas	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
Tannerella	Tannerella	NNP	B-NP	O
forsythia	forsythia	NNP	I-NP	O
(	(	(	O	O
previously	previously	RB	B-NP	O
T.	T.	FW	I-NP	O
forsythensis	forsythensis	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
Treponema	Treponema	NNP	B-NP	O
denticola	denticola	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
plaque	plaque	NN	I-NP	O
.	.	.	O	O

Fluorescence	Fluorescence	NN	B-NP	O
in	in	FW	B-NP	O
situ	situ	FW	I-NP	O
hybridization	hybridization	NN	I-NP	O
and	and	CC	O	O
confocal	confocal	JJ	B-NP	O
microscopy	microscopy	NN	I-NP	O
determined	determine	VBD	B-VP	O
the	the	DT	B-NP	O
extent	extent	NN	I-NP	O
of	of	IN	B-PP	O
intracellular	intracellular	JJ	B-NP	O
invasion	invasion	NN	I-NP	O
in	in	IN	B-PP	O
epithelial	epithelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Clinical	Clinical	JJ	B-NP	O
measurements	measurement	NNS	I-NP	O
improved	improve	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
following	follow	VBG	I-VP	O
treatment	treatment	NN	B-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
except	except	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
reduced	reduce	VBN	I-VP	O
in	in	IN	B-PP	O
plaque	plaque	NN	B-NP	O
between	between	IN	B-PP	O
baseline	baseline	NN	B-NP	O
and	and	CC	O	O
3	3	CD	B-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
all	all	DT	B-NP	O
species	specie	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
trend	trend	NN	I-NP	O
to	to	TO	B-VP	O
repopulate	repopulate	VB	I-VP	O
between	between	IN	B-NP	O
3	3	CD	I-NP	O
and	and	CC	I-NP	O
6	6	CD	I-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
increase	increase	NN	I-NP	O
was	be	VBD	B-VP	O
statistically	statistically	RB	B-ADJP	O
significant	significant	JJ	I-ADJP	O
for	for	IN	B-PP	O
log	log	NN	B-NP	O
T.	T.	NN	I-NP	O
denticola	denticola	NN	I-NP	O
counts	count	NNS	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
species	specie	NNS	I-NP	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
intracellularly	intracellularly	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
percentage	percentage	NN	I-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
infected	infect	VBN	B-VP	O
intracellularly	intracellularly	RB	B-ADVP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
affected	affect	VBN	I-VP	O
by	by	IN	B-PP	O
therapy	therapy	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
6-month	6-month	JJ	I-NP	O
increasing	increase	VBG	I-NP	O
trend	trend	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
plaque	plaque	NN	B-NP	O
bacteria	bacteria	NNS	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
subgingival	subgingival	JJ	B-NP	O
recolonization	recolonization	NN	I-NP	O
was	be	VBD	B-VP	O
occurring	occur	VBG	I-VP	O
.	.	.	O	O

Because	Because	IN	B-SBAR	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
species	specie	NNS	I-NP	O
within	within	IN	B-PP	O
epithelial	epithelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
altered	alter	VBN	I-VP	O
after	after	IN	B-PP	O
treatment	treatment	NN	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
plausible	plausible	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
recolonization	recolonization	NN	B-NP	O
may	may	MD	B-VP	O
occur	occur	VB	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
.	.	.	O	O

Systemic	Systemic	JJ	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
and	and	CC	O	O
topical	topical	JJ	B-NP	O
chlorhexidine	chlorhexidine	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
reduce	reduce	VB	I-VP	O
the	the	DT	B-NP	O
percentage	percentage	NN	I-NP	O
of	of	IN	B-PP	O
invaded	invaded	JJ	B-NP	B-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
support	support	VBP	B-VP	O
the	the	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
that	that	IN	B-SBAR	O
extracrevicular	extracrevicular	JJ	B-NP	O
reservoirs	reservoir	NNS	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
exist	exist	VBP	B-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
might	might	MD	B-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
recurrent	recurrent	JJ	B-NP	O
or	or	CC	I-NP	O
refractory	refractory	JJ	I-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
some	some	DT	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
oral	oral	JJ	I-NP	O
pathogen	pathogen	NN	I-NP	O
Porphyromonas	Porphyromonas	NN	I-NP	O
gingivalis	gingivalis	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
modulate	modulate	VB	I-VP	O
apoptosis	apoptosis	NN	B-NP	O
in	in	IN	B-PP	O
different	different	JJ	B-NP	O
cell	cell	NN	I-NP	O
types	type	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
its	its	PRP$	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
epithelial	epithelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
remains	remain	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
.	.	.	O	O

We	We	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
primary	primary	JJ	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
gingival	gingival	JJ	I-NP	I-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
HGECs	HGEC	NNS	B-NP	B-cell_type
)	)	)	O	O
challenged	challenge	VBN	B-VP	O
with	with	IN	B-PP	O
live	live	JJ	B-NP	O
P.	P.	NNP	I-NP	O
gingivalis	gingivalis	NN	I-NP	O
for	for	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
exhibit	exhibit	VBP	B-VP	O
apoptosis	apoptosis	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
we	we	PRP	B-NP	O
characterize	characterize	VBP	B-VP	O
this	this	DT	B-NP	O
by	by	IN	B-PP	O
M30	M30	NN	B-NP	B-protein
epitope	epitope	NN	I-NP	O
detection	detection	NN	I-NP	O
,	,	,	O	O
caspase-3	caspase-3	NN	B-NP	B-protein
activity	activity	NN	I-NP	O
,	,	,	O	O
DNA	DNA	NN	B-NP	O
fragmentation	fragmentation	NN	I-NP	O
and	and	CC	O	O
Annexin-V	Annexin-V	JJ	B-NP	O
staining	staining	NN	I-NP	O
.	.	.	O	O

Live	Live	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
strongly	strongly	RB	B-ADVP	O
upregulated	upregulate	VBD	B-VP	O
intrinsic	intrinsic	JJ	B-NP	O
and	and	CC	I-NP	O
extrinsic	extrinsic	JJ	I-NP	O
apoptotic	apoptotic	JJ	I-NP	O
pathways	pathway	NNS	I-NP	O
.	.	.	O	O

Pro-apoptotic	Pro-apoptotic	JJ	B-NP	B-protein
molecules	molecule	NNS	I-NP	I-protein
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
caspase-3	caspase-3	NN	B-NP	B-protein
,	,	,	O	O
-8	-8	CD	B-NP	O
,	,	,	I-NP	O
-9	-9	CD	I-NP	O
,	,	,	I-NP	O
Bid	Bid	NN	I-NP	O
and	and	CC	I-NP	O
Bax	Bax	NN	I-NP	B-protein
were	be	VBD	B-VP	O
upregulated	upregulate	VBN	I-VP	O
after	after	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
anti-apoptotic	anti-apoptotic	JJ	I-NP	O
Bcl-2	Bcl-2	NN	I-NP	B-protein
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
upregulated	upregulate	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
sufficient	sufficient	JJ	B-ADJP	O
to	to	TO	B-VP	O
ensure	ensure	VB	I-VP	O
cell	cell	NN	B-NP	O
survival	survival	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
main	main	JJ	I-NP	O
P.	P.	NNP	I-NP	O
gingivalis	gingivalis	NN	I-NP	O
proteases	protease	NNS	I-NP	O
arginine	arginine	NN	I-NP	O
and	and	CC	I-NP	O
lysine	lysine	NN	I-NP	B-protein
gingipains	gingipain	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
necessary	necessary	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
sufficient	sufficient	JJ	I-ADJP	O
to	to	TO	B-VP	O
induce	induce	VB	I-VP	O
host	host	NN	B-NP	O
cell	cell	NN	I-NP	O
apoptosis	apoptosis	NN	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
live	live	VBP	B-VP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
can	can	MD	B-VP	O
invoke	invoke	VB	I-VP	O
gingival	gingival	JJ	B-NP	O
epithelial	epithelial	JJ	I-NP	O
cell	cell	NN	I-NP	O
apoptosis	apoptosis	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
time	time	NN	I-NP	O
and	and	CC	I-NP	O
dose	dose	NN	I-NP	O
dependent	dependent	JJ	I-NP	O
manner	manner	NN	I-NP	O
with	with	IN	B-PP	O
significant	significant	JJ	B-NP	O
apoptosis	apoptosis	NN	I-NP	O
occurring	occur	VBG	B-VP	O
between	between	IN	B-PP	O
12	12	CD	B-NP	O
and	and	CC	I-NP	O
24	24	CD	I-NP	O
hours	hour	NNS	I-NP	O
of	of	IN	B-PP	O
challenge	challenge	NN	B-NP	O
via	via	IN	B-PP	O
a	a	DT	B-NP	O
gingipain-dependent	gingipain-dependent	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
provides	provide	VBZ	B-VP	O
evidence	evidence	NN	B-NP	O
that	that	IN	B-SBAR	O
live	live	JJ	B-NP	O
,	,	,	I-NP	O
but	but	CC	I-NP	O
not	not	RB	I-NP	O
heat-killed	heat-killed	JJ	I-NP	O
,	,	,	O	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
can	can	MD	B-VP	O
induce	induce	VB	I-VP	O
apoptosis	apoptosis	NN	B-NP	O
after	after	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
of	of	IN	B-PP	O
challenge	challenge	NN	B-NP	O
in	in	IN	B-PP	O
primary	primary	JJ	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
gingival	gingival	JJ	I-NP	I-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Either	Either	CC	O	O
arginine	arginine	NN	B-NP	O
or	or	CC	I-NP	O
lysine	lysine	NN	I-NP	O
gingipains	gingipain	NNS	I-NP	O
are	be	VBP	B-VP	O
necessary	necessary	JJ	B-NP	O
and	and	CC	I-NP	O
sufficient	sufficient	JJ	I-NP	O
factors	factor	NNS	I-NP	O
in	in	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
elicited	elicit	VBD	B-VP	O
apoptosis	apoptosis	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
covers	cover	VBZ	B-VP	O
phase	phase	NN	B-NP	O
IV	IV	CD	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
prospective	prospective	JJ	I-NP	O
clinical	clinical	JJ	I-NP	O
long-term	long-term	JJ	I-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

Objective	Objective	JJ	B-ADJP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
investigation	investigation	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
analyze	analyze	VB	I-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
long-term	long-term	JJ	I-NP	O
prevention	prevention	NN	I-NP	O
program	program	NN	I-NP	O
on	on	IN	B-PP	O
dental	dental	JJ	B-NP	O
and	and	CC	I-NP	O
oral	oral	JJ	I-NP	O
health	health	NN	I-NP	O
of	of	IN	B-PP	O
teenagers	teenager	NNS	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
age	age	NN	I-NP	O
of	of	IN	B-PP	O
13	13	CD	B-NP	O
to	to	TO	I-NP	O
14	14	CD	I-NP	O
years	year	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
entire	entire	JJ	I-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
subdivided	subdivide	VBN	I-VP	O
into	into	IN	B-PP	O
four	four	CD	B-NP	O
phases	phase	NNS	I-NP	O
.	.	.	O	O

Phase	Phase	NN	B-NP	O
I	I	PRP	B-NP	O
comprised	comprise	VBD	B-VP	O
an	an	DT	B-NP	O
individual	individual	JJ	I-NP	O
preventive	preventive	JJ	I-NP	O
care	care	NN	I-NP	O
during	during	IN	B-PP	O
pregnancy	pregnancy	NN	B-NP	O
(	(	(	O	O
``	``	``	O	O
primary-primary	primary-primary	JJ	B-NP	O
prevention	prevention	NN	I-NP	O
''	''	''	O	O
)	)	)	O	O
;	;	:	O	O
phase	phase	NN	B-NP	O
II	II	CD	I-NP	O
assessed	assess	VBN	I-NP	O
mothers	mother	NNS	I-NP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
young	young	JJ	I-NP	O
children	child	NNS	I-NP	O
until	until	IN	B-PP	O
the	the	DT	B-NP	O
age	age	NN	I-NP	O
of	of	IN	B-PP	O
3	3	CD	B-NP	O
years	year	NNS	I-NP	O
(	(	(	O	O
``	``	``	O	O
primary	primary	JJ	B-NP	O
prevention	prevention	NN	I-NP	O
''	''	''	O	O
)	)	)	O	O
;	;	:	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
phase	phase	NN	B-NP	O
III	III	CD	I-NP	O
,	,	,	O	O
mothers	mother	NNS	B-NP	O
and	and	CC	I-NP	O
children	child	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
age	age	NN	I-NP	O
of	of	IN	B-PP	O
6	6	CD	B-NP	O
years	year	NNS	I-NP	O
were	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
phase	phase	NN	B-NP	O
IV	IV	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
health	health	NN	I-NP	O
of	of	IN	B-PP	O
13-	13-	CD	B-NP	O
to	to	TO	B-PP	O
14-year-old	14-year-old	JJ	B-NP	O
teenagers	teenager	NNS	I-NP	O
was	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
(	(	(	O	O
13.4	13.4	CD	B-NP	O
+/-	+/-	CC	I-NP	O
0.5	0.5	CD	I-NP	O
years	year	NNS	I-NP	O
;	;	:	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
29	29	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

All	All	DT	B-NP	O
phases	phase	NNS	I-NP	O
consisted	consist	VBD	B-VP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
examination	examination	NN	I-NP	O
,	,	,	O	O
education	education	NN	B-NP	O
about	about	IN	B-PP	O
oral	oral	JJ	B-NP	O
health	health	NN	I-NP	O
care	care	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
treatment	treatment	NN	B-NP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
concept	concept	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
early	early	JJ	I-NP	O
oral	oral	JJ	I-NP	O
health	health	NN	I-NP	O
care	care	NN	I-NP	O
promotion	promotion	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
consisted	consist	VBD	B-VP	O
of	of	IN	B-PP	O
randomly	randomly	RB	B-NP	O
selected	select	VBN	I-NP	O
adolescents	adolescent	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
age	age	NN	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
30	30	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
following	follow	VBG	I-NP	O
clinical	clinical	JJ	I-NP	O
parameters	parameter	NNS	I-NP	O
were	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
:	:	:	O	O
decayed/missing/filled	decayed/missing/fille	VBN	B-NP	O
teeth	tooth	NNS	I-NP	O
(	(	(	O	O
DMF-T	DMF-T	NN	B-NP	O
)	)	)	O	O
/decayed	/decaye	VBD	B-VP	O
,	,	,	O	O
missing	miss	VBG	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
filled	fill	VBN	B-NP	O
surface	surface	NN	I-NP	O
teeth	tooth	NNS	I-NP	O
index	index	NN	I-NP	O
,	,	,	O	O
hygiene	hygiene	NN	B-NP	O
index	index	NN	I-NP	O
,	,	,	O	O
papilla	papilla	NN	B-NP	O
bleeding	bleed	VBG	B-VP	O
index	index	NN	B-NP	O
,	,	,	O	O
Periodontal	Periodontal	NNP	B-NP	O
Screening	Screening	NNP	I-NP	O
Index	Index	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans/Lactobacillus	mutans/Lactobacillus	NN	I-NP	O
concentration	concentration	NN	I-NP	O
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
teenagers	teenager	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
``	``	``	I-NP	O
prevention	prevention	NN	I-NP	O
''	''	''	I-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
phase	phase	NN	B-NP	O
IV	IV	CD	I-NP	O
of	of	IN	B-PP	O
our	our	PRP$	B-NP	O
prospective	prospective	JJ	I-NP	O
study	study	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
share	share	NN	I-NP	O
of	of	IN	B-PP	O
89.7	89.7	CD	B-NP	O
%	%	NN	I-NP	O
caries-free	caries-free	JJ	I-NP	O
dentitions	dentition	NNS	I-NP	O
(	(	(	O	O
65.5	65.5	CD	B-NP	O
%	%	NN	I-NP	O
sound	sound	NN	I-NP	O
;	;	:	O	O
24.2	24.2	CD	B-NP	O
%	%	NN	I-NP	O
caries-free	caries-free	JJ	B-ADJP	O
with	with	IN	B-PP	O
fillings	filling	NNS	B-NP	O
)	)	)	O	O
.	.	.	O	O

Mean	Mean	JJ	B-NP	O
DMF-T	DMF-T	NN	I-NP	O
was	be	VBD	B-VP	O
0.55	0.55	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
1.0	1.0	CD	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
significantly	significantly	RB	I-NP	O
higher	high	JJR	I-NP	O
mean	mean	JJ	I-NP	O
DMF-T	DMF-T	NN	I-NP	O
of	of	IN	B-PP	O
1.5	1.5	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
1.5	1.5	CD	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
revealed	reveal	VBD	B-VP	O
56.7	56.7	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
caries-free	caries-free	JJ	B-NP	O
dentitions	dentition	NNS	I-NP	O
(	(	(	O	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
sound	sound	NN	I-NP	O
,	,	,	O	O
26.7	26.7	CD	B-NP	O
%	%	NN	I-NP	O
caries-free	caries-free	JJ	B-ADJP	O
with	with	IN	B-PP	O
restorations	restoration	NNS	B-NP	O
)	)	)	O	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
data	datum	NNS	I-NP	O
clearly	clearly	RB	B-ADVP	O
document	document	VBP	B-VP	O
that	that	IN	B-SBAR	O
an	an	DT	B-NP	O
early	early	JJ	I-NP	O
oral	oral	JJ	I-NP	O
health	health	NN	I-NP	O
care	care	NN	I-NP	O
promotion	promotion	NN	I-NP	O
starting	start	VBG	B-VP	O
during	during	IN	B-PP	O
pregnancy	pregnancy	NN	B-NP	O
may	may	MD	B-VP	O
cause	cause	VB	I-VP	O
a	a	DT	B-NP	O
sustained	sustained	JJ	I-NP	O
and	and	CC	I-NP	O
long-term	long-term	JJ	I-NP	O
improvement	improvement	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
health	health	NN	I-NP	O
of	of	IN	B-PP	O
children	child	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
arginine	arginine	NN	I-NP	B-protein
deiminase	deiminase	NN	I-NP	I-protein
system	system	NN	I-NP	O
(	(	(	O	O
ADS	ADS	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
generator	generator	NN	I-NP	O
of	of	IN	B-PP	O
alkali	alkali	NN	B-NP	O
(	(	(	O	O
ammonia	ammonia	NN	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
considered	consider	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
anticaries	anticary	NNS	B-NP	O
effects	effect	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
many	many	JJ	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
agents	agent	NNS	I-NP	O
used	use	VBN	B-VP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
care	care	NN	I-NP	O
products	product	NNS	I-NP	O
may	may	MD	B-VP	O
reduce	reduce	VB	I-VP	O
alkali	alkali	JJ	B-NP	O
production	production	NN	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
ADS	ADS	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
objective	objective	NN	I-NP	O
of	of	IN	B-PP	O
our	our	PRP$	B-NP	O
work	work	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ADS	ADS	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
streptococci	streptococci	NNS	I-NP	O
to	to	TO	B-PP	O
commonly	commonly	RB	B-NP	O
used	use	VBN	I-NP	O
antimicrobials	antimicrobial	NNS	I-NP	O
,	,	,	O	O
fluoride	fluoride	NN	B-NP	O
,	,	,	O	O
triclosan	triclosan	NN	B-NP	O
and	and	CC	O	O
organic	organic	JJ	B-NP	O
weak	weak	JJ	I-NP	O
acids	acid	NNS	I-NP	O
.	.	.	O	O

Streptococcus	Streptococcus	NNP	B-NP	O
sanguinis	sanguinis	NNP	I-NP	O
NCTC	NCTC	NNP	I-NP	O
10904	10904	CD	I-NP	O
and	and	CC	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
ratti	ratti	NNS	I-NP	O
FA-1	FA-1	NN	I-NP	B-protein
were	be	VBD	B-VP	O
grown	grow	VBN	I-VP	O
in	in	IN	B-PP	O
suspension	suspension	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
and	and	CC	O	O
mono-organism	mono-organism	NN	B-NP	O
biofilms	biofilm	NNS	I-NP	O
.	.	.	O	O

ADS	ADS	NN	B-NP	O
activity	activity	NN	I-NP	O
at	at	IN	B-PP	O
pH	pH	NN	B-NP	O
values	value	NNS	I-NP	O
of	of	IN	B-PP	O
4	4	CD	B-NP	O
,	,	,	I-NP	O
5	5	CD	I-NP	O
and	and	CC	I-NP	O
6	6	CD	I-NP	O
was	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
actions	action	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
agents	agent	NNS	I-NP	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
reduced	reduced	JJ	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
alkali	alkali	NNS	B-NP	O
from	from	IN	B-PP	O
arginine	arginine	NN	B-NP	O
,	,	,	O	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
ADS	ADS	NN	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
and	and	CC	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
uptake	uptake	NN	B-NP	O
of	of	IN	B-PP	O
arginine	arginine	NN	B-NP	O
.	.	.	O	O

ADS	ADS	NN	B-NP	O
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
greatly	greatly	RB	I-VP	O
affected	affect	VBN	I-VP	O
by	by	IN	B-PP	O
pH	pH	NN	B-NP	O
changes	change	NNS	I-NP	O
between	between	IN	B-PP	O
4	4	CD	B-NP	O
and	and	CC	I-NP	O
6	6	CD	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
per	per	IN	B-PP	O
unit	unit	NN	B-NP	O
of	of	IN	B-PP	O
biomass	biomass	NN	B-NP	O
for	for	IN	B-PP	O
cell	cell	NN	B-NP	O
suspensions	suspension	NNS	I-NP	O
than	than	IN	B-PP	O
for	for	IN	B-PP	O
biofilms	biofilm	NNS	B-NP	O
.	.	.	O	O

NaF	NaF	NN	B-NP	B-protein
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
poor	poor	JJ	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
triclosan	triclosan	NN	B-NP	O
was	be	VBD	B-VP	O
highly	highly	RB	B-ADJP	O
effective	effective	JJ	I-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
50	50	CD	I-NP	O
%	%	NN	I-NP	O
inhibitory	inhibitory	JJ	I-NP	O
dose	dose	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
organisms	organism	NNS	I-NP	O
between	between	IN	B-PP	O
0.03	0.03	CD	B-NP	O
and	and	CC	I-NP	O
0.05	0.05	CD	I-NP	O
and	and	CC	O	O
between	between	IN	B-PP	O
0.10	0.10	CD	B-NP	O
and	and	CC	I-NP	O
0.15	0.15	CD	I-NP	O
mm-h	mm-h	NN	I-NP	O
for	for	IN	B-PP	O
suspension	suspension	NN	B-NP	O
cells	cell	NNS	I-NP	O
and	and	CC	O	O
biofilms	biofilm	NNS	B-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
weak	weak	JJ	I-NP	O
acid	acid	NN	I-NP	O
indomethacin	indomethacin	NN	I-NP	O
was	be	VBD	B-VP	O
nearly	nearly	RB	B-ADJP	O
as	as	RB	I-ADJP	O
potent	potent	JJ	I-ADJP	O
at	at	IN	B-PP	O
pH	pH	NN	B-NP	O
4.0	4.0	CD	I-NP	O
as	as	IN	B-PP	O
triclosan	triclosan	NN	B-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
capric	capric	JJ	B-NP	O
and	and	CC	I-NP	O
lauric	lauric	JJ	I-NP	O
acids	acid	NNS	I-NP	O
were	be	VBD	B-VP	O
less	less	RBR	B-ADJP	O
potent	potent	JJ	I-ADJP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
for	for	IN	B-PP	O
biofilms	biofilm	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
methyl	methyl	NN	I-NP	O
ester	ester	NN	I-NP	O
of	of	IN	B-PP	O
lauric	lauric	JJ	B-NP	O
acid	acid	NN	I-NP	O
was	be	VBD	B-VP	O
slightly	slightly	RB	B-ADJP	O
stimulatory	stimulatory	JJ	I-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
major	major	JJ	I-NP	O
targets	target	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
inhibitors	inhibitor	NNS	I-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
transport	transport	NN	B-NP	O
systems	system	NNS	I-NP	O
for	for	IN	B-PP	O
arginine	arginine	NN	B-NP	O
uptake	uptake	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
carbamate	carbamate	NN	B-NP	B-protein
kinase	kinase	NN	I-NP	I-protein
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
secondary	secondary	JJ	I-NP	O
target	target	NN	I-NP	O
.	.	.	O	O

Triclosan	Triclosan	NN	B-NP	O
,	,	,	I-NP	O
indomethacin	indomethacin	NN	I-NP	O
,	,	,	I-NP	O
caprate	caprate	NN	I-NP	O
and	and	CC	I-NP	O
laurate	laurate	NN	I-NP	O
can	can	MD	B-VP	O
reduce	reduce	VB	I-VP	O
ADS	ADS	NN	B-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
objective	objective	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
select	select	JJ	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
biofilms	biofilm	NNS	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
relationships	relationship	NNS	B-NP	O
between	between	IN	B-PP	O
oral	oral	JJ	B-NP	O
and	and	CC	I-NP	O
respiratory	respiratory	JJ	I-NP	O
status	status	NN	I-NP	O
in	in	IN	B-PP	O
persons	person	NNS	B-NP	O
with	with	IN	B-PP	O
mental	mental	JJ	B-NP	O
retardation/intellectual	retardation/intellectual	JJ	I-NP	O
and	and	CC	I-NP	O
developmental	developmental	JJ	I-NP	O
disabilities	disability	NNS	I-NP	O
(	(	(	O	O
IDD	IDD	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

We	We	PRP	B-NP	O
conducted	conduct	VBD	B-VP	O
a	a	DT	B-NP	O
6-month-long	6-month-long	JJ	I-NP	O
observational	observational	JJ	I-NP	O
cohort	cohort	JJ	I-NP	O
study	study	NN	I-NP	O
with	with	IN	B-PP	O
63	63	CD	B-NP	O
persons	person	NNS	I-NP	O
with	with	IN	B-PP	O
IDD	IDD	NN	B-NP	B-protein
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
examinations	examination	NNS	I-NP	O
,	,	,	O	O
oral	oral	JJ	B-NP	O
sampling	sampling	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
medical	medical	JJ	B-NP	O
record	record	NN	I-NP	O
reviews	review	NNS	I-NP	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
and	and	CC	O	O
then	then	RB	O	O
monthly	monthly	RB	B-ADVP	O
.	.	.	O	O

Polymerase	Polymerase	NN	B-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
(	(	(	O	O
PCR	PCR	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
analyze	analyze	VB	I-VP	O
all	all	DT	B-NP	O
baseline	baseline	NN	I-NP	O
oral	oral	JJ	I-NP	O
samples	sample	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
pneumoniae	pneumoniae	NNP	I-NP	O
,	,	,	O	O
Methicillin-resistant	Methicillin-resistant	JJ	B-NP	O
Staphylococcus	Staphylococcus	FW	I-NP	O
aureus	aureus	FW	I-NP	O
(	(	(	O	O
MRSA	MRSA	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
Prevotella	Prevotella	NN	B-NP	O
melaninogenica	melaninogenica	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Candida	Candida	NNP	B-NP	O
albicans	albicans	NNP	I-NP	O
.	.	.	O	O

PCR	PCR	NN	B-NP	O
analyses	analysis	NNS	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
performed	perform	VBN	I-VP	O
on	on	IN	B-PP	O
participants	participant	NNS	B-NP	O
'	'	POS	B-NP	O
samples	sample	NNS	I-NP	O
collected	collect	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
month	month	NN	I-NP	O
before	before	IN	B-PP	O
being	be	VBG	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
respiratory	respiratory	JJ	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
subjects	subject	NNS	I-NP	O
had	have	VBD	B-VP	O
P.	P.	NNP	B-NP	O
melaninogenica	melaninogenica	NN	I-NP	O
detected	detect	VBN	B-VP	O
by	by	IN	B-PP	O
PCR	PCR	NN	B-NP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
oral	oral	JJ	I-NP	O
samples	sample	NNS	I-NP	O
.	.	.	O	O

Fifty-five	Fifty-five	CD	B-NP	O
percent	percent	NN	I-NP	O
(	(	(	O	O
35	35	CD	B-NP	O
of	of	IN	B-PP	O
63	63	CD	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
participants	participant	NNS	B-NP	O
had	have	VBD	B-VP	O
S.	S.	NNP	B-NP	O
pneumoniae	pneumoniae	NNP	I-NP	O
,	,	,	O	O
MRSA	MRSA	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
C.	C.	NNP	B-NP	O
albicans	albicans	NNP	I-NP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
oral	oral	JJ	I-NP	O
samples	sample	NNS	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dental	dental	JJ	I-NP	O
decay	decay	NN	I-NP	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
clinically	clinically	RB	B-ADVP	O
,	,	,	O	O
oral	oral	JJ	B-NP	O
hygiene	hygiene	NN	I-NP	O
was	be	VBD	B-VP	O
fair	fair	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
dysphagia	dysphagia	NN	B-NP	O
was	be	VBD	B-VP	O
common	common	JJ	B-ADJP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
6	6	CD	I-NP	O
months	month	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
22	22	CD	B-NP	O
respiratory	respiratory	JJ	I-NP	O
infections	infection	NNS	I-NP	O
(	(	(	O	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
participants	participant	NNS	B-NP	O
)	)	)	O	O
-12	-12	CD	B-NP	O
pneumonias	pneumonia	NNS	I-NP	O
,	,	,	O	O
7	7	CD	B-NP	O
sinusitis	sinusitis	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
bronchitis	bronchitis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
upper	upper	JJ	I-NP	O
respiratory	respiratory	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

Participants	Participant	NNS	B-NP	O
with	with	IN	B-PP	O
microorganisms	microorganism	NNS	B-NP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
more	more	RBR	I-ADJP	O
likely	likely	JJ	I-ADJP	O
to	to	TO	B-VP	O
develop	develop	VB	I-VP	O
any	any	DT	B-NP	O
respiratory	respiratory	JJ	I-NP	O
infection	infection	NN	I-NP	O
and	and	CC	O	O
those	those	DT	B-NP	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
poor	poor	JJ	B-NP	O
oral	oral	JJ	I-NP	O
status	status	NN	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
more	more	RBR	I-ADJP	O
likely	likely	JJ	I-ADJP	O
to	to	TO	B-VP	O
develop	develop	VB	I-VP	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

Almost	Almost	RB	B-NP	O
60	60	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
participants	participant	NNS	B-NP	O
who	who	WP	B-NP	O
developed	develop	VBD	B-VP	O
respiratory	respiratory	JJ	B-NP	O
infections	infection	NNS	I-NP	O
had	have	VBD	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
microorganism	microorganism	NN	I-NP	O
detected	detect	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
sample	sample	NN	I-NP	O
collected	collect	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
month	month	NN	I-NP	O
before	before	IN	B-PP	O
infection	infection	NN	B-NP	O
as	as	IN	B-SBAR	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
sample	sample	NN	I-NP	O
.	.	.	O	O

Potentially	Potentially	RB	B-NP	O
pathogenic	pathogenic	JJ	I-NP	O
microorganisms	microorganism	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
and	and	CC	O	O
poor	poor	JJ	B-NP	O
oral	oral	JJ	I-NP	O
status	status	NN	I-NP	O
significantly	significantly	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
the	the	DT	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
developing	develop	VBG	B-VP	O
respiratory	respiratory	JJ	B-NP	O
infections	infection	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
persons	person	NNS	B-NP	O
with	with	IN	B-PP	O
IDD	IDD	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
colonization	colonization	NN	B-NP	O
with	with	IN	B-PP	O
these	these	DT	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
may	may	MD	B-VP	O
persist	persist	VB	I-VP	O
despite	despite	IN	B-PP	O
routine	routine	JJ	B-NP	O
tooth	tooth	NN	I-NP	O
brushing	brushing	NN	I-NP	O
.	.	.	O	O

Meticulous	Meticulous	JJ	B-NP	O
comprehensive	comprehensive	JJ	I-NP	O
oral	oral	JJ	I-NP	O
hygiene	hygiene	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
needed	need	VBN	I-VP	O
to	to	TO	B-VP	O
reduce	reduce	VB	I-VP	O
oropharyngeal	oropharyngeal	JJ	B-NP	O
microbial	microbial	JJ	I-NP	O
load	load	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
study	study	VB	I-VP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
carriage	carriage	NN	I-NP	O
of	of	IN	B-PP	O
Enterococcus	Enterococcus	NN	B-NP	O
and	and	CC	O	O
Escherichia	Escherichia	FW	B-NP	O
coli	coli	FW	I-NP	O
isolates	isolate	NNS	I-NP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
content	content	NN	I-NP	O
in	in	IN	B-PP	O
antimicrobial-resistance	antimicrobial-resistance	JJ	B-NP	O
and	and	CC	I-NP	O
virulence	virulence	NN	I-NP	O
genes	gene	NNS	B-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
fixed	fix	VBN	B-NP	O
appliances	appliance	NNS	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
volunteers	volunteer	NNS	I-NP	O
.	.	.	O	O

STUDY	STUDY	NN	B-NP	O
Samples	Sample	NNS	I-NP	O
from	from	IN	B-PP	O
supragingival	supragingival	JJ	B-NP	O
plaques/tooth	plaques/tooth	NN	I-NP	O
surfaces/fixed	surfaces/fixe	VBD	B-VP	O
orthodontic	orthodontic	JJ	B-NP	O
appliances	appliance	NNS	I-NP	O
were	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
fixed	fix	VBN	B-NP	O
appliances	appliance	NNS	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
46	46	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
volunteers	volunteer	NNS	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
55	55	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Samples	Sample	NNS	B-NP	O
were	be	VBD	B-VP	O
seeded	seed	VBN	I-VP	O
on	on	IN	B-PP	O
specific	specific	JJ	B-NP	O
media	medium	NNS	I-NP	O
for	for	IN	B-PP	O
enterococcal	enterococcal	JJ	B-NP	O
and	and	CC	I-NP	O
E.	E.	FW	I-NP	O
coli	coli	FW	I-NP	O
recovery	recovery	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
1	1	CD	B-NP	O
isolate	isolate	NN	I-NP	O
of	of	IN	B-PP	O
each	each	DT	B-NP	O
type	type	NN	I-NP	O
per	per	IN	B-PP	O
sample	sample	NN	B-NP	O
was	be	VBD	B-VP	O
selected	select	VBN	I-VP	O
.	.	.	O	O

Antimicrobial	Antimicrobial	JJ	B-NP	O
susceptibility	susceptibility	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
genes	gene	NNS	B-NP	O
encoding	encode	VBG	B-VP	O
antimicrobial	antimicrobial	JJ	B-NP	O
resistance	resistance	NN	I-NP	O
,	,	,	O	O
bacteriocins	bacteriocin	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
virulence	virulence	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
by	by	IN	B-PP	O
polymerase	polymerase	NN	B-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
.	.	.	O	O

Enterococci	Enterococci	NNS	B-NP	O
or	or	CC	O	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
recovered	recover	VBN	I-VP	O
from	from	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
volunteers	volunteer	NNS	I-NP	O
.	.	.	O	O

Nevertheless	Nevertheless	RB	B-ADVP	O
,	,	,	O	O
10	10	CD	B-NP	O
isolates	isolate	NNS	I-NP	O
(	(	(	O	O
5	5	CD	B-NP	O
E.	E.	NNP	I-NP	O
faecium	faecium	NN	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
E.	E.	NNP	I-NP	O
faecalis	faecalis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
2	2	CD	B-NP	O
E.	E.	FW	I-NP	O
coli	coli	FW	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
from	from	IN	B-PP	O
19.5	19.5	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
fixed	fix	VBN	B-NP	O
appliances	appliance	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
poor	poor	JJ	B-NP	O
oral	oral	JJ	I-NP	O
hygiene	hygiene	NN	I-NP	O
was	be	VBD	B-VP	O
evidenced	evidence	VBN	I-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
these	these	DT	I-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

Percentages	Percentage	NNS	B-NP	O
of	of	IN	B-PP	O
antimicrobial	antimicrobial	JJ	B-NP	O
resistance	resistance	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
resistance	resistance	NN	I-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
detected	detect	VBN	B-VP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
enterococci	enterococci	NNS	I-NP	O
were	be	VBD	B-VP	O
:	:	:	O	O
erythromycin	erythromycin	NN	B-NP	O
:	:	:	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
erm	erm	NN	B-NP	O
(	(	(	O	O
B	B	NN	B-NP	O
)	)	)	O	O
;	;	:	O	O
kanamycin	kanamycin	NN	B-NP	O
:	:	:	O	O
75	75	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
aph	aph	NN	B-NP	O
(	(	(	O	O
3	3	CD	O	O
'	'	SYM	O	O
)	)	)	O	O
-IIIa	-IIIa	NN	B-NP	O
;	;	:	O	O
tetracycline	tetracycline	NN	B-NP	O
:	:	:	O	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
tet	tet	NN	B-NP	O
(	(	(	O	O
L	L	NN	B-NP	O
)	)	)	O	O
with/without	with/without	IN	B-PP	O
tet	tet	NN	B-NP	O
(	(	(	O	O
M	M	NN	B-NP	O
)	)	)	O	O
;	;	:	O	O
streptomycin	streptomycin	NN	B-NP	O
:	:	:	O	O
37	37	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
ant	ant	NN	B-NP	O
(	(	(	O	O
6	6	CD	B-NP	O
)	)	)	O	O
-Ia	-Ia	NN	B-NP	O
;	;	:	O	O
chloramphenicol	chloramphenicol	NN	B-NP	O
:	:	:	O	O
12	12	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
catA	catA	NN	B-NP	B-protein
.	.	.	O	O

One	One	CD	B-NP	O
E.	E.	FW	I-NP	O
coli	coli	FW	I-NP	O
isolate	isolate	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
phenotype	phenotype	NN	I-NP	O
of	of	IN	B-PP	O
multiresistance	multiresistance	NN	B-NP	O
containing	contain	VBG	B-VP	O
5	5	CD	B-NP	B-DNA
resistance	resistance	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
and	and	CC	O	O
class	class	NN	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
2	2	CD	I-NP	O
integrons	integron	NNS	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
enterococci	enterococci	NNS	I-NP	O
produced	produce	VBD	B-VP	O
gelatinase	gelatinase	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
4	4	CD	B-NP	O
isolates	isolate	NNS	I-NP	O
contained	contain	VBD	B-VP	O
genes	gene	NNS	B-NP	O
encoding	encode	VBG	B-VP	O
enterocins	enterocin	NNS	B-NP	O
L50A/B	L50A/B	NN	I-NP	B-protein
and	and	CC	O	O
P.	P.	NNP	B-NP	O
The	The	DT	B-NP	O
esp	esp	NN	I-NP	B-DNA
virulence	virulence	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
multiresistant	multiresistant	JJ	I-NP	O
E.	E.	NNP	I-NP	O
faecalis	faecalis	NN	I-NP	O
isolate	isolate	NN	I-NP	O
.	.	.	O	O

Poor	Poor	NN	B-NP	O
or	or	CC	I-NP	O
improper	improper	JJ	I-NP	O
oral	oral	JJ	I-NP	O
hygiene	hygiene	NN	I-NP	O
in	in	IN	B-PP	O
individuals	individual	NNS	B-NP	O
with	with	IN	B-PP	O
fixed	fixed	JJ	B-NP	O
appliances	appliance	NNS	I-NP	O
favors	favor	VBZ	B-VP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
carriage	carriage	NN	I-NP	O
of	of	IN	B-PP	O
antimicrobial-resistant	antimicrobial-resistant	JJ	B-NP	O
E.	E.	FW	I-NP	O
coli	coli	FW	I-NP	O
and	and	CC	O	O
enterococci	enterococci	NNS	B-NP	O
.	.	.	O	O

Additional	Additional	JJ	B-NP	O
investigations	investigation	NNS	I-NP	O
are	be	VBP	B-VP	O
needed	need	VBN	I-VP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
its	its	PRP$	B-NP	O
implication	implication	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
health	health	NN	I-NP	O
.	.	.	O	O

Vaccination	Vaccination	NN	B-NP	O
against	against	IN	B-PP	O
Pseudomonas	Pseudomonas	NN	B-NP	O
aeruginosa	aeruginosa	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
desirable	desirable	JJ	I-NP	O
,	,	,	I-NP	O
yet	yet	RB	I-NP	O
challenging	challenging	JJ	I-NP	O
strategy	strategy	NN	I-NP	O
for	for	IN	B-PP	O
prevention	prevention	NN	B-NP	O
of	of	IN	B-PP	O
airway	airway	NN	B-NP	O
infection	infection	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
cystic	cystic	JJ	B-NP	O
fibrosis	fibrosis	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
compared	compare	VBD	B-VP	O
the	the	DT	B-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
antibodies	antibody	NNS	B-NP	B-protein
in	in	IN	B-PP	O
lower	low	JJR	B-NP	O
airways	airway	NNS	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
systemic	systemic	JJ	B-NP	O
and	and	CC	I-NP	O
mucosal	mucosal	JJ	I-NP	O
vaccination	vaccination	NN	I-NP	O
strategies	strategy	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
immunised	immunise	VBD	B-VP	O
48	48	CD	B-NP	O
volunteers	volunteer	NNS	I-NP	O
in	in	IN	B-PP	O
six	six	CD	B-NP	O
vaccination	vaccination	NN	I-NP	O
groups	group	NNS	I-NP	O
with	with	IN	B-PP	O
either	either	CC	O	O
a	a	DT	B-NP	O
systemic	systemic	JJ	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
nasal	nasal	JJ	I-NP	O
,	,	,	O	O
or	or	CC	O	O
four	four	CD	B-NP	O
newly	newly	RB	I-NP	O
constructed	construct	VBN	I-NP	O
oral	oral	JJ	I-NP	O
live	live	JJ	I-NP	O
vaccines	vaccine	NNS	I-NP	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
attenuated	attenuate	VBN	B-NP	O
live	live	JJ	I-NP	O
Salmonella	Salmonella	NNP	I-NP	O
(	(	(	O	O
strains	strain	NNS	B-NP	O
CVD908	CVD908	NN	B-NP	O
and	and	CC	O	O
Ty21a	Ty21a	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
systemic	systemic	JJ	I-NP	O
booster	booster	NN	I-NP	O
vaccination	vaccination	NN	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
vaccines	vaccine	NNS	I-NP	O
were	be	VBD	B-VP	O
based	base	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
recombinant	recombinant	JJ	I-NP	B-protein
fusion	fusion	NN	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
highly	highly	RB	I-NP	O
conserved	conserve	VBN	I-NP	O
P.	P.	NNP	I-NP	O
aeruginosa	aeruginosa	NNP	I-NP	O
outer	outer	JJ	I-NP	O
membrane	membrane	NN	I-NP	O
proteins	protein	NNS	I-NP	O
OprF	OprF	NN	I-NP	B-protein
and	and	CC	I-NP	O
OprI	OprI	NN	I-NP	B-protein
as	as	IN	B-PP	O
antigen	antigen	NN	B-NP	B-protein
.	.	.	O	O

While	While	IN	B-SBAR	O
systemic	systemic	JJ	B-NP	O
and	and	CC	I-NP	O
mucosal	mucosal	JJ	I-NP	O
vaccines	vaccine	NNS	I-NP	O
induced	induce	VBD	B-VP	O
a	a	DT	B-NP	O
comparable	comparable	JJ	I-NP	O
rise	rise	NN	I-NP	O
of	of	IN	B-PP	O
serum	serum	NN	B-NP	O
antibody	antibody	NN	I-NP	O
titers	titer	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
rise	rise	NN	I-NP	O
of	of	IN	B-PP	O
IgA	IgA	NN	B-NP	B-protein
and	and	CC	I-NP	O
IgG	IgG	NN	I-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
airways	airway	NNS	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
only	only	RB	B-ADVP	O
after	after	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
and	and	CC	I-NP	O
oral	oral	JJ	I-NP	O
vaccinations	vaccination	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
nasal	nasal	JJ	B-NP	O
and	and	CC	I-NP	O
oral	oral	JJ	I-NP	O
OprF-OprI	OprF-OprI	NN	I-NP	O
vaccines	vaccine	NNS	I-NP	O
are	be	VBP	B-VP	O
promising	promising	JJ	B-NP	O
candidates	candidate	NNS	I-NP	O
for	for	IN	B-PP	O
development	development	NN	B-NP	O
of	of	IN	B-PP	O
antipseudomonal	antipseudomonal	JJ	B-NP	O
immunisation	immunisation	NN	I-NP	O
through	through	IN	B-PP	O
inducing	induce	VBG	B-VP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
antibody	antibody	NN	I-NP	O
response	response	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lung	lung	NN	I-NP	O
.	.	.	O	O

Periodontal	Periodontal	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
(	(	(	O	O
PDs	PD	NNS	B-NP	O
)	)	)	O	O
are	be	VBP	B-VP	O
infectious	infectious	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
periodontopathogens	periodontopathogen	NNS	B-NP	O
trigger	trigger	VBP	B-VP	O
chronic	chronic	JJ	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
and	and	CC	I-NP	O
immune	immune	JJ	I-NP	O
responses	response	NNS	I-NP	O
that	that	WDT	B-NP	O
lead	lead	VBP	B-VP	O
to	to	TO	B-PP	O
tissue	tissue	NN	B-NP	O
destruction	destruction	NN	I-NP	O
.	.	.	O	O

Recently	Recently	RB	B-ADVP	O
,	,	,	O	O
viruses	virus	NNS	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
implicated	implicate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
PDs	PD	NNS	B-NP	O
.	.	.	O	O

Individuals	Individual	NNS	B-NP	O
infected	infect	VBN	B-VP	O
with	with	IN	B-PP	O
human	human	JJ	B-NP	O
T	T	NN	I-NP	O
lymphotropic	lymphotropic	JJ	I-NP	O
virus	virus	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
HTLV-1	HTLV-1	NN	B-NP	O
)	)	)	O	O
present	present	JJ	B-ADJP	O
with	with	IN	B-PP	O
abnormal	abnormal	JJ	B-NP	O
oral	oral	JJ	I-NP	O
health	health	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
marked	marked	JJ	I-NP	O
increased	increase	VBN	I-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
patterns	pattern	NNS	I-NP	O
of	of	IN	B-PP	O
periodontopathogen	periodontopathogen	NN	B-NP	O
infection	infection	NN	I-NP	O
and	and	CC	O	O
local	local	JJ	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
immune	immune	JJ	I-NP	O
markers	marker	NNS	I-NP	O
in	in	IN	B-PP	O
HTLV-1-seropositive	HTLV-1-seropositive	JJ	B-NP	O
individuals	individual	NNS	I-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
(	(	(	O	O
CP/HTLV-1	CP/HTLV-1	NN	B-NP	O
group	group	NN	I-NP	O
)	)	)	O	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
HTLV-1-seronegative	HTLV-1-seronegative	JJ	B-NP	O
individuals	individual	NNS	I-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
(	(	(	O	O
CP	CP	NN	B-NP	B-protein
group	group	NN	I-NP	I-protein
)	)	)	O	O
and	and	CC	O	O
periodontally	periodontally	RB	B-NP	O
healthy	healthy	JJ	I-NP	O
,	,	,	I-NP	O
HTLV-1-seronegative	HTLV-1-seronegative	JJ	I-NP	O
individuals	individual	NNS	I-NP	O
(	(	(	O	O
control	control	NN	B-NP	O
group	group	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Patients	Patient	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CP/HTLV-1	CP/HTLV-1	NN	I-NP	O
group	group	NN	I-NP	O
had	have	VBD	B-VP	O
significantly	significantly	RB	B-NP	O
higher	high	JJR	I-NP	O
values	value	NNS	I-NP	O
of	of	IN	B-PP	O
bleeding	bleed	VBG	B-VP	O
on	on	IN	B-PP	O
probing	probing	NN	B-NP	O
,	,	,	O	O
mean	mean	JJ	B-NP	O
probing	probing	NN	I-NP	O
depth	depth	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
attachment	attachment	NN	B-NP	O
loss	loss	NN	I-NP	O
than	than	IN	B-PP	O
patients	patient	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CP	CP	NN	I-NP	B-DNA
group	group	NN	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
tumor	tumor	NN	B-NP	B-protein
necrosis	necrosis	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
alpha	alpha	NN	I-NP	I-protein
and	and	CC	O	O
interleukin	interleukin	NN	B-NP	B-protein
(	(	(	O	I-protein
IL	IL	NN	B-NP	I-protein
)	)	)	O	I-protein
4	4	CD	B-NP	I-protein
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
similar	similar	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CP	CP	NN	I-NP	B-DNA
and	and	CC	I-NP	O
CP/HTLV-1	CP/HTLV-1	NN	I-NP	B-protein
groups	group	NNS	I-NP	I-protein
,	,	,	O	O
whereas	whereas	IN	O	O
IL-12	IL-12	NN	B-NP	B-protein
and	and	CC	I-NP	O
IL-17	IL-17	NN	I-NP	B-protein
levels	level	NNS	I-NP	O
trended	trend	VBN	B-VP	O
toward	toward	IN	B-PP	O
a	a	DT	B-NP	O
higher	high	JJR	I-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CP/HTLV-1	CP/HTLV-1	NN	I-NP	O
group	group	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
significant	significant	JJ	I-NP	O
increase	increase	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
IL-1beta	IL-1beta	NN	B-NP	B-protein
and	and	CC	I-NP	O
interferon	interferon	NN	I-NP	B-protein
gamma	gamma	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CP/HTLV-1	CP/HTLV-1	NN	I-NP	O
group	group	NN	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
CP	CP	NN	I-NP	B-DNA
group	group	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	O
T	T	NN	I-NP	O
cell	cell	NN	I-NP	O
marker	marker	NN	I-NP	O
FOXp3	FOXp3	NN	I-NP	O
and	and	CC	I-NP	O
IL-10	IL-10	NN	I-NP	B-protein
was	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lesions	lesion	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
CP/HTLV-1	CP/HTLV-1	NN	I-NP	B-protein
group	group	NN	I-NP	I-protein
.	.	.	O	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
similar	similar	JJ	B-NP	O
frequency	frequency	NN	I-NP	O
and/or	and/or	CC	I-NP	O
load	load	NN	I-NP	O
of	of	IN	B-PP	O
periodontopathogens	periodontopathogen	NNS	B-NP	O
(	(	(	O	O
Porphyromonas	Porphyromonas	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
Tannerella	Tannerella	NNP	B-NP	O
forsythia	forsythia	NNP	I-NP	O
,	,	,	O	O
Treponema	Treponema	NNP	B-NP	O
denticola	denticola	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Aggregatibacter	Aggregatibacter	NNP	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
)	)	)	O	O
and	and	CC	O	O
frequency	frequency	NN	B-NP	O
of	of	IN	B-PP	O
viruses	virus	NNS	B-NP	O
(	(	(	O	O
herpes	herpes	NN	B-NP	O
simplex	simplex	NN	I-NP	O
virus	virus	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	O	O
human	human	JJ	B-NP	O
cytomegalovirus	cytomegalovirus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Epstein-Barr	Epstein-Barr	JJ	B-NP	O
virus	virus	NN	I-NP	O
)	)	)	O	O
characteristically	characteristically	RB	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
PDs	PD	NNS	B-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CP/HTLV	CP/HTLV	NN	I-NP	O
and	and	CC	I-NP	O
CP	CP	NN	I-NP	B-protein
groups	group	NNS	I-NP	I-protein
.	.	.	O	O

HTLV-1	HTLV-1	NN	B-NP	O
may	may	MD	B-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
critical	critical	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
deregulation	deregulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
local	local	JJ	I-NP	O
cytokine	cytokine	NN	I-NP	O
network	network	NN	I-NP	O
,	,	,	O	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
exacerbated	exacerbated	JJ	I-NP	O
response	response	NN	I-NP	O
against	against	IN	B-PP	O
a	a	DT	B-NP	O
standard	standard	JJ	I-NP	O
periodontopathogen	periodontopathogen	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
well	well	RB	I-VP	O
established	establish	VBN	I-VP	O
that	that	IN	B-SBAR	O
severe	severe	JJ	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
clusters	cluster	NNS	I-NP	O
in	in	IN	B-PP	O
families	family	NNS	B-NP	O
,	,	,	O	O
but	but	CC	O	O
there	there	EX	B-NP	O
are	be	VBP	B-VP	O
no	no	DT	B-NP	O
data	datum	NNS	I-NP	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
mothers	mother	NNS	B-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
children	child	NNS	I-NP	O
's	's	POS	B-NP	O
periodontal	periodontal	JJ	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
a	a	DT	B-NP	O
risk	risk	NN	I-NP	O
for	for	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
in	in	IN	B-PP	O
children	child	NNS	B-NP	O
of	of	IN	B-PP	O
periodontally	periodontally	RB	B-NP	O
diseased	diseased	JJ	I-NP	O
and	and	CC	I-NP	O
healthy	healthy	JJ	I-NP	O
mothers	mother	NNS	I-NP	O
.	.	.	O	O

Four	Four	CD	B-NP	O
study	study	NN	I-NP	O
groups	group	NNS	I-NP	O
were	be	VBD	B-VP	O
included	include	VBN	I-VP	O
:	:	:	O	O
(	(	(	O	O
I	I	CD	B-NP	O
)	)	)	O	O
20	20	CD	B-NP	O
female	female	JJ	I-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
untreated	untreated	JJ	B-NP	O
generalized	generalize	VBN	I-NP	O
severe	severe	JJ	I-NP	O
chronic	chronic	JJ	I-NP	O
periodontitis	periodontitis	NN	I-NP	O
,	,	,	O	O
(	(	(	O	O
II	II	CD	B-NP	O
)	)	)	O	O
their	their	PRP$	B-NP	O
children	child	NNS	I-NP	O
(	(	(	O	O
34	34	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
(	(	(	O	O
III	III	CD	B-NP	O
)	)	)	O	O
13	13	CD	B-NP	O
periodontally	periodontally	RB	I-NP	O
healthy	healthy	JJ	I-NP	O
mothers	mother	NNS	I-NP	O
and	and	CC	O	O
(	(	(	O	O
IV	IV	CD	B-NP	O
)	)	)	O	O
their	their	PRP$	B-NP	O
children	child	NNS	I-NP	O
(	(	(	O	O
13	13	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Material	Material	NN	B-NP	O
was	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
from	from	IN	B-PP	O
years	year	NNS	B-NP	O
2004-2006	2004-2006	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
examination	examination	NN	I-NP	O
included	include	VBD	B-VP	O
registration	registration	NN	B-NP	O
of	of	IN	B-PP	O
visible	visible	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
index	index	NN	I-NP	O
,	,	,	O	O
modified	modify	VBN	B-VP	O
gingival	gingival	JJ	B-NP	O
index	index	NN	I-NP	O
and	and	CC	O	O
,	,	,	O	O
bleeding	bleed	VBG	B-VP	O
sites	site	NNS	B-NP	O
on	on	IN	B-PP	O
probing	probing	NN	B-NP	O
.	.	.	O	O

Periodontal	Periodontal	JJ	B-NP	O
microbiological	microbiological	JJ	I-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
from	from	IN	B-PP	O
all	all	DT	B-NP	O
study	study	NN	I-NP	O
subjects	subject	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
isolates	isolate	NNS	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
morphology	morphology	NN	B-NP	O
and	and	CC	O	O
biochemical	biochemical	JJ	B-NP	O
profiles	profile	NNS	I-NP	O
;	;	:	O	O
similar	similar	JJ	B-NP	O
interfamilial	interfamilial	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
by	by	IN	B-PP	O
PCR-technique	PCR-technique	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
children	child	NNS	I-NP	O
of	of	IN	B-PP	O
diseased	diseased	JJ	B-NP	O
mothers	mother	NNS	I-NP	O
more	more	RBR	B-ADVP	O
frequently	frequently	RB	I-ADVP	O
had	have	VBD	B-VP	O
periodontal	periodontal	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
,	,	,	O	O
especially	especially	RB	B-NP	O
gingivitis	gingivitis	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
clinical	clinical	JJ	B-NP	O
parameters	parameter	NNS	I-NP	O
of	of	IN	B-PP	O
gingival	gingival	JJ	B-NP	O
inflammation	inflammation	NN	I-NP	O
were	be	VBD	B-VP	O
more	more	RBR	B-NP	O
expressed	express	VBN	I-NP	O
and	and	CC	I-NP	O
oral	oral	JJ	I-NP	O
hygiene	hygiene	NN	I-NP	O
was	be	VBD	B-VP	O
worse	worse	JJR	B-ADJP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
children	child	NNS	B-NP	O
.	.	.	O	O

VPI	VPI	NN	B-NP	B-protein
and	and	CC	I-NP	O
VPI	VPI	NN	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
diseased	diseased	JJ	I-NP	O
and	and	CC	I-NP	O
healthy	healthy	JJ	I-NP	O
mothers	mother	NNS	I-NP	O
differed	differ	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
most	most	RBS	I-NP	O
common	common	JJ	I-NP	O
oral	oral	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
were	be	VBD	B-VP	O
P.	P.	NNP	B-NP	O
intermedia/nigrescens	intermedia/nigrescen	NNS	I-NP	O
and	and	CC	O	O
A.	A.	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
children	child	NNS	I-NP	O
of	of	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
mothers	mother	NNS	I-NP	O
harboured	harbour	VBD	B-VP	O
pathogens	pathogen	NNS	B-NP	O
less	less	RBR	B-ADVP	O
frequently	frequently	RB	I-ADVP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
children	child	NNS	I-NP	O
of	of	IN	B-PP	O
diseased	diseased	JJ	B-NP	O
mothers	mother	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
sharing	sharing	NN	I-NP	O
of	of	IN	B-PP	O
P.	P.	NNP	B-NP	O
intermedia/nigrescens	intermedia/nigrescens	NNP	I-NP	O
was	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
frequent	frequent	JJ	I-ADJP	O
(	(	(	O	O
5	5	CD	B-NP	O
families	family	NNS	I-NP	O
)	)	)	O	O
than	than	IN	B-PP	O
A.	A.	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
families	family	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O

Maternal	Maternal	JJ	B-NP	O
indicators	indicator	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
periodontitis	periodontitis	NN	B-NP	O
,	,	,	O	O
hygiene	hygiene	NN	B-NP	O
habits	habit	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
periodontal	periodontal	JJ	B-NP	O
microflora	microflora	NNS	I-NP	O
are	be	VBP	B-VP	O
risk	risk	NN	B-NP	O
factors	factor	NNS	I-NP	O
for	for	IN	B-PP	O
childhood	childhood	NN	B-NP	O
periodontal	periodontal	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
predictive	predictive	JJ	B-ADJP	O
of	of	IN	B-PP	O
future	future	JJ	B-NP	O
childhood	childhood	NN	I-NP	O
and	and	CC	O	O
adolescent	adolescent	JJ	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
.	.	.	O	O

A-type	A-type	JJ	B-NP	B-protein
cranberry	cranberry	NN	I-NP	I-protein
proanthocyanidins	proanthocyanidin	NNS	I-NP	I-protein
(	(	(	O	O
AC-PACs	AC-PAC	NNS	B-NP	O
)	)	)	O	O
have	have	VBP	B-VP	O
recently	recently	RB	I-VP	O
been	be	VBN	I-VP	O
reported	report	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
beneficial	beneficial	JJ	B-ADJP	O
for	for	IN	B-PP	O
human	human	JJ	B-NP	O
health	health	NN	I-NP	O
,	,	,	O	O
especially	especially	RB	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
health	health	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
proanthocyanidins	proanthocyanidin	NNS	I-NP	B-protein
on	on	IN	B-PP	O
periodontitis	periodontitis	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
destructive	destructive	JJ	I-NP	O
disease	disease	NN	I-NP	O
of	of	IN	B-PP	O
tooth-supporting	tooth-supporting	JJ	B-NP	O
tissues	tissue	NNS	I-NP	O
,	,	,	O	O
needs	need	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
investigated	investigate	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
purpose	purpose	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
AC-PACs	AC-PAC	NNS	B-NP	O
on	on	IN	B-PP	O
various	various	JJ	B-NP	O
virulence	virulence	NN	I-NP	O
determinants	determinant	NNS	I-NP	O
of	of	IN	B-PP	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
response	response	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	B-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
stimulated	stimulate	VBN	B-VP	O
by	by	IN	B-PP	O
this	this	DT	B-NP	O
periodontopathogen	periodontopathogen	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
AC-PACs	AC-PAC	NNS	B-NP	O
on	on	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
growth	growth	NN	I-NP	O
and	and	CC	I-NP	O
biofilm	biofilm	NN	I-NP	O
formation	formation	NN	I-NP	O
,	,	,	O	O
adherence	adherence	NN	B-NP	O
to	to	TO	B-PP	O
human	human	JJ	B-NP	B-cell_type
oral	oral	JJ	I-NP	I-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
protein-coated	protein-coated	JJ	B-NP	O
surfaces	surface	NNS	I-NP	O
,	,	,	O	O
collagenase	collagenase	NN	B-NP	B-protein
activity	activity	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
invasiveness	invasiveness	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
tested	test	VBD	B-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
AC-PACs	AC-PAC	NNS	B-NP	O
to	to	TO	B-VP	O
modulate	modulate	VB	I-VP	O
the	the	DT	B-NP	O
P.	P.	NNP	I-NP	O
gingivalis-induced	gingivalis-induced	JJ	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
response	response	NN	I-NP	O
by	by	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
oral	oral	JJ	I-NP	I-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
while	while	IN	B-SBAR	O
AC-PACs	AC-PAC	NNS	B-NP	O
neutralized	neutralize	VBD	B-VP	O
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
virulence	virulence	NN	I-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
dose-dependent	dose-dependent	JJ	I-NP	O
fashion	fashion	NN	I-NP	O
,	,	,	O	O
they	they	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
interfere	interfere	VB	I-VP	O
with	with	IN	B-PP	O
growth	growth	NN	B-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
also	also	RB	B-ADVP	O
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
secretion	secretion	NN	I-NP	O
of	of	IN	B-PP	O
interleukin-8	interleukin-8	NN	B-NP	B-protein
(	(	(	O	O
IL-8	IL-8	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
chemokine	chemokine	NN	B-NP	B-protein
(	(	(	O	O
C-C	C-C	NN	B-NP	B-DNA
motif	motif	NN	I-NP	I-DNA
)	)	)	O	O
ligand	ligand	NN	B-NP	O
5	5	CD	I-NP	O
(	(	(	O	O
CCL5	CCL5	NN	B-NP	B-protein
)	)	)	O	O
but	but	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
affect	affect	VB	I-VP	O
the	the	DT	B-NP	O
secretion	secretion	NN	I-NP	O
of	of	IN	B-PP	O
IL-6	IL-6	NN	B-NP	B-protein
by	by	IN	B-PP	O
epithelial	epithelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
stimulated	stimulate	VBN	B-VP	O
with	with	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
anti-inflammatory	anti-inflammatory	JJ	I-NP	O
effect	effect	NN	I-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
reduced	reduce	VBN	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	B-protein
factor-kappaB	factor-kappaB	NN	I-NP	I-protein
(	(	(	O	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
)	)	)	O	O
p65	p65	NN	B-NP	O
pathway	pathway	NN	I-NP	O
.	.	.	O	O

AC-PACs	AC-PAC	NNS	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
potentially	potentially	RB	B-NP	O
valuable	valuable	JJ	I-NP	O
bioactive	bioactive	JJ	I-NP	O
molecules	molecule	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
new	new	JJ	B-NP	O
strategies	strategy	NNS	I-NP	O
to	to	TO	B-VP	O
treat	treat	VB	I-VP	O
and	and	CC	I-VP	O
prevent	prevent	VB	I-VP	O
P.	P.	NNP	B-NP	O
gingivalis-associated	gingivalis-associated	JJ	I-NP	O
periodontal	periodontal	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
subgingival	subgingival	JJ	I-NP	O
microbiome	microbiome	NN	I-NP	O
is	be	VBZ	B-VP	O
largely	largely	RB	B-ADJP	O
uncultivated	uncultivated	JJ	I-ADJP	O
,	,	,	O	O
and	and	CC	O	O
therefore	therefore	RB	B-ADVP	O
,	,	,	O	O
cultivation-based	cultivation-based	JJ	B-ADJP	O
and	and	CC	O	O
targeted	target	VBN	B-VP	O
molecular	molecular	JJ	B-NP	O
approaches	approach	NNS	I-NP	O
have	have	VBP	B-VP	O
limited	limit	VBN	I-VP	O
value	value	NN	B-NP	O
in	in	IN	B-PP	O
examining	examine	VBG	B-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
smoking	smoking	NN	B-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
community	community	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
tested	test	VBD	B-VP	O
the	the	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
subgingival	subgingival	JJ	I-NP	O
biofilm	biofilm	NN	I-NP	O
is	be	VBZ	B-VP	O
compositionally	compositionally	RB	B-ADJP	O
different	different	JJ	I-ADJP	O
in	in	IN	B-PP	O
current	current	JJ	B-ADJP	O
and	and	CC	O	O
never-smokers	never-smoker	NNS	B-NP	O
by	by	IN	B-PP	O
using	use	VBG	B-VP	O
an	an	DT	B-NP	O
open-ended	open-ended	JJ	I-NP	O
molecular	molecular	JJ	I-NP	O
approach	approach	NN	I-NP	O
for	for	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
identification	identification	NN	I-NP	O
.	.	.	O	O

Subgingival	Subgingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
from	from	IN	B-PP	O
deep	deep	JJ	B-NP	O
sites	site	NNS	I-NP	O
of	of	IN	B-PP	O
current	current	JJ	O	O
and	and	CC	O	O
never-smokers	never-smoker	NNS	B-NP	O
matched	match	VBN	B-VP	O
for	for	IN	B-PP	O
disease	disease	NN	B-NP	O
was	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
by	by	IN	B-PP	O
16S	16S	NN	B-NP	O
sequencing	sequencing	NN	I-NP	O
.	.	.	O	O

Smokers	Smoker	NNS	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
greater	great	JJR	B-NP	O
abundance	abundance	NN	I-NP	O
of	of	IN	B-PP	O
Parvimonas	Parvimonas	NNP	B-NP	O
,	,	,	O	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
,	,	,	O	O
Campylobacter	Campylobacter	NNP	B-NP	O
,	,	,	O	O
Bacteroides	Bacteroides	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Treponema	Treponema	NNP	B-NP	O
and	and	CC	O	O
lower	low	JJR	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
Veillonella	Veillonella	NNP	B-NP	O
,	,	,	O	O
Neisseria	Neisseria	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
.	.	.	O	O

Several	Several	JJ	B-NP	O
uncultivated	uncultivated	JJ	I-NP	O
Peptostreptococci	Peptostreptococci	NNP	I-NP	O
,	,	,	O	O
Parvimonas	Parvimonas	NNP	B-NP	O
micra	micra	NNP	I-NP	O
,	,	,	O	O
Campylobacter	Campylobacter	NNP	B-NP	O
gracilis	gracilis	NNP	I-NP	O
,	,	,	O	O
Treponema	Treponema	NNP	B-NP	O
socranskii	socranskii	NNP	I-NP	O
,	,	,	O	O
Dialister	Dialister	NNP	B-NP	O
pneumosintes	pneumosinte	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Tannerella	Tannerella	NNP	B-NP	O
forsythia	forsythia	NNP	I-NP	O
were	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
Veillonella	Veillonella	NN	B-NP	B-protein
sp	sp	NN	I-NP	I-protein
.	.	.	O	O

oral	oral	JJ	B-NP	O
clone	clone	NN	I-NP	O
B2	B2	NN	I-NP	O
,	,	,	O	O
Neisseria	Neisseria	NNP	B-NP	O
sp	sp	NN	I-NP	O
.	.	.	O	O

oral	oral	JJ	B-NP	O
clone	clone	NN	I-NP	O
2.24	2.24	CD	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
sanguinis	sanguinis	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Capnocytophaga	Capnocytophaga	NNP	B-NP	O
sp	sp	NN	I-NP	O
.	.	.	O	O

clone	clone	NN	B-NP	O
AH015	AH015	NN	I-NP	O
were	be	VBD	B-VP	O
at	at	IN	B-PP	O
lower	low	JJR	B-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
microbial	microbial	JJ	I-NP	O
profile	profile	NN	I-NP	O
of	of	IN	B-PP	O
smoking-associated	smoking-associated	JJ	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
is	be	VBZ	B-VP	O
distinct	distinct	JJ	B-ADJP	O
from	from	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
non-smokers	non-smoker	NNS	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
significant	significant	JJ	B-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
and	and	CC	I-NP	O
abundance	abundance	NN	I-NP	O
of	of	IN	B-PP	O
disease-associated	disease-associated	JJ	B-NP	O
and	and	CC	I-NP	O
health-compatible	health-compatible	JJ	I-NP	O
organisms	organism	NNS	I-NP	O
.	.	.	O	O

Feline	Feline	NN	B-NP	O
chronic	chronic	JJ	I-NP	O
gingivostomatitis	gingivostomatitis	NN	I-NP	O
(	(	(	O	O
FCGS	FCGS	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
disease	disease	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
that	that	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
severe	severe	JJ	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
currently	currently	RB	B-ADVP	O
no	no	DT	B-NP	O
specific	specific	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
methods	method	NNS	I-NP	O
available	available	JJ	B-ADJP	O
and	and	CC	O	O
little	little	JJ	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
regarding	regard	VBG	B-PP	O
its	its	PRP$	B-NP	O
aetiology	aetiology	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
bacteria	bacteria	NNS	B-NP	O
are	be	VBP	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
role	role	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
purpose	purpose	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
flora	flora	NN	I-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
and	and	CC	I-NP	O
diseased	diseased	JJ	I-NP	O
cats	cat	NNS	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
swabs	swab	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
palatoglossal	palatoglossal	JJ	I-NP	O
folds	fold	NNS	I-NP	O
of	of	IN	B-PP	O
eight	eight	CD	B-NP	O
cats	cat	NNS	I-NP	O
(	(	(	O	O
three	three	CD	B-NP	O
normal	normal	JJ	I-NP	O
and	and	CC	I-NP	O
five	five	CD	I-NP	O
FCGS	FCGS	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
were	be	VBD	B-VP	O
subjected	subject	VBN	I-VP	O
to	to	TO	B-PP	O
microbiological	microbiological	JJ	B-NP	B-cell_line
culture	culture	NN	I-NP	I-cell_line
.	.	.	O	O

Pasteurella	Pasteurella	NN	B-NP	O
pneumotropica	pneumotropica	NN	I-NP	O
and	and	CC	O	O
Pasteurella	Pasteurella	NN	B-NP	O
multocida	multocida	NN	I-NP	O
subsp	subsp	NN	I-NP	O
.	.	.	I-NP	O
multocida	multocida	NN	I-NP	O
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
prevalent	prevalent	JJ	I-NP	O
species	specie	NNS	I-NP	O
identified	identify	VBN	B-VP	O
by	by	IN	B-PP	O
culture	culture	NN	B-NP	O
methods	method	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
and	and	CC	I-NP	O
FCGS	FCGS	NN	I-NP	O
samples	sample	NNS	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

Bacteria	Bacteria	NNS	B-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
identified	identify	VBN	I-VP	O
using	use	VBG	B-VP	O
culture-independent	culture-independent	JJ	B-NP	O
methods	method	NNS	I-NP	O
(	(	(	O	O
bacterial	bacterial	JJ	B-NP	O
16S	16S	NN	I-NP	O
rRNA	rRNA	NN	I-NP	O
gene	gene	NN	I-NP	O
sequencing	sequencing	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

For	For	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
samples	sample	NNS	I-NP	O
,	,	,	O	O
158	158	CD	B-NP	O
clones	clone	NNS	I-NP	O
were	be	VBD	B-VP	O
analysed	analyse	VBN	I-VP	O
and	and	CC	O	O
85	85	CD	B-NP	O
clones	clone	NNS	I-NP	O
were	be	VBD	B-VP	O
sequenced	sequence	VBN	I-VP	O
.	.	.	O	O

Capnocytophaga	Capnocytophaga	NNP	B-NP	O
canimorsus	canimorsus	NN	I-NP	O
(	(	(	O	O
10.8	10.8	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
clones	clone	NNS	B-NP	O
analysed	analyse	VBN	B-VP	O
)	)	)	O	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
predominant	predominant	JJ	I-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

Uncultured	Uncultured	JJ	B-NP	O
species	specie	NNS	I-NP	O
accounted	account	VBD	B-VP	O
for	for	IN	B-PP	O
8.2	8.2	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
clones	clone	NNS	B-NP	O
analysed	analyse	VBN	B-VP	O
,	,	,	O	O
and	and	CC	O	O
43.7	43.7	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
clones	clone	NNS	B-NP	O
analysed	analyse	VBN	B-VP	O
represented	represent	VBD	B-VP	O
potentially	potentially	RB	B-NP	O
novel	novel	JJ	I-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
the	the	DT	B-NP	O
FCGS	FCGS	NN	I-NP	O
samples	sample	NNS	I-NP	O
,	,	,	O	O
253	253	CD	B-NP	O
clones	clone	NNS	I-NP	O
were	be	VBD	B-VP	O
analysed	analyse	VBN	I-VP	O
and	and	CC	O	O
91	91	CD	B-NP	O
clones	clone	NNS	I-NP	O
were	be	VBD	B-VP	O
sequenced	sequence	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
predominant	predominant	JJ	I-NP	O
species	specie	NNS	I-NP	O
was	be	VBD	B-VP	O
P.	P.	NNP	B-NP	O
multocida	multocida	NNP	I-NP	O
subsp	subsp	NN	I-NP	O
.	.	.	I-NP	O
multocida	multocida	NN	I-NP	O
(	(	(	O	O
51.8	51.8	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
clones	clone	NNS	B-NP	O
analysed	analyse	VBN	B-VP	O
)	)	)	O	O
.	.	.	O	O

Uncultured	Uncultured	JJ	B-NP	O
species	specie	NNS	I-NP	O
accounted	account	VBD	B-VP	O
for	for	IN	B-PP	O
8.7	8.7	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
clones	clone	NNS	B-NP	O
analysed	analyse	VBN	B-VP	O
,	,	,	O	O
and	and	CC	O	O
4.7	4.7	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
clones	clone	NNS	B-NP	O
analysed	analyse	VBN	B-VP	O
represented	represent	VBD	B-VP	O
potentially	potentially	RB	B-NP	O
novel	novel	JJ	I-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
flora	flora	NN	I-NP	O
in	in	IN	B-PP	O
cats	cat	NNS	B-NP	O
with	with	IN	B-PP	O
FCGS	FCGS	NN	B-NP	B-protein
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
less	less	RBR	B-ADJP	O
diverse	diverse	JJ	I-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
cats	cat	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
P.	P.	NNP	B-NP	O
multocida	multocida	NNP	I-NP	O
subsp	subsp	NN	I-NP	O
.	.	.	I-NP	O
multocida	multocida	NN	I-NP	O
is	be	VBZ	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
significantly	significantly	RB	B-ADJP	O
more	more	RBR	I-ADJP	O
prevalent	prevalent	JJ	I-ADJP	O
in	in	IN	B-PP	O
FCGS	FCGS	NN	B-NP	B-protein
than	than	IN	B-PP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
cats	cat	NNS	I-NP	O
and	and	CC	O	O
consequently	consequently	RB	B-VP	O
may	may	MD	I-VP	O
be	be	VB	I-VP	O
of	of	IN	B-PP	O
aetiological	aetiological	JJ	B-NP	O
significance	significance	NN	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
compare	compare	VB	I-VP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
and	and	CC	O	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
oral	oral	JJ	B-NP	O
microflora	microflora	NNS	I-NP	O
among	among	IN	B-PP	O
smokeless	smokeless	JJ	B-NP	O
tobacco	tobacco	NN	I-NP	O
chewers	chewer	NNS	I-NP	O
and	and	CC	I-NP	O
non-chewers	non-chewer	NNS	I-NP	O
.	.	.	O	O

Forty-two	Forty-two	CD	B-NP	O
smokeless	smokeless	JJ	I-NP	O
tobacco	tobacco	NN	I-NP	O
chewers	chewer	NNS	I-NP	O
and	and	CC	O	O
42	42	CD	B-NP	O
non-chewers	non-chewer	NNS	I-NP	O
(	(	(	O	O
age	age	NN	B-NP	O
20	20	CD	I-NP	O
to	to	TO	I-NP	O
60	60	CD	I-NP	O
years	year	NNS	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
for	for	IN	B-PP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
and	and	CC	O	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
Decayed	Decayed	NNP	I-NP	O
Missing	Missing	NNP	I-NP	O
Filled	Filled	NNP	I-NP	O
Surface	Surface	NNP	I-NP	O
(	(	(	O	O
DMFS	DMFS	NNP	B-NP	O
)	)	)	O	O
Index	Index	NNP	B-NP	O
,	,	,	O	O
Community	Community	NNP	B-NP	O
Periodontal	Periodontal	NNP	I-NP	O
Index	Index	NNP	I-NP	O
(	(	(	O	O
CPI	CPI	NNP	B-NP	O
)	)	)	O	O
and	and	CC	O	O
Loss	Loss	NN	B-NP	O
of	of	IN	B-PP	O
Attachment	Attachment	NN	B-NP	O
(	(	(	O	O
LA	LA	NN	B-NP	O
)	)	)	O	O
Index	Index	NN	B-NP	O
.	.	.	O	O

Stimulated	Stimulated	JJ	B-NP	O
saliva	saliva	NN	I-NP	O
and	and	CC	O	O
subgingival	subgingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
from	from	IN	B-PP	O
each	each	DT	B-NP	O
subject	subject	NN	I-NP	O
for	for	IN	B-PP	O
performing	perform	VBG	B-VP	O
a	a	DT	B-NP	O
culture-based	culture-based	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
.	.	.	O	O

Qualitative	Qualitative	JJ	B-NP	O
and	and	CC	I-NP	O
semi-quantitative	semi-quantitative	JJ	I-NP	O
culture-based	culture-based	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
using	use	VBG	B-VP	O
MacConkey	MacConkey	NN	B-NP	O
agar	agar	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
aerobic	aerobic	JJ	B-NP	O
and	and	CC	I-NP	O
anaerobic	anaerobic	JJ	I-NP	O
blood	blood	NN	I-NP	O
agar	agar	NN	I-NP	O
was	be	VBD	B-VP	O
carried	carry	VBN	I-VP	O
out	out	RP	B-PRT	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
cultivable	cultivable	JJ	I-NP	O
microflora	microflora	NN	I-NP	O
.	.	.	O	O

Mutans-Sanguis	Mutans-Sanguis	JJ	B-NP	O
agar	agar	NN	I-NP	O
,	,	,	O	O
Pfizer	Pfizer	NNP	B-NP	O
selective	selective	JJ	I-NP	O
Enterococcus	Enterococcus	NNP	I-NP	O
agar	agar	NN	I-NP	O
and	and	CC	O	O
Rogosa	Rogosa	NNP	B-NP	O
SL	SL	NNP	I-NP	O
agar	agar	NN	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
culture	culture	NN	I-NP	O
of	of	IN	B-PP	O
microorganisms	microorganism	NNS	B-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
.	.	.	O	O

Mann-Whitney	Mann-Whitney	JJ	B-NP	O
U	U	NN	I-NP	O
test	test	NN	I-NP	O
and	and	CC	O	O
Student	Student	NN	B-NP	O
t	t	NN	I-NP	O
test	test	NN	I-NP	O
were	be	VBD	B-VP	O
employed	employ	VBN	I-VP	O
to	to	TO	B-VP	O
compare	compare	VB	I-VP	O
colony-forming	colony-forming	JJ	B-NP	B-protein
units	unit	NNS	I-NP	I-protein
(	(	(	O	O
CFUs	CFU	NNS	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
caries	cary	NNS	B-NP	O
experience	experience	NN	I-NP	O
between	between	IN	B-PP	O
smokeless	smokeless	JJ	B-NP	O
tobacco	tobacco	NN	I-NP	O
chewers	chewer	NNS	I-NP	O
and	and	CC	I-NP	O
nonchewers	nonchewer	NNS	I-NP	O
.	.	.	O	O

Z	Z	NN	B-NP	O
proportionality	proportionality	NN	I-NP	O
test	test	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
compare	compare	VB	I-VP	O
the	the	DT	B-NP	O
periodontal	periodontal	JJ	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

Caries	Cary	NNS	B-NP	O
experience	experience	NN	I-NP	O
among	among	IN	B-PP	O
chewers	chewer	NNS	B-NP	O
(	(	(	O	O
26	26	CD	B-NP	O
of	of	IN	B-PP	O
42	42	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
those	those	DT	B-NP	O
subjects	subject	NNS	I-NP	O
who	who	WP	B-NP	O
were	be	VBD	B-VP	O
affected	affect	VBN	I-VP	O
by	by	IN	B-PP	O
caries	cary	NNS	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
less	less	JJR	I-ADJP	O
at	at	IN	B-PP	O
61.9	61.9	CD	B-NP	O
%	%	NN	I-NP	O
(	(	(	O	O
mean	mean	JJ	B-NP	O
DMFS	DMFS	NN	I-NP	O
=	=	SYM	B-VP	O
3.5	3.5	CD	B-NP	O
)	)	)	O	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
non-chewers	non-chewer	NNS	B-NP	O
(	(	(	O	O
38	38	CD	B-NP	O
of	of	IN	B-PP	O
42	42	CD	B-NP	O
,	,	,	O	O
90.5	90.5	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
(	(	(	O	O
mean	mean	JJ	B-NP	O
DMFS	DMFS	NN	I-NP	O
=	=	SYM	B-VP	O
5.5	5.5	CD	B-NP	O
)	)	)	O	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Deep	Deep	NN	B-NP	O
pockets	pocket	NNS	I-NP	O
measuring	measure	VBG	B-VP	O
>	>	SYM	B-NP	O
5.5	5.5	CD	B-NP	O
mm	mm	NN	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
CPI	CPI	NN	I-NP	B-DNA
probe	probe	NN	I-NP	I-DNA
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
among	among	IN	B-PP	O
26.2	26.2	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
chewers	chewer	NNS	B-NP	O
and	and	CC	O	O
19.1	19.1	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
nonchewers	nonchewer	NNS	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
statistically	statistically	RB	I-NP	O
significant	significant	JJ	I-NP	O
differences	difference	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
>	>	JJR	B-NP	O
0.05	0.05	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

Counts	Count	NNS	B-NP	O
of	of	IN	B-PP	O
Lactobacillus	Lactobacillus	NN	B-NP	B-protein
species	specie	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
among	among	IN	B-PP	O
chewers	chewer	NNS	B-NP	O
(	(	(	O	O
median	median	JJ	B-NP	O
CFU	CFU	NN	I-NP	O
=	=	SYM	B-VP	O
0.788	0.788	CD	B-NP	O
x	x	SYM	O	O
10	10	CD	B-NP	O
(	(	(	O	O
5	5	CD	B-NP	O
)	)	)	O	O
)	)	)	O	O
than	than	IN	B-PP	O
among	among	IN	B-PP	O
non-chewers	non-chewers	JJ	O	O
(	(	(	O	O
median	median	JJ	B-NP	O
CFU	CFU	NN	I-NP	O
=	=	SYM	B-VP	O
1.52	1.52	CD	B-NP	O
x	x	SYM	O	O
10	10	CD	B-NP	O
(	(	(	O	O
5	5	CD	B-NP	O
)	)	)	O	O
)	)	)	O	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Prevotella	Prevotella	NN	B-NP	O
and	and	CC	I-NP	O
Porphyromonas	Porphyromonas	NN	I-NP	O
species	specie	NNS	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
median	median	JJ	I-NP	O
CFU	CFU	NN	I-NP	O
of	of	IN	B-PP	O
0.04	0.04	CD	B-NP	O
x	x	SYM	I-NP	O
105	105	CD	I-NP	O
in	in	IN	B-PP	O
chewers	chewer	NNS	B-NP	O
and	and	CC	O	O
0.15	0.15	CD	B-NP	O
x	x	CC	I-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
5	5	CD	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
non-chewers	non-chewer	NNS	B-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
species	specie	NNS	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
median	median	JJ	I-NP	O
CFU	CFU	NN	I-NP	O
of	of	IN	B-PP	O
0.02	0.02	CD	B-NP	O
x	x	SYM	I-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
5	5	CD	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
chewers	chewer	NNS	B-NP	O
and	and	CC	O	O
0.1	0.1	CD	B-NP	O
x	x	CC	I-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
5	5	CD	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
non-chewers	non-chewer	NNS	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

A	A	DT	B-NP	O
higher	high	JJR	I-NP	O
percentage	percentage	NN	I-NP	O
of	of	IN	B-PP	O
caries	cary	NNS	B-NP	O
among	among	IN	B-PP	O
non-chewers	non-chewer	NNS	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
explained	explain	VBN	I-VP	O
by	by	IN	B-PP	O
greater	great	JJR	B-NP	O
numbers	number	NNS	I-NP	O
of	of	IN	B-PP	O
Lactobacillus	Lactobacillus	NN	B-NP	B-protein
species	specie	NNS	I-NP	I-protein
in	in	IN	B-PP	O
this	this	DT	B-NP	O
population	population	NN	I-NP	O
.	.	.	O	O

Chewers	Chewer	NNS	B-NP	O
experienced	experience	VBD	B-VP	O
a	a	DT	B-NP	O
slightly	slightly	RB	I-NP	O
higher	high	JJR	I-NP	O
incidence	incidence	NN	I-NP	O
of	of	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
than	than	IN	B-PP	O
non-chewers	non-chewer	NNS	B-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
difference	difference	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
significant	significant	JJ	B-ADJP	O
.	.	.	O	O

These	These	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
observations	observation	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
a	a	DT	B-NP	O
lower	low	JJR	I-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
Gram-negative	Gram-negative	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
to	to	TO	B-VP	O
mediate	mediate	VB	I-VP	O
more	more	RBR	B-NP	O
periodontal	periodontal	JJ	I-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
population	population	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
escalating	escalate	VBG	I-NP	O
global	global	JJ	I-NP	O
incidence	incidence	NN	I-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
particularly	particularly	RB	B-ADVP	O
in	in	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
wounds	wound	NNS	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
problem	problem	NN	I-NP	O
that	that	WDT	B-NP	O
requires	require	VBZ	B-VP	O
significant	significant	JJ	B-NP	O
improvements	improvement	NNS	I-NP	O
to	to	TO	B-PP	O
existing	exist	VBG	B-NP	O
therapies	therapy	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
developed	develop	VBN	I-VP	O
hyperbranched	hyperbranched	JJ	B-NP	O
poly	poly	NN	I-NP	O
(	(	(	O	O
NIPAM	NIPAM	NN	B-NP	B-protein
)	)	)	O	O
polymers	polymer	NNS	B-NP	O
functionalized	functionalize	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
Vancomycin	Vancomycin	NN	I-NP	O
and	and	CC	I-NP	O
Polymyxin-B	Polymyxin-B	NN	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
in	in	IN	B-PP	O
solution	solution	NN	B-NP	O
.	.	.	O	O

Binding	Binding	NN	B-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
polymers	polymer	NNS	I-NP	O
causes	cause	VBZ	B-VP	O
a	a	DT	B-NP	O
conformational	conformational	JJ	I-NP	O
change	change	NN	I-NP	O
,	,	,	O	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
collapse	collapse	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
polymers	polymer	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
insoluble	insoluble	JJ	B-NP	B-protein
polymer/bacteria	polymer/bacteria	NNS	I-NP	I-protein
complexes	complex	NNS	I-NP	I-protein
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
applied	apply	VBN	I-VP	O
these	these	DT	B-NP	O
novel	novel	JJ	I-NP	O
polymers	polymer	NNS	I-NP	O
to	to	TO	B-PP	O
our	our	PRP$	B-NP	O
tissue	tissue	NN	I-NP	O
engineered	engineer	VBD	B-VP	O
human	human	JJ	B-NP	O
skin	skin	NN	I-NP	O
model	model	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
burn	burn	JJ	I-NP	O
wound	wound	NN	I-NP	O
infected	infect	VBN	B-VP	O
with	with	IN	B-PP	O
Pseudomonas	Pseudomonas	NN	B-NP	O
aeruginosa	aeruginosa	NN	I-NP	O
and	and	CC	O	O
Staphylococcus	Staphylococcus	FW	B-NP	O
aureus	aureus	FW	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
the	the	DT	B-NP	O
polymers	polymer	NNS	I-NP	O
were	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
infected	infected	JJ	I-NP	O
skin	skin	NN	I-NP	O
,	,	,	O	O
either	either	CC	O	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
polymer	polymer	NN	I-NP	O
gel	gel	NN	I-NP	O
solution	solution	NN	I-NP	O
or	or	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
hydrogel	hydrogel	NN	B-NP	O
membranes	membrane	NNS	I-NP	O
,	,	,	O	O
they	they	PRP	B-NP	O
removed	remove	VBD	B-VP	O
bound	bind	VBN	B-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
thus	thus	RB	B-ADVP	O
reducing	reduce	VBG	B-VP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
load	load	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
infected	infected	JJ	I-NP	O
skin	skin	NN	I-NP	O
model	model	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
bacteria-binding	bacteria-binding	JJ	I-NP	B-protein
polymers	polymer	NNS	I-NP	I-protein
have	have	VBP	B-VP	O
many	many	JJ	B-NP	O
potential	potential	JJ	I-NP	O
uses	use	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
coatings	coating	NNS	B-NP	O
for	for	IN	B-PP	O
wound	wound	NN	B-NP	O
dressings	dressing	NNS	I-NP	O
.	.	.	O	O

Following	Follow	VBG	B-PP	O
an	an	DT	B-NP	O
outbreak	outbreak	NN	I-NP	O
of	of	IN	B-PP	O
carbapenem	carbapenem	NN	B-NP	O
resistant	resistant	JJ	I-NP	O
Klebsiella	Klebsiella	NN	I-NP	O
pneumoniae	pneumoniae	NN	I-NP	O
(	(	(	O	O
CRKP	CRKP	NN	B-NP	O
)	)	)	O	O
bacteremia	bacteremia	NN	B-NP	O
among	among	IN	B-PP	O
inpatients	inpatient	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Hemato-oncology	Hemato-oncology	NN	I-NP	O
and	and	CC	I-NP	O
BMT	BMT	NN	I-NP	B-DNA
unit	unit	NN	I-NP	I-DNA
,	,	,	O	O
we	we	PRP	B-NP	O
studied	study	VBD	B-VP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
infection	infection	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
undergoing	undergo	VBG	B-VP	O
intensive	intensive	JJ	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
and	and	CC	I-NP	O
SCT	SCT	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
conducted	conduct	VBD	B-VP	O
a	a	DT	B-NP	O
pilot	pilot	NN	I-NP	O
study	study	NN	I-NP	O
aimed	aim	VBD	B-VP	O
to	to	TO	I-VP	O
eradicate	eradicate	VB	I-VP	O
CRKP	CRKP	NN	B-NP	O
colonization	colonization	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
gastrointestinal	gastrointestinal	JJ	I-NP	O
tract	tract	NN	I-NP	O
,	,	,	O	O
using	use	VBG	B-VP	O
oral	oral	JJ	B-NP	O
gentamicin	gentamicin	NN	I-NP	O
.	.	.	O	O

Adult	Adult	JJ	B-NP	O
patients	patient	NNS	I-NP	O
admitted	admit	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
BMT	BMT	NN	I-NP	B-DNA
unit	unit	NN	I-NP	I-DNA
,	,	,	O	O
identified	identify	VBN	B-VP	O
as	as	IN	B-PP	O
CRKP	CRKP	NN	B-NP	B-cell_line
carriers	carrier	NNS	I-NP	I-cell_line
on	on	IN	B-PP	I-cell_line
surveillance	surveillance	NN	B-NP	I-cell_line
rectal	rectal	JJ	I-NP	I-cell_line
cultures	culture	NNS	I-NP	I-cell_line
,	,	,	O	O
were	be	VBD	B-VP	O
included	include	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
gentamicin	gentamicin	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
q.i.d	q.i.d	NN	I-NP	O
.	.	.	O	O

was	be	VBD	B-VP	O
administered	administer	VBN	I-VP	O
to	to	TO	B-PP	O
all	all	DT	B-NP	O
identified	identify	VBN	I-NP	O
carriers	carrier	NNS	I-NP	O
until	until	IN	B-PP	O
eradication	eradication	NN	B-NP	O
.	.	.	O	O

Among	Among	IN	B-PP	O
15	15	CD	B-NP	O
colonized	colonize	VBN	I-NP	O
patients	patient	NNS	I-NP	O
included	include	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
eradication	eradication	NN	I-NP	O
rate	rate	NN	I-NP	O
achieved	achieve	VBD	B-VP	O
was	be	VBD	B-VP	O
66	66	CD	B-NP	O
%	%	NN	I-NP	O
(	(	(	O	O
10/15	10/15	CD	B-NP	O
)	)	)	O	O
;	;	:	O	O
discontinuation	discontinuation	NN	B-NP	O
of	of	IN	B-PP	O
persistent	persistent	JJ	B-NP	O
bacteremia	bacteremia	NN	I-NP	O
occurred	occur	VBD	B-VP	O
in	in	IN	B-PP	O
62.5	62.5	CD	B-NP	O
%	%	NN	I-NP	O
(	(	(	O	O
5/8	5/8	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
nosocomial	nosocomial	JJ	B-NP	O
spread	spread	NN	I-NP	O
of	of	IN	B-PP	O
CRKP	CRKP	NN	B-NP	O
carrier	carrier	NN	I-NP	O
state	state	NN	I-NP	O
ceased	cease	VBD	B-VP	O
.	.	.	O	O

Administration	Administration	NN	B-NP	O
of	of	IN	B-PP	O
intensive	intensive	JJ	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
and	and	CC	I-NP	O
SCT	SCT	NN	I-NP	O
is	be	VBZ	B-VP	O
feasible	feasible	JJ	B-ADJP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
risk	risk	NN	I-NP	O
.	.	.	O	O

Hematological	Hematological	JJ	B-NP	O
patients	patient	NNS	I-NP	O
in	in	IN	B-PP	O
need	need	NN	B-NP	O
of	of	IN	B-PP	O
intensive	intensive	JJ	B-NP	O
chemotherapy/SCT	chemotherapy/SCT	NN	I-NP	O
should	should	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
denied	deny	VBN	I-VP	O
the	the	DT	B-NP	O
required	required	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
being	be	VBG	B-VP	O
CRKP	CRKP	NN	B-NP	O
carriers	carrier	NNS	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
gentamicin	gentamicin	NN	I-NP	O
treatment	treatment	NN	I-NP	O
for	for	IN	B-PP	O
eradication	eradication	NN	B-NP	O
of	of	IN	B-PP	O
CRKP	CRKP	NN	B-NP	B-protein
from	from	IN	B-PP	O
the	the	DT	B-NP	O
gastrointestinal	gastrointestinal	JJ	I-NP	O
reservoir	reservoir	NN	I-NP	O
could	could	MD	B-VP	O
serve	serve	VB	I-VP	O
as	as	IN	B-PP	O
additional	additional	JJ	B-NP	O
tool	tool	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
combat	combat	NN	I-NP	O
against	against	IN	B-PP	O
the	the	DT	B-NP	O
nosocomial	nosocomial	JJ	I-NP	O
spread	spread	NN	I-NP	O
and	and	CC	O	O
severe	severe	JJ	B-NP	O
infections	infection	NNS	I-NP	O
caused	cause	VBN	B-VP	O
by	by	IN	B-PP	O
this	this	DT	B-NP	O
difficult-to-treat	difficult-to-treat	JJ	I-NP	O
organism	organism	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
electrochemical	electrochemical	JJ	I-NP	O
behavior	behavior	NN	I-NP	O
of	of	IN	B-PP	O
nickel	nickel	NN	B-NP	B-DNA
titanium	titanium	NN	I-NP	I-DNA
(	(	(	O	I-DNA
NiTi	NiTi	NN	B-NP	I-DNA
)	)	)	O	I-DNA
orthodontic	orthodontic	JJ	B-NP	I-DNA
wires	wire	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
a	a	DT	B-NP	O
solution	solution	NN	I-NP	O
containing	contain	VBG	B-VP	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
article	article	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
explain	explain	VBP	B-VP	O
our	our	PRP$	B-NP	O
choice	choice	NN	I-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
species	specie	NNS	I-NP	O
before	before	IN	B-PP	O
describing	describe	VBG	B-VP	O
the	the	DT	B-NP	O
culture	culture	NN	I-NP	O
process	process	NN	I-NP	O
in	in	IN	B-PP	O
artificial	artificial	JJ	B-NP	O
saliva	saliva	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
precautions	precaution	NNS	I-NP	O
needed	need	VBN	B-VP	O
to	to	TO	B-VP	O
prevent	prevent	VB	I-VP	O
contamination	contamination	NN	B-NP	O
by	by	IN	B-PP	O
other	other	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
electrochemical	electrochemical	JJ	I-NP	O
behavior	behavior	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
alloy	alloy	NN	I-NP	O
(	(	(	O	O
NiTi	NiTi	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
electrochemically	electrochemically	RB	B-ADVP	O
in	in	IN	B-PP	O
Ringer	Ringer	NN	B-NP	O
sterile	sterile	JJ	I-NP	O
artificial	artificial	JJ	I-NP	O
saliva	saliva	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
artificial	artificial	JJ	B-NP	O
saliva	saliva	NN	I-NP	O
enriched	enrich	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
sterile	sterile	JJ	I-NP	O
broth	broth	NN	I-NP	O
and	and	CC	O	O
modified	modify	VBN	B-VP	O
by	by	IN	B-PP	O
addition	addition	NN	B-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
electrochemical	electrochemical	JJ	I-NP	O
procedures	procedure	NNS	I-NP	O
chosen	choose	VBN	B-VP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
were	be	VBD	B-VP	O
:	:	:	O	O
free	free	JJ	B-NP	O
corrosion	corrosion	NN	I-NP	O
potential	potential	NN	I-NP	O
,	,	,	O	O
potentiodynamic	potentiodynamic	JJ	B-NP	O
curves	curve	NNS	I-NP	O
and	and	CC	O	O
impedance	impedance	NN	B-NP	O
spectroscopy	spectroscopy	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
way	way	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
were	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
show	show	VB	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
free	free	JJ	I-NP	O
corrosion	corrosion	NN	I-NP	O
potential	potential	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NiTi	NiTi	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Ringer	Ringer	NN	I-NP	O
solution	solution	NN	I-NP	O
increases	increase	VBZ	B-VP	O
with	with	IN	B-PP	O
time	time	NN	B-NP	O
and	and	CC	O	O
then	then	RB	B-VP	O
stabilizes	stabilize	VBZ	I-VP	O
,	,	,	O	O
thus	thus	RB	B-ADVP	O
passivating	passivate	VBG	B-VP	O
the	the	DT	B-NP	O
alloy	alloy	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
colonization	colonization	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
metal	metal	NN	I-NP	O
surface	surface	NN	I-NP	O
by	by	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
triggered	trigger	VBD	B-VP	O
a	a	DT	B-NP	O
drop	drop	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
free	free	JJ	I-NP	O
corrosion	corrosion	NN	I-NP	O
potential	potential	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
electrochemical	electrochemical	JJ	I-NP	O
impedance	impedance	NN	I-NP	O
findings	finding	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
NiTi	NiTi	NNP	B-NP	O
behavior	behavior	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
media	medium	NNS	I-NP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
observed	observe	VBD	B-VP	O
a	a	DT	B-NP	O
slight	slight	JJ	I-NP	O
difference	difference	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
corrosion	corrosion	NN	I-NP	O
currents	current	NNS	I-NP	O
in	in	IN	B-PP	O
favor	favor	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bacteria-enriched	bacteria-enriched	JJ	I-NP	O
solution	solution	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
NiTi	NiTi	NNP	I-NP	O
underwent	undergo	VBD	B-VP	O
greater	great	JJR	B-NP	O
corrosion	corrosion	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
the	the	DT	B-NP	O
impact	impact	NN	I-NP	O
of	of	IN	B-PP	O
acidogenic	acidogenic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
on	on	IN	B-PP	O
corrosion	corrosion	NN	B-NP	O
behavior	behavior	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NiTi	NiTi	NNP	I-NP	O
wires	wire	VBZ	B-VP	O
investigated	investigate	VBN	I-VP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
further	further	JJ	B-NP	O
research	research	NN	I-NP	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
,	,	,	O	O
notably	notably	RB	B-VP	O
incorporating	incorporate	VBG	I-VP	O
longer	long	JJR	B-NP	O
immersion	immersion	NN	I-NP	O
times	time	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
media	medium	NNS	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
in	in	IN	B-PP	O
other	other	JJ	B-NP	O
fields	field	NNS	I-NP	O
of	of	IN	B-PP	O
healthcare	healthcare	NN	B-NP	O
,	,	,	O	O
probiotics	probiotic	NNS	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
introduced	introduce	VBN	I-VP	O
for	for	IN	B-PP	O
prevention	prevention	NN	B-NP	O
and	and	CC	I-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
review	review	NN	I-NP	O
was	be	VBD	B-VP	O
initiated	initiate	VBN	I-VP	O
to	to	TO	I-VP	O
explore	explore	VB	I-VP	O
whether	whether	IN	B-SBAR	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
probiotics	probiotic	NNS	B-NP	O
can	can	MD	B-VP	O
influence	influence	VB	I-VP	O
the	the	DT	B-NP	O
periodontal	periodontal	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
and	and	CC	O	O
periodontal	periodontal	JJ	B-NP	O
health	health	NN	I-NP	O
.	.	.	O	O

Literature	Literature	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
mode	mode	NN	I-NP	O
of	of	IN	B-PP	O
action	action	NN	B-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
probiotics	probiotic	NNS	I-NP	O
was	be	VBD	B-VP	O
reviewed	review	VBN	I-VP	O
and	and	CC	O	O
a	a	DT	B-NP	O
systematic	systematic	JJ	I-NP	O
review	review	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
microbiological	microbiological	JJ	I-NP	O
and	and	CC	I-NP	O
clinical	clinical	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
probiotics	probiotic	NNS	I-NP	O
on	on	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
health	health	NN	I-NP	O
.	.	.	O	O

Three	Three	CD	B-NP	O
animal	animal	NN	I-NP	O
and	and	CC	O	O
11	11	CD	B-NP	O
in	in	FW	I-NP	O
vivo	vivo	FW	I-NP	O
human	human	JJ	I-NP	O
studies	study	NNS	I-NP	O
were	be	VBD	B-VP	O
retrieved	retrieve	VBN	I-VP	O
.	.	.	O	O

Six	Six	CD	B-NP	O
studies	study	NNS	I-NP	O
reported	report	VBN	B-VP	O
on	on	IN	B-PP	O
microbiological	microbiological	JJ	B-NP	O
effects	effect	NNS	I-NP	O
whereas	whereas	IN	B-PP	O
eight	eight	CD	B-NP	O
studies	study	NNS	I-NP	O
report	report	VBP	B-VP	O
on	on	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
effects	effect	NNS	I-NP	O
.	.	.	O	O

Seven	Seven	CD	B-NP	O
studies	study	NNS	I-NP	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
on	on	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
or	or	CC	I-NP	O
gingivitis	gingivitis	NN	I-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	O	O
four	four	CD	B-NP	O
studies	study	NNS	I-NP	O
on	on	IN	B-PP	O
periodontitis	periodontitis	NN	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

Many	Many	JJ	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
retrieved	retrieved	JJ	I-NP	O
studies	study	NNS	I-NP	O
are	be	VBP	B-VP	O
pilot	pilot	NN	B-NP	B-protein
in	in	IN	B-PP	O
nature	nature	NN	B-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
quality	quality	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
high	high	JJ	I-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
heterogeneity	heterogeneity	NN	B-NP	O
between	between	IN	B-PP	O
studies	study	NNS	B-NP	O
hampered	hamper	VBD	B-VP	O
analysis	analysis	NN	B-NP	O
.	.	.	O	O

Taking	Take	VBG	B-VP	O
into	into	IN	B-PP	O
consideration	consideration	NN	B-NP	O
all	all	DT	B-NP	O
limitations	limitation	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
currently	currently	RB	I-NP	O
available	available	JJ	I-NP	O
data	datum	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
an	an	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
probiotics	probiotic	NNS	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
more	more	RBR	I-NP	O
limited	limited	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
periodontal	periodontal	JJ	I-NP	O
outcome	outcome	NN	I-NP	O
measures	measure	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
urgent	urgent	JJ	I-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
properly	properly	RB	B-NP	O
conducted	conduct	VBN	I-NP	O
clinical	clinical	JJ	I-NP	O
trials	trial	NNS	I-NP	O
where	where	WRB	B-ADVP	O
probiotics	probiotic	NNS	B-NP	O
are	be	VBP	B-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
adjuncts	adjunct	NNS	B-NP	O
to	to	TO	B-PP	O
standard	standard	JJ	B-NP	O
periodontal	periodontal	JJ	I-NP	O
care	care	NN	I-NP	O
,	,	,	O	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
,	,	,	O	O
using	use	VBG	B-VP	O
probiotic	probiotic	JJ	B-NP	O
strains	strain	NNS	I-NP	O
with	with	IN	B-PP	O
,	,	,	O	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
at	at	IN	B-PP	O
an	an	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
level	level	NN	I-NP	O
,	,	,	O	O
proven	prove	VBN	B-VP	O
periodontal	periodontal	JJ	B-NP	O
probiotic	probiotic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
.	.	.	O	O

Atopic	Atopic	JJ	B-NP	O
dermatitis	dermatitis	NN	I-NP	O
(	(	(	O	O
AD	AD	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
marked	mark	VBN	I-VP	O
by	by	IN	B-PP	O
elevated	elevate	VBN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
immunoglobulin	immunoglobulin	NN	B-NP	B-protein
E	E	NN	I-NP	I-protein
and	and	CC	I-NP	O
skin	skin	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
oedema	oedema	NN	B-NP	O
and	and	CC	I-NP	O
haemorrhage	haemorrhage	NN	I-NP	O
.	.	.	O	O

Kimchi	Kimchi	NNP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
Korean	Korean	JJ	I-NP	O
fermented	fermented	JJ	I-NP	O
food	food	NN	I-NP	O
that	that	WDT	B-NP	O
contains	contain	VBZ	B-VP	O
beneficial	beneficial	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
for	for	IN	B-PP	O
human	human	JJ	B-NP	O
health	health	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
Lactobacillus	Lactobacillus	NN	B-NP	B-protein
plantarum	plantarum	NN	I-NP	I-protein
CJLP55	CJLP55	NN	I-NP	I-protein
,	,	,	O	O
CJLP56	CJLP56	NN	B-NP	B-protein
,	,	,	O	O
CJLP133	CJLP133	NN	B-NP	B-protein
and	and	CC	I-NP	O
CJLP136	CJLP136	NN	I-NP	B-protein
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
Kimchi	Kimchi	NNP	B-NP	O
were	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
for	for	IN	B-PP	O
their	their	PRP$	B-NP	O
capacity	capacity	NN	I-NP	O
to	to	TO	B-VP	O
inhibit	inhibit	VB	I-VP	O
AD	AD	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
three	three	CD	I-NP	O
strains	strain	NNS	I-NP	O
,	,	,	I-NP	O
CJLP55	CJLP55	NN	I-NP	B-protein
,	,	,	I-NP	O
CJLP133	CJLP133	NN	I-NP	B-protein
and	and	CC	I-NP	O
CJLP136	CJLP136	NN	I-NP	B-protein
,	,	,	O	O
suppressed	suppress	VBD	B-VP	O
AD-like	AD-like	JJ	B-NP	O
skin	skin	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
,	,	,	O	O
high	high	JJ	B-NP	O
serum	serum	NN	I-NP	O
IgE	IgE	NN	I-NP	B-protein
levels	level	NNS	I-NP	O
and	and	CC	O	O
epidermal	epidermal	JJ	B-NP	O
thickening	thickening	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
three	three	CD	I-NP	O
strains	strain	NNS	I-NP	O
diminished	diminish	VBD	B-VP	O
the	the	DT	B-NP	O
accumulation	accumulation	NN	I-NP	O
of	of	IN	B-PP	O
eosinophils	eosinophil	NNS	B-NP	B-cell_type
and	and	CC	O	O
mast	mast	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
into	into	IN	B-PP	O
topical	topical	JJ	B-NP	B-DNA
inflammatory	inflammatory	JJ	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
and	and	CC	O	O
the	the	DT	B-NP	O
enlargement	enlargement	NN	I-NP	O
of	of	IN	B-PP	O
axillary	axillary	JJ	B-NP	O
lymph	lymph	NN	I-NP	O
nodes	node	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
dorsal	dorsal	JJ	I-NP	O
dermatitis	dermatitis	NN	I-NP	O
.	.	.	O	O

CJLP55	CJLP55	NN	B-NP	B-protein
,	,	,	I-NP	O
CJLP133	CJLP133	NN	I-NP	B-protein
and	and	CC	I-NP	O
CJLP136	CJLP136	NN	I-NP	B-protein
decreased	decrease	VBD	B-VP	O
production	production	NN	B-NP	O
of	of	IN	B-PP	O
type	type	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
cytokines	cytokine	NNS	I-NP	I-protein
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
IL-4	IL-4	NN	B-NP	B-protein
and	and	CC	I-NP	O
IL-5	IL-5	NN	I-NP	B-protein
in	in	IN	B-PP	O
lymph	lymph	NN	B-NP	B-cell_line
node	node	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
culture	culture	NN	I-NP	I-cell_line
.	.	.	O	O

CJLP133	CJLP133	NN	B-NP	B-protein
and	and	CC	I-NP	O
CJLP136	CJLP136	NN	I-NP	B-protein
increased	increase	VBD	B-VP	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
secretion	secretion	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
CJLP55	CJLP55	NN	B-NP	B-protein
enhanced	enhance	VBD	B-VP	O
IL-10	IL-10	NN	B-NP	B-protein
production	production	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
three	three	CD	I-NP	O
strains	strain	NNS	I-NP	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
Kimchi	Kimchi	NNP	B-NP	O
suppress	suppress	VBP	B-VP	O
house-dust	house-dust	JJ	B-NP	O
mite-induced	mite-induced	JJ	I-NP	O
dermatitis	dermatitis	NN	I-NP	O
in	in	IN	B-PP	O
NC/Nga	NC/Nga	NNP	B-NP	O
mouse	mouse	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
representative	representative	JJ	I-NP	O
animal	animal	NN	I-NP	O
model	model	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
AD	AD	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
lactobacilli	lactobacillus	NNS	B-NP	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
Kimchi	Kimchi	NNP	B-NP	O
inhibit	inhibit	VBP	B-VP	O
AD	AD	NN	B-NP	O
,	,	,	O	O
probably	probably	RB	B-ADVP	O
by	by	IN	B-PP	O
altering	alter	VBG	B-VP	O
the	the	DT	B-NP	O
balance	balance	NN	I-NP	O
of	of	IN	B-PP	O
Th1/Th2	Th1/Th2	NN	B-NP	O
ratio	ratio	NN	I-NP	O
or	or	CC	O	O
inducing	induce	VBG	B-VP	O
IL-10	IL-10	NN	B-NP	B-protein
production	production	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
areca	areca	NN	I-NP	O
nut	nut	NN	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
widely	widely	RB	I-NP	O
consumed	consume	VBN	I-NP	O
psychoactive	psychoactive	JJ	I-NP	O
substance	substance	NN	I-NP	O
in	in	IN	B-PP	O
Taiwan	Taiwan	NNP	B-NP	O
,	,	,	O	O
India	India	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Southeast	Southeast	NNP	B-NP	O
Asia	Asia	NNP	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
considered	consider	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
environmental	environmental	JJ	I-NP	O
risk	risk	NN	I-NP	O
factor	factor	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
submucous	submucous	JJ	I-NP	O
fibrosis	fibrosis	NN	I-NP	O
and	and	CC	I-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

Arecoline	Arecoline	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
alkaloid	alkaloid	NN	I-NP	O
of	of	IN	B-PP	O
areca	areca	NN	B-NP	O
nut	nut	NN	I-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
cause	cause	VB	I-VP	O
cytotoxicity	cytotoxicity	NN	B-NP	O
and	and	CC	I-NP	O
genotoxicity	genotoxicity	NN	I-NP	O
in	in	IN	B-PP	O
various	various	JJ	B-NP	O
systems	system	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
active	active	JJ	I-NP	O
compound	compound	NN	I-NP	O
accounting	accounting	NN	I-NP	O
for	for	IN	B-PP	O
arecoline-induced	arecoline-induced	JJ	B-NP	O
damage	damage	NN	I-NP	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	B-cell_type
human	human	JJ	I-NP	I-cell_type
oral	oral	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
is	be	VBZ	B-VP	O
still	still	RB	B-ADVP	O
uncharacterized	uncharacterized	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
undertaken	undertake	VBN	I-VP	O
to	to	TO	I-VP	O
identify	identify	VB	I-VP	O
the	the	DT	B-NP	O
active	active	JJ	I-NP	O
metabolite	metabolite	NN	I-NP	O
of	of	IN	B-PP	O
arecoline	arecoline	NN	B-NP	O
that	that	WDT	B-NP	O
might	might	MD	B-VP	O
induce	induce	VB	I-VP	O
damage	damage	NN	B-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
oral	oral	JJ	I-NP	O
tissues	tissue	NNS	I-NP	O
and	and	CC	O	O
cause	cause	VBP	B-VP	O
mutagenicity	mutagenicity	NN	B-NP	O
in	in	IN	B-PP	O
Salmonella	Salmonella	NNP	B-NP	O
typhimurium	typhimurium	NNP	I-NP	O
tester	tester	NN	I-NP	O
strains	strain	VBZ	B-VP	O
TA	TA	NN	B-NP	B-DNA
100	100	CD	I-NP	I-DNA
and	and	CC	O	O
TA	TA	NN	B-NP	B-protein
98	98	CD	I-NP	I-protein
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
interesting	interesting	JJ	B-ADJP	O
to	to	TO	B-VP	O
find	find	VB	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
metabolite	metabolite	NN	I-NP	O
of	of	IN	B-PP	O
arecoline	arecoline	NN	B-NP	O
,	,	,	O	O
arecoline	arecoline	NN	B-NP	O
N-oxide	N-oxide	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
moderately	moderately	RB	B-ADJP	O
mutagenic	mutagenic	JJ	I-ADJP	O
to	to	TO	B-PP	O
these	these	DT	B-NP	O
Salmonella	Salmonella	NNP	I-NP	O
tester	tester	NN	I-NP	O
strains	strain	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
mutagenicity	mutagenicity	NN	I-NP	O
was	be	VBD	B-VP	O
potently	potently	RB	I-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
sulfhydryl	sulfhydryl	NN	B-NP	O
compounds	compound	NNS	I-NP	O
,	,	,	O	O
namely	namely	RB	B-ADVP	O
,	,	,	O	O
glutathione	glutathione	NN	B-NP	O
,	,	,	O	O
N-acetylcysteine	N-acetylcysteine	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
cysteine	cysteine	NN	B-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
methionine	methionine	NN	B-NP	O
is	be	VBZ	B-VP	O
inactive	inactive	JJ	B-ADJP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
inhibition	inhibition	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
mutagenicity	mutagenicity	NN	I-NP	O
of	of	IN	B-PP	O
arecoline	arecoline	NN	B-NP	O
N-oxide	N-oxide	NN	I-NP	O
was	be	VBD	B-VP	O
strongly	strongly	RB	I-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
N-oxide	N-oxide	NN	I-NP	O
reducing	reduce	VBG	B-VP	O
agent	agent	NN	B-NP	O
titanium	titanium	NN	I-NP	O
trichloride	trichloride	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
possible	possible	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
arecoline	arecoline	NN	B-NP	O
N-oxide	N-oxide	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
carcinogenesis	carcinogenesis	NN	I-NP	O
by	by	IN	B-PP	O
areca	areca	NN	B-NP	O
nut	nut	NN	I-NP	O
chewing	chewing	NN	I-NP	O
is	be	VBZ	B-VP	O
discussed	discuss	VBN	I-VP	O
.	.	.	O	O

Periodontal	Periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
is	be	VBZ	B-VP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
common	common	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
of	of	IN	B-PP	O
adult	adult	JJ	B-NP	O
dogs	dog	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
80	80	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
animals	animal	NNS	B-NP	O
affected	affect	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
aetiology	aetiology	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
disease	disease	NN	I-NP	O
is	be	VBZ	B-VP	O
poorly	poorly	RB	I-VP	O
studied	study	VBN	I-VP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
bacteria	bacteria	NNS	B-NP	O
are	be	VBP	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
role	role	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
purpose	purpose	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
the	the	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
canine	canine	JJ	B-NP	O
gingivitis	gingivitis	NN	I-NP	O
and	and	CC	I-NP	O
periodontitis	periodontitis	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
compare	compare	VB	I-VP	O
this	this	DT	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
oral	oral	JJ	I-NP	O
flora	flora	NN	I-NP	O
.	.	.	O	O

Swabs	Swab	NNS	B-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
gingival	gingival	JJ	I-NP	O
margin	margin	NN	I-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
dogs	dog	NNS	I-NP	O
with	with	IN	B-PP	O
gingivitis	gingivitis	NN	B-NP	O
and	and	CC	O	O
three	three	CD	B-NP	O
orally	orally	RB	I-NP	O
healthy	healthy	JJ	I-NP	O
controls	control	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
subgingival	subgingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
was	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
from	from	IN	B-PP	O
three	three	CD	B-NP	O
dogs	dog	NNS	I-NP	O
with	with	IN	B-PP	O
periodontitis	periodontitis	NN	B-NP	O
.	.	.	O	O

Samples	Sample	NNS	B-NP	O
were	be	VBD	B-VP	O
subjected	subject	VBN	I-VP	O
to	to	TO	B-PP	O
routine	routine	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
culture	culture	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
prevalent	prevalent	JJ	I-NP	O
species	specie	NNS	I-NP	O
identified	identify	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
,	,	,	I-NP	O
gingivitis	gingivitis	NN	I-NP	O
and	and	CC	I-NP	O
periodontitis	periodontitis	NN	I-NP	O
groups	group	NNS	I-NP	O
were	be	VBD	B-VP	O
uncultured	uncultured	JJ	B-NP	O
bacterium	bacterium	NN	I-NP	O
(	(	(	O	O
12.5	12.5	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
isolates	isolate	NNS	B-NP	O
)	)	)	O	O
,	,	,	O	O
Bacteroides	Bacteroide	VBZ	B-VP	O
heparinolyticus/Pasteurella	heparinolyticus/Pasteurella	NN	B-NP	O
dagmatis	dagmatis	NN	I-NP	O
(	(	(	O	O
10.0	10.0	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
Actinomyces	Actinomyces	NN	B-NP	O
canis	canis	NN	I-NP	O
(	(	(	O	O
19.4	19.4	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

Bacteria	Bacteria	NNS	B-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
identified	identify	VBN	I-VP	O
using	use	VBG	B-VP	O
culture-independent	culture-independent	JJ	B-NP	O
methods	method	NNS	I-NP	O
(	(	(	O	O
16S	16S	NN	B-NP	O
rRNA	rRNA	NN	I-NP	O
gene	gene	NN	I-NP	O
sequencing	sequencing	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
predominant	predominant	JJ	I-NP	O
species	specie	NNS	I-NP	O
identified	identify	VBN	B-VP	O
were	be	VBD	B-VP	O
Pseudomonas	Pseudomonas	NNP	B-NP	O
sp	sp	NN	I-NP	O
.	.	.	O	O

(	(	(	O	O
30.9	30.9	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
clones	clone	NNS	B-NP	O
analysed	analyse	VBN	B-VP	O
)	)	)	O	O
,	,	,	O	O
Porphyromonas	Porphyromonas	NN	B-NP	O
cangingivalis	cangingivalis	NN	I-NP	O
(	(	(	O	O
16.1	16.1	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
Desulfomicrobium	Desulfomicrobium	NN	B-NP	O
orale	orale	NN	I-NP	O
(	(	(	O	O
12.0	12.0	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
,	,	,	I-NP	O
gingivitis	gingivitis	NN	I-NP	O
and	and	CC	I-NP	O
periodontitis	periodontitis	NN	I-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

Uncultured	Uncultured	JJ	B-NP	O
species	specie	NNS	I-NP	O
accounted	account	VBD	B-VP	O
for	for	IN	B-PP	O
13.2	13.2	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
2.0	2.0	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
10.5	10.5	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
potentially	potentially	RB	B-NP	O
novel	novel	JJ	I-NP	O
species	specie	NNS	I-NP	O
for	for	IN	B-PP	O
38.2	38.2	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
38.3	38.3	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
35.3	35.3	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
of	of	IN	B-PP	O
clones	clone	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
,	,	,	I-NP	O
gingivitis	gingivitis	NN	I-NP	O
and	and	CC	I-NP	O
periodontitis	periodontitis	NN	I-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
study	study	NN	I-NP	O
to	to	TO	B-VP	O
use	use	VB	I-VP	O
utilise	utilise	JJ	B-NP	O
culture-independent	culture-independent	JJ	I-NP	O
methods	method	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
identification	identification	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
canine	canine	JJ	I-NP	O
oral	oral	JJ	I-NP	O
flora	flora	NN	I-NP	O
in	in	IN	B-PP	O
health	health	NN	B-NP	O
and	and	CC	I-NP	O
disease	disease	NN	I-NP	O
is	be	VBZ	B-VP	O
highly	highly	RB	B-ADJP	O
diverse	diverse	JJ	I-ADJP	O
and	and	CC	O	O
also	also	RB	B-VP	O
contains	contain	VBZ	I-VP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
proportion	proportion	NN	I-NP	O
of	of	IN	B-PP	O
uncultured	uncultured	JJ	B-NP	O
and	and	CC	O	O
,	,	,	O	O
in	in	IN	B-PP	O
particular	particular	JJ	B-NP	O
,	,	,	I-NP	O
potentially	potentially	RB	I-NP	O
novel	novel	JJ	I-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

Advances	Advance	NNS	B-NP	O
in	in	IN	B-PP	O
isolation	isolation	NN	B-NP	O
and	and	CC	I-NP	O
culturing	culturing	NN	I-NP	O
techniques	technique	NNS	I-NP	O
have	have	VBP	B-VP	O
brought	bring	VBN	I-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
bacteria-causing	bacteria-causing	JJ	I-NP	O
maxillofacial	maxillofacial	JJ	I-NP	O
infections	infection	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
fore	fore	NN	I-NP	O
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
literature	literature	NN	I-NP	O
also	also	RB	B-ADVP	O
favors	favor	VBZ	B-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
anaerobes	anaerobe	NNS	B-NP	O
in	in	IN	B-PP	O
maxillofacial	maxillofacial	JJ	B-NP	O
infections	infection	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
prospective	prospective	JJ	I-NP	O
clinical	clinical	JJ	I-NP	O
and	and	CC	I-NP	O
microbiological	microbiological	JJ	I-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
designed	design	VBN	I-VP	O
to	to	TO	B-VP	O
check	check	VB	I-VP	O
the	the	DT	B-NP	O
validity	validity	NN	I-NP	O
of	of	IN	B-PP	O
such	such	JJ	B-NP	O
claims	claim	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
included	include	VBD	B-VP	O
88	88	CD	B-NP	O
patients	patient	NNS	I-NP	O
who	who	WP	B-NP	O
fulfilled	fulfil	VBD	B-VP	O
the	the	DT	B-NP	O
inclusion	inclusion	NN	I-NP	O
criteria	criterion	NNS	I-NP	O
.	.	.	O	O

Pus	Pus	NN	B-NP	B-protein
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
by	by	IN	B-PP	O
aspirating	aspirate	VBG	B-VP	O
the	the	DT	B-NP	O
involved	involve	VBN	I-NP	O
spaces	space	NNS	I-NP	O
and	and	CC	O	O
culture	culture	NN	B-NP	O
and	and	CC	I-NP	O
sensitivity	sensitivity	NN	I-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
microbes	microbe	NNS	I-NP	O
involved	involve	VBN	B-VP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
to	to	TO	B-PP	O
various	various	JJ	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
isolating	isolate	VBG	B-VP	O
the	the	DT	B-NP	O
various	various	JJ	I-NP	O
organisms	organism	NNS	I-NP	O
causing	cause	VBG	B-VP	O
infection	infection	NN	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
that	that	IN	B-SBAR	O
68.2	68.2	CD	B-NP	O
%	%	NN	I-NP	O
were	be	VBD	B-VP	O
aerobes	aerobe	NNS	B-NP	O
,	,	,	O	O
13.6	13.6	CD	B-NP	O
%	%	NN	I-NP	O
were	be	VBD	B-VP	O
mixed	mixed	JJ	B-NP	O
infections	infection	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
9.1	9.1	CD	B-NP	O
%	%	NN	I-NP	O
were	be	VBD	B-VP	O
anaerobes	anaerobe	NNS	B-NP	O
.	.	.	O	O

Streptococcus	Streptococcus	NNP	B-NP	O
and	and	CC	I-NP	O
Peptostreptococcus	Peptostreptococcus	NNP	I-NP	O
species	specie	NNS	I-NP	O
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
common	common	JJ	I-NP	O
among	among	IN	B-PP	O
aerobes	aerobe	NNS	B-NP	O
and	and	CC	I-NP	O
anaerobes	anaerobe	NNS	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

On	On	IN	B-PP	O
determining	determine	VBG	B-VP	O
sensitivity	sensitivity	NN	B-NP	O
to	to	TO	B-PP	O
penicillin	penicillin	NN	B-NP	B-protein
,	,	,	O	O
81.3	81.3	CD	B-NP	O
%	%	NN	I-NP	O
were	be	VBD	B-VP	O
sensitive	sensitive	JJ	B-ADJP	O
and	and	CC	O	O
18.8	18.8	CD	B-NP	O
%	%	NN	I-NP	O
were	be	VBD	B-VP	O
resistant	resistant	JJ	B-ADJP	O
.	.	.	O	O

Coagulase-negative	Coagulase-negative	JJ	B-NP	O
Staphylococcus	Staphylococcus	NNP	I-NP	O
and	and	CC	O	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
aureus	aureus	NNP	I-NP	O
were	be	VBD	B-VP	O
predominantly	predominantly	RB	B-ADJP	O
resistant	resistant	JJ	I-ADJP	O
to	to	TO	B-PP	O
penicillin	penicillin	NN	B-NP	B-protein
.	.	.	O	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
indicated	indicate	VBD	B-VP	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
microflora-causing	microflora-causing	JJ	B-NP	O
infections	infection	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
maxillofacial	maxillofacial	JJ	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
and	and	CC	I-NP	O
penicillin	penicillin	NN	I-NP	B-protein
remains	remain	VBZ	B-VP	O
the	the	DT	B-NP	O
drug	drug	NN	I-NP	O
of	of	IN	B-PP	O
choice	choice	NN	B-NP	O
in	in	IN	B-PP	O
treating	treat	VBG	B-VP	O
these	these	DT	B-NP	O
infections	infection	NNS	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
clarify	clarify	VB	I-VP	O
the	the	DT	B-NP	O
regulatory	regulatory	JJ	I-NP	O
mechanism	mechanism	NN	I-NP	O
by	by	IN	B-PP	O
bactericidal	bactericidal	JJ	B-NP	O
peptides	peptide	NNS	I-NP	O
secretion	secretion	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
secretion	secretion	NN	I-NP	O
of	of	IN	B-PP	O
bactericidal	bactericidal	JJ	B-NP	O
peptides	peptide	NNS	I-NP	O
was	be	VBD	B-VP	O
immunohistochemically	immunohistochemically	RB	B-ADVP	O
and	and	CC	I-ADVP	O
histoplanimetrically	histoplanimetrically	RB	I-ADVP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
Gram-positive/negative	Gram-positive/negative	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
colonization	colonization	NN	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	O
alimentary	alimentary	JJ	I-NP	O
tract	tract	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
associated	associate	VBN	I-NP	O
exocrine	exocrine	JJ	I-NP	O
glands	gland	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
stomach	stomach	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
comparable	comparable	JJ	I-NP	O
differences	difference	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
changes	change	NNS	I-NP	O
of	of	IN	B-PP	O
development	development	NN	B-NP	O
of	of	IN	B-PP	O
indigenous	indigenous	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
colonies	colony	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
small	small	JJ	I-NP	O
intestine	intestine	NN	I-NP	O
,	,	,	O	O
immunopositive	immunopositive	JJ	B-NP	O
granules	granule	NNS	I-NP	O
for	for	IN	B-PP	O
lysozyme	lysozyme	NN	B-NP	B-protein
and	and	CC	O	O
secretory	secretory	JJ	B-NP	B-protein
phospholipase	phospholipase	NN	I-NP	I-protein
A2	A2	NN	I-NP	I-protein
(	(	(	O	O
sPLA2	sPLA2	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
markedly	markedly	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
,	,	,	O	O
whereas	whereas	IN	O	O
immunopositive	immunopositive	JJ	B-NP	O
vacuoles	vacuole	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Paneth	Paneth	NN	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
increased	increase	VBN	I-ADJP	O
at	at	IN	B-PP	O
sites	site	NNS	B-NP	O
with	with	IN	B-PP	O
hyper-development	hyper-development	NN	B-NP	O
of	of	IN	B-PP	O
indigenous	indigenous	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
colonies	colony	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
intervillous	intervillous	JJ	I-NP	O
spaces	space	NNS	I-NP	O
than	than	IN	B-PP	O
at	at	IN	B-PP	O
sites	site	NNS	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
or	or	CC	I-NP	O
less	less	JJR	I-NP	O
development	development	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
exocrine	exocrine	JJ	B-NP	O
glands	gland	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
large	large	JJ	I-NP	O
intestine	intestine	NN	I-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
constant	constant	JJ	I-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
large	large	JJ	B-NP	O
quantities	quantity	NNS	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
.	.	.	O	O

Gram-positive	Gram-positive	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
colonies	colony	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
mucosal	mucosal	JJ	I-NP	O
surfaces	surface	NNS	I-NP	O
were	be	VBD	B-VP	O
dominant	dominant	JJ	B-ADJP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Gram-negative	Gram-negative	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
dominant	dominant	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
large	large	JJ	I-NP	O
intestine	intestine	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
distributions	distribution	NNS	I-NP	O
of	of	IN	B-PP	O
both	both	CC	B-NP	O
Gram-positive	Gram-positive	JJ	I-NP	O
and	and	CC	I-NP	O
negative	negative	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
intermediate	intermediate	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
small	small	JJ	I-NP	O
intestine	intestine	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
lysozyme	lysozyme	NN	B-NP	B-protein
and	and	CC	I-NP	O
sPLA2	sPLA2	NN	I-NP	B-protein
secreted	secrete	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Paneth	Paneth	NN	I-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
contribute	contribute	VBP	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
regulation	regulation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proliferation	proliferation	NN	I-NP	O
of	of	IN	B-PP	O
indigenous	indigenous	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
intervillous	intervillous	JJ	I-NP	O
spaces	space	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
small	small	JJ	I-NP	O
intestine	intestine	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
inversion	inversion	NN	I-NP	O
of	of	IN	B-PP	O
distributions	distribution	NNS	B-NP	O
of	of	IN	B-PP	O
Gram-positive	Gram-positive	JJ	B-NP	O
and	and	CC	I-NP	O
-negative	-negative	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
alimentary	alimentary	JJ	I-NP	O
tract	tract	NN	I-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
caused	cause	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
secretion	secretion	NN	I-NP	O
of	of	IN	B-PP	O
lysozyme	lysozyme	NN	B-NP	B-protein
and	and	CC	I-NP	O
sPLA2	sPLA2	NN	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
small	small	JJ	I-NP	O
intestine	intestine	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
project	project	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
develop	develop	VB	I-VP	O
an	an	DT	B-NP	O
alternative	alternative	JJ	I-NP	O
foot	foot	NN	I-NP	O
and	and	CC	I-NP	O
mouth	mouth	NN	I-NP	O
disease	disease	NN	I-NP	O
(	(	(	O	O
FMD	FMD	NN	B-NP	O
)	)	)	O	O
vaccine	vaccine	NN	B-NP	O
candidate	candidate	NN	I-NP	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
recombinant	recombinant	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
consisting	consist	VBG	B-VP	O
of	of	IN	B-PP	O
efficient	efficient	JJ	B-NP	B-protein
viral	viral	JJ	I-NP	I-protein
epitopes	epitope	NNS	I-NP	I-protein
.	.	.	O	O

A	A	DT	B-NP	O
recombinant	recombinant	JJ	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
designed	design	VBN	I-VP	O
that	that	WDT	B-NP	O
encodes	encode	VBZ	B-VP	O
B-cell	B-cell	NN	B-NP	B-protein
epitopes	epitope	NNS	I-NP	I-protein
of	of	IN	B-PP	O
proteins	protein	NNS	B-NP	O
VP1	VP1	NN	I-NP	B-protein
and	and	CC	I-NP	O
VP4	VP4	NN	I-NP	B-protein
and	and	CC	I-NP	O
T-cell	T-cell	NN	I-NP	B-protein
epitopes	epitope	NNS	I-NP	I-protein
of	of	IN	B-PP	O
proteins	protein	NNS	B-NP	O
2C	2C	NN	I-NP	O
and	and	CC	I-NP	O
3D	3D	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
polyepitope	polyepitope	NN	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
(	(	(	O	O
H-PE	H-PE	NN	B-NP	B-protein
)	)	)	O	O
was	be	VBD	B-VP	O
produced	produce	VBN	I-VP	O
in	in	IN	B-PP	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
bacteria	bacteria	NNS	I-NP	O
or	or	CC	B-PP	O
in	in	IN	B-PP	O
N.	N.	NNP	B-NP	O
benthamiana	benthamiana	NNP	I-NP	O
plants	plant	NNS	I-NP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
phytovirus	phytovirus	NN	I-NP	O
expression	expression	NN	I-NP	O
system	system	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
methods	method	NNS	I-NP	O
of	of	IN	B-PP	O
extraction	extraction	NN	B-NP	O
and	and	CC	I-NP	O
purification	purification	NN	I-NP	O
of	of	IN	B-PP	O
H-PE	H-PE	NN	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
from	from	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
and	and	CC	I-NP	O
plants	plant	NNS	I-NP	O
were	be	VBD	B-VP	O
developed	develop	VBN	I-VP	O
.	.	.	O	O

Immunization	Immunization	NN	B-NP	O
of	of	IN	B-PP	O
guinea	guinea	NN	B-NP	O
pigs	pig	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
purified	purify	VBN	I-NP	B-protein
H-PE	H-PE	NN	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
induced	induce	VBD	B-VP	O
an	an	DT	B-NP	O
efficient	efficient	JJ	I-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O
against	against	IN	B-PP	O
foot	foot	NN	B-NP	O
and	and	CC	I-NP	O
mouth	mouth	NN	I-NP	O
disease	disease	NN	I-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
FMDV	FMDV	NN	B-NP	O
)	)	)	O	O
serotype	serotype	NN	B-NP	O
O/Taiwan/99	O/Taiwan/99	NN	I-NP	O
and	and	CC	I-NP	O
protection	protection	NN	I-NP	O
against	against	IN	B-PP	O
the	the	DT	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
polyepitope	polyepitope	NN	I-NP	O
protein	protein	NN	I-NP	O
H-PE	H-PE	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
basis	basis	NN	I-NP	O
for	for	IN	B-PP	O
developing	develop	VBG	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
recombinant	recombinant	JJ	I-NP	O
vaccine	vaccine	NN	I-NP	O
against	against	IN	B-PP	O
FMD	FMD	NN	B-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
Candida	Candida	NNP	B-NP	O
albicans	albicans	NNP	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
pockets	pocket	NNS	I-NP	O
,	,	,	O	O
its	its	PRP$	B-NP	O
relationship	relationship	NN	I-NP	O
to	to	TO	B-PP	O
periodontitis	periodontitis	NN	B-NP	O
is	be	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
C.	C.	FW	B-NP	O
albicans	albicans	FW	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
adhesion	adhesion	NN	I-NP	O
and	and	CC	I-NP	O
invasion	invasion	NN	I-NP	O
of	of	IN	B-PP	O
Ca9-22	Ca9-22	NN	B-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
human	human	JJ	I-NP	B-cell_line
gingival	gingival	JJ	I-NP	I-cell_line
epithelial	epithelial	JJ	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
,	,	,	O	O
and	and	CC	O	O
human	human	JJ	B-NP	B-cell_type
gingival	gingival	JJ	I-NP	I-cell_type
fibroblasts	fibroblast	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
.	.	.	O	O

Heat-killed	Heat-killed	JJ	B-NP	O
C.	C.	NNP	I-NP	O
albicans	albicans	NNP	I-NP	O
and	and	CC	O	O
water-soluble	water-soluble	JJ	B-NP	B-protein
mannoprotein-beta-glucan	mannoprotein-beta-glucan	JJ	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
from	from	IN	B-PP	O
C.	C.	FW	B-NP	O
albicans	albicans	FW	I-NP	O
(	(	(	O	O
CAWS	CAWS	NN	B-NP	O
)	)	)	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
enhance	enhance	VB	I-VP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
adhesion	adhesion	NN	I-NP	O
or	or	CC	O	O
upregulate	upregulate	VBP	B-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
beta1	beta1	NN	B-NP	B-protein
integrin	integrin	NN	I-NP	I-protein
and	and	CC	I-NP	O
ICAM-1	ICAM-1	NN	I-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
invasion	invasion	NN	I-NP	O
;	;	:	O	O
both	both	CC	O	O
the	the	DT	B-NP	O
epithelial	epithelial	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	I-NP	O
fibroblasts	fibroblast	NNS	I-NP	B-cell_type
expressed	express	VBD	B-VP	O
dectin-1	dectin-1	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
recognizes	recognize	VBZ	B-VP	O
components	component	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
C.	C.	FW	I-NP	O
albicans	albicans	FW	I-NP	O
cell	cell	NN	I-NP	O
wall	wall	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
pretreatment	pretreatment	NN	B-NP	O
of	of	IN	B-PP	O
Ca9-22	Ca9-22	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
and	and	CC	O	O
human	human	JJ	B-NP	B-cell_type
gingival	gingival	JJ	I-NP	I-cell_type
fibroblasts	fibroblast	NNS	I-NP	I-cell_type
with	with	IN	B-PP	O
heat-killed	heat-killed	JJ	B-NP	O
C.	C.	FW	I-NP	O
albicans	albicans	FW	I-NP	O
or	or	CC	O	O
CAWS	CAWS	NN	B-NP	B-protein
significantly	significantly	RB	B-VP	O
enhanced	enhance	VBD	I-VP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
invasion	invasion	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
C.	C.	NNP	B-NP	O
albicans	albicans	NNP	I-NP	O
may	may	MD	B-VP	O
exacerbate	exacerbate	VB	I-VP	O
infectious	infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
by	by	IN	B-PP	O
enhancing	enhance	VBG	B-VP	O
the	the	DT	B-NP	O
invasion	invasion	NN	I-NP	O
of	of	IN	B-PP	O
host	host	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

Retrospective	Retrospective	JJ	B-NP	O
and	and	CC	I-NP	O
prospective	prospective	JJ	I-NP	O
studies	study	NNS	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
numbers	number	NNS	I-NP	O
,	,	,	O	O
types	type	NNS	B-NP	O
and	and	CC	O	O
persistence	persistence	NN	B-NP	O
of	of	IN	B-PP	O
microbes	microbe	NNS	B-NP	O
that	that	WDT	B-NP	O
contaminate	contaminate	VBP	B-VP	O
wind	wind	NN	B-NP	O
instruments	instrument	NNS	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
previously	previously	RB	I-NP	O
played	play	VBN	I-NP	O
instruments	instrument	NNS	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
20	20	CD	B-NP	O
)	)	)	O	O
harbored	harbor	VBD	B-VP	O
viable	viable	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
mold	mold	NN	B-NP	O
and/or	and/or	CC	I-NP	O
yeast	yeast	NN	I-NP	O
.	.	.	O	O

Reedinstruments	Reedinstrument	NNS	B-NP	O
consistently	consistently	RB	B-ADVP	O
carried	carry	VBD	B-VP	O
higher	high	JJR	B-NP	O
microbial	microbial	JJ	I-NP	O
loads	load	NNS	I-NP	O
than	than	IN	B-SBAR	O
did	do	VBD	B-VP	O
flutes	flute	NNS	B-NP	O
or	or	CC	I-NP	O
trumpets	trumpet	NNS	I-NP	O
.	.	.	O	O

Instruments	Instrument	NNS	B-NP	O
played	play	VBD	B-VP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
previous	previous	JJ	I-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
bore	bear	VBD	B-VP	O
typical	typical	JJ	B-NP	O
mouth	mouth	NN	I-NP	O
flora	flora	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
bacteria	bacteria	NNS	B-NP	O
recovered	recover	VBN	B-VP	O
after	after	IN	B-PP	O
72	72	CD	B-NP	O
h	h	NN	I-NP	O
following	follow	VBG	B-PP	O
play	play	NN	B-NP	O
consisted	consist	VBD	B-VP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
environmental	environmental	JJ	I-NP	O
flora	flora	NN	I-NP	O
.	.	.	O	O

Prospective	Prospective	JJ	B-NP	O
studies	study	NNS	I-NP	O
tested	test	VBN	B-VP	O
survival	survival	NN	B-NP	O
of	of	IN	B-PP	O
potentially	potentially	RB	B-NP	O
pathogenic	pathogenic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
(	(	(	O	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
,	,	,	O	O
Moraxella	Moraxella	NNP	B-NP	O
,	,	,	O	O
Escherichia	Escherichia	NNP	B-NP	O
coli	coli	NNP	I-NP	O
and	and	CC	O	O
attenuated	attenuate	VBD	B-VP	O
Mycobacterium	Mycobacterium	NN	B-NP	O
tuberculosis	tuberculosis	NN	I-NP	O
)	)	)	O	O
when	when	WRB	B-ADVP	O
applied	apply	VBN	B-VP	O
to	to	TO	B-PP	O
reeds	reed	NNS	B-NP	O
or	or	CC	O	O
following	follow	VBG	B-PP	O
simulated	simulated	JJ	B-NP	O
'play	'play	NN	I-NP	O
'	'	''	O	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
clarinet	clarinet	NN	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
species	specie	NNS	I-NP	O
survived	survive	VBD	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
maximum	maximum	NN	I-NP	O
of	of	IN	B-PP	O
24-48	24-48	CD	B-NP	O
h	h	NN	I-NP	O
on	on	IN	B-PP	O
reeds	reed	NNS	B-NP	O
,	,	,	O	O
except	except	IN	B-PP	O
Mycobacterium	Mycobacterium	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
persisted	persist	VBD	B-VP	O
through	through	IN	B-PP	O
13	13	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
simulated	simulate	VBN	B-NP	O
play	play	NN	I-NP	O
experiments	experiment	NNS	I-NP	O
,	,	,	O	O
test	test	NN	B-NP	O
bacteria	bacteria	NNS	I-NP	O
could	could	MD	B-VP	O
persist	persist	VB	I-VP	O
for	for	IN	B-PP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
five	five	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
support	support	VBP	B-VP	O
the	the	DT	B-NP	O
establishment	establishment	NN	I-NP	O
of	of	IN	B-PP	O
guidelines	guideline	NNS	B-NP	O
for	for	IN	B-PP	O
decontamination	decontamination	NN	B-NP	O
of	of	IN	B-PP	O
wind	wind	NN	B-NP	O
instruments	instrument	NNS	I-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
sharing	share	VBG	B-NP	O
or	or	CC	I-NP	O
transfer	transfer	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
instruments	instrument	NNS	I-NP	O
among	among	IN	B-PP	O
players	player	NNS	B-NP	O
.	.	.	O	O

Patients	Patient	NNS	B-NP	O
with	with	IN	B-PP	O
xerostomia	xerostomia	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
dry	dry	JJ	B-NP	O
mouth	mouth	NN	I-NP	O
,	,	,	O	O
resulting	result	VBG	B-VP	O
from	from	IN	B-PP	O
various	various	JJ	B-NP	O
causes	cause	NNS	I-NP	O
,	,	,	O	O
are	be	VBP	B-VP	O
at	at	IN	B-PP	O
higher	high	JJR	B-NP	O
risk	risk	NN	I-NP	O
for	for	IN	B-PP	O
developing	develop	VBG	B-VP	O
caries	cary	NNS	B-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
a	a	DT	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
saliva	saliva	NN	B-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
benefits	benefit	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
saliva	saliva	NN	B-NP	O
increases	increase	VBZ	B-VP	O
the	the	DT	B-NP	O
acidity	acidity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
affects	affect	VBZ	B-VP	O
many	many	JJ	B-NP	O
factors	factor	NNS	I-NP	O
that	that	WDT	B-NP	O
contribute	contribute	VBP	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
caries	cary	NNS	B-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
proliferation	proliferation	NN	B-NP	O
of	of	IN	B-PP	O
acid-producing	acid-producing	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
inability	inability	NN	B-NP	O
to	to	TO	B-VP	O
buffer	buffer	VB	I-VP	O
the	the	DT	B-NP	O
acid	acid	NN	I-NP	O
produced	produce	VBN	B-VP	O
by	by	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
or	or	CC	B-PP	O
from	from	IN	B-PP	O
ingested	ingest	VBN	B-NP	O
foods	food	NNS	I-NP	O
,	,	,	O	O
loss	loss	NN	B-NP	O
of	of	IN	B-PP	O
minerals	mineral	NNS	B-NP	O
from	from	IN	B-PP	O
tooth	tooth	JJ	B-NP	O
surfaces	surface	NNS	I-NP	O
and	and	CC	O	O
inability	inability	NN	B-NP	O
to	to	TO	B-VP	O
replenish	replenish	VB	I-VP	O
the	the	DT	B-NP	O
lost	lose	VBN	I-NP	O
minerals	mineral	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
loss	loss	NN	B-NP	O
of	of	IN	B-PP	O
lubrication	lubrication	NN	B-NP	O
.	.	.	O	O

Currently	Currently	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
new	new	JJ	B-NP	O
products	product	NNS	I-NP	O
that	that	WDT	B-NP	O
can	can	MD	B-VP	O
substitute	substitute	VB	I-VP	O
for	for	IN	B-PP	O
these	these	DT	B-NP	O
functions	function	NNS	I-NP	O
of	of	IN	B-PP	O
saliva	saliva	NN	B-NP	O
or	or	CC	O	O
induce	induce	VB	B-VP	O
production	production	NN	B-NP	O
of	of	IN	B-PP	O
saliva	saliva	NN	B-NP	O
are	be	VBP	B-VP	O
available	available	JJ	B-ADJP	O
in	in	IN	B-PP	O
Canada	Canada	NNP	B-NP	O
.	.	.	O	O

Some	Some	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
products	product	NNS	I-NP	O
are	be	VBP	B-VP	O
reviewed	review	VBN	I-VP	O
and	and	CC	O	O
a	a	DT	B-NP	O
protocol	protocol	NN	I-NP	O
for	for	IN	B-PP	O
caries	cary	NNS	B-NP	O
prevention	prevention	NN	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
high-risk	high-risk	JJ	I-NP	O
population	population	NN	I-NP	O
is	be	VBZ	B-VP	O
proposed	propose	VBN	I-VP	O
.	.	.	O	O

Trying	Try	VBG	B-VP	O
to	to	TO	I-VP	O
find	find	VB	I-VP	O
out	out	RP	B-PRT	O
the	the	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
microstructure	microstructure	NN	B-NP	O
influencing	influence	VBG	B-VP	O
bacterial	bacterial	JJ	B-NP	O
adhesion	adhesion	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
prepared	prepare	VBD	B-VP	O
different	different	JJ	B-NP	O
microstructures	microstructure	NNS	I-NP	O
to	to	TO	B-VP	O
compare	compare	VB	I-VP	O
the	the	DT	B-NP	O
adsorptive	adsorptive	JJ	I-NP	O
behavior	behavior	NN	I-NP	O
of	of	IN	B-PP	O
graphite	graphite	JJ	B-NP	O
powder	powder	NN	I-NP	O
and	and	CC	O	O
adhesive	adhesive	JJ	B-NP	O
behavior	behavior	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
microbe	microbe	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
used	use	VBD	B-VP	O
polydimethylsiloxane	polydimethylsiloxane	NN	B-NP	O
(	(	(	O	O
PDMS	PDMS	NN	B-NP	O
)	)	)	O	O
to	to	TO	B-VP	O
copy	copy	VB	I-VP	O
23	23	CD	B-NP	O
microstructures	microstructure	NNS	I-NP	O
of	of	IN	B-PP	O
hydroxyapatite	hydroxyapatite	NN	B-NP	O
(	(	(	O	O
HA	HA	NN	B-NP	O
)	)	)	O	O
chip	chip	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
cultured	culture	VBN	B-VP	O
them	them	PRP	B-NP	O
with	with	IN	B-PP	O
different	different	JJ	B-NP	O
sizes	size	NNS	I-NP	O
graphite	graphite	VBP	B-VP	O
powder	powder	NN	B-NP	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
microbes	microbe	NNS	I-NP	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
to	to	TO	B-VP	O
observe	observe	VB	I-VP	O
and	and	CC	I-VP	O
compare	compare	VB	I-VP	O
their	their	PRP$	B-NP	O
behavior	behavior	NN	I-NP	O
on	on	IN	B-PP	O
microstructures	microstructure	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
adsorption	adsorption	NN	I-NP	O
of	of	IN	B-PP	O
30-50	30-50	CD	B-NP	O
microm	microm	NN	I-NP	O
powder	powder	NN	I-NP	O
on	on	IN	B-PP	O
different	different	JJ	B-NP	O
microstructures	microstructure	NNS	I-NP	O
was	be	VBD	B-VP	O
insignificant	insignificant	JJ	B-ADJP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
10-20	10-20	CD	B-NP	O
microm	microm	NN	I-NP	O
powder	powder	NN	I-NP	O
had	have	VBD	B-VP	O
maximum	maximum	JJ	B-NP	O
adsorption	adsorption	NN	I-NP	O
on	on	IN	B-PP	O
10	10	CD	B-NP	O
microm	microm	NN	I-NP	O
and	and	CC	O	O
20	20	CD	B-NP	O
microm	microm	NN	I-NP	O
microstructures	microstructure	NNS	I-NP	O
.	.	.	O	O

Saccharomyces	Saccharomyces	NNP	B-NP	O
albicans	albican	NNS	I-NP	O
was	be	VBD	B-VP	O
most	most	RBS	B-ADJP	O
likely	likely	JJ	I-ADJP	O
to	to	TO	B-VP	O
adhere	adhere	VB	I-VP	O
to	to	TO	B-PP	O
5	5	CD	B-NP	O
microm	microm	NN	I-NP	O
microstructures	microstructure	NNS	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
equivalent	equivalent	JJ	B-ADJP	O
to	to	TO	B-PP	O
its	its	PRP$	B-NP	O
own	own	JJ	I-NP	O
size	size	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
microstructures	microstructure	NNS	B-NP	O
had	have	VBD	B-VP	O
little	little	JJ	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
adhesion	adhesion	NN	B-NP	O
of	of	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
which	which	WDT	B-NP	O
grew	grow	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
chain	chain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
size	size	NN	I-NP	O
of	of	IN	B-PP	O
microstructure	microstructure	NN	B-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
effective	effective	JJ	I-NP	O
factor	factor	NN	I-NP	O
that	that	WDT	B-NP	O
affects	affect	VBZ	B-VP	O
the	the	DT	B-NP	O
adsorption	adsorption	NN	I-NP	O
of	of	IN	B-PP	O
non-living	non-living	JJ	B-NP	O
powder	powder	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
microbial	microbial	JJ	I-NP	O
adhesion	adhesion	NN	I-NP	O
;	;	:	O	O
but	but	CC	O	O
some	some	DT	B-NP	O
special	special	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
which	which	WDT	B-NP	O
grew	grow	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
chain	chain	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
affected	affect	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
sizes	size	NNS	I-NP	O
or	or	CC	I-NP	O
shapes	shape	NNS	I-NP	O
of	of	IN	B-PP	O
microstructures	microstructure	NNS	B-NP	O
.	.	.	O	O

Helicobacter	Helicobacter	NN	B-NP	O
pylori	pylori	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
causative	causative	JJ	I-NP	O
agent	agent	NN	I-NP	O
of	of	IN	B-PP	O
gastritis	gastritis	NN	B-NP	O
and	and	CC	O	O
gastric	gastric	JJ	B-NP	O
ulcer	ulcer	NN	I-NP	O
,	,	,	O	O
plays	play	VBZ	B-VP	O
a	a	DT	B-NP	O
crucial	crucial	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
development	development	NN	B-NP	O
of	of	IN	B-PP	O
gastric	gastric	JJ	B-NP	O
carcinomas	carcinoma	NNS	I-NP	O
.	.	.	O	O

Antibiotic	Antibiotic	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
fails	fail	VBZ	B-VP	O
in	in	IN	B-PP	O
almost	almost	RB	B-NP	O
20	20	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
cases	case	NNS	B-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
development	development	NN	B-NP	O
of	of	IN	B-PP	O
antibiotic	antibiotic	JJ	B-NP	O
resistance	resistance	NN	I-NP	O
.	.	.	O	O

Development	Development	NN	B-NP	O
of	of	IN	B-PP	O
antibodies	antibody	NNS	B-NP	B-protein
against	against	IN	B-PP	O
specific	specific	JJ	B-NP	O
H.	H.	NN	I-NP	O
pylori	pylori	NN	I-NP	O
targets	target	NNS	I-NP	O
could	could	MD	B-VP	O
have	have	VB	I-VP	O
significant	significant	JJ	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
research	research	NN	I-NP	O
attempts	attempt	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
made	make	VBN	I-VP	O
to	to	TO	B-VP	O
study	study	VB	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
IgY	IgY	NN	B-NP	B-protein
purified	purify	VBN	B-VP	O
from	from	IN	B-PP	O
egg	egg	NN	B-NP	O
yolk	yolk	NN	I-NP	O
of	of	IN	B-PP	O
hens	hen	NNS	B-NP	O
immunized	immunize	VBN	B-VP	O
with	with	IN	B-PP	O
recombinant	recombinant	JJ	B-NP	B-protein
UreC	UreC	NN	I-NP	I-protein
in	in	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
mice	mouse	NNS	B-NP	O
infected	infect	VBN	B-VP	O
with	with	IN	B-PP	O
H.	H.	NN	B-NP	O
pylori	pylori	NN	I-NP	O
.	.	.	O	O

Purified	Purify	VBN	B-NP	O
IgY-HpUc	IgY-HpUc	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
forms	form	NNS	I-NP	O
:	:	:	O	O
powdered	powdered	JJ	B-ADJP	O
and	and	CC	O	O
PBS	PBS	NNP	B-NP	O
dissolved	dissolve	VBD	B-VP	O
.	.	.	O	O

10	10	CD	B-NP	O
(	(	(	O	O
9	9	CD	B-NP	O
)	)	)	O	O
bacteria	bacteria	NNS	B-NP	O
in	in	IN	B-PP	O
BHI	BHI	NN	B-NP	B-protein
were	be	VBD	B-VP	O
orally	orally	RB	I-VP	O
administered	administer	VBN	I-VP	O
to	to	TO	B-PP	O
C57BL6/j	C57BL6/j	NN	B-NP	O
mice	mouse	NNS	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
on	on	IN	B-PP	O
alternate	alternate	JJ	B-NP	O
day	day	NN	I-NP	O
intervals	interval	NNS	I-NP	O
.	.	.	O	O

Eight	Eight	CD	B-NP	O
weeks	week	NNS	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
inoculation	inoculation	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
serum	serum	NN	I-NP	O
was	be	VBD	B-VP	O
assayed	assay	VBN	I-VP	O
for	for	IN	B-PP	O
infection	infection	NN	B-NP	O
rate	rate	NN	I-NP	O
by	by	IN	B-PP	O
ELISA	ELISA	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
severity	severity	NN	I-NP	O
of	of	IN	B-PP	O
gastritis	gastritis	NN	B-NP	O
was	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
histopathologically	histopathologically	RB	B-ADVP	O
.	.	.	O	O

Infected	Infected	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
were	be	VBD	B-VP	O
randomly	randomly	RB	I-VP	O
divided	divide	VBN	I-VP	O
into	into	IN	B-PP	O
three	three	CD	B-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

Groups	Group	NNS	B-NP	O
one	one	CD	B-NP	O
and	and	CC	I-NP	O
two	two	CD	I-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
dietary	dietary	JJ	B-NP	O
IgY-HpUc	IgY-HpUc	NN	I-NP	O
and	and	CC	I-NP	O
IgY-HpUc	IgY-HpUc	NN	I-NP	O
dissolved	dissolve	VBN	B-VP	O
in	in	IN	B-PP	O
PBS	PBS	NNP	B-NP	O
respectively	respectively	RB	B-ADVP	O
for	for	IN	B-PP	O
28	28	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
untreated	untreated	JJ	I-NP	O
group	group	NN	I-NP	O
served	serve	VBD	B-VP	O
as	as	IN	B-PP	O
control	control	NN	B-NP	O
.	.	.	O	O

Serology	Serology	NN	B-NP	O
and	and	CC	I-NP	O
histopathology	histopathology	NN	I-NP	O
confirmed	confirm	VBD	B-VP	O
the	the	DT	B-NP	O
establishment	establishment	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

Indirect	Indirect	JJ	B-NP	O
ELISA	ELISA	NN	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treated	treat	VBN	I-NP	O
animals	animal	NNS	I-NP	O
showed	show	VBD	B-VP	O
considerable	considerable	JJ	B-NP	O
reduction	reduction	NN	I-NP	O
of	of	IN	B-PP	O
H.	H.	NN	B-NP	B-protein
pylori	pylori	NN	I-NP	I-protein
specific	specific	JJ	I-NP	I-protein
antibodies	antibody	NNS	I-NP	I-protein
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
sera	serum	NNS	I-NP	O
.	.	.	O	O

Pathological	Pathological	JJ	B-NP	O
examination	examination	NN	I-NP	O
of	of	IN	B-PP	O
gastric	gastric	JJ	B-NP	O
mucosa	mucosa	NN	I-NP	O
of	of	IN	B-PP	O
infected	infected	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
IgY-HpUc	IgY-HpUc	NN	B-NP	O
showed	show	VBD	B-VP	O
considerable	considerable	JJ	B-NP	O
reduction	reduction	NN	I-NP	O
of	of	IN	B-PP	O
inflammation	inflammation	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
stomach	stomach	NN	I-NP	O
tissues	tissue	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
presence	presence	NN	I-NP	O
on	on	IN	B-PP	O
mucosal	mucosal	JJ	B-NP	O
layer	layer	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
stomach	stomach	NN	I-NP	O
was	be	VBD	B-VP	O
considerably	considerably	RB	I-VP	O
reduced	reduce	VBN	I-VP	O
.	.	.	O	O

UreC-induced	UreC-induced	JJ	B-NP	O
IgY	IgY	NN	I-NP	O
is	be	VBZ	B-VP	O
specifically	specifically	RB	B-ADJP	O
successful	successful	JJ	I-ADJP	O
in	in	IN	B-PP	O
inhibition	inhibition	NN	B-NP	O
of	of	IN	B-PP	O
H.	H.	NN	B-NP	O
pylori	pylori	NN	I-NP	O
infection	infection	NN	I-NP	O
and	and	CC	O	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
alternative	alternative	NN	I-NP	O
to	to	TO	B-PP	O
antibiotic	antibiotic	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
vaginal	vaginal	JJ	I-NP	O
microbiome	microbiome	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
harbors	harbor	VBZ	B-VP	O
beneficial	beneficial	JJ	B-NP	O
Lactobacillus	Lactobacillus	NN	I-NP	O
strains	strain	NNS	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
believed	believe	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
host	host	NN	I-NP	O
defense	defense	NN	I-NP	O
mechanism	mechanism	NN	I-NP	O
for	for	IN	B-PP	O
preventing	prevent	VBG	B-VP	O
infections	infection	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
urogenital	urogenital	JJ	I-NP	O
tract	tract	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
suggested	suggest	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
gastrointestinal	gastrointestinal	JJ	I-NP	O
tract	tract	NN	I-NP	O
serves	serve	VBZ	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
reservoir	reservoir	NN	I-NP	O
for	for	IN	B-PP	O
lactobacilli	lactobacillus	NNS	B-NP	O
that	that	WDT	B-NP	O
colonize	colonize	VBP	B-VP	O
the	the	DT	B-NP	O
vagina	vagina	NN	I-NP	O
.	.	.	O	O

Using	Use	VBG	B-VP	O
rhesus	rhesus	NN	B-NP	O
macaques	macaque	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
examined	examine	VBD	B-VP	O
whether	whether	IN	B-SBAR	O
oral	oral	JJ	B-NP	O
delivery	delivery	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
vaginal	vaginal	JJ	I-NP	O
Lactobacillus	Lactobacillus	NN	I-NP	O
jensenii	jensenii	NNS	I-NP	O
1153-1646	1153-1646	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
GusA-producing	GusA-producing	JJ	I-NP	O
strain	strain	NN	I-NP	O
,	,	,	O	O
would	would	MD	B-VP	O
result	result	VB	I-VP	O
in	in	IN	B-PP	O
colonization	colonization	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
rectum	rectum	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
vagina	vagina	NN	I-NP	O
.	.	.	O	O

Lactobacilli	Lactobacillus	NNS	B-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
vagina	vagina	NN	I-NP	O
tracts	tract	NNS	I-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
macaques	macaque	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
beta-glucuronidase	beta-glucuronidase	NN	B-NP	B-protein
enzyme	enzyme	NN	I-NP	I-protein
production	production	NN	I-NP	O
,	,	,	O	O
16S	16S	NN	B-NP	B-DNA
rRNA	rRNA	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
and	and	CC	O	O
DNA	DNA	NN	B-NP	O
homology	homology	NN	I-NP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
repetitive	repetitive	JJ	I-NP	O
sequence-based	sequence-based	JJ	I-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
consensus	consensus	NN	I-NP	O
has	have	VBZ	B-VP	O
yet	yet	RB	I-VP	O
been	be	VBN	I-VP	O
reached	reach	VBN	I-VP	O
to	to	TO	B-VP	O
associate	associate	VB	I-VP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
conclusively	conclusively	RB	B-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
etio-pathogenesis	etio-pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
bisphosphonate-induced	bisphosphonate-induced	JJ	B-NP	O
osteonecrosis	osteonecrosis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
jaw	jaw	NN	I-NP	O
(	(	(	O	O
BONJ	BONJ	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
BONJ-like	BONJ-like	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
mouse	mouse	NN	I-NP	O
model	model	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
pamidronate	pamidronate	NN	I-NP	O
(	(	(	O	O
Pam	Pam	NN	B-NP	B-protein
)	)	)	O	O
-treated	-treated	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
control	control	VB	B-VP	O
non-drug-treated	non-drug-treated	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
,	,	,	O	O
tooth	tooth	DT	B-NP	O
extraction	extraction	NN	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
oral	oral	JJ	B-NP	O
infection	infection	NN	I-NP	O
with	with	IN	B-PP	O
Fusobacterium	Fusobacterium	NN	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
caused	cause	VBD	B-VP	O
BONJ-like	BONJ-like	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
and	and	CC	O	O
delayed	delay	VBN	B-VP	O
epithelial	epithelial	JJ	B-NP	O
healing	healing	NN	I-NP	O
,	,	,	O	O
both	both	DT	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
completely	completely	RB	I-VP	O
suppressed	suppress	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
broad-spectrum	broad-spectrum	JJ	I-NP	O
antibiotic	antibiotic	JJ	I-NP	O
cocktail	cocktail	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
both	both	CC	O	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
and	and	CC	O	O
in	in	FW	B-NP	O
vivo	vivo	FW	I-NP	O
experiments	experiment	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
Pam	Pam	NN	B-NP	B-protein
and	and	CC	I-NP	O
Fusobacterium	Fusobacterium	NN	I-NP	O
nucleatum	nucleatum	NN	I-NP	O
caused	cause	VBD	B-VP	O
the	the	DT	B-NP	O
death	death	NN	I-NP	O
of	of	IN	B-PP	O
gingival	gingival	JJ	B-NP	B-cell_type
fibroblasts	fibroblast	NNS	I-NP	I-cell_type
(	(	(	O	O
GFs	GF	NNS	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
down-regulated	down-regulate	VBD	B-VP	O
their	their	PRP$	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
keratinocyte	keratinocyte	NN	B-NP	B-protein
growth	growth	NN	I-NP	I-protein
factor	factor	NN	I-NP	I-protein
(	(	(	O	O
KGF	KGF	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
induces	induce	VBZ	B-VP	O
epithelial	epithelial	JJ	B-NP	O
cell	cell	NN	I-NP	O
growth	growth	NN	I-NP	O
and	and	CC	I-NP	O
migration	migration	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
tissues	tissue	NNS	I-NP	O
pre-exposed	pre-exposed	JJ	B-ADJP	O
to	to	TO	B-VP	O
bisphosphonate	bisphosphonate	VB	I-VP	O
,	,	,	O	O
bacterial	bacterial	JJ	B-NP	O
infection	infection	NN	I-NP	O
at	at	IN	B-PP	O
tooth	tooth	JJ	B-NP	B-DNA
extraction	extraction	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
caused	cause	VBD	B-VP	O
diminished	diminish	VBN	I-VP	O
KGF	KGF	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
GFs	GF	NNS	B-NP	B-protein
,	,	,	O	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
delay	delay	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
epithelial	epithelial	JJ	I-NP	O
wound-healing	wound-healing	JJ	I-NP	O
process	process	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
mitigated	mitigate	VBN	I-VP	O
by	by	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
dental	dental	JJ	B-NP	O
enamel	enamel	NN	I-NP	O
defects	defect	NNS	I-NP	O
,	,	,	O	O
recurrent	recurrent	JJ	B-NP	O
aphthous	aphthous	JJ	I-NP	O
stomatitis	stomatitis	NN	I-NP	O
(	(	(	O	O
RAS	RAS	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
caries	cary	NNS	B-NP	O
experience	experience	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
measure	measure	VB	I-VP	O
salivary	salivary	JJ	B-NP	O
flow	flow	NN	I-NP	O
rate	rate	NN	I-NP	O
,	,	,	O	O
buffer	buffer	NN	B-NP	O
capacity	capacity	NN	I-NP	O
,	,	,	O	O
saliva	saliva	NN	B-NP	O
and	and	CC	O	O
plaque	plaque	NN	B-NP	O
pH	pH	NN	I-NP	O
and	and	CC	O	O
salivary	salivary	JJ	B-NP	O
cariogenic	cariogenic	JJ	I-NP	O
microflora	microflora	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
celiac	celiac	JJ	B-NP	O
disease	disease	NN	I-NP	O
(	(	(	O	O
CD	CD	NN	B-NP	O
)	)	)	O	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
healthy	healthy	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O
Thirty-five	Thirty-five	CD	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
aged	age	VBN	B-VP	O
6-19	6-19	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
CD	CD	NN	B-NP	O
and	and	CC	O	O
35	35	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
children	child	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
age	age	NN	I-NP	O
participated	participate	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

Enamel	Enamel	NN	B-NP	O
defects	defect	NNS	I-NP	O
were	be	VBD	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
and	and	CC	O	O
classified	classify	VBN	B-VP	O
using	use	VBG	B-VP	O
Aine	Aine	NN	B-NP	O
's	's	POS	B-NP	O
classification	classification	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
RAS	RAS	NN	B-NP	B-protein
and	and	CC	O	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
were	be	VBD	B-VP	O
recorded	record	VBN	I-VP	O
using	use	VBG	B-VP	O
WHO	WHO	NN	B-NP	O
criteria	criterion	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
parents	parent	NNS	I-NP	O
were	be	VBD	B-VP	O
interviewed	interview	VBN	I-VP	O
about	about	IN	B-PP	O
various	various	JJ	B-NP	O
oral	oral	JJ	I-NP	B-protein
health-related	health-related	JJ	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
.	.	.	O	O

Saliva	Saliva	NN	B-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
to	to	TO	B-VP	O
measure	measure	VB	I-VP	O
the	the	DT	B-NP	O
stimulated	stimulate	VBN	I-NP	O
salivary	salivary	JJ	I-NP	O
flow	flow	NN	I-NP	O
rate	rate	NN	I-NP	O
,	,	,	O	O
buffer	buffer	NN	B-NP	O
capacity	capacity	NN	I-NP	O
and	and	CC	I-NP	O
pH	pH	NN	I-NP	O
values	value	NNS	I-NP	O
of	of	IN	B-PP	O
saliva	saliva	NN	B-NP	O
and	and	CC	I-NP	O
plaque	plaque	NN	I-NP	O
.	.	.	O	O

Salivary	Salivary	JJ	B-NP	O
mutans	mutan	NNS	I-NP	O
streptococci	streptococci	NNS	I-NP	O
and	and	CC	I-NP	O
lactobacilli	lactobacillus	NNS	I-NP	O
were	be	VBD	B-VP	O
counted	count	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
enamel	enamel	NN	I-NP	O
defects	defect	NNS	I-NP	O
and	and	CC	O	O
RAS	RAS	NN	B-NP	O
prevalence	prevalence	NN	I-NP	O
were	be	VBD	B-VP	O
statistically	statistically	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
(	(	(	O	O
40	40	CD	B-NP	O
and	and	CC	I-NP	O
37.1	37.1	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CD	CD	NNP	I-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
salivary	salivary	JJ	B-NP	O
mutans	mutan	NNS	I-NP	O
streptococci	streptococci	NNS	I-NP	O
(	(	(	O	O
48	48	CD	B-NP	O
and	and	CC	I-NP	O
14	14	CD	I-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
lactobacilli	lactobacilli	NN	B-NP	O
(	(	(	O	O
51	51	CD	B-NP	O
and	and	CC	I-NP	O
34	34	CD	I-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
colonization	colonization	NN	B-NP	O
was	be	VBD	B-VP	O
statistically	statistically	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
(	(	(	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
0.012	0.012	CD	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
0.010	0.010	CD	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CD	CD	NNP	I-NP	O
group	group	NN	I-NP	O
;	;	:	O	O
the	the	DT	B-NP	O
DMFS	DMFS	NN	I-NP	O
and	and	CC	I-NP	O
dfs	df	NNS	I-NP	O
values	value	NNS	I-NP	O
were	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

CD	CD	NN	B-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
significantly	significantly	RB	I-NP	O
higher	high	JJR	I-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
developing	develop	VBG	B-VP	O
enamel	enamel	NN	B-NP	O
defects	defect	NNS	I-NP	O
and	and	CC	O	O
RAS	RAS	NN	B-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
a	a	DT	B-NP	O
lower	low	JJR	I-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
salivary	salivary	JJ	B-NP	O
mutans	mutan	NNS	I-NP	O
streptococci	streptococci	NNS	I-NP	O
and	and	CC	O	O
lactobacilli	lactobacilli	NN	B-NP	O
colonization	colonization	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
oral	oral	JJ	I-NP	O
manifestations	manifestation	NNS	I-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
helpful	helpful	JJ	B-ADJP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
early	early	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
CD	CD	NNP	B-NP	O
.	.	.	O	O

Previously	Previously	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
reported	report	VBD	B-VP	O
that	that	IN	B-SBAR	O
epithelial	epithelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
respond	respond	VBP	B-VP	O
to	to	TO	B-PP	O
exogenous	exogenous	JJ	B-NP	O
interleukin	interleukin	NN	I-NP	B-protein
(	(	(	O	I-protein
IL	IL	NN	B-NP	I-protein
)	)	)	O	I-protein
-1alpha	-1alpha	NN	B-NP	I-protein
by	by	IN	B-PP	O
increasing	increase	VBG	B-VP	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
genes	gene	NNS	I-NP	B-DNA
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
host	host	NN	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
microbes	microbe	NNS	B-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	B-protein
protein	protein	NN	I-NP	I-protein
complex	complex	NN	I-NP	I-protein
calprotectin	calprotectin	NN	I-NP	O
(	(	(	O	O
S100A8/A9	S100A8/A9	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

Given	Give	VBN	B-VP	O
that	that	IN	B-SBAR	O
S100A8/A9	S100A8/A9	NN	B-NP	B-protein
protects	protect	VBZ	B-VP	O
epithelial	epithelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
against	against	IN	B-PP	O
invading	invade	VBG	B-VP	O
bacteria	bacteria	NNS	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
studied	study	VBD	B-VP	O
whether	whether	IN	B-SBAR	O
IL-1alpha	IL-1alpha	NN	B-NP	B-protein
augments	augment	VBZ	B-VP	O
S100A8/A9-dependent	S100A8/A9-dependent	JJ	B-NP	O
resistance	resistance	NN	I-NP	O
to	to	TO	B-PP	O
bacterial	bacterial	JJ	B-NP	O
invasion	invasion	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	B-cell_type
keratinocytes	keratinocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

When	When	WRB	B-ADVP	O
inoculated	inoculate	VBN	B-VP	O
with	with	IN	B-PP	O
Listeria	Listeria	NNP	B-NP	O
monocytogenes	monocytogene	NNS	I-NP	O
,	,	,	O	O
human	human	JJ	B-NP	B-cell_line
buccal	buccal	JJ	I-NP	I-cell_line
epithelial	epithelial	JJ	I-NP	I-cell_line
(	(	(	O	I-cell_line
TR146	TR146	NN	B-NP	I-cell_line
)	)	)	O	I-cell_line
cells	cell	NNS	B-NP	I-cell_line
expressed	express	VBN	B-VP	O
and	and	CC	I-VP	O
released	release	VBN	I-VP	O
IL-1alpha	IL-1alpha	NN	B-NP	B-protein
.	.	.	O	O

Subsequently	Subsequently	RB	B-ADVP	O
,	,	,	O	O
IL-1alpha-containing	IL-1alpha-containing	JJ	B-NP	O
media	medium	NNS	I-NP	O
from	from	IN	B-PP	O
Listeria-infected	Listeria-infected	JJ	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
increased	increase	VBD	B-VP	O
S100A8/A9	S100A8/A9	NN	B-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
naive	naive	JJ	B-NP	B-cell_line
TR146	TR146	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
an	an	DT	B-NP	O
IL-1	IL-1	NN	I-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	I-NP	O
IL-1R	IL-1R	NN	I-NP	B-protein
)	)	)	I-NP	O
-dependent	-dependent	JJ	I-NP	O
manner	manner	NN	I-NP	O
.	.	.	O	O

Incubation	Incubation	NN	B-NP	O
with	with	IN	B-PP	O
exogenous	exogenous	JJ	B-NP	O
IL-1alpha	IL-1alpha	NN	I-NP	B-protein
decreased	decrease	VBD	B-VP	O
Listeria	Listeria	NNP	B-NP	O
invasion	invasion	NN	I-NP	O
into	into	IN	B-PP	O
TR146	TR146	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
,	,	,	O	O
whereas	whereas	IN	O	O
invasion	invasion	NN	B-NP	O
increased	increase	VBD	B-VP	O
with	with	IN	B-PP	O
IL-1R	IL-1R	NN	B-NP	B-protein
antagonist	antagonist	NN	I-NP	O
.	.	.	O	O

Conversely	Conversely	RB	B-ADVP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
S100A8/A9	S100A8/A9	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
were	be	VBD	B-VP	O
knocked	knock	VBN	I-VP	O
down	down	RB	B-ADVP	O
using	use	VBG	B-VP	O
short	short	JJ	B-NP	O
hairpin	hairpin	NN	I-NP	O
RNA	RNA	NN	I-NP	O
(	(	(	O	O
shRNA	shRNA	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
TR146	TR146	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
responded	respond	VBD	B-VP	O
to	to	TO	B-PP	O
exogenous	exogenous	JJ	B-NP	O
IL-1alpha	IL-1alpha	NN	I-NP	B-protein
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
intracellular	intracellular	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
strongly	strongly	RB	B-VP	O
suggest	suggest	VBP	I-VP	O
that	that	IN	B-SBAR	O
infected	infected	JJ	B-NP	B-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
release	release	VBP	B-VP	O
IL-1alpha	IL-1alpha	NN	B-NP	B-protein
to	to	TO	B-VP	O
signal	signal	VB	I-VP	O
neighboring	neighboring	JJ	B-NP	B-cell_type
keratinocytes	keratinocyte	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
a	a	DT	B-NP	O
paracrine	paracrine	JJ	I-NP	O
manner	manner	NN	I-NP	O
,	,	,	O	O
promoting	promote	VBG	B-VP	O
S100A8/A9-dependent	S100A8/A9-dependent	JJ	B-NP	O
resistance	resistance	NN	I-NP	O
to	to	TO	B-PP	O
invasive	invasive	JJ	B-NP	B-DNA
L.	L.	NNP	I-NP	I-DNA
monocytogenes	monocytogene	NNS	I-NP	I-DNA
.	.	.	O	O

Modifications	Modification	NNS	B-NP	O
of	of	IN	B-PP	O
titanium	titanium	NN	B-NP	O
(	(	(	O	O
Ti	Ti	NN	B-NP	B-DNA
)	)	)	O	O
implant	implant	NN	B-NP	O
surfaces	surface	NNS	I-NP	O
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
early	early	JJ	B-NP	O
biofilm	biofilm	NN	I-NP	O
formation	formation	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
outcome	outcome	NN	I-NP	O
of	of	IN	B-PP	O
implant	implant	NN	B-NP	O
procedures	procedure	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
examine	examine	VB	I-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
plasma	plasma	NN	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
and	and	CC	O	O
electrostatic	electrostatic	JJ	B-NP	O
forces	force	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
adhesion	adhesion	NN	I-NP	O
mechanism	mechanism	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
to	to	TO	B-PP	O
modified	modify	VBN	B-NP	O
Ti	Ti	NNP	I-NP	O
surfaces	surface	NNS	I-NP	O
.	.	.	O	O

Ti	Ti	NN	B-NP	O
discs	disc	NNS	I-NP	O
with	with	IN	B-PP	O
three	three	CD	B-NP	O
different	different	JJ	I-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
surface	surface	NN	B-NP	O
modifications	modification	NNS	I-NP	O
,	,	,	O	O
machined	machine	VBN	B-VP	O
,	,	,	O	O
acid-etched	acid-etched	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
acid-etched	acid-etched	JJ	B-NP	O
and	and	CC	I-NP	O
blasted	blasted	JJ	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
for	for	IN	B-PP	O
adhesion	adhesion	NN	B-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
:	:	:	O	O
Streptococcus	Streptococcus	NN	B-NP	O
mutans	mutan	NNS	I-NP	O
,	,	,	O	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Fusobacterium	Fusobacterium	NN	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
.	.	.	O	O

Following	Follow	VBG	B-PP	O
pretreatment	pretreatment	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Ti	Ti	NNP	I-NP	O
with	with	IN	B-PP	O
ion	ion	NN	B-NP	O
rich	rich	JJ	I-NP	O
solutions	solution	NNS	I-NP	O
or	or	CC	O	O
coating	coat	VBG	B-VP	O
by	by	IN	B-PP	O
human	human	JJ	B-NP	B-protein
serum	serum	NN	I-NP	I-protein
albumin	albumin	NN	I-NP	I-protein
or	or	CC	I-NP	O
fibronectin	fibronectin	NN	I-NP	B-protein
,	,	,	O	O
bacterial	bacterial	JJ	B-NP	O
adhesion	adhesion	NN	I-NP	O
was	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
by	by	IN	B-PP	O
scanning	scan	VBG	B-VP	O
electron	electron	NN	B-NP	O
microscopy	microscopy	NN	I-NP	O
and	and	CC	O	O
assessed	assess	VBN	B-VP	O
quantitatively	quantitatively	RB	B-ADVP	O
by	by	IN	B-PP	O
DNA	DNA	NN	B-NP	O
analysis	analysis	NN	I-NP	O
.	.	.	O	O

Ti	Ti	NNP	B-NP	O
coating	coat	VBG	B-VP	O
by	by	IN	B-PP	O
proteins	protein	NNS	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
bacterial	bacterial	JJ	B-NP	O
adhesion	adhesion	NN	I-NP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
interrelationships	interrelationship	NNS	I-NP	O
were	be	VBD	B-VP	O
further	further	RB	I-VP	O
investigated	investigate	VBN	I-VP	O
through	through	IN	B-PP	O
confocal	confocal	JJ	B-NP	O
scanning	scanning	NN	I-NP	O
laser	laser	NN	I-NP	O
microscopy	microscopy	NN	I-NP	O
.	.	.	O	O

Acid-etched	Acid-etched	JJ	B-ADJP	O
and	and	CC	O	O
blasted	blast	VBD	B-VP	O
Ti	Ti	NNP	B-NP	O
surfaces	surface	NNS	I-NP	O
exhibited	exhibit	VBD	B-VP	O
significantly	significantly	RB	B-NP	O
higher	high	JJR	I-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
adhesion	adhesion	NN	I-NP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
two	two	CD	I-NP	O
surfaces	surface	NNS	I-NP	O
.	.	.	O	O

Calcium	Calcium	NN	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
serve	serve	VB	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
bridging	bridge	VBG	I-NP	O
agent	agent	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
adhesion	adhesion	NN	I-NP	O
process	process	NN	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
and	and	CC	O	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
to	to	TO	B-PP	O
Ti	Ti	NNP	B-NP	O
surfaces	surface	NNS	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
albumin	albumin	NN	B-NP	O
coating	coating	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Ti	Ti	NNP	I-NP	O
reduced	reduce	VBD	B-VP	O
the	the	DT	B-NP	O
adhesion	adhesion	NN	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
to	to	TO	B-PP	O
all	all	DT	B-NP	O
surfaces	surface	NNS	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
influence	influence	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
adhesion	adhesion	NN	I-NP	O
of	of	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
or	or	CC	O	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
.	.	.	O	O

Coating	Coat	VBG	B-VP	O
the	the	DT	B-NP	O
Ti	Ti	NNP	I-NP	O
with	with	IN	B-PP	O
fibronectin	fibronectin	NN	B-NP	B-protein
enhanced	enhance	VBD	B-VP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
and	and	CC	O	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
adhesion	adhesion	NN	I-NP	O
.	.	.	O	O

Bacterial	Bacterial	JJ	B-NP	O
adhesion	adhesion	NN	I-NP	O
to	to	TO	B-PP	O
Ti	Ti	NNP	B-NP	O
surfaces	surface	NNS	I-NP	O
is	be	VBZ	B-VP	O
roughness-dependent	roughness-dependent	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
adhesion	adhesion	NN	I-NP	O
mechanism	mechanism	NN	I-NP	O
is	be	VBZ	B-VP	O
influenced	influence	VBN	I-VP	O
by	by	IN	B-PP	O
ions	ion	NNS	B-NP	O
and	and	CC	I-NP	O
proteins	protein	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
coating	coating	NN	I-NP	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
profiles	profile	NNS	I-NP	O
of	of	IN	B-PP	O
periodontopathogenic	periodontopathogenic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
Chinese	Chinese	JJ	I-NP	B-cell_line
population	population	NN	I-NP	I-cell_line
using	use	VBG	B-VP	O
quantitative	quantitative	JJ	B-NP	O
real-time	real-time	JJ	I-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
(	(	(	O	O
qRT-PCR	qRT-PCR	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Twenty-four	Twenty-four	CD	B-NP	O
periodontally	periodontally	RB	I-NP	O
healthy	healthy	JJ	I-NP	O
Chinese	Chinese	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
and	and	CC	O	O
60	60	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
(	(	(	O	O
CP	CP	NN	B-NP	B-DNA
)	)	)	O	O
were	be	VBD	B-VP	O
enrolled	enrol	VBN	I-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
cross-sectional	cross-sectional	JJ	I-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

qRT-PCR	qRT-PCR	NN	B-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
quantify	quantify	VB	I-VP	O
Aggregatibacter	Aggregatibacter	NNP	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
,	,	,	O	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
,	,	,	O	O
Porphyromonas	Porphyromonas	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Prevotella	Prevotella	NNP	B-NP	O
intermedia	intermedia	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
total	total	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
counts	count	NNS	I-NP	O
from	from	IN	B-PP	O
252	252	CD	B-NP	O
samples	sample	NNS	I-NP	O
collected	collect	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
saliva	saliva	NN	I-NP	O
,	,	,	O	O
supragingival	supragingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
subgingival	subgingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
84	84	CD	I-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
detection	detection	NN	I-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
A.	A.	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
was	be	VBD	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
50	50	CD	I-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

F.	F.	NN	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
subjects	subject	NNS	I-NP	O
and	and	CC	O	O
CP	CP	NN	B-NP	O
patients	patient	NNS	I-NP	O
had	have	VBD	B-VP	O
higher	high	JJR	B-NP	O
bacterial	bacterial	JJ	I-NP	O
loads	load	NNS	I-NP	O
than	than	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
median	median	JJ	I-NP	O
proportion	proportion	NN	I-NP	O
of	of	IN	B-PP	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
in	in	IN	B-PP	O
subgingival	subgingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
supragingival	supragingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
and	and	CC	I-NP	O
saliva	saliva	NN	I-NP	O
.	.	.	O	O

P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
and	and	CC	O	O
P.	P.	NNP	B-NP	O
intermedia	intermedia	NNS	I-NP	O
had	have	VBD	B-VP	O
higher	high	JJR	B-NP	O
detection	detection	NN	I-NP	O
frequencies	frequency	NNS	I-NP	O
and	and	CC	O	O
bacterial	bacterial	JJ	B-NP	O
loads	load	NNS	I-NP	O
in	in	IN	B-PP	O
CP	CP	NN	B-NP	O
patients	patient	NNS	I-NP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
median	median	JJ	I-NP	O
proportion	proportion	NN	I-NP	O
of	of	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
different	different	JJ	I-ADJP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
intraoral	intraoral	JJ	I-NP	O
locations	location	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CP	CP	NN	I-NP	B-DNA
group	group	NN	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
proportion	proportion	NN	I-NP	O
in	in	IN	B-PP	O
subgingival	subgingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
was	be	VBD	B-VP	O
9.01	9.01	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
strong	strong	JJ	B-NP	O
positive	positive	JJ	I-NP	O
Spearman	Spearman	NNP	I-NP	O
's	's	POS	B-NP	O
correlations	correlation	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
A.	A.	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
,	,	,	O	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
P.	P.	NNP	B-NP	O
intermedia	intermedia	NNS	I-NP	O
counts	count	VBZ	B-VP	O
across	across	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
intraoral	intraoral	JJ	I-NP	O
locations	location	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
presence	presence	NN	I-NP	O
and	and	CC	I-NP	O
bacteria	bacteria	NNS	I-NP	O
loads	load	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
four	four	CD	I-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
Chinese	Chinese	JJ	I-NP	O
population	population	NN	I-NP	O
are	be	VBP	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
from	from	IN	B-PP	O
other	other	JJ	B-NP	O
populations	population	NNS	I-NP	O
.	.	.	O	O

Examination	Examination	NN	B-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
detection	detection	NN	I-NP	O
frequency	frequency	NN	I-NP	O
and	and	CC	O	O
loads	load	NNS	B-NP	O
in	in	IN	B-PP	O
Chinese	Chinese	JJ	B-NP	O
adults	adult	NNS	I-NP	O
may	may	MD	B-VP	O
assist	assist	VB	I-VP	O
microbial	microbial	JJ	B-NP	O
studies	study	NNS	I-NP	O
of	of	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
shed	shed	VB	I-VP	O
light	light	NN	B-NP	O
on	on	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
and	and	CC	I-NP	O
treatment	treatment	NN	I-NP	O
using	use	VBG	B-VP	O
antibiotics	antibiotic	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Chinese	Chinese	JJ	I-NP	B-cell_type
population	population	NN	I-NP	I-cell_type
.	.	.	O	O

Recently	Recently	RB	B-ADVP	O
,	,	,	O	O
plasma	plasma	NN	B-NP	O
sterilization	sterilization	NN	I-NP	O
has	have	VBZ	B-VP	O
attracted	attract	VBN	I-VP	O
increasing	increase	VBG	B-NP	O
attention	attention	NN	I-NP	O
in	in	IN	B-PP	O
dental	dental	JJ	B-NP	O
community	community	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
atmospheric	atmospheric	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
non-equilibrium	non-equilibrium	JJ	I-NP	O
plasma	plasma	NN	I-NP	O
jet	jet	NN	I-NP	O
(	(	(	O	O
APNPs	APNP	NNS	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
driven	drive	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
kilohertz	kilohertz	NN	I-NP	O
pulsed	pulsed	JJ	I-NP	O
DC	DC	NN	I-NP	O
power	power	NN	I-NP	O
,	,	,	O	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
applied	apply	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
dental	dental	JJ	I-NP	O
and	and	CC	I-NP	O
oral	oral	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
still	still	RB	B-ADVP	O
in	in	IN	B-PP	O
doubt	doubt	NN	B-NP	O
whether	whether	IN	B-SBAR	O
APNPs	APNP	NNS	B-NP	B-protein
can	can	MD	B-VP	O
effectively	effectively	RB	I-VP	O
kill	kill	VB	I-VP	O
pathogenic	pathogenic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
and	and	CC	O	O
produce	produce	VB	B-VP	O
no	no	DT	B-NP	O
harmful	harmful	JJ	I-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
normal	normal	JJ	B-NP	O
oral	oral	JJ	I-NP	O
tissues	tissue	NNS	I-NP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
on	on	IN	B-PP	O
normal	normal	JJ	B-NP	O
mucosa	mucosa	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
bacterial-killing	bacterial-killing	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
APNPs	APNP	NNS	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
biofilms	biofilm	NNS	I-NP	O
containing	contain	VBG	B-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
breed	breed	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
(	(	(	O	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
,	,	,	O	O
P.g	P.g	NN	B-NP	O
.	.	.	O	O

)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
pathological	pathological	JJ	I-NP	O
changes	change	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
after	after	IN	B-PP	O
treatment	treatment	NN	B-NP	O
by	by	IN	B-PP	O
APNPs	APNP	NNS	B-NP	B-protein
.	.	.	O	O

P.g	P.g	NN	B-NP	O
.	.	.	O	O

was	be	VBD	B-VP	O
incubated	incubate	VBN	I-VP	O
to	to	TO	B-VP	O
form	form	VB	I-VP	O
the	the	DT	B-NP	O
biofilms	biofilm	NNS	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
divided	divide	VBN	I-VP	O
into	into	IN	B-PP	O
three	three	CD	B-NP	O
groups	group	NNS	I-NP	O
randomly	randomly	RB	B-ADVP	O
:	:	:	O	O
group	group	NN	B-NP	O
A	A	NN	I-NP	O
(	(	(	O	O
blank	blank	JJ	B-NP	O
control	control	NN	I-NP	O
)	)	)	O	O
;	;	:	O	O
group	group	NN	B-NP	O
B	B	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
biofilms	biofilm	NNS	I-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
by	by	IN	B-PP	O
APNPs	APNP	NNS	B-NP	B-protein
(	(	(	O	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
equipment	equipment	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
kHz	kHz	NN	I-NP	O
,	,	,	O	O
1600	1600	CD	B-NP	O
ns	n	NNS	I-NP	O
and	and	CC	O	O
8	8	CD	B-NP	O
kV	kV	NN	I-NP	O
)	)	)	O	O
;	;	:	O	O
group	group	NN	B-NP	O
C	C	NN	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
biofilms	biofilm	NNS	I-NP	O
were	be	VBD	B-VP	O
exposed	expose	VBN	I-VP	O
only	only	RB	B-ADVP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
gas	gas	NN	I-NP	O
jet	jet	NN	I-NP	O
without	without	IN	B-PP	O
ignition	ignition	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
plasma	plasma	NN	I-NP	O
.	.	.	O	O

Each	Each	DT	B-NP	O
group	group	NN	I-NP	O
had	have	VBD	B-VP	O
three	three	CD	B-NP	O
samples	sample	NNS	I-NP	O
and	and	CC	O	O
each	each	DT	B-NP	O
sample	sample	NN	I-NP	O
was	be	VBD	B-VP	O
processed	process	VBN	I-VP	O
for	for	IN	B-PP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
5	5	CD	I-NP	O
min	min	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
biofilms	biofilm	NNS	I-NP	O
were	be	VBD	B-VP	O
then	then	RB	I-VP	O
fluorescently	fluorescently	RB	I-VP	O
stained	stain	VBN	I-VP	O
,	,	,	O	O
observed	observe	VBN	B-VP	O
and	and	CC	I-VP	O
photographed	photograph	VBN	I-VP	O
under	under	IN	B-PP	O
a	a	DT	B-NP	O
laser	laser	NN	I-NP	O
scanning	scan	VBG	B-VP	O
confocal	confocal	JJ	B-NP	O
microscope	microscope	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
animal	animal	NN	I-NP	O
experiment	experiment	NN	I-NP	O
,	,	,	O	O
six	six	CD	B-NP	O
male	male	JJ	I-NP	O
Japanese	Japanese	JJ	I-NP	O
white	white	JJ	I-NP	O
rabbits	rabbit	NNS	I-NP	O
were	be	VBD	B-VP	O
divided	divide	VBN	I-VP	O
into	into	IN	B-PP	O
two	two	CD	B-NP	O
groups	group	NNS	I-NP	O
randomly	randomly	RB	B-ADVP	O
(	(	(	O	O
n=3	n=3	NN	B-NP	O
in	in	IN	B-PP	O
each	each	DT	B-NP	O
group	group	NN	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
different	different	JJ	I-NP	O
post-treatment	post-treatment	JJ	I-NP	O
time	time	NN	I-NP	O
(	(	(	O	O
1-day	1-day	JJ	B-NP	O
group	group	NN	I-NP	O
and	and	CC	O	O
5-day	5-day	JJ	B-NP	O
group	group	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
buccal	buccal	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
side	side	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
mucosa	mucosa	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ventral	ventral	JJ	I-NP	O
surface	surface	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tongue	tongue	NN	I-NP	O
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
by	by	IN	B-PP	O
APNPs	APNP	NNS	B-NP	B-protein
for	for	IN	B-PP	O
10	10	CD	B-NP	O
min	min	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
way	way	NN	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
biofilm	biofilm	NN	I-NP	O
experiment	experiment	NN	I-NP	O
in	in	IN	B-PP	O
each	each	DT	B-NP	O
rabbit	rabbit	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
corresponding	corresponding	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
sides	side	NNS	I-NP	O
served	serve	VBD	B-VP	O
as	as	IN	B-PP	O
normal	normal	JJ	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
manifestations	manifestation	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
and	and	CC	O	O
recorded	record	VBN	B-VP	O
every	every	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
rabbits	rabbit	NNS	I-NP	O
were	be	VBD	B-VP	O
sacrificed	sacrifice	VBN	I-VP	O
one	one	CD	B-NP	O
or	or	CC	I-NP	O
five	five	CD	I-NP	O
day	day	NN	I-NP	O
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
after	after	IN	B-SBAR	O
APNPs	APNP	NNS	B-NP	B-protein
treatment	treatment	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
oral	oral	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
were	be	VBD	B-VP	O
harvested	harvest	VBN	I-VP	O
and	and	CC	O	O
prepared	prepare	VBN	B-VP	O
to	to	TO	B-PP	O
haematoxylin	haematoxylin	NN	B-NP	O
and	and	CC	O	O
eosin-stained	eosin-stained	JJ	B-NP	O
sections	section	NNS	I-NP	O
.	.	.	O	O

Clinical	Clinical	JJ	B-NP	O
observation	observation	NN	I-NP	O
and	and	CC	O	O
histopathological	histopathological	JJ	B-NP	O
scores	score	NNS	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
mucosal	mucosal	JJ	B-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
obvious	obvious	JJ	I-NP	O
P.g	P.g	NN	I-NP	O
.	.	.	O	O

biofilms	biofilm	NNS	B-NP	O
were	be	VBD	B-VP	O
formed	form	VBN	I-VP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
most	most	JJS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
groups	group	NNS	B-NP	O
A	A	NN	I-NP	O
and	and	CC	I-NP	O
C	C	NN	I-NP	O
were	be	VBD	B-VP	O
alive	alive	JJ	B-ADJP	O
under	under	IN	B-PP	O
a	a	DT	B-NP	O
laser	laser	NN	I-NP	O
scanning	scan	VBG	B-VP	O
confocal	confocal	JJ	B-NP	O
microscope	microscope	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
group	group	NN	I-NP	O
B	B	NN	I-NP	O
were	be	VBD	B-VP	O
almost	almost	RB	B-NP	O
all	all	DT	I-NP	O
dead	dead	JJ	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
animal	animal	NN	B-NP	O
experiment	experiment	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ulcers	ulcer	NNS	I-NP	O
,	,	,	O	O
anabrosis	anabrosis	NN	B-NP	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
mucositis	mucositis	NN	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
the	the	DT	I-NP	O
1-day	1-day	JJ	I-NP	O
and	and	CC	I-NP	O
5-day	5-day	JJ	I-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
average	average	JJ	I-NP	O
mucous	mucous	JJ	I-NP	O
membrane	membrane	NN	I-NP	O
irritation	irritation	NN	I-NP	O
index	index	NN	I-NP	O
was	be	VBD	B-VP	O
-0.83	-0.83	CD	B-NP	O
and	and	CC	I-NP	O
-0.67	-0.67	CD	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
1-day	1-day	JJ	I-NP	O
and	and	CC	I-NP	O
5-day	5-day	JJ	I-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
no	no	DT	B-NP	O
intense	intense	JJ	I-NP	O
mucosal	mucosal	JJ	I-NP	O
membrane	membrane	NN	I-NP	O
irritation	irritation	NN	I-NP	O
responses	response	NNS	I-NP	O
occurred	occur	VBD	B-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
APNPs	APNP	NNS	B-NP	B-protein
could	could	MD	B-VP	O
effectively	effectively	RB	I-VP	O
kill	kill	VB	I-VP	O
P.g	P.g	NN	B-NP	O
.	.	.	O	O

in	in	IN	B-PP	O
the	the	DT	B-NP	O
biofilms	biofilm	NNS	I-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
cause	cause	VB	I-VP	O
any	any	DT	B-NP	O
pathological	pathological	JJ	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
plasma	plasma	NN	I-NP	O
jet	jet	NN	I-NP	O
(	(	(	O	O
APNPs	APNP	NNS	B-NP	B-protein
)	)	)	O	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
applied	apply	VBN	I-VP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
sterilization	sterilization	NN	I-NP	O
device	device	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
future	future	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
sought	seek	VBD	B-VP	O
to	to	TO	I-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
the	the	DT	B-NP	O
mechanical	mechanical	JJ	I-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
titanium	titanium	NN	B-NP	O
dental	dental	JJ	I-NP	O
implants	implant	NNS	I-NP	O
changed	change	VBD	B-VP	O
after	after	IN	B-SBAR	O
exposure	exposure	NN	B-NP	O
to	to	TO	B-PP	O
bacteria	bacteria	NNS	B-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
(	(	(	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
sanguinis	sanguinis	NNP	I-NP	O
and	and	CC	O	O
Lactobacillus	Lactobacillus	NNP	B-NP	O
salivarius	salivarius	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
adhesive	adhesive	JJ	I-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
strains	strain	NNS	I-NP	O
were	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
as	as	IN	B-PP	O
follows	follow	VBZ	B-VP	O
.	.	.	O	O

Titanium	Titanium	NN	B-NP	O
implants	implant	NNS	I-NP	O
were	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
in	in	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
broth	broth	NN	I-NP	O
,	,	,	O	O
seeded	seed	VBD	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
bacteria	bacteria	NNS	I-NP	O
strains	strain	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
left	leave	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
broth	broth	NN	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
or	or	CC	I-NP	O
3	3	CD	I-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

Another	Another	DT	B-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
titanium	titanium	NN	B-NP	O
implants	implant	NNS	I-NP	O
was	be	VBD	B-VP	O
immersed	immerse	VBN	I-VP	O
in	in	IN	B-PP	O
artificial	artificial	JJ	B-NP	O
saliva	saliva	NN	I-NP	O
at	at	IN	B-PP	O
37	37	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
for	for	IN	B-PP	O
3	3	CD	B-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

Ten	Ten	CD	B-NP	O
implants	implant	NNS	I-NP	O
in	in	IN	B-PP	O
each	each	DT	B-NP	O
group	group	NN	I-NP	O
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
in	in	IN	B-PP	O
37	37	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-NP	O
artificial	artificial	JJ	I-NP	O
saliva	saliva	NN	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
their	their	PRP$	B-NP	O
mechanical	mechanical	JJ	I-NP	O
flexural	flexural	JJ	I-NP	O
strength	strength	NN	I-NP	O
and	and	CC	I-NP	O
fatigue	fatigue	NN	I-NP	O
life	life	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
grew	grow	VBD	B-VP	O
quickly	quickly	RB	B-ADVP	O
on	on	IN	B-PP	O
titanium	titanium	NN	B-NP	O
surfaces	surface	NNS	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
1	1	CD	B-NP	O
month	month	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
culture	culture	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
had	have	VBD	B-VP	O
produced	produce	VBN	I-VP	O
corrosion	corrosion	NN	B-NP	O
pits	pit	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
titanium	titanium	NN	I-NP	O
surfaces	surface	NNS	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
3	3	CD	B-NP	O
months	month	NNS	I-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	B-cell_line
culture	culture	NN	I-NP	I-cell_line
,	,	,	O	O
a	a	DT	B-NP	O
7	7	CD	I-NP	O
%	%	NN	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
flexural	flexural	JJ	I-NP	O
strength	strength	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
implant	implant	NN	I-NP	O
samples	sample	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
of	of	IN	B-PP	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
cycles	cycle	NNS	B-NP	O
to	to	TO	B-VP	O
failure	failure	VB	I-VP	O
by	by	IN	B-PP	O
fatigue	fatigue	NN	B-NP	O
were	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
versus	versus	IN	B-PP	O
implants	implant	NNS	B-NP	O
not	not	RB	B-VP	O
exposed	expose	VBN	I-VP	O
to	to	TO	B-PP	O
bacteria	bacteria	NNS	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
,	,	,	O	O
in	in	IN	B-PP	O
physiologic	physiologic	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
,	,	,	O	O
bacteria	bacteria	NNS	B-NP	O
have	have	VBP	B-VP	O
the	the	DT	B-NP	O
capacity	capacity	NN	I-NP	O
to	to	TO	B-VP	O
produce	produce	VB	I-VP	O
a	a	DT	B-NP	O
pitting	pit	VBG	I-NP	O
corrosion	corrosion	NN	I-NP	O
phenomenon	phenomenon	NN	I-NP	O
on	on	IN	B-PP	O
exposed	expose	VBN	B-NP	O
titanium	titanium	NN	I-NP	O
surfaces	surface	NNS	I-NP	O
,	,	,	O	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
deterioration	deterioration	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mechanical	mechanical	JJ	I-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
implant	implant	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
therefore	therefore	RB	B-ADVP	O
logical	logical	JJ	B-ADJP	O
to	to	TO	B-VP	O
conclude	conclude	VB	I-VP	O
that	that	IN	B-SBAR	O
bacteria	bacteria	NNS	B-NP	O
may	may	MD	B-VP	O
produce	produce	VB	I-VP	O
corrosion	corrosion	NN	B-NP	O
that	that	WDT	B-NP	O
reduces	reduce	VBZ	B-VP	O
the	the	DT	B-NP	O
useful	useful	JJ	I-NP	O
life	life	NN	I-NP	O
of	of	IN	B-PP	O
dental	dental	JJ	B-NP	O
implants	implant	NNS	I-NP	O
.	.	.	O	O

Treponema	Treponema	NN	B-NP	O
denticola	denticola	NN	I-NP	O
is	be	VBZ	B-VP	O
found	find	VBN	I-VP	O
ubiquitously	ubiquitously	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
mainly	mainly	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
communities	community	NNS	I-NP	O
implicated	implicate	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
establishment	establishment	NN	I-NP	O
and	and	CC	I-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
become	become	VB	I-VP	O
integrated	integrate	VBN	I-VP	O
within	within	IN	B-PP	O
biofilm	biofilm	NN	B-NP	O
communities	community	NNS	I-NP	O
is	be	VBZ	B-VP	O
crucial	crucial	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
and	and	CC	I-NP	O
survival	survival	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
involves	involve	VBZ	B-VP	O
inter-bacterial	inter-bacterial	JJ	B-NP	O
coaggregation	coaggregation	NN	I-NP	O
,	,	,	O	O
metabolic	metabolic	JJ	B-NP	O
cooperation	cooperation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
synergy	synergy	NN	B-NP	O
against	against	IN	B-PP	O
host	host	NN	B-NP	O
defences	defence	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
article	article	NN	I-NP	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
chymotrypsin-like	chymotrypsin-like	JJ	I-NP	B-protein
proteinase	proteinase	NN	I-NP	I-protein
(	(	(	O	O
CTLP	CTLP	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
found	find	VBN	B-VP	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
high-molecular-mass	high-molecular-mass	JJ	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
on	on	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
surface	surface	NN	I-NP	O
,	,	,	O	O
mediates	mediate	VBZ	B-VP	O
adherence	adherence	NN	B-NP	O
of	of	IN	B-PP	O
T.	T.	NNP	B-NP	O
denticola	denticola	NN	I-NP	O
to	to	TO	B-PP	O
other	other	JJ	B-NP	O
potential	potential	JJ	I-NP	O
periodontal	periodontal	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
,	,	,	O	O
Porphyromonas	Porphyromonas	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
,	,	,	O	O
Prevotella	Prevotella	NNP	B-NP	O
intermedia	intermedia	NNP	I-NP	O
and	and	CC	I-NP	O
Parvimonas	Parvimonas	NNP	I-NP	O
micra	micra	NNS	I-NP	O
.	.	.	O	O

Proteolytic	Proteolytic	JJ	B-NP	O
activity	activity	NN	I-NP	O
per	per	FW	B-ADVP	O
se	se	FW	I-ADVP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
appear	appear	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
interactions	interaction	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	B-protein
outer-sheath	outer-sheath	JJ	I-NP	I-protein
protein	protein	NN	I-NP	I-protein
(	(	(	O	O
Msp	Msp	NN	B-NP	B-protein
)	)	)	O	O
was	be	VBD	B-VP	O
not	not	RB	O	O
necessary	necessary	JJ	B-ADJP	O
,	,	,	O	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
binding	bind	VBG	B-VP	O
Parv	Parv	NNP	B-NP	O
.	.	.	O	O

micra	micra	NNS	B-NP	O
.	.	.	O	O

Biofilms	Biofilm	NNS	B-NP	O
of	of	IN	B-PP	O
densely	densely	RB	B-NP	B-cell_type
packed	pack	VBN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
matrix	matrix	NN	B-NP	O
,	,	,	O	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
40	40	CD	I-NP	O
microm	microm	NN	I-NP	O
in	in	IN	B-PP	O
depth	depth	NN	B-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
formed	form	VBN	I-VP	O
between	between	IN	B-PP	O
T.	T.	NNP	B-NP	O
denticola	denticola	NNP	I-NP	O
and	and	CC	O	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
on	on	IN	B-PP	O
salivary	salivary	JJ	B-NP	O
pellicle	pellicle	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
T.	T.	NN	B-NP	B-cell_line
denticola	denticola	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
enriched	enrich	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
layers	layer	NNS	I-NP	O
.	.	.	O	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
CTLP	CTLP	NN	B-NP	B-protein
,	,	,	B-NP	O
but	but	CC	I-NP	O
not	not	RB	I-NP	O
Msp	Msp	NN	B-NP	B-protein
,	,	,	O	O
was	be	VBD	B-VP	O
critical	critical	JJ	B-ADJP	O
for	for	IN	B-PP	O
dual-species	dual-species	JJ	B-NP	O
biofilm	biofilm	NN	I-NP	O
formation	formation	NN	I-NP	O
with	with	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
.	.	.	O	O

T.	T.	NN	B-NP	O
denticola	denticola	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
form	form	VB	I-VP	O
dual-species	dual-species	JJ	B-NP	O
biofilms	biofilm	NNS	I-NP	O
with	with	IN	B-PP	O
any	any	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
three	three	CD	I-NP	O
periodontal	periodontal	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
under	under	IN	B-PP	O
various	various	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
.	.	.	O	O

Synergy	Synergy	NN	B-NP	O
between	between	IN	B-PP	O
T.	T.	NNP	B-NP	O
denticola	denticola	NNP	I-NP	O
and	and	CC	O	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
shown	show	VBN	I-VP	O
by	by	IN	B-PP	O
increased	increase	VBN	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
clotting	clotting	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
CTLP-dependent	CTLP-dependent	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
the	the	DT	B-NP	O
critical	critical	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
CTLP	CTLP	NN	B-NP	B-protein
in	in	IN	B-PP	O
interactions	interaction	NNS	B-NP	O
of	of	IN	B-PP	O
T.	T.	NN	B-NP	O
denticola	denticola	NN	I-NP	O
with	with	IN	B-PP	O
other	other	JJ	B-NP	O
oral	oral	JJ	I-NP	O
micro-organisms	micro-organism	NNS	I-NP	O
,	,	,	O	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
synergy	synergy	NN	B-NP	O
in	in	IN	B-PP	O
microbial	microbial	JJ	B-NP	O
community	community	NN	I-NP	O
development	development	NN	I-NP	O
and	and	CC	O	O
host	host	NN	B-NP	O
tissue	tissue	NN	I-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
.	.	.	O	O

Periodontitis	Periodontitis	NN	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
disease	disease	NN	I-NP	O
caused	cause	VBN	B-VP	O
by	by	IN	B-PP	O
pathogenic	pathogenic	JJ	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
characterized	characterize	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
destruction	destruction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
periodontium	periodontium	NN	I-NP	O
.	.	.	O	O

Obese	Obese	JJ	B-NP	O
individuals	individual	NNS	I-NP	O
have	have	VBP	B-VP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
risk	risk	NN	I-NP	O
for	for	IN	B-PP	O
periodontitis	periodontitis	NN	B-NP	O
and	and	CC	O	O
show	show	VBP	B-VP	O
decreased	decrease	VBN	I-VP	O
serum	serum	NN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
adiponectin	adiponectin	NN	B-NP	B-protein
.	.	.	O	O

This	This	DT	B-NP	O
in-vitro	in-vitro	FW	I-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
established	establish	VBN	I-VP	O
to	to	TO	I-VP	O
examine	examine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
adiponectin	adiponectin	NN	B-NP	B-protein
modulates	modulate	VBZ	B-VP	O
critical	critical	JJ	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
lipopolysaccharide	lipopolysaccharide	NN	B-NP	O
(	(	(	O	O
LPS	LPS	NN	B-NP	O
)	)	)	O	O
from	from	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	B-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
OECs	OEC	NNS	B-NP	B-cell_type
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
adiponectin	adiponectin	NN	B-NP	B-protein
and	and	CC	O	O
its	its	PRP$	B-NP	O
receptors	receptor	NNS	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
gingival	gingival	JJ	I-NP	I-cell_type
tissue	tissue	NN	I-NP	I-cell_type
samples	sample	NNS	I-NP	I-cell_type
and	and	CC	I-NP	O
OECs	OEC	NNS	I-NP	B-cell_type
was	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
by	by	IN	B-PP	O
immunohistochemistry	immunohistochemistry	NN	B-NP	O
and	and	CC	I-NP	O
PCR	PCR	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
OECs	OEC	NNS	B-NP	B-cell_type
were	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
LPS	LPS	NN	B-NP	O
and/or	and/or	CC	I-NP	O
adiponectin	adiponectin	NN	I-NP	O
for	for	IN	B-PP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
72	72	CD	I-NP	O
h	h	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
and	and	CC	O	O
protein	protein	NN	B-NP	O
synthesis	synthesis	NN	I-NP	O
of	of	IN	B-PP	O
pro-	pro-	JJ	B-NP	O
and	and	CC	I-NP	O
anti-inflammatory	anti-inflammatory	JJ	I-NP	B-protein
mediators	mediator	NNS	I-NP	I-protein
,	,	,	O	O
matrix	matrix	NN	B-NP	B-protein
metalloproteinases	metalloproteinas	NNS	I-NP	I-protein
(	(	(	O	O
MMPs	MMP	NNS	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
growth	growth	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
by	by	IN	B-PP	O
real-time	real-time	JJ	B-NP	O
PCR	PCR	NN	I-NP	O
and	and	CC	I-NP	O
ELISA	ELISA	NN	I-NP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
cell	cell	NN	B-NP	O
proliferation	proliferation	NN	I-NP	O
,	,	,	O	O
differentiation	differentiation	NN	B-NP	O
and	and	CC	O	O
in-vitro	in-vitro	FW	B-NP	O
wound	wound	FW	I-NP	O
healing	healing	NN	I-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
nuclear	nuclear	JJ	I-NP	O
translocation	translocation	NN	I-NP	O
of	of	IN	B-PP	O
NFkappaB	NFkappaB	NN	B-NP	B-protein
was	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
by	by	IN	B-PP	O
immunofluorescence	immunofluorescence	NN	B-NP	O
.	.	.	O	O

Gingival	Gingival	JJ	B-NP	O
tissue	tissue	NN	I-NP	O
sections	section	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
strong	strong	JJ	I-NP	O
synthesis	synthesis	NN	I-NP	O
of	of	IN	B-PP	O
adiponectin	adiponectin	NN	B-NP	B-protein
and	and	CC	O	O
its	its	PRP$	B-NP	O
receptors	receptor	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
epithelial	epithelial	JJ	I-NP	O
layer	layer	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
cell	cell	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
,	,	,	O	O
LPS	LPS	NN	B-NP	O
induced	induce	VBD	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
up-regulation	up-regulation	NN	I-NP	O
of	of	IN	B-PP	O
interleukin	interleukin	NN	B-NP	B-protein
(	(	(	O	I-protein
IL	IL	NN	B-NP	I-protein
)	)	)	O	I-protein
1beta	1beta	NN	B-NP	I-protein
,	,	,	I-NP	O
IL6	IL6	NN	I-NP	B-protein
,	,	,	I-NP	O
IL8	IL8	NN	I-NP	B-protein
,	,	,	I-NP	O
MMP1	MMP1	NN	I-NP	B-protein
and	and	CC	I-NP	O
MMP3	MMP3	NN	I-NP	B-protein
.	.	.	O	O

Adiponectin	Adiponectin	NN	B-NP	B-protein
abrogated	abrogate	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
the	the	DT	B-NP	O
stimulatory	stimulatory	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
LPS	LPS	NN	B-NP	O
on	on	IN	B-PP	O
these	these	DT	B-NP	O
molecules	molecule	NNS	I-NP	O
.	.	.	O	O

Similarly	Similarly	RB	B-ADVP	O
,	,	,	O	O
adiponectin	adiponectin	NN	B-NP	B-protein
inhibited	inhibit	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
the	the	DT	B-NP	O
LPS-induced	LPS-induced	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
cell	cell	NN	B-NP	O
viability	viability	NN	I-NP	O
and	and	CC	O	O
increase	increase	NN	B-NP	O
in	in	IN	B-PP	O
cell	cell	NN	B-NP	O
proliferation	proliferation	NN	I-NP	O
and	and	CC	O	O
differentiation	differentiation	NN	B-NP	O
.	.	.	O	O

Adiponectin	Adiponectin	NN	B-NP	B-protein
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
time-dependent	time-dependent	JJ	I-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
anti-inflammatory	anti-inflammatory	JJ	I-NP	B-protein
mediators	mediator	NNS	I-NP	I-protein
IL10	IL10	NN	I-NP	B-protein
and	and	CC	I-NP	O
heme	heme	NN	I-NP	B-protein
oxygenase	oxygenase	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
blocked	block	VBD	B-VP	O
the	the	DT	B-NP	O
LPS-stimulated	LPS-stimulated	JJ	I-NP	O
NFkappaB	NFkappaB	NN	I-NP	B-protein
nuclear	nuclear	JJ	I-NP	O
translocation	translocation	NN	I-NP	O
.	.	.	O	O

Adiponectin	Adiponectin	NN	B-NP	B-protein
may	may	MD	B-VP	O
counteract	counteract	VB	I-VP	O
critical	critical	JJ	B-NP	O
actions	action	NNS	I-NP	O
of	of	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	B-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Low	Low	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
adiponectin	adiponectin	NN	B-NP	B-protein
,	,	,	O	O
as	as	IN	B-SBAR	O
observed	observe	VBN	B-VP	O
in	in	IN	B-PP	O
obese	obese	JJ	B-NP	O
individuals	individual	NNS	I-NP	O
,	,	,	O	O
may	may	MD	B-VP	O
increase	increase	VB	I-VP	O
the	the	DT	B-NP	O
risk	risk	NN	I-NP	O
for	for	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
inflammation	inflammation	NN	I-NP	O
and	and	CC	I-NP	O
destruction	destruction	NN	I-NP	O

.	.	.	O	O

Latently	Latently	RB	B-NP	B-cell_type
infected	infected	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
harbor	harbor	VBP	B-VP	O
human	human	JJ	B-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
virus	virus	NN	I-NP	O
type	type	NN	I-NP	O
1	1	CD	I-NP	O
(	(	(	O	O
HIV-1	HIV-1	NN	B-NP	O
)	)	)	I-NP	O
proviral	proviral	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
copies	copy	NNS	I-NP	O
integrated	integrate	VBN	B-VP	O
in	in	IN	B-PP	O
heterochromatin	heterochromatin	NN	B-NP	B-protein
,	,	,	O	O
allowing	allow	VBG	B-VP	O
persistence	persistence	NN	B-NP	O
of	of	IN	B-PP	O
transcriptionally	transcriptionally	RB	B-NP	O
silent	silent	JJ	I-NP	O
proviruses	provirus	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
widely	widely	RB	I-VP	O
accepted	accept	VBN	I-VP	O
that	that	IN	B-SBAR	O
hypoacetylation	hypoacetylation	NN	B-NP	O
of	of	IN	B-PP	O
histone	histone	NN	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
by	by	IN	B-PP	O
histone	histone	NN	B-NP	B-protein
deacetylases	deacetylas	NNS	I-NP	I-protein
(	(	(	O	O
HDACs	HDAC	NNS	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
maintaining	maintain	VBG	B-VP	O
the	the	DT	B-NP	O
HIV-1	HIV-1	NN	I-NP	O
latency	latency	NN	I-NP	O
by	by	IN	B-PP	O
repressing	repress	VBG	B-VP	O
viral	viral	JJ	B-NP	O
transcription	transcription	NN	I-NP	O
.	.	.	O	O

HIV-1	HIV-1	NN	B-NP	O
replication	replication	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
induced	induce	VBN	I-VP	O
from	from	IN	B-PP	O
latently	latently	RB	B-NP	B-cell_type
infected	infected	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
environmental	environmental	JJ	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
inflammation	inflammation	NN	B-NP	O
and	and	CC	I-NP	O
co-infection	co-infection	NN	I-NP	O
with	with	IN	B-PP	O
other	other	JJ	B-NP	O
microbes	microbe	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
metabolite	metabolite	NN	I-NP	O
butyric	butyric	JJ	I-NP	O
acid	acid	NN	I-NP	O
inhibits	inhibit	VBZ	B-VP	O
catalytic	catalytic	JJ	B-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
HDAC	HDAC	NN	B-NP	B-protein
and	and	CC	O	O
induces	induce	VBZ	B-VP	O
transcription	transcription	NN	B-NP	O
of	of	IN	B-PP	O
silenced	silenced	JJ	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
including	include	VBG	B-PP	O
HIV-1	HIV-1	NN	B-NP	O
provirus	provirus	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
such	such	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
gut	gut	NN	B-NP	O
,	,	,	O	O
vaginal	vaginal	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
cavities	cavity	NNS	I-NP	O
that	that	WDT	B-NP	O
produce	produce	VBP	B-VP	O
butyric	butyric	JJ	B-NP	O
acid	acid	NN	I-NP	O
during	during	IN	B-PP	O
their	their	PRP$	B-NP	O
anaerobic	anaerobic	JJ	I-NP	O
glycolysis	glycolysis	NN	I-NP	O
.	.	.	O	O

Since	Since	IN	B-SBAR	O
these	these	DT	B-NP	O
organs	organ	NNS	I-NP	O
are	be	VBP	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
HIV-1	HIV-1	NN	B-NP	O
transmission	transmission	NN	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
replication	replication	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
explored	explore	VBD	B-VP	O
a	a	DT	B-NP	O
possibility	possibility	NN	I-NP	O
that	that	IN	B-SBAR	O
explosive	explosive	JJ	B-NP	O
viral	viral	JJ	I-NP	O
replication	replication	NN	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
organs	organ	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
ascribable	ascribable	JJ	B-ADJP	O
to	to	TO	B-PP	O
butyric	butyric	JJ	B-NP	O
acid	acid	NN	I-NP	O
produced	produce	VBN	B-VP	O
from	from	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
resident	resident	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
culture	culture	NN	I-NP	O
supernatant	supernatant	NN	I-NP	O
of	of	IN	B-PP	O
various	various	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
producing	produce	VBG	B-VP	O
butyric	butyric	JJ	B-NP	O
acid	acid	NN	I-NP	O
could	could	MD	B-VP	O
greatly	greatly	RB	I-VP	O
reactivate	reactivate	VB	I-VP	O
the	the	DT	B-NP	O
latently-infected	latently-infected	JJ	I-NP	O
HIV-1	HIV-1	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
include	include	VBP	B-VP	O
Fusobacterium	Fusobacterium	NN	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
(	(	(	O	O
commonly	commonly	RB	B-ADJP	O
present	present	JJ	I-ADJP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
cavity	cavity	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
gut	gut	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
Clostridium	Clostridium	NN	B-NP	O
cochlearium	cochlearium	NN	I-NP	O
,	,	,	O	O
Eubacterium	Eubacterium	NNP	B-NP	O
multiforme	multiforme	NNP	I-NP	O
(	(	(	O	O
gut	gut	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
Anaerococcus	Anaerococcus	NN	B-NP	O
tetradius	tetradius	NN	I-NP	O
(	(	(	O	O
vagina	vagina	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
clarified	clarify	VBD	B-VP	O
that	that	DT	O	O
butyric	butyric	JJ	B-NP	O
acid	acid	NN	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
culture	culture	NN	I-NP	O
supernatants	supernatant	NNS	I-NP	O
could	could	MD	B-VP	O
induce	induce	VB	I-VP	O
histone	histone	NN	B-NP	O
acetylation	acetylation	NN	I-NP	O
and	and	CC	O	O
HIV-1	HIV-1	NN	B-NP	O
replication	replication	NN	I-NP	O
by	by	IN	B-PP	O
inhibiting	inhibit	VBG	B-VP	O
HDAC	HDAC	NN	B-NP	B-protein
.	.	.	O	O

Our	Our	PRP$	B-NP	O
observations	observation	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
butyric	butyric	JJ	B-NP	O
acid-producing	acid-producing	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
AIDS	AIDS	NN	B-NP	O
progression	progression	NN	I-NP	O
by	by	IN	B-PP	O
reactivating	reactivate	VBG	B-VP	O
the	the	DT	B-NP	O
latent	latent	JJ	I-NP	O
HIV	HIV	NN	I-NP	O
provirus	provirus	NN	I-NP	O
and	and	CC	O	O
,	,	,	O	O
subsequently	subsequently	RB	B-ADVP	O
,	,	,	O	O
by	by	IN	B-PP	O
eliminating	eliminate	VBG	B-VP	O
such	such	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
infection	infection	NN	I-NP	O
may	may	MD	B-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
prevention	prevention	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
AIDS	AIDS	NNP	I-NP	O
development	development	NN	I-NP	O
and	and	CC	I-NP	O
transmission	transmission	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
purpose	purpose	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
examine	examine	VB	I-VP	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
turbidity	turbidity	NN	B-NP	O
of	of	IN	B-PP	O
mouth	mouth	NN	B-NP	O
rinsed	rinsed	JJ	I-NP	O
water	water	NN	I-NP	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
health	health	NN	I-NP	O
status	status	NN	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
dental	dental	JJ	B-NP	O
and	and	CC	I-NP	O
periodontal	periodontal	JJ	I-NP	O
conditions	condition	NNS	I-NP	O
,	,	,	O	O
oral	oral	JJ	B-NP	O
hygiene	hygiene	NN	I-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
flow	flow	NN	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
saliva	saliva	NN	B-NP	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

Subjects	Subject	NNS	B-NP	O
were	be	VBD	B-VP	O
165	165	CD	B-NP	O
patients	patient	NNS	I-NP	O
who	who	WP	B-NP	O
visited	visit	VBD	B-VP	O
the	the	DT	B-NP	O
Dental	Dental	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
Tokyo	Tokyo	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
and	and	CC	O	O
Dental	Dental	NNP	B-NP	O
University	University	NNP	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
health	health	NN	I-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
dental	dental	JJ	B-NP	O
and	and	CC	I-NP	O
periodontal	periodontal	JJ	I-NP	O
conditions	condition	NNS	I-NP	O
,	,	,	O	O
oral	oral	JJ	B-NP	O
hygiene	hygiene	NN	I-NP	O
status	status	NN	I-NP	O
and	and	CC	O	O
flow	flow	NN	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
saliva	saliva	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
clinically	clinically	RB	I-VP	O
examined	examine	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
turbidity	turbidity	NN	I-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
turbidimeter	turbidimeter	NN	I-NP	O
.	.	.	O	O

Quantification	Quantification	NN	B-NP	O
of	of	IN	B-PP	O
Fusobacterium	Fusobacterium	NN	B-NP	O
spp	spp	NN	I-NP	O
,	,	,	O	O
Porphyromonas	Porphyromonas	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
Tannerella	Tannerella	NNP	B-NP	O
forsythia	forsythia	NNP	I-NP	O
,	,	,	O	O
Treponema	Treponema	NNP	B-NP	O
denticola	denticola	NNP	I-NP	O
and	and	CC	O	O
total	total	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
levels	level	NNS	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
using	use	VBG	B-VP	O
real-time	real-time	JJ	B-NP	O
PCR	PCR	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Pearson	Pearson	NNP	I-NP	O
correlation	correlation	NN	I-NP	O
and	and	CC	O	O
multiple	multiple	JJ	B-NP	O
regression	regression	NN	I-NP	O
analysis	analysis	NN	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
explore	explore	VB	I-VP	O
the	the	DT	B-NP	O
associations	association	NNS	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
turbidity	turbidity	NN	I-NP	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
health	health	NN	I-NP	O
parameters	parameter	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
turbidity	turbidity	NN	I-NP	O
showed	show	VBD	B-VP	O
significant	significant	JJ	B-NP	O
correlations	correlation	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
decayed	decay	VBN	B-NP	O
teeth	tooth	NNS	I-NP	O
and	and	CC	O	O
deep	deep	JJ	B-NP	O
pockets	pocket	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
plaque	plaque	NN	I-NP	O
index	index	NN	I-NP	O
,	,	,	O	O
extent	extent	NN	B-NP	O
of	of	IN	B-PP	O
tongue	tongue	NN	B-NP	O
coating	coating	NN	I-NP	O
and	and	CC	O	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
spp	spp	NN	I-NP	O
,	,	,	O	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
T.	T.	NNP	B-NP	O
forsythia	forsythia	NNP	I-NP	O
,	,	,	O	O
T.	T.	NNP	B-NP	O
denticola	denticola	NNP	I-NP	O
and	and	CC	O	O
total	total	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
a	a	DT	B-NP	O
multiple	multiple	JJ	I-NP	O
regression	regression	NN	I-NP	O
model	model	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
turbidity	turbidity	NN	I-NP	O
was	be	VBD	B-VP	O
negatively	negatively	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
flow	flow	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
saliva	saliva	NN	B-NP	O
and	and	CC	O	O
positively	positively	RB	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.001	0.001	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Current	Current	JJ	B-NP	O
findings	finding	NNS	I-NP	O
suggested	suggest	VBD	B-VP	O
that	that	IN	B-SBAR	O
turbidity	turbidity	NN	B-NP	O
of	of	IN	B-PP	O
mouth	mouth	NN	B-NP	O
rinsed	rinsed	JJ	I-NP	O
water	water	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
indicator	indicator	NN	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
oral	oral	JJ	B-NP	O
health	health	NN	I-NP	O
condition	condition	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
turbiditimeter	turbiditimeter	NN	I-NP	O
appeared	appear	VBD	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
simple	simple	JJ	I-NP	O
and	and	CC	I-NP	O
objective	objective	JJ	I-NP	O
device	device	NN	I-NP	O
for	for	IN	B-PP	O
screening	screen	VBG	B-VP	O
abnormality	abnormality	NN	B-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
health	health	NN	I-NP	O
condition	condition	NN	I-NP	O
at	at	IN	B-PP	O
chair	chair	NN	B-NP	O
side	side	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
community-based	community-based	JJ	B-NP	O
research	research	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
objective	objective	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
paper	paper	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
oil	oil	NN	B-NP	O
drops	drop	NNS	I-NP	O
containing	contain	VBG	B-VP	O
Lactobacillus	Lactobacillus	NN	B-NP	O
salivarius	salivarius	NN	I-NP	O
WB21	WB21	NN	I-NP	O
on	on	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
health	health	NN	I-NP	O
and	and	CC	I-NP	O
oral	oral	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
producing	produce	VBG	B-VP	O
volatile	volatile	JJ	B-NP	O
sulfur	sulfur	NN	I-NP	O
compounds	compound	NNS	I-NP	O
(	(	(	O	O
VSCs	VSC	NNS	B-NP	B-cell_type
)	)	)	O	O
.	.	.	O	O

For	For	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
42	42	CD	B-NP	O
subjects	subject	NNS	I-NP	O
were	be	VBD	B-VP	O
randomly	randomly	RB	I-VP	O
assigned	assign	VBN	I-VP	O
to	to	TO	I-VP	O
receive	receive	VB	I-VP	O
oil	oil	NN	B-NP	O
samples	sample	NNS	I-NP	O
containing	contain	VBG	B-VP	O
L.	L.	NNP	B-NP	O
salivarius	salivarius	NN	I-NP	O
WB21	WB21	NN	I-NP	O
or	or	CC	O	O
a	a	DT	B-NP	O
placebo	placebo	NN	I-NP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
assessment	assessment	NN	I-NP	O
and	and	CC	I-NP	O
saliva	saliva	NN	I-NP	O
collection	collection	NN	I-NP	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
on	on	IN	B-PP	O
days	day	NNS	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
15	15	CD	I-NP	O
.	.	.	O	O

Bacterial	Bacterial	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
real-time	real-time	JJ	I-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
and	and	CC	O	O
terminal	terminal	JJ	B-NP	O
restriction	restriction	NN	I-NP	O
fragment	fragment	NN	I-NP	O
length	length	NN	I-NP	O
polymorphism	polymorphism	NN	I-NP	O
(	(	(	O	O
T-RFLP	T-RFLP	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

In	In	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
experimental	experimental	JJ	I-NP	O
and	and	CC	I-NP	O
placebo	placebo	NN	I-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
average	average	JJ	I-NP	O
probing	probe	VBG	I-NP	O
depth	depth	NN	I-NP	O
,	,	,	O	O
number	number	NN	B-NP	O
of	of	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
pockets	pocket	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
percentage	percentage	NN	I-NP	O
of	of	IN	B-PP	O
bleeding	bleed	VBG	B-VP	O
on	on	IN	B-PP	O
probing	probing	NN	B-NP	O
(	(	(	O	O
BOP	BOP	NN	B-NP	O
)	)	)	O	O
decreased	decrease	VBD	B-VP	O
while	while	IN	B-SBAR	O
stimulated	stimulate	VBN	B-NP	O
salivary	salivary	JJ	I-NP	O
flow	flow	NN	I-NP	O
increased	increase	VBD	B-VP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
15	15	CD	I-NP	O
.	.	.	O	O

BOP	BOP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
experimental	experimental	JJ	I-NP	O
group	group	NN	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
placebo	placebo	NN	I-NP	O
group	group	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
0.010	0.010	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
experimental	experimental	JJ	I-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
numbers	number	NNS	I-NP	O
decreased	decrease	VBD	B-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
L.	L.	NNP	B-NP	O
salivarius	salivarius	NN	I-NP	O
increased	increase	VBD	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
Prevotella	Prevotella	NNP	B-NP	O
intermedia	intermedia	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
hydrogen	hydrogen	NN	B-NP	O
sulfide	sulfide	NN	I-NP	O
concentration	concentration	NN	I-NP	O
in	in	IN	B-PP	O
mouth	mouth	NN	B-NP	O
air	air	NN	I-NP	O
,	,	,	O	O
increased	increase	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
placebo	placebo	NN	I-NP	O
group	group	NN	I-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
change	change	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
experimental	experimental	JJ	I-NP	O
group	group	NN	I-NP	O
.	.	.	O	O

T-RFLP	T-RFLP	NN	B-NP	O
analysis	analysis	NN	I-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
peak	peak	JJ	I-NP	O
area	area	NN	I-NP	O
proportions	proportion	NNS	I-NP	O
representing	represent	VBG	B-VP	O
Porphyromonas	Porphyromonas	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
P.	P.	NNP	B-NP	O
intermedia	intermedia	NNP	I-NP	O
,	,	,	O	O
Tannerella	Tannerella	NNP	B-NP	O
forsythensis	forsythensis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
decreased	decrease	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
experimental	experimental	JJ	I-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
composition	composition	NN	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
we	we	PRP	B-NP	O
observed	observe	VBD	B-VP	O
oil	oil	NN	B-NP	O
drops	drop	NNS	I-NP	O
containing	contain	VBG	B-VP	O
L.	L.	NNP	B-NP	O
salivarius	salivarius	NN	I-NP	O
WB21	WB21	NN	I-NP	O
improved	improve	VBD	B-VP	O
BOP	BOP	NN	B-NP	O
and	and	CC	O	O
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
reproduction	reproduction	NN	I-NP	O
of	of	IN	B-PP	O
total	total	JJ	B-NP	O
and	and	CC	I-NP	O
VSC-producing	VSC-producing	JJ	I-NP	O
periodontopathic	periodontopathic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
placebo	placebo	NN	I-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
limit	limit	NN	I-NP	O
of	of	IN	B-PP	O
its	its	PRP$	B-NP	O
efficacy	efficacy	NN	I-NP	O
in	in	IN	B-PP	O
controlling	control	VBG	B-VP	O
VSCs	VSC	NNS	B-NP	B-protein
producing	produce	VBG	B-VP	O
and	and	CC	O	O
periodontal	periodontal	JJ	B-NP	O
pathogens	pathogen	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
reference	reference	NN	I-NP	O
study	study	NN	I-NP	O
aims	aim	VBZ	B-VP	O
to	to	TO	I-VP	O
survey	survey	VB	I-VP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
flora	flora	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
healthy	healthy	JJ	I-NP	O
lower	low	JJR	I-NP	O
human	human	JJ	I-NP	O
esophagus	esophagus	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
compare	compare	VB	I-VP	O
it	it	PRP	B-NP	O
with	with	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
esophagus	esophagus	NN	I-NP	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
mucosa	mucosa	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
biopsies	biopsy	NNS	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-VP	O
brush	brush	VB	I-VP	O
samples	sample	NNS	B-NP	O
,	,	,	O	O
allows	allow	VBZ	B-VP	O
inclusion	inclusion	NN	B-NP	O
of	of	IN	B-PP	O
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
transient	transient	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
present	present	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
surface	surface	NN	I-NP	O
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
bacteria	bacteria	NNS	B-NP	O
residing	reside	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
epithelia	epithelia	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
yield	yield	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
methods	method	NNS	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
compared	compare	VBN	I-VP	O
.	.	.	O	O

Forty	Forty	CD	B-NP	O
patients	patient	NNS	I-NP	O
scheduled	schedule	VBN	B-VP	O
for	for	IN	B-PP	O
surgery	surgery	NN	B-NP	O
for	for	IN	B-PP	O
reasons	reason	NNS	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
known	known	JJ	I-NP	O
influence	influence	NN	I-NP	O
on	on	IN	B-PP	O
esophageal	esophageal	JJ	B-NP	O
flora	flora	NN	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
or	or	CC	O	O
endoscopic	endoscopic	JJ	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
esophageal	esophageal	JJ	B-NP	O
disease	disease	NN	I-NP	O
were	be	VBD	B-VP	O
included	include	VBN	I-VP	O
.	.	.	O	O

Samples	Sample	NNS	B-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
,	,	,	I-NP	O
upper	upper	JJ	I-NP	O
esophageal	esophageal	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
lower	low	JJR	B-NP	O
esophageal	esophageal	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
using	use	VBG	B-VP	O
sealed	seal	VBN	B-NP	O
brushes	brush	NNS	I-NP	O
and	and	CC	I-NP	O
biopsy	biopsy	NN	I-NP	O
forceps	forcep	NNS	I-NP	O
.	.	.	O	O

Colonies	Colony	NNS	B-NP	O
cultivated	cultivate	VBN	B-VP	O
on	on	IN	B-PP	O
agar	agar	NN	B-NP	O
plates	plate	NNS	I-NP	O
were	be	VBD	B-VP	O
classified	classify	VBN	I-VP	O
and	and	CC	O	O
semiquantified	semiquantifie	VBN	B-VP	O
.	.	.	O	O

Twenty-three	Twenty-three	CD	B-NP	O
different	different	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
,	,	,	O	O
with	with	IN	B-PP	O
similar	similar	JJ	B-NP	O
strains	strain	NNS	I-NP	O
present	present	JJ	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
sites	site	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
most	most	RBS	I-NP	O
common	common	JJ	I-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
was	be	VBD	B-VP	O
viridans	viridan	NNS	B-NP	O
streptococci	streptococci	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
occurrence	occurrence	NN	I-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
brush	brush	NN	B-NP	O
samples	sample	NNS	I-NP	O
and	and	CC	I-NP	O
biopsies	biopsy	NNS	I-NP	O
of	of	IN	B-PP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
median	median	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
species	specie	NNS	B-NP	O
occurring	occur	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
,	,	,	O	O
upper	upper	JJ	B-NP	O
esophagus	esophagus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
lower	low	JJR	B-NP	O
esophagus	esophagus	NN	I-NP	O
was	be	VBD	B-VP	O
between	between	IN	B-PP	O
3	3	CD	B-NP	O
and	and	CC	I-NP	O
4	4	CD	I-NP	O
(	(	(	O	O
range	range	NN	B-NP	B-protein
0-7	0-7	CD	I-NP	I-protein
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
total	total	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
species	specie	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
when	when	WRB	B-ADVP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
either	either	CC	O	O
level	level	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
esophagus	esophagus	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
yields	yield	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O
by	by	IN	B-PP	O
brush	brush	NN	B-NP	O
and	and	CC	I-NP	O
biopsy	biopsy	NN	I-NP	O
sampling	sampling	NN	I-NP	O
were	be	VBD	B-VP	O
highly	highly	RB	I-VP	O
correlated	correlate	VBN	I-VP	O
.	.	.	O	O

Hence	Hence	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
human	human	JJ	I-NP	O
esophagus	esophagus	NN	I-NP	O
is	be	VBZ	B-VP	O
colonized	colonize	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
resident	resident	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
flora	flora	NN	I-NP	O
of	of	IN	B-PP	O
its	its	PRP$	B-NP	O
own	own	JJ	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
similarities	similarity	NNS	B-NP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
diverse	diverse	JJ	B-NP	O
species	specie	NNS	I-NP	O
that	that	WDT	B-NP	O
make	make	VBP	B-VP	O
up	up	RP	B-PRT	O
this	this	DT	B-NP	O
flora	flora	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
in	in	IN	B-PP	O
relatively	relatively	RB	B-NP	O
low	low	JJ	I-NP	O
amounts	amount	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
most	most	RBS	I-NP	O
frequent	frequent	JJ	I-NP	O
inhabitants	inhabitant	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
esophagus	esophagus	NN	I-NP	O
are	be	VBP	B-VP	O
streptococci	streptococci	NNS	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
occurrence	occurrence	NN	I-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
brush	brush	NN	B-NP	O
samples	sample	NNS	I-NP	O
and	and	CC	I-NP	O
biopsies	biopsy	NNS	I-NP	O
of	of	IN	B-PP	O
95-98	95-98	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Comparative	Comparative	JJ	B-NP	O
studies	study	NNS	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
eosinophilic	eosinophilic	JJ	B-NP	O
esophagitis	esophagitis	NN	I-NP	O
and	and	CC	O	O
gastroesophageal	gastroesophageal	JJ	B-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
are	be	VBP	B-VP	O
warranted	warrant	VBN	I-VP	O
.	.	.	O	O

To	To	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bacteriocin-producing	bacteriocin-producing	JJ	I-NP	O
strain	strain	NN	I-NP	O
Streptococcus	Streptococcus	NN	I-NP	O
salivarius	salivarius	NN	I-NP	O
K12	K12	NN	I-NP	O
against	against	IN	B-PP	O
several	several	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
halitosis	halitosis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
salivarius	salivarius	NN	I-NP	O
K12	K12	NN	I-NP	O
against	against	IN	B-PP	O
Solobacterium	Solobacterium	NNP	B-NP	O
moorei	moorei	NNP	I-NP	O
CCUG39336	CCUG39336	NNP	I-NP	O
,	,	,	O	O
four	four	CD	B-NP	O
clinical	clinical	JJ	I-NP	O
S.	S.	NNP	I-NP	O
moorei	moorei	NN	I-NP	O
isolates	isolate	NNS	I-NP	O
,	,	,	O	O
Atopobium	Atopobium	NN	B-NP	O
parvulum	parvulum	NN	I-NP	O
ATCC33793	ATCC33793	NN	I-NP	O
and	and	CC	O	O
Eubacterium	Eubacterium	NN	B-NP	O
sulci	sulci	NN	I-NP	O
ATCC35585	ATCC35585	NN	I-NP	O
was	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
deferred	defer	VBN	I-NP	O
antagonism	antagonism	NN	I-NP	O
test	test	NN	I-NP	O
.	.	.	O	O

Eubacterium	Eubacterium	NN	B-NP	O
saburreum	saburreum	NN	I-NP	O
ATCC33271	ATCC33271	NN	I-NP	O
and	and	CC	O	O
Parvimonas	Parvimonas	NNP	B-NP	O
micra	micra	NN	I-NP	O
ATCC33270	ATCC33270	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
tested	test	VBN	I-VP	O
in	in	IN	B-PP	O
previous	previous	JJ	B-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
served	serve	VBD	B-VP	O
as	as	IN	B-PP	O
positive	positive	JJ	B-NP	O
controls	control	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
Gram-negative	Gram-negative	JJ	I-NP	O
strain	strain	NN	I-NP	O
Bacteroides	Bacteroide	NNS	I-NP	O
fragilis	fragilis	NN	I-NP	O
ZIB2800	ZIB2800	NN	I-NP	O
served	serve	VBD	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
occurrence	occurrence	NN	I-NP	O
of	of	IN	B-PP	O
resistance	resistance	NN	B-NP	O
in	in	IN	B-PP	O
S.	S.	NNP	B-NP	O
moorei	moorei	NNP	I-NP	O
CCUG39336	CCUG39336	NN	I-NP	O
to	to	TO	B-PP	O
S.	S.	NNP	B-NP	O
salivarius	salivarius	NN	I-NP	O
K12	K12	NN	I-NP	O
was	be	VBD	B-VP	O
analysed	analyse	VBN	I-VP	O
by	by	IN	B-PP	O
either	either	CC	B-NP	O
direct	direct	JJ	I-NP	O
plating	plating	NN	I-NP	O
or	or	CC	B-PP	O
by	by	IN	B-PP	O
passage	passage	NN	B-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
moorei	moorei	NNP	I-NP	O
CCUG39336	CCUG39336	NN	I-NP	O
on	on	IN	B-PP	O
chloroform-inactived	chloroform-inactived	JJ	B-NP	O
S.	S.	NNP	I-NP	O
salivarius	salivarius	NN	I-NP	O
K12-containing	K12-containing	NN	I-NP	O
agar	agar	NN	I-NP	O
plates	plate	NNS	I-NP	O
.	.	.	O	O

S.	S.	NN	B-NP	O
salivarius	salivarius	NN	I-NP	O
K12	K12	NN	I-NP	O
suppressed	suppress	VBD	B-VP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
Gram-positive	Gram-positive	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
tested	test	VBN	B-VP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
extent	extent	NN	I-NP	O
to	to	TO	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
inhibited	inhibit	VBN	I-VP	O
varied	vary	VBN	I-VP	O
.	.	.	O	O

E.	E.	NN	B-NP	O
sulci	sulci	NN	I-NP	O
ATCC35585	ATCC35585	NN	I-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
sensitive	sensitive	JJ	I-NP	O
strain	strain	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
all	all	DT	B-NP	O
five	five	CD	I-NP	O
S.	S.	NNP	I-NP	O
moorei	moorei	NNP	I-NP	O
isolates	isolate	NNS	I-NP	O
were	be	VBD	B-VP	O
inhibited	inhibit	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
lesser	less	JJR	I-NP	O
extent	extent	NN	I-NP	O
.	.	.	O	O

Natural	Natural	JJ	B-NP	O
resistance	resistance	NN	I-NP	O
seems	seem	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
very	very	RB	B-ADJP	O
low	low	JJ	I-ADJP	O
in	in	IN	B-PP	O
S.	S.	NNP	B-NP	O
moorei	moorei	NNP	I-NP	O
CCUG39336	CCUG39336	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
only	only	RB	B-NP	O
a	a	DT	I-NP	O
slight	slight	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
sensitivity	sensitivity	NN	B-NP	O
after	after	IN	B-PP	O
exposure	exposure	NN	B-NP	O
to	to	TO	B-PP	O
S.	S.	NNP	B-NP	O
salivarius	salivarius	NN	I-NP	O
K12	K12	NN	I-NP	O
over	over	IN	B-PP	O
10	10	CD	B-NP	O
passages	passage	NNS	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
studies	study	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
S.	S.	NNP	B-NP	O
salivarius	salivarius	NN	I-NP	O
K12	K12	NN	I-NP	O
has	have	VBZ	B-VP	O
antimicrobial	antimicrobial	JJ	B-NP	O
activity	activity	NN	I-NP	O
against	against	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
halitosis	halitosis	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
strain	strain	NN	I-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
interesting	interesting	JJ	I-NP	O
and	and	CC	I-NP	O
valuable	valuable	JJ	I-NP	O
candidate	candidate	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
for	for	IN	B-PP	O
halitosis	halitosis	NN	B-NP	O
.	.	.	O	O

Bacterial	Bacterial	JJ	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
and	and	CC	O	O
chemical	chemical	NN	B-NP	O
analyses	analysis	NNS	I-NP	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
from	from	IN	B-PP	O
cloacal	cloacal	JJ	B-NP	O
and	and	CC	I-NP	O
oral	oral	JJ	I-NP	O
swabs	swab	NNS	I-NP	O
taken	take	VBN	B-VP	O
from	from	IN	B-PP	O
43	43	CD	B-NP	O
American	American	JJ	I-NP	O
crocodiles	crocodile	NNS	I-NP	O
Crocodylus	Crocodylus	CC	I-NP	O
acutus	acutus	NN	I-NP	O
and	and	CC	O	O
28	28	CD	O	O
Morelet's	Morelet's	POS	B-NP	O
crocodiles	crocodile	NNS	I-NP	O
C.	C.	FW	B-ADVP	O
moreletii	moreletii	FW	I-ADVP	O
captured	capture	VBN	B-VP	O
in	in	IN	B-PP	O
Quintana	Quintana	NNP	B-NP	O
Roo	Roo	NNP	I-NP	O
State	State	NNP	I-NP	O
,	,	,	O	O
Mexico	Mexico	NNP	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
recovered	recover	VBD	B-VP	O
47	47	CD	B-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
(	(	(	O	O
28	28	CD	B-NP	O
genera	genera	NN	I-NP	O
and	and	CC	O	O
14	14	CD	B-NP	O
families	family	NNS	I-NP	O
)	)	)	O	O
from	from	IN	B-PP	O
all	all	DT	B-NP	O
samples	sample	NNS	I-NP	O
with	with	IN	B-PP	O
51.1	51.1	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
belonging	belong	VBG	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
family	family	NN	I-NP	O
Enterobacteriaceae	Enterobacteriaceae	NNP	I-NP	O
.	.	.	O	O

Fourteen	Fourteen	CD	B-NP	O
species	specie	NNS	I-NP	O
(	(	(	O	O
29.8	29.8	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	CC	O	O
crocodile	crocodile	NN	B-NP	O
species	specie	NNS	I-NP	O
and	and	CC	O	O
18	18	CD	B-NP	O
(	(	(	O	O
38.3	38.3	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
15	15	CD	B-NP	O
(	(	(	O	O
31.9	31.9	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
species	specie	NNS	B-NP	O
were	be	VBD	B-VP	O
only	only	RB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
American	American	NNP	B-NP	O
and	and	CC	I-NP	O
Morelet	Morelet	NNP	I-NP	O
's	's	POS	B-NP	O
crocodiles	crocodile	NNS	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

We	We	PRP	B-NP	O
recovered	recover	VBD	B-VP	O
35	35	CD	B-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
from	from	IN	B-PP	O
all	all	DT	B-NP	O
oral	oral	JJ	I-NP	O
samples	sample	NNS	I-NP	O
,	,	,	O	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
9	9	CD	B-NP	O
(	(	(	O	O
25.8	25.8	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	CC	O	O
crocodile	crocodile	NN	B-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
all	all	DT	B-NP	O
cloacal	cloacal	JJ	I-NP	O
samples	sample	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
recovered	recover	VBD	B-VP	O
21	21	CD	B-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
8	8	CD	B-NP	O
(	(	(	O	O
38.1	38.1	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	CC	O	O
crocodile	crocodile	NN	B-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
most	most	RBS	I-NP	O
commonly	commonly	RB	I-NP	O
isolated	isolate	VBN	I-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
cloacal	cloacal	JJ	B-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
Aeromonas	Aeromonas	NNP	B-NP	O
hydrophila	hydrophila	NN	I-NP	O
and	and	CC	O	O
Escherichia	Escherichia	FW	B-ADVP	O
coli	coli	FW	I-ADVP	O
,	,	,	O	O
whereas	whereas	IN	O	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
samples	sample	NNS	I-NP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
common	common	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
A.	A.	NN	B-NP	O
hydrophila	hydrophila	NN	I-NP	O
and	and	CC	I-NP	O
Arcanobacterium	Arcanobacterium	NN	I-NP	B-DNA
pyogenes	pyogene	NNS	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
isolated	isolate	VBN	B-VP	O
represent	represent	VBP	B-VP	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
threat	threat	NN	I-NP	O
to	to	TO	B-VP	O
crocodile	crocodile	VB	I-VP	O
health	health	NN	B-NP	O
during	during	IN	B-PP	O
conditions	condition	NNS	B-NP	O
of	of	IN	B-PP	O
stress	stress	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
threat	threat	NN	I-NP	O
to	to	TO	B-PP	O
human	human	JJ	B-NP	O
health	health	NN	I-NP	O
through	through	IN	B-PP	O
crocodile	crocodile	NN	B-NP	O
bites	bite	NNS	I-NP	O
,	,	,	O	O
crocodile	crocodile	NN	B-NP	O
meat	meat	NN	I-NP	O
consumption	consumption	NN	I-NP	O
or	or	CC	O	O
carrying	carry	VBG	B-VP	O
out	out	RP	B-PRT	O
activities	activity	NNS	B-NP	O
in	in	IN	B-PP	O
crocodile	crocodile	NN	B-NP	O
habitat	habitat	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
especially	especially	RB	B-ADVP	O
warn	warn	VBP	B-VP	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
Salmonella	Salmonella	NNP	B-NP	O
arizonae	arizonae	NNP	I-NP	O
and	and	CC	O	O
S.	S.	NNP	B-NP	O
typhi	typhi	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
cause	cause	VBP	B-VP	O
enteritis	enteritis	NN	B-NP	O
and	and	CC	I-NP	O
septicemia	septicemia	NN	I-NP	O
in	in	IN	B-PP	O
crocodiles	crocodile	NNS	B-NP	O
and	and	CC	O	O
salmonellosis	salmonellosis	NN	B-NP	O
and	and	CC	O	O
typhoid	typhoid	JJ	B-NP	O
fever	fever	NN	I-NP	O
in	in	IN	B-PP	O
humans	human	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
contamination	contamination	NN	I-NP	O
from	from	IN	B-PP	O
crocodiles	crocodile	NNS	B-NP	O
to	to	TO	B-PP	O
humans	human	NNS	B-NP	O
could	could	MD	B-VP	O
increase	increase	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
future	future	NN	I-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
accelerated	accelerate	VBN	I-NP	O
destruction	destruction	NN	I-NP	O
of	of	IN	B-PP	O
crocodile	crocodile	NN	B-NP	O
habitat	habitat	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
could	could	MD	B-VP	O
lead	lead	VB	I-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
augmentation	augmentation	NN	I-NP	O
of	of	IN	B-PP	O
human-crocodile	human-crocodile	JJ	B-NP	O
interactions	interaction	NNS	I-NP	O
.	.	.	O	O

Information	Information	NN	B-NP	O
on	on	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
diversity	diversity	NN	I-NP	O
reported	report	VBN	B-VP	O
here	here	RB	B-ADVP	O
could	could	MD	B-VP	O
help	help	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
choice	choice	NN	I-NP	O
of	of	IN	B-PP	O
antibacterial	antibacterial	JJ	B-NP	B-protein
products	product	NNS	I-NP	I-protein
in	in	IN	B-PP	O
case	case	NN	B-NP	O
of	of	IN	B-PP	O
infections	infection	NNS	B-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
of	of	IN	B-PP	O
crocodile	crocodile	NN	B-NP	O
origin	origin	NN	I-NP	O
.	.	.	O	O

Infection	Infection	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
hypothesized	hypothesize	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
contributing	contribute	VBG	I-NP	O
factor	factor	NN	I-NP	O
to	to	TO	B-PP	O
bisphosphonate	bisphosphonate	NN	B-NP	O
(	(	(	O	O
BP	BP	NN	B-NP	O
)	)	)	O	O
-related	-related	JJ	B-NP	O
osteonecrosis	osteonecrosis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
jaw	jaw	NN	I-NP	O
(	(	(	O	O
BRONJ	BRONJ	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
objective	objective	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
colonization	colonization	NN	I-NP	O
of	of	IN	B-PP	O
jawbone	jawbone	NN	B-NP	O
and	and	CC	O	O
identify	identify	VBP	B-VP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
phylotypes	phylotype	NNS	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
BRONJ	BRONJ	NN	B-NP	B-protein
.	.	.	O	O
Culture-independent	Culture-independent	JJ	B-NP	O
16S	16S	NN	I-NP	O
rRNA	rRNA	NN	I-NP	O
gene-based	gene-based	JJ	I-NP	O
molecular	molecular	JJ	I-NP	O
techniques	technique	NNS	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
and	and	CC	I-VP	O
compare	compare	VB	I-VP	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
diversity	diversity	NN	I-NP	O
in	in	IN	B-PP	O
bone	bone	NN	B-NP	O
samples	sample	NNS	I-NP	O
collected	collect	VBN	B-VP	O
from	from	IN	B-PP	O
12	12	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
cancer	cancer	NN	B-NP	O
(	(	(	O	O
six	six	CD	B-NP	O
,	,	,	O	O
BRONJ	BRONJ	NN	B-NP	B-protein
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
BP	BP	NN	B-NP	O
;	;	:	O	O
six	six	CD	B-NP	O
,	,	,	O	O
controls	control	NNS	B-NP	O
without	without	IN	B-PP	O
BRONJ	BRONJ	NNP	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
BP	BP	NN	B-NP	B-protein
but	but	CC	O	O
have	have	VBP	B-VP	O
infection	infection	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Denaturing	Denature	VBG	B-VP	O
gradient	gradient	NN	B-NP	O
gel	gel	NN	I-NP	O
electrophoresis	electrophoresis	NN	I-NP	O
profile	profile	NN	I-NP	O
and	and	CC	O	O
Dice	Dice	NN	B-NP	O
coefficient	coefficient	NN	I-NP	O
displayed	display	VBD	B-VP	O
a	a	DT	B-NP	O
statistically	statistically	RB	I-NP	O
significant	significant	JJ	I-NP	O
clustering	clustering	NN	I-NP	O
of	of	IN	B-PP	O
profiles	profile	NNS	B-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
different	different	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
population	population	NN	I-NP	O
in	in	IN	B-PP	O
BRONJ	BRONJ	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
and	and	CC	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
top	top	JJ	I-NP	O
three	three	CD	I-NP	O
genera	genus	NNS	I-NP	O
ranked	rank	VBD	B-VP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
BRONJ	BRONJ	NN	I-NP	O
group	group	NN	I-NP	O
were	be	VBD	B-VP	O
Streptococcus	Streptococcus	NNP	B-NP	O
(	(	(	O	O
29	29	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Eubacterium	Eubacterium	NN	B-NP	O
(	(	(	O	O
9	9	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
Pseudoramibacter	Pseudoramibacter	NN	B-NP	O
(	(	(	O	O
8	8	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
were	be	VBD	B-VP	O
Parvimonas	Parvimonas	NNP	B-NP	O
(	(	(	O	O
17	17	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
(	(	(	O	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
Fusobacterium	Fusobacterium	NN	B-NP	O
(	(	(	O	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

H	H	NN	B-NP	O
&	&	CC	I-NP	O
E	E	NN	I-NP	O
sections	section	NNS	I-NP	O
of	of	IN	B-PP	O
BRONJ	BRONJ	NN	B-NP	O
bone	bone	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
layers	layer	NNS	B-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
along	along	IN	B-PP	O
the	the	DT	B-NP	O
surfaces	surface	NNS	I-NP	O
and	and	CC	O	O
often	often	RB	B-VP	O
are	be	VBP	I-VP	O
packed	pack	VBN	I-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
scalloped	scallop	VBN	I-NP	O
edges	edge	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bone	bone	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
using	use	VBG	B-VP	O
limited	limit	VBN	B-NP	O
sample	sample	NN	I-NP	O
size	size	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
jawbone	jawbone	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
BRONJ	BRONJ	NN	B-NP	B-protein
was	be	VBD	B-VP	O
heavily	heavily	RB	I-VP	O
colonized	colonize	VBN	I-VP	O
by	by	IN	B-PP	O
specific	specific	JJ	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
apparent	apparent	JJ	B-NP	O
differences	difference	NNS	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
microbiota	microbiota	NN	I-NP	O
of	of	IN	B-PP	O
BRONJ	BRONJ	NN	B-NP	B-protein
and	and	CC	I-NP	O
controls	control	NNS	I-NP	O
.	.	.	O	O

Bacterial	Bacterial	JJ	B-NP	O
vaginosis	vaginosis	NN	I-NP	O
(	(	(	O	O
BV	BV	NN	B-NP	O
)	)	)	O	O
represents	represent	VBZ	B-VP	O
shifts	shift	NNS	B-NP	O
in	in	IN	B-PP	O
microbiota	microbiota	NN	B-NP	O
from	from	IN	B-PP	O
Lactobacillus	Lactobacillus	NN	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

to	to	TO	B-PP	O
diverse	diverse	JJ	B-NP	O
anaerobes	anaerobe	NNS	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
antibiotics	antibiotic	NNS	B-NP	O
relieve	relieve	VBP	B-VP	O
symptoms	symptom	NNS	B-NP	O
and	and	CC	O	O
temporarily	temporarily	RB	B-VP	O
eradicate	eradicate	VBP	I-VP	O
BV-associated	BV-associated	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
(	(	(	O	O
BVAB	BVAB	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
BV	BV	NN	B-NP	O
usually	usually	RB	B-ADVP	O
recurs	recur	VBZ	B-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
extravaginal	extravaginal	JJ	B-NP	O
BVAB	BVAB	NN	I-NP	O
reservoirs	reservoir	NNS	I-NP	O
in	in	IN	B-PP	O
recurrence	recurrence	NN	B-NP	O
.	.	.	O	O

Risks	Risk	NNS	B-NP	O
for	for	IN	B-PP	O
BV	BV	NN	B-NP	O
acquisition	acquisition	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
year	year	NN	I-NP	O
were	be	VBD	B-VP	O
defined	define	VBN	I-VP	O
.	.	.	O	O

DNA	DNA	NN	B-NP	O
in	in	IN	B-PP	O
vaginal	vaginal	JJ	B-NP	O
,	,	,	I-NP	O
anal	anal	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
swab	swab	NN	I-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
enrollment	enrollment	NN	B-NP	O
was	be	VBD	B-VP	O
subjected	subject	VBN	I-VP	O
to	to	TO	B-PP	O
quantitative	quantitative	JJ	B-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
assays	assay	NNS	I-NP	O
targeting	target	VBG	B-VP	O
16S	16S	NN	B-NP	B-DNA
ribosomal	ribosomal	JJ	I-NP	I-DNA
RNA	RNA	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
of	of	IN	B-PP	O
Gardnerella	Gardnerella	FW	B-ADVP	O
vaginalis	vaginalis	FW	I-ADVP	O
,	,	,	O	O
Lactobacillus	Lactobacillus	NN	B-NP	O
crispatus	crispatus	NN	I-NP	O
,	,	,	O	O
BVAB1	BVAB1	NN	B-NP	B-protein
,	,	,	O	O
BVAB2	BVAB2	NN	B-NP	B-protein
,	,	,	O	O
BVAB3	BVAB3	NN	B-NP	B-protein
,	,	,	O	O
Megasphaera	Megasphaera	NNP	B-NP	O
spp.	spp.	NNP	I-NP	O
,	,	,	O	O
Lactobacillus	Lactobacillus	NNP	B-NP	O
jensenii	jensenii	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Leptotrichia/Sneathia	Leptotrichia/Sneathia	NNP	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
case-control	case-control	JJ	I-NP	O
approach	approach	NN	I-NP	O
analyzed	analyze	VBD	B-VP	O
BVAB	BVAB	NN	B-NP	B-protein
detection	detection	NN	I-NP	O
at	at	IN	B-PP	O
enrollment	enrollment	NN	B-NP	O
for	for	IN	B-SBAR	O
case	case	NN	O	O
patients	patient	NNS	B-NP	O
(	(	(	O	O
BV	BV	NN	B-NP	O
acquisition	acquisition	NN	I-NP	O
)	)	)	O	O
versus	versus	IN	B-PP	O
controls	control	NNS	B-NP	O
(	(	(	O	O
none	none	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Of	Of	IN	B-PP	O
239	239	CD	B-NP	O
women	woman	NNS	I-NP	O
enrolled	enrol	VBN	B-VP	O
without	without	IN	B-PP	O
BV	BV	NN	B-NP	O
,	,	,	O	O
199	199	CD	B-NP	O
were	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
follow-up	follow-up	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
40	40	CD	B-NP	O
experienced	experienced	JJ	I-NP	O
BV	BV	NN	I-NP	O
;	;	:	O	O
15	15	CD	B-NP	O
had	have	VBD	B-VP	O
all	all	DT	B-NP	O
samples	sample	NNS	I-NP	O
for	for	IN	B-PP	O
analysis	analysis	NN	B-NP	O
.	.	.	O	O

Detection	Detection	NN	B-NP	O
of	of	IN	B-PP	O
G.	G.	FW	B-NP	O
vaginalis	vaginalis	FW	I-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
cavity	cavity	NN	I-NP	O
or	or	CC	O	O
anal	anal	JJ	B-NP	O
samples	sample	NNS	I-NP	O
and	and	CC	O	O
Leptotrichia/Sneathia	Leptotrichia/Sneathia	NNP	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

in	in	IN	B-PP	O
anal	anal	JJ	B-NP	O
samples	sample	NNS	I-NP	O
was	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
common	common	JJ	I-ADJP	O
at	at	IN	B-PP	O
enrollment	enrollment	NN	B-NP	O
among	among	IN	B-PP	O
case	case	NN	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
higher	high	JJR	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
Megasphaera	Megasphaera	NN	B-NP	O
relative	relative	JJ	B-ADJP	O
to	to	TO	B-PP	O
30	30	CD	B-NP	O
controls	control	NNS	I-NP	O
at	at	IN	B-PP	O
each	each	DT	B-NP	O
site	site	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
L.	L.	NNP	B-NP	O
crispatus	crispatus	NN	I-NP	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
more	more	RBR	B-ADVP	O
frequently	frequently	RB	I-ADVP	O
in	in	IN	B-PP	O
anal	anal	JJ	B-NP	O
samples	sample	NNS	I-NP	O
among	among	IN	B-PP	O
controls	control	NNS	B-NP	O
.	.	.	O	O

Women	Woman	NNS	B-NP	O
who	who	WP	B-NP	O
acquire	acquire	VBP	B-VP	O
BV	BV	NN	B-NP	O
are	be	VBP	B-VP	O
more	more	RBR	B-ADJP	O
likely	likely	JJ	I-ADJP	O
have	have	VBP	B-VP	O
previous	previous	JJ	B-NP	O
colonization	colonization	NN	I-NP	O
of	of	IN	B-PP	O
extravaginal	extravaginal	JJ	B-NP	O
reservoirs	reservoir	NNS	I-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
BVAB	BVAB	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
less	less	RBR	B-ADJP	O
likely	likely	JJ	I-ADJP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
L.	L.	NNP	B-NP	O
crispatus	crispatus	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
BVAB	BVAB	NN	B-NP	B-protein
may	may	MD	B-VP	O
be	be	VB	I-VP	O
acquired	acquire	VBN	I-VP	O
vaginally	vaginally	RB	B-ADVP	O
from	from	IN	B-PP	O
extravaginal	extravaginal	JJ	B-NP	O
reservoirs	reservoir	NNS	I-NP	O
.	.	.	O	O

Treating	Treat	VBG	B-VP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
systemic	systemic	JJ	B-NP	O
lupus	lupus	NN	I-NP	O
erythematosus	erythematosus	NN	I-NP	O
(	(	(	O	O
SLE	SLE	NN	B-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
and	and	CC	O	O
immunosuppressive	immunosuppressive	JJ	B-NP	O
drugs	drug	NNS	I-NP	O
may	may	MD	B-VP	O
interfere	interfere	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
potentially	potentially	RB	B-NP	O
opportunistic	opportunistic	JJ	I-NP	O
microorganisms	microorganism	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
Candida	Candida	NNP	B-NP	O
spp.	spp.	NNP	I-NP	O
,	,	,	O	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
spp.	spp.	NN	I-NP	O
,	,	,	O	O
Enterobacteria	Enterobacteria	NNS	B-NP	O
and	and	CC	O	O
Pseudomonas	Pseudomonas	NN	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
of	of	IN	B-PP	O
SLE	SLE	NN	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
controls	control	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
40	40	CD	B-NP	O
patients	patient	NNS	I-NP	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
received	receive	VBN	I-VP	O
therapy	therapy	NN	B-NP	O
for	for	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
60	60	CD	I-NP	O
days	day	NNS	I-NP	O
was	be	VBD	B-VP	O
selected	select	VBN	I-VP	O
(	(	(	O	O
19-53	19-53	CD	B-NP	O
years	year	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O

For	For	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
40	40	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
individuals	individual	NNS	I-NP	O
matched	match	VBN	B-VP	O
for	for	IN	B-PP	O
age	age	NN	B-NP	O
,	,	,	I-NP	O
gender	gender	NN	I-NP	O
and	and	CC	I-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
partial	partial	JJ	B-NP	O
prosthesis	prosthesis	NN	I-NP	O
were	be	VBD	B-VP	O
selected	select	VBN	I-VP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
rinse	rinse	NN	I-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
and	and	CC	O	O
plated	plat	VBN	B-VP	O
on	on	IN	B-PP	O
specific	specific	JJ	B-NP	O
culture	culture	NN	I-NP	O
media	medium	NNS	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
incubation	incubation	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
colony	colony	NN	B-NP	B-protein
forming	form	VBG	B-VP	I-protein
units	unit	NNS	B-NP	I-protein
(	(	(	O	O
CFU	CFU	NN	B-NP	B-protein
)	)	)	O	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
isolates	isolate	NNS	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
at	at	IN	B-PP	O
species	specie	NNS	B-NP	O
level	level	NN	B-NP	O
.	.	.	O	O

Microbial	Microbial	JJ	B-NP	O
counts	count	NNS	I-NP	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
between	between	IN	B-PP	O
SLE	SLE	NN	B-NP	O
and	and	CC	I-NP	O
control	control	NN	I-NP	O
by	by	IN	B-PP	O
analysis	analysis	NN	B-NP	O
of	of	IN	B-PP	O
variance	variance	NN	B-NP	O
(	(	(	O	O
ANOVA	ANOVA	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
Mann-Whitney	Mann-Whitney	NN	B-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.05	0.05	CD	B-NP	O
significant	significant	JJ	I-NP	O
)	)	)	O	O
.	.	.	O	O

Microorganism	Microorganism	NN	B-NP	O
counts	count	NNS	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
and	and	CC	O	O
without	without	IN	B-PP	O
immunosuppressive	immunosuppressive	JJ	B-NP	O
drugs	drug	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
with	with	IN	B-PP	O
active	active	JJ	B-NP	O
and	and	CC	I-NP	O
inactive	inactive	JJ	I-NP	O
disease	disease	NN	I-NP	O
(	(	(	O	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
SLEDAI	SLEDAI	NN	B-NP	O
score	score	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
compared	compare	VBN	I-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
significant	significant	JJ	I-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
CFU/mL	CFU/mL	NN	B-NP	O
between	between	IN	B-PP	O
SLE	SLE	NN	B-NP	O
and	and	CC	I-NP	O
control	control	NN	I-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
(	(	(	O	O
yeasts	yeast	NNS	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
0.55	0.55	CD	B-NP	O
;	;	:	O	O
Staphylococci	Staphylococci	NNS	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
0.24	0.24	CD	B-NP	O
;	;	:	O	O
Enterobacteria/Pseudomonas	Enterobacteria/Pseudomonas	NNP	B-NP	O
spp.	spp.	NN	I-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
0.26	0.26	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

No	No	DT	B-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
microbial	microbial	JJ	B-NP	O
counts	count	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
regarding	regard	VBG	B-PP	O
clinical	clinical	JJ	B-NP	O
parameters	parameter	NNS	I-NP	O
tested	test	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
most	most	RBS	I-NP	O
frequent	frequent	JJ	I-NP	O
species	specie	NNS	I-NP	O
isolated	isolate	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
SLE	SLE	NN	I-NP	O
group	group	NN	I-NP	O
were	be	VBD	B-VP	O
Candida	Candida	NNP	B-NP	O
albicans	albicans	NNP	I-NP	O
,	,	,	O	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
epidermidis	epidermidis	NN	I-NP	O
and	and	CC	I-NP	O
Klebsiella	Klebsiella	NN	I-NP	O
oxytoca	oxytoca	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
conclusion	conclusion	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
frequency	frequency	NN	B-NP	O
and	and	CC	I-NP	O
microorganism	microorganism	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
between	between	IN	B-PP	O
SLE	SLE	NN	B-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	O	O
healthy	healthy	JJ	B-NP	O
individuals	individual	NNS	I-NP	O
.	.	.	O	O

SGP1	SGP1	NN	B-NP	B-protein
(	(	(	O	O
T	T	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
strain	strain	NN	I-NP	O
belonging	belong	VBG	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
lineage	lineage	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
phylum	phylum	NN	I-NP	O
Synergistetes	Synergistete	VBZ	B-VP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
previously	previously	RB	I-NP	O
cultivated	cultivate	VBN	I-NP	O
representatives	representative	NNS	I-NP	O
was	be	VBD	B-VP	O
subjected	subject	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
comprehensive	comprehensive	JJ	I-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
phenotypic	phenotypic	JJ	B-NP	O
and	and	CC	I-NP	O
genotypic	genotypic	JJ	I-NP	O
tests	test	NNS	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
good	good	JJ	B-NP	O
growth	growth	NN	I-NP	O
the	the	DT	B-NP	O
strain	strain	NN	I-NP	O
was	be	VBD	B-VP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
co-culture	co-culture	NN	B-NP	O
with	with	IN	B-PP	O
,	,	,	O	O
or	or	CC	O	O
extracts	extract	NNS	B-NP	O
from	from	IN	B-PP	O
,	,	,	O	O
selected	select	VBN	B-VP	O
other	other	JJ	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

Cells	Cell	NNS	B-NP	O
of	of	IN	B-PP	O
strain	strain	NN	B-NP	O
SGP1	SGP1	NN	I-NP	O
(	(	(	O	O
T	T	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
asaccharolytic	asaccharolytic	JJ	B-NP	O
and	and	CC	I-NP	O
major	major	JJ	I-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
acetic	acetic	JJ	B-NP	O
acid	acid	NN	I-NP	O
and	and	CC	O	O
moderate	moderate	JJ	B-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
propionic	propionic	JJ	B-NP	O
acid	acid	NN	I-NP	O
were	be	VBD	B-VP	O
produced	produce	VBN	I-VP	O
as	as	IN	B-PP	O
end	end	NN	B-NP	O
products	product	NNS	I-NP	O
of	of	IN	B-PP	O
metabolism	metabolism	NN	B-NP	O
in	in	IN	B-PP	O
peptone-yeast	peptone-yeast	JJ	B-NP	O
extract-glucose	extract-glucose	NN	I-NP	O
broth	broth	NN	I-NP	O
supplemented	supplement	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
filtered	filter	VBN	I-NP	O
cell	cell	NN	I-NP	O
sonicate	sonicate	NN	I-NP	O
of	of	IN	B-PP	O
Fusobacterium	Fusobacterium	NN	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
subsp	subsp	NN	I-NP	O
.	.	.	O	O

nucleatum	nucleatum	NN	B-NP	O
ATCC	ATCC	NN	I-NP	O
25586	25586	CD	I-NP	O
(	(	(	O	O
T	T	NN	B-NP	O
)	)	)	O	O
(	(	(	O	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
v/v	v/v	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Hydrogen	Hydrogen	NN	B-NP	O
sulphide	sulphide	NN	I-NP	O
was	be	VBD	B-VP	O
produced	produce	VBN	I-VP	O
and	and	CC	O	O
gelatin	gelatin	NN	B-NP	O
was	be	VBD	B-VP	O
weakly	weakly	RB	I-VP	O
hydrolysed	hydrolyse	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
major	major	JJ	I-NP	O
cellular	cellular	JJ	I-NP	O
fatty	fatty	JJ	I-NP	O
acids	acid	NNS	I-NP	O
were	be	VBD	B-VP	O
C	C	NN	B-NP	O
(	(	(	O	O
14	14	CD	B-NP	O
:	:	:	O	O
0	0	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
C	C	NN	B-NP	O
(	(	(	O	O
18	18	CD	B-NP	O
:	:	:	O	O
0	0	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
C	C	NN	B-NP	O
(	(	(	O	O
16	16	CD	B-NP	O
:	:	:	O	O
0	0	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
DNA	DNA	NN	I-NP	O
G+C	G+C	NN	I-NP	O
content	content	NN	I-NP	O
of	of	IN	B-PP	O
strain	strain	NN	B-NP	O
SGP1	SGP1	NN	I-NP	O
(	(	(	O	O
T	T	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
63	63	CD	B-NP	O
mol	mol	NN	I-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Phylogenetic	Phylogenetic	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
full-length	full-length	JJ	I-NP	B-DNA
16S	16S	NN	I-NP	I-DNA
rRNA	rRNA	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
strain	strain	NN	B-NP	O
SGP1	SGP1	NN	I-NP	O
(	(	(	O	O
T	T	NN	B-NP	O
)	)	)	O	O
represented	represent	VBD	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
group	group	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
phylum	phylum	NN	I-NP	O
Synergistetes	Synergistetes	NNP	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
novel	novel	JJ	I-NP	O
species	specie	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
genus	genus	NN	I-NP	O
,	,	,	O	O
Fretibacterium	Fretibacterium	NNP	B-NP	O
fastidiosum	fastidiosum	NNP	I-NP	O
gen.	gen.	NNP	I-NP	O
nov.	nov.	NNP	I-NP	O
,	,	,	O	O
sp	sp	NN	B-NP	O
.	.	.	O	O

nov.	nov.	RB	B-ADVP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
proposed	propose	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
type	type	NN	I-NP	O
strain	strain	NN	I-NP	O
of	of	IN	B-PP	O
Fretibacterium	Fretibacterium	NN	B-NP	O
fastidiosum	fastidiosum	NN	I-NP	O
is	be	VBZ	B-VP	O
SGP1	SGP1	NN	B-NP	B-protein
(	(	(	O	O
T	T	NN	B-NP	O
)	)	)	O	O
(	(	(	O	O
=	=	SYM	B-VP	O
DSM	DSM	NN	B-NP	O
25557	25557	CD	I-NP	O
(	(	(	O	O
T	T	NN	B-NP	O
)	)	)	O	O
=	=	SYM	B-VP	O
JCM	JCM	NN	B-NP	O
16858	16858	CD	I-NP	O
(	(	(	O	O
T	T	NN	B-NP	O
)	)	)	O	O
)	)	)	O	O
.	.	.	O	O

Critical	Critical	JJ	B-NP	O
care	care	NN	I-NP	O
nursing	nursing	NN	I-NP	O
interventions	intervention	NNS	I-NP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
care	care	NN	I-NP	O
can	can	MD	B-VP	O
reduce	reduce	VB	I-VP	O
microorganisms	microorganism	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oropharynx	oropharynx	NN	I-NP	O
available	available	JJ	B-ADJP	O
for	for	IN	B-PP	O
translocation	translocation	NN	B-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
analyse	analyse	VB	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
0.12	0.12	CD	B-NP	O
%	%	NN	I-NP	O
chlorhexidine	chlorhexidine	NN	I-NP	O
digluconate	digluconate	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
colonization	colonization	NN	I-NP	O
of	of	IN	B-PP	O
oropharyngeal	oropharyngeal	JJ	B-NP	O
and	and	CC	I-NP	O
tracheal	tracheal	JJ	I-NP	O
secretions	secretion	NNS	I-NP	O
by	by	IN	B-PP	O
Gram-negative	Gram-negative	JJ	B-NP	O
pathogens	pathogen	NNS	I-NP	O
in	in	IN	B-PP	O
mechanically	mechanically	RB	B-NP	O
ventilated	ventilate	VBN	I-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
randomized	randomize	VBN	I-NP	O
,	,	,	I-NP	O
controlled	control	VBN	I-NP	O
and	and	CC	I-NP	O
double-blinded	double-blinded	JJ	I-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
paediatric	paediatric	JJ	I-NP	O
intensive	intensive	JJ	I-NP	O
care	care	NN	I-NP	O
unit	unit	NN	I-NP	O
(	(	(	O	O
PICU	PICU	NN	B-NP	B-DNA
)	)	)	O	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
Brazilian	Brazilian	JJ	I-NP	O
university	university	NN	I-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

Exclusion	Exclusion	NN	B-NP	O
criteria	criterion	NNS	I-NP	O
included	include	VBD	B-VP	O
child	child	NN	B-NP	O
age	age	NN	I-NP	O
under	under	IN	B-PP	O
28	28	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
pneumonia	pneumonia	NN	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
at	at	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
use	use	NN	B-NP	O
of	of	IN	B-PP	O
tracheostomy	tracheostomy	NN	B-NP	O
,	,	,	O	O
PICU	PICU	NN	B-NP	O
length	length	NN	I-NP	O
of	of	IN	B-PP	O
stay	stay	NN	B-NP	O
(	(	(	O	O
LOS	LOS	NN	B-NP	O
)	)	)	O	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
48	48	CD	I-NP	O
h	h	NN	I-NP	O
and	and	CC	I-NP	O
refusal	refusal	NN	I-NP	O
to	to	TO	B-VP	O
participate	participate	VB	I-VP	O
.	.	.	O	O

Children	Child	NNS	B-NP	O
were	be	VBD	B-VP	O
randomly	randomly	RB	I-VP	O
allocated	allocate	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
interventional	interventional	JJ	I-NP	O
group	group	NN	I-NP	O
(	(	(	O	O
IG	IG	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
oral	oral	JJ	B-NP	O
care	care	NN	I-NP	O
with	with	IN	B-PP	O
chlorhexidine	chlorhexidine	NN	B-NP	O
was	be	VBD	B-VP	O
administered	administer	VBN	I-VP	O
,	,	,	O	O
or	or	CC	O	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
placebo	placebo	NN	I-NP	O
group	group	NN	I-NP	O
(	(	(	O	O
PG	PG	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
received	receive	VBD	B-VP	O
oral	oral	JJ	B-NP	O
care	care	NN	I-NP	O
without	without	IN	B-PP	O
antiseptic	antiseptic	JJ	B-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
data	datum	NNS	I-NP	O
were	be	VBD	B-VP	O
analysed	analyse	VBN	I-VP	O
through	through	IN	B-PP	O
Pearson	Pearson	NNP	B-NP	O
's	's	POS	B-NP	O
chi	chi	NN	I-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
test	test	NN	B-NP	O
,	,	,	O	O
Fisher's	Fisher's	NNP	B-NP	O
exact	exact	NN	I-NP	O
and	and	CC	I-NP	O
ANOVA	ANOVA	NN	I-NP	O
tests	test	NNS	I-NP	O
with	with	IN	B-PP	O
significance	significance	NN	B-NP	O
levels	level	NNS	I-NP	O
set	set	VBN	B-VP	O
at	at	IN	B-PP	O
0.05	0.05	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
demographic	demographic	JJ	I-NP	O
characteristics	characteristic	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
74	74	CD	I-NP	O
children	child	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	O	O
statistically	statistically	RB	B-ADJP	O
different	different	JJ	I-ADJP	O
between	between	IN	B-PP	O
groups	group	NNS	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
between-group	between-group	JJ	I-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
oropharyx	oropharyx	NN	B-NP	O
colonization	colonization	NN	I-NP	O
by	by	IN	B-PP	O
Gram-negative	Gram-negative	JJ	B-NP	O
pathogens	pathogen	NNS	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
(	(	(	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
0.316	0.316	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Pathogens	Pathogen	NNS	B-NP	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
tracheal	tracheal	JJ	I-NP	O
secretions	secretion	NNS	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
(	(	(	O	O
10.0	10.0	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
children	child	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
PG	PG	NN	I-NP	O
and	and	CC	O	O
four	four	CD	B-NP	O
(	(	(	O	O
19.0	19.0	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
children	child	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
IG	IG	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
0.355	0.355	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
chlorhexidine	chlorhexidine	NN	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
significantly	significantly	RB	I-VP	O
influence	influence	VB	I-VP	O
the	the	DT	B-NP	O
colonization	colonization	NN	I-NP	O
of	of	IN	B-PP	O
oropharyngeal	oropharyngeal	JJ	B-NP	O
and	and	CC	I-NP	O
tracheal	tracheal	JJ	I-NP	O
secretions	secretion	NNS	I-NP	O
by	by	IN	B-PP	O
Gram-negative	Gram-negative	JJ	B-NP	O
pathogens	pathogen	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
studied	study	VBN	I-NP	O
sample	sample	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
no	no	DT	B-NP	O
influence	influence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
antiseptic	antiseptic	JJ	I-NP	O
agent	agent	NN	I-NP	O
on	on	IN	B-PP	O
colonization	colonization	NN	B-NP	O
profile	profile	NN	I-NP	O
of	of	IN	B-PP	O
mechanically	mechanically	RB	B-NP	O
ventilated	ventilate	VBN	I-NP	O
children	child	NNS	I-NP	O
in	in	IN	B-PP	O
PICU	PICU	NN	B-NP	B-protein
.	.	.	O	O

Further	Further	JJ	B-NP	O
research	research	NN	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
field	field	NN	I-NP	O
is	be	VBZ	B-VP	O
necessary	necessary	JJ	B-ADJP	O
to	to	TO	B-VP	O
promote	promote	VB	I-VP	O
evidence-based	evidence-based	JJ	B-NP	O
nursing	nursing	NN	I-NP	O
practice	practice	NN	I-NP	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	O
care	care	NN	I-NP	O
of	of	IN	B-PP	O
critically	critically	RB	B-NP	O
ill	ill	JJ	I-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

Helicobacter	Helicobacter	NN	B-NP	O
pylori	pylori	NN	I-NP	O
colonizes	colonize	VBZ	B-VP	O
the	the	DT	B-NP	O
stomachs	stomach	NNS	I-NP	O
of	of	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
half	half	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
world	world	NN	I-NP	O
's	's	POS	B-NP	O
human	human	JJ	I-NP	O
population	population	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
colonization	colonization	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
clear	clear	JJ	B-ADJP	O
and	and	CC	O	O
there	there	EX	B-NP	O
are	be	VBP	B-VP	O
,	,	,	O	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
comprehensive	comprehensive	JJ	I-NP	O
data	datum	NNS	I-NP	O
that	that	WDT	B-NP	O
clearly	clearly	RB	B-ADVP	O
demonstrate	demonstrate	VBP	B-VP	O
the	the	DT	B-NP	O
isolation	isolation	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
bacterium	bacterium	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
H.	H.	NN	B-NP	O
pylori	pylori	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
of	of	IN	B-PP	O
15	15	CD	B-NP	O
patients	patient	NNS	I-NP	O
who	who	WP	B-NP	O
tested	test	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
H.	H.	NN	B-NP	O
pylori	pylori	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
comprehensive	comprehensive	JJ	I-NP	O
dental	dental	JJ	I-NP	O
examination	examination	NN	I-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
patients	patient	NNS	I-NP	O
was	be	VBD	B-VP	O
conducted	conduct	VBN	I-VP	O
.	.	.	O	O

Samples	Sample	NNS	B-NP	O
were	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
from	from	IN	B-PP	O
supragingival	supragingival	JJ	B-NP	O
and	and	CC	I-NP	O
subgingival	subgingival	JJ	I-NP	O
plaque	plaque	NN	I-NP	O
,	,	,	O	O
saliva	saliva	NN	B-NP	O
,	,	,	O	O
periapical	periapical	JJ	B-NP	O
exudates	exudate	NNS	I-NP	O
and	and	CC	O	O
tongue	tongue	NN	B-NP	B-protein
swabs	swab	NNS	I-NP	I-protein
.	.	.	O	O

All	All	DT	B-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
before	before	IN	B-PP	O
the	the	DT	B-NP	O
application	application	NN	I-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
163	163	CD	B-NP	O
oral	oral	JJ	I-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
by	by	IN	B-PP	O
PCR	PCR	NN	B-NP	O
using	use	VBG	B-VP	O
two	two	CD	B-NP	O
different	different	JJ	I-NP	O
H.	H.	NN	I-NP	B-DNA
pylori-specific	pylori-specific	JJ	I-NP	I-DNA
primer	primer	NN	I-NP	I-DNA
pairs	pair	NNS	I-NP	I-DNA
.	.	.	O	O

A	A	DT	B-NP	O
PCR	PCR	NN	I-NP	O
inhibition	inhibition	NN	I-NP	O
control	control	NN	I-NP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
modified	modify	VBN	I-NP	B-DNA
plasmid	plasmid	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
always	always	RB	I-VP	O
included	include	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
specific	specific	JJ	I-NP	O
primer	primer	NN	I-NP	O
pair	pair	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
culture	culture	NN	I-NP	O
technique	technique	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
confirm	confirm	VB	I-VP	O
PCR	PCR	NN	B-NP	O
results	result	NNS	I-NP	O
.	.	.	O	O

Despite	Despite	IN	B-PP	O
a	a	DT	B-NP	O
PCR	PCR	NN	I-NP	O
detection	detection	NN	I-NP	O
limit	limit	NN	I-NP	O
of	of	IN	B-PP	O
10	10	CD	B-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
bacteria	bacteria	NNS	B-NP	O
ml	ml	NN	I-NP	O
(	(	(	O	O
-1	-1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
14	14	CD	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
H.	H.	NN	B-NP	O
pylori	pylori	NN	I-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
any	any	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
samples	sample	NNS	I-NP	O
taken	take	VBN	B-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
one	one	CD	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
H.	H.	NNP	B-NP	O
pylori-positive	pylori-positive	JJ	I-NP	O
PCR	PCR	NN	I-NP	O
signals	signal	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
samples	sample	NNS	I-NP	O
using	use	VBG	B-VP	O
only	only	RB	B-NP	O
one	one	CD	I-NP	O
primer	primer	NN	I-NP	O
pair	pair	NN	I-NP	O
.	.	.	O	O

H.	H.	NN	B-NP	O
pylori	pylori	NN	I-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
cultivated	cultivate	VBN	I-VP	O
from	from	IN	B-PP	O
these	these	DT	B-NP	O
two	two	CD	I-NP	O
PCR-positive	PCR-positive	JJ	I-NP	O
samples	sample	NNS	I-NP	O
;	;	:	O	O
therefore	therefore	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
correlation	correlation	NN	I-NP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
colonization	colonization	NN	I-NP	O
status	status	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
established	establish	VBN	I-VP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
challenges	challenge	VBZ	B-VP	O
the	the	DT	B-NP	O
misleading	misleading	JJ	I-NP	O
preconception	preconception	NN	I-NP	O
that	that	IN	B-NP	O
H.	H.	NN	B-NP	O
pylori	pylori	NN	I-NP	O
resides	reside	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
and	and	CC	O	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
bacterium	bacterium	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
transient	transient	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
independent	independent	JJ	I-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-PP	O
date	date	NN	B-NP	O
,	,	,	O	O
positive	positive	JJ	B-NP	O
PCR	PCR	NN	I-NP	O
results	result	NNS	I-NP	O
for	for	IN	B-PP	O
H.	H.	NN	B-NP	O
pylori	pylori	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
overestimated	overestimate	VBN	I-VP	O
and	and	CC	O	O
not	not	RB	B-VP	O
critically	critically	RB	I-VP	O
interpreted	interpret	VBN	I-VP	O
in	in	IN	B-PP	O
literature	literature	NN	B-NP	O
.	.	.	O	O

Microbial	Microbial	JJ	B-NP	O
flora	flora	NN	I-NP	O
can	can	MD	B-VP	O
provide	provide	VB	I-VP	O
insight	insight	NN	B-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
ecology	ecology	NN	I-NP	O
and	and	CC	O	O
natural	natural	JJ	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
wildlife	wildlife	NN	B-NP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
improving	improve	VBG	B-VP	O
understanding	understanding	NN	B-NP	O
of	of	IN	B-PP	O
health	health	NN	B-NP	O
risks	risk	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
examines	examine	VBZ	B-VP	O
the	the	DT	B-NP	O
anaerobic	anaerobic	JJ	I-NP	O
oral	oral	JJ	I-NP	O
flora	flora	NN	I-NP	O
of	of	IN	B-PP	O
hunter	hunter	NN	B-NP	O
killed	kill	VBD	B-VP	O
black	black	JJ	B-NP	O
bears	bear	NNS	I-NP	O
(	(	(	O	O
Ursus	Ursus	NN	B-NP	O
americanus	americanus	NN	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
eastern	eastern	JJ	B-NP	O
North	North	NNP	I-NP	O
Carolina	Carolina	NNP	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
swabs	swab	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
buccal	buccal	JJ	I-NP	O
and	and	CC	I-NP	O
lingual	lingual	JJ	I-NP	O
supragingival	supragingival	JJ	I-NP	O
tooth	tooth	JJ	I-NP	O
surfaces	surface	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
and	and	CC	I-NP	O
second	second	JJ	I-NP	O
mandibular	mandibular	JJ	I-NP	O
and	and	CC	I-NP	O
maxillary	maxillary	JJ	I-NP	O
molars	molar	NNS	I-NP	O
of	of	IN	B-PP	O
22	22	CD	B-NP	O
black	black	JJ	I-NP	O
bears	bear	NNS	I-NP	O
were	be	VBD	B-VP	O
inoculated	inoculate	VBN	I-VP	O
onto	onto	IN	B-PP	O
Brucella	Brucella	NNP	B-NP	O
Blood	Blood	NNP	I-NP	O
Agar	Agar	NNP	I-NP	O
plates	plat	VBZ	B-VP	O
supplemented	supplement	VBN	I-VP	O
with	with	IN	B-PP	O
hemin	hemin	NN	B-NP	B-protein
and	and	CC	I-NP	O
vitamin	vitamin	NN	I-NP	O
K	K	NN	I-NP	O
after	after	IN	B-PP	O
transport	transport	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
field	field	NN	I-NP	O
using	use	VBG	B-VP	O
reduced	reduce	VBN	B-NP	O
oxoid	oxoid	JJ	I-NP	O
nutrient	nutrient	NN	I-NP	O
broth	broth	NN	I-NP	O
.	.	.	O	O

Sixteen	Sixteen	CD	B-NP	O
anaerobic	anaerobic	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
representing	represent	VBG	B-VP	O
nine	nine	CD	B-NP	O
genera	genus	NNS	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
RapID	RapID	NN	I-NP	O
ANA	ANA	NN	I-NP	O
II	II	CD	I-NP	O
Micromethod	Micromethod	NN	I-NP	O
Kit	Kit	NN	I-NP	O
system	system	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
organisms	organism	NNS	B-NP	O
grown	grow	VBN	B-VP	O
that	that	WDT	B-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
identified	identify	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
system	system	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
most	most	RBS	I-NP	O
frequently	frequently	RB	I-NP	O
identified	identify	VBN	I-NP	O
anaerobes	anaerobe	NNS	I-NP	O
were	be	VBD	B-VP	O
Peptostreptococcus	Peptostreptococcus	NNP	B-NP	O
prevotii	prevotii	NNP	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
constellatus	constellatus	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
diversity	diversity	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
anaerobic	anaerobic	JJ	I-NP	O
oral	oral	JJ	I-NP	O
flora	flora	NN	I-NP	O
of	of	IN	B-PP	O
black	black	JJ	B-NP	O
bear	bear	NN	I-NP	O
in	in	IN	B-PP	O
eastern	eastern	JJ	B-NP	O
North	North	NNP	I-NP	O
Carolina	Carolina	NNP	I-NP	O
suggests	suggest	VBZ	B-VP	O
the	the	DT	B-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
including	include	VBG	B-VP	O
these	these	DT	B-NP	O
organisms	organism	NNS	I-NP	O
in	in	IN	B-PP	O
basic	basic	JJ	B-NP	O
health	health	NN	I-NP	O
risk	risk	NN	I-NP	O
assessment	assessment	NN	I-NP	O
protocols	protocol	NNS	I-NP	O
and	and	CC	O	O
suggests	suggest	VBZ	B-VP	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
tool	tool	NN	I-NP	O
for	for	IN	B-PP	O
assessment	assessment	NN	B-NP	O
of	of	IN	B-PP	O
bear/habitat	bear/habitat	NN	B-NP	O
interactions	interaction	NNS	I-NP	O
.	.	.	O	O

Tobacco	Tobacco	NNP	B-NP	O
chewing	chew	VBG	B-VP	O
habit	habit	NN	B-NP	O
,	,	,	O	O
presence	presence	NN	B-NP	O
of	of	IN	B-PP	O
squamous	squamous	JJ	B-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
cavity	cavity	NN	I-NP	O
and	and	CC	I-NP	O
radiotherapy	radiotherapy	NN	I-NP	O
causes	cause	VBZ	B-VP	O
alterations	alteration	NNS	B-NP	O
in	in	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
oral	oral	JJ	I-NP	O
microflora	microflora	NN	I-NP	O
.	.	.	O	O

Abnormal	Abnormal	JJ	B-NP	O
flora	flora	NN	I-NP	O
developed	develop	VBD	B-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
radiotherapy	radiotherapy	NN	B-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
squamous	squamous	JJ	I-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
(	(	(	O	O
OSCC	OSCC	NN	B-NP	O
)	)	)	O	O
patients	patient	NNS	B-NP	O
can	can	MD	B-VP	O
exacerbate	exacerbate	VB	I-VP	O
mucositis	mucositis	NN	B-NP	O
and	and	CC	O	O
can	can	MD	B-VP	O
cause	cause	VB	I-VP	O
systemic	systemic	JJ	B-NP	O
infections	infection	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
in	in	IN	B-PP	O
carcinogenesis	carcinogenesis	NN	B-NP	O
is	be	VBZ	B-VP	O
gaining	gain	VBG	I-VP	O
interest	interest	NN	B-NP	O
recently	recently	RB	B-ADVP	O
.	.	.	O	O

Abnormal	Abnormal	JJ	B-NP	O
flora	flora	NN	I-NP	O
in	in	IN	B-PP	O
development	development	NN	B-NP	O
of	of	IN	B-PP	O
second	second	JJ	B-NP	O
tumor	tumor	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
field	field	NN	I-NP	O
of	of	IN	B-PP	O
first	first	JJ	B-NP	O
tumor	tumor	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
established	establish	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
study	study	NN	I-NP	O
fundamentally	fundamentally	RB	B-ADVP	O
tries	try	VBZ	B-VP	O
to	to	TO	I-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
shift	shift	NN	I-NP	O
that	that	WDT	B-NP	O
occurs	occur	VBZ	B-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
radiotherapy	radiotherapy	NN	I-NP	O
in	in	IN	B-PP	O
OSCC	OSCC	NN	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

Microbial	Microbial	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
saliva	saliva	NN	B-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
OSCC	OSCC	NN	B-NP	O
patients	patient	NNS	I-NP	O
undergoing	undergo	VBG	B-VP	O
radiotherapy	radiotherapy	NN	B-NP	O
,	,	,	O	O
tobacco	tobacco	NN	B-NP	O
chewers	chewer	NNS	I-NP	O
and	and	CC	I-NP	O
controls	control	NNS	I-NP	O
was	be	VBD	B-VP	O
undertaken	undertake	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
were	be	VBD	B-VP	O
grouped	group	VBN	I-VP	O
into	into	IN	B-PP	O
categories	category	NNS	B-NP	O
as	as	IN	B-PP	O
total	total	JJ	B-NP	O
aerobes	aerobe	NNS	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
anaerobes	anaerobe	NNS	I-NP	O
,	,	,	O	O
candida	candida	NN	B-NP	O
,	,	,	O	O
coliforms	coliform	NNS	B-NP	O
and	and	CC	O	O
gram	gram	NN	B-NP	O
negative	negative	JJ	I-NP	O
anaerobic	anaerobic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
isolation	isolation	NN	B-NP	O
of	of	IN	B-PP	O
total	total	JJ	B-NP	O
aerobes	aerobe	NNS	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
anaerobes	anaerobe	NNS	I-NP	O
,	,	,	O	O
coliforms	coliform	NNS	B-NP	O
and	and	CC	O	O
gram	gram	NN	B-NP	O
negative	negative	JJ	I-NP	O
anaerobic	anaerobic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
in	in	IN	B-PP	O
OSCC	OSCC	NN	B-NP	O
patients	patient	NNS	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
healthy	healthy	JJ	B-NP	O
controls	control	NNS	I-NP	O
whereas	whereas	IN	B-PP	O
candida	candida	NN	B-NP	O
was	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
most	most	RBS	B-ADVP	O
frequently	frequently	RB	I-ADVP	O
during	during	IN	B-PP	O
radiation	radiation	NN	B-NP	O
period	period	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
tobacco	tobacco	NN	I-NP	O
chewers	chewer	NNS	I-NP	O
showed	show	VBD	B-VP	O
significant	significant	JJ	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
colony	colony	NN	B-NP	O
forming	form	VBG	B-VP	O
units	unit	NNS	B-NP	O
of	of	IN	B-PP	O
total	total	JJ	B-NP	O
aerobes	aerobe	NNS	I-NP	O
and	and	CC	I-NP	O
coliforms	coliform	NNS	I-NP	O
.	.	.	O	O

All	All	PDT	B-NP	O
the	the	DT	I-NP	O
microbial	microbial	JJ	I-NP	O
groups	group	NNS	I-NP	O
were	be	VBD	B-VP	O
high	high	JJ	B-ADJP	O
in	in	IN	B-PP	O
OSCC	OSCC	NN	B-NP	O
and	and	CC	I-NP	O
radiotherapy	radiotherapy	NN	I-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
OSCC	OSCC	NN	B-NP	O
patients	patient	NNS	I-NP	O
showed	show	VBD	B-VP	O
significant	significant	JJ	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
total	total	JJ	B-NP	O
anaerobes	anaerobe	NNS	I-NP	O
and	and	CC	O	O
gram	gram	NN	B-NP	O
negative	negative	JJ	I-NP	O
anaerobes	anaerobe	NNS	I-NP	O
,	,	,	O	O
candida	candida	NN	B-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
in	in	IN	B-PP	O
radiotherapy	radiotherapy	NN	B-NP	O
patients	patient	NNS	I-NP	O
only	only	RB	B-ADVP	O
.	.	.	O	O

Habits	Habit	NNS	B-NP	O
promote	promote	VBP	B-VP	O
coliforms	coliform	NNS	B-NP	O
.	.	.	O	O

Tumor	Tumor	NN	B-NP	O
supports	support	VBZ	B-VP	O
efficiently	efficiently	RB	B-NP	O
anaerobes	anaerobe	NNS	I-NP	O
and	and	CC	I-NP	O
candida	candida	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
latter	latter	JJ	I-NP	O
is	be	VBZ	B-VP	O
supported	support	VBN	I-VP	O
more	more	JJR	B-NP	O
by	by	IN	B-PP	O
radiation	radiation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
study	study	NN	I-NP	O
stresses	stress	VBZ	B-VP	O
the	the	DT	B-NP	O
importance	importance	NN	I-NP	O
on	on	IN	B-PP	O
administration	administration	NN	B-NP	O
of	of	IN	B-PP	O
appropriate	appropriate	JJ	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
right	right	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
diagnosis	diagnosis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

High	High	JJ	B-NP	O
throughput	throughput	NN	I-NP	O
sequencing	sequencing	NN	I-NP	O
of	of	IN	B-PP	O
16S	16S	NN	B-NP	O
ribosomal	ribosomal	JJ	I-NP	O
RNA	RNA	NN	I-NP	O
gene	gene	NN	I-NP	O
amplicons	amplicon	NNS	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
cost-effective	cost-effective	JJ	I-NP	O
method	method	NN	I-NP	O
for	for	IN	B-PP	O
characterization	characterization	NN	B-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
communities	community	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
before	before	IN	B-PP	O
undertaking	undertake	VBG	B-VP	O
large-scale	large-scale	JJ	B-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
necessary	necessary	JJ	B-ADJP	O
to	to	TO	B-VP	O
understand	understand	VB	I-VP	O
the	the	DT	B-NP	O
technique-associated	technique-associated	JJ	I-NP	O
limitations	limitation	NNS	I-NP	O
and	and	CC	O	O
intrinsic	intrinsic	JJ	B-NP	O
variability	variability	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
ecosystem	ecosystem	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
work	work	NN	I-NP	O
we	we	PRP	B-NP	O
evaluated	evaluate	VBD	B-VP	O
bias	bias	NN	B-NP	O
in	in	IN	B-PP	O
species	specie	NNS	B-NP	O
representation	representation	NN	I-NP	O
using	use	VBG	B-VP	O
an	an	DT	B-NP	O
in	in	IN	B-PP	O
vitro-assembled	vitro-assembled	JJ	B-NP	O
mock	mock	JJ	I-NP	O
community	community	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
then	then	RB	B-ADVP	O
characterized	characterize	VBD	B-VP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
communities	community	NNS	I-NP	O
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
and	and	CC	O	O
buccal	buccal	JJ	B-NP	O
mucosa	mucosa	NN	I-NP	O
of	of	IN	B-PP	O
five	five	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
power	power	NN	I-NP	O
of	of	IN	B-PP	O
high	high	JJ	B-NP	O
throughput	throughput	NN	I-NP	O
sequencing	sequencing	NN	I-NP	O
in	in	IN	B-PP	O
revealing	reveal	VBG	B-VP	O
their	their	PRP$	B-NP	O
diversity	diversity	NN	I-NP	O
and	and	CC	I-NP	O
biogeography	biogeography	NN	I-NP	O
patterns	pattern	NNS	I-NP	O
.	.	.	O	O

Mock	Mock	NN	B-NP	O
community	community	NN	I-NP	O
analysis	analysis	NN	I-NP	O
showed	show	VBD	B-VP	O
primer	primer	NN	B-NP	O
and	and	CC	I-NP	O
DNA	DNA	NN	I-NP	B-protein
isolation	isolation	NN	I-NP	I-protein
biases	bias	NNS	I-NP	I-protein
and	and	CC	O	O
an	an	DT	B-NP	O
overestimation	overestimation	NN	I-NP	O
of	of	IN	B-PP	O
diversity	diversity	NN	B-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
after	after	IN	B-PP	O
eliminating	eliminate	VBG	B-VP	O
singleton	singleton	JJ	B-NP	O
operational	operational	JJ	I-NP	O
taxonomic	taxonomic	JJ	I-NP	O
units	unit	NNS	I-NP	O
(	(	(	O	O
OTUs	OTU	NNS	B-NP	O
)	)	)	O	O
.	.	.	O	O

Sequencing	Sequencing	NN	B-NP	O
of	of	IN	B-PP	O
salivary	salivary	JJ	B-NP	O
and	and	CC	I-NP	O
mucosal	mucosal	JJ	I-NP	O
communities	community	NNS	I-NP	O
found	find	VBD	B-VP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
455	455	CD	B-NP	O
OTUs	OTU	NNS	I-NP	O
(	(	(	O	O
0.3	0.3	CD	B-NP	O
%	%	NN	I-NP	O
dissimilarity	dissimilarity	NN	I-NP	O
)	)	)	O	O
with	with	IN	B-PP	O
only	only	RB	B-NP	O
78	78	CD	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
present	present	JJ	I-NP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
variability	variability	NN	I-NP	O
was	be	VBD	B-VP	O
partly	partly	RB	B-ADVP	O
the	the	DT	B-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
incomplete	incomplete	JJ	B-NP	O
richness	richness	NN	I-NP	O
coverage	coverage	NN	I-NP	O
even	even	RB	B-ADVP	O
at	at	IN	B-PP	O
great	great	JJ	B-NP	O
sequencing	sequencing	NN	I-NP	O
depths	depth	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
so	so	RB	B-ADVP	O
comparing	compare	VBG	B-VP	O
communities	community	NNS	B-NP	O
by	by	IN	B-PP	O
their	their	PRP$	B-NP	O
structure	structure	NN	I-NP	O
was	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
effective	effective	JJ	I-ADJP	O
than	than	IN	B-PP	O
comparisons	comparison	NNS	B-NP	O
based	base	VBN	B-VP	O
solely	solely	RB	B-ADVP	O
on	on	IN	B-PP	O
membership	membership	NN	B-NP	O
.	.	.	O	O

With	With	IN	B-PP	O
respect	respect	NN	B-NP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
biogeography	biogeography	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
inter-subject	inter-subject	JJ	B-NP	O
variability	variability	NN	I-NP	O
in	in	IN	B-PP	O
community	community	NN	B-NP	O
structure	structure	NN	I-NP	O
was	be	VBD	B-VP	O
lower	low	JJR	B-ADJP	O
than	than	IN	B-PP	O
site	site	NN	B-NP	O
differences	difference	NNS	I-NP	O
between	between	IN	B-PP	O
salivary	salivary	JJ	B-NP	O
and	and	CC	I-NP	O
mucosal	mucosal	JJ	I-NP	O
communities	community	NNS	I-NP	O
within	within	IN	B-PP	O
subjects	subject	NNS	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
differences	difference	NNS	I-NP	O
were	be	VBD	B-VP	O
evident	evident	JJ	B-ADJP	O
at	at	IN	B-PP	O
very	very	RB	B-NP	O
low	low	JJ	I-NP	O
sequencing	sequencing	NN	I-NP	O
depths	depth	NNS	I-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
mostly	mostly	RB	I-VP	O
caused	cause	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
abundance	abundance	NN	I-NP	O
of	of	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
mitis	mitis	NN	I-NP	O
and	and	CC	I-NP	O
Gemella	Gemella	NN	I-NP	O
haemolysans	haemolysan	NNS	I-NP	O
in	in	IN	B-PP	O
mucosa	mucosa	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
summary	summary	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
present	present	VBP	B-VP	O
an	an	DT	B-NP	O
experimental	experimental	JJ	I-NP	O
and	and	CC	I-NP	O
data	datum	NNS	I-NP	O
analysis	analysis	NN	I-NP	O
framework	framework	NN	I-NP	O
that	that	WDT	B-NP	O
will	will	MD	B-VP	O
facilitate	facilitate	VB	I-VP	O
design	design	NN	B-NP	O
and	and	CC	I-NP	O
interpretation	interpretation	NN	I-NP	O
of	of	IN	B-PP	O
pyrosequencing-based	pyrosequencing-based	JJ	B-NP	O
studies	study	NNS	I-NP	O
.	.	.	O	O

Despite	Despite	IN	B-PP	O
challenges	challenge	NNS	B-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
technique	technique	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
its	its	PRP$	B-NP	O
power	power	NN	I-NP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
diversity	diversity	NN	I-NP	O
and	and	CC	I-NP	O
biogeography	biogeography	NN	I-NP	O
patterns	pattern	NNS	I-NP	O
.	.	.	O	O

to	to	TO	B-VP	O
test	test	VB	I-VP	O
the	the	DT	B-NP	O
association	association	NN	I-NP	O
between	between	IN	B-PP	O
Candida	Candida	NNP	B-NP	O
and	and	CC	O	O
mutans	mutan	NNS	B-NP	O
streptococci	streptococci	NNS	I-NP	O
(	(	(	O	O
ms	m	NNS	B-NP	O
)	)	)	O	O
,	,	,	O	O
oral	oral	JJ	B-NP	O
hygiene	hygiene	NN	I-NP	O
and	and	CC	I-NP	O
caries	cary	NNS	I-NP	O
levels	level	NNS	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
children	child	NNS	B-NP	O
.	.	.	O	O

22	22	CD	B-NP	O
boys	boy	NNS	I-NP	O
and	and	CC	O	O
12	12	CD	B-NP	O
girls	girl	NNS	I-NP	O
(	(	(	O	O
age	age	NN	B-NP	O
6	6	CD	I-NP	O
to	to	TO	I-NP	O
14.5	14.5	CD	I-NP	O
years	year	NNS	I-NP	O
)	)	)	O	O
participated	participate	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

Each	Each	DT	B-NP	O
participant	participant	NN	I-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
toothbrush	toothbrush	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
asked	ask	VBN	I-VP	O
to	to	TO	I-VP	O
brush	brush	VB	I-VP	O
his/her	his/h	JJR	B-NP	O
teeth	tooth	NNS	I-NP	O
after	after	IN	B-PP	O
proper	proper	JJ	B-NP	O
instructions	instruction	NNS	I-NP	O
.	.	.	O	O

Dental	Dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
hygiene	hygiene	NN	I-NP	O
were	be	VBD	B-VP	O
recorded	record	VBN	I-VP	O
.	.	.	O	O

Candida	Candida	NNP	B-NP	O
and	and	CC	I-NP	O
ms	m	NNS	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
samples	sample	NNS	I-NP	O
.	.	.	O	O

Candida	Candida	NNP	B-NP	O
colonies	colony	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
70.5	70.5	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
association	association	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
between	between	IN	B-PP	O
Candida	Candida	NNP	B-NP	O
and	and	CC	O	O
caries	cary	NNS	B-NP	O
or	or	CC	O	O
plaque	plaque	NN	B-NP	O
and	and	CC	O	O
gingival	gingival	JJ	B-NP	O
indices	index	NNS	I-NP	O
.	.	.	O	O

C.	C.	FW	B-NP	O
albicans-positive	albicans-positive	JJ	I-NP	O
children	child	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
significantly	significantly	RB	B-NP	O
higher	high	JJR	I-NP	O
brushing	brush	VBG	I-NP	O
scores	score	NNS	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
findings	finding	NNS	I-NP	O
may	may	MD	B-VP	O
suggest	suggest	VB	I-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
clear	clear	JJ	I-NP	O
association	association	NN	I-NP	O
between	between	IN	B-PP	O
Candida	Candida	NNP	B-NP	O
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
cariogenic	cariogenic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	I-NP	O
caries	cary	NNS	I-NP	O
risk	risk	VBP	B-VP	O
in	in	IN	B-PP	O
children	child	NNS	B-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
mucositis	mucositis	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
serious	serious	JJ	I-NP	O
and	and	CC	I-NP	O
debilitating	debilitate	VBG	I-NP	O
side	side	NN	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
conditioning	condition	VBG	B-VP	O
regimens	regimen	NNS	B-NP	O
for	for	IN	B-PP	O
hematopoietic	hematopoietic	JJ	B-NP	O
stem	stem	NN	I-NP	O
cell	cell	NN	I-NP	O
transplant	transplant	NN	I-NP	O
(	(	(	O	O
HSCT	HSCT	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

Through	Through	IN	B-PP	O
HSCT	HSCT	NN	B-NP	B-protein
,	,	,	O	O
the	the	DT	B-NP	O
homeostasis	homeostasis	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
is	be	VBZ	B-VP	O
disrupted	disrupt	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
contribution	contribution	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microflora	microflora	NN	I-NP	O
to	to	TO	B-PP	O
mucositis	mucositis	NN	B-NP	O
remains	remain	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
clarified	clarify	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
our	our	PRP$	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
yeasts	yeast	NNS	B-NP	O
,	,	,	O	O
bacteria	bacteria	NNS	B-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
periodontitis	periodontitis	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
ulcerations	ulceration	NNS	I-NP	O
in	in	IN	B-PP	O
HSCT	HSCT	NN	B-NP	O
recipients	recipient	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
prospective	prospective	JJ	I-NP	O
observational	observational	JJ	I-NP	O
study	study	NN	I-NP	O
included	include	VBD	B-VP	O
49	49	CD	B-NP	O
adult	adult	JJ	I-NP	O
HSCT	HSCT	NN	I-NP	O
recipients	recipient	NNS	I-NP	O
.	.	.	O	O

Twice	Twice	NNP	B-NP	O
weekly	weekly	RB	B-ADVP	O
,	,	,	O	O
oral	oral	JJ	B-NP	O
ulcerations	ulceration	NNS	I-NP	O
were	be	VBD	B-VP	O
scored	score	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
rinsing	rinsing	NN	I-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
.	.	.	O	O

Samples	Sample	NNS	B-NP	O
were	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
load	load	NN	I-NP	O
;	;	:	O	O
the	the	DT	B-NP	O
Gram-negative	Gram-negative	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
:	:	:	O	O
Aggregatibacter	Aggregatibacter	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
,	,	,	O	O
Porphyromonas	Porphyromonas	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
Prevotella	Prevotella	NNP	B-NP	O
intermedia	intermedia	NNS	I-NP	O
,	,	,	O	O
Parvimonas	Parvimonas	NNP	B-NP	O
micra	micra	NNP	I-NP	O
,	,	,	O	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
,	,	,	O	O
Tannerella	Tannerella	NNP	B-NP	O
forsythia	forsythia	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Treponema	Treponema	NNP	B-NP	O
denticola	denticola	NN	I-NP	O
;	;	:	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
yeasts	yeast	NNS	I-NP	O
:	:	:	O	O
Candida	Candida	NNP	B-NP	O
albicans	albicans	NNP	I-NP	O
,	,	,	O	O
Candida	Candida	NNP	B-NP	O
glabrata	glabrata	NNP	I-NP	O
,	,	,	O	O
Candida	Candida	NNP	B-NP	O
kefyr	kefyr	NNP	I-NP	O
,	,	,	O	O
Candida	Candida	NNP	B-NP	O
krusei	krusei	NNP	I-NP	O
,	,	,	O	O
Candida	Candida	NNP	B-NP	O
parapsilosis	parapsilosis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Candida	Candida	NNP	B-NP	O
tropicalis	tropicalis	NN	I-NP	O
using	use	VBG	B-VP	O
real-time	real-time	JJ	B-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
with	with	IN	B-PP	O
specific	specific	JJ	B-NP	O
primers	primer	NNS	I-NP	O
and	and	CC	I-NP	O
probes	probe	NNS	I-NP	O
.	.	.	O	O

Explanatory	Explanatory	JJ	B-NP	O
variables	variable	NNS	I-NP	O
for	for	IN	B-PP	O
oral	oral	JJ	B-NP	O
ulcerations	ulceration	NNS	I-NP	O
were	be	VBD	B-VP	O
calculated	calculate	VBN	I-VP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
multilevel	multilevel	JJ	I-NP	O
generalized	generalize	VBN	I-NP	O
estimated	estimate	VBN	I-NP	O
equations	equation	NNS	I-NP	O
(	(	(	O	O
GEE	GEE	NN	B-NP	O
)	)	)	O	O
technique	technique	NN	B-NP	O
.	.	.	O	O

None	None	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
samples	sample	NNS	I-NP	O
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
A.	A.	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
most	most	RBS	B-ADVP	O
often	often	RB	I-ADVP	O
(	(	(	O	O
66	66	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
samples	sample	NNS	B-NP	O
)	)	)	O	O
.	.	.	O	O

C.	C.	NNP	B-NP	O
albicans	albicans	NNP	I-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
isolated	isolate	VBN	I-NP	O
yeast	yeast	NN	I-NP	O
(	(	(	O	O
88	88	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
samples	sample	NNS	B-NP	O
)	)	)	O	O
,	,	,	O	O
whereas	whereas	IN	O	O
C.	C.	NN	B-NP	O
parapsilosis	parapsilosis	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
only	only	RB	B-NP	O
8	8	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
samples	sample	NNS	I-NP	O
.	.	.	O	O

Multivariate	Multivariate	JJ	B-NP	O
GEE	GEE	NN	I-NP	O
analyses	analysis	NNS	I-NP	O
identified	identify	VBD	B-VP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
P.	P.	NNP	B-NP	O
micra	micra	NNP	I-NP	O
,	,	,	O	O
T.	T.	NNP	B-NP	O
denticola	denticola	NNP	I-NP	O
,	,	,	O	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
,	,	,	O	O
C.	C.	NNP	B-NP	O
glabrata	glabrata	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
C.	C.	NNP	B-NP	O
kefyr	kefyr	NN	I-NP	O
as	as	IN	B-PP	O
significant	significant	JJ	B-NP	O
explanatory	explanatory	JJ	I-NP	O
variables	variable	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
ulcerations	ulceration	NNS	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
data	datum	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
in	in	IN	B-PP	O
particular	particular	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
P.	P.	NNP	B-NP	O
micra	micra	NNP	I-NP	O
,	,	,	O	O
T.	T.	NNP	B-NP	O
denticola	denticola	NNP	I-NP	O
,	,	,	O	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
,	,	,	O	O
C.	C.	NNP	B-NP	O
glabrata	glabrata	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
C.	C.	NNP	B-NP	O
kefyr	kefyr	NN	I-NP	O
may	may	MD	B-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
ulcerative	ulcerative	JJ	B-NP	O
oral	oral	JJ	I-NP	O
mucositis	mucositis	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
undergoing	undergo	VBG	B-VP	O
HSCT	HSCT	NN	B-NP	B-DNA
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
aims	aim	VBZ	B-VP	O
to	to	TO	I-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
rinsing	rinse	VBG	B-VP	O
with	with	IN	B-PP	O
zinc-	zinc-	JJ	B-NP	O
and	and	CC	I-NP	O
chlorhexidine-containing	chlorhexidine-containing	JJ	I-NP	O
mouth	mouth	NN	I-NP	O
rinse	rinse	NN	I-NP	O
with	with	IN	B-PP	O
or	or	CC	B-PP	O
without	without	IN	B-PP	O
adjunct	adjunct	JJ	B-NP	O
tongue	tongue	NN	I-NP	O
scraping	scrap	VBG	B-VP	O
on	on	IN	B-PP	O
volatile	volatile	JJ	B-NP	O
sulfur	sulfur	NN	I-NP	O
compounds	compound	NNS	I-NP	O
(	(	(	O	O
VSCs	VSC	NNS	B-NP	B-cell_type
)	)	)	O	O
in	in	IN	B-PP	O
breath	breath	NN	B-NP	O
air	air	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
microbiota	microbiota	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
dorsum	dorsum	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tongue	tongue	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
randomized	randomize	VBN	I-NP	O
single-masked	single-masked	JJ	I-NP	O
controlled	controlled	JJ	I-NP	O
clinical	clinical	JJ	I-NP	O
trial	trial	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
cross-over	cross-over	JJ	I-NP	O
study	study	NN	I-NP	O
design	design	NN	I-NP	O
over	over	IN	B-PP	O
14	14	CD	B-NP	O
days	day	NNS	I-NP	O
including	include	VBG	B-PP	O
21	21	CD	B-NP	O
subjects	subject	NNS	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
.	.	.	O	O

Bacterial	Bacterial	JJ	B-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
dorsum	dorsum	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tongue	tongue	NN	I-NP	O
were	be	VBD	B-VP	O
assayed	assay	VBN	I-VP	O
by	by	IN	B-PP	O
checkerboard	checkerboard	NN	B-NP	O
DNA-DNA	DNA-DNA	NN	I-NP	O
hybridization	hybridization	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
halitosis	halitosis	NN	I-NP	O
(	(	(	O	O
identified	identify	VBN	B-VP	O
by	by	IN	B-PP	O
VSC	VSC	NNP	B-NP	O
assessments	assessment	NNS	I-NP	O
)	)	)	O	O
at	at	IN	B-PP	O
day	day	NN	B-NP	O
14	14	CD	I-NP	O
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
in	in	IN	B-PP	O
12/21	12/21	CD	B-NP	O
subjects	subject	NNS	I-NP	O
with	with	IN	B-PP	O
active	active	JJ	B-NP	O
rinse	rinse	NN	I-NP	O
alone	alone	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
10/21	10/21	CD	B-NP	O
with	with	IN	B-PP	O
adjunct	adjunct	JJ	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
tongue	tongue	NN	B-NP	O
scraper	scraper	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
1/21	1/21	CD	B-NP	O
for	for	IN	B-PP	O
negative	negative	JJ	B-NP	O
control	control	NN	I-NP	O
rinse	rinse	NN	I-NP	O
alone	alone	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
3/21	3/21	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
and	and	CC	I-NP	O
tongue	tongue	NN	I-NP	O
scraping	scraping	NN	I-NP	O
sequence	sequence	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
day	day	NN	B-NP	O
14	14	CD	I-NP	O
,	,	,	O	O
significantly	significantly	RB	B-NP	O
lower	low	JJR	I-NP	O
counts	count	NNS	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
only	only	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
active	active	JJ	I-NP	B-DNA
rinse	rinse	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.001	0.001	CD	B-NP	O
)	)	)	O	O
for	for	IN	B-PP	O
15/78	15/78	CD	B-NP	O
species	specie	NNS	I-NP	O
including	include	VBG	B-PP	O
,	,	,	O	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
sp.	sp.	NNP	I-NP	O
,	,	,	O	O
Porphyromonas	Porphyromonas	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
Pseudomonas	Pseudomonas	NNP	B-NP	O
aeruginosa	aeruginosa	NNP	I-NP	O
,	,	,	O	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
aureus	aureus	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Tannerella	Tannerella	NNP	B-NP	O
forsythia	forsythia	NNP	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
from	from	IN	B-PP	O
baseline	baseline	NN	B-NP	O
to	to	TO	B-PP	O
day	day	NN	B-NP	O
14	14	CD	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
successfully	successfully	RB	B-NP	O
treated	treat	VBN	I-NP	O
subjects	subject	NNS	I-NP	O
for	for	IN	B-PP	O
9/74	9/74	CD	B-NP	O
species	specie	NNS	I-NP	O
including	include	VBG	B-PP	O
:	:	:	O	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
Prevotella	Prevotella	NNP	B-NP	O
melaninogenica	melaninogenica	NNP	I-NP	O
,	,	,	O	O
S.	S.	NNP	B-NP	O
aureus	aureus	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Treponema	Treponema	NNP	B-NP	O
denticola	denticola	NNP	I-NP	O
.	.	.	O	O

Baseline	Baseline	NNP	B-NP	O
VSC	VSC	NNP	I-NP	O
scores	score	NNS	I-NP	O
were	be	VBD	B-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
several	several	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
tongue	tongue	NN	I-NP	O
scraper	scraper	NN	I-NP	O
combined	combine	VBN	B-VP	O
with	with	IN	B-PP	O
active	active	JJ	B-NP	O
rinse	rinse	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
change	change	VB	I-VP	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
VSC	VSC	NNP	B-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
rinsing	rinse	VBG	B-VP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O

VSC	VSC	NN	B-NP	O
scores	score	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
counts	count	NNS	I-NP	O
in	in	IN	B-PP	O
samples	sample	NNS	B-NP	O
taken	take	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
dorsum	dorsum	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tongue	tongue	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
active	active	JJ	I-NP	O
rinse	rinse	NN	I-NP	O
alone	alone	RB	B-VP	O
containing	contain	VBG	I-VP	O
zinc	zinc	NN	B-NP	O
and	and	CC	I-NP	O
chlorhexidine	chlorhexidine	NN	I-NP	O
had	have	VBD	B-VP	O
effects	effect	NNS	B-NP	O
on	on	IN	B-PP	O
intra-oral	intra-oral	JJ	B-NP	O
halitosis	halitosis	NN	I-NP	O
and	and	CC	O	O
reduced	reduce	VBD	B-VP	O
bacterial	bacterial	JJ	B-NP	O
counts	count	NNS	I-NP	O
of	of	IN	B-PP	O
species	specie	NNS	B-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
malodor	malodor	NN	B-NP	O
.	.	.	O	O

Tongue	Tongue	NN	B-NP	O
scraping	scrap	VBG	B-VP	O
provided	provide	VBN	B-VP	O
no	no	DT	B-NP	O
beneficial	beneficial	JJ	I-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
microbiota	microbiota	NN	I-NP	O
studied	study	VBN	B-VP	O
.	.	.	O	O

Periodontally	Periodontally	RB	B-NP	O
healthy	healthy	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
with	with	IN	B-PP	O
intra-oral	intra-oral	JJ	B-NP	O
halitosis	halitosis	NN	I-NP	O
benefit	benefit	NN	I-NP	O
from	from	IN	B-PP	O
daily	daily	JJ	B-NP	O
rinsing	rinsing	NN	I-NP	O
with	with	IN	B-PP	O
zinc-	zinc-	JJ	B-NP	O
and	and	CC	I-NP	O
chlorhexidine-containing	chlorhexidine-containing	JJ	I-NP	O
mouth	mouth	NN	I-NP	O
rinse	rinse	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
profile	profile	VB	I-VP	O
the	the	DT	B-NP	O
abundance	abundance	NN	I-NP	O
and	and	CC	I-NP	O
diversity	diversity	NN	I-NP	O
of	of	IN	B-PP	O
subgingival	subgingival	JJ	B-NP	O
oral	oral	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
never-treated	never-treated	JJ	B-NP	O
,	,	,	I-NP	O
new-onset	new-onset	JJ	I-NP	O
rheumatoid	rheumatoid	JJ	I-NP	O
arthritis	arthritis	NN	I-NP	O
(	(	(	O	O
RA	RA	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Periodontal	Periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
(	(	(	O	O
PD	PD	NN	B-NP	O
)	)	)	O	O
status	status	NN	B-NP	O
,	,	,	O	O
clinical	clinical	JJ	B-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
sociodemographic	sociodemographic	JJ	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
new-onset	new-onset	JJ	B-NP	O
RA	RA	NN	I-NP	O
,	,	,	O	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
RA	RA	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
healthy	healthy	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O

Multiplexed-454	Multiplexed-454	JJ	B-NP	O
pyrosequencing	pyrosequencing	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
compare	compare	VB	I-VP	O
the	the	DT	B-NP	O
composition	composition	NN	I-NP	O
of	of	IN	B-PP	O
subgingival	subgingival	JJ	B-NP	O
microbiota	microbiota	NN	I-NP	O
and	and	CC	O	O
establish	establish	VB	B-VP	O
correlations	correlation	NNS	B-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
presence/abundance	presence/abundance	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
and	and	CC	O	O
disease	disease	NN	B-NP	O
phenotypes	phenotype	NNS	I-NP	O
.	.	.	O	O

Anti-Porphyromonas	Anti-Porphyromonas	JJ	B-NP	B-protein
gingivalis	gingivalis	NN	I-NP	I-protein
antibody	antibody	NN	I-NP	I-protein
testing	testing	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
to	to	TO	I-VP	O
assess	assess	VB	I-VP	O
prior	prior	JJ	B-NP	O
exposure	exposure	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
pathogen	pathogen	NN	I-NP	O
P	P	NN	I-NP	O
gingivalis	gingivalis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
more	more	RBR	I-NP	O
advanced	advanced	JJ	I-NP	O
forms	form	NNS	I-NP	O
of	of	IN	B-PP	O
periodontitis	periodontitis	NN	B-NP	O
were	be	VBD	B-VP	O
already	already	RB	B-ADVP	O
present	present	JJ	B-ADJP	O
at	at	IN	B-PP	O
disease	disease	NN	B-NP	O
onset	onset	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
new-onset	new-onset	JJ	B-NP	O
RA	RA	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
subgingival	subgingival	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
observed	observe	VBN	B-VP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
new-onset	new-onset	JJ	B-NP	O
RA	RA	NN	I-NP	O
was	be	VBD	B-VP	O
distinct	distinct	JJ	B-ADJP	O
from	from	IN	B-PP	O
that	that	DT	B-NP	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
controls	control	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
most	most	JJS	B-NP	O
cases	case	NNS	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
microbial	microbial	JJ	I-NP	O
differences	difference	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
attributed	attribute	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
severity	severity	NN	I-NP	O
of	of	IN	B-PP	O
PD	PD	NN	B-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
not	not	RB	O	O
inherent	inherent	JJ	B-ADJP	O
to	to	TO	B-PP	O
RA	RA	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
presence	presence	NN	I-NP	O
and	and	CC	I-NP	O
abundance	abundance	NN	I-NP	O
of	of	IN	B-PP	O
P	P	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
directly	directly	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
severity	severity	NN	I-NP	O
of	of	IN	B-PP	O
PD	PD	NN	B-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
not	not	RB	O	O
unique	unique	JJ	B-ADJP	O
to	to	TO	B-PP	O
RA	RA	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
P	P	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
anti-citrullinated	anti-citrullinated	JJ	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
antibody	antibody	NN	I-NP	I-protein
(	(	(	O	O
ACPA	ACPA	NN	B-NP	O
)	)	)	O	O
titers	titer	NNS	B-NP	O
.	.	.	O	O

Overall	Overall	JJ	B-NP	O
exposure	exposure	NN	I-NP	O
to	to	TO	B-PP	O
P	P	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
was	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
between	between	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
new-onset	new-onset	JJ	B-NP	O
RA	RA	NN	I-NP	O
and	and	CC	I-NP	O
controls	control	NNS	I-NP	O
,	,	,	O	O
observed	observe	VBN	B-VP	O
in	in	IN	B-PP	O
78	78	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
and	and	CC	O	O
83	83	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
controls	control	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
presence	presence	NN	I-NP	O
and	and	CC	I-NP	O
abundance	abundance	NN	I-NP	O
of	of	IN	B-PP	O
Anaeroglobus	Anaeroglobus	NNP	B-NP	O
geminatus	geminatus	NNP	I-NP	O
correlated	correlate	VBD	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
ACPAs/rheumatoid	ACPAs/rheumatoid	JJ	B-NP	B-protein
factor	factor	NN	I-NP	I-protein
.	.	.	O	O

Prevotella	Prevotella	NNP	B-NP	O
and	and	CC	I-NP	O
Leptotrichia	Leptotrichia	NNP	I-NP	O
species	specie	NNS	I-NP	O
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
only	only	RB	I-NP	O
characteristic	characteristic	JJ	I-NP	O
taxa	taxa	NN	I-NP	O
observed	observe	VBN	B-VP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
new-onset	new-onset	JJ	B-NP	O
RA	RA	NN	I-NP	O
irrespective	irrespective	JJ	B-ADJP	O
of	of	IN	B-PP	O
PD	PD	NN	B-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

Patients	Patient	NNS	B-NP	O
with	with	IN	B-PP	O
new-onset	new-onset	JJ	B-NP	O
RA	RA	NN	I-NP	O
exhibited	exhibit	VBD	B-VP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
PD	PD	NN	B-NP	O
at	at	IN	B-PP	O
disease	disease	NN	B-NP	O
onset	onset	NN	I-NP	O
,	,	,	O	O
despite	despite	IN	B-PP	O
their	their	PRP$	B-NP	O
young	young	JJ	I-NP	O
age	age	NN	I-NP	O
and	and	CC	I-NP	O
paucity	paucity	NN	I-NP	O
of	of	IN	B-PP	O
smoking	smoking	NN	B-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
subgingival	subgingival	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
profile	profile	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
new-onset	new-onset	JJ	B-NP	O
RA	RA	NN	I-NP	O
was	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
RA	RA	NN	I-NP	O
and	and	CC	O	O
healthy	healthy	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
whose	whose	WP$	B-NP	O
PD	PD	NN	I-NP	O
was	be	VBD	B-VP	O
of	of	IN	B-PP	O
comparable	comparable	JJ	B-NP	O
severity	severity	NN	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
colonization	colonization	NN	B-NP	O
with	with	IN	B-PP	O
P	P	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
correlated	correlate	VBD	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
severity	severity	NN	I-NP	O
of	of	IN	B-PP	O
PD	PD	NN	B-NP	O
,	,	,	O	O
overall	overall	JJ	B-NP	O
exposure	exposure	NN	I-NP	O
to	to	TO	B-PP	O
P	P	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
was	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
A	A	NN	B-NP	O
geminatus	geminatus	NN	I-NP	O
and	and	CC	I-NP	O
Prevotella/Leptotrichia	Prevotella/Leptotrichia	NN	I-NP	O
species	specie	NNS	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
process	process	NN	I-NP	O
merits	merit	VBZ	B-VP	O
further	further	JJ	B-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

Antimicrobial	Antimicrobial	JJ	B-NP	O
peptides	peptide	NNS	I-NP	O
,	,	,	O	O
molecules	molecule	NNS	B-NP	O
produced	produce	VBN	B-VP	O
in	in	IN	B-PP	O
many	many	JJ	B-NP	O
different	different	JJ	I-NP	O
organisms	organism	NNS	I-NP	O
,	,	,	O	O
have	have	VBP	B-VP	O
high	high	JJ	B-NP	O
biocidal	biocidal	JJ	I-NP	O
activity	activity	NN	I-NP	O
against	against	IN	B-PP	O
several	several	JJ	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
several	several	JJ	B-NP	O
questions	question	NNS	I-NP	O
about	about	IN	B-PP	O
these	these	DT	B-NP	O
molecules	molecule	NNS	I-NP	O
remain	remain	VBP	B-VP	O
unclear	unclear	JJ	B-ADJP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
report	report	NN	I-NP	O
details	detail	VBZ	B-VP	O
a	a	DT	B-NP	O
systematic	systematic	JJ	I-NP	O
survey	survey	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
literature	literature	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
antimicrobial	antimicrobial	JJ	B-NP	O
peptides	peptide	NNS	I-NP	O
against	against	IN	B-PP	O
oral	oral	JJ	B-NP	O
pathogens	pathogen	NNS	I-NP	O
and	and	CC	O	O
indicates	indicate	VBZ	B-VP	O
which	which	WDT	B-NP	O
peptides	peptide	NNS	B-NP	O
and	and	CC	I-NP	O
microorganisms	microorganism	NNS	I-NP	O
are	be	VBP	B-VP	O
most	most	RBS	I-VP	O
extensively	extensively	RB	I-VP	O
studied	study	VBN	I-VP	O
.	.	.	O	O

Articles	Article	NNS	B-NP	O
were	be	VBD	B-VP	O
located	locate	VBN	I-VP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
PubMed	PubMed	NNP	I-NP	O
and	and	CC	I-NP	O
Science	Science	NNP	I-NP	O
Direct	Direct	NNP	I-NP	O
databases	database	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
inclusion	inclusion	NN	I-NP	O
criteria	criterion	NNS	I-NP	O
:	:	:	O	O
publication	publication	NN	B-NP	O
date	date	NN	I-NP	O
between	between	IN	B-PP	O
2002	2002	CD	B-NP	O
and	and	CC	I-NP	O
2011	2011	CD	I-NP	O
;	;	:	O	O
keywords	keyword	NNS	B-NP	O
``	``	``	O	O
biofilm	biofilm	NN	B-NP	O
OR	OR	NN	I-NP	O
biological	biological	JJ	I-NP	O
film	film	NN	I-NP	O
OR	OR	NN	I-NP	O
biological	biological	JJ	I-NP	O
layer	layer	NN	I-NP	O
OR	OR	NN	I-NP	O
bacterial	bacterial	JJ	I-NP	O
growth	growth	NN	I-NP	O
''	''	''	O	O
AND	AND	CC	B-NP	O
``	``	``	I-NP	O
peptide	peptide	NN	I-NP	O
''	''	''	O	O
AND	AND	CC	O	O
``	``	``	O	O
oral	oral	JJ	B-NP	O
cavity	cavity	NN	I-NP	O
OR	OR	NN	I-NP	O
mouth	mouth	NN	I-NP	O
OR	OR	NN	I-NP	O
buccal	buccal	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
OR	OR	NN	I-NP	O
oral	oral	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
OR	OR	NN	I-NP	O
mouth	mouth	NN	I-NP	O
mucosa	mucosa	NN	I-NP	O
''	''	''	O	O
;	;	:	O	O
and	and	CC	O	O
abstract	abstract	VB	B-VP	O
in	in	IN	B-PP	O
English	English	NNP	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
73	73	CD	B-NP	O
articles	article	NNS	I-NP	O
were	be	VBD	B-VP	O
selected	select	VBN	I-VP	O
after	after	IN	B-PP	O
refinement	refinement	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
data	datum	NNS	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
publications	publication	NNS	B-NP	O
focusing	focus	VBG	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
antimicrobial	antimicrobial	JJ	B-NP	O
peptides	peptide	NNS	I-NP	O
against	against	IN	B-PP	O
oral	oral	JJ	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
peptides	peptide	NNS	I-NP	O
produced	produce	VBN	B-VP	O
by	by	IN	B-PP	O
cells	cell	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
(	(	(	O	O
defensins	defensin	NNS	B-NP	B-protein
,	,	,	O	O
LL-37	LL-37	NN	B-NP	B-protein
and	and	CC	I-NP	O
histatins	histatin	NNS	I-NP	O
)	)	)	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
(	(	(	O	O
among	among	IN	B-PP	O
cariogenic	cariogenic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
)	)	)	O	O
and	and	CC	O	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
(	(	(	O	O
among	among	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
studied	study	VBN	I-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
antimicrobial	antimicrobial	JJ	B-NP	O
peptides	peptide	NNS	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
tool	tool	NN	I-NP	O
for	for	IN	B-PP	O
microbial	microbial	JJ	B-NP	O
control	control	NN	I-NP	O
is	be	VBZ	B-VP	O
of	of	IN	B-PP	O
increasing	increase	VBG	B-NP	O
importance	importance	NN	I-NP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
its	its	PRP$	B-NP	O
widespread	widespread	JJ	I-NP	O
use	use	NN	I-NP	O
,	,	,	O	O
mechanism	mechanism	NN	B-NP	O
of	of	IN	B-PP	O
action	action	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
low	low	JJ	B-NP	O
rates	rate	NNS	I-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
resistance	resistance	NN	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
health	health	NN	I-NP	O
is	be	VBZ	B-VP	O
affected	affect	VBN	I-VP	O
by	by	IN	B-PP	O
its	its	PRP$	B-NP	O
resident	resident	JJ	I-NP	O
microorganisms	microorganism	NNS	I-NP	O
.	.	.	O	O

Three	Three	CD	B-NP	O
prominent	prominent	JJ	I-NP	O
oral	oral	JJ	I-NP	O
disorders	disorder	NNS	I-NP	O
are	be	VBP	B-VP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
,	,	,	O	O
gingivitis	gingivitis	NN	B-NP	O
and	and	CC	I-NP	O
periodontitis	periodontitis	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
playing	play	VBG	B-VP	O
a	a	DT	B-NP	O
key	key	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
initiation/progression	initiation/progression	NN	I-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
three	three	CD	I-NP	O
.	.	.	O	O

Understanding	Understand	VBG	B-VP	O
the	the	DT	B-NP	O
microbiota	microbiota	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
diseases	disease	NNS	I-NP	O
they	they	PRP	B-NP	O
may	may	MD	B-VP	O
cause	cause	VB	I-VP	O
is	be	VBZ	B-VP	O
critical	critical	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
new	new	JJ	B-NP	O
therapeutics	therapeutic	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
review	review	NN	I-NP	O
is	be	VBZ	B-VP	O
focused	focus	VBN	I-VP	O
on	on	IN	B-PP	O
probiotics	probiotic	NNS	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
prevention	prevention	NN	I-NP	O
and/or	and/or	CC	I-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
review	review	NN	I-NP	O
describes	describe	VBZ	B-VP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
ecosystem	ecosystem	NN	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
correlation	correlation	NN	I-NP	O
with	with	IN	B-PP	O
oral	oral	JJ	B-NP	O
health/disease	health/disease	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
and	and	CC	O	O
current	current	JJ	B-NP	O
prevention/treatment	prevention/treatment	NN	I-NP	O
strategies	strategy	NNS	I-NP	O
of	of	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
(	(	(	O	O
PD	PD	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
(	(	(	O	O
DC	DC	NNS	B-NP	B-cell_type
)	)	)	O	O
are	be	VBP	B-VP	O
depicted	depict	VBN	I-VP	O
.	.	.	O	O

An	An	DT	B-NP	O
introduction	introduction	NN	I-NP	O
of	of	IN	B-PP	O
probiotics	probiotic	NNS	B-NP	O
is	be	VBZ	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
an	an	DT	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
PD	PD	NN	B-NP	O
and	and	CC	I-NP	O
DC	DC	NN	I-NP	B-cell_type
,	,	,	O	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
potential	potential	JJ	I-NP	O
role	role	NN	I-NP	O
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
health	health	NN	I-NP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
discussion	discussion	NN	I-NP	O
ensues	ensue	VBZ	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
future	future	JJ	I-NP	O
research	research	NN	I-NP	O
directions	direction	NNS	I-NP	O
and	and	CC	I-NP	O
limitations	limitation	NNS	I-NP	O
of	of	IN	B-PP	O
probiotics	probiotic	NNS	B-NP	O
for	for	IN	B-PP	O
oral	oral	JJ	B-NP	O
health	health	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
effective	effective	JJ	I-NP	O
oral	oral	JJ	I-NP	O
probiotic	probiotic	JJ	I-NP	O
formulation	formulation	NN	I-NP	O
should	should	MD	B-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
prevention/treatment	prevention/treatment	NN	I-NP	O
of	of	IN	B-PP	O
microbial	microbial	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

Understanding	Understand	VBG	B-VP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
's	's	POS	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
disease	disease	NN	I-NP	O
is	be	VBZ	B-VP	O
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
to	to	TO	B-VP	O
prevent/treat	prevent/treat	VB	I-VP	O
dental	dental	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
investigations	investigation	NNS	B-NP	O
into	into	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
efficacy	efficacy	NN	I-NP	O
,	,	,	O	O
delivery/dose	delivery/dose	NN	B-NP	O
optimization	optimization	NN	I-NP	O
,	,	,	O	O
mechanism	mechanism	NN	B-NP	O
(	(	(	O	O
s	s	NNS	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
action	action	NN	B-NP	O
and	and	CC	O	O
other	other	JJ	B-NP	O
related	related	JJ	I-NP	O
parameters	parameter	NNS	I-NP	O
are	be	VBP	B-VP	O
yet	yet	RB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
fully	fully	RB	I-VP	O
explored	explore	VBN	I-VP	O
.	.	.	O	O

Keeping	Keep	VBG	B-VP	O
this	this	DT	B-NP	O
in	in	IN	B-PP	O
mind	mind	NN	B-NP	O
,	,	,	O	O
investigations	investigation	NNS	B-NP	O
into	into	IN	B-PP	O
oral	oral	JJ	B-NP	O
probiotic	probiotic	JJ	I-NP	O
therapies	therapy	NNS	I-NP	O
are	be	VBP	B-VP	O
proving	prove	VBG	I-VP	O
promising	promising	JJ	B-ADJP	O
.	.	.	O	O

To	To	TO	B-VP	O
understand	understand	VB	I-VP	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
our	our	PRP$	B-NP	O
bacterial	bacterial	JJ	I-NP	O
microbiome	microbiome	NN	I-NP	O
and	and	CC	I-NP	O
health	health	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
to	to	TO	B-VP	O
define	define	VB	I-VP	O
the	the	DT	B-NP	O
microbiome	microbiome	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
disease	disease	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
digestive	digestive	JJ	I-NP	O
tract	tract	NN	I-NP	O
includes	include	VBZ	B-VP	O
diverse	diverse	JJ	B-NP	O
habitats	habitat	NNS	I-NP	O
and	and	CC	O	O
hosts	host	VBZ	B-VP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
body	body	NN	I-NP	O
's	's	POS	B-NP	O
greatest	great	JJS	I-NP	O
bacterial	bacterial	JJ	I-NP	O
density	density	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
describe	describe	VBP	B-VP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
community	community	NN	I-NP	O
composition	composition	NN	I-NP	O
of	of	IN	B-PP	O
ten	ten	CD	B-NP	O
digestive	digestive	JJ	I-NP	O
tract	tract	NN	I-NP	O
sites	site	NNS	I-NP	O
from	from	IN	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
200	200	CD	I-NP	O
normal	normal	JJ	I-NP	O
adults	adult	NNS	I-NP	O
enrolled	enrol	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Human	Human	NNP	I-NP	O
Microbiome	Microbiome	NNP	I-NP	O
Project	Project	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
metagenomically	metagenomically	RB	B-VP	O
determined	determine	VBN	I-VP	O
metabolic	metabolic	JJ	B-NP	O
potentials	potential	NNS	I-NP	O
of	of	IN	B-PP	O
four	four	CD	B-NP	O
representative	representative	JJ	I-NP	O
sites	site	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
microbiota	microbiota	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
diverse	diverse	JJ	I-NP	O
habitats	habitat	NNS	I-NP	O
formed	form	VBD	B-VP	O
four	four	CD	B-NP	O
groups	group	NNS	I-NP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
similar	similar	JJ	B-NP	O
community	community	NN	I-NP	O
compositions	composition	NNS	I-NP	O
:	:	:	O	O
buccal	buccal	JJ	B-NP	O
mucosa	mucosa	NN	I-NP	O
,	,	,	O	O
keratinized	keratinize	VBN	B-NP	O
gingiva	gingiva	NN	I-NP	O
,	,	,	O	O
hard	hard	JJ	B-NP	O
palate	palate	NN	I-NP	O
;	;	:	O	O
saliva	saliva	NN	B-NP	O
,	,	,	O	O
tongue	tongue	NN	B-NP	O
,	,	,	O	O
tonsils	tonsil	NNS	B-NP	O
,	,	,	O	O
throat	throat	NN	B-NP	O
;	;	:	O	O
sub-	sub-	JJ	B-NP	O
and	and	CC	I-NP	O
supra-gingival	supra-gingival	JJ	I-NP	O
plaques	plaque	NNS	I-NP	O
;	;	:	O	O
and	and	CC	O	O
stool	stool	NN	B-NP	O
.	.	.	O	O

Phyla	Phyla	NN	B-NP	O
initially	initially	RB	B-VP	O
identified	identify	VBN	I-VP	O
from	from	IN	B-PP	O
environmental	environmental	JJ	B-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
throughout	throughout	IN	B-PP	O
this	this	DT	B-NP	O
population	population	NN	I-NP	O
,	,	,	O	O
primarily	primarily	RB	B-NP	O
TM7	TM7	NN	I-NP	B-protein
,	,	,	O	O
SR1	SR1	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
Synergistetes	Synergistete	NNS	B-NP	O
.	.	.	O	O

Genera	Genera	NN	B-NP	O
with	with	IN	B-PP	O
pathogenic	pathogenic	JJ	B-NP	O
members	member	NNS	I-NP	O
were	be	VBD	B-VP	O
well-represented	well-represented	JJ	B-ADJP	O
among	among	IN	B-PP	O
this	this	DT	B-NP	O
disease-free	disease-free	JJ	I-NP	O
cohort	cohort	NN	I-NP	O
.	.	.	O	O

Tooth-associated	Tooth-associated	JJ	B-NP	O
communities	community	NNS	I-NP	O
were	be	VBD	B-VP	O
distinct	distinct	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	B-ADJP	O
entirely	entirely	RB	I-ADJP	O
dissimilar	dissimilar	JJ	I-ADJP	O
,	,	,	O	O
from	from	IN	B-PP	O
other	other	JJ	B-NP	O
oral	oral	JJ	I-NP	O
surfaces	surface	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Porphyromonadaceae	Porphyromonadaceae	NNP	I-NP	O
,	,	,	I-NP	O
Veillonellaceae	Veillonellaceae	NNP	I-NP	O
and	and	CC	I-NP	O
Lachnospiraceae	Lachnospiraceae	NNP	I-NP	O
families	family	NNS	I-NP	O
were	be	VBD	B-VP	O
common	common	JJ	B-ADJP	O
to	to	TO	B-PP	O
all	all	DT	B-NP	O
sites	site	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
distributions	distribution	NNS	I-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
genera	genera	NN	I-NP	O
varied	vary	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
.	.	.	O	O

Most	Most	JJS	B-NP	O
metabolic	metabolic	JJ	I-NP	O
processes	process	NNS	I-NP	O
were	be	VBD	B-VP	O
distributed	distribute	VBN	I-VP	O
widely	widely	RB	B-ADVP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
digestive	digestive	JJ	I-NP	O
tract	tract	NN	I-NP	O
microbiota	microbiota	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
variations	variation	NNS	B-NP	O
in	in	IN	B-PP	O
metagenomic	metagenomic	JJ	B-NP	O
abundance	abundance	NN	I-NP	O
between	between	IN	B-PP	O
body	body	NN	B-NP	O
habitats	habitat	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
included	include	VBD	B-VP	O
shifts	shift	NNS	B-NP	O
in	in	IN	B-PP	O
sugar	sugar	NN	B-NP	O
transporter	transporter	NN	I-NP	O
types	type	NNS	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
supragingival	supragingival	JJ	I-NP	O
plaque	plaque	NN	I-NP	O
,	,	,	O	O
other	other	JJ	B-NP	O
oral	oral	JJ	I-NP	O
surfaces	surface	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
stool	stool	NN	B-NP	O
;	;	:	O	O
hydrogen	hydrogen	NN	B-NP	O
and	and	CC	I-NP	O
hydrogen	hydrogen	NN	I-NP	O
sulfide	sulfide	NN	I-NP	O
production	production	NN	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
differentially	differentially	RB	B-ADJP	O
distributed	distribute	VBN	I-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
microbiomes	microbiome	NNS	I-NP	O
of	of	IN	B-PP	O
ten	ten	CD	B-NP	O
digestive	digestive	JJ	I-NP	O
tract	tract	NN	I-NP	O
sites	site	NNS	I-NP	O
separated	separate	VBN	B-VP	O
into	into	IN	B-PP	O
four	four	CD	B-NP	O
types	type	NNS	I-NP	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
composition	composition	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
core	core	NN	I-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
metabolic	metabolic	JJ	B-NP	O
pathways	pathway	NNS	I-NP	O
was	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
across	across	IN	B-PP	O
these	these	DT	B-NP	O
diverse	diverse	JJ	I-NP	O
digestive	digestive	JJ	I-NP	O
tract	tract	NN	I-NP	O
habitats	habitat	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
provide	provide	VBP	B-VP	O
a	a	DT	B-NP	O
critical	critical	JJ	I-NP	O
baseline	baseline	NN	I-NP	O
for	for	IN	B-PP	O
future	future	JJ	B-NP	O
studies	study	NNS	I-NP	O
investigating	investigate	VBG	B-VP	O
local	local	JJ	B-NP	O
and	and	CC	I-NP	O
systemic	systemic	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
affecting	affect	VBG	B-VP	O
human	human	JJ	B-NP	O
health	health	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
compounds	compound	NNS	I-NP	O
2',6'-dihydroxy-4'-geranyloxyacetophenone	2',6'-dihydroxy-4'-geranyloxyacetophenone	NN	B-NP	O
(	(	(	O	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
2',6'-dihydroxy-4'-farnesyloxy-acetophenone	2',6'-dihydroxy-4'-farnesyloxy-acetophenone	NN	B-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
are	be	VBP	B-VP	O
oxyprenylated	oxyprenylate	VBN	I-VP	O
secondary	secondary	JJ	B-NP	O
metabolites	metabolite	NNS	I-NP	O
extracted	extract	VBN	B-VP	O
from	from	IN	B-PP	O
plants	plant	NNS	B-NP	O
belonging	belong	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Rutaceae	Rutaceae	NNP	I-NP	B-protein
family	family	NN	I-NP	I-protein
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
2	2	CD	I-NP	O
were	be	VBD	B-VP	O
synthesized	synthesize	VBN	I-VP	O
and	and	CC	O	O
tested	test	VBN	B-VP	O
for	for	IN	B-PP	O
their	their	PRP$	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
activity	activity	NN	I-NP	O
toward	toward	IN	B-PP	O
major	major	JJ	B-NP	O
oral	oral	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
.	.	.	O	O

Compounds	Compound	NNS	B-NP	O
1	1	CD	I-NP	O
and	and	CC	I-NP	O
2	2	CD	I-NP	O
were	be	VBD	B-VP	O
synthesized	synthesize	VBN	I-VP	O
by	by	IN	B-PP	O
selective	selective	JJ	B-NP	O
prenylation	prenylation	NN	I-NP	O
of	of	IN	B-PP	O
2,4,6-trihydroxyacetophenone	2,4,6-trihydroxyacetophenone	CD	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
4	4	CD	I-NP	B-DNA
'	'	POS	B-NP	I-DNA
position	position	NN	I-NP	I-DNA
with	with	IN	B-PP	O
geranyl	geranyl	NN	B-NP	O
and	and	CC	I-NP	O
farnesyl	farnesyl	NN	I-NP	O
bromide	bromide	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

Compound	Compound	NN	B-NP	O
1	1	CD	I-NP	O
showed	show	VBD	B-VP	O
stronger	strong	JJR	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
activity	activity	NN	I-NP	O
than	than	IN	B-PP	O
2	2	CD	B-NP	O
against	against	IN	B-PP	O
major	major	JJ	B-NP	O
oral	oral	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
Gram	Gram	NN	B-NP	O
positive	positive	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
(	(	(	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
sobrinus	sobrinus	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Gram	Gram	NN	B-NP	O
negative	negative	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
(	(	(	O	O
Prevotella	Prevotella	NNP	B-NP	O
intermedia	intermedia	NNP	I-NP	O
,	,	,	O	O
Porphyromonas	Porphyromonas	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
)	)	)	O	O
and	and	CC	O	O
Candida	Candida	NN	B-NP	O
albicans	albican	NNS	I-NP	O
.	.	.	O	O

Evidences	Evidence	NNS	B-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
mode	mode	NN	I-NP	O
of	of	IN	B-PP	O
action	action	NN	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
2	2	CD	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
their	their	PRP$	B-NP	O
iron-chelating	iron-chelating	JJ	I-NP	O
property	property	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
2	2	CD	I-NP	O
may	may	MD	B-VP	O
represent	represent	VB	I-VP	O
potential	potential	JJ	B-NP	O
natural	natural	JJ	I-NP	O
molecules	molecule	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
prevention/treatment	prevention/treatment	NN	I-NP	O
of	of	IN	B-PP	O
common	common	JJ	B-NP	O
oral	oral	JJ	I-NP	O
infections	infection	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
,	,	,	O	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
candidiasis	candidiasis	NN	B-NP	O
.	.	.	O	O

Attenuated	Attenuated	NNP	B-NP	O
Salmonella	Salmonella	NNP	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
carrier	carrier	NN	I-NP	O
for	for	IN	B-PP	O
DNA	DNA	NN	B-NP	O
vaccine	vaccine	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
and	and	CC	O	O
in	in	FW	B-NP	O
vivo	vivo	FW	I-NP	O
studies	study	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
following	follow	VBG	B-PP	O
transfection	transfection	NN	B-NP	O
of	of	IN	B-PP	O
plasmid	plasmid	NN	B-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
were	be	VBD	B-VP	O
poorly	poorly	RB	I-VP	O
studied	study	VBN	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
paper	paper	NN	I-NP	O
,	,	,	O	O
eukaryotic	eukaryotic	JJ	B-NP	B-DNA
expression	expression	NN	I-NP	I-DNA
plasmids	plasmid	NNS	I-NP	I-DNA
encoding	encode	VBG	B-VP	O
avian	avian	JJ	B-NP	B-DNA
influenza	influenza	NN	I-NP	I-DNA
virus	virus	NN	I-NP	I-DNA
(	(	(	O	I-DNA
AIV	AIV	NN	B-NP	I-DNA
)	)	)	O	I-DNA
subtype	subtype	NN	B-NP	I-DNA
H5N1	H5N1	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
,	,	,	O	O
pcDNA3.1/HA	pcDNA3.1/HA	NN	B-NP	O
,	,	,	O	O
NA	NA	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
NP	NP	NN	B-NP	B-protein
,	,	,	O	O
were	be	VBD	B-VP	O
transfected	transfecte	VBN	I-VP	O
into	into	IN	B-PP	O
an	an	DT	B-NP	O
attenuated	attenuate	VBN	I-NP	O
Salmonella	Salmonella	NNP	I-NP	O
enteric	enteric	JJ	I-NP	O
typhimurium	typhimurium	NN	I-NP	O
SV4089	SV4089	NN	I-NP	O
.	.	.	O	O

In	In	FW	B-NP	O
vitro	vitro	FW	I-NP	O
stability	stability	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
transfected	transfecte	VBN	I-NP	B-DNA
plasmids	plasmid	NNS	I-NP	I-DNA
into	into	IN	B-PP	O
Salmonella	Salmonella	NNP	B-NP	O
were	be	VBD	B-VP	O
over	over	IN	B-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
after	after	IN	B-PP	O
100	100	CD	B-NP	O
generations	generation	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
attenuated	attenuate	VBN	I-NP	O
Salmonella	Salmonella	NNP	I-NP	O
were	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
invade	invade	VB	I-VP	O
MCF-7	MCF-7	NN	B-NP	B-protein
(	(	(	O	O
1.2	1.2	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
MCF-10A	MCF-10A	NN	B-NP	O
(	(	(	O	O
0.5	0.5	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	I-NP	O
human	human	JJ	I-NP	B-cell_type
breast	breast	NN	I-NP	I-cell_type
cancer	cancer	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Newly	Newly	RB	B-NP	O
hatched	hatch	VBN	I-NP	O
specific-pathogen-free	specific-pathogen-free	JJ	I-NP	O
(	(	(	O	O
SPF	SPF	NN	B-NP	B-protein
)	)	)	O	O
chicks	chick	NNS	B-NP	O
were	be	VBD	B-VP	O
inoculated	inoculate	VBN	I-VP	O
once	once	RB	B-ADVP	O
by	by	IN	B-PP	O
oral	oral	JJ	B-NP	O
gavage	gavage	NN	I-NP	O
with	with	IN	B-PP	O
10	10	CD	B-NP	O
(	(	(	O	O
9	9	CD	B-NP	O
)	)	)	O	O
colony-forming	colony-forming	JJ	B-NP	O
unit	unit	NN	I-NP	O
(	(	(	O	O
CFU	CFU	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
attenuated	attenuate	VBN	I-NP	O
Salmonella	Salmonella	NNP	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
abnormal	abnormal	JJ	I-NP	O
clinical	clinical	JJ	I-NP	O
signs	sign	NNS	I-NP	O
or	or	CC	I-NP	O
deaths	death	NNS	I-NP	O
were	be	VBD	B-VP	O
recorded	record	VBN	I-VP	O
after	after	IN	B-PP	O
inoculation	inoculation	NN	B-NP	O
.	.	.	O	O

Viable	Viable	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
inoculation	inoculation	NN	B-NP	O
by	by	IN	B-PP	O
plating	plat	VBG	B-VP	O
from	from	IN	B-PP	O
spleen	spleen	NN	B-NP	O
,	,	,	O	O
liver	liver	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
cecum	cecum	NN	B-NP	O
.	.	.	O	O

Fluorescent	Fluorescent	JJ	B-NP	O
in	in	FW	I-NP	O
situ	situ	FW	I-NP	O
hybridization	hybridization	NN	I-NP	O
(	(	(	O	O
FISH	FISH	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
polymerase	polymerase	NN	B-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
(	(	(	O	O
PCR	PCR	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
carried	carry	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
confirmation	confirmation	NN	B-NP	O
.	.	.	O	O

Salmonella	Salmonella	NNP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
blood	blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
although	although	IN	B-SBAR	O
serum	serum	NN	B-NP	O
antibody	antibody	NN	I-NP	O
immune	immune	JJ	I-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-PP	O
Salmonella	Salmonella	NNP	B-NP	O
O	O	NNP	I-NP	O
antiserum	antiserum	NN	I-NP	O
group	group	NN	I-NP	O
D1	D1	NN	I-NP	O
factor	factor	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
9	9	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
12	12	CD	B-NP	B-protein
antigens	antigen	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
inoculated	inoculate	VBN	I-NP	O
chickens	chicken	NNS	I-NP	O
after	after	IN	B-PP	O
7	7	CD	B-NP	O
days	day	NNS	I-NP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
35	35	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
live	live	NN	B-NP	O
attenuated	attenuate	VBD	B-VP	O
S.	S.	NNP	B-NP	O
typhimurium	typhimurium	NNP	I-NP	O
SV4089	SV4089	NN	I-NP	O
harboring	harbor	VBG	B-VP	O
pcDNA3.1/HA	pcDNA3.1/HA	NN	B-NP	O
,	,	,	O	O
NA	NA	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
NP	NP	NN	B-NP	B-protein
may	may	MD	B-VP	O
provide	provide	VB	I-VP	O
a	a	DT	B-NP	O
unique	unique	JJ	I-NP	O
alternative	alternative	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
carrier	carrier	NN	I-NP	O
for	for	IN	B-PP	O
DNA	DNA	NN	B-NP	O
oral	oral	JJ	I-NP	O
vaccine	vaccine	NN	I-NP	O
in	in	IN	B-PP	O
chickens	chicken	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
microorganisms	microorganism	NNS	B-NP	O
in	in	IN	B-PP	O
pharmaceuticals	pharmaceutical	NNS	B-NP	O
is	be	VBZ	B-VP	O
undesirable	undesirable	JJ	B-ADJP	O
because	because	IN	B-SBAR	O
they	they	PRP	B-NP	O
may	may	MD	B-VP	O
cause	cause	VB	I-VP	O
spoilage	spoilage	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
product	product	NN	I-NP	O
and	and	CC	O	O
may	may	MD	B-VP	O
present	present	VB	I-VP	O
an	an	DT	B-NP	O
infection	infection	NN	I-NP	O
hazard	hazard	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
consumers	consumer	NNS	I-NP	O
or	or	CC	I-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
102	102	CD	B-NP	O
samples	sample	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
and	and	CC	I-NP	O
topical	topical	JJ	I-NP	B-protein
non-sterile	non-sterile	JJ	I-NP	I-protein
pharmaceutical	pharmaceutical	JJ	I-NP	I-protein
products	product	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
at	at	IN	B-PP	O
random	random	NN	B-NP	O
from	from	IN	B-PP	O
different	different	JJ	B-NP	O
drug	drug	NN	I-NP	O
houses	house	NNS	I-NP	O
and	and	CC	I-NP	O
pharmacies	pharmacy	NNS	I-NP	O
in	in	IN	B-PP	O
Iraq	Iraq	NNP	B-NP	O
,	,	,	O	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
microbial	microbial	JJ	I-NP	O
contamination	contamination	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

Bacterial	Bacterial	JJ	B-NP	O
isolates	isolate	NNS	I-NP	O
recovered	recover	VBN	B-VP	O
from	from	IN	B-PP	O
these	these	DT	B-NP	O
medicaments	medicament	NNS	I-NP	O
were	be	VBD	B-VP	O
subjected	subject	VBN	I-VP	O
to	to	TO	B-PP	O
susceptibility	susceptibility	NN	B-NP	O
testing	testing	NN	I-NP	O
against	against	IN	B-PP	O
various	various	JJ	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
by	by	IN	B-PP	O
disk	disk	NN	B-NP	O
diffusion	diffusion	NN	I-NP	O
method	method	NN	I-NP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
Clinical	Clinical	JJ	B-NP	O
and	and	CC	I-NP	O
Laboratory	Laboratory	NN	I-NP	O
Standards	Standard	NNS	I-NP	O
(	(	(	O	O
CLSI	CLSI	NN	B-NP	O
)	)	)	O	O
guidelines	guideline	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
occurrence	occurrence	NN	I-NP	O
of	of	IN	B-PP	O
gram-positive	gram-positive	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
and	and	CC	I-NP	O
topical	topical	JJ	I-NP	O
medicaments	medicament	NNS	I-NP	O
while	while	IN	B-SBAR	O
gram-negative	gram-negative	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
only	only	RB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
topical	topical	JJ	B-NP	O
medicaments	medicament	NNS	I-NP	O
.	.	.	O	O

More	More	JJR	B-NP	O
than	than	IN	I-NP	O
58	58	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
Bacillus	Bacillus	NN	B-NP	O
isolates	isolate	NNS	I-NP	O
were	be	VBD	B-VP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
lincomycin	lincomycin	NN	B-NP	O
and	and	CC	I-NP	O
Bacillus	Bacillus	NN	I-NP	O
mycoides	mycoide	NNS	I-NP	O
isolates	isolate	NNS	I-NP	O
were	be	VBD	B-VP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
beta-lactam	beta-lactam	NN	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
and	and	CC	O	O
trimethoprim-sulfamethoxazole	trimethoprim-sulfamethoxazole	NN	B-NP	O
.	.	.	O	O

Staphylococcus	Staphylococcus	NN	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
relatively	relatively	RB	I-NP	O
high	high	JJ	I-NP	O
resistance	resistance	NN	I-NP	O
to	to	TO	B-PP	O
ampicillin	ampicillin	NN	B-NP	O
,	,	,	O	O
amoxicillin	amoxicillin	NN	B-NP	B-protein
,	,	,	O	O
penicillin	penicillin	NN	B-NP	B-protein
,	,	,	O	O
tetracycline	tetracycline	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
trimethoprim-sulfamethoxazole	trimethoprim-sulfamethoxazole	NN	B-NP	O
.	.	.	O	O

S.	S.	NNP	B-NP	O
epidermidis	epidermidis	NNP	I-NP	O
had	have	VBD	B-VP	O
the	the	DT	B-NP	O
highest	high	JJS	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
multi-resistant	multi-resistant	JJ	B-NP	O
isolates	isolate	NNS	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
87.5	87.5	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
isolated	isolate	VBN	B-NP	O
gram-negative	gram-negative	JJ	I-NP	O
rods	rod	NNS	I-NP	O
showed	show	VBD	B-VP	O
high	high	JJ	B-NP	O
resistance	resistance	NN	I-NP	O
to	to	TO	B-PP	O
beta-lactam	beta-lactam	NN	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
and	and	CC	O	O
75	75	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
them	them	PRP	B-NP	O
were	be	VBD	B-VP	O
highly	highly	RB	B-ADJP	O
resistant	resistant	JJ	I-ADJP	O
to	to	TO	B-PP	O
erythromycin	erythromycin	NN	B-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
isolate	isolate	NN	I-NP	O
of	of	IN	B-PP	O
Pseudomonas	Pseudomonas	NN	B-NP	O
aeruginosa	aeruginosa	NN	I-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
resistant	resistant	JJ	I-NP	O
among	among	IN	B-PP	O
all	all	DT	B-NP	O
gram-negative	gram-negative	JJ	I-NP	O
rod	rod	NN	I-NP	O
isolates	isolate	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
high	high	JJ	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
resistance	resistance	NN	B-NP	O
to	to	TO	B-PP	O
antimicrobial	antimicrobial	JJ	B-NP	O
agents	agent	NNS	I-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
isolates	isolate	NNS	I-NP	O
recovered	recover	VBN	B-VP	O
from	from	IN	B-PP	O
oral	oral	JJ	B-NP	O
and	and	CC	I-NP	O
topical	topical	JJ	I-NP	O
medicaments	medicament	NNS	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
may	may	MD	B-VP	O
indicate	indicate	VB	I-VP	O
a	a	DT	B-NP	O
widespread	widespread	JJ	I-NP	O
antibiotic	antibiotic	JJ	I-NP	O
resistance	resistance	NN	I-NP	O
among	among	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
different	different	JJ	B-NP	O
sources	source	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
anthropological	anthropological	JJ	B-NP	O
and	and	CC	I-NP	O
environmental	environmental	JJ	I-NP	O
origin	origin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
inherent	inherent	JJ	I-NP	O
instabilities	instability	NNS	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
multispecies	multispecies	JJ	B-NP	O
biofilm	biofilm	NN	I-NP	O
communities	community	NNS	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
constant-depth	constant-depth	JJ	I-NP	O
film	film	NN	I-NP	O
fermenter	fermenter	NN	I-NP	O
(	(	(	O	O
CDFF	CDFF	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
other	other	JJ	B-NP	O
microcosm	microcosm	NN	I-NP	O
systems	system	NNS	I-NP	O
can	can	MD	B-VP	O
yield	yield	VB	I-VP	O
unacceptable	unacceptable	JJ	B-NP	O
variability	variability	NN	I-NP	O
between	between	IN	B-PP	O
experiments	experiment	NNS	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
could	could	MD	B-VP	O
limit	limit	VB	I-VP	O
their	their	PRP$	B-NP	O
potential	potential	JJ	I-NP	O
applications	application	NNS	I-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
microbiology	microbiology	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
extent	extent	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
variability	variability	NN	I-NP	O
needs	need	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
determined	determine	VBN	I-VP	O
and	and	CC	O	O
a	a	DT	B-NP	O
protocol	protocol	NN	I-NP	O
developed	develop	VBD	B-VP	O
which	which	WDT	B-NP	O
minimizes	minimize	VBZ	B-VP	O
it	it	PRP	B-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
custom-made	custom-made	JJ	I-NP	O
CDFFs	CDFF	NNS	I-NP	B-protein
were	be	VBD	B-VP	O
supplied	supply	VBN	I-VP	O
concurrently	concurrently	RB	B-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
inoculation	inoculation	NN	I-NP	O
culture	culture	NN	I-NP	O
,	,	,	O	O
begat	beget	VBD	B-VP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
aliquot	aliquot	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
saliva	saliva	NN	I-NP	O
pool	pool	NN	I-NP	O
and	and	CC	O	O
artificial	artificial	JJ	B-NP	O
saliva	saliva	NN	I-NP	O
growth	growth	NN	I-NP	O
medium	medium	NN	I-NP	O
via	via	IN	B-PP	O
a	a	DT	B-NP	O
dual-channel	dual-channel	JJ	I-NP	O
pump	pump	NN	I-NP	O
.	.	.	O	O

Transformed	Transform	VBN	B-NP	O
log	log	NN	I-NP	O
(	(	(	O	O
10	10	CD	B-NP	O
)	)	)	O	O
data	datum	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
viable	viable	JJ	I-NP	O
counts	count	NNS	I-NP	O
at	at	IN	B-PP	O
fixed	fix	VBN	B-NP	O
time	time	NN	I-NP	O
points	point	NNS	I-NP	O
were	be	VBD	B-VP	O
analysed	analyse	VBN	I-VP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
Bland-Altman	Bland-Altman	JJ	I-NP	O
approach	approach	NN	I-NP	O
to	to	TO	B-VP	O
test	test	VB	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
agreement	agreement	NN	B-NP	O
between	between	IN	B-PP	O
two	two	CD	B-NP	O
CDFFs	CDFF	NNS	I-NP	B-protein
running	run	VBG	B-VP	O
concurrently	concurrently	RB	B-ADVP	O
and	and	CC	O	O
those	those	DT	B-NP	O
CDFFs	CDFF	NNS	I-NP	B-protein
run	run	VBP	B-VP	O
in	in	IN	B-PP	O
series	series	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
coefficients	coefficient	NNS	I-NP	O
(	(	(	O	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
agreement	agreement	NN	B-NP	O
were	be	VBD	B-VP	O
lower	low	JJR	B-ADJP	O
(	(	(	O	O
i.e	i.e	JJ	B-ADJP	O
.	.	.	O	O

less	less	RBR	B-ADJP	O
variable	variable	JJ	I-ADJP	O
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
concurrent	concurrent	JJ	I-NP	O
model	model	NN	I-NP	O
than	than	IN	B-PP	O
when	when	WRB	B-ADVP	O
run	run	VBN	B-VP	O
in	in	IN	B-PP	O
series	series	NN	B-NP	O
for	for	IN	B-PP	O
total	total	JJ	B-NP	O
counts	count	NNS	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
(	(	(	O	O
1.238	1.238	CD	B-NP	O
vs	vs	CC	I-NP	O
2.124	2.124	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
Lactobacillus	Lactobacillus	NN	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

(	(	(	O	O
0.517	0.517	CD	B-NP	O
vs	vs	CC	I-NP	O
1.431	1.431	CD	I-NP	O
)	)	)	O	O
and	and	CC	O	O
Mutans	Mutan	NNPS	B-NP	B-cell_line
streptococci	streptococci	NNS	I-NP	I-cell_line
(	(	(	O	O
2.817	2.817	CD	B-NP	O
vs	vs	CC	I-NP	O
3.864	3.864	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

Other	Other	JJ	B-NP	O
measures	measure	NNS	I-NP	O
of	of	IN	B-PP	O
variability	variability	NN	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
similar	similar	JJ	I-NP	O
trend	trend	NN	I-NP	O
.	.	.	O	O

Operating	Operating	NN	B-NP	B-protein
CDFFs	CDFF	NNS	I-NP	I-protein
concurrently	concurrently	RB	B-ADVP	O
minimizes	minimize	VBZ	B-VP	O
the	the	DT	B-NP	O
degree	degree	NN	I-NP	O
of	of	IN	B-PP	O
difference	difference	NN	B-NP	O
and	and	CC	I-NP	O
variability	variability	NN	I-NP	O
between	between	IN	B-PP	O
them	them	PRP	B-NP	O
.	.	.	O	O

Operating	Operating	NN	B-NP	B-protein
CDFFs	CDFF	NNS	I-NP	I-protein
concurrently	concurrently	RB	B-ADVP	O
will	will	MD	B-VP	O
improve	improve	VB	I-VP	O
the	the	DT	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
for	for	IN	B-PP	O
experiments	experiment	NNS	B-NP	O
that	that	WDT	B-NP	O
seek	seek	VBP	B-VP	O
to	to	TO	I-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
variable	variable	JJ	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
a	a	DT	B-NP	O
nutritional	nutritional	JJ	I-NP	O
supplement	supplement	NN	I-NP	O
or	or	CC	O	O
antimicrobial	antimicrobial	JJ	B-NP	O
agent	agent	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

Five	Five	CD	B-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
,	,	,	I-NP	O
gram-negative	gram-negative	JJ	I-NP	O
bacilli	bacilli	NNS	I-NP	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
were	be	VBD	B-VP	O
subjected	subject	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
comprehensive	comprehensive	JJ	I-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
phenotypic	phenotypic	JJ	B-NP	O
and	and	CC	I-NP	O
genotypic	genotypic	JJ	I-NP	O
tests	test	NNS	I-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
comprise	comprise	VB	I-VP	O
a	a	DT	B-NP	O
homogeneous	homogeneous	JJ	I-NP	O
group	group	NN	I-NP	O
.	.	.	O	O

Phylogenetic	Phylogenetic	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
full-length	full-length	JJ	B-NP	B-DNA
16S	16S	NN	I-NP	I-DNA
rRNA	rRNA	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
strains	strain	NNS	I-NP	O
represented	represent	VBD	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
group	group	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
family	family	NN	I-NP	O
Prevotellaceae	Prevotellaceae	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
closely	closely	RB	I-NP	O
related	related	JJ	I-NP	O
species	specie	NNS	I-NP	O
was	be	VBD	B-VP	O
Prevotella	Prevotella	NNP	B-NP	O
tannerae	tannerae	NNS	I-NP	O
.	.	.	O	O

P.	P.	NNP	B-NP	O
tannerae	tannerae	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
novel	novel	JJ	I-NP	O
taxon	taxon	NN	I-NP	O
are	be	VBP	B-VP	O
deeply	deeply	RB	I-VP	O
branched	branch	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
genus	genus	NN	I-NP	O
Prevotella	Prevotella	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
sequence	sequence	NN	B-NP	O
identities	identity	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
type	type	NN	I-NP	O
strain	strain	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
type	type	NN	I-NP	O
species	specie	NNS	I-NP	O
of	of	IN	B-PP	O
Prevotella	Prevotella	NNP	B-NP	O
,	,	,	O	O
Prevotella	Prevotella	NNP	B-NP	O
melaninogenica	melaninogenica	NNP	I-NP	O
,	,	,	O	O
of	of	IN	B-PP	O
82.2	82.2	CD	B-NP	O
and	and	CC	I-NP	O
85.6	85.6	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
novel	novel	JJ	I-NP	O
genus	genus	NN	I-NP	O
Alloprevotella	Alloprevotella	NNP	I-NP	O
gen.	gen.	NNP	I-NP	O
nov.	nov.	NN	I-NP	O
is	be	VBZ	B-VP	O
proposed	propose	VBN	I-VP	O
to	to	TO	I-VP	O
accommodate	accommodate	VB	I-VP	O
the	the	DT	B-NP	O
novel	novel	JJ	I-NP	O
species	specie	NNS	I-NP	O
Alloprevotella	Alloprevotella	NNP	I-NP	O
rava	rava	NN	I-NP	O
gen.	gen.	NNP	I-NP	O
nov.	nov.	NNP	I-NP	O
,	,	,	O	O
sp	sp	NN	B-NP	O
.	.	.	O	O

nov.	nov.	RB	B-ADVP	O
and	and	CC	O	O
the	the	DT	B-NP	O
previously	previously	RB	I-NP	O
named	name	VBN	I-NP	O
Prevotella	Prevotella	NNP	I-NP	O
tannerae	tannerae	FW	I-NP	O
Moore	Moore	NNP	I-NP	O
et	et	FW	I-NP	O
al	al	FW	I-NP	O
.	.	.	O	O

1994	1994	CD	B-NP	O
as	as	IN	B-PP	O
Alloprevotella	Alloprevotella	NNP	B-NP	O
tannerae	tannerae	NNP	I-NP	O
gen.	gen.	NNP	I-NP	O
nov.	nov.	NNP	I-NP	O
,	,	,	O	O
comb	comb	NN	B-NP	O
.	.	.	O	O

nov	nov	UH	B-INTJ	O
.	.	.	O	O

The	The	DT	B-NP	O
type	type	NN	I-NP	O
species	species	NN	I-NP	O
is	be	VBZ	B-VP	O
Alloprevotella	Alloprevotella	NNP	B-NP	O
tannerae	tannerae	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
type	type	NN	I-NP	O
strain	strain	NN	I-NP	O
of	of	IN	B-PP	O
Alloprevotella	Alloprevotella	NN	B-NP	O
rava	rava	NN	I-NP	O
is	be	VBZ	B-VP	O
81/4-12	81/4-12	CD	B-NP	O
(	(	(	O	O
T	T	NN	B-NP	O
)	)	)	O	O
(	(	(	O	O
=	=	SYM	B-VP	O
DSM	DSM	NN	B-NP	O
22548	22548	CD	I-NP	O
(	(	(	O	O
T	T	NN	B-NP	O
)	)	)	O	O
=	=	SYM	B-VP	O
CCUG	CCUG	NN	B-NP	O
58091	58091	CD	I-NP	O
(	(	(	O	O
T	T	NN	B-NP	O
)	)	)	O	O
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
type	type	NN	I-NP	O
strain	strain	NN	I-NP	O
of	of	IN	B-PP	O
Alloprevotella	Alloprevotella	NNP	B-NP	O
tannerae	tannerae	NN	I-NP	O
is	be	VBZ	B-VP	O
ATCC	ATCC	NN	B-NP	O
51259	51259	CD	I-NP	O
(	(	(	O	O
T	T	NN	B-NP	O
)	)	)	O	O
=	=	SYM	B-VP	O
CCUG	CCUG	NN	B-NP	O
34292	34292	CD	I-NP	O
(	(	(	O	O
T	T	NN	B-NP	O
)	)	)	O	O
=	=	SYM	B-VP	O
CIP	CIP	NN	B-NP	O
104476	104476	CD	I-NP	O
(	(	(	O	O
T	T	NN	B-NP	O
)	)	)	O	O
=	=	SYM	B-VP	O
NCTC	NCTC	NN	B-NP	O
13073	13073	CD	I-NP	O
(	(	(	O	O
T	T	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Alloprevotella	Alloprevotella	NN	B-NP	O
rava	rava	NN	I-NP	O
is	be	VBZ	B-VP	O
weakly	weakly	RB	B-ADVP	O
to	to	TO	B-PP	O
moderately	moderately	RB	B-NP	O
saccharolytic	saccharolytic	JJ	I-NP	O
and	and	CC	O	O
produces	produce	VBZ	B-VP	O
moderate	moderate	JJ	B-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
acetic	acetic	JJ	B-NP	O
acid	acid	NN	I-NP	O
and	and	CC	O	O
major	major	JJ	B-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
succinic	succinic	JJ	B-NP	O
acid	acid	NN	I-NP	O
as	as	IN	B-PP	O
end	end	NN	B-NP	O
products	product	NNS	I-NP	O
of	of	IN	B-PP	O
fermentation	fermentation	NN	B-NP	O
.	.	.	O	O

Strains	Strain	NNS	B-NP	O
are	be	VBP	B-VP	O
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-PP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
bile	bile	NN	I-NP	O
and	and	CC	I-NP	O
hydrolyse	hydrolyse	NN	I-NP	O
gelatin	gelatin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
principal	principal	JJ	I-NP	O
cellular	cellular	JJ	I-NP	O
long-chain	long-chain	JJ	I-NP	O
fatty	fatty	JJ	I-NP	O
acids	acid	NNS	I-NP	O
are	be	VBP	B-VP	O
anteiso-C15	anteiso-C15	NN	B-NP	O
:	:	:	O	O
0	0	CD	B-NP	O
,	,	,	O	O
iso-C15	iso-C15	NN	B-NP	O
:	:	:	O	O
0	0	CD	B-NP	O
,	,	,	O	O
C16	C16	NN	B-NP	O
:	:	:	O	O
0	0	CD	B-NP	O
,	,	,	O	O
iso-C17	iso-C17	NN	B-NP	O
:	:	:	O	O
0	0	CD	B-NP	O
and	and	CC	I-NP	O
iso-C17	iso-C17	NN	I-NP	O
:	:	:	O	O
0	0	CD	B-NP	O
3-OH	3-OH	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
G+C	G+C	NN	I-NP	O
content	content	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
type	type	NN	I-NP	O
strain	strain	NN	I-NP	O
is	be	VBZ	B-VP	O
47	47	CD	B-NP	O
mol	mol	NN	I-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Despite	Despite	IN	B-PP	O
the	the	DT	B-NP	O
increased	increase	VBN	I-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
recurrent	recurrent	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
in	in	IN	B-PP	O
HIV-infected	HIV-infected	JJ	B-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	O	O
recent	recent	JJ	B-NP	O
studies	study	NNS	I-NP	O
linking	link	VBG	B-VP	O
the	the	DT	B-NP	O
airway	airway	NN	I-NP	O
bacterial	bacterial	JJ	I-NP	O
community	community	NN	I-NP	O
(	(	(	O	O
microbiota	microbiota	NN	B-NP	O
)	)	)	O	O
to	to	TO	B-PP	O
acute	acute	JJ	B-NP	O
and	and	CC	I-NP	O
chronic	chronic	JJ	I-NP	O
respiratory	respiratory	JJ	I-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
little	little	JJ	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
and	and	CC	I-NP	O
airway	airway	NN	I-NP	O
microbiota	microbiota	NNS	I-NP	O
that	that	WDT	B-NP	O
exist	exist	VBP	B-VP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
individuals	individual	NNS	I-NP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
propensity	propensity	NN	I-NP	O
to	to	TO	B-VP	O
harbor	harbor	VB	I-VP	O
pathogens	pathogen	NNS	B-NP	O
despite	despite	IN	B-PP	O
antimicrobial	antimicrobial	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
pilot	pilot	NN	I-NP	O
study	study	NN	I-NP	O
compared	compare	VBD	B-VP	O
paired	paired	JJ	B-NP	O
samples	sample	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
and	and	CC	I-NP	O
airway	airway	NN	I-NP	O
microbiota	microbiota	NN	I-NP	O
from	from	IN	B-PP	O
15	15	CD	B-NP	O
hospitalized	hospitalize	VBD	B-VP	O
HIV-infected	HIV-infected	JJ	B-NP	O
patients	patient	NNS	I-NP	O
receiving	receive	VBG	B-VP	O
antimicrobial	antimicrobial	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

Total	Total	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
was	be	VBD	B-VP	O
extracted	extract	VBN	I-VP	O
,	,	,	O	O
bacterial	bacterial	JJ	B-NP	O
burden	burden	NN	I-NP	O
was	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
by	by	IN	B-PP	O
quantitative	quantitative	JJ	B-NP	O
PCR	PCR	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
amplified	amplify	VBN	B-NP	O
16S	16S	NN	I-NP	O
rRNA	rRNA	NN	I-NP	O
was	be	VBD	B-VP	O
profiled	profile	VBN	I-VP	O
for	for	IN	B-PP	O
microbiome	microbiome	NN	B-NP	O
composition	composition	NN	I-NP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
phylogenetic	phylogenetic	JJ	I-NP	O
microarray	microarray	NN	I-NP	O
(	(	(	O	O
16S	16S	NN	B-NP	O
rRNA	rRNA	NN	I-NP	O
PhyloChip	PhyloChip	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Though	Though	IN	B-SBAR	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
burden	burden	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
airway	airway	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
,	,	,	O	O
microbiota	microbiota	NN	B-NP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
niches	niche	NNS	I-NP	O
were	be	VBD	B-VP	O
comparably	comparably	RB	B-ADJP	O
diverse	diverse	JJ	I-ADJP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
oral	oral	JJ	B-NP	O
and	and	CC	I-NP	O
airway	airway	NN	I-NP	O
microbiota	microbiota	NN	I-NP	O
exhibited	exhibit	VBD	B-VP	O
niche	niche	NN	B-NP	O
specificity	specificity	NN	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
microbiota	microbiota	NNS	I-NP	O
were	be	VBD	B-VP	O
characterized	characterize	VBN	I-VP	O
by	by	IN	B-PP	O
significantly	significantly	RB	B-NP	O
increased	increase	VBN	I-NP	O
relative	relative	JJ	I-NP	O
abundance	abundance	NN	I-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
species	specie	NNS	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Bacteroides	Bacteroide	NNS	I-NP	O
,	,	,	O	O
Firmicutes	Firmicute	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
TM7	TM7	NN	B-NP	O
phyla	phyla	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
airway	airway	NN	B-NP	O
microbiota	microbiota	NNS	I-NP	O
were	be	VBD	B-VP	O
primarily	primarily	RB	I-VP	O
characterized	characterize	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
relative	relative	JJ	I-NP	O
expansion	expansion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Proteobacteria	Proteobacteria	NNP	I-NP	O
.	.	.	O	O

Twenty-two	Twenty-two	CD	B-NP	O
taxa	taxa	NN	I-NP	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
niches	niche	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
bovis	bovis	NNP	I-NP	O
and	and	CC	I-NP	O
Chryseobacterium	Chryseobacterium	NNP	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
pathogens	pathogen	NNS	B-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
HIV-infected	HIV-infected	JJ	B-NP	B-cell_type
populations	population	NNS	I-NP	I-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
compared	compare	VBD	B-VP	O
the	the	DT	B-NP	O
airway	airway	NN	I-NP	O
microbiota	microbiota	NN	I-NP	O
of	of	IN	B-PP	O
five	five	CD	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
patients	patient	NNS	I-NP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
five	five	CD	B-NP	O
non-HIV-infected	non-HIV-infected	JJ	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
patients	patient	NNS	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
previous	previous	JJ	I-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

Compared	Compare	VBN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
population	population	NN	I-NP	O
,	,	,	O	O
HIV-infected	HIV-infected	JJ	B-NP	O
patients	patient	NNS	I-NP	O
exhibited	exhibit	VBD	B-VP	O
relative	relative	JJ	B-NP	O
increased	increase	VBN	I-NP	O
abundance	abundance	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
phylogenetically	phylogenetically	RB	B-NP	O
distinct	distinct	JJ	I-NP	O
taxa	taxa	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
included	include	VBD	B-VP	O
several	several	JJ	B-NP	O
known	know	VBN	I-NP	O
or	or	CC	I-NP	O
suspected	suspect	VBN	I-NP	O
pathogenic	pathogenic	JJ	I-NP	O
organisms	organism	NNS	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
recurrent	recurrent	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
in	in	IN	B-PP	O
HIV-infected	HIV-infected	JJ	B-NP	B-cell_type
populations	population	NNS	I-NP	I-cell_type
may	may	MD	B-VP	O
be	be	VB	I-VP	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

Rothia	Rothia	NNP	B-NP	O
dentocariosa	dentocariosa	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
indigenous	indigenous	JJ	I-NP	O
microbial	microbial	JJ	I-NP	O
flora	flora	NN	I-NP	O
of	of	IN	B-PP	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
examine	examine	VB	I-VP	O
the	the	DT	B-NP	O
bacterium	bacterium	NN	I-NP	O
population	population	NN	I-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
cavities	cavity	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
selective	selective	JJ	I-NP	O
medium	medium	NN	I-NP	O
,	,	,	O	O
designated	designate	VBN	B-VP	O
RDSM	RDSM	NN	B-NP	B-protein
,	,	,	O	O
was	be	VBD	B-VP	O
developed	develop	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
isolation	isolation	NN	I-NP	O
of	of	IN	B-PP	O
R.	R.	NNP	B-NP	O
dentocariosa	dentocariosa	NNP	I-NP	O
.	.	.	O	O

RDSM	RDSM	NN	B-NP	B-protein
was	be	VBD	B-VP	O
prepared	prepare	VBN	I-VP	O
by	by	IN	B-PP	O
adding	add	VBG	B-VP	O
0.5	0.5	CD	B-NP	O
mug/ml	mug/ml	NN	I-NP	O
of	of	IN	B-PP	O
lincomycin	lincomycin	NN	B-NP	O
,	,	,	O	O
10	10	CD	B-NP	O
mug/ml	mug/ml	NN	I-NP	O
of	of	IN	B-PP	O
colistin	colistin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
sucrose	sucrose	NN	I-NP	O
to	to	TO	B-PP	O
Heart	Heart	NN	B-NP	O
Infusion	Infusion	NN	I-NP	O
(	(	(	O	O
HI	HI	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Average	Average	JJ	B-NP	O
growth	growth	NN	I-NP	O
recovery	recovery	NN	I-NP	O
of	of	IN	B-PP	O
R.	R.	NNP	B-NP	O
dentocariosa	dentocariosa	NN	I-NP	O
on	on	IN	B-PP	O
RDSM	RDSM	NN	B-NP	B-protein
was	be	VBD	B-VP	O
93.8	93.8	CD	B-NP	O
%	%	NN	I-NP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
HI	HI	NN	B-NP	O
medium	medium	NN	I-NP	O
.	.	.	O	O

Growth	Growth	NN	B-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
including	include	VBG	B-PP	O
Rothia	Rothia	NNP	B-NP	O
mucilaginosa	mucilaginosa	NNP	I-NP	O
,	,	,	O	O
Neisseria	Neisseria	NNP	B-NP	O
,	,	,	O	O
Actinomyces	Actinomyces	NNP	B-NP	O
,	,	,	O	O
or	or	CC	O	O
streptococci	streptococci	NNS	B-NP	O
was	be	VBD	B-VP	O
remarkably	remarkably	RB	I-VP	O
inhibited	inhibit	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
selective	selective	JJ	I-NP	O
medium	medium	NN	I-NP	O
.	.	.	O	O

Clinical	Clinical	JJ	B-NP	O
efficacy	efficacy	NN	I-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
recovery	recovery	NN	I-NP	O
of	of	IN	B-PP	O
R.	R.	NNP	B-NP	O
dentocariosa	dentocariosa	NN	I-NP	O
on	on	IN	B-PP	O
RDSM	RDSM	NN	B-NP	B-protein
from	from	IN	B-PP	O
the	the	DT	B-NP	O
stimulated	stimulate	VBN	I-NP	O
saliva	saliva	NN	I-NP	O
samples	sample	NNS	I-NP	O
of	of	IN	B-PP	O
8	8	CD	B-NP	O
volunteers	volunteer	NNS	I-NP	O
.	.	.	O	O

R.	R.	NN	B-NP	O
dentocariosa	dentocariosa	NN	I-NP	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
at	at	IN	B-PP	O
2.6	2.6	CD	B-NP	O
(	(	(	O	O
range	range	NN	B-NP	O
:	:	:	O	O
1.0-4.6	1.0-4.6	CD	B-NP	O
)	)	)	O	O
%	%	NN	B-NP	O
to	to	TO	B-PP	O
total	total	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
of	of	IN	B-PP	O
8.0x10	8.0x10	CD	B-NP	O
(	(	(	O	O
7	7	CD	B-NP	O
)	)	)	O	O
CFU/ml	CFU/ml	NN	B-NP	O
on	on	IN	B-PP	O
BHI	BHI	NN	B-NP	B-protein
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
oral	oral	JJ	I-NP	O
cavities	cavity	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
new	new	JJ	I-NP	O
selective	selective	JJ	I-NP	O
medium	medium	NN	I-NP	O
,	,	,	O	O
RDSM	RDSM	NN	B-NP	B-protein
,	,	,	O	O
was	be	VBD	B-VP	O
highly	highly	RB	B-ADJP	O
selective	selective	JJ	I-ADJP	O
for	for	IN	B-PP	O
R.	R.	NNP	B-NP	O
dentocariosa	dentocariosa	NNP	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
useful	useful	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
isolation	isolation	NN	I-NP	O
of	of	IN	B-PP	O
R.	R.	NNP	B-NP	O
dentocariosa	dentocariosa	NN	I-NP	O
from	from	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
samples	sample	NNS	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
well-known	well-known	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
variations	variation	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
microbial	microbial	JJ	I-NP	O
community	community	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
location	location	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
body	body	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
diseases	disease	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
developing	develop	VBG	I-NP	O
change	change	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
before	before	IN	B-PP	O
and	and	CC	I-PP	O
after	after	IN	I-PP	O
wearing	wear	VBG	B-VP	O
the	the	DT	B-NP	O
removable	removable	JJ	I-NP	O
partial	partial	JJ	I-NP	O
dentures	denture	NNS	I-NP	O
(	(	(	O	O
RPD	RPD	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
completely	completely	RB	B-ADJP	O
understood	understand	VBN	I-ADJP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
three	three	CD	B-NP	O
kinds	kind	NNS	I-NP	O
of	of	IN	B-PP	O
samples	sample	NNS	B-NP	O
(	(	(	O	O
saliva	saliva	NN	B-NP	O
,	,	,	O	O
supra-	supra-	NN	B-NP	O
and	and	CC	O	O
subgingival	subgingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
mucosal	mucosal	JJ	I-NP	O
surfaces	surface	NNS	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
10-patients	10-patient	NNS	I-NP	O
group	group	NN	I-NP	O
at	at	IN	B-PP	O
three	three	CD	B-NP	O
different	different	JJ	I-NP	O
times	time	NNS	I-NP	O
:	:	:	O	O
before	before	RB	B-ADVP	O
,	,	,	O	O
1-month	1-month	JJ	B-ADJP	O
and	and	CC	O	O
6-months	6-month	NNS	B-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

Ten	Ten	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
adults	adult	NNS	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
selected	select	VBN	I-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
.	.	.	O	O

Denaturing	Denature	VBG	B-VP	O
gradient	gradient	NN	B-NP	O
gel	gel	NN	I-NP	O
electrophoresis	electrophoresis	NN	I-NP	O
was	be	VBD	B-VP	O
applied	apply	VBN	I-VP	O
to	to	TO	I-VP	O
identify	identify	VB	I-VP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
profiles	profile	NNS	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
analyze	analyze	VB	I-VP	O
the	the	DT	B-NP	O
dynamics	dynamic	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microbial	microbial	JJ	I-NP	O
population	population	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pre-	pre-	JJ	I-NP	O
and	and	CC	I-NP	O
post-therapy	post-therapy	JJ	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
ANOVA	ANOVA	NN	I-NP	B-protein
of	of	IN	B-PP	O
Repeated	Repeated	NNP	B-NP	O
Measurement	Measurement	NNP	I-NP	O
Data	Data	NNP	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
saliva	saliva	NN	I-NP	O
and	and	CC	O	O
mucosal	mucosal	JJ	B-NP	O
surfaces	surface	NNS	I-NP	O
,	,	,	O	O
wearing	wear	VBG	B-NP	O
RPDs	RPD	NNS	I-NP	B-protein
caused	cause	VBD	B-VP	O
significant	significant	JJ	B-NP	O
change	change	NN	I-NP	O
of	of	IN	B-PP	O
numbers	number	NNS	B-NP	O
of	of	IN	B-PP	O
amplicons	amplicon	NNS	B-NP	O
.	.	.	O	O

As	As	RB	B-NP	O
many	many	JJ	I-NP	O
as	as	IN	I-NP	O
607	607	CD	I-NP	O
amplicons	amplicon	NNS	I-NP	O
were	be	VBD	B-VP	O
chosen	choose	VBN	I-VP	O
to	to	TO	I-VP	O
cut	cut	VB	I-VP	O
out	out	RP	B-PRT	O
and	and	CC	O	O
re-amplify	re-amplify	JJ	B-ADJP	O
by	by	IN	B-PP	O
PCR	PCR	NN	B-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
cloning	cloning	NN	B-NP	O
and	and	CC	I-NP	O
sequencing	sequencing	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
16	16	CD	B-NP	O
bacterial	bacterial	JJ	I-NP	O
genera	genus	NNS	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
health-associated	health-associated	JJ	I-NP	O
genera	genera	NN	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
,	,	,	O	O
Neisseria	Neisseria	NNP	B-NP	O
,	,	,	O	O
Rothia	Rothia	NNP	B-NP	O
,	,	,	O	O
Corynebacterium	Corynebacterium	NNP	B-NP	O
,	,	,	O	O
Leptotrichia	Leptotrichia	NNP	B-NP	O
,	,	,	O	O
Gemella	Gemella	NNP	B-NP	O
,	,	,	O	O
Veillonella	Veillonella	NNP	B-NP	O
,	,	,	O	O
Selenomona	Selenomona	NNP	B-NP	O
and	and	CC	O	O
Actinomyces	Actinomyces	NNP	B-NP	O
tended	tend	VBD	B-VP	O
to	to	TO	I-VP	O
decrease	decrease	VB	I-VP	O
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
disease-associated	disease-associated	JJ	I-NP	O
species	specie	NNS	I-NP	O
including	include	VBG	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
tended	tend	VBD	B-VP	O
to	to	TO	I-VP	O
increase	increase	VB	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
general	general	JJ	B-ADJP	O
,	,	,	O	O
wearing	wear	VBG	B-NP	O
RPDs	RPD	NNS	I-NP	B-protein
influenced	influence	VBD	B-VP	O
the	the	DT	B-NP	O
diversity	diversity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microbial	microbial	JJ	I-NP	O
ecosystem	ecosystem	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
noteworthy	noteworthy	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
environment	environment	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
changed	change	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
healthy	healthy	JJ	I-NP	O
status	status	NN	I-NP	O
towards	towards	IN	B-PP	O
the	the	DT	B-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
purpose	purpose	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
analyze	analyze	VB	I-VP	O
the	the	DT	B-NP	O
association	association	NN	I-NP	O
of	of	IN	B-PP	O
maternal	maternal	JJ	B-NP	O
antenatal	antenatal	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
on	on	IN	B-PP	O
initial	initial	JJ	B-NP	O
preterm	preterm	JJ	I-NP	O
infant	infant	NN	I-NP	O
oral	oral	JJ	I-NP	O
microbial	microbial	JJ	I-NP	O
acquisition	acquisition	NN	I-NP	O
of	of	IN	B-PP	O
gut	gut	NN	B-NP	O
metabolically	metabolically	RB	B-NP	O
important	important	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
:	:	:	O	O
Firmicutes	Firmicute	NNS	B-NP	O
,	,	,	O	O
Bacteroidetes	Bacteroidete	NNS	B-NP	O
,	,	,	O	O
Lactobacillus	Lactobacillus	NN	B-NP	O
,	,	,	O	O
Bifidobacterium	Bifidobacterium	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Bacteroides	Bacteroides	NNP	B-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

Infant	Infant	JJ	B-NP	O
oral	oral	JJ	I-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
prefeeding	prefeede	VBG	I-VP	O
at	at	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
and	and	CC	O	O
analyzed	analyze	VBN	B-VP	O
using	use	VBG	B-VP	O
group-specific	group-specific	JJ	B-NP	O
primers	primer	NNS	I-NP	O
by	by	IN	B-PP	O
real-time	real-time	JJ	B-NP	O
16S	16S	NN	I-NP	O
rRNA	rRNA	NN	I-NP	O
quantitative	quantitative	JJ	I-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
with	with	IN	B-PP	O
analysis	analysis	NN	B-NP	O
of	of	IN	B-PP	O
variance	variance	NN	B-NP	O
and	and	CC	O	O
logistic	logistic	JJ	B-NP	O
regression	regression	NN	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
effect	effect	NN	B-NP	O
of	of	IN	B-PP	O
antenatal	antenatal	JJ	B-NP	O
exposure	exposure	NN	I-NP	O
.	.	.	O	O

Sixty-five	Sixty-five	CD	B-NP	O
infants	infant	NNS	I-NP	O
<	<	SYM	B-NP	O
34	34	CD	B-NP	O
weeks	week	NNS	I-NP	O
'	'	POS	B-NP	O
gestational	gestational	JJ	I-NP	O
age	age	NN	I-NP	O
(	(	(	O	O
GA	GA	NN	B-NP	B-DNA
)	)	)	O	O
were	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
;	;	:	O	O
mean	mean	JJ	B-NP	O
GA	GA	NN	I-NP	O
was	be	VBD	B-VP	O
28.6	28.6	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
2.6	2.6	CD	I-NP	O
(	(	(	O	O
standard	standard	JJ	B-NP	O
deviation	deviation	NN	I-NP	O
)	)	)	O	O
weeks	week	NNS	B-NP	O
.	.	.	O	O

Infants	Infant	NNS	B-NP	O
unexposed	unexposed	JJ	B-ADJP	O
to	to	TO	B-PP	O
antenatal	antenatal	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
5	5	CD	B-NP	O
)	)	)	O	O
acquired	acquire	VBD	B-VP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
%	%	NN	I-NP	O
Firmicutes	Firmicute	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
composed	compose	VBN	I-VP	O
of	of	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
Lactobacillus	Lactobacillus	NN	I-NP	O
species	specie	NNS	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
detectable	detectable	JJ	I-NP	O
Bifidobacterium	Bifidobacterium	NN	I-NP	O
,	,	,	O	O
Bacteroidetes	Bacteroidete	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
Bacteroides	Bacteroides	NNP	B-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

Infants	Infant	NNS	B-NP	O
exposed	expose	VBN	B-VP	O
to	to	TO	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
7	7	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
acquired	acquire	VBD	B-VP	O
fivefold	fivefold	RB	B-NP	O
less	less	RBR	I-NP	O
total	total	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
density	density	NN	I-NP	O
(	(	(	O	O
TBD	TBD	NN	B-NP	B-protein
)	)	)	O	O
with	with	IN	B-PP	O
45	45	CD	B-NP	O
%	%	NN	I-NP	O
Firmicutes	Firmicute	NNS	I-NP	O
1.3	1.3	CD	B-NP	O
%	%	NN	I-NP	O
Lactobacillus	Lactobacillus	NN	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
23.5	23.5	CD	B-NP	O
%	%	NN	I-NP	O
Bacteroidetes	Bacteroidete	NNS	I-NP	O
and	and	CC	O	O
rare	rare	JJ	B-NP	O
Bacteroides	Bacteroide	NNS	I-NP	O
.	.	.	O	O

Compared	Compare	VBN	B-PP	O
with	with	IN	B-PP	O
unexposed	unexposed	JJ	B-NP	O
infants	infant	NNS	I-NP	O
,	,	,	O	O
steroids	steroid	NNS	B-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
26	26	CD	B-NP	O
)	)	)	O	O
or	or	CC	O	O
steroid	steroid	NN	B-NP	O
and	and	CC	I-NP	O
antibiotics	antibiotic	NNS	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
27	27	CD	B-NP	O
)	)	)	O	O
exposure	exposure	NN	B-NP	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
eightfold	eightfold	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
TBD	TBD	NN	B-NP	B-protein
with	with	IN	B-PP	O
<	<	SYM	B-NP	O
1	1	CD	I-NP	O
%	%	NN	I-NP	O
Lactobacillus	Lactobacillus	NN	I-NP	O
species	specie	NNS	I-NP	O
and	and	CC	I-NP	O
Bacteroides	Bacteroide	NNS	I-NP	O
species	specy	VBZ	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	I-NP	O
30	30	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	JJR	B-NP	O
0.04	0.04	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

Bifidobacterium	Bifidobacterium	NN	B-NP	O
was	be	VBD	B-VP	O
undetectable	undetectable	JJ	B-ADJP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

Preterm	Preterm	JJ	B-NP	O
infant	infant	JJ	I-NP	O
exposure	exposure	NN	I-NP	O
to	to	TO	B-PP	O
routine	routine	JJ	B-NP	O
maternal	maternal	JJ	I-NP	O
antenatal	antenatal	JJ	I-NP	O
treatments	treatment	NNS	I-NP	O
influence	influence	VBP	B-VP	O
early	early	JJ	B-NP	O
oral	oral	JJ	I-NP	O
microbial	microbial	JJ	I-NP	O
acquisition	acquisition	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
hours	hour	NNS	I-NP	O
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
establishment	establishment	NN	B-NP	O
of	of	IN	B-PP	O
gut	gut	NN	B-NP	O
commensal	commensal	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

Bacterial	Bacterial	JJ	B-NP	O
infections	infection	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
linked	link	VBN	I-VP	O
to	to	TO	B-PP	O
malignancies	malignancy	NNS	B-NP	O
due	due	JJ	B-PP	O
to	to	TO	I-PP	O
their	their	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
induce	induce	VB	I-VP	O
chronic	chronic	JJ	B-NP	O
inflammation	inflammation	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
association	association	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
squamous	squamous	JJ	I-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
(	(	(	O	O
OSCC/tumor	OSCC/tumor	NN	B-NP	O
)	)	)	O	O
tissues	tissue	NNS	B-NP	O
and	and	CC	O	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
adjacent	adjacent	JJ	B-NP	O
non-tumor	non-tumor	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
sampled	sample	VBN	B-VP	O
5	5	CD	B-NP	O
cm	cm	NN	I-NP	O
distant	distant	JJ	B-ADJP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
patient	patient	NN	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
10	10	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

By	By	IN	B-PP	O
using	use	VBG	B-VP	O
culture-independent	culture-independent	JJ	B-NP	O
16S	16S	NN	I-NP	O
rRNA	rRNA	NN	I-NP	O
approaches	approach	NNS	I-NP	O
,	,	,	O	O
denaturing	denature	VBG	B-VP	O
gradient	gradient	NN	B-NP	O
gel	gel	NN	I-NP	O
electrophoresis	electrophoresis	NN	I-NP	O
(	(	(	O	O
DGGE	DGGE	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
cloning	cloning	NN	B-NP	O
and	and	CC	I-NP	O
sequencing	sequencing	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
assessed	assess	VBD	B-VP	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
diversity	diversity	NN	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
samples	sample	NNS	I-NP	O
.	.	.	O	O

DGGE	DGGE	NN	B-NP	O
fingerprints	fingerprint	NNS	I-NP	O
showed	show	VBD	B-VP	O
variations	variation	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
band	band	NN	I-NP	O
intensity	intensity	NN	I-NP	O
profiles	profile	NNS	I-NP	O
within	within	IN	B-PP	O
non-tumor	non-tumor	JJ	B-NP	O
and	and	CC	I-NP	O
tumor	tumor	NN	I-NP	O
tissues	tissue	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
patient	patient	NN	I-NP	O
and	and	CC	B-PP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
clonal	clonal	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
1200	1200	CD	B-NP	B-DNA
sequences	sequence	NNS	I-NP	I-DNA
characterized	characterize	VBN	B-VP	O
,	,	,	O	O
80	80	CD	B-NP	O
bacterial	bacterial	JJ	I-NP	O
species/phylotypes	species/phylotype	NNS	I-NP	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
representing	represent	VBG	B-VP	O
six	six	CD	B-NP	O
phyla	phyla	NN	I-NP	O
,	,	,	O	O
Firmicutes	Firmicute	NNPS	B-NP	O
,	,	,	O	O
Bacteroidetes	Bacteroidetes	NNP	B-NP	O
,	,	,	O	O
Proteobacteria	Proteobacteria	NNP	B-NP	O
,	,	,	O	O
Fusobacteria	Fusobacteria	NNP	B-NP	O
,	,	,	O	O
Actinobacteria	Actinobacteria	NNP	B-NP	O
and	and	CC	O	O
uncultivated	uncultivated	JJ	B-NP	O
TM7	TM7	NN	I-NP	O
in	in	IN	B-PP	O
non-tumor	non-tumor	JJ	B-NP	O
and	and	CC	I-NP	O
tumor	tumor	NN	I-NP	O
libraries	library	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
combined	combine	VBN	B-NP	O
library	library	NN	I-NP	O
,	,	,	O	O
12	12	CD	B-NP	O
classes	class	NNS	I-NP	O
,	,	,	O	O
16	16	CD	B-NP	O
order	order	NN	I-NP	O
,	,	,	O	O
26	26	CD	B-NP	O
families	family	NNS	I-NP	O
and	and	CC	O	O
40	40	CD	B-NP	O
genera	genus	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O

Bacterial	Bacterial	JJ	B-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
sp	sp	NN	I-NP	O
.	.	.	O	O

oral	oral	JJ	B-NP	O
taxon	taxon	NN	I-NP	O
058	058	CD	I-NP	O
,	,	,	O	O
Peptostreptococcus	Peptostreptococcus	NNP	B-NP	O
stomatis	stomati	VBD	B-VP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
salivarius	salivarius	NNP	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
gordonii	gordonii	NNP	I-NP	O
,	,	,	O	O
Gemella	Gemella	NNP	B-NP	O
haemolysans	haemolysan	NNS	I-NP	O
,	,	,	O	O
Gemella	Gemella	NNP	B-NP	O
morbillorum	morbillorum	NN	I-NP	O
,	,	,	O	O
Johnsonella	Johnsonella	NNP	B-NP	O
ignava	ignava	NNP	I-NP	O
and	and	CC	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
parasanguinis	parasanguinis	NN	I-NP	O
I	I	PRP	B-NP	O
were	be	VBD	B-VP	O
highly	highly	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
tumor	tumor	NN	B-NP	O
site	site	NN	I-NP	O
where	where	WRB	B-ADVP	O
as	as	IN	B-PP	O
Granulicatella	Granulicatella	NNP	B-NP	O
adiacens	adiacen	NNS	I-NP	O
was	be	VBD	B-VP	O
prevalent	prevalent	JJ	B-ADJP	O
at	at	IN	B-PP	O
non-tumor	non-tumor	JJ	B-NP	B-DNA
site	site	NN	I-NP	I-DNA
.	.	.	O	O

Streptococcus	Streptococcus	NN	B-NP	O
intermedius	intermedius	NN	I-NP	O
was	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
both	both	CC	B-NP	O
non-tumor	non-tumor	JJ	I-NP	O
and	and	CC	I-NP	O
tumor	tumor	NN	I-NP	O
sites	site	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
underlying	underlie	VBG	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
diversity	diversity	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
mucosal	mucosal	JJ	I-NP	O
tissues	tissue	NNS	I-NP	O
from	from	IN	B-PP	O
non-tumor	non-tumor	JJ	B-NP	O
and	and	CC	I-NP	O
tumor	tumor	NN	I-NP	O
sites	site	NNS	I-NP	O
of	of	IN	B-PP	O
OSCC	OSCC	NN	B-NP	O
subjects	subject	NNS	I-NP	O
indicated	indicate	VBD	B-VP	O
a	a	DT	B-NP	O
shift	shift	NN	I-NP	O
in	in	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
colonization	colonization	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
most	most	RBS	I-NP	O
prevalent	prevalent	JJ	I-NP	O
or	or	CC	I-NP	O
unique	unique	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
species/phylotypes	species/phylotype	NNS	I-NP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
tumor	tumor	NN	B-NP	O
tissues	tissue	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
OSCC	OSCC	NN	B-NP	B-protein
and	and	CC	O	O
needs	need	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
further	further	RBR	B-ADJP	O
investigated	investigate	VBN	I-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
larger	large	JJR	I-NP	O
sample	sample	NN	I-NP	O
size	size	NN	I-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
decade	decade	NN	I-NP	O
,	,	,	O	O
advances	advance	NNS	B-NP	O
in	in	IN	B-PP	O
cancer	cancer	NN	B-NP	O
treatments	treatment	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
counterbalanced	counterbalance	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
rising	rise	VBG	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
immunosuppressed	immunosuppressed	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
multitude	multitude	NN	I-NP	O
of	of	IN	B-PP	O
new	new	JJ	B-NP	O
risk	risk	NN	I-NP	O
factors	factor	NNS	I-NP	O
for	for	IN	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

Hence	Hence	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
risk	risk	NN	B-NP	O
factors	factor	NNS	I-NP	O
,	,	,	O	O
infectious	infectious	JJ	B-NP	O
pathogens	pathogen	NNS	I-NP	O
in	in	IN	B-PP	O
blood	blood	NN	B-NP	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
cavity	cavity	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
patients	patient	NNS	I-NP	O
undergoing	undergo	VBG	B-VP	O
different	different	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
procedures	procedure	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
present	present	JJ	I-NP	O
prospective	prospective	JJ	I-NP	O
cohort	cohort	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
was	be	VBD	B-VP	O
conducted	conduct	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
undergoing	undergo	VBG	B-VP	O
treatment	treatment	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
radiotherapy	radiotherapy	NN	I-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
Regional	Regional	NNP	B-NP	O
Cancer	Cancer	NNP	I-NP	O
Institute	Institute	NNP	I-NP	O
,	,	,	O	O
Pt	Pt	NNP	B-NP	O
.	.	.	O	O

B.D	B.D	NN	B-NP	O
.	.	.	O	O

Sharma	Sharma	NNP	B-NP	O
University	University	NNP	I-NP	O
of	of	IN	B-PP	O
Health	Health	NNP	B-NP	O
Sciences	Sciences	NNP	B-NP	O
,	,	,	O	O
Rohtak	Rohtak	NNP	B-NP	O
,	,	,	O	O
Haryana	Haryana	NNP	B-NP	O
,	,	,	O	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
January	January	NNP	B-NP	O
2007	2007	CD	I-NP	O
to	to	TO	B-PP	O
October	October	NNP	B-NP	O
2009	2009	CD	I-NP	O
.	.	.	O	O

Total	Total	JJ	B-NP	O
186	186	CD	I-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
squamous	squamous	JJ	B-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
cavity	cavity	NN	I-NP	O
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

Based	Base	VBN	B-PP	O
on	on	IN	B-PP	O
treatment	treatment	NN	B-NP	O
procedures	procedure	NNS	I-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
divided	divide	VBN	I-VP	O
into	into	IN	B-PP	O
three	three	CD	B-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
group	group	NN	B-NP	O
I	I	PRP	B-NP	O
were	be	VBD	B-VP	O
under	under	IN	B-PP	O
radiotherapy	radiotherapy	NN	B-NP	O
,	,	,	O	O
group	group	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
under	under	IN	B-PP	O
chemotherapy	chemotherapy	NN	B-NP	O
and	and	CC	O	O
group	group	NN	B-NP	O
III	III	CD	I-NP	O
were	be	VBD	B-VP	O
of	of	IN	B-PP	O
radio	radio	NN	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
together	together	RB	B-ADVP	O
.	.	.	O	O

Clinical	Clinical	JJ	B-NP	O
isolates	isolate	NNS	I-NP	O
from	from	IN	B-PP	O
blood	blood	NN	B-NP	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
cavity	cavity	NN	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
by	by	IN	B-PP	O
following	follow	VBG	B-VP	O
general	general	JJ	B-NP	O
microbiological	microbiological	JJ	I-NP	O
,	,	,	I-NP	O
staining	staining	NN	I-NP	O
and	and	CC	I-NP	O
biochemical	biochemical	JJ	I-NP	O
methods	method	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
absolute	absolute	JJ	I-NP	O
neutrophile	neutrophile	NN	I-NP	O
counts	count	NNS	I-NP	O
were	be	VBD	B-VP	O
done	do	VBN	I-VP	O
by	by	IN	B-PP	O
following	follow	VBG	B-VP	O
the	the	DT	B-NP	O
standard	standard	JJ	I-NP	O
methods	method	NNS	I-NP	O
.	.	.	O	O

Prevalent	Prevalent	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
isolated	isolate	VBN	B-VP	O
were	be	VBD	B-VP	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
aureus	aureus	NNP	I-NP	O
,	,	,	O	O
Escherichia	Escherichia	NNP	B-NP	O
coli	coli	NNP	I-NP	O
,	,	,	O	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
epidermidis	epidermidis	NNP	I-NP	O
,	,	,	O	O
Pseudomonas	Pseudomonas	NNP	B-NP	O
aeruginosa	aeruginosa	NNP	I-NP	O
,	,	,	O	O
Klebsiella	Klebsiella	NNP	B-NP	O
pneumonia	pneumonia	NNP	I-NP	O
,	,	,	O	O
Proteus	Proteus	NNP	B-NP	O
mirabilis	mirabilis	NNP	I-NP	O
,	,	,	O	O
Proteus	Proteus	NNP	B-NP	O
vulgaris	vulgaris	NNP	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
fungal	fungal	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
were	be	VBD	B-VP	O
Candida	Candida	NNP	B-NP	O
albicans	albicans	NNP	I-NP	O
,	,	,	O	O
Aspergillus	Aspergillus	NNP	B-NP	O
fumigatus	fumigatus	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
predominant	predominant	JJ	I-NP	O
gram	gram	NN	I-NP	O
negative	negative	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
Pseudomonas	Pseudomonas	NN	B-NP	O
aeruginosa	aeruginosa	NN	I-NP	O
and	and	CC	O	O
Klebsiella	Klebsiella	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
blood	blood	NN	B-NP	O
of	of	IN	B-PP	O
radiotherapy	radiotherapy	NN	B-NP	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
cavity	cavity	NN	I-NP	O
of	of	IN	B-PP	O
chemotherapy	chemotherapy	NN	B-NP	O
treated	treat	VBN	B-NP	O
cases	case	NNS	I-NP	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
predominance	predominance	NN	I-NP	O
of	of	IN	B-PP	O
gram	gram	NN	B-NP	O
positive	positive	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
(	(	(	O	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
aureus	aureus	NNP	I-NP	O
and	and	CC	O	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
epidermidis	epidermidis	NNP	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
blood	blood	NN	B-NP	O
of	of	IN	B-PP	O
chemotherapy	chemotherapy	NN	B-NP	O
,	,	,	O	O
radio	radio	NN	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
cases	case	NNS	I-NP	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
cavity	cavity	NN	I-NP	O
of	of	IN	B-PP	O
radiotherapy	radiotherapy	NN	B-NP	O
,	,	,	O	O
radio	radio	NN	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
treated	treat	VBN	B-NP	O
cases	case	NNS	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
study	study	NN	I-NP	O
also	also	RB	B-ADVP	O
revealed	reveal	VBD	B-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
C.	C.	NNP	B-NP	O
albicans	albicans	NNP	I-NP	O
fungi	fungus	NNS	I-NP	O
as	as	IN	B-PP	O
most	most	JJS	B-NP	O
significant	significant	JJ	I-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
pathogens	pathogen	NNS	I-NP	O
in	in	IN	B-PP	O
radiotherapy	radiotherapy	NN	B-NP	O
and	and	CC	I-NP	O
radio	radio	NN	I-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
cases	case	NNS	I-NP	O
.	.	.	O	O

Gram	Gram	NN	B-NP	O
positive	positive	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
Gram	Gram	NN	B-NP	O
negative	negative	JJ	I-NP	O
were	be	VBD	B-VP	O
reported	report	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
of	of	IN	B-PP	O
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
three	three	CD	I-NP	O
groups	group	NNS	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
mucositis	mucositis	NN	I-NP	O
played	play	VBD	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
cavity	cavity	NN	I-NP	O
infection	infection	NN	I-NP	O
and	and	CC	O	O
make	make	VB	B-VP	O
patients	patient	NNS	B-NP	O
more	more	RBR	B-ADJP	O
prone	prone	JJ	I-ADJP	O
to	to	TO	B-PP	O
C.	C.	FW	B-NP	O
albicans	albicans	FW	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

Despite	Despite	IN	B-PP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
reservoir	reservoir	NN	I-NP	O
of	of	IN	B-PP	O
opportunistic	opportunistic	JJ	B-NP	O
pathogens	pathogen	NNS	I-NP	O
for	for	IN	B-PP	O
infection	infection	NN	B-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
following	follow	VBG	B-PP	O
stroke	stroke	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
hygiene	hygiene	NN	I-NP	O
interventions	intervention	NNS	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
largely	largely	RB	I-VP	O
neglected	neglect	VBN	I-VP	O
.	.	.	O	O

This	This	DT	B-NP	O
randomized	randomize	VBN	I-NP	O
clinical	clinical	JJ	I-NP	O
trial	trial	NN	I-NP	O
included	include	VBD	B-VP	O
102	102	CD	B-NP	O
patients	patient	NNS	I-NP	O
undergoing	undergo	VBG	B-VP	O
hospital-based	hospital-based	JJ	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
for	for	IN	B-PP	O
stroke	stroke	NN	B-NP	O
.	.	.	O	O

Patients	Patient	NNS	B-NP	O
were	be	VBD	B-VP	O
randomized	randomize	VBN	I-VP	O
to	to	TO	B-PP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
3	3	CD	B-NP	O
groups	group	NNS	I-NP	O
:	:	:	O	O
oral	oral	JJ	B-NP	O
hygiene	hygiene	NN	I-NP	O
instruction	instruction	NN	I-NP	O
(	(	(	O	O
OHI	OHI	NN	B-NP	O
)	)	)	O	O
only	only	RB	B-ADVP	O
;	;	:	O	O
OHI	OHI	NN	B-NP	O
and	and	CC	O	O
0.2	0.2	CD	B-NP	O
%	%	NN	I-NP	O
chlorhexidine	chlorhexidine	NN	I-NP	O
mouth	mouth	NN	I-NP	O
rinse	rinse	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	B-ADVP	O
;	;	:	O	O
or	or	CC	O	O
OHI	OHI	CD	B-NP	O
,	,	,	O	O
0.2	0.2	CD	B-NP	O
%	%	NN	I-NP	O
chlorhexidine	chlorhexidine	NN	I-NP	O
mouth	mouth	NN	I-NP	O
rinse	rinse	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
assisted	assist	VBD	B-VP	O
brushing	brush	VBG	I-VP	O
twice	twice	RB	B-ADVP	O
weekly	weekly	RB	I-ADVP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
and	and	CC	O	O
after	after	IN	B-PP	O
3	3	CD	B-NP	O
weeks	week	NNS	I-NP	O
for	for	IN	B-PP	O
detection	detection	NN	B-NP	O
of	of	IN	B-PP	O
Staphylococcus	Staphylococcus	FW	B-NP	O
aureus	aureus	FW	I-NP	O
,	,	,	O	O
aerobic	aerobic	JJ	B-NP	O
and	and	CC	I-NP	O
facultatively	facultatively	RB	I-NP	O
anaerobic	anaerobic	JJ	I-NP	O
gram-negative	gram-negative	JJ	I-NP	O
bacilli	bacilli	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
yeasts	yeast	NNS	B-NP	O
.	.	.	O	O

Almost	Almost	RB	B-NP	O
three-quarters	three-quarter	NNS	I-NP	O
(	(	(	O	O
72.8	72.8	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
harbored	harbor	VBD	B-VP	O
oral	oral	JJ	B-NP	O
anaerobic	anaerobic	JJ	I-NP	O
gram-negative	gram-negative	JJ	I-NP	O
bacilli	bacilli	NNS	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
half	half	NN	I-NP	O
had	have	VBD	B-VP	O
detectable	detectable	JJ	B-NP	O
S	S	NN	I-NP	O
aureus	aureus	NN	I-NP	O
(	(	(	O	O
56.8	56.8	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
yeasts	yeast	NNS	B-NP	O
(	(	(	O	O
59.3	59.3	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Percentage	Percentage	NN	B-NP	O
frequencies	frequency	NNS	I-NP	O
and	and	CC	O	O
viable	viable	JJ	B-NP	O
counts	count	NNS	I-NP	O
of	of	IN	B-PP	O
pathogens	pathogen	NNS	B-NP	O
remained	remain	VBD	B-VP	O
relatively	relatively	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
trial	trial	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
differences	difference	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
3	3	CD	I-NP	O
patient	patient	NN	I-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
our	our	PRP$	B-NP	O
study	study	NN	I-NP	O
cohort	cohort	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
effectiveness	effectiveness	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
3	3	CD	I-NP	O
different	different	JJ	I-NP	O
oral	oral	JJ	I-NP	O
hygiene	hygiene	NN	I-NP	O
interventions	intervention	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
or	or	CC	O	O
viable	viable	JJ	B-NP	O
counts	count	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
opportunistic	opportunistic	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
.	.	.	O	O

Endodontic	Endodontic	JJ	B-NP	O
infections	infection	NNS	I-NP	O
are	be	VBP	B-VP	O
a	a	DT	B-NP	O
leading	lead	VBG	I-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
oro-facial	oro-facial	JJ	B-NP	B-protein
pain	pain	NN	I-NP	I-protein
and	and	CC	O	O
tooth	tooth	JJ	B-NP	O
loss	loss	NN	I-NP	O
in	in	IN	B-PP	O
western	western	JJ	B-NP	O
countries	country	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
may	may	MD	B-VP	O
lead	lead	VB	I-VP	O
to	to	TO	B-PP	O
severe	severe	JJ	B-NP	O
life-threatening	life-threatening	JJ	I-NP	O
infections	infection	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
infections	infection	NNS	I-NP	O
are	be	VBP	B-VP	O
polymicrobial	polymicrobial	JJ	B-ADJP	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
diversity	diversity	NN	I-NP	O
.	.	.	O	O

Understanding	Understand	VBG	B-VP	O
the	the	DT	B-NP	O
spatial	spatial	JJ	I-NP	O
transition	transition	NN	I-NP	O
of	of	IN	B-PP	O
microbiota	microbiota	NN	B-NP	O
from	from	IN	B-PP	O
normal	normal	JJ	B-NP	O
oral	oral	JJ	I-NP	O
cavities	cavity	NNS	I-NP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
infected	infected	JJ	I-NP	O
root	root	NN	I-NP	O
canal	canal	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
acute	acute	JJ	I-NP	O
periapical	periapical	JJ	I-NP	O
abscess	abscess	NN	I-NP	O
can	can	MD	B-VP	O
improve	improve	VB	I-VP	O
our	our	PRP$	B-NP	O
knowledge	knowledge	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
endodontic	endodontic	JJ	B-NP	O
infections	infection	NNS	I-NP	O
and	and	CC	O	O
lead	lead	VBP	B-VP	O
to	to	TO	B-PP	O
more	more	RBR	B-NP	O
effective	effective	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
obtained	obtain	VBD	B-VP	O
samples	sample	NNS	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
,	,	,	O	O
infected	infected	JJ	B-NP	O
root	root	NN	I-NP	O
canal	canal	NN	I-NP	O
and	and	CC	O	O
periapical	periapical	JJ	B-NP	O
abscess	abscess	NN	I-NP	O
of	of	IN	B-PP	O
8	8	CD	B-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
5	5	CD	B-NP	O
with	with	IN	B-PP	O
localized	localize	VBN	B-NP	O
and	and	CC	I-NP	O
3	3	CD	I-NP	O
with	with	IN	B-PP	O
systemic	systemic	JJ	B-NP	O
infections	infection	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O

Microbial	Microbial	JJ	B-NP	B-cell_type
populations	population	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
these	these	DT	B-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
using	use	VBG	B-VP	O
next-generation	next-generation	JJ	B-NP	O
sequencing	sequencing	NN	I-NP	O
of	of	IN	B-PP	O
16S	16S	NN	B-NP	O
rRNA	rRNA	NN	I-NP	O
amplicons	amplicon	NNS	I-NP	O
.	.	.	O	O

Bioinformatics	Bioinformatic	NNS	B-NP	O
tools	tool	NNS	I-NP	O
and	and	CC	O	O
statistical	statistical	JJ	B-NP	O
tests	test	NNS	I-NP	O
with	with	IN	B-PP	O
rigorous	rigorous	JJ	B-NP	O
criteria	criterion	NNS	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
elucidate	elucidate	VB	I-VP	O
the	the	DT	B-NP	O
spatial	spatial	JJ	I-NP	O
transition	transition	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
microbiota	microbiota	NN	I-NP	O
from	from	IN	B-PP	O
normal	normal	JJ	B-ADJP	O
to	to	TO	B-PP	O
diseased	disease	VBN	B-NP	O
sites	site	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
average	average	NN	B-NP	O
,	,	,	O	O
10,000	10,000	CD	B-NP	O
partial	partial	JJ	I-NP	I-DNA
16S	16S	NN	I-NP	I-DNA
rRNA	rRNA	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
from	from	IN	B-PP	O
each	each	DT	B-NP	O
sample	sample	NN	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
sequences	sequence	NNS	I-NP	O
fell	fall	VBD	B-VP	O
into	into	IN	B-PP	O
11	11	CD	B-NP	O
different	different	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
phyla	phyla	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
microbial	microbial	JJ	I-NP	O
diversity	diversity	NN	I-NP	O
in	in	IN	B-PP	O
root	root	NN	B-NP	O
canal	canal	NN	I-NP	O
and	and	CC	I-NP	O
abscess	abscess	NN	I-NP	O
samples	sample	NNS	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
samples	sample	NNS	I-NP	O
.	.	.	O	O

Streptococcus	Streptococcus	NNP	B-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
abundant	abundant	JJ	I-NP	O
genus	genus	NN	I-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
cavities	cavity	NNS	I-NP	O
while	while	IN	B-SBAR	O
Prevotella	Prevotella	NNP	B-NP	O
and	and	CC	I-NP	O
Fusobacterium	Fusobacterium	NNP	I-NP	O
were	be	VBD	B-VP	O
most	most	RBS	B-ADJP	O
abundant	abundant	JJ	I-ADJP	O
in	in	IN	B-PP	O
diseased	diseased	JJ	B-NP	O
samples	sample	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
microbiota	microbiota	NN	I-NP	O
community	community	NN	I-NP	O
structures	structure	NNS	I-NP	O
of	of	IN	B-PP	O
root	root	NN	B-NP	O
canal	canal	NN	I-NP	O
and	and	CC	I-NP	O
abscess	abscess	NN	I-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
more	more	RBR	B-ADJP	O
similar	similar	JJ	I-ADJP	O
to	to	TO	B-PP	O
each	each	DT	B-NP	O
other	other	JJ	I-NP	O
than	than	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
microbiota	microbiota	NN	I-NP	O
.	.	.	O	O

Using	Use	VBG	B-VP	O
rigorous	rigorous	JJ	B-NP	O
criteria	criterion	NNS	I-NP	O
and	and	CC	O	O
novel	novel	JJ	B-NP	O
bioinformatics	bioinformatic	NNS	I-NP	O
tools	tool	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
Granulicatella	Granulicatella	NNP	B-NP	O
adiacens	adiacens	NNP	I-NP	O
,	,	,	O	O
Eubacterium	Eubacterium	NNP	B-NP	O
yurii	yurii	NNP	I-NP	O
,	,	,	O	O
Prevotella	Prevotella	NNP	B-NP	O
melaninogenica	melaninogenica	NNP	I-NP	O
,	,	,	O	O
Prevotella	Prevotella	NNP	B-NP	O
salivae	salivae	NNP	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mitis	mitis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Atopobium	Atopobium	NN	B-NP	O
rimae	rimae	NNS	I-NP	O
were	be	VBD	B-VP	O
over-represented	over-represented	JJ	B-ADJP	O
in	in	IN	B-PP	O
diseased	diseased	JJ	B-NP	O
samples	sample	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
used	use	VBD	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
approach	approach	NN	I-NP	O
and	and	CC	O	O
high-throughput	high-throughput	JJ	B-NP	O
methodologies	methodology	NNS	I-NP	O
to	to	TO	B-VP	O
characterize	characterize	VB	I-VP	O
the	the	DT	B-NP	O
microbiota	microbiota	NN	I-NP	B-DNA
associated	associate	VBN	B-VP	I-DNA
normal	normal	JJ	B-NP	I-DNA
and	and	CC	I-NP	I-DNA
diseased	diseased	JJ	I-NP	I-DNA
oral	oral	JJ	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
individuals	individual	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
salivary	salivary	JJ	I-NP	O
glands	gland	NNS	I-NP	O
of	of	IN	B-PP	O
adults	adult	NNS	B-NP	O
concentrate	concentrate	VBP	B-VP	O
nitrate	nitrate	NN	B-NP	O
from	from	IN	B-PP	O
plasma	plasma	NN	B-NP	O
into	into	IN	B-PP	O
saliva	saliva	NN	B-NP	O
where	where	WRB	B-ADVP	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
converted	convert	VBN	I-VP	O
to	to	TO	B-PP	O
nitrite	nitrite	NN	B-NP	O
by	by	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	B-protein
nitrate	nitrate	NN	I-NP	I-protein
reductases	reductas	NNS	I-NP	I-protein
.	.	.	O	O

Nitrite	Nitrite	NN	B-NP	O
can	can	MD	B-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
beneficial	beneficial	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
adult	adult	JJ	B-NP	O
gastrointestinal	gastrointestinal	JJ	I-NP	O
and	and	CC	I-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
physiology	physiology	NN	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
nitrite	nitrite	NN	B-NP	O
is	be	VBZ	B-VP	O
swallowed	swallow	VBN	I-VP	O
,	,	,	O	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
converted	convert	VBN	I-VP	O
to	to	TO	B-PP	O
nitric	nitric	JJ	B-NP	O
oxide	oxide	NN	I-NP	O
(	(	(	O	O
NO	NO	NN	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
stomach	stomach	NN	I-NP	O
and	and	CC	O	O
may	may	MD	B-VP	O
then	then	RB	I-VP	O
exert	exert	VB	I-VP	O
protective	protective	JJ	B-NP	O
effects	effect	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
gastrointestinal	gastrointestinal	JJ	I-NP	O
tract	tract	NN	I-NP	O
and	and	CC	B-PP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
body	body	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
has	have	VBZ	B-VP	O
yet	yet	RB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
determined	determine	VBN	I-VP	O
either	either	CC	O	O
when	when	WRB	B-ADVP	O
newborn	newborn	JJ	B-NP	O
infants	infant	NNS	I-NP	O
acquire	acquire	VBP	B-VP	O
oral	oral	JJ	B-NP	O
nitrate	nitrate	NN	I-NP	O
reducing	reduce	VBG	B-VP	O
bacteria	bacteria	NNS	B-NP	O
or	or	CC	O	O
what	what	WP	B-NP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
antimicrobial	antimicrobial	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
or	or	CC	O	O
premature	premature	JJ	B-NP	O
birth	birth	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
processing	processing	NN	I-NP	O
of	of	IN	B-PP	O
nitrate	nitrate	NN	B-NP	O
to	to	TO	B-PP	O
nitrite	nitrite	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
measured	measure	VBD	B-VP	O
nitrate	nitrate	NN	B-NP	O
and	and	CC	I-NP	O
nitrite	nitrite	NN	I-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
saliva	saliva	NN	I-NP	O
of	of	IN	B-PP	O
adults	adult	NNS	B-NP	O
and	and	CC	O	O
both	both	CC	O	O
preterm	preterm	NN	B-NP	O
and	and	CC	O	O
term	term	NN	B-NP	O
human	human	JJ	I-NP	O
infants	infant	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
life	life	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
measured	measure	VBD	B-VP	O
oral	oral	JJ	B-NP	B-protein
bacterial	bacterial	JJ	I-NP	I-protein
reductase	reductase	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
saliva	saliva	NN	I-NP	O
of	of	IN	B-PP	O
both	both	DT	B-NP	O
infants	infant	NNS	I-NP	O
and	and	CC	I-NP	O
adults	adult	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
characterized	characterize	VBD	B-VP	O
the	the	DT	B-NP	O
species	species	NN	I-NP	O
of	of	IN	B-PP	O
nitrate	nitrate	NN	B-NP	O
reducing	reduce	VBG	B-VP	O
bacteria	bacteria	NNS	B-NP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
conversion	conversion	NN	I-NP	O
of	of	IN	B-PP	O
nitrate	nitrate	NN	B-NP	O
to	to	TO	B-PP	O
nitrite	nitrite	NN	B-NP	O
in	in	IN	B-PP	O
infants	infant	NNS	B-NP	O
was	be	VBD	B-VP	O
either	either	CC	O	O
undetectable	undetectable	JJ	B-ADJP	O
or	or	CC	O	O
markedly	markedly	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
conversion	conversion	NN	I-NP	O
rates	rate	NNS	I-NP	O
of	of	IN	B-PP	O
adults	adult	NNS	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
measurable	measurable	JJ	I-NP	B-protein
reductase	reductase	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
infants	infant	NNS	B-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
life	life	NN	B-NP	O
,	,	,	O	O
despite	despite	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
nitrate	nitrate	NN	I-NP	O
reducing	reduce	VBG	B-VP	O
bacteria	bacteria	NNS	B-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
Actinomyces	Actinomyce	NNS	B-NP	O
odontolyticus	odontolyticus	NN	I-NP	O
,	,	,	O	O
Veillonella	Veillonella	NNP	B-NP	O
atypica	atypica	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Rothia	Rothia	NNP	B-NP	O
mucilaginosa	mucilaginosa	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
relatively	relatively	RB	B-NP	O
little	little	JJ	I-NP	O
nitrite	nitrite	NN	I-NP	O
reaches	reach	VBZ	B-VP	O
the	the	DT	B-NP	O
infant	infant	JJ	I-NP	O
gastrointestinal	gastrointestinal	JJ	I-NP	O
tract	tract	NN	I-NP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
lack	lack	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	B-protein
bacterial	bacterial	JJ	I-NP	I-protein
nitrate	nitrate	NN	I-NP	I-protein
reductase	reductase	NN	I-NP	I-protein
activity	activity	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
the	the	DT	B-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
nitrate-nitrite-NO	nitrate-nitrite-NO	NN	I-NP	O
axis	axis	NN	I-NP	O
in	in	IN	B-PP	O
adults	adult	NNS	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
lack	lack	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
nitrate-reducing	nitrate-reducing	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
infants	infant	NNS	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
relevant	relevant	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
vulnerability	vulnerability	NN	I-NP	O
of	of	IN	B-PP	O
newborns	newborn	NNS	B-NP	O
to	to	TO	B-PP	O
hypoxic	hypoxic	JJ	B-NP	O
stress	stress	NN	I-NP	O
and	and	CC	O	O
gastrointestinal	gastrointestinal	JJ	B-NP	O
tract	tract	NN	I-NP	O
pathologies	pathology	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
strictly	strictly	RB	I-NP	O
anaerobic	anaerobic	JJ	I-NP	O
Gram-stain-variable	Gram-stain-variable	JJ	I-NP	O
but	but	CC	I-NP	O
positive	positive	JJ	I-NP	O
by	by	IN	B-PP	O
structure	structure	NN	B-NP	O
,	,	,	O	O
non-spore-forming	non-spore-forming	JJ	B-NP	O
bacterium	bacterium	NN	I-NP	O
designated	designate	VBN	B-VP	O
Lachnospiraceae	Lachnospiraceae	NNP	B-NP	O
bacterium	bacterium	NN	I-NP	O
ACC2	ACC2	NN	I-NP	O
strain	strain	NN	I-NP	O
DSM	DSM	NN	I-NP	O
24645	24645	CD	I-NP	O
(	(	(	O	O
T	T	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
human	human	JJ	B-NP	O
subgingival	subgingival	JJ	I-NP	O
dental	dental	JJ	I-NP	O
plaque	plaque	NN	I-NP	O
.	.	.	O	O

Bacterial	Bacterial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
4-40	4-40	CD	B-NP	O
microm	microm	NN	I-NP	O
long	long	JJ	I-NP	O
non-motile	non-motile	JJ	I-NP	O
rods	rod	NNS	I-NP	O
,	,	,	O	O
often	often	RB	B-VP	O
swollen	swell	VBN	I-VP	O
and	and	CC	O	O
forming	form	VBG	B-VP	O
curved	curve	VBN	B-NP	O
filaments	filament	NNS	I-NP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
200	200	CD	I-NP	O
microm	microm	NN	I-NP	O
.	.	.	O	O

Cells	Cell	NNS	B-NP	O
contained	contain	VBD	B-VP	O
intracellular	intracellular	JJ	B-NP	O
,	,	,	I-NP	O
poorly	poorly	JJ	I-NP	O
crystalline	crystalline	NN	I-NP	O
,	,	,	O	O
nanometre-sized	nanometre-sized	JJ	B-NP	O
iron-	iron-	NN	I-NP	O
and	and	CC	O	O
sulfur-rich	sulfur-rich	JJ	B-NP	O
particles	particle	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
micro-organism	micro-organism	NN	I-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
grow	grow	VB	I-VP	O
on	on	IN	B-PP	O
yeast	yeast	NN	B-NP	O
extract	extract	NN	I-NP	O
,	,	,	O	O
trypticase	trypticase	NN	B-NP	O
peptone	peptone	NN	I-NP	O
,	,	,	O	O
milk	milk	NN	B-NP	O
,	,	,	O	O
some	some	DT	B-NP	O
sugars	sugar	NNS	I-NP	O
and	and	CC	O	O
organic	organic	JJ	B-NP	O
acids	acid	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
major	major	JJ	I-NP	O
metabolic	metabolic	JJ	I-NP	O
end-products	end-product	NNS	I-NP	O
of	of	IN	B-PP	O
glucose	glucose	NN	B-NP	O
fermentation	fermentation	NN	I-NP	O
were	be	VBD	B-VP	O
butyrate	butyrate	NN	B-NP	O
,	,	,	I-NP	O
lactate	lactate	NN	I-NP	O
,	,	,	I-NP	O
isovalerate	isovalerate	NN	I-NP	O
and	and	CC	I-NP	O
acetate	acetate	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
growth	growth	NN	I-NP	O
temperature	temperature	NN	I-NP	O
and	and	CC	I-NP	O
pH	pH	NN	I-NP	O
ranges	range	NNS	I-NP	O
were	be	VBD	B-VP	O
30-42	30-42	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
and	and	CC	O	O
4.9-7.5	4.9-7.5	CD	B-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

Major	Major	JJ	B-NP	O
fatty	fatty	JJ	I-NP	O
acids	acid	NNS	I-NP	O
were	be	VBD	B-VP	O
C14	C14	NN	B-NP	O
:	:	:	O	O
0	0	CD	B-NP	O
,	,	,	O	O
C14	C14	NN	B-NP	O
:	:	:	O	O
0	0	CD	B-NP	O
DMA	DMA	NN	I-NP	O
(	(	(	O	O
dimethyl	dimethyl	NN	B-NP	O
aldehyde	aldehyde	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
C16	C16	NN	B-NP	O
:	:	:	O	O
0	0	CD	B-NP	O
,	,	,	O	O
C16	C16	NN	B-NP	O
:	:	:	O	O
1omega7c	1omega7c	CD	B-NP	O
DMA	DMA	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
whole-cell	whole-cell	JJ	I-NP	O
hydrolysate	hydrolysate	NN	I-NP	O
contained	contain	VBD	B-VP	O
meso-diaminopimelic	meso-diaminopimelic	JJ	B-NP	O
acid	acid	NN	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
peptidoglycan	peptidoglycan	NN	B-NP	B-protein
type	type	NN	I-NP	I-protein
A1gamma	A1gamma	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
DNA	DNA	NN	I-NP	O
G+C	G+C	NN	I-NP	O
content	content	NN	I-NP	O
was	be	VBD	B-VP	O
calculated	calculate	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
55.05	55.05	CD	B-NP	O
mol	mol	NN	I-NP	O
%	%	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
whole-genome	whole-genome	JJ	I-NP	B-DNA
sequence	sequence	NN	I-NP	I-DNA
and	and	CC	O	O
55.3	55.3	CD	B-NP	O
mol	mol	NN	I-NP	O
%	%	NN	I-NP	O
as	as	IN	B-SBAR	O
determined	determine	VBN	B-VP	O
by	by	IN	B-PP	O
HPLC	HPLC	NN	B-NP	B-protein
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
predicted	predict	VBN	I-NP	O
genes	gene	NNS	I-NP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
biosynthesis	biosynthesis	NN	B-NP	O
of	of	IN	B-PP	O
respiratory	respiratory	JJ	B-NP	O
lipoquinones	lipoquinone	NNS	I-NP	O
,	,	,	O	O
mycolic	mycolic	JJ	B-NP	O
acids	acid	NNS	I-NP	O
and	and	CC	I-NP	O
lipopolysaccharides	lipopolysaccharide	NNS	I-NP	O
.	.	.	O	O

Genes	Gene	NNS	B-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
synthesis	synthesis	NN	B-NP	O
of	of	IN	B-PP	O
teichoic	teichoic	JJ	B-NP	O
and	and	CC	I-NP	O
lipoteichoic	lipoteichoic	JJ	I-NP	O
acids	acid	NNS	I-NP	O
,	,	,	O	O
diaminopimelic	diaminopimelic	JJ	B-NP	O
acid	acid	NN	I-NP	O
,	,	,	O	O
polar	polar	JJ	B-NP	O
lipids	lipid	NNS	I-NP	O
and	and	CC	I-NP	O
polyamines	polyamine	NNS	I-NP	O
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

According	Accord	VBG	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
16S	16S	NN	I-NP	B-DNA
rRNA	rRNA	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	O
phylogeny	phylogeny	NN	I-NP	O
,	,	,	O	O
strain	strain	NN	B-NP	O
DSM	DSM	NN	I-NP	O
24645	24645	CD	I-NP	O
(	(	(	O	O
T	T	NN	B-NP	O
)	)	)	O	O
formed	form	VBN	B-VP	O
,	,	,	O	O
together	together	RB	B-ADVP	O
with	with	IN	B-PP	O
several	several	JJ	B-NP	O
uncultured	uncultured	JJ	I-NP	B-cell_line
oral	oral	JJ	I-NP	I-cell_line
clones	clone	NNS	I-NP	I-cell_line
,	,	,	O	O
a	a	DT	B-NP	O
separate	separate	JJ	I-NP	O
branch	branch	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
family	family	NN	I-NP	O
Lachnospiraceae	Lachnospiraceae	NNP	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
highest	high	JJS	I-NP	O
sequence	sequence	NN	I-NP	O
similarity	similarity	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
type	type	NN	I-NP	O
strain	strain	NN	I-NP	O
of	of	IN	B-PP	O
Moryella	Moryella	NN	B-NP	B-DNA
indoligenes	indoligene	NNS	I-NP	I-DNA
at	at	IN	B-PP	O
94.2	94.2	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Based	Base	VBN	B-PP	O
on	on	IN	B-PP	O
distinct	distinct	JJ	B-NP	O
phenotypic	phenotypic	JJ	I-NP	O
and	and	CC	I-NP	O
genotypic	genotypic	JJ	I-NP	O
characteristics	characteristic	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
strain	strain	NN	B-NP	O
DSM	DSM	NN	I-NP	O
24645	24645	CD	I-NP	O
(	(	(	O	O
T	T	NN	B-NP	O
)	)	)	O	O
represents	represent	VBZ	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
species	specie	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
genus	genus	NN	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
name	name	NN	I-NP	O
Stomatobaculum	Stomatobaculum	NNP	I-NP	O
longum	longum	NNP	I-NP	O
gen.	gen.	NNP	I-NP	O
nov.	nov.	NNP	I-NP	O
,	,	,	O	O
sp	sp	NN	B-NP	O
.	.	.	O	O

nov.	nov.	LS	B-LST	O
is	be	VBZ	B-VP	O
proposed	propose	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
type	type	NN	I-NP	O
strain	strain	NN	I-NP	O
of	of	IN	B-PP	O
Stomatobaculum	Stomatobaculum	NN	B-NP	O
longum	longum	NN	I-NP	O
is	be	VBZ	B-VP	O
DSM	DSM	NN	B-NP	O
24645	24645	CD	I-NP	O
(	(	(	O	O
T	T	NN	B-NP	O
)	)	)	O	O
(	(	(	O	O
=	=	SYM	O	O
HM-480	HM-480	NN	B-NP	O
(	(	(	O	O
T	T	NN	B-NP	O
)	)	)	O	O
;	;	:	O	O
deposited	deposit	VBN	B-VP	O
in	in	IN	B-PP	O
BEI	BEI	NNP	B-NP	O
Resources	Resource	NNPS	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
NIH	NIH	NNP	I-NP	O
collection	collection	NN	I-NP	O
managed	manage	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
ATCC	ATCC	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Tobacco	Tobacco	NNP	B-NP	O
use	use	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
important	important	JJ	I-NP	O
environmental	environmental	JJ	I-NP	O
risk	risk	NN	I-NP	O
factor	factor	NN	I-NP	O
for	for	IN	B-PP	O
periodontitis	periodontitis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
green	green	JJ	B-NP	O
tea	tea	NN	I-NP	O
epigallocatechin-3-gallate	epigallocatechin-3-gallate	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
nicotine-induced	nicotine-induced	JJ	I-NP	O
toxic	toxic	JJ	I-NP	O
and	and	CC	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
responses	response	NNS	I-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	B-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
gingival	gingival	JJ	B-NP	B-cell_type
fibroblasts	fibroblast	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
nicotine	nicotine	NN	B-NP	O
,	,	,	O	O
alone	alone	RB	B-ADVP	O
and	and	CC	O	O
in	in	IN	B-PP	O
combination	combination	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
lipopolysaccharide	lipopolysaccharide	NN	I-NP	O
of	of	IN	B-PP	O
Aggregatibacter	Aggregatibacter	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
viability	viability	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	B-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
fibroblasts	fibroblast	NNS	B-NP	B-cell_type
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
using	use	VBG	I-VP	O
a	a	DT	B-NP	O
3-	3-	NN	I-NP	O
(	(	(	O	O
4,5-dimethylthiazol-2-yl	4,5-dimethylthiazol-2-yl	NN	B-NP	O
)	)	)	O	O
-2,5-diphenyltetrazolium	-2,5-diphenyltetrazolium	NN	B-NP	O
bromide	bromide	NN	I-NP	O
colorimetric	colorimetric	JJ	I-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
epigallocatechin-3-gallate	epigallocatechin-3-gallate	NN	B-NP	O
to	to	TO	B-VP	O
neutralize	neutralize	VB	I-VP	O
the	the	DT	B-NP	O
nicotine-induced	nicotine-induced	JJ	I-NP	O
cytotoxicity	cytotoxicity	NN	I-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
investigated	investigate	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
nicotine-induced	nicotine-induced	JJ	I-NP	B-protein
cytokine	cytokine	NN	I-NP	I-protein
secretion	secretion	NN	I-NP	O
in	in	IN	B-PP	O
epithelial	epithelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
the	the	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
epigallocatechin-3-gallate	epigallocatechin-3-gallate	NN	B-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
by	by	IN	B-PP	O
enzyme-linked	enzyme-linked	JJ	B-NP	O
immunosorbent	immunosorbent	JJ	I-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
nicotine	nicotine	NN	B-NP	O
caused	cause	VBD	B-VP	O
a	a	DT	B-NP	O
dose-dependent	dose-dependent	JJ	I-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
viability	viability	NN	B-NP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
epithelial	epithelial	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	I-NP	O
fibroblasts	fibroblast	NNS	I-NP	B-cell_type
.	.	.	O	O

A	A	DT	B-NP	O
mixture	mixture	NN	I-NP	O
of	of	IN	B-PP	O
nicotine	nicotine	NN	B-NP	O
and	and	CC	I-NP	O
A.	A.	NN	I-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
lipopolysaccharide	lipopolysaccharide	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
additive	additive	JJ	B-ADJP	O
instead	instead	RB	B-PP	O
of	of	IN	I-PP	O
synergistic	synergistic	JJ	B-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
loss	loss	NN	B-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
viability	viability	NN	I-NP	O
.	.	.	O	O

Pretreatment	Pretreatment	NN	B-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
with	with	IN	B-PP	O
epigallocatechin-3-gallate	epigallocatechin-3-gallate	NN	B-NP	O
efficiently	efficiently	RB	B-ADVP	O
neutralized	neutralize	VBD	B-VP	O
the	the	DT	B-NP	O
nicotine-induced	nicotine-induced	JJ	I-NP	O
toxic	toxic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
in	in	IN	B-PP	O
epithelial	epithelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
fibroblasts	fibroblast	NNS	B-NP	B-cell_type
.	.	.	O	O

It	It	PRP	B-NP	O
also	also	RB	B-ADVP	O
dose	dose	NN	B-NP	O
dependently	dependently	RB	B-ADVP	O
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
nicotine-induced	nicotine-induced	JJ	I-NP	O
secretion	secretion	NN	I-NP	O
of	of	IN	B-PP	O
chemokine	chemokine	NN	B-NP	B-protein
(	(	(	O	O
C-C	C-C	NN	B-NP	B-DNA
motif	motif	NN	I-NP	I-DNA
)	)	)	O	O
ligand	ligand	NN	B-NP	O
5	5	CD	I-NP	O
by	by	IN	B-PP	O
epithelial	epithelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
epigallocatechin-3-gallate	epigallocatechin-3-gallate	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
polyphenol	polyphenol	NN	I-NP	O
in	in	IN	B-PP	O
green	green	JJ	B-NP	O
tea	tea	NN	I-NP	O
,	,	,	O	O
may	may	MD	B-VP	O
represent	represent	VB	I-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
preventive/therapeutic	preventive/therapeutic	JJ	I-NP	O
agent	agent	NN	I-NP	O
for	for	IN	B-PP	O
smoking-related	smoking-related	JJ	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
periodontal	periodontal	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
are	be	VBP	B-VP	O
characterised	characterise	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
dysregulated	dysregulate	VBN	I-NP	O
and	and	CC	I-NP	O
exaggerated	exaggerate	VBN	I-NP	O
inflammatory/immune	inflammatory/immune	JJ	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-VP	O
plaque	plaque	VB	I-VP	O
bacteria	bacteria	NNS	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
previously	previously	RB	B-ADVP	O
that	that	IN	B-SBAR	O
oral	oral	JJ	B-NP	B-cell_type
keratinocytes	keratinocyte	NNS	I-NP	I-cell_type
up-regulate	up-regulate	VBP	B-VP	O
key	key	JJ	B-NP	O
molecular	molecular	JJ	I-NP	O
markers	marker	NNS	I-NP	O
of	of	IN	B-PP	O
inflammation	inflammation	NN	B-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
and	and	CC	I-NP	O
cytokine	cytokine	NN	I-NP	B-protein
signalling	signalling	NN	I-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
exposed	expose	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
periodontal	periodontal	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
Porphyromonas	Porphyromonas	NN	I-NP	O
gingivalis	gingivalis	NN	I-NP	O
and	and	CC	O	O
Fusobacterium	Fusobacterium	NN	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
purpose	purpose	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
current	current	JJ	I-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
whether	whether	IN	B-SBAR	O
alpha-lipoic	alpha-lipoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
abrogate	abrogate	VB	I-VP	O
bacterially-induced	bacterially-induced	JJ	B-NP	O
pro-inflammatory	pro-inflammatory	JJ	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
H400	H400	NN	I-NP	B-cell_line
oral	oral	JJ	I-NP	I-cell_line
epithelial	epithelial	JJ	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

Initial	Initial	JJ	B-NP	O
studies	study	NNS	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
alpha-lipoic	alpha-lipoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
supplementation	supplementation	NN	I-NP	O
(	(	(	O	O
1-4	1-4	CD	B-NP	O
mM	mM	NN	I-NP	O
)	)	)	O	O
significantly	significantly	RB	B-ADVP	O
reduced	reduce	VBD	B-VP	O
cell	cell	NN	B-NP	O
attachment	attachment	NN	I-NP	O
;	;	:	O	O
lower	low	JJR	B-NP	O
concentrations	concentration	NNS	I-NP	O
(	(	(	O	O
<	<	SYM	B-NP	O
0.5	0.5	CD	B-NP	O
mM	mM	NN	I-NP	O
)	)	)	O	O
enabled	enable	VBD	B-VP	O
>	>	SYM	B-NP	O
85	85	CD	B-NP	O
%	%	NN	I-NP	O
cell	cell	NN	I-NP	O
adhesion	adhesion	NN	I-NP	O
at	at	IN	B-PP	O
24	24	CD	B-NP	O
h.	h.	NN	I-NP	O
While	While	IN	B-SBAR	O
a	a	DT	B-NP	O
pro-inflammatory	pro-inflammatory	JJ	I-NP	O
response	response	NN	I-NP	O
,	,	,	O	O
demonstrable	demonstrable	JJ	B-ADJP	O
by	by	IN	B-PP	O
NF-kappaB	NF-kappaB	NN	B-NP	B-protein
translocation	translocation	NN	I-NP	O
,	,	,	O	O
gene	gene	NN	B-NP	O
expression	expression	NN	B-NP	O
and	and	CC	O	O
protein	protein	NN	B-NP	O
production	production	NN	I-NP	O
was	be	VBD	B-VP	O
evident	evident	JJ	B-ADJP	O
in	in	IN	B-PP	O
H400	H400	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
following	follow	VBG	B-PP	O
exposure	exposure	NN	B-NP	O
to	to	TO	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
and	and	CC	O	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
,	,	,	O	O
pre-incubation	pre-incubation	NN	B-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
with	with	IN	B-PP	O
0.5	0.5	CD	B-NP	O
mM	mM	NN	I-NP	O
alpha-lipoic	alpha-lipoic	JJ	I-NP	O
acid	acid	NN	I-NP	O
modulated	modulate	VBD	B-VP	O
this	this	DT	B-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

alpha-Lipoic	alpha-Lipoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
pre-treatment	pre-treatment	NN	I-NP	O
significantly	significantly	RB	B-ADVP	O
decreased	decrease	VBD	B-VP	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
bacterially-induced	bacterially-induced	JJ	B-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
activation	activation	NN	I-NP	O
and	and	CC	O	O
IL-8	IL-8	NN	B-NP	B-protein
protein	protein	NN	I-NP	I-protein
production	production	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
differentially	differentially	RB	B-VP	O
modulated	modulate	VBN	I-VP	O
transcript	transcript	NN	B-NP	O
levels	level	NNS	I-NP	O
for	for	IN	B-PP	O
IL-8	IL-8	NN	B-NP	B-protein
,	,	,	O	O
IL-1beta	IL-1beta	NN	B-NP	B-protein
,	,	,	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
and	and	CC	O	O
GM-CSF	GM-CSF	NN	B-NP	B-protein
,	,	,	O	O
TLR2	TLR2	NN	B-NP	B-protein
,	,	,	O	O
4	4	CD	B-NP	O
,	,	,	I-NP	O
9	9	CD	I-NP	O
,	,	,	O	O
S100A8	S100A8	NN	B-NP	B-protein
,	,	,	O	O
S100A9	S100A9	NN	B-NP	B-protein
,	,	,	O	O
lysyl	lysyl	NN	B-NP	B-protein
oxidase	oxidase	NN	I-NP	I-protein
,	,	,	O	O
NF-kappaB1	NF-kappaB1	NN	B-NP	B-protein
,	,	,	O	O
HMOX	HMOX	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
SOD2	SOD2	NN	B-NP	B-protein
.	.	.	O	O

Overall	Overall	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
data	datum	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
alpha-lipoic	alpha-lipoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
exerts	exert	VBZ	B-VP	O
an	an	DT	B-NP	O
anti-inflammatory	anti-inflammatory	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	B-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
exposed	expose	VBN	B-VP	O
to	to	TO	B-PP	O
periodontal	periodontal	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
thus	thus	RB	B-VP	O
may	may	MD	I-VP	O
provide	provide	VB	I-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
adjunctive	adjunctive	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
for	for	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
determine	determine	VB	I-VP	O
if	if	IN	B-SBAR	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
formulation	formulation	NN	I-NP	O
is	be	VBZ	B-VP	O
effective	effective	JJ	B-ADJP	O
in	in	IN	B-PP	O
killing	kill	VBG	B-VP	O
oral	oral	JJ	B-NP	O
biofilm	biofilm	NN	I-NP	O
streptococci	streptococci	NNS	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
and	and	CC	O	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
.	.	.	O	O

Efficacy	Efficacy	NN	B-NP	O
of	of	IN	B-PP	O
0.5	0.5	CD	B-NP	O
%	%	NN	I-NP	O
levulinic	levulinic	JJ	I-NP	O
acid	acid	NN	I-NP	O
and	and	CC	O	O
0.05	0.05	CD	B-NP	O
%	%	NN	I-NP	O
sodium	sodium	NN	I-NP	O
dodecyl	dodecyl	NN	I-NP	O
sulfate	sulfate	NN	I-NP	O
(	(	(	O	O
SDS	SDS	NN	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
killing	kill	VBG	B-VP	O
Streptococcus	Streptococcus	NNP	B-NP	O
gordonii	gordonii	NNP	I-NP	O
CH1	CH1	NNP	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
gordonii	gordonii	NNP	I-NP	O
DL1	DL1	NNP	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mitis	mitis	NNP	I-NP	O
NCTC10712	NCTC10712	NNP	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
oralis	oralis	NNP	I-NP	O
KS32AR	KS32AR	NN	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
BM71	BM71	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
GS5	GS5	NN	I-NP	B-protein
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
biofilm	biofilm	NN	I-NP	O
form	form	NN	I-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
,	,	,	O	O
using	use	VBG	B-VP	O
microtiter	microtiter	NN	B-NP	O
plates	plate	NNS	I-NP	O
and	and	CC	O	O
subsequent	subsequent	JJ	B-NP	O
counts	count	NNS	I-NP	O
on	on	IN	B-PP	O
Mitis-Salivarius	Mitis-Salivarius	NNP	B-NP	O
agar	agar	NN	I-NP	O
plates	plate	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
safety	safety	NN	I-NP	O
and	and	CC	I-NP	O
efficacy	efficacy	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
were	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
mouse	mouse	NN	I-NP	O
model	model	NN	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
anti-microbial	anti-microbial	JJ	I-NP	O
formulation	formulation	NN	I-NP	O
completely	completely	RB	B-ADVP	O
eliminated	eliminate	VBD	B-VP	O
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
biofilm	biofilm	NN	I-NP	O
streptococcal	streptococcal	JJ	I-NP	O
species	specie	NNS	I-NP	O
tested	test	VBN	B-VP	O
within	within	IN	B-PP	O
30	30	CD	B-NP	O
seconds	second	NNS	I-NP	O
(	(	(	O	O
a	a	DT	B-NP	O
reduction	reduction	NN	I-NP	O
of	of	IN	B-PP	O
10	10	CD	B-NP	O
(	(	(	O	O
7	7	CD	B-NP	O
)	)	)	O	O
CFU/ml	CFU/ml	NNP	B-NP	O
)	)	)	O	O
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
positive	positive	JJ	I-NP	O
control	control	NN	I-NP	O
Listerine	Listerine	NN	I-NP	O
only	only	RB	B-ADVP	O
demonstrated	demonstrate	VBD	B-VP	O
moderate	moderate	JJ	B-NP	O
reduction	reduction	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O

Application	Application	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
formulation	formulation	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
for	for	IN	B-PP	O
7	7	CD	B-NP	O
days	day	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
murine	murine	JJ	I-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
significantly	significantly	RB	B-NP	O
more	more	JJR	I-NP	O
reduction	reduction	NN	I-NP	O
of	of	IN	B-PP	O
established	establish	VBN	B-NP	O
S.	S.	NNP	I-NP	O
gordonii	gordonii	NN	I-NP	O
DL1	DL1	NN	I-NP	O
oral	oral	JJ	I-NP	O
biofilm	biofilm	NN	I-NP	O
bacteria	bacteria	NNS	I-NP	O
than	than	IN	B-PP	O
Listerine	Listerine	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
formulation	formulation	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
cause	cause	VB	I-VP	O
any	any	DT	B-NP	O
adverse	adverse	JJ	I-NP	O
effect	effect	NN	I-NP	O
in	in	IN	B-PP	O
murine	murine	JJ	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
2-week	2-week	JJ	I-NP	O
period	period	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
novel	novel	JJ	I-NP	O
mouth	mouth	NN	I-NP	O
rinse	rinse	NN	I-NP	O
exhibits	exhibit	VBZ	B-VP	O
high	high	JJ	B-NP	O
efficacy	efficacy	NN	I-NP	O
in	in	IN	B-PP	O
killing	kill	VBG	B-VP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
biofilm	biofilm	NN	I-NP	O
forms	form	NNS	I-NP	O
,	,	,	O	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
adverse	adverse	JJ	I-NP	O
effect	effect	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
contains	contain	VBZ	B-VP	O
alcohol-free	alcohol-free	JJ	B-NP	B-protein
components	component	NNS	I-NP	I-protein
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
compared	compare	VBD	B-VP	O
the	the	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
commercial	commercial	JJ	I-NP	O
dentifrice	dentifrice	NN	I-NP	O
formulations	formulation	NNS	I-NP	O
:	:	:	O	O
sodium	sodium	NN	B-NP	O
fluoride/triclosan/copolymer	fluoride/triclosan/copolymer	NN	I-NP	O
(	(	(	O	O
TCN/C	TCN/C	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
stannous	stannous	JJ	B-NP	O
fluoride/sodium	fluoride/sodium	NN	I-NP	O
hexametaphosphate/zinc	hexametaphosphate/zinc	NN	I-NP	O
lactate	lactate	NN	I-NP	O
(	(	(	O	O
SnF	SnF	NN	B-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
/SHMP	/SHMP	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
sodium	sodium	NN	B-NP	O
fluoride	fluoride	NN	I-NP	O
(	(	(	O	O
NaF	NaF	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O


adults	adult	NNS	B-NP	O
(	(	(	O	O
15	15	CD	B-NP	O
men	man	NNS	I-NP	O
and	and	CC	O	O
20	20	CD	B-NP	O
women	woman	NNS	I-NP	O
;	;	:	O	O
average	average	JJ	B-NP	O
age	age	NN	I-NP	O
33	33	CD	B-NP	O
years	year	NNS	I-NP	O
and	and	CC	O	O
pockets	pocket	NNS	B-NP	O
<	<	SYM	O	O
5	5	CD	B-NP	O
mm	mm	NN	I-NP	O
)	)	)	O	O
completed	complete	VBD	B-VP	O
this	this	DT	B-NP	O
double-blind	double-blind	JJ	I-NP	O
,	,	,	I-NP	O
triple-crossover	triple-crossover	JJ	I-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
washout	washout	NN	B-NP	O
,	,	,	O	O
baseline	baseline	NN	B-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
four	four	CD	B-NP	O
sites	site	NNS	I-NP	O
,	,	,	O	O
plaque	plaque	NN	B-NP	O
,	,	,	O	O
saliva	saliva	NN	B-NP	O
,	,	,	O	O
tongue	tongue	NN	B-NP	O
and	and	CC	O	O
buccal	buccal	JJ	B-NP	O
mucosa	mucosa	NN	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
and	and	CC	O	O
evaluated	evaluate	VBN	B-VP	O
for	for	IN	B-PP	O
six	six	CD	B-NP	O
microbial	microbial	JJ	I-NP	O
types	type	NNS	I-NP	O
,	,	,	O	O
anaerobes	anaerobe	NNS	B-NP	O
,	,	,	O	O
Streptococci	Streptococci	NNP	B-NP	O
,	,	,	O	O
Actinomyces	Actinomyces	NNP	B-NP	O
,	,	,	O	O
hydrogen-sulphide	hydrogen-sulphide	NN	B-NP	O
(	(	(	O	O
H	H	NN	B-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
S	S	NN	B-NP	O
)	)	)	O	O
-producing	-producing	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
Fusobacteria	Fusobacteria	NNS	B-NP	O
and	and	CC	O	O
Veillonella	Veillonella	NNP	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
specific	specific	JJ	I-NP	O
dentifrice	dentifrice	NN	I-NP	O
was	be	VBD	B-VP	O
randomly	randomly	RB	I-VP	O
assigned	assign	VBN	I-VP	O
for	for	IN	B-PP	O
twice-daily	twice-daily	JJ	B-NP	O
use	use	NN	I-NP	O
for	for	IN	B-PP	O
13	13	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
day	day	NN	B-NP	O
14	14	CD	I-NP	O
,	,	,	I-NP	O
12	12	CD	I-NP	O
h	h	NN	I-NP	O
after	after	IN	B-PP	O
brushing	brush	VBG	B-VP	O
,	,	,	O	O
samples	sample	NNS	B-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
for	for	IN	B-PP	O
microbiological	microbiological	JJ	B-NP	O
evaluations	evaluation	NNS	I-NP	O
.	.	.	O	O

Alternate	Alternate	JJ	B-NP	O
dentifrices	dentifrice	NNS	I-NP	O
followed	follow	VBD	B-VP	O
this	this	DT	B-NP	O
identical	identical	JJ	I-NP	O
protocol	protocol	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
all	all	DT	B-NP	O
four	four	CD	I-NP	O
oral	oral	JJ	I-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
and	and	CC	O	O
six	six	CD	B-NP	O
organisms	organism	NNS	I-NP	O
evaluated	evaluate	VBN	B-VP	O
in	in	IN	B-PP	O
each	each	DT	B-NP	O
site	site	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
TCN/C	TCN/C	NN	I-NP	B-protein
demonstrated	demonstrate	VBD	B-VP	O
significant	significant	JJ	B-NP	O
reductions	reduction	NNS	I-NP	O
(	(	(	O	O
49-83	49-83	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
as	as	IN	B-PP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
treatments	treatment	NNS	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.01	0.01	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
SnF	SnF	NN	I-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
/SHMP	/SHMP	NN	B-NP	B-protein
group	group	NN	I-NP	I-protein
showed	show	VBD	B-VP	O
significant	significant	JJ	B-NP	O
reductions	reduction	NNS	I-NP	O
of	of	IN	B-PP	O
14-43	14-43	CD	B-NP	O
%	%	NN	I-NP	O
for	for	IN	B-PP	O
14	14	CD	B-NP	O
of	of	IN	B-PP	O
24	24	CD	B-NP	O
outcomes	outcome	NNS	I-NP	O
as	as	IN	B-PP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
NaF	NaF	NN	I-NP	B-protein
group	group	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.01	0.01	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
10	10	CD	B-NP	O
outcomes	outcome	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
TCN/C	TCN/C	NN	I-NP	O
dentifrice	dentifrice	NN	I-NP	O
formulation	formulation	NN	I-NP	O
consistently	consistently	RB	B-ADVP	O
demonstrated	demonstrate	VBD	B-VP	O
significant	significant	JJ	B-NP	O
reductions	reduction	NNS	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
microorganisms	microorganism	NNS	B-NP	O
in	in	IN	B-PP	O
diverse	diverse	JJ	B-NP	O
oral	oral	JJ	I-NP	O
sites	site	NNS	I-NP	O
in	in	IN	B-PP	O
comparison	comparison	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
NaF	NaF	NN	I-NP	B-protein
,	,	,	O	O
or	or	CC	O	O
the	the	DT	B-NP	O
SnF	SnF	NN	I-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
/SHMP	/SHMP	NN	B-NP	B-protein
dentifrice	dentifrice	NN	I-NP	O
formulations	formulation	NNS	I-NP	O
as	as	IN	B-PP	O
seen	see	VBN	B-NP	O
12	12	CD	I-NP	O
h	h	NN	I-NP	O
after	after	IN	B-PP	O
brushing	brush	VBG	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
University	University	NNP	I-NP	O
of	of	IN	B-PP	O
Nevada	Nevada	NNP	B-NP	O
,	,	,	O	O
Las	Las	NNP	B-NP	O
Vegas	Vegas	NNP	I-NP	O
School	School	NNP	I-NP	O
of	of	IN	B-PP	O
Dental	Dental	NNP	B-NP	O
Medicine	Medicine	NNP	I-NP	O
recently	recently	RB	B-ADVP	O
opened	open	VBD	B-VP	O
an	an	DT	B-NP	O
orthodontic	orthodontic	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
clinic	clinic	NN	I-NP	O
to	to	TO	B-VP	O
address	address	VB	I-VP	O
the	the	DT	B-NP	O
needs	need	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
racially	racially	RB	I-NP	O
and	and	CC	O	O
ethnically	ethnically	RB	B-NP	O
diverse	diverse	JJ	I-NP	O
population	population	NN	I-NP	O
of	of	IN	B-PP	O
Southern	Southern	NNP	B-NP	O
Nevada	Nevada	NNP	I-NP	O
,	,	,	O	O
primarily	primarily	RB	B-ADVP	O
focusing	focus	VBG	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
and	and	CC	I-NP	O
care	care	NN	I-NP	O
of	of	IN	B-PP	O
low-income	low-income	NN	B-NP	O
and	and	CC	I-NP	O
minority	minority	NN	I-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
orthodontic	orthodontic	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
and	and	CC	I-NP	O
therapy	therapy	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
induce	induce	VB	I-VP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
,	,	,	O	O
much	much	JJ	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
evidence	evidence	NN	I-NP	O
was	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
from	from	IN	B-PP	O
traditional	traditional	JJ	B-NP	O
White	White	NNP	I-NP	O
,	,	,	O	O
teenage	teenage	VB	B-VP	O
orthodontic	orthodontic	JJ	B-NP	B-cell_type
clinic	clinic	NN	I-NP	I-cell_type
populations	population	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
primary	primary	JJ	I-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
describe	describe	VB	I-VP	O
the	the	DT	B-NP	O
microbial	microbial	JJ	I-NP	O
burden	burden	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cariogenic	cariogenic	JJ	I-NP	O
and	and	CC	I-NP	O
periodontal	periodontal	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
and	and	CC	O	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
UNLV-SDM	UNLV-SDM	NN	I-NP	B-cell_line
patient	patient	NN	I-NP	I-cell_line
population	population	NN	I-NP	I-cell_line
.	.	.	O	O

Representative	Representative	JJ	B-NP	O
saliva	saliva	NN	I-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
from	from	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
adult	adult	JJ	I-NP	O
patients	patient	NNS	I-NP	O
for	for	IN	B-PP	O
DNA	DNA	NN	B-NP	O
isolation	isolation	NN	I-NP	O
.	.	.	O	O

Relative	Relative	JJ	B-NP	O
endpoint	endpoint	NN	I-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
(	(	(	O	O
RE-PCR	RE-PCR	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
to	to	TO	I-VP	O
ascertain	ascertain	VB	I-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
and	and	CC	O	O
relative	relative	JJ	B-NP	O
microbial	microbial	JJ	I-NP	O
burden	burden	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
oral	oral	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
.	.	.	O	O

Nearly	Nearly	RB	B-NP	O
one	one	CD	I-NP	O
quarter	quarter	NN	I-NP	O
(	(	(	O	O
13/56	13/56	CD	B-NP	O
)	)	)	O	O
or	or	CC	O	O
23.3	23.3	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
patients	patient	NNS	I-NP	O
had	have	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
(	(	(	O	O
10/56	10/56	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
17.8	17.8	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
elevated	elevate	VBN	I-VP	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
-	-	HYPH	O	O
with	with	IN	B-PP	O
(	(	(	O	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
P.	P.	NN	B-NP	O
gingivalis-positive	gingivalis-positive	JJ	I-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
minority	minority	NN	B-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
X2=17.921	X2=17.921	NN	B-NP	O
,	,	,	O	O
d.f	d.f	NN	B-NP	O
.	.	.	O	O

=	=	SYM	O	O
1	1	CD	B-NP	O
;	;	:	O	O
p	p	NN	B-NP	O
<	<	SYM	B-NP	O
0.0001	0.0001	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
of	of	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
P.	P.	NNP	I-NP	O
gingivalis	gingivalis	NN	I-NP	O
levels	level	NNS	I-NP	O
,	,	,	O	O
primarily	primarily	RB	B-ADVP	O
among	among	IN	B-PP	O
minority	minority	NN	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
may	may	MD	B-VP	O
suggest	suggest	VB	I-VP	O
underlying	underlie	VBG	I-VP	O
oral	oral	JJ	B-NP	O
health	health	NN	I-NP	O
practices	practice	NNS	I-NP	O
contributing	contribute	VBG	B-VP	O
to	to	TO	B-PP	O
adverse	adverse	JJ	B-NP	O
oral	oral	JJ	I-NP	O
health	health	NN	I-NP	O
conditions	condition	NNS	I-NP	O
within	within	IN	B-PP	O
this	this	DT	B-NP	O
population	population	NN	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
health	health	NN	I-NP	O
knowledge	knowledge	NN	I-NP	O
and	and	CC	O	O
practices	practice	NNS	B-NP	O
among	among	IN	B-PP	O
minority	minority	NN	B-NP	O
patients	patient	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
strongly	strongly	RB	I-VP	O
influenced	influence	VBN	I-VP	O
by	by	IN	B-PP	O
other	other	JJ	B-NP	O
factors	factor	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
education	education	NN	B-NP	O
and	and	CC	O	O
socioeconomic	socioeconomic	JJ	B-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
additional	additional	JJ	B-NP	O
research	research	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
needed	need	VBN	I-VP	O
to	to	TO	B-VP	O
accurately	accurately	RB	I-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
appropriate	appropriate	JJ	I-NP	O
standards	standard	NNS	I-NP	O
for	for	IN	B-PP	O
care	care	NN	B-NP	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
health	health	NN	I-NP	O
education	education	NN	I-NP	O
within	within	IN	B-PP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
population	population	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
compare	compare	VB	I-VP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
prevalence	prevalence	NN	I-NP	O
and	and	CC	O	O
antimicrobial	antimicrobial	JJ	B-NP	O
susceptibility	susceptibility	NN	I-NP	O
of	of	IN	B-PP	O
candida	candida	NN	B-NP	O
spp.	spp.	NN	I-NP	O
,	,	,	O	O
staphylococci	staphylococci	NN	B-NP	O
,	,	,	O	O
enterobacteriaceae	enterobacteriaceae	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
pseudomonas	pseudomonas	NN	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

from	from	IN	B-PP	O
ankylosing	ankylose	VBG	B-VP	O
spondylitis	spondylitis	NN	B-NP	O
(	(	(	O	O
AS	AS	NN	B-NP	O
)	)	)	O	O
patients	patient	NNS	B-NP	O
receiving	receive	VBG	B-VP	O
conventional	conventional	JJ	B-NP	O
and	and	CC	I-NP	O
anti-TNF-alpha	anti-TNF-alpha	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
study	study	NN	I-NP	O
included	include	VBD	B-VP	O
70	70	CD	B-NP	O
AS	AS	JJ	I-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
diagnosed	diagnose	VBN	B-VP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
modified	modify	VBN	I-NP	O
New	New	NNP	I-NP	O
York	York	NNP	I-NP	O
criteria	criterion	NNS	I-NP	O
(	(	(	O	O
1984	1984	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
volunteers	volunteer	NNS	I-NP	O
were	be	VBD	B-VP	O
divided	divide	VBN	I-VP	O
into	into	IN	B-PP	O
2	2	CD	B-NP	O
groups	group	NNS	I-NP	O
:	:	:	O	O
a	a	DT	B-NP	O
biological	biological	JJ	I-NP	O
group	group	NN	I-NP	O
(	(	(	O	O
AS	AS	NNP	B-NP	O
BioG	BioG	NNP	I-NP	O
)	)	)	O	O
(	(	(	O	O
n=35	n=35	NN	B-NP	O
)	)	)	O	O
(	(	(	O	O
on	on	IN	B-PP	O
anti-TNF-alpha	anti-TNF-alpha	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
conventional	conventional	JJ	I-NP	O
group	group	NN	I-NP	O
(	(	(	O	O
AS	AS	JJ	B-NP	O
ConvG	ConvG	NN	I-NP	O
)	)	)	O	O
(	(	(	O	O
n=35	n=35	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
(	(	(	O	O
ContG	ContG	NN	B-NP	O
)	)	)	O	O
(	(	(	O	O
n=70	n=70	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
up	up	RP	B-PRT	O
of	of	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
individuals	individual	NNS	I-NP	O
matched	match	VBN	B-VP	O
for	for	IN	B-PP	O
age	age	NN	B-NP	O
,	,	,	O	O
gender	gender	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
examination	examination	NN	I-NP	O
,	,	,	O	O
oral	oral	JJ	B-NP	O
rinse	rinse	NN	I-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
and	and	CC	O	O
plated	plat	VBN	B-VP	O
in	in	IN	B-PP	O
specific	specific	JJ	B-NP	O
culture	culture	NN	I-NP	O
media	medium	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
colony-forming	colony-forming	JJ	B-NP	B-protein
units	unit	NNS	I-NP	I-protein
per	per	IN	B-PP	O
milliliter	milliliter	NN	B-NP	O
(	(	(	O	O
cfu/ml	cfu/ml	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
isolates	isolate	NNS	B-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
API	API	NN	I-NP	O
system	system	NN	I-NP	O
.	.	.	O	O

Antimicrobial	Antimicrobial	JJ	B-NP	O
susceptibility	susceptibility	NN	I-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
NCCLS	NCCLS	NN	I-NP	B-cell_line
guidelines	guideline	NNS	I-NP	I-cell_line
.	.	.	O	O

Prevalence	Prevalence	NN	B-NP	O
and	and	CC	I-NP	O
counts	count	NNS	I-NP	O
of	of	IN	B-PP	O
microorganisms	microorganism	NNS	B-NP	O
were	be	VBD	B-VP	O
statistically	statistically	RB	I-VP	O
compared	compare	VBN	I-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
3	3	CD	I-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
Mann-Whitney	Mann-Whitney	JJ	I-NP	O
and	and	CC	I-NP	O
Chi-square	Chi-square	JJ	I-NP	O
tests	test	NNS	I-NP	O
.	.	.	O	O

Significance	Significance	NN	B-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
set	set	VBN	I-VP	O
at	at	IN	B-PP	O
5	5	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
AS	AS	NNP	I-NP	O
BioG	BioG	NNP	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
AS	AS	NNP	I-NP	O
ConvG	ConvG	NNP	I-NP	O
,	,	,	O	O
staphylococci	staphylococci	NNS	B-NP	O
counts	count	NNS	I-NP	O
were	be	VBD	B-VP	O
higher	high	JJR	B-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ContG	ContG	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.0001	0.0001	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Candida	Candida	NN	B-NP	O
albicans	albican	NNS	I-NP	O
and	and	CC	O	O
staphylococcus	staphylococcus	NN	B-NP	B-protein
epidermidis	epidermidis	NN	I-NP	I-protein
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
commonly	commonly	RB	I-NP	O
found	find	VBN	I-NP	O
species	specie	NNS	I-NP	O
in	in	IN	B-PP	O
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

Serratia	Serratia	NNP	B-NP	O
marcescens	marcescen	NNS	I-NP	O
and	and	CC	O	O
klebsiella	klebsiella	NN	B-NP	O
oxytoca	oxytoca	NN	I-NP	O
were	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
prevalent	prevalent	JJ	I-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
AS	AS	NNP	I-NP	O
BioG	BioG	NNP	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
AS	AS	NNP	I-NP	O
ConvG	ConvG	NNP	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
candida	candida	NN	I-NP	O
isolates	isolate	NNS	I-NP	O
(	(	(	O	O
2.8	2.8	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
AS	AS	NNP	I-NP	O
BioG	BioG	NNP	I-NP	O
and	and	CC	O	O
5	5	CD	B-NP	O
(	(	(	O	O
10.8	10.8	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
AS	AS	JJ	I-NP	O
ConvG	ConvG	NN	I-NP	O
were	be	VBD	B-VP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
amphotericin	amphotericin	NN	B-NP	O
B	B	NN	I-NP	O
and	and	CC	O	O
5-fluorocytosine	5-fluorocytosine	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
low	low	JJ	I-NP	O
percentage	percentage	NN	I-NP	O
of	of	IN	B-PP	O
staphylococci	staphylococci	NNS	B-NP	O
isolates	isolate	NNS	I-NP	O
was	be	VBD	B-VP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
amoxicillin	amoxicillin	NN	B-NP	O
,	,	,	O	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
doxycycline	doxycycline	NN	B-NP	O
.	.	.	O	O

Higher	High	JJR	B-NP	O
counts	count	NNS	I-NP	O
of	of	IN	B-PP	O
staphylococci	staphylococci	NNS	B-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
AS	AS	JJ	I-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
regardless	regardless	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
current	current	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
,	,	,	O	O
age	age	NN	B-NP	O
,	,	,	O	O
sex	sex	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
.	.	.	O	O

Anti-TNF-alpha	Anti-TNF-alpha	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
counts	count	NNS	I-NP	O
of	of	IN	B-PP	O
microorganisms	microorganism	NNS	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
aimed	aim	VBD	B-VP	O
to	to	TO	I-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
capacity	capacity	NN	I-NP	O
of	of	IN	B-PP	O
whole-genome	whole-genome	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
probes	probe	NNS	I-NP	O
prepared	prepare	VBN	B-VP	O
from	from	IN	B-PP	O
human	human	JJ	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
to	to	TO	B-VP	O
cross-react	cross-react	VB	I-VP	O
with	with	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
of	of	IN	B-PP	O
rats	rat	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
influence	influence	NN	I-NP	O
of	of	IN	B-PP	O
alcohol	alcohol	NN	B-NP	O
ingestion	ingestion	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
animals	animal	NNS	I-NP	O
'	'	POS	B-NP	O
oral	oral	JJ	I-NP	O
biofilm	biofilm	NN	I-NP	O
.	.	.	O	O

Twenty	Twenty	CD	B-NP	O
four	four	CD	I-NP	O
mature	mature	JJ	I-NP	O
Wistar	Wistar	NNP	I-NP	O
rats	rat	NNS	I-NP	O
were	be	VBD	B-VP	O
equally	equally	RB	I-VP	O
divided	divide	VBN	I-VP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
group	group	NN	I-NP	O
(	(	(	O	O
control	control	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
fed	feed	VBN	I-VP	O
balanced	balanced	JJ	B-NP	O
diet	diet	NN	I-NP	O
of	of	IN	B-PP	O
rat	rat	NN	B-NP	O
pellets	pellet	NNS	I-NP	O
and	and	CC	O	O
water	water	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
alcohol-treated	alcohol-treated	JJ	I-NP	O
group	group	NN	I-NP	O
(	(	(	O	O
AT	AT	NN	B-NP	O
)	)	)	O	O
received	receive	VBD	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
ethanol	ethanol	NN	I-NP	O
solution	solution	NN	I-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
euthanasia	euthanasia	NN	B-NP	O
after	after	IN	B-PP	O
30	30	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
bacterial	bacterial	JJ	B-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
biofilm	biofilm	NN	I-NP	O
covering	cover	VBG	B-VP	O
the	the	DT	B-NP	O
animals	animal	NNS	I-NP	O
'	'	POS	B-NP	O
teeth	tooth	NNS	I-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
using	use	VBG	B-VP	O
microbrushes	microbrush	NNS	B-NP	O
.	.	.	O	O

Bacteria	Bacteria	NN	B-NP	O
identification	identification	NN	I-NP	O
and	and	CC	I-NP	O
quantification	quantification	NN	I-NP	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	O
checkerboard	checkerboard	NN	I-NP	O
hybridization	hybridization	NN	I-NP	O
method	method	NN	I-NP	O
with	with	IN	B-PP	O
33	33	CD	B-NP	O
probes	probe	NNS	I-NP	O
prepared	prepare	VBN	B-VP	O
from	from	IN	B-PP	O
human	human	JJ	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

Signals	Signal	NNS	B-NP	O
corresponding	correspond	VBG	B-VP	O
to	to	TO	B-PP	O
bacterial	bacterial	JJ	B-NP	O
genome	genome	NN	I-NP	O
counts	count	NNS	I-NP	O
and	and	CC	I-NP	O
percentages	percentage	NNS	I-NP	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
Mann-Whitney	Mann-Whitney	NNP	I-NP	O
U	U	NNP	I-NP	O
test	test	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
significance	significance	NN	I-NP	O
level	level	NN	I-NP	O
<	<	SYM	B-NP	O
0.05	0.05	CD	I-NP	O
.	.	.	O	O

Cross-reaction	Cross-reaction	NN	B-NP	O
for	for	IN	B-PP	O
all	all	DT	B-NP	O
targeted	target	VBN	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
except	except	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
and	and	CC	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mitis-like	mitis-like	JJ	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
occurred	occur	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
.	.	.	O	O

Escherichia	Escherichia	NNP	B-NP	O
coli	coli	NNP	I-NP	O
,	,	,	O	O
Pseudomonas	Pseudomonas	NNP	B-NP	O
aeruginosa	aeruginosa	NNP	I-NP	O
,	,	,	O	O
Porphyromonas	Porphyromonas	NNP	B-NP	O
endodontalis	endodontalis	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Veillonella	Veillonella	NN	B-NP	B-protein
parvula-like	parvula-like	JJ	I-NP	I-protein
species	specie	NNS	I-NP	I-protein
only	only	RB	B-ADVP	O
produced	produce	VBD	B-VP	O
detectable	detectable	JJ	B-NP	O
signals	signal	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
AT	AT	NN	I-NP	O
group	group	NN	I-NP	O
.	.	.	O	O

Significantly	Significantly	RB	B-NP	O
more	more	JJR	I-NP	O
signals	signal	NNS	I-NP	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
AT	AT	NN	I-NP	O
group	group	NN	I-NP	O
(	(	(	O	O
p=0.001	p=0.001	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
percentage	percentage	NN	I-NP	O
of	of	IN	B-PP	O
E.	E.	FW	B-NP	O
coli-like	coli-like	JJ	I-NP	O
species	specie	NNS	I-NP	O
was	be	VBD	B-VP	O
highest	high	JJS	B-ADJP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

Whole-genome	Whole-genome	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
probes	probe	NNS	I-NP	O
prepared	prepare	VBN	B-VP	O
from	from	IN	B-PP	O
human	human	JJ	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
can	can	MD	B-VP	O
cross-react	cross-react	VB	I-VP	O
with	with	IN	B-PP	O
rats	rat	NNS	B-NP	O
'	'	POS	B-NP	O
oral	oral	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

Alcohol	Alcohol	NN	B-NP	O
consumption	consumption	NN	I-NP	O
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
lower	low	JJR	B-NP	O
levels	level	NNS	I-NP	O
and	and	CC	O	O
diversity	diversity	NN	B-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	B-protein
species	specie	NNS	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
of	of	IN	B-PP	O
rats	rat	NNS	B-NP	O
.	.	.	O	O

Little	Little	JJ	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
diet	diet	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
of	of	IN	B-PP	O
infants	infant	NNS	B-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
diet	diet	NN	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
affect	affect	VB	I-VP	O
the	the	DT	B-NP	O
gut	gut	NN	I-NP	O
microbiota	microbiota	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aims	aim	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
were	be	VBD	B-VP	O
to	to	TO	I-VP	O
compare	compare	VB	I-VP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
in	in	IN	B-PP	O
breast-fed	breast-fed	JJ	B-NP	O
and	and	CC	I-NP	O
formula-fed	formula-fed	JJ	I-NP	O
infants	infant	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
investigate	investigate	NN	B-NP	O
growth	growth	NN	I-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
streptococci	streptococci	NNS	B-NP	O
by	by	IN	B-PP	O
infant-isolated	infant-isolated	JJ	B-NP	O
lactobacilli	lactobacilli	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
207	207	CD	B-NP	O
mothers	mother	NNS	I-NP	O
consented	consent	VBD	B-VP	O
to	to	TO	B-PP	O
participation	participation	NN	B-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
3-month-old	3-month-old	JJ	I-NP	O
infants	infant	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
146	146	CD	B-NP	O
(	(	(	O	O
70.5	70.5	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
infants	infant	NNS	B-NP	O
were	be	VBD	B-VP	O
exclusively	exclusively	RB	B-ADVP	O
and	and	CC	O	O
38	38	CD	B-NP	O
(	(	(	O	O
18.4	18.4	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
partially	partially	RB	B-ADJP	O
breast-fed	breast-fed	JJ	I-ADJP	O
,	,	,	O	O
and	and	CC	O	O
23	23	CD	B-NP	O
(	(	(	O	O
11.1	11.1	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
exclusively	exclusively	RB	B-ADJP	O
formula-fed	formula-fed	JJ	I-ADJP	O
.	.	.	O	O

Saliva	Saliva	NN	B-NP	O
from	from	IN	B-PP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
infants	infant	NNS	I-NP	O
was	be	VBD	B-VP	O
cultured	culture	VBN	I-VP	O
for	for	IN	B-PP	O
Lactobacillus	Lactobacillus	NN	B-NP	B-protein
species	specie	NNS	I-NP	I-protein
,	,	,	O	O
with	with	IN	B-PP	O
isolate	isolate	JJ	B-NP	O
identifications	identification	NNS	I-NP	O
from	from	IN	B-PP	O
21	21	CD	B-NP	O
infants	infant	NNS	I-NP	O
.	.	.	O	O

Lactobacillus	Lactobacillus	NN	B-NP	O
isolates	isolate	NNS	I-NP	O
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
for	for	IN	B-PP	O
their	their	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
suppress	suppress	VB	I-VP	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
and	and	CC	O	O
S.	S.	NNP	B-NP	O
sanguinis	sanguinis	NNP	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
swabs	swab	NNS	I-NP	O
from	from	IN	B-PP	O
73	73	CD	B-NP	O
infants	infant	NNS	I-NP	O
were	be	VBD	B-VP	O
analysed	analyse	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Human	Human	NNP	I-NP	O
Oral	Oral	NNP	I-NP	O
Microbe	Microbe	NNP	I-NP	O
Identification	Identification	NNP	I-NP	O
Microarray	Microarray	NNP	I-NP	O
(	(	(	O	O
HOMIM	HOMIM	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
by	by	IN	B-PP	O
quantitative	quantitative	JJ	B-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
for	for	IN	B-PP	O
Lactobacillus	Lactobacillus	NNP	B-NP	O
gasseri	gasseri	NNP	I-NP	O
.	.	.	O	O

Lactobacilli	Lactobacillus	NNS	B-NP	O
were	be	VBD	B-VP	O
cultured	culture	VBN	I-VP	O
from	from	IN	B-PP	O
27.8	27.8	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
exclusively	exclusively	RB	B-ADVP	O
and	and	CC	I-ADVP	O
partially	partially	RB	B-NP	O
breast-fed	breast-fed	JJ	I-NP	O
infants	infant	NNS	I-NP	O
,	,	,	B-PP	O
but	but	CC	I-PP	O
not	not	RB	I-PP	O
from	from	IN	B-PP	O
formula-fed	formula-fed	JJ	B-NP	O
infants	infant	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
14	14	CD	B-NP	O
HOMIM-detected	HOMIM-detected	JJ	I-NP	O
taxa	taxa	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
total	total	JJ	B-NP	O
salivary	salivary	JJ	I-NP	O
lactobacilli	lactobacilli	NN	I-NP	O
counts	count	NNS	I-NP	O
differed	differ	VBN	B-VP	O
by	by	IN	B-PP	O
feeding	feed	VBG	B-VP	O
method	method	NN	B-NP	O
.	.	.	O	O

Multivariate	Multivariate	JJ	B-NP	O
modelling	modelling	NN	I-NP	O
of	of	IN	B-PP	O
HOMIM-detected	HOMIM-detected	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
possible	possible	JJ	B-NP	O
confounders	confounder	NNS	I-NP	O
clustered	cluster	VBD	B-VP	O
samples	sample	NNS	B-NP	O
from	from	IN	B-PP	O
breast-fed	breast-fed	JJ	B-NP	O
infants	infant	NNS	I-NP	O
separately	separately	RB	B-ADVP	O
from	from	IN	B-PP	O
formula-fed	formula-fed	JJ	B-NP	O
infants	infant	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
microbiota	microbiota	NN	I-NP	O
of	of	IN	B-PP	O
breast-fed	breast-fed	JJ	B-NP	O
infants	infant	NNS	I-NP	O
differed	differ	VBD	B-VP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
vaginal	vaginal	JJ	B-NP	O
or	or	CC	I-NP	O
C-section	C-section	NN	I-NP	O
delivery	delivery	NN	I-NP	O
.	.	.	O	O

Isolates	Isolate	NNS	B-NP	O
of	of	IN	B-PP	O
L	L	NN	B-NP	O
plantarum	plantarum	NN	I-NP	O
,	,	,	O	O
L	L	NNP	B-NP	O
gasseri	gasseri	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
L	L	NN	B-NP	O
vaginalis	vaginalis	NN	I-NP	O
inhibited	inhibit	VBD	B-VP	O
growth	growth	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cariogenic	cariogenic	JJ	I-NP	O
S	S	NN	I-NP	O
mutans	mutan	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
commensal	commensal	JJ	I-NP	O
S	S	NN	I-NP	O
sanguinis	sanguinis	NN	I-NP	O
:	:	:	O	O
L	L	NN	B-NP	O
plantarum	plantarum	NN	I-NP	O
>	>	SYM	B-NP	O
L	L	NN	I-NP	O
gasseri	gasseri	NN	I-NP	O
>	>	SYM	B-VP	O
L	L	NN	B-NP	O
vaginalis	vaginalis	FW	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
microbiota	microbiota	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
differs	differ	VBZ	B-VP	O
between	between	IN	B-PP	O
3-month-old	3-month-old	JJ	B-NP	O
breast-fed	breast-fed	JJ	I-NP	O
and	and	CC	I-NP	O
formula-fed	formula-fed	JJ	I-NP	O
infants	infant	NNS	I-NP	O
.	.	.	O	O

Possible	Possible	JJ	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
for	for	IN	B-PP	O
microbial	microbial	JJ	B-NP	O
differences	difference	NNS	I-NP	O
observed	observe	VBN	B-VP	O
include	include	VBP	B-VP	O
species	specie	NNS	B-NP	O
suppression	suppression	NN	I-NP	O
by	by	IN	B-PP	O
lactobacilli	lactobacilli	NN	B-NP	O
indigenous	indigenous	JJ	B-ADJP	O
to	to	TO	B-PP	O
breast	breast	NN	B-NP	O
milk	milk	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
purpose	purpose	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
analyze	analyze	VB	I-VP	O
the	the	DT	B-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
function	function	NN	I-NP	O
and	and	CC	I-NP	O
environment	environment	NN	I-NP	O
in	in	IN	B-PP	O
high-risk	high-risk	JJ	B-NP	O
elderly	elderly	JJ	I-NP	O
persons	person	NNS	I-NP	O
participating	participate	VBG	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
program	program	NN	I-NP	O
to	to	TO	B-VP	O
improve	improve	VB	I-VP	O
oral	oral	JJ	B-NP	O
function	function	NN	I-NP	O
organized	organize	VBN	B-VP	O
by	by	IN	B-PP	O
their	their	PRP$	B-NP	O
local	local	JJ	I-NP	O
government	government	NN	I-NP	O
.	.	.	O	O

Participants	Participant	NNS	B-NP	O
comprised	comprise	VBD	B-VP	O
36	36	CD	B-NP	O
high-risk	high-risk	JJ	I-NP	O
elderly	elderly	JJ	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
mean	mean	JJ	I-NP	O
age	age	NN	I-NP	O
was	be	VBD	B-VP	O
77.11	77.11	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
7.24	7.24	CD	I-NP	O
years	year	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
program	program	NN	I-NP	O
involved	involve	VBN	B-VP	O
training	training	NN	B-NP	O
sessions	session	NNS	I-NP	O
carried	carry	VBD	B-VP	O
out	out	RP	B-PRT	O
five	five	CD	B-NP	O
or	or	CC	I-NP	O
six	six	CD	I-NP	O
times	time	NNS	I-NP	O
every	every	DT	B-NP	O
2-3	2-3	CD	I-NP	O
weeks	week	NNS	I-NP	O
for	for	IN	B-PP	O
3	3	CD	B-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
function	function	NN	I-NP	O
and	and	CC	I-NP	O
environment	environment	NN	I-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
before	before	IN	B-PP	O
and	and	CC	I-PP	O
after	after	IN	I-PP	O
the	the	DT	B-NP	O
program	program	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
research	research	NN	I-NP	O
period	period	NN	I-NP	O
extended	extend	VBD	B-VP	O
from	from	IN	B-PP	O
2008	2008	CD	B-NP	O
to	to	TO	B-PP	O
2010	2010	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
intervention	intervention	NN	B-NP	O
were	be	VBD	B-VP	O
clearly	clearly	RB	I-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
diadochokinesis	diadochokinesis	NN	I-NP	O
score	score	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
high-risk	high-risk	JJ	I-NP	O
elderly	elderly	JJ	I-NP	O
.	.	.	O	O

Persons	Person	NNS	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
lower	low	JJR	I-NP	O
repetitive	repetitive	JJ	I-NP	O
saliva	saliva	NN	I-NP	O
swallowing	swallow	VBG	B-VP	O
test	test	NN	B-NP	O
(	(	(	O	O
RSST	RSST	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
diadochokinesis	diadochokinesis	NN	I-NP	O
score	score	NN	I-NP	O
before	before	IN	B-SBAR	O
intervention	intervention	NN	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
tendency	tendency	NN	I-NP	O
toward	toward	IN	B-PP	O
even	even	RB	B-NP	O
greater	great	JJR	I-NP	O
improvement	improvement	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
significant	significant	JJ	I-NP	O
changes	change	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
secretion	secretion	NN	I-NP	O
or	or	CC	O	O
total	total	JJ	B-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
,	,	,	O	O
Lactobacilli	Lactobacilli	NNP	B-NP	O
,	,	,	O	O
Candida	Candida	NNP	B-NP	O
or	or	CC	O	O
total	total	JJ	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
intervention	intervention	NN	B-NP	O
were	be	VBD	B-VP	O
clearly	clearly	RB	I-VP	O
recognized	recognize	VBN	I-VP	O
in	in	IN	B-PP	O
regards	regard	NNS	B-NP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
diadochokinesis	diadochokinesis	NN	I-NP	O
.	.	.	O	O

Improvement	Improvement	NN	B-NP	O
in	in	IN	B-PP	O
RSST	RSST	NN	B-NP	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
diadochokinesis	diadochokinesis	NN	I-NP	O
scores	score	NNS	I-NP	O
was	be	VBD	B-VP	O
marked	mark	VBN	I-VP	O
in	in	IN	B-PP	O
those	those	DT	B-NP	O
persons	person	NNS	I-NP	O
showing	show	VBG	B-VP	O
a	a	DT	B-NP	O
lower	low	JJR	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
articulations	articulation	NNS	B-NP	O
before	before	IN	B-PP	O
intervention	intervention	NN	B-NP	O
.	.	.	O	O

Salvadora	Salvadora	NNP	B-NP	O
persica	persica	NNP	I-NP	O
L.	L.	NNP	I-NP	O
(	(	(	O	O
miswak	miswak	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
traditionally	traditionally	RB	I-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
ensure	ensure	VB	I-VP	O
oral	oral	JJ	B-NP	O
hygiene	hygiene	NN	I-NP	O
Muslim	Muslim	NN	I-NP	O
people	people	NNS	I-NP	O
in	in	IN	B-PP	O
developing	develop	VBG	B-NP	O
countries	country	NNS	I-NP	O
where	where	WRB	B-ADVP	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
growing	grow	VBG	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
antibacterial	antibacterial	JJ	I-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
Salvadora	Salvadora	NNP	B-NP	O
persica	persica	NNP	I-NP	O
L.	L.	NNP	I-NP	O
originating	originate	VBG	B-VP	O
from	from	IN	B-PP	O
various	various	JJ	B-NP	O
geographic	geographic	JJ	I-NP	O
areas	area	NNS	I-NP	O
have	have	VBP	B-VP	O
already	already	RB	I-VP	O
been	be	VBN	I-VP	O
reported	report	VBN	I-VP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
they	they	PRP	B-NP	O
have	have	VBP	B-VP	O
never	never	RB	I-VP	O
been	be	VBN	I-VP	O
tested	test	VBN	I-VP	O
for	for	IN	B-PP	O
samples	sample	NNS	B-NP	O
originating	originate	VBG	B-VP	O
from	from	IN	B-PP	O
Hoggar	Hoggar	NNP	B-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
extreme	extreme	JJ	B-NP	O
weather	weather	NN	I-NP	O
conditions	condition	NNS	I-NP	O
could	could	MD	B-VP	O
lead	lead	VB	I-VP	O
to	to	TO	B-PP	O
different	different	JJ	B-NP	O
properties	property	NNS	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
Salvadora	Salvadora	NNP	I-NP	O
persica	persica	NNP	I-NP	O
L.	L.	NNP	I-NP	O
ecotype	ecotype	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
and	and	CC	O	O
in	in	FW	B-NP	O
vivo	vivo	FW	I-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
methanolic	methanolic	JJ	B-NP	O
extract	extract	NN	I-NP	O
of	of	IN	B-PP	O
Algerian	Algerian	NNP	B-NP	O
Hoggar	Hoggar	NNP	I-NP	O
Salvadora	Salvadora	NNP	I-NP	O
persica	persica	NNP	I-NP	O
L.	L.	NNP	I-NP	O
(	(	(	O	O
miswak	miswak	NN	B-NP	O
)	)	)	O	O
on	on	IN	B-PP	O
some	some	DT	B-NP	O
isolated	isolate	VBN	I-NP	O
and	and	CC	I-NP	O
identified	identify	VBN	I-NP	O
strains	strain	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
of	of	IN	B-PP	O
school	school	NN	B-NP	O
children	child	NNS	I-NP	O
aged	age	VBN	B-VP	O
from	from	IN	B-PP	O
6	6	CD	B-NP	O
to	to	TO	B-PP	O
12	12	CD	B-NP	O
with	with	IN	B-PP	O
(	(	(	O	O
n=20	n=20	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
without	without	IN	B-PP	O
(	(	(	O	O
n=20	n=20	NN	B-NP	O
)	)	)	O	O
caries	cary	NNS	B-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
a	a	DT	B-NP	O
qualitative	qualitative	JJ	I-NP	O
and	and	CC	I-NP	O
quantitative	quantitative	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
selected	select	VBN	I-NP	O
children	child	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
methanolic	methanolic	JJ	B-NP	O
extract	extract	NN	I-NP	O
of	of	IN	B-PP	O
Hoggar	Hoggar	NN	B-NP	O
miswak	miswak	NN	I-NP	O
against	against	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
and	and	CC	I-NP	O
fungal	fungal	JJ	I-NP	O
strains	strain	NNS	I-NP	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
of	of	IN	B-PP	O
children	child	NNS	B-NP	O
with	with	IN	B-PP	O
caries	cary	NNS	B-NP	O
was	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
by	by	IN	B-PP	O
both	both	CC	O	O
agar	agar	NN	B-NP	O
disc	disc	NN	I-NP	O
diffusion	diffusion	NN	I-NP	O
and	and	CC	I-NP	O
microdilution	microdilution	NN	I-NP	O
methods	method	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
stability	stability	NN	I-NP	O
and	and	CC	I-NP	O
physicochemical	physicochemical	JJ	I-NP	O
parameters	parameter	NNS	I-NP	O
of	of	IN	B-PP	O
Hoggar	Hoggar	NNP	B-NP	O
Salvadora	Salvadora	NNP	I-NP	O
persica	persica	NNP	I-NP	O
L.	L.	NNP	I-NP	O
mouthwash	mouthwash	NN	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
assessed	assess	VBN	I-VP	O
compared	compare	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
in	in	FW	I-NP	O
vivo	vivo	FW	I-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
Hoggar	Hoggar	NN	B-NP	O
miswak	miswak	NN	I-NP	O
rinse	rinse	NN	I-NP	O
on	on	IN	B-PP	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
samples	sample	NNS	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
tested	test	VBN	I-VP	O
over	over	IN	B-PP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

Four	Four	CD	B-NP	O
bacterial	bacterial	JJ	I-NP	O
genera	genera	NN	I-NP	O
(	(	(	O	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
,	,	,	I-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
,	,	,	I-NP	O
Escherichia	Escherichia	NNP	I-NP	O
and	and	CC	I-NP	O
Lactobacillus	Lactobacillus	NNP	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
commonly	commonly	RB	I-VP	O
identified	identify	VBN	I-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
subjects	subject	NNS	I-NP	O
at	at	IN	B-PP	O
different	different	JJ	B-NP	O
colonization	colonization	NN	I-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
statistically	statistically	RB	I-NP	O
significant	significant	JJ	I-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
colonization	colonization	NN	B-NP	O
levels	level	NNS	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
groups	group	NNS	I-NP	O
of	of	IN	B-PP	O
children	child	NNS	B-NP	O
was	be	VBD	B-VP	O
recorded	record	VBN	I-VP	O
.	.	.	O	O

Hoggar	Hoggar	NN	B-NP	O
miswak	miswak	VBP	B-VP	O
extract	extract	NN	B-NP	O
more	more	RBR	B-ADVP	O
significantly	significantly	RB	I-ADVP	O
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
Gram	Gram	NN	B-NP	O
negative	negative	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
dental	dental	JJ	I-NP	O
plaque	plaque	NN	I-NP	O
than	than	IN	B-PP	O
Gram	Gram	NN	B-NP	O
positive	positive	JJ	I-NP	O
ones	one	NNS	I-NP	O
.	.	.	O	O

Hoggar	Hoggar	NNP	B-NP	O
Salvadora	Salvadora	NNP	I-NP	O
persica	persica	NNP	I-NP	O
L.	L.	NNP	I-NP	O
mouthwash	mouthwash	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
4	4	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
and	and	CC	O	O
25	25	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
conservation	conservation	NN	B-NP	O
(	(	(	O	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
)	)	)	O	O
while	while	IN	B-SBAR	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
40	40	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	NN	I-NP	O
induced	induce	VBD	B-VP	O
variations	variation	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
physicochemical	physicochemical	JJ	I-NP	O
parameters	parameter	NNS	I-NP	O
and	and	CC	O	O
considered	consider	VBN	B-VP	O
not	not	RB	B-ADJP	O
suitable	suitable	JJ	I-ADJP	O
for	for	IN	B-PP	O
preservation	preservation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
in	in	FW	I-NP	O
vivo	vivo	FW	I-NP	O
study	study	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
using	use	VBG	B-VP	O
miswak	miswak	NN	B-NP	O
mouthwash	mouthwash	NN	I-NP	O
as	as	IN	B-SBAR	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
placebo	placebo	NN	B-NP	O
.	.	.	O	O

Hoggar	Hoggar	NN	B-NP	O
miswak	miswak	NN	I-NP	O
extract	extract	NN	I-NP	O
displayed	display	VBD	B-VP	O
a	a	DT	B-NP	O
strong	strong	JJ	I-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
effect	effect	NN	I-NP	O
both	both	CC	O	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
and	and	CC	O	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
.	.	.	O	O

Its	Its	PRP$	B-NP	O
use	use	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
mouthrinse	mouthrinse	NN	I-NP	O
could	could	MD	B-VP	O
therefore	therefore	RB	I-VP	O
be	be	VB	I-VP	O
recommended	recommend	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
preventive	preventive	JJ	I-NP	O
measure	measure	NN	I-NP	O
to	to	TO	B-VP	O
preserve	preserve	VB	I-VP	O
from	from	IN	B-PP	O
tooth	tooth	JJ	B-NP	O
decay	decay	NN	I-NP	O
.	.	.	O	O

Examine	Examine	VB	B-VP	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
antibodies	antibody	NNS	B-NP	B-protein
to	to	TO	B-PP	O
25	25	CD	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
pancreatic	pancreatic	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
risk	risk	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
prospective	prospective	JJ	I-NP	O
cohort	cohort	JJ	I-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
measured	measure	VBD	B-VP	O
antibodies	antibody	NNS	B-NP	B-protein
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
prediagnosis	prediagnosis	NN	B-NP	O
blood	blood	NN	I-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
405	405	CD	B-NP	O
pancreatic	pancreatic	JJ	I-NP	O
cancer	cancer	NN	I-NP	O
cases	case	NNS	I-NP	O
and	and	CC	O	O
416	416	CD	B-NP	O
matched	match	VBN	I-NP	O
controls	control	NNS	I-NP	O
,	,	,	O	O
nested	nest	VBN	B-VP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
European	European	JJ	I-NP	O
Prospective	Prospective	JJ	I-NP	O
Investigation	Investigation	NN	I-NP	O
into	into	IN	B-PP	O
Cancer	Cancer	NN	B-NP	O
and	and	CC	I-NP	O
Nutrition	Nutrition	NN	I-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

Analyses	Analysis	NNS	B-NP	O
were	be	VBD	B-VP	O
conducted	conduct	VBN	I-VP	O
using	use	VBG	B-VP	O
conditional	conditional	JJ	B-NP	O
logistic	logistic	JJ	I-NP	O
regression	regression	NN	I-NP	O
and	and	CC	O	O
additionally	additionally	RB	B-VP	O
adjusted	adjust	VBN	I-VP	O
for	for	IN	B-PP	O
smoking	smoking	NN	B-NP	O
status	status	NN	I-NP	O
and	and	CC	O	O
body	body	NN	B-NP	O
mass	mass	NN	I-NP	O
index	index	NN	I-NP	O
.	.	.	O	O

Individuals	Individual	NNS	B-NP	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
antibodies	antibody	NNS	B-NP	B-protein
against	against	IN	B-PP	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
ATTC	ATTC	NN	I-NP	O
53978	53978	CD	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
pathogenic	pathogenic	JJ	I-NP	O
periodontal	periodontal	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
twofold	twofold	RB	I-NP	O
higher	high	JJR	I-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
pancreatic	pancreatic	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
than	than	IN	B-PP	O
individuals	individual	NNS	B-NP	O
with	with	IN	B-PP	O
lower	low	JJR	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
antibodies	antibody	NNS	I-NP	B-protein
(	(	(	O	O
OR	OR	NN	B-NP	O
2.14	2.14	CD	I-NP	O
;	;	:	O	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
CI	CI	NN	I-NP	O
1.05	1.05	CD	I-NP	O
to	to	TO	B-PP	O
4.36	4.36	CD	B-NP	O
;	;	:	O	O
>	>	SYM	B-NP	O
200	200	CD	B-NP	O
ng/ml	ng/ml	NN	I-NP	O
vs	vs	IN	B-PP	O
<	<	SYM	B-NP	O
/=200	/=200	CD	I-NP	O
ng/ml	ng/ml	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

To	To	TO	B-VP	O
explore	explore	VB	I-VP	O
the	the	DT	B-NP	O
association	association	NN	I-NP	O
with	with	IN	B-PP	O
commensal	commensal	JJ	O	O
(	(	(	O	O
non-pathogenic	non-pathogenic	JJ	B-ADJP	O
)	)	)	O	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
performed	perform	VBD	B-VP	O
a	a	DT	B-NP	O
cluster	cluster	NN	I-NP	O
analysis	analysis	NN	I-NP	O
and	and	CC	O	O
identified	identify	VBD	B-VP	O
two	two	CD	B-NP	O
groups	group	NNS	I-NP	O
of	of	IN	B-PP	O
individuals	individual	NNS	B-NP	O
,	,	,	O	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
their	their	PRP$	B-NP	O
antibody	antibody	NN	I-NP	O
profiles	profile	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
cluster	cluster	NN	I-NP	O
with	with	IN	B-PP	O
overall	overall	JJ	B-NP	O
higher	high	JJR	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
antibodies	antibody	NNS	B-NP	B-protein
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
45	45	CD	I-NP	O
%	%	NN	I-NP	O
lower	low	JJR	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
pancreatic	pancreatic	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
than	than	IN	B-PP	O
a	a	DT	B-NP	O
cluster	cluster	NN	I-NP	O
with	with	IN	B-PP	O
overall	overall	JJ	B-NP	O
lower	low	JJR	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
antibodies	antibody	NNS	B-NP	B-protein
(	(	(	O	O
OR	OR	NN	B-NP	O
0.55	0.55	CD	I-NP	O
;	;	:	O	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
CI	CI	NN	I-NP	O
0.36	0.36	CD	I-NP	O
to	to	TO	B-PP	O
0.83	0.83	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Periodontal	Periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
might	might	MD	B-VP	O
increase	increase	VB	I-VP	O
the	the	DT	B-NP	O
risk	risk	NN	I-NP	O
for	for	IN	B-PP	O
pancreatic	pancreatic	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
increased	increase	VBN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
antibodies	antibody	NNS	B-NP	B-protein
against	against	IN	B-PP	O
specific	specific	JJ	B-NP	O
commensal	commensal	JJ	I-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
can	can	MD	B-VP	O
inhibit	inhibit	VB	I-VP	O
growth	growth	NN	B-NP	O
of	of	IN	B-PP	O
pathogenic	pathogenic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
might	might	MD	B-VP	O
reduce	reduce	VB	I-VP	O
the	the	DT	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
pancreatic	pancreatic	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

Studies	Study	NNS	B-NP	O
are	be	VBP	B-VP	O
needed	need	VBN	I-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
have	have	VBP	B-VP	O
direct	direct	JJ	B-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
pancreatic	pancreatic	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
or	or	CC	O	O
serve	serve	VB	B-VP	O
as	as	IN	B-PP	O
markers	marker	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
microbial	microbial	JJ	I-NP	O
flora	flora	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
damaged	damage	VBN	I-NP	O
oral	oral	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
may	may	MD	B-VP	O
increase	increase	VB	I-VP	O
the	the	DT	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
bacteriemia	bacteriemia	NN	B-NP	O
,	,	,	O	O
fungemia	fungemia	NN	B-NP	O
and	and	CC	O	O
complications	complication	NNS	B-NP	O
in	in	IN	B-PP	O
immunocompromised	immunocompromised	JJ	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O


Assessment	Assessment	NN	B-NP	O
of	of	IN	B-PP	O
presence	presence	NN	B-NP	O
:	:	:	O	O
bacteria	bacteria	NNS	B-NP	O
and	and	CC	O	O
Candida	Candida	NNP	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

in	in	IN	B-PP	O
different	different	JJ	B-NP	O
oral	oral	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
incidence	incidence	NN	I-NP	O
of	of	IN	B-PP	O
bacteremia	bacteremia	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
case	case	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
damaged	damage	VBN	I-NP	O
mucosa	mucosa	NN	I-NP	O
in	in	IN	B-PP	O
transplant	transplant	NN	B-NP	O
recipients	recipient	NNS	I-NP	O
and	and	CC	O	O
patients	patient	NNS	B-NP	O
receiving	receive	VBG	B-VP	O
anti-tumour	anti-tumour	JJ	B-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
.	.	.	O	O


Forty-five	Forty-five	CD	B-NP	O
patients	patient	NNS	I-NP	O
-	-	SYM	B-NP	O
18	18	CD	B-NP	O
months	month	NNS	I-NP	O
to	to	TO	B-PP	O
18	18	CD	B-NP	O
years	year	NNS	I-NP	O
of	of	IN	B-PP	O
life	life	NN	B-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
included	include	VBN	I-VP	O
(	(	(	O	O
20	20	CD	B-NP	O
-	-	HYPH	I-NP	O
organ	organ	NN	I-NP	O
recipients	recipient	NNS	I-NP	O
,	,	,	O	O
14-	14-	CD	B-NP	O
anti-tumour	anti-tumour	JJ	I-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
,	,	,	O	O
11	11	CD	B-NP	O
-	-	HYPH	I-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Clinical	Clinical	JJ	B-NP	O
,	,	,	I-NP	O
oral	oral	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
examination	examination	NN	I-NP	O
focused	focus	VBD	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
type	type	NN	I-NP	O
,	,	,	I-NP	O
severity	severity	NN	I-NP	O
and	and	CC	I-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
lesions	lesion	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
microbiology	microbiology	NN	B-NP	O
assessed	assess	VBD	B-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
and	and	CC	I-NP	O
fungi	fungus	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
material	material	NN	I-NP	O
from	from	IN	B-PP	O
lesions	lesion	NNS	B-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
in	in	IN	B-PP	O
ten	ten	CD	B-NP	O
immunocompromised	immunocompromised	JJ	I-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
manifestations	manifestation	NNS	B-NP	O
of	of	IN	B-PP	O
systemic	systemic	JJ	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
control	control	NN	I-NP	O
material	material	NN	I-NP	O
consisted	consist	VBD	B-VP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
made	make	VBD	B-VP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
and	and	CC	O	O
after	after	IN	B-PP	O
4-6	4-6	CD	B-NP	O
weeks	week	NNS	I-NP	O
following	follow	VBG	B-PP	O
their	their	PRP$	B-NP	O
remission	remission	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
diagnosed	diagnose	VBN	I-NP	O
bacteremia	bacteremia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
statistical	statistical	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
subjects	subject	NNS	I-NP	O
with	with	IN	B-PP	O
secondary	secondary	JJ	B-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
,	,	,	O	O
among	among	IN	B-PP	O
other	other	JJ	B-NP	O
coagulase-negative	coagulase-negative	JJ	I-NP	O
Staphylococcus	Staphylococcus	NN	I-NP	O
(	(	(	O	O
CoNS	CoNS	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
Candidia	Candidia	NNP	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

were	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
frequent	frequent	JJ	I-ADJP	O
.	.	.	O	O

In	In	IN	B-PP	O
cancer	cancer	NN	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
mucositis	mucositis	NN	B-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
Candida	Candida	NNP	B-NP	O
spp.	spp.	NNP	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

Organ	Organ	JJ	B-NP	O
recipients	recipient	NNS	I-NP	O
with	with	IN	B-PP	O
stomatitis	stomatitis	NN	B-NP	O
exhibited	exhibit	VBD	B-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
CoNS	CoNS	NN	B-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
viridians	viridian	NNS	I-NP	O
and	and	CC	O	O
other	other	JJ	B-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
contained	contain	VBD	B-VP	O
Haemophilus	Haemophilus	NNP	B-NP	O
parainfluenzae	parainfluenzae	NNS	I-NP	O
,	,	,	O	O
Neisseria	Neisseria	NNP	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

and	and	CC	O	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
aureus	aureus	NNP	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
immunocompromised	immunocompromised	JJ	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
oral	oral	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
were	be	VBD	B-VP	O
accompanied	accompany	VBN	I-VP	O
by	by	IN	B-PP	O
bacteremia	bacteremia	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
correlation	correlation	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
found	find	VBN	I-VP	O
between	between	IN	B-PP	O
oral	oral	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
aureus	aureus	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
without	without	IN	B-PP	O
secondary	secondary	JJ	B-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
,	,	,	B-PP	O
and	and	CC	I-PP	O
of	of	IN	B-PP	O
CoNS	CoNS	NN	B-NP	O
,	,	,	O	O
Enterococcus	Enterococcus	NNP	B-NP	O
spp.	spp.	NNP	I-NP	O
,	,	,	O	O
Candida	Candida	NNP	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

in	in	IN	B-PP	O
immunocompromised	immunocompromised	JJ	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

Infants	Infant	NNS	B-NP	O
with	with	IN	B-PP	O
moderate	moderate	JJ	B-ADJP	O
to	to	TO	B-PP	O
severe	severe	JJ	B-NP	O
congenital	congenital	JJ	I-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
(	(	(	O	O
CHD	CHD	NN	B-NP	O
)	)	)	O	O
are	be	VBP	B-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
higher	high	JJR	I-NP	O
risk	risk	NN	I-NP	O
for	for	IN	B-PP	O
growth	growth	NN	B-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
malnutrition	malnutrition	NN	B-NP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
increased	increase	VBN	B-NP	O
metabolic	metabolic	JJ	I-NP	O
demands	demand	NNS	I-NP	O
and	and	CC	O	O
inadequate	inadequate	JJ	B-NP	O
energy	energy	NN	I-NP	O
intake	intake	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
state	state	NN	I-NP	O
requires	require	VBZ	B-VP	O
meals	meal	NNS	B-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
more	more	RBR	B-ADJP	O
frequent	frequent	JJ	I-ADJP	O
and	and	CC	O	O
a	a	DT	B-NP	O
special	special	JJ	I-NP	O
enriched	enrich	VBN	I-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
negative	negative	JJ	B-NP	O
implications	implication	NNS	I-NP	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	O
health	health	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
examine	examine	VB	I-VP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
colonisation	colonisation	NN	I-NP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
caries	cary	NNS	B-NP	O
development	development	NN	I-NP	O
during	during	IN	B-PP	O
infancy	infancy	NN	B-NP	O
;	;	:	O	O
mutans	mutan	NNS	B-NP	O
streptococci	streptococci	NNS	I-NP	O
(	(	(	O	O
MS	MS	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
lactobacilli	lactobacilli	NN	B-NP	O
(	(	(	O	O
LCB	LCB	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
infants	infant	NNS	B-NP	O
with	with	IN	B-PP	O
CHD	CHD	NN	B-NP	O
and	and	CC	B-PP	O
whether	whether	IN	B-SBAR	O
their	their	PRP$	B-NP	O
dietary	dietary	JJ	I-NP	O
intake	intake	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
impact	impact	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
prospective	prospective	JJ	I-NP	O
case-control	case-control	JJ	I-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
infants	infant	NNS	I-NP	O
with	with	IN	B-PP	O
CHD	CHD	NN	B-NP	O
and	and	CC	O	O
22	22	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
,	,	,	I-NP	O
age-matched	age-matched	JJ	I-NP	O
infants	infant	NNS	I-NP	O
were	be	VBD	B-VP	O
enrolled	enrol	VBN	I-VP	O
.	.	.	O	O

Saliva	Saliva	NN	B-NP	O
samples	sample	NNS	I-NP	O
and	and	CC	O	O
food	food	NN	B-NP	O
diaries	diary	NNS	I-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
at	at	IN	B-PP	O
6	6	CD	B-NP	O
,	,	,	I-NP	O
9	9	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
12	12	CD	B-NP	O
months	month	NNS	I-NP	O
of	of	IN	B-PP	O
age	age	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
total	total	JJ	I-NP	O
viable	viable	JJ	I-NP	O
counts	count	NNS	I-NP	O
of	of	IN	B-PP	O
MS	MS	NN	B-NP	O
and	and	CC	I-NP	O
LCB	LCB	NN	I-NP	B-protein
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
energy	energy	NN	B-NP	O
intake	intake	NN	I-NP	O
,	,	,	O	O
meal	meal	JJ	B-NP	O
frequency	frequency	NN	I-NP	O
,	,	,	O	O
intake	intake	NN	B-NP	O
of	of	IN	B-PP	O
proteins	protein	NNS	B-NP	O
,	,	,	O	O
fat	fat	NN	B-NP	O
,	,	,	O	O
carbohydrates	carbohydrate	NNS	B-NP	O
and	and	CC	O	O
sucrose	sucrose	NN	B-NP	O
were	be	VBD	B-VP	O
calculated	calculate	VBN	I-VP	O
.	.	.	O	O

At	At	IN	B-PP	O
12	12	CD	B-NP	O
months	month	NNS	I-NP	O
of	of	IN	B-PP	O
age	age	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
MS	MS	NN	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
higher	high	JJR	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CHD	CHD	NN	I-NP	O
group	group	NN	I-NP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
controls	control	NNS	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.01	0.01	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
MS	MS	NN	B-NP	O
constituted	constitute	VBD	B-VP	O
a	a	DT	B-NP	O
higher	high	JJR	I-NP	O
ratio	ratio	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
viable	viable	JJ	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.01	0.01	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Meal	Meal	JJ	B-NP	O
frequency	frequency	NN	I-NP	O
was	be	VBD	B-VP	O
higher	high	JJR	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CHD	CHD	NN	I-NP	O
group	group	NN	I-NP	O
at	at	IN	B-PP	O
6	6	CD	B-NP	O
and	and	CC	I-NP	O
9	9	CD	I-NP	O
months	month	NNS	I-NP	O
of	of	IN	B-PP	O
age	age	NN	B-NP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
controls	control	NNS	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
intake	intake	NN	I-NP	O
of	of	IN	B-PP	O
sucrose	sucrose	NN	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
differ	differ	VB	I-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
carbohydrate	carbohydrate	NN	I-NP	O
intake	intake	NN	I-NP	O
was	be	VBD	B-VP	O
higher	high	JJR	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
at	at	IN	B-PP	O
6	6	CD	B-NP	O
and	and	CC	I-NP	O
12	12	CD	I-NP	O
months	month	NNS	I-NP	O
of	of	IN	B-PP	O
age	age	NN	B-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Compared	Compare	VBN	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
six	six	CD	B-NP	O
courses	course	NNS	I-NP	O
of	of	IN	B-PP	O
antibiotic	antibiotic	JJ	B-NP	O
administration	administration	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
CHD	CHD	NN	I-NP	O
infants	infant	NNS	I-NP	O
had	have	VBD	B-VP	O
21	21	CD	B-NP	O
courses	course	NNS	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Infants	Infant	NNS	B-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
CHD	CHD	NN	I-NP	O
have	have	VBP	B-VP	O
higher	high	JJR	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
MS	MS	NN	B-NP	O
at	at	IN	B-PP	O
12	12	CD	B-NP	O
months	month	NNS	I-NP	O
of	of	IN	B-PP	O
age	age	NN	B-NP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
healthy	healthy	JJ	I-NP	O
controls	control	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
higher	high	JJR	I-NP	O
meal	meal	JJ	I-NP	O
frequency	frequency	NN	I-NP	O
and	and	CC	I-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
diuretic	diuretic	JJ	B-NP	O
medication	medication	NN	I-NP	O
and	and	CC	I-NP	O
antibiotics	antibiotic	NNS	I-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
influenced	influence	VBN	I-VP	O
MS	MS	NN	B-NP	O
colonisation	colonisation	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
550	550	CD	B-NP	O
oral	oral	JJ	I-NP	O
streptococci	streptococci	NNS	I-NP	O
:	:	:	O	O
270	270	CD	B-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
mitis	mitis	NN	I-NP	O
,	,	,	O	O
110	110	CD	B-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
sanguis	sanguis	NNP	I-NP	O
,	,	,	O	O
90	90	CD	B-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
anginosus	anginosus	NNP	I-NP	O
,	,	,	O	O
50	50	CD	B-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
mutans	mutan	NNS	I-NP	O
,	,	,	O	O
30	30	CD	B-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
salivarius	salivarius	NNP	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
and	and	CC	O	O
gengival	gengival	JJ	B-NP	O
crevices	crevice	NNS	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
and	and	CC	O	O
tested	test	VBN	B-VP	O
for	for	IN	B-PP	O
their	their	PRP$	B-NP	O
susceptibility	susceptibility	NN	I-NP	O
to	to	TO	B-PP	O
12	12	CD	B-NP	O
beta-lactam	beta-lactam	NN	I-NP	O
antibiotics	antibiotic	NNS	I-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
5	5	CD	B-NP	O
non-beta-lactam	non-beta-lactam	JJ	I-NP	O
antibiotics	antibiotic	NNS	I-NP	O
,	,	,	O	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
microdiluition	microdiluition	NN	I-NP	O
method	method	NN	I-NP	O
.	.	.	O	O

Overall	Overall	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
reduced	reduce	VBN	I-NP	O
susceptibility	susceptibility	NN	I-NP	O
to	to	TO	B-PP	O
penicillin	penicillin	NN	B-NP	O
was	be	VBD	B-VP	O
recorded	record	VBN	I-VP	O
in	in	IN	B-PP	O
13.4	13.4	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
cases	case	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
percentage	percentage	NN	I-NP	O
of	of	IN	B-PP	O
strains	strain	NNS	B-NP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
penicillin	penicillin	NN	B-NP	B-protein
appeared	appear	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
in	in	IN	B-PP	O
S.	S.	NNP	B-NP	O
mitis	mitis	NN	I-NP	O
(	(	(	O	O
24	24	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
S.	S.	NNP	B-NP	O
sanguis	sanguis	NNP	I-NP	O
(	(	(	O	O
19	19	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
in	in	IN	B-PP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
(	(	(	O	O
14	14	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
S.	S.	NNP	B-NP	O
salivarius	salivarius	NN	I-NP	O
(	(	(	O	O
10	10	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

No	No	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
penicillin	penicillin	NN	B-NP	O
resistance	resistance	NN	I-NP	O
were	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
by	by	IN	B-PP	O
90	90	CD	B-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
S.	S.	NN	B-NP	O
anginosus	anginosus	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
susceptibility	susceptibility	NN	B-NP	O
test	test	NN	I-NP	O
to	to	TO	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
,	,	,	O	O
imipenem	imipenem	NN	B-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
active	active	JJ	I-NP	O
molecule	molecule	NN	I-NP	O
tested	test	VBN	B-VP	O
,	,	,	O	O
confirming	confirm	VBG	B-VP	O
its	its	PRP$	B-NP	O
general	general	JJ	I-NP	O
good	good	JJ	I-NP	O
activity	activity	NN	I-NP	O
against	against	IN	B-PP	O
oral	oral	JJ	B-NP	O
streptococci	streptococci	NNS	I-NP	O
.	.	.	O	O

Also	Also	RB	B-NP	O
third	third	JJ	I-NP	O
generation	generation	NN	I-NP	O
cephalosporins	cephalosporin	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
ceftriaxone	ceftriaxone	NN	B-NP	O
and	and	CC	O	O
fourth	fourth	JJ	B-NP	O
generation	generation	NN	I-NP	O
cephalosporins	cephalosporin	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
cefepime	cefepime	NN	B-NP	O
,	,	,	O	O
showed	show	VBD	B-VP	O
good	good	JJ	B-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

Chinolones	Chinolone	NNS	B-NP	O
,	,	,	I-NP	O
glycopeptides	glycopeptide	NNS	I-NP	O
and	and	CC	I-NP	O
rifampicin	rifampicin	NN	I-NP	O
confirmed	confirm	VBD	B-VP	O
a	a	DT	B-NP	O
good	good	JJ	I-NP	O
activity	activity	NN	I-NP	O
against	against	IN	B-PP	O
oral	oral	JJ	B-NP	O
streptococci	streptococci	NNS	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
compare	compare	VB	I-VP	O
the	the	DT	B-NP	O
virulence	virulence	NN	I-NP	O
genotype	genotype	NN	I-NP	O
(	(	(	O	O
cagA	cagA	NN	B-NP	O
and	and	CC	O	O
vacA	vacA	NN	B-NP	B-DNA
ml	ml	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
)	)	)	O	O
of	of	IN	B-PP	O
Helicobacter	Helicobacter	NN	B-NP	O
pylori	pylorus	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O
simultaneously	simultaneously	RB	B-ADVP	O
from	from	IN	B-PP	O
gastric	gastric	JJ	B-NP	O
mucosa	mucosa	NN	I-NP	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

Gastric	Gastric	JJ	B-NP	O
samples	sample	NNS	I-NP	O
of	of	IN	B-PP	O
18	18	CD	B-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
by	by	IN	B-PP	O
endoscopic	endoscopic	JJ	B-NP	O
biopsies	biopsy	NNS	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
samples	sample	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
from	from	IN	B-PP	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
and	and	CC	I-NP	O
saliva	saliva	NN	I-NP	B-protein
swabs	swab	NNS	I-NP	I-protein
from	from	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
base	base	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tongue	tongue	NN	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
by	by	IN	B-PP	O
conventional	conventional	JJ	B-NP	O
PCR	PCR	NN	I-NP	O
and	and	CC	O	O
real-time	real-time	JJ	B-NP	O
PCR	PCR	NN	I-NP	O
(	(	(	O	O
RT-PCR	RT-PCR	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Virulence	Virulence	NN	B-NP	O
genes	gene	NNS	I-NP	O
cagA	cagA	NN	I-NP	B-DNA
and	and	CC	I-NP	O
vacA	vacA	NN	I-NP	O
ml	ml	NN	I-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
by	by	IN	B-PP	O
RT-	RT-	NN	B-NP	O
PCR	PCR	NN	I-NP	O
.	.	.	O	O

According	Accord	VBG	B-PP	O
to	to	TO	B-PP	O
presence	presence	NN	B-NP	O
and/or	and/or	CC	I-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
cagA	cagA	NN	B-NP	B-DNA
and	and	CC	I-NP	I-DNA
vacAm1	vacAm1	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
,	,	,	O	O
seven	seven	CD	B-NP	O
different	different	JJ	I-NP	O
combinations	combination	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
genetic	genetic	JJ	B-NP	O
profiles	profile	NNS	I-NP	O
of	of	IN	B-PP	O
Helicobacter	Helicobacter	NN	B-NP	O
pylori	pylori	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
stomach	stomach	NN	I-NP	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
cavity	cavity	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
predominance	predominance	NN	I-NP	O
of	of	IN	B-PP	O
less	less	JJR	B-NP	O
virulent	virulent	JJ	I-NP	O
genotypes	genotype	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
included	include	VBN	B-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
(	(	(	O	O
cagA-	cagA-	NN	B-NP	O
,	,	,	O	O
vacA	vacA	NN	B-NP	O
m1-	m1-	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
can	can	MD	B-VP	O
find	find	VB	I-VP	O
a	a	DT	B-NP	O
complex	complex	JJ	I-NP	O
mixture	mixture	NN	I-NP	O
of	of	IN	B-PP	O
microorganisms	microorganism	NNS	B-NP	O
,	,	,	O	O
commensals	commensal	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
pathogens	pathogen	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
studies	study	NNS	I-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
oral	oral	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
studies	study	NNS	I-NP	O
of	of	IN	B-PP	O
much	much	JJ	B-NP	O
oral	oral	JJ	I-NP	O
pathology	pathology	NN	I-NP	O
(	(	(	O	O
e.g.	e.g.	FW	B-NP	O
,	,	,	O	O
caries	cary	NNS	B-NP	O
,	,	,	O	O
periodontitis	periodontitis	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
involve	involve	VBP	B-VP	O
the	the	DT	B-NP	O
isolation	isolation	NN	I-NP	O
and	and	CC	I-NP	O
cultivation	cultivation	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
molecular	molecular	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
validate	validate	VB	I-VP	O
a	a	DT	B-NP	O
quick	quick	JJ	I-NP	O
,	,	,	I-NP	O
easy	easy	JJ	I-NP	O
,	,	,	I-NP	O
efficient	efficient	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
inexpensive	inexpensive	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
extraction	extraction	NN	I-NP	O
method	method	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
recovery	recovery	NN	I-NP	O
of	of	IN	B-PP	O
genomic	genomic	JJ	B-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
from	from	IN	B-PP	O
gram-positive	gram-positive	JJ	B-NP	O
and	and	CC	I-NP	O
gram-negative	gram-negative	JJ	I-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
in	in	IN	B-PP	O
polymerase	polymerase	NN	B-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
amplification	amplification	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
method	method	NN	I-NP	O
worked	work	VBD	B-VP	O
great	great	JJ	B-ADJP	O
with	with	IN	B-PP	O
all	all	DT	B-NP	O
samples	sample	NNS	I-NP	O
analyzed	analyze	VBN	B-VP	O
,	,	,	O	O
providing	provide	VBG	B-VP	O
an	an	DT	B-NP	O
approach	approach	NN	I-NP	O
to	to	TO	B-VP	O
extract	extract	VB	I-VP	O
DNA	DNA	NN	B-NP	O
for	for	IN	B-PP	O
different	different	JJ	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
.	.	.	O	O

Streptococcus	Streptococcus	NN	B-NP	O
mutans	mutan	NNS	I-NP	O
(	(	(	O	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
prime	prime	JJ	I-NP	O
pathogen	pathogen	NN	I-NP	O
of	of	IN	B-PP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
few	few	JJ	B-NP	O
reports	report	NNS	I-NP	O
that	that	WDT	B-NP	O
studied	study	VBD	B-VP	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
,	,	,	O	O
bacteria	bacteria	NNS	B-NP	O
and	and	CC	O	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
in	in	IN	B-PP	O
permanent	permanent	JJ	B-NP	O
teeth	tooth	NNS	I-NP	O
when	when	WRB	B-ADVP	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
in	in	IN	B-PP	O
primary	primary	JJ	B-NP	O
teeth	tooth	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
aimed	aim	VBD	B-VP	O
to	to	TO	I-VP	O
detect	detect	VB	I-VP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
and	and	CC	I-NP	O
bacteria	bacteria	NNS	I-NP	O
of	of	IN	B-PP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
and	and	CC	O	O
non-caries	non-caries	JJ	B-NP	O
groups	group	NNS	I-NP	O
in	in	IN	B-PP	O
permanent	permanent	JJ	B-NP	O
teeth	tooth	NNS	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
north	north	JJ	I-NP	O
China	China	NNP	I-NP	O
population	population	NN	I-NP	O
by	by	IN	B-PP	O
real-time	real-time	JJ	B-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
(	(	(	O	O
PCR	PCR	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
compare	compare	VBP	B-VP	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
in	in	IN	B-PP	O
permanent	permanent	JJ	B-NP	O
teeth	tooth	NNS	I-NP	O
.	.	.	O	O

Human	Human	JJ	B-NP	O
saliva	saliva	NN	I-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
from	from	IN	B-PP	O
142	142	CD	B-NP	O
subjects	subject	NNS	I-NP	O
with	with	IN	B-PP	O
permanent	permanent	JJ	B-NP	O
teeth	tooth	NNS	I-NP	O
.	.	.	O	O

According	Accord	VBG	B-PP	O
to	to	TO	B-PP	O
their	their	PRP$	B-NP	O
dental	dental	JJ	I-NP	O
tooth	tooth	NN	I-NP	O
(	(	(	O	O
DT	DT	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
142	142	CD	B-NP	O
subjects	subject	NNS	I-NP	O
were	be	VBD	B-VP	O
divided	divide	VBN	I-VP	O
into	into	IN	B-PP	O
a	a	DT	B-NP	O
dental	dental	JJ	I-NP	O
caries	cary	NNS	I-NP	O
group	group	NN	I-NP	O
(	(	(	O	O
DT	DT	NN	B-NP	B-protein
>	>	SYM	O	I-protein
/=	/=	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
)	)	)	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
non-caries	non-caries	JJ	I-NP	O
group	group	NN	I-NP	O
(	(	(	O	O
DT	DT	NN	B-NP	B-protein
=	=	SYM	B-VP	I-protein
0	0	CD	B-NP	I-protein
)	)	)	O	O
.	.	.	O	O

With	With	IN	B-PP	O
specific	specific	JJ	B-NP	O
primers	primer	NNS	I-NP	O
for	for	IN	B-PP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
and	and	CC	O	O
16S	16S	NN	B-NP	O
rRNA	rRNA	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
and	and	CC	O	O
total	total	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
of	of	IN	B-PP	O
142	142	CD	B-NP	O
saliva	saliva	NN	I-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
by	by	IN	B-PP	O
real-time	real-time	JJ	B-NP	O
PCR	PCR	NN	I-NP	O
and	and	CC	O	O
statistically	statistically	RB	B-VP	O
analyzed	analyze	VBN	I-VP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
difference	difference	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
detection	detection	NN	I-NP	O
rates	rate	NNS	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
0.118	0.118	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
medians	median	NNS	B-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
0.115	0.115	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
ratio	ratio	NN	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
to	to	TO	B-PP	O
total	total	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
people	people	NNS	B-NP	O
with	with	IN	B-PP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
those	those	DT	B-NP	O
without	without	IN	B-PP	O
caries	cary	NNS	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
0.001	0.001	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
in	in	IN	B-PP	O
people	people	NNS	B-NP	O
with	with	IN	B-PP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
those	those	DT	B-NP	O
without	without	IN	B-PP	O
caries	cary	NNS	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
0.001	0.001	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

S.	S.	NN	B-NP	O
mutans	mutan	NNS	I-NP	O
had	have	VBD	B-VP	O
different	different	JJ	B-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
caries	cary	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
permanent	permanent	JJ	I-NP	O
teeth	teeth	NN	I-NP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
individuals	individual	NNS	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
north	north	JJ	I-NP	O
China	China	NNP	I-NP	O
population	population	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
ratios	ratio	NNS	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
to	to	TO	B-PP	O
total	total	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
detected	detect	VBN	B-VP	O
by	by	IN	B-PP	O
real-time	real-time	JJ	B-NP	O
PCR	PCR	NN	I-NP	O
with	with	IN	B-PP	O
Sm479F/R	Sm479F/R	NN	B-NP	O
and	and	CC	I-NP	O
16S	16S	NN	I-NP	O
RNA	RNA	NN	I-NP	O
primers	primer	NNS	I-NP	O
were	be	VBD	B-VP	O
closely	closely	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
population	population	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
assays	assay	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
useful	useful	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
assessment	assessment	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
individual	individual	NN	I-NP	O
's	's	POS	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
measurements	measurement	NNS	B-NP	O
of	of	IN	B-PP	O
volatile	volatile	JJ	B-NP	O
sulfur	sulfur	NN	I-NP	O
compounds	compound	NNS	I-NP	O
(	(	(	O	O
VSCs	VSC	NNS	B-NP	B-cell_type
)	)	)	O	O
are	be	VBP	B-VP	O
useful	useful	JJ	B-ADJP	O
to	to	TO	B-VP	O
predict	predict	VB	I-VP	O
colonization	colonization	NN	B-NP	O
of	of	IN	B-PP	O
periodontopathic	periodontopathic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
this	this	DT	B-NP	O
purpose	purpose	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
assessed	assess	VBD	B-VP	O
the	the	DT	B-NP	O
relationships	relationship	NNS	I-NP	O
among	among	IN	B-PP	O
distributions	distribution	NNS	B-NP	O
of	of	IN	B-PP	O
4	4	CD	B-NP	O
species	specie	NNS	I-NP	O
of	of	IN	B-PP	O
periodontopathic	periodontopathic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
tongue	tongue	NN	B-NP	O
coating	coating	NN	I-NP	O
and	and	CC	O	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
,	,	,	O	O
oral	oral	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
including	include	VBG	B-PP	O
VSC	VSC	NN	B-NP	B-protein
concentration	concentration	NN	I-NP	O
in	in	IN	B-PP	O
mouth	mouth	NN	B-NP	O
air	air	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
smoking	smoking	NN	B-NP	O
habit	habit	NN	I-NP	O
of	of	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
healthy	healthy	JJ	I-NP	O
young	young	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
subjects	subject	NNS	I-NP	O
were	be	VBD	B-VP	O
108	108	CD	B-NP	O
young	young	JJ	I-NP	O
adults	adult	NNS	I-NP	O
(	(	(	O	O
mean	mean	JJ	B-NP	O
age	age	NN	I-NP	O
,	,	,	O	O
23.5+/-2.56	23.5+/-2.56	CD	B-NP	O
years	year	NNS	I-NP	O
)	)	)	O	O
without	without	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
periodontal	periodontal	JJ	I-NP	O
pockets	pocket	NNS	I-NP	O
.	.	.	O	O

Information	Information	NN	B-NP	O
regarding	regard	VBG	B-VP	O
smoking	smoking	NN	B-NP	O
habit	habit	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
by	by	IN	B-PP	O
interview	interview	NN	B-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
VSC	VSC	NNP	B-NP	O
concentration	concentration	NN	I-NP	O
in	in	IN	B-PP	O
mouth	mouth	NN	B-NP	O
,	,	,	O	O
air	air	NN	B-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
portable	portable	JJ	I-NP	O
sulfide	sulfide	NN	I-NP	O
monitor	monitor	NN	I-NP	O
(	(	(	O	O
Halimeter	Halimeter	NN	B-NP	O
(	(	(	O	O
(	(	(	O	O
R	R	NN	B-NP	O
)	)	)	O	O
)	)	)	O	O
)	)	)	O	O
,	,	,	O	O
non-stimulated	non-stimulated	JJ	B-NP	O
saliva	saliva	NN	I-NP	O
flow	flow	NN	I-NP	O
and	and	CC	O	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
status	status	NN	I-NP	O
were	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
tongue	tongue	NN	B-NP	O
coating	coating	NN	I-NP	O
and	and	CC	O	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
tongue	tongue	NN	I-NP	O
coating	coating	NN	I-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
weighed	weigh	VBN	I-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
amount	amount	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
colonization	colonization	NN	I-NP	O
of	of	IN	B-PP	O
Porphyromonas	Porphyromonas	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
Tannerella	Tannerella	NNP	B-NP	O
forsythia	forsythia	NNP	I-NP	O
,	,	,	O	O
Prevotella	Prevotella	NNP	B-NP	O
intermedia	intermedia	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Treponema	Treponema	NNP	B-NP	O
denticola	denticola	NN	I-NP	O
in	in	IN	B-PP	O
both	both	CC	O	O
tongue	tongue	NN	B-NP	O
coating	coating	NN	I-NP	O
and	and	CC	O	O
plaque	plaque	NN	B-NP	O
samples	sample	NNS	I-NP	O
was	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
using	use	VBG	B-VP	O
species-specific	species-specific	JJ	B-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
assays	assay	NNS	I-NP	O
.	.	.	O	O

Significant	Significant	JJ	B-NP	O
relationships	relationship	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
colonization	colonization	NN	I-NP	O
of	of	IN	B-PP	O
periodontopathic	periodontopathic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
tongue	tongue	NN	B-NP	O
coating	coating	NN	I-NP	O
and	and	CC	I-NP	O
plaque	plaque	NN	I-NP	O
samples	sample	NNS	I-NP	O
,	,	,	O	O
especially	especially	RB	B-NP	O
that	that	DT	I-NP	O
of	of	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
.	.	.	O	O

VSC	VSC	NN	B-NP	O
concentration	concentration	NN	I-NP	O
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
significant	significant	JJ	I-NP	O
association	association	NN	I-NP	O
with	with	IN	B-PP	O
colonization	colonization	NN	B-NP	O
of	of	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
in	in	IN	B-PP	O
both	both	CC	O	O
tongue	tongue	NN	B-NP	O
coating	coating	NN	I-NP	O
and	and	CC	O	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
.	.	.	O	O

Logistic	Logistic	JJ	B-NP	O
regression	regression	NN	I-NP	O
analysis	analysis	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
adjusted	adjust	VBN	I-NP	O
partial	partial	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
coefficient	coefficient	NN	I-NP	O
[	[	(	O	O
Exp	Exp	NN	B-NP	O
(	(	(	O	O
B	B	NN	B-NP	O
)	)	)	O	O
]	]	)	O	O
values	value	NNS	B-NP	O
for	for	IN	B-PP	O
VSC	VSC	NNP	B-NP	O
concentration	concentration	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
colonization	colonization	NN	I-NP	O
of	of	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
P.	P.	NNP	B-NP	O
intermedia	intermedia	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
T.	T.	NNP	B-NP	O
denticola	denticola	NN	I-NP	O
in	in	IN	B-PP	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
were	be	VBD	B-VP	O
135	135	CD	B-NP	O
,	,	,	I-NP	O
35.4	35.4	CD	I-NP	O
and	and	CC	I-NP	O
10.4	10.4	CD	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
smoking	smoking	NN	B-NP	O
habit	habit	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
variable	variable	NN	I-NP	O
in	in	IN	B-PP	O
regression	regression	NN	B-NP	O
models	model	NNS	I-NP	O
[	[	(	O	O
Exp	Exp	NN	B-NP	O
(	(	(	O	O
B	B	NN	B-NP	O
)	)	)	O	O
=6.19	=6.19	CD	B-NP	O
,	,	,	I-NP	O
8.92	8.92	CD	I-NP	O
and	and	CC	I-NP	O
2.53	2.53	CD	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
]	]	)	O	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
receiver	receiver	NN	B-NP	O
operating	operate	VBG	B-VP	O
characteristic	characteristic	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
to	to	TO	I-VP	O
predict	predict	VB	I-VP	O
the	the	DT	B-NP	O
colonization	colonization	NN	I-NP	O
of	of	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
subjects	subject	NNS	I-NP	O
divided	divide	VBN	B-VP	O
by	by	IN	B-PP	O
smoking	smoking	NN	B-NP	O
habit	habit	NN	I-NP	O
.	.	.	O	O

Based	Base	VBN	B-PP	O
on	on	IN	B-PP	O
our	our	PRP$	B-NP	O
results	result	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
cut-off	cut-off	JJ	B-NP	O
values	value	NNS	I-NP	O
that	that	WDT	B-NP	O
indicated	indicate	VBD	B-VP	O
likelihood	likelihood	NN	B-NP	O
ratios	ratio	NNS	I-NP	O
(	(	(	O	O
LR	LR	NN	B-NP	O
)	)	)	O	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
efficient	efficient	JJ	I-NP	O
range	range	NN	I-NP	O
for	for	IN	B-PP	O
positive	positive	JJ	B-NP	O
findings	finding	NNS	I-NP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
present	present	JJ	I-NP	O
results	result	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
measurement	measurement	NN	B-NP	O
of	of	IN	B-PP	O
VSC	VSC	NN	B-NP	O
concentration	concentration	NN	I-NP	O
in	in	IN	B-PP	O
mouth	mouth	NN	B-NP	O
air	air	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
useful	useful	JJ	I-NP	O
method	method	NN	I-NP	O
to	to	TO	B-VP	O
predict	predict	VB	I-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
colonization	colonization	NN	B-NP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
periodontopathic	periodontopathic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
.	.	.	O	O

Numerous	Numerous	JJ	B-NP	O
publications	publication	NNS	I-NP	O
have	have	VBP	B-VP	O
reported	report	VBN	I-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
periodontopathogenic	periodontopathogenic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	O
and	and	CC	I-NP	O
central	central	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
how	how	WRB	B-ADVP	O
this	this	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
translocation	translocation	NN	I-NP	O
occurs	occur	VBZ	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
objective	objective	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
whether	whether	IN	B-SBAR	O
periodontopathic	periodontopathic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
are	be	VBP	B-VP	O
translocated	translocate	VBN	I-VP	O
to	to	TO	B-PP	O
lymph	lymph	NN	B-NP	O
nodes	node	NNS	I-NP	O
proximal	proximal	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

Obtaining	Obtain	VBG	B-VP	O
lymph	lymph	NN	B-NP	O
node	node	NN	I-NP	O
samples	sample	NNS	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
ethically	ethically	RB	B-ADJP	O
feasible	feasible	JJ	I-ADJP	O
unless	unless	IN	B-SBAR	O
they	they	PRP	B-NP	O
are	be	VBP	B-VP	O
excised	excise	VBN	I-VP	O
as	as	IN	B-PP	O
part	part	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
surgical	surgical	JJ	I-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
cancer	cancer	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
analyzed	analyze	VBD	B-VP	O
formalin-fixed	formalin-fixed	JJ	B-NP	O
and	and	CC	I-NP	O
paraffin-embedded	paraffin-embedded	JJ	I-NP	O
lymph	lymph	NN	I-NP	O
nodes	node	NNS	I-NP	O
,	,	,	O	O
histologically	histologically	RB	B-ADJP	O
negative	negative	JJ	I-ADJP	O
for	for	IN	B-PP	O
cancer	cancer	NN	B-NP	O
cell	cell	NN	I-NP	O
invasion	invasion	NN	I-NP	O
,	,	,	O	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
excised	excise	VBN	I-VP	O
from	from	IN	B-PP	O
66	66	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
histories	history	NNS	B-NP	O
of	of	IN	B-PP	O
head	head	NN	B-NP	O
and	and	CC	I-NP	O
neck	neck	NN	I-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

Real-time	Real-time	JJ	B-NP	O
PCR	PCR	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
to	to	TO	I-VP	O
amplify	amplify	VB	I-VP	O
the	the	DT	B-NP	O
16S	16S	NN	I-NP	B-DNA
ribosomal	ribosomal	JJ	I-NP	I-DNA
DNA	DNA	NN	I-NP	I-DNA
fragments	fragment	NNS	I-NP	I-DNA
from	from	IN	B-PP	O
Porphyromonas	Porphyromonas	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
Treponema	Treponema	NNP	B-NP	O
denticola	denticola	NNP	I-NP	O
,	,	,	O	O
Aggregatibacter	Aggregatibacter	NNP	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
,	,	,	O	O
Tannerella	Tannerella	NNP	B-NP	O
forsythia	forsythia	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Prevotella	Prevotella	NNP	B-NP	O
intermedia	intermedia	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
detection	detection	NN	I-NP	O
and	and	CC	I-NP	O
cancer	cancer	NN	I-NP	O
severity	severity	NN	I-NP	O
,	,	,	O	O
gender	gender	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
anti-cancer	anti-cancer	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
was	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
by	by	IN	B-PP	O
Fisher	Fisher	NNP	B-NP	O
's	's	POS	B-NP	O
exact	exact	JJ	I-NP	O
test	test	NN	I-NP	O
.	.	.	O	O

P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
T.	T.	NNP	B-NP	O
forsythia	forsythia	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
P.	P.	NNP	B-NP	O
intermedia	intermedia	NNS	I-NP	O
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
17	17	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
8	8	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
8	8	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
samples	sample	NNS	I-NP	O
of	of	IN	B-PP	O
submandibular	submandibular	JJ	B-NP	O
and	and	CC	I-NP	O
submental	submental	JJ	I-NP	O
lymph	lymph	NN	I-NP	O
nodes	node	NNS	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
relationships	relationship	NNS	I-NP	O
between	between	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
detection	detection	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
cancer	cancer	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
gender	gender	NN	I-NP	O
or	or	CC	I-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
anticancer	anticancer	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

According	Accord	VBG	B-PP	O
to	to	TO	B-PP	O
these	these	DT	B-NP	O
data	datum	NNS	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
appears	appear	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
translocation	translocation	NN	I-NP	O
of	of	IN	B-PP	O
periodontopathic	periodontopathic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
may	may	MD	B-VP	O
occur	occur	VB	I-VP	O
via	via	IN	B-PP	O
lymphatic	lymphatic	JJ	B-NP	O
drainage	drainage	NN	I-NP	O
,	,	,	O	O
irrespective	irrespective	JJ	B-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cancer	cancer	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
gender	gender	NN	B-NP	O
or	or	CC	O	O
anticancer	anticancer	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
aim	aim	VBP	B-VP	O
to	to	TO	I-VP	O
develop	develop	VB	I-VP	O
antibacterial	antibacterial	JJ	B-NP	O
peptide	peptide	NN	I-NP	O
mimics	mimic	NNS	I-NP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
protease	protease	NN	B-NP	B-protein
degradation	degradation	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
broad-spectrum	broad-spectrum	NN	B-NP	O
activity	activity	NN	I-NP	O
at	at	IN	B-PP	O
sites	site	NNS	B-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
bactericidal	bactericidal	JJ	I-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
LL-37	LL-37	NN	B-NP	B-protein
,	,	,	O	O
ceragenins	ceragenin	NNS	B-NP	O
CSA-13	CSA-13	NN	I-NP	B-protein
,	,	,	I-NP	O
CSA-90	CSA-90	NN	I-NP	B-protein
and	and	CC	I-NP	O
CSA-92	CSA-92	NN	I-NP	B-protein
and	and	CC	O	O
the	the	DT	B-NP	O
spermine-conjugated	spermine-conjugated	JJ	I-NP	O
dexamethasone	dexamethasone	NN	I-NP	O
derivative	derivative	NN	I-NP	O
D2S	D2S	NN	I-NP	O
were	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
using	use	VBG	B-VP	O
MIC	MIC	NN	B-NP	O
and	and	CC	I-NP	O
MBC	MBC	NN	I-NP	O
measurements	measurement	NNS	I-NP	O
.	.	.	O	O

Gingival	Gingival	JJ	B-NP	O
fibroblast	fibroblast	NN	I-NP	O
counting	counting	NN	I-NP	O
,	,	,	O	O
interleukin-8	interleukin-8	NN	B-NP	B-protein
(	(	(	O	O
IL-8	IL-8	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
lactate	lactate	NN	B-NP	B-protein
dehydrogenase	dehydrogenase	NN	I-NP	I-protein
(	(	(	O	O
LDH	LDH	NN	B-NP	O
)	)	)	O	O
release	release	NN	B-NP	O
from	from	IN	B-PP	O
keratinocytes	keratinocyte	NNS	B-NP	B-cell_type
(	(	(	O	O
HaCat	HaCat	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
effects	effect	NNS	B-NP	O
on	on	IN	B-PP	O
cell	cell	NN	B-NP	O
growth	growth	NN	I-NP	O
,	,	,	O	O
pro-inflammatory	pro-inflammatory	JJ	B-NP	O
response	response	NN	I-NP	O
and	and	CC	I-NP	O
toxicity	toxicity	NN	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
tested	test	VBN	I-NP	O
cationic	cationic	JJ	I-NP	O
lipids	lipid	NNS	I-NP	O
showed	show	VBD	B-VP	O
stronger	strong	JJR	B-NP	O
bactericidal	bactericidal	JJ	I-NP	O
activity	activity	NN	I-NP	O
than	than	IN	B-PP	O
LL-37	LL-37	NN	B-NP	B-protein
.	.	.	O	O

Incubation	Incubation	NN	B-NP	O
of	of	IN	B-PP	O
Staphylococcus	Staphylococcus	FW	B-NP	O
aureus	aureus	FW	I-NP	O
with	with	IN	B-PP	O
half	half	PDT	B-NP	O
the	the	DT	I-NP	O
MIC	MIC	NN	I-NP	O
of	of	IN	B-PP	O
LL-37	LL-37	NN	B-NP	B-protein
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
appearance	appearance	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
its	its	PRP$	B-NP	O
bactericidal	bactericidal	JJ	I-NP	O
effects	effect	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
identical	identical	JJ	B-NP	O
incubations	incubation	NNS	I-NP	O
with	with	IN	B-PP	O
CSA-13	CSA-13	NN	B-NP	B-protein
or	or	CC	I-NP	O
D2S	D2S	NN	I-NP	B-protein
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
produce	produce	VB	I-VP	O
resistant	resistant	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

Cathelicidin	Cathelicidin	NN	B-NP	B-protein
LL-37	LL-37	NN	I-NP	I-protein
significantly	significantly	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
gingival	gingival	JJ	B-NP	B-cell_type
fibroblasts	fibroblast	NNS	I-NP	I-cell_type
,	,	,	O	O
but	but	CC	O	O
ceragenins	ceragenin	NNS	B-NP	O
and	and	CC	O	O
D2S	D2S	NN	B-NP	B-protein
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
alter	alter	VB	I-VP	O
gingival	gingival	JJ	B-NP	O
fibroblast	fibroblast	NN	I-NP	O
growth	growth	NN	I-NP	O
.	.	.	O	O

Cationic	Cationic	JJ	B-NP	O
lipids	lipid	NNS	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
toxicity	toxicity	NN	I-NP	O
to	to	TO	B-PP	O
HaCat	HaCat	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
at	at	IN	B-PP	O
concentrations	concentration	NNS	B-NP	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
killing	killing	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
data	datum	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
cationic	cationic	JJ	B-NP	O
lipids	lipid	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
ceragenins	ceragenin	NNS	B-NP	B-protein
warrant	warrant	VBP	B-VP	O
further	far	JJR	B-NP	O
testing	testing	NN	I-NP	O
as	as	IN	B-PP	O
potential	potential	JJ	B-NP	O
novel	novel	JJ	I-NP	O
antibacterial	antibacterial	JJ	I-NP	O
agents	agent	NNS	I-NP	O
.	.	.	O	O

Beta-lactam	Beta-lactam	NN	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
prescribed	prescribe	VBN	B-VP	O
in	in	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
are	be	VBP	B-VP	O
vulnerable	vulnerable	JJ	B-ADJP	O
to	to	TO	B-PP	O
degradation	degradation	NN	B-NP	O
by	by	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	B-protein
beta-lactamases	beta-lactamas	NNS	I-NP	I-protein
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
evaluated	evaluate	VBD	B-VP	O
the	the	DT	B-NP	O
occurrence	occurrence	NN	I-NP	O
of	of	IN	B-PP	O
beta-lactamase-positive	beta-lactamase-positive	JJ	B-NP	O
subgingival	subgingival	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
subjects	subject	NNS	I-NP	O
of	of	IN	B-PP	O
USA	USA	NNP	B-NP	O
origin	origin	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
assessed	assess	VBD	B-VP	O
their	their	PRP$	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
resistance	resistance	NN	I-NP	O
to	to	TO	B-PP	O
metronidazole	metronidazole	NN	B-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
breakpoint	breakpoint	NN	I-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
4	4	CD	B-NP	O
mug/mL	mug/mL	NN	I-NP	O
.	.	.	O	O

Subgingival	Subgingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
specimens	specimen	NNS	I-NP	O
from	from	IN	B-PP	O
deep	deep	JJ	B-NP	O
periodontal	periodontal	JJ	I-NP	O
pockets	pocket	NNS	I-NP	O
with	with	IN	B-PP	O
bleeding	bleed	VBG	B-VP	O
on	on	IN	B-PP	O
probing	probing	NN	B-NP	O
were	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
from	from	IN	B-PP	O
564	564	CD	B-NP	O
adults	adult	NNS	I-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
chronic	chronic	JJ	I-NP	O
periodontitis	periodontitis	NN	I-NP	O
before	before	IN	B-PP	O
treatment	treatment	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
transported	transport	VBN	I-VP	O
in	in	IN	B-PP	O
VMGA	VMGA	NN	B-NP	B-protein
III	III	CD	I-NP	I-protein
and	and	CC	O	O
then	then	RB	O	O
plated	plat	VBN	B-VP	O
onto	onto	IN	B-PP	O
:	:	:	O	O
(	(	(	B-LST	O
i	i	LS	I-LST	O
)	)	)	O	O
nonselective	nonselective	JJ	B-NP	O
enriched	enrich	VBN	I-NP	O
Brucella	Brucella	NNP	I-NP	O
blood	blood	NN	I-NP	O
agar	agar	NN	I-NP	O
(	(	(	O	O
EBBA	EBBA	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
incubated	incubate	VBN	B-VP	O
anaerobically	anaerobically	RB	B-ADVP	O
for	for	IN	B-PP	O
7	7	CD	B-NP	O
d	d	NN	I-NP	O
;	;	:	O	O
and	and	CC	O	O
(	(	(	B-LST	O
ii	ii	LS	I-LST	O
)	)	)	O	O
selective	selective	JJ	B-NP	O
trypticase	trypticase	NN	I-NP	O
soy-bacitracin-vancomycin	soy-bacitracin-vancomycin	NN	I-NP	O
(	(	(	O	O
TSBV	TSBV	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
incubated	incubate	VBN	B-VP	O
for	for	IN	B-PP	O
3	3	CD	B-NP	O
d	d	NN	I-NP	O
in	in	IN	B-PP	O
air	air	NN	B-NP	O
+	+	SYM	O	O
5	5	CD	B-NP	O
%	%	NN	I-NP	O
CO2	CO2	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
end	end	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
incubation	incubation	NN	I-NP	O
periods	period	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	B-protein
test	test	NN	I-NP	I-protein
species	specie	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
and	and	CC	O	O
quantified	quantify	VBN	B-VP	O
.	.	.	O	O

Specimen	Specimen	NN	B-NP	O
dilutions	dilution	NNS	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
plated	plat	VBN	I-VP	O
onto	onto	IN	B-PP	O
EBBA	EBBA	NN	B-NP	O
plates	plate	NNS	I-NP	O
supplemented	supplement	VBN	B-VP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
mug/mL	mug/mL	NN	I-NP	O
of	of	IN	B-PP	O
amoxicillin	amoxicillin	NN	B-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
mug/mL	mug/mL	NN	I-NP	O
of	of	IN	B-PP	O
amoxicillin	amoxicillin	NN	B-NP	B-protein
plus	plus	CC	O	O
2	2	CD	B-NP	O
mug/mL	mug/mL	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
beta-lactamase	beta-lactamase	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
clavulanic	clavulanic	JJ	I-NP	O
acid	acid	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
4	4	CD	B-NP	O
mug/mL	mug/mL	NN	I-NP	O
of	of	IN	B-PP	O
metronidazole	metronidazole	NN	B-NP	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
incubation	incubation	NN	I-NP	O
for	for	IN	B-PP	O
7	7	CD	B-NP	O
d.	d.	NN	I-NP	O
Bacterial	Bacterial	JJ	I-NP	O
test	test	NN	I-NP	O
species	specie	NNS	I-NP	O
presumptively	presumptively	RB	B-ADJP	O
positive	positive	JJ	I-ADJP	O
for	for	IN	B-PP	O
beta-lactamase	beta-lactamase	NN	B-NP	B-protein
production	production	NN	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
by	by	IN	B-PP	O
growth	growth	NN	B-NP	O
on	on	IN	B-PP	O
EBBA	EBBA	NN	B-NP	O
primary	primary	JJ	I-NP	O
isolation	isolation	NN	I-NP	O
plates	plate	NNS	I-NP	O
supplemented	supplement	VBN	B-VP	O
with	with	IN	B-PP	O
amoxicillin	amoxicillin	NN	B-NP	B-protein
alone	alone	RB	B-ADVP	O
and	and	CC	O	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
on	on	IN	B-PP	O
EBBA	EBBA	NN	B-NP	O
primary	primary	JJ	I-NP	O
isolation	isolation	NN	I-NP	O
plates	plate	NNS	I-NP	O
containing	contain	VBG	B-VP	O
both	both	CC	O	O
amoxicillin	amoxicillin	NN	B-NP	O
plus	plus	CC	O	O
clavulanic	clavulanic	JJ	B-NP	O
acid	acid	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
subset	subset	NN	I-NP	O
of	of	IN	B-PP	O
such	such	JJ	B-NP	O
isolates	isolate	NNS	I-NP	O
was	be	VBD	B-VP	O
subjected	subject	VBN	I-VP	O
to	to	TO	B-PP	O
nitrocefin-based	nitrocefin-based	JJ	B-NP	O
chromogenic	chromogenic	JJ	I-NP	O
disk	disk	NN	I-NP	O
testing	testing	NN	I-NP	O
to	to	TO	B-VP	O
confirm	confirm	VB	I-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
beta-lactamase	beta-lactamase	NN	B-NP	B-protein
activity	activity	NN	I-NP	O
.	.	.	O	O

In	In	FW	B-NP	O
vitro	vitro	FW	I-NP	O
resistance	resistance	NN	I-NP	O
to	to	TO	B-PP	O
4	4	CD	B-NP	O
mug/mL	mug/mL	NN	I-NP	O
of	of	IN	B-PP	O
metronidazole	metronidazole	NN	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
when	when	WRB	B-ADVP	O
growth	growth	NN	B-NP	O
of	of	IN	B-PP	O
test	test	NN	B-NP	O
species	specie	NNS	I-NP	O
occurred	occur	VBD	B-VP	O
on	on	IN	B-PP	O
metronidazole-supplemented	metronidazole-supplemented	JJ	B-NP	O
EBBA	EBBA	NN	I-NP	O
culture	culture	NN	I-NP	O
plates	plate	NNS	I-NP	O
.	.	.	O	O

Two-hundred	Two-hundred	CD	B-NP	O
and	and	CC	I-NP	O
ninety-four	ninety-four	CD	I-NP	O
(	(	(	O	O
52.1	52.1	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
subjects	subject	NNS	I-NP	O
yielded	yield	VBD	B-VP	O
beta-lactamase-producing	beta-lactamase-produce	VBG	I-VP	O
subgingival	subgingival	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
test	test	NN	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
Prevotella	Prevotella	NNP	B-NP	O
intermedia/nigrescens	intermedia/nigrescens	NNP	I-NP	O
,	,	,	O	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
and	and	CC	O	O
other	other	JJ	B-NP	O
Prevotella	Prevotella	NN	I-NP	O
species	specie	NNS	I-NP	O
most	most	RBS	B-VP	O
frequently	frequently	RB	I-VP	O
identified	identify	VBN	I-VP	O
as	as	IN	B-PP	O
beta-lactamase-producing	beta-lactamase-producing	JJ	B-NP	O
organisms	organism	NNS	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
the	the	DT	B-NP	O
beta-lactamase-producing	beta-lactamase-producing	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
test	test	NN	I-NP	O
species	species	NN	I-NP	O
strains	strain	NNS	I-NP	O
recovered	recover	VBD	B-VP	O
,	,	,	O	O
98.9	98.9	CD	B-NP	O
%	%	NN	I-NP	O
were	be	VBD	B-VP	O
susceptible	susceptible	JJ	B-ADJP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
to	to	TO	B-PP	O
metronidazole	metronidazole	NN	B-NP	O
at	at	IN	B-PP	O
4	4	CD	B-NP	O
mug/mL	mug/mL	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
occurrence	occurrence	NN	I-NP	O
of	of	IN	B-PP	O
beta-lactamase-positive	beta-lactamase-positive	JJ	B-NP	B-protein
subgingival	subgingival	JJ	I-NP	I-protein
bacterial	bacterial	JJ	I-NP	I-protein
species	specie	NNS	I-NP	I-protein
in	in	IN	B-PP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
half	half	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
subjects	subject	NNS	I-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
chronic	chronic	JJ	I-NP	O
periodontitis	periodontitis	NN	I-NP	O
raises	raise	VBZ	B-VP	O
questions	question	NNS	B-NP	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
potential	potential	NN	I-NP	O
of	of	IN	B-PP	O
single-drug	single-drug	JJ	B-NP	O
regimens	regimen	NNS	I-NP	O
with	with	IN	B-PP	O
beta-lactam	beta-lactam	NN	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
in	in	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
effectiveness	effectiveness	NN	I-NP	O
of	of	IN	B-PP	O
metronidazole	metronidazole	NN	B-NP	O
against	against	IN	B-PP	O
nearly	nearly	RB	B-NP	O
all	all	DT	I-NP	O
recovered	recover	VBD	B-VP	O
beta-lactamase-producing	beta-lactamase-produce	VBG	B-VP	O
subgingival	subgingival	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
further	further	RBR	B-ADVP	O
supports	support	VBZ	B-VP	O
clinical	clinical	JJ	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
treatment	treatment	NN	I-NP	O
strategies	strategy	NNS	I-NP	O
involving	involve	VBG	B-VP	O
the	the	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
systemic	systemic	JJ	B-NP	O
amoxicillin	amoxicillin	NN	I-NP	O
plus	plus	CC	I-NP	O
metronidazole	metronidazole	NN	I-NP	O
.	.	.	O	O

Circulating	Circulate	VBG	B-VP	O
nitrate	nitrate	NN	B-NP	O
(	(	(	O	O
NO	NO	NN	B-NP	O
(	(	(	O	O
3	3	CD	B-NP	O
)	)	)	O	O
(	(	(	O	O
-	-	SYM	O	O
)	)	)	O	O
)	)	)	O	O
,	,	,	O	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
dietary	dietary	JJ	B-NP	O
sources	source	NNS	I-NP	O
or	or	CC	O	O
endogenous	endogenous	JJ	B-NP	O
nitric	nitric	JJ	I-NP	O
oxide	oxide	NN	I-NP	O
production	production	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
extracted	extract	VBN	I-VP	O
from	from	IN	B-PP	O
blood	blood	NN	B-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
salivary	salivary	JJ	I-NP	O
glands	gland	NNS	I-NP	O
,	,	,	O	O
accumulates	accumulate	VBZ	B-VP	O
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
then	then	RB	I-VP	O
reduced	reduce	VBN	I-VP	O
to	to	TO	B-PP	O
nitrite	nitrite	NN	B-NP	O
(	(	(	O	O
NO	NO	NN	B-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
(	(	(	O	O
-	-	SYM	O	O
)	)	)	O	O
)	)	)	O	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microflora	microflora	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
process	process	NN	I-NP	O
has	have	VBZ	B-VP	O
historically	historically	RB	I-VP	O
been	be	VBN	I-VP	O
viewed	view	VBN	I-VP	O
as	as	IN	B-PP	O
harmful	harmful	JJ	B-ADJP	O
,	,	,	O	O
because	because	IN	B-SBAR	O
nitrite	nitrite	NN	B-NP	O
can	can	MD	B-VP	O
promote	promote	VB	I-VP	O
formation	formation	NN	B-NP	O
of	of	IN	B-PP	O
potentially	potentially	RB	B-NP	O
carcinogenic	carcinogenic	JJ	I-NP	O
N-nitrosamines	N-nitrosamine	NNS	I-NP	O
.	.	.	O	O

More	More	RBR	B-NP	O
recent	recent	JJ	I-NP	O
research	research	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
nitrite	nitrite	NN	B-NP	O
can	can	MD	B-VP	O
also	also	RB	I-VP	O
serve	serve	VB	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
precursor	precursor	NN	I-NP	O
for	for	IN	B-PP	O
systemic	systemic	JJ	B-NP	O
generation	generation	NN	I-NP	O
of	of	IN	B-PP	O
vasodilatory	vasodilatory	JJ	B-NP	O
nitric	nitric	JJ	I-NP	O
oxide	oxide	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
exogenous	exogenous	JJ	B-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
nitrate	nitrate	NN	B-NP	O
reduces	reduce	VBZ	B-VP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
in	in	IN	B-PP	O
humans	human	NNS	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
whether	whether	IN	B-SBAR	O
oral	oral	JJ	B-NP	O
nitrate-reducing	nitrate-reducing	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
participate	participate	VBP	B-VP	O
in	in	IN	B-PP	O
``	``	``	B-NP	O
setting	set	VBG	I-NP	O
''	''	''	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
is	be	VBZ	B-VP	O
unknown	unknown	JJ	B-ADJP	O
.	.	.	O	O

We	We	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
whether	whether	IN	B-SBAR	O
suppression	suppression	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microflora	microflora	NN	I-NP	O
affects	affect	VBZ	B-VP	O
systemic	systemic	JJ	B-NP	O
nitrite	nitrite	NN	I-NP	O
levels	level	NNS	I-NP	O
and	and	CC	O	O
hence	hence	RB	B-ADVP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
in	in	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
individuals	individual	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
measured	measure	VBD	B-VP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
(	(	(	O	O
clinic	clinic	NN	B-NP	O
,	,	,	O	O
home	home	NN	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
24-h	24-h	JJ	B-NP	O
ambulatory	ambulatory	JJ	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
19	19	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
volunteers	volunteer	NNS	I-NP	O
during	during	IN	B-PP	O
an	an	DT	B-NP	O
initial	initial	JJ	I-NP	O
7-day	7-day	JJ	I-NP	O
control	control	NN	I-NP	O
period	period	NN	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
7-day	7-day	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
period	period	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
chlorhexidine-based	chlorhexidine-based	JJ	I-NP	O
antiseptic	antiseptic	JJ	I-NP	O
mouthwash	mouthwash	NN	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
nitrate-reducing	nitrate-reducing	JJ	I-NP	O
capacity	capacity	NN	I-NP	O
and	and	CC	I-NP	O
nitrite	nitrite	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
after	after	IN	B-PP	O
each	each	DT	B-NP	O
study	study	NN	I-NP	O
period	period	NN	I-NP	O
.	.	.	O	O

Antiseptic	Antiseptic	JJ	B-NP	O
mouthwash	mouthwash	NN	I-NP	O
treatment	treatment	NN	I-NP	O
reduced	reduce	VBD	B-VP	O
oral	oral	JJ	B-NP	O
nitrite	nitrite	NN	I-NP	O
production	production	NN	I-NP	O
by	by	IN	B-PP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.001	0.001	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
plasma	plasma	NN	B-NP	O
nitrite	nitrite	NN	I-NP	O
levels	level	NNS	I-NP	O
by	by	IN	B-PP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
0.001	0.001	CD	B-NP	O
)	)	)	O	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
control	control	NN	I-NP	O
period	period	NN	I-NP	O
.	.	.	O	O

Systolic	Systolic	JJ	B-NP	O
and	and	CC	I-NP	O
diastolic	diastolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
increased	increase	VBD	B-VP	O
by	by	IN	B-PP	O
2-3	2-3	NN	B-NP	O
.5mmHg	.5mmHg	NN	I-NP	O
,	,	,	O	O
increases	increase	VBZ	B-VP	O
correlated	correlate	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
circulating	circulate	VBG	B-VP	O
nitrite	nitrite	NN	B-NP	O
concentrations	concentration	NNS	I-NP	O
(	(	(	O	O
r	r	NN	B-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
=	=	SYM	B-VP	O
0.56	0.56	CD	B-NP	O
,	,	,	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
0.002	0.002	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
effect	effect	NN	I-NP	O
appeared	appear	VBD	B-VP	O
within	within	IN	B-PP	O
1	1	CD	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
disruption	disruption	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microflora	microflora	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
sustained	sustained	JJ	B-ADJP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
7-day	7-day	JJ	I-NP	O
mouthwash	mouthwash	NN	I-NP	O
intervention	intervention	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
recycling	recycling	NN	I-NP	O
of	of	IN	B-PP	O
endogenous	endogenous	JJ	B-NP	O
nitrate	nitrate	NN	I-NP	O
by	by	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
plays	play	VBZ	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
determination	determination	NN	B-NP	O
of	of	IN	B-PP	O
plasma	plasma	NN	B-NP	O
nitrite	nitrite	NN	I-NP	O
levels	level	NNS	I-NP	O
and	and	CC	O	O
thereby	thereby	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
physiological	physiological	JJ	I-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
human	human	JJ	I-NP	O
mouth	mouth	NN	I-NP	O
harbours	harbour	VBZ	B-VP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
diverse	diverse	JJ	I-NP	O
microbiomes	microbiome	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
body	body	NN	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
viruses	virus	NNS	B-NP	O
,	,	,	I-NP	O
fungi	fungus	NNS	I-NP	O
,	,	,	I-NP	O
protozoa	protozoa	NN	I-NP	O
,	,	,	I-NP	O
archaea	archaea	NN	I-NP	O
and	and	CC	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
are	be	VBP	B-VP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
commonest	commonest	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
of	of	IN	B-PP	O
man	man	NN	B-NP	O
:	:	:	O	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
(	(	(	O	O
tooth	tooth	NN	B-NP	O
decay	decay	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
periodontal	periodontal	JJ	I-NP	O
(	(	(	O	O
gum	gum	NN	B-NP	O
)	)	)	O	O
diseases	disease	NNS	B-NP	O
.	.	.	O	O

Archaea	Archaea	NNP	B-NP	O
are	be	VBP	B-VP	O
restricted	restricted	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
species	specie	NNS	B-NP	O
of	of	IN	B-PP	O
methanogens	methanogen	NNS	B-NP	O
while	while	IN	B-SBAR	O
around	around	IN	B-NP	O
1000	1000	CD	I-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
found	find	VBN	I-VP	O
,	,	,	O	O
with	with	IN	B-PP	O
representatives	representative	NNS	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
phyla	phyla	NN	I-NP	O
Actinobacteria	Actinobacteria	NNP	B-NP	O
,	,	,	O	O
Bacteroidetes	Bacteroidetes	NNP	B-NP	O
,	,	,	O	O
Firmicutes	Firmicutes	NNP	B-NP	O
,	,	,	O	O
Proteobacteria	Proteobacteria	NNP	B-NP	O
,	,	,	O	O
Spirochaetes	Spirochaetes	NNP	B-NP	O
,	,	,	O	O
Synergistetes	Synergistetes	NNP	B-NP	O
and	and	CC	O	O
Tenericutes	Tenericute	NNPS	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
uncultured	uncultured	JJ	I-NP	O
divisions	division	NNS	I-NP	O
GN02	GN02	NN	I-NP	B-protein
,	,	,	O	O
SR1	SR1	NN	B-NP	B-protein
and	and	CC	I-NP	O
TM7	TM7	NN	I-NP	B-protein
.	.	.	O	O

Around	Around	IN	B-PP	O
half	half	DT	B-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
are	be	VBP	B-VP	O
as	as	IN	B-PP	O
yet	yet	RB	B-NP	O
uncultured	uncultured	JJ	I-NP	O
and	and	CC	I-NP	O
culture-independent	culture-independent	JJ	I-NP	O
methods	method	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
successfully	successfully	RB	I-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
comprehensively	comprehensively	RB	I-VP	O
describe	describe	VB	I-VP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
community	community	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
human	human	JJ	I-NP	O
oral	oral	JJ	I-NP	O
microbiome	microbiome	NN	I-NP	O
database	database	NN	I-NP	O
(	(	(	O	O
HOMD	HOMD	NN	B-NP	O
,	,	,	O	O
www.homd.org	www.homd.org	NN	B-NP	O
)	)	)	O	O
provides	provide	VBZ	B-VP	O
a	a	DT	B-NP	O
comprehensive	comprehensive	JJ	I-NP	O
resource	resource	NN	I-NP	O
consisting	consist	VBG	B-VP	O
of	of	IN	B-PP	O
descriptions	description	NNS	B-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
taxa	taxa	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
16S	16S	NN	I-NP	O
rRNA	rRNA	NN	I-NP	O
identification	identification	NN	I-NP	O
tool	tool	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
repository	repository	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	B-DNA
bacterial	bacterial	JJ	I-NP	I-DNA
genome	genome	NN	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
.	.	.	O	O

Individuals	Individual	NNS	B-NP	O
'	'	POS	B-NP	O
oral	oral	JJ	I-NP	O
microbiomes	microbiome	NNS	I-NP	O
are	be	VBP	B-VP	O
highly	highly	RB	B-ADJP	O
specific	specific	JJ	I-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
species	species	NN	I-NP	O
level	level	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
overall	overall	RB	B-ADVP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
oral	oral	JJ	I-NP	I-DNA
microbiome	microbiome	NN	I-NP	I-DNA
shows	show	VBZ	B-VP	O
few	few	JJ	B-NP	O
geographical	geographical	JJ	I-NP	O
differences	difference	NNS	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
caries	cary	NNS	B-NP	O
and	and	CC	O	O
periodontitis	periodontitis	NN	B-NP	O
are	be	VBP	B-VP	O
clearly	clearly	RB	B-ADVP	O
bacterial	bacterial	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
,	,	,	O	O
they	they	PRP	B-NP	O
are	be	VBP	B-VP	O
not	not	RB	O	O
infectious	infectious	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
classical	classical	JJ	I-NP	O
sense	sense	NN	I-NP	O
because	because	IN	B-SBAR	O
they	they	PRP	B-NP	O
result	result	VBP	B-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
complex	complex	JJ	I-NP	O
interaction	interaction	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
commensal	commensal	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
,	,	,	O	O
host	host	NN	B-NP	O
susceptibility	susceptibility	NN	I-NP	O
and	and	CC	O	O
environmental	environmental	JJ	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
diet	diet	NN	B-NP	O
and	and	CC	I-NP	O
smoking	smoking	NN	I-NP	O
.	.	.	O	O

Periodontitis	Periodontitis	NN	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
particular	particular	JJ	B-ADJP	O
,	,	,	O	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
result	result	VB	I-VP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
inappropriate	inappropriate	JJ	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
,	,	,	O	O
exacerbated	exacerbate	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
disease-associated	disease-associated	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
functional	functional	JJ	B-NP	O
terms	term	NNS	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	B-PP	O
considerable	considerable	JJ	B-NP	O
redundancy	redundancy	NN	I-NP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
focus	focus	NN	I-NP	O
on	on	IN	B-PP	O
functional	functional	JJ	B-ADJP	O
rather	rather	RB	B-PP	O
than	than	IN	I-PP	O
phylogenetic	phylogenetic	JJ	B-NP	O
diversity	diversity	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
required	require	VBN	I-VP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
fully	fully	RB	I-VP	O
understand	understand	VB	I-VP	O
host-microbiome	host-microbiome	JJ	B-NP	O
interactions	interaction	NNS	I-NP	O
.	.	.	O	O

Lactic	Lactic	JJ	B-NP	O
acid	acid	NN	I-NP	O
bacteria	bacteria	NNS	I-NP	O
(	(	(	O	O
LAB	LAB	NN	B-NP	B-protein
)	)	)	O	O
have	have	VBP	B-VP	O
become	become	VBN	I-VP	O
increasingly	increasingly	RB	B-ADJP	O
studied	study	VBN	I-ADJP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
two	two	CD	I-NP	O
decades	decade	NNS	I-NP	O
as	as	IN	B-PP	O
potential	potential	JJ	B-NP	O
delivery	delivery	NN	I-NP	O
systems	system	NNS	I-NP	O
for	for	IN	B-PP	O
various	various	JJ	B-NP	O
biological	biological	JJ	I-NP	O
molecules	molecule	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
gastrointestinal	gastrointestinal	JJ	I-NP	O
tract	tract	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
article	article	NN	I-NP	O
presents	present	VBZ	B-VP	O
an	an	DT	B-NP	O
overview	overview	NN	I-NP	O
of	of	IN	B-PP	O
characteristics	characteristic	NNS	B-NP	O
of	of	IN	B-PP	O
LAB	LAB	NN	B-NP	B-protein
as	as	IN	B-PP	O
delivery	delivery	NN	B-NP	O
systems	system	NNS	I-NP	O
and	and	CC	B-PP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
applications	application	NNS	I-NP	O
which	which	WDT	B-NP	O
have	have	VBP	B-VP	O
already	already	RB	I-VP	O
been	be	VBN	I-VP	O
developed	develop	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
majority	majority	NN	I-NP	O
of	of	IN	B-PP	O
LAB	LAB	NN	B-NP	O
strains	strain	NNS	I-NP	O
are	be	VBP	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
survive	survive	VB	I-VP	O
the	the	DT	B-NP	O
intestinal	intestinal	JJ	I-NP	O
passage	passage	NN	I-NP	O
and	and	CC	O	O
some	some	DT	B-NP	O
are	be	VBP	B-VP	O
also	also	RB	B-ADVP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
persist	persist	VB	I-VP	O
and	and	CC	I-VP	O
colonize	colonize	VB	I-VP	O
the	the	DT	B-NP	O
intestine	intestine	NN	I-NP	O
.	.	.	O	O

Several	Several	JJ	B-NP	O
strains	strain	NNS	I-NP	O
were	be	VBD	B-VP	O
in	in	IN	B-PP	O
fact	fact	NN	B-NP	O
described	describe	VBN	B-VP	O
as	as	IN	B-PP	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
commensal	commensal	JJ	I-NP	O
flora	flora	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
can	can	MD	B-VP	O
interact	interact	VB	I-VP	O
with	with	IN	B-PP	O
their	their	PRP$	B-NP	O
host	host	NN	I-NP	O
and	and	CC	O	O
are	be	VBP	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
deliver	deliver	VB	I-VP	O
large	large	JJ	B-NP	B-protein
molecular	molecular	JJ	I-NP	I-protein
weight	weight	NN	I-NP	I-protein
biomolecules	biomolecule	NNS	I-NP	I-protein
across	across	IN	B-PP	O
the	the	DT	B-NP	O
epithelium	epithelium	NN	I-NP	O
via	via	IN	B-PP	O
M-cells	M-cell	NNS	B-NP	B-cell_type
or	or	CC	O	O
dendritic	dendritic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
most	most	RBS	I-NP	O
widely	widely	RB	I-NP	O
applied	apply	VBN	I-NP	O
LAB	LAB	NN	I-NP	O
species	specie	NNS	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
Lactococcus	Lactococcus	NNP	B-NP	O
lactis	lactis	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-NP	O
species	specie	NNS	I-NP	O
from	from	IN	B-PP	O
genus	genus	NN	B-NP	O
Lactobacillus	Lactobacillus	NN	I-NP	O
are	be	VBP	B-VP	O
gaining	gain	VBG	I-VP	O
popularity	popularity	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
examples	example	NNS	I-NP	O
from	from	IN	B-PP	O
genus	genus	NN	B-NP	O
Bifidobacterium	Bifidobacterium	NN	I-NP	O
are	be	VBP	B-VP	O
starting	start	VBG	I-VP	O
to	to	TO	I-VP	O
emerge	emerge	VB	I-VP	O
.	.	.	O	O

Bacteria	Bacteria	NNS	B-NP	O
are	be	VBP	B-VP	O
mostly	mostly	RB	I-VP	O
applied	apply	VBN	I-VP	O
live	live	JJ	B-NP	O
and	and	CC	I-NP	O
enable	enable	JJ	I-NP	O
continuous	continuous	JJ	I-NP	O
delivery	delivery	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
biomolecules	biomolecule	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
killed	kill	VBN	B-NP	O
bacteria	bacteria	NNS	I-NP	O
(	(	(	O	O
e.g	e.g	NN	B-NP	O
.	.	.	O	O

gram-positive	gram-positive	JJ	B-NP	O
enhancer	enhancer	NN	I-NP	O
matrix	matrix	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
with	with	IN	B-PP	O
bound	bind	VBN	B-NP	O
biomolecules	biomolecule	NNS	I-NP	O
or	or	CC	B-PP	O
as	as	IN	B-PP	O
adjuvants	adjuvant	NNS	B-NP	O
,	,	,	O	O
are	be	VBP	B-VP	O
also	also	RB	I-VP	O
being	be	VBG	I-VP	O
developed	develop	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
techniques	technique	NNS	I-NP	O
for	for	IN	B-PP	O
genetic	genetic	JJ	B-NP	O
modification	modification	NN	I-NP	O
of	of	IN	B-PP	O
LAB	LAB	NN	B-NP	B-protein
are	be	VBP	B-VP	O
well	well	RB	I-VP	O
known	know	VBN	I-VP	O
.	.	.	O	O

This	This	DT	B-NP	O
review	review	NN	I-NP	O
focuses	focus	VBZ	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
delivery	delivery	NN	I-NP	O
of	of	IN	B-PP	O
recombinant	recombinant	JJ	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
and	and	CC	O	O
DNA	DNA	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
can	can	MD	B-VP	O
cause	cause	VB	I-VP	O
either	either	CC	O	O
local	local	JJ	B-NP	O
or	or	CC	I-NP	O
systemic	systemic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
divide	divide	VBP	B-VP	O
recombinant	recombinant	JJ	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
into	into	IN	B-PP	O
antigens	antigen	NNS	B-NP	O
and	and	CC	O	O
therapeutic	therapeutic	JJ	B-NP	O
proteins	protein	NNS	I-NP	O
.	.	.	O	O

Delivery	Delivery	NN	B-NP	O
of	of	IN	B-PP	O
antigens	antigen	NNS	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
purpose	purpose	NN	I-NP	O
of	of	IN	B-PP	O
vaccination	vaccination	NN	B-NP	O
represents	represent	VBZ	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
abundant	abundant	JJ	I-NP	O
application	application	NN	I-NP	O
with	with	IN	B-PP	O
numerous	numerous	JJ	B-NP	O
successful	successful	JJ	I-NP	O
demonstrations	demonstration	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
efficacy	efficacy	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
animal	animal	NN	I-NP	O
model	model	NN	I-NP	O
.	.	.	O	O

Therapeutic	Therapeutic	JJ	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
have	have	VBP	B-VP	O
mostly	mostly	RB	I-VP	O
been	be	VBN	I-VP	O
developed	develop	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
delivery	delivery	NN	I-NP	O
of	of	IN	B-PP	O
anti-inflammatory	anti-inflammatory	JJ	B-NP	B-protein
cytokines	cytokine	NNS	I-NP	I-protein
,	,	,	O	O
or	or	CC	O	O
downregulation	downregulation	NN	B-NP	O
of	of	IN	B-PP	O
proinflammatory	proinflammatory	JJ	B-NP	B-protein
cytokines	cytokine	NNS	I-NP	I-protein
.	.	.	O	O

Delivery	Delivery	NN	B-NP	O
of	of	IN	B-PP	O
allergens	allergen	NNS	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
modulation	modulation	NN	I-NP	O
of	of	IN	B-PP	O
allergic	allergic	JJ	B-NP	O
disorders	disorder	NNS	I-NP	O
represents	represent	VBZ	B-VP	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
most	most	RBS	I-NP	O
popular	popular	JJ	I-NP	O
application	application	NN	I-NP	O
of	of	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	B-protein
proteins	protein	NNS	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
delivery	delivery	NN	I-NP	O
of	of	IN	B-PP	O
DNA	DNA	NN	B-NP	O
by	by	IN	B-PP	O
LAB	LAB	NN	B-NP	B-protein
was	be	VBD	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
and	and	CC	O	O
offers	offer	VBZ	B-VP	O
exciting	exciting	JJ	B-NP	O
opportunities	opportunity	NNS	I-NP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
vaccine	vaccine	NN	I-NP	O
.	.	.	O	O

New	New	JJ	B-NP	O
discoveries	discovery	NNS	I-NP	O
may	may	MD	B-VP	O
eventually	eventually	RB	I-VP	O
lead	lead	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
transition	transition	NN	I-NP	O
of	of	IN	B-PP	O
LAB	LAB	NN	B-NP	B-protein
as	as	IN	B-PP	O
delivery	delivery	NN	B-NP	O
systems	system	NNS	I-NP	O
in	in	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
practice	practice	NN	I-NP	O
.	.	.	O	O

Efficient	Efficient	JJ	B-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
canine	canine	JJ	I-NP	O
oral	oral	JJ	I-NP	O
microbiome	microbiome	NN	I-NP	O
is	be	VBZ	B-VP	O
critical	critical	JJ	B-ADJP	O
for	for	IN	B-PP	O
understanding	understand	VBG	B-VP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
health	health	NN	B-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
providing	provide	VBG	B-VP	O
insight	insight	NN	B-NP	O
into	into	IN	B-PP	O
early	early	JJ	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
and	and	CC	I-NP	O
treatment	treatment	NN	I-NP	O
strategies	strategy	NNS	I-NP	O
against	against	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-PP	O
date	date	NN	B-NP	O
,	,	,	O	O
characterization	characterization	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
limited	limit	VBN	I-VP	O
to	to	TO	B-PP	O
cloning-based	cloning-based	JJ	B-NP	O
sequencing	sequencing	NN	I-NP	O
and	and	CC	O	O
conventional	conventional	JJ	B-NP	O
culture-based	culture-based	JJ	I-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
generally	generally	RB	B-ADVP	O
underestimate	underestimate	VBP	B-VP	O
community	community	NN	B-NP	O
diversity	diversity	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
inherent	inherent	JJ	B-NP	B-protein
biases	bias	NNS	I-NP	I-protein
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
methodologies	methodology	NNS	I-NP	O
.	.	.	O	O

Pyrosequencing	Pyrosequencing	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
cloning-	cloning-	NN	I-NP	O
and	and	CC	I-NP	O
culture-independent	culture-independent	JJ	I-NP	O
sequencing	sequencing	NN	I-NP	O
approach	approach	NN	I-NP	O
,	,	,	O	O
eliminates	eliminate	VBZ	B-VP	O
these	these	DT	B-NP	O
elements	element	NNS	I-NP	O
of	of	IN	B-PP	O
bias	bias	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
analysis	analysis	NN	I-NP	O
and	and	CC	O	O
enables	enable	VBZ	B-VP	O
extensive	extensive	JJ	B-NP	O
sequencing	sequencing	NN	I-NP	O
of	of	IN	B-PP	O
microbial	microbial	JJ	B-NP	B-cell_type
populations	population	NNS	I-NP	I-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
report	report	NN	I-NP	O
,	,	,	O	O
pyrosequencing	pyrosequencing	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
16S	16S	NN	I-NP	B-DNA
rRNA	rRNA	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
examine	examine	VB	I-VP	O
oral	oral	JJ	B-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
six	six	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
dogs	dog	NNS	I-NP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
effort	effort	NN	I-NP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
community	community	NN	B-NP	O
membership	membership	NN	I-NP	O
,	,	,	O	O
diversity	diversity	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
zoonotic	zoonotic	JJ	B-NP	O
implications	implication	NNS	I-NP	O
.	.	.	O	O

Pyrosequencing	Pyrosequencing	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	O	O
mean	mean	JJ	O	O
(	(	(	O	O
SD	SD	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
226	226	CD	B-NP	B-DNA
(	(	(	O	I-DNA
59	59	CD	B-NP	I-DNA
)	)	)	O	I-DNA
operational	operational	JJ	B-NP	I-DNA
taxonomic	taxonomic	JJ	I-NP	I-DNA
units	unit	NNS	I-NP	I-DNA
(	(	(	O	O
OTUs	OTU	NNS	B-NP	O
,	,	,	O	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
similarity	similarity	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
representing	represent	VBG	B-VP	O
181	181	CD	B-NP	O
genera	genera	NN	I-NP	O
from	from	IN	B-PP	O
13	13	CD	B-NP	O
bacterial	bacterial	JJ	I-NP	O
phyla	phyla	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
phyla	phyla	NN	I-NP	O
Bacteroidetes	Bacteroidete	NNS	I-NP	O
(	(	(	O	O
60.2	60.2	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Proteobacteria	Proteobacteria	NNP	B-NP	O
(	(	(	O	O
20.8	20.8	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Firmicutes	Firmicute	NNPS	B-NP	O
(	(	(	O	O
11.4	11.4	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Fusobacteria	Fusobacteria	NNS	B-NP	O
(	(	(	O	O
4.7	4.7	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
Spirochaetes	Spirochaetes	NNP	B-NP	O
(	(	(	O	O
1.7	1.7	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
predominated	predominate	VBD	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
most	most	RBS	I-NP	O
commonly	commonly	RB	I-NP	O
identified	identify	VBN	I-NP	O
genera	genera	NN	I-NP	O
were	be	VBD	B-VP	O
Porphyromonas	Porphyromonas	NNP	B-NP	O
(	(	(	O	O
39.2	39.2	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
sequences	sequence	NNS	B-NP	O
)	)	)	O	O
,	,	,	O	O
Fusobacterium	Fusobacterium	NN	B-NP	O
(	(	(	O	O
4.5	4.5	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Capnocytophaga	Capnocytophaga	NNP	B-NP	O
(	(	(	O	O
3.8	3.8	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Derxia	Derxia	NN	B-NP	O
(	(	(	O	O
3.7	3.7	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Moraxella	Moraxella	NN	B-NP	O
(	(	(	O	O
3.3	3.3	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
Bergeyella	Bergeyella	NN	B-NP	O
(	(	(	O	O
2.7	2.7	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Fifty-six	Fifty-six	CD	B-NP	O
OTUs	OTU	NNS	I-NP	O
,	,	,	O	O
corresponding	correspond	VBG	B-VP	O
to	to	TO	B-PP	O
38	38	CD	B-NP	O
unique	unique	JJ	I-NP	O
genus-level	genus-level	JJ	I-NP	O
identifications	identification	NNS	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
samples	sample	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
supports	support	VBZ	B-VP	O
the	the	DT	B-NP	O
concept	concept	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
stable	stable	JJ	I-NP	O
core	core	NN	I-NP	O
microbiome	microbiome	NN	I-NP	O
existing	exist	VBG	B-VP	O
between	between	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
dogs	dog	NNS	I-NP	O
.	.	.	O	O

Potentially	Potentially	RB	B-NP	O
zoonotic	zoonotic	JJ	I-NP	O
and	and	CC	I-NP	O
periodontal	periodontal	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
dogs	dog	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
highlights	highlight	VBZ	B-VP	O
the	the	DT	B-NP	O
zoonotic	zoonotic	JJ	I-NP	O
and	and	CC	I-NP	O
disease	disease	NN	I-NP	O
potential	potential	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microflora	microflora	NN	I-NP	O
.	.	.	O	O

Results	Result	NNS	B-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
canine	canine	JJ	I-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
harbors	harbor	VBZ	B-VP	O
a	a	DT	B-NP	O
rich	rich	JJ	I-NP	O
and	and	CC	I-NP	O
diverse	diverse	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
community	community	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
exceeds	exceed	VBZ	B-VP	O
estimates	estimate	NNS	B-NP	O
by	by	IN	B-PP	O
previous	previous	JJ	B-NP	O
culture-	culture-	NN	I-NP	O
and	and	CC	O	O
cloning-based	cloning-based	JJ	B-NP	O
studies	study	NNS	I-NP	O
.	.	.	O	O

Children	Child	NNS	B-NP	O
born	bear	VBN	B-VP	O
extremely	extremely	RB	B-ADJP	O
preterm	preterm	JJ	I-ADJP	O
often	often	RB	B-ADVP	O
suffer	suffer	VBP	B-VP	O
from	from	IN	B-PP	O
medical	medical	JJ	B-NP	O
complications	complication	NNS	I-NP	O
that	that	WDT	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
affect	affect	VB	I-VP	O
their	their	PRP$	B-NP	O
oral	oral	JJ	I-NP	O
health	health	NN	I-NP	O
as	as	IN	B-PP	O
toddlers	toddler	NNS	B-NP	O
and	and	CC	O	O
school	school	NN	B-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O
The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
oral	oral	JJ	B-NP	O
health	health	NN	I-NP	O
and	and	CC	I-NP	O
possible	possible	JJ	I-NP	O
risk	risk	NN	I-NP	O
indicators	indicator	NNS	I-NP	O
for	for	IN	B-PP	O
poor	poor	JJ	B-NP	O
oral	oral	JJ	I-NP	O
health	health	NN	I-NP	O
in	in	IN	B-PP	O
adolescents	adolescent	NNS	B-NP	O
born	bear	VBN	B-VP	O
extremely	extremely	RB	B-ADJP	O
preterm	preterm	JJ	I-ADJP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
and	and	CC	O	O
relate	relate	VB	B-VP	O
the	the	DT	B-NP	O
findings	finding	NNS	I-NP	O
to	to	TO	B-PP	O
medical	medical	JJ	B-NP	O
diagnoses	diagnosis	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
examination	examination	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
compare	compare	VBP	B-VP	O
the	the	DT	B-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
mineralization	mineralization	NN	B-NP	O
disturbances	disturbance	NNS	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
relation	relation	NN	I-NP	O
to	to	TO	B-PP	O
postnatal	postnatal	JJ	B-NP	O
morbidity	morbidity	NN	I-NP	O
and	and	CC	I-NP	O
treatments	treatment	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
medical	medical	JJ	I-NP	O
records	record	NNS	I-NP	O
postnatally	postnatally	RB	B-ADVP	O
,	,	,	O	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
in	in	IN	B-PP	O
45	45	CD	B-NP	O
extremely	extremely	RB	I-NP	O
preterm	preterm	JJ	I-NP	O
infants	infant	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
gestational	gestational	JJ	I-NP	O
age	age	NN	I-NP	O
(	(	(	O	O
GA	GA	NN	B-NP	B-DNA
)	)	)	O	O
of	of	IN	B-PP	O
<	<	SYM	B-NP	O
29	29	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
12	12	CD	B-NP	O
-	-	HYPH	I-NP	O
16	16	CD	I-NP	O
years	year	NNS	I-NP	O
of	of	IN	B-PP	O
age	age	NN	B-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
age	age	NN	B-NP	O
and	and	CC	I-NP	O
gender	gender	NN	I-NP	O
matched	match	VBD	B-VP	O
fullterm	fullterm	JJ	B-NP	O
controls	control	NNS	I-NP	O
with	with	IN	B-PP	O
37-43	37-43	CD	B-NP	O
weeks	week	NNS	I-NP	O
GA.	GA.	NN	I-NP	O
A	A	DT	B-NP	O
dental	dental	JJ	I-NP	O
clinical	clinical	JJ	I-NP	O
examination	examination	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
including	include	VBG	B-PP	O
a	a	DT	B-NP	O
salivary	salivary	JJ	I-NP	O
examination	examination	NN	I-NP	O
.	.	.	O	O

Medical	Medical	JJ	B-NP	O
diagnoses	diagnosis	NNS	I-NP	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
survey	survey	NN	I-NP	O
.	.	.	O	O

Data	Datum	NNS	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
dental	dental	JJ	I-NP	O
records	record	NNS	I-NP	O
at	at	IN	B-PP	O
3	3	CD	B-NP	O
,	,	,	I-NP	O
6	6	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
9	9	CD	B-NP	O
years	year	NNS	I-NP	O
of	of	IN	B-PP	O
age	age	NN	B-NP	O
was	be	VBD	B-VP	O
compiled	compile	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
findings	finding	NNS	I-NP	O
were	be	VBD	B-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
gestational	gestational	JJ	B-NP	O
age	age	NN	I-NP	O
,	,	,	O	O
birth	birth	NN	B-NP	O
weight	weight	NN	I-NP	O
,	,	,	O	O
neonatal	neonatal	JJ	B-NP	O
and	and	CC	I-NP	O
postnatal	postnatal	JJ	I-NP	O
medical	medical	JJ	I-NP	O
diagnoses	diagnosis	NNS	I-NP	O
treatments	treatment	NNS	I-NP	O
and	and	CC	O	O
medical	medical	JJ	B-NP	O
diagnoses	diagnosis	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
examination	examination	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
result	result	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
plaque	plaque	NN	B-NP	O
,	,	,	O	O
gingivitis	gingivitis	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
occurrence	occurrence	NN	I-NP	O
of	of	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
were	be	VBD	B-VP	O
higher	high	JJR	B-ADJP	O
among	among	IN	B-PP	O
adolescents	adolescent	NNS	B-NP	O
born	bear	VBN	B-VP	O
extremely	extremely	RB	B-ADJP	O
preterm	preterm	JJ	I-ADJP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
matched	match	VBN	B-NP	O
controls	control	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
saliva	saliva	NN	I-NP	O
secretion	secretion	NN	I-NP	O
was	be	VBD	B-VP	O
lower	low	JJR	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
extremely	extremely	RB	I-NP	O
preterm	preterm	JJ	I-NP	O
infants	infant	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
caries	cary	NNS	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
differ	differ	VB	I-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

Mineralization	Mineralization	NN	B-NP	O
disturbances	disturbance	NNS	I-NP	O
were	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
frequent	frequent	JJ	I-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
dentition	dentition	NN	I-NP	O
and	and	CC	O	O
more	more	RBR	B-ADJP	O
severe	severe	JJ	I-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
permanent	permanent	JJ	I-NP	O
dentition	dentition	NN	I-NP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
children	child	NNS	I-NP	O
born	bear	VBN	B-VP	O
extremely	extremely	RB	B-ADJP	O
preterm	preterm	JJ	I-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
association	association	NN	I-NP	O
between	between	IN	B-PP	O
dental	dental	JJ	B-NP	O
pathology	pathology	NN	I-NP	O
,	,	,	O	O
neonatal	neonatal	JJ	B-NP	O
and	and	CC	I-NP	O
postnatal	postnatal	JJ	I-NP	O
morbidity	morbidity	NN	I-NP	O
and	and	CC	I-NP	O
treatments	treatment	NNS	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
conclusion	conclusion	NN	B-NP	O
,	,	,	O	O
adolescents	adolescent	NNS	B-NP	O
born	bear	VBN	B-VP	O
extremely	extremely	RB	B-ADJP	O
preterm	preterm	JJ	I-ADJP	O
have	have	VBP	B-VP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
risk	risk	NN	B-NP	B-protein
indicators	indicator	NNS	I-NP	I-protein
for	for	IN	B-PP	O
a	a	DT	B-NP	O
poorer	poor	JJR	I-NP	O
oral	oral	JJ	I-NP	O
outcome	outcome	NN	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
controls	control	NNS	I-NP	O
and	and	CC	O	O
more	more	RBR	B-NP	O
severe	severe	JJ	I-NP	O
mineralization	mineralization	NN	I-NP	O
disturbances	disturbance	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
may	may	MD	B-VP	O
imply	imply	VB	I-VP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
vulnerability	vulnerability	NN	I-NP	O
for	for	IN	B-PP	O
poorer	poor	JJR	B-NP	O
oral	oral	JJ	I-NP	O
health	health	NN	I-NP	O
later	later	RB	B-ADVP	O
in	in	IN	B-PP	O
life	life	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
occurrence	occurrence	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
belonging	belong	VBG	B-VP	O
to	to	TO	B-PP	O
Pasteurellaceae	Pasteurellaceae	NNP	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
of	of	IN	B-PP	O
captive	captive	JJ	B-NP	O
marine	marine	JJ	I-NP	O
mammals	mammal	NNS	I-NP	O
was	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
using	use	VBG	B-VP	O
culture	culture	NN	B-NP	O
and	and	CC	O	O
subsequent	subsequent	JJ	B-NP	O
geno-	geno-	JJ	I-NP	O
and	and	CC	I-NP	O
phenotypic	phenotypic	JJ	I-NP	O
characterization	characterization	NN	I-NP	O
and	and	CC	O	O
phylogenetic	phylogenetic	JJ	B-NP	O
analyses	analysis	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
89	89	CD	B-NP	O
bacterial	bacterial	JJ	I-NP	O
isolates	isolate	NNS	I-NP	O
from	from	IN	B-PP	O
pinnipeds	pinniped	NNS	B-NP	O
tentatively	tentatively	RB	B-VP	O
classified	classify	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
family	family	NN	I-NP	O
Pasteurellaceae	Pasteurellaceae	NNP	B-NP	O
were	be	VBD	B-VP	O
further	further	RB	I-VP	O
characterized	characterize	VBN	I-VP	O
by	by	IN	B-PP	O
phylogenetic	phylogenetic	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
rpoB	rpoB	NN	B-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
isolates	isolate	NNS	I-NP	O
investigated	investigate	VBN	B-VP	O
formed	form	VBD	B-VP	O
five	five	CD	B-NP	O
distinct	distinct	JJ	I-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

Four	Four	CD	B-NP	O
strains	strain	NNS	I-NP	O
from	from	IN	B-PP	O
California	California	NNP	B-NP	O
sea	sea	NN	I-NP	O
lions	lion	NNS	I-NP	O
(	(	(	O	O
Zalophus	Zalophus	NN	B-NP	O
californianus	californianus	NN	I-NP	O
)	)	)	O	O
made	make	VBD	B-VP	O
up	up	RP	B-PRT	O
group	group	NN	B-NP	O
I	I	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
classified	classify	VBN	I-VP	O
with	with	IN	B-PP	O
Pasteurella	Pasteurella	NN	B-NP	O
canis	canis	NN	I-NP	O
.	.	.	O	O

Group	Group	NN	B-NP	B-protein
II	II	CD	I-NP	I-protein
comprised	comprise	VBD	B-VP	O
four	four	CD	B-NP	O
strains	strain	NNS	I-NP	O
from	from	IN	B-PP	O
harbor	harbor	NN	B-NP	O
seals	seal	NNS	I-NP	O
(	(	(	O	O
Phoca	Phoca	NNP	B-NP	O
vitulina	vitulina	NNP	I-NP	O
)	)	)	O	O
and	and	CC	O	O
grey	grey	JJ	B-NP	O
seals	seal	NNS	I-NP	O
(	(	(	O	O
Halichoerus	Halichoerus	NNP	B-NP	O
grypus	grypus	NNP	I-NP	O
)	)	)	O	O
classified	classify	VBN	B-VP	O
with	with	IN	B-PP	O
Pasteurella	Pasteurella	NN	B-NP	O
stomatis	stomatis	NN	I-NP	O
.	.	.	O	O

Group	Group	NN	B-NP	B-protein
III	III	CD	I-NP	I-protein
consisted	consist	VBD	B-VP	O
of	of	IN	B-PP	O
28	28	CD	B-NP	O
strains	strain	NNS	I-NP	O
,	,	,	O	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
harbor	harbor	NN	B-NP	O
and	and	CC	O	O
gray	gray	JJ	B-NP	O
seals	seal	NNS	I-NP	O
and	and	CC	O	O
represented	represent	VBD	B-VP	O
Bisgaardia	Bisgaardia	NNP	B-NP	O
genomospecies	genomospecy	NNS	I-NP	O
1	1	CD	I-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
strains	strain	NNS	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
harbor	harbor	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
grey	grey	JJ	I-NP	O
seal	seal	NN	I-NP	O
,	,	,	O	O
group	group	NN	B-NP	O
IV	IV	CD	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
classified	classify	VBN	I-VP	O
with	with	IN	B-PP	O
Bisgaardia	Bisgaardia	NN	B-NP	O
hudsonensis	hudsonensis	NN	I-NP	O
.	.	.	O	O

Fifty-two	Fifty-two	CD	B-NP	O
strains	strain	NNS	I-NP	O
from	from	IN	B-PP	O
northern	northern	JJ	B-NP	O
fur	fur	NN	I-NP	O
seals	seal	NNS	I-NP	O
(	(	(	O	O
Callorhinus	Callorhinus	NN	B-NP	O
ursinus	ursinus	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
walruses	walrus	NNS	B-NP	O
(	(	(	O	O
Odobenus	Odobenus	NN	B-NP	O
rosmarus	rosmarus	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
California	California	NNP	B-NP	O
and	and	CC	I-NP	O
Steller	Steller	NNP	I-NP	O
sea	sea	NN	I-NP	O
lions	lion	NNS	I-NP	O
(	(	(	O	O
Eumetopias	Eumetopia	NNS	B-NP	O
jubatus	jubatus	NN	I-NP	O
)	)	)	O	O
formed	form	VBD	B-VP	O
group	group	NN	B-NP	O
V	V	NN	I-NP	O
and	and	CC	O	O
represented	represent	VBD	B-VP	O
Otariodibacter	Otariodibacter	NNP	B-NP	O
oris	oris	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
Pasteurellaceae	Pasteurellaceae	NNP	I-NP	O
isolates	isolate	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
from	from	IN	B-PP	O
cetaceans	cetacean	NNS	B-NP	O
,	,	,	O	O
but	but	CC	O	O
Pasteurellaceae	Pasteurellaceae	NNP	B-NP	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
all	all	DT	B-NP	O
sampled	sample	VBN	I-NP	O
pinnipeds	pinniped	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
results	result	NNS	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
very	very	RB	B-ADJP	O
likely	likely	JJ	I-ADJP	O
that	that	IN	B-SBAR	O
Pasteurellaceae	Pasteurellaceae	NNP	B-NP	O
bacteria	bacteria	NNS	I-NP	O
represent	represent	VBP	B-VP	O
a	a	DT	B-NP	O
part	part	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
oral	oral	JJ	I-NP	O
flora	flora	NN	I-NP	O
in	in	IN	B-PP	O
pinnipeds	pinniped	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
:	:	:	O	O
(	(	(	B-LST	O
i	i	LS	I-LST	O
)	)	)	O	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
whether	whether	IN	B-SBAR	O
an	an	DT	B-NP	O
endodontic	endodontic	JJ	I-NP	O
pathology	pathology	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
extracted	extract	VBN	I-NP	O
tooth	tooth	NN	I-NP	O
or	or	CC	I-NP	O
adjacent	adjacent	JJ	I-NP	O
teeth	tooth	NNS	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
implant	implant	NN	I-NP	O
site	site	NN	I-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
influence	influence	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
emergence	emergence	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
periapical	periapical	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
(	(	(	B-LST	O
ii	ii	LS	I-LST	O
)	)	)	O	O
to	to	TO	B-VP	O
retrospectively	retrospectively	RB	I-VP	O
analyse	analyse	VB	I-VP	O
the	the	DT	B-NP	O
outcome	outcome	NN	I-NP	O
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
strategies	strategy	NNS	I-NP	O
,	,	,	O	O
(	(	(	B-LST	O
iii	iii	LS	I-LST	O
)	)	)	O	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
which	which	WDT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
periapical	periapical	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
endodontic	endodontic	JJ	I-NP	O
status	status	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tooth	tooth	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
implant	implant	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
and	and	CC	O	O
the	the	DT	B-NP	O
adjacent	adjacent	JJ	I-NP	O
teeth	teeth	NN	I-NP	O
was	be	VBD	B-VP	O
explored	explore	VBN	I-VP	O
and	and	CC	O	O
linked	link	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
periapical	periapical	JJ	I-NP	O
status	status	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
implant	implant	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
lesions	lesion	NNS	I-NP	O
treated	treat	VBN	B-VP	O
since	since	IN	B-PP	O
2000	2000	CD	B-NP	O
,	,	,	O	O
their	their	PRP$	B-NP	O
survival	survival	NN	I-NP	O
was	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
microbial	microbial	JJ	B-NP	O
samples	sample	NNS	I-NP	O
(	(	(	O	O
culturing	culture	VBG	B-VP	O
)	)	)	O	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
periapical	periapical	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
analysed	analyse	VBN	I-VP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
an	an	DT	B-NP	O
endodontic	endodontic	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
or	or	CC	O	O
a	a	DT	B-NP	O
periapical	periapical	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
apex	apex	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
tooth	tooth	NN	I-NP	O
is	be	VBZ	B-VP	O
present	present	JJ	B-ADJP	O
,	,	,	O	O
a	a	DT	B-NP	O
periapical	periapical	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
around	around	IN	B-PP	O
the	the	DT	B-NP	O
implant	implant	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
8.2	8.2	CD	B-NP	O
%	%	NN	I-NP	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
13.6	13.6	CD	I-NP	O
%	%	NN	I-NP	O
(	(	(	O	O
OR	OR	NN	B-NP	B-protein
7.2	7.2	CD	I-NP	I-protein
)	)	)	O	O
.	.	.	O	O

For	For	IN	B-PP	O
periapical	periapical	JJ	B-NP	O
pathology	pathology	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
adjacent	adjacent	JJ	I-NP	O
teeth	tooth	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
percentage	percentage	NN	I-NP	O
rises	rise	VBZ	B-VP	O
to	to	TO	B-PP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
(	(	(	O	O
OR	OR	NN	B-NP	B-protein
8.0	8.0	CD	I-NP	I-protein
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
best	good	JJS	I-NP	O
treatment	treatment	NN	I-NP	O
option	option	NN	I-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
found	find	VBN	I-VP	O
.	.	.	O	O

Bacteria	Bacteria	NNS	B-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
9/21	9/21	CD	B-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
most	most	RBS	I-NP	O
prominent	prominent	JJ	I-NP	O
species	specie	NNS	I-NP	O
was	be	VBD	B-VP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
an	an	DT	B-NP	O
endodontic	endodontic	JJ	I-NP	O
pathology	pathology	NN	I-NP	O
is	be	VBZ	B-VP	O
present	present	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
extracted	extract	VBN	I-NP	O
or	or	CC	I-NP	O
neighbouring	neighbour	VBG	I-NP	O
teeth	tooth	NNS	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
significantly	significantly	RB	B-ADJP	O
more	more	RBR	I-ADJP	O
likely	likely	JJ	I-ADJP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
periapical	periapical	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
will	will	MD	B-VP	O
develop	develop	VB	I-VP	O
around	around	IN	B-PP	O
a	a	DT	B-NP	O
future	future	JJ	I-NP	O
implant	implant	NN	I-NP	O
.	.	.	O	O

Feline	Feline	NN	B-NP	O
chronic	chronic	JJ	I-NP	O
gingivostomatitis	gingivostomatitis	NN	I-NP	O
(	(	(	O	O
FCGS	FCGS	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
disease	disease	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
that	that	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
severe	severe	JJ	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
distress	distress	NN	I-NP	O
in	in	IN	B-PP	O
affected	affect	VBN	B-NP	O
cats	cat	NNS	I-NP	O
.	.	.	O	O

Treatment	Treatment	NN	B-NP	O
methods	method	NNS	I-NP	O
are	be	VBP	B-VP	O
currently	currently	RB	B-ADVP	O
very	very	RB	B-ADJP	O
limited	limited	JJ	I-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
aims	aim	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
were	be	VBD	B-VP	O
to	to	TO	I-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
feline	feline	NN	I-NP	O
innate	innate	JJ	I-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O
by	by	IN	B-PP	O
investigating	investigate	VBG	B-VP	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
cytokine	cytokine	NN	B-NP	B-protein
and	and	CC	O	O
Toll-like	Toll-like	JJ	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
(	(	(	O	O
TLR	TLR	NN	B-NP	B-protein
)	)	)	O	O
mRNAs	mRNA	NNS	B-NP	O
in	in	IN	B-PP	O
tissue	tissue	NN	B-NP	O
biopsies	biopsy	NNS	I-NP	O
of	of	IN	B-PP	O
cats	cat	NNS	B-NP	O
with	with	IN	B-PP	O
and	and	CC	I-PP	O
without	without	IN	I-PP	O
FCGS	FCGS	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
to	to	TO	B-VP	O
relate	relate	VB	I-VP	O
this	this	DT	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
or	or	CC	I-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
putative	putative	JJ	B-NP	O
oral	oral	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
identified	identify	VBN	B-VP	O
previously	previously	RB	B-ADVP	O
within	within	IN	B-PP	O
these	these	DT	B-NP	O
cats	cat	NNS	I-NP	O
.	.	.	O	O

Mucosal	Mucosal	JJ	B-NP	O
biopsies	biopsy	NNS	I-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
from	from	IN	B-PP	O
28	28	CD	B-NP	O
cats	cat	NNS	I-NP	O
with	with	IN	B-PP	O
FCGS	FCGS	NN	B-NP	B-protein
and	and	CC	O	O
eight	eight	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
cats	cat	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
TLR	TLR	NN	B-NP	B-protein
(	(	(	O	O
TLR2	TLR2	NN	B-NP	B-protein
,	,	,	O	O
TLR3	TLR3	NN	B-NP	B-protein
,	,	,	O	O
TLR4	TLR4	NN	B-NP	B-protein
,	,	,	O	O
TLR7	TLR7	NN	B-NP	B-protein
,	,	,	O	O
TLR9	TLR9	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
cytokine	cytokine	NN	B-NP	B-protein
(	(	(	O	O
IL-1beta	IL-1beta	NN	B-NP	B-protein
,	,	,	O	O
IL-4	IL-4	NN	B-NP	B-protein
,	,	,	O	O
IL-6	IL-6	NN	B-NP	B-protein
,	,	,	O	O
IL-10	IL-10	NN	B-NP	B-protein
,	,	,	O	O
IL-12	IL-12	NN	B-NP	B-protein
,	,	,	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
,	,	,	O	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
)	)	)	O	O
mRNA	mRNA	NN	B-NP	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
using	use	VBG	B-VP	O
quantitative	quantitative	JJ	B-NP	O
PCR	PCR	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
FCGS	FCGS	NN	I-NP	O
group	group	NN	I-NP	O
a	a	DT	B-NP	O
statistically	statistically	RB	I-NP	O
significant	significant	JJ	I-NP	O
increase	increase	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
TLR2	TLR2	NN	B-NP	B-protein
,	,	,	O	O
TLR7	TLR7	NN	B-NP	B-protein
,	,	,	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
,	,	,	O	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
,	,	,	O	O
IL-1beta	IL-1beta	NN	B-NP	B-protein
and	and	CC	O	O
IL-6	IL-6	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
levels	level	NNS	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
healthy	healthy	JJ	I-NP	O
group	group	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
cats	cat	NNS	B-NP	O
where	where	WRB	B-ADVP	O
Tannerella	Tannerella	NN	B-NP	O
forsythia	forsythia	NN	I-NP	O
was	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
,	,	,	O	O
statistically	statistically	RB	B-NP	O
significant	significant	JJ	I-NP	O
increases	increase	NNS	I-NP	O
were	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
TLR2	TLR2	NN	B-NP	B-protein
,	,	,	O	O
TLR4	TLR4	NN	B-NP	B-protein
,	,	,	O	O
TLR7	TLR7	NN	B-NP	B-protein
,	,	,	O	O
TLR9	TLR9	NN	B-NP	B-protein
,	,	,	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
and	and	CC	O	O
IL-1beta	IL-1beta	NN	B-NP	B-RNA
mRNA	mRNA	NN	I-NP	I-RNA
levels	level	NNS	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
cats	cat	NNS	B-NP	O
where	where	WRB	B-ADVP	O
this	this	DT	B-NP	O
putative	putative	JJ	I-NP	O
pathogen	pathogen	NN	I-NP	O
was	be	VBD	B-VP	O
absent	absent	JJ	B-ADJP	O
.	.	.	O	O

Statistically	Statistically	RB	B-NP	O
significant	significant	JJ	I-NP	O
increases	increase	NNS	I-NP	O
in	in	IN	B-PP	O
mRNA	mRNA	NN	B-NP	B-RNA
expression	expression	NN	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
cats	cat	NNS	B-NP	O
harbouring	harbour	VBG	B-VP	O
feline	feline	NN	B-NP	O
calicivirus	calicivirus	NN	I-NP	O
(	(	(	O	O
FCV	FCV	NN	B-NP	O
)	)	)	O	O
(	(	(	O	O
TLR2	TLR2	NN	B-NP	B-protein
,	,	,	O	O
IL-1beta	IL-1beta	NN	B-NP	B-protein
,	,	,	O	O
IL-6	IL-6	NN	B-NP	B-protein
,	,	,	O	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
Porphyromonas	Porphyromonas	NN	B-NP	O
circumdentaria	circumdentaria	NN	I-NP	O
(	(	(	O	O
TLR2	TLR2	NN	B-NP	B-protein
,	,	,	O	O
TLR3	TLR3	NN	B-NP	B-protein
)	)	)	O	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
cats	cat	NNS	B-NP	O
where	where	WRB	B-ADVP	O
these	these	DT	B-NP	O
putative	putative	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
were	be	VBD	B-VP	O
absent	absent	JJ	B-ADJP	O
.	.	.	O	O

Pasteurella	Pasteurella	NN	B-NP	O
multocida	multocida	NN	I-NP	O
subsp	subsp	NN	I-NP	O
.	.	.	O	O

multocida	multocida	SYM	O	O
and	and	CC	O	O
Pseudomonas	Pseudomonas	NN	B-NP	O
sp	sp	NN	I-NP	O
.	.	.	O	O

did	do	VBD	B-VP	O
not	not	RB	I-VP	O
significantly	significantly	RB	I-VP	O
alter	alter	VB	I-VP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
TLR	TLR	NN	I-NP	B-protein
or	or	CC	I-NP	O
cytokine	cytokine	NN	I-NP	B-RNA
mRNAs	mRNA	NNS	I-NP	I-RNA
when	when	WRB	B-ADVP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
animals	animal	NNS	B-NP	O
who	who	WP	B-NP	O
tested	test	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
these	these	DT	B-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
cats	cat	NNS	B-NP	O
colonised	colonise	VBN	B-VP	O
with	with	IN	B-PP	O
P.	P.	NNP	B-NP	O
multocida	multocida	NNP	I-NP	O
subsp	subsp	NN	I-NP	O
.	.	.	O	O

septica	septica	NN	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
statistically	statistically	RB	I-NP	O
significant	significant	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
TLR7	TLR7	NN	B-NP	B-protein
,	,	,	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
and	and	CC	I-NP	O
IFN-gamma	IFN-gamma	NN	I-NP	B-RNA
mRNAs	mRNA	NNS	I-NP	I-RNA
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
cats	cat	NNS	B-NP	O
free	free	JJ	B-ADJP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
mRNA	mRNA	NN	B-NP	B-RNA
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
TLRs	TLR	NNS	I-NP	B-protein
and	and	CC	I-NP	O
cytokines	cytokine	NNS	I-NP	B-protein
is	be	VBZ	B-VP	O
elevated	elevate	VBN	I-VP	O
in	in	IN	B-PP	O
FCGS	FCGS	NN	B-NP	B-protein
.	.	.	O	O

A	A	DT	B-NP	O
positive	positive	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
between	between	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
disease	disease	NN	I-NP	O
severity	severity	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
FCV	FCV	NN	B-NP	O
(	(	(	O	O
p=0.001	p=0.001	NN	B-NP	O
;	;	:	O	O
Rho=0.58	Rho=0.58	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
cats	cat	NNS	B-NP	B-protein
harbouring	harbour	VBG	B-VP	I-protein
T.	T.	NN	B-NP	I-protein
forsythia	forsythia	NN	I-NP	I-protein
was	be	VBD	B-VP	O
low	low	JJ	B-ADJP	O
by	by	IN	B-PP	O
comparison	comparison	NN	B-NP	O
,	,	,	O	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
samples	sample	NNS	B-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
were	be	VBD	B-VP	O
from	from	IN	B-PP	O
cases	case	NNS	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
highest	high	JJS	I-NP	O
clinical	clinical	JJ	I-NP	O
disease	disease	NN	I-NP	O
severity	severity	NN	I-NP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
correlations	correlation	NNS	I-NP	O
with	with	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
disease	disease	NN	I-NP	O
severity	severity	NN	I-NP	O
were	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
for	for	IN	B-PP	O
TLR2	TLR2	NN	B-NP	B-protein
(	(	(	O	O
p=0.00086	p=0.00086	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
TLR7	TLR7	NN	B-NP	B-protein
(	(	(	O	O
p=0.049	p=0.049	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
TNF-alpha	TNF-alpha	NN	B-NP	B-protein
(	(	(	O	O
p=0.027	p=0.027	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
IFN-gamma	IFN-gamma	NN	B-NP	B-protein
(	(	(	O	O
p=0.0015	p=0.0015	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
IL-1beta	IL-1beta	NN	B-NP	B-protein
(	(	(	O	O
p=0.004	p=0.004	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
IL-6	IL-6	NN	B-NP	B-protein
(	(	(	O	O
p=0.00001	p=0.00001	NN	B-NP	O
)	)	)	O	O
mRNAs	mRNA	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
putative	putative	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
FCV	FCV	NN	I-NP	O
and	and	CC	I-NP	O
T.	T.	NN	I-NP	O
forsythia	forsythia	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
important	important	JJ	B-ADJP	O
in	in	IN	B-PP	O
stimulating	stimulate	VBG	B-VP	O
a	a	DT	B-NP	O
host	host	NN	I-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
FCGS	FCGS	NN	B-NP	B-protein
and	and	CC	O	O
may	may	MD	B-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
compare	compare	VB	I-VP	O
the	the	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
mouth	mouth	NN	I-NP	O
rinse	rinse	NN	I-NP	O
containing	contain	VBG	B-VP	O
chlorhexidine	chlorhexidine	NN	B-NP	O
and	and	CC	O	O
cetylpyridinium	cetylpyridinium	NN	B-NP	O
chloride	chloride	NN	I-NP	O
(	(	(	O	O
MR1	MR1	NN	B-NP	B-protein
)	)	)	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
stannous	stannous	JJ	I-NP	O
fluoride-based	fluoride-based	JJ	I-NP	O
mouth	mouth	NN	I-NP	O
rinse	rinse	NN	I-NP	O
(	(	(	O	O
MR2	MR2	NN	B-NP	B-protein
)	)	)	O	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O

Samples	Sample	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tongues	tongue	NNS	I-NP	O
from	from	IN	B-PP	O
10	10	CD	B-NP	O
subjects	subject	NNS	I-NP	O
with	with	IN	B-PP	O
and	and	CC	O	O
10	10	CD	B-NP	O
subjects	subject	NNS	I-NP	O
without	without	IN	B-PP	O
halitosis	halitosis	NN	B-NP	O
were	be	VBD	B-VP	O
inoculated	inoculate	VBN	I-VP	O
on	on	IN	B-PP	O
blood	blood	NN	B-NP	O
agar	agar	NN	I-NP	O
plates	plate	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
agar	agar	NN	I-NP	O
was	be	VBD	B-VP	O
perforated	perforate	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
cylindrical	cylindrical	JJ	I-NP	O
holes	hole	NNS	I-NP	O
were	be	VBD	B-VP	O
filled	fill	VBN	I-VP	O
either	either	CC	B-PP	O
with	with	IN	I-PP	O
mouth	mouth	NN	B-NP	O
rinse	rinse	NN	I-NP	O
MR1	MR1	NN	I-NP	O
or	or	CC	B-PP	O
with	with	IN	B-PP	O
mouth	mouth	NN	B-NP	B-protein
rinse	rinse	NN	I-NP	I-protein
MR2	MR2	NN	I-NP	I-protein
.	.	.	O	O

After	After	IN	B-PP	O
incubation	incubation	NN	B-NP	O
,	,	,	O	O
inhibition	inhibition	NN	B-NP	O
zones	zone	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
whole	whole	JJ	I-NP	O
tongue	tongue	NN	I-NP	O
microbiota	microbiota	NN	I-NP	O
and	and	CC	O	O
Fusobacterium	Fusobacterium	NN	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
were	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
MR1	MR1	NN	B-NP	B-protein
and	and	CC	I-NP	O
MR2	MR2	NN	I-NP	B-protein
were	be	VBD	B-VP	O
applied	apply	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
short	short	JJ	I-NP	O
interval	interval	NN	I-NP	O
killing	killing	NN	I-NP	O
test	test	NN	I-NP	O
(	(	(	O	O
SIKT	SIKT	NN	B-NP	O
)	)	)	O	O
on	on	IN	B-PP	O
four	four	CD	B-NP	O
oral	oral	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
Porphyromonas	Porphyromonas	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
Prevotella	Prevotella	NNP	B-NP	O
intermedia	intermedia	NNS	I-NP	O
,	,	,	O	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
and	and	CC	I-NP	O
Aggregatibacter	Aggregatibacter	NNP	I-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
.	.	.	O	O

Total	Total	JJ	B-NP	O
viable	viable	JJ	I-NP	O
cell	cell	NN	I-NP	O
counts	count	NNS	I-NP	O
were	be	VBD	B-VP	O
made	make	VBN	I-VP	O
after	after	IN	B-PP	O
two	two	CD	B-NP	O
minutes	minute	NNS	I-NP	O
of	of	IN	B-PP	O
incubation	incubation	NN	B-NP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
MR1	MR1	NN	B-NP	B-protein
and	and	CC	I-NP	O
MR2	MR2	NN	I-NP	B-protein
.	.	.	O	O

MR1	MR1	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
significantly	significantly	RB	I-NP	O
higher	high	JJR	I-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
activity	activity	NN	I-NP	O
against	against	IN	B-PP	O
the	the	DT	B-NP	O
whole	whole	JJ	I-NP	O
tongue	tongue	NN	I-NP	O
microbiota	microbiota	NN	I-NP	O
and	and	CC	O	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
than	than	IN	B-PP	O
MR2	MR2	NN	B-NP	B-protein
in	in	IN	B-PP	O
both	both	DT	B-NP	O
groups	group	NNS	I-NP	O
of	of	IN	B-PP	O
subjects	subject	NNS	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
SIK	SIK	NN	I-NP	O
test	test	NN	I-NP	O
,	,	,	O	O
MR1	MR1	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
significantly	significantly	RB	I-NP	O
greater	great	JJR	I-NP	O
killing	killing	NN	I-NP	O
capacity	capacity	NN	I-NP	O
than	than	IN	B-PP	O
MR2	MR2	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
mouth	mouth	JJ	I-NP	O
rinse	rinse	NN	I-NP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
chlorhexidine	chlorhexidine	NN	B-NP	O
and	and	CC	O	O
0.05	0.05	CD	B-NP	O
%	%	NN	I-NP	O
cetylpyridinium	cetylpyridinium	NN	I-NP	O
chloride	chloride	NN	I-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
more	more	RBR	B-ADJP	O
effective	effective	JJ	I-ADJP	O
in	in	IN	B-PP	O
inhibiting	inhibit	VBG	B-VP	O
growth	growth	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-protein
tongue	tongue	NN	I-NP	I-protein
microbiota	microbiota	NN	I-NP	I-protein
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
than	than	IN	B-PP	O
a	a	DT	B-NP	O
fluoride/stannous	fluoride/stannous	JJ	I-NP	O
fluoride-containing	fluoride-containing	JJ	I-NP	O
mouth	mouth	NN	I-NP	O
rinse	rinse	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
observation	observation	NN	I-NP	O
supports	support	VBZ	B-VP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
chlorhexidine	chlorhexidine	NN	B-NP	O
and	and	CC	I-NP	O
cetylpyridinium	cetylpyridinium	NN	I-NP	O
chloride	chloride	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
halitosis	halitosis	NN	I-NP	O
.	.	.	O	O

Dental	Dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
and	and	CC	O	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
are	be	VBP	B-VP	O
widespread	widespread	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
microorganism	microorganism	NN	B-NP	O
infections	infection	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
identified	identify	VBN	I-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
main	main	JJ	I-NP	O
etiology	etiology	NN	I-NP	O
.	.	.	O	O

Silver	Silver	NN	B-NP	O
nanoparticles	nanoparticle	NNS	I-NP	O
(	(	(	O	O
Ag	Ag	NN	B-NP	O
Nps	Np	NNS	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
considered	consider	VBN	I-VP	O
as	as	IN	B-PP	O
potential	potential	JJ	B-NP	O
control	control	NN	I-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
infection	infection	NN	I-NP	O
agent	agent	NN	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
its	its	PRP$	B-NP	O
excellent	excellent	JJ	I-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
activity	activity	NN	I-NP	O
and	and	CC	O	O
non	non	JJ	B-NP	O
acute	acute	JJ	I-NP	O
toxic	toxic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
work	work	NN	I-NP	O
,	,	,	O	O
stable	stable	JJ	B-NP	O
Ag	Ag	NN	I-NP	O
Nps	Np	NNS	I-NP	O
with	with	IN	B-PP	O
different	different	JJ	B-NP	O
sizes	size	NNS	I-NP	O
(	(	(	O	O
~5	~5	CD	B-NP	O
,	,	,	I-NP	O
15	15	CD	I-NP	O
and	and	CC	I-NP	O
55	55	CD	I-NP	O
nm	nm	NN	I-NP	O
mean	mean	NN	I-NP	O
values	value	NNS	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
synthesized	synthesize	VBN	I-VP	O
by	by	IN	B-PP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
simple	simple	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
method	method	NN	I-NP	O
or	or	CC	O	O
hydrothermal	hydrothermal	JJ	B-NP	O
method	method	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Nps	Np	NNS	I-NP	B-protein
were	be	VBD	B-VP	O
characterized	characterize	VBN	I-VP	O
by	by	IN	B-PP	O
powder	powder	NN	B-NP	O
X-ray	X-ray	NN	I-NP	O
diffraction	diffraction	NN	I-NP	O
,	,	,	O	O
transmission	transmission	NN	B-NP	O
electron	electron	NN	I-NP	O
microscopy	microscopy	NN	I-NP	O
and	and	CC	O	O
UV-vis	UV-vis	JJ	B-NP	O
absorption	absorption	NN	I-NP	O
spectroscopy	spectroscopy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
antibacterial	antibacterial	JJ	I-NP	O
activities	activity	NNS	I-NP	O
were	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
colony	colony	NN	B-NP	O
counting	counting	NN	I-NP	O
assay	assay	NN	I-NP	O
and	and	CC	I-NP	O
growth	growth	NN	I-NP	O
inhibition	inhibition	NN	I-NP	O
curve	curve	NN	I-NP	O
method	method	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
corresponding	correspond	VBG	B-VP	O
minimum	minimum	JJ	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
(	(	(	O	O
MIC	MIC	NN	B-NP	O
)	)	)	O	O
against	against	IN	B-PP	O
five	five	CD	B-NP	O
anaerobic	anaerobic	JJ	I-NP	O
oral	oral	JJ	I-NP	O
pathogenic	pathogenic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
aerobic	aerobic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
E.	E.	FW	B-ADVP	O
coli	coli	FW	I-ADVP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
Ag	Ag	NN	B-NP	O
Nps	Np	NNS	I-NP	O
had	have	VBD	B-VP	O
apparent	apparent	JJ	B-NP	O
antibacterial	antibacterial	JJ	I-NP	O
effects	effect	NNS	I-NP	O
against	against	IN	B-PP	O
the	the	DT	B-NP	O
anaerobic	anaerobic	JJ	I-NP	O
oral	oral	JJ	I-NP	O
pathogenic	pathogenic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
aerobic	aerobic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
MIC	MIC	NN	I-NP	O
values	value	NNS	I-NP	O
of	of	IN	B-PP	O
5-nm	5-nm	JJ	B-NP	B-protein
Ag	Ag	NN	I-NP	I-protein
against	against	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
oral	oral	JJ	I-NP	O
pathogenic	pathogenic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
A.	A.	NN	I-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
,	,	,	O	O
F.	F.	NNP	B-NP	O
nuceatum	nuceatum	NNP	I-NP	O
,	,	,	O	O
S.	S.	NNP	B-NP	O
mitis	mitis	NN	I-NP	O
,	,	,	O	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
and	and	CC	O	O
S.	S.	NNP	B-NP	O
sanguis	sanguis	NNP	I-NP	O
were	be	VBD	B-VP	O
25	25	CD	B-NP	O
,	,	,	I-NP	O
25	25	CD	I-NP	O
,	,	,	I-NP	O
25	25	CD	I-NP	O
,	,	,	I-NP	O
50	50	CD	I-NP	O
and	and	CC	I-NP	O
50	50	CD	I-NP	O
mug/mL	mug/mL	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
aerobic	aerobic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
susceptible	susceptible	JJ	I-ADJP	O
to	to	TO	B-PP	O
Ag	Ag	NN	B-NP	O
NPs	NP	NNS	I-NP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
anaerobic	anaerobic	JJ	I-NP	O
oral	oral	JJ	I-NP	O
pathogenic	pathogenic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
mean	mean	JJ	I-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
Ag	Ag	NN	B-NP	O
NPs	NP	NNS	I-NP	O
displayed	display	VBD	B-VP	O
an	an	DT	B-NP	O
obvious	obvious	JJ	I-NP	O
size-dependent	size-dependent	JJ	I-NP	O
antibacterial	antibacterial	JJ	I-NP	O
activity	activity	NN	I-NP	O
against	against	IN	B-PP	O
the	the	DT	B-NP	O
anaerobic	anaerobic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
5-nm	5-nm	JJ	I-NP	B-protein
Ag	Ag	NN	I-NP	I-protein
presents	present	VBZ	B-VP	O
the	the	DT	B-NP	O
highest	high	JJS	I-NP	O
antibacterial	antibacterial	JJ	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
work	work	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
application	application	NN	I-NP	O
of	of	IN	B-PP	O
Ag	Ag	NN	B-NP	O
Nps	Np	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
microorganism	microorganism	NN	I-NP	O
infections	infection	NNS	I-NP	O
.	.	.	O	O

Autologous	Autologous	JJ	B-NP	O
platelet	platelet	NN	I-NP	O
concentrates	concentrate	NNS	I-NP	O
(	(	(	O	O
PCs	PC	NNS	B-NP	B-cell_type
)	)	)	O	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
extensively	extensively	RB	I-VP	O
used	use	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
medical	medical	JJ	B-NP	O
fields	field	NNS	I-NP	O
to	to	TO	B-VP	O
promote	promote	VB	I-VP	O
soft	soft	JJ	B-NP	O
and	and	CC	I-NP	O
hard	hard	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
regeneration	regeneration	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
significance	significance	NN	I-NP	O
behind	behind	IN	B-PP	O
their	their	PRP$	B-NP	O
use	use	NN	I-NP	O
lies	lie	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
abundance	abundance	NN	I-NP	O
of	of	IN	B-PP	O
growth	growth	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
in	in	IN	B-PP	O
platelets	platelet	NNS	B-NP	B-cell_type
alpha-granules	alpha-granule	NNS	I-NP	O
that	that	WDT	B-NP	O
promotes	promote	VBZ	B-VP	O
wound	wound	NN	B-NP	O
healing	healing	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
antibacterial	antibacterial	JJ	B-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
PCs	PC	NNS	B-NP	B-cell_type
against	against	IN	B-PP	O
various	various	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
recently	recently	RB	I-VP	O
pointed	point	VBN	I-VP	O
out	out	RP	B-PRT	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
pure	pure	JJ	B-NP	O
platelet-rich	platelet-rich	JJ	I-NP	O
plasma	plasma	NN	I-NP	O
(	(	(	O	O
P-PRP	P-PRP	NN	B-NP	B-protein
)	)	)	O	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
against	against	IN	B-PP	O
oral	oral	JJ	B-NP	O
cavity	cavity	NN	I-NP	O
microorganisms	microorganism	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
Enterococcus	Enterococcus	NNP	B-NP	O
faecalis	faecalis	NNP	I-NP	O
,	,	,	O	O
Candida	Candida	NNP	B-NP	O
albicans	albicans	NNP	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
agalactiae	agalactiae	NNP	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
oralis	oralis	NNP	I-NP	O
and	and	CC	O	O
Pseudomonas	Pseudomonas	NNP	B-NP	O
aeruginosa	aeruginosa	NN	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
from	from	IN	B-PP	O
17	17	CD	B-NP	O
patients	patient	NNS	I-NP	O
who	who	WP	B-NP	O
underwent	undergo	VBD	B-VP	O
oral	oral	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
procedures	procedure	NNS	I-NP	O
involving	involve	VBG	B-VP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
P-PRP	P-PRP	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
antibacterial	antibacterial	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
P-PRP	P-PRP	NN	B-NP	B-protein
,	,	,	O	O
evaluated	evaluate	VBN	B-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
minimum	minimum	JJ	I-NP	O
inhibitory	inhibitory	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
(	(	(	O	O
MIC	MIC	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
microdilution	microdilution	NN	I-NP	O
twofold	twofold	JJ	I-NP	O
serial	serial	JJ	I-NP	O
method	method	NN	I-NP	O
.	.	.	O	O

P-PRP	P-PRP	NN	B-NP	B-protein
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
Enterococcus	Enterococcus	NNP	B-NP	O
faecalis	faecalis	NNP	I-NP	O
,	,	,	O	O
Candida	Candida	NNP	B-NP	O
albicans	albicans	NNP	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
agalactiae	agalactiae	NNP	I-NP	O
and	and	CC	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
oralis	oralis	NNP	I-NP	O
,	,	,	O	O
but	but	CC	B-PP	O
not	not	RB	B-PP	O
of	of	IN	I-PP	O
Pseudomonas	Pseudomonas	NNP	B-NP	O
aeruginosa	aeruginosa	NN	I-NP	O
strains	strain	NNS	I-NP	O
.	.	.	O	O

P-PRP	P-PRP	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
potentially	potentially	RB	I-NP	O
useful	useful	JJ	I-NP	O
substance	substance	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
fight	fight	NN	I-NP	O
against	against	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
infections	infection	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
might	might	MD	B-VP	O
represent	represent	VB	I-VP	O
a	a	DT	B-NP	O
valuable	valuable	JJ	I-NP	O
property	property	NN	I-NP	O
in	in	IN	B-PP	O
adjunct	adjunct	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
enhancement	enhancement	NN	I-NP	O
of	of	IN	B-PP	O
tissue	tissue	NN	B-NP	O
regeneration	regeneration	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
compare	compare	VB	I-VP	O
via	via	IN	B-PP	O
a	a	DT	B-NP	O
split-mouth	split-mouth	JJ	I-NP	O
randomized	randomize	VBN	I-NP	O
clinical	clinical	JJ	I-NP	O
trial	trial	NN	I-NP	O
the	the	DT	B-NP	O
efficacy	efficacy	NN	I-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
%	%	NN	I-NP	O
chlorhexidine	chlorhexidine	NN	I-NP	O
gel	gel	NN	I-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
hydroxide/camphorated	hydroxide/camphorate	VBD	B-VP	O
paramonochlorophenol	paramonochlorophenol	NN	B-NP	O
(	(	(	O	O
Callen	Callen	VBN	B-NP	O
PMCC	PMCC	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
one-visit	one-visit	JJ	I-NP	O
endodontic	endodontic	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
against	against	IN	B-PP	O
mutans	mutan	NNS	B-NP	O
streptococci	streptococci	NNS	I-NP	O
and	and	CC	O	O
anaerobic	anaerobic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
primary	primary	JJ	B-NP	O
molars	molar	NNS	I-NP	O
with	with	IN	B-PP	O
necrotic	necrotic	JJ	B-NP	O
pulps	pulp	NNS	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
clinical	clinical	JJ	B-NP	O
success	success	NN	I-NP	O
rates	rate	NNS	I-NP	O
after	after	IN	B-PP	O
12	12	CD	B-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

Pre-	Pre-	NN	B-NP	O
and	and	CC	I-NP	O
posttreatment	posttreatment	NN	I-NP	O
intracanal	intracanal	JJ	I-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
from	from	IN	B-PP	O
37	37	CD	B-NP	O
teeth	tooth	NNS	I-NP	O
(	(	(	O	O
from	from	IN	B-PP	O
21	21	CD	B-NP	O
children	child	NNS	I-NP	O
)	)	)	O	O
for	for	IN	B-PP	O
analysis	analysis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
mutans	mutan	NNS	B-NP	O
streptococci	streptococci	NNS	I-NP	O
and	and	CC	O	O
anaerobic	anaerobic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

Clinical	Clinical	JJ	B-NP	O
and	and	CC	I-NP	O
radiographic	radiographic	JJ	I-NP	O
criteria	criterion	NNS	I-NP	O
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
treatment	treatment	NN	B-NP	O
outcome	outcome	NN	I-NP	O
.	.	.	O	O

Chlorhexidine	Chlorhexidine	NN	B-NP	O
gel	gel	NN	I-NP	O
significantly	significantly	RB	B-ADVP	O
reduced	reduce	VBD	B-VP	O
mutans	mutan	NNS	B-NP	O
streptococci	streptococci	NNS	I-NP	O
levels	level	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
.010	.010	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
whereas	whereas	IN	O	O
Callen	Callen	NN	B-NP	O
PMCC	PMCC	NN	I-NP	O
significantly	significantly	RB	B-ADVP	O
reduced	reduce	VBD	B-VP	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
.002	.002	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

No	No	DT	B-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
reduction	reduction	NN	I-NP	O
of	of	IN	B-PP	O
mutans	mutan	NNS	B-NP	O
streptococci	streptococci	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
.187	.187	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
anaerobes	anaerobe	NNS	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
.564	.564	CD	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
between	between	IN	B-PP	O
groups	group	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
success	success	NN	I-NP	O
rates	rate	NNS	I-NP	O
were	be	VBD	B-VP	O
85.71	85.71	CD	B-NP	O
%	%	NN	I-NP	O
(	(	(	O	O
Callen	Callen	VBN	B-NP	O
PMCC	PMCC	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
78.57	78.57	CD	B-NP	O
%	%	NN	I-NP	O
(	(	(	O	O
chlorexidine	chlorexidine	NN	B-NP	O
gel	gel	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
77.77	77.77	CD	B-NP	O
%	%	NN	I-NP	O
(	(	(	O	O
one-visit	one-visit	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Teeth	Teeth	NN	B-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
Callen	Callen	VBN	B-NP	O
PMCC	PMCC	NN	I-NP	O
presented	present	VBD	B-VP	O
the	the	DT	B-NP	O
highest	high	JJS	I-NP	O
clinical	clinical	JJ	I-NP	O
success	success	NN	I-NP	O
rate	rate	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
1	1	CD	I-NP	O
%	%	NN	I-NP	O
chlorhexidine	chlorhexidine	NN	I-NP	O
gel	gel	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
calcium	calcium	NN	B-NP	O
hydroxide/camphorated	hydroxide/camphorate	VBD	B-VP	O
paramonochlorophenol	paramonochlorophenol	NN	B-NP	O
,	,	,	O	O
presented	present	VBN	B-VP	O
limited	limited	JJ	B-NP	O
efficacy	efficacy	NN	I-NP	O
in	in	IN	B-PP	O
reducing	reduce	VBG	B-VP	O
bacteria	bacteria	NNS	B-NP	O
from	from	IN	B-PP	O
necrotic	necrotic	JJ	B-NP	O
primary	primary	JJ	I-NP	O
root	root	NN	I-NP	O
canals	canal	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
compounds	compound	NNS	B-NP	O
in	in	IN	B-PP	O
exhaled	exhale	VBN	B-NP	O
mouth	mouth	NN	I-NP	O
air	air	NN	I-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
necessarily	necessarily	RB	I-VP	O
reflect	reflect	VB	I-VP	O
levels	level	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
systemic	systemic	JJ	I-NP	O
circulation	circulation	NN	I-NP	O
as	as	IN	B-SBAR	O
bacteria	bacteria	NNS	B-NP	O
can	can	MD	B-VP	O
bio-transform	bio-transform	VB	I-VP	O
substrates	substrate	NNS	B-NP	O
to	to	TO	B-VP	O
produce	produce	VB	I-VP	O
compounds	compound	NNS	B-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
of	of	IN	B-PP	O
concern	concern	NN	B-NP	O
to	to	TO	B-PP	O
researchers	researcher	NNS	B-NP	O
measuring	measure	VBG	B-VP	O
breath	breath	NN	B-NP	O
volatiles	volatile	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
diagnosing	diagnose	VBG	B-VP	O
systemic	systemic	JJ	B-NP	O
or	or	CC	I-NP	O
metabolic	metabolic	JJ	I-NP	O
conditions	condition	NNS	I-NP	O
as	as	RB	B-PP	O
very	very	RB	B-ADJP	O
little	little	JJ	I-ADJP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
origin	origin	NN	I-NP	O
of	of	IN	B-PP	O
many	many	JJ	B-NP	O
compounds	compound	NNS	I-NP	O
detected	detect	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
breath	breath	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
pilot	pilot	NN	I-NP	O
study	study	NN	I-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
volatile	volatile	JJ	B-NP	O
compounds	compound	NNS	I-NP	O
by	by	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
communities	community	NNS	I-NP	O
present	present	JJ	B-ADJP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
.	.	.	O	O

Solid-phase	Solid-phase	JJ	B-NP	O
micro-extraction	micro-extraction	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
extract	extract	VB	I-VP	O
volatiles	volatile	NNS	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
headspace	headspace	NN	I-NP	O
gas	gas	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
Gram-positive	Gram-positive	JJ	I-NP	O
and	and	CC	O	O
two	two	CD	B-NP	O
Gram-negative	Gram-negative	JJ	I-NP	B-cell_line
bacterial	bacterial	JJ	I-NP	I-cell_line
cultures	culture	NNS	I-NP	I-cell_line
known	know	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
present	present	JJ	B-ADJP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
and	and	CC	B-PP	O
from	from	IN	B-PP	O
tongue	tongue	NN	B-NP	O
biofilm	biofilm	NN	I-NP	O
microflora	microflora	NN	I-NP	O
.	.	.	O	O

Analyses	Analysis	NNS	B-NP	O
were	be	VBD	B-VP	O
undertaken	undertake	VBN	I-VP	O
using	use	VBG	B-VP	O
gas	gas	NN	B-NP	O
chromatography	chromatography	NN	I-NP	O
mass	mass	NN	I-NP	O
spectrometry	spectrometry	NN	I-NP	O
.	.	.	O	O

Between	Between	IN	B-PP	O
64	64	CD	B-NP	O
and	and	CC	I-NP	O
82	82	CD	I-NP	O
volatile	volatile	JJ	I-NP	O
compounds	compound	NNS	I-NP	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
from	from	IN	B-PP	O
sampling	sample	VBG	B-VP	O
the	the	DT	B-NP	O
headspace	headspace	NN	I-NP	O
gas	gas	NN	I-NP	O
above	above	IN	B-PP	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cultures	culture	NNS	I-NP	O
.	.	.	O	O

Gram-negative	Gram-negative	JJ	B-NP	O
anaerobes	anaerobe	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
produce	produce	VB	I-VP	O
more	more	RBR	B-NP	O
volatile	volatile	JJ	I-NP	O
sulfur	sulfur	NN	I-NP	O
compounds	compound	NNS	I-NP	O
(	(	(	O	O
VSCs	VSC	NNS	B-NP	B-cell_type
)	)	)	O	O
and	and	CC	O	O
amines	amine	NNS	B-NP	O
.	.	.	O	O

Solobacterium	Solobacterium	NNP	B-NP	O
moorei	moorei	NNP	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
Gram-positive	Gram-positive	JJ	I-NP	O
species	species	NN	I-NP	O
was	be	VBD	B-VP	O
however	however	RB	I-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
produce	produce	VB	I-VP	O
higher	high	JJR	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
acids	acid	NNS	B-NP	O
,	,	,	O	O
hydrocarbons	hydrocarbon	NNS	B-NP	O
,	,	,	O	O
alcohols	alcohol	NNS	B-NP	O
and	and	CC	I-NP	O
aldehydes	aldehyde	NNS	I-NP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
species	specie	NNS	I-NP	O
studied	study	VBN	B-VP	O
.	.	.	O	O

Tongue-scrape	Tongue-scrape	JJ	B-NP	O
biofilm	biofilm	NN	I-NP	O
systems	system	NNS	I-NP	O
at	at	IN	B-PP	O
lower	low	JJR	B-NP	O
pH	pH	NN	I-NP	O
gave	give	VBD	B-VP	O
more	more	JJR	B-NP	O
hydrocarbons	hydrocarbon	NNS	I-NP	O
,	,	,	O	O
ketones	ketone	NNS	B-NP	O
and	and	CC	O	O
fatty	fatty	JJ	B-NP	O
acids	acid	NNS	I-NP	O
whilst	whilst	IN	B-ADVP	O
at	at	IN	B-PP	O
higher	high	JJR	B-NP	O
pH	pH	NN	I-NP	O
more	more	JJR	I-NP	O
alcohols	alcohol	NNS	I-NP	O
,	,	,	O	O
aldehydes	aldehyde	NNS	B-NP	O
,	,	,	O	O
VSCs	VSC	NNS	B-NP	B-cell_type
and	and	CC	I-NP	O
amines	amine	NNS	I-NP	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
headspace	headspace	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
compounds	compound	NNS	B-NP	O
detected	detect	VBN	B-VP	O
in	in	IN	B-PP	O
mouth	mouth	NN	B-NP	O
breath	breath	NN	I-NP	O
are	be	VBP	B-VP	O
produced	produce	VBN	I-VP	O
by	by	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
tongue	tongue	NN	B-NP	O
biofilms	biofilm	NNS	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
contribution	contribution	NN	I-NP	O
of	of	IN	B-PP	O
volatiles	volatile	NNS	B-NP	O
from	from	IN	B-PP	O
oral	oral	JJ	B-NP	O
anaerobes	anaerobe	NNS	I-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
ignored	ignore	VBN	I-VP	O
and	and	CC	O	O
more	more	JJR	B-NP	O
research	research	NN	I-NP	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
to	to	TO	I-VP	O
identify	identify	VB	I-VP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
compounds	compound	NNS	I-NP	O
as	as	IN	B-PP	O
this	this	DT	B-NP	O
will	will	MD	B-VP	O
help	help	VB	I-VP	O
determine	determine	VB	I-VP	O
their	their	PRP$	B-NP	O
clinical	clinical	JJ	I-NP	O
significance	significance	NN	I-NP	O
as	as	IN	B-PP	O
indicators	indicator	NNS	B-NP	O
of	of	IN	B-PP	O
systemic	systemic	JJ	B-NP	O
disease	disease	NN	I-NP	O
or	or	CC	O	O
metabolic	metabolic	JJ	B-NP	O
disorders	disorder	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
body	body	NN	I-NP	O
.	.	.	O	O

Traditional	Traditional	JJ	B-NP	O
Chinese	Chinese	JJ	I-NP	O
medicine	medicine	NN	I-NP	O
(	(	(	O	O
TCM	TCM	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
used	use	VBN	B-VP	O
in	in	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
practice	practice	NN	I-NP	O
for	for	IN	B-PP	O
thousands	thousand	NNS	B-NP	O
of	of	IN	B-PP	O
years	year	NNS	B-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
taken	take	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
way	way	NN	I-NP	O
to	to	TO	B-VP	O
tackle	tackle	VB	I-VP	O
chronic	chronic	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
Chinese	Chinese	JJ	B-NP	O
medicine	medicine	NN	I-NP	O
,	,	,	O	O
many	many	JJ	B-NP	O
ingredients	ingredient	NNS	I-NP	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
biological	biological	JJ	B-NP	O
effects	effect	NNS	I-NP	O
just	just	RB	B-ADVP	O
pass	pass	VBP	B-VP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
gut	gut	NN	I-NP	O
,	,	,	O	O
they	they	PRP	B-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
get	get	VB	I-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
bloodstream	bloodstream	NN	I-NP	O
.	.	.	O	O

Study	Study	NN	B-NP	O
on	on	IN	B-PP	O
interactions	interaction	NNS	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
active	active	JJ	I-NP	O
ingredients	ingredient	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
intestinal	intestinal	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
is	be	VBZ	B-VP	O
very	very	RB	B-ADJP	O
helpful	helpful	JJ	I-ADJP	O
to	to	TO	B-VP	O
unravel	unravel	VB	I-VP	O
how	how	WRB	B-ADVP	O
TCM	TCM	NN	B-NP	B-protein
works	work	VBZ	B-VP	O
.	.	.	O	O

AIM	AIM	NN	B-NP	O
OF	OF	IN	B-PP	O
THE	THE	DT	B-NP	O
STUDY	STUDY	NN	I-NP	O
:	:	:	O	O
Hyperoside	Hyperoside	NN	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
active	active	JJ	I-NP	O
constituent	constituent	NN	I-NP	O
in	in	IN	B-PP	O
many	many	JJ	B-NP	O
medicinal	medicinal	JJ	I-NP	O
plants	plant	NNS	I-NP	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
traditionally	traditionally	RB	I-VP	O
used	use	VBN	I-VP	O
in	in	IN	B-PP	O
Chinese	Chinese	JJ	B-NP	O
medicines	medicine	NNS	I-NP	O
for	for	IN	B-PP	O
their	their	PRP$	B-NP	O
neuroprotective	neuroprotective	JJ	I-NP	O
,	,	,	I-NP	O
anti-inflammatory	anti-inflammatory	JJ	I-NP	O
and	and	CC	I-NP	O
anti-oxidative	anti-oxidative	JJ	I-NP	O
effects	effect	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
metabolized	metabolize	VBN	I-VP	O
by	by	IN	B-PP	O
intestinal	intestinal	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
after	after	IN	B-PP	O
oral	oral	JJ	B-NP	O
administration	administration	NN	I-NP	O
which	which	WDT	B-NP	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
variation	variation	NN	I-NP	O
of	of	IN	B-PP	O
ethnopharmacological	ethnopharmacological	JJ	B-NP	O
profile	profile	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
traditional	traditional	JJ	I-NP	O
medicines	medicine	NNS	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
necessary	necessary	JJ	B-ADJP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
metabolic	metabolic	JJ	I-NP	O
routes	route	NNS	I-NP	O
and	and	CC	I-NP	O
metabolites	metabolite	NNS	I-NP	O
of	of	IN	B-PP	O
hyperoside	hyperoside	NN	B-NP	O
produced	produce	VBN	B-VP	O
by	by	IN	B-PP	O
human	human	JJ	B-NP	O
intestinal	intestinal	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

MATERIALS	MATERIALS	NNS	B-NP	O
AND	AND	CC	O	O
Ultra	Ultra	NNP	B-NP	O
performance	performance	NN	I-NP	O
liquid	liquid	JJ	I-NP	O
chromatography/quadrupole-time-of-flight	chromatography/quadrupole-time-of-flight	NN	I-NP	O
mass	mass	NN	I-NP	O
spectrometry	spectrometry	NN	I-NP	O
(	(	(	O	O
UPLC/QTOF-MS	UPLC/QTOF-MS	NN	B-NP	O
)	)	)	O	O
technique	technique	NN	B-NP	O
combined	combine	VBN	B-VP	O
with	with	IN	B-PP	O
Metabolynx	Metabolynx	NN	B-NP	O
(	(	(	O	O
)	)	)	O	O
software	software	NN	B-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
for	for	IN	B-PP	O
analysis	analysis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
metabolic	metabolic	JJ	I-NP	O
profile	profile	NN	I-NP	O
of	of	IN	B-PP	O
hyperoside	hyperoside	NN	B-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
isolated	isolate	VBN	I-NP	O
human	human	JJ	I-NP	O
intestinal	intestinal	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
feces	fece	NNS	I-NP	O
.	.	.	O	O

Parent	Parent	JJ	B-NP	O
compound	compound	NN	I-NP	O
and	and	CC	I-NP	O
6	6	CD	I-NP	O
metabolites	metabolite	NNS	I-NP	O
(	(	(	O	O
M1-M7	M1-M7	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
isolated	isolate	VBN	I-NP	O
bacterial	bacterial	JJ	I-NP	O
samples	sample	NNS	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
blank	blank	JJ	B-NP	O
samples	sample	NNS	I-NP	O
.	.	.	O	O

Quercetin	Quercetin	NNP	B-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
,	,	,	O	O
4-dihydroxyphenylacetic	4-dihydroxyphenylacetic	JJ	B-NP	O
acid	acid	NN	I-NP	O
and	and	CC	O	O
3	3	CD	B-NP	O
,	,	,	O	O
4-dihydroxyphenylbenzoic	4-dihydroxyphenylbenzoic	JJ	B-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
M2-M4	M2-M4	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
only	only	RB	I-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
sample	sample	NN	I-NP	O
of	of	IN	B-PP	O
Bacteroides	Bacteroide	NNS	B-NP	O
sp	sp	NN	I-NP	O
.	.	.	O	O

45	45	CD	B-NP	O
.	.	.	O	O

Dehydroxylation	Dehydroxylation	NN	B-NP	O
of	of	IN	B-PP	O
hyperoside	hyperoside	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
conjugates	conjugate	NNS	I-NP	O
:	:	:	O	O
acetylation	acetylation	NN	B-NP	O
and	and	CC	I-NP	O
hydroxylation	hydroxylation	NN	I-NP	O
of	of	IN	B-PP	O
hyperoside	hyperoside	NN	B-NP	O
(	(	(	O	O
M5-M7	M5-M7	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
majority	majority	NN	I-NP	O
of	of	IN	B-PP	O
isolated	isolate	VBN	B-NP	O
intestinal	intestinal	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
samples	sample	NNS	I-NP	O
.	.	.	O	O

Only	Only	RB	B-ADVP	O
Bacteroides	Bacteroide	VBZ	B-VP	O
sp	sp	NN	B-NP	O
.	.	.	O	O

45	45	CD	B-NP	O
could	could	MD	B-VP	O
metabolize	metabolize	VB	I-VP	O
hyperoside	hyperoside	NN	B-NP	O
to	to	TO	B-VP	O
form	form	VB	I-VP	O
its	its	PRP$	B-NP	O
aglycone	aglycone	NN	I-NP	O
quercetin	quercetin	NN	I-NP	O
,	,	,	O	O
thereafter	thereafter	RB	B-ADVP	O
,	,	,	O	O
quercetin	quercetin	NN	B-NP	O
was	be	VBD	B-VP	O
further	further	RB	I-VP	O
metabolized	metabolize	VBN	I-VP	O
to	to	TO	B-PP	O
3,4-dihydroxyphenylacetic	3,4-dihydroxyphenylacetic	JJ	B-NP	O
acid	acid	NN	I-NP	O
and	and	CC	O	O
3,4-dihydroxyphenylacetic	3,4-dihydroxyphenylacetic	JJ	B-NP	O
acid	acid	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
majority	majority	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
could	could	MD	B-VP	O
metabolize	metabolize	VB	I-VP	O
hyperoside	hyperoside	NN	B-NP	O
to	to	TO	B-PP	O
dehydroxylation	dehydroxylation	NN	B-NP	O
of	of	IN	B-PP	O
hyperoside	hyperoside	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
conjugates	conjugate	NNS	I-NP	O
:	:	:	O	O
hydroxylation	hydroxylation	NN	B-NP	O
and	and	CC	I-NP	O
acetylation	acetylation	NN	I-NP	O
of	of	IN	B-PP	O
hyperoside	hyperoside	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
metabolic	metabolic	JJ	I-NP	O
routes	route	NNS	I-NP	O
and	and	CC	I-NP	O
metabolites	metabolite	NNS	I-NP	O
of	of	IN	B-PP	O
hyperoside	hyperoside	NN	B-NP	O
produced	produce	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
different	different	JJ	I-NP	O
intestinal	intestinal	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
metabolites	metabolite	NNS	B-NP	O
of	of	IN	B-PP	O
hyperoside	hyperoside	NN	B-NP	O
might	might	MD	B-VP	O
influence	influence	VB	I-VP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
traditional	traditional	JJ	B-NP	O
medicines	medicine	NNS	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
metabolism	metabolism	NN	I-NP	O
of	of	IN	B-PP	O
hyperoside	hyperoside	NN	B-NP	O
by	by	IN	B-PP	O
human	human	JJ	B-NP	O
intestinal	intestinal	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
is	be	VBZ	B-VP	O
of	of	IN	B-PP	O
great	great	JJ	B-NP	O
importance	importance	NN	I-NP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
understanding	understanding	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
traditional	traditional	JJ	B-NP	O
medicines	medicine	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
leprosy	leprosy	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
nasal	nasal	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
is	be	VBZ	B-VP	O
considered	consider	VBN	I-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
principal	principal	JJ	I-NP	O
route	route	NN	I-NP	O
of	of	IN	B-PP	O
transmission	transmission	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
bacillus	bacillus	NN	I-NP	O
Mycobacterium	Mycobacterium	NNP	I-NP	O
leprae	leprae	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
objective	objective	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
M.	M.	NNP	B-NP	O
leprae	leprae	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
of	of	IN	B-PP	O
50	50	CD	B-NP	O
untreated	untreated	JJ	I-NP	O
leprosy	leprosy	JJ	I-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
21	21	CD	B-NP	O
paucibacillary	paucibacillary	NN	I-NP	O
(	(	(	O	O
PB	PB	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
29	29	CD	B-NP	O
multibacillary	multibacillary	JJ	I-NP	O
(	(	(	O	O
MB	MB	NN	B-NP	O
)	)	)	O	O
patients	patient	NNS	B-NP	O
,	,	,	O	O
using	use	VBG	B-VP	O
immunohistochemistry	immunohistochemistry	NN	B-NP	O
(	(	(	O	O
IHC	IHC	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
with	with	IN	B-PP	O
antibodies	antibody	NNS	B-NP	B-protein
against	against	IN	B-PP	O
bacillus	bacillus	NN	B-NP	O
Calmette-Guerin	Calmette-Guerin	NN	I-NP	O
(	(	(	O	O
BCG	BCG	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
phenolic	phenolic	JJ	B-NP	O
glycolipid	glycolipid	NN	I-NP	B-protein
antigen-1	antigen-1	NN	I-NP	I-protein
(	(	(	O	O
PGL-1	PGL-1	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
polymerase	polymerase	NN	B-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
(	(	(	O	O
PCR	PCR	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
with	with	IN	B-PP	O
MntH-specific	MntH-specific	JJ	B-NP	B-protein
primers	primer	NNS	I-NP	I-protein
for	for	IN	B-PP	O
M.	M.	NNP	B-NP	O
leprae	leprae	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
to	to	TO	B-VP	O
compare	compare	VB	I-VP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
material	material	NN	I-NP	O
was	be	VBD	B-VP	O
represented	represent	VBN	I-VP	O
by	by	IN	B-PP	O
163	163	CD	B-NP	O
paraffin	paraffin	NN	I-NP	O
blocks	block	NNS	I-NP	O
containing	contain	VBG	B-VP	O
biopsy	biopsy	NN	B-NP	O
samples	sample	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
clinically	clinically	RB	B-NP	O
normal	normal	JJ	I-NP	O
sites	site	NNS	I-NP	O
(	(	(	O	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
tongue	tongue	NN	I-NP	O
,	,	,	O	O
buccal	buccal	JJ	B-NP	O
mucosa	mucosa	NN	I-NP	O
and	and	CC	O	O
soft	soft	JJ	B-NP	O
palate	palate	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
visible	visible	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
anywhere	anywhere	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	O	O
158	158	CD	B-NP	O
available	available	JJ	I-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
included	include	VBN	I-VP	O
for	for	IN	B-PP	O
IHC	IHC	NN	B-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

Among	Among	IN	B-PP	O
the	the	DT	B-NP	O
161	161	CD	I-NP	O
available	available	JJ	I-NP	O
samples	sample	NNS	I-NP	O
for	for	IN	B-PP	O
PCR	PCR	NN	B-NP	O
,	,	,	O	O
110	110	CD	B-NP	O
had	have	VBD	B-VP	O
viable	viable	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
viable	viable	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
in	in	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
one	one	CD	I-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
for	for	IN	B-PP	O
47	47	CD	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

M.	M.	NN	B-NP	O
leprae	leprae	NNS	I-NP	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	I-NP	O
78	78	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
using	use	VBG	B-VP	O
IHC	IHC	NN	B-NP	B-protein
and	and	CC	I-NP	O
PCR	PCR	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
94	94	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
by	by	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
one	one	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
diagnostic	diagnostic	JJ	I-NP	O
methods	method	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
detection	detection	NN	B-NP	O
of	of	IN	B-PP	O
M.	M.	NN	B-NP	O
leprae	leprae	NNS	I-NP	O
between	between	IN	B-PP	O
MB	MB	NN	B-NP	B-protein
and	and	CC	I-NP	O
PB	PB	NN	I-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

Similar	Similar	JJ	B-NP	O
results	result	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
using	use	VBG	B-VP	O
anti-BCG	anti-BCG	JJ	B-NP	O
and	and	CC	I-NP	O
anti-PGL-1	anti-PGL-1	JJ	I-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
immunoreactivity	immunoreactivity	NN	B-NP	O
occurred	occur	VBD	B-VP	O
predominantly	predominantly	RB	B-ADVP	O
on	on	IN	B-PP	O
free-living	free-living	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
epithelial	epithelial	JJ	I-NP	O
surface	surface	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
predilection	predilection	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
tongue	tongue	NN	I-NP	O
.	.	.	O	O

Conversely	Conversely	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
predilection	predilection	NN	B-NP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
PCR	PCR	NN	I-NP	O
results	result	NNS	I-NP	O
.	.	.	O	O

M.	M.	NNP	B-NP	O
leprae	leprae	NNP	I-NP	O
is	be	VBZ	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
frequency	frequency	NN	I-NP	O
,	,	,	O	O
implicating	implicate	VBG	B-VP	O
this	this	DT	B-NP	O
site	site	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
means	mean	NNS	I-NP	O
of	of	IN	B-PP	O
leprosy	leprosy	JJ	B-NP	O
transmission	transmission	NN	I-NP	O
.	.	.	O	O

Results	Result	NNS	B-NP	O
from	from	IN	B-PP	O
16S	16S	NN	B-NP	B-DNA
rDNA-encoding	rDNA-encoding	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
sequence-based	sequence-based	JJ	B-NP	O
,	,	,	I-NP	O
culture-independent	culture-independent	JJ	I-NP	O
techniques	technique	NNS	I-NP	O
have	have	VBP	B-VP	O
led	lead	VBN	I-VP	O
to	to	TO	B-PP	O
conflicting	conflict	VBG	B-VP	O
conclusions	conclusion	NNS	B-NP	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
composition	composition	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
respiratory	respiratory	JJ	I-NP	O
tract	tract	NN	I-NP	O
microbiome	microbiome	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
compare	compare	VB	I-VP	O
the	the	DT	B-NP	O
microbiome	microbiome	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
and	and	CC	I-NP	O
lower	low	JJR	I-NP	O
respiratory	respiratory	JJ	I-NP	O
tract	tract	NN	I-NP	O
in	in	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
HIV-uninfected	HIV-uninfected	JJ	I-NP	O
nonsmokers	nonsmoker	NNS	I-NP	O
and	and	CC	I-NP	O
smokers	smoker	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
multicenter	multicenter	JJ	I-NP	O
cohort	cohort	NN	I-NP	O
.	.	.	O	O

Participants	Participant	NNS	B-NP	O
were	be	VBD	B-VP	O
nonsmokers	nonsmoker	NNS	B-NP	O
and	and	CC	I-NP	O
smokers	smoker	NNS	I-NP	O
without	without	IN	B-PP	O
significant	significant	JJ	B-NP	O
comorbidities	comorbidity	NNS	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
washes	wash	NNS	I-NP	O
and	and	CC	O	O
bronchoscopic	bronchoscopic	JJ	B-NP	O
alveolar	alveolar	JJ	I-NP	O
lavages	lavage	NNS	I-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
standardized	standardized	JJ	I-NP	O
manner	manner	NN	I-NP	O
.	.	.	O	O

Sequence	Sequence	NN	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	B-DNA
16S	16S	NN	I-NP	I-DNA
rRNA-encoding	rRNA-encoding	JJ	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
neutral	neutral	JJ	I-NP	O
model	model	NN	I-NP	O
in	in	IN	B-PP	O
community	community	NN	B-NP	O
ecology	ecology	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
bacteria	bacteria	NNS	B-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
plausible	plausible	JJ	I-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
lung	lung	NN	I-NP	B-DNA
microbiome	microbiome	NN	I-NP	I-DNA
.	.	.	O	O

Sixty-four	Sixty-four	CD	B-NP	O
participants	participant	NNS	I-NP	O
were	be	VBD	B-VP	O
enrolled	enrol	VBN	I-VP	O
.	.	.	O	O

Most	Most	JJS	B-NP	O
bacteria	bacteria	NNS	I-NP	O
identified	identify	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lung	lung	NN	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
specific	specific	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
Enterobacteriaceae	Enterobacteriaceae	NNP	B-NP	O
,	,	,	O	O
Haemophilus	Haemophilus	NNP	B-NP	O
,	,	,	O	O
Methylobacterium	Methylobacterium	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Ralstonia	Ralstonia	NNP	B-NP	O
species	specie	NNS	I-NP	O
were	be	VBD	B-VP	O
disproportionally	disproportionally	RB	I-VP	O
represented	represent	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lungs	lung	NNS	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
values	value	NNS	B-NP	O
predicted	predict	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
neutral	neutral	JJ	I-NP	O
model	model	NN	I-NP	O
.	.	.	O	O

Tropheryma	Tropheryma	NN	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lung	lung	NN	I-NP	O
,	,	,	O	O
but	but	CC	B-CONJP	O
not	not	RB	I-CONJP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
.	.	.	O	O

Mouth	Mouth	NN	B-NP	O
communities	community	NNS	I-NP	O
differed	differ	VBD	B-VP	O
between	between	IN	B-PP	O
nonsmokers	nonsmoker	NNS	B-NP	O
and	and	CC	I-NP	O
smokers	smoker	NNS	I-NP	O
in	in	IN	B-PP	O
species	specie	NNS	B-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
Porphyromonas	Porphyromonas	NNP	B-NP	O
,	,	,	O	O
Neisseria	Neisseria	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Gemella	Gemella	NNP	B-NP	O
,	,	,	O	O
but	but	CC	O	O
lung	lung	NN	B-NP	B-cell_type
bacterial	bacterial	JJ	I-NP	I-cell_type
populations	population	NNS	I-NP	I-cell_type
did	do	VBD	B-VP	O
not	not	RB	O	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
largest	large	JJS	I-NP	O
to	to	TO	B-VP	O
examine	examine	VB	I-VP	O
composition	composition	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
respiratory	respiratory	JJ	I-NP	O
tract	tract	NN	I-NP	O
microbiome	microbiome	NN	I-NP	O
in	in	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
individuals	individual	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
to	to	TO	B-VP	O
use	use	VB	I-VP	O
the	the	DT	B-NP	O
neutral	neutral	JJ	I-NP	O
model	model	NN	I-NP	O
to	to	TO	B-VP	O
compare	compare	VB	I-VP	O
the	the	DT	B-NP	O
lung	lung	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
.	.	.	O	O

Specific	Specific	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
appear	appear	VBP	B-VP	O
in	in	IN	B-PP	O
significantly	significantly	RB	B-NP	O
higher	high	JJR	I-NP	O
abundance	abundance	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lungs	lung	NNS	I-NP	O
than	than	IN	B-SBAR	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
expected	expect	VBN	I-VP	O
if	if	IN	B-SBAR	O
they	they	PRP	B-NP	O
originated	originate	VBD	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
,	,	,	O	O
demonstrating	demonstrate	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
lung	lung	NN	I-NP	O
microbiome	microbiome	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
derive	derive	VB	I-VP	O
entirely	entirely	RB	B-ADVP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
mouth	mouth	NN	I-NP	O
microbiome	microbiome	NN	I-NP	O
differs	differ	VBZ	B-VP	O
in	in	IN	B-PP	O
nonsmokers	nonsmoker	NNS	B-NP	O
and	and	CC	I-NP	O
smokers	smoker	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
lung	lung	NN	B-NP	O
communities	community	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
significantly	significantly	RB	I-VP	O
altered	alter	VBN	I-VP	O
by	by	IN	B-PP	O
smoking	smoking	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
composition	composition	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-protein
microbiota	microbiota	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
recognized	recognize	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
factor	factor	NN	I-NP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
health	health	NN	I-NP	O
and	and	CC	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Many	Many	JJ	B-NP	O
of	of	IN	B-PP	O
our	our	PRP$	B-NP	O
cohabitating	cohabitate	VBG	I-NP	O
microbes	microbe	NNS	I-NP	O
belong	belong	VBP	B-VP	O
to	to	TO	B-PP	O
phylum-level	phylum-level	JJ	B-NP	O
divisions	division	NNS	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
there	there	EX	B-NP	O
are	be	VBP	B-VP	O
no	no	DT	B-NP	O
cultivated	cultivate	VBN	I-NP	O
representatives	representative	NNS	I-NP	O
and	and	CC	O	O
are	be	VBP	B-VP	O
only	only	RB	I-VP	O
represented	represent	VBN	I-VP	O
by	by	IN	B-PP	O
small	small	JJ	B-NP	B-DNA
subunit	subunit	NN	I-NP	I-DNA
rRNA	rRNA	NN	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
.	.	.	O	O

For	For	IN	B-PP	O
one	one	CD	B-NP	O
such	such	JJ	I-NP	O
taxon	taxon	NN	I-NP	O
(	(	(	O	O
SR1	SR1	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
which	which	WDT	B-NP	O
includes	include	VBZ	B-VP	O
bacteria	bacteria	NNS	B-NP	O
with	with	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
abundance	abundance	NN	I-NP	O
in	in	IN	B-PP	O
periodontitis	periodontitis	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
provide	provide	VBP	B-VP	O
a	a	DT	B-NP	O
single-cell	single-cell	JJ	I-NP	O
genome	genome	NN	I-NP	O
sequence	sequence	NN	I-NP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
healthy	healthy	JJ	I-NP	O
oral	oral	JJ	I-NP	O
sample	sample	NN	I-NP	O
.	.	.	O	O

SR1	SR1	NN	B-NP	O
bacteria	bacteria	NNS	I-NP	O
use	use	VBP	B-VP	O
a	a	DT	B-NP	O
unique	unique	JJ	I-NP	O
genetic	genetic	JJ	I-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

In-frame	In-frame	NN	B-NP	O
TGA	TGA	NN	I-NP	O
(	(	(	O	O
opal	opal	JJ	O	O
)	)	)	O	O
codons	codon	NNS	B-NP	O
are	be	VBP	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
most	most	JJS	B-NP	O
genes	gene	NNS	I-NP	O
(	(	(	O	O
85	85	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
often	often	RB	B-ADVP	O
at	at	IN	B-PP	O
loci	locus	NNS	B-NP	O
normally	normally	RB	B-VP	O
encoding	encode	VBG	I-VP	O
conserved	conserve	VBN	B-NP	O
glycine	glycine	NN	I-NP	O
residues	residue	NNS	I-NP	O
.	.	.	O	O

UGA	UGA	NN	B-NP	B-protein
appears	appear	VBZ	B-VP	O
not	not	RB	O	O
to	to	TO	B-VP	O
function	function	VB	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
stop	stop	NN	I-NP	B-DNA
codon	codon	NN	I-NP	I-DNA
and	and	CC	O	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
equilibrium	equilibrium	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
canonical	canonical	JJ	I-NP	B-DNA
GGN	GGN	NN	I-NP	I-DNA
glycine	glycine	NN	I-NP	I-DNA
codons	codon	NNS	I-NP	I-DNA
,	,	,	O	O
displaying	display	VBG	B-VP	O
strain-specific	strain-specific	JJ	B-NP	O
variation	variation	NN	I-NP	O
across	across	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-cell_type
population	population	NN	I-NP	I-cell_type
.	.	.	O	O

SR1	SR1	NN	B-NP	B-protein
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
divergent	divergent	JJ	I-NP	O
tRNA	tRNA	NN	I-NP	O
(	(	(	O	O
Gly	Gly	NN	B-NP	O
)	)	)	O	O
UCA	UCA	NN	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
opal-decoding	opal-decoding	JJ	I-NP	O
anticodon	anticodon	NN	I-NP	O
.	.	.	O	O

SR1	SR1	NN	B-NP	B-protein
glycyl-tRNA	glycyl-tRNA	NN	I-NP	I-protein
synthetase	synthetase	NN	I-NP	I-protein
acylates	acylate	VBZ	B-VP	O
tRNA	tRNA	NN	B-NP	O
(	(	(	O	O
Gly	Gly	NN	B-NP	O
)	)	)	O	O
UCA	UCA	NN	B-NP	O
with	with	IN	B-PP	O
glycine	glycine	NN	B-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
with	with	IN	B-PP	O
similar	similar	JJ	B-NP	O
activity	activity	NN	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
tRNA	tRNA	NN	I-NP	O
(	(	(	O	O
Gly	Gly	NN	B-NP	O
)	)	)	O	O
UCC	UCC	NN	B-NP	O
.	.	.	O	O

Coexpression	Coexpression	NN	B-NP	O
of	of	IN	B-PP	O
SR1	SR1	NN	B-NP	B-protein
glycyl-tRNA	glycyl-tRNA	NN	I-NP	I-protein
synthetase	synthetase	NN	I-NP	I-protein
and	and	CC	O	O
tRNA	tRNA	NN	B-NP	O
(	(	(	O	O
Gly	Gly	NN	B-NP	O
)	)	)	O	O
UCA	UCA	NN	B-NP	O
in	in	IN	B-PP	O
Escherichia	Escherichia	FW	B-NP	O
coli	coli	FW	I-NP	O
yields	yield	VBZ	B-VP	O
significant	significant	JJ	B-NP	O
beta-galactosidase	beta-galactosidase	NN	I-NP	B-protein
activity	activity	NN	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
lacZ	lacZ	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
containing	contain	VBG	B-VP	O
an	an	DT	B-NP	O
in-frame	in-frame	JJ	I-NP	O
TGA	TGA	NN	I-NP	O
codon	codon	NN	I-NP	O
.	.	.	O	O

Comparative	Comparative	JJ	B-NP	O
genomic	genomic	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
with	with	IN	B-PP	O
Human	Human	JJ	B-NP	O
Microbiome	Microbiome	NNP	I-NP	O
Project	Project	NNP	I-NP	O
data	datum	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
body	body	NN	I-NP	O
harbors	harbor	VBZ	B-VP	O
a	a	DT	B-NP	O
striking	striking	JJ	I-NP	O
diversity	diversity	NN	I-NP	O
of	of	IN	B-PP	O
SR1	SR1	NN	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
surprising	surprising	JJ	I-NP	O
finding	finding	NN	I-NP	O
because	because	IN	B-SBAR	O
SR1	SR1	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
most	most	RBS	B-ADJP	O
closely	closely	RB	I-ADJP	O
related	related	JJ	I-ADJP	O
to	to	TO	B-PP	O
bacteria	bacteria	NNS	B-NP	O
that	that	WDT	B-NP	O
live	live	VBP	B-VP	O
in	in	IN	B-PP	O
anoxic	anoxic	JJ	B-NP	O
and	and	CC	I-NP	O
thermal	thermal	JJ	I-NP	O
environments	environment	NNS	I-NP	O
.	.	.	O	O

Some	Some	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
share	share	VBP	B-VP	O
common	common	JJ	B-NP	O
genetic	genetic	JJ	I-NP	O
and	and	CC	I-NP	O
metabolic	metabolic	JJ	I-NP	O
features	feature	NNS	I-NP	O
with	with	IN	B-PP	O
SR1	SR1	NN	B-NP	B-protein
,	,	,	O	O
including	include	VBG	B-PP	O
UGA	UGA	NN	B-NP	B-protein
to	to	TO	B-PP	O
glycine	glycine	NN	B-NP	O
reassignment	reassignment	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
archaeal-type	archaeal-type	JJ	I-NP	O
ribulose-1,5-bisphosphate	ribulose-1,5-bisphosphate	NN	I-NP	O
carboxylase	carboxylase	NN	I-NP	I-protein
(	(	(	O	O
RubisCO	RubisCO	NN	B-NP	O
)	)	)	O	O
involved	involve	VBN	B-VP	O
in	in	IN	B-PP	O
AMP	AMP	NN	B-NP	O
recycling	recycling	NN	I-NP	O
.	.	.	O	O

UGA	UGA	NN	B-NP	O
codon	codon	NN	I-NP	O
reassignment	reassignment	NN	I-NP	O
renders	render	VBZ	B-VP	O
SR1	SR1	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
untranslatable	untranslatable	JJ	B-ADJP	O
by	by	IN	B-PP	O
other	other	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
impacts	impact	VBZ	B-VP	O
horizontal	horizontal	JJ	B-NP	O
gene	gene	NN	I-NP	O
transfer	transfer	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-protein
microbiota	microbiota	NN	I-NP	I-protein
.	.	.	O	O

To	To	TO	B-VP	O
study	study	VB	I-VP	O
the	the	DT	B-NP	O
preventive	preventive	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
chlorhexidine	chlorhexidine	NN	B-NP	O
against	against	IN	B-PP	O
root	root	NN	B-NP	O
caries	cary	NNS	I-NP	O
under	under	IN	B-PP	O
oral	oral	JJ	B-NP	O
biofilm	biofilm	NN	I-NP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
artificial	artificial	JJ	I-NP	O
mouth	mouth	NN	I-NP	O
.	.	.	O	O

Sixteen	Sixteen	CD	B-NP	O
human	human	JJ	I-NP	O
tooth-root	tooth-root	JJ	I-NP	O
disks	disk	NNS	I-NP	O
were	be	VBD	B-VP	O
inoculated	inoculate	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
salivary	salivary	JJ	I-NP	O
sample	sample	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
produced	produce	VBN	I-VP	O
by	by	IN	B-PP	O
mixing	mix	VBG	B-VP	O
the	the	DT	B-NP	O
unstimulated	unstimulated	JJ	I-NP	O
saliva	saliva	NN	I-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
adults	adult	NNS	I-NP	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
untreated	untreated	JJ	I-NP	O
caries	cary	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
disks	disk	NNS	I-NP	O
were	be	VBD	B-VP	O
incubated	incubate	VBN	I-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
artificial	artificial	JJ	I-NP	O
mouth	mouth	NN	I-NP	O
fed	feed	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
5	5	CD	I-NP	O
%	%	NN	I-NP	O
sucrose	sucrose	NN	I-NP	O
solution	solution	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
daily	daily	RB	I-NP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

Eight	Eight	CD	B-NP	O
disks	disk	NNS	I-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
twice	twice	RB	I-NP	O
daily	daily	JJ	I-NP	O
rinse	rinse	NN	I-NP	O
of	of	IN	B-PP	O
0.12	0.12	CD	B-NP	O
%	%	NN	I-NP	O
chlorhexidine	chlorhexidine	NN	I-NP	O
(	(	(	O	O
test	test	NN	B-NP	O
group	group	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
other	other	JJ	I-NP	O
eight	eight	CD	I-NP	O
disks	disk	NNS	I-NP	O
were	be	VBD	B-VP	O
rinsed	rinse	VBN	I-VP	O
in	in	IN	B-PP	O
distilled	distilled	JJ	B-NP	O
water	water	NN	I-NP	O
(	(	(	O	O
control	control	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
biofilm	biofilm	NN	I-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
studied	study	VBN	I-VP	O
with	with	IN	B-PP	O
three	three	CD	B-NP	O
techniques	technique	NNS	I-NP	O
:	:	:	O	O
colony	colony	NN	B-NP	O
forming	form	VBG	B-VP	O
unit	unit	NN	B-NP	O
(	(	(	O	O
CFU	CFU	NN	B-NP	O
)	)	)	O	O
counting	counting	NN	B-NP	O
,	,	,	O	O
scanning	scanning	NN	B-NP	O
electron	electron	NN	I-NP	O
microscopy	microscopy	NN	I-NP	O
(	(	(	O	O
SEM	SEM	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
confocal	confocal	JJ	B-NP	O
laser	laser	NN	I-NP	O
scanning	scanning	NN	I-NP	O
microscopy	microscopy	NN	I-NP	O
(	(	(	O	O
CLSM	CLSM	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
chemical	chemical	JJ	I-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
root	root	NN	I-NP	O
surface	surface	NN	I-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
using	use	VBG	B-VP	O
Fourier	Fourier	NNP	B-NP	O
transform	transform	VB	B-VP	O
infra-Red	infra-Red	JJ	B-NP	O
spectroscopy	spectroscopy	NN	I-NP	O
.	.	.	O	O

Type-I	Type-I	NN	B-NP	B-protein
collagen	collagen	NN	I-NP	I-protein
and	and	CC	O	O
proteoglycans	proteoglycan	NNS	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
root	root	NN	I-NP	O
surface	surface	NN	I-NP	O
were	be	VBD	B-VP	O
quantified	quantify	VBN	I-VP	O
using	use	VBG	B-VP	O
immunocytochemical	immunocytochemical	JJ	B-NP	O
staining	staining	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
log	log	NN	I-NP	O
CFU	CFU	NNP	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
test	test	NN	I-NP	O
and	and	CC	I-NP	O
control	control	NN	I-NP	O
groups	group	NNS	I-NP	O
were	be	VBD	B-VP	O
4.21	4.21	CD	B-NP	O
and	and	CC	I-NP	O
8.27	8.27	CD	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.001	0.001	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
CFU	CFU	NNP	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
Streptococci	Streptococci	NNP	B-NP	O
and	and	CC	I-NP	O
Lactobacilli	Lactobacilli	NNP	I-NP	O
were	be	VBD	B-VP	O
negligible	negligible	JJ	B-ADJP	O
.	.	.	O	O

Both	Both	CC	O	O
the	the	DT	B-NP	O
SEM	SEM	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
CLSM	CLSM	NN	I-NP	O
showed	show	VBD	B-VP	O
suppressed	suppress	VBN	B-NP	O
bacteria	bacteria	NNS	I-NP	O
growth	growth	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
test	test	NN	I-NP	O
group	group	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
log	log	NN	I-NP	O
[	[	(	O	O
amide-I	amide-I	NN	B-NP	O
:	:	:	O	O
HPO	HPO	NN	B-NP	B-protein
(	(	(	O	O
4	4	CD	B-NP	O
)	)	)	O	O
(	(	(	O	O
2-	2-	CD	B-NP	O
)	)	)	O	O
]	]	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
test	test	NN	I-NP	O
and	and	CC	I-NP	O
control	control	NN	I-NP	O
groups	group	NNS	I-NP	O
were	be	VBD	B-VP	O
1.11	1.11	CD	B-NP	O
and	and	CC	I-NP	O
1.93	1.93	CD	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
(	(	(	O	O
p=0.02	p=0.02	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
mean	mean	JJ	I-NP	O
counts	count	NNS	I-NP	O
of	of	IN	B-PP	O
sound	sound	JJ	B-NP	B-protein
type-I	type-I	NN	I-NP	I-protein
collagen	collagen	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
test	test	NN	I-NP	O
and	and	CC	I-NP	O
control	control	NN	I-NP	O
groups	group	NNS	I-NP	O
were	be	VBD	B-VP	O
16.8/mum	16.8/mum	NN	B-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
13.0/mum	13.0/mum	NN	B-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.001	0.001	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
mean	mean	JJ	I-NP	O
counts	count	NNS	I-NP	O
of	of	IN	B-PP	O
intact	intact	JJ	B-NP	O
proteoglycans	proteoglycan	NNS	I-NP	O
were	be	VBD	B-VP	O
5.6/mum	5.6/mum	JJ	B-ADJP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
3.5/mum	3.5/mum	NN	B-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
0.001	0.001	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Chlorhexidine	Chlorhexidine	NN	B-NP	O
suppressed	suppress	VBD	B-VP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
selected	select	VBN	B-NP	O
cariogenic	cariogenic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
biofilm	biofilm	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
root	root	NN	I-NP	O
surface	surface	NN	I-NP	O
and	and	CC	O	O
thus	thus	RB	B-VP	O
protected	protect	VBD	I-VP	O
tooth-root	tooth-root	NN	B-NP	O
from	from	IN	B-PP	O
cariogenic	cariogenic	JJ	B-NP	O
challenge	challenge	NN	I-NP	O
.	.	.	O	O

Despite	Despite	IN	B-PP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
investigation	investigation	NN	B-NP	O
,	,	,	O	O
many	many	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
have	have	VBP	B-VP	O
yet	yet	RB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
cultured	culture	VBN	I-VP	O
.	.	.	O	O

Studies	Study	NNS	B-NP	O
that	that	WDT	B-NP	O
correlate	correlate	VBP	B-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
or	or	CC	I-NP	O
abundance	abundance	NN	I-NP	O
of	of	IN	B-PP	O
uncultured	uncultured	JJ	B-NP	O
species	specie	NNS	I-NP	O
with	with	IN	B-PP	O
oral	oral	JJ	B-NP	O
health	health	NN	I-NP	O
or	or	CC	I-NP	O
disease	disease	NN	I-NP	O
highlight	highlight	VBP	B-VP	O
the	the	DT	B-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
community	community	NN	I-NP	O
members	member	NNS	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
sequenced	sequence	VBD	B-VP	O
several	several	JJ	B-NP	O
single-cell	single-cell	JJ	I-NP	O
genomic	genomic	JJ	I-NP	O
amplicons	amplicon	NNS	I-NP	O
from	from	IN	B-PP	O
Desulfobulbus	Desulfobulbus	NNP	B-NP	O
and	and	CC	I-NP	O
Desulfovibrio	Desulfovibrio	NNP	I-NP	O
(	(	(	O	O
class	class	NN	B-NP	O
Deltaproteobacteria	Deltaproteobacteria	NN	I-NP	O
)	)	)	O	O
to	to	TO	B-VP	O
better	well	RBR	I-VP	O
understand	understand	VB	I-VP	O
their	their	PRP$	B-NP	O
function	function	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
oral	oral	JJ	I-NP	O
community	community	NN	I-NP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
association	association	NN	I-NP	O
with	with	IN	B-PP	O
periodontitis	periodontitis	NN	B-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
other	other	JJ	B-NP	O
systemic	systemic	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

Genomic	Genomic	JJ	B-NP	O
data	datum	NNS	I-NP	O
from	from	IN	B-PP	O
oral	oral	JJ	B-NP	O
Desulfobulbus	Desulfobulbus	NNP	I-NP	O
and	and	CC	I-NP	O
Desulfovibrio	Desulfovibrio	NNP	I-NP	O
species	specie	NNS	I-NP	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
to	to	TO	B-PP	O
other	other	JJ	B-NP	O
available	available	JJ	I-NP	B-DNA
deltaproteobacterial	deltaproteobacterial	JJ	I-NP	I-DNA
genomes	genome	NNS	I-NP	I-DNA
,	,	,	O	O
including	include	VBG	B-PP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
subset	subset	NN	I-NP	O
of	of	IN	B-PP	O
host-associated	host-associated	JJ	B-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
both	both	DT	B-NP	O
groups	group	NNS	I-NP	O
share	share	VBP	B-VP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
genes	gene	NNS	B-NP	B-DNA
with	with	IN	B-PP	O
other	other	JJ	B-NP	O
environmental	environmental	JJ	I-NP	B-DNA
Deltaproteobacteria	Deltaproteobacteria	NNP	I-NP	I-DNA
genomes	genome	NNS	I-NP	I-DNA
,	,	,	O	O
they	they	PRP	B-NP	O
encode	encode	VBP	B-VP	O
a	a	DT	B-NP	O
wide	wide	JJ	I-NP	O
array	array	NN	I-NP	O
of	of	IN	B-PP	O
unique	unique	JJ	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
that	that	WDT	B-NP	O
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
function	function	VB	I-VP	O
in	in	IN	B-PP	O
survival	survival	NN	B-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
host	host	NN	I-NP	O
environment	environment	NN	I-NP	O
.	.	.	O	O

Many	Many	JJ	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
genes	gene	NNS	I-NP	O
are	be	VBP	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
virulence	virulence	NN	B-NP	O
and	and	CC	I-NP	O
host	host	NN	I-NP	O
adaptation	adaptation	NN	I-NP	O
factors	factor	NNS	I-NP	O
of	of	IN	B-PP	O
known	know	VBN	B-NP	O
human	human	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
Deltaproteobacteria	Deltaproteobacteria	NNP	I-NP	O
have	have	VBP	B-VP	O
the	the	DT	B-NP	O
potential	potential	NN	I-NP	O
to	to	TO	B-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
etiology	etiology	NN	I-NP	O
of	of	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
test	test	VB	I-VP	O
the	the	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
source	source	NN	I-NP	O
for	for	IN	B-PP	O
implantable	implantable	JJ	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
and	and	CC	I-NP	O
cardioverter	cardioverter	NN	I-NP	O
defibrillators	defibrillator	NNS	I-NP	O
infections	infection	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
diversity	diversity	NN	I-NP	O
on	on	IN	B-PP	O
explanted	explante	VBN	B-NP	O
rhythm	rhythm	NN	I-NP	O
heart	heart	NN	I-NP	O
management	management	NN	I-NP	O
devices	device	NNS	I-NP	O
was	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
and	and	CC	O	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microbiome	microbiome	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
metagenomic	metagenomic	JJ	I-NP	O
approach	approach	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
analyze	analyze	VB	I-VP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
diversity	diversity	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
surfaces	surface	NNS	I-NP	O
of	of	IN	B-PP	O
non-infected	non-infected	JJ	B-NP	O
and	and	CC	I-NP	O
infected	infected	JJ	I-NP	O
pacemakers	pacemaker	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
DNA	DNA	NN	I-NP	O
from	from	IN	B-PP	O
surfaces	surface	NNS	B-NP	O
swaps	swap	NNS	I-NP	O
of	of	IN	B-PP	O
24	24	CD	B-NP	O
non-infected	non-infected	JJ	I-NP	O
and	and	CC	O	O
23	23	CD	B-NP	O
infected	infected	JJ	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
and	and	CC	O	O
subjected	subject	VBN	B-VP	O
to	to	TO	B-PP	O
bacterial-specific	bacterial-specific	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
amplification	amplification	NN	I-NP	O
,	,	,	O	O
single	single	JJ	B-NP	O
strand	strand	NN	I-NP	O
conformation	conformation	NN	I-NP	O
polymorphism-	polymorphism-	NN	I-NP	O
(	(	(	O	O
SSCP	SSCP	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
sequencing	sequencing	NN	B-NP	O
analysis	analysis	NN	I-NP	O
.	.	.	O	O

Species-specific	Species-specific	JJ	B-NP	O
primer	primer	NN	I-NP	O
sets	set	NNS	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
analyze	analyze	VB	I-VP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
diversity	diversity	NN	I-NP	O
on	on	IN	B-PP	O
pacemakers	pacemaker	NNS	B-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

DNA	DNA	NN	B-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	B-protein
origin	origin	NN	I-NP	I-protein
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
21	21	CD	B-NP	O
cases	case	NNS	I-NP	O
on	on	IN	B-PP	O
infected	infected	JJ	B-NP	O
pacemakers	pacemaker	NNS	I-NP	O
and	and	CC	O	O
assigned	assign	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
phylotypes	phylotype	NNS	I-NP	O
Staphylococcus	Staphylococcus	NN	I-NP	O
epidermidis	epidermidis	NN	I-NP	O
,	,	,	O	O
Propionibacterium	Propionibacterium	NN	B-NP	O
acnes	acne	NNS	I-NP	O
,	,	,	O	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
aureus	aureus	NNP	I-NP	O
,	,	,	O	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
schleiferi	schleiferi	NNP	I-NP	O
and	and	CC	O	O
Stapyhlococcus	Stapyhlococcus	NNP	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
17	17	CD	B-NP	O
cases	case	NNS	I-NP	O
bacterial	bacterial	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
on	on	IN	B-PP	O
pacemakers	pacemaker	NNS	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
infections	infection	NNS	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
obtained	obtain	VBN	I-NP	O
sequence	sequence	NN	I-NP	O
data	datum	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
phylotypes	phylotype	NNS	I-NP	O
Propionibacterium	Propionibacterium	NN	I-NP	O
acnes	acne	NNS	I-NP	O
,	,	,	O	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
uncultured	uncultured	JJ	I-NP	O
bacterium	bacterium	NN	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
.	.	.	O	O

Propionibacterium	Propionibacterium	NN	B-NP	O
acnes	acne	NNS	I-NP	O
and	and	CC	O	O
Staphylococcus	Staphylococcus	NN	B-NP	B-protein
epidermidis	epidermidis	NN	I-NP	I-protein
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
only	only	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
detected	detect	VBN	B-VP	O
in	in	IN	B-PP	O
pacemeaker	pacemeaker	NN	B-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
25	25	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
samples	sample	NNS	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
11	11	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
coincidental	coincidental	JJ	I-NP	O
detection	detection	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
on	on	IN	B-PP	O
infected	infected	JJ	B-NP	O
devices	device	NNS	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
is	be	VBZ	B-VP	O
low	low	JJ	B-ADJP	O
and	and	CC	O	O
the	the	DT	B-NP	O
detected	detect	VBN	I-NP	O
bacteria	bacteria	NNS	I-NP	O
are	be	VBP	B-VP	O
highly	highly	RB	B-NP	O
abundant	abundant	JJ	I-NP	O
colonizers	colonizer	NNS	I-NP	O
of	of	IN	B-PP	O
non-oral	non-oral	JJ	B-NP	O
human	human	JJ	I-NP	O
niches	niche	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
transmission	transmission	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
lead	lead	NN	I-NP	O
or	or	CC	I-NP	O
device	device	NN	I-NP	O
of	of	IN	B-PP	O
implantable	implantable	JJ	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
or	or	CC	I-NP	O
cardioverter	cardioverter	NN	I-NP	O
defibrillators	defibrillator	NNS	I-NP	O
is	be	VBZ	B-VP	O
unlikely	unlikely	JJ	B-NP	O
relevant	relevant	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
pacemaker	pacemaker	NN	B-NP	O
or	or	CC	I-NP	O
cardioverter	cardioverter	NN	I-NP	O
defibrillators	defibrillator	NNS	I-NP	O
infections	infection	NNS	I-NP	O
.	.	.	O	O

Tea	Tea	NNP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
suggested	suggest	VBN	I-VP	O
to	to	TO	I-VP	O
promote	promote	VB	I-VP	O
oral	oral	JJ	B-NP	O
health	health	NN	I-NP	O
by	by	IN	B-PP	O
inhibiting	inhibit	VBG	B-VP	O
bacterial	bacterial	JJ	B-NP	O
attachment	attachment	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

Most	Most	JJS	B-NP	O
studies	study	NNS	I-NP	O
have	have	VBP	B-VP	O
focused	focus	VBN	I-VP	O
on	on	IN	B-PP	O
prevention	prevention	NN	B-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
attachment	attachment	NN	I-NP	O
to	to	TO	B-PP	O
hard	hard	JJ	B-NP	O
surfaces	surface	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
enamel	enamel	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
five	five	CD	B-NP	O
commercial	commercial	JJ	I-NP	O
tea	tea	NN	I-NP	O
(	(	(	O	O
green	green	JJ	B-NP	O
,	,	,	I-NP	O
oolong	oolong	JJ	I-NP	O
,	,	,	I-NP	O
black	black	JJ	I-NP	O
,	,	,	I-NP	O
pu-erh	pu-erh	JJ	I-NP	O
and	and	CC	I-NP	O
chrysanthemum	chrysanthemum	NN	I-NP	O
)	)	)	O	O
extracts	extract	NNS	B-NP	O
and	and	CC	O	O
tea	tea	NN	B-NP	O
components	component	NNS	I-NP	O
(	(	(	O	O
epigallocatechin	epigallocatechin	NN	B-NP	O
gallate	gallate	NN	I-NP	O
and	and	CC	O	O
gallic	gallic	JJ	B-NP	O
acid	acid	NN	I-NP	O
)	)	)	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
attachment	attachment	NN	I-NP	O
of	of	IN	B-PP	O
five	five	CD	B-NP	O
oral	oral	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
(	(	(	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
ATCC	ATCC	NN	I-NP	O
25175	25175	CD	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
ATCC	ATCC	NN	I-NP	O
35668	35668	CD	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mitis	mitis	NNP	I-NP	O
ATCC	ATCC	NNP	I-NP	O
49456	49456	CD	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
salivarius	salivarius	NNP	I-NP	O
ATCC	ATCC	NNP	I-NP	O
13419	13419	CD	I-NP	O
and	and	CC	O	O
Actinomyces	Actinomyce	VBZ	B-VP	O
naeslundii	naeslundii	NN	B-NP	O
ATCC	ATCC	NN	I-NP	O
51655	51655	CD	I-NP	O
)	)	)	O	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
HGF-1	HGF-1	NN	I-NP	B-cell_line
gingival	gingival	NN	I-NP	I-cell_line
cell	cell	NN	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

Extracts	Extract	NNS	B-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
teas	tea	NNS	I-NP	O
(	(	(	O	O
pu-erh	pu-erh	NN	B-NP	O
and	and	CC	O	O
chrysanthemum	chrysanthemum	NN	B-NP	O
)	)	)	O	O
significantly	significantly	RB	B-ADVP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
reduced	reduce	VBD	B-VP	O
attachment	attachment	NN	B-NP	O
of	of	IN	B-PP	O
all	all	PDT	B-NP	O
the	the	DT	I-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
strains	strain	NNS	I-NP	O
by	by	IN	B-PP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
4	4	CD	I-NP	O
log	log	NN	I-NP	O
CFU/well	CFU/well	NNP	I-NP	O
but	but	CC	O	O
effects	effect	NNS	B-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
teas	tea	NNS	I-NP	O
and	and	CC	I-NP	O
components	component	NNS	I-NP	O
were	be	VBD	B-VP	O
small	small	JJ	B-ADJP	O
.	.	.	O	O

Pu-erh	Pu-erh	NN	B-NP	O
and	and	CC	I-NP	O
chrysanthemum	chrysanthemum	NN	I-NP	O
tea	tea	NN	I-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
the	the	DT	B-NP	O
potential	potential	NN	I-NP	O
to	to	TO	B-VP	O
reduce	reduce	VB	I-VP	O
attachment	attachment	NN	B-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
pathogens	pathogen	NNS	I-NP	O
to	to	TO	B-PP	O
gingival	gingival	JJ	B-NP	O
tissue	tissue	NN	I-NP	O
and	and	CC	O	O
improve	improve	VB	B-VP	O
the	the	DT	B-NP	O
health	health	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
soft	soft	JJ	I-NP	O
tissues	tissue	NNS	I-NP	O
.	.	.	O	O

Laminaria	Laminaria	NNP	B-NP	O
japonica	japonica	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
brown	brown	JJ	I-NP	O
alga	alga	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
consumed	consume	VBN	I-VP	O
widely	widely	RB	B-ADVP	O
in	in	IN	B-PP	O
Korea	Korea	NNP	B-NP	O
,	,	,	O	O
Japan	Japan	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
China	China	NNP	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
ethanol	ethanol	NN	B-NP	O
extracts	extract	NNS	I-NP	O
of	of	IN	B-PP	O
L.	L.	NNP	B-NP	O
japonica	japonica	NNP	I-NP	O
against	against	IN	B-PP	O
oral	oral	JJ	B-NP	O
microbial	microbial	JJ	I-NP	O
species	specie	NNS	I-NP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
possible	possible	JJ	I-NP	O
application	application	NN	I-NP	O
of	of	IN	B-PP	O
L.	L.	NNP	B-NP	O
japonica	japonica	NN	I-NP	O
extracts	extract	NNS	I-NP	O
in	in	IN	B-PP	O
dental	dental	JJ	B-NP	O
care	care	NN	I-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
minimal	minimal	JJ	I-NP	O
inhibitory	inhibitory	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
(	(	(	O	O
MIC	MIC	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
minimal	minimal	JJ	B-NP	O
bactericidal	bactericidal	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
(	(	(	O	O
MBC	MBC	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
in	in	IN	B-PP	O
culture	culture	NN	B-NP	O
medium	medium	NN	I-NP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
microdilution	microdilution	NN	I-NP	O
method	method	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
MICs	MIC	NNS	I-NP	O
of	of	IN	B-PP	O
ethanol	ethanol	NN	B-NP	O
extracts	extract	NNS	I-NP	O
of	of	IN	B-PP	O
L.	L.	NNP	B-NP	O
japonica	japonica	NN	I-NP	O
with	with	IN	B-PP	O
oral	oral	JJ	B-NP	O
streptococci	streptococci	NNS	I-NP	O
were	be	VBD	B-VP	O
62.5-500	62.5-500	CD	B-NP	O
mug/ml	mug/ml	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
MBCs	MBC	NNS	I-NP	B-cell_type
were	be	VBD	B-VP	O
125-1000	125-1000	CD	B-NP	O
mug/ml	mug/ml	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
MICs	MIC	NNS	I-NP	O
of	of	IN	B-PP	O
Actinomyces	Actinomyce	NNS	B-NP	O
naeslundii	naeslundii	NN	I-NP	O
and	and	CC	I-NP	O
Actinomyces	Actinomyce	NNS	I-NP	O
odontolyticus	odontolyticus	NN	I-NP	O
were	be	VBD	B-VP	O
250	250	CD	B-NP	O
and	and	CC	I-NP	O
62.5	62.5	CD	I-NP	O
mug/ml	mug/ml	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
MBCs	MBC	NNS	I-NP	O
of	of	IN	B-PP	O
A.	A.	NN	B-NP	O
naeslundii	naeslundii	NN	I-NP	O
and	and	CC	O	O
A.	A.	NN	B-NP	O
odontolyticus	odontolyticus	NN	I-NP	O
were	be	VBD	B-VP	O
500	500	CD	B-NP	O
and	and	CC	I-NP	O
250	250	CD	I-NP	O
mug/ml	mug/ml	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
MICs	MIC	NNS	I-NP	O
were	be	VBD	B-VP	O
250	250	CD	B-NP	O
and	and	CC	I-NP	O
62.5	62.5	CD	I-NP	O
mug/ml	mug/ml	NN	I-NP	O
for	for	IN	B-PP	O
Fusobacterium	Fusobacterium	NN	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
and	and	CC	O	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
killing	killing	NN	I-NP	O
of	of	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
and	and	CC	O	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
was	be	VBD	B-VP	O
dependent	dependent	JJ	B-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
incubation	incubation	NN	I-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
killing	killing	NN	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
,	,	,	O	O
A.	A.	NN	B-NP	O
odontolyticus	odontolyticus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
dependent	dependent	JJ	I-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
extract	extract	NN	I-NP	O
concentration	concentration	NN	I-NP	O
.	.	.	O	O

Bacterial	Bacterial	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
with	with	IN	B-PP	O
L.	L.	NN	B-NP	O
japonica	japonica	NN	I-NP	O
extracts	extract	NNS	I-NP	O
changed	change	VBD	B-VP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
surface	surface	NN	I-NP	O
texture	texture	NN	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
,	,	,	O	O
A.	A.	NN	B-NP	O
odontolyticus	odontolyticus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
L.	L.	NN	B-NP	O
japonica	japonica	NN	I-NP	O
extracts	extract	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
useful	useful	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
antimicrobial	antimicrobial	JJ	B-NP	O
agents	agent	NNS	I-NP	O
to	to	TO	B-VP	O
combat	combat	VB	I-VP	O
oral	oral	JJ	B-NP	O
pathogens	pathogen	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
human	human	JJ	I-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
indigenous	indigenous	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
known	know	VBN	B-VP	O
to	to	TO	B-VP	O
include	include	VB	I-VP	O
a	a	DT	B-NP	O
robust	robust	JJ	I-NP	O
community	community	NN	I-NP	O
of	of	IN	B-PP	O
viruses	virus	NNS	B-NP	O
.	.	.	O	O

Very	Very	RB	B-NP	O
little	little	JJ	I-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
about	about	IN	B-PP	O
how	how	WRB	B-ADVP	O
oral	oral	JJ	B-NP	O
viruses	virus	NNS	I-NP	O
are	be	VBP	B-VP	O
spread	spread	VBN	I-VP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
environment	environment	NN	I-NP	O
or	or	CC	B-PP	O
to	to	TO	B-PP	O
which	which	WDT	B-NP	O
viruses	virus	NNS	B-NP	O
individuals	individual	NNS	I-NP	O
are	be	VBP	B-VP	O
exposed	expose	VBN	I-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
sought	seek	VBD	B-VP	O
to	to	TO	I-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
shared	share	VBN	B-NP	O
living	living	NN	I-NP	O
environment	environment	NN	I-NP	O
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
composition	composition	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
oral	oral	JJ	I-NP	O
viral	viral	JJ	I-NP	O
communities	community	NNS	I-NP	O
by	by	IN	B-PP	O
examining	examine	VBG	B-VP	O
the	the	DT	B-NP	O
saliva	saliva	NN	I-NP	O
of	of	IN	B-PP	O
21	21	CD	B-NP	O
human	human	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
;	;	:	O	O
11	11	CD	B-NP	O
subjects	subject	NNS	I-NP	O
from	from	IN	B-PP	O
different	different	JJ	B-NP	O
households	household	NNS	I-NP	O
and	and	CC	O	O
10	10	CD	B-NP	O
unrelated	unrelated	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
comprising	comprise	VBG	B-VP	O
4	4	CD	B-NP	O
separate	separate	JJ	I-NP	O
households	household	NNS	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
many	many	JJ	B-NP	O
viral	viral	JJ	I-NP	O
homologues	homologue	NNS	I-NP	O
shared	share	VBN	B-VP	O
among	among	IN	B-PP	O
all	all	DT	B-NP	O
subjects	subject	NNS	I-NP	O
studied	study	VBN	B-VP	O
,	,	,	O	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
significant	significant	JJ	B-NP	O
patterns	pattern	NNS	I-NP	O
of	of	IN	B-PP	O
shared	shared	JJ	B-NP	B-protein
homologues	homologue	NNS	I-NP	I-protein
in	in	IN	B-PP	O
three	three	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
four	four	CD	I-NP	O
households	household	NNS	I-NP	O
that	that	WDT	B-NP	O
suggest	suggest	VBP	B-VP	O
shared	share	VBN	I-VP	O
living	live	VBG	I-VP	O
environment	environment	NN	B-NP	O
affects	affect	VBZ	B-VP	O
viral	viral	JJ	B-NP	O
community	community	NN	I-NP	O
composition	composition	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
examined	examine	VBD	B-VP	O
CRISPR	CRISPR	NN	B-NP	B-protein
(	(	(	O	O
clustered	cluster	VBN	B-VP	O
regularly	regularly	RB	B-NP	O
interspaced	interspace	VBN	I-NP	O
short	short	JJ	I-NP	O
palindromic	palindromic	JJ	I-NP	O
repeat	repeat	NN	I-NP	O
)	)	)	O	O
loci	locus	NNS	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
acquired	acquire	VBN	B-NP	O
bacterial	bacterial	JJ	I-NP	O
and	and	CC	I-NP	O
archaeal	archaeal	JJ	I-NP	O
resistance	resistance	NN	I-NP	O
against	against	IN	B-PP	O
invading	invade	VBG	B-VP	O
viruses	virus	NNS	B-NP	O
by	by	IN	B-PP	O
acquiring	acquire	VBG	B-VP	O
short	short	JJ	B-NP	B-DNA
viral	viral	JJ	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
.	.	.	O	O

We	We	PRP	B-NP	O
analyzed	analyze	VBD	B-VP	O
2	2	CD	B-NP	O
065	065	CD	I-NP	O
246	246	CD	I-NP	O
CRISPR	CRISPR	NN	I-NP	O
spacers	spacer	NNS	I-NP	O
from	from	IN	B-PP	O
5	5	CD	B-NP	B-DNA
separate	separate	JJ	I-NP	I-DNA
repeat	repeat	NN	I-NP	I-DNA
motifs	motif	NNS	I-NP	I-DNA
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
of	of	IN	B-PP	O
Gemella	Gemella	NNP	B-NP	O
,	,	,	O	O
Veillonella	Veillonella	NNP	B-NP	O
,	,	,	O	O
Leptotrichia	Leptotrichia	NNP	B-NP	O
and	and	CC	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
individuals	individual	NNS	B-NP	O
from	from	IN	B-PP	O
shared	share	VBN	B-NP	O
living	living	NN	I-NP	O
environments	environment	NNS	I-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
exposed	expose	VBN	I-VP	O
to	to	TO	B-PP	O
similar	similar	JJ	B-NP	O
viruses	virus	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
significant	significant	JJ	I-NP	O
proportion	proportion	NN	I-NP	O
of	of	IN	B-PP	O
CRISPR	CRISPR	NN	B-NP	O
spacers	spacer	NNS	I-NP	O
were	be	VBD	B-VP	O
shared	share	VBN	I-VP	O
within	within	IN	B-PP	O
subjects	subject	NNS	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
households	household	NNS	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
either	either	CC	O	O
shared	share	VBN	B-VP	O
ancestry	ancestry	NN	B-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
oral	oral	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
or	or	CC	O	O
similar	similar	JJ	B-NP	O
viral	viral	JJ	I-NP	O
exposures	exposure	NNS	I-NP	O
.	.	.	O	O

Many	Many	JJ	B-NP	O
CRISPR	CRISPR	NN	I-NP	B-DNA
spacers	spacer	NNS	I-NP	I-DNA
matched	match	VBD	B-VP	I-DNA
virome	virome	NN	B-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
from	from	IN	B-PP	O
different	different	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
pattern	pattern	NN	I-NP	O
specific	specific	JJ	B-ADJP	O
to	to	TO	B-PP	O
any	any	DT	B-NP	O
household	household	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
data	datum	NNS	I-NP	O
on	on	IN	B-PP	O
viromes	virome	NNS	B-NP	O
and	and	CC	O	O
CRISPR	CRISPR	NN	B-NP	O
content	content	NN	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
shared	share	VBN	B-NP	O
living	live	VBG	I-NP	O
environment	environment	NN	I-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
determining	determine	VBG	B-VP	O
the	the	DT	B-NP	O
ecology	ecology	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
oral	oral	JJ	I-NP	O
viruses	virus	NNS	I-NP	O
.	.	.	O	O

Helicobacter	Helicobacter	NN	B-NP	O
pylori	pylori	NN	I-NP	O
since	since	IN	B-PP	O
Marshall	Marshall	NNP	B-NP	O
and	and	CC	O	O
Warren	Warren	NNP	B-NP	O
's	's	POS	B-NP	O
discovery	discovery	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
an	an	DT	B-NP	O
object	object	NN	I-NP	O
of	of	IN	B-PP	O
interest	interest	NN	B-NP	O
of	of	IN	B-PP	O
gastroenterologists	gastroenterologist	NNS	B-NP	O
and	and	CC	O	O
many	many	JJ	B-NP	O
researchers	researcher	NNS	I-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
specialties	specialty	NNS	I-NP	O
.	.	.	O	O

What	What	WP	B-NP	O
needs	need	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
highlighted	highlight	VBN	I-VP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
the	the	DT	B-NP	O
growing	grow	VBG	I-NP	O
interest	interest	NN	I-NP	O
of	of	IN	B-PP	O
dentists	dentist	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
residue	residue	NN	I-NP	O
of	of	IN	B-PP	O
H.	H.	NN	B-NP	O
pylori	pylori	NN	I-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
pathologies	pathology	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
burning	burn	VBG	B-VP	O
mouth	mouth	NN	B-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
periodontitis	periodontitis	NN	B-NP	O
and	and	CC	I-NP	O
gingivitis	gingivitis	NN	I-NP	O
.	.	.	O	O

With	With	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
medical	medical	JJ	B-NP	O
techniques	technique	NNS	I-NP	O
more	more	JJR	B-NP	O
studies	study	NNS	I-NP	O
using	use	VBG	B-VP	O
highly	highly	RB	B-NP	O
specific	specific	JJ	I-NP	O
diagnostic	diagnostic	JJ	I-NP	O
methods	method	NNS	I-NP	O
are	be	VBP	B-VP	O
performed	perform	VBN	I-VP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
transmission	transmission	NN	I-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

Suggested	Suggest	VBN	B-NP	O
faecal-oral	faecal-oral	JJ	I-NP	O
and	and	CC	I-NP	O
oral-oral	oral-oral	JJ	I-NP	O
routes	route	NNS	I-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
transmission	transmission	NN	I-NP	O
raised	raise	VBD	B-VP	O
interest	interest	NN	B-NP	O
in	in	IN	B-PP	O
molecular	molecular	JJ	B-NP	O
biology	biology	NN	I-NP	O
methods	method	NNS	I-NP	O
as	as	IN	B-PP	O
tools	tool	NNS	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
environments	environment	NNS	I-NP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
co-existence	co-existence	NN	B-NP	O
of	of	IN	B-PP	O
helical	helical	JJ	B-NP	O
and	and	CC	I-NP	O
coccoidal	coccoidal	JJ	I-NP	O
forms	form	NNS	I-NP	O
of	of	IN	B-PP	O
H.	H.	NN	B-NP	O
pylori	pylori	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mentioned	mention	VBN	I-NP	O
niches	niche	NNS	I-NP	O
raised	raise	VBD	B-VP	O
the	the	DT	B-NP	O
question	question	NN	I-NP	O
whether	whether	IN	B-SBAR	O
the	the	DT	B-NP	O
latter	latter	JJ	I-NP	O
is	be	VBZ	B-VP	O
potentially	potentially	RB	B-ADJP	O
pathogenic	pathogenic	JJ	I-ADJP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
why	why	WRB	B-ADVP	O
molecular	molecular	JJ	B-NP	O
biology	biology	NN	I-NP	O
is	be	VBZ	B-VP	O
now	now	RB	I-VP	O
giving	give	VBG	I-VP	O
a	a	DT	B-NP	O
great	great	JJ	I-NP	O
opportunity	opportunity	NN	I-NP	O
to	to	TO	B-VP	O
explore	explore	VB	I-VP	O
parts	part	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
body	body	NN	I-NP	O
that	that	WDT	B-NP	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
diagnosed	diagnose	VBN	I-VP	O
before	before	IN	B-PP	O
using	use	VBG	B-VP	O
only	only	RB	B-NP	O
gold	gold	JJ	I-NP	O
standard	standard	JJ	I-NP	O
diagnostic	diagnostic	JJ	I-NP	O
methods	method	NNS	I-NP	O
.	.	.	O	O

Molecular	Molecular	JJ	B-NP	O
techniques	technique	NNS	I-NP	O
have	have	VBP	B-VP	O
shown	show	VBN	I-VP	O
their	their	PRP$	B-NP	O
usefulness	usefulness	NN	I-NP	O
in	in	IN	B-PP	O
examining	examine	VBG	B-VP	O
the	the	DT	B-NP	O
potential	potential	JJ	I-NP	O
virulence	virulence	NN	I-NP	O
of	of	IN	B-PP	O
coccoid	coccoid	JJ	B-NP	O
forms	form	NNS	I-NP	O
of	of	IN	B-PP	O
bacterium	bacterium	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
review	review	NN	I-NP	O
was	be	VBD	B-VP	O
created	create	VBN	I-VP	O
also	also	RB	B-ADVP	O
to	to	TO	B-VP	O
summarize	summarize	VB	I-VP	O
the	the	DT	B-NP	O
knowledge	knowledge	NN	I-NP	O
about	about	IN	B-PP	O
molecular	molecular	JJ	B-NP	O
methods	method	NNS	I-NP	O
,	,	,	O	O
especially	especially	RB	B-NP	O
different	different	JJ	I-NP	O
PCR	PCR	NN	I-NP	O
techniques	technique	NNS	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
diagnostic	diagnostic	JJ	B-NP	O
tools	tool	NNS	I-NP	O
that	that	WDT	B-NP	O
can	can	MD	B-VP	O
help	help	VB	I-VP	O
medical	medical	JJ	B-NP	O
teams	team	NNS	I-NP	O
during	during	IN	B-PP	O
regular	regular	JJ	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
gastritis	gastritis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
link	link	NN	I-NP	O
between	between	IN	B-PP	O
oral	oral	JJ	B-NP	O
infections	infection	NNS	I-NP	O
and	and	CC	O	O
adverse	adverse	JJ	B-NP	O
systemic	systemic	JJ	I-NP	O
conditions	condition	NNS	I-NP	O
has	have	VBZ	B-VP	O
attracted	attract	VBN	I-VP	O
much	much	JJ	B-NP	O
attention	attention	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
research	research	NN	I-NP	O
community	community	NN	I-NP	O
.	.	.	O	O

Several	Several	JJ	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
proposed	propose	VBN	I-VP	O
,	,	,	O	O
including	include	VBG	B-PP	O
spread	spread	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
infection	infection	NN	I-NP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
transient	transient	JJ	B-NP	O
bacteremia	bacteremia	NN	I-NP	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
colonization	colonization	NN	I-NP	O
in	in	IN	B-PP	O
extra-oral	extra-oral	JJ	B-NP	O
sites	site	NNS	I-NP	O
,	,	,	O	O
systemic	systemic	JJ	B-NP	O
injury	injury	NN	I-NP	O
by	by	IN	B-PP	O
free	free	JJ	B-NP	O
toxins	toxin	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
pathogens	pathogen	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
systemic	systemic	JJ	B-NP	O
inflammation	inflammation	NN	I-NP	O
caused	cause	VBN	B-VP	O
by	by	IN	B-PP	O
soluble	soluble	JJ	B-NP	B-protein
antigens	antigen	NNS	I-NP	I-protein
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
pathogens	pathogen	NNS	I-NP	O
.	.	.	O	O

Mounting	Mount	VBG	B-VP	O
evidence	evidence	NN	B-NP	O
supports	support	VBZ	B-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
systemic	systemic	JJ	I-NP	O
spread	spread	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
commensals	commensal	NNS	I-NP	O
and	and	CC	I-NP	O
pathogens	pathogen	NNS	I-NP	O
to	to	TO	B-PP	O
distant	distant	JJ	B-NP	B-DNA
body	body	NN	I-NP	I-DNA
sites	site	NNS	I-NP	I-DNA
causing	cause	VBG	B-VP	O
extra-oral	extra-oral	JJ	B-NP	O
infections	infection	NNS	I-NP	O
and	and	CC	I-NP	O
inflammation	inflammation	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
review	review	VBP	B-VP	O
here	here	RB	B-ADVP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
recent	recent	JJ	I-NP	O
findings	finding	NNS	I-NP	O
on	on	IN	B-PP	O
systemic	systemic	JJ	B-NP	O
infections	infection	NNS	I-NP	O
and	and	CC	O	O
inflammation	inflammation	NN	B-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
cardiovascular	cardiovascular	JJ	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
adverse	adverse	JJ	B-NP	O
pregnancy	pregnancy	NN	I-NP	O
outcomes	outcome	NNS	I-NP	O
,	,	,	O	O
rheumatoid	rheumatoid	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
,	,	,	O	O
inflammatory	inflammatory	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
colorectal	colorectal	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
tract	tract	NN	I-NP	O
infections	infection	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
organ	organ	NN	B-NP	O
inflammations	inflammation	NNS	I-NP	O
and	and	CC	I-NP	O
abscesses	abscess	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
recently	recently	RB	I-NP	O
identified	identify	VBN	I-NP	O
virulence	virulence	NN	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
species	specie	NNS	I-NP	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
,	,	,	O	O
Porphyromonas	Porphyromonas	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Campylobacter	Campylobacter	NNP	B-NP	O
rectus	rectus	NN	I-NP	O
are	be	VBP	B-VP	O
also	also	RB	I-VP	O
reviewed	review	VBN	I-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
pattern	pattern	NN	I-NP	O
emerges	emerge	VBZ	B-VP	O
indicating	indicate	VBG	I-VP	O
that	that	IN	B-SBAR	O
only	only	RB	B-NP	O
select	select	JJ	I-NP	O
subtype	subtype	NN	I-NP	O
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
given	give	VBN	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
e.g.	e.g.	FW	B-NP	O
,	,	,	O	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
subspecies	subspecy	NNS	I-NP	O
animalis	animalis	NN	I-NP	O
and	and	CC	I-NP	O
polymorphum	polymorphum	NN	I-NP	O
and	and	CC	I-NP	O
S.	S.	NN	I-NP	O
mutans	mutan	NNS	I-NP	O
non-c	non-c	JJ	B-NP	O
serotypes	serotype	NNS	I-NP	O
,	,	,	O	O
are	be	VBP	B-VP	O
prone	prone	JJ	B-ADJP	O
to	to	TO	B-PP	O
extra-oral	extra-oral	JJ	B-NP	O
translocation	translocation	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
advocate	advocate	VBP	B-VP	O
the	the	DT	B-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
identification	identification	NN	B-NP	O
and	and	CC	I-NP	O
quantification	quantification	NN	I-NP	O
of	of	IN	B-PP	O
potential	potential	JJ	B-NP	O
pathogens	pathogen	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
subtype	subtype	NN	I-NP	O
levels	level	NNS	I-NP	O
for	for	IN	B-PP	O
accurate	accurate	JJ	B-NP	O
prediction	prediction	NN	I-NP	O
of	of	IN	B-PP	O
disease	disease	NN	B-NP	O
potential	potential	NN	I-NP	O
.	.	.	O	O

Ethanol	Ethanol	NN	B-NP	O
consumption	consumption	NN	I-NP	O
and	and	CC	O	O
poor	poor	JJ	B-NP	O
oral	oral	JJ	I-NP	O
hygiene	hygiene	NN	I-NP	O
are	be	VBP	B-VP	O
risk	risk	NN	B-NP	O
factors	factor	NNS	I-NP	O
for	for	IN	B-PP	O
oral	oral	JJ	B-NP	O
and	and	CC	I-NP	O
oesophageal	oesophageal	JJ	I-NP	O
cancers	cancer	NNS	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
oral	oral	JJ	B-NP	O
streptococci	streptococci	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
produce	produce	VB	I-VP	O
excessive	excessive	JJ	B-NP	O
acetaldehyde	acetaldehyde	NN	I-NP	O
from	from	IN	B-PP	O
ethanol	ethanol	NN	B-NP	O
,	,	,	O	O
little	little	JJ	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
this	this	DT	B-NP	O
carcinogen	carcinogen	NN	I-NP	O
is	be	VBZ	B-VP	O
produced	produce	VBN	I-VP	O
.	.	.	O	O

By	By	IN	B-PP	O
screening	screen	VBG	B-VP	O
52	52	CD	B-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
diverse	diverse	JJ	B-NP	O
oral	oral	JJ	I-NP	O
streptococcal	streptococcal	JJ	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
identified	identify	VBD	B-VP	O
Streptococcus	Streptococcus	NNP	B-NP	O
gordonii	gordonii	NNP	I-NP	O
V2016	V2016	NN	I-NP	O
that	that	WDT	B-NP	O
produced	produce	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	JJS	I-NP	O
acetaldehyde	acetaldehyde	NN	I-NP	O
from	from	IN	B-PP	O
ethanol	ethanol	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
then	then	RB	B-ADVP	O
constructed	construct	VBD	B-VP	O
gene	gene	NN	B-NP	O
deletion	deletion	NN	I-NP	O
mutants	mutant	NNS	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
strain	strain	NN	I-NP	O
and	and	CC	O	O
analysed	analyse	VBD	B-VP	O
them	them	PRP	B-NP	O
for	for	IN	B-PP	O
alcohol	alcohol	NN	B-NP	O
and	and	CC	I-NP	O
acetaldehyde	acetaldehyde	NN	I-NP	B-protein
dehydrogenases	dehydrogenas	NNS	I-NP	I-protein
by	by	IN	B-PP	O
zymograms	zymogram	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
S.	S.	NNP	B-NP	O
gordonii	gordonii	NNP	I-NP	O
V2016	V2016	NNP	I-NP	O
expressed	express	VBD	B-VP	O
three	three	CD	B-NP	O
primary	primary	JJ	I-NP	B-protein
alcohol	alcohol	NN	I-NP	I-protein
dehydrogenases	dehydrogenas	NNS	I-NP	I-protein
,	,	,	O	O
AdhA	AdhA	NN	B-NP	B-protein
,	,	,	O	O
AdhB	AdhB	NN	B-NP	B-protein
and	and	CC	I-NP	O
AdhE	AdhE	NN	I-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
all	all	DT	O	O
oxidize	oxidize	VBP	B-VP	O
ethanol	ethanol	NN	B-NP	O
to	to	TO	B-PP	O
acetaldehyde	acetaldehyde	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
their	their	PRP$	B-NP	O
preferred	prefer	VBN	I-NP	O
substrates	substrate	NNS	I-NP	O
were	be	VBD	B-VP	O
1-propanol	1-propanol	NN	B-NP	O
,	,	,	I-NP	O
1-butanol	1-butanol	NN	I-NP	O
and	and	CC	I-NP	O
ethanol	ethanol	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
additional	additional	JJ	I-NP	O
dehydrogenases	dehydrogenas	NNS	I-NP	O
,	,	,	I-NP	O
S-AdhA	S-AdhA	NN	I-NP	O
and	and	CC	I-NP	O
TdhA	TdhA	NN	I-NP	B-protein
,	,	,	O	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
with	with	IN	B-PP	O
specificities	specificity	NNS	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
secondary	secondary	JJ	I-NP	O
alcohol	alcohol	NN	I-NP	O
2-propanol	2-propanol	NN	I-NP	O
and	and	CC	I-NP	O
threonine	threonine	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	B-PP	O
to	to	TO	I-PP	O
ethanol	ethanol	NN	B-NP	O
.	.	.	O	O

S.	S.	NNP	B-NP	O
gordonii	gordonii	NN	I-NP	O
V2016	V2016	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
show	show	VB	I-VP	O
a	a	DT	B-NP	O
detectable	detectable	JJ	I-NP	O
acetaldehyde	acetaldehyde	NN	I-NP	B-protein
dehydrogenase	dehydrogenase	NN	I-NP	I-protein
even	even	RB	B-SBAR	O
though	though	IN	I-SBAR	O
its	its	PRP$	B-NP	O
adhE	adhE	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
encodes	encode	VBZ	B-VP	O
a	a	DT	B-NP	O
putative	putative	JJ	I-NP	B-protein
bifunctional	bifunctional	JJ	I-NP	I-protein
acetaldehyde/alcohol	acetaldehyde/alcohol	NN	I-NP	I-protein
dehydrogenase	dehydrogenase	NN	I-NP	I-protein
.	.	.	O	O

Mutants	Mutant	NNS	B-NP	O
with	with	IN	B-PP	O
adhE	adhE	NN	B-NP	O
deletion	deletion	NN	I-NP	O
showed	show	VBD	B-VP	O
greater	great	JJR	B-NP	O
tolerance	tolerance	NN	I-NP	O
to	to	TO	B-PP	O
ethanol	ethanol	NN	B-NP	O
in	in	IN	B-PP	O
comparison	comparison	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
wild-type	wild-type	JJ	I-NP	O
and	and	CC	I-NP	O
mutant	mutant	JJ	I-NP	O
with	with	IN	B-PP	O
adhA	adhA	NN	B-NP	O
or	or	CC	I-NP	O
adhB	adhB	NN	I-NP	O
deletion	deletion	NN	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
AdhE	AdhE	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	B-protein
alcohol	alcohol	NN	I-NP	I-protein
dehydrogenase	dehydrogenase	NN	I-NP	I-protein
in	in	IN	B-PP	O
S.	S.	NNP	B-NP	O
gordonii	gordonii	NNP	I-NP	O
.	.	.	O	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
19	19	CD	B-NP	O
additional	additional	JJ	I-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
gordonii	gordonii	NNP	I-NP	O
,	,	,	O	O
S.	S.	NNP	B-NP	O
mitis	mitis	NN	I-NP	O
,	,	,	O	O
S.	S.	NNP	B-NP	O
oralis	oralis	NNP	I-NP	O
,	,	,	O	O
S.	S.	NNP	B-NP	O
salivarius	salivarius	NNP	I-NP	O
and	and	CC	O	O
S.	S.	NNP	B-NP	O
sanguinis	sanguinis	NNP	I-NP	O
showed	show	VBD	B-VP	O
expressions	expression	NNS	B-NP	O
of	of	IN	B-PP	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
three	three	CD	I-NP	O
alcohol	alcohol	NN	I-NP	B-protein
dehydrogenases	dehydrogenas	NNS	I-NP	I-protein
,	,	,	O	O
but	but	CC	O	O
none	none	NN	B-NP	O
showed	show	VBD	B-VP	O
detectable	detectable	JJ	B-NP	O
acetaldehyde	acetaldehyde	NN	I-NP	B-protein
dehydrogenase	dehydrogenase	NN	I-NP	I-protein
,	,	,	O	O
except	except	IN	B-PP	O
one	one	CD	B-NP	O
strain	strain	NN	I-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
ALDH	ALDH	NN	I-NP	B-protein
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
expression	expression	NN	B-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
alcohol	alcohol	NN	I-NP	B-protein
dehydrogenases	dehydrogenas	NNS	I-NP	I-protein
but	but	CC	O	O
no	no	DT	B-NP	O
functional	functional	JJ	I-NP	O
acetaldehyde	acetaldehyde	NN	I-NP	B-protein
dehydrogenase	dehydrogenase	NN	I-NP	I-protein
may	may	MD	B-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
excessive	excessive	JJ	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
acetaldehyde	acetaldehyde	NN	B-NP	O
from	from	IN	B-PP	O
ethanol	ethanol	NN	B-NP	O
by	by	IN	B-PP	O
certain	certain	JJ	B-NP	O
oral	oral	JJ	I-NP	O
streptococci	streptococci	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
current	current	JJ	I-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
sulphate-reducing	sulphate-reducing	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
(	(	(	O	O
SRB	SRB	NN	B-NP	B-protein
)	)	)	O	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
saliva	saliva	NN	I-NP	O
and	and	CC	O	O
correlate	correlate	VBP	B-VP	O
with	with	IN	B-PP	O
oral	oral	JJ	B-NP	O
and	and	CC	I-NP	O
systemic	systemic	JJ	I-NP	O
conditions	condition	NNS	I-NP	O
.	.	.	O	O

Saliva	Saliva	NN	B-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
from	from	IN	B-PP	O
118	118	CD	B-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	O	O
inoculated	inoculate	VBN	B-VP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
ml	ml	NN	I-NP	O
of	of	IN	B-PP	O
modified	modify	VBN	B-VP	B-cell_line
Postgate	Postgate	NNP	B-NP	I-cell_line
's	's	POS	B-NP	I-cell_line
E	E	NN	I-NP	I-cell_line
medium	medium	NN	I-NP	I-cell_line
culture	culture	NN	I-NP	I-cell_line
.	.	.	O	O

After	After	IN	B-PP	O
28	28	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
incubation	incubation	NN	B-NP	O
at	at	IN	B-PP	O
30	30	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
SRB	SRB	NN	B-NP	B-protein
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
sulphide	sulphide	NN	B-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
118	118	CD	B-NP	O
saliva	saliva	NN	I-NP	O
samples	sample	NNS	I-NP	O
collected	collect	VBN	B-VP	O
,	,	,	O	O
35	35	CD	B-NP	O
were	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
SRB	SRB	NN	B-NP	B-protein
.	.	.	O	O

Three	Three	CD	B-NP	O
positive	positive	JJ	I-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
randomly	randomly	RB	I-VP	O
chosen	choose	VBN	I-VP	O
to	to	TO	I-VP	O
identify	identify	VB	I-VP	O
the	the	DT	B-NP	O
species	species	NN	I-NP	O
of	of	IN	B-PP	O
SRB	SRB	NN	B-NP	B-protein
by	by	IN	B-PP	O
PCR	PCR	NN	B-NP	O
and	and	CC	O	O
sequenced	sequence	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
three	three	CD	I-NP	O
selected	select	VBN	I-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
as	as	IN	B-PP	O
Desulfovibrio	Desulfovibrio	NNP	B-NP	O
fairfieldensis	fairfieldensis	NNP	I-NP	O
,	,	,	O	O
Desulfovibrio	Desulfovibrio	NNP	B-NP	O
desulfuricans	desulfurican	NNS	I-NP	O
and	and	CC	O	O
Raoultella	Raoultella	NN	B-NP	O
ornithinolytic	ornithinolytic	JJ	B-ADJP	O
.	.	.	O	O

Gastritis	Gastritis	NN	B-NP	O
(	(	(	O	O
14.4	14.4	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
prevalent	prevalent	JJ	I-NP	O
systemic	systemic	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
(	(	(	O	O
3.4	3.4	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
while	while	IN	B-SBAR	O
periodontitis	periodontitis	NN	B-NP	O
(	(	(	O	O
11	11	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
traumatic	traumatic	JJ	B-NP	O
fibroma	fibroma	NN	I-NP	O
(	(	(	O	O
4.2	4.2	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
manifestations	manifestation	NNS	I-NP	O
most	most	RBS	B-VP	O
frequently	frequently	RB	I-VP	O
found	find	VBN	I-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
bivariate	bivariate	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
to	to	TO	I-VP	O
examine	examine	VB	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
SRB	SRB	NN	B-NP	B-protein
and	and	CC	O	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
prevalent	prevalent	JJ	I-NP	O
systemic	systemic	JJ	I-NP	O
and	and	CC	I-NP	O
oral	oral	JJ	I-NP	O
manifestations	manifestation	NNS	I-NP	O
.	.	.	O	O

Only	Only	RB	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
statistically	statistically	RB	I-NP	O
significant	significant	JJ	I-NP	O
association	association	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
0.0003	0.0003	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
showed	show	VBD	B-VP	O
SRB	SRB	NN	B-NP	B-protein
can	can	MD	B-VP	O
be	be	VB	I-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
microbiota	microbiota	NN	I-NP	O
of	of	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

Regarding	Regard	VBG	B-VP	O
the	the	DT	B-NP	O
several	several	JJ	I-NP	O
conditions	condition	NNS	I-NP	O
studied	study	VBN	B-VP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
higher	high	JJR	I-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
SRB	SRB	NN	B-NP	B-protein
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
gastritis	gastritis	NN	B-NP	O
and	and	CC	O	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
SRB	SRB	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
and	and	CC	O	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
cavity	cavity	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
proposed	propose	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
reservoir	reservoir	NN	I-NP	O
of	of	IN	B-PP	O
H.pylori	H.pylori	NNP	B-NP	O
,	,	,	O	O
being	be	VBG	B-VP	O
implicated	implicate	VBN	I-VP	O
in	in	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
transmission	transmission	NN	I-NP	O
through	through	IN	B-PP	O
oral-oral	oral-oral	JJ	B-NP	O
route	route	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
some	some	DT	B-NP	O
investigators	investigator	NNS	I-NP	O
believe	believe	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
newborn	newborn	NN	I-NP	O
acquires	acquire	VBZ	B-VP	O
H.pylori	H.pylori	NNP	B-NP	O
from	from	IN	B-PP	O
mother	mother	NN	B-NP	O
through	through	IN	B-PP	O
vaginal	vaginal	JJ	B-NP	O
delivery	delivery	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
oral	oral	JJ	B-NP	O
and	and	CC	I-NP	O
vaginal	vaginal	JJ	I-NP	O
yeasts	yeast	NNS	I-NP	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
intracellular	intracellular	JJ	I-NP	O
occurrence	occurrence	NN	I-NP	O
of	of	IN	B-PP	O
H.pylori	H.pylori	NNP	B-NP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
possible	possible	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
transmission	transmission	NN	I-NP	O
.	.	.	O	O

Sixty	Sixty	CD	B-NP	O
nine	nine	CD	I-NP	O
oral	oral	JJ	I-NP	O
and	and	CC	I-NP	O
vaginal	vaginal	JJ	I-NP	O
yeasts	yeast	NNS	I-NP	O
from	from	IN	B-PP	O
expecting	expect	VBG	B-VP	O
mothers	mother	NNS	B-NP	O
(	(	(	O	O
39	39	CD	B-NP	O
oral	oral	JJ	I-NP	O
and	and	CC	O	O
30	30	CD	B-NP	O
vaginal	vaginal	JJ	I-NP	O
)	)	)	O	O
and	and	CC	O	O
seven	seven	CD	B-NP	O
oral	oral	JJ	I-NP	O
yeasts	yeast	NNS	I-NP	O
from	from	IN	B-PP	O
neonates	neonate	NNS	B-NP	O
(	(	(	O	O
6/46	6/46	CD	B-NP	O
vaginal	vaginal	JJ	I-NP	O
delivery	delivery	NN	I-NP	O
,	,	,	O	O
1/43	1/43	CD	B-NP	O
cesarean	cesarean	JJ	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
and	and	CC	O	O
studied	study	VBN	B-VP	O
by	by	IN	B-PP	O
light	light	NN	B-NP	O
and	and	CC	O	O
fluorescent	fluorescent	JJ	B-NP	O
microscopy	microscopy	NN	I-NP	O
for	for	IN	B-PP	O
observing	observe	VBG	B-VP	O
the	the	DT	B-NP	O
intracellular	intracellular	JJ	I-NP	O
bacterium-like	bacterium-like	JJ	I-NP	O
bodies	body	NNS	I-NP	O
(	(	(	O	O
BLBs	BLB	NNS	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

Whole	Whole	JJ	B-NP	O
DNAs	DNA	NNS	I-NP	O
of	of	IN	B-PP	O
yeasts	yeast	NNS	B-NP	O
were	be	VBD	B-VP	O
recruited	recruit	VBN	I-VP	O
for	for	IN	B-PP	O
detection	detection	NN	B-NP	O
of	of	IN	B-PP	O
H.pylori-specific	H.pylori-specific	JJ	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

Urea	Urea	NN	B-NP	O
breath	breath	NN	I-NP	O
test	test	NN	I-NP	O
(	(	(	O	O
UBT	UBT	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
for	for	IN	B-PP	O
detection	detection	NN	B-NP	O
of	of	IN	B-PP	O
H.pylori	H.pylori	NN	B-NP	O
infection	infection	NN	I-NP	O
in	in	IN	B-PP	O
mothers	mother	NNS	B-NP	O
.	.	.	O	O

Stool	Stool	NN	B-NP	O
antigen	antigen	NN	I-NP	O
test	test	NN	I-NP	O
(	(	(	O	O
SAT	SAT	NN	B-NP	B-protein
)	)	)	O	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
for	for	IN	B-PP	O
detection	detection	NN	B-NP	O
of	of	IN	B-PP	O
H.pylori	H.pylori	NN	B-NP	B-protein
antigens	antigen	NNS	I-NP	I-protein
in	in	IN	B-PP	O
infants	infant	NNS	B-NP	O
'	'	POS	B-NP	O
stool	stool	NN	I-NP	O
at	at	IN	B-PP	O
birth	birth	NN	B-NP	O
and	and	CC	O	O
six	six	CD	B-NP	O
months	month	NNS	I-NP	O
of	of	IN	B-PP	O
age	age	NN	B-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
yeasts	yeast	NNS	I-NP	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
more	more	RBR	B-ADVP	O
frequently	frequently	RB	I-ADVP	O
from	from	IN	B-PP	O
normally-delivered	normally-delivered	JJ	B-NP	O
neonates	neonate	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
H.pylori	H.pylori	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
mothers	mother	NNS	B-NP	O
'	'	POS	B-NP	O
vaginal	vaginal	JJ	I-NP	O
yeasts	yeast	NNS	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
mothers	mother	NNS	B-NP	O
'	'	POS	B-NP	O
oral	oral	JJ	I-NP	O
yeasts	yeast	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
significant	significant	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
occurrence	occurrence	NN	I-NP	O
of	of	IN	B-PP	O
H.pylori	H.pylori	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
vaginal	vaginal	JJ	B-NP	O
yeasts	yeast	NNS	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
neonates	neonate	NNS	B-NP	O
'	'	POS	B-NP	O
oral	oral	JJ	I-NP	O
yeasts	yeast	NNS	I-NP	O
,	,	,	O	O
occurrence	occurrence	NN	B-NP	O
of	of	IN	B-PP	O
H.pylori	H.pylori	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
mothers	mother	NNS	B-NP	O
'	'	POS	B-NP	O
vaginal	vaginal	JJ	I-NP	O
yeasts	yeast	NNS	I-NP	O
or	or	CC	I-NP	O
neonates	neonate	NNS	I-NP	O
'	'	POS	B-NP	O
oral	oral	JJ	I-NP	O
yeasts	yeast	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
UBT+	UBT+	JJ	B-NP	O
results	result	NNS	I-NP	O
in	in	IN	B-PP	O
mothers	mother	NNS	B-NP	O
.	.	.	O	O

C.albicans	C.albican	NNS	B-NP	O
which	which	WDT	B-NP	O
colonizes	colonize	VBZ	B-VP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
of	of	IN	B-PP	O
neonates	neonate	NNS	B-NP	O
through	through	IN	B-PP	O
vaginal	vaginal	JJ	B-NP	O
delivery	delivery	NN	I-NP	O
or	or	CC	I-NP	O
contact	contact	NN	I-NP	O
with	with	IN	B-PP	O
environment	environment	NN	B-NP	O
or	or	CC	I-NP	O
healthcare	healthcare	NN	I-NP	O
workers	worker	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
reservoir	reservoir	NN	I-NP	O
of	of	IN	B-PP	O
H.pylori	H.pylori	NNP	B-NP	O
.	.	.	O	O

Vaginal	Vaginal	JJ	B-NP	O
yeasts	yeast	NNS	I-NP	O
are	be	VBP	B-VP	O
more	more	RBR	B-ADJP	O
potent	potent	JJ	I-ADJP	O
in	in	IN	B-PP	O
accommodating	accommodate	VBG	B-VP	O
H.pylori	H.pylori	NNP	B-NP	O
than	than	IN	B-PP	O
oral	oral	JJ	B-NP	O
yeasts	yeast	NNS	I-NP	O
.	.	.	O	O

Accordingly	Accordingly	RB	B-ADVP	O
,	,	,	O	O
vaginal	vaginal	JJ	B-NP	O
yeast	yeast	NN	I-NP	O
is	be	VBZ	B-VP	O
proposed	propose	VBN	I-VP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
reservoir	reservoir	NN	I-NP	O
of	of	IN	B-PP	O
H.pylori	H.pylori	NNP	B-NP	O
which	which	WDT	B-NP	O
facilitates	facilitate	VBZ	B-VP	O
H.pylori	H.pylori	NNP	B-NP	O
transmission	transmission	NN	I-NP	O
to	to	TO	B-PP	O
neonates	neonate	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
red	red	JJ	I-NP	O
autofluorescence	autofluorescence	NN	I-NP	O
from	from	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
species	specie	NNS	I-NP	O
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
and	and	CC	O	O
periodontitis	periodontitis	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
nutrients	nutrient	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
medium	medium	NN	I-NP	O
.	.	.	O	O

Bacteria	Bacteria	NNS	B-NP	O
were	be	VBD	B-VP	O
grown	grow	VBN	I-VP	O
anaerobically	anaerobically	RB	B-ADVP	O
on	on	IN	B-PP	O
tryptic	tryptic	JJ	B-NP	O
soy	soy	NN	I-NP	O
agar	agar	NN	I-NP	O
(	(	(	O	O
TSA	TSA	NN	B-NP	O
)	)	)	O	O
supplemented	supplement	VBN	B-VP	O
with	with	IN	B-PP	O
nutrients	nutrient	NNS	B-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
magnesium-porphyrins	magnesium-porphyrin	NNS	B-NP	B-protein
from	from	IN	B-PP	O
spinach	spinach	NN	B-NP	O
and	and	CC	I-NP	O
iron-porphyrins	iron-porphyrin	NNS	I-NP	B-protein
from	from	IN	B-PP	O
heme	heme	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
autofluorescence	autofluorescence	NN	I-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
assessed	assess	VBN	I-VP	O
at	at	IN	B-PP	O
405	405	CD	B-NP	O
nm	nm	NN	I-NP	O
excitation	excitation	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
TSA	TSA	NN	I-NP	B-protein
without	without	IN	B-PP	O
additives	additive	NNS	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
autofluorescence	autofluorescence	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
from	from	IN	B-PP	O
any	any	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
species	specie	NNS	I-NP	O
tested	test	VBN	B-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
TSA	TSA	NN	I-NP	O
containing	contain	VBG	B-VP	O
sheep	sheep	NN	B-NP	O
blood	blood	NN	I-NP	O
,	,	,	O	O
red	red	JJ	B-NP	O
autofluorescence	autofluorescence	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
only	only	RB	B-ADVP	O
from	from	IN	B-PP	O
Parvimonas	Parvimonas	NNP	B-NP	O
micra	micra	NN	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
the	the	DT	B-NP	O
TSA	TSA	NN	I-NP	B-protein
was	be	VBD	B-VP	O
supplemented	supplement	VBN	I-VP	O
with	with	IN	B-PP	O
blood	blood	NN	B-NP	O
,	,	,	O	O
hemin	hemin	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
vitamin	vitamin	NN	B-NP	O
K	K	NN	I-NP	O
,	,	,	O	O
red	red	JJ	B-NP	O
autofluorescence	autofluorescence	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
from	from	IN	B-PP	O
Actinomyces	Actinomyces	NNP	B-NP	O
naeslundii	naeslundii	NNP	I-NP	O
,	,	,	O	O
Bifidobacterium	Bifidobacterium	NNP	B-NP	O
dentium	dentium	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
TSA	TSA	NN	I-NP	O
supplemented	supplement	VBN	B-VP	O
with	with	IN	B-PP	O
spinach	spinach	NN	B-NP	O
extract	extract	NN	I-NP	O
,	,	,	O	O
red	red	JJ	B-NP	O
autofluorescence	autofluorescence	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
from	from	IN	B-PP	O
Aggregatibacter	Aggregatibacter	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
,	,	,	O	O
A.	A.	NNP	B-NP	O
naeslundii	naeslundii	NNP	I-NP	O
,	,	,	O	O
Enterococcus	Enterococcus	NNP	B-NP	O
faecalis	faecalis	NNP	I-NP	O
,	,	,	O	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
,	,	,	O	O
Lactobacillus	Lactobacillus	NNP	B-NP	O
salivarius	salivarius	NN	I-NP	O
,	,	,	O	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Veillonella	Veillonella	NN	B-NP	O
parvula	parvula	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
conclude	conclude	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
and	and	CC	O	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
exhibit	exhibit	VBP	B-VP	O
red	red	JJ	B-NP	O
autofluorescence	autofluorescence	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
autofluorescence	autofluorescence	NN	I-NP	O
characteristics	characteristic	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tested	test	VBN	I-NP	O
strains	strain	NNS	I-NP	O
depended	depend	VBD	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
nutrients	nutrient	NNS	I-NP	O
present	present	JJ	B-ADJP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
metalloporphyrins	metalloporphyrin	NNS	B-NP	B-protein
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
metabolic	metabolic	JJ	I-NP	B-protein
products	product	NNS	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
biofilm	biofilm	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
red	red	JJ	B-NP	O
autofluorescence	autofluorescence	NN	I-NP	O
.	.	.	O	O

Approximately	Approximately	RB	B-NP	O
15	15	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
deaths	death	NNS	I-NP	O
from	from	IN	B-PP	O
cancer	cancer	NN	B-NP	O
are	be	VBP	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
viral	viral	JJ	I-NP	O
or	or	CC	I-NP	O
bacterial	bacterial	JJ	I-NP	O
infections	infection	NNS	I-NP	O
.	.	.	O	O

Helicobacter	Helicobacter	NN	B-NP	O
pylori	pylori	NN	I-NP	O
(	(	(	O	O
HP	HP	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
flagellated	flagellated	JJ	I-NP	O
,	,	,	I-NP	O
Gram-negative	Gram-negative	JJ	I-NP	O
,	,	,	I-NP	O
spiral	spiral	JJ	I-NP	O
,	,	,	I-NP	O
microaerophilic	microaerophilic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
is	be	VBZ	B-VP	O
considered	consider	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
common	common	JJ	I-NP	O
chronic	chronic	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
infection	infection	NN	I-NP	O
in	in	IN	B-PP	O
humans	human	NNS	B-NP	O
.	.	.	O	O

Toll-like	Toll-like	JJ	B-NP	B-protein
receptor	receptor	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
(	(	(	O	O
TLR5	TLR5	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
recognition	recognition	NN	B-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
flagella	flagella	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
promote	promote	VB	I-VP	O
tumour	tumour	NN	B-NP	O
growth	growth	NN	I-NP	O
through	through	IN	B-PP	O
inflammation-dependent	inflammation-dependent	JJ	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
in	in	IN	B-PP	O
epithelial	epithelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Expression	Expression	NN	B-NP	O
of	of	IN	B-PP	O
HP	HP	NN	B-NP	O
and	and	CC	I-NP	O
TLR5	TLR5	NN	I-NP	B-protein
was	be	VBD	B-VP	O
analysed	analyse	VBN	I-VP	O
in	in	IN	B-PP	O
OSCC	OSCC	NN	B-NP	O
specimen	specimen	NN	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
191	191	CD	B-NP	O
)	)	)	O	O
by	by	IN	B-PP	O
immunohistochemistry	immunohistochemistry	NN	B-NP	O
.	.	.	O	O

TLR5	TLR5	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
specificity	specificity	NN	I-NP	O
was	be	VBD	B-VP	O
conducted	conduct	VBN	I-VP	O
by	by	IN	B-PP	O
Western	Western	JJ	B-NP	O
blotting	blotting	NN	I-NP	O
in	in	IN	B-PP	O
cancer	cancer	NN	B-NP	B-cell_line
cell	cell	NN	I-NP	I-cell_line
lines	line	NNS	I-NP	I-cell_line
(	(	(	O	O
BICR3	BICR3	NN	B-NP	B-protein
,	,	,	I-NP	O
BICR56	BICR56	NN	I-NP	B-protein
)	)	)	O	O
.	.	.	O	O

TLR5-stained	TLR5-stained	JJ	B-NP	O
sections	section	NNS	I-NP	O
were	be	VBD	B-VP	O
scanned	scan	VBN	I-VP	O
and	and	CC	O	O
digitally	digitally	RB	B-VP	O
analysed	analyse	VBN	I-VP	O
using	use	VBG	B-VP	O
ImageJ	ImageJ	NN	B-NP	B-protein
and	and	CC	O	O
the	the	DT	B-NP	O
immunomembrane	immunomembrane	NN	I-NP	B-protein
plug-in	plug-in	NN	I-NP	I-protein
.	.	.	O	O

HP	HP	NN	B-NP	O
expression	expression	NN	I-NP	O
and	and	CC	O	O
TLR5	TLR5	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
were	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
clinicopathological	clinicopathological	JJ	B-NP	O
characteristics	characteristic	NNS	I-NP	O
and	and	CC	O	O
impact	impact	NN	B-NP	O
on	on	IN	B-PP	O
survival	survival	NN	B-NP	O
.	.	.	O	O

Helicobacter	Helicobacter	NN	B-NP	O
pylori	pylori	NN	I-NP	O
detection	detection	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
recurrence	recurrence	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tumour	tumour	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
TLR5	TLR5	NN	B-NP	B-protein
expression	expression	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
.	.	.	O	O

Multivariate	Multivariate	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
HP	HP	NN	B-NP	O
expression	expression	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
independent	independent	JJ	I-NP	O
prognostic	prognostic	JJ	I-NP	O
factor	factor	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
0.0260	0.0260	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

TLR5	TLR5	NN	B-NP	B-protein
specificity	specificity	NN	I-NP	O
was	be	VBD	B-VP	O
confirmed	confirm	VBN	I-VP	O
by	by	IN	B-PP	O
Western	Western	JJ	B-NP	O
blot	blot	NN	I-NP	O
analysis	analysis	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
provides	provide	VBZ	B-VP	O
evidence	evidence	NN	B-NP	O
that	that	IN	B-SBAR	O
immunohistochemically	immunohistochemically	RB	B-NP	O
detected	detect	VBN	I-NP	O
HP	HP	NN	I-NP	O
expression	expression	NN	I-NP	O
in	in	IN	B-PP	O
OSCC	OSCC	NN	B-NP	O
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
reduced	reduce	VBN	B-NP	O
disease-free	disease-free	JJ	I-NP	O
survival	survival	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
patient	patient	NN	I-NP	O
cohort	cohort	NN	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
TLR5	TLR5	NN	B-NP	B-protein
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
any	any	DT	B-NP	O
clinicopathological	clinicopathological	JJ	I-NP	O
characteristics	characteristic	NNS	I-NP	O
or	or	CC	I-NP	O
impact	impact	NN	I-NP	O
on	on	IN	B-PP	O
survival	survival	NN	B-NP	O
,	,	,	O	O
investigation	investigation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
TLR	TLR	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
seems	seem	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
reasonable	reasonable	JJ	B-ADJP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
possible	possible	JJ	I-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
pathogenic	pathogenic	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
or	or	CC	I-NP	O
viral	viral	JJ	I-NP	O
compounds	compound	NNS	I-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
cavity	cavity	NN	I-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
paucity	paucity	NN	I-NP	O
of	of	IN	B-PP	O
data	datum	NNS	B-NP	O
in	in	IN	B-PP	O
relation	relation	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
possible	possible	JJ	I-NP	O
emergence	emergence	NN	I-NP	O
of	of	IN	B-PP	O
triclosan	triclosan	NN	B-NP	O
(	(	(	O	O
TCS	TCS	NN	B-NP	O
)	)	)	O	O
-resistant	-resistant	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
following	follow	VBG	B-PP	O
long-term	long-term	JJ	B-NP	O
exposure	exposure	NN	I-NP	O
to	to	TO	B-PP	O
TCS	TCS	NN	B-NP	O
toothpaste	toothpaste	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
investigated	investigate	VBD	B-VP	O
whether	whether	IN	B-SBAR	O
long-term	long-term	JJ	B-NP	O
continuous	continuous	JJ	I-NP	O
exposure	exposure	NN	I-NP	O
to	to	TO	B-PP	O
TCS	TCS	NN	B-NP	B-protein
in	in	IN	B-PP	O
toothpaste	toothpaste	NN	B-NP	O
selects	select	VBZ	B-VP	O
for	for	IN	B-PP	O
TCS-resistant	TCS-resistant	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
biofilm	biofilm	NN	I-NP	O
.	.	.	O	O

Dental	Dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
from	from	IN	B-PP	O
40	40	CD	B-NP	O
individuals	individual	NNS	I-NP	O
during	during	IN	B-PP	O
year	year	NN	B-NP	O
5	5	CD	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
randomised	randomise	VBN	I-NP	O
controlled	control	VBN	I-NP	O
trial	trial	NN	I-NP	O
.	.	.	O	O

Participants	Participant	NNS	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
randomly	randomly	RB	I-VP	O
assigned	assign	VBN	I-VP	O
to	to	TO	I-VP	O
use	use	VB	I-VP	O
TCS	TCS	NN	B-NP	B-protein
(	(	(	O	O
3000	3000	CD	B-NP	O
mug/mL	mug/mL	NN	I-NP	O
TCS	TCS	NN	I-NP	O
)	)	)	O	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
18	18	CD	B-NP	O
)	)	)	O	O
or	or	CC	O	O
placebo	placebo	NN	B-NP	O
toothpaste	toothpaste	NN	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
22	22	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Diluted	Dilute	VBN	B-NP	O
plaque	plaque	NN	I-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
plated	plat	VBN	I-VP	O
on	on	RP	B-PRT	O
to	to	TO	B-PP	O
Wilkins-Chalgren	Wilkins-Chalgren	JJ	B-NP	O
agar	agar	NN	I-NP	O
plates	plate	NNS	I-NP	O
containing	contain	VBG	B-VP	O
5	5	CD	B-NP	O
%	%	NN	I-NP	O
(	(	(	O	O
v/v	v/v	NN	B-NP	O
)	)	)	O	O
laked	lake	VBD	B-VP	O
sheep	sheep	NN	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
TCS	TCS	NN	B-NP	B-cell_type
(	(	(	O	O
concentrations	concentration	NNS	B-NP	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
25	25	CD	B-NP	O
to	to	TO	I-NP	O
150	150	CD	I-NP	O
mug/mL	mug/mL	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
incubated	incubate	VBN	B-VP	O
at	at	IN	B-PP	O
37	37	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
under	under	IN	B-PP	O
microaerophilic	microaerophilic	JJ	B-NP	O
and	and	CC	I-NP	O
anaerobic	anaerobic	JJ	I-NP	O
conditions	condition	NNS	I-NP	O
for	for	IN	B-PP	O
2-10	2-10	CD	B-NP	O
d.	d.	NN	I-NP	O
Selected	Select	VBN	B-VP	O
bacterial	bacterial	JJ	B-NP	O
isolates	isolate	NNS	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
by	by	IN	B-PP	O
partial	partial	JJ	B-NP	O
16S	16S	NN	I-NP	O
rDNA	rDNA	NN	I-NP	O
sequencing	sequencing	NN	I-NP	O
and	and	CC	I-NP	O
TCS	TCS	NN	I-NP	O
minimum	minimum	NN	I-NP	O
inhibitory	inhibitory	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
(	(	(	O	O
MIC	MIC	NN	B-NP	O
)	)	)	O	O
determined	determine	VBN	B-VP	O
for	for	IN	B-PP	O
each	each	DT	B-NP	O
isolate	isolate	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
3000	3000	CD	B-NP	O
mug/mL	mug/mL	NN	I-NP	O
TCS	TCS	VBZ	B-VP	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
under	under	IN	B-PP	O
microaerophilic	microaerophilic	JJ	B-NP	O
or	or	CC	I-NP	O
anaerobic	anaerobic	JJ	I-NP	O
conditions	condition	NNS	I-NP	O
in	in	IN	B-PP	O
either	either	DT	B-NP	O
group	group	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
MICs	MIC	NNS	I-NP	O
of	of	IN	B-PP	O
TCS	TCS	NN	B-NP	B-protein
for	for	IN	B-PP	O
all	all	DT	B-NP	O
isolates	isolate	NNS	I-NP	O
ranged	range	VBD	B-VP	O
from	from	IN	B-PP	O
125	125	CD	B-NP	O
to	to	TO	I-NP	O
1000	1000	CD	I-NP	O
mug/mL	mug/mL	NN	I-NP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

Species	Specie	NNS	B-NP	O
common	common	JJ	B-ADJP	O
to	to	TO	B-PP	O
both	both	DT	B-NP	O
groups	group	NNS	I-NP	O
had	have	VBD	B-VP	O
similar	similar	JJ	B-NP	O
MICs	MIC	NNS	I-NP	O
.	.	.	O	O

Veillonella	Veillonella	NN	B-NP	O
parvula	parvula	NN	I-NP	O
and	and	CC	I-NP	O
Campylobacter	Campylobacter	NN	I-NP	O
gracilis	gracili	NNS	I-NP	O
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
frequent	frequent	JJ	I-NP	O
isolates	isolate	NNS	I-NP	O
from	from	IN	B-PP	O
both	both	DT	B-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
similar	similar	JJ	B-NP	O
MICs	MIC	NNS	I-NP	O
in	in	IN	B-PP	O
both	both	DT	B-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
TCS-containing	TCS-containing	JJ	B-NP	O
toothpaste	toothpaste	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
appear	appear	VB	I-VP	O
to	to	TO	I-VP	O
lead	lead	VB	I-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
MIC	MIC	NN	B-NP	O
of	of	IN	B-PP	O
TCS	TCS	NN	B-NP	B-protein
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
isolates	isolate	NNS	I-NP	O
.	.	.	O	O

Molecular	Molecular	JJ	B-NP	O
biological	biological	JJ	I-NP	O
modalities	modality	NNS	I-NP	O
with	with	IN	B-PP	O
better	good	JJR	B-NP	O
detection	detection	NN	I-NP	O
rates	rate	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
applied	apply	VBN	I-VP	O
to	to	TO	I-VP	O
identify	identify	VB	I-VP	O
the	the	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
causing	cause	VBG	B-VP	O
infectious	infectious	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

Approximately	Approximately	RB	B-NP	O
10-48	10-48	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
pathogens	pathogen	NNS	I-NP	O
causing	cause	VBG	B-VP	O
community-acquired	community-acquired	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
identified	identify	VBN	I-VP	O
using	use	VBG	B-VP	O
conventional	conventional	JJ	B-NP	O
cultivation	cultivation	NN	I-NP	O
methods	method	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
evaluated	evaluate	VBD	B-VP	O
the	the	DT	B-NP	O
bacteriological	bacteriological	JJ	I-NP	O
causes	cause	NNS	I-NP	O
of	of	IN	B-PP	O
community-acquired	community-acquired	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
cultivation-independent	cultivation-independent	JJ	I-NP	O
clone	clone	NN	I-NP	O
library	library	NN	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
16S	16S	NN	I-NP	B-DNA
ribosomal	ribosomal	JJ	I-NP	I-DNA
RNA	RNA	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
of	of	IN	B-PP	O
bronchoalveolar	bronchoalveolar	JJ	B-NP	O
lavage	lavage	NN	I-NP	O
specimens	specimen	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
compared	compare	VBD	B-VP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
with	with	IN	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
conventional	conventional	JJ	B-NP	O
cultivation	cultivation	NN	I-NP	O
methods	method	NNS	I-NP	O
.	.	.	O	O

Patients	Patient	NNS	B-NP	O
with	with	IN	B-PP	O
community-acquired	community-acquired	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
were	be	VBD	B-VP	O
enrolled	enrol	VBN	I-VP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
their	their	PRP$	B-NP	O
clinical	clinical	JJ	I-NP	O
and	and	CC	I-NP	O
radiological	radiological	JJ	I-NP	O
findings	finding	NNS	I-NP	O
.	.	.	O	O

Bronchoalveolar	Bronchoalveolar	JJ	B-NP	O
lavage	lavage	NN	I-NP	O
specimens	specimen	NNS	I-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
from	from	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
pathological	pathological	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
using	use	VBG	B-VP	O
bronchoscopy	bronchoscopy	NN	B-NP	O
and	and	CC	O	O
evaluated	evaluate	VBN	B-VP	O
by	by	IN	B-PP	O
both	both	CC	O	O
a	a	DT	B-NP	O
culture-independent	culture-independent	JJ	I-NP	O
molecular	molecular	JJ	I-NP	O
method	method	NN	I-NP	O
and	and	CC	O	O
conventional	conventional	JJ	B-NP	O
cultivation	cultivation	NN	I-NP	O
methods	method	NNS	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
the	the	DT	B-NP	O
culture-independent	culture-independent	JJ	I-NP	O
molecular	molecular	JJ	I-NP	O
method	method	NN	I-NP	O
,	,	,	O	O
approximately	approximately	RB	B-NP	O
600	600	CD	I-NP	O
base	base	NN	I-NP	O
pairs	pair	NNS	I-NP	O
of	of	IN	B-PP	O
16S	16S	NN	B-NP	B-DNA
ribosomal	ribosomal	JJ	I-NP	I-DNA
RNA	RNA	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
were	be	VBD	B-VP	O
amplified	amplify	VBN	I-VP	O
using	use	VBG	B-VP	O
polymerase	polymerase	NN	B-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
with	with	IN	B-PP	O
universal	universal	JJ	B-NP	O
primers	primer	NNS	I-NP	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
construction	construction	NN	I-NP	O
of	of	IN	B-PP	O
clone	clone	NN	B-NP	B-DNA
libraries	library	NNS	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
nucleotide	nucleotide	NN	I-NP	B-DNA
sequences	sequence	NNS	I-NP	I-DNA
of	of	IN	B-PP	O
96	96	CD	B-NP	O
clones	clone	NNS	I-NP	O
randomly	randomly	RB	B-VP	O
chosen	choose	VBN	I-VP	O
for	for	IN	B-PP	O
each	each	DT	B-NP	O
specimen	specimen	NN	I-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
bacterial	bacterial	JJ	B-NP	O
homology	homology	NN	I-NP	O
was	be	VBD	B-VP	O
searched	search	VBN	I-VP	O
.	.	.	O	O

Conventional	Conventional	JJ	B-NP	O
cultivation	cultivation	NN	I-NP	O
methods	method	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
cultures	culture	NNS	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
performed	perform	VBN	I-VP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
specimens	specimen	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
known	know	VBN	B-NP	O
common	common	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
of	of	IN	B-PP	O
community-acquired	community-acquired	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
[	[	(	O	O
Streptococcus	Streptococcus	FW	B-NP	O
pneumoniae	pneumoniae	FW	I-NP	O
(	(	(	O	O
18.8	18.8	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Haemophilus	Haemophilus	NN	B-NP	O
influenzae	influenzae	NNS	I-NP	O
(	(	(	O	O
18.8	18.8	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Mycoplasma	Mycoplasma	NN	B-NP	O
pneumoniae	pneumoniae	FW	I-NP	O
(	(	(	O	O
17.2	17.2	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
]	]	)	O	O
,	,	,	O	O
molecular	molecular	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
specimens	specimen	NNS	B-NP	O
from	from	IN	B-PP	O
64	64	CD	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
community-acquired	community-acquired	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
showed	show	VBD	B-VP	O
relatively	relatively	RB	B-NP	O
higher	high	JJR	I-NP	O
rates	rate	NNS	I-NP	O
of	of	IN	B-PP	O
anaerobes	anaerobe	NNS	B-NP	O
(	(	(	O	O
15.6	15.6	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
(	(	(	O	O
15.6	15.6	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
than	than	IN	B-PP	O
previous	previous	JJ	B-NP	O
reports	report	NNS	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
findings	finding	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
anaerobes	anaerobe	NNS	B-NP	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
are	be	VBP	B-VP	O
more	more	RBR	I-VP	O
frequently	frequently	RB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
community-acquired	community-acquired	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
than	than	IN	B-SBAR	O
previously	previously	RB	B-ADVP	O
believed	believe	VBN	B-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
possible	possible	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
may	may	MD	B-VP	O
play	play	VB	I-VP	O
more	more	RBR	B-NP	O
important	important	JJ	I-NP	O
roles	role	NNS	I-NP	O
in	in	IN	B-PP	O
community-acquired	community-acquired	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
aimed	aim	VBD	B-VP	O
to	to	TO	I-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
diversity	diversity	NN	I-NP	O
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
oral	oral	JJ	I-NP	O
micro-niches	micro-nich	NNS	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
whether	whether	IN	B-SBAR	O
saliva	saliva	NN	B-NP	O
and	and	CC	I-NP	O
plaque	plaque	NN	I-NP	O
samples	sample	NNS	I-NP	O
are	be	VBP	B-VP	O
representative	representative	JJ	B-ADJP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
microbial	microbial	JJ	I-NP	O
composition	composition	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
took	take	VBD	B-VP	O
minute	minute	NN	B-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
each	each	DT	B-NP	O
surface	surface	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
individual	individual	JJ	I-NP	O
teeth	tooth	NNS	I-NP	O
and	and	CC	O	O
gingival	gingival	JJ	B-NP	O
crevices	crevice	NNS	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
volunteers	volunteer	NNS	I-NP	O
(	(	(	O	O
112	112	CD	B-NP	O
samples	sample	NNS	I-NP	O
per	per	IN	B-PP	O
donor	donor	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
samples	sample	NNS	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
tongue	tongue	NN	I-NP	O
dorsum	dorsum	NN	I-NP	O
and	and	CC	O	O
non-stimulated	non-stimulated	JJ	B-NP	O
and	and	CC	I-NP	O
stimulated	stimulate	VBN	I-NP	O
saliva	saliva	NN	I-NP	O
.	.	.	O	O

DNA	DNA	NN	B-NP	O
was	be	VBD	B-VP	O
extracted	extract	VBN	I-VP	O
from	from	IN	B-PP	O
67	67	CD	B-NP	O
selected	select	VBN	I-NP	O
samples	sample	NNS	I-NP	O
of	of	IN	B-PP	O
each	each	DT	B-NP	O
donor	donor	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
16S	16S	NN	I-NP	B-DNA
rRNA	rRNA	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
amplified	amplify	VBN	I-VP	O
by	by	IN	B-PP	O
PCR	PCR	NN	B-NP	O
and	and	CC	O	O
pyrosequenced	pyrosequence	VBN	B-VP	O
to	to	TO	B-VP	O
obtain	obtain	VB	I-VP	O
,	,	,	O	O
on	on	IN	B-PP	O
average	average	NN	B-NP	O
,	,	,	O	O
over	over	IN	B-PP	O
2,700	2,700	CD	B-NP	O
reads	read	NNS	I-NP	O
per	per	IN	B-PP	O
sample	sample	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
taxonomically	taxonomically	RB	I-VP	O
assigned	assign	VBN	I-VP	O
to	to	TO	B-VP	O
obtain	obtain	VB	I-VP	O
a	a	DT	B-NP	O
geographic	geographic	JJ	I-NP	O
map	map	NN	I-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
diversity	diversity	NN	I-NP	O
at	at	IN	B-PP	O
each	each	DT	B-NP	O
tooth	tooth	NN	I-NP	O
and	and	CC	I-NP	O
sulcus	sulcus	NN	I-NP	O
location	location	NN	I-NP	O
.	.	.	O	O

Analysis	Analysis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
data	data	NN	I-NP	O
shows	show	VBZ	B-VP	O
considerable	considerable	JJ	B-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
composition	composition	NN	I-NP	O
between	between	IN	B-PP	O
teeth	tooth	NNS	B-NP	O
at	at	IN	B-PP	O
different	different	JJ	B-NP	O
intra-oral	intra-oral	JJ	I-NP	O
locations	location	NNS	I-NP	O
and	and	CC	B-PP	O
between	between	IN	B-PP	O
surfaces	surface	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
tooth	tooth	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
most	most	RBS	I-NP	O
pronounced	pronounced	JJ	I-NP	O
differences	difference	NNS	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
incisors	incisor	NNS	B-NP	O
and	and	CC	I-NP	O
canines	canine	NNS	I-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
genera	genera	NN	B-NP	O
like	like	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
at	at	IN	B-PP	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	I-NP	O
70	70	CD	I-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
vestibular	vestibular	JJ	I-NP	O
surfaces	surface	NNS	I-NP	O
but	but	CC	O	O
were	be	VBD	B-VP	O
almost	almost	RB	B-ADJP	O
absent	absent	JJ	I-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
lingual	lingual	JJ	I-NP	O
sides	side	NNS	I-NP	O
.	.	.	O	O

Saliva	Saliva	NN	B-NP	O
samples	sample	NNS	I-NP	O
,	,	,	O	O
especially	especially	RB	B-NP	O
non-stimulated	non-stimulated	JJ	I-NP	O
saliva	saliva	NN	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
not	not	RB	O	O
representative	representative	JJ	B-ADJP	O
of	of	IN	B-PP	O
supra-and	supra-and	JJ	B-NP	O
subgingival	subgingival	JJ	I-NP	O
plaque	plaque	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
individuals	individual	NNS	I-NP	O
tested	test	VBN	B-VP	O
.	.	.	O	O

We	We	PRP	B-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
more	more	RBR	B-NP	O
precise	precise	JJ	I-NP	O
sampling	sampling	NN	I-NP	O
is	be	VBZ	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
proper	proper	JJ	I-NP	O
determination	determination	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
microbial	microbial	JJ	I-NP	O
composition	composition	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
relate	relate	VB	I-VP	O
that	that	DT	B-NP	O
diversity	diversity	NN	I-NP	O
to	to	TO	B-PP	O
epidemiological	epidemiological	JJ	B-NP	O
,	,	,	I-NP	O
clinical	clinical	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
etiological	etiological	JJ	B-NP	O
parameters	parameter	NNS	I-NP	O
.	.	.	O	O

Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
can	can	MD	B-VP	O
aggravate	aggravate	VB	I-VP	O
colitis	colitis	NN	B-NP	O
in	in	IN	B-PP	O
mice	mouse	NNS	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
evaluated	evaluate	VBD	B-VP	O
the	the	DT	B-NP	O
virulence	virulence	NN	I-NP	O
of	of	IN	B-PP	O
colitis	colitis	NN	B-NP	O
using	use	VBG	B-VP	O
type	type	NN	B-NP	O
strains	strain	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
blood	blood	NN	B-NP	O
isolates	isolate	NNS	I-NP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
oral	oral	JJ	I-NP	O
streptococcal	streptococcal	JJ	I-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
susceptibility	susceptibility	NN	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
isolates	isolate	NNS	I-NP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
oral	oral	JJ	I-NP	O
streptococci	streptococci	NNS	I-NP	O
to	to	TO	B-PP	O
phagocytosis	phagocytosis	NN	B-NP	O
,	,	,	O	O
adhesion	adhesion	NN	B-NP	O
to	to	TO	B-PP	O
and	and	CC	O	O
invasion	invasion	NN	B-NP	O
of	of	IN	B-PP	O
hepatic	hepatic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
interferon-gamma	interferon-gamma	NN	B-NP	B-protein
secretion	secretion	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
mouse	mouse	NN	I-NP	O
model	model	NN	I-NP	O
of	of	IN	B-PP	O
dextran	dextran	NN	B-NP	O
sodium	sodium	NN	I-NP	O
sulphate-induced	sulphate-induced	JJ	I-NP	O
colitis	colitis	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
bacterial	bacterial	JJ	B-NP	O
aggravation	aggravation	NN	I-NP	O
of	of	IN	B-PP	O
colitis	colitis	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
interferon-gamma	interferon-gamma	NN	B-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
was	be	VBD	B-VP	O
administered	administer	VBN	I-VP	O
to	to	TO	B-PP	O
mice	mouse	NNS	B-NP	O
with	with	IN	B-PP	O
prominent	prominent	JJ	B-NP	O
aggravation	aggravation	NN	I-NP	O
of	of	IN	B-PP	O
colitis	colitis	NN	B-NP	O
.	.	.	O	O

In	In	FW	B-NP	O
vitro	vitro	FW	I-NP	O
analyses	analysis	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
Streptococcus	Streptococcus	NNP	B-NP	O
sanguinis	sanguinis	NNP	I-NP	O
ATCC	ATCC	NN	I-NP	O
10556	10556	CD	I-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
virulent	virulent	JJ	I-NP	O
strain	strain	NN	I-NP	O
among	among	IN	B-PP	O
type	type	NN	B-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
oral	oral	JJ	I-NP	O
streptococci	streptococci	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
analysis	analysis	NN	B-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
isolates	isolate	NNS	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
sanguinis	sanguinis	NNP	I-NP	O
TW289	TW289	NNP	I-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
virulent	virulent	JJ	I-NP	O
strain	strain	NN	I-NP	O
.	.	.	O	O

Intravenous	Intravenous	JJ	B-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
ATCC	ATCC	NN	B-NP	O
10556	10556	CD	I-NP	O
and	and	CC	O	O
TW289	TW289	NN	B-NP	O
caused	cause	VBD	B-VP	O
prominent	prominent	JJ	B-NP	O
aggravation	aggravation	NN	I-NP	O
of	of	IN	B-PP	O
dextran	dextran	NN	B-NP	O
sodium	sodium	NN	I-NP	O
sulphate-induced	sulphate-induced	JJ	I-NP	O
colitis	colitis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
histopathological	histopathological	JJ	B-NP	O
examinations	examination	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
interferon-gamma	interferon-gamma	NN	B-NP	B-protein
secretion	secretion	NN	I-NP	O
due	due	IN	B-PP	O
to	to	TO	I-PP	O
infection	infection	NN	B-NP	O
of	of	IN	B-PP	O
hepatic	hepatic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
caused	cause	VBD	B-VP	O
colitis	colitis	NN	B-NP	O
aggravation	aggravation	NN	I-NP	O
.	.	.	O	O

Administration	Administration	NN	B-NP	O
of	of	IN	B-PP	O
interferon-gamma	interferon-gamma	NN	B-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
suppressed	suppress	VBD	B-VP	O
TW289-induced	TW289-induced	JJ	B-NP	O
colitis	colitis	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
some	some	DT	B-NP	O
virulent	virulent	JJ	I-NP	O
oral	oral	JJ	I-NP	O
streptococcal	streptococcal	JJ	I-NP	O
strains	strain	NNS	I-NP	O
are	be	VBP	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
aggravation	aggravation	NN	I-NP	O
of	of	IN	B-PP	O
colitis	colitis	NN	B-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
enhanced	enhance	VBN	B-NP	O
secretion	secretion	NN	I-NP	O
of	of	IN	B-PP	O
interferon-gamma	interferon-gamma	NN	B-NP	B-protein
when	when	WRB	B-ADVP	O
they	they	PRP	B-NP	O
invade	invade	VBP	B-VP	O
the	the	DT	B-NP	O
bloodstream	bloodstream	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
introduced	introduce	VBD	B-VP	O
species-specific	species-specific	JJ	B-NP	O
quantitative	quantitative	JJ	I-NP	O
real-time	real-time	JJ	I-NP	O
PCR	PCR	NN	I-NP	O
(	(	(	O	O
qPCR	qPCR	NN	B-NP	O
)	)	)	O	O
primers	primer	NNS	B-NP	O
designed	design	VBN	B-VP	O
based	base	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
DNA-dependent	DNA-dependent	JJ	I-NP	B-DNA
RNA	RNA	NN	I-NP	I-DNA
polymerase	polymerase	NN	I-NP	I-DNA
beta-subunit	beta-subunit	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
(	(	(	O	O
rpoB	rpoB	NN	B-NP	B-DNA
)	)	)	O	O
for	for	IN	B-PP	O
detecting	detect	VBG	B-VP	O
42	42	CD	B-NP	O
oral	oral	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
specificity	specificity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
qPCR	qPCR	NN	I-NP	B-DNA
primers	primer	NNS	I-NP	I-DNA
was	be	VBD	B-VP	O
confirmed	confirm	VBN	I-VP	O
by	by	IN	B-PP	O
conventional	conventional	JJ	B-NP	O
PCR	PCR	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
genomic	genomic	JJ	I-NP	B-DNA
DNAs	DNA	NNS	I-NP	I-DNA
of	of	IN	B-PP	O
73-79	73-79	CD	B-NP	O
strains	strain	NNS	I-NP	O
regarding	regard	VBG	B-VP	O
73-75	73-75	CD	B-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
type	type	NN	I-NP	O
strain	strain	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
target	target	NN	I-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
standard	standard	JJ	I-NP	O
curves	curve	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
detection	detection	NN	I-NP	O
limits	limit	NNS	I-NP	O
of	of	IN	B-PP	O
42	42	CD	B-NP	O
bacterial	bacterial	JJ	I-NP	O
species-specific	species-specific	JJ	I-NP	O
qPCR	qPCR	NN	I-NP	O
primers	primer	NNS	I-NP	O
ranged	range	VBD	B-VP	O
from	from	IN	B-PP	O
4	4	CD	B-NP	O
to	to	TO	I-NP	O
40	40	CD	I-NP	O
fg	fg	NN	I-NP	O
below	below	IN	B-PP	O
a	a	DT	B-NP	O
cycle	cycle	NN	I-NP	O
threshold	threshold	NN	I-NP	O
(	(	(	O	O
C	C	NN	B-NP	O
T	T	NN	I-NP	O
)	)	)	O	O
value	value	NN	B-NP	O
of	of	IN	B-PP	O
35	35	CD	B-NP	O
,	,	,	O	O
except	except	IN	B-PP	O
Atopobium	Atopobium	NNP	B-NP	O
rimae	rimae	NNP	I-NP	O
,	,	,	O	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
,	,	,	O	O
Neisseria	Neisseria	NNP	B-NP	O
meningitidis	meningitidis	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Porphyromonas	Porphyromonas	NN	B-NP	O
asaccharolytica	asaccharolytica	NN	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
400	400	CD	B-NP	O
fg	fg	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
42	42	CD	B-NP	O
bacterial	bacterial	JJ	I-NP	O
species-specific	species-specific	JJ	I-NP	O
qPCR	qPCR	NN	I-NP	O
primers	primer	NNS	I-NP	O
are	be	VBP	B-VP	O
suitable	suitable	JJ	B-ADJP	O
for	for	IN	B-PP	O
applications	application	NNS	B-NP	O
in	in	IN	B-PP	O
epidemiological	epidemiological	JJ	B-NP	O
studies	study	NNS	I-NP	O
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
infectious	infectious	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
periodontal	periodontal	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
,	,	,	O	O
endodontic	endodontic	JJ	B-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
health	health	NN	I-NP	O
is	be	VBZ	B-VP	O
influenced	influence	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
's	's	POS	B-NP	O
resident	resident	JJ	I-NP	O
microorganisms	microorganism	NNS	I-NP	O
.	.	.	O	O

Dental	Dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
and	and	CC	O	O
periodontitis	periodontitis	NN	B-NP	O
are	be	VBP	B-VP	O
oral	oral	JJ	B-NP	O
disorders	disorder	NNS	I-NP	O
caused	cause	VBN	B-VP	O
by	by	IN	B-PP	O
imbalances	imbalance	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
.	.	.	O	O

Probiotics	Probiotic	NNS	B-NP	O
have	have	VBP	B-VP	O
potential	potential	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
prevention	prevention	NN	I-NP	O
and	and	CC	I-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
disorders	disorder	NNS	I-NP	O
.	.	.	O	O

Current	Current	JJ	B-NP	O
formulations	formulation	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
supplements	supplement	NNS	B-NP	O
and	and	CC	I-NP	O
foods	food	NNS	I-NP	O
,	,	,	O	O
have	have	VBP	B-VP	O
limitations	limitation	NNS	B-NP	O
for	for	IN	B-PP	O
oral	oral	JJ	B-NP	O
delivery	delivery	NN	I-NP	O
including	include	VBG	B-PP	O
short	short	JJ	B-NP	O
storage	storage	NN	I-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
residence	residence	NN	I-NP	O
time	time	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
,	,	,	O	O
effects	effect	NNS	B-NP	O
on	on	IN	B-PP	O
food	food	NN	B-NP	O
consistency	consistency	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
low	low	JJ	B-NP	O
patient	patient	NN	I-NP	O
compliance	compliance	NN	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
thin	thin	JJ	I-NP	O
films	film	NNS	I-NP	O
(	(	(	O	O
OTFs	OTF	NNS	B-NP	B-protein
)	)	)	O	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
efficient	efficient	JJ	B-ADJP	O
in	in	IN	B-PP	O
delivering	deliver	VBG	B-VP	O
probiotics	probiotic	NNS	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
research	research	NN	I-NP	O
aims	aim	VBZ	B-VP	O
to	to	TO	I-VP	O
develop	develop	VB	I-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
carboxymethyl	carboxymethyl	NN	I-NP	B-protein
cellulose	cellulose	NN	I-NP	I-protein
(	(	(	O	I-protein
CMC	CMC	NN	B-NP	I-protein
)	)	)	O	I-protein
-probiotic-OTF	-probiotic-OTF	NN	B-NP	I-protein
to	to	TO	B-VP	O
deliver	deliver	VB	I-VP	O
probiotics	probiotic	NNS	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
treatment/prevention	treatment/prevention	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
disorders	disorder	NNS	I-NP	O
.	.	.	O	O

CMC-OTFs	CMC-OTF	NNS	B-NP	B-protein
were	be	VBD	B-VP	O
developed	develop	VBN	I-VP	O
with	with	IN	B-PP	O
varying	vary	VBG	B-VP	O
CMC	CMC	NN	B-NP	O
concentration	concentration	NN	I-NP	O
(	(	(	O	O
1.25	1.25	CD	B-NP	O
-	-	HYPH	I-NP	O
10	10	CD	I-NP	O
mg/mL	mg/mL	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
weight	weight	NN	B-NP	O
(	(	(	O	O
5	5	CD	B-NP	O
-	-	HYPH	I-NP	O
40	40	CD	I-NP	O
g	g	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
thickness	thickness	NN	B-NP	O
(	(	(	O	O
16	16	CD	B-NP	O
-	-	HYPH	I-NP	O
262	262	CD	I-NP	O
mum	mum	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
hygroscopicity	hygroscopicity	NN	B-NP	O
(	(	(	O	O
30.8	30.8	CD	B-NP	O
-	-	HYPH	I-NP	O
78.9	78.9	CD	I-NP	O
mg/cm	mg/cm	NN	I-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
film	film	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
dissolving	dissolve	VBG	B-VP	O
time	time	NN	B-NP	O
(	(	(	O	O
135	135	CD	B-NP	O
-	-	HYPH	I-NP	O
600	600	CD	I-NP	O
s	s	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
10	10	CD	I-NP	O
g	g	NN	I-NP	O
5	5	CD	I-NP	O
mg/mL	mg/mL	NN	I-NP	O
CMC-OTF	CMC-OTF	NN	I-NP	O
was	be	VBD	B-VP	O
selected	select	VBN	I-VP	O
and	and	CC	O	O
used	use	VBN	B-VP	O
to	to	TO	B-VP	O
incorporate	incorporate	VB	I-VP	O
Lactobacillus	Lactobacillus	NN	B-NP	O
fermentum	fermentum	NN	I-NP	O
NCIMB	NCIMB	NN	I-NP	O
5221	5221	CD	I-NP	O
(	(	(	O	O
6.75	6.75	CD	B-NP	O
x	x	CC	I-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
8	8	CD	B-NP	O
)	)	)	O	O
cells/film	cells/film	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
a	a	DT	B-NP	O
probiotic	probiotic	NN	I-NP	O
with	with	IN	B-PP	O
anti-inflammatory	anti-inflammatory	JJ	B-NP	O
potential	potential	NN	I-NP	O
for	for	IN	B-PP	O
periodontitis	periodontitis	NN	B-NP	O
treatment	treatment	NN	I-NP	O
and	and	CC	O	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
inhibiting	inhibit	VBG	B-VP	O
microorganisms	microorganism	NNS	B-NP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
candidiasis	candidiasis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
CMC-OTF	CMC-OTF	NN	I-NP	B-protein
maintained	maintain	VBD	B-VP	O
probiotic	probiotic	JJ	B-NP	O
viability	viability	NN	I-NP	O
and	and	CC	O	O
antioxidant	antioxidant	JJ	B-NP	O
activity	activity	NN	I-NP	O
following	follow	VBG	B-PP	O
150	150	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
storage	storage	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
549.52	549.52	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
26.08	26.08	CD	I-NP	O
muM	muM	NN	I-NP	O
Trolox	Trolox	NN	I-NP	O
equivalents	equivalent	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
research	research	NN	I-NP	O
shows	show	VBZ	B-VP	O
the	the	DT	B-NP	O
successful	successful	JJ	I-NP	O
development	development	NN	I-NP	O
and	and	CC	O	O
characterization	characterization	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
probiotic-CMC-OTF	probiotic-CMC-OTF	NN	I-NP	O
with	with	IN	B-PP	O
potential	potential	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
oral	oral	JJ	I-NP	O
health	health	NN	I-NP	O
biotherapeutic	biotherapeutic	JJ	B-ADJP	O
.	.	.	O	O

Coeliac	Coeliac	JJ	B-NP	O
disease	disease	NN	I-NP	O
is	be	VBZ	B-VP	O
characterized	characterize	VBN	I-VP	O
by	by	IN	B-PP	O
intestinal	intestinal	JJ	B-NP	O
inflammation	inflammation	NN	I-NP	O
caused	cause	VBN	B-VP	O
by	by	IN	B-PP	O
gluten	gluten	NN	B-NP	B-protein
,	,	,	O	I-protein
proteins	protein	NNS	B-NP	I-protein
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
widely	widely	RB	I-VP	O
contained	contain	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Western	Western	JJ	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Mammalian	Mammalian	JJ	B-NP	B-protein
digestive	digestive	JJ	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
only	only	RB	B-ADVP	O
partly	partly	RB	B-ADJP	O
capable	capable	JJ	I-ADJP	O
of	of	IN	B-PP	O
cleaving	cleave	VBG	B-VP	O
gluten	gluten	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
fragments	fragment	NNS	B-NP	O
remain	remain	VBP	B-VP	O
that	that	WDT	B-NP	O
induce	induce	VBP	B-VP	O
toxic	toxic	JJ	B-NP	O
responses	response	NNS	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
coeliac	coeliac	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	B-DNA
microbiome	microbiome	NN	I-NP	I-DNA
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
and	and	CC	I-NP	O
rich	rich	JJ	I-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
gluten-degrading	gluten-degrading	JJ	B-NP	O
organisms	organism	NNS	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
report	report	VBP	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
isolation	isolation	NN	I-NP	O
and	and	CC	I-NP	O
characterization	characterization	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cultivable	cultivable	JJ	I-NP	O
resident	resident	JJ	I-NP	O
oral	oral	JJ	I-NP	O
microbes	microbe	NNS	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
cleaving	cleave	VBG	B-VP	O
gluten	gluten	NN	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
special	special	JJ	B-NP	O
emphasis	emphasis	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
immunogenic	immunogenic	JJ	I-NP	B-protein
domains	domain	NNS	I-NP	I-protein
.	.	.	O	O

Bacteria	Bacteria	NNS	B-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
selective	selective	JJ	I-NP	O
culturing	culturing	NN	I-NP	O
approach	approach	NN	I-NP	O
and	and	CC	I-NP	O
enzyme	enzyme	NN	I-NP	O
activities	activity	NNS	I-NP	O
were	be	VBD	B-VP	O
characterized	characterize	VBN	I-VP	O
by	by	IN	B-PP	O
:	:	:	O	O
(	(	(	B-LST	O
i	i	LS	I-LST	O
)	)	)	O	O
hydrolysis	hydrolysis	NN	B-NP	O
of	of	IN	B-PP	O
paranitroanilide-derivatized	paranitroanilide-derivatized	JJ	B-NP	B-protein
gliadin-derived	gliadin-derived	JJ	I-NP	I-protein
tripeptide	tripeptide	NN	I-NP	I-protein
substrates	substrate	NNS	I-NP	I-protein
;	;	:	O	O
(	(	(	B-LST	O
ii	ii	LS	I-LST	O
)	)	)	O	O
gliadin	gliadin	NN	B-NP	O
degradation	degradation	NN	I-NP	O
in-gel	in-gel	NN	I-NP	O
(	(	(	O	O
gliadin	gliadin	NN	B-NP	O
zymography	zymography	NN	I-NP	O
)	)	)	O	O
;	;	:	O	O
(	(	(	B-LST	O
iii	iii	LS	I-LST	O
)	)	)	O	O
gliadin	gliadin	NN	B-NP	O
degradation	degradation	NN	I-NP	O
in	in	IN	B-PP	O
solution	solution	NN	B-NP	O
;	;	:	O	O
(	(	(	B-LST	O
iv	iv	LS	I-LST	O
)	)	)	O	O
proteolysis	proteolysis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
highly	highly	RB	I-NP	O
immunogenic	immunogenic	JJ	I-NP	O
alpha-gliadin-derived	alpha-gliadin-derived	JJ	I-NP	O
33-mer	33-mer	NN	I-NP	O
peptide	peptide	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
selected	select	VBN	B-NP	O
strains	strain	NNS	I-NP	O
pH	pH	NN	I-NP	O
activity	activity	NN	I-NP	O
profiles	profile	NNS	I-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
culturing	culture	VBG	I-NP	O
strategy	strategy	NN	I-NP	O
yielded	yield	VBD	B-VP	O
87	87	CD	B-NP	O
aerobic	aerobic	JJ	I-NP	O
and	and	CC	O	O
63	63	CD	B-NP	O
anaerobic	anaerobic	JJ	I-NP	O
strains	strain	NNS	I-NP	O
.	.	.	O	O

Species	Specie	NNS	B-NP	O
with	with	IN	B-PP	O
activity	activity	NN	B-NP	O
in	in	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
two	two	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
four	four	CD	I-NP	O
assays	assay	NNS	I-NP	O
were	be	VBD	B-VP	O
typed	type	VBN	I-VP	O
as	as	IN	B-SBAR	O
:	:	:	O	O
Rothia	Rothia	NNP	B-NP	O
mucilaginosa	mucilaginosa	NNP	I-NP	O
HOT-681	HOT-681	NNP	I-NP	O
,	,	,	O	O
Rothia	Rothia	NNP	B-NP	O
aeria	aeria	NN	I-NP	O
HOT-188	HOT-188	NN	I-NP	O
,	,	,	O	O
Actinomyces	Actinomyce	VBZ	B-VP	O
odontolyticus	odontolyticus	NN	B-NP	O
HOT-701	HOT-701	NN	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mitis	mitis	NN	I-NP	O
HOT-677	HOT-677	NN	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
sp	sp	NN	I-NP	O
.	.	.	I-NP	O
HOT-071	HOT-071	NN	I-NP	B-protein
,	,	,	O	O
Neisseria	Neisseria	NNP	B-NP	O
mucosa	mucosa	NNP	I-NP	O
HOT-682	HOT-682	NNP	I-NP	O
and	and	CC	O	O
Capnocytophaga	Capnocytophaga	NNP	B-NP	O
sputigena	sputigena	NN	I-NP	O
HOT-775	HOT-775	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
Rothia	Rothia	NNP	B-NP	O
species	specie	NNS	I-NP	O
being	be	VBG	B-VP	O
active	active	JJ	B-ADJP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
four	four	CD	I-NP	O
assays	assay	NNS	I-NP	O
.	.	.	O	O

Cleavage	Cleavage	NN	B-NP	O
specificities	specificity	NNS	I-NP	O
and	and	CC	O	O
substrate	substrate	NN	B-NP	O
preferences	preference	NNS	I-NP	O
differed	differ	VBD	B-VP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
strains	strain	NNS	I-NP	O
identified	identify	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
approximate	approximate	JJ	I-NP	O
molecular	molecular	JJ	I-NP	O
weights	weight	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
enzymes	enzyme	NNS	I-NP	B-protein
were	be	VBD	B-VP	O
~75	~75	CD	B-NP	O
kD	kD	NN	I-NP	O
(	(	(	O	O
Rothia	Rothia	NNP	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

)	)	)	O	O
,	,	,	O	O
~60	~60	CD	B-NP	O
kD	kD	NN	I-NP	O
(	(	(	O	O
A.	A.	NN	B-NP	O
odontolyticus	odontolyticus	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
~150	~150	CD	B-NP	O
kD	kD	NN	I-NP	O
(	(	(	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O
)	)	)	O	O
.	.	.	O	O

In	In	IN	B-PP	O
conclusion	conclusion	NN	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
identified	identify	VBD	B-VP	O
new	new	JJ	B-NP	O
gluten-degrading	gluten-degrading	JJ	I-NP	O
microorganisms	microorganism	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
gastrointestinal	gastrointestinal	JJ	I-NP	O
tract	tract	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
cocktail	cocktail	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
active	active	JJ	I-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
or	or	CC	O	O
their	their	PRP$	B-NP	O
isolated	isolate	VBN	I-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
,	,	,	O	O
may	may	MD	B-VP	O
offer	offer	VB	I-VP	O
promising	promising	JJ	B-NP	O
new	new	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
modalities	modality	NNS	I-NP	O
for	for	IN	B-PP	O
coeliac	coeliac	NN	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
purpose	purpose	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
microflora	microflora	NN	I-NP	O
and	and	CC	I-NP	O
association	association	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
candidiasis	candidiasis	NN	I-NP	O
and	and	CC	O	O
multiple	multiple	JJ	B-NP	O
risk	risk	NN	I-NP	O
factors	factor	NNS	I-NP	O
in	in	IN	B-PP	O
HIV	HIV	NN	B-NP	O
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
patients	patient	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
included	include	VBD	B-VP	O
100	100	CD	B-NP	O
HIV-infected	HIV-infected	JJ	I-NP	O
patients	patient	NNS	I-NP	O
participated	participate	VBD	B-VP	O
in	in	IN	B-PP	O
Imam	Imam	NNP	B-NP	O
Khomeini	Khomeini	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
Tehran	Tehran	NNP	B-NP	O
,	,	,	O	O
Iran	Iran	NNP	B-NP	O
for	for	IN	B-PP	O
Oropharyngeal	Oropharyngeal	NNP	B-NP	O
candidiasis	candidiasis	NN	I-NP	O
(	(	(	O	O
OPC	OPC	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
HIV	HIV	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
assessed	assess	VBD	B-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
or	or	CC	I-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
OPC	OPC	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
samples	sample	NNS	B-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
and	and	CC	O	O
direct	direct	JJ	B-NP	O
microscopic	microscopic	JJ	I-NP	O
examination	examination	NN	I-NP	O
,	,	,	O	O
gram	gram	NN	B-NP	O
staining	staining	NN	I-NP	O
and	and	CC	I-NP	O
culture	culture	NN	I-NP	O
on	on	IN	B-PP	O
standard	standard	JJ	B-NP	O
microbiological	microbiological	JJ	I-NP	O
media	medium	NNS	I-NP	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

CD4	CD4	NN	B-NP	B-protein
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
cell	cell	NN	B-NP	O
count/CD4	count/CD4	NN	I-NP	O
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
percentage	percentage	NN	B-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
calculated	calculate	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
demographic	demographic	JJ	I-NP	O
characteristics	characteristic	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
mean	mean	JJ	I-NP	O
age	age	NN	I-NP	O
of	of	IN	B-PP	O
32.3	32.3	CD	B-NP	O
years	year	NNS	I-NP	O
old	old	JJ	B-ADJP	O
,	,	,	O	O
78	78	CD	B-NP	O
%	%	NN	I-NP	O
male	male	JJ	B-ADJP	O
and	and	CC	O	O
22	22	CD	B-NP	O
%	%	NN	I-NP	O
female	female	JJ	B-ADJP	O
.	.	.	O	O

Patients	Patient	NNS	B-NP	O
belonging	belong	VBG	B-VP	O
to	to	TO	B-PP	O
'O	'O	NN	B-NP	O
(	(	(	O	O
+	+	SYM	B-NP	O
)	)	)	O	O
'	'	''	O	O
blood	blood	NN	B-NP	O
group	group	NN	I-NP	O
(	(	(	O	O
27	27	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
prone	prone	JJ	I-ADJP	O
to	to	TO	B-VP	O
develop	develop	VB	I-VP	O
OPC	OPC	NN	B-NP	B-protein
.	.	.	O	O

A	A	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
460	460	CD	B-NP	O
bacterial	bacterial	JJ	I-NP	O
colonies	colony	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
and	and	CC	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
(	(	(	O	O
15.4	15.4	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
frequently	frequently	RB	I-NP	O
isolated	isolate	VBN	I-NP	O
species	specie	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
HIV	HIV	NN	I-NP	O
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
patients	patient	NNS	B-NP	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
Staphylococcus	Staphylococcus	NN	B-NP	O
epidermidis	epidermidis	NN	I-NP	O
(	(	(	O	O
12.8	12.8	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
Corynebacterium	Corynebacterium	NN	B-NP	O
(	(	(	O	O
8.7	8.7	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
254	254	CD	B-NP	O
yeasts	yeast	NNS	I-NP	O
(	(	(	O	O
from	from	IN	B-PP	O
four	four	CD	B-NP	O
different	different	JJ	I-NP	O
genera	genera	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
under	under	IN	B-PP	O
study	study	NN	B-NP	O
.	.	.	O	O

Candida	Candida	NN	B-NP	B-protein
species	specie	NNS	I-NP	I-protein
(	(	(	O	O
94.4	94.4	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
frequently	frequently	RB	I-NP	O
obtained	obtain	VBN	I-NP	O
genera	genera	NN	I-NP	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
Saccharomyces	Saccharomyce	NNS	B-NP	O
(	(	(	O	O
2.4	2.4	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Kluyveromyces	Kluyveromyce	NNPS	B-NP	O
and	and	CC	I-NP	O
Cryptococcus	Cryptococcu	NNPS	I-NP	O
(	(	(	O	O
1.6	1.6	CD	B-NP	O
%	%	NN	I-NP	O
for	for	IN	B-PP	O
both	both	DT	O	O
)	)	)	O	O
species	specie	NNS	B-NP	O
.	.	.	O	O

Candida	Candida	NN	B-NP	O
albicans	albican	NNS	I-NP	O
(	(	(	O	O
37.2	37.2	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
common	common	JJ	I-NP	O
species	specie	NNS	I-NP	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
HIV	HIV	NN	B-NP	O
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
OPC	OPC	NN	B-NP	B-protein
and	and	CC	O	O
its	its	PRP$	B-NP	O
frequency	frequency	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
Candida	Candida	NNP	I-NP	O
species	specie	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Candida	Candida	NNP	B-NP	O
glabrata	glabrata	NNP	I-NP	O
,	,	,	O	O
C.	C.	NNP	B-NP	O
dubliniensis	dubliniensis	NNP	I-NP	O
,	,	,	O	O
C.	C.	NNP	B-NP	O
tropicalis	tropicalis	NNP	I-NP	O
,	,	,	O	O
C.	C.	NNP	B-NP	O
parapsilosis	parapsilosis	NN	I-NP	O
,	,	,	O	O
C.	C.	NNP	B-NP	O
krusei	krusei	NNP	I-NP	O
,	,	,	O	O
C.	C.	NNP	B-NP	O
lusitaniae	lusitaniae	NNP	I-NP	O
,	,	,	O	O
C.	C.	NNP	B-NP	O
guilliermondii	guilliermondii	NNP	I-NP	O
and	and	CC	O	O
C.	C.	NNP	B-NP	O
norvegensis	norvegensis	NNP	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
identified	identify	VBN	I-VP	O
.	.	.	O	O

Forty	Forty	CD	B-NP	O
percent	percent	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
had	have	VBD	B-VP	O
angular	angular	JJ	B-NP	O
cheilitis	cheilitis	NN	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
frequent	frequent	JJ	I-NP	O
clinical	clinical	JJ	I-NP	O
variant	variant	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
mean	mean	JJ	I-NP	O
CD4	CD4	NN	I-NP	O
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
cell	cell	NN	B-NP	O
counts	count	NNS	I-NP	O
were	be	VBD	B-VP	O
154.5	154.5	CD	B-NP	O
cells/muL	cells/muL	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
8	8	CD	B-NP	O
to	to	TO	I-NP	O
611	611	CD	I-NP	O
cells/muL	cells/muL	NN	I-NP	O
.	.	.	O	O

Thirty	Thirty	CD	B-NP	O
percent	percent	NN	I-NP	O
patients	patient	NNS	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
CD4	CD4	NN	I-NP	O
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
cell	cell	NN	B-NP	O
count	count	NN	I-NP	O
between	between	IN	B-PP	O
101	101	CD	B-NP	O
and	and	CC	I-NP	O
200	200	CD	I-NP	O
cells/muL	cells/muL	NN	I-NP	O
(	(	(	O	O
28.7	28.7	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
total	total	JJ	B-NP	O
yeasts	yeast	NNS	I-NP	O
isolated	isolate	VBN	B-VP	O
)	)	)	O	O
.	.	.	O	O

Yeast	Yeast	NN	B-NP	O
and	and	CC	I-NP	O
bacteria	bacteria	NNS	I-NP	O
counts	count	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
differ	differ	VB	I-VP	O
statistically	statistically	RB	B-ADVP	O
among	among	IN	B-PP	O
HIV	HIV	NN	B-NP	O
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
patients	patient	NNS	B-NP	O
'	'	POS	B-NP	O
subgroups	subgroup	NNS	I-NP	O
with	with	IN	B-PP	O
different	different	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
CD4	CD4	NN	B-NP	B-cell_type
(	(	(	O	I-cell_type
+	+	SYM	O	I-cell_type
)	)	)	O	I-cell_type
cells	cell	NNS	B-NP	I-cell_type
counts	count	NNS	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
yeasts	yeast	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
genus	genus	NN	I-NP	O
Candida	Candida	NNP	B-NP	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
comparable	comparable	JJ	I-NP	O
rate	rate	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
of	of	IN	B-PP	O
HIV	HIV	NN	B-NP	O
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
patients	patient	NNS	B-NP	O
and	and	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
difference	difference	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
variables	variable	NNS	I-NP	O
CD4	CD4	NN	I-NP	O
(	(	(	O	O
+	+	SYM	O	O
)	)	)	O	O
cell	cell	NN	B-NP	O
count	count	NN	I-NP	O
and	and	CC	O	O
yeast	yeast	NN	B-NP	O
counts	count	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
findings	finding	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
helpful	helpful	JJ	B-ADJP	O
in	in	IN	B-PP	O
any	any	DT	B-NP	O
further	further	JJ	I-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
done	do	VBN	B-VP	O
prospectively	prospectively	RB	B-ADVP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
cohort	cohort	JJ	I-NP	O
,	,	,	O	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
confirmatory	confirmatory	JJ	B-ADJP	O
.	.	.	O	O

Experimental	Experimental	JJ	B-NP	O
infection	infection	NN	I-NP	O
systems	system	NNS	I-NP	O
are	be	VBP	B-VP	O
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
studying	study	VBG	B-VP	O
antagonistic	antagonistic	JJ	B-NP	O
interactions	interaction	NNS	I-NP	O
and	and	CC	O	O
coevolution	coevolution	NN	B-NP	O
between	between	IN	B-PP	O
hosts	host	NNS	B-NP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
pathogens	pathogen	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
red	red	JJ	I-NP	O
flour	flour	NN	I-NP	O
beetle	beetle	NN	I-NP	O
Tribolium	Tribolium	NN	I-NP	O
castaneum	castaneum	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
spore-forming	spore-forming	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
insect	insect	NN	I-NP	O
pathogen	pathogen	NN	I-NP	O
Bacillus	Bacillus	NN	I-NP	O
thuringiensis	thuringiensis	NN	I-NP	O
(	(	(	O	O
Bt	Bt	NN	B-NP	O
)	)	)	O	O
are	be	VBP	B-VP	O
widely	widely	RB	I-VP	O
used	use	VBN	I-VP	O
and	and	CC	O	O
tractable	tractable	JJ	B-NP	O
model	model	NN	I-NP	O
organisms	organism	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
they	they	PRP	B-NP	O
have	have	VBP	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
employed	employ	VBN	I-VP	O
yet	yet	RB	B-ADVP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
efficient	efficient	JJ	I-NP	O
experimental	experimental	JJ	I-NP	O
system	system	NN	I-NP	O
to	to	TO	B-VP	O
study	study	VB	I-VP	O
host-pathogen	host-pathogen	NN	B-NP	O
interactions	interaction	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
used	use	VBD	B-VP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
throughput	throughput	NN	I-NP	O
oral	oral	JJ	I-NP	O
infection	infection	NN	I-NP	O
protocol	protocol	NN	I-NP	O
to	to	TO	B-VP	O
infect	infect	VB	I-VP	O
T.	T.	NNP	B-NP	O
castaneum	castaneum	NN	I-NP	O
insects	insect	VBZ	B-VP	O
with	with	IN	B-PP	O
coleopteran	coleopteran	NN	B-NP	O
specific	specific	JJ	B-NP	O
B.	B.	NNP	I-NP	O
thuringiensis	thuringiensis	NN	I-NP	O
bv	bv	NN	I-NP	O
.	.	.	O	O

tenebrionis	tenebrionis	NN	B-NP	O
(	(	(	O	O
Btt	Btt	NN	B-NP	O
)	)	)	O	O
bacteria	bacteria	NNS	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
larval	larval	JJ	B-NP	O
mortality	mortality	NN	I-NP	O
depends	depend	VBZ	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
dietary	dietary	JJ	I-NP	O
spore	spore	NN	I-NP	O
concentration	concentration	NN	I-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
duration	duration	NN	I-NP	O
of	of	IN	B-PP	O
exposure	exposure	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
spores	spore	NNS	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
differential	differential	JJ	B-NP	O
susceptibility	susceptibility	NN	I-NP	O
of	of	IN	B-PP	O
larvae	larva	NNS	B-NP	O
from	from	IN	B-PP	O
different	different	JJ	B-NP	O
T.	T.	NN	I-NP	B-cell_type
castaneum	castaneum	NN	I-NP	I-cell_type
populations	population	NNS	I-NP	I-cell_type
indicates	indicate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
host	host	NN	I-NP	O
genetic	genetic	JJ	I-NP	O
background	background	NN	I-NP	O
influences	influence	VBZ	B-VP	O
infection	infection	NN	B-NP	O
success	success	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
recovery	recovery	NN	I-NP	O
of	of	IN	B-PP	O
high	high	JJ	B-NP	O
numbers	number	NNS	I-NP	O
of	of	IN	B-PP	O
infectious	infectious	JJ	B-NP	O
spores	spore	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
cadavers	cadaver	NNS	I-NP	O
indicates	indicate	VBZ	B-VP	O
successful	successful	JJ	B-NP	O
replication	replication	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
host	host	NN	I-NP	O
and	and	CC	O	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
Btt	Btt	NN	B-NP	B-protein
could	could	MD	B-VP	O
establish	establish	VB	I-VP	O
infectious	infectious	JJ	B-NP	O
cycles	cycle	NNS	I-NP	O
in	in	IN	B-PP	O
T.	T.	NN	B-NP	O
castaneum	castaneum	NN	I-NP	O
in	in	IN	B-PP	O
nature	nature	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
were	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
transfer	transfer	VB	I-VP	O
plasmids	plasmid	NNS	B-NP	B-DNA
from	from	IN	B-PP	O
Btt	Btt	NNP	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
non-pathogenic	non-pathogenic	JJ	I-NP	O
but	but	CC	I-NP	O
genetically	genetically	RB	I-NP	O
well-characterised	well-characterised	JJ	I-NP	O
Bt	Bt	NN	I-NP	O
strain	strain	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
thereafter	thereafter	RB	B-ADJP	O
able	able	JJ	I-ADJP	O
to	to	TO	B-VP	O
successfully	successfully	RB	I-VP	O
infect	infect	VB	I-VP	O
T.	T.	NNP	B-NP	O
castaneum	castaneum	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
factors	factor	NNS	B-NP	O
residing	reside	VBG	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
plasmids	plasmid	NNS	I-NP	B-DNA
are	be	VBP	B-VP	O
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
virulence	virulence	NN	I-NP	O
of	of	IN	B-PP	O
Btt	Btt	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
availability	availability	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
genetically	genetically	RB	I-NP	O
accessible	accessible	JJ	I-NP	O
strain	strain	NN	I-NP	O
will	will	MD	B-VP	O
provide	provide	VB	I-VP	O
an	an	DT	B-NP	O
ideal	ideal	JJ	I-NP	O
model	model	NN	I-NP	O
for	for	IN	B-PP	O
more	more	RBR	B-NP	O
in-depth	in-depth	JJ	I-NP	O
analyses	analysis	NNS	I-NP	O
of	of	IN	B-PP	O
pathogenicity	pathogenicity	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
during	during	IN	B-PP	O
oral	oral	JJ	B-NP	O
infections	infection	NNS	I-NP	O
.	.	.	O	O

Combined	Combine	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
availability	availability	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
full	full	JJ	I-NP	O
genome	genome	NN	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
T.	T.	NN	B-NP	O
castaneum	castaneum	NN	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
system	system	NN	I-NP	O
will	will	MD	B-VP	O
enable	enable	VB	I-VP	O
analyses	analysis	NNS	B-NP	O
of	of	IN	B-PP	O
host	host	NN	B-NP	O
responses	response	NNS	I-NP	O
during	during	IN	B-PP	O
infection	infection	NN	B-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
addressing	address	VBG	B-VP	O
basic	basic	JJ	B-NP	O
questions	question	NNS	I-NP	O
concerning	concern	VBG	B-VP	O
host-parasite	host-parasite	JJ	B-NP	O
coevolution	coevolution	NN	I-NP	O
.	.	.	O	O

Drug-resistant	Drug-resistant	JJ	B-NP	O
opportunistic	opportunistic	JJ	I-NP	O
infections	infection	NNS	I-NP	O
may	may	MD	B-VP	O
cause	cause	VB	I-VP	O
health	health	NN	B-NP	O
problems	problem	NNS	I-NP	O
in	in	IN	B-PP	O
immunocompromised	immunocompromised	JJ	B-NP	O
hosts	host	NNS	I-NP	O
.	.	.	O	O

Representative	Representative	JJ	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
in	in	IN	B-PP	O
opportunistic	opportunistic	JJ	B-NP	O
infections	infection	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
are	be	VBP	B-VP	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
aureus	aureus	NNP	I-NP	O
,	,	,	O	O
Pseudomonas	Pseudomonas	NNP	B-NP	O
aeruginosa	aeruginosa	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Candida	Candida	NNP	B-NP	O
albicans	albicans	NNP	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
drug-resistant	drug-resistant	JJ	B-NP	O
opportunistic	opportunistic	JJ	I-NP	O
microorganisms	microorganism	NNS	I-NP	O
in	in	IN	B-PP	O
elderly	elderly	JJ	B-NP	O
adults	adult	NNS	I-NP	O
receiving	receive	VBG	B-VP	O
follow-up	follow-up	JJ	B-NP	O
examinations	examination	NNS	I-NP	O
after	after	IN	B-PP	O
primary	primary	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
satisfactorily	satisfactorily	RB	B-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
oral	oral	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
(	(	(	O	O
defined	define	VBN	B-VP	O
as	as	IN	B-PP	O
good	good	JJ	B-NP	O
outcomes	outcome	NNS	I-NP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
adults	adult	NNS	I-NP	O
(	(	(	O	O
controls	control	NNS	B-NP	O
)	)	)	O	O
.	.	.	O	O

After	After	IN	B-PP	O
identification	identification	NN	B-NP	O
of	of	IN	B-PP	O
microorganisms	microorganism	NNS	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
drug-resistant	drug-resistant	JJ	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
was	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
.	.	.	O	O

Pulsed-field	Pulsed-field	JJ	B-NP	O
gel	gel	NN	I-NP	O
electrophoresis	electrophoresis	NN	I-NP	O
(	(	(	O	O
PFGE	PFGE	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
staphylococcal	staphylococcal	JJ	B-NP	O
cassette	cassette	NN	I-NP	O
chromosome	chromosome	NN	I-NP	O
mec	mec	NN	I-NP	O
(	(	(	O	O
SCCmec	SCCmec	NN	B-NP	O
)	)	)	O	O
typing	typing	NN	B-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
performed	perform	VBN	I-VP	O
for	for	IN	B-PP	O
methicillin-resistant	methicillin-resistant	JJ	B-NP	O
S	S	NN	I-NP	O
aureus	aureus	NN	I-NP	O
(	(	(	O	O
MRSA	MRSA	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Statistical	Statistical	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
prevalences	prevalence	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
microorganisms	microorganism	NNS	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

Surprisingly	Surprisingly	RB	B-ADVP	O
,	,	,	O	O
69.2	69.2	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
S	S	NN	B-NP	O
aureus	aureus	NN	I-NP	O
isolates	isolate	NNS	I-NP	O
showed	show	VBD	B-VP	O
oxacillin	oxacillin	NN	B-NP	O
resistance	resistance	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
MRSA	MRSA	NN	B-NP	O
colonization	colonization	NN	I-NP	O
is	be	VBZ	B-VP	O
increasing	increase	VBG	I-VP	O
among	among	IN	B-PP	O
older	old	JJR	B-NP	O
Japanese	Japanese	NNPS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
MRSA	MRSA	NN	I-NP	O
isolates	isolate	NNS	I-NP	O
possessed	possess	VBD	B-VP	O
SCCmec	SCCmec	NN	B-NP	B-protein
types	type	NNS	I-NP	I-protein
II	II	CD	B-NP	I-protein
and	and	CC	I-NP	O
IV	IV	CD	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
representative	representative	JJ	I-NP	B-DNA
toxin	toxin	NN	I-NP	I-DNA
genes	gene	NNS	I-NP	I-DNA
.	.	.	O	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
basic	basic	JJ	I-NP	O
infection	infection	NN	I-NP	O
control	control	NN	I-NP	O
strategy	strategy	NN	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
standard	standard	JJ	B-NP	O
precautions	precaution	NNS	I-NP	O
against	against	IN	B-PP	O
MRSA	MRSA	NN	B-NP	B-protein
,	,	,	O	O
is	be	VBZ	B-VP	O
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
elderly	elderly	JJ	B-NP	O
adults	adult	NNS	I-NP	O
,	,	,	O	O
particularly	particularly	RB	B-ADVP	O
after	after	IN	B-PP	O
treatment	treatment	NN	B-NP	O
for	for	IN	B-PP	O
oral	oral	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
compare	compare	VB	I-VP	O
early	early	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
adhesion	adhesion	NN	I-NP	O
and	and	CC	I-NP	O
biofilm	biofilm	NN	I-NP	O
formation	formation	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
by	by	IN	B-PP	O
different	different	JJ	B-NP	O
oral	oral	JJ	I-NP	O
streptococci	streptococci	NNS	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
commercial	commercial	JJ	B-NP	O
brackets	bracket	NNS	I-NP	O
.	.	.	O	O

Adhesion	Adhesion	NN	B-NP	O
and	and	CC	I-NP	O
biofilm	biofilm	NN	I-NP	O
formation	formation	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
of	of	IN	B-PP	O
6	6	CD	B-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

on	on	IN	B-PP	O
15	15	CD	B-NP	O
different	different	JJ	I-NP	O
commercial	commercial	JJ	I-NP	O
brackets	bracket	NNS	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
standard	standard	JJ	B-NP	O
culture	culture	NN	I-NP	O
medium	medium	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
human	human	JJ	B-NP	O
saliva	saliva	NN	I-NP	O
were	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
MTT	MTT	NN	I-NP	O
reduction	reduction	NN	I-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

Significant	Significant	JJ	B-NP	O
differences	difference	NNS	I-NP	O
were	be	VBD	B-VP	O
evidenced	evidence	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
early	early	JJ	I-NP	O
adhesion	adhesion	NN	I-NP	O
and	and	CC	I-NP	O
biofilm	biofilm	NN	I-NP	O
formation	formation	NN	I-NP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
studied	study	VBN	I-NP	O
brackets	bracket	NNS	I-NP	O
and	and	CC	B-PP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
conditions	condition	NNS	I-NP	O
of	of	IN	B-PP	O
growth	growth	NN	B-NP	O
.	.	.	O	O

Gold	Gold	NN	B-NP	O
brackets	bracket	NNS	I-NP	O
resulted	result	VBD	B-VP	O
less	less	RBR	B-ADJP	O
prone	prone	JJ	I-ADJP	O
to	to	TO	B-PP	O
colonisation	colonisation	NN	B-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
composite	composite	JJ	B-NP	O
brackets	bracket	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
growth	growth	NN	I-NP	O
rates	rate	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tested	test	VBN	I-NP	O
species	specie	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
different	different	JJ	I-NP	O
tested	test	VBN	I-NP	O
materials	material	NNS	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
different	different	JJ	I-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
adopted	adopt	VBN	I-NP	O
experimental	experimental	JJ	I-NP	O
plan	plan	NN	I-NP	O
,	,	,	O	O
dissecting	dissect	VBG	B-VP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
phases	phase	NNS	I-NP	O
of	of	IN	B-PP	O
plaque	plaque	NN	B-NP	O
formation	formation	NN	I-NP	O
on	on	IN	B-PP	O
different	different	JJ	B-NP	O
brackets	bracket	NNS	I-NP	O
in	in	IN	B-PP	O
different	different	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
,	,	,	O	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
composite	composite	JJ	B-NP	O
brackets	bracket	NNS	I-NP	O
are	be	VBP	B-VP	O
more	more	RBR	B-ADJP	O
susceptible	susceptible	JJ	I-ADJP	O
to	to	TO	B-PP	O
adhesion	adhesion	NN	B-NP	O
and	and	CC	I-NP	O
colonisation	colonisation	NN	I-NP	O
by	by	IN	B-PP	O
streptococci	streptococci	NNS	B-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
remaining	remain	VBG	I-NP	O
tested	test	VBN	I-NP	O
brackets	bracket	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
show	show	VB	I-VP	O
differences	difference	NNS	B-NP	O
that	that	WDT	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
clinically	clinically	RB	B-ADJP	O
relevant	relevant	JJ	I-ADJP	O
.	.	.	O	O

Data	Datum	NNS	B-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
different	different	JJ	B-NP	O
personal	personal	JJ	I-NP	O
behaviours	behaviour	NNS	I-NP	O
affecting	affect	VBG	B-VP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
environment	environment	NN	I-NP	O
could	could	MD	B-VP	O
significantly	significantly	RB	I-VP	O
affect	affect	VB	I-VP	O
colonisation	colonisation	NN	B-NP	O
of	of	IN	B-PP	O
brackets	bracket	NNS	B-NP	O
by	by	IN	B-PP	O
oral	oral	JJ	B-NP	O
streptococci	streptococci	NNS	I-NP	O
.	.	.	O	O

Patients	Patient	NNS	B-NP	O
with	with	IN	B-PP	O
ruptured	ruptured	JJ	B-NP	O
saccular	saccular	JJ	I-NP	O
intracranial	intracranial	JJ	I-NP	O
aneurysms	aneurysm	NNS	I-NP	O
have	have	VBP	B-VP	O
excess	excess	JJ	B-NP	O
long-term	long-term	JJ	I-NP	O
mortality	mortality	NN	I-NP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
cerebrovascular	cerebrovascular	JJ	B-NP	O
and	and	CC	I-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
general	general	JJ	B-NP	O
population	population	NN	I-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
inflammation	inflammation	NN	I-NP	O
is	be	VBZ	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
ruptured	rupture	VBN	B-NP	O
intracranial	intracranial	JJ	I-NP	O
aneurysms	aneurysm	NNS	I-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
aortic	aortic	JJ	I-NP	O
aneurysms	aneurysm	NNS	I-NP	O
and	and	CC	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
plaques	plaque	NNS	I-NP	O
.	.	.	O	O

Bacterial	Bacterial	JJ	B-NP	O
infections	infection	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
suggested	suggest	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
aetiology	aetiology	NN	I-NP	O
of	of	IN	B-PP	O
atherosclerosis	atherosclerosis	NN	B-NP	O
.	.	.	O	O

Bacteria	Bacteria	NNS	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
detected	detect	VBN	I-VP	O
both	both	CC	O	O
in	in	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
and	and	CC	I-NP	O
coronary	coronary	JJ	I-NP	O
arteries	artery	NNS	I-NP	O
but	but	CC	O	O
their	their	PRP$	B-NP	O
presence	presence	NN	I-NP	O
in	in	IN	B-PP	O
intracranial	intracranial	JJ	B-NP	O
aneurysms	aneurysm	NNS	I-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
yet	yet	RB	I-VP	O
been	be	VBN	I-VP	O
properly	properly	RB	I-VP	O
studied	study	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
preliminary	preliminary	JJ	I-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
and	and	CC	I-NP	O
pharyngeal	pharyngeal	JJ	I-NP	B-DNA
bacterial	bacterial	JJ	I-NP	I-DNA
genome	genome	NN	I-NP	I-DNA
in	in	IN	B-PP	O
ruptured	ruptured	JJ	B-NP	O
intracranial	intracranial	JJ	I-NP	O
aneurysms	aneurysm	NNS	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
ascertain	ascertain	VB	I-VP	O
if	if	IN	B-SBAR	O
dental	dental	JJ	B-NP	O
infection	infection	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
previously	previously	RB	I-NP	O
unknown	unknown	JJ	I-NP	O
risk	risk	NN	I-NP	O
factor	factor	NN	I-NP	O
for	for	IN	B-PP	O
subarachnoid	subarachnoid	JJ	B-NP	O
haemorrhage	haemorrhage	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
36	36	CD	B-NP	O
ruptured	rupture	VBN	I-NP	O
aneurysm	aneurysm	NN	I-NP	O
specimens	specimen	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
perioperatively	perioperatively	RB	B-ADVP	O
in	in	IN	B-PP	O
aneurysm	aneurysm	NN	B-NP	O
clipping	clipping	NN	I-NP	O
operations	operation	NNS	I-NP	O
(	(	(	O	O
n=29	n=29	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
by	by	IN	B-PP	O
autopsy	autopsy	NN	B-NP	O
(	(	(	O	O
n=7	n=7	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Aneurysmal	Aneurysmal	JJ	B-NP	O
sac	sac	NN	I-NP	O
tissue	tissue	NN	I-NP	O
was	be	VBD	B-VP	O
analysed	analyse	VBN	I-VP	O
by	by	IN	B-PP	O
real	real	JJ	B-NP	O
time	time	NN	I-NP	O
quantitative	quantitative	JJ	B-NP	O
PCR	PCR	NN	I-NP	O
with	with	IN	B-PP	O
specific	specific	JJ	B-NP	O
primers	primer	NNS	I-NP	O
and	and	CC	I-NP	O
probes	probe	NNS	I-NP	O
to	to	TO	B-VP	O
detect	detect	VB	I-VP	O
bacterial	bacterial	JJ	B-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
from	from	IN	B-PP	O
several	several	JJ	B-NP	O
oral	oral	JJ	I-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

Immunohistochemical	Immunohistochemical	JJ	B-NP	O
staining	staining	NN	I-NP	O
for	for	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	B-protein
receptors	receptor	NNS	I-NP	I-protein
(	(	(	O	O
CD14	CD14	NN	B-NP	B-protein
and	and	CC	O	O
toll-like	toll-like	JJ	B-NP	B-protein
receptor-2	receptor-2	NN	I-NP	I-protein
(	(	(	O	O
TLR-2	TLR-2	NN	B-NP	B-protein
)	)	)	O	O
)	)	)	O	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
from	from	IN	B-PP	O
four	four	CD	B-NP	O
autopsy	autopsy	NN	I-NP	O
cases	case	NNS	I-NP	O
.	.	.	O	O

Bacterial	Bacterial	JJ	B-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
21/36	21/36	CD	B-NP	O
(	(	(	O	O
58	58	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
specimens	specimen	NNS	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
third	third	JJ	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
positive	positive	JJ	I-NP	O
samples	sample	NNS	I-NP	O
contained	contain	VBD	B-VP	O
DNA	DNA	NN	B-NP	O
from	from	IN	B-PP	O
both	both	CC	B-NP	O
endodontic	endodontic	JJ	I-NP	O
and	and	CC	I-NP	O
periodontal	periodontal	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

DNA	DNA	NN	B-NP	O
from	from	IN	B-PP	O
endodontic	endodontic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
20/36	20/36	CD	B-NP	O
(	(	(	O	O
56	56	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
and	and	CC	B-PP	O
from	from	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
17/36	17/36	CD	B-NP	O
(	(	(	O	O
47	47	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
samples	sample	NNS	B-NP	O
.	.	.	O	O

Bacterial	Bacterial	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
mitis	mitis	NN	I-NP	O
group	group	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
most	most	RBS	B-ADJP	O
common	common	JJ	I-ADJP	O
.	.	.	O	O

Aggregatibacter	Aggregatibacter	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
,	,	,	O	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
nucleatu	nucleatu	NN	I-NP	O
and	and	CC	I-NP	O
Treponema	Treponema	NN	I-NP	O
denticola	denticola	NN	I-NP	O
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
most	most	RBS	I-NP	O
common	common	JJ	I-NP	O
periodontal	periodontal	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
highly	highly	RB	I-NP	O
intensive	intensive	JJ	I-NP	O
staining	staining	NN	I-NP	O
of	of	IN	B-PP	O
CD14	CD14	NN	B-NP	B-protein
and	and	CC	I-NP	O
TLR-2	TLR-2	NN	I-NP	B-protein
in	in	IN	B-PP	O
ruptured	rupture	VBN	B-NP	O
aneurysms	aneurysm	NNS	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
report	report	NN	I-NP	O
showing	show	VBG	B-VP	O
evidence	evidence	NN	B-NP	O
that	that	IN	B-SBAR	O
dental	dental	JJ	B-NP	O
infection	infection	NN	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
part	part	NN	I-NP	O
of	of	IN	B-PP	O
pathophysiology	pathophysiology	NN	B-NP	O
in	in	IN	B-PP	O
intracranial	intracranial	JJ	B-NP	O
aneurysm	aneurysm	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Bacteriocin-producing	Bacteriocin-producing	JJ	B-NP	O
probiotic	probiotic	JJ	I-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
salivarius	salivarius	NN	I-NP	O
M18	M18	NN	I-NP	B-protein
offers	offer	VBZ	B-VP	O
beneficial	beneficial	JJ	B-NP	O
modulatory	modulatory	JJ	I-NP	O
capabilities	capability	NNS	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microbiome	microbiome	NN	I-NP	O
,	,	,	O	O
apparently	apparently	RB	B-ADVP	O
through	through	IN	B-PP	O
potent	potent	JJ	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
activity	activity	NN	I-NP	O
against	against	IN	B-PP	O
potentially	potentially	RB	B-NP	O
deleterious	deleterious	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
Streptococcus	Streptococcus	NNP	B-NP	B-DNA
pyogenes	pyogene	NNS	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
persistence	persistence	NN	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
salivarius	salivarius	NN	I-NP	O
M18	M18	NN	I-NP	B-protein
was	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
in	in	IN	B-PP	O
75	75	CD	B-NP	O
subjects	subject	NNS	I-NP	O
receiving	receive	VBG	B-VP	O
four	four	CD	B-NP	O
different	different	JJ	I-NP	O
doses	dose	NNS	I-NP	O
for	for	IN	B-PP	O
28	28	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Sixty	Sixty	CD	B-NP	O
per	per	IN	B-PP	O
cent	cent	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
subjects	subject	NNS	I-NP	O
already	already	RB	B-ADVP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
inhibitor-producing	inhibitor-producing	JJ	I-NP	O
S.	S.	NNP	I-NP	O
salivarius	salivarius	NN	I-NP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
saliva	saliva	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
probiotic	probiotic	JJ	B-NP	O
intervention	intervention	NN	I-NP	O
.	.	.	O	O

Strain	Strain	NN	B-NP	O
M18	M18	NN	I-NP	B-protein
's	's	POS	B-NP	O
persistence	persistence	NN	I-NP	O
was	be	VBD	B-VP	O
dependent	dependent	JJ	B-ADJP	O
upon	upon	IN	B-PP	O
the	the	DT	B-NP	O
dose	dose	NN	I-NP	O
,	,	,	O	O
but	but	CC	B-CONJP	O
not	not	RB	I-CONJP	O
the	the	DT	B-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
administration	administration	NN	B-NP	O
.	.	.	O	O

Culture	Culture	NN	B-NP	O
analysis	analysis	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
some	some	DT	B-NP	O
individuals	individual	NNS	I-NP	O
the	the	DT	B-NP	O
introduced	introduce	VBN	I-NP	O
strain	strain	NN	I-NP	O
had	have	VBD	B-VP	O
almost	almost	RB	I-VP	O
entirely	entirely	RB	I-VP	O
replaced	replace	VBD	I-VP	O
the	the	DT	B-NP	O
indigenous	indigenous	JJ	I-NP	O
S.	S.	NNP	I-NP	O
salivarius	salivarius	NN	I-NP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
numbers	number	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
species	species	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
increase	increase	VB	I-VP	O
.	.	.	O	O

Selected	Selected	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
showing	show	VBG	B-VP	O
either	either	CC	O	O
high	high	JJ	B-NP	O
or	or	CC	I-NP	O
low	low	JJ	I-NP	O
probiotic	probiotic	JJ	I-NP	O
persistence	persistence	NN	I-NP	O
had	have	VBD	B-VP	O
their	their	PRP$	B-NP	O
salivary	salivary	JJ	I-NP	B-cell_type
populations	population	NNS	I-NP	I-cell_type
profiled	profile	VBD	B-VP	O
using	use	VBG	I-VP	O
Illumina	Illumina	NNP	B-NP	O
sequencing	sequencing	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
V6	V6	NN	I-NP	B-protein
region	region	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
16S	16S	NN	I-NP	B-DNA
rRNA	rRNA	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
.	.	.	O	O

Analysis	Analysis	NN	B-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
while	while	IN	B-SBAR	O
certain	certain	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
phenotypes	phenotype	NNS	I-NP	O
were	be	VBD	B-VP	O
markedly	markedly	RB	I-VP	O
modulated	modulate	VBN	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
overall	overall	JJ	I-NP	O
composition	composition	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microbiome	microbiome	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
modified	modify	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
probiotic	probiotic	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

Megaplasmids	Megaplasmid	NNS	B-NP	B-DNA
encoding	encode	VBG	B-VP	O
bacteriocins	bacteriocin	NNS	B-NP	O
and	and	CC	O	O
adhesion	adhesion	NN	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
to	to	TO	B-VP	O
generate	generate	VB	I-VP	O
a	a	DT	B-NP	O
transconjugant	transconjugant	JJ	I-NP	O
S.	S.	NNP	I-NP	O
salivarius	salivarius	NN	I-NP	O
exhibiting	exhibit	VBG	B-VP	O
enhanced	enhance	VBN	B-VP	O
antimicrobial	antimicrobial	JJ	B-NP	O
production	production	NN	I-NP	O
and	and	CC	I-NP	O
binding	binding	NN	I-NP	O
capabilities	capability	NNS	I-NP	O
to	to	TO	B-PP	O
HEp-2	HEp-2	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
.	.	.	O	O

Since	Since	IN	B-SBAR	O
no	no	DT	B-NP	O
widespread	widespread	JJ	I-NP	O
perturbation	perturbation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
existing	exist	VBG	I-NP	O
indigenous	indigenous	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
oral	oral	JJ	B-NP	O
instillation	instillation	NN	I-NP	O
and	and	CC	O	O
given	give	VBN	B-VP	O
its	its	PRP$	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
activity	activity	NN	I-NP	O
against	against	IN	B-PP	O
potentially	potentially	RB	B-NP	O
pathogenic	pathogenic	JJ	I-NP	O
streptococci	streptococci	NNS	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
appears	appear	VBZ	B-VP	O
that	that	IN	B-SBAR	O
application	application	NN	B-NP	O
of	of	IN	B-PP	O
probiotic	probiotic	JJ	B-NP	O
strain	strain	NN	I-NP	O
M18	M18	NN	I-NP	B-protein
offers	offer	VBZ	B-VP	O
potential	potential	JJ	B-NP	O
low	low	JJ	I-NP	O
impact	impact	NN	I-NP	O
alternative	alternative	NN	I-NP	O
to	to	TO	B-PP	O
classical	classical	JJ	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
candidate	candidate	NN	B-NP	O
probiotic	probiotic	JJ	I-NP	O
strains	strain	NNS	I-NP	O
having	have	VBG	B-VP	O
relatively	relatively	RB	B-NP	O
poor	poor	JJ	I-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
or	or	CC	I-NP	O
adhesive	adhesive	JJ	I-NP	O
properties	property	NNS	I-NP	O
,	,	,	O	O
unique	unique	JJ	B-NP	O
derivatives	derivative	NNS	I-NP	O
displaying	display	VBG	B-VP	O
improved	improve	VBN	B-NP	O
probiotic	probiotic	JJ	I-NP	O
performance	performance	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
engineered	engineer	VBN	I-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
by	by	IN	B-PP	O
megaplasmid	megaplasmid	NN	B-NP	O
transfer	transfer	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
purpose	purpose	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
prospective	prospective	JJ	I-NP	O
clinical	clinical	JJ	I-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
spectra	spectrum	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
surface	surface	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
squamous	squamous	JJ	I-NP	O
cell	cell	NN	I-NP	O
carcinomas	carcinoma	NNS	I-NP	O
(	(	(	O	O
OSCC	OSCC	NN	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
comparison	comparison	NN	B-NP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
mucosa	mucosa	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
higher	high	JJR	I-NP	O
risk	risk	NN	I-NP	O
to	to	TO	B-VP	O
emerge	emerge	VB	I-VP	O
an	an	DT	B-NP	O
OSCC	OSCC	NN	I-NP	B-DNA
and	and	CC	O	O
a	a	DT	B-NP	O
control	control	NN	I-NP	O
group	group	NN	I-NP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
their	their	PRP$	B-NP	O
susceptibility	susceptibility	NN	I-NP	O
to	to	TO	B-PP	O
various	various	JJ	B-NP	O
common	common	JJ	I-NP	O
antibiotics	antibiotic	NNS	I-NP	O
.	.	.	O	O

Swabs	Swab	NNS	B-NP	O
from	from	IN	B-PP	O
90	90	CD	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
30	30	CD	B-NP	O
patients	patient	NNS	I-NP	O
of	of	IN	B-PP	O
each	each	DT	B-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
cultured	culture	VBN	I-VP	O
on	on	IN	B-PP	O
media	medium	NNS	B-NP	O
for	for	IN	B-PP	O
aerobes	aerobe	NNS	B-NP	O
and	and	CC	I-NP	O
anaerobes	anaerobe	NNS	I-NP	O
and	and	CC	O	O
tested	test	VBN	B-VP	O
with	with	IN	B-PP	O
agar	agar	NN	B-NP	O
diffusion	diffusion	NN	I-NP	O
and	and	CC	I-NP	O
Etest	Etest	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
predominant	predominant	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
healthy	healthy	JJ	I-NP	O
oral	oral	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
were	be	VBD	B-VP	O
aerobes	aerobe	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
ratio	ratio	NN	I-NP	O
between	between	IN	B-PP	O
aerobes	aerobe	NNS	B-NP	O
and	and	CC	I-NP	O
anaerobes	anaerobe	NNS	I-NP	O
was	be	VBD	B-VP	O
2:1	2:1	CD	B-NP	O
,	,	,	O	O
balanced	balance	VBN	B-VP	O
in	in	IN	B-PP	O
risk	risk	NN	B-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	O	O
inverted	invert	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
OSCC	OSCC	NN	I-NP	O
group	group	NN	I-NP	O
.	.	.	O	O

Altogether	Altogether	RB	B-ADVP	O
,	,	,	O	O
1,006	1,006	CD	B-NP	O
isolates	isolate	NNS	I-NP	O
were	be	VBD	B-VP	O
cultured	culture	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
most	most	RBS	I-NP	O
frequent	frequent	JJ	I-NP	O
strains	strain	NNS	I-NP	O
were	be	VBD	B-VP	O
47	47	CD	B-NP	O
viridans	viridan	NNS	I-NP	O
streptococci	streptococci	NNS	I-NP	O
,	,	,	O	O
30	30	CD	B-NP	O
Staphylococcus	Staphylococcus	NNP	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
14	14	CD	B-NP	O
Enterococcus	Enterococcus	NNP	I-NP	O
faecalis	faecalis	NN	I-NP	O
,	,	,	O	O
36	36	CD	B-NP	O
Neisseria	Neisseria	NNP	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
14	14	CD	B-NP	O
Escherichia	Escherichia	NNP	I-NP	O
coli	coli	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
23	23	CD	B-NP	O
other	other	JJ	I-NP	O
aerobes	aerobe	NNS	I-NP	O
,	,	,	O	O
66	66	CD	B-NP	O
Peptostreptococcus	Peptostreptococcus	NNP	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
39	39	CD	B-NP	O
Fusobacterium	Fusobacterium	NNP	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
34	34	CD	B-NP	O
Prevotella	Prevotella	NN	I-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
resistance	resistance	NN	I-NP	O
rates	rate	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
OSCC	OSCC	NN	I-NP	O
group	group	NN	I-NP	O
were	be	VBD	B-VP	O
penicillin	penicillin	NN	B-NP	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
ampicillin	ampicillin	NN	B-NP	O
57	57	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
doxycycline	doxycycline	NN	B-NP	O
23	23	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
clindamycin	clindamycin	NN	B-NP	O
47	47	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
amoxicillin/clavulanic	amoxicillin/clavulanic	JJ	B-NP	O
acid	acid	NN	I-NP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
pathogens	pathogen	NNS	B-NP	O
were	be	VBD	B-VP	O
susceptible	susceptible	JJ	B-ADJP	O
to	to	TO	B-PP	O
azithromycin	azithromycin	NN	B-NP	O
,	,	,	O	O
telithromycin	telithromycin	NN	B-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
moxifloxacin	moxifloxacin	NN	B-NP	O
.	.	.	O	O

Gram-negative	Gram-negative	JJ	B-NP	O
anaerobes	anaerobe	NNS	I-NP	O
play	play	VBP	B-VP	O
a	a	DT	B-NP	O
decisive	decisive	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
infections	infection	NNS	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
OSCC	OSCC	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
tumor	tumor	NN	I-NP	O
special	special	JJ	I-NP	O
type	type	NN	I-NP	O
of	of	IN	B-PP	O
colonization	colonization	NN	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
agree	agree	VB	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
flora	flora	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

Biofilms	Biofilm	NNS	B-NP	O
on	on	IN	B-PP	O
OSCC	OSCC	NN	B-NP	O
surfaces	surface	NNS	I-NP	O
provide	provide	VBP	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
reservoir	reservoir	NN	I-NP	O
for	for	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
a	a	DT	B-NP	O
consequence	consequence	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
proposal	proposal	NN	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
prophylactic	prophylactic	JJ	I-NP	O
regime	regime	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
.	.	.	O	O

Epithelial	Epithelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
cavities	cavity	NNS	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
reservoirs	reservoir	NNS	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
polymicrobial	polymicrobial	JJ	I-NP	O
intracellular	intracellular	JJ	I-NP	O
flora	flora	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
demonstrated	demonstrate	VBN	I-VP	O
in	in	IN	B-PP	O
buccal	buccal	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Important	Important	JJ	B-NP	O
aetiological	aetiological	JJ	I-NP	O
agents	agent	NNS	I-NP	O
of	of	IN	B-PP	O
systemic	systemic	JJ	B-NP	O
and	and	CC	I-NP	O
nosocomial	nosocomial	JJ	I-NP	O
infections	infection	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
microbiota	microbiota	NN	I-NP	O
of	of	IN	B-PP	O
subgingival	subgingival	JJ	B-NP	O
biofilm	biofilm	NN	I-NP	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
in	in	IN	B-PP	O
individuals	individual	NNS	B-NP	O
with	with	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
non-oral	non-oral	JJ	B-NP	O
pathogens	pathogen	NNS	I-NP	O
internalized	internalize	VBN	B-VP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	B-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
their	their	PRP$	B-NP	O
relationship	relationship	NN	I-NP	O
with	with	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
status	status	NN	I-NP	O
are	be	VBP	B-VP	O
poorly	poorly	RB	I-VP	O
understood	understand	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
purpose	purpose	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
detect	detect	VB	I-VP	O
opportunistic	opportunistic	JJ	B-NP	O
species	specie	NNS	I-NP	O
within	within	IN	B-PP	O
buccal	buccal	JJ	B-NP	O
and	and	CC	I-NP	O
gingival	gingival	JJ	I-NP	B-cell_type
crevice	crevice	NN	I-NP	I-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
collected	collect	VBN	B-VP	O
from	from	IN	B-PP	O
subjects	subject	NNS	B-NP	O
with	with	IN	B-PP	O
periodontitis	periodontitis	NN	B-NP	O
or	or	CC	I-NP	O
individuals	individual	NNS	I-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
periodontal	periodontal	JJ	I-NP	O
health	health	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
to	to	TO	B-VP	O
associate	associate	VB	I-VP	O
their	their	PRP$	B-NP	O
prevalence	prevalence	NN	I-NP	O
with	with	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
clinical	clinical	JJ	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

Quantitative	Quantitative	JJ	B-NP	O
detection	detection	NN	I-NP	O
of	of	IN	B-PP	O
total	total	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
aureus	aureus	NNP	I-NP	O
,	,	,	O	O
Pseudomonas	Pseudomonas	NNP	B-NP	O
aeruginosa	aeruginosa	NN	I-NP	O
and	and	CC	I-NP	O
Enterococcus	Enterococcus	NN	I-NP	O
faecalis	faecalis	NN	I-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	B-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
by	by	IN	B-PP	O
quantitative	quantitative	JJ	B-NP	O
real-time	real-time	JJ	I-NP	O
PCR	PCR	NN	I-NP	O
using	use	VBG	B-VP	O
universal	universal	JJ	B-NP	O
and	and	CC	I-NP	O
species-specific	species-specific	JJ	I-NP	O
primer	primer	NN	I-NP	O
sets	set	NNS	I-NP	O
.	.	.	O	O

Intracellular	Intracellular	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
visualized	visualize	VBN	I-VP	O
by	by	IN	B-PP	O
confocal	confocal	JJ	B-NP	O
microscopy	microscopy	NN	I-NP	O
and	and	CC	I-NP	O
fluorescence	fluorescence	NN	I-NP	O
in	in	FW	B-NP	O
situ	situ	FW	I-NP	O
hybridization	hybridization	NN	I-NP	O
.	.	.	O	O

Overall	Overall	RB	B-ADVP	O
,	,	,	O	O
33	33	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
cell	cell	NN	B-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
periodontitis	periodontitis	NN	B-NP	O
contained	contain	VBD	B-VP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
one	one	CD	I-NP	O
opportunistic	opportunistic	JJ	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
15	15	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
samples	sample	NNS	B-NP	O
from	from	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
individuals	individual	NNS	I-NP	O
.	.	.	O	O

E.	E.	FW	B-NP	O
faecalis	faecalis	NN	I-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
prevalent	prevalent	JJ	I-NP	O
species	specie	NNS	I-NP	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	B-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
(	(	(	O	O
detected	detect	VBN	B-VP	O
in	in	IN	B-PP	O
20.6	20.6	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
periodontitis	periodontitis	NN	B-NP	O
,	,	,	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
0.03	0.03	CD	B-NP	O
versus	versus	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
individuals	individual	NNS	I-NP	O
)	)	)	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
only	only	RB	B-ADVP	O
in	in	IN	B-PP	O
cells	cell	NNS	B-NP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
periodontitis	periodontitis	NN	B-NP	O
.	.	.	O	O

Quantitative	Quantitative	JJ	B-NP	O
real-time	real-time	JJ	I-NP	O
PCR	PCR	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
P.	P.	NNP	B-NP	O
aeruginosa	aeruginosa	NNP	I-NP	O
and	and	CC	O	O
S.	S.	NNP	B-NP	O
aureus	aureus	NN	I-NP	O
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
both	both	CC	O	O
the	the	DT	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
and	and	CC	I-NP	O
healthy	healthy	JJ	I-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
proportion	proportion	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
species	species	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
in	in	IN	B-PP	O
epithelial	epithelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
subjects	subject	NNS	B-NP	O
with	with	IN	B-PP	O
periodontitis	periodontitis	NN	B-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
individuals	individual	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
0.016	0.016	CD	B-NP	O
for	for	IN	B-PP	O
P.	P.	NNP	B-NP	O
aeruginosa	aeruginosa	NN	I-NP	O
and	and	CC	I-NP	O
P	P	NN	I-NP	O
=	=	SYM	B-VP	O
0.047	0.047	CD	B-NP	O
for	for	IN	B-PP	O
S.	S.	NNP	B-NP	O
aureus	aureus	NNP	I-NP	O
)	)	)	O	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
E.	E.	NNP	B-NP	O
faecalis	faecalis	NN	I-NP	O
and	and	CC	O	O
P.	P.	NNP	B-NP	O
aeruginosa	aeruginosa	NNP	I-NP	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
57	57	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	I-NP	O
50	50	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
with	with	IN	B-PP	O
probing	probe	VBG	B-VP	O
depth	depth	NN	B-NP	O
and	and	CC	O	O
clinical	clinical	JJ	B-NP	O
attachment	attachment	NN	I-NP	O
level	level	NN	I-NP	O
>	>	SYM	O	O
/=6	/=6	CD	B-NP	O
mm	mm	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
correlation	correlation	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
with	with	IN	B-PP	O
age	age	NN	B-NP	O
,	,	,	O	O
sex	sex	NN	B-NP	O
,	,	,	O	O
bleeding	bleed	VBG	B-VP	O
on	on	IN	B-PP	O
probing	probing	NN	B-NP	O
or	or	CC	O	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
supragingival	supragingival	JJ	B-NP	O
biofilm	biofilm	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
pathogens	pathogen	NNS	I-NP	O
in	in	IN	B-PP	O
epithelial	epithelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
is	be	VBZ	B-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
speculated	speculate	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
flora	flora	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Komodo	Komodo	NNP	I-NP	O
dragon	dragon	NN	I-NP	O
(	(	(	O	O
Varanus	Varanus	NN	B-NP	O
komodoensis	komodoensis	NN	I-NP	O
)	)	)	O	O
exerts	exert	VBZ	B-VP	O
a	a	DT	B-NP	O
lethal	lethal	JJ	I-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
its	its	PRP$	B-NP	O
prey	prey	NN	I-NP	O
;	;	:	O	O
yet	yet	RB	B-ADVP	O
,	,	,	O	O
scant	scant	JJ	B-NP	O
information	information	NN	I-NP	O
about	about	IN	B-PP	O
their	their	PRP$	B-NP	O
specific	specific	JJ	I-NP	O
oral	oral	JJ	I-NP	O
flora	flora	NN	I-NP	O
bacteriology	bacteriology	NN	I-NP	O
,	,	,	O	O
especially	especially	RB	B-NP	O
anaerobes	anaerobe	NNS	I-NP	O
,	,	,	O	O
exists	exist	VBZ	B-VP	O
.	.	.	O	O

Consequently	Consequently	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
aerobic	aerobic	JJ	I-NP	O
and	and	CC	I-NP	O
anaerobic	anaerobic	JJ	I-NP	O
oral	oral	JJ	I-NP	O
bacteriology	bacteriology	NN	I-NP	O
of	of	IN	B-PP	O
16	16	CD	B-NP	O
captive	captive	JJ	I-NP	O
Komodo	Komodo	NNP	I-NP	O
dragons	dragon	NNS	I-NP	O
(	(	(	O	O
10	10	CD	B-NP	O
adults	adult	NNS	I-NP	O
and	and	CC	O	O
six	six	CD	B-NP	O
neonates	neonate	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
aged	age	VBN	B-VP	O
2-17	2-17	CD	B-NP	O
yr	yr	NN	I-NP	O
for	for	IN	B-PP	O
adults	adult	NNS	B-NP	O
and	and	CC	O	O
7-10	7-10	CD	B-NP	O
days	day	NNS	I-NP	O
for	for	IN	B-PP	O
neonates	neonate	NNS	B-NP	O
,	,	,	O	O
from	from	IN	B-PP	O
three	three	CD	B-NP	O
U.S.	U.S.	NNP	I-NP	O
zoos	zoo	NNS	I-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
.	.	.	O	O

Saliva	Saliva	NNP	B-NP	O
and	and	CC	O	O
gingival	gingival	JJ	B-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
by	by	IN	B-PP	O
zoo	zoo	NN	B-NP	O
personnel	personnel	NNS	I-NP	O
,	,	,	O	O
inoculated	inoculate	VBN	B-VP	O
into	into	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
transport	transport	NN	I-NP	O
media	medium	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
delivered	deliver	VBN	B-VP	O
by	by	IN	B-PP	O
courier	courier	NN	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
reference	reference	NN	I-NP	O
laboratory	laboratory	NN	I-NP	O
.	.	.	O	O

Samples	Sample	NNS	B-NP	O
were	be	VBD	B-VP	O
cultured	culture	VBN	I-VP	O
for	for	IN	B-PP	O
aerobes	aerobe	NNS	B-NP	O
and	and	CC	I-NP	O
anaerobes	anaerobe	NNS	I-NP	O
.	.	.	O	O

Strains	Strain	NNS	B-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
by	by	IN	B-PP	O
standard	standard	JJ	B-NP	O
methods	method	NNS	I-NP	O
and	and	CC	O	O
16S	16S	NN	B-NP	O
rRNA	rRNA	NN	I-NP	O
gene	gene	NN	I-NP	O
sequencing	sequencing	NN	I-NP	O
when	when	WRB	B-ADVP	O
required	require	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
oral	oral	JJ	I-NP	O
flora	flora	NN	I-NP	O
consisted	consist	VBD	B-VP	O
of	of	IN	B-PP	O
39	39	CD	B-NP	O
aerobic	aerobic	JJ	I-NP	O
and	and	CC	O	O
21	21	CD	B-NP	O
anaerobic	anaerobic	JJ	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
variation	variation	NN	I-NP	O
by	by	IN	B-PP	O
zoo	zoo	NN	B-NP	B-protein
.	.	.	O	O

Adult	Adult	JJ	B-NP	O
dragons	dragon	NNS	I-NP	O
grew	grow	VBD	B-VP	O
128	128	CD	B-NP	O
isolates	isolate	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
37	37	CD	B-NP	O
aerobic	aerobic	JJ	I-NP	O
gram-negative	gram-negative	JJ	I-NP	O
rods	rod	NNS	I-NP	O
(	(	(	O	O
one	one	CD	B-NP	O
to	to	TO	O	O
eight	eight	CD	B-NP	O
per	per	IN	B-PP	O
specimen	specimen	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
Enterobacteriaceae	Enterobacteriaceae	NNP	B-NP	O
;	;	:	O	O
50	50	CD	B-NP	O
aerobic	aerobic	JJ	I-NP	O
gram-positive	gram-positive	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
(	(	(	O	O
two	two	CD	B-NP	O
to	to	TO	I-NP	O
nine	nine	CD	I-NP	O
per	per	IN	B-PP	O
specimen	specimen	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
especially	especially	RB	B-ADVP	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
sciuri	sciuri	NNP	I-NP	O
and	and	CC	O	O
Enterococcusfaecalis	Enterococcusfaecalis	NNP	B-NP	O
,	,	,	O	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
eight	eight	CD	B-NP	O
of	of	IN	B-PP	O
10	10	CD	B-NP	O
and	and	CC	I-NP	O
nine	nine	CD	I-NP	O
of	of	IN	B-PP	O
10	10	CD	B-NP	O
dragons	dragon	NNS	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
;	;	:	O	O
and	and	CC	O	O
41	41	CD	B-NP	O
anaerobes	anaerobe	NNS	I-NP	O
(	(	(	O	O
one	one	CD	B-NP	O
to	to	TO	O	O
six	six	CD	B-NP	O
per	per	IN	B-PP	O
specimen	specimen	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
especially	especially	RB	B-NP	O
clostridia	clostridia	NN	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
hatchlings	hatchling	NNS	I-NP	O
grew	grow	VBD	B-VP	O
aerobes	aerobe	NNS	B-NP	O
but	but	CC	O	O
none	none	NN	B-NP	O
grew	grow	VBD	B-VP	O
anaerobes	anaerobe	NNS	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
virulent	virulent	JJ	I-NP	O
species	specie	NNS	I-NP	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
.	.	.	O	O

As	As	IN	B-PP	O
with	with	IN	B-PP	O
other	other	JJ	B-NP	O
carnivores	carnivore	NNS	I-NP	O
,	,	,	O	O
captive	captive	JJ	B-NP	O
Komodo	Komodo	NNP	I-NP	O
oral	oral	JJ	I-NP	O
flora	flora	NN	I-NP	O
is	be	VBZ	B-VP	O
simply	simply	RB	B-ADJP	O
reflective	reflective	JJ	I-ADJP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
gut	gut	NN	I-NP	O
and	and	CC	I-NP	O
skin	skin	NN	I-NP	O
flora	flora	NN	I-NP	O
of	of	IN	B-PP	O
their	their	PRP$	B-NP	O
recent	recent	JJ	I-NP	O
meals	meal	NNS	I-NP	O
and	and	CC	I-NP	O
environment	environment	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
unlikely	unlikely	JJ	B-ADJP	O
to	to	TO	B-VP	O
cause	cause	VB	I-VP	O
rapid	rapid	JJ	B-NP	O
fatal	fatal	JJ	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

Bacteria	Bacteria	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
grow	grow	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
biofilms	biofilm	NNS	B-NP	O
;	;	:	O	O
these	these	DT	B-NP	O
structures	structure	NNS	I-NP	O
are	be	VBP	B-VP	O
subject	subject	JJ	B-ADJP	O
to	to	TO	B-PP	O
constant	constant	JJ	B-NP	O
saliva	saliva	NN	I-NP	O
or	or	CC	O	O
gingival	gingival	JJ	B-NP	O
crevicular	crevicular	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
flow	flow	NN	I-NP	O
conditions	condition	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aims	aim	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
were	be	VBD	B-VP	O
:	:	:	O	O
(	(	(	B-LST	O
i	i	LS	I-LST	O
)	)	)	O	O
to	to	TO	B-VP	O
develop	develop	VB	I-VP	O
and	and	CC	O	O
to	to	TO	B-VP	O
characterize	characterize	VB	I-VP	O
an	an	DT	B-NP	O
in-vitro	in-vitro	FW	I-NP	O
biofilm	biofilm	NN	I-NP	O
model	model	NN	I-NP	O
with	with	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
growing	grow	VBG	B-VP	O
under	under	IN	B-PP	O
flow	flow	NN	B-NP	O
and	and	CC	I-NP	O
shear	shear	NN	I-NP	O
conditions	condition	NNS	I-NP	O
;	;	:	O	O
and	and	CC	O	O
(	(	(	B-LST	O
ii	ii	LS	I-LST	O
)	)	)	O	O
to	to	TO	B-VP	O
demonstrate	demonstrate	VB	I-VP	O
the	the	DT	B-NP	O
usefulness	usefulness	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
model	model	NN	I-NP	O
for	for	IN	B-PP	O
evaluating	evaluate	VBG	B-VP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
antiplaque	antiplaque	JJ	I-NP	O
agents	agent	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
used	use	VBD	B-VP	O
a	a	DT	B-NP	O
bioreactor	bioreactor	NN	I-NP	O
to	to	TO	B-VP	O
grow	grow	VB	I-VP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
oralis	oralis	NNP	I-NP	O
,	,	,	O	O
Actinomyces	Actinomyces	NNP	B-NP	O
naeslundii	naeslundii	NNP	I-NP	O
,	,	,	O	O
Veillonella	Veillonella	NNP	B-NP	O
parvula	parvula	NN	I-NP	O
,	,	,	O	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
,	,	,	O	O
Aggregatibacter	Aggregatibacter	NNP	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
and	and	CC	O	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
under	under	IN	B-PP	O
planktonic	planktonic	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
.	.	.	O	O

Biofilms	Biofilm	NNS	B-NP	O
were	be	VBD	B-VP	O
established	establish	VBN	I-VP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
modified	modify	VBN	I-NP	O
Robbins	Robbins	NNP	I-NP	O
device	device	NN	I-NP	O
on	on	IN	B-PP	O
hydroxyapatite	hydroxyapatite	NN	B-NP	B-cell_type
(	(	(	O	I-cell_type
HAP	HAP	NN	B-NP	I-cell_type
)	)	)	O	I-cell_type
discs	disc	NNS	B-NP	I-cell_type
.	.	.	O	O

Three-	Three-	NN	B-NP	O
to	to	TO	B-PP	O
7-d-old	7-d-old	JJ	B-NP	O
biofilms	biofilm	NNS	I-NP	O
were	be	VBD	B-VP	O
analysed	analyse	VBN	I-VP	O
using	use	VBG	B-VP	O
culture	culture	NN	B-NP	O
methods	method	NNS	I-NP	O
,	,	,	O	O
scanning	scan	VBG	B-VP	O
electron	electron	NN	B-NP	O
microscopy	microscopy	NN	I-NP	O
,	,	,	O	O
Live/Dead	Live/Dead	JJ	B-NP	O
staining	staining	NN	I-NP	O
and	and	CC	I-NP	O
fluorescence	fluorescence	NN	I-NP	O
in-situ	in-situ	FW	I-NP	O
hybridization	hybridization	NN	I-NP	O
(	(	(	O	O
confocal	confocal	JJ	B-NP	O
laser	laser	NN	I-NP	O
scanning	scanning	NN	I-NP	O
microscopy	microscopy	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
assessed	assess	VBD	B-VP	O
the	the	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
mouthrinses	mouthrins	NNS	I-NP	O
[	[	(	O	O
0.12	0.12	CD	B-NP	O
%	%	NN	I-NP	O
chlorhexidine	chlorhexidine	NN	I-NP	O
(	(	(	O	O
CHX	CHX	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
0.12	0.12	CD	B-NP	O
%	%	NN	I-NP	O
chlorhexidine	chlorhexidine	NN	I-NP	O
and	and	CC	O	O
sodium	sodium	NN	B-NP	O
fluoride	fluoride	NN	I-NP	O
(	(	(	O	O
CHX+NaF	CHX+NaF	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
0.12	0.12	CD	B-NP	O
%	%	NN	I-NP	O
chlorhexidine	chlorhexidine	NN	I-NP	O
and	and	CC	O	O
0.05	0.05	CD	B-NP	O
%	%	NN	I-NP	O
cetylpyridinium	cetylpyridinium	NN	I-NP	O
chloride	chloride	NN	I-NP	O
(	(	(	O	O
CHX+CPC	CHX+CPC	NN	B-NP	O
)	)	)	O	O
]	]	)	O	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
planktonic	planktonic	JJ	I-NP	O
test	test	NN	I-NP	O
(	(	(	O	O
short	short	JJ	B-NP	O
interval-killing	interval-killing	JJ	I-NP	O
test	test	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
our	our	PRP$	B-NP	O
4-d	4-d	JJ	I-NP	O
biofilm	biofilm	NN	I-NP	O
model	model	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
viable	viable	JJ	I-NP	O
cell	cell	NN	I-NP	O
counts	count	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
each	each	DT	B-NP	O
species	species	NN	I-NP	O
was	be	VBD	B-VP	O
consistently	consistently	RB	I-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
biofilms	biofilm	NNS	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
architecture	architecture	NN	I-NP	O
and	and	CC	I-NP	O
cell	cell	NN	I-NP	O
distribution	distribution	NN	I-NP	O
were	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
described	describe	VBN	B-VP	O
for	for	IN	B-PP	O
biofilms	biofilm	NNS	B-NP	O
in	in	FW	B-ADVP	O
situ	situ	FW	I-ADVP	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
exception	exception	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
thin	thin	JJ	I-NP	O
layer	layer	NN	I-NP	O
of	of	IN	B-PP	O
living	live	VBG	B-VP	B-cell_type
cells	cell	NNS	B-NP	I-cell_type
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
close	close	RB	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
HAP	HAP	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
effectiveness	effectiveness	NN	I-NP	O
test	test	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mouthwashes	mouthwash	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
cells	cell	NNS	B-NP	O
in	in	IN	B-PP	O
biofilms	biofilm	NNS	B-NP	O
showed	show	VBD	B-VP	O
more	more	JJR	B-NP	O
tolerance	tolerance	NN	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
planktonic	planktonic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
that	that	IN	B-SBAR	O
in	in	IN	B-PP	O
4-d	4-d	JJ	B-NP	O
biofilm	biofilm	NN	I-NP	O
formed	form	VBN	B-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
,	,	,	O	O
CHX+CPC	CHX+CPC	NN	B-NP	O
caused	cause	VBD	B-VP	O
significantly	significantly	RB	B-NP	O
higher	high	JJR	I-NP	O
mortality	mortality	NN	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
CHX	CHX	NN	B-NP	B-protein
(	(	(	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
0.003	0.003	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
CHX+NaF	CHX+NaF	NN	B-NP	B-protein
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.001	0.001	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
highly	highly	RB	I-NP	O
reproducible	reproducible	JJ	I-NP	O
system	system	NN	I-NP	O
for	for	IN	B-PP	O
multispecies	multispecies	JJ	B-NP	O
oral	oral	JJ	I-NP	O
biofilm	biofilm	NN	I-NP	O
formation	formation	NN	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
useful	useful	JJ	I-NP	O
tool	tool	NN	I-NP	O
for	for	IN	B-PP	O
assessing	assess	VBG	B-VP	O
antibacterial	antibacterial	JJ	B-NP	B-protein
molecules	molecule	NNS	I-NP	I-protein
before	before	IN	B-PP	O
their	their	PRP$	B-NP	O
clinical	clinical	JJ	I-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
great	great	JJ	B-NP	O
potential	potential	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
in	in	IN	B-PP	O
basic	basic	JJ	B-NP	O
research	research	NN	I-NP	O
on	on	IN	B-PP	O
supragingival	supragingival	JJ	B-NP	O
and	and	CC	I-NP	O
subgingival	subgingival	JJ	I-NP	O
biofilms	biofilm	NNS	I-NP	O
.	.	.	O	O

Mucosal	Mucosal	JJ	B-NP	O
surfaces	surface	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
the	the	DT	B-NP	O
gut	gut	NN	I-NP	O
,	,	,	O	O
vagina	vagina	NN	B-NP	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
cavity	cavity	NN	I-NP	O
are	be	VBP	B-VP	O
colonized	colonize	VBN	I-VP	O
by	by	IN	B-PP	O
microbiota	microbiota	NNS	B-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
an	an	DT	B-NP	O
integral	integral	JJ	I-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
healthy	healthy	JJ	I-NP	O
ecosystem	ecosystem	NN	I-NP	O
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
molecular	molecular	JJ	I-NP	O
techniques	technique	NNS	I-NP	O
make	make	VBP	B-VP	O
it	it	PRP	B-NP	O
feasible	feasible	JJ	B-ADJP	O
to	to	TO	B-VP	O
correlate	correlate	VB	I-VP	O
antimicrobial	antimicrobial	JJ	B-NP	O
dosing	dosing	NN	I-NP	O
levels	level	NNS	I-NP	O
with	with	IN	B-PP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
microbiome	microbiome	NN	B-NP	O
composition	composition	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
objective	objective	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
characterize	characterize	VB	I-VP	O
the	the	DT	B-NP	O
rat	rat	NN	I-NP	O
oral	oral	JJ	I-NP	O
plaque	plaque	NN	I-NP	O
microbiome	microbiome	NN	I-NP	O
composition	composition	NN	I-NP	O
at	at	IN	B-PP	O
doses	dose	NNS	B-NP	O
of	of	IN	B-PP	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
considerably	considerably	RB	B-ADVP	O
above	above	IN	B-PP	O
and	and	CC	I-PP	O
below	below	IN	I-PP	O
nominal	nominal	JJ	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
minimal	minimal	JJ	I-NP	O
inhibitory	inhibitory	JJ	I-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
gram-positive	gram-positive	JJ	B-NP	O
oral	oral	JJ	I-NP	O
commensal	commensal	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
exposed	expose	VBD	B-VP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavities	cavity	NNS	I-NP	O
of	of	IN	B-PP	O
rats	rat	NNS	B-NP	O
to	to	TO	B-PP	O
relatively	relatively	RB	B-NP	O
low	low	JJ	I-NP	O
(	(	(	O	O
0.1	0.1	CD	B-NP	O
mug	mug	NN	I-NP	O
ml	ml	NN	I-NP	O
(	(	(	O	O
-1	-1	CD	B-NP	O
)	)	)	O	O
)	)	)	O	O
and	and	CC	O	O
high	high	JJ	B-ADJP	O
(	(	(	O	O
20	20	CD	B-NP	O
mug	mug	NN	I-NP	O
ml	ml	NN	I-NP	O
(	(	(	O	O
-1	-1	CD	B-NP	O
)	)	)	O	O
)	)	)	O	O
doses	dose	NNS	B-NP	O
of	of	IN	B-PP	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
drinking	drinking	NN	I-NP	O
water	water	NN	I-NP	O
over	over	IN	B-PP	O
a	a	DT	B-NP	O
3-day	3-day	JJ	I-NP	O
period	period	NN	I-NP	O
.	.	.	O	O

Plaque	Plaque	NN	B-NP	O
microbiota	microbiota	NNS	I-NP	O
were	be	VBD	B-VP	O
characterized	characterize	VBN	I-VP	O
using	use	VBG	B-VP	O
454	454	CD	B-NP	O
pyrosequencing	pyrosequencing	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
rat	rat	NN	I-NP	O
indigenous	indigenous	JJ	I-NP	O
community	community	NN	I-NP	O
was	be	VBD	B-VP	O
dominated	dominate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
genera	genera	NN	I-NP	O
Rothia	Rothia	NNP	I-NP	O
(	(	(	O	O
74.4	74.4	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
(	(	(	O	O
4.7	4.7	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Dosing	Dose	VBG	B-VP	O
at	at	IN	B-PP	O
0.1	0.1	CD	B-NP	O
mug	mug	NN	I-NP	O
ml	ml	NN	I-NP	O
(	(	(	O	O
-1	-1	NN	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
Rothia	Rothia	NNP	B-NP	O
and	and	CC	I-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
species	specie	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
not	not	RB	O	O
significant	significant	JJ	B-ADJP	O
,	,	,	O	O
whereas	whereas	IN	O	O
dosing	dosing	NN	B-NP	O
at	at	IN	B-PP	O
20	20	CD	B-NP	O
mug	mug	NN	I-NP	O
ml	ml	NN	I-NP	O
(	(	(	O	O
-1	-1	NN	B-NP	O
)	)	)	O	O
caused	cause	VBD	B-VP	O
a	a	DT	O	O
pronounced	pronounced	JJ	O	O
(	(	(	O	O
significant	significant	JJ	B-ADJP	O
)	)	)	O	O
reduction	reduction	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
relative	relative	JJ	I-NP	O
abundance	abundance	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
genus	genus	NN	I-NP	O
.	.	.	O	O

Taxonomic	Taxonomic	JJ	B-NP	O
independent	independent	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
perturbation	perturbation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
overall	overall	JJ	I-NP	O
community	community	NN	I-NP	O
structure	structure	NN	I-NP	O
attributed	attribute	VBN	B-VP	O
to	to	TO	B-PP	O
dosing	dosing	NN	B-NP	O
with	with	IN	B-PP	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
at	at	IN	B-PP	O
either	either	CC	O	O
the	the	DT	B-NP	O
low	low	JJ	I-NP	O
or	or	CC	I-NP	O
high	high	JJ	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
relatively	relatively	RB	B-ADJP	O
low	low	JJ	I-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
feasible	feasible	JJ	B-ADJP	O
to	to	TO	B-VP	O
use	use	VB	I-VP	O
an	an	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
dosing	dosing	NN	I-NP	O
regimen	regimen	NN	I-NP	O
to	to	TO	B-VP	O
selectively	selectively	RB	I-VP	O
target	target	VB	I-VP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
subset	subset	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
mucosal	mucosal	JJ	I-NP	O
microbiome	microbiome	NN	I-NP	O
for	for	IN	B-PP	O
elimination	elimination	NN	B-NP	O
with	with	IN	B-PP	O
minimal	minimal	JJ	B-NP	O
perturbation	perturbation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
entire	entire	JJ	I-NP	O
community	community	NN	I-NP	O
.	.	.	O	O

Streptococcus	Streptococcus	NN	B-NP	O
mutans	mutan	NNS	I-NP	O
and	and	CC	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
sobrinus	sobrinus	NN	I-NP	O
are	be	VBP	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
in	in	IN	B-PP	O
humans	human	NNS	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
previous	previous	JJ	B-NP	O
diagnostic	diagnostic	JJ	I-NP	O
systems	system	NNS	I-NP	O
are	be	VBP	B-VP	O
unsuitable	unsuitable	JJ	B-ADJP	O
for	for	IN	B-PP	O
monitoring	monitor	VBG	B-VP	O
viable	viable	JJ	B-NP	O
cell	cell	NN	I-NP	O
numbers	number	NNS	I-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
specimens	specimen	NNS	I-NP	O
.	.	.	O	O

Assessing	Assess	VBG	B-VP	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
numbers	number	NNS	I-NP	O
of	of	IN	B-PP	O
viable	viable	JJ	B-NP	O
and	and	CC	I-NP	O
dead	dead	JJ	I-NP	B-cell_type
bacterial	bacterial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
oral	oral	JJ	B-NP	O
status	status	NN	I-NP	O
is	be	VBZ	B-VP	O
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
understanding	understand	VBG	B-VP	O
oral	oral	JJ	B-NP	O
infectious	infectious	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

Propidium	Propidium	NN	B-NP	O
monoazide	monoazide	NN	I-NP	O
(	(	(	O	O
PMA	PMA	NN	B-NP	O
)	)	)	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
reported	report	VBN	I-VP	O
to	to	TO	I-VP	O
penetrate	penetrate	VB	I-VP	O
dead	dead	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
following	follow	VBG	B-PP	O
membrane	membrane	NN	B-NP	O
damage	damage	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
cross-link	cross-link	VB	I-VP	O
DNA	DNA	NN	B-NP	O
,	,	,	O	O
thereby	thereby	RB	B-VP	O
inhibiting	inhibit	VBG	I-VP	O
DNA	DNA	NN	B-NP	O
amplification	amplification	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
established	establish	VBD	B-VP	O
an	an	DT	B-NP	O
assay	assay	NN	I-NP	O
for	for	IN	B-PP	O
selective	selective	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
viable	viable	JJ	I-NP	O
human	human	JJ	I-NP	O
cariogenic	cariogenic	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
,	,	,	O	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
and	and	CC	O	O
S.	S.	NNP	B-NP	O
sobrinus	sobrinus	NN	I-NP	O
,	,	,	O	O
using	use	VBG	B-VP	O
PMA	PMA	NN	B-NP	O
combined	combine	VBN	B-VP	O
with	with	IN	B-PP	O
real-time	real-time	JJ	B-NP	O
PCR	PCR	NN	I-NP	O
(	(	(	O	O
PMA-qPCR	PMA-qPCR	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

We	We	PRP	B-NP	O
designed	design	VBD	B-VP	O
species-specific	species-specific	JJ	B-NP	O
primer	primer	NN	I-NP	O
sets	set	NNS	I-NP	O
for	for	IN	B-PP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
and	and	CC	O	O
S.	S.	NNP	B-NP	O
sobrinus	sobrinus	NN	I-NP	O
,	,	,	O	O
generated	generate	VBD	B-VP	O
standard	standard	JJ	B-NP	O
curves	curve	NNS	I-NP	O
for	for	IN	B-PP	O
measuring	measure	VBG	B-VP	O
cell	cell	NN	B-NP	O
numbers	number	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
evaluated	evaluate	VBD	B-VP	O
the	the	DT	B-NP	O
dynamic	dynamic	JJ	I-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
effectiveness	effectiveness	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
assay	assay	NN	I-NP	O
,	,	,	O	O
PMA	PMA	NN	B-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
to	to	TO	B-PP	O
viable	viable	JJ	B-NP	O
and	and	CC	I-NP	O
autoclave-killed	autoclave-killed	JJ	I-NP	O
cell	cell	NN	I-NP	O
mixtures	mixture	NNS	I-NP	O
.	.	.	O	O

PMA	PMA	NN	B-NP	O
treatment	treatment	NN	I-NP	O
effectively	effectively	RB	B-ADVP	O
prevented	prevent	VBD	B-VP	O
DNA	DNA	NN	B-NP	O
amplification	amplification	NN	I-NP	O
from	from	IN	B-PP	O
dead	dead	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

No	No	DT	B-NP	O
amplification	amplification	NN	I-NP	O
of	of	IN	B-PP	O
DNA	DNA	NN	B-NP	O
from	from	IN	B-PP	O
dead	dead	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
organisms	organism	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
applied	apply	VBD	B-VP	O
this	this	DT	B-NP	O
assay	assay	NN	I-NP	O
to	to	TO	B-VP	O
analyze	analyze	VB	I-VP	O
viable	viable	JJ	B-NP	O
cell	cell	NN	I-NP	O
numbers	number	NNS	I-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
specimens	specimen	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
significant	significant	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
viable	viable	JJ	B-NP	B-cell_type
S.	S.	NNP	I-NP	I-cell_type
mutans	mutan	NNS	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
and	and	CC	O	O
that	that	DT	B-NP	O
in	in	IN	B-PP	O
plaque	plaque	NN	B-NP	O
among	among	IN	B-PP	O
caries-free	caries-free	JJ	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
no	no	DT	B-NP	O
correlation	correlation	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
between	between	IN	B-PP	O
saliva	saliva	NN	B-NP	O
and	and	CC	O	O
carious	carious	JJ	B-NP	O
dentin	dentin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
total	total	JJ	I-NP	O
and	and	CC	I-NP	O
viable	viable	JJ	I-NP	O
cell	cell	NN	I-NP	O
numbers	number	NNS	I-NP	O
in	in	IN	B-PP	O
caries-positive	caries-positive	JJ	B-NP	O
saliva	saliva	NN	I-NP	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
than	than	IN	B-PP	O
those	those	DT	B-NP	O
in	in	IN	B-PP	O
caries-free	caries-free	JJ	B-NP	O
saliva	saliva	NN	I-NP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
analyzed	analyze	VBD	B-VP	O
the	the	DT	B-NP	O
usefulness	usefulness	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
assay	assay	NN	I-NP	O
for	for	IN	B-PP	O
in	in	FW	B-NP	O
vitro	vitro	FW	I-NP	O
oral	oral	JJ	I-NP	O
biofilm	biofilm	NN	I-NP	O
analysis	analysis	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
applied	apply	VBD	B-VP	O
PMA-qPCR	PMA-qPCR	NN	B-NP	O
for	for	IN	B-PP	O
monitoring	monitor	VBG	B-VP	O
viable	viable	JJ	B-NP	O
S.	S.	NNP	I-NP	O
mutans	mutan	NNS	I-NP	O
cell	cell	NN	I-NP	O
numbers	number	NNS	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
in	in	IN	B-PP	O
planktonic	planktonic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
oral	oral	JJ	B-NP	O
biofilm	biofilm	NN	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
hydrogen	hydrogen	NN	B-NP	O
peroxide	peroxide	NN	I-NP	O
(	(	(	O	O
H	H	NN	B-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
O	O	NN	B-NP	O
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
)	)	)	O	O
.	.	.	O	O

In	In	IN	B-PP	O
planktonic	planktonic	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
viable	viable	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
decreased	decrease	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-NP	O
H	H	NN	I-NP	B-protein
(	(	(	O	I-protein
2	2	CD	B-NP	I-protein
)	)	)	O	I-protein
O	O	NN	B-NP	I-protein
(	(	(	O	O
2	2	CD	B-NP	O
)	)	)	O	O
concentration	concentration	NN	B-NP	O
,	,	,	O	O
whereas	whereas	IN	B-PP	O
only	only	RB	B-NP	O
a	a	DT	I-NP	O
small	small	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
in	in	IN	B-PP	O
biofilm	biofilm	NN	B-NP	O
cell	cell	NN	I-NP	O
numbers	number	NNS	I-NP	O
.	.	.	O	O

PMA-qPCR	PMA-qPCR	NN	B-NP	O
is	be	VBZ	B-VP	O
potentially	potentially	RB	B-ADJP	O
useful	useful	JJ	I-ADJP	O
for	for	IN	B-PP	O
quantifying	quantify	VBG	B-VP	O
viable	viable	JJ	B-NP	O
cariogenic	cariogenic	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
specimens	specimen	NNS	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
applicable	applicable	JJ	B-ADJP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
biofilm	biofilm	NN	I-NP	O
experiments	experiment	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
assay	assay	NN	I-NP	O
will	will	MD	B-VP	O
help	help	VB	I-VP	O
to	to	TO	I-VP	O
elucidate	elucidate	VB	I-VP	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
viable	viable	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
specimens	specimen	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
oral	oral	JJ	B-NP	O
cavity	cavity	NN	I-NP	O
we	we	PRP	B-NP	O
isolated	isolate	VBD	B-VP	O
and	and	CC	I-VP	O
characterized	characterize	VBD	I-VP	O
probiotic	probiotic	JJ	B-NP	O
lactobacilli	lactobacilli	NN	I-NP	O
that	that	WDT	B-NP	O
could	could	MD	B-VP	O
probability	probability	NN	B-NP	O
be	be	VB	B-VP	O
applied	apply	VBN	I-VP	O
to	to	TO	B-PP	O
therapy	therapy	NN	B-NP	O
and	and	CC	I-NP	O
prevention	prevention	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

Lactobacillus	Lactobacillus	NN	B-NP	O
strains	strain	NNS	I-NP	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
by	by	IN	B-PP	O
plating	plat	VBG	B-VP	O
the	the	DT	B-NP	O
saliva	saliva	NN	I-NP	O
and	and	CC	O	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
of	of	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
donors	donor	NNS	I-NP	O
on	on	IN	B-PP	O
selective	selective	JJ	B-NP	O
medium	medium	NN	I-NP	O
.	.	.	O	O

Then	Then	RB	O	O
the	the	DT	B-NP	O
target	target	NN	I-NP	O
strains	strain	NNS	I-NP	O
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
for	for	IN	B-PP	O
inhibiting	inhibit	VBG	B-VP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
mutans	mutan	NNS	I-NP	O
strain	strain	VBP	B-VP	O
belonging	belong	VBG	I-VP	O
to	to	TO	B-PP	O
cariogenic	cariogenic	JJ	B-NP	B-protein
pathogen	pathogen	NN	I-NP	I-protein
species	specie	NNS	I-NP	I-protein
.	.	.	O	O

Other	Other	JJ	B-NP	O
properties	property	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
production	production	NN	B-NP	O
of	of	IN	B-PP	O
extracellular	extracellular	JJ	B-NP	O
polysaccharide	polysaccharide	NN	I-NP	O
and	and	CC	I-NP	O
resistance	resistance	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
antibacterial	antibacterial	JJ	I-NP	O
substances	substance	NNS	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
investigated	investigate	VBN	I-VP	O
.	.	.	O	O

Lactobacillus	Lactobacillus	NN	B-NP	O
fermentum	fermentum	NN	I-NP	O
Y29	Y29	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
strain	strain	NN	I-NP	O
with	with	IN	B-PP	O
antimicrobial	antimicrobial	JJ	B-NP	O
activity	activity	NN	I-NP	O
against	against	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
from	from	IN	B-PP	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
strain	strain	NN	I-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
extracellular	extracellular	JJ	I-NP	O
polysaccharide	polysaccharide	NN	I-NP	O
producer	producer	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
corresponds	correspond	VBZ	B-VP	O
to	to	TO	B-PP	O
its	its	PRP$	B-NP	O
aggregation	aggregation	NN	I-NP	O
ability	ability	NN	I-NP	O
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
L.	L.	NN	B-NP	O
fermentum	fermentum	NN	I-NP	O
Y29	Y29	NN	I-NP	O
showed	show	VBD	B-VP	O
resistance	resistance	NN	B-NP	O
to	to	TO	B-PP	O
1.0	1.0	CD	B-NP	O
mg/mL	mg/mL	NN	I-NP	O
lysozyme	lysozyme	NN	I-NP	O
and	and	CC	O	O
140	140	CD	B-NP	O
microg/g	microg/g	NN	I-NP	O
hydrogen	hydrogen	NN	I-NP	O
peroxide	peroxide	NN	I-NP	O
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
guarantee	guarantee	VB	I-VP	O
its	its	PRP$	B-NP	O
persistence	persistence	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
complex	complex	JJ	I-NP	O
oral	oral	JJ	I-NP	O
niche	niche	NN	I-NP	O
.	.	.	O	O

Probiotic	Probiotic	JJ	B-NP	O
properties	property	NNS	I-NP	O
were	be	VBD	B-VP	O
characterized	characterize	VBN	I-VP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
oral	oral	JJ	I-NP	O
isolate	isolate	NN	I-NP	O
L.	L.	NNP	I-NP	O
fermentum	fermentum	NNP	I-NP	O
Y29	Y29	NNP	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
provided	provide	VBD	B-VP	O
a	a	DT	B-NP	O
possibility	possibility	NN	I-NP	O
for	for	IN	B-PP	O
its	its	PRP$	B-NP	O
application	application	NN	I-NP	O
in	in	IN	B-PP	O
prevention	prevention	NN	B-NP	O
and	and	CC	I-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
mucosal	mucosal	JJ	I-NP	O
and	and	CC	I-NP	O
salivary	salivary	JJ	I-NP	O
lipids	lipid	NNS	I-NP	O
exhibit	exhibit	VBP	B-VP	O
potent	potent	JJ	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
activity	activity	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
Gram-positive	Gram-positive	JJ	B-NP	O
and	and	CC	I-NP	O
Gram-negative	Gram-negative	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
little	little	JJ	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
about	about	IN	B-PP	O
their	their	PRP$	B-NP	O
spectrum	spectrum	NN	I-NP	O
of	of	IN	B-PP	O
antimicrobial	antimicrobial	JJ	B-NP	O
activity	activity	NN	I-NP	O
or	or	CC	O	O
mechanisms	mechanism	NNS	B-NP	O
of	of	IN	B-PP	O
action	action	NN	B-NP	O
against	against	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
examine	examine	VBP	B-VP	O
the	the	DT	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
fatty	fatty	JJ	I-NP	O
acids	acid	NNS	I-NP	O
and	and	CC	O	O
three	three	CD	B-NP	O
sphingoid	sphingoid	JJ	I-NP	O
bases	base	NNS	I-NP	O
against	against	IN	B-PP	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
colonizer	colonizer	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
implicated	implicate	VBN	B-VP	O
in	in	IN	B-PP	O
periodontitis	periodontitis	NN	B-NP	O
.	.	.	O	O

Minimal	Minimal	JJ	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
concentrations	concentration	NNS	I-NP	O
,	,	,	O	O
minimal	minimal	JJ	B-NP	O
bactericidal	bactericidal	JJ	I-NP	O
concentrations	concentration	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
kill	kill	NN	B-NP	O
kinetics	kinetic	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
variable	variable	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
potent	potent	JJ	B-ADJP	O
,	,	,	O	O
activity	activity	NN	B-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
mucosal	mucosal	JJ	I-NP	O
and	and	CC	I-NP	O
salivary	salivary	JJ	I-NP	O
lipids	lipid	NNS	I-NP	O
against	against	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
lipid	lipid	NN	B-NP	O
structure	structure	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
determinant	determinant	NN	I-NP	O
in	in	IN	B-PP	O
lipid	lipid	NN	B-NP	O
mechanisms	mechanism	NNS	I-NP	O
of	of	IN	B-PP	O
activity	activity	NN	B-NP	O
against	against	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
specific	specific	JJ	B-NP	O
components	component	NNS	I-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
membranes	membrane	NNS	I-NP	O
are	be	VBP	B-VP	O
also	also	RB	B-ADVP	O
likely	likely	RB	B-ADJP	O
important	important	JJ	I-ADJP	O
.	.	.	O	O

Electron	Electron	NN	B-NP	O
micrographs	micrograph	NNS	I-NP	O
showed	show	VBD	B-VP	O
ultrastructural	ultrastructural	JJ	B-NP	O
damage	damage	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
sapienic	sapienic	JJ	B-NP	O
acid	acid	NN	I-NP	O
and	and	CC	I-NP	O
phytosphingosine	phytosphingosine	NN	I-NP	O
and	and	CC	O	O
confirmed	confirm	VBD	B-VP	O
disruption	disruption	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
plasma	plasma	NN	I-NP	O
membrane	membrane	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
information	information	NN	I-NP	O
,	,	,	O	O
coupled	couple	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
association	association	NN	I-NP	O
of	of	IN	B-PP	O
treatment	treatment	NN	B-NP	O
lipids	lipid	NNS	I-NP	O
with	with	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
lipids	lipid	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
via	via	IN	B-PP	O
thin	thin	JJ	B-NP	O
layer	layer	NN	I-NP	O
chromatography	chromatography	NN	I-NP	O
,	,	,	O	O
suggests	suggest	VBZ	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
plasma	plasma	NN	I-NP	O
membrane	membrane	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
likely	likely	JJ	I-NP	O
target	target	NN	I-NP	O
of	of	IN	B-PP	O
lipid	lipid	NN	B-NP	O
antibacterial	antibacterial	JJ	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

Utilizing	Utilize	VBG	B-VP	O
a	a	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
two-dimensional	two-dimensional	JJ	B-NP	O
in-gel	in-gel	JJ	I-NP	O
electrophoresis	electrophoresis	NN	I-NP	O
and	and	CC	I-NP	O
Western	Western	NN	I-NP	O
blot	blot	NN	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
mass	mass	NN	B-NP	O
spectroscopy	spectroscopy	NN	I-NP	O
and	and	CC	O	O
N-terminus	N-terminus	NN	B-NP	B-protein
degradation	degradation	NN	I-NP	O
sequencing	sequencing	NN	I-NP	O
we	we	PRP	B-NP	O
also	also	RB	B-ADVP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
treatment	treatment	NN	B-NP	O
with	with	IN	B-PP	O
sapienic	sapienic	JJ	B-NP	O
acid	acid	NN	I-NP	O
induces	induce	VBZ	B-VP	O
upregulation	upregulation	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
proteins	protein	NNS	B-NP	O
comprising	comprise	VBG	B-VP	O
a	a	DT	B-NP	O
unique	unique	JJ	I-NP	O
P.	P.	NNP	I-NP	O
gingivalis	gingivalis	NN	I-NP	O
stress	stress	NN	I-NP	O
response	response	NN	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
proteins	protein	NNS	B-NP	O
important	important	JJ	B-ADJP	O
in	in	IN	B-PP	O
fatty	fatty	JJ	B-NP	O
acid	acid	NN	I-NP	O
biosynthesis	biosynthesis	NN	I-NP	O
,	,	,	O	O
metabolism	metabolism	NN	B-NP	O
and	and	CC	I-NP	O
energy	energy	NN	I-NP	O
production	production	NN	I-NP	O
,	,	,	O	O
protein	protein	NN	B-NP	O
processing	processing	NN	I-NP	O
,	,	,	O	O
cell	cell	NN	B-NP	O
adhesion	adhesion	NN	I-NP	O
and	and	CC	I-NP	O
virulence	virulence	NN	I-NP	O
.	.	.	O	O

Prophylactic	Prophylactic	JJ	B-NP	O
or	or	CC	I-NP	O
therapeutic	therapeutic	JJ	I-NP	O
lipid	lipid	NN	I-NP	O
treatments	treatment	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
beneficial	beneficial	JJ	B-ADJP	O
for	for	IN	B-PP	O
intervention	intervention	NN	B-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
by	by	IN	B-PP	O
supplementing	supplement	VBG	B-VP	O
the	the	DT	B-NP	O
natural	natural	JJ	I-NP	O
immune	immune	JJ	I-NP	O
function	function	NN	I-NP	O
of	of	IN	B-PP	O
endogenous	endogenous	JJ	B-NP	O
lipids	lipid	NNS	I-NP	O
on	on	IN	B-PP	O
mucosal	mucosal	JJ	B-NP	O
surfaces	surface	NNS	I-NP	O
.	.	.	O	O

Adhesion	Adhesion	NN	B-NP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
soft	soft	JJ	I-NP	O
and	and	CC	I-NP	O
hard	hard	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
is	be	VBZ	B-VP	O
crucial	crucial	JJ	B-ADJP	O
for	for	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
colonisation	colonisation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
work	work	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
select	select	VB	I-VP	O
strains	strain	NNS	B-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
lactic	lactic	JJ	I-NP	O
acid	acid	NN	I-NP	O
bacteria	bacteria	NNS	I-NP	O
that	that	WDT	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
probiotics	probiotic	NNS	B-NP	O
for	for	IN	B-PP	O
oral	oral	JJ	B-NP	O
health	health	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-PP	O
this	this	DT	B-NP	O
end	end	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
adhesive	adhesive	JJ	I-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
lactic	lactic	JJ	I-NP	O
acid	acid	NN	I-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
.	.	.	O	O

Seventeen	Seventeen	CD	B-NP	O
lactic	lactic	JJ	I-NP	O
acid	acid	NN	I-NP	O
bacteria	bacteria	NNS	I-NP	O
including	include	VBG	B-PP	O
two	two	CD	B-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
mutans	mutan	NNS	I-NP	O
strains	strain	NNS	I-NP	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
of	of	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
children	child	NNS	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
other	other	JJ	B-NP	O
strains	strain	NNS	I-NP	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
fermented	ferment	VBN	B-NP	B-protein
meat	meat	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
strains	strain	NNS	I-NP	O
were	be	VBD	B-VP	O
applied	apply	VBN	I-VP	O
to	to	TO	B-PP	O
teeth	teeth	JJ	B-NP	O
surfaces	surface	NNS	I-NP	O
covered	cover	VBN	B-VP	O
with	with	IN	B-PP	O
saliva	saliva	NN	B-NP	O
or	or	CC	B-PP	O
without	without	IN	B-PP	O
saliva	saliva	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
significant	significant	JJ	I-NP	O
diversity	diversity	NN	I-NP	O
in	in	IN	B-PP	O
adhesion	adhesion	NN	B-NP	O
capacity	capacity	NN	I-NP	O
to	to	TO	B-PP	O
teeth	teeth	JJ	B-NP	O
surfaces	surface	NNS	I-NP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
lactic	lactic	JJ	I-NP	O
acid	acid	NN	I-NP	O
bacteria	bacteria	NNS	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O

Lactic	Lactic	JJ	B-NP	O
acid	acid	NN	I-NP	O
bacteria	bacteria	NNS	I-NP	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
adhered	adhere	VBD	B-VP	O
the	the	DT	B-NP	O
best	good	JJS	I-NP	O
to	to	TO	B-PP	O
teeth	teeth	JJ	B-NP	O
surfaces	surface	NNS	I-NP	O
covered	cover	VBN	B-VP	O
with	with	IN	B-PP	O
saliva	saliva	NN	B-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
lactic	lactic	JJ	B-NP	O
acid	acid	NN	I-NP	O
bacteria	bacteria	NNS	I-NP	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
fermented	ferment	VBN	B-NP	O
meat	meat	NN	I-NP	O
samples	sample	NNS	I-NP	O
adhered	adhere	VBD	B-VP	O
the	the	DT	B-NP	O
best	good	JJS	I-NP	O
to	to	TO	B-VP	O
tooth	tooth	VB	I-VP	O
surface	surface	NN	B-NP	O
without	without	IN	B-PP	O
saliva	saliva	NN	B-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
lactic	lactic	JJ	B-NP	O
acid	acid	NN	I-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
reduce	reduce	VB	I-VP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	B-cell_type
mutans	mutan	NNS	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
in	in	IN	B-PP	O
particular	particular	JJ	B-ADJP	O
on	on	IN	B-PP	O
saliva-coated	saliva-coated	JJ	B-NP	O
tooth	tooth	NN	I-NP	O
surface	surface	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
they	they	PRP	B-NP	O
might	might	MD	B-VP	O
have	have	VB	I-VP	O
potential	potential	NN	B-NP	O
as	as	IN	B-PP	O
probiotics	probiotic	NNS	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
objective	objective	NN	I-NP	O
of	of	IN	B-PP	O
our	our	PRP$	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
halitosis	halitosis	NN	B-NP	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
tongue	tongue	NN	B-NP	O
coating	coating	NN	I-NP	O
(	(	(	O	O
TC	TC	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
saliva	saliva	NN	B-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
halitosis	halitosis	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
tongue	tongue	NN	B-NP	O
cleaning	cleaning	NN	I-NP	O
on	on	IN	B-PP	O
halitosis	halitosis	NN	B-NP	O
.	.	.	O	O

Ninety-four	Ninety-four	CD	B-NP	O
participants	participant	NNS	I-NP	O
complaining	complain	VBG	B-VP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
malodour	malodour	NN	I-NP	O
were	be	VBD	B-VP	O
included	include	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

Organoleptic	Organoleptic	JJ	O	O
(	(	(	O	O
OR	OR	NN	B-NP	O
)	)	)	O	O
values	value	NNS	B-NP	O
,	,	,	O	O
volatile	volatile	JJ	B-NP	O
sulphur	sulphur	NN	I-NP	O
compound	compound	NN	I-NP	O
(	(	(	O	O
VSC	VSC	NN	B-NP	O
)	)	)	O	O
concentrations	concentration	NNS	B-NP	O
determined	determine	VBN	B-VP	O
by	by	IN	B-PP	O
gas	gas	NN	B-NP	O
chromatography	chromatography	NN	I-NP	O
and	and	CC	I-NP	O
TC	TC	NN	I-NP	O
scores	score	NNS	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
parameters	parameter	NNS	I-NP	O
of	of	IN	B-PP	O
halitosis	halitosis	NN	B-NP	O
.	.	.	O	O

Quantitative	Quantitative	JJ	B-NP	O
real-time	real-time	JJ	I-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reactions	reaction	NNS	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
numbers	number	NNS	I-NP	O
of	of	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
disease-associated	disease-associated	JJ	I-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
TC	TC	NN	B-NP	O
scores	score	NNS	I-NP	O
and	and	CC	O	O
OR	OR	NN	B-NP	O
values	value	NNS	I-NP	O
,	,	,	O	O
methylmercaptan	methylmercaptan	NN	B-NP	O
(	(	(	O	O
CH3	CH3	NN	B-NP	O
SH	SH	NN	I-NP	O
)	)	)	O	O
concentrations	concentration	NNS	B-NP	O
and	and	CC	O	O
VSC	VSC	NN	B-NP	O
concentrations	concentration	NNS	I-NP	O
(	(	(	O	O
Spearman	Spearman	NNP	B-NP	O
's	's	POS	B-NP	O
rank-correlation	rank-correlation	NN	I-NP	O
coefficient	coefficient	JJ	I-NP	O
test	test	NN	I-NP	O
,	,	,	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
0.01	0.01	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
parameters	parameter	NNS	I-NP	O
of	of	IN	B-PP	O
halitosis	halitosis	NN	B-NP	O
and	and	CC	O	O
total	total	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
numbers	number	NNS	I-NP	O
and	and	CC	O	O
Prevotella	Prevotella	NNP	B-NP	O
intermedia	intermedia	NNS	I-NP	O
,	,	,	O	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
and	and	CC	O	O
Campylobacter	Campylobacter	NNP	B-NP	O
rectus	rectus	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
TC	TC	NN	I-NP	O
samples	sample	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
similar	similar	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
with	with	IN	B-PP	O
respect	respect	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
saliva	saliva	NN	I-NP	O
samples	sample	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
participants	participant	NNS	I-NP	O
were	be	VBD	B-VP	O
sub-divided	sub-divided	JJ	B-ADJP	O
into	into	IN	B-PP	O
two	two	CD	B-NP	O
groups	group	NNS	I-NP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
whether	whether	IN	B-SBAR	O
they	they	PRP	B-NP	O
had	have	VBD	B-VP	O
the	the	DT	B-NP	O
habit	habit	NN	I-NP	O
of	of	IN	B-PP	O
tongue	tongue	NN	B-NP	O
cleaning	cleaning	NN	I-NP	O
or	or	CC	O	O
not	not	RB	O	O
.	.	.	O	O

The	The	DT	B-NP	O
participants	participant	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
habit	habit	NN	I-NP	O
of	of	IN	B-PP	O
tongue	tongue	NN	B-NP	O
cleaning	cleaning	NN	I-NP	O
had	have	VBD	B-VP	O
significantly	significantly	RB	B-NP	O
lower	low	JJR	I-NP	O
OR	OR	NN	I-NP	O
scores	score	NNS	I-NP	O
,	,	,	O	O
VSC	VSC	NN	B-NP	O
concentrations	concentration	NNS	I-NP	O
and	and	CC	O	O
P.	P.	NNP	B-NP	O
intermedia	intermedia	NNP	I-NP	O
,	,	,	O	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
and	and	CC	O	O
C.	C.	NNP	B-NP	O
rectus	rectus	NN	I-NP	O
levels	level	NNS	I-NP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
participants	participant	NNS	I-NP	O
(	(	(	O	O
Mann-Whitney	Mann-Whitney	NNP	B-NP	O
U-test	U-test	NNP	I-NP	O
,	,	,	O	O
P	P	NN	B-NP	O
<	<	SYM	B-NP	O
0.05	0.05	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggested	suggest	VBD	B-VP	O
that	that	IN	B-SBAR	O
periodontal	periodontal	JJ	B-NP	O
disease-associated	disease-associated	JJ	I-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
TCs	TC	NNS	B-NP	B-cell_type
are	be	VBP	B-VP	O
closely	closely	RB	B-ADJP	O
related	related	JJ	I-ADJP	O
to	to	TO	B-PP	O
halitosis	halitosis	NN	B-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
tongue	tongue	NN	B-NP	O
cleaning	cleaning	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
effective	effective	JJ	I-NP	O
method	method	NN	I-NP	O
for	for	IN	B-PP	O
improving	improve	VBG	B-VP	O
halitosis	halitosis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
,	,	,	I-NP	O
oligosaccharide	oligosaccharide	NN	I-NP	O
nanomedicine	nanomedicine	NN	I-NP	O
OligoG	OligoG	NN	I-NP	O
against	against	IN	B-PP	O
oral	oral	JJ	B-NP	O
pathogen-related	pathogen-related	JJ	I-NP	O
biofilms	biofilm	NNS	I-NP	O
,	,	,	O	O
both	both	CC	O	O
alone	alone	RB	B-ADVP	O
and	and	CC	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
conventional	conventional	JJ	I-NP	O
anti-bacterial	anti-bacterial	JJ	I-NP	O
agent	agent	NN	I-NP	O
triclosan	triclosan	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
OligoG+/-triclosan	OligoG+/-triclosan	NN	B-NP	O
was	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
against	against	IN	B-PP	O
established	establish	VBN	B-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
mutans	mutan	NNS	I-NP	O
and	and	CC	O	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
biofilms	biofilm	NNS	I-NP	O
by	by	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
counts	count	NNS	I-NP	O
and	and	CC	O	O
image	image	NN	B-NP	O
analysis	analysis	NN	I-NP	O
using	use	VBG	B-VP	O
LIVE/DEAD	LIVE/DEAD	NN	B-NP	O
(	(	(	O	O
(	(	(	O	O
R	R	NN	B-NP	O
)	)	)	O	O
)	)	)	O	O
staining	staining	NN	B-NP	O
and	and	CC	O	O
atomic	atomic	JJ	B-NP	O
force	force	NN	I-NP	O
microscopy	microscopy	NN	I-NP	O
(	(	(	O	O
AFM	AFM	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
triclosan	triclosan	NN	B-NP	O
and	and	CC	I-NP	O
OligoG	OligoG	NN	I-NP	O
surface	surface	NN	I-NP	O
pre-treatments	pre-treatment	NNS	I-NP	O
on	on	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
attachment	attachment	NN	I-NP	O
to	to	TO	B-PP	O
titanium	titanium	NN	B-NP	O
and	and	CC	I-NP	O
polymethylmethacrylate	polymethylmethacrylate	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
studied	study	VBN	I-VP	O
.	.	.	O	O

OligoG	OligoG	NN	B-NP	O
potentiated	potentiate	VBD	B-VP	O
the	the	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
triclosan	triclosan	NN	B-NP	O
,	,	,	O	O
particularly	particularly	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
used	use	VBN	B-VP	O
in	in	IN	B-PP	O
combination	combination	NN	B-NP	O
at	at	IN	B-PP	O
0.3	0.3	CD	B-NP	O
%	%	NN	I-NP	O
against	against	IN	B-PP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
grown	grow	VBN	B-VP	O
in	in	IN	B-PP	O
artificial	artificial	JJ	B-NP	O
saliva	saliva	NN	I-NP	O
.	.	.	O	O

OligoG	OligoG	NN	B-NP	O
was	be	VBD	B-VP	O
less	less	RBR	B-ADJP	O
effective	effective	JJ	I-ADJP	O
against	against	IN	B-PP	O
established	establish	VBN	B-NP	O
P.	P.	NNP	I-NP	O
gingivalis	gingivalis	NN	I-NP	O
biofilms	biofilm	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
attachment	attachment	NN	B-NP	O
of	of	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
to	to	TO	B-PP	O
titanium	titanium	NN	B-NP	O
in	in	IN	B-PP	O
particular	particular	JJ	B-ADJP	O
,	,	,	O	O
was	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
reduced	reduce	VBN	I-VP	O
after	after	IN	B-PP	O
surface	surface	NN	B-NP	O
pre-treatment	pre-treatment	NN	I-NP	O
with	with	IN	B-PP	O
OligoG	OligoG	NN	B-NP	O
and	and	CC	I-NP	O
triclosan	triclosan	NN	I-NP	O
at	at	IN	B-PP	O
0.01	0.01	CD	B-NP	O
%	%	NN	I-NP	O
when	when	WRB	B-ADVP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
controls	control	NNS	B-NP	O
.	.	.	O	O

Light	Light	NN	B-NP	O
microscopy	microscopy	NN	I-NP	O
and	and	CC	I-NP	O
AFM	AFM	NN	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
OligoG	OligoG	NN	B-NP	B-protein
was	be	VBD	B-VP	O
biocidal	biocidal	JJ	B-ADJP	O
to	to	TO	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
.	.	.	O	O

OligoG	OligoG	NN	B-NP	O
and	and	CC	I-NP	O
triclosan	triclosan	NN	I-NP	O
when	when	WRB	B-ADVP	O
used	use	VBN	B-VP	O
in	in	IN	B-PP	O
combination	combination	NN	B-NP	O
produced	produce	VBD	B-VP	O
an	an	DT	B-NP	O
enhanced	enhance	VBN	I-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
effect	effect	NN	I-NP	O
against	against	IN	B-PP	O
two	two	CD	B-NP	O
important	important	JJ	I-NP	O
oral	oral	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
and	and	CC	O	O
reduced	reduce	VBN	B-NP	O
bacterial	bacterial	JJ	I-NP	O
attachment	attachment	NN	I-NP	O
to	to	TO	B-PP	O
dental	dental	JJ	B-NP	O
materials	material	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
titanium	titanium	NN	B-NP	O
,	,	,	O	O
even	even	RB	B-ADVP	O
at	at	IN	B-PP	O
reduced	reduce	VBN	B-NP	O
triclosan	triclosan	NN	I-NP	O
concentrations	concentration	NNS	I-NP	O
.	.	.	O	O

Whilst	Whilst	IN	B-PP	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
triclosan	triclosan	NN	B-NP	O
against	against	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
widely	widely	RB	I-VP	O
documented	document	VBN	I-VP	O
,	,	,	O	O
its	its	PRP$	B-NP	O
synergistic	synergistic	JJ	I-NP	O
use	use	NN	I-NP	O
with	with	IN	B-PP	O
OligoG	OligoG	NN	B-NP	O
described	describe	VBN	B-VP	O
here	here	RB	B-ADVP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
previously	previously	RB	I-VP	O
been	be	VBN	I-VP	O
reported	report	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
lower	low	JJR	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
triclosan	triclosan	NN	B-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
used	use	VBN	B-VP	O
in	in	IN	B-PP	O
combination	combination	NN	B-NP	O
therapy	therapy	NN	I-NP	O
with	with	IN	B-PP	O
OligoG	OligoG	NN	B-NP	O
,	,	,	O	O
could	could	MD	B-VP	O
have	have	VB	I-VP	O
environmental	environmental	JJ	B-NP	O
benefits	benefit	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
potentiation	potentiation	NN	I-NP	O
of	of	IN	B-PP	O
antimicrobial	antimicrobial	JJ	B-NP	O
agents	agent	NNS	I-NP	O
by	by	IN	B-PP	O
naturally	naturally	RB	B-ADVP	O
occurring	occur	VBG	B-VP	O
oligomers	oligomer	NNS	B-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
OligoG	OligoG	NN	B-NP	O
may	may	MD	B-VP	O
represent	represent	VB	I-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
,	,	,	I-NP	O
safe	safe	JJ	I-NP	O
adjunct	adjunct	NN	I-NP	O
to	to	TO	B-PP	O
conventional	conventional	JJ	B-NP	O
oral	oral	JJ	I-NP	O
hygiene	hygiene	NN	I-NP	O
and	and	CC	O	O
periodontal	periodontal	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
OligoG	OligoG	NN	B-NP	B-protein
to	to	TO	B-VP	O
inhibit	inhibit	VB	I-VP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
and	and	CC	I-NP	O
impair	impair	NN	I-NP	O
bacterial	bacterial	JJ	I-NP	O
adherence	adherence	NN	I-NP	O
highlights	highlight	VBZ	B-VP	O
its	its	PRP$	B-NP	O
potential	potential	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
peri-implantitis	peri-implantitis	NN	B-NP	O
.	.	.	O	O

'Broken	'Broken	JJ	B-NP	O
mouth	mouth	NN	I-NP	O
'	'	POS	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
(	(	(	O	O
BMP	BMP	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
painful	painful	JJ	I-NP	O
condition	condition	NN	I-NP	O
of	of	IN	B-PP	O
sheep	sheep	NNS	B-NP	O
grazed	graze	VBN	B-VP	O
on	on	IN	B-PP	O
rough	rough	JJ	B-NP	O
pasture	pasture	NN	I-NP	O
and	and	CC	O	O
involves	involve	VBZ	B-VP	O
periodontal	periodontal	JJ	B-NP	O
infection	infection	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
incisor	incisor	NN	I-NP	O
teeth	teeth	NN	I-NP	O
and	and	CC	O	O
progressive	progressive	JJ	B-NP	O
tooth	tooth	JJ	I-NP	O
loss	loss	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
can	can	MD	B-VP	O
reduce	reduce	VB	I-VP	O
the	the	DT	B-NP	O
efficiency	efficiency	NN	I-NP	O
of	of	IN	B-PP	O
grazing	grazing	NN	B-NP	O
of	of	IN	B-PP	O
sheep	sheep	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
contributes	contribute	VBZ	B-VP	O
to	to	TO	B-PP	O
malnutrition	malnutrition	NN	B-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
loss	loss	NN	I-NP	O
,	,	,	O	O
systemic	systemic	JJ	B-NP	O
health	health	NN	I-NP	O
problems	problem	NNS	I-NP	O
,	,	,	O	O
poor	poor	JJ	B-NP	O
quality	quality	NN	I-NP	O
of	of	IN	B-PP	O
life	life	NN	B-NP	O
and	and	CC	O	O
early	early	JJ	B-NP	O
culling	culling	NN	I-NP	O
from	from	IN	B-PP	O
flocks	flock	NNS	B-NP	O
.	.	.	O	O

Consequently	Consequently	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
condition	condition	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
economic	economic	JJ	I-NP	O
problem	problem	NN	I-NP	O
to	to	TO	B-VP	O
sheep	sheep	VB	I-VP	O
farmers	farmer	NNS	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
are	be	VBP	B-VP	O
no	no	DT	B-NP	O
treatment	treatment	NN	I-NP	O
or	or	CC	I-NP	O
control	control	NN	I-NP	O
methods	method	NNS	I-NP	O
available	available	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
the	the	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
BMP	BMP	NN	B-NP	B-protein
and	and	CC	O	O
oral	oral	JJ	B-NP	O
health	health	NN	I-NP	O
in	in	IN	B-PP	O
sheep	sheep	NN	B-NP	O
.	.	.	O	O

Swabs	Swab	NNS	B-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
gingival	gingival	JJ	I-NP	O
pockets	pocket	NNS	I-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
sheep	sheep	NNS	I-NP	O
with	with	IN	B-PP	O
BMP	BMP	NN	B-NP	B-protein
and	and	CC	B-PP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
gingival	gingival	JJ	I-NP	O
margin	margin	NN	I-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
orally	orally	RB	I-NP	O
healthy	healthy	JJ	I-NP	O
(	(	(	O	O
normal	normal	JJ	B-ADJP	O
)	)	)	O	O
sheep	sheep	NNS	B-NP	O
.	.	.	O	O

Bacteria	Bacteria	NNS	B-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
using	use	VBG	B-VP	O
culture-independent	culture-independent	JJ	B-ADJP	O
(	(	(	O	O
16S	16S	NN	B-NP	O
rRNA	rRNA	NN	I-NP	O
gene	gene	NN	I-NP	O
sequencing	sequencing	NN	I-NP	O
)	)	)	O	O
methods	method	NNS	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
samples	sample	NNS	I-NP	O
,	,	,	O	O
26	26	CD	B-NP	O
phylotypes	phylotype	NNS	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
most	most	RBS	I-NP	O
prevalent	prevalent	JJ	I-NP	O
species	specie	NNS	I-NP	O
were	be	VBD	B-VP	O
Enterobacter	Enterobacter	NN	B-NP	O
hormaechei	hormaechei	NN	I-NP	O
(	(	(	O	O
21.3	21.3	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
analysed	analyse	VBN	B-NP	O
clones	clone	NNS	I-NP	O
)	)	)	O	O
and	and	CC	O	O
Hafnia	Hafnia	NNP	B-NP	O
alvei	alvei	NNP	I-NP	O
(	(	(	O	O
21.3	21.3	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
with	with	IN	B-PP	O
uncultured	uncultured	JJ	B-ADJP	O
(	(	(	O	O
4.4	4.4	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
novel	novel	JJ	B-ADJP	O
(	(	(	O	O
5.0	5.0	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
phylotypes	phylotype	NNS	B-NP	O
also	also	RB	B-VP	O
being	be	VBG	I-VP	O
identified	identify	VBN	I-VP	O
.	.	.	O	O

For	For	IN	B-PP	O
the	the	DT	B-NP	O
BMP	BMP	NN	I-NP	O
samples	sample	NNS	I-NP	O
,	,	,	O	O
24	24	CD	B-NP	O
phylotypes	phylotype	NNS	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
most	most	RBS	I-NP	O
prevalent	prevalent	JJ	I-NP	O
species	specie	NNS	I-NP	O
were	be	VBD	B-VP	O
Mannheimia	Mannheimia	NNP	B-NP	O
ruminalis	ruminalis	NN	I-NP	O
(	(	(	O	O
28.4	28.4	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
Moraxella	Moraxella	NN	B-NP	O
caprae	caprae	NNS	I-NP	O
(	(	(	O	O
13.5	13.5	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
with	with	IN	B-PP	O
uncultured	uncultured	JJ	B-ADJP	O
(	(	(	O	O
2.6	2.6	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
novel	novel	JJ	B-ADJP	O
(	(	(	O	O
24.5	24.5	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
phylotypes	phylotype	NNS	B-NP	O
also	also	RB	B-VP	O
being	be	VBG	I-VP	O
identified	identify	VBN	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
conclusion	conclusion	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
distinct	distinct	JJ	I-NP	O
microflora	microflora	NN	I-NP	O
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
BMP	BMP	NN	B-NP	B-protein
and	and	CC	O	O
oral	oral	JJ	B-NP	O
health	health	NN	I-NP	O
in	in	IN	B-PP	O
sheep	sheep	NN	B-NP	O
and	and	CC	O	O
M.	M.	NNP	B-NP	O
ruminalis	ruminalis	NNP	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
aetiology	aetiology	NN	I-NP	O
of	of	IN	B-PP	O
BMP	BMP	NN	B-NP	B-protein
.	.	.	O	O

Lactobacillus	Lactobacillus	NN	B-NP	B-protein
species	specie	NNS	I-NP	I-protein
can	can	MD	B-VP	O
contribute	contribute	VB	I-VP	O
positively	positively	RB	B-ADVP	O
to	to	TO	B-PP	O
general	general	JJ	B-NP	O
and	and	CC	I-NP	O
oral	oral	JJ	I-NP	O
health	health	NN	I-NP	O
and	and	CC	O	O
are	be	VBP	B-VP	O
frequently	frequently	RB	I-VP	O
acquired	acquire	VBN	I-VP	O
by	by	IN	B-PP	O
breastfeeding	breastfeed	VBG	B-VP	O
in	in	IN	B-PP	O
infancy	infancy	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
aimed	aim	VBD	B-VP	O
to	to	TO	I-VP	O
identify	identify	VB	I-VP	O
oral	oral	JJ	B-NP	O
lactobacilli	lactobacilli	NN	I-NP	O
in	in	IN	B-PP	O
breast	breast	NN	B-NP	O
and	and	CC	O	O
formula-fed	formula-fed	JJ	B-NP	O
4	4	CD	I-NP	O
month-old	month-old	JJ	I-NP	O
infants	infant	NNS	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
potential	potential	JJ	B-NP	O
probiotic	probiotic	JJ	I-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
dominant	dominant	JJ	I-NP	B-protein
Lactobacillus	Lactobacillus	NN	I-NP	I-protein
species	specie	NNS	I-NP	I-protein
detected	detect	VBN	B-VP	O
.	.	.	O	O

Saliva	Saliva	NNP	B-NP	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
swab	swab	NN	I-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
from	from	IN	B-PP	O
133	133	CD	B-NP	O
infants	infant	NNS	I-NP	O
who	who	WP	B-NP	O
were	be	VBD	B-VP	O
enrolled	enrol	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
longitudinal	longitudinal	JJ	I-NP	O
study	study	NN	I-NP	O
(	(	(	O	O
n=240	n=240	NN	B-NP	O
)	)	)	O	O
examining	examine	VBG	B-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
infant	infant	NN	I-NP	O
formula	formula	NN	I-NP	O
on	on	IN	B-PP	O
child	child	NN	B-NP	O
growth	growth	NN	I-NP	O
and	and	CC	I-NP	O
development	development	NN	I-NP	O
.	.	.	O	O

Saliva	Saliva	NNP	B-NP	O
was	be	VBD	B-VP	O
cultured	culture	VBN	I-VP	O
and	and	CC	O	O
Lactobacillus	Lactobacillus	NN	B-NP	O
isolates	isolate	NNS	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
from	from	IN	B-PP	O
16S	16S	NN	B-NP	B-DNA
rRNA	rRNA	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
.	.	.	O	O

Five	Five	CD	B-NP	O
L.	L.	NNP	I-NP	O
gasseri	gasseri	NNP	I-NP	O
isolates	isolate	NNS	I-NP	O
that	that	WDT	B-NP	O
differed	differ	VBD	B-VP	O
in	in	IN	B-PP	O
16S	16S	NN	B-NP	B-DNA
rRNA	rRNA	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
for	for	IN	B-PP	O
their	their	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
inhibit	inhibit	VB	I-VP	O
growth	growth	NN	B-NP	O
of	of	IN	B-PP	O
selected	select	VBN	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
adhesion	adhesion	NN	B-NP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
tissues	tissue	NNS	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
swab	swab	NN	I-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
by	by	IN	B-PP	O
qPCR	qPCR	NN	B-NP	O
for	for	IN	B-PP	O
Lactobacillus	Lactobacillus	NNP	B-NP	O
gasseri	gasseri	NNP	I-NP	O
.	.	.	O	O

43	43	CD	B-NP	O
(	(	(	O	O
32.3	32.3	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
infants	infant	NNS	B-NP	O
were	be	VBD	B-VP	O
breastfed	breastfe	VBN	I-VP	O
and	and	CC	O	O
90	90	CD	B-NP	O
(	(	(	O	O
67.7	67.7	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
formula-fed	formula-fe	VBN	I-VP	O
with	with	IN	B-PP	O
either	either	CC	O	O
a	a	DT	B-NP	O
standard	standard	JJ	I-NP	O
formula	formula	NN	I-NP	O
(	(	(	O	O
43	43	CD	B-NP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
90	90	CD	B-NP	O
)	)	)	O	O
or	or	CC	O	O
formula	formula	NN	B-NP	O
supplemented	supplement	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
milk	milk	NN	I-NP	O
fat	fat	NN	I-NP	O
globule	globule	NN	I-NP	O
membrane	membrane	NN	I-NP	O
(	(	(	O	O
MFGM	MFGM	NN	B-NP	O
)	)	)	O	O
fraction	fraction	NN	B-NP	O
(	(	(	O	O
47	47	CD	B-NP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
90	90	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

lactobacilli	lactobacillus	NNS	B-NP	O
were	be	VBD	B-VP	O
cultured	culture	VBN	I-VP	O
from	from	IN	B-PP	O
saliva	saliva	NN	B-NP	O
of	of	IN	B-PP	O
34.1	34.1	CD	B-NP	O
%	%	NN	I-NP	O
breastfed	breastfe	VBN	B-NP	O
infants	infant	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
only	only	RB	B-PP	O
in	in	IN	I-PP	O
4.7	4.7	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
standard	standard	JJ	I-NP	O
and	and	CC	O	O
9.3	9.3	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
MFGM	MFGM	NNP	I-NP	O
supplemented	supplement	VBD	B-VP	O
formula-fed	formula-fed	JJ	B-NP	O
infants	infant	NNS	I-NP	O
.	.	.	O	O

L.	L.	NNP	B-NP	O
gasseri	gasseri	NNP	I-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
prevalent	prevalent	JJ	I-NP	O
(	(	(	O	O
88	88	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
Lactobacillus	Lactobacillus	NN	B-NP	O
positive	positive	JJ	I-NP	O
infants	infant	NNS	I-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
six	six	CD	B-NP	O
Lactobacillus	Lactobacillus	NN	I-NP	O
species	specie	NNS	I-NP	O
detected	detect	VBN	B-VP	O
.	.	.	O	O

L.	L.	NNP	B-NP	O
gasseri	gasseri	NNP	I-NP	O
isolates	isolate	NNS	I-NP	O
inhibited	inhibit	VBD	B-VP	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
binding	bind	VBG	B-VP	O
to	to	TO	B-PP	O
saliva-coated	saliva-coated	JJ	B-NP	O
hydroxyapatite	hydroxyapatite	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
inhibited	inhibit	VBD	B-VP	O
growth	growth	NN	B-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
sobrinus	sobrinus	NNP	I-NP	O
,	,	,	O	O
Actinomyces	Actinomyces	NNP	B-NP	O
naeslundii	naeslundii	NNP	I-NP	O
,	,	,	O	O
Actinomyces	Actinomyces	NNP	B-NP	O
oris	oris	NNP	I-NP	O
,	,	,	O	O
Candida	Candida	NNP	B-NP	O
albicans	albicans	NNP	I-NP	O
and	and	CC	O	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
concentration	concentration	NN	I-NP	O
dependent	dependent	JJ	I-NP	O
fashion	fashion	NN	I-NP	O
.	.	.	O	O

L.	L.	NNP	B-NP	O
gasseri	gasseri	NNP	I-NP	O
isolates	isolate	NNS	I-NP	O
bound	bind	VBD	B-VP	O
to	to	TO	B-PP	O
parotid	parotid	NN	B-NP	O
and	and	CC	O	O
submandibular	submandibular	JJ	B-NP	O
saliva	saliva	NN	I-NP	O
,	,	,	O	O
salivary	salivary	JJ	B-NP	O
gp340	gp340	NN	I-NP	O
and	and	CC	I-NP	O
MUC7	MUC7	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
purified	purify	VBN	B-VP	O
MFGM	MFGM	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
adhered	adhere	VBD	B-VP	O
to	to	TO	B-PP	O
epithelial	epithelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

L.	L.	NNP	B-NP	O
gasseri	gasseri	NNP	I-NP	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
by	by	IN	B-PP	O
qPCR	qPCR	NN	B-NP	B-protein
in	in	IN	B-PP	O
29.7	29.7	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
swabs	swab	NNS	I-NP	O
.	.	.	O	O

Breastfed	Breastfe	VBN	B-NP	O
infants	infant	NNS	I-NP	O
had	have	VBD	B-VP	O
significantly	significantly	RB	B-NP	O
higher	high	JJR	I-NP	O
mean	mean	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
L.	L.	FW	B-NP	O
gasseri	gasseri	FW	I-NP	O
(	(	(	O	O
2.14	2.14	CD	B-NP	O
pg/uL	pg/uL	NN	I-NP	O
)	)	)	O	O
than	than	IN	B-PP	O
infants	infant	NNS	B-NP	O
fed	feed	VBN	B-VP	O
the	the	DT	B-NP	O
standard	standard	JJ	I-NP	O
(	(	(	O	O
0.363	0.363	CD	B-NP	O
pg/uL	pg/uL	NN	I-NP	O
)	)	)	O	O
or	or	CC	O	O
MFGM	MFGM	NN	B-NP	B-protein
(	(	(	O	O
0.697	0.697	CD	B-NP	O
pg/uL	pg/uL	NN	I-NP	O
)	)	)	O	O
formula	formula	NN	B-NP	O
.	.	.	O	O

lactobacilli	lactobacillus	NNS	B-NP	O
colonized	colonize	VBD	B-VP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
of	of	IN	B-PP	O
breastfed	breastfe	VBN	B-NP	O
infants	infant	NNS	I-NP	O
significantly	significantly	RB	B-ADVP	O
more	more	RBR	I-ADVP	O
frequently	frequently	RB	I-ADVP	O
than	than	IN	B-PP	O
formula-fed	formula-fed	JJ	B-NP	O
infants	infant	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
dominant	dominant	JJ	I-NP	O
Lactobacillus	Lactobacillus	NN	I-NP	O
was	be	VBD	B-VP	O
L.	L.	NNP	B-NP	O
gasseri	gasseri	NNP	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
at	at	IN	B-PP	O
higher	high	JJR	B-NP	O
levels	level	NNS	I-NP	O
in	in	IN	B-PP	O
breastfed	breastfe	VBN	B-VP	O
than	than	IN	B-PP	O
formula-fed	formula-fed	JJ	B-NP	O
infants	infant	NNS	I-NP	O
and	and	CC	O	O
displayed	display	VBD	B-VP	O
probiotic	probiotic	JJ	B-NP	O
traits	trait	NNS	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
infection	infection	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
bacteremia	bacteremia	NN	B-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
undergoing	undergo	VBG	B-VP	O
hematopoietic	hematopoietic	JJ	B-NP	O
stem	stem	NN	I-NP	O
cell	cell	NN	I-NP	O
transplant	transplant	NN	I-NP	O
(	(	(	O	O
HSCT	HSCT	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
poor	poor	JJ	B-NP	O
periodontal	periodontal	JJ	I-NP	O
status	status	NN	I-NP	O
and	and	CC	O	O
complications	complication	NNS	B-NP	O
after	after	IN	B-PP	O
HSCT	HSCT	NN	B-NP	B-protein
.	.	.	O	O

A	A	DT	B-NP	O
cohort	cohort	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
hematological	hematological	JJ	B-NP	O
malignancies	malignancy	NNS	I-NP	O
candidates	candidate	NNS	I-NP	O
for	for	IN	B-PP	O
autologous	autologous	JJ	B-NP	O
HSCT	HSCT	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
before	before	IN	B-PP	O
and	and	CC	I-PP	O
during	during	IN	I-PP	O
the	the	DT	B-NP	O
neutropenic	neutropenic	JJ	I-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
HSCT	HSCT	NN	B-NP	B-protein
.	.	.	O	O

A	A	DT	B-NP	O
primary	primary	JJ	I-NP	O
evaluation	evaluation	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
before	before	IN	B-PP	O
the	the	DT	B-NP	O
HSCT	HSCT	NN	I-NP	O
procedure	procedure	NN	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
medical	medical	JJ	B-NP	O
and	and	CC	I-NP	O
socio-demographic	socio-demographic	JJ	I-NP	O
data	datum	NNS	I-NP	O
and	and	CC	O	O
physical	physical	JJ	B-NP	O
examination	examination	NN	I-NP	O
(	(	(	O	O
number	number	NN	B-NP	O
of	of	IN	B-PP	O
teeth	tooth	NNS	B-NP	O
and	and	CC	O	O
decayed	decay	VBN	B-VP	O
,	,	,	O	O
missing	miss	VBG	B-VP	O
and	and	CC	O	O
filled	fill	VBN	B-VP	O
teeth	teeth	JJ	B-NP	O
index	index	NN	I-NP	O
(	(	(	O	O
DMFT	DMFT	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
oral	oral	JJ	B-NP	O
mucosa	mucosa	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
full	full	JJ	B-NP	O
mouth	mouth	NN	I-NP	O
periodontal	periodontal	JJ	I-NP	O
assessment	assessment	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
neutropenic	neutropenic	JJ	I-NP	O
phase	phase	NN	I-NP	O
,	,	,	O	O
data	datum	NNS	B-NP	O
regarding	regard	VBG	B-VP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
febrile	febrile	JJ	B-NP	O
neutropenia	neutropenia	NN	I-NP	O
,	,	,	O	O
bacteremia	bacteremia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
mucositis	mucositis	NN	B-NP	O
were	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
prospectively	prospectively	RB	B-ADJP	O
obtained	obtain	VBN	I-ADJP	O
.	.	.	O	O

Forty-eight	Forty-eight	CD	B-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
included	include	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
most	most	RBS	I-NP	O
common	common	JJ	I-NP	O
baseline	baseline	NN	I-NP	O
disease	disease	NN	I-NP	O
was	be	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
myeloma	myeloma	NN	I-NP	O
(	(	(	O	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
evaluations	evaluation	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
median	median	JJ	I-NP	O
DMFT	DMFT	NN	I-NP	O
was	be	VBD	B-VP	O
13	13	CD	B-NP	O
(	(	(	O	O
ranging	range	VBG	B-VP	B-protein
0-27	0-27	CD	B-NP	I-protein
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
periodontitis	periodontitis	NN	B-NP	O
and	and	CC	I-NP	O
gingivitis	gingivitis	NN	I-NP	O
were	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
29	29	CD	B-NP	O
and	and	CC	I-NP	O
60	60	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
neutropenic	neutropenic	JJ	I-NP	O
phase	phase	NN	I-NP	O
of	of	IN	B-PP	O
HSCT	HSCT	NN	B-NP	B-protein
,	,	,	O	O
fever	fever	NN	B-NP	O
occurred	occur	VBD	B-VP	O
in	in	IN	B-PP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
bacteremia	bacteremia	NN	B-NP	O
was	be	VBD	B-VP	O
documented	document	VBN	I-VP	O
in	in	IN	B-PP	O
29	29	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Coagulase-negative	Coagulase-negative	JJ	B-NP	O
Staphylococcus	Staphylococcus	NN	I-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
common	common	JJ	I-NP	O
isolated	isolate	VBN	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

Patients	Patient	NNS	B-NP	O
who	who	WP	B-NP	O
developed	develop	VBD	B-VP	O
bacteremia	bacteremia	NN	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
higher	high	JJR	I-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
disorders	disorder	NNS	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
those	those	DT	B-NP	O
without	without	IN	B-PP	O
bacteremia	bacteremia	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
statistically	statistically	RB	B-ADJP	O
significant	significant	JJ	I-ADJP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
mucositis	mucositis	NN	I-NP	O
affected	affect	VBD	B-VP	O
89.6	89.6	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
gingivitis	gingivitis	NN	B-NP	O
or	or	CC	O	O
periodontal	periodontal	JJ	B-NP	O
disorders	disorder	NNS	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
high	high	JJ	I-NP	O
frequency	frequency	NN	I-NP	O
of	of	IN	B-PP	O
mucositis	mucositis	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
pathologic	pathologic	JJ	I-NP	O
conditions	condition	NNS	I-NP	O
previous	previous	JJ	B-ADJP	O
to	to	TO	B-PP	O
HSCT	HSCT	NN	B-NP	O
procedures	procedure	NNS	I-NP	O
was	be	VBD	B-VP	O
very	very	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
studied	study	VBN	I-NP	O
population	population	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
possible	possible	JJ	I-NP	O
association	association	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
between	between	IN	B-PP	O
previous	previous	JJ	B-NP	O
gingivitis	gingivitis	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
mucositis	mucositis	NN	B-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
neutropenia	neutropenia	NN	I-NP	O
of	of	IN	B-PP	O
HSCT	HSCT	NN	B-NP	B-protein
.	.	.	O	O

To	To	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
DNA	DNA	NN	I-NP	O
sequence	sequence	NN	I-NP	O
variations	variation	NNS	I-NP	O
of	of	IN	B-PP	O
Helicobacter	Helicobacter	NN	B-NP	O
pylori	pylori	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavities	cavity	NNS	I-NP	O
and	and	CC	I-NP	O
stomachs	stomach	NNS	I-NP	O
of	of	IN	B-PP	O
children	child	NNS	B-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
gastritis	gastritis	NN	I-NP	O
.	.	.	O	O

Dental	Dental	JJ	B-NP	O
plaques	plaque	NNS	I-NP	O
and	and	CC	O	O
gargle	gargle	NN	B-NP	O
on	on	IN	B-PP	O
235	235	CD	B-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
before	before	IN	B-PP	O
gastroscopy	gastroscopy	NN	B-NP	O
.	.	.	O	O

Gastric	Gastric	JJ	B-NP	O
H.	H.	NN	I-NP	O
pylori	pylori	NN	I-NP	O
infection	infection	NN	I-NP	O
was	be	VBD	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
using	use	VBG	B-VP	O
rapid	rapid	JJ	B-NP	O
urease	urease	NN	I-NP	O
test	test	NN	I-NP	O
or	or	CC	O	O
Giemsa	Giemsa	NN	B-NP	O
staining	staining	NN	I-NP	O
.	.	.	O	O

H.	H.	NN	B-NP	O
pylori	pylori	NN	I-NP	O
16S	16S	NN	I-NP	O
rDNA	rDNA	NN	I-NP	O
and	and	CC	I-NP	O
CagA	CagA	NN	I-NP	O
gene	gene	NN	I-NP	O
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
using	use	VBG	B-VP	O
PCR	PCR	NN	B-NP	O
methods	method	NNS	I-NP	O
.	.	.	O	O

Thymine	Thymine	NN	B-NP	O
adenine	adenine	NN	I-NP	O
cloning-based	cloning-based	JJ	I-NP	O
sequencing	sequencing	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
CagA	CagA	NN	B-NP	O
gene	gene	NN	I-NP	O
positive	positive	JJ	B-ADJP	O
from	from	IN	B-PP	O
oral	oral	JJ	B-NP	O
cavities	cavity	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
sequence	sequence	NN	I-NP	O
alignments	alignment	NNS	I-NP	O
and	and	CC	O	O
V1	V1	NN	B-NP	B-protein
variable	variable	JJ	I-NP	I-protein
region	region	NN	I-NP	I-protein
were	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
comparison	comparison	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
standard	standard	JJ	I-NP	O
H.	H.	NN	I-NP	O
pylori	pylori	NN	I-NP	O
26695	26695	CD	I-NP	O
strain	strain	NN	I-NP	O
.	.	.	O	O

Totally	Totally	RB	B-ADVP	O
,	,	,	O	O
46	46	CD	B-NP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
235	235	CD	I-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
gastric	gastric	JJ	B-NP	O
H.	H.	NN	I-NP	O
pylori	pylori	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
the	the	DT	B-NP	O
46	46	CD	I-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
26	26	CD	B-NP	O
cases	case	NNS	I-NP	O
had	have	VBD	B-VP	O
amplified	amplify	VBN	I-VP	O
H.	H.	NN	B-NP	B-DNA
pylori	pylori	NN	I-NP	I-DNA
16S	16S	NN	I-NP	I-DNA
rDNA	rDNA	NN	I-NP	I-DNA
in	in	IN	B-PP	O
both	both	CC	O	O
oral	oral	JJ	O	O
(	(	(	O	O
plaque	plaque	NN	B-NP	O
and	and	CC	O	O
gargle	gargle	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
gastric	gastric	JJ	B-NP	O
samples	sample	NNS	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
the	the	DT	B-NP	O
26	26	CD	I-NP	O
cases	case	NNS	I-NP	O
,	,	,	O	O
12	12	CD	B-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
46.1	46.1	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
H.	H.	NN	I-NP	B-DNA
pylori	pylori	NN	I-NP	I-DNA
CagA	CagA	NN	I-NP	I-DNA
gene	gene	NN	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
samples	sample	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
lower	low	JJR	I-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
gastric	gastric	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
(	(	(	O	O
80.8	80.8	CD	B-NP	O
%	%	NN	I-NP	O
;	;	:	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
0.010	0.010	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
homology	homology	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
complete	complete	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
alignment	alignment	NN	I-NP	O
ranged	range	VBD	B-VP	O
from	from	IN	B-PP	O
74.0	74.0	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	B-PP	O
92.1	92.1	CD	B-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
and	and	CC	I-NP	O
gastric	gastric	JJ	I-NP	O
samples	sample	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
V1	V1	NN	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
alleles	allele	NNS	I-NP	I-DNA
(	(	(	O	O
positions	position	NNS	B-NP	O
75-99	75-99	CD	B-NP	O
)	)	)	O	O
had	have	VBD	B-VP	O
7-22	7-22	CD	B-NP	O
polymorphisms	polymorphism	NNS	I-NP	O
(	(	(	O	O
homology	homology	NN	B-NP	O
from	from	IN	B-PP	O
12.0	12.0	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	B-PP	O
72.0	72.0	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
11	11	CD	B-NP	O
patients	patient	NNS	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
and	and	CC	I-NP	O
gastric	gastric	JJ	I-NP	O
samples	sample	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
had	have	VBD	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
homology	homology	NN	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
study	study	NN	I-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
distinct	distinct	JJ	B-NP	O
H.	H.	NN	I-NP	O
pylori	pylori	NN	I-NP	O
strains	strain	NNS	I-NP	O
exist	exist	VBP	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavities	cavity	NNS	I-NP	O
of	of	IN	B-PP	O
children	child	NNS	B-NP	O
,	,	,	O	O
but	but	CC	O	O
we	we	PRP	B-NP	O
would	would	MD	B-VP	O
not	not	RB	I-VP	O
support	support	VB	I-VP	O
the	the	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
that	that	IN	B-SBAR	O
H.	H.	NN	B-NP	O
pylori	pylori	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavities	cavity	NNS	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
reservoir	reservoir	NN	I-NP	O
of	of	IN	B-PP	O
gastric	gastric	JJ	B-NP	O
H.	H.	NN	I-NP	O
pylori	pylori	NN	I-NP	O
infections	infection	NNS	I-NP	O
in	in	IN	B-PP	O
children	child	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
purpose	purpose	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
association	association	NN	I-NP	O
of	of	IN	B-PP	O
dry	dry	JJ	B-NP	O
mouth	mouth	NN	I-NP	O
with	with	IN	B-PP	O
denture	denture	NN	B-NP	O
plaque	plaque	NN	I-NP	O
microflora	microflora	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
palatal	palatal	JJ	B-NP	O
obturator	obturator	NN	I-NP	O
prostheses	prosthesis	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
viewpoint	viewpoint	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

Thirty	Thirty	CD	B-NP	O
palatal	palatal	JJ	I-NP	O
obturator	obturator	NN	I-NP	O
prosthesis	prosthesis	NN	I-NP	O
wearers	wearer	NNS	I-NP	O
were	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
with	with	IN	B-PP	O
30	30	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
maxillary	maxillary	JJ	I-NP	O
complete	complete	JJ	I-NP	O
denture	denture	NN	I-NP	O
wearers	wearer	NNS	I-NP	O
.	.	.	O	O

Dry	Dry	NN	B-NP	O
mouth	mouth	NN	I-NP	O
was	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
moisture-checking	moisture-checking	JJ	I-NP	O
device	device	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
measured	measure	VBN	I-NP	O
moisture	moisture	NN	I-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

Denture	Denture	NN	B-NP	O
plaque	plaque	NN	I-NP	O
was	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
by	by	IN	B-PP	O
rubbing	rub	VBG	B-VP	O
the	the	DT	B-NP	O
mucosal	mucosal	JJ	I-NP	O
surface	surface	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
denture	denture	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
swab	swab	NN	I-NP	O
;	;	:	O	O
collected	collect	VBN	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
were	be	VBD	B-VP	O
cultured	culture	VBN	I-VP	O
and	and	CC	I-VP	O
identified	identify	VBN	I-VP	O
using	use	VBG	B-VP	O
culture-dependent	culture-dependent	JJ	B-NP	O
methods	method	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
colonising	colonise	VBG	B-VP	O
microorganisms	microorganism	NNS	B-NP	O
and	and	CC	I-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
microorganisms	microorganism	NNS	B-NP	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
type	type	NN	I-NP	O
of	of	IN	B-PP	O
prostheses	prosthesis	NNS	B-NP	O
and	and	CC	O	O
presence	presence	NN	B-NP	O
of	of	IN	B-PP	O
dry	dry	JJ	B-NP	O
mouth	mouth	NN	I-NP	O
using	use	VBG	B-VP	O
nonparametric	nonparametric	JJ	B-NP	O
tests	test	NNS	I-NP	O
and	and	CC	O	O
frequency	frequency	NN	B-NP	O
analysis	analysis	NN	I-NP	O
(	(	(	O	O
alpha	alpha	SYM	B-NP	O
=	=	SYM	B-VP	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
Candida	Candida	NNP	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

and	and	CC	O	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

in	in	IN	B-PP	O
palatal	palatal	JJ	B-NP	O
obturator	obturator	NN	I-NP	O
prostheses	prosthesis	NNS	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
in	in	IN	B-PP	O
complete	complete	JJ	B-NP	O
dentures	denture	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
palatal	palatal	JJ	B-NP	O
obturator	obturator	NN	I-NP	O
prostheses	prosthesis	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
colonising	colonise	VBG	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
differences	difference	NNS	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
groups	group	NNS	I-NP	O
with	with	IN	B-PP	O
and	and	CC	B-PP	O
without	without	IN	B-PP	O
dry	dry	JJ	B-NP	O
mouth	mouth	NN	I-NP	O
on	on	IN	B-PP	O
each	each	DT	B-NP	O
side	side	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
prostheses	prosthesis	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
Candida	Candida	NNP	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

and	and	CC	O	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

in	in	IN	B-PP	O
the	the	DT	B-NP	O
group	group	NN	I-NP	O
with	with	IN	B-PP	O
dry	dry	JJ	B-NP	O
mouth	mouth	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
group	group	NN	I-NP	O
without	without	IN	B-PP	O
dry	dry	JJ	B-NP	O
mouth	mouth	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
microorganisms	microorganism	NNS	B-NP	O
and	and	CC	O	O
moisture	moisture	NN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
palatal	palatal	JJ	B-NP	O
obturator	obturator	NN	I-NP	O
prosthesis	prosthesis	NN	I-NP	O
wearers	wearer	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
significantly	significantly	RB	I-NP	O
negative	negative	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
with	with	IN	B-PP	O
Candida	Candida	NNP	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

and	and	CC	O	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
spp.	spp.	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
with	with	IN	B-PP	O
Neisseria	Neisseria	NN	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
palatal	palatal	JJ	B-NP	O
obturator	obturator	NN	I-NP	O
prosthesis	prosthesis	NN	I-NP	O
wearers	wearer	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
dry	dry	JJ	I-NP	O
mouth	mouth	NN	I-NP	O
have	have	VBP	B-VP	O
greater	great	JJR	B-NP	O
colonisation	colonisation	NN	I-NP	O
by	by	IN	B-PP	O
Candida	Candida	NNP	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

and	and	CC	O	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

than	than	IN	B-SBAR	O
do	do	VBP	B-VP	O
complete	complete	JJ	B-NP	O
denture	denture	NN	I-NP	O
wearers	wearer	NNS	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
detect	detect	VB	I-VP	O
predominant	predominant	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
radicular	radicular	JJ	B-NP	O
cysts	cyst	NNS	I-NP	O
and	and	CC	O	O
discuss	discuss	VBP	B-VP	O
in	in	IN	B-PP	O
light	light	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
literature	literature	NN	I-NP	O
.	.	.	O	O

Clinical	Clinical	JJ	B-NP	O
materials	material	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
from	from	IN	B-PP	O
35	35	CD	B-NP	O
radicular	radicular	JJ	I-NP	O
cysts	cyst	NNS	I-NP	O
by	by	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
.	.	.	O	O

Cultures	Culture	NNS	B-NP	O
were	be	VBD	B-VP	O
made	make	VBN	I-VP	O
from	from	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
materials	material	NNS	I-NP	O
by	by	IN	B-PP	O
modern	modern	JJ	B-NP	O
laboratory	laboratory	NN	I-NP	O
techniques	technique	NNS	I-NP	O
,	,	,	O	O
they	they	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
microbiologic	microbiologic	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
following	follow	VBG	I-NP	O
are	be	VBP	B-VP	O
microorganisms	microorganism	NNS	B-NP	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
cultures	culture	NNS	B-NP	O
:	:	:	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
milleri	milleri	NNP	I-NP	O
Group	Group	NNP	I-NP	O
(	(	(	O	O
SMG	SMG	NN	B-NP	O
)	)	)	O	O
(	(	(	O	O
23.8	23.8	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
[	[	(	O	O
Streptococcus	Streptococcus	NN	B-NP	O
constellatus	constellatus	NN	I-NP	O
(	(	(	O	O
19.1	19.1	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
Streptococcus	Streptococcus	NN	B-NP	O
anginosus	anginosus	NN	I-NP	O
(	(	(	O	O
4.7	4.7	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
]	]	)	O	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
sanguis	sanguis	NNP	I-NP	O
(	(	(	O	O
14.3	14.3	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Streptococcus	Streptococcus	NN	B-NP	O
mitis	mitis	NN	I-NP	O
(	(	(	O	O
4.7	4.7	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Streptococcus	Streptococcus	NN	B-NP	O
cremoris	cremoris	NN	I-NP	O
(	(	(	O	O
4.7	4.7	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Peptostreptococcus	Peptostreptococcus	NNP	B-NP	O
pevotii	pevotii	NN	I-NP	O
(	(	(	O	O
4.7	4.7	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Prevotella	Prevotella	NN	B-NP	O
buccae	buccae	NNS	I-NP	O
(	(	(	O	O
4.7	4.7	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Prevotella	Prevotella	NN	B-NP	O
intermedia	intermedia	NNS	I-NP	O
(	(	(	O	O
4.7	4.7	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Actinomyces	Actinomyce	NNPS	B-NP	O
meyeri	meyeri	NNS	I-NP	O
(	(	(	O	O
4.7	4.7	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Actinomyces	Actinomyce	NNPS	B-NP	O
viscosus	viscosus	NN	I-NP	O
(	(	(	O	O
4.7	4.7	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Propionibacterium	Propionibacterium	NN	B-NP	O
propionicum	propionicum	NN	I-NP	O
(	(	(	O	O
4.7	4.7	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Bacteroides	Bacteroide	NNS	B-NP	O
capillosus	capillosus	NN	I-NP	O
(	(	(	O	O
4.7	4.7	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Staphylococcus	Staphylococcus	NN	B-NP	B-protein
hominis	hominis	NN	I-NP	I-protein
(	(	(	O	O
4.7	4.7	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Rothia	Rothia	NNP	B-NP	O
denticariosa	denticariosa	NNP	I-NP	O
(	(	(	O	O
4.7	4.7	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Gemella	Gemella	NN	B-NP	O
haemolysans	haemolysan	NNS	I-NP	O
(	(	(	O	O
4.7	4.7	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
Fusobacterium	Fusobacterium	NN	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
(	(	(	O	O
4.7	4.7	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Results	Result	NNS	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
radicular	radicular	JJ	B-NP	O
cysts	cyst	NNS	I-NP	O
show	show	VBP	B-VP	O
a	a	DT	B-NP	O
great	great	JJ	I-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
and	and	CC	I-NP	O
facultative	facultative	JJ	I-NP	O
anaerobic	anaerobic	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
flora	flora	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
that	that	IN	B-SBAR	O
all	all	DT	B-NP	O
isolated	isolate	VBN	I-NP	O
microorganisms	microorganism	NNS	I-NP	O
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
types	type	NNS	I-NP	O
commonly	commonly	RB	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
flora	flora	NN	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
no	no	DT	B-NP	O
specific	specific	JJ	I-NP	O
microorganism	microorganism	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	I-NP	O
bacteria	bacteria	NNS	I-NP	O
(	(	(	O	O
47.5	47.5	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
especially	especially	RB	I-NP	O
SMG	SMG	NN	I-NP	O
(	(	(	O	O
23.8	23.8	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
-	-	HYPH	B-NP	O
were	be	VBD	B-VP	O
predominantly	predominantly	RB	I-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
isolated	isolate	VBN	B-VP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
radicular	radicular	JJ	B-NP	O
cysts	cyst	NNS	I-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
polymicrobial	polymicrobial	JJ	B-ADJP	O
originated	originate	VBN	B-VP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
radicular	radicular	JJ	B-NP	O
cyst	cyst	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
cyst	cyst	NN	I-NP	O
,	,	,	O	O
some	some	DT	B-NP	O
radicular	radicular	JJ	I-NP	O
cyst	cyst	NN	I-NP	O
fluids	fluid	NNS	I-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
sterile	sterile	JJ	B-ADJP	O
.	.	.	O	O

Gingivitis	Gingivitis	NN	B-NP	O
and	and	CC	I-NP	O
lumpy	lumpy	JJ	I-NP	O
jaw	jaw	NN	I-NP	O
are	be	VBP	B-VP	O
diseases	disease	NNS	B-NP	O
of	of	IN	B-PP	O
polymicrobial	polymicrobial	JJ	B-NP	O
aetiology	aetiology	NN	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
Fusobacterium	Fusobacterium	NN	B-NP	O
necrophorum	necrophorum	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
these	these	DT	B-NP	O
diseases	disease	NNS	I-NP	O
in	in	IN	B-PP	O
macropods	macropod	NNS	B-NP	O
,	,	,	O	O
little	little	JJ	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
about	about	IN	B-PP	O
other	other	JJ	B-NP	O
organisms	organism	NNS	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
these	these	DT	B-NP	O
diseases	disease	NNS	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
animal	animal	NN	I-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

PCR-DGGE	PCR-DGGE	NN	B-NP	O
analysis	analysis	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
the	the	DT	B-NP	O
potential	potential	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
gingivitis	gingivitis	NN	B-NP	O
and	and	CC	O	O
lumpy	lumpy	JJ	B-NP	O
jaw	jaw	NN	I-NP	O
in	in	IN	B-PP	O
macropods	macropod	NNS	B-NP	O
.	.	.	O	O

PCR-DGGE	PCR-DGGE	NN	B-NP	O
profile	profile	NN	I-NP	O
comparison	comparison	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
healthy	healthy	JJ	I-NP	O
and	and	CC	I-NP	O
disease	disease	NN	I-NP	O
groups	group	NNS	I-NP	O
indicated	indicate	VBD	B-VP	O
a	a	DT	B-NP	O
shift	shift	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
community	community	NN	I-NP	O
structures	structure	NNS	I-NP	O
with	with	IN	B-PP	O
similarity	similarity	NN	B-NP	O
coefficients	coefficient	NNS	I-NP	O
of	of	IN	B-PP	O
48	48	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
for	for	IN	B-PP	O
gingivitis	gingivitis	NN	B-NP	O
and	and	CC	O	O
lumpy	lumpy	JJ	B-NP	O
jaw	jaw	NN	I-NP	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
gingivitis	gingivitis	NN	B-NP	O
was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
increase	increase	NN	B-NP	O
in	in	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
diversity	diversity	NN	I-NP	O
(	(	(	O	O
Shannon	Shannon	NN	B-NP	O
index	index	NN	I-NP	O
=	=	SYM	B-VP	O
2.87	2.87	CD	B-NP	O
;	;	:	O	O
PL	PL	NN	B-NP	O
curve	curve	NN	I-NP	O
=	=	SYM	B-VP	O
45	45	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
while	while	IN	B-SBAR	O
lumpy	lumpy	JJ	B-NP	O
jaw	jaw	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
decline	decline	NN	I-NP	O
in	in	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
diversity	diversity	NN	I-NP	O
(	(	(	O	O
Shannon	Shannon	NN	B-NP	O
index	index	NN	I-NP	O
=	=	SYM	B-VP	O
2.47	2.47	CD	B-NP	O
;	;	:	O	O
PL	PL	NN	B-NP	O
curve	curve	NN	I-NP	O
=	=	SYM	B-VP	O
74	74	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
establishment	establishment	NN	I-NP	O
of	of	IN	B-PP	O
gingivitis	gingivitis	NN	B-NP	O
and	and	CC	O	O
lumpy	lumpy	JJ	B-NP	O
jaw	jaw	NN	I-NP	O
diseases	disease	NNS	I-NP	O
follows	follow	VBZ	B-VP	O
the	the	DT	B-NP	O
ecological	ecological	JJ	I-NP	O
plaque	plaque	NN	I-NP	O
hypothesis	hypothesis	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
forms	form	VBZ	B-VP	O
the	the	DT	B-NP	O
basis	basis	NN	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
expanded	expand	VBN	I-NP	O
investigation	investigation	NN	I-NP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
epidemiological	epidemiological	JJ	I-NP	O
scale	scale	NN	I-NP	O
and	and	CC	O	O
suggests	suggest	VBZ	B-VP	O
the	the	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
appropriate	appropriate	JJ	I-NP	O
choice	choice	NN	I-NP	O
of	of	IN	B-PP	O
antimicrobial	antimicrobial	JJ	B-NP	O
agent	agent	NN	I-NP	O
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
and	and	CC	O	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
effective	effective	JJ	I-NP	O
management	management	NN	I-NP	O
and	and	CC	O	O
control	control	NN	B-NP	O
of	of	IN	B-PP	O
polymicrobial	polymicrobial	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

Induced	Induce	VBN	B-NP	O
plant	plant	NN	I-NP	O
defenses	defense	NNS	I-NP	O
in	in	IN	B-PP	O
response	response	NN	B-NP	O
to	to	TO	B-VP	O
herbivore	herbivore	VB	I-VP	O
attack	attack	NN	B-NP	O
are	be	VBP	B-VP	O
modulated	modulate	VBN	I-VP	O
by	by	IN	B-PP	O
cross-talk	cross-talk	NN	B-NP	O
between	between	IN	B-PP	O
jasmonic	jasmonic	JJ	B-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
JA	JA	NN	B-NP	O
)	)	)	O	O
-	-	:	O	O
and	and	CC	O	O
salicylic	salicylic	JJ	B-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
SA	SA	NN	B-NP	O
)	)	)	O	O
-signaling	-signaling	JJ	B-NP	O
pathways	pathway	NNS	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
secretions	secretion	NNS	I-NP	O
from	from	IN	B-PP	O
some	some	DT	B-NP	O
insect	insect	NN	I-NP	O
herbivores	herbivore	NNS	I-NP	O
contain	contain	VBP	B-VP	O
effectors	effector	NNS	B-NP	O
that	that	WDT	B-NP	O
overcome	overcome	VBP	B-VP	O
these	these	DT	B-NP	O
antiherbivore	antiherbivore	JJ	I-NP	O
defenses	defense	NNS	I-NP	O
.	.	.	O	O

Herbivores	Herbivore	NNS	B-NP	O
possess	possess	VBP	B-VP	O
diverse	diverse	JJ	B-NP	O
microbes	microbe	NNS	I-NP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
digestive	digestive	JJ	I-NP	O
systems	system	NNS	I-NP	O
and	and	CC	O	O
these	these	DT	B-NP	O
microbial	microbial	JJ	I-NP	O
symbionts	symbiont	NNS	I-NP	O
can	can	MD	B-VP	O
modify	modify	VB	I-VP	O
plant-insect	plant-insect	JJ	B-NP	O
interactions	interaction	NNS	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
specific	specific	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
herbivore-associated	herbivore-associated	JJ	B-NP	B-DNA
microbes	microbe	NNS	I-NP	I-DNA
in	in	IN	B-PP	O
manipulating	manipulate	VBG	B-VP	O
plant	plant	NN	B-NP	O
defenses	defense	NNS	I-NP	O
remains	remain	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
Colorado	Colorado	NNP	B-NP	O
potato	potato	NN	I-NP	O
beetle	beetle	NN	I-NP	O
(	(	(	O	O
Leptinotarsa	Leptinotarsa	NNP	B-NP	O
decemlineata	decemlineata	NNP	I-NP	O
)	)	)	O	O
larvae	larvae	VBP	B-VP	O
exploit	exploit	NN	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
oral	oral	JJ	I-NP	O
secretions	secretion	NNS	I-NP	O
to	to	TO	B-VP	O
suppress	suppress	VB	I-VP	O
antiherbivore	antiherbivore	JJ	B-NP	O
defenses	defense	NNS	I-NP	O
in	in	IN	B-PP	O
tomato	tomato	NN	B-NP	O
(	(	(	O	O
Solanum	Solanum	NN	B-NP	O
lycopersicum	lycopersicum	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
antibiotic-untreated	antibiotic-untreated	JJ	B-NP	O
larvae	larva	NNS	I-NP	O
decreased	decrease	VBN	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
JA	JA	NN	B-NP	B-protein
and	and	CC	O	O
JA-responsive	JA-responsive	JJ	B-NP	O
antiherbivore	antiherbivore	JJ	I-NP	O
defenses	defense	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
increased	increase	VBD	B-VP	O
SA	SA	NN	B-NP	O
accumulation	accumulation	NN	I-NP	O
and	and	CC	O	O
SA-responsive	SA-responsive	JJ	B-NP	O
gene	gene	NN	I-NP	O
expression	expression	NN	I-NP	O
.	.	.	O	O

Beetles	Beetle	NNS	B-NP	O
benefit	benefit	NN	I-NP	O
from	from	IN	B-PP	O
down-regulating	down-regulate	VBG	B-VP	O
plant	plant	NN	B-NP	O
defenses	defense	NNS	I-NP	O
by	by	IN	B-PP	O
exhibiting	exhibit	VBG	B-VP	O
enhanced	enhance	VBN	I-VP	O
larval	larval	JJ	B-NP	O
growth	growth	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
SA-deficient	SA-deficient	JJ	B-NP	O
plants	plant	NNS	I-NP	O
,	,	,	O	O
suppression	suppression	NN	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
observed	observe	VBN	I-VP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
suppression	suppression	NN	B-NP	O
of	of	IN	B-PP	O
JA-regulated	JA-regulated	JJ	B-NP	O
defenses	defense	NNS	I-NP	O
depends	depend	VBZ	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
SA-signaling	SA-signaling	JJ	I-NP	O
pathway	pathway	NN	I-NP	O
.	.	.	O	O

Applying	Apply	VBG	B-VP	O
bacteria	bacteria	NNS	B-NP	O
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
larval	larval	JJ	B-NP	O
oral	oral	JJ	I-NP	O
secretions	secretion	NNS	I-NP	O
to	to	TO	B-PP	O
wounded	wound	VBN	B-NP	O
plants	plant	NNS	I-NP	O
confirmed	confirm	VBD	B-VP	O
that	that	IN	B-SBAR	O
three	three	CD	B-NP	O
microbial	microbial	JJ	I-NP	O
symbionts	symbiont	NNS	I-NP	O
belonging	belong	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
genera	genera	NN	I-NP	O
Stenotrophomonas	Stenotrophomonas	NNP	B-NP	O
,	,	,	O	O
Pseudomonas	Pseudomonas	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Enterobacter	Enterobacter	NNP	B-NP	O
are	be	VBP	B-VP	O
responsible	responsible	JJ	B-ADJP	O
for	for	IN	B-PP	O
defense	defense	NN	B-NP	O
suppression	suppression	NN	I-NP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
reinoculation	reinoculation	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
to	to	TO	B-PP	O
antibiotic-treated	antibiotic-treated	JJ	B-NP	O
larvae	larva	NNS	I-NP	O
restored	restore	VBD	B-VP	O
their	their	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
suppress	suppress	VB	I-VP	O
defenses	defense	NNS	B-NP	O
.	.	.	O	O

Flagellin	Flagellin	NN	B-NP	B-protein
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
Pseudomonas	Pseudomonas	NN	B-NP	B-protein
sp	sp	NN	I-NP	I-protein
.	.	.	O	O

was	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
defense	defense	NN	B-NP	O
suppression	suppression	NN	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
findings	finding	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
herbivore	herbivore	NN	I-NP	O
exploits	exploit	VBZ	B-VP	O
symbiotic	symbiotic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
decoy	decoy	NN	I-NP	O
to	to	TO	B-VP	O
deceive	deceive	VB	I-VP	O
plants	plant	NNS	B-NP	O
into	into	IN	B-PP	O
incorrectly	incorrectly	RB	B-VP	O
perceiving	perceive	VBG	I-VP	O
the	the	DT	B-NP	O
threat	threat	NN	I-NP	O
as	as	IN	B-PP	O
microbial	microbial	JJ	B-ADJP	O
.	.	.	O	O

By	By	IN	B-PP	O
interfering	interfere	VBG	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
perception	perception	NN	I-NP	O
of	of	IN	B-PP	O
herbivory	herbivory	NN	B-NP	O
,	,	,	O	O
beetles	beetle	NNS	B-NP	O
can	can	MD	B-VP	O
evade	evade	VB	I-VP	O
antiherbivore	antiherbivore	JJ	B-NP	O
defenses	defense	NNS	I-NP	O
of	of	IN	B-PP	O
its	its	PRP$	B-NP	O
host	host	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
examine	examine	VB	I-VP	O
the	the	DT	B-NP	O
histopathological	histopathological	JJ	I-NP	O
characteristics	characteristic	NNS	I-NP	O
of	of	IN	B-PP	O
inflammatory	inflammatory	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
containing	contain	VBG	B-VP	O
Actinomyces	Actinomyce	NNS	B-NP	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
DNA	DNA	NN	B-NP	O
sequencing	sequencing	NN	I-NP	O
.	.	.	O	O

Furthermore	Furthermore	RB	B-ADVP	O
,	,	,	O	O
case	case	NN	B-NP	O
reports	report	NNS	I-NP	O
of	of	IN	B-PP	O
actinomycosis	actinomycosis	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
maxillofacial	maxillofacial	JJ	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
are	be	VBP	B-VP	O
summarized	summarize	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
review	review	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
literature	literature	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
study	study	NN	I-NP	O
comprised	comprise	VBD	B-VP	O
12	12	CD	B-NP	O
cases	case	NNS	I-NP	O
of	of	IN	B-PP	O
inflammatory	inflammatory	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
containing	contain	VBG	B-VP	O
Actinomyces	Actinomyce	NNS	B-NP	O
as	as	IN	B-SBAR	O
diagnosed	diagnose	VBN	B-VP	O
by	by	IN	B-PP	O
DNA	DNA	NN	B-NP	O
analysis	analysis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
average	average	JJ	I-NP	O
age	age	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
subjects	subject	NNS	I-NP	O
was	be	VBD	B-VP	O
59	59	CD	B-NP	O
+/-	+/-	SYM	I-NP	O
15	15	CD	I-NP	O
years	year	NNS	I-NP	O
(	(	(	O	O
6	6	CD	B-NP	O
males	male	NNS	I-NP	O
;	;	:	O	O
6	6	CD	B-NP	O
females	female	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
distribution	distribution	NN	I-NP	O
of	of	IN	B-PP	O
causative	causative	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
was	be	VBD	B-VP	O
:	:	:	O	O
Actinomyces	Actinomyce	NNS	B-NP	O
israelii	israelii	NNS	I-NP	O
in	in	IN	B-PP	O
9	9	CD	B-NP	O
cases	case	NNS	I-NP	O
,	,	,	O	O
Actinomyces	Actinomyce	VBZ	B-VP	O
gerencseriae	gerencseriae	NNS	B-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
cases	case	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Actinomyces	Actinomyce	VBZ	B-VP	O
naeslundii	naeslundii	NN	B-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
case	case	NN	I-NP	O
.	.	.	O	O

Four	Four	CD	B-NP	O
cases	case	NNS	I-NP	O
diagnosed	diagnose	VBN	B-VP	O
by	by	IN	B-PP	O
DNA	DNA	NN	B-NP	O
sequencing	sequencing	NN	I-NP	O
were	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
``	``	``	O	O
Druse	Druse	NNP	B-NP	O
,	,	,	O	O
''	''	''	O	O
a	a	DT	B-NP	O
known	known	JJ	I-NP	O
morphological	morphological	JJ	I-NP	O
diagnostic	diagnostic	JJ	I-NP	O
characteristic	characteristic	NN	I-NP	O
of	of	IN	B-PP	O
actinomycosis	actinomycosis	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
8	8	CD	B-NP	O
cases	case	NNS	I-NP	O
lacked	lack	VBD	B-VP	O
typical	typical	JJ	B-NP	O
colony	colony	NN	I-NP	O
formation	formation	NN	I-NP	O
.	.	.	O	O

DNA	DNA	NN	B-NP	O
analysis	analysis	NN	I-NP	O
using	use	VBG	B-VP	O
paraffin-embedded	paraffin-embedded	JJ	B-NP	O
samples	sample	NNS	I-NP	O
is	be	VBZ	B-VP	O
effective	effective	JJ	B-ADJP	O
for	for	IN	B-PP	O
both	both	CC	O	O
early	early	JJ	B-NP	O
and	and	CC	I-NP	O
accurate	accurate	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
containing	contain	VBG	B-VP	O
Actinomyces	Actinomyce	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
isothiocyanates	isothiocyanate	NNS	B-NP	O
(	(	(	O	O
ITCs	ITC	NNS	B-NP	O
)	)	)	O	O
extracted	extract	VBN	B-VP	O
from	from	IN	B-PP	O
horseradish	horseradish	JJ	B-NP	O
root	root	NN	I-NP	O
was	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
against	against	IN	B-PP	O
oral	oral	JJ	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
:	:	:	O	O
6	6	CD	B-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
facultative	facultative	JJ	B-NP	O
anaerobic	anaerobic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
sobrinus	sobrinus	NNP	I-NP	O
,	,	,	O	O
Lactobacillus	Lactobacillus	NNP	B-NP	O
casei	casei	NNP	I-NP	O
,	,	,	O	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
aureus	aureus	NNP	I-NP	O
,	,	,	O	O
Enterococcus	Enterococcus	NNP	B-NP	O
faecalis	faecalis	NNP	I-NP	O
and	and	CC	O	O
Aggregatibacter	Aggregatibacter	NNP	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
;	;	:	O	O
one	one	CD	B-NP	O
strain	strain	NN	I-NP	O
of	of	IN	B-PP	O
yeast	yeast	NN	B-NP	O
,	,	,	O	O
Candida	Candida	NNP	B-NP	O
albicans	albicans	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
3	3	CD	B-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
,	,	,	O	O
Prevotella	Prevotella	NNP	B-NP	O
nigrescens	nigrescens	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Clostridium	Clostridium	NN	B-NP	O
perfringens	perfringen	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
ITCs	ITC	NNS	I-NP	B-protein
extracted	extract	VBN	B-VP	O
from	from	IN	B-PP	O
horseradish	horseradish	JJ	B-NP	O
root	root	NN	I-NP	O
showed	show	VBD	B-VP	O
antimicrobial	antimicrobial	JJ	B-NP	O
activity	activity	NN	I-NP	O
against	against	IN	B-PP	O
all	all	DT	B-NP	O
oral	oral	JJ	I-NP	O
microorganisms	microorganism	NNS	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
paper	paper	NN	I-NP	O
disk	disk	NN	I-NP	O
method	method	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
minimum	minimum	JJ	I-NP	O
bactericidal	bactericidal	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
(	(	(	O	O
MBC	MBC	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ITCs	ITC	NNS	I-NP	B-protein
extracted	extract	VBN	B-VP	O
from	from	IN	B-PP	O
horseradish	horseradish	JJ	B-NP	O
root	root	NN	I-NP	O
ranged	range	VBD	B-VP	O
from	from	IN	B-PP	O
1.25	1.25	CD	B-NP	O
to	to	TO	I-NP	O
5.00	5.00	CD	I-NP	O
mg/ml	mg/ml	NN	I-NP	O
against	against	IN	B-PP	O
6	6	CD	B-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
facultative	facultative	JJ	B-NP	O
anaerobic	anaerobic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
one	one	CD	B-NP	O
strain	strain	NN	I-NP	O
of	of	IN	B-PP	O
yeast	yeast	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
4.17	4.17	CD	B-NP	O
to	to	TO	I-NP	O
16.67	16.67	CD	I-NP	O
mg/ml	mg/ml	NN	I-NP	O
against	against	IN	B-PP	O
3	3	CD	B-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
ITCs	ITC	NNS	I-NP	B-protein
extracted	extract	VBN	B-VP	O
from	from	IN	B-PP	O
horseradish	horseradish	JJ	B-NP	O
root	root	NN	I-NP	O
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
strongest	strong	JJS	I-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
MBC	MBC	NN	I-NP	O
of	of	IN	B-PP	O
1.25	1.25	CD	B-NP	O
mg/ml	mg/ml	NN	I-NP	O
,	,	,	O	O
against	against	IN	B-PP	O
C.	C.	FW	B-NP	O
albicans	albicans	FW	I-NP	O
among	among	IN	B-PP	O
facultative	facultative	JJ	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
4.17	4.17	CD	B-NP	O
mg/ml	mg/ml	NN	I-NP	O
against	against	IN	B-PP	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
among	among	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
ITCs	ITC	NNS	I-NP	B-protein
extracted	extract	VBN	B-VP	O
from	from	IN	B-PP	O
horseradish	horseradish	NN	B-NP	O
root	root	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
candidate	candidate	NN	I-NP	O
for	for	IN	B-PP	O
use	use	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
agent	agent	NN	I-NP	O
against	against	IN	B-PP	O
oral	oral	JJ	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
.	.	.	O	O

Filamentous	Filamentous	JJ	B-NP	O
multicellular	multicellular	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
are	be	VBP	B-VP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
ancient	ancient	JJ	I-NP	O
multicellular	multicellular	JJ	I-NP	O
organisms	organism	NNS	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
inhabit	inhabit	VBP	B-VP	O
a	a	DT	B-NP	O
great	great	JJ	I-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
environments	environment	NNS	B-NP	O
and	and	CC	O	O
are	be	VBP	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
body	body	NN	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

Beside	Beside	IN	B-PP	O
the	the	DT	B-NP	O
selective	selective	JJ	I-NP	O
advantages	advantage	NNS	I-NP	O
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
larger	large	JJR	I-NP	O
size	size	NN	I-NP	O
achieved	achieve	VBN	B-VP	O
through	through	IN	B-PP	O
filamentation	filamentation	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
multicellular	multicellular	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
also	also	RB	I-VP	O
driven	drive	VBN	I-VP	O
by	by	IN	B-PP	O
simple	simple	JJ	B-NP	B-protein
ecological	ecological	JJ	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
birth	birth	NN	B-NP	O
and	and	CC	I-NP	O
death	death	NN	I-NP	O
rates	rate	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
cellular	cellular	JJ	I-NP	O
level	level	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
extend	extend	VB	I-VP	O
earlier	early	JJR	B-NP	O
results	result	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O
in	in	IN	B-PP	O
aquatic	aquatic	JJ	B-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
investigate	investigate	VBP	B-VP	O
the	the	DT	B-NP	O
filamentation	filamentation	NN	I-NP	O
process	process	NN	I-NP	O
of	of	IN	B-PP	O
four	four	CD	B-NP	O
different	different	JJ	I-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
streptococci	streptococci	NNS	I-NP	O
,	,	,	O	O
namely	namely	RB	B-ADVP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
,	,	,	O	O
S.	S.	NNP	B-NP	O
salivarius	salivarius	NNP	I-NP	O
,	,	,	O	O
S.	S.	NNP	B-NP	O
oralis	oralis	NNP	I-NP	O
and	and	CC	O	O
S.	S.	NNP	B-NP	O
anginosus	anginosus	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
differences	difference	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
capacities	capacity	NNS	I-NP	O
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
streptococcus	streptococcus	NN	I-NP	O
species	specie	NNS	I-NP	O
to	to	TO	B-VP	O
form	form	VB	I-VP	O
filaments	filament	NNS	B-NP	O
,	,	,	O	O
manifested	manifest	VBN	B-VP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
length	length	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
time-scale	time-scale	NN	I-NP	O
of	of	IN	B-PP	O
filament	filament	NN	B-NP	O
elongation	elongation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
filamentation	filamentation	NN	I-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
oral	oral	JJ	I-NP	O
streptococci	streptococci	NNS	I-NP	O
resembles	resemble	VBZ	B-VP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
aquatic	aquatic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
whereby	whereby	WRB	B-ADVP	O
filaments	filament	NNS	B-NP	O
reach	reach	VBP	B-VP	O
a	a	DT	B-NP	O
peak	peak	JJ	I-NP	O
length	length	NN	I-NP	O
during	during	IN	B-PP	O
exponential	exponential	JJ	B-NP	O
growth	growth	NN	I-NP	O
and	and	CC	O	O
become	become	VB	B-VP	O
short	short	JJ	B-ADJP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
population	population	NN	I-NP	O
reaches	reach	VBZ	B-VP	O
a	a	DT	B-NP	O
steady	steady	JJ	I-NP	O
state	state	NN	I-NP	O
.	.	.	O	O

Hence	Hence	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
validates	validate	VBZ	B-VP	O
that	that	IN	B-SBAR	O
multicellularity	multicellularity	NN	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
an	an	DT	B-NP	O
emergent	emergent	JJ	I-NP	O
property	property	NN	I-NP	O
of	of	IN	B-PP	O
filamentous	filamentous	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
ecological	ecological	JJ	I-NP	O
niches	niche	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
phenotypic	phenotypic	JJ	B-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
filamentation	filamentation	NN	B-NP	O
can	can	MD	B-VP	O
occur	occur	VB	I-VP	O
within	within	IN	B-PP	O
species	specie	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
genus	genus	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
case	case	NN	I-NP	O
oral	oral	JJ	B-NP	O
streptococci	streptococci	NNS	I-NP	O
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
that	that	WDT	B-NP	O
specific	specific	JJ	B-NP	O
oral	oral	JJ	I-NP	O
streptococci	streptococci	NNS	I-NP	O
can	can	MD	B-VP	O
play	play	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
etiology	etiology	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
,	,	,	O	O
these	these	DT	B-NP	O
results	result	NNS	I-NP	O
can	can	MD	B-VP	O
possibly	possibly	RB	I-VP	O
open	open	VB	I-VP	O
new	new	JJ	B-NP	O
perspectives	perspective	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
virulence	virulence	NN	I-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

Filifactor	Filifactor	NN	B-NP	O
alocis	alocis	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
gram	gram	NN	I-NP	O
positive	positive	JJ	I-NP	O
anaerobe	anaerobe	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
emerging	emerge	VBG	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
periodontal	periodontal	JJ	I-NP	O
pathogen	pathogen	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
F.	F.	NNP	I-NP	O
alocis	alocis	NNP	I-NP	O
colonizes	colonize	VBZ	B-VP	O
polymicrobial	polymicrobial	JJ	B-NP	O
biofilm	biofilm	NN	I-NP	O
communities	community	NNS	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
little	little	JJ	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
regarding	regard	VBG	B-PP	O
the	the	DT	B-NP	O
nature	nature	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
interactions	interaction	NNS	I-NP	O
between	between	IN	B-PP	O
F.	F.	NNP	B-NP	O
alocis	alocis	NN	I-NP	O
and	and	CC	O	O
other	other	JJ	B-NP	O
oral	oral	JJ	I-NP	O
biofilm	biofilm	NN	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
investigate	investigate	VBP	B-VP	O
the	the	DT	B-NP	O
community	community	NN	I-NP	O
interactions	interaction	NNS	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
F.	F.	NNP	B-NP	O
alocis	alocis	NNP	I-NP	O
with	with	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
gordonii	gordonii	NNP	I-NP	O
,	,	,	O	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
,	,	,	O	O
Porphyromonas	Porphyromonas	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
and	and	CC	O	O
Aggregatibacter	Aggregatibacter	NNP	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
,	,	,	O	O
organisms	organism	NNS	B-NP	O
with	with	IN	B-PP	O
differing	differ	VBG	B-VP	O
pathogenic	pathogenic	JJ	B-NP	O
potential	potential	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
an	an	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
community	community	NN	I-NP	O
development	development	NN	I-NP	O
model	model	NN	I-NP	O
,	,	,	O	O
S.	S.	NNP	B-NP	O
gordonii	gordonii	NN	I-NP	O
was	be	VBD	B-VP	O
antagonistic	antagonistic	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
accumulation	accumulation	NN	I-NP	O
of	of	IN	B-PP	O
F.	F.	NNP	B-NP	O
alocis	alocis	RB	B-ADVP	O
into	into	IN	B-PP	O
a	a	DT	B-NP	O
dual	dual	JJ	I-NP	O
species	specie	NNS	I-NP	O
community	community	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
type	type	NN	I-NP	O
strain	strain	NN	I-NP	O
of	of	IN	B-PP	O
F.	F.	NNP	B-NP	O
alocis	alocis	RB	B-VP	O
formed	form	VBD	I-VP	O
a	a	DT	B-NP	O
synergistic	synergistic	JJ	I-NP	O
partnership	partnership	NN	I-NP	O
.	.	.	O	O

Accumulation	Accumulation	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
passage	passage	NN	I-NP	O
isolate	isolate	NN	I-NP	O
of	of	IN	B-PP	O
F.	F.	NNP	B-NP	O
alocis	alocis	NNP	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
enhanced	enhance	VBN	I-VP	O
by	by	IN	B-PP	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
three	three	CD	B-NP	O
species	specie	NNS	I-NP	O
communities	community	NNS	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
gordonii	gordonii	NNP	I-NP	O
,	,	,	O	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
and	and	CC	O	O
F.	F.	NNP	B-NP	O
alocis	alocis	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
antagonistic	antagonistic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
gordonii	gordonii	NNP	I-NP	O
superseded	supersede	VBD	B-VP	O
the	the	DT	B-NP	O
synergistic	synergistic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
toward	toward	IN	B-PP	O
F.	F.	NNP	B-NP	O
alocis	alocis	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
interaction	interaction	NN	I-NP	O
between	between	IN	B-PP	O
A.	A.	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
and	and	CC	O	O
F.	F.	NNP	B-NP	O
alocis	alocis	NN	I-NP	O
was	be	VBD	B-VP	O
strain	strain	NN	B-NP	O
specific	specific	JJ	I-NP	O
and	and	CC	I-NP	O
A.	A.	NN	I-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
could	could	MD	B-VP	O
either	either	RB	I-VP	O
stimulate	stimulate	VB	I-VP	O
F.	F.	NNP	B-NP	O
alocis	alocis	NN	I-NP	O
accumulation	accumulation	NN	I-NP	O
or	or	CC	O	O
have	have	VB	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
depending	depend	VBG	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
strain	strain	NN	I-NP	O
.	.	.	O	O

P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
and	and	CC	O	O
F.	F.	NNP	B-NP	O
alocis	alocis	RB	B-ADVP	O
formed	form	VBD	B-VP	O
heterotypic	heterotypic	JJ	B-NP	O
communities	community	NNS	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
F.	F.	NNP	B-NP	O
alocis	alocis	NNP	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
benefited	benefit	VBD	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
,	,	,	O	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
F.	F.	NNP	B-NP	O
alocis	alocis	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
dual	dual	JJ	I-NP	O
species	specie	NNS	I-NP	O
community	community	NN	I-NP	O
were	be	VBD	B-VP	O
lower	low	JJR	B-ADJP	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
F.	F.	NNP	B-NP	O
alocis	alocis	RB	B-ADVP	O
alone	alone	RB	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
toward	toward	IN	B-PP	O
F.	F.	NNP	B-NP	O
alocis	alocis	NN	I-NP	O
was	be	VBD	B-VP	O
dependent	dependent	JJ	B-ADJP	O
,	,	,	O	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
partially	partially	RB	B-ADVP	O
,	,	,	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Mfa1	Mfa1	NN	I-NP	B-protein
fimbrial	fimbrial	JJ	I-NP	I-protein
subunit	subunit	NN	I-NP	I-protein
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
AI-2	AI-2	NN	B-NP	B-protein
production	production	NN	I-NP	O
by	by	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
helped	help	VBD	B-VP	O
maintain	maintain	VB	I-VP	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
F.	F.	NNP	B-NP	O
alocis	alocis	NNP	I-NP	O
.	.	.	O	O

Collectively	Collectively	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
results	result	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
pattern	pattern	NN	I-NP	O
of	of	IN	B-PP	O
F.	F.	NNP	B-NP	O
alocis	alocis	NNP	I-NP	O
colonization	colonization	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
dictated	dictate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
spatial	spatial	JJ	I-NP	O
composition	composition	NN	I-NP	O
of	of	IN	B-PP	O
microbial	microbial	JJ	B-NP	O
microenvironments	microenvironment	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
organism	organism	NN	I-NP	O
may	may	MD	B-VP	O
preferentially	preferentially	RB	I-VP	O
accumulate	accumulate	VB	I-VP	O
at	at	IN	B-PP	O
sites	site	NNS	B-NP	O
rich	rich	JJ	B-ADJP	O
in	in	IN	B-PP	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
better	well	RBR	I-VP	O
understand	understand	VB	I-VP	O
the	the	DT	B-NP	O
microbial	microbial	JJ	I-NP	O
basis	basis	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
malodor	malodor	NN	I-NP	O
development	development	NN	I-NP	O
in	in	IN	B-PP	O
humans	human	NNS	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
used	use	VBD	B-VP	O
a	a	DT	B-NP	O
cross-sectional	cross-sectional	JJ	I-NP	O
and	and	CC	I-NP	O
longitudinal	longitudinal	JJ	I-NP	O
study	study	NN	I-NP	O
design	design	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
pyrosequencing	pyrosequencing	NN	I-NP	O
approach	approach	NN	I-NP	O
to	to	TO	B-VP	O
track	track	VB	I-VP	O
and	and	CC	I-VP	O
compare	compare	VB	I-VP	O
the	the	DT	B-NP	O
tongue	tongue	NN	I-NP	O
microbiota	microbiota	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
oral	oral	JJ	B-NP	O
malodor	malodor	NN	I-NP	O
in	in	IN	B-PP	O
29	29	CD	B-NP	O
Chinese	Chinese	JJ	I-NP	O
adults	adult	NNS	I-NP	O
who	who	WP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
consecutive	consecutive	JJ	I-NP	O
three-day	three-day	JJ	I-NP	O
evaluation	evaluation	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
H2S	H2S	NN	B-NP	B-protein
excreted	excrete	VBN	B-VP	O
orally	orally	RB	B-ADVP	O
.	.	.	O	O

Three	Three	CD	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
malodor	malodor	NN	I-NP	O
state	state	NN	I-NP	O
(	(	(	O	O
healthy	healthy	JJ	B-NP	O
,	,	,	I-NP	O
oral	oral	JJ	I-NP	O
malodor	malodor	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
severe	severe	JJ	B-NP	O
oral	oral	JJ	I-NP	O
malodor	malodor	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
defined	define	VBN	I-VP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
H2S	H2S	NN	I-NP	B-protein
level	level	NN	I-NP	O
.	.	.	O	O

Community	Community	NN	B-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tongue	tongue	NN	I-NP	O
plaques	plaque	NNS	I-NP	O
was	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
sensitive	sensitive	JJ	I-ADJP	O
to	to	TO	B-PP	O
changes	change	NNS	B-NP	O
of	of	IN	B-PP	O
malodor	malodor	NN	B-NP	O
state	state	NN	I-NP	O
than	than	IN	B-PP	O
to	to	TO	B-PP	O
interpersonal	interpersonal	JJ	B-NP	O
variations	variation	NNS	I-NP	O
or	or	CC	I-NP	O
differences	difference	NNS	I-NP	O
in	in	IN	B-PP	O
sampling	sample	VBG	B-VP	O
times	time	NNS	B-NP	O
.	.	.	O	O

Within	Within	IN	B-PP	O
each	each	DT	B-NP	O
individual	individual	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
microbiota	microbiota	NN	B-NP	B-protein
was	be	VBD	B-VP	O
relatively	relatively	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
their	their	PRP$	B-NP	O
variations	variation	NNS	I-NP	O
were	be	VBD	B-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
H2S	H2S	NN	I-NP	B-protein
level	level	NN	I-NP	O
.	.	.	O	O

Severe	Severe	JJ	B-NP	O
oral	oral	JJ	I-NP	O
malodor	malodor	NN	I-NP	O
microbiota	microbiota	NNS	I-NP	O
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
conserved	conserve	VBN	B-VP	O
in	in	IN	B-PP	O
community	community	NN	B-NP	O
structure	structure	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
healthy	healthy	JJ	I-NP	O
ones	one	NNS	I-NP	O
were	be	VBD	B-VP	O
relatively	relatively	RB	B-ADJP	O
varied	varied	JJ	I-ADJP	O
.	.	.	O	O

Oral-malodor-associated	Oral-malodor-associated	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
relative	relative	JJ	I-NP	O
abundance	abundance	NN	I-NP	O
of	of	IN	B-PP	O
Leptotrichia	Leptotrichia	NNP	B-NP	O
and	and	CC	I-NP	O
Prevotella	Prevotella	NNP	I-NP	O
was	be	VBD	B-VP	O
positively	positively	RB	I-VP	O
correlated	correlate	VBN	I-VP	O
with	with	IN	B-PP	O
oral	oral	JJ	B-NP	O
malodor	malodor	NN	I-NP	O
severity	severity	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
Hemophilus	Hemophilus	NN	B-NP	O
and	and	CC	I-NP	O
Gemella	Gemella	NN	I-NP	O
exhibited	exhibit	VBD	B-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
relationship	relationship	NN	I-NP	O
with	with	IN	B-PP	O
oral	oral	JJ	B-NP	O
malodor	malodor	NN	I-NP	O
severity	severity	NN	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
study	study	NN	I-NP	O
provides	provide	VBZ	B-VP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
landscapes	landscape	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
microbiota	microbiota	NN	I-NP	O
changes	change	NNS	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
oral	oral	JJ	B-NP	O
malodor	malodor	NN	I-NP	O
development	development	NN	I-NP	O
and	and	CC	O	O
reveals	reveal	VBZ	B-VP	O
microbes	microbe	NNS	B-NP	O
potentially	potentially	RB	B-ADJP	O
useful	useful	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
evaluation	evaluation	NN	I-NP	O
and	and	CC	O	O
control	control	NN	B-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
malodor	malodor	NN	I-NP	O
.	.	.	O	O

Actinomyces	Actinomyce	NNS	B-NP	O
are	be	VBP	B-VP	O
predominant	predominant	JJ	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
their	their	PRP$	B-NP	O
cariogenic	cariogenic	JJ	I-NP	O
potential	potential	NN	I-NP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
acid	acid	NN	B-NP	O
production	production	NN	I-NP	O
and	and	CC	O	O
fluoride	fluoride	NN	B-NP	O
sensitivity	sensitivity	NN	I-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
elucidated	elucidate	VBN	I-VP	O
in	in	IN	B-PP	O
detail	detail	NN	B-NP	O
and	and	CC	O	O
compared	compare	VBN	B-VP	O
with	with	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
caries-associated	caries-associated	JJ	I-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
aimed	aim	VBD	B-VP	O
to	to	TO	I-VP	O
elucidate	elucidate	VB	I-VP	O
and	and	CC	I-VP	O
compare	compare	VB	I-VP	O
the	the	DT	B-NP	O
acid	acid	NN	I-NP	O
production	production	NN	I-NP	O
and	and	CC	O	O
growth	growth	NN	B-NP	O
of	of	IN	B-PP	O
Actinomyces	Actinomyces	NNP	B-NP	O
and	and	CC	I-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	I-PP	O
presence	presence	NN	I-PP	O
of	of	IN	I-PP	O
bicarbonate	bicarbonate	NN	B-NP	O
and	and	CC	I-NP	O
fluoride	fluoride	NN	I-NP	O
to	to	TO	B-PP	O
mimic	mimic	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

Acid	Acid	NN	B-NP	O
production	production	NN	I-NP	O
from	from	IN	B-PP	O
glucose	glucose	NN	B-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
by	by	IN	B-PP	O
pH-stat	pH-stat	NN	B-NP	O
at	at	IN	B-PP	O
pH	pH	NN	B-NP	O
5.5	5.5	CD	I-NP	O
and	and	CC	I-NP	O
7.0	7.0	CD	I-NP	O
under	under	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
.	.	.	O	O

Growth	Growth	NN	B-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
by	by	IN	B-PP	O
optical	optical	JJ	B-NP	O
density	density	NN	I-NP	O
in	in	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
culture	culture	NN	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
Actinomyces	Actinomyce	NNS	B-NP	O
produced	produce	VBD	B-VP	O
acid	acid	NN	B-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
lower	low	JJR	I-NP	O
rate	rate	NN	I-NP	O
than	than	IN	B-SBAR	O
did	do	VBD	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
,	,	,	O	O
their	their	PRP$	B-NP	O
acid	acid	NN	I-NP	O
production	production	NN	I-NP	O
was	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
tolerant	tolerant	JJ	I-ADJP	O
of	of	IN	B-PP	O
fluoride	fluoride	NN	B-NP	O
(	(	(	O	O
IDacid	IDacid	NN	B-NP	O
production	production	NN	I-NP	O
50	50	CD	I-NP	O
=	=	JJ	I-NP	O
110-170	110-170	CD	I-NP	O
ppm	ppm	NN	I-NP	O
at	at	IN	B-PP	O
pH	pH	NN	B-NP	O
7.0	7.0	CD	I-NP	O
and	and	CC	I-NP	O
10-13	10-13	CD	I-NP	O
ppm	ppm	NN	I-NP	O
at	at	IN	B-PP	O
pH	pH	NN	B-NP	O
5.5	5.5	CD	I-NP	O
)	)	)	O	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
(	(	(	O	O
IDacid	IDacid	NN	B-NP	O
production	production	NN	I-NP	O
50	50	CD	I-NP	O
=	=	JJ	I-NP	O
36-53	36-53	CD	I-NP	O
ppm	ppm	NN	I-NP	O
at	at	IN	B-PP	O
pH	pH	NN	B-NP	O
7.0	7.0	CD	I-NP	O
and	and	CC	I-NP	O
6.3-6.5	6.3-6.5	CD	I-NP	O
ppm	ppm	NN	I-NP	O
at	at	IN	B-PP	O
pH	pH	NN	B-NP	O
5.5	5.5	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

Bicarbonate	Bicarbonate	NN	B-NP	O
increased	increase	VBD	B-VP	O
acid	acid	NN	B-NP	O
production	production	NN	I-NP	O
by	by	IN	B-PP	O
Actinomyces	Actinomyce	NNS	B-NP	O
with	with	IN	B-PP	O
prominent	prominent	JJ	B-NP	O
succinate	succinate	NN	I-NP	O
production	production	NN	I-NP	O
and	and	CC	O	O
enhanced	enhance	VBD	B-VP	O
their	their	PRP$	B-NP	O
fluoride	fluoride	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
(	(	(	O	O
IDacid	IDacid	NN	B-NP	O
production	production	NN	I-NP	O
50	50	CD	I-NP	O
=	=	JJ	I-NP	O
220-320	220-320	CD	I-NP	O
ppm	ppm	NN	I-NP	O
at	at	IN	B-PP	O
pH	pH	NN	B-NP	O
7.0	7.0	CD	I-NP	O
and	and	CC	I-NP	O
33-52	33-52	CD	I-NP	O
ppm	ppm	NN	I-NP	O
at	at	IN	B-PP	O
pH	pH	NN	B-NP	O
5.5	5.5	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

Bicarbonate	Bicarbonate	NN	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
these	these	DT	B-NP	O
variables	variable	NNS	I-NP	O
in	in	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
Actinomyces	Actinomyce	NNS	B-NP	O
was	be	VBD	B-VP	O
lower	low	JJR	B-ADJP	O
than	than	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
,	,	,	O	O
Actinomyces	Actinomyces	NNP	B-NP	O
growth	growth	NN	I-NP	O
was	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
tolerant	tolerant	JJ	I-ADJP	O
of	of	IN	B-PP	O
fluoride	fluoride	NN	B-NP	O
(	(	(	O	O
IDgrowth	IDgrowth	NN	B-NP	O
50	50	CD	I-NP	O
=	=	JJ	I-NP	O
130-160	130-160	CD	I-NP	O
ppm	ppm	NN	I-NP	O
)	)	)	O	O
than	than	IN	B-SBAR	O
was	be	VBD	B-VP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
(	(	(	O	O
IDgrowth	IDgrowth	NN	B-NP	O
50	50	CD	I-NP	O
=	=	JJ	I-NP	O
27-36	27-36	CD	I-NP	O
ppm	ppm	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
oral	oral	JJ	B-NP	O
Actinomyces	Actinomyce	NNS	I-NP	O
are	be	VBP	B-VP	O
more	more	RBR	B-ADJP	O
tolerant	tolerant	JJ	I-ADJP	O
of	of	IN	B-PP	O
fluoride	fluoride	NN	B-NP	O
than	than	IN	B-PP	O
oral	oral	JJ	B-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
bicarbonate	bicarbonate	NN	B-NP	O
enhances	enhance	VBZ	B-VP	O
the	the	DT	B-NP	O
fluoride	fluoride	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
Actinomyces	Actinomyce	NNS	I-NP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
limited	limited	JJ	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
species	specie	NNS	B-NP	O
tested	test	VBN	B-VP	O
here	here	RB	B-ADVP	O
,	,	,	O	O
further	further	JJ	B-NP	O
study	study	NN	I-NP	O
is	be	VBZ	B-VP	O
needed	need	VBN	I-VP	O
to	to	TO	B-VP	O
generalize	generalize	VB	I-VP	O
these	these	DT	B-NP	O
findings	finding	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
genus	genus	NN	I-NP	O
level	level	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
distribution	distribution	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
dentine	dentine	JJ	I-NP	O
tubular	tubular	JJ	I-NP	O
network	network	NN	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
two-chamber	two-chamber	JJ	I-NP	O
model	model	NN	I-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
route	route	NN	I-NP	O
of	of	IN	B-PP	O
penetration	penetration	NN	B-NP	O
.	.	.	O	O

Root	Root	NN	B-NP	O
canals	canal	NNS	I-NP	O
of	of	IN	B-PP	O
teeth	tooth	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
experimental	experimental	JJ	I-NP	O
group	group	NN	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
16	16	CD	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
instrumented	instrument	VBN	I-VP	O
and	and	CC	O	O
root	root	NN	B-NP	O
filled	fill	VBN	B-VP	O
using	use	VBG	B-VP	O
AH26	AH26	NN	B-NP	B-protein
and	and	CC	I-NP	O
gutta-percha	gutta-percha	NN	I-NP	O
.	.	.	O	O

Canals	Canal	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
teeth	tooth	NNS	I-NP	O
serving	serve	VBG	B-VP	O
as	as	IN	B-PP	O
positive	positive	JJ	B-ADJP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
negative	negative	JJ	B-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
1	1	CD	B-NP	O
)	)	)	O	O
controls	control	NNS	B-NP	O
were	be	VBD	B-VP	O
instrumented	instrument	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
root	root	NN	B-NP	O
filled	fill	VBN	B-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
two-chamber	two-chamber	JJ	I-NP	O
model	model	NN	I-NP	O
was	be	VBD	B-VP	O
fabricated	fabricate	VBN	I-VP	O
for	for	IN	B-PP	O
each	each	DT	B-NP	O
root	root	NN	I-NP	O
-	-	HYPH	B-NP	O
upper	upper	JJ	I-NP	O
chambers	chamber	NNS	I-NP	O
were	be	VBD	B-VP	O
inoculated	inoculate	VBN	I-VP	O
weekly	weekly	RB	B-ADVP	O
with	with	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
gordonii	gordonii	NNP	I-NP	O
in	in	IN	B-PP	O
brain-heart	brain-heart	NN	B-NP	O
infusion	infusion	NN	I-NP	O
broth	broth	NN	I-NP	O
over	over	IN	B-PP	O
90	90	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Turbidity	Turbidity	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
chamber	chamber	NN	I-NP	O
was	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Samples	Sample	NNS	B-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
turbidity	turbidity	NN	B-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
experimental	experimental	JJ	I-NP	O
period	period	NN	I-NP	O
and	and	CC	I-NP	O
samples	sample	NNS	I-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
turbidity	turbidity	NN	B-NP	O
at	at	IN	B-PP	O
90	90	CD	B-NP	O
days	day	NNS	I-NP	O
were	be	VBD	B-VP	O
fractured	fracture	VBN	I-VP	O
and	and	CC	O	O
prepared	prepare	VBN	B-VP	O
for	for	IN	B-PP	O
SEM	SEM	NN	B-NP	O
examination	examination	NN	I-NP	O
.	.	.	O	O

SEM	SEM	NN	B-NP	O
examination	examination	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
dentinal	dentinal	JJ	I-NP	O
tubules	tubule	NNS	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cervical	cervical	JJ	I-NP	O
,	,	,	I-NP	O
middle	middle	JJ	I-NP	O
and	and	CC	I-NP	O
apical	apical	JJ	I-NP	O
root	root	NN	I-NP	O
thirds	third	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
each	each	DT	B-NP	O
root	root	NN	I-NP	O
third	third	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
depth	depth	NN	I-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
penetration	penetration	NN	I-NP	O
was	be	VBD	B-VP	O
recorded	record	VBN	I-VP	O
as	as	IN	B-PP	O
inner	inner	JJ	B-NP	O
,	,	,	I-NP	O
middle	middle	JJ	I-NP	O
or	or	CC	I-NP	O
outer	outer	JJ	I-NP	O
dentine	dentine	NN	I-NP	O
.	.	.	O	O

Bacteria	Bacteria	NNS	B-NP	O
were	be	VBD	B-VP	O
most	most	RBS	I-VP	O
commonly	commonly	RB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
cervical	cervical	JJ	I-NP	O
third	third	JJ	I-NP	O
(	(	(	O	O
14	14	CD	B-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
areas	area	NNS	I-NP	O
)	)	)	O	O
.	.	.	O	O

Irrespective	Irrespective	JJ	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
root	root	NN	I-NP	O
third	third	JJ	I-NP	O
examined	examine	VBN	B-VP	O
,	,	,	O	O
bacteria	bacteria	NNS	B-NP	O
were	be	VBD	B-VP	O
most	most	RBS	I-VP	O
commonly	commonly	RB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
inner	inner	JJ	I-NP	O
dentine	dentine	NN	I-NP	O
(	(	(	O	O
i.e	i.e	JJ	B-ADJP	O
.	.	.	O	O

adjacent	adjacent	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
root	root	NN	I-NP	O
canal	canal	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Only	Only	RB	B-NP	O
two	two	CD	I-NP	O
samples	sample	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
bacterial	bacterial	JJ	B-NP	O
penetration	penetration	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
outer	outer	JJ	I-NP	O
dentine	dentine	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
dentine	dentine	JJ	I-NP	O
tubular	tubular	JJ	I-NP	O
network	network	NN	I-NP	O
provides	provide	VBZ	B-VP	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
pathway	pathway	NN	I-NP	O
for	for	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
to	to	TO	B-VP	O
penetrate	penetrate	VB	I-VP	O
tooth	tooth	JJ	B-NP	O
roots	root	NNS	I-NP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
two-chamber	two-chamber	JJ	I-NP	O
model	model	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
selective	selective	JJ	B-NP	O
detection	detection	NN	I-NP	O
of	of	IN	B-PP	O
viable	viable	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
with	with	IN	B-PP	O
molecular	molecular	JJ	B-NP	O
methods	method	NNS	I-NP	O
,	,	,	O	O
propidium	propidium	NN	B-NP	O
monoazide	monoazide	NN	I-NP	O
(	(	(	O	O
PMA	PMA	NN	B-NP	O
)	)	)	O	O
treatment	treatment	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
successfully	successfully	RB	I-VP	O
applied	apply	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
wide	wide	JJ	I-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
purpose	purpose	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
compare	compare	VB	I-VP	O
the	the	DT	B-NP	O
quantity	quantity	NN	I-NP	O
of	of	IN	B-PP	O
live	live	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
with	with	IN	B-PP	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
both	both	CC	B-NP	O
live	live	JJ	I-NP	O
and	and	CC	I-NP	O
dead	dead	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
before	before	IN	B-PP	O
and	and	CC	I-PP	O
after	after	IN	I-PP	O
chemomechanical	chemomechanical	JJ	B-NP	O
preparation	preparation	NN	I-NP	O
by	by	IN	B-PP	O
using	use	VBG	B-VP	O
PMA	PMA	NN	B-NP	O
in	in	IN	B-PP	O
combination	combination	NN	B-NP	O
with	with	IN	B-PP	O
real-time	real-time	JJ	B-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
(	(	(	O	O
qPCR	qPCR	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

Twenty-one	Twenty-one	CD	B-NP	O
teeth	tooth	NNS	I-NP	O
with	with	IN	B-PP	O
pulp	pulp	NN	B-NP	O
necrosis	necrosis	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
periapical	periapical	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
were	be	VBD	B-VP	O
included	include	VBN	I-VP	O
.	.	.	O	O

Bacterial	Bacterial	JJ	B-NP	O
sampling	sampling	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
root	root	NN	I-NP	O
canals	canal	NNS	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
before	before	IN	B-PP	O
(	(	(	O	O
S1	S1	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
after	after	IN	B-SBAR	O
(	(	(	O	O
S2	S2	NN	B-NP	B-protein
)	)	)	I-NP	O
chemomechanical	chemomechanical	JJ	I-NP	O
root	root	NN	I-NP	O
canal	canal	NN	I-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

Each	Each	DT	B-NP	O
sample	sample	NN	I-NP	O
was	be	VBD	B-VP	O
separated	separate	VBN	I-VP	O
into	into	IN	B-PP	O
2	2	CD	B-NP	O
different	different	JJ	I-NP	O
tubes	tube	NNS	I-NP	O
.	.	.	O	O

PMA	PMA	NN	B-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
to	to	TO	B-PP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tubes	tube	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
was	be	VBD	B-VP	O
left	leave	VBN	I-VP	O
untreated	untreated	JJ	B-ADJP	O
.	.	.	O	O

Then	Then	RB	B-ADVP	O
,	,	,	O	O
DNA	DNA	NN	B-NP	O
extraction	extraction	NN	I-NP	O
and	and	CC	I-NP	O
qPCR	qPCR	NN	I-NP	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
.	.	.	O	O

To	To	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
validity	validity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
PMA	PMA	NN	I-NP	O
treatment	treatment	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
defined	define	VBN	I-NP	O
mixtures	mixture	NNS	I-NP	O
containing	contain	VBG	B-VP	O
different	different	JJ	B-NP	O
ratios	ratio	NNS	I-NP	O
of	of	IN	B-PP	O
live	live	JJ	B-NP	O
and	and	CC	I-NP	O
dead	dead	JJ	I-NP	O
cell	cell	NN	I-NP	O
suspensions	suspension	NNS	I-NP	O
of	of	IN	B-PP	O
Enterococcus	Enterococcus	NNP	B-NP	O
faecalis	faecali	NNPS	I-NP	O
were	be	VBD	B-VP	O
either	either	RB	I-VP	O
subjected	subject	VBN	I-VP	O
to	to	TO	B-PP	O
PMA	PMA	NN	B-NP	O
treatment	treatment	NN	I-NP	O
or	or	CC	O	O
not	not	RB	B-VP	O
subjected	subject	VBN	I-VP	O
to	to	TO	B-PP	O
PMA	PMA	NN	B-NP	O
treatment	treatment	NN	I-NP	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
qPCR	qPCR	NN	B-NP	O
quantification	quantification	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
paired	paired	JJ	I-NP	O
t	t	NN	I-NP	O
test	test	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
highly	highly	RB	I-NP	O
significant	significant	JJ	I-NP	O
difference	difference	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mean	mean	JJ	I-NP	O
threshold	threshold	NN	I-NP	O
cycle	cycle	NN	I-NP	O
values	value	NNS	I-NP	O
between	between	IN	B-PP	O
S1	S1	NN	B-NP	B-protein
with	with	IN	B-PP	O
and	and	CC	I-PP	O
without	without	IN	I-PP	O
PMA	PMA	NN	B-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
.0002	.0002	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
difference	difference	NN	I-NP	O
(	(	(	O	O
0.89	0.89	CD	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
(	(	(	O	O
0.96	0.96	CD	O	O
)	)	)	O	O
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
samples	sample	NNS	I-NP	O
consisting	consist	VBG	B-VP	O
of	of	IN	B-PP	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
live	live	JJ	I-NP	O
cell	cell	NN	I-NP	O
suspension	suspension	NN	I-NP	O
and	and	CC	O	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
dead	dead	JJ	I-NP	O
cell	cell	NN	I-NP	O
suspension	suspension	NN	I-NP	O
of	of	IN	B-PP	O
E.	E.	NNP	B-NP	O
faecalis	faecalis	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
threshold	threshold	NN	I-NP	O
cycle	cycle	NN	I-NP	O
values	value	NNS	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
S2	S2	NN	I-NP	O
samples	sample	NNS	I-NP	O
with	with	IN	B-PP	O
and	and	CC	I-PP	O
without	without	IN	I-PP	O
PMA	PMA	NN	B-NP	O
were	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
significantly	significantly	RB	B-ADJP	O
different	different	JJ	I-ADJP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
.0134	.0134	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
difference	difference	NN	I-NP	O
(	(	(	O	O
0.37	0.37	CD	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
live	live	JJ	I-NP	O
cell	cell	NN	I-NP	O
suspension	suspension	NN	I-NP	O
of	of	IN	B-PP	O
E.	E.	FW	B-NP	O
faecalis	faecalis	NN	I-NP	O
(	(	(	O	O
0.42	0.42	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

PMA	PMA	NN	B-NP	O
in	in	IN	B-PP	O
conjunction	conjunction	NN	B-NP	O
with	with	IN	B-PP	O
qPCR	qPCR	NN	B-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
useful	useful	JJ	B-ADJP	O
in	in	IN	B-PP	O
analyzing	analyze	VBG	B-VP	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
infections	infection	NNS	I-NP	O
of	of	IN	B-PP	O
root	root	NN	B-NP	O
canals	canal	NNS	I-NP	O
because	because	IN	B-SBAR	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
significant	significant	JJ	B-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
dead	dead	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
root	root	NN	I-NP	O
canals	canal	NNS	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
PMA	PMA	NN	B-NP	O
treatment	treatment	NN	I-NP	O
in	in	IN	B-PP	O
post-preparation	post-preparation	JJ	B-NP	O
samples	sample	NNS	I-NP	O
significantly	significantly	RB	B-ADVP	O
reduced	reduce	VBD	B-VP	O
the	the	DT	B-NP	O
detection	detection	NN	I-NP	O
of	of	IN	B-PP	O
dead	dead	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
difference	difference	NN	I-NP	O
was	be	VBD	B-VP	O
still	still	RB	B-ADVP	O
small	small	JJ	B-ADJP	O
,	,	,	O	O
so	so	RB	O	O
further	further	JJ	B-NP	O
studies	study	NNS	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
carried	carry	VBN	I-VP	O
out	out	RP	B-PRT	O
to	to	TO	B-VP	O
confirm	confirm	VB	I-VP	O
the	the	DT	B-NP	O
necessity	necessity	NN	I-NP	O
of	of	IN	B-PP	O
PMA	PMA	NN	B-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
acquisition	acquisition	NN	I-NP	O
and	and	CC	I-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
complex	complex	JJ	I-NP	O
oral	oral	JJ	I-NP	O
microbiome	microbiome	NN	I-NP	O
remain	remain	VBP	B-VP	O
ill	ill	RB	B-ADJP	O
defined	define	VBN	I-ADJP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
selected	select	VBN	B-NP	O
species	specie	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
examined	examine	VBN	I-VP	O
in	in	IN	B-PP	O
relation	relation	NN	B-NP	O
to	to	TO	B-PP	O
their	their	PRP$	B-NP	O
initial	initial	JJ	I-NP	O
colonization	colonization	NN	I-NP	O
in	in	IN	B-PP	O
neonates	neonate	NNS	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
more	more	RBR	I-NP	O
detailed	detailed	JJ	I-NP	O
understanding	understanding	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
dynamics	dynamic	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
microbiome	microbiome	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
developed	develop	VBN	I-VP	O
only	only	RB	B-ADVP	O
in	in	IN	B-PP	O
adults	adult	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
current	current	JJ	I-NP	O
investigation	investigation	NN	I-NP	O
used	use	VBD	B-VP	O
a	a	DT	B-NP	O
nonhuman	nonhuman	JJ	I-NP	O
primate	primate	JJ	I-NP	O
model	model	NN	I-NP	O
to	to	TO	B-VP	O
document	document	VB	I-VP	O
the	the	DT	B-NP	O
kinetics	kinetic	NNS	I-NP	O
of	of	IN	B-PP	O
colonization	colonization	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavities	cavity	NNS	I-NP	O
of	of	IN	B-PP	O
newborns	newborn	NNS	B-NP	O
and	and	CC	I-NP	O
infants	infant	NNS	I-NP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
commensals	commensal	NNS	I-NP	O
and	and	CC	I-NP	O
pathogens	pathogen	NNS	I-NP	O
.	.	.	O	O

Differences	Difference	NNS	B-NP	O
in	in	IN	B-PP	O
colonization	colonization	NN	B-NP	O
were	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
in	in	IN	B-PP	O
newborns	newborn	NNS	B-NP	O
from	from	IN	B-PP	O
mothers	mother	NNS	B-NP	O
who	who	WP	B-NP	O
were	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
oral	oral	JJ	I-NP	O
hygiene	hygiene	NN	I-NP	O
regimen	regimen	NN	I-NP	O
pre-	pre-	NN	I-NP	O
and	and	CC	I-NP	O
postparturition	postparturition	NN	I-NP	O
with	with	IN	B-PP	O
those	those	DT	B-NP	O
displaying	display	VBG	B-NP	O
naturally	naturally	RB	I-NP	O
acquired	acquire	VBN	I-NP	O
gingivitis/periodontitis	gingivitis/periodontitis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
distinct	distinct	JJ	B-NP	O
profiles	profile	NNS	I-NP	O
of	of	IN	B-PP	O
acquisition	acquisition	NN	B-NP	O
of	of	IN	B-PP	O
selected	select	VBN	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
transmission	transmission	NN	I-NP	O
of	of	IN	B-PP	O
targeted	target	VBN	B-NP	O
pathogens	pathogen	NNS	I-NP	O
,	,	,	O	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
and	and	CC	I-NP	O
Aggregatibacter	Aggregatibacter	NN	I-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
,	,	,	O	O
being	be	VBG	B-VP	O
passed	pass	VBN	I-VP	O
on	on	RP	B-PRT	O
primarily	primarily	RB	B-ADVP	O
from	from	IN	B-PP	O
mothers	mother	NNS	B-NP	O
with	with	IN	B-PP	O
gingivitis/periodontitis	gingivitis/periodontitis	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
colonization	colonization	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
defined	define	VBN	B-NP	O
patterns	pattern	NNS	I-NP	O
of	of	IN	B-PP	O
systemic	systemic	JJ	B-NP	O
antibody	antibody	NN	I-NP	O
responses	response	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
infants	infant	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
significant	significant	JJ	I-NP	O
relative	relative	JJ	I-NP	O
risk	risk	NN	I-NP	O
measures	measure	NNS	I-NP	O
for	for	IN	B-PP	O
infection	infection	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
pathogens	pathogen	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
infection	infection	NN	I-NP	O
and	and	CC	I-NP	O
blood	blood	NN	I-NP	O
serum	serum	NN	I-NP	O
antibody	antibody	NN	I-NP	O
levels	level	NNS	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
those	those	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
newborns	newborn	NNS	I-NP	O
from	from	IN	B-PP	O
mothers	mother	NNS	B-NP	O
with	with	IN	B-PP	O
gingivitis/periodontitis	gingivitis/periodontitis	NN	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
acquisition	acquisition	NN	I-NP	O
of	of	IN	B-PP	O
potentially	potentially	RB	B-NP	O
pathogenic	pathogenic	JJ	I-NP	O
oral	oral	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
might	might	MD	B-VP	O
impact	impact	VB	I-VP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
mucosal	mucosal	JJ	B-NP	O
responses	response	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
gingiva	gingiva	NN	I-NP	O
and	and	CC	O	O
may	may	MD	B-VP	O
provide	provide	VB	I-VP	O
an	an	DT	B-NP	O
enhanced	enhance	VBN	I-NP	O
risk	risk	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
periodontitis	periodontitis	NN	B-NP	O
later	later	RB	B-ADVP	O
in	in	IN	B-PP	O
life	life	NN	B-NP	O
.	.	.	O	O

Oropharyngeal	Oropharyngeal	JJ	B-NP	O
candidiasis	candidiasis	NN	I-NP	O
(	(	(	O	O
OPC	OPC	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
caused	cause	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
opportunistic	opportunistic	JJ	I-NP	O
fungi	fungus	NNS	I-NP	O
Candida	Candida	NNP	B-NP	O
albicans	albican	VBZ	B-VP	O
and	and	CC	I-VP	O
is	be	VBZ	I-VP	O
prevalent	prevalent	JJ	B-ADJP	O
in	in	IN	B-PP	O
immunocompromised	immunocompromised	JJ	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
individuals	individual	NNS	B-NP	O
with	with	IN	B-PP	O
dry	dry	JJ	B-NP	O
mouth	mouth	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
prolonged	prolonged	JJ	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
therapies	therapy	NNS	I-NP	O
that	that	WDT	B-NP	O
reduce	reduce	VBP	B-VP	O
oral	oral	JJ	B-NP	O
commensal	commensal	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

Human	Human	JJ	B-NP	B-protein
salivary	salivary	JJ	I-NP	I-protein
histatins	histatin	NNS	I-NP	I-protein
,	,	,	O	O
including	include	VBG	B-PP	O
histatin	histatin	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
(	(	(	O	O
Hst	Hst	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
)	)	)	O	O
,	,	,	O	O
are	be	VBP	B-VP	O
small	small	JJ	B-NP	B-protein
cationic	cationic	JJ	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
fungicidal	fungicidal	JJ	B-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
saliva	saliva	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
Hsts	Hst	NNS	B-NP	O
are	be	VBP	B-VP	O
rapidly	rapidly	RB	I-VP	O
degraded	degrade	VBN	I-VP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
,	,	,	O	O
limiting	limit	VBG	B-VP	O
their	their	PRP$	B-NP	O
usefulness	usefulness	NN	I-NP	O
as	as	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	O
agents	agent	NNS	I-NP	O
despite	despite	IN	B-PP	O
their	their	PRP$	B-NP	O
lack	lack	NN	I-NP	O
of	of	IN	B-PP	O
toxicity	toxicity	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
constructed	construct	VBD	B-VP	O
a	a	DT	B-NP	O
conjugate	conjugate	JJ	I-NP	O
peptide	peptide	NN	I-NP	O
using	use	VBG	B-VP	O
spermidine	spermidine	NN	B-NP	O
(	(	(	O	O
Spd	Spd	NN	B-NP	O
)	)	)	O	O
linked	link	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
active	active	JJ	I-NP	O
fragment	fragment	NN	I-NP	O
of	of	IN	B-PP	O
Hst	Hst	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
(	(	(	O	O
Hst	Hst	NN	B-NP	O
54-15	54-15	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
based	base	VBN	B-VP	O
upon	upon	IN	B-PP	O
our	our	PRP$	B-NP	O
findings	finding	NNS	I-NP	O
that	that	IN	B-SBAR	O
C.	C.	FW	B-NP	B-protein
albicans	albicans	FW	I-NP	I-protein
spermidine	spermidine	NN	I-NP	I-protein
transporters	transporter	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
required	require	VBN	I-VP	O
for	for	IN	B-PP	O
Hst	Hst	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
uptake	uptake	NN	I-NP	O
and	and	CC	O	O
fungicidal	fungicidal	JJ	B-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
found	find	VBD	B-VP	O
that	that	IN	B-SBAR	O
Hst	Hst	NN	B-NP	O
54-15-Spd	54-15-Spd	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	B-ADJP	O
more	more	RBR	I-ADJP	O
effective	effective	JJ	I-ADJP	O
in	in	IN	B-PP	O
killing	kill	VBG	B-VP	O
C.	C.	NNP	B-NP	O
albicans	albicans	NNP	I-NP	O
and	and	CC	I-NP	O
Candida	Candida	NNP	I-NP	O
glabrata	glabrata	NNS	I-NP	O
than	than	IN	B-PP	O
Hst	Hst	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
alone	alone	RB	B-ADVP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
planktonic	planktonic	JJ	I-NP	O
and	and	CC	I-NP	O
biofilm	biofilm	NN	I-NP	O
growth	growth	NN	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
Hst	Hst	NN	B-NP	O
54-15-Spd	54-15-Spd	JJ	I-NP	O
retained	retain	VBN	I-NP	O
high	high	JJ	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
both	both	CC	O	O
serum	serum	NN	B-NP	O
and	and	CC	I-NP	O
saliva	saliva	NN	I-NP	O
.	.	.	O	O

Hst	Hst	NN	B-NP	O
54-15-Spd	54-15-Spd	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
bactericidal	bactericidal	JJ	B-ADJP	O
against	against	IN	B-PP	O
streptococcal	streptococcal	JJ	B-NP	O
oral	oral	JJ	I-NP	O
commensal	commensal	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
hemolytic	hemolytic	JJ	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
tested	test	VBD	B-VP	O
the	the	DT	B-NP	O
effectiveness	effectiveness	NN	I-NP	O
of	of	IN	B-PP	O
Hst	Hst	NNP	B-NP	O
54-15-Spd	54-15-Spd	NNP	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
by	by	IN	B-PP	O
topical	topical	JJ	B-NP	O
application	application	NN	I-NP	O
to	to	TO	B-VP	O
tongue	tongue	VB	I-VP	O
surfaces	surface	NNS	B-NP	O
of	of	IN	B-PP	O
immunocompromised	immunocompromised	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
with	with	IN	B-PP	O
OPC	OPC	NN	B-NP	B-protein
.	.	.	O	O

Mice	Mouse	NNS	B-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
Hst	Hst	NN	B-NP	O
54-15-Spd	54-15-Spd	NN	I-NP	O
had	have	VBD	B-VP	O
significant	significant	JJ	B-NP	O
clearance	clearance	NN	I-NP	O
of	of	IN	B-PP	O
candidal	candidal	JJ	B-NP	O
tongue	tongue	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
macroscopically	macroscopically	RB	B-ADVP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
confirmed	confirm	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
3-	3-	CD	I-NP	O
to	to	TO	I-NP	O
5-log	5-log	CD	I-NP	O
fold	fold	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
of	of	IN	B-PP	O
C.	C.	NNP	B-NP	O
albicans	albicans	NNP	I-NP	O
colonies	colony	NNS	I-NP	O
recovered	recover	VBN	B-VP	O
from	from	IN	B-PP	O
tongue	tongue	NN	B-NP	O
tissues	tissue	NNS	I-NP	O
.	.	.	O	O

Hst	Hst	JJ	B-NP	O
54-15-Spd	54-15-Spd	JJ	I-NP	O
conjugates	conjugate	NNS	I-NP	O
are	be	VBP	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
class	class	NN	I-NP	O
of	of	IN	B-PP	O
peptide-based	peptide-based	JJ	B-NP	O
drugs	drug	NNS	I-NP	O
with	with	IN	B-PP	O
high	high	JJ	B-NP	O
selectivity	selectivity	NN	I-NP	O
for	for	IN	B-PP	O
fungi	fungi	NN	B-NP	O
and	and	CC	I-NP	O
potential	potential	NN	I-NP	O
as	as	IN	B-PP	O
topical	topical	JJ	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
agents	agent	NNS	I-NP	O
for	for	IN	B-PP	O
oral	oral	JJ	B-NP	O
candidiasis	candidiasis	NN	I-NP	O
.	.	.	O	O

Previous	Previous	JJ	B-NP	O
findings	finding	NNS	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
association	association	NN	I-NP	O
between	between	IN	B-PP	O
25-hydroxyvitamin	25-hydroxyvitamin	NN	B-NP	O
D	D	NN	I-NP	O
[	[	(	O	O
25	25	CD	B-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
D	D	NN	B-NP	O
]	]	)	O	O
concentrations	concentration	NNS	B-NP	O
and	and	CC	O	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
partially	partially	RB	I-VP	O
explained	explain	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
vitamin	vitamin	NN	B-NP	O
D.	D.	NNP	I-NP	O
To	To	TO	B-PP	O
the	the	DT	B-NP	O
best	good	JJS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
authors	author	NNS	I-NP	O
'	'	POS	B-NP	O
knowledge	knowledge	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
study	study	NN	I-NP	O
has	have	VBZ	B-VP	O
investigated	investigate	VBN	I-VP	O
the	the	DT	B-NP	O
association	association	NN	I-NP	O
between	between	IN	B-PP	O
25	25	CD	B-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
D	D	NN	B-NP	O
and	and	CC	O	O
pathogenic	pathogenic	JJ	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
putative	putative	JJ	I-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
association	association	NN	I-NP	O
between	between	IN	B-PP	O
plasma	plasma	NN	B-NP	O
25	25	CD	I-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
D	D	NN	B-NP	O
concentrations	concentration	NNS	I-NP	O
and	and	CC	O	O
pathogenic	pathogenic	JJ	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
was	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
among	among	IN	B-PP	O
postmenopausal	postmenopausal	JJ	B-NP	O
females	female	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Buffalo	Buffalo	NNP	I-NP	O
Osteoporosis	Osteoporosis	NNP	I-NP	O
and	and	CC	O	O
Periodontal	Periodontal	NNP	B-NP	O
Disease	Disease	NNP	I-NP	O
Study	Study	NNP	I-NP	O
(	(	(	O	O
1997	1997	CD	B-NP	O
to	to	TO	O	O
2000	2000	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
an	an	DT	B-NP	O
ancillary	ancillary	JJ	I-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Women	Women	NNP	I-NP	O
's	's	POS	B-NP	O
Health	Health	NNP	I-NP	O
Initiative	Initiative	NNP	I-NP	O
Observational	Observational	NNP	I-NP	O
Study	Study	NNP	I-NP	O
.	.	.	O	O

Subgingival	Subgingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
using	use	VBG	B-VP	O
immunofluorescence	immunofluorescence	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
Porphyromonas	Porphyromonas	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
Tannerella	Tannerella	NNP	B-NP	O
forsythia	forsythia	NNP	I-NP	O
,	,	,	O	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
,	,	,	O	O
Prevotella	Prevotella	NNP	B-NP	O
intermedia	intermedia	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Campylobacter	Campylobacter	NNP	B-NP	O
rectus	rectus	NN	I-NP	O
.	.	.	O	O

Logistic	Logistic	JJ	B-NP	O
regression	regression	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
calculate	calculate	VB	I-VP	O
odds	odd	NNS	B-NP	O
ratios	ratio	NNS	I-NP	O
(	(	(	O	O
ORs	OR	NNS	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
confidence	confidence	NN	I-NP	O
intervals	interval	NNS	I-NP	O
(	(	(	O	O
CIs	CI	NNS	B-NP	B-protein
)	)	)	O	O
for	for	IN	B-PP	O
prevalent	prevalent	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
by	by	IN	B-PP	O
quintile	quintile	NN	B-NP	O
(	(	(	O	O
Q	Q	NN	B-NP	O
)	)	)	O	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
D	D	NN	B-NP	O
concentrations	concentration	NNS	I-NP	O
,	,	,	O	O
adjusting	adjust	VBG	B-VP	O
for	for	IN	B-PP	O
age	age	NN	B-NP	O
and	and	CC	I-NP	O
body	body	NN	I-NP	O
mass	mass	NN	I-NP	O
index	index	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
the	the	DT	B-NP	O
855	855	CD	I-NP	O
participants	participant	NNS	I-NP	O
,	,	,	O	O
288	288	CD	B-NP	O
(	(	(	O	O
34	34	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
had	have	VBD	B-VP	O
deficient/inadequate	deficient/inadequate	JJ	B-ADJP	O
(	(	(	O	O
<	<	SYM	O	O
50	50	CD	B-NP	O
nmol/L	nmol/L	NN	I-NP	O
)	)	)	O	O
25	25	CD	B-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
D	D	NN	B-NP	O
concentrations	concentration	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
496	496	CD	B-NP	O
(	(	(	O	O
58	58	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
had	have	VBD	B-VP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
one	one	CD	I-NP	O
species	specie	NNS	I-NP	O
of	of	IN	B-PP	O
pathogenic	pathogenic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
significant	significant	JJ	I-NP	O
association	association	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
between	between	IN	B-PP	O
25	25	CD	B-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
D	D	NN	B-NP	O
and	and	CC	I-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
(	(	(	O	O
adjusted	adjust	VBN	B-NP	O
OR	OR	NN	I-NP	O
for	for	IN	B-PP	O
high	high	JJ	B-NP	O
[	[	(	I-NP	O
Q5	Q5	NN	I-NP	O
]	]	)	O	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
low	low	JJ	B-NP	O
[	[	(	O	O
Q1	Q1	NN	B-NP	O
]	]	)	O	O
25	25	CD	B-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
D	D	NN	B-NP	O
=	=	SYM	B-VP	O
0.96	0.96	CD	B-NP	O
;	;	:	O	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
CI	CI	NN	I-NP	O
:	:	:	O	O
0.61	0.61	CD	B-NP	O
to	to	TO	B-PP	O
1.50	1.50	CD	B-NP	O
;	;	:	O	O
P	P	NN	B-NP	O
for	for	IN	B-PP	O
trend	trend	NN	B-NP	O
=	=	SYM	B-VP	O
0.50	0.50	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Inverse	Inverse	JJ	B-ADVP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
not	not	RB	O	O
statistically	statistically	RB	B-ADJP	O
significant	significant	JJ	I-ADJP	O
,	,	,	O	O
associations	association	NNS	B-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
between	between	IN	B-PP	O
25	25	CD	B-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
D	D	NN	B-NP	O
and	and	CC	O	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
one	one	CD	I-NP	O
species	specie	NNS	I-NP	O
of	of	IN	B-PP	O
pathogenic	pathogenic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
(	(	(	O	O
adjusted	adjust	VBN	B-NP	O
OR	OR	NN	I-NP	O
for	for	IN	B-PP	O
adequate	adequate	JJ	B-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	I-VP	O
deficient/inadequate	deficient/inadequate	VB	I-VP	O
25	25	CD	B-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
D	D	NN	B-NP	O
=	=	SYM	B-VP	O
0.85	0.85	CD	B-NP	O
;	;	:	O	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
CI	CI	NN	I-NP	O
:	:	:	O	O
0.60	0.60	CD	B-NP	O
to	to	TO	B-PP	O
1.19	1.19	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

No	No	DT	B-NP	O
association	association	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
between	between	IN	B-PP	O
pathogenic	pathogenic	JJ	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
25	25	CD	B-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
D	D	NN	B-NP	O
concentrations	concentration	NNS	I-NP	O
in	in	IN	B-PP	O
postmenopausal	postmenopausal	JJ	B-NP	O
females	female	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
attributable	attributable	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
species	specie	NNS	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
assessed	assess	VBN	B-VP	O
,	,	,	O	O
small	small	JJ	B-NP	O
effect	effect	NN	I-NP	O
size	size	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
a	a	DT	B-NP	O
true	true	JJ	I-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
association	association	NN	I-NP	O
.	.	.	O	O

Streptococcus	Streptococcus	NN	B-NP	O
salivarius	salivarius	NN	I-NP	O
is	be	VBZ	B-VP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
colonizers	colonizer	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
and	and	CC	I-NP	O
gut	gut	NN	I-NP	O
after	after	IN	B-PP	O
birth	birth	NN	B-NP	O
and	and	CC	O	O
therefore	therefore	RB	B-VP	O
may	may	MD	I-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
establishment	establishment	NN	I-NP	O
of	of	IN	B-PP	O
immune	immune	JJ	B-NP	O
homeostasis	homeostasis	NN	I-NP	O
and	and	CC	O	O
regulation	regulation	NN	B-NP	O
of	of	IN	B-PP	O
host	host	NN	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
responses	response	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
anti-inflammatory	anti-inflammatory	JJ	I-NP	O
potential	potential	NN	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
salivarius	salivarius	NN	I-NP	O
was	be	VBD	B-VP	O
first	first	RB	I-VP	O
evaluated	evaluate	VBN	I-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
on	on	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
intestinal	intestinal	JJ	I-NP	I-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
human	human	JJ	B-NP	B-cell_type
peripheral	peripheral	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
mononuclear	mononuclear	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
live	live	JJ	B-NP	O
S.	S.	NNP	I-NP	O
salivarius	salivarius	NN	I-NP	O
strains	strain	NNS	I-NP	O
inhibited	inhibit	VBD	B-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
the	the	DT	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
NF-kappaB	NF-kappaB	NN	I-NP	B-protein
pathway	pathway	NN	I-NP	O
on	on	IN	B-PP	O
intestinal	intestinal	JJ	B-NP	B-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
live	live	JJ	I-NP	O
S.	S.	NNP	I-NP	O
salivarius	salivarius	NN	I-NP	O
JIM8772	JIM8772	NN	I-NP	O
strain	strain	NN	I-NP	O
significantly	significantly	RB	B-ADVP	O
inhibited	inhibit	VBD	B-VP	O
inflammation	inflammation	NN	B-NP	O
in	in	IN	B-PP	O
severe	severe	JJ	B-NP	O
and	and	CC	I-NP	O
moderate	moderate	JJ	I-NP	O
colitis	colitis	NN	I-NP	O
mouse	mouse	NN	I-NP	O
models	model	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
and	and	CC	O	O
in	in	FW	B-NP	O
vivo	vivo	FW	I-NP	O
anti-inflammatory	anti-inflammatory	JJ	I-NP	O
properties	property	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
found	find	VBN	I-VP	O
with	with	IN	B-PP	O
heat-killed	heat-killed	JJ	B-NP	O
S.	S.	NNP	I-NP	O
salivarius	salivarius	NN	I-NP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
a	a	DT	B-NP	O
protective	protective	JJ	I-NP	O
response	response	NN	I-NP	O
exclusively	exclusively	RB	B-ADVP	O
with	with	IN	B-PP	O
metabolically	metabolically	RB	B-NP	O
active	active	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

Salivary	Salivary	JJ	B-NP	O
contamination	contamination	NN	I-NP	O
of	of	IN	B-PP	O
surgical	surgical	JJ	B-NP	O
wounds	wound	NNS	I-NP	O
in	in	IN	B-PP	O
clean-contaminated	clean-contaminated	JJ	B-NP	O
head	head	NN	I-NP	O
and	and	CC	I-NP	O
neck	neck	NN	I-NP	O
surgery	surgery	NN	I-NP	O
with	with	IN	B-PP	O
free	free	JJ	B-NP	O
flap	flap	NN	I-NP	O
reconstruction	reconstruction	NN	I-NP	O
remains	remain	VBZ	B-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
and	and	CC	O	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
significant	significant	JJ	B-NP	O
morbidity	morbidity	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
investigates	investigate	VBZ	B-VP	O
the	the	DT	B-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
intraoral	intraoral	JJ	B-NP	O
flora	flora	NN	I-NP	O
and	and	CC	O	O
surgical	surgical	JJ	B-NP	O
site	site	NN	I-NP	O
infections	infection	NNS	I-NP	O
(	(	(	O	O
SSIs	SSI	NNS	B-NP	O
)	)	)	O	O
among	among	IN	B-PP	O
high-risk	high-risk	JJ	B-NP	O
head	head	NN	I-NP	O
and	and	CC	O	O
neck	neck	NN	B-NP	O
cancer	cancer	NN	I-NP	O
patients	patient	NNS	I-NP	O
undergoing	undergo	VBG	B-VP	O
resection	resection	NN	B-NP	O
and	and	CC	O	O
free	free	JJ	B-NP	O
flap	flap	NN	I-NP	O
reconstruction	reconstruction	NN	I-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
hundred	hundred	CD	I-NP	O
twenty-nine	twenty-nine	CD	I-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
as	as	IN	B-PP	O
being	be	VBG	B-VP	O
at	at	IN	B-PP	O
high	high	JJ	B-NP	O
risk	risk	NN	I-NP	O
for	for	IN	B-PP	O
infective	infective	JJ	B-NP	O
complications	complication	NNS	I-NP	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
cancer	cancer	NN	B-NP	O
stage	stage	NN	I-NP	O
,	,	,	O	O
tumor	tumor	NN	B-NP	O
size	size	NN	I-NP	O
,	,	,	O	O
comorbid	comorbid	JJ	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
extent	extent	NN	B-NP	O
of	of	IN	B-PP	O
reconstruction	reconstruction	NN	B-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
patients	patient	NNS	I-NP	O
had	have	VBD	B-VP	O
intraoral	intraoral	JJ	B-NP	O
swab	swab	NN	I-NP	O
cultures	culture	NNS	I-NP	O
before	before	IN	B-PP	O
surgery	surgery	NN	B-NP	O
.	.	.	O	O

Patients	Patient	NNS	B-NP	O
with	with	IN	B-PP	O
culture-confirmed	culture-confirmed	JJ	B-NP	O
SSI	SSI	NN	I-NP	O
after	after	IN	B-PP	O
surgery	surgery	NN	B-NP	O
were	be	VBD	B-VP	O
chosen	choose	VBN	I-VP	O
for	for	IN	B-PP	O
analysis	analysis	NN	B-NP	O
,	,	,	O	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
kappa	kappa	NN	I-NP	O
index	index	NN	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
95	95	CD	I-NP	O
%	%	NN	I-NP	O
confidence	confidence	NN	I-NP	O
interval	interval	NN	I-NP	O
for	for	IN	B-PP	O
concordance	concordance	NN	B-NP	O
analysis	analysis	NN	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
patients	patient	NNS	I-NP	O
received	receive	VBD	B-VP	O
clindamycin	clindamycin	NN	B-NP	O
and	and	CC	I-NP	O
gentamicin	gentamicin	NN	I-NP	O
for	for	IN	B-PP	O
antibiotic	antibiotic	JJ	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
for	for	IN	B-PP	O
5	5	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Antibiotic	Antibiotic	JJ	B-NP	O
susceptibility	susceptibility	NN	I-NP	O
testing	testing	NN	I-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
isolates	isolate	NNS	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
and	and	CC	I-VP	O
analyzed	analyze	VBN	I-VP	O
.	.	.	O	O

Thirty-seven	Thirty-seven	CD	B-NP	O
patients	patient	NNS	I-NP	O
experienced	experience	VBD	B-VP	O
SSI	SSI	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
an	an	DT	B-NP	O
infection	infection	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
28.3	28.3	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
occurring	occur	VBG	B-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
mean	mean	NN	I-NP	O
of	of	IN	B-PP	O
9.3	9.3	CD	B-NP	O
postoperative	postoperative	JJ	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
overall	overall	JJ	I-NP	O
concordance	concordance	NN	I-NP	O
between	between	IN	B-PP	O
oral	oral	JJ	B-NP	O
flora	flora	NN	I-NP	O
and	and	CC	I-NP	O
SSI	SSI	NN	I-NP	O
was	be	VBD	B-VP	O
fair	fair	JJ	B-ADJP	O
to	to	TO	B-PP	O
moderate	moderate	JJ	B-NP	O
(	(	(	O	O
kappa	kappa	NN	B-NP	O
index	index	NN	I-NP	O
of	of	IN	B-PP	O
0.25	0.25	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
but	but	CC	O	O
detailed	detailed	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
shows	show	VBZ	B-VP	O
a	a	DT	B-NP	O
higher	high	JJR	I-NP	O
concordance	concordance	NN	I-NP	O
for	for	IN	B-PP	O
known	known	JJ	B-NP	O
and	and	CC	I-NP	O
opportunistic	opportunistic	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
Pseudomonas	Pseudomonas	NNP	B-NP	O
aeruginosa	aeruginosa	NN	I-NP	O
and	and	CC	O	O
Enterococcus	Enterococcus	NNP	B-NP	O
faecalis	faecalis	NNP	I-NP	O
,	,	,	O	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
typical	typical	JJ	B-NP	O
oral	oral	JJ	I-NP	O
commensals	commensal	NNS	I-NP	O
.	.	.	O	O

Antibiotic	Antibiotic	JJ	B-NP	O
susceptibility	susceptibility	NN	I-NP	O
tests	test	NNS	I-NP	O
show	show	VBP	B-VP	O
rapid	rapid	JJ	B-NP	O
and	and	CC	I-NP	O
significant	significant	JJ	I-NP	O
increases	increase	NNS	I-NP	O
in	in	IN	B-PP	O
resistance	resistance	NN	B-NP	O
to	to	TO	B-PP	O
clindamycin	clindamycin	NN	B-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
a	a	DT	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
more	more	RBR	I-NP	O
effective	effective	JJ	I-NP	O
alternative	alternative	NN	I-NP	O
.	.	.	O	O

Predicting	Predict	VBG	B-VP	O
pathogens	pathogen	NNS	B-NP	O
in	in	IN	B-PP	O
SSI	SSI	NN	B-NP	O
using	use	VBG	B-VP	O
preoperative	preoperative	JJ	B-NP	O
oral	oral	JJ	I-NP	O
swabs	swab	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
demonstrate	demonstrate	VB	I-VP	O
a	a	DT	B-NP	O
good	good	JJ	I-NP	O
concordance	concordance	NN	I-NP	O
in	in	IN	B-PP	O
general	general	JJ	B-ADJP	O
for	for	IN	B-PP	O
patients	patient	NNS	B-NP	O
undergoing	undergo	VBG	B-VP	O
clean-contaminated	clean-contaminated	JJ	B-NP	O
head	head	NN	I-NP	O
and	and	CC	I-NP	O
neck	neck	NN	I-NP	O
surgery	surgery	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
concordance	concordance	NN	B-NP	O
for	for	IN	B-PP	O
certain	certain	JJ	B-NP	O
pathogenic	pathogenic	JJ	I-NP	O
species	specie	NNS	I-NP	O
seem	seem	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
higher	high	JJR	B-ADJP	O
than	than	IN	B-PP	O
for	for	IN	B-PP	O
typical	typical	JJ	B-NP	O
intraoral	intraoral	JJ	I-NP	O
commensals	commensal	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
resistance	resistance	NN	B-NP	O
to	to	TO	B-PP	O
clindamycin	clindamycin	NN	B-NP	O
precludes	preclude	VBZ	B-VP	O
its	its	PRP$	B-NP	O
use	use	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
prophylactic	prophylactic	JJ	I-NP	O
agent	agent	NN	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
ulcerations	ulceration	NNS	I-NP	O
often	often	RB	B-ADVP	O
arise	arise	VBP	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
side	side	NN	I-NP	O
effect	effect	NN	I-NP	O
from	from	IN	B-PP	O
chemo-	chemo-	NN	B-NP	O
and	and	CC	I-NP	O
radiation	radiation	NN	I-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
a	a	DT	B-NP	O
previous	previous	JJ	I-NP	O
clinical	clinical	JJ	I-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
predictor	predictor	NN	I-NP	O
for	for	IN	B-PP	O
oral	oral	JJ	B-NP	O
ulcerations	ulceration	NNS	I-NP	O
after	after	IN	B-PP	O
hematopoetic	hematopoetic	JJ	B-NP	O
stem	stem	NN	I-NP	O
cell	cell	NN	I-NP	O
transplantation	transplantation	NN	I-NP	O
,	,	,	O	O
possibly	possibly	RB	B-ADVP	O
incriminating	incriminate	VBG	B-VP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
in	in	IN	B-PP	O
delayed	delay	VBN	B-NP	O
healing	healing	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ulcerations	ulceration	NNS	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
whether	whether	IN	B-SBAR	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
secreted	secrete	VBN	I-NP	O
products	product	NNS	I-NP	O
could	could	MD	B-VP	O
inhibit	inhibit	VB	I-VP	O
the	the	DT	B-NP	O
migration	migration	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	B-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
an	an	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
scratch	scratch	NN	I-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
compare	compare	VB	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
Prevotella	Prevotella	NNP	I-NP	O
nigrescens	nigrescens	NNP	I-NP	O
,	,	,	O	O
Prevotella	Prevotella	NNP	B-NP	O
intermedia	intermedia	NNS	I-NP	O
,	,	,	O	O
Tannerella	Tannerella	NNP	B-NP	O
forsythia	forsythia	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mitis	mitis	NN	I-NP	O
were	be	VBD	B-VP	O
included	include	VBN	I-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
standardized	standardized	JJ	I-NP	O
scratch	scratch	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
confluent	confluent	JJ	I-NP	O
layer	layer	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
oral	oral	JJ	I-NP	I-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
epithelial	epithelial	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
challenged	challenge	VBN	I-VP	O
with	with	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	B-PP	O
with	with	IN	B-PP	O
medium	medium	NN	B-NP	O
containing	contain	VBG	B-VP	O
secretions	secretion	NNS	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

Closure	Closure	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
scratch	scratch	NN	I-NP	O
was	be	VBD	B-VP	O
measured	measure	VBN	I-VP	O
after	after	IN	B-PP	O
17	17	CD	B-NP	O
h	h	NN	I-NP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
phase	phase	NN	I-NP	O
contrast	contrast	NN	I-NP	O
microscope	microscope	NN	I-NP	O
.	.	.	O	O

P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
P.	P.	NNP	B-NP	O
nigrescens	nigrescens	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
secretions	secretion	NNS	B-NP	O
of	of	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
strongly	strongly	RB	B-ADVP	O
inhibited	inhibit	VBD	B-VP	O
cell	cell	NN	B-NP	O
migration	migration	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
challenge	challenge	NN	I-NP	O
with	with	IN	B-PP	O
1000	1000	CD	B-NP	O
heat-killed	heat-killed	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
versus	versus	IN	B-PP	O
1	1	CD	B-NP	O
epithelial	epithelial	JJ	I-NP	O
cell	cell	NN	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
relative	relative	JJ	I-NP	O
closure	closure	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
scratch	scratch	NN	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
for	for	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
and	and	CC	O	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
for	for	IN	B-PP	O
P.	P.	NNP	B-NP	O
nigrescens	nigrescens	NNP	I-NP	O
.	.	.	O	O

Weaker	Weaker	NNP	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effects	effect	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
confirmed	confirm	VBD	B-VP	O
our	our	PRP$	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
delayed	delay	VBN	B-NP	O
wound	wound	NN	I-NP	O
healing	healing	NN	I-NP	O
.	.	.	O	O

Modern	Modern	JJ	B-NP	O
dentistry	dentistry	NN	I-NP	O
emphasizes	emphasize	VBZ	B-VP	O
the	the	DT	B-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
control	control	NN	I-NP	O
to	to	TO	B-VP	O
improve	improve	VB	I-VP	O
oral	oral	JJ	B-NP	O
health	health	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-PP	O
that	that	DT	B-NP	O
end	end	NN	I-NP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
care	care	NN	I-NP	O
formulations	formulation	NNS	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
geared	gear	VBN	I-VP	O
toward	toward	IN	B-PP	O
the	the	DT	B-NP	O
incorporation	incorporation	NN	I-NP	O
of	of	IN	B-PP	O
antiplaque	antiplaque	JJ	B-NP	O
agents	agent	NNS	I-NP	O
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
play	play	VB	I-VP	O
a	a	DT	B-NP	O
crucial	crucial	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
health	health	NN	I-NP	O
maintenance	maintenance	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
later	later	JJ	B-NP	O
years	year	NNS	I-NP	O
the	the	DT	B-NP	O
research	research	NN	I-NP	O
into	into	IN	B-PP	O
antiplaque	antiplaque	JJ	B-NP	O
agents	agent	NNS	I-NP	O
has	have	VBZ	B-VP	O
led	lead	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
discovery	discovery	NN	I-NP	O
of	of	IN	B-PP	O
compounds	compound	NNS	B-NP	O
with	with	IN	B-PP	O
significant	significant	JJ	B-NP	O
capability	capability	NN	I-NP	O
to	to	TO	B-VP	O
affect	affect	VB	I-VP	O
biofilm	biofilm	NN	B-NP	O
formation	formation	NN	I-NP	O
.	.	.	O	O

Among	Among	IN	B-PP	O
these	these	DT	B-NP	O
compounds	compound	NNS	I-NP	O
was	be	VBD	B-VP	O
chitosan	chitosan	JJ	B-ADJP	O
,	,	,	O	O
a	a	DT	B-NP	O
polysaccharide	polysaccharide	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
great	great	JJ	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-VP	O
interfere	interfere	VB	I-VP	O
with	with	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
biofilm	biofilm	NN	I-NP	O
formation	formation	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
such	such	JJ	B-NP	O
the	the	DT	I-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
work	work	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-PP	O
incorporate	incorporate	JJ	B-NP	O
chitosan	chitosan	NN	I-NP	O
into	into	IN	B-PP	O
a	a	DT	B-NP	O
mouthwash	mouthwash	NN	I-NP	O
matrix	matrix	NN	I-NP	O
and	and	CC	O	O
assess	assess	VB	B-VP	O
its	its	PRP$	B-NP	O
effect	effect	NN	I-NP	O
upon	upon	IN	B-PP	O
biofilm	biofilm	NN	B-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
assessment	assessment	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
via	via	IN	B-PP	O
study	study	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
impact	impact	NN	I-NP	O
the	the	DT	B-NP	O
mouthwash	mouthwash	NN	I-NP	O
upon	upon	IN	B-PP	O
microbial	microbial	JJ	B-NP	O
adherence	adherence	NN	I-NP	O
,	,	,	O	O
biofilm	biofilm	NN	B-NP	O
formation	formation	NN	I-NP	O
and	and	CC	O	O
mature	mature	JJ	B-NP	O
biofilms	biofilm	NNS	I-NP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
chitosan	chitosan	NN	I-NP	O
mouthwash	mouthwash	NN	I-NP	O
was	be	VBD	B-VP	O
compared	compare	VBN	I-VP	O
with	with	IN	B-PP	O
two	two	CD	B-NP	O
commercially	commercially	RB	I-NP	O
available	available	JJ	I-NP	O
mouthwashes	mouthwash	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
here	here	RB	B-VP	O
obtained	obtain	VBN	I-VP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
only	only	RB	B-NP	O
the	the	DT	I-NP	O
chitosan	chitosan	NN	I-NP	O
containing	contain	VBG	B-VP	O
mouthwash	mouthwash	NN	B-NP	O
was	be	VBD	B-VP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
interfering	interfere	VBG	B-VP	O
with	with	IN	B-PP	O
all	all	DT	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
'	'	POS	B-NP	O
adherence	adherence	NN	I-NP	O
,	,	,	O	O
biofilm	biofilm	NN	B-NP	O
formation	formation	NN	I-NP	O
and	and	CC	O	O
mature	mature	JJ	B-NP	O
biofilms	biofilm	NNS	I-NP	O
while	while	IN	B-SBAR	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
time	time	NN	I-NP	O
showing	show	VBG	B-VP	O
vastly	vastly	RB	B-NP	O
superior	superior	JJ	I-NP	O
activity	activity	NN	I-NP	O
than	than	IN	B-PP	O
both	both	DT	B-NP	O
commercial	commercial	JJ	I-NP	O
mouthwashes	mouthwash	NNS	I-NP	O
assayed	assay	VBN	B-VP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
such	such	PDT	B-NP	O
a	a	DT	I-NP	O
chitosan	chitosan	JJ	I-NP	O
mouthwash	mouthwash	NN	I-NP	O
shows	show	VBZ	B-VP	O
great	great	JJ	B-NP	O
potential	potential	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
natural	natural	JJ	I-NP	O
and	and	CC	I-NP	O
efficient	efficient	JJ	I-NP	O
alternative	alternative	NN	I-NP	O
to	to	TO	B-PP	O
traditional	traditional	JJ	B-NP	O
mouthwashes	mouthwash	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
carried	carry	VBN	I-VP	O
out	out	RP	B-PRT	O
to	to	TO	B-VP	O
see	see	VB	I-VP	O
the	the	DT	B-NP	O
diversity	diversity	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
microflora	microflora	NNS	I-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
sensitivity	sensitivity	NN	I-NP	O
test	test	NN	I-NP	O
in	in	IN	B-PP	O
children	child	NNS	B-NP	O
of	of	IN	B-PP	O
age	age	NN	B-NP	O
group	group	NN	I-NP	O
6	6	CD	B-NP	O
to	to	TO	I-NP	O
12	12	CD	I-NP	O
years	year	NNS	I-NP	O
was	be	VBD	B-VP	O
carried	carry	VBN	I-VP	O
.	.	.	O	O

Total	Total	JJ	B-NP	O
50	50	CD	I-NP	O
patients	patient	NNS	I-NP	O
of	of	IN	B-PP	O
age	age	NN	B-NP	O
group	group	NN	I-NP	O
6	6	CD	B-NP	O
to	to	TO	I-NP	O
12	12	CD	I-NP	O
years	year	NNS	I-NP	O
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
for	for	IN	B-PP	O
their	their	PRP$	B-NP	O
oral	oral	JJ	I-NP	O
microflora	microflora	NN	I-NP	O
and	and	CC	O	O
then	then	RB	B-VP	O
checked	check	VBD	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
susceptibility	susceptibility	NN	I-NP	O
test	test	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
samples	sample	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
were	be	VBD	B-VP	O
incubated	incubate	VBN	I-VP	O
at	at	IN	B-PP	O
37	37	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
for	for	IN	B-PP	O
48	48	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

Once	Once	RB	B-NP	O
dispersed	disperse	VBN	I-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
and	and	CC	O	O
Gram	Gram	NN	B-NP	O
staining	staining	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
they	they	PRP	B-NP	O
were	be	VBD	B-VP	O
spread	spread	VBN	I-VP	O
on	on	IN	B-PP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
freshly	freshly	RB	B-NP	O
prepared	prepare	VBN	I-NP	O
agar	agar	NN	I-NP	O
plates	plate	NNS	I-NP	O
and	and	CC	O	O
incubated	incubate	VBN	B-VP	O
to	to	TO	B-VP	O
allow	allow	VB	I-VP	O
cells	cell	NNS	B-NP	O
to	to	TO	B-VP	O
form	form	VB	I-VP	O
microbial	microbial	JJ	B-NP	O
colony	colony	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
result	result	NN	I-NP	O
showed	show	VBD	B-VP	O
microflora	microflora	NNS	B-NP	O
common	common	JJ	B-ADJP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
types	type	NNS	I-NP	O
,	,	,	O	O
Gram-positive	Gram-positive	JJ	B-NP	O
facultative	facultative	JJ	I-NP	O
anaerobic	anaerobic	JJ	I-NP	O
rods	rod	NNS	I-NP	O
and	and	CC	I-NP	O
cocci	coccus	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
normal	normal	JJ	B-NP	O
children	child	NNS	I-NP	O
Gram-positive	Gram-positive	JJ	B-NP	O
facultative	facultative	JJ	I-NP	O
anaerobic	anaerobic	JJ	I-NP	O
and	and	CC	I-NP	O
fermenting	fermenting	JJ	I-NP	O
cocci	coccus	NNS	I-NP	O
were	be	VBD	B-VP	O
predominant	predominant	JJ	B-ADJP	O
where	where	WRB	B-ADVP	O
as	as	IN	B-PP	O
in	in	IN	B-PP	O
children	child	NNS	B-NP	O
with	with	IN	B-PP	O
caries	cary	NNS	B-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
microbiota	microbiota	NN	B-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
Gram-negative	Gram-negative	JJ	B-NP	O
and	and	CC	I-NP	O
positive	positive	JJ	I-NP	O
,	,	,	I-NP	O
capnophilic	capnophilic	JJ	I-NP	O
,	,	,	I-NP	O
motile	motile	JJ	I-NP	O
and	and	CC	I-NP	O
anaerobic	anaerobic	JJ	I-NP	O
rods	rod	NNS	I-NP	O
and	and	CC	I-NP	O
cocci	coccus	NNS	I-NP	O
belonging	belong	VBG	B-VP	O
to	to	TO	B-PP	O
members	member	NNS	B-NP	O
of	of	IN	B-PP	O
genera	genera	NN	B-NP	O
S.	S.	NNP	I-NP	O
mutans	mutan	NNS	I-NP	O
and	and	CC	O	O
A.	A.	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
.	.	.	O	O

By	By	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
it	it	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
determined	determine	VBN	B-VP	O
by	by	IN	B-PP	O
microscopic	microscopic	JJ	B-NP	O
counts	count	NNS	I-NP	O
was	be	VBD	B-VP	O
twice	twice	RB	B-ADJP	O
as	as	RB	I-ADJP	O
high	high	JJ	I-ADJP	O
in	in	IN	B-PP	O
caries	cary	NNS	B-NP	O
patients	patient	NNS	I-NP	O
as	as	IN	B-PP	O
in	in	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
sites	site	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
also	also	RB	B-VP	O
recommended	recommend	VBD	I-VP	O
that	that	IN	B-SBAR	O
amoxicillin	amoxicillin	NN	B-NP	B-protein
,	,	,	I-NP	O
ampicillin	ampicillin	NN	I-NP	O
and	and	CC	I-NP	O
amikacin	amikacin	NN	I-NP	O
are	be	VBP	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
effective	effective	JJ	I-NP	O
antibacterial	antibacterial	JJ	I-NP	O
drugs	drug	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
study	study	VB	I-VP	O
and	and	CC	I-VP	O
compare	compare	VB	I-VP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
colony	colony	NN	B-NP	O
forming	form	VBG	B-VP	O
units	unit	NNS	B-NP	O
of	of	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
sanguis	sanguis	NNP	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
salivarius	salivarius	NNP	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mitis	mitis	NNP	I-NP	O
and	and	CC	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
milleri	milleri	NNP	I-NP	O
in	in	IN	B-PP	O
dentulous	dentulous	JJ	B-NP	O
,	,	,	I-NP	O
edentulous	edentulous	JJ	I-NP	O
and	and	CC	O	O
in	in	IN	B-PP	O
those	those	DT	B-NP	O
wearing	wear	VBG	I-NP	O
partial	partial	JJ	I-NP	O
and	and	CC	I-NP	O
complete	complete	JJ	I-NP	O
dentures	denture	NNS	I-NP	O
by	by	IN	B-PP	O
using	use	VBG	B-VP	O
semi-quantitative	semi-quantitative	JJ	B-NP	O
culture	culture	NN	I-NP	O
method	method	NN	I-NP	O
of	of	IN	B-PP	O
saliva	saliva	NN	B-NP	O
samples	sample	NNS	I-NP	O
with	with	IN	B-PP	O
calibrated	calibrate	VBN	B-NP	O
standard	standard	JJ	I-NP	O
loop	loop	NN	I-NP	O
.	.	.	O	O

Sterile	Sterile	JJ	B-NP	O
specimen	specimen	NN	I-NP	O
collection	collection	NN	I-NP	O
bottles	bottle	NNS	I-NP	O
,	,	,	O	O
Mitis	Mitis	NNP	B-NP	O
salivarius	salivarius	NN	I-NP	O
agar	agar	NN	I-NP	O
plates	plate	NNS	I-NP	O
,	,	,	O	O
Standard	Standard	NNP	B-NP	O
loop	loop	NN	I-NP	O
,	,	,	O	O
Candle	Candle	NNP	B-NP	O
jar	jar	NNP	I-NP	O
,	,	,	O	O
Incubator	Incubator	NNP	B-NP	O
,	,	,	O	O
Colony	Colony	NNP	B-NP	O
counter	counter	NN	I-NP	O
.	.	.	O	O

Study	Study	NN	B-NP	O
population	population	NN	I-NP	O
consisted	consist	VBD	B-VP	O
of	of	IN	B-PP	O
100	100	CD	B-NP	O
subjects	subject	NNS	I-NP	O
with	with	IN	B-PP	O
25	25	CD	B-NP	O
in	in	IN	B-PP	O
each	each	DT	B-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
age	age	NN	I-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
40	40	CD	B-NP	O
to	to	TO	I-NP	O
80	80	CD	I-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
were	be	VBD	B-VP	O
attending	attend	VBG	I-VP	O
the	the	DT	B-NP	O
Department	Department	NNP	I-NP	O
of	of	IN	B-PP	O
Community	Community	NNP	B-NP	O
Dentistry	Dentistry	NNP	I-NP	O
and	and	CC	I-NP	O
Prosthodontics	Prosthodontics	NNP	I-NP	O
at	at	IN	B-PP	O
MNR	MNR	NNP	B-NP	O
Dental	Dental	NNP	I-NP	O
College	College	NNP	I-NP	O
,	,	,	O	O
Sangareddy	Sangareddy	NNP	B-NP	O
,	,	,	O	O
Hyderabad	Hyderabad	NNP	B-NP	O
.	.	.	O	O

Unstimulated	Unstimulated	JJ	B-NP	O
saliva	saliva	NN	I-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
from	from	IN	B-PP	O
patients	patient	NNS	B-NP	O
and	and	CC	O	O
inoculated	inoculate	VBN	B-VP	O
on	on	RP	B-PRT	O
to	to	TO	B-PP	O
Mitis	Mitis	NNP	B-NP	O
salivarius	salivarius	NN	I-NP	O
agar	agar	NN	I-NP	O
plates	plate	NNS	I-NP	O
using	use	VBG	B-VP	O
calibrated	calibrate	VBN	B-NP	O
standard	standard	JJ	I-NP	O
loop	loop	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
plates	plate	NNS	I-NP	O
were	be	VBD	B-VP	O
then	then	RB	I-VP	O
incubated	incubate	VBN	I-VP	O
anaerobically	anaerobically	RB	B-ADVP	O
at	at	IN	B-PP	O
37	37	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
for	for	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
at	at	IN	B-PP	O
room	room	NN	B-NP	O
temperature	temperature	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
24	24	CD	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

Using	Use	VBG	B-VP	O
a	a	DT	B-NP	O
colony	colony	NN	I-NP	O
counter	counter	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
colonies	colony	NNS	B-NP	O
of	of	IN	B-PP	O
each	each	DT	B-NP	O
species	species	NN	I-NP	O
was	be	VBD	B-VP	O
counted	count	VBN	I-VP	O
.	.	.	O	O

Streptococcus	Streptococcus	NN	B-NP	O
mutans	mutan	NNS	I-NP	O
and	and	CC	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mitis	mitis	NN	I-NP	O
predominates	predominate	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
dentulous	dentulous	JJ	I-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
sanguis	sanguis	NNP	I-NP	O
in	in	IN	B-PP	O
complete	complete	JJ	B-NP	O
denture	denture	NN	I-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
salivarius	salivarius	NN	I-NP	O
in	in	IN	B-PP	O
edentulous	edentulous	JJ	B-NP	O
group	group	NN	I-NP	O
and	and	CC	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
milleri	milleri	NNP	I-NP	O
in	in	IN	B-PP	O
removable	removable	JJ	B-NP	O
partial	partial	JJ	I-NP	O
denture	denture	NN	I-NP	O
group	group	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
our	our	PRP$	B-NP	O
study	study	NN	I-NP	O
are	be	VBP	B-VP	O
in	in	IN	B-PP	O
accordance	accordance	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
previous	previous	JJ	I-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
have	have	VBP	B-VP	O
sought	seek	VBN	I-VP	O
to	to	TO	I-VP	O
differentiate	differentiate	VB	I-VP	O
different	different	JJ	B-NP	O
groups	group	NNS	I-NP	O
of	of	IN	B-PP	O
mutans	mutan	NNS	B-NP	O
streptococci	streptococci	NNS	I-NP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
simple	simple	JJ	I-NP	O
calibrated	calibrate	VBN	I-NP	O
standard	standard	JJ	I-NP	O
loop	loop	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
majority	majority	NN	I-NP	O
of	of	IN	B-PP	O
individuals	individual	NNS	B-NP	O
infected	infect	VBN	B-VP	O
with	with	IN	B-PP	O
human	human	JJ	B-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
HIV	HIV	NN	B-NP	O
)	)	)	O	O
have	have	VBP	B-VP	O
inadequate	inadequate	JJ	B-NP	O
access	access	NN	I-NP	O
to	to	TO	B-PP	O
antiretroviral	antiretroviral	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
and	and	CC	O	O
ultimately	ultimately	RB	B-VP	O
develop	develop	VBP	I-VP	O
debilitating	debilitate	VBG	I-VP	O
oral	oral	JJ	B-NP	O
infections	infection	NNS	I-NP	O
that	that	WDT	B-NP	O
often	often	RB	B-ADVP	O
correlate	correlate	VBP	B-VP	O
with	with	IN	B-PP	O
disease	disease	NN	B-NP	O
progression	progression	NN	I-NP	O
.	.	.	O	O

Due	Due	JJ	B-PP	O
to	to	TO	I-PP	O
the	the	DT	B-NP	O
impracticalities	impracticality	NNS	I-NP	O
of	of	IN	B-PP	O
conducting	conduct	VBG	B-VP	O
host-microbe	host-microbe	JJ	B-NP	O
systems-based	systems-based	JJ	I-NP	O
studies	study	NNS	I-NP	O
in	in	IN	B-PP	O
HIV	HIV	NN	B-NP	O
infected	infected	JJ	I-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
evaluated	evaluate	VBN	I-VP	O
the	the	DT	B-NP	O
potential	potential	NN	I-NP	O
of	of	IN	B-PP	O
simian	simian	JJ	B-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
virus	virus	NN	I-NP	O
(	(	(	O	O
SIV	SIV	NN	B-NP	O
)	)	)	O	O
infected	infected	JJ	B-NP	O
rhesus	rhesus	NN	I-NP	O
macaques	macaque	NNS	I-NP	O
to	to	TO	B-VP	O
serve	serve	VB	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
non-human	non-human	JJ	I-NP	O
primate	primate	JJ	I-NP	O
model	model	NN	I-NP	O
for	for	IN	B-PP	O
oral	oral	JJ	B-NP	O
manifestations	manifestation	NNS	I-NP	O
of	of	IN	B-PP	O
HIV	HIV	NN	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
present	present	VBP	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
description	description	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
rhesus	rhesus	NN	I-NP	O
macaque	macaque	NN	I-NP	O
oral	oral	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
and	and	CC	O	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
mixture	mixture	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
commensal	commensal	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
``	``	``	O	O
macaque	macaque	NN	B-NP	O
versions	version	NNS	I-NP	O
''	''	''	O	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
commensals	commensal	NNS	I-NP	O
colonize	colonize	VBP	B-VP	O
the	the	DT	B-NP	O
tongue	tongue	NN	I-NP	O
dorsum	dorsum	NN	I-NP	O
and	and	CC	O	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
findings	finding	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
SIV	SIV	NN	B-NP	O
infection	infection	NN	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
activation	activation	NN	I-NP	O
of	of	IN	B-PP	O
antiviral	antiviral	JJ	B-NP	O
and	and	CC	I-NP	O
inflammatory	inflammatory	JJ	I-NP	O
responses	response	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
tongue	tongue	NN	I-NP	O
mucosa	mucosa	NN	I-NP	O
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
collectively	collectively	RB	I-VP	O
lead	lead	VB	I-VP	O
to	to	TO	B-PP	O
repression	repression	NN	B-NP	O
of	of	IN	B-PP	O
epithelial	epithelial	JJ	B-NP	O
development	development	NN	I-NP	O
and	and	CC	O	O
impact	impact	VB	B-VP	O
the	the	DT	B-NP	O
microbiome	microbiome	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
dysbiosis	dysbiosis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
lingual	lingual	JJ	I-NP	O
microbiome	microbiome	NN	I-NP	O
in	in	IN	B-PP	O
SIV	SIV	NN	B-NP	O
infection	infection	NN	I-NP	O
is	be	VBZ	B-VP	O
characterized	characterize	VBN	I-VP	O
by	by	IN	B-PP	O
outgrowth	outgrowth	NN	B-NP	O
of	of	IN	B-PP	O
Gemella	Gemella	NN	B-NP	O
morbillorum	morbillorum	NN	I-NP	O
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
result	result	VB	I-VP	O
from	from	IN	B-PP	O
impaired	impaired	JJ	B-NP	O
macrophage	macrophage	NN	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
provide	provide	VBP	B-VP	O
evidence	evidence	NN	B-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
increased	increase	VBN	I-NP	O
capacity	capacity	NN	I-NP	O
of	of	IN	B-PP	O
opportunistic	opportunistic	JJ	B-NP	O
pathogens	pathogen	NNS	I-NP	O
(	(	(	O	O
e.g	e.g	NN	B-NP	O
.	.	.	O	O

E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
)	)	)	O	O
to	to	TO	B-VP	O
colonize	colonize	VB	I-VP	O
the	the	DT	B-NP	O
microbiome	microbiome	NN	I-NP	O
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
reduced	reduce	VBN	B-NP	O
production	production	NN	I-NP	O
of	of	IN	B-PP	O
antimicrobial	antimicrobial	JJ	B-NP	O
peptides	peptide	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
compared	compare	VBD	B-VP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
hygiene	hygiene	NN	I-NP	O
and	and	CC	I-NP	O
caries	cary	NNS	I-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
labial	labial	JJ	B-NP	O
and	and	CC	I-NP	O
lingual	lingual	JJ	I-NP	O
orthodontic	orthodontic	JJ	I-NP	O
appliances	appliance	NNS	I-NP	O
throughout	throughout	IN	B-PP	O
a	a	DT	B-NP	O
prospective	prospective	JJ	I-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
status	status	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
environment	environment	NN	I-NP	O
before	before	IN	B-PP	O
and	and	CC	I-PP	O
after	after	IN	I-PP	O
bracket	bracket	NN	B-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
orthodontic	orthodontic	JJ	I-NP	O
patients	patient	NNS	I-NP	O
aged	age	VBN	B-ADJP	O
19	19	CD	B-NP	O
to	to	TO	I-NP	O
23	23	CD	I-NP	O
years	year	NNS	I-NP	O
were	be	VBD	B-VP	O
included	include	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
divided	divide	VBN	I-VP	O
into	into	IN	B-PP	O
two	two	CD	B-NP	O
groups	group	NNS	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
patients	patient	NNS	I-NP	O
wore	wear	VBD	B-VP	O
Roth	Roth	NNP	B-NP	O
labial	labial	JJ	I-NP	O
appliance	appliance	NN	I-NP	O
(	(	(	O	O
American	American	NNP	B-NP	O
Orthodontics	Orthodontics	NNP	I-NP	O
,	,	,	O	O
Sheboygan	Sheboygan	NNP	B-NP	O
,	,	,	O	O
WI	WI	NNP	B-NP	O
,	,	,	O	O
USA	USA	NNP	B-NP	O
)	)	)	O	O
and	and	CC	O	O
10	10	CD	B-NP	O
patients	patient	NNS	I-NP	O
wore	wear	VBD	B-VP	O
STb	STb	NN	B-NP	O
lingual	lingual	JJ	I-NP	O
appliance	appliance	NN	I-NP	O
(	(	(	O	O
Ormco	Ormco	NNP	B-NP	O
Corporation	Corporation	NNP	I-NP	O
,	,	,	O	O
Glendora	Glendora	NNP	B-NP	O
,	,	,	O	O
CA	CA	NNP	B-NP	O
,	,	,	O	O
USA	USA	NNP	B-NP	O
)	)	)	O	O
.	.	.	O	O

Plaque	Plaque	NN	B-NP	O
index	index	NN	I-NP	O
(	(	(	O	O
PI	PI	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
gingival	gingival	JJ	B-NP	O
bleeding	bleed	VBG	I-NP	O
index	index	NN	I-NP	O
(	(	(	O	O
GBI	GBI	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
salivary	salivary	JJ	B-NP	O
flow	flow	NN	I-NP	O
rate	rate	NN	I-NP	O
,	,	,	O	O
saliva	saliva	NN	B-NP	O
buffer	buffer	NN	I-NP	O
capacity	capacity	NN	I-NP	O
,	,	,	O	O
salivary	salivary	JJ	B-NP	O
pH	pH	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
and	and	CC	O	O
Lactobacillus	Lactobacillus	NN	B-NP	O
counts	count	NNS	I-NP	O
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
at	at	IN	B-PP	O
three	three	CD	B-NP	O
time	time	NN	I-NP	O
points	point	NNS	I-NP	O
:	:	:	O	O
before	before	IN	B-SBAR	O
orthodontic	orthodontic	JJ	B-NP	O
appliance	appliance	NN	I-NP	O
placement	placement	NN	I-NP	O
(	(	(	O	O
T0	T0	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
4	4	CD	B-NP	O
weeks	week	NNS	I-NP	O
after	after	IN	B-PP	O
bonding	bonding	NN	B-NP	O
(	(	(	O	O
T1	T1	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
8	8	CD	B-NP	O
weeks	week	NNS	I-NP	O
after	after	IN	B-PP	O
bonding	bonding	NN	B-NP	O
(	(	(	O	O
T2	T2	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

After	After	IN	B-PP	O
appliance	appliance	NN	B-NP	O
placement	placement	NN	I-NP	O
,	,	,	O	O
all	all	DT	B-NP	O
patients	patient	NNS	I-NP	O
were	be	VBD	B-VP	O
periodically	periodically	RB	I-VP	O
educated	educate	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
hygiene	hygiene	NN	I-NP	O
procedures	procedure	NNS	I-NP	O
.	.	.	O	O

Wilcoxon	Wilcoxon	NN	B-NP	O
rank	rank	NN	I-NP	O
and	and	CC	O	O
Mann-Whitney	Mann-Whitney	JJ	B-NP	O
U	U	NN	I-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
intragroup	intragroup	NN	B-NP	O
and	and	CC	I-NP	O
intergroup	intergroup	NN	I-NP	O
differences	difference	NNS	I-NP	O
as	as	IN	B-PP	O
regards	regard	NNS	B-NP	O
qualitative	qualitative	JJ	B-NP	O
data	datum	NNS	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
compare	compare	VB	I-VP	O
quantitative	quantitative	JJ	B-NP	O
data	datum	NNS	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
chi-square	chi-square	JJ	B-ADJP	O
and	and	CC	O	O
Fisher	Fisher	NNP	B-NP	O
's	's	POS	B-NP	O
exact	exact	JJ	I-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
undertaken	undertake	VBN	I-VP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
intragroup	intragroup	JJ	B-NP	O
differences	difference	NNS	I-NP	O
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
with	with	IN	B-PP	O
McNemar	McNemar	NNP	B-NP	O
test	test	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
statistical	statistical	JJ	B-NP	O
significance	significance	NN	I-NP	O
was	be	VBD	B-VP	O
set	set	VBN	I-VP	O
at	at	IN	B-PP	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.05	0.05	CD	B-NP	O
.	.	.	O	O

Statistical	Statistical	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
data	datum	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
statistically	statistically	RB	I-NP	O
significant	significant	JJ	I-NP	O
difference	difference	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
data	datum	NNS	I-NP	O
of	of	IN	B-PP	O
T0	T0	NN	B-NP	O
and	and	CC	I-NP	O
T1	T1	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
data	datum	NNS	I-NP	O
of	of	IN	B-PP	O
T0	T0	NN	B-NP	O
and	and	CC	I-NP	O
T2	T2	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
PI	PI	NN	I-NP	B-DNA
scores	score	NNS	I-NP	I-DNA
and	and	CC	B-PP	O
between	between	IN	B-PP	O
T0	T0	NN	B-NP	O
and	and	CC	I-NP	O
T2	T2	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
GBI	GBI	NNP	I-NP	O
scores	score	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
group	group	NN	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
lingual	lingual	JJ	I-NP	O
appliance	appliance	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
GBI	GBI	NNP	I-NP	O
value	value	NN	I-NP	O
increased	increase	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
between	between	IN	B-PP	O
T0	T0	NN	B-NP	O
and	and	CC	I-NP	O
T1	T1	NN	I-NP	O
but	but	CC	O	O
decreased	decrease	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
between	between	IN	B-PP	O
T1	T1	NN	B-NP	O
and	and	CC	I-NP	O
T2	T2	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.01	0.01	CD	B-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
group	group	NN	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
labial	labial	JJ	B-NP	O
appliance	appliance	NN	I-NP	O
.	.	.	O	O

S.	S.	NN	B-NP	O
mutans	mutan	NNS	I-NP	O
counts	count	NNS	I-NP	O
increased	increase	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
between	between	IN	B-PP	O
T0	T0	NN	B-NP	O
and	and	CC	I-NP	O
T2	T2	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
saliva	saliva	NN	I-NP	O
samples	sample	NNS	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
lingual	lingual	JJ	B-NP	O
appliance	appliance	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
statistically	statistically	RB	I-NP	O
significant	significant	JJ	I-NP	O
differences	difference	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
between	between	IN	B-PP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
and	and	CC	O	O
Lactobacillus	Lactobacillus	NN	B-NP	O
counts	count	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
terms	term	NNS	I-NP	O
of	of	IN	B-PP	O
saliva	saliva	NN	B-NP	O
collection	collection	NN	I-NP	O
in	in	IN	B-PP	O
patients	patient	NNS	B-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
labial	labial	JJ	B-NP	O
appliance	appliance	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
statistically	statistically	RB	I-NP	O
significant	significant	JJ	I-NP	O
differences	difference	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
groups	group	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
time	time	NN	I-NP	O
points	point	NNS	I-NP	O
as	as	IN	B-SBAR	O
regards	regard	VBZ	B-VP	O
the	the	DT	B-NP	O
salivary	salivary	JJ	I-NP	O
flow	flow	NN	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
saliva	saliva	NN	I-NP	O
buffer	buffer	NN	I-NP	O
capacity	capacity	NN	I-NP	O
.	.	.	O	O

Lingual	Lingual	JJ	B-NP	O
and	and	CC	I-NP	O
labial	labial	JJ	I-NP	O
orthodontic	orthodontic	JJ	I-NP	O
appliances	appliance	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
different	different	JJ	I-NP	O
potential	potential	NN	I-NP	O
in	in	IN	B-PP	O
modifying	modify	VBG	B-VP	O
the	the	DT	B-NP	O
investigated	investigate	VBN	I-NP	O
clinical	clinical	JJ	I-NP	O
parameters	parameter	NNS	I-NP	O
:	:	:	O	O
patients	patient	NNS	B-NP	O
wearing	wear	VBG	B-VP	O
STb	STb	NN	B-NP	O
lingual	lingual	JJ	I-NP	O
orthodontic	orthodontic	JJ	I-NP	O
appliance	appliance	NN	I-NP	O
had	have	VBD	B-VP	O
more	more	RBR	B-NP	O
plaque	plaque	JJ	I-NP	O
retention	retention	NN	I-NP	O
4	4	CD	I-NP	O
and	and	CC	I-NP	O
8	8	CD	I-NP	O
weeks	week	NNS	I-NP	O
after	after	IN	B-PP	O
bonding	bonding	NN	B-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
more	more	RBR	B-NP	O
gingival	gingival	JJ	I-NP	O
inflammation	inflammation	NN	I-NP	O
and	and	CC	O	O
more	more	JJR	B-NP	O
S.	S.	NNP	I-NP	O
mutans	mutan	NNS	I-NP	O
counts	count	VBZ	B-VP	O
8	8	CD	B-NP	O
weeks	week	NNS	I-NP	O
after	after	IN	B-PP	O
bonding	bonding	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
differences	difference	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
groups	group	NNS	I-NP	O
as	as	IN	B-SBAR	O
regards	regard	VBZ	B-VP	O
the	the	DT	B-NP	O
Lactobacillus	Lactobacillus	NN	I-NP	O
counts	count	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
salivary	salivary	JJ	I-NP	O
flow	flow	NN	I-NP	O
rate	rate	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
saliva	saliva	NN	B-NP	O
buffer	buffer	NN	I-NP	O
capacity	capacity	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
significant	significant	JJ	I-NP	O
portion	portion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
taking	take	VBG	B-VP	O
part	part	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
microbiome	microbiome	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
apical	apical	JJ	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
still	still	RB	B-ADVP	O
remain	remain	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
cultivated	cultivate	VBN	I-VP	O
and	and	CC	O	O
phenotypically	phenotypically	RB	B-VP	O
characterized	characterize	VBN	I-VP	O
.	.	.	O	O

This	This	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
study	study	NN	I-NP	O
evaluated	evaluate	VBD	B-VP	O
the	the	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
selected	select	VBN	B-NP	O
as-yet-uncultivated	as-yet-uncultivated	JJ	I-NP	O
and	and	CC	I-NP	O
difficult-to-culture	difficult-to-culture	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
taxa	taxa	NN	I-NP	O
in	in	IN	B-PP	O
infected	infected	JJ	B-NP	O
root	root	NN	I-NP	O
canals	canal	NNS	I-NP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
susceptibility	susceptibility	NN	I-NP	O
to	to	TO	B-PP	O
chemomechanical	chemomechanical	JJ	B-NP	O
procedures	procedure	NNS	I-NP	O
.	.	.	O	O

Root	Root	NN	B-NP	O
canals	canal	NNS	I-NP	O
of	of	IN	B-PP	O
single-rooted	single-rooted	JJ	B-NP	O
teeth	tooth	NNS	I-NP	O
with	with	IN	B-PP	O
apical	apical	JJ	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
were	be	VBD	B-VP	O
prepared	prepare	VBN	I-VP	O
using	use	VBG	B-VP	O
rotary	rotary	JJ	B-NP	O
nickel-titanium	nickel-titanium	NN	I-NP	O
instruments	instrument	NNS	I-NP	O
and	and	CC	O	O
2.5	2.5	CD	B-NP	O
%	%	NN	I-NP	O
sodium	sodium	NN	I-NP	O
hypochlorite	hypochlorite	NN	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
irrigant	irrigant	NN	I-NP	O
.	.	.	O	O

DNA	DNA	NN	B-NP	O
extracts	extract	NNS	I-NP	O
from	from	IN	B-PP	O
samples	sample	NNS	B-NP	O
taken	take	VBN	B-VP	O
before	before	RB	O	O
(	(	(	O	O
S1	S1	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
after	after	IN	B-SBAR	O
(	(	(	O	O
S2	S2	NN	B-NP	B-protein
)	)	)	I-NP	O
chemomechanical	chemomechanical	JJ	I-NP	O
preparation	preparation	NN	I-NP	O
were	be	VBD	B-VP	O
surveyed	survey	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
7	7	CD	B-NP	O
as-yet-uncultivated	as-yet-uncultivated	JJ	I-NP	O
phylotypes	phylotype	NNS	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
difficult-to-culture	difficult-to-culture	JJ	I-NP	O
species	specie	NNS	I-NP	O
using	use	VBG	B-VP	O
end-point	end-point	JJ	B-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
.	.	.	O	O

Samples	Sample	NNS	B-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
subjected	subject	VBN	I-VP	O
to	to	TO	B-PP	O
quantitative	quantitative	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
total	total	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	I-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
2	2	CD	I-NP	O
most	most	RBS	I-NP	O
prevalent	prevalent	JJ	I-NP	O
taxa	taxa	NN	I-NP	O
.	.	.	O	O

Bacteroidaceae	Bacteroidaceae	NNP	B-NP	O
sp	sp	NN	I-NP	O
.	.	.	O	O

HOT-272	HOT-272	NN	B-NP	B-protein
(	(	(	O	O
24	24	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
Fretibacterium	Fretibacterium	NN	B-NP	O
fastidiosum	fastidiosum	NN	I-NP	O
(	(	(	O	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
prevalent	prevalent	JJ	I-NP	O
taxa	taxa	NN	I-NP	O
in	in	IN	B-PP	O
S1	S1	NN	B-NP	B-protein
.	.	.	O	O

Their	Their	PRP$	B-NP	O
mean	mean	JJ	I-NP	O
counts	count	NNS	I-NP	O
in	in	IN	B-PP	O
S1	S1	NN	B-NP	B-protein
were	be	VBD	B-VP	O
8.25	8.25	CD	B-NP	O
x	x	SYM	O	O
10	10	CD	B-NP	O
(	(	(	O	O
3	3	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
2.13	2.13	CD	B-NP	O
x	x	CC	I-NP	O
10	10	CD	I-NP	O
(	(	(	O	O
3	3	CD	B-NP	O
)	)	)	O	O
rRNA	rRNA	NN	B-NP	O
gene	gene	NN	I-NP	O
copies	copy	NNS	I-NP	O
,	,	,	O	O
corresponding	correspond	VBG	B-VP	O
to	to	TO	B-PP	O
0.18	0.18	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
0.55	0.55	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

Chemomechanical	Chemomechanical	JJ	B-NP	O
debridement	debridement	NN	I-NP	O
promoted	promote	VBD	B-VP	O
a	a	DT	B-NP	O
highly	highly	RB	I-NP	O
statistically	statistically	RB	I-NP	O
significant	significant	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
total	total	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
counts	count	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	JJR	B-NP	O
.001	.001	CD	I-NP	O
)	)	)	O	O
,	,	,	O	O
but	but	CC	O	O
64	64	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
canals	canal	NNS	I-NP	O
were	be	VBD	B-VP	O
still	still	RB	B-ADVP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
presence	presence	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
the	the	DT	B-NP	O
target	target	NN	I-NP	O
taxa	taxa	NN	I-NP	O
,	,	,	O	O
only	only	RB	B-NP	O
Bacteroidaceae	Bacteroidaceae	NNP	I-NP	O
sp	sp	NN	I-NP	O
.	.	.	O	O

HOT-272	HOT-272	NN	B-NP	O
and	and	CC	O	O
F.	F.	NNP	B-NP	O
fastidiosum	fastidiosum	NN	I-NP	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
S2	S2	NN	B-NP	B-protein
(	(	(	O	O
each	each	DT	B-NP	O
one	one	CD	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
sample	sample	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
counts	count	NNS	B-NP	O
of	of	IN	B-PP	O
both	both	DT	B-NP	O
taxa	taxa	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
highly	highly	RB	B-ADJP	O
significant	significant	JJ	I-ADJP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	JJR	B-NP	O
.001	.001	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

Findings	Finding	NNS	B-NP	O
confirmed	confirm	VBD	B-VP	O
that	that	IN	B-SBAR	O
several	several	JJ	B-NP	O
as-yet-uncultivated	as-yet-uncultivated	JJ	I-NP	O
and	and	CC	I-NP	O
difficult-to-grow	difficult-to-grow	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
taxa	taxa	NN	I-NP	O
can	can	MD	B-VP	O
participate	participate	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
microbiome	microbiome	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
apical	apical	JJ	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
of	of	IN	B-PP	O
them	them	PRP	B-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
relatively	relatively	RB	B-NP	O
high	high	JJ	I-NP	O
prevalence	prevalence	NN	I-NP	O
but	but	CC	O	O
rarely	rarely	RB	B-ADVP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
dominant	dominant	JJ	I-NP	B-protein
species	specie	NNS	I-NP	I-protein
.	.	.	O	O

Chemomechanical	Chemomechanical	JJ	B-NP	O
procedures	procedure	NNS	I-NP	O
were	be	VBD	B-VP	O
highly	highly	RB	B-ADJP	O
effective	effective	JJ	I-ADJP	O
in	in	IN	B-PP	O
completely	completely	RB	B-ADVP	O
eliminating	eliminate	VBG	B-VP	O
these	these	DT	B-NP	O
taxa	taxa	NN	I-NP	O
or	or	CC	O	O
at	at	IN	B-VP	O
least	least	JJS	I-VP	O
substantially	substantially	RB	I-VP	O
reducing	reduce	VBG	I-VP	O
their	their	PRP$	B-NP	O
numbers	number	NNS	I-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
important	important	JJ	I-NP	O
factors	factor	NNS	I-NP	O
implicated	implicate	VBN	B-VP	O
in	in	IN	B-PP	O
preterm	preterm	JJ	B-NP	O
birth	birth	NN	I-NP	O
(	(	(	O	O
PTB	PTB	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
acute	acute	JJ	B-NP	O
genitourinary	genitourinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
causing	cause	VBG	B-VP	O
chronic	chronic	JJ	B-NP	O
periodontal	periodontal	JJ	I-NP	O
inflammation	inflammation	NN	I-NP	O
include	include	VBP	B-VP	O
Gram-negative	Gram-negative	JJ	B-NP	O
rods	rod	NNS	I-NP	O
and	and	CC	O	O
anaerobes	anaerobe	NNS	B-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
those	those	DT	B-NP	O
found	find	VBN	B-VP	O
in	in	IN	B-PP	O
women	woman	NNS	B-NP	O
with	with	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
vaginosis	vaginosis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
prospective	prospective	JJ	I-NP	O
study	study	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
oral	oral	JJ	B-NP	O
and	and	CC	I-NP	O
vaginal	vaginal	JJ	I-NP	O
microflora	microflora	NN	I-NP	O
and	and	CC	O	O
preterm	preterm	VB	B-VP	O
low	low	JJ	B-NP	O
birth	birth	NN	I-NP	O
weight	weight	NN	I-NP	O
.	.	.	O	O

Real-time	Real-time	JJ	B-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
detect	detect	VB	I-VP	O
both	both	CC	O	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
and	and	CC	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
six	six	CD	B-NP	O
periodontitis-related	periodontitis-related	JJ	I-NP	O
species	specie	NNS	I-NP	O
:	:	:	O	O
Aggregatibacter	Aggregatibacter	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
(	(	(	O	O
Aa	Aa	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
(	(	(	O	O
Pg	Pg	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
Tannerella	Tannerella	NN	B-NP	O
forsythia	forsythia	NN	I-NP	O
(	(	(	O	O
Tf	Tf	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
Treponema	Treponema	NN	B-NP	O
denticola	denticola	NN	I-NP	O
(	(	(	O	O
Td	Td	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
Fusobacterium	Fusobacterium	NN	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
ssp	ssp	NN	I-NP	O
(	(	(	O	O
Fn	Fn	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
Prevotella	Prevotella	NN	B-NP	O
intermedia	intermedia	NNS	I-NP	O
(	(	(	O	O
Pi	Pi	NNP	B-NP	O
)	)	)	O	O
for	for	IN	B-PP	O
both	both	DT	B-NP	O
oral	oral	JJ	I-NP	O
samples	sample	NNS	I-NP	O
of	of	IN	B-PP	O
subgingival	subgingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
and	and	CC	O	O
cervical	cervical	JJ	B-NP	O
samples	sample	NNS	I-NP	O
,	,	,	O	O
obtained	obtain	VBN	B-VP	O
from	from	IN	B-PP	O
80	80	CD	B-NP	O
patients	patient	NNS	I-NP	O
,	,	,	O	O
during	during	IN	B-PP	O
gynaecological	gynaecological	JJ	B-NP	O
examinations	examination	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
more	more	RBR	I-NP	O
representative	representative	JJ	I-NP	O
oral	oral	JJ	I-NP	O
pathogen	pathogen	NN	I-NP	O
(	(	(	O	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
60	60	CD	I-NP	O
percent	percent	NN	I-NP	O
)	)	)	O	O
species	specie	NNS	B-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
samples	sample	NNS	I-NP	O
of	of	IN	B-PP	O
preterm	preterm	NN	B-NP	O
and	and	CC	I-NP	O
term	term	NN	I-NP	O
group	group	NN	I-NP	O
were	be	VBD	B-VP	O
Tf	Tf	NN	B-NP	B-protein
,	,	,	O	O
Td	Td	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Fn	Fn	NNP	B-NP	B-protein
.	.	.	O	O

24.4	24.4	CD	B-NP	O
percent	percent	NN	I-NP	O
of	of	IN	B-PP	O
pregnant	pregnant	JJ	B-NP	O
women	woman	NNS	I-NP	O
presented	present	VBD	B-VP	O
periodontal	periodontal	JJ	B-NP	O
pathogens	pathogen	NNS	I-NP	O
in	in	IN	B-PP	O
vaginal	vaginal	JJ	B-NP	O
swab	swab	NN	I-NP	O
;	;	:	O	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
representative	representative	JJ	I-NP	O
species	specie	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
percentage	percentage	NN	I-NP	O
over	over	IN	B-PP	O
0.1	0.1	CD	B-NP	O
percent	percent	NN	I-NP	O
of	of	IN	B-PP	O
total	total	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
genital	genital	JJ	B-NP	O
tract	tract	NN	I-NP	O
of	of	IN	B-PP	O
preterm	preterm	JJ	B-NP	O
group	group	NN	I-NP	O
were	be	VBD	B-VP	O
Tf	Tf	NN	B-NP	B-protein
,	,	,	O	O
Td	Td	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Pi	Pi	NNP	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
(	(	(	O	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
0.5	0.5	CD	I-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bacterium	bacterium	NN	I-NP	O
T.	T.	NN	I-NP	O
denticolain	denticolain	VBP	B-VP	O
the	the	DT	B-NP	O
vagina	vagina	NN	I-NP	O
,	,	,	O	O
regardless	regardless	RB	B-ADVP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
amount	amount	NN	I-NP	O
,	,	,	O	O
adversely	adversely	RB	B-ADVP	O
affects	affect	VBZ	B-VP	O
preterm	preterm	JJ	B-NP	O
delivery	delivery	NN	I-NP	O
.	.	.	O	O

Astilbin	Astilbin	NN	B-NP	O
,	,	,	O	O
mainly	mainly	RB	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
commonly	commonly	RB	I-NP	O
used	use	VBN	I-NP	O
herbal	herbal	JJ	I-NP	O
medicine	medicine	NN	I-NP	O
,	,	,	O	O
Smilax	Smilax	NN	B-NP	O
glabra	glabra	NN	I-NP	O
Roxb	Roxb	NN	I-NP	O
(	(	(	O	O
SGR	SGR	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
exhibits	exhibit	VBZ	B-VP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
pharmacological	pharmacological	JJ	B-NP	O
activities	activity	NNS	I-NP	O
and	and	CC	O	O
biological	biological	JJ	B-NP	O
effects	effect	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
metabolized	metabolize	VBN	I-VP	O
by	by	IN	B-PP	O
intestinal	intestinal	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
after	after	IN	B-PP	O
oral	oral	JJ	B-NP	O
administration	administration	NN	I-NP	O
which	which	WDT	B-NP	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
variation	variation	NN	I-NP	O
of	of	IN	B-PP	O
ethnopharmacological	ethnopharmacological	JJ	B-NP	O
profile	profile	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
traditional	traditional	JJ	I-NP	O
medicine	medicine	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
little	little	JJ	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
interactions	interaction	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
active	active	JJ	I-NP	O
compound	compound	NN	I-NP	O
with	with	IN	B-PP	O
intestinal	intestinal	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
very	very	RB	B-ADJP	O
helpful	helpful	JJ	I-ADJP	O
in	in	IN	B-PP	O
unravelling	unravel	VBG	B-VP	O
how	how	WRB	B-ADVP	O
SGR	SGR	NN	B-NP	B-protein
works	work	VBZ	B-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
different	different	JJ	B-NP	O
pure	pure	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
from	from	IN	B-PP	O
human	human	JJ	B-NP	O
feces	fece	NNS	I-NP	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
their	their	PRP$	B-NP	O
conversion	conversion	NN	I-NP	O
capability	capability	NN	I-NP	O
of	of	IN	B-PP	O
astilbin	astilbin	NN	B-NP	O
.	.	.	O	O

Ultra-performance	Ultra-performance	JJ	B-NP	O
liquid	liquid	JJ	I-NP	O
chromatography/quadrupole-time-of-flight	chromatography/quadrupole-time-of-flight	JJ	I-NP	O
mass	mass	NN	I-NP	O
spectrometry	spectrometry	NN	I-NP	O
(	(	(	O	O
UPLC-Q-TOF/MS	UPLC-Q-TOF/MS	NN	B-NP	O
)	)	)	O	O
technique	technique	NN	B-NP	O
combined	combine	VBN	B-VP	O
with	with	IN	B-PP	O
Metabolynx	Metabolynx	NN	B-NP	O
(	(	(	O	O
TM	TM	NN	B-NP	O
)	)	)	O	O
software	software	NN	B-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
analyze	analyze	VB	I-VP	O
astilbin	astilbin	NN	B-NP	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
metabolites	metabolite	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
parent	parent	NN	I-NP	O
compound	compound	NN	I-NP	O
and	and	CC	O	O
two	two	CD	B-NP	O
metabolites	metabolite	NNS	I-NP	O
(	(	(	O	O
quercetin	quercetin	NN	B-NP	O
and	and	CC	O	O
eriodictyol	eriodictyol	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
isolated	isolate	VBN	I-NP	O
bacterial	bacterial	JJ	I-NP	O
samples	sample	NNS	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
blank	blank	JJ	B-NP	O
samples	sample	NNS	I-NP	O
.	.	.	O	O

Quercetin	Quercetin	NN	B-NP	O
was	be	VBD	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
Enterococcus	Enterococcus	NN	B-NP	O
sp	sp	NN	I-NP	O
.	.	.	O	O

8B	8B	NN	B-NP	O
,	,	,	O	O
8-2	8-2	CD	B-NP	O
and	and	CC	I-NP	O
9-2	9-2	CD	I-NP	O
samples	sample	NNS	I-NP	O
.	.	.	O	O

Eriodictyol	Eriodictyol	NN	B-NP	O
was	be	VBD	B-VP	O
only	only	RB	I-VP	O
identified	identify	VBN	I-VP	O
in	in	IN	B-PP	O
Enterococcus	Enterococcus	NN	B-NP	O
sp	sp	NN	I-NP	O
.	.	.	O	O

8B	8B	NN	B-NP	O
sample	sample	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
metabolic	metabolic	JJ	I-NP	O
routes	route	NNS	I-NP	O
and	and	CC	I-NP	O
metabolites	metabolite	NNS	I-NP	O
of	of	IN	B-PP	O
astilbin	astilbin	NN	B-NP	O
produced	produce	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
different	different	JJ	I-NP	O
intestinal	intestinal	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
are	be	VBP	B-VP	O
reported	report	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
useful	useful	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
investigation	investigation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
pharmacokinetic	pharmacokinetic	JJ	I-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
astilbin	astilbin	NN	B-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
and	and	CC	O	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
intestinal	intestinal	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
metabolism	metabolism	NN	I-NP	O
of	of	IN	B-PP	O
natural	natural	JJ	B-NP	O
compounds	compound	NNS	I-NP	O
.	.	.	O	O

Periodontitis	Periodontitis	NN	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
common	common	JJ	I-NP	O
dental	dental	JJ	I-NP	O
disease	disease	NN	I-NP	O
which	which	WDT	B-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
irreversible	irreversible	JJ	B-NP	O
alveolar	alveolar	JJ	I-NP	O
bone	bone	NN	I-NP	O
loss	loss	NN	I-NP	O
around	around	IN	B-PP	O
teeth	tooth	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
subsequent	subsequent	JJ	B-NP	O
tooth	tooth	JJ	I-NP	O
loss	loss	NN	I-NP	O
.	.	.	O	O

Previous	Previous	JJ	B-NP	O
studies	study	NNS	I-NP	O
have	have	VBP	B-VP	O
focused	focus	VBN	I-VP	O
on	on	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
that	that	WDT	B-NP	O
damage	damage	VBP	B-VP	O
the	the	DT	B-NP	O
host	host	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
roles	role	NNS	I-NP	O
of	of	IN	B-PP	O
commensals	commensal	NNS	B-NP	O
to	to	TO	B-VP	O
facilitate	facilitate	VB	I-VP	O
their	their	PRP$	B-NP	O
colonization	colonization	NN	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
some	some	DT	B-NP	O
immune	immune	JJ	I-NP	O
responses	response	NNS	I-NP	O
targeting	target	VBG	B-VP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
protect	protect	VBP	B-VP	O
the	the	DT	B-NP	O
host	host	NN	I-NP	O
from	from	IN	B-PP	O
alveolar	alveolar	JJ	B-NP	O
bone	bone	NN	I-NP	O
loss	loss	NN	I-NP	O
,	,	,	O	O
recent	recent	JJ	B-NP	O
studies	study	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
particular	particular	JJ	B-NP	O
host	host	NN	I-NP	O
defense	defense	NN	I-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
can	can	MD	B-VP	O
induce	induce	VB	I-VP	O
alveolar	alveolar	JJ	B-NP	O
bone	bone	NN	I-NP	O
loss	loss	NN	I-NP	O
.	.	.	O	O

Host-damaging	Host-damaging	JJ	B-NP	O
and	and	CC	I-NP	O
immunostimulatory	immunostimulatory	JJ	I-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
cooperatively	cooperatively	RB	B-ADVP	O
induce	induce	VBP	B-VP	O
bone	bone	NN	B-NP	O
loss	loss	NN	I-NP	O
by	by	IN	B-PP	O
inducing	induce	VBG	B-VP	O
gingival	gingival	JJ	B-NP	O
damage	damage	NN	I-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
immunostimulation	immunostimulation	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
mouse	mouse	NN	B-NP	O
models	model	NNS	I-NP	O
of	of	IN	B-PP	O
experimental	experimental	JJ	B-NP	O
periodontitis	periodontitis	NN	I-NP	O
induced	induce	VBN	B-VP	O
by	by	IN	B-PP	O
either	either	CC	O	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
or	or	CC	I-NP	O
ligature	ligature	NN	I-NP	O
,	,	,	O	O
gamma-proteobacteria	gamma-proteobacteria	NNS	B-NP	O
accumulate	accumulate	VBP	B-VP	O
and	and	CC	I-VP	O
stimulate	stimulate	VBP	I-VP	O
host	host	NN	B-NP	O
immune	immune	JJ	I-NP	O
responses	response	NNS	I-NP	O
to	to	TO	B-VP	O
induce	induce	VB	I-VP	O
host	host	NN	B-NP	O
damage	damage	NN	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
review	review	VBP	B-VP	O
the	the	DT	B-NP	O
differential	differential	JJ	I-NP	O
roles	role	NNS	I-NP	O
of	of	IN	B-PP	O
individual	individual	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
groups	group	NNS	I-NP	O
in	in	IN	B-PP	O
promoting	promote	VBG	B-VP	O
bone	bone	NN	B-NP	O
loss	loss	NN	I-NP	O
through	through	IN	B-PP	O
the	the	DT	B-NP	O
induction	induction	NN	I-NP	O
of	of	IN	B-PP	O
host	host	NN	B-NP	O
damage	damage	NN	I-NP	O
and	and	CC	I-NP	O
immunostimulation	immunostimulation	NN	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
biofilms	biofilm	NNS	I-NP	O
harbor	harbor	VBP	B-VP	O
several	several	JJ	B-NP	O
hundreds	hundred	NNS	I-NP	O
of	of	IN	B-PP	O
species	specie	NNS	B-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
spirochetes	spirochete	NNS	B-NP	O
,	,	,	O	O
protozoa	protozoa	NN	B-NP	O
,	,	,	O	O
fungi	fungus	NNS	B-NP	O
and	and	CC	I-NP	O
viruses	virus	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
composition	composition	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
biofilm	biofilm	NN	I-NP	O
varies	vary	VBZ	B-VP	O
from	from	IN	B-PP	O
health	health	NN	B-NP	O
to	to	TO	B-PP	O
disease	disease	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
microorganisms	microorganism	NNS	B-NP	O
that	that	WDT	B-NP	O
cause	cause	VBP	B-VP	O
dental	dental	JJ	B-NP	O
and	and	CC	I-NP	O
periodontal	periodontal	JJ	I-NP	O
infections	infection	NNS	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
infections	infection	NNS	I-NP	O
and	and	CC	O	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
implicated	implicate	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
etiopathogenesis	etiopathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
important	important	JJ	I-NP	O
chronic	chronic	JJ	I-NP	O
systemic	systemic	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
now	now	RB	B-ADVP	O
clear	clear	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
common	common	JJ	I-NP	O
oral	oral	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
,	,	,	O	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
and	and	CC	O	O
periodontitis	periodontitis	NN	B-NP	O
,	,	,	O	O
are	be	VBP	B-VP	O
caused	cause	VBN	I-VP	O
by	by	IN	B-PP	O
mixed-species	mixed-species	JJ	B-NP	O
communities	community	NNS	I-NP	O
rather	rather	RB	B-CONJP	O
than	than	IN	I-CONJP	O
by	by	IN	B-PP	O
individual	individual	JJ	B-NP	O
pathogens	pathogen	NNS	I-NP	O
working	work	VBG	B-VP	O
in	in	IN	B-PP	O
isolation	isolation	NN	B-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
streptococci	streptococci	NNS	I-NP	O
are	be	VBP	B-VP	O
central	central	JJ	B-ADJP	O
to	to	TO	B-PP	O
these	these	DT	B-NP	O
disease	disease	NN	I-NP	O
processes	process	NNS	I-NP	O
since	since	IN	B-SBAR	O
they	they	PRP	B-NP	O
are	be	VBP	B-VP	O
frequently	frequently	RB	B-ADVP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
microorganisms	microorganism	NNS	I-NP	O
to	to	TO	B-VP	O
colonize	colonize	VB	I-VP	O
oral	oral	JJ	B-NP	O
surfaces	surface	NNS	I-NP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
are	be	VBP	B-VP	O
numerically	numerically	RB	B-ADVP	O
the	the	DT	B-NP	O
dominant	dominant	JJ	I-NP	O
microorganisms	microorganism	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
mouth	mouth	NN	I-NP	O
.	.	.	O	O

Numerous	Numerous	JJ	B-NP	O
interactions	interaction	NNS	I-NP	O
between	between	IN	B-PP	O
oral	oral	JJ	B-NP	O
streptococci	streptococci	NNS	I-NP	O
and	and	CC	O	O
other	other	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
documented	document	VBN	I-VP	O
.	.	.	O	O

These	These	DT	B-NP	O
are	be	VBP	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
critical	critical	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
mixed-species	mixed-species	JJ	B-NP	O
oral	oral	JJ	I-NP	O
microbial	microbial	JJ	I-NP	O
communities	community	NNS	I-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
transition	transition	NN	I-NP	O
from	from	IN	B-PP	O
oral	oral	JJ	B-NP	O
health	health	NN	I-NP	O
to	to	TO	B-PP	O
disease	disease	NN	B-NP	O
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
metagenomic	metagenomic	JJ	I-NP	O
studies	study	NNS	I-NP	O
are	be	VBP	B-VP	O
beginning	begin	VBG	I-VP	O
to	to	TO	I-VP	O
shed	shed	VB	I-VP	O
light	light	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
co-occurrence	co-occurrence	NN	I-NP	O
patterns	pattern	NNS	I-NP	O
of	of	IN	B-PP	O
streptococci	streptococci	NNS	B-NP	O
with	with	IN	B-PP	O
other	other	JJ	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

Refinements	Refinement	NNS	B-NP	O
in	in	IN	B-PP	O
microscopy	microscopy	NN	B-NP	O
techniques	technique	NNS	I-NP	O
and	and	CC	O	O
biofilm	biofilm	NN	B-NP	O
models	model	NNS	I-NP	O
are	be	VBP	B-VP	O
providing	provide	VBG	I-VP	O
detailed	detailed	JJ	B-NP	O
insights	insight	NNS	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
spatial	spatial	JJ	I-NP	O
distribution	distribution	NN	I-NP	O
of	of	IN	B-PP	O
streptococci	streptococci	NNS	B-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
biofilms	biofilm	NNS	I-NP	O
.	.	.	O	O

Targeted	Target	VBN	B-NP	O
genetic	genetic	JJ	I-NP	O
manipulation	manipulation	NN	I-NP	O
is	be	VBZ	B-VP	O
increasingly	increasingly	RB	I-VP	O
being	be	VBG	I-VP	O
applied	apply	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
specific	specific	JJ	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
and	and	CC	I-NP	O
networks	network	NNS	I-NP	O
that	that	WDT	B-NP	O
modulate	modulate	VBP	B-VP	O
interspecies	interspecies	JJ	B-NP	O
interactions	interaction	NNS	I-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
this	this	DT	B-NP	O
work	work	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
clear	clear	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
streptococci	streptococci	NNS	B-NP	O
produce	produce	VBP	B-VP	O
a	a	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
extracellular	extracellular	JJ	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
promote	promote	VBP	B-VP	O
their	their	PRP$	B-NP	O
integration	integration	NN	I-NP	O
into	into	IN	B-PP	O
mixed-species	mixed-species	JJ	B-NP	O
communities	community	NNS	I-NP	O
and	and	CC	O	O
enable	enable	VB	B-VP	O
them	them	PRP	B-NP	O
to	to	TO	B-VP	O
form	form	VB	I-VP	O
social	social	JJ	B-NP	O
networks	network	NNS	I-NP	O
with	with	IN	B-PP	O
neighboring	neighbor	VBG	B-NP	O
taxa	taxa	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
``	``	``	I-NP	B-protein
community	community	NN	I-NP	I-protein
integration	integration	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
''	''	''	O	O
include	include	VBP	B-VP	O
coaggregation-mediating	coaggregation-mediating	JJ	B-NP	B-protein
adhesins	adhesin	NNS	I-NP	I-protein
and	and	CC	I-NP	O
receptors	receptor	NNS	I-NP	O
,	,	,	O	O
small	small	JJ	B-NP	B-protein
signaling	signal	VBG	I-NP	I-protein
molecules	molecule	NNS	I-NP	I-protein
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
peptides	peptide	NNS	B-NP	O
or	or	CC	O	O
autoinducer-2	autoinducer-2	NN	B-NP	B-protein
,	,	,	O	O
bacteriocins	bacteriocin	NNS	B-NP	O
,	,	,	O	O
by-products	by-product	NNS	B-NP	O
of	of	IN	B-PP	O
metabolism	metabolism	NN	B-NP	O
including	include	VBG	B-PP	O
hydrogen	hydrogen	NN	B-NP	O
peroxide	peroxide	NN	I-NP	O
and	and	CC	O	O
lactic	lactic	JJ	B-NP	O
acid	acid	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
extracellular	extracellular	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
.	.	.	O	O

Here	Here	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
provide	provide	VBP	B-VP	O
an	an	DT	B-NP	O
overview	overview	NN	I-NP	O
of	of	IN	B-PP	O
various	various	JJ	B-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
community	community	NN	B-NP	O
interactions	interaction	NNS	I-NP	O
between	between	IN	B-PP	O
oral	oral	JJ	B-NP	O
streptococci	streptococci	NNS	I-NP	O
and	and	CC	O	O
other	other	JJ	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
we	we	PRP	B-NP	O
consider	consider	VBP	B-VP	O
the	the	DT	B-NP	O
possibilities	possibility	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
new	new	JJ	B-NP	O
technologies	technology	NNS	I-NP	O
to	to	TO	B-VP	O
interfere	interfere	VB	I-VP	O
with	with	IN	B-PP	O
these	these	DT	B-NP	O
interactions	interaction	NNS	I-NP	O
to	to	TO	B-VP	O
help	help	VB	I-VP	O
control	control	VB	I-VP	O
oral	oral	JJ	B-NP	O
biofilms	biofilm	NNS	I-NP	O
.	.	.	O	O

Wounded	Wound	VBN	B-NP	O
tissue	tissue	NN	I-NP	O
offers	offer	VBZ	B-VP	O
opportunity	opportunity	NN	B-NP	O
to	to	TO	B-PP	O
microflora	microflora	NN	B-NP	O
to	to	TO	B-VP	O
adhere	adhere	VB	I-VP	O
,	,	,	I-VP	O
colonize	colonize	VB	I-VP	O
,	,	,	I-VP	O
invade	invade	VB	I-VP	O
and	and	CC	I-VP	O
infect	infect	VB	I-VP	O
surrounding	surround	VBG	B-VP	O
healthy	healthy	JJ	B-NP	O
tissue	tissue	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
have	have	VBP	B-VP	O
the	the	DT	B-NP	O
potential	potential	NN	I-NP	O
to	to	TO	B-VP	O
alter	alter	VB	I-VP	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	O
healing	healing	NN	I-NP	O
process	process	NN	I-NP	O
by	by	IN	B-PP	O
interacting	interact	VBG	B-VP	O
with	with	IN	B-PP	O
keratinocytes	keratinocyte	NNS	B-NP	B-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
mechanisms	mechanism	NNS	B-NP	O
through	through	IN	B-PP	O
which	which	WDT	B-NP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
may	may	MD	B-VP	O
influence	influence	VB	I-VP	O
re-epithelialization	re-epithelialization	NN	B-NP	O
by	by	IN	B-PP	O
interacting	interact	VBG	B-VP	O
with	with	IN	B-PP	O
gingival	gingival	JJ	B-NP	B-cell_type
keratinocytes	keratinocyte	NNS	I-NP	I-cell_type
.	.	.	O	O

By	By	IN	B-PP	O
an	an	DT	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
scratch	scratch	NN	I-NP	O
assay	assay	NN	I-NP	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
primary	primary	JJ	B-NP	B-cell_type
gingival	gingival	JJ	I-NP	I-cell_type
keratinocytes	keratinocyte	NNS	I-NP	I-cell_type
have	have	VBP	B-VP	O
impaired	impair	VBN	I-VP	O
closure	closure	NN	B-NP	O
when	when	WRB	B-ADVP	O
exposed	expose	VBN	B-VP	O
to	to	TO	B-PP	O
two	two	CD	B-NP	O
well	well	RB	I-NP	O
characterized	characterize	VBN	I-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
lesser	less	JJR	I-NP	O
extent	extent	NN	I-NP	O
,	,	,	O	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
.	.	.	O	O

P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
reduced	reduce	VBD	B-VP	O
wound	wound	JJ	B-NP	O
closure	closure	NN	I-NP	O
by	by	IN	B-PP	O
approximately	approximately	RB	B-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
partially	partially	RB	B-ADJP	O
dependent	dependent	JJ	I-ADJP	O
on	on	IN	B-PP	O
proteolytic	proteolytic	JJ	B-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
bacteria	bacteria	NNS	B-NP	O
was	be	VBD	B-VP	O
still	still	RB	B-ADVP	O
present	present	JJ	B-ADJP	O
within	within	IN	B-PP	O
infected	infected	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
9	9	CD	B-NP	O
days	day	NNS	I-NP	O
later	later	RBR	B-ADVP	O
despite	despite	IN	B-PP	O
exposure	exposure	NN	B-NP	O
to	to	TO	B-PP	O
bacteria	bacteria	NNS	B-NP	O
for	for	IN	B-PP	O
only	only	RB	B-NP	O
24	24	CD	I-NP	O
h.	h.	NN	I-NP	O
Both	Both	CC	O	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
caused	cause	VBD	B-VP	O
keratinocyte	keratinocyte	NN	B-NP	O
apoptosis	apoptosis	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
with	with	IN	B-PP	O
cell	cell	NN	B-NP	O
death	death	NN	I-NP	O
being	be	VBG	B-VP	O
greatest	great	JJS	B-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	O
edge	edge	NN	I-NP	O
.	.	.	O	O

P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
and	and	CC	O	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
adversely	adversely	RB	B-VP	O
affected	affect	VBD	I-VP	O
cell	cell	NN	B-NP	O
proliferation	proliferation	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
spatial	spatial	JJ	I-NP	O
component	component	NN	I-NP	O
being	be	VBG	B-VP	O
most	most	RBS	B-ADJP	O
striking	striking	JJ	I-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
edge	edge	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
impact	impact	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
was	be	VBD	B-VP	O
long	long	RB	I-VP	O
lasting	last	VBG	I-VP	O
even	even	RB	B-ADVP	O
when	when	WRB	I-ADVP	O
exposure	exposure	NN	B-NP	O
was	be	VBD	B-VP	O
brief	brief	JJ	B-ADJP	O
.	.	.	O	O

Cell	Cell	NN	B-NP	O
migration	migration	NN	I-NP	O
was	be	VBD	B-VP	O
compromised	compromise	VBN	I-VP	O
in	in	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	B-cell_type
challenged	challenge	VBD	B-VP	I-cell_type
keratinocytes	keratinocyte	NNS	B-NP	I-cell_type
with	with	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
having	have	VBG	B-VP	O
more	more	RBR	B-NP	O
severe	severe	JJ	I-NP	O
effect	effect	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
than	than	IN	B-PP	O
F.	F.	NN	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
.	.	.	O	O

Quantitative	Quantitative	JJ	B-NP	O
real	real	JJ	I-NP	O
time	time	NN	I-NP	O
PCR	PCR	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	B-cell_type
challenged	challenge	VBD	B-VP	I-cell_type
cells	cell	NNS	B-NP	I-cell_type
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
lesser	less	JJR	I-NP	O
extent	extent	NN	I-NP	O
F.	F.	NNP	I-NP	O
nucleatum	nucleatum	NNP	I-NP	O
significantly	significantly	RB	B-ADVP	O
downregulated	downregulate	VBD	B-VP	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
genes	gene	NNS	I-NP	O
cyclin1	cyclin1	NN	I-NP	B-protein
,	,	,	O	O
CDK1	CDK1	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
CDK4	CDK4	NN	B-NP	B-protein
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	B-NP	O
0.05	0.05	CD	I-NP	O
)	)	)	O	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
critical	critical	JJ	B-ADJP	O
for	for	IN	B-PP	O
GI/S	GI/S	NN	B-NP	O
transition	transition	NN	I-NP	O
.	.	.	O	O

Further	Further	RB	B-ADVP	O
,	,	,	O	O
genes	gene	NNS	B-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
cell	cell	NN	B-NP	O
migration	migration	NN	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
integrin	integrin	NN	B-NP	B-protein
beta-3	beta-3	NN	I-NP	I-protein
and	and	CC	O	I-protein
-6	-6	CD	B-NP	I-protein
were	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
downregulated	downregulate	VBN	I-VP	O
by	by	IN	B-PP	O
P.	P.	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

We	We	PRP	B-NP	O
investigated	investigate	VBD	B-VP	O
the	the	DT	B-NP	O
response	response	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	B-cell_type
cancer	cancer	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
to	to	TO	B-PP	O
intracellular	intracellular	JJ	B-NP	O
invasion	invasion	NN	I-NP	O
of	of	IN	B-PP	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
to	to	TO	B-VP	O
define	define	VB	I-VP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
biological	biological	JJ	I-NP	O
characteristics	characteristic	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	B-cell_type
cancer	cancer	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
evoked	evoke	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
pathogenic	pathogenic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
tumour	tumour	NN	I-NP	O
microenvironment	microenvironment	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
proliferative	proliferative	JJ	I-NP	O
activity	activity	NN	I-NP	O
,	,	,	O	O
cell	cell	NN	B-NP	O
cycle	cycle	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
autophagic	autophagic	JJ	B-NP	O
response	response	NN	I-NP	O
were	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	B-cell_type
cancer	cancer	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
infected	infect	VBN	B-VP	O
with	with	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
381	381	CD	I-NP	O
.	.	.	O	O

ROS	ROS	NN	B-NP	O
generation	generation	NN	I-NP	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
cells	cell	NNS	I-NP	O
by	by	IN	B-PP	O
DCFDA	DCFDA	NN	B-NP	B-protein
assay	assay	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
responses	response	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	B-cell_type
cancer	cancer	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
to	to	TO	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
infection	infection	NN	I-NP	O
was	be	VBD	B-VP	O
further	further	RB	I-VP	O
investigated	investigate	VBN	I-VP	O
.	.	.	O	O

P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
inhibited	inhibit	VBD	B-VP	O
proliferation	proliferation	NN	B-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	B-cell_type
cancer	cancer	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
by	by	IN	B-PP	O
inducing	induce	VBG	B-VP	O
G1	G1	NN	B-NP	O
cell	cell	NN	I-NP	O
cycle	cycle	NN	I-NP	O
arrest	arrest	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
apoptosis	apoptosis	NN	B-NP	O
.	.	.	O	O

Following	Follow	VBG	B-NP	O
infection	infection	NN	I-NP	O
with	with	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
cyclin	cyclin	NN	B-NP	B-protein
D1	D1	NN	I-NP	I-protein
and	and	CC	I-NP	O
cdk4	cdk4	NN	I-NP	B-protein
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	B-cell_type
cancer	cancer	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
whereas	whereas	IN	O	O
p21	p21	NN	B-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
Cdk	Cdk	NN	I-NP	B-protein
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
upregulated	upregulate	VBN	I-VP	O
,	,	,	O	O
in	in	IN	B-PP	O
comparison	comparison	NN	B-NP	O
with	with	IN	B-PP	O
non-infected	non-infected	JJ	B-NP	O
controls	control	NNS	I-NP	O
.	.	.	O	O

Autophagy	Autophagy	NNP	B-NP	O
was	be	VBD	B-VP	O
prominently	prominently	RB	I-VP	O
enhanced	enhance	VBN	I-VP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
infected	infected	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
,	,	,	O	O
presumably	presumably	RB	B-VP	O
contributing	contribute	VBG	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
suppressed	suppress	VBN	I-NP	O
proliferation	proliferation	NN	I-NP	O
.	.	.	O	O

Further	Far	JJR	B-NP	O
experiments	experiment	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
that	that	IN	B-SBAR	O
such	such	JJ	B-NP	O
autophagic	autophagic	JJ	I-NP	O
response	response	NN	I-NP	O
was	be	VBD	B-VP	O
activated	activate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
formation	formation	NN	I-NP	O
of	of	IN	B-PP	O
reactive	reactive	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
evidenced	evidence	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
lack	lack	NN	I-NP	O
of	of	IN	B-PP	O
autophagic	autophagic	JJ	B-NP	O
response	response	NN	I-NP	O
and	and	CC	O	O
cell	cell	NN	B-NP	O
proliferation	proliferation	NN	I-NP	O
upon	upon	IN	B-PP	O
removal	removal	NN	B-NP	O
of	of	IN	B-PP	O
reactive	reactive	JJ	B-NP	O
oxygen	oxygen	NN	I-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
provide	provide	VBP	B-VP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
insight	insight	NN	I-NP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
mechanism	mechanism	NN	I-NP	O
by	by	IN	B-PP	O
which	which	WDT	B-NP	O
cancer	cancer	NN	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
are	be	VBP	B-VP	O
influenced	influence	VBN	I-VP	O
by	by	IN	B-PP	O
tumour	tumour	NN	B-NP	O
microenvironment	microenvironment	NN	I-NP	O
including	include	VBG	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

Titanium	Titanium	NN	B-NP	O
and	and	CC	O	O
stainless	stainless	JJ	B-NP	O
steel	steel	NN	I-NP	O
wires	wire	NNS	I-NP	O
used	use	VBN	B-VP	O
for	for	IN	B-PP	O
retainers	retainer	NNS	B-NP	O
in	in	IN	B-PP	O
orthodontic	orthodontic	JJ	B-NP	O
procedures	procedure	NNS	I-NP	O
were	be	VBD	B-VP	O
coated	coat	VBN	I-VP	O
with	with	IN	B-PP	O
Ag	Ag	NN	B-NP	O
ions	ion	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
coating	coating	NN	I-NP	O
on	on	IN	B-PP	O
common	common	JJ	B-NP	O
oral	oral	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
pathogenicity	pathogenicity	NN	I-NP	O
were	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
species	specie	NNS	I-NP	O
of	of	IN	B-PP	O
cariogenic	cariogenic	JJ	O	O
and	and	CC	O	O
three	three	CD	B-NP	O
species	specie	NNS	I-NP	O
of	of	IN	B-PP	O
periodontopathic	periodontopathic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
.	.	.	O	O

Biofilms	Biofilms	NNP	B-NP	O
of	of	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
sobrinus	sobrinus	NNP	I-NP	O
and	and	CC	O	O
two	two	CD	B-NP	O
VSC	VSC	NN	I-NP	B-protein
gases	gas	NNS	I-NP	I-protein
produced	produce	VBN	B-VP	O
by	by	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
examined	examine	VBN	I-VP	O
.	.	.	O	O

Ag	Ag	NN	B-NP	O
ion-coated	ion-coated	JJ	I-NP	O
wires	wire	NNS	I-NP	O
showed	show	VBD	B-VP	O
marked	marked	JJ	B-NP	O
antibacterial	antibacterial	JJ	I-NP	O
activities	activity	NNS	I-NP	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
uncoated	uncoated	JJ	B-NP	O
wires	wire	NNS	I-NP	O
;	;	:	O	O
in	in	IN	B-PP	O
most	most	JJS	B-NP	O
cases	case	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
differences	difference	NNS	I-NP	O
were	be	VBD	B-VP	O
statistically	statistically	RB	B-ADJP	O
significant	significant	JJ	I-ADJP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

All	All	DT	B-NP	O
Ag	Ag	NN	I-NP	B-protein
ion-coated	ion-coated	JJ	I-NP	O
wires	wire	NNS	I-NP	O
(	(	(	O	O
Ti+	Ti+	JJ	B-NP	O
and	and	CC	I-NP	O
SS+	SS+	JJ	I-NP	O
wires	wire	NNS	I-NP	O
)	)	)	O	O
displayed	display	VBD	B-VP	O
more	more	JJR	B-NP	O
than	than	IN	B-PP	O
2-mm	2-mm	JJ	B-NP	O
diameter	diameter	NN	I-NP	O
bacteria	bacteria	NNS	I-NP	O
growth-resistant	growth-resistant	JJ	B-NP	O
zones	zone	NNS	I-NP	O
around	around	IN	B-PP	O
them	them	PRP	B-NP	O
in	in	IN	B-PP	O
radial	radial	JJ	B-NP	O
diffusion	diffusion	NN	I-NP	O
tests	test	NNS	I-NP	O
.	.	.	O	O

Ag	Ag	NN	B-NP	O
ion	ion	NN	I-NP	O
release	release	NN	I-NP	O
was	be	VBD	B-VP	O
0.043+/-0.005	0.043+/-0.005	CD	B-NP	O
ppm	ppm	NN	I-NP	O
in	in	IN	B-PP	O
24	24	CD	B-NP	O
h	h	NN	I-NP	O
that	that	WDT	B-NP	O
did	do	VBD	B-VP	O
n't	n't	RB	I-VP	O
show	show	VB	I-VP	O
cytotoxicity	cytotoxicity	NN	B-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
these	these	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
a	a	DT	B-NP	O
simple	simple	JJ	I-NP	O
Ag	Ag	NN	I-NP	O
ion	ion	NN	I-NP	O
coating	coat	VBG	B-VP	O
on	on	IN	B-PP	O
pure	pure	JJ	B-NP	O
titanium	titanium	NN	I-NP	O
and	and	CC	O	O
stainless	stainless	JJ	B-NP	O
steel	steel	NN	I-NP	O
wires	wire	NNS	I-NP	O
can	can	MD	B-VP	O
restrict	restrict	VB	I-VP	O
growth	growth	NN	B-NP	O
and	and	CC	O	O
pathogenic	pathogenic	JJ	B-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
pathogenic	pathogenic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
even	even	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
early	early	JJ	I-NP	O
stages	stage	NNS	I-NP	O
of	of	IN	B-PP	O
culture	culture	NN	B-NP	O
.	.	.	O	O

Mycoplasma	Mycoplasma	NN	B-NP	O
salivarium	salivarium	NN	I-NP	O
belongs	belong	VBZ	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
class	class	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
smallest	small	JJS	I-NP	O
self-replicating	self-replicating	JJ	I-NP	O
Tenericutes	Tenericute	NNPS	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
predominantly	predominantly	RB	I-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
of	of	IN	B-PP	O
humans	human	NNS	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
general	general	JJ	B-NP	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
considered	consider	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
non-pathogenic	non-pathogenic	JJ	I-NP	O
commensal	commensal	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
some	some	DT	B-NP	O
reports	report	NNS	I-NP	O
point	point	VBP	B-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
association	association	NN	I-NP	O
with	with	IN	B-PP	O
human	human	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

M.	M.	NN	B-NP	O
salivarium	salivarium	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
e.g	e.g	NN	B-NP	O
.	.	.	O	O

as	as	IN	B-PP	O
causative	causative	JJ	B-NP	O
agent	agent	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
submasseteric	submasseteric	JJ	I-NP	O
abscess	abscess	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
necrotic	necrotic	JJ	B-NP	O
dental	dental	JJ	I-NP	O
pulp	pulp	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
brain	brain	NN	B-NP	O
abscess	abscess	NN	I-NP	O
and	and	CC	O	O
clogged	clog	VBD	B-VP	O
biliary	biliary	JJ	B-NP	O
stent	stent	NN	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
describe	describe	VBP	B-VP	O
the	the	DT	B-NP	O
detection	detection	NN	I-NP	O
of	of	IN	B-PP	O
M.	M.	NN	B-NP	O
salivarium	salivarium	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
surface	surface	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
squamous	squamous	JJ	I-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tongue	tongue	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
Fanconi	Fanconi	NNP	B-NP	O
anaemia	anaemia	NN	I-NP	O
(	(	(	O	O
FA	FA	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

FA	FA	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
inherited	inherit	VBN	I-NP	O
bone	bone	NN	I-NP	O
marrow	marrow	NN	I-NP	O
failure	failure	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
defective	defective	JJ	B-NP	O
DNA-repair	DNA-repair	NN	I-NP	O
that	that	WDT	B-NP	O
increases	increase	VBZ	B-VP	O
the	the	DT	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
carcinomas	carcinoma	NNS	B-NP	O
especially	especially	RB	B-NP	O
oral	oral	JJ	I-NP	O
squamous	squamous	JJ	I-NP	O
cell	cell	NN	I-NP	O
carcinoma	carcinoma	NN	I-NP	O
.	.	.	O	O

Employing	Employ	VBG	B-VP	O
high	high	JJ	B-NP	O
coverage	coverage	NN	I-NP	O
,	,	,	O	O
massive	massive	JJ	B-NP	O
parallel	parallel	JJ	I-NP	O
Roche/454-next-generation-sequencing	Roche/454-next-generation-sequencing	NN	I-NP	O
of	of	IN	B-PP	O
16S	16S	NN	B-NP	O
rRNA	rRNA	NN	I-NP	O
gene	gene	NN	I-NP	O
amplicons	amplicon	NNS	I-NP	O
we	we	PRP	B-NP	O
analysed	analyse	VBD	B-VP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microbiome	microbiome	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
FA	FA	NN	I-NP	O
patient	patient	NN	I-NP	O
in	in	IN	B-PP	O
comparison	comparison	NN	B-NP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
FA	FA	NN	I-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
benign	benign	JJ	I-NP	O
leukoplakia	leukoplakia	NN	I-NP	O
and	and	CC	O	O
five	five	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
individuals	individual	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
microbiota	microbiota	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
FA	FA	NN	I-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
leukoplakia	leukoplakia	NN	B-NP	O
correlated	correlate	VBD	B-VP	O
well	well	RB	B-ADVP	O
with	with	IN	B-PP	O
that	that	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
healthy	healthy	JJ	I-NP	O
controls	control	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
dominance	dominance	NN	I-NP	O
of	of	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
,	,	,	I-NP	O
Veillonella	Veillonella	NNP	I-NP	O
and	and	CC	I-NP	O
Neisseria	Neisseria	NNP	I-NP	O
species	specie	NNS	I-NP	O
was	be	VBD	B-VP	O
typically	typically	RB	I-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
microbiome	microbiome	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cancer	cancer	NN	I-NP	O
bearing	bear	VBG	B-VP	O
FA	FA	NN	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
dominated	dominate	VBN	I-VP	O
by	by	IN	B-PP	O
Pseudomonas	Pseudomonas	NN	B-NP	O
aeruginosa	aeruginosa	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
healthy	healthy	JJ	I-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
,	,	,	O	O
which	which	WDT	B-NP	O
changed	change	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
predominance	predominance	NN	I-NP	O
of	of	IN	B-PP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
M.	M.	NN	I-NP	O
salivarium	salivarium	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
tumour	tumour	NN	I-NP	O
surface	surface	NN	I-NP	O
.	.	.	O	O

Quantification	Quantification	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mycoplasma	mycoplasma	NN	I-NP	O
load	load	NN	I-NP	O
in	in	IN	B-PP	O
five	five	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
tumour-	tumour-	NN	I-NP	O
and	and	CC	O	O
two	two	CD	B-NP	O
leukoplakia-FA	leukoplakia-FA	NN	I-NP	O
patients	patient	NNS	I-NP	O
by	by	IN	B-PP	O
TaqMan-PCR	TaqMan-PCR	NN	B-NP	O
confirmed	confirm	VBD	B-VP	O
the	the	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
M.	M.	NN	B-NP	O
salivarium	salivarium	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
tumour	tumour	NN	I-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
.	.	.	O	O

These	These	DT	B-NP	O
new	new	JJ	I-NP	O
findings	finding	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
mycoplasma	mycoplasma	NN	I-NP	B-protein
species	specie	NNS	I-NP	I-protein
with	with	IN	B-PP	O
its	its	PRP$	B-NP	O
reduced	reduce	VBN	I-NP	O
coding	coding	NN	I-NP	O
capacity	capacity	NN	I-NP	O
found	find	VBD	B-VP	O
ideal	ideal	JJ	B-NP	O
breeding	breed	VBG	I-NP	O
grounds	ground	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
tumour	tumour	NN	I-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
.	.	.	O	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
FA	FA	NN	I-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	O	O
especially	especially	RB	B-ADVP	O
samples	sample	NNS	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
tumour	tumour	NN	I-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
were	be	VBD	B-VP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
Candida	Candida	NNP	B-NP	O
albicans	albicans	NNP	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
remains	remain	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
elucidated	elucidate	VBN	I-VP	O
in	in	IN	B-PP	O
further	further	JJ	B-NP	O
studies	study	NNS	I-NP	O
whether	whether	IN	B-SBAR	O
M.	M.	NN	B-NP	O
salivarium	salivarium	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
predictive	predictive	JJ	I-NP	O
biomarker	biomarker	NN	I-NP	O
for	for	IN	B-PP	O
tumour	tumour	NN	B-NP	O
development	development	NN	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
patients	patient	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
microbiota	microbiota	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
lower	low	JJR	I-NP	O
intestinal	intestinal	JJ	I-NP	O
tract	tract	NN	I-NP	O
helps	help	VBZ	B-VP	O
maintain	maintain	VB	I-VP	O
healthy	healthy	JJ	B-NP	O
host	host	NN	I-NP	O
physiology	physiology	NN	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
example	example	NN	B-NP	O
through	through	IN	B-PP	O
nutrient	nutrient	NN	B-NP	O
acquisition	acquisition	NN	I-NP	O
and	and	CC	I-NP	O
bile	bile	NN	I-NP	O
acid	acid	NN	I-NP	O
recycling	recycling	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
specific	specific	JJ	B-NP	O
positive	positive	JJ	I-NP	O
contributions	contribution	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
to	to	TO	B-PP	O
host	host	NN	B-NP	O
health	health	NN	I-NP	O
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
well	well	RB	I-VP	O
established	establish	VBN	I-VP	O
.	.	.	O	O

Nitric	Nitric	JJ	B-NP	O
oxide	oxide	NN	I-NP	O
(	(	(	O	O
NO	NO	NN	B-NP	O
)	)	)	O	O
homeostasis	homeostasis	NN	B-NP	O
is	be	VBZ	B-VP	O
crucial	crucial	JJ	B-ADJP	O
to	to	TO	B-PP	O
mammalian	mammalian	JJ	B-NP	O
physiology	physiology	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
recently	recently	RB	I-NP	O
described	describe	VBN	I-NP	O
entero-salivary	entero-salivary	JJ	I-NP	O
nitrate-nitrite-nitric	nitrate-nitrite-nitric	JJ	I-NP	O
oxide	oxide	NN	I-NP	O
pathway	pathway	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
provide	provide	VB	I-VP	O
bioactive	bioactive	JJ	B-NP	O
NO	NO	NN	I-NP	O
from	from	IN	B-PP	O
dietary	dietary	JJ	B-NP	O
nitrate	nitrate	NN	I-NP	O
sources	source	NNS	I-NP	O
.	.	.	O	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
pathway	pathway	NN	I-NP	O
is	be	VBZ	B-VP	O
dependent	dependent	JJ	B-ADJP	O
upon	upon	IN	B-PP	O
oral	oral	JJ	B-NP	O
nitrate-reducing	nitrate-reducing	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
since	since	IN	B-SBAR	O
humans	human	NNS	B-NP	O
lack	lack	VBP	B-VP	O
this	this	DT	B-NP	O
enzyme	enzyme	NN	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
pathway	pathway	NN	I-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
represent	represent	VB	I-VP	O
a	a	DT	B-NP	O
newly	newly	RB	I-NP	O
recognized	recognize	VBN	I-NP	O
symbiosis	symbiosis	NN	I-NP	O
between	between	IN	B-PP	O
oral	oral	JJ	B-NP	O
nitrate-reducing	nitrate-reducing	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
human	human	JJ	I-NP	O
hosts	host	NNS	I-NP	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
provide	provide	VBP	B-VP	O
nitrite	nitrite	NN	B-NP	O
and	and	CC	O	O
nitric	nitric	JJ	B-NP	O
oxide	oxide	NN	I-NP	O
from	from	IN	B-PP	O
nitrate	nitrate	NN	B-NP	O
reduction	reduction	NN	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
we	we	PRP	B-NP	O
measure	measure	VBP	B-VP	O
the	the	DT	B-NP	O
nitrate-reducing	nitrate-reducing	JJ	I-NP	O
capacity	capacity	NN	I-NP	O
of	of	IN	B-PP	O
tongue-scraping	tongue-scraping	JJ	B-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
six	six	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
human	human	JJ	I-NP	O
volunteers	volunteer	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
analyze	analyze	NN	B-NP	O
metagenomes	metagenome	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
communities	community	NNS	I-NP	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
bacteria	bacteria	NNS	B-NP	O
contributing	contribute	VBG	B-VP	O
to	to	TO	B-PP	O
nitrate	nitrate	NN	B-NP	O
reduction	reduction	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
identified	identify	VBD	B-VP	O
14	14	CD	B-NP	O
candidate	candidate	NN	I-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
seven	seven	CD	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
previously	previously	RB	I-VP	O
believed	believe	VBN	I-VP	O
to	to	TO	I-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
nitrate	nitrate	NN	B-NP	O
reduction	reduction	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
cultivated	cultivate	VBD	B-VP	O
isolates	isolate	NNS	B-NP	O
of	of	IN	B-PP	O
four	four	CD	B-NP	O
candidate	candidate	NN	I-NP	O
species	specie	NNS	I-NP	O
in	in	IN	B-PP	O
single-	single-	JJ	B-NP	O
and	and	CC	I-NP	O
mixed-species	mixed-species	JJ	I-NP	O
biofilms	biofilm	NNS	I-NP	O
,	,	,	O	O
revealing	reveal	VBG	B-VP	O
that	that	IN	B-SBAR	O
they	they	PRP	B-NP	O
have	have	VBP	B-VP	O
substantial	substantial	JJ	B-NP	O
nitrate-	nitrate-	NN	I-NP	O
and	and	CC	I-NP	O
nitrite-reduction	nitrite-reduction	NN	I-NP	O
capabilities	capability	NNS	I-NP	O
.	.	.	O	O

Colonization	Colonization	NN	B-NP	O
by	by	IN	B-PP	O
specific	specific	JJ	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
may	may	MD	B-VP	O
thus	thus	RB	I-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
host	host	NN	B-NP	O
NO	NO	NN	I-NP	O
homeostasis	homeostasis	NN	I-NP	O
by	by	IN	B-PP	O
providing	provide	VBG	B-VP	O
nitrite	nitrite	NN	B-NP	O
and	and	CC	O	O
nitric	nitric	JJ	B-NP	O
oxide	oxide	NN	I-NP	O
.	.	.	O	O

Conversely	Conversely	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
lack	lack	NN	I-NP	O
of	of	IN	B-PP	O
specific	specific	JJ	B-NP	O
nitrate-reducing	nitrate-reducing	JJ	I-NP	O
communities	community	NNS	I-NP	O
may	may	MD	B-VP	O
disrupt	disrupt	VB	I-VP	O
the	the	DT	B-NP	O
nitrate-nitrite-nitric	nitrate-nitrite-nitric	JJ	I-NP	O
oxide	oxide	NN	I-NP	O
pathway	pathway	NN	I-NP	O
and	and	CC	O	O
lead	lead	VBP	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
NO	NO	NN	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
may	may	MD	B-VP	O
also	also	RB	I-VP	O
provide	provide	VB	I-VP	O
mechanistic	mechanistic	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
systemic	systemic	JJ	I-NP	O
link	link	NN	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
provide	provide	VBP	B-VP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
new	new	JJ	I-NP	O
therapeutic	therapeutic	JJ	I-NP	O
target	target	NN	I-NP	O
and	and	CC	I-NP	O
paradigm	paradigm	NN	I-NP	O
for	for	IN	B-PP	O
NO	NO	NN	B-NP	O
restoration	restoration	NN	I-NP	O
in	in	IN	B-PP	O
humans	human	NNS	B-NP	O
by	by	IN	B-PP	O
specific	specific	JJ	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

Knowledge	Knowledge	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
microbial	microbial	JJ	I-NP	O
composition	composition	NN	I-NP	O
of	of	IN	B-PP	O
deciduous	deciduous	JJ	B-NP	O
endodontic	endodontic	JJ	I-NP	O
infections	infection	NNS	I-NP	O
is	be	VBZ	B-VP	O
limited	limit	VBN	B-ADJP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
aimed	aim	VBD	B-VP	O
to	to	TO	I-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
10	10	CD	I-NP	O
oral	oral	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
in	in	IN	B-PP	O
samples	sample	NNS	B-NP	O
from	from	IN	B-PP	O
primary	primary	JJ	B-NP	O
tooth	tooth	JJ	I-NP	O
root	root	NN	I-NP	O
canals	canal	NNS	I-NP	O
by	by	IN	B-PP	O
using	use	VBG	B-VP	O
microarray	microarray	NN	B-NP	O
technology	technology	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
association	association	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
organisms	organism	NNS	I-NP	O
with	with	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
from	from	IN	B-PP	O
30	30	CD	B-NP	O
root	root	NN	I-NP	O
canals	canal	NNS	I-NP	O
of	of	IN	B-PP	O
primary	primary	JJ	B-NP	O
teeth	tooth	NNS	I-NP	O
with	with	IN	B-PP	O
primer	primer	NN	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
composition	composition	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
samples	sample	NNS	I-NP	O
was	be	VBD	B-VP	O
semi-quantitatively	semi-quantitatively	RB	I-VP	O
defined	define	VBN	I-VP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
microarray	microarray	NN	I-NP	O
system	system	NN	I-NP	O
(	(	(	O	O
Parocheck	Parocheck	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

All	All	PDT	B-NP	O
the	the	DT	I-NP	O
tested	test	VBN	I-NP	O
species	specie	NNS	I-NP	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
samples	sample	NNS	I-NP	O
.	.	.	O	O

Fusobacterium	Fusobacterium	NN	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
frequently	frequently	RB	I-NP	O
isolated	isolate	VBN	I-NP	O
bacterium	bacterium	NN	I-NP	O
(	(	(	O	O
96.7	96.7	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
Prevotella	Prevotella	NN	B-NP	O
intermedia	intermedia	NN	I-NP	O
(	(	(	O	O
86.7	86.7	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Parvimonas	Parvimonas	NNP	B-NP	O
micra	micra	NN	I-NP	O
(	(	(	O	O
83.3	83.3	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
Treponema	Treponema	NN	B-NP	O
denticola	denticola	NN	I-NP	O
(	(	(	O	O
76.7	76.7	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
and	and	CC	O	O
Tannerella	Tannerella	NN	B-NP	O
forsythia	forsythia	NN	I-NP	O
(	(	(	O	O
66.7	66.7	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

These	These	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
high	high	JJ	B-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
pairs	pair	NNS	I-NP	O
of	of	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
species	specie	NNS	I-NP	O
were	be	VBD	B-VP	O
positively	positively	RB	I-VP	O
associated	associate	VBN	I-VP	O
(	(	(	O	O
RR	RR	NN	B-NP	B-protein
>	>	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
)	)	)	O	O
,	,	,	O	O
except	except	IN	B-PP	O
Pintermedia	Pintermedia	NNP	B-NP	O
and	and	CC	O	O
P	P	NN	B-NP	O
>	>	SYM	I-NP	O
micra	micra	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
average	average	NN	B-NP	O
,	,	,	O	O
five	five	CD	B-NP	O
species	specie	NNS	I-NP	O
(	(	(	O	O
range:3-8	range:3-8	NN	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
per	per	IN	B-PP	O
amplified	amplify	VBN	B-NP	O
sample	sample	NN	I-NP	O
.	.	.	O	O

Root	Root	NN	B-NP	O
canals	canal	NNS	I-NP	O
of	of	IN	B-PP	O
teeth	tooth	NNS	B-NP	O
with	with	IN	B-PP	O
>	>	SYM	B-NP	O
5	5	CD	I-NP	O
different	different	JJ	I-NP	O
species	specie	NNS	I-NP	O
were	be	VBD	B-VP	O
statistically	statistically	RB	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
periapical	periapical	JJ	B-NP	O
radiolucency	radiolucency	NN	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
=	=	SYM	B-VP	O
0.049	0.049	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Primary	Primary	JJ	B-NP	O
teeth	tooth	NNS	I-NP	O
with	with	IN	B-PP	O
endodontic	endodontic	JJ	B-NP	O
infections	infection	NNS	I-NP	O
show	show	VBP	B-VP	O
a	a	DT	B-NP	O
highly	highly	RB	I-NP	O
diverse	diverse	JJ	I-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
prevalent	prevalent	JJ	I-NP	O
specie	specie	NN	I-NP	O
are	be	VBP	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
high	high	JJ	B-NP	O
proportions	proportion	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
well-directed	well-directed	JJ	I-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
improved	improve	VBN	I-NP	O
microarray	microarray	NN	I-NP	O
technology	technology	NN	I-NP	O
will	will	MD	B-VP	O
provide	provide	VB	I-VP	O
additional	additional	JJ	B-NP	O
valuable	valuable	JJ	I-NP	O
information	information	NN	I-NP	O
for	for	IN	B-PP	O
causative	causative	JJ	B-NP	B-protein
factors	factor	NNS	I-NP	I-protein
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
endodontic	endodontic	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
,	,	,	O	O
helping	help	VBG	B-VP	O
to	to	TO	I-VP	O
develop	develop	VB	I-VP	O
more	more	RBR	B-NP	O
successful	successful	JJ	I-NP	O
antibacterial	antibacterial	JJ	I-NP	O
or	or	CC	I-NP	O
anti-inflammatory	anti-inflammatory	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
strategies	strategy	NNS	I-NP	O
.	.	.	O	O

Peanut	Peanut	NN	B-NP	O
allergy	allergy	NN	I-NP	O
(	(	(	O	O
PNA	PNA	NN	B-NP	O
)	)	)	O	O
has	have	VBZ	B-VP	O
becoming	become	VBG	I-VP	O
a	a	DT	B-NP	O
non-negligible	non-negligible	JJ	I-NP	O
health	health	NN	I-NP	O
concern	concern	NN	I-NP	O
worldwide	worldwide	RB	B-ADVP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
far	far	RB	I-ADVP	O
,	,	,	O	O
allergen-specific	allergen-specific	JJ	B-NP	O
immunotherapy	immunotherapy	NN	I-NP	O
aimed	aim	VBN	B-VP	O
at	at	IN	B-PP	O
inducing	induce	VBG	B-VP	O
mucosal	mucosal	JJ	B-NP	O
tolerance	tolerance	NN	I-NP	O
has	have	VBZ	B-VP	O
widely	widely	RB	I-VP	O
been	be	VBN	I-VP	O
regarded	regard	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
management	management	NN	I-NP	O
strategy	strategy	NN	I-NP	O
for	for	IN	B-PP	O
PNA	PNA	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
safety	safety	NN	I-NP	O
profiles	profile	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
intrinsic	intrinsic	JJ	I-NP	O
probiotic	probiotic	JJ	I-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
lactic	lactic	JJ	B-NP	O
acid	acid	NN	I-NP	O
bacteria	bacteria	NNS	I-NP	O
(	(	(	O	O
LAB	LAB	NN	B-NP	B-protein
)	)	)	O	O
render	render	VBP	B-VP	O
them	them	PRP	B-NP	O
attractive	attractive	JJ	B-NP	O
delivery	delivery	NN	I-NP	O
vehicles	vehicle	NNS	I-NP	O
for	for	IN	B-PP	O
mucosal	mucosal	JJ	B-NP	O
vaccines	vaccine	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
exploited	exploit	VBD	B-VP	O
genetically	genetically	RB	B-NP	O
modified	modify	VBN	I-NP	O
Lactococcus	Lactococcus	NN	I-NP	O
lactis	lactis	NN	I-NP	O
to	to	TO	B-VP	O
produce	produce	VB	I-VP	O
peanut	peanut	NN	B-NP	B-protein
allergen	allergen	NN	I-NP	I-protein
Ara	Ara	NN	I-NP	I-protein
h	h	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
via	via	IN	B-PP	O
different	different	JJ	B-NP	O
protein-targeting	protein-targeting	JJ	I-NP	O
systems	system	NNS	I-NP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
immunomodulatory	immunomodulatory	JJ	I-NP	O
potency	potency	NN	I-NP	O
for	for	IN	B-PP	O
allergic	allergic	JJ	B-NP	O
immune	immune	JJ	I-NP	O
responses	response	NNS	I-NP	O
in	in	IN	B-PP	O
mice	mouse	NNS	B-NP	O
were	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
.	.	.	O	O

By	By	IN	B-PP	O
comparison	comparison	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
strain	strain	NN	I-NP	O
expressing	express	VBG	B-VP	O
the	the	DT	B-NP	O
cytoplasmic	cytoplasmic	JJ	I-NP	B-protein
form	form	NN	I-NP	I-protein
of	of	IN	B-PP	O
Ara	Ara	NN	B-NP	B-protein
h	h	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
(	(	(	O	O
LL1	LL1	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
strains	strain	NNS	I-NP	O
expressing	express	VBG	B-VP	O
the	the	DT	B-NP	O
secreted	secrete	VBN	I-NP	O
and	and	CC	I-NP	O
anchored	anchor	VBN	I-NP	O
forms	form	NNS	I-NP	O
of	of	IN	B-PP	O
Ara	Ara	NN	B-NP	B-protein
h	h	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
(	(	(	O	O
LL2	LL2	NN	B-NP	B-protein
and	and	CC	O	O
LL3	LL3	NN	B-NP	B-protein
)	)	)	O	O
were	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
potent	potent	JJ	I-ADJP	O
in	in	IN	B-PP	O
redirecting	redirect	VBG	B-VP	O
a	a	DT	B-NP	O
Th2-polarized	Th2-polarized	JJ	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
non-allergic	non-allergic	JJ	I-NP	O
Th1	Th1	NN	I-NP	O
immune	immune	JJ	I-NP	O
responses	response	NNS	I-NP	O
.	.	.	O	O

Induction	Induction	NN	B-NP	O
of	of	IN	B-PP	O
SIgA	SIgA	NN	B-NP	B-protein
and	and	CC	I-NP	O
regulatory	regulatory	JJ	I-NP	B-cell_type
T	T	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
observed	observe	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
local	local	JJ	I-NP	O
levels	level	NNS	I-NP	O
by	by	IN	B-PP	O
orally	orally	RB	B-NP	O
administration	administration	NN	I-NP	O
of	of	IN	B-PP	O
recombinant	recombinant	JJ	B-NP	O
L.	L.	NNP	I-NP	O
lactis	lactis	NN	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
allergen-producing	allergen-producing	JJ	B-NP	O
L.	L.	NNP	I-NP	O
lactis	lactis	NN	I-NP	O
strains	strain	NNS	I-NP	O
modulated	modulate	VBD	B-VP	O
allergic	allergic	JJ	B-NP	O
immune	immune	JJ	I-NP	O
responses	response	NNS	I-NP	O
and	and	CC	O	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
developed	develop	VBN	I-VP	O
as	as	IN	B-PP	O
promising	promising	JJ	B-NP	O
mucosal	mucosal	JJ	I-NP	O
vaccines	vaccine	NNS	I-NP	O
for	for	IN	B-PP	O
managing	manage	VBG	B-VP	O
allergic	allergic	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

Atherosclerotic	Atherosclerotic	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
leading	lead	VBG	I-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
and	and	CC	O	O
cerebrovascular	cerebrovascular	JJ	B-NP	O
accident	accident	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
independent	independent	JJ	B-NP	O
associations	association	NNS	I-NP	O
with	with	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
(	(	(	O	O
PD	PD	NN	B-NP	O
)	)	)	O	O
are	be	VBP	B-VP	O
reported	report	VBN	I-VP	O
.	.	.	O	O

PD	PD	NN	B-NP	O
is	be	VBZ	B-VP	O
caused	cause	VBN	I-VP	O
by	by	IN	B-PP	O
polymicrobial	polymicrobial	JJ	B-NP	O
infections	infection	NNS	I-NP	O
and	and	CC	O	O
aggressive	aggressive	JJ	B-NP	O
immune	immune	JJ	I-NP	O
responses	response	NNS	I-NP	O
.	.	.	O	O

Genomic	Genomic	JJ	B-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
of	of	IN	B-PP	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
best-studied	best-studied	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
pathogen	pathogen	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
PD	PD	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
detected	detect	VBN	I-VP	O
within	within	IN	B-PP	O
atherosclerotic	atherosclerotic	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
examined	examine	VBD	B-VP	O
causal	causal	JJ	B-NP	O
relationships	relationship	NNS	I-NP	O
between	between	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
P.	P.	NNP	I-NP	O
gingivalis	gingivalis	NN	I-NP	O
oral	oral	JJ	I-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
PD	PD	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
atherosclerosis	atherosclerosis	NN	B-NP	O
in	in	IN	B-PP	O
hyperlipidemic	hyperlipidemic	JJ	B-NP	O
ApoEnull	ApoEnull	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
.	.	.	O	O

ApoEnull	ApoEnull	JJ	B-NP	O
mice	mouse	NNS	I-NP	O
(	(	(	O	O
n	n	NN	B-NP	O
=	=	SYM	B-VP	O
24	24	CD	B-NP	O
)	)	)	O	O
were	be	VBD	B-VP	O
orally	orally	RB	I-VP	O
infected	infect	VBN	I-VP	O
with	with	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
for	for	IN	B-PP	O
12	12	CD	B-NP	O
and	and	CC	I-NP	O
24	24	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

PD	PD	NN	B-NP	O
was	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
by	by	IN	B-PP	O
standard	standard	JJ	B-NP	O
clinical	clinical	JJ	I-NP	O
measurements	measurement	NNS	I-NP	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
aorta	aorta	NN	I-NP	O
was	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
for	for	IN	B-PP	O
atherosclerotic	atherosclerotic	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
and	and	CC	O	O
inflammatory	inflammatory	JJ	B-NP	B-protein
markers	marker	NNS	I-NP	I-protein
by	by	IN	B-PP	O
array	array	NN	B-NP	O
.	.	.	O	O

Systemic	Systemic	JJ	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
markers	marker	NNS	I-NP	O
serum	serum	NN	I-NP	B-protein
amyloid	amyloid	NN	I-NP	I-protein
A	A	NN	I-NP	I-protein
,	,	,	O	O
nitric	nitric	JJ	B-NP	O
oxide	oxide	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
oxidized	oxidize	VBN	B-VP	O
low-density	low-density	JJ	B-NP	B-protein
lipoprotein	lipoprotein	NN	I-NP	I-protein
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
.	.	.	O	O

P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
infection	infection	NN	I-NP	O
elicited	elicit	VBD	B-VP	O
specific	specific	JJ	B-NP	O
antibodies	antibody	NNS	I-NP	O
and	and	CC	O	O
alveolar	alveolar	JJ	B-NP	O
bone	bone	NN	I-NP	O
loss	loss	NN	I-NP	O
.	.	.	O	O

Fluorescent	Fluorescent	JJ	B-NP	O
in	in	FW	I-NP	O
situ	situ	FW	I-NP	O
hybridization	hybridization	NN	I-NP	O
detected	detect	VBD	B-VP	O
viable	viable	JJ	B-NP	O
P.	P.	NNP	I-NP	O
gingivalis	gingivalis	NN	I-NP	O
within	within	IN	B-PP	O
oral	oral	JJ	B-NP	O
epithelium	epithelium	NN	I-NP	O
and	and	CC	I-NP	O
aorta	aorta	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
genomic	genomic	JJ	B-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
within	within	IN	B-PP	O
systemic	systemic	JJ	B-NP	O
organs	organ	NNS	I-NP	O
.	.	.	O	O

Aortic	Aortic	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
area	area	NN	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
increased	increase	VBN	I-VP	O
in	in	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis-infected	gingivalis-infected	JJ	I-NP	O
mice	mouse	NNS	I-NP	O
at	at	IN	B-PP	O
24	24	CD	B-NP	O
weeks	week	NNS	I-NP	O
(	(	(	O	O
P	P	NN	B-NP	O
<	<	SYM	O	O
0.01	0.01	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

Aortic	Aortic	JJ	B-NP	B-RNA
RNA	RNA	NN	I-NP	I-RNA
and	and	CC	I-NP	O
protein	protein	NN	I-NP	O
arrays	array	NNS	I-NP	O
indicated	indicate	VBD	B-VP	O
a	a	DT	B-NP	O
strong	strong	JJ	I-NP	O
Th2	Th2	NN	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
oral	oral	JJ	I-NP	O
infection	infection	NN	I-NP	O
with	with	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
results	result	VBZ	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
specific	specific	JJ	I-NP	O
immune	immune	JJ	I-NP	O
response	response	NN	I-NP	O
,	,	,	O	O
significant	significant	JJ	B-NP	O
increases	increase	NNS	I-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
bone	bone	NN	I-NP	O
resorption	resorption	NN	I-NP	O
,	,	,	O	O
aortic	aortic	JJ	B-NP	O
inflammation	inflammation	NN	I-NP	O
,	,	,	O	O
viable	viable	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
epithelium	epithelium	NN	I-NP	O
and	and	CC	I-NP	O
aorta	aorta	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
plaque	plaque	NN	B-NP	O
development	development	NN	I-NP	O
.	.	.	O	O

Individual	Individual	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	I-NP	O
shifts	shift	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
composition	composition	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
microbiome	microbiome	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
human	human	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
including	include	VBG	B-PP	O
cancer	cancer	NN	B-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
investigate	investigate	VB	I-VP	O
changes	change	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
microbiome	microbiome	NN	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
oral	oral	JJ	B-NP	O
cancers	cancer	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
profiled	profile	VBD	B-VP	O
cancers	cancer	NNS	B-NP	O
and	and	CC	O	O
anatomically	anatomically	RB	B-VP	O
matched	match	VBD	I-VP	O
contralateral	contralateral	JJ	B-NP	O
normal	normal	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
patient	patient	NN	I-NP	O
by	by	IN	B-PP	O
sequencing	sequence	VBG	B-VP	O
16S	16S	NN	B-NP	O
rDNA	rDNA	NN	I-NP	O
hypervariable	hypervariable	JJ	I-NP	O
region	region	NN	I-NP	O
amplicons	amplicon	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
cancer	cancer	NN	B-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
both	both	CC	O	O
a	a	DT	B-NP	O
discovery	discovery	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
subsequent	subsequent	JJ	I-NP	O
confirmation	confirmation	NN	I-NP	O
cohort	cohort	NN	I-NP	O
,	,	,	O	O
abundance	abundance	NN	B-NP	O
of	of	IN	B-PP	O
Firmicutes	Firmicute	NNS	B-NP	O
(	(	(	O	O
especially	especially	RB	B-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
)	)	)	O	O
and	and	CC	O	O
Actinobacteria	Actinobacteria	NN	B-NP	O
(	(	(	O	O
especially	especially	RB	B-ADVP	O
Rothia	Rothia	NNP	B-NP	O
)	)	)	O	O
was	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
relative	relative	JJ	B-ADVP	O
to	to	TO	B-PP	O
contralateral	contralateral	JJ	B-NP	O
normal	normal	JJ	I-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

Significant	Significant	JJ	B-NP	O
decreases	decrease	NNS	I-NP	O
in	in	IN	B-PP	O
abundance	abundance	NN	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
phyla	phyla	NN	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
for	for	IN	B-PP	O
pre-cancers	pre-cancer	NNS	B-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
when	when	WRB	B-ADVP	O
comparing	compare	VBG	B-VP	O
samples	sample	NNS	B-NP	O
from	from	IN	B-PP	O
contralateral	contralateral	JJ	B-NP	O
sites	site	NNS	I-NP	O
(	(	(	O	O
tongue	tongue	NN	B-NP	O
and	and	CC	I-NP	O
floor	floor	NN	I-NP	O
of	of	IN	B-PP	O
mouth	mouth	NN	B-NP	O
)	)	)	O	O
from	from	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
individuals	individual	NNS	I-NP	O
.	.	.	O	O

Weighted	Weighted	NNP	B-NP	O
UniFrac	UniFrac	NNP	I-NP	O
principal	principal	NN	I-NP	O
coordinates	coordinate	VBZ	B-VP	O
analysis	analysis	NN	B-NP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
12	12	CD	B-NP	O
taxa	taxa	NN	I-NP	O
separated	separate	VBD	B-VP	O
most	most	JJS	B-NP	O
cancers	cancer	NNS	I-NP	O
from	from	IN	B-PP	O
other	other	JJ	B-NP	O
samples	sample	NNS	I-NP	O
with	with	IN	B-PP	O
greatest	great	JJS	B-NP	O
separation	separation	NN	I-NP	O
of	of	IN	B-PP	O
node	node	NN	B-NP	O
positive	positive	JJ	I-NP	O
cases	case	NNS	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
studies	study	NNS	I-NP	O
begin	begin	VBP	B-VP	O
to	to	TO	I-VP	O
develop	develop	VB	I-VP	O
a	a	DT	B-NP	O
framework	framework	NN	I-NP	O
for	for	IN	B-PP	O
exploiting	exploit	VBG	B-VP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microbiome	microbiome	NN	I-NP	O
for	for	IN	B-PP	O
monitoring	monitor	VBG	B-VP	O
oral	oral	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
development	development	NN	I-NP	O
,	,	,	O	O
progression	progression	NN	B-NP	O
and	and	CC	I-NP	O
recurrence	recurrence	NN	I-NP	O
.	.	.	O	O

Fusobacterium	Fusobacterium	NN	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
ubiquitous	ubiquitous	JJ	I-NP	B-protein
member	member	NN	I-NP	I-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
oral	oral	JJ	I-NP	O
flora	flora	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
development	development	NN	I-NP	O
of	of	IN	B-PP	O
periodontitis	periodontitis	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
polymicrobial	polymicrobial	JJ	B-NP	O
infections	infection	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mucosa	mucosa	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
species	species	NN	I-NP	O
is	be	VBZ	B-VP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
few	few	JJ	I-NP	O
that	that	DT	B-NP	O
is	be	VBZ	B-VP	O
prevalent	prevalent	JJ	B-ADJP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
healthy	healthy	JJ	I-NP	O
and	and	CC	I-NP	O
diseased	diseased	JJ	I-NP	O
subgingival	subgingival	JJ	I-NP	O
plaque	plaque	NN	I-NP	O
.	.	.	O	O

Using	Use	VBG	B-VP	O
microarray	microarray	NN	B-NP	O
analysis	analysis	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
transcriptional	transcriptional	JJ	I-NP	O
response	response	NN	I-NP	O
of	of	IN	B-PP	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
subspecies	subspecy	NNS	I-NP	O
nucleatum	nucleatum	NN	I-NP	O
to	to	TO	B-PP	O
whole	whole	JJ	B-NP	O
blood	blood	NN	I-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
identify	identify	VB	I-VP	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
genetic	genetic	JJ	I-NP	O
responses	response	NNS	I-NP	O
that	that	WDT	B-NP	O
might	might	MD	B-VP	O
occur	occur	VB	I-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
transition	transition	NN	I-NP	O
from	from	IN	B-PP	O
health	health	NN	B-NP	O
to	to	TO	B-PP	O
disease	disease	NN	B-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
these	these	DT	B-NP	O
studies	study	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
identified	identify	VBD	B-VP	O
a	a	DT	B-NP	O
sialic	sialic	JJ	I-NP	B-protein
acid	acid	NN	I-NP	I-protein
catabolism	catabolism	NN	I-NP	I-protein
operon	operon	NN	I-NP	I-protein
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
induced	induce	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
subsequently	subsequently	RB	B-ADVP	O
confirmed	confirm	VBD	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
operon	operon	NN	I-NP	O
was	be	VBD	B-VP	O
inducible	inducible	JJ	B-ADJP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
synthetic	synthetic	JJ	B-NP	O
sialic	sialic	JJ	I-NP	O
acid	acid	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
we	we	PRP	B-NP	O
found	find	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
suggesting	suggest	VBG	B-VP	O
sialic	sialic	JJ	B-NP	O
acid	acid	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
carbon	carbon	NN	I-NP	O
source	source	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
organism	organism	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
possess	possess	VB	I-VP	O
a	a	DT	B-NP	O
de	de	FW	I-NP	O
novo	novo	FW	I-NP	O
synthesized	synthesize	VBN	B-NP	O
surface	surface	NN	I-NP	O
sialylation	sialylation	NN	I-NP	O
ability	ability	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
widely	widely	RB	I-VP	O
conserved	conserve	VBN	I-VP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
various	various	JJ	I-NP	O
F.	F.	NNP	I-NP	O
nucleatum	nucleatum	NN	I-NP	O
subspecies	subspecy	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
in	in	IN	B-PP	O
F.	F.	NNP	B-NP	O
periodonticum	periodonticum	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
provide	provide	VBP	B-VP	O
evidence	evidence	NN	B-NP	O
that	that	IN	B-SBAR	O
fusobacterial	fusobacterial	JJ	B-NP	O
sialylation	sialylation	NN	I-NP	O
does	do	VBZ	B-VP	O
occur	occur	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
irrespective	irrespective	JJ	B-ADJP	O
of	of	IN	B-PP	O
health	health	NN	B-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
only	only	RB	B-NP	O
a	a	DT	I-NP	O
minority	minority	NN	I-NP	O
of	of	IN	B-PP	O
fusobacterial	fusobacterial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
exhibit	exhibit	VBP	B-VP	O
surface	surface	NN	B-NP	O
sialylation	sialylation	NN	I-NP	O
within	within	IN	B-PP	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
most	most	JJS	B-NP	O
cells	cell	NNS	I-NP	O
are	be	VBP	B-VP	O
uniformly	uniformly	RB	I-VP	O
sialylated	sialylate	VBN	I-VP	O
when	when	WRB	B-ADVP	O
grown	grow	VBN	B-VP	O
in	in	IN	B-PP	O
pure	pure	JJ	B-NP	B-cell_line
culture	culture	NN	I-NP	I-cell_line
.	.	.	O	O

The	The	DT	B-NP	O
implications	implication	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
results	result	NNS	I-NP	O
are	be	VBP	B-VP	O
discussed	discuss	VBN	I-VP	O
.	.	.	O	O

Many	Many	JJ	B-NP	O
viruses	virus	NNS	I-NP	O
,	,	,	O	O
fungi	fungus	NNS	B-NP	O
and	and	CC	I-NP	O
bacteria	bacteria	NNS	I-NP	O
inhabit	inhabit	VBP	B-VP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
.	.	.	O	O

Most	Most	JJS	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
easily	easily	RB	I-VP	O
cultured	culture	VBN	I-VP	O
and	and	CC	I-VP	O
identified	identify	VBN	I-VP	O
by	by	IN	B-PP	O
classical	classical	JJ	B-NP	O
microbiological	microbiological	JJ	I-NP	O
tests	test	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
them	them	PRP	B-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
human	human	JJ	B-NP	O
papilloma	papilloma	NN	I-NP	O
virus	virus	NN	I-NP	O
,	,	,	O	O
can	can	MD	B-VP	O
only	only	RB	I-VP	O
be	be	VB	I-VP	O
identified	identify	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
methods	method	NNS	I-NP	O
of	of	IN	B-PP	O
molecular	molecular	JJ	B-NP	O
biology	biology	NN	I-NP	O
.	.	.	O	O

Some	Some	DT	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
are	be	VBP	B-VP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
small	small	JJ	I-NP	O
amount	amount	NN	I-NP	O
and	and	CC	O	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
detected	detect	VBN	I-VP	O
by	by	IN	B-PP	O
classical	classical	JJ	B-NP	O
tests	test	NNS	I-NP	O
;	;	:	O	O
therefore	therefore	RB	B-ADVP	O
,	,	,	O	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
case	case	NN	I-NP	O
,	,	,	O	O
molecular	molecular	JJ	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
a	a	DT	B-NP	O
logical	logical	JJ	I-NP	O
alternative	alternative	NN	I-NP	O
.	.	.	O	O

Molecular	Molecular	JJ	B-NP	O
biology	biology	NN	I-NP	O
assays	assay	NNS	I-NP	O
are	be	VBP	B-VP	O
sensitive	sensitive	JJ	B-ADJP	O
,	,	,	O	O
objective	objective	JJ	B-ADJP	O
,	,	,	O	O
easy	easy	JJ	B-ADJP	O
to	to	TO	B-VP	O
perform	perform	VB	I-VP	O
and	and	CC	O	O
less	less	JJR	B-NP	O
demanding	demand	VBG	I-NP	O
than	than	IN	B-PP	O
conventional	conventional	JJ	B-NP	O
microbiological	microbiological	JJ	I-NP	O
methods	method	NNS	I-NP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
training	training	NN	B-NP	O
and	and	CC	I-NP	O
quality	quality	NN	I-NP	O
assurance	assurance	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
paper	paper	NN	I-NP	O
describes	describe	VBZ	B-VP	O
the	the	DT	B-NP	O
molecular	molecular	JJ	I-NP	O
methods	method	NNS	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
commonly	commonly	RB	I-VP	O
used	use	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
detection	detection	NN	I-NP	O
of	of	IN	B-PP	O
microorganisms	microorganism	NNS	B-NP	O
that	that	WDT	B-NP	O
colonize	colonize	VBP	B-VP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
leukemia	leukemia	NN	B-NP	O
,	,	,	O	O
oral	oral	JJ	B-NP	O
manifestations	manifestation	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
aberrations	aberration	NNS	B-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
microbiota	microbiota	NN	I-NP	O
.	.	.	O	O

Microbiota	Microbiota	NN	B-NP	B-protein
structure	structure	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
determined	determine	VBN	I-VP	O
by	by	IN	B-PP	O
both	both	CC	O	O
host	host	NN	B-NP	O
and	and	CC	O	O
environmental	environmental	JJ	B-NP	O
factors	factor	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
human	human	JJ	B-NP	O
hosts	host	NNS	I-NP	O
,	,	,	O	O
how	how	WRB	B-ADVP	O
health	health	NN	B-NP	O
status	status	NN	I-NP	O
shapes	shape	VBZ	B-VP	O
the	the	DT	B-NP	O
composition	composition	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
microbiota	microbiota	NN	I-NP	O
is	be	VBZ	B-VP	O
largely	largely	RB	B-ADJP	O
unknown	unknown	JJ	I-ADJP	O
.	.	.	O	O

Taking	Take	VBG	B-VP	O
advantage	advantage	NN	B-NP	O
of	of	IN	B-PP	O
advances	advance	NNS	B-NP	O
in	in	IN	B-PP	O
high-throughput	high-throughput	JJ	B-NP	O
sequencing	sequencing	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
compared	compare	VBD	B-VP	O
the	the	DT	B-NP	O
composition	composition	NN	I-NP	O
of	of	IN	B-PP	O
supragingival	supragingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
microbiota	microbiota	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
lymphoblastic	lymphoblastic	JJ	I-NP	O
leukemia	leukemia	NN	I-NP	O
(	(	(	O	O
ALL	ALL	NN	B-NP	O
)	)	)	O	O
pediatric	pediatric	JJ	B-NP	O
patients	patient	NNS	I-NP	O
with	with	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
controls	control	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
oral	oral	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
of	of	IN	B-PP	O
leukemia	leukemia	NN	B-NP	O
patients	patient	NNS	I-NP	O
had	have	VBD	B-VP	O
lower	low	JJR	B-NP	O
richness	richness	NN	I-NP	O
and	and	CC	O	O
less	less	JJR	B-NP	O
diversity	diversity	NN	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
healthy	healthy	JJ	B-NP	O
controls	control	NNS	I-NP	O
.	.	.	O	O

Microbial	Microbial	JJ	B-NP	O
samples	sample	NNS	I-NP	O
clustered	cluster	VBN	B-VP	O
into	into	IN	B-PP	O
two	two	CD	B-NP	O
major	major	JJ	I-NP	O
groups	group	NNS	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
ALL	ALL	NN	B-NP	O
patients	patient	NNS	I-NP	O
and	and	CC	O	O
another	another	DT	B-NP	O
of	of	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
children	child	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
different	different	JJ	B-NP	O
structure	structure	NN	I-NP	O
and	and	CC	I-NP	O
composition	composition	NN	I-NP	O
.	.	.	O	O

Abundance	Abundance	NN	B-NP	O
changes	change	NNS	I-NP	O
of	of	IN	B-PP	O
certain	certain	JJ	B-NP	O
taxa	taxa	NN	I-NP	O
including	include	VBG	B-PP	O
the	the	DT	B-NP	O
Phylum	Phylum	NNP	I-NP	O
Firmicutes	Firmicute	NNPS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
Class	Class	NNP	I-NP	O
Bacilli	Bacilli	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
Order	Order	NNP	I-NP	O
Lactobacillales	Lactobacillales	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
Family	Family	NNP	I-NP	O
Aerococcaceae	Aerococcaceae	NNP	I-NP	O
and	and	CC	I-NP	O
Carnobacteriaceae	Carnobacteriaceae	NNP	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
Genus	Genus	NNP	I-NP	O
Abiotrophia	Abiotrophia	NNP	I-NP	O
and	and	CC	I-NP	O
Granulicatella	Granulicatella	NNP	I-NP	O
were	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
leukemia	leukemia	NN	B-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

ALL	ALL	NN	B-NP	O
patients	patient	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
structural	structural	JJ	I-NP	O
imbalance	imbalance	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
,	,	,	O	O
characterized	characterize	VBN	B-VP	O
by	by	IN	B-PP	O
reduced	reduce	VBN	B-NP	O
diversity	diversity	NN	I-NP	O
and	and	CC	I-NP	O
abundance	abundance	NN	I-NP	O
alterations	alteration	NNS	I-NP	O
,	,	,	O	O
possibly	possibly	RB	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
systemic	systemic	JJ	B-NP	O
infections	infection	NNS	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
the	the	DT	B-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
immune	immune	JJ	B-NP	O
status	status	NN	I-NP	O
in	in	IN	B-PP	O
shaping	shape	VBG	B-VP	O
the	the	DT	B-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
microbiota	microbiota	NN	I-NP	O
.	.	.	O	O

Nature	Nature	NNP	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
unexplored	unexplored	JJ	I-NP	O
reservoir	reservoir	NN	I-NP	O
of	of	IN	B-PP	O
novel	novel	JJ	B-NP	O
phytopharmaceuticals	phytopharmaceutical	NNS	I-NP	O
.	.	.	O	O

Since	Since	IN	B-SBAR	O
biofilm-related	biofilm-related	JJ	B-NP	O
oral	oral	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
often	often	RB	B-ADVP	O
correlate	correlate	VBP	B-VP	O
with	with	IN	B-PP	O
antibiotic	antibiotic	JJ	B-NP	O
resistance	resistance	NN	I-NP	O
,	,	,	O	O
plant-derived	plant-derived	JJ	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
agents	agent	NNS	I-NP	O
could	could	MD	B-VP	O
enhance	enhance	VB	I-VP	O
existing	exist	VBG	B-NP	O
treatment	treatment	NN	I-NP	O
options	option	NNS	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
rationale	rationale	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
report	report	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
examine	examine	VB	I-VP	O
the	the	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
impact	impact	NN	I-NP	O
of	of	IN	B-PP	O
Mediterranean	Mediterranean	JJ	B-NP	O
natural	natural	JJ	I-NP	O
extracts	extract	NNS	I-NP	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
.	.	.	O	O

Five	Five	CD	B-NP	O
different	different	JJ	I-NP	O
extracts	extract	NNS	I-NP	O
from	from	IN	B-PP	O
Olea	Olea	NNP	B-NP	O
europaea	europaea	NNP	I-NP	O
,	,	,	O	O
mastic	mastic	JJ	B-NP	O
gum	gum	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Inula	Inula	NNP	B-NP	O
viscosa	viscosa	NNP	I-NP	O
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
against	against	IN	B-PP	O
ten	ten	CD	B-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
one	one	CD	B-NP	O
Candida	Candida	NN	I-NP	O
albicans	albican	NNS	I-NP	O
strain	strain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
extraction	extraction	NN	I-NP	O
protocols	protocol	NNS	I-NP	O
were	be	VBD	B-VP	O
conducted	conduct	VBN	I-VP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
established	establish	VBN	B-NP	O
experimental	experimental	JJ	I-NP	O
procedures	procedure	NNS	I-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
assays	assay	NNS	I-NP	O
--	--	:	O	O
the	the	DT	B-NP	O
minimum	minimum	JJ	I-NP	O
inhibitory	inhibitory	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
(	(	(	O	O
MIC	MIC	NN	B-NP	O
)	)	)	O	O
assay	assay	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
minimum	minimum	JJ	I-NP	O
bactericidal	bactericidal	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
(	(	(	O	O
MBC	MBC	NN	B-NP	O
)	)	)	O	O
assay	assay	NN	B-NP	O
--	--	:	O	O
were	be	VBD	B-VP	O
applied	apply	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
screened	screen	VBN	I-NP	O
extracts	extract	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
active	active	JJ	B-ADJP	O
against	against	IN	B-PP	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tested	test	VBN	I-NP	O
microorganisms	microorganism	NNS	I-NP	O
.	.	.	O	O

O.	O.	NN	B-NP	O
europaea	europaea	NN	I-NP	O
presented	present	VBD	B-VP	O
MIC	MIC	NN	B-NP	O
and	and	CC	I-NP	O
MBC	MBC	NN	I-NP	O
ranges	range	NNS	I-NP	O
of	of	IN	B-PP	O
0.07-10.00	0.07-10.00	CD	B-NP	O
mg	mg	NN	I-NP	O
mL	mL	NN	I-NP	O
(	(	(	O	O
-1	-1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
0.60-10.00	0.60-10.00	CD	B-NP	O
mg	mg	NN	I-NP	O
mL	mL	NN	I-NP	O
(	(	(	O	O
-1	-1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
mean	mean	JJ	I-NP	O
MBC	MBC	NN	I-NP	O
values	value	NNS	I-NP	O
for	for	IN	B-PP	O
mastic	mastic	JJ	B-NP	O
gum	gum	NN	I-NP	O
and	and	CC	I-NP	O
I.	I.	NN	I-NP	O
viscosa	viscosa	NN	I-NP	O
were	be	VBD	B-VP	O
0.07-10.00	0.07-10.00	CD	B-NP	O
mg	mg	NN	I-NP	O
mL	mL	NN	I-NP	O
(	(	(	O	O
-1	-1	CD	B-NP	O
)	)	)	O	O
and	and	CC	O	O
0.15-10.00	0.15-10.00	CD	B-NP	O
mg	mg	NN	I-NP	O
mL	mL	NN	I-NP	O
(	(	(	O	O
-1	-1	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

Extracts	Extract	NNS	B-NP	O
were	be	VBD	B-VP	O
less	less	RBR	B-ADJP	O
effective	effective	JJ	I-ADJP	O
against	against	IN	B-PP	O
C.	C.	NNP	B-NP	O
albicans	albicans	NNP	I-NP	O
and	and	CC	O	O
exerted	exert	VBD	B-VP	O
bactericidal	bactericidal	JJ	B-NP	O
effects	effect	NNS	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
concentration	concentration	NN	I-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
0.07-5.00	0.07-5.00	CD	B-NP	O
mg	mg	NN	I-NP	O
mL	mL	NN	I-NP	O
(	(	(	O	O
-1	-1	CD	B-NP	O
)	)	)	O	O
on	on	IN	B-PP	O
strict	strict	JJ	B-NP	O
anaerobic	anaerobic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
(	(	(	O	O
Porphyromonas	Porphyromonas	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
Prevotella	Prevotella	NNP	B-NP	O
intermedia	intermedia	NNS	I-NP	O
,	,	,	O	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Parvimonas	Parvimonas	NNP	B-NP	O
micra	micra	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Ethyl	Ethyl	NN	B-NP	O
acetate	acetate	NN	I-NP	O
I.	I.	NN	I-NP	O
viscosa	viscosa	NN	I-NP	O
extract	extract	NN	I-NP	O
and	and	CC	O	O
total	total	JJ	B-NP	O
mastic	mastic	JJ	I-NP	O
extract	extract	NN	I-NP	O
showed	show	VBD	B-VP	O
considerable	considerable	JJ	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
activity	activity	NN	I-NP	O
against	against	IN	B-PP	O
oral	oral	JJ	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
and	and	CC	O	O
could	could	MD	B-VP	O
therefore	therefore	RB	I-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
as	as	IN	B-PP	O
alternative	alternative	JJ	B-NP	O
natural	natural	JJ	I-NP	O
anti-infectious	anti-infectious	JJ	I-NP	O
agents	agent	NNS	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
live	live	VBP	B-VP	O
in	in	IN	B-PP	O
symbiosis	symbiosis	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
host	host	NN	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
mouthwashes	mouthwash	NNS	B-NP	O
are	be	VBP	B-VP	O
indicated	indicate	VBN	I-VP	O
,	,	,	O	O
selective	selective	JJ	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
taxa	taxa	NN	B-NP	O
contributing	contribute	VBG	B-VP	O
to	to	TO	B-PP	O
disease	disease	NN	B-NP	O
is	be	VBZ	B-VP	O
preferred	prefer	VBN	I-VP	O
instead	instead	RB	B-PP	O
of	of	IN	I-PP	O
broad-spectrum	broad-spectrum	NN	B-NP	O
antimicrobials	antimicrobial	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
potential	potential	JJ	I-NP	O
selectivity	selectivity	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
oxygenating	oxygenate	VBG	I-NP	O
mouthwash	mouthwash	NN	I-NP	O
,	,	,	O	O
Ardox-X	Ardox-X	NN	B-NP	B-protein
(	(	(	O	O
R	R	NN	B-NP	O
)	)	)	O	O
(	(	(	O	O
AX	AX	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
been	be	VBN	I-VP	O
assessed	assess	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
the	the	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
potential	potential	NN	I-NP	O
of	of	IN	B-PP	O
AX	AX	NN	B-NP	B-protein
and	and	CC	O	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
twice-daily	twice-daily	JJ	I-NP	O
oral	oral	JJ	I-NP	O
rinse	rinse	NN	I-NP	O
on	on	IN	B-PP	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
composition	composition	NN	I-NP	O
.	.	.	O	O

In	In	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
,	,	,	O	O
16	16	CD	B-NP	O
oral	oral	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
strains	strain	NNS	I-NP	O
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
using	use	VBG	B-VP	O
agar	agar	NN	B-NP	O
diffusion	diffusion	NN	I-NP	O
susceptibility	susceptibility	NN	I-NP	O
,	,	,	O	O
minimum	minimum	JJ	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
and	and	CC	I-NP	O
minimum	minimum	JJ	I-NP	O
bactericidal	bactericidal	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
tests	test	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
pilot	pilot	NN	I-NP	O
clinical	clinical	JJ	I-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
with	with	IN	B-PP	O
25	25	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
volunteers	volunteer	NNS	I-NP	O
.	.	.	O	O

Clinical	Clinical	JJ	B-NP	O
assessments	assessment	NNS	I-NP	O
and	and	CC	O	O
microbiological	microbiological	JJ	B-NP	O
sampling	sampling	NN	I-NP	O
of	of	IN	B-PP	O
supragingival	supragingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
month	month	NN	I-NP	O
before	before	IN	B-PP	O
the	the	DT	B-NP	O
experiment	experiment	NN	I-NP	O
(	(	(	O	O
Pre-exp	Pre-exp	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
start	start	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
experiment	experiment	NN	I-NP	O
(	(	(	O	O
Baseline	Baseline	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
one-week	one-week	JJ	I-NP	O
experimental	experimental	JJ	I-NP	O
period	period	NN	I-NP	O
(	(	(	O	O
Post-exp	Post-exp	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
experiment	experiment	NN	I-NP	O
individuals	individual	NNS	I-NP	O
used	use	VBD	B-VP	O
AX	AX	NN	B-NP	O
mouthwash	mouthwash	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
in	in	IN	B-PP	O
absence	absence	NN	B-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
oral	oral	JJ	I-NP	O
hygiene	hygiene	NN	I-NP	O
measures	measure	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
microbiological	microbiological	JJ	I-NP	O
composition	composition	NN	I-NP	O
of	of	IN	B-PP	O
plaque	plaque	NN	B-NP	O
was	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
by	by	IN	B-PP	O
16S	16S	NN	B-NP	O
rRNA	rRNA	NN	I-NP	O
gene	gene	NN	I-NP	O
amplicon	amplicon	NN	I-NP	O
sequencing	sequencing	NN	I-NP	O
.	.	.	O	O

AX	AX	NN	B-NP	O
showed	show	VBD	B-VP	O
high	high	JJ	B-NP	O
inter-species	inter-species	JJ	I-NP	O
variation	variation	NN	I-NP	O
in	in	IN	B-PP	O
microbial	microbial	JJ	B-NP	O
growth	growth	NN	I-NP	O
inhibition	inhibition	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
tested	test	VBN	I-NP	O
Prevotella	Prevotella	NN	I-NP	O
strains	strain	NNS	I-NP	O
and	and	CC	O	O
Fusobacterium	Fusobacterium	NN	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
highest	high	JJS	I-NP	O
sensitivity	sensitivity	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
streptococci	streptococci	NNS	B-NP	O
and	and	CC	O	O
Lactobacillus	Lactobacillus	NN	B-NP	O
acidophilus	acidophilus	NN	I-NP	O
were	be	VBD	B-VP	O
most	most	RBS	B-ADJP	O
resistant	resistant	JJ	I-ADJP	O
to	to	TO	B-PP	O
AX	AX	NNP	B-NP	O
.	.	.	O	O

Plaque	Plaque	NN	B-NP	O
scores	score	NNS	I-NP	O
at	at	IN	B-PP	O
Pre-exp	Pre-exp	NNP	B-NP	O
and	and	CC	I-NP	O
Baseline	Baseline	NNP	I-NP	O
visits	visit	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
differ	differ	VB	I-VP	O
significantly	significantly	RB	B-ADVP	O
(	(	(	O	O
p	p	NN	B-NP	O
=	=	SYM	B-VP	O
0.193	0.193	CD	B-NP	O
)	)	)	O	O
,	,	,	O	O
nor	nor	CC	O	O
did	do	VBD	O	O
the	the	DT	B-NP	O
microbial	microbial	JJ	I-NP	O
composition	composition	NN	I-NP	O
of	of	IN	B-PP	O
plaque	plaque	NN	B-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
a	a	DT	B-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
7-days	7-day	NNS	B-NP	O
non-brushing	non-brushing	JJ	B-ADJP	O
but	but	CC	B-NP	O
twice	twice	RB	I-NP	O
daily	daily	JJ	I-NP	O
rinsing	rinse	VBG	I-NP	O
plaque	plaque	NN	I-NP	O
scores	score	NNS	I-NP	O
increased	increase	VBD	B-VP	O
from	from	IN	B-PP	O
2.21	2.21	CD	B-NP	O
(	(	(	O	O
0.31	0.31	CD	B-NP	O
)	)	)	O	O
at	at	IN	B-PP	O
Baseline	Baseline	NNP	B-NP	O
to	to	TO	B-PP	O
2.43	2.43	CD	B-NP	O
(	(	(	O	O
0.39	0.39	CD	B-NP	O
)	)	)	O	O
Post-exp	Post-exp	NNP	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
significant	significant	JJ	I-NP	O
microbial	microbial	JJ	I-NP	O
shift	shift	NN	I-NP	O
in	in	IN	B-PP	O
composition	composition	NN	B-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
:	:	:	O	O
genus	genus	NN	B-NP	O
Streptococcus	Streptococcus	NNP	I-NP	O
and	and	CC	O	O
Veillonella	Veillonella	NNP	B-NP	O
increased	increase	VBD	B-VP	O
while	while	IN	B-SBAR	O
Corynebacterium	Corynebacterium	NNP	B-NP	O
,	,	,	O	O
Haemophilus	Haemophilus	NNP	B-NP	O
,	,	,	O	O
Leptotrichia	Leptotrichia	NNP	B-NP	O
,	,	,	O	O
Cardiobacterium	Cardiobacterium	NNP	B-NP	O
and	and	CC	O	O
Capnocytophaga	Capnocytophaga	NNP	B-NP	O
decreased	decrease	VBD	B-VP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
/=	/=	SYM	O	O
0.001	0.001	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

AX	AX	NNP	B-NP	O
has	have	VBZ	B-VP	O
the	the	DT	B-NP	O
potential	potential	NN	I-NP	O
for	for	IN	B-PP	O
selective	selective	JJ	B-NP	O
inhibition	inhibition	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
shift	shift	NN	I-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
microbiome	microbiome	NN	I-NP	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
of	of	IN	B-PP	O
rinsing	rinsing	NN	B-NP	O
deserves	deserve	VBZ	B-VP	O
further	further	JJ	B-NP	O
research	research	NN	I-NP	O
.	.	.	O	O

Sharks	Shark	NNS	B-NP	O
possess	possess	VBP	B-VP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
pathogenic	pathogenic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
their	their	PRP$	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
that	that	WDT	B-NP	O
may	may	MD	B-VP	O
potentially	potentially	RB	I-VP	O
be	be	VB	I-VP	O
transferred	transfer	VBN	I-VP	O
into	into	IN	B-PP	O
humans	human	NNS	B-NP	O
during	during	IN	B-PP	O
a	a	DT	B-NP	O
bite	bite	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
presented	present	VBN	I-NP	O
study	study	NN	I-NP	O
focused	focus	VBD	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
identification	identification	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
present	present	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mouths	mouth	NNS	I-NP	O
of	of	IN	B-PP	O
live	live	JJ	B-NP	O
blacktip	blacktip	NN	I-NP	O
sharks	shark	NNS	I-NP	O
,	,	,	O	O
Carcharhinus	Carcharhinus	NNP	B-NP	O
limbatus	limbatus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
extent	extent	NN	I-NP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
possess	possess	VBP	B-VP	O
multi-drug	multi-drug	JJ	B-NP	O
resistance	resistance	NN	I-NP	O
.	.	.	O	O

Swabs	Swab	NNS	B-NP	O
were	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
of	of	IN	B-PP	O
nineteen	nineteen	CD	B-NP	O
live	live	JJ	I-NP	O
blacktip	blacktip	NN	I-NP	O
sharks	shark	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
released	release	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
average	average	JJ	I-NP	O
fork	fork	NN	I-NP	O
length	length	NN	I-NP	O
was	be	VBD	B-VP	O
146	146	CD	B-NP	O
cm	cm	NN	I-NP	O
(	(	(	O	O
+/-11	+/-11	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
the	the	DT	B-NP	O
blacktip	blacktip	NN	I-NP	O
sharks	shark	NNS	I-NP	O
were	be	VBD	B-VP	O
mature	mature	JJ	B-NP	O
adults	adult	NNS	I-NP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
8	8	CD	I-NP	O
years	year	NNS	I-NP	O
old	old	JJ	B-ADJP	O
.	.	.	O	O

All	All	DT	B-NP	O
swabs	swab	NNS	I-NP	O
underwent	undergo	VBD	B-VP	O
standard	standard	JJ	B-NP	O
microbiological	microbiological	JJ	I-NP	O
work-up	work-up	NN	I-NP	O
with	with	IN	B-PP	O
identification	identification	NN	B-NP	O
of	of	IN	B-PP	O
organisms	organism	NNS	B-NP	O
and	and	CC	I-NP	O
reporting	reporting	NN	I-NP	O
of	of	IN	B-PP	O
antibiotic	antibiotic	JJ	B-NP	O
susceptibilities	susceptibility	NNS	I-NP	O
using	use	VBG	B-VP	O
an	an	DT	B-NP	O
automated	automate	VBN	I-NP	O
microbiology	microbiology	NN	I-NP	O
system	system	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
oral	oral	JJ	I-NP	O
samples	sample	NNS	I-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
average	average	NN	I-NP	O
of	of	IN	B-PP	O
2.72	2.72	CD	B-NP	O
(	(	(	O	O
+/-1.4	+/-1.4	CD	B-NP	O
)	)	)	O	O
bacterial	bacterial	JJ	B-NP	O
isolates	isolate	NNS	I-NP	O
per	per	IN	B-PP	O
shark	shark	NN	B-NP	O
.	.	.	O	O

Gram-negative	Gram-negative	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
making	make	VBG	B-VP	O
up	up	RP	B-PRT	O
61	61	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
isolates	isolate	NNS	I-NP	O
,	,	,	O	O
were	be	VBD	B-VP	O
significantly	significantly	RB	B-ADVP	O
(	(	(	O	O
p	p	NN	B-NP	O
<	<	SYM	O	O
0.001	0.001	CD	B-NP	O
)	)	)	O	O
more	more	RBR	B-ADJP	O
common	common	JJ	I-ADJP	O
than	than	IN	B-PP	O
gram-positive	gram-positive	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
(	(	(	O	O
39	39	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
most	most	RBS	I-NP	O
common	common	JJ	I-NP	O
organisms	organism	NNS	I-NP	O
were	be	VBD	B-VP	O
Vibrio	Vibrio	NNP	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

(	(	(	O	O
28	28	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
various	various	JJ	B-NP	O
coagulase-negative	coagulase-negative	JJ	I-NP	O
Staphylococcus	Staphylococcus	NN	I-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

(	(	(	O	O
16	16	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
Pasteurella	Pasteurella	NN	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

(	(	(	O	O
12	12	CD	B-NP	O
%	%	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
overall	overall	JJ	I-NP	O
resistance	resistance	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
12	12	CD	B-NP	O
%	%	NN	I-NP	O
for	for	IN	B-PP	O
all	all	DT	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
tested	test	VBN	B-VP	O
with	with	IN	B-PP	O
nearly	nearly	RB	B-NP	O
43	43	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
resistant	resistant	JJ	B-ADJP	O
to	to	TO	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
one	one	CD	I-NP	O
antibiotic	antibiotic	JJ	I-NP	O
.	.	.	O	O

Multi-drug	Multi-drug	JJ	B-NP	O
resistance	resistance	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
4	4	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
association	association	NN	I-NP	O
between	between	IN	B-PP	O
shark	shark	NN	B-NP	O
gender	gender	NN	I-NP	O
or	or	CC	O	O
fork	fork	NN	B-NP	O
length	length	NN	I-NP	O
with	with	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	O
density	density	NN	I-NP	O
or	or	CC	O	O
antibiotic	antibiotic	JJ	B-NP	O
resistance	resistance	NN	I-NP	O
was	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O

Antibiotics	Antibiotic	NNS	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
highest	high	JJS	I-NP	O
overall	overall	JJ	I-NP	O
susceptibility	susceptibility	NN	I-NP	O
rates	rate	NNS	I-NP	O
included	include	VBD	B-VP	O
fluoroquinolones	fluoroquinolone	NNS	B-NP	O
,	,	,	O	O
3rd	3rd	JJ	B-NP	O
generation	generation	NN	I-NP	O
cephalosporins	cephalosporin	NNS	I-NP	O
and	and	CC	I-NP	O
sulfamethoxazole/trimethoprim	sulfamethoxazole/trimethoprim	NN	I-NP	O
.	.	.	O	O

Recommended	Recommend	VBN	B-NP	O
empiric	empiric	JJ	I-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
for	for	IN	B-PP	O
adult	adult	JJ	B-NP	O
blacktip	blacktip	NN	I-NP	O
shark	shark	NN	I-NP	O
bites	bite	NNS	I-NP	O
should	should	MD	B-VP	O
encompass	encompass	VB	I-VP	O
either	either	CC	O	O
a	a	DT	B-NP	O
fluoroquinolone	fluoroquinolone	NN	I-NP	O
or	or	CC	I-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
3rd	3rd	JJ	I-NP	O
generation	generation	NN	I-NP	O
cephalosporin	cephalosporin	NN	I-NP	O
plus	plus	CC	O	O
doxycycline	doxycycline	NN	B-NP	O
.	.	.	O	O

Dental	Dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
is	be	VBZ	B-VP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
common	common	JJ	I-NP	O
chronic	chronic	JJ	I-NP	O
and	and	CC	I-NP	O
multifactorial	multifactorial	JJ	I-NP	O
diseases	disease	NNS	I-NP	O
affecting	affect	VBG	B-VP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-cell_type
population	population	NN	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
appearance	appearance	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
caries	cary	NNS	I-NP	O
lesion	lesion	NN	I-NP	O
is	be	VBZ	B-VP	O
determined	determine	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
coexistence	coexistence	NN	I-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
main	main	JJ	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
:	:	:	O	O
acidogenic	acidogenic	JJ	B-NP	O
and	and	CC	I-NP	O
acidophilic	acidophilic	JJ	I-NP	O
microorganisms	microorganism	NNS	I-NP	O
,	,	,	O	O
carbohydrates	carbohydrate	NNS	B-NP	O
derived	derive	VBN	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
host	host	NN	B-NP	O
factors	factor	NNS	I-NP	O
.	.	.	O	O

Socio-economic	Socio-economic	JJ	B-NP	O
and	and	CC	I-NP	O
behavioral	behavioral	JJ	I-NP	B-protein
factors	factor	NNS	I-NP	I-protein
also	also	RB	B-ADVP	O
play	play	VBP	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
etiology	etiology	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Caries	Cary	NNS	B-NP	O
develops	develop	VBZ	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
ecological	ecological	JJ	I-NP	O
imbalance	imbalance	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
stable	stable	JJ	I-NP	O
oral	oral	JJ	I-NP	O
microbiom	microbiom	NN	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
form	form	VBP	B-VP	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
surfaces	surface	NNS	I-NP	O
of	of	IN	B-PP	O
teeth	tooth	NNS	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
caries	cary	NNS	I-NP	O
process	process	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
shows	show	VBZ	B-VP	O
features	feature	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
classic	classic	JJ	I-NP	O
biofilm	biofilm	NN	I-NP	O
.	.	.	O	O

Biofilm	Biofilm	NN	B-NP	O
formation	formation	NN	I-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
influenced	influence	VBN	I-VP	O
by	by	IN	B-PP	O
large	large	JJ	B-NP	O
scale	scale	NN	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
protein	protein	NN	B-NP	O
expression	expression	NN	I-NP	O
over	over	IN	B-PP	O
time	time	NN	B-NP	O
and	and	CC	O	O
under	under	IN	B-PP	O
genetic	genetic	JJ	B-NP	O
control	control	NN	I-NP	O
Cariogenic	Cariogenic	JJ	I-NP	O
microorganisms	microorganism	NNS	I-NP	O
produce	produce	VBP	B-VP	O
lactic	lactic	JJ	B-NP	O
,	,	,	I-NP	O
formic	formic	JJ	I-NP	O
,	,	,	I-NP	O
acetic	acetic	JJ	I-NP	O
and	and	CC	I-NP	O
propionic	propionic	JJ	I-NP	O
acids	acid	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
a	a	DT	B-NP	O
product	product	NN	I-NP	O
of	of	IN	B-PP	O
carbohydrate	carbohydrate	NN	B-NP	O
metabolism	metabolism	NN	I-NP	O
.	.	.	O	O

Their	Their	PRP$	B-NP	O
presence	presence	NN	I-NP	O
causes	cause	VBZ	B-VP	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
pH	pH	NN	B-NP	O
level	level	NN	I-NP	O
below	below	IN	B-PP	O
5.5	5.5	CD	B-NP	O
,	,	,	O	O
resulting	result	VBG	B-VP	O
in	in	IN	B-PP	O
demineralization	demineralization	NN	B-NP	O
of	of	IN	B-PP	O
enamel	enamel	NN	B-NP	O
hydroxyapatite	hydroxyapatite	NN	I-NP	O
crystals	crystal	NNS	I-NP	O
and	and	CC	O	O
proteolytic	proteolytic	JJ	B-NP	O
breakdown	breakdown	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
structure	structure	NN	I-NP	O
of	of	IN	B-PP	O
tooth	tooth	JJ	B-NP	O
hard	hard	JJ	I-NP	O
tissues	tissue	NNS	I-NP	O
.	.	.	O	O

Streptococcus	Streptococcus	NN	B-NP	O
mutans	mutan	NNS	I-NP	O
,	,	,	O	O
other	other	JJ	B-NP	O
streptococci	streptococci	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
so-called	so-called	JJ	I-NP	O
non-mutans	non-mutans	JJ	I-NP	O
streptococci	streptococci	NNS	I-NP	O
group	group	NN	I-NP	O
,	,	,	O	O
Actinomyces	Actinomyce	NNS	B-NP	O
and	and	CC	O	O
Lactobacillus	Lactobacillus	NN	B-NP	O
play	play	VBP	B-VP	O
a	a	DT	B-NP	O
key	key	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

Dental	Dental	JJ	B-NP	O
biofilm	biofilm	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
dynamic	dynamic	JJ	I-NP	O
,	,	,	I-NP	O
constantly	constantly	RB	I-NP	O
active	active	JJ	I-NP	O
metabolically	metabolically	RB	I-NP	O
structure	structure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
alternating	alternate	VBG	I-NP	O
processes	process	NNS	I-NP	O
of	of	IN	B-PP	O
decrease	decrease	NN	B-NP	O
and	and	CC	I-NP	O
increase	increase	NN	I-NP	O
of	of	IN	B-PP	O
biofilm	biofilm	NN	B-NP	O
pH	pH	NN	I-NP	O
occur	occur	VBP	B-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
are	be	VBP	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
respective	respective	JJ	I-NP	O
processes	process	NNS	I-NP	O
of	of	IN	B-PP	O
de-	de-	NN	B-NP	O
and	and	CC	I-NP	O
remineralisation	remineralisation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
tooth	tooth	NN	I-NP	O
surface	surface	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
,	,	,	O	O
these	these	DT	B-NP	O
processes	process	NNS	I-NP	O
are	be	VBP	B-VP	O
in	in	IN	B-PP	O
balance	balance	NN	B-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
permanent	permanent	JJ	I-NP	O
damage	damage	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
tooth	tooth	JJ	I-NP	O
enamel	enamel	NN	I-NP	O
surface	surface	NN	I-NP	O
occurs	occur	VBZ	B-VP	O
.	.	.	O	O

High	High	JJ	B-NP	O
throughput	throughput	NN	I-NP	O
sequencing	sequencing	NN	I-NP	O
has	have	VBZ	B-VP	O
accelerated	accelerate	VBN	I-VP	O
knowledge	knowledge	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microbiome	microbiome	NN	I-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
communities	community	NNS	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
extensively	extensively	RB	I-VP	O
characterized	characterize	VBN	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
fungal	fungal	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
is	be	VBZ	B-VP	O
largely	largely	RB	B-ADJP	O
unknown	unknown	JJ	I-ADJP	O
.	.	.	O	O

Interactions	Interaction	NNS	B-NP	O
among	among	IN	B-PP	O
fungi	fungus	NNS	B-NP	O
and	and	CC	I-NP	O
bacteria	bacteria	NNS	I-NP	O
are	be	VBP	B-VP	O
likely	likely	JJ	B-ADJP	O
to	to	TO	B-VP	O
influence	influence	VB	I-VP	O
oral	oral	JJ	B-NP	O
health	health	NN	I-NP	O
as	as	IN	B-SBAR	O
exemplified	exemplify	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
synergistic	synergistic	JJ	I-NP	O
relationship	relationship	NN	I-NP	O
between	between	IN	B-PP	O
Candida	Candida	NNP	B-NP	O
albicans	albican	NNS	I-NP	O
and	and	CC	O	O
oral	oral	JJ	B-NP	O
streptococci	streptococci	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
perspective	perspective	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
discuss	discuss	VBP	B-VP	O
the	the	DT	B-NP	O
current	current	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
field	field	NN	I-NP	O
of	of	IN	B-PP	O
fungal-bacterial	fungal-bacterial	JJ	B-NP	O
interactions	interaction	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
highlight	highlight	VBP	B-VP	O
the	the	DT	B-NP	O
need	need	NN	I-NP	O
to	to	TO	B-VP	O
conduct	conduct	VB	I-VP	O
longitudinal	longitudinal	JJ	B-NP	O
clinical	clinical	JJ	I-NP	O
studies	study	NNS	I-NP	O
to	to	TO	B-VP	O
simultaneously	simultaneously	RB	I-VP	O
characterize	characterize	VB	I-VP	O
the	the	DT	B-NP	O
bacterial	bacterial	JJ	I-NP	O
and	and	CC	I-NP	O
fungal	fungal	JJ	I-NP	O
components	component	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
oral	oral	JJ	I-NP	I-DNA
microbiome	microbiome	NN	I-NP	I-DNA
in	in	IN	B-PP	O
health	health	NN	B-NP	O
and	and	CC	B-PP	O
during	during	IN	B-PP	O
disease	disease	NN	B-NP	O
progression	progression	NN	I-NP	O
.	.	.	O	O

Such	Such	JJ	B-NP	O
studies	study	NNS	I-NP	O
need	need	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
coupled	couple	VBN	I-VP	O
with	with	IN	B-PP	O
investigations	investigation	NNS	B-NP	O
using	use	VBG	B-VP	O
disease-relevant	disease-relevant	JJ	B-NP	O
models	model	NNS	I-NP	O
to	to	TO	B-VP	O
mechanistically	mechanistically	RB	I-VP	O
test	test	VB	I-VP	O
the	the	DT	B-NP	O
associations	association	NNS	I-NP	O
observed	observe	VBN	B-VP	O
in	in	IN	B-PP	O
humans	human	NNS	B-NP	O
and	and	CC	O	O
eventually	eventually	RB	B-VP	O
identify	identify	VBP	I-VP	O
fungal-bacterial	fungal-bacterial	JJ	B-NP	O
interactions	interaction	NNS	I-NP	O
that	that	WDT	B-NP	O
could	could	MD	B-VP	O
serve	serve	VB	I-VP	O
as	as	IN	B-PP	O
preventive	preventive	JJ	B-NP	O
or	or	CC	I-NP	O
therapeutic	therapeutic	JJ	I-NP	O
targets	target	NNS	I-NP	O
for	for	IN	B-PP	O
oral	oral	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

Antrodia	Antrodia	NNP	B-NP	O
camphorata	camphorata	NNS	I-NP	O
(	(	(	O	O
A.	A.	NN	B-NP	O
camphorata	camphorata	NN	I-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
unique	unique	JJ	I-NP	O
,	,	,	I-NP	O
endemic	endemic	JJ	I-NP	O
and	and	CC	I-NP	O
extremely	extremely	RB	I-NP	O
rare	rare	JJ	I-NP	O
mushroom	mushroom	NN	I-NP	O
species	specie	NNS	I-NP	O
native	native	JJ	B-ADJP	O
to	to	TO	B-PP	O
Taiwan	Taiwan	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
both	both	DT	B-NP	O
crude	crude	JJ	I-NP	O
extracts	extract	NNS	I-NP	O
of	of	IN	B-PP	O
and	and	CC	O	O
purified	purify	VBN	B-VP	O
chemical	chemical	JJ	B-NP	O
compounds	compound	NNS	I-NP	O
from	from	IN	B-PP	O
A.	A.	NN	B-NP	O
camphorata	camphorata	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
reported	report	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
variety	variety	NN	I-NP	O
of	of	IN	B-PP	O
significant	significant	JJ	B-NP	O
beneficial	beneficial	JJ	I-NP	O
effects	effect	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
anti-tumor	anti-tumor	JJ	B-NP	O
and	and	CC	I-NP	O
anti-inflammatory	anti-inflammatory	JJ	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
reports	report	NNS	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
A.	A.	NN	B-NP	O
camphorata	camphorata	NNS	I-NP	O
against	against	IN	B-PP	O
dental	dental	JJ	B-NP	O
pathogens	pathogen	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
limited	limit	VBN	I-VP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
health	health	NN	I-NP	O
is	be	VBZ	B-VP	O
now	now	RB	I-VP	O
recognized	recognize	VBN	I-VP	O
as	as	IN	B-PP	O
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
overall	overall	JJ	B-NP	O
general	general	JJ	I-NP	O
health	health	NN	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
conditions	condition	NNS	B-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
,	,	,	O	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
rheumatoid	rheumatoid	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
.	.	.	O	O

Streptococcus	Streptococcus	NN	B-NP	O
mutans	mutan	NNS	I-NP	O
(	(	(	O	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
)	)	)	O	O
and	and	CC	O	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
(	(	(	O	O
P.	P.	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
)	)	)	O	O
are	be	VBP	B-VP	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
common	common	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
and	and	CC	O	O
periodontopathic	periodontopathic	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
our	our	PRP$	B-NP	O
study	study	NN	I-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
five	five	CD	B-NP	O
various	various	JJ	I-NP	O
crude	crude	JJ	I-NP	O
extracts	extract	NNS	I-NP	O
of	of	IN	B-PP	O
A.	A.	NN	B-NP	O
camphorata	camphorata	NNS	I-NP	O
to	to	TO	B-VP	O
inhibit	inhibit	VB	I-VP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
dental	dental	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
anti-adherence	anti-adherence	JJ	B-NP	O
in	in	FW	I-NP	O
vitro	vitro	FW	I-NP	O
.	.	.	O	O

Among	Among	IN	B-PP	O
the	the	DT	B-NP	O
extracts	extract	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
ethanol	ethanol	NN	I-NP	O
,	,	,	O	O
ethyl	ethyl	NN	B-NP	O
acetate	acetate	NN	I-NP	O
and	and	CC	I-NP	O
chloroform	chloroform	NN	I-NP	O
extracts	extract	NNS	I-NP	O
exhibited	exhibit	VBD	B-VP	O
the	the	DT	B-NP	O
lowest	low	JJS	I-NP	O
MICs	MIC	NNS	I-NP	O
against	against	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
and	and	CC	I-NP	O
S.	S.	NNP	I-NP	O
mutans	mutan	NNS	I-NP	O
(	(	(	O	O
MIC	MIC	NN	B-NP	B-protein
=	=	SYM	B-VP	I-protein
4	4	CD	B-NP	I-protein
approximately	approximately	RB	I-NP	O
16	16	CD	I-NP	O
microg/mL	microg/mL	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
MIC	MIC	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
aqueous	aqueous	JJ	I-NP	O
extract	extract	NN	I-NP	O
was	be	VBD	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
2048	2048	CD	B-NP	O
microg/mL	microg/mL	NN	I-NP	O
against	against	IN	B-PP	O
both	both	DT	B-NP	O
P.	P.	NNP	I-NP	O
gingivalis	gingivalis	NNP	I-NP	O
and	and	CC	I-NP	O
S.	S.	NNP	I-NP	O
mutans	mutan	NNS	I-NP	O
.	.	.	O	O

In	In	FW	B-NP	O
vitro	vitro	FW	I-NP	O
adherence	adherence	NN	I-NP	O
of	of	IN	B-PP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
was	be	VBD	B-VP	O
significantly	significantly	RB	I-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
addition	addition	NN	I-NP	O
of	of	IN	B-PP	O
either	either	CC	O	O
the	the	DT	B-NP	O
ethyl	ethyl	NN	I-NP	O
acetate	acetate	NN	I-NP	O
extract	extract	NN	I-NP	O
or	or	CC	O	O
chloroform	chloroform	NN	B-NP	O
extract	extract	NN	I-NP	O
(	(	(	O	O
MIC	MIC	NN	B-NP	O
=	=	SYM	B-VP	O
16	16	CD	B-NP	O
approximately	approximately	RB	I-NP	O
24	24	CD	I-NP	O
microg/mL	microg/mL	NN	I-NP	O
)	)	)	O	O
,	,	,	O	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
ethanol	ethanol	NN	I-NP	O
extract	extract	NN	I-NP	O
(	(	(	O	O
MIC	MIC	NN	B-NP	O
=	=	SYM	B-VP	O
32	32	CD	B-NP	O
approximately	approximately	RB	I-NP	O
64	64	CD	I-NP	O
microg/mL	microg/mL	NN	I-NP	O
)	)	)	O	O
exhibited	exhibit	VBD	B-VP	O
moderate	moderate	JJ	B-NP	O
inhibitory	inhibitory	JJ	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

Based	Base	VBN	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
ethyl	ethyl	NN	I-NP	O
acetate	acetate	NN	I-NP	O
and	and	CC	I-NP	O
chloroform	chloroform	NN	I-NP	O
extracts	extract	NNS	I-NP	O
of	of	IN	B-PP	O
A.	A.	NN	B-NP	O
camphorata	camphorata	NNS	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
good	good	JJ	B-NP	O
candidates	candidate	NNS	I-NP	O
for	for	IN	B-PP	O
oral	oral	JJ	B-NP	O
hygiene	hygiene	NN	I-NP	O
agents	agent	NNS	I-NP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
and	and	CC	O	O
periodontopathic	periodontopathic	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
.	.	.	O	O

Chlorhexidine	Chlorhexidine	NN	B-NP	O
(	(	(	O	O
CHX	CHX	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
widely	widely	RB	I-NP	O
used	use	VBN	I-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
agent	agent	NN	I-NP	O
in	in	IN	B-PP	O
dentistry	dentistry	NN	B-NP	O
.	.	.	O	O

Herein	Herein	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
report	report	VBP	B-VP	O
the	the	DT	B-NP	O
synthesis	synthesis	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
mesoporous	mesoporous	JJ	I-NP	O
silica	silica	NN	I-NP	O
nanoparticle-encapsulated	nanoparticle-encapsulated	JJ	I-NP	O
pure	pure	JJ	I-NP	O
CHX	CHX	NN	I-NP	O
(	(	(	O	O
Nano-CHX	Nano-CHX	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
its	its	PRP$	B-NP	O
mechanical	mechanical	JJ	I-NP	O
profile	profile	NN	I-NP	O
and	and	CC	O	O
antimicrobial	antimicrobial	JJ	B-NP	O
properties	property	NNS	I-NP	O
against	against	IN	B-PP	O
oral	oral	JJ	B-NP	O
biofilms	biofilm	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
release	release	NN	I-NP	O
of	of	IN	B-PP	O
CHX	CHX	NN	B-NP	B-protein
from	from	IN	B-PP	O
the	the	DT	B-NP	O
Nano-CHX	Nano-CHX	NN	I-NP	B-protein
was	be	VBD	B-VP	O
characterized	characterize	VBN	I-VP	O
by	by	IN	B-PP	O
UV/visible	UV/visible	JJ	B-NP	O
absorption	absorption	NN	I-NP	O
spectroscopy	spectroscopy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
properties	property	NNS	I-NP	O
of	of	IN	B-PP	O
Nano-CHX	Nano-CHX	NN	B-NP	B-protein
were	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
planktonic	planktonic	JJ	I-NP	O
and	and	CC	I-NP	O
biofilm	biofilm	NN	I-NP	O
modes	mode	NNS	I-NP	O
of	of	IN	B-PP	O
representative	representative	JJ	B-NP	O
oral	oral	JJ	I-NP	O
pathogenic	pathogenic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Nano-CHX	Nano-CHX	NN	I-NP	B-protein
demonstrated	demonstrate	VBD	B-VP	O
potent	potent	JJ	B-NP	O
antibacterial	antibacterial	JJ	I-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
planktonic	planktonic	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
mono-species	mono-species	JJ	B-NP	O
biofilms	biofilm	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
50-200	50-200	CD	B-NP	O
microg/mL	microg/mL	NN	I-NP	O
against	against	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
sobrinus	sobrinus	NNP	I-NP	O
,	,	,	O	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
,	,	,	O	O
Aggregatibacter	Aggregatibacter	NNP	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
and	and	CC	O	O
Enterococccus	Enterococccus	NNP	B-NP	O
faecalis	faecalis	NNP	I-NP	O
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
Nano-CHX	Nano-CHX	NN	B-NP	B-protein
effectively	effectively	RB	B-ADVP	O
suppressed	suppress	VBD	B-VP	O
multi-species	multi-species	JJ	B-NP	O
biofilms	biofilm	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
,	,	,	O	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
,	,	,	O	O
A.	A.	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
and	and	CC	O	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
72	72	CD	I-NP	O
h.	h.	NN	I-NP	O
This	This	DT	B-NP	O
pioneering	pioneering	NN	I-NP	O
study	study	NN	I-NP	O
demonstrates	demonstrate	VBZ	B-VP	O
the	the	DT	B-NP	O
potent	potent	JJ	I-NP	O
antibacterial	antibacterial	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Nano-CHX	Nano-CHX	NN	I-NP	B-protein
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	O
biofilms	biofilm	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
developed	develop	VBN	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
novel	novel	JJ	I-NP	O
and	and	CC	I-NP	O
promising	promising	JJ	I-NP	O
anti-biofilm	anti-biofilm	JJ	I-NP	O
agent	agent	NN	I-NP	O
for	for	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
infections	infection	NNS	B-NP	O
caused	cause	VBN	B-VP	O
by	by	IN	B-PP	O
Cefotaximase-Munich	Cefotaximase-Munich	JJ	B-NP	O
(	(	(	O	O
CTX-M	CTX-M	NN	B-NP	O
)	)	)	I-NP	O
-type	-type	JJ	I-NP	O
extended-spectrum	extended-spectrum	NN	I-NP	O
beta-lactamase-producing	beta-lactamase-producing	JJ	I-NP	O
Enterobacteriaceae	Enterobacteriaceae	NNP	I-NP	O
(	(	(	O	O
ESBL-E	ESBL-E	NNP	B-NP	O
)	)	)	O	O
has	have	VBZ	B-VP	O
rapidly	rapidly	RB	I-VP	O
increased	increase	VBN	I-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
15	15	CD	I-NP	O
years	year	NNS	I-NP	O
.	.	.	O	O

Enterobacteriaceae	Enterobacteriaceae	NNS	B-NP	O
are	be	VBP	B-VP	O
commonly	commonly	RB	I-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
gastrointestinal	gastrointestinal	JJ	I-NP	O
tract	tract	NN	I-NP	O
and	and	CC	O	O
long-term	long-term	JJ	B-NP	O
intestinal	intestinal	JJ	I-NP	O
carriage	carriage	NN	I-NP	O
is	be	VBZ	B-VP	O
considered	consider	VBN	I-VP	O
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
spread	spread	NN	I-NP	O
of	of	IN	B-PP	O
ESBL	ESBL	NN	B-NP	B-protein
and	and	CC	B-PP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
infections	infection	NNS	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
biofilm	biofilm	NN	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
supragingival	supragingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
contain	contain	VB	I-VP	O
numerous	numerous	JJ	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
resistance	resistance	NN	I-NP	O
determinants	determinant	NNS	I-NP	O
and	and	CC	O	O
may	may	MD	B-VP	O
also	also	RB	I-VP	O
represent	represent	VB	I-VP	O
a	a	DT	B-NP	O
poorly	poorly	RB	I-NP	O
investigated	investigate	VBN	I-NP	O
site	site	NN	I-NP	O
for	for	IN	B-PP	O
ESBL	ESBL	NN	B-NP	O
carriage	carriage	NN	I-NP	O
and	and	CC	O	O
further	further	JJ	B-NP	O
spread	spread	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
investigate	investigate	VB	I-VP	O
possible	possible	JJ	B-NP	O
carriage	carriage	NN	I-NP	O
of	of	IN	B-PP	O
ESBL-producing	ESBL-producing	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
supragingival	supragingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
of	of	IN	B-PP	O
known	known	JJ	B-NP	O
fecal	fecal	JJ	I-NP	O
carriers	carrier	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
screened	screen	VBD	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
aerobic	aerobic	JJ	B-NP	O
and	and	CC	I-NP	O
anaerobic	anaerobic	JJ	I-NP	O
ESBL-producing	ESBL-producing	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
bla	bla	NN	B-NP	O
CTX-M	CTX-M	NN	I-NP	O
in	in	IN	B-PP	O
supragingival	supragingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
human	human	JJ	I-NP	O
adults	adult	NNS	I-NP	O
with	with	IN	B-PP	O
culture-verified	culture-verified	JJ	B-NP	O
fecal	fecal	JJ	I-NP	O
carriage	carriage	NN	I-NP	O
of	of	IN	B-PP	O
CTX-M-producing	CTX-M-producing	JJ	B-NP	O
Escherichia	Escherichia	NNP	I-NP	O
coli	coli	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
presence	presence	NN	I-NP	O
or	or	CC	I-NP	O
absence	absence	NN	I-NP	O
of	of	IN	B-PP	O
Enterobacteriaceae	Enterobacteriaceae	NNP	B-NP	O
and	and	CC	I-NP	O
ESBL-producing	ESBL-producing	NNP	I-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
plaque	plaque	NN	B-NP	O
samples	sample	NNS	I-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
using	use	VBG	B-VP	O
culture-based	culture-based	JJ	B-NP	O
methods	method	NNS	I-NP	O
and	and	CC	O	O
consensus	consensus	NN	B-NP	O
CTX-M	CTX-M	NN	I-NP	O
PCR	PCR	NN	I-NP	O
.	.	.	O	O

Oral	Oral	JJ	B-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
from	from	IN	B-PP	O
17	17	CD	B-NP	O
participants	participant	NNS	I-NP	O
with	with	IN	B-PP	O
known	known	JJ	B-NP	O
previous	previous	JJ	I-NP	O
carriage	carriage	NN	I-NP	O
of	of	IN	B-PP	O
ESBL-producing	ESBL-producing	NNP	B-NP	O
E.	E.	NNP	I-NP	O
coli	coli	NNP	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
ESBL-producing	ESBL-producing	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
or	or	CC	O	O
ESBL	ESBL	NN	B-NP	B-DNA
genes	gene	NNS	I-NP	I-DNA
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
using	use	VBG	B-VP	O
culture-based	culture-based	JJ	B-NP	O
and	and	CC	I-NP	O
molecular	molecular	JJ	I-NP	O
methods	method	NNS	I-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
colony	colony	NN	I-NP	O
of	of	IN	B-PP	O
Rahnella	Rahnella	NNP	B-NP	O
aquatilis	aquatilis	NN	I-NP	O
harboring	harbor	VBG	B-VP	O
the	the	DT	B-NP	O
class	class	NN	I-NP	O
A	A	NN	I-NP	O
ESBL	ESBL	NN	I-NP	O
gene	gene	NN	I-NP	O
bla	bla	NN	I-NP	O
RAHN-1/2	RAHN-1/2	NN	I-NP	O
was	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
oral	oral	JJ	I-NP	O
sample	sample	NN	I-NP	O
from	from	IN	B-PP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
participants	participant	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
pilot	pilot	NN	I-NP	O
study	study	NN	I-NP	O
supports	support	VBZ	B-VP	O
the	the	DT	B-NP	O
notion	notion	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
CTX-M-producing	CTX-M-producing	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
is	be	VBZ	B-VP	O
uncommon	uncommon	JJ	B-ADJP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
of	of	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
human	human	JJ	I-NP	O
adult	adult	JJ	I-NP	O
fecal	fecal	JJ	I-NP	O
carriers	carrier	NNS	I-NP	O
.	.	.	O	O

Due	Due	JJ	B-PP	O
to	to	TO	I-PP	O
the	the	DT	B-NP	O
limited	limit	VBN	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
persons	person	NNS	B-NP	O
tested	test	VBN	B-VP	O
,	,	,	O	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
ESBL-carriage	ESBL-carriage	NN	I-NP	O
in	in	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
adults	adult	NNS	I-NP	O
or	or	CC	O	O
carriage	carriage	NN	B-NP	O
in	in	IN	B-PP	O
selected	select	VBN	B-NP	O
groups	group	NNS	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
excluded	exclude	VBN	I-VP	O
.	.	.	O	O

To	To	TO	B-PP	O
our	our	PRP$	B-NP	O
knowledge	knowledge	NN	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
description	description	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
R.	R.	NNP	I-NP	O
aquatilis	aquatilis	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
RAHN-1/2	RAHN-1/2	NN	I-NP	B-DNA
gene	gene	NN	I-NP	I-DNA
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

Microorganisms	Microorganism	NNS	B-NP	O
interact	interact	VBP	B-VP	O
with	with	IN	B-PP	O
each	each	DT	B-NP	O
other	other	JJ	I-NP	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
community	community	NN	I-NP	O
.	.	.	O	O

Within	Within	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
community	community	NN	I-NP	O
,	,	,	O	O
some	some	DT	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
tend	tend	VBP	B-VP	O
to	to	TO	I-VP	O
co-exist	co-exist	VB	I-VP	O
,	,	,	O	O
whereas	whereas	IN	O	O
some	some	DT	B-NP	O
others	other	NNS	I-NP	O
tend	tend	VBP	B-VP	O
to	to	TO	I-VP	O
avoid	avoid	VB	I-VP	O
each	each	DT	B-NP	O
other	other	JJ	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
association	association	NN	I-NP	O
among	among	IN	B-PP	O
microorganisms	microorganism	NNS	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
revealed	reveal	VBN	I-VP	O
by	by	IN	B-PP	O
computing	compute	VBG	B-VP	O
the	the	DT	B-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
their	their	PRP$	B-NP	O
abundance	abundance	NN	I-NP	O
patterns	pattern	NNS	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
measured	measure	VBN	I-VP	O
through	through	IN	B-PP	O
metagenomic	metagenomic	JJ	B-NP	O
sequencing	sequencing	NN	I-NP	O
across	across	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
communities	community	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
paper	paper	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
built	build	VBD	B-VP	O
an	an	DT	B-NP	O
association	association	NN	I-NP	O
network	network	NN	I-NP	O
among	among	IN	B-PP	O
microorganisms	microorganism	NNS	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	B-DNA
oral	oral	JJ	I-NP	I-DNA
microbiome	microbiome	NN	I-NP	I-DNA
.	.	.	O	O

To	To	TO	B-VP	O
improve	improve	VB	I-VP	O
its	its	PRP$	B-NP	O
accuracy	accuracy	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
adopted	adopt	VBD	B-VP	O
a	a	DT	B-NP	O
network	network	NN	I-NP	O
deconvolution	deconvolution	NN	I-NP	O
algorithm	algorithm	NN	I-NP	O
to	to	TO	B-VP	O
filter	filter	VB	I-VP	O
out	out	RP	B-PRT	O
indirect	indirect	JJ	B-NP	O
associations	association	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
we	we	PRP	B-NP	O
used	use	VBD	B-VP	O
an	an	DT	B-NP	O
ensemble	ensemble	NN	I-NP	O
of	of	IN	B-PP	O
three	three	CD	B-NP	O
correlation	correlation	NN	I-NP	O
measures	measure	NNS	I-NP	O
to	to	TO	B-VP	O
filter	filter	VB	I-VP	O
out	out	RP	B-PRT	O
the	the	DT	B-NP	O
false-positive	false-positive	JJ	I-NP	O
associations	association	NNS	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
applying	apply	VBG	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
metagenomic	metagenomic	JJ	I-NP	O
data	datum	NNS	I-NP	O
from	from	IN	B-PP	O
human	human	JJ	B-NP	O
oral	oral	JJ	I-NP	O
samples	sample	NNS	I-NP	O
,	,	,	O	O
experimental	experimental	JJ	B-NP	O
results	result	NNS	I-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
phylogenetically	phylogenetically	RB	B-NP	O
close	close	JJ	I-NP	O
microorganisms	microorganism	NNS	I-NP	O
formed	form	VBN	B-VP	O
highly	highly	RB	B-NP	O
correlated	correlate	VBN	I-NP	O
network	network	NN	I-NP	O
clusters	cluster	NNS	I-NP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
most	most	JJS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
identified	identify	VBN	I-NP	O
mutually	mutually	RB	I-NP	O
exclusive	exclusive	JJ	I-NP	O
associations	association	NNS	I-NP	O
were	be	VBD	B-VP	O
related	relate	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
order	order	NN	I-NP	O
Lactobacillales	Lactobacillales	NNP	I-NP	O
.	.	.	O	O

Polycystic	Polycystic	JJ	B-NP	O
ovary	ovary	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
(	(	(	O	O
PCOS	PCOS	NN	B-NP	O
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
hormonal	hormonal	JJ	I-NP	O
disorder	disorder	NN	I-NP	O
of	of	IN	B-PP	O
women	woman	NNS	B-NP	O
that	that	WDT	B-NP	O
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
leading	lead	VBG	I-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
infertility	infertility	NN	B-NP	O
but	but	CC	O	O
also	also	RB	B-VP	O
shows	show	VBZ	I-VP	O
a	a	DT	B-NP	O
reciprocal	reciprocal	JJ	I-NP	O
link	link	NN	I-NP	O
with	with	IN	B-PP	O
oral	oral	JJ	B-NP	O
health	health	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
aimed	aim	VBD	B-VP	O
to	to	TO	I-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
putative	putative	JJ	B-NP	O
periodontal	periodontal	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
and	and	CC	O	O
their	their	PRP$	B-NP	O
antibody	antibody	NN	I-NP	O
response	response	NN	I-NP	O
in	in	IN	B-PP	O
serum	serum	NN	B-NP	O
are	be	VBP	B-VP	O
elevated	elevated	JJ	B-ADJP	O
in	in	IN	B-PP	O
PCOS	PCOS	NN	B-NP	O
,	,	,	O	O
compared	compare	VBN	B-PP	O
to	to	TO	B-PP	O
systemic	systemic	JJ	B-NP	O
health	health	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
125	125	CD	B-NP	O
women	woman	NNS	I-NP	O
were	be	VBD	B-VP	O
included	include	VBN	I-VP	O
in	in	IN	B-PP	O
four	four	CD	B-NP	O
groups	group	NNS	I-NP	O
;	;	:	O	O
45	45	CD	B-NP	O
women	woman	NNS	I-NP	O
with	with	IN	B-PP	O
PCOS	PCOS	NN	B-NP	B-protein
and	and	CC	O	O
healthy	healthy	JJ	B-NP	O
periodontium	periodontium	NN	I-NP	O
,	,	,	O	O
35	35	CD	B-NP	O
women	woman	NNS	I-NP	O
with	with	IN	B-PP	O
PCOS	PCOS	NN	B-NP	B-protein
and	and	CC	I-NP	O
gingivitis	gingivitis	NN	I-NP	O
,	,	,	O	O
25	25	CD	B-NP	O
systemically	systemically	RB	I-NP	O
and	and	CC	O	O
periodontally	periodontally	RB	B-NP	O
healthy	healthy	JJ	I-NP	O
women	woman	NNS	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
systemically	systemically	RB	I-NP	O
healthy	healthy	JJ	I-NP	O
women	woman	NNS	I-NP	O
with	with	IN	B-PP	O
gingivitis	gingivitis	NN	B-NP	O
.	.	.	O	O

Salivary	Salivary	JJ	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
seven	seven	CD	B-NP	O
putative	putative	JJ	I-NP	O
periodontal	periodontal	JJ	I-NP	O
pathogens	pathogen	NNS	I-NP	O
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
by	by	IN	B-PP	O
quantitative	quantitative	JJ	B-NP	O
real-time	real-time	JJ	I-NP	O
polymerase	polymerase	NN	I-NP	O
chain	chain	NN	I-NP	O
reaction	reaction	NN	I-NP	O
and	and	CC	I-NP	O
serum	serum	NN	I-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
analyzed	analyze	VBN	I-VP	O
by	by	IN	B-PP	O
ELISA	ELISA	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
women	woman	NNS	B-NP	O
with	with	IN	B-PP	O
PCOS	PCOS	NN	B-NP	O
,	,	,	O	O
salivary	salivary	JJ	B-NP	O
Porphyromonas	Porphyromonas	NNP	I-NP	O
gingivalis	gingivalis	NN	I-NP	O
,	,	,	O	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
oralis	oralis	NNP	I-NP	O
and	and	CC	O	O
Tannerella	Tannerella	NNP	B-NP	O
forsythia	forsythia	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
higher	high	JJR	B-ADJP	O
than	than	IN	B-PP	O
matched	match	VBN	B-NP	O
systemically	systemically	RB	I-NP	O
healthy	healthy	JJ	I-NP	O
women	woman	NNS	I-NP	O
,	,	,	O	O
particularly	particularly	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
case	case	NN	I-NP	O
of	of	IN	B-PP	O
gingivitis	gingivitis	NN	B-NP	O
.	.	.	O	O

Aggregatibacter	Aggregatibacter	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
and	and	CC	O	O
Treponema	Treponema	NN	B-NP	O
denticola	denticola	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
among	among	IN	B-PP	O
study	study	NN	B-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
PCOS	PCOS	NN	B-NP	B-protein
also	also	RB	B-ADVP	O
enhanced	enhance	VBD	B-VP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
Prevotella	Prevotella	NNP	B-NP	O
intermedia	intermedia	NNP	I-NP	O
and	and	CC	O	O
S.	S.	NNP	B-NP	O
oralis	oralis	CC	O	O
serum	serum	NN	B-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
levels	level	NNS	I-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
gingivitis	gingivitis	NN	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

Gingival	Gingival	JJ	B-NP	O
inflammation	inflammation	NN	I-NP	O
correlated	correlate	VBD	B-VP	O
positively	positively	RB	B-ADVP	O
with	with	IN	B-PP	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
studied	study	VBN	I-NP	O
taxa	taxa	NN	I-NP	O
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
,	,	,	O	O
particularly	particularly	RB	B-ADVP	O
in	in	IN	B-PP	O
PCOS	PCOS	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
and	and	CC	O	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
also	also	RB	B-ADVP	O
exhibited	exhibit	VBD	B-VP	O
a	a	DT	B-NP	O
strong	strong	JJ	I-NP	O
positive	positive	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
corresponding	correspond	VBG	I-NP	O
serum	serum	NN	I-NP	B-protein
antibody	antibody	NN	I-NP	I-protein
levels	level	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
conclusion	conclusion	NN	B-NP	O
,	,	,	O	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
underlying	underlie	VBG	I-NP	O
systemic	systemic	JJ	I-NP	O
endocrine	endocrine	JJ	I-NP	O
condition	condition	NN	I-NP	O
,	,	,	O	O
PCOS	PCOS	NN	B-NP	B-protein
may	may	MD	B-VP	O
quantitatively	quantitatively	RB	I-VP	O
affect	affect	VB	I-VP	O
the	the	DT	B-NP	O
composition	composition	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
microbiota	microbiota	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
raised	raise	VBN	I-NP	O
systemic	systemic	JJ	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
selective	selective	JJ	B-NP	O
members	member	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
microbial	microbial	JJ	I-NP	O
community	community	NN	I-NP	O
,	,	,	O	O
exerting	exert	VBG	B-VP	O
a	a	DT	B-NP	O
confounding	confound	VBG	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
resultant	resultant	JJ	B-NP	O
gingival	gingival	JJ	I-NP	O
inflammation	inflammation	NN	I-NP	O
and	and	CC	O	O
periodontal	periodontal	JJ	B-NP	O
health	health	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
most	most	RBS	I-NP	O
consistent	consistent	JJ	I-NP	O
effect	effect	NN	I-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
exerted	exert	VBN	I-VP	O
on	on	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
.	.	.	O	O

Honey	Honey	NN	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
ancient	ancient	JJ	I-NP	O
natural	natural	JJ	I-NP	O
remedy	remedy	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
infected	infected	JJ	B-NP	O
wounds	wound	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
has	have	VBZ	B-VP	O
regained	regain	VBN	I-VP	O
attention	attention	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
medical	medical	JJ	I-NP	O
profession	profession	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
it	it	PRP	B-NP	O
has	have	VBZ	B-VP	O
recently	recently	RB	I-VP	O
been	be	VBN	I-VP	O
reported	report	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
broad-spectrum	broad-spectrum	JJ	I-NP	O
inhibitory	inhibitory	JJ	I-NP	O
effect	effect	NN	I-NP	O
against	against	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
.	.	.	O	O

Data	Datum	NNS	B-NP	O
concerning	concern	VBG	B-VP	O
Manuka	Manuka	NNP	B-NP	O
honey	honey	NN	I-NP	O
of	of	IN	B-PP	O
New	New	NNP	B-NP	O
Zealand	Zealand	NNP	I-NP	B-protein
origin	origin	NN	I-NP	I-protein
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
claimed	claim	VBN	I-VP	O
to	to	TO	I-VP	O
provide	provide	VB	I-VP	O
additional	additional	JJ	B-NP	O
non-peroxide	non-peroxide	JJ	I-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
activity	activity	NN	I-NP	O
(	(	(	O	O
so-called	so-called	JJ	B-NP	O
standard	standard	JJ	I-NP	O
NPA	NPA	NN	I-NP	O
)	)	)	O	O
against	against	IN	B-PP	O
oral	oral	JJ	B-NP	O
pathogens	pathogen	NNS	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
still	still	RB	B-ADVP	O
scarce	scarce	JJ	B-ADJP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
aimed	aim	VBD	B-VP	O
to	to	TO	I-VP	O
screen	screen	VB	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
antibacterial	antibacterial	JJ	I-NP	O
efficacy	efficacy	NN	I-NP	O
of	of	IN	B-PP	O
different	different	JJ	B-NP	O
Manuka	Manuka	NNP	I-NP	O
honey	honey	NN	I-NP	O
products	product	NNS	I-NP	O
against	against	IN	B-PP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
(	(	(	O	O
OMZ	OMZ	NN	B-NP	B-protein
918	918	CD	I-NP	I-protein
)	)	)	O	O
,	,	,	O	O
P.	P.	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
(	(	(	O	O
OMZ	OMZ	NN	B-NP	B-protein
925	925	CD	I-NP	I-protein
)	)	)	O	O
and	and	CC	O	O
A.	A.	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
(	(	(	O	O
OMZ	OMZ	NN	B-NP	B-protein
299	299	CD	I-NP	I-protein
)	)	)	O	O
.	.	.	O	O

Chlorhexidine	Chlorhexidine	NN	B-NP	O
and	and	CC	I-NP	O
saline	saline	NN	I-NP	O
served	serve	VBD	B-VP	O
as	as	IN	B-PP	O
positive	positive	JJ	B-NP	O
and	and	CC	I-NP	O
negative	negative	JJ	I-NP	O
controls	control	NNS	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
,	,	,	O	O
whereas	whereas	IN	O	O
a	a	DT	B-NP	O
Swiss	Swiss	JJ	I-NP	O
multifloral	multifloral	JJ	I-NP	O
honey	honey	NN	I-NP	O
served	serve	VBD	B-VP	O
as	as	IN	B-PP	O
control	control	NN	B-NP	O
honey	honey	NN	I-NP	O
without	without	IN	B-PP	O
intrinsic	intrinsic	JJ	B-NP	O
non-peroxide	non-peroxide	JJ	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

Chlorhexidine	Chlorhexidine	NN	B-NP	O
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
highest	high	JJS	I-NP	O
inhibiting	inhibiting	NN	I-NP	O
potential	potential	NN	I-NP	O
against	against	IN	B-PP	O
all	all	DT	B-NP	O
specimens	specimen	NNS	I-NP	O
tested	test	VBN	B-VP	O
.	.	.	O	O

Manuka	Manuka	NN	B-NP	O
honey	honey	NN	I-NP	O
below	below	IN	B-PP	O
an	an	DT	B-NP	O
NPA	NPA	NN	I-NP	O
value	value	NN	I-NP	O
of	of	IN	B-PP	O
15	15	CD	B-NP	O
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
least	least	JJS	I-NP	O
bacterial	bacterial	JJ	I-NP	O
growth-inhibiting	growth-inhibiting	JJ	I-NP	O
potential	potential	NN	I-NP	O
,	,	,	O	O
even	even	RB	B-ADVP	O
less	less	JJR	I-ADVP	O
although	although	IN	B-ADVP	O
not	not	RB	O	O
significantly	significantly	RB	B-ADVP	O
so	so	RB	I-ADVP	O
than	than	IN	B-PP	O
multifloral	multifloral	JJ	B-NP	O
Swiss	Swiss	JJ	I-NP	O
honey	honey	NN	I-NP	O
.	.	.	O	O

Manuka	Manuka	NN	B-NP	O
honey	honey	NN	I-NP	O
above	above	IN	B-PP	O
an	an	DT	B-NP	O
NPA	NPA	NN	I-NP	O
value	value	NN	I-NP	O
of	of	IN	B-PP	O
15	15	CD	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
significantly	significantly	RB	I-NP	O
higher	high	JJR	I-NP	O
antibacterial	antibacterial	JJ	I-NP	O
effect	effect	NN	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
honeys	honey	NNS	I-NP	O
tested	test	VBN	B-VP	O
.	.	.	O	O

All	All	DT	B-NP	O
Manuka	Manuka	NNP	I-NP	O
honey	honey	NN	I-NP	O
preparations	preparation	NNS	I-NP	O
were	be	VBD	B-VP	O
more	more	RBR	B-ADJP	O
effective	effective	JJ	I-ADJP	O
in	in	IN	B-PP	O
inhibiting	inhibit	VBG	B-VP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
and	and	CC	I-NP	O
A.	A.	NN	I-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
,	,	,	O	O
rather	rather	RB	B-PP	O
than	than	IN	I-PP	O
S.	S.	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
conclusion	conclusion	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
NPA	NPA	NN	I-NP	O
dose-dependent	dose-dependent	JJ	I-NP	O
antibacterial	antibacterial	JJ	I-NP	O
efficacy	efficacy	NN	I-NP	O
of	of	IN	B-PP	O
Manuka	Manuka	NNP	B-NP	O
honey	honey	NN	I-NP	O
.	.	.	O	O

Further	Further	JJ	B-NP	O
investigations	investigation	NNS	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
natural	natural	JJ	I-NP	O
product	product	NN	I-NP	O
are	be	VBP	B-VP	O
now	now	RB	B-ADVP	O
open	open	JJ	B-ADJP	O
for	for	IN	B-PP	O
scrutiny	scrutiny	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
complex	complex	NN	I-NP	O
of	of	IN	B-PP	O
species	specie	NNS	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
dental	dental	JJ	B-NP	O
caries	cary	NNS	I-NP	O
under	under	IN	B-PP	O
the	the	DT	B-NP	O
ecological	ecological	JJ	I-NP	O
hypothesis	hypothesis	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
aimed	aim	VBD	B-VP	O
to	to	TO	I-VP	O
develop	develop	VB	I-VP	O
a	a	DT	B-NP	O
rapid	rapid	JJ	I-NP	O
,	,	,	I-NP	O
sensitive	sensitive	JJ	I-NP	O
PCR-dipstick	PCR-dipstick	NN	I-NP	O
DNA	DNA	NN	I-NP	O
chromatography	chromatography	NN	I-NP	O
assay	assay	NN	I-NP	O
that	that	WDT	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
read	read	VBN	I-VP	O
by	by	IN	B-PP	O
eye	eye	NN	B-NP	O
for	for	IN	B-PP	O
multiplex	multiplex	JJ	B-NP	O
and	and	CC	I-NP	O
semiquantitative	semiquantitative	JJ	I-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
plaque	plaque	NN	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

Parallel	Parallel	JJ	B-NP	O
oligonucleotides	oligonucleotide	NNS	I-NP	O
were	be	VBD	B-VP	O
immobilized	immobilize	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
dipstick	dipstick	JJ	I-NP	O
strip	strip	NN	I-NP	O
for	for	IN	B-PP	O
multiplex	multiplex	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
target	target	NN	B-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
sequences	sequence	NNS	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
caries-associated	caries-associated	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
sobrinus	sobrinus	NNP	I-NP	O
,	,	,	O	O
Scardovia	Scardovia	NNP	B-NP	O
wiggsiae	wiggsiae	NNP	I-NP	O
,	,	,	O	O
Actinomyces	Actinomyces	NNP	B-NP	O
species	specie	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Veillonella	Veillonella	NN	B-NP	O
parvula	parvula	NN	I-NP	O
.	.	.	O	O

Streptavidin-coated	Streptavidin-coated	JJ	B-NP	O
blue-colored	blue-colored	JJ	I-NP	O
latex	latex	JJ	I-NP	O
microspheres	microsphere	NNS	I-NP	O
were	be	VBD	B-VP	O
to	to	TO	I-VP	O
generate	generate	VB	I-VP	O
signal	signal	NN	B-NP	O
.	.	.	O	O

Target	Target	NN	B-NP	O
DNA	DNA	NN	I-NP	O
amplicons	amplicon	NNS	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
oligonucleotide-tagged	oligonucleotide-tagged	JJ	I-NP	O
terminus	terminus	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
biotinylated	biotinylate	VBN	I-NP	B-protein
terminus	terminus	NN	I-NP	I-protein
were	be	VBD	B-VP	O
coupled	couple	VBN	I-VP	O
with	with	IN	B-PP	O
latex	latex	JJ	B-NP	O
beads	bead	NNS	I-NP	O
through	through	IN	B-PP	O
a	a	DT	B-NP	O
streptavidin-biotin	streptavidin-biotin	JJ	I-NP	O
interaction	interaction	NN	I-NP	O
and	and	CC	O	O
then	then	RB	B-VP	O
hybridized	hybridize	VBN	I-VP	O
with	with	IN	B-PP	O
complementary	complementary	JJ	B-NP	O
oligonucleotides	oligonucleotide	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
strip	strip	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
accumulation	accumulation	NN	I-NP	O
of	of	IN	B-PP	O
captured	captured	JJ	B-NP	O
latex	latex	JJ	I-NP	O
beads	bead	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
test	test	NN	I-NP	O
and	and	CC	I-NP	O
control	control	NN	I-NP	O
lines	line	NNS	I-NP	O
produced	produce	VBD	B-VP	O
blue	blue	JJ	B-NP	O
bands	band	NNS	I-NP	O
,	,	,	O	O
enabling	enable	VBG	B-VP	O
visual	visual	JJ	B-NP	O
detection	detection	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
naked	naked	JJ	I-NP	O
eye	eye	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
PCR-dipstick	PCR-dipstick	JJ	I-NP	O
DNA	DNA	NN	I-NP	O
chromatography	chromatography	NN	I-NP	O
detected	detect	VBD	B-VP	O
quantities	quantity	NNS	B-NP	O
as	as	RB	B-ADJP	O
low	low	JJ	I-ADJP	O
as	as	IN	B-PP	O
100	100	CD	B-NP	O
pg	pg	NN	I-NP	O
of	of	IN	B-PP	O
DNA	DNA	NN	B-NP	O
amplicons	amplicon	NNS	I-NP	O
and	and	CC	O	O
demonstrated	demonstrate	VBD	B-VP	O
10-	10-	CD	B-NP	O
to	to	TO	B-PP	O
1000-fold	1000-fold	RB	B-NP	O
higher	high	JJR	I-NP	O
sensitivity	sensitivity	NN	I-NP	O
than	than	IN	B-PP	O
PCR-agarose	PCR-agarose	NN	B-NP	O
gel	gel	NN	I-NP	O
electrophoresis	electrophoresis	NN	I-NP	O
,	,	,	O	O
depending	depend	VBG	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
target	target	NN	I-NP	B-DNA
bacterial	bacterial	JJ	I-NP	I-DNA
species	specie	NNS	I-NP	I-DNA
.	.	.	O	O

Semiquantification	Semiquantification	NN	B-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
by	by	IN	B-PP	O
obtaining	obtain	VBG	B-VP	O
a	a	DT	B-NP	O
series	series	NN	I-NP	O
of	of	IN	B-PP	O
chromatograms	chromatogram	NNS	B-NP	O
using	use	VBG	B-VP	O
serial	serial	JJ	B-NP	O
10-fold	10-fold	JJ	I-NP	O
dilution	dilution	NN	I-NP	O
of	of	IN	B-PP	O
PCR-amplified	PCR-amplified	JJ	B-NP	O
DNA	DNA	NN	I-NP	O
extracted	extract	VBN	B-VP	O
from	from	IN	B-PP	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
samples	sample	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
assay	assay	NN	I-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
3	3	CD	I-NP	O
h.	h.	NN	I-NP	O
The	The	DT	B-NP	O
semiquantification	semiquantification	NN	I-NP	O
procedure	procedure	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
the	the	DT	B-NP	O
relative	relative	JJ	I-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
each	each	DT	B-NP	O
test	test	NN	I-NP	O
species	specie	NNS	I-NP	O
in	in	IN	B-PP	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
samples	sample	NNS	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
disposable	disposable	JJ	I-NP	O
device	device	NN	I-NP	O
has	have	VBZ	B-VP	O
great	great	JJ	B-NP	O
potential	potential	NN	I-NP	O
in	in	IN	B-PP	O
analysis	analysis	NN	B-NP	O
of	of	IN	B-PP	O
microbial	microbial	JJ	B-NP	O
composition	composition	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
and	and	CC	O	O
intestinal	intestinal	JJ	B-NP	O
tract	tract	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
in	in	IN	B-PP	O
point-of-care	point-of-care	JJ	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
microbiota-associated	microbiota-associated	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
.	.	.	O	O

Black	Black	JJ	B-NP	O
lion	lion	NN	I-NP	O
tamarins	tamarin	NNS	I-NP	O
(	(	(	O	O
Leontopithecus	Leontopithecus	NN	B-NP	O
chrysopygus	chrysopygus	NN	I-NP	O
)	)	)	O	O
are	be	VBP	B-VP	O
endangered	endanger	VBN	I-VP	O
callithrichids	callithrichid	NNS	B-NP	O
.	.	.	O	O

Their	Their	PRP$	B-NP	O
conservation	conservation	NN	I-NP	O
may	may	MD	B-VP	O
require	require	VB	I-VP	O
future	future	JJ	B-NP	O
translocations	translocation	NNS	I-NP	O
or	or	CC	I-NP	O
reintroductions	reintroduction	NNS	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
these	these	DT	B-NP	O
approaches	approach	NNS	I-NP	O
involve	involve	VBP	B-VP	O
risks	risk	NNS	B-NP	O
of	of	IN	B-PP	O
pathogen	pathogen	NN	B-NP	O
introduction	introduction	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
environment	environment	NN	I-NP	O
and	and	CC	O	O
stress-related	stress-related	JJ	B-NP	O
opportunistic	opportunistic	JJ	I-NP	O
infections	infection	NNS	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
animals	animal	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
screen	screen	VB	I-VP	O
for	for	IN	B-PP	O
opportunistic	opportunistic	JJ	B-NP	O
and	and	CC	I-NP	O
potential	potential	JJ	I-NP	O
pathogenic	pathogenic	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
and	and	CC	I-NP	O
fungal	fungal	JJ	I-NP	O
microbiota	microbiota	NN	I-NP	O
,	,	,	O	O
ten	ten	CD	B-NP	O
free-ranging	free-ranging	JJ	I-NP	O
and	and	CC	O	O
ten	ten	CD	B-NP	O
captive	captive	JJ	I-NP	O
Black	Black	NNP	I-NP	O
lion	lion	NN	I-NP	O
tamarins	tamarin	NNS	I-NP	O
were	be	VBD	B-VP	O
studied	study	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
compared	compare	VBN	B-VP	O
.	.	.	O	O

Nasal	Nasal	JJ	B-NP	O
,	,	,	I-NP	O
oral	oral	JJ	I-NP	O
and	and	CC	I-NP	O
rectal	rectal	JJ	I-NP	O
swabs	swab	NNS	I-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
and	and	CC	O	O
cultured	culture	VBN	B-VP	O
for	for	IN	B-PP	O
aerobic	aerobic	JJ	B-NP	O
and	and	CC	I-NP	O
facultative	facultative	JJ	I-NP	O
anaerobic	anaerobic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	I-NP	O
fungi	fungus	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
total	total	JJ	I-NP	O
203	203	CD	I-NP	O
bacterial	bacterial	JJ	I-NP	O
and	and	CC	O	O
84	84	CD	B-NP	O
fungal	fungal	JJ	I-NP	O
isolates	isolate	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
.	.	.	O	O

Overall	Overall	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
most	most	RBS	I-NP	O
frequent	frequent	JJ	I-NP	O
organisms	organism	NNS	I-NP	O
were	be	VBD	B-VP	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
spp.	spp.	NNP	I-NP	O
,	,	,	O	O
Bacillus	Bacillus	NNP	B-NP	O
spp.	spp.	NNP	I-NP	O
,	,	,	O	O
Candida	Candida	NNP	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

and	and	CC	O	O
Aspergillus	Aspergillus	NN	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

Microbiota	Microbiota	NN	B-NP	O
of	of	IN	B-PP	O
free-ranging	free-ranging	JJ	B-NP	O
and	and	CC	I-NP	O
captive	captive	JJ	I-NP	O
animals	animal	NNS	I-NP	O
were	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
in	in	IN	B-PP	O
composition	composition	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
potentially	potentially	RB	B-NP	O
pathogenic	pathogenic	JJ	I-NP	O
organisms	organism	NNS	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
,	,	,	O	O
emphasizing	emphasize	VBG	B-VP	O
the	the	DT	B-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
microbiological	microbiological	JJ	B-NP	O
screening	screening	NN	I-NP	O
in	in	IN	B-PP	O
future	future	JJ	B-NP	O
translocation	translocation	NN	I-NP	O
or	or	CC	I-NP	O
reintroduction	reintroduction	NN	I-NP	O
conservation	conservation	NN	I-NP	O
management	management	NN	I-NP	O
programs	program	NNS	I-NP	O
.	.	.	O	O

Nonimmune	Nonimmune	JJ	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
immunoglobulins	immunoglobulin	NNS	B-NP	B-protein
via	via	IN	B-PP	O
the	the	DT	B-NP	O
Fc	Fc	NN	I-NP	B-DNA
fragment	fragment	NN	I-NP	I-DNA
may	may	MD	B-VP	O
reduce	reduce	VB	I-VP	O
opsonization	opsonization	NN	B-NP	O
and	and	CC	I-NP	O
phagocytosis	phagocytosis	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
thus	thus	RB	I-VP	O
considered	consider	VBN	I-VP	O
a	a	DT	B-NP	O
virulence	virulence	NN	I-NP	B-protein
factor	factor	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
a	a	DT	B-NP	O
wide	wide	JJ	I-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
strains	strain	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
immunoglobulin	immunoglobulin	NN	I-NP	O
G	G	NN	I-NP	O
(	(	(	O	O
IgG	IgG	NN	B-NP	B-protein
)	)	)	O	O
Fc-binding	Fc-binding	JJ	B-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
132	132	CD	B-NP	O
strains	strain	NNS	I-NP	O
representing	represent	VBG	B-VP	O
40	40	CD	B-NP	O
different	different	JJ	I-NP	O
gram-positive	gram-positive	JJ	I-NP	O
and	and	CC	I-NP	O
gram	gram	NN	I-NP	O
negative	negative	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
for	for	IN	B-PP	O
IgG	IgG	NN	B-NP	B-protein
Fc-binding	Fc-binding	JJ	I-NP	O
activity	activity	NN	I-NP	O
by	by	IN	B-PP	O
using	use	VBG	B-VP	O
a	a	DT	B-NP	O
fast	fast	JJ	I-NP	O
and	and	CC	I-NP	O
simple	simple	JJ	I-NP	O
dot	dot	NN	I-NP	O
blot	blot	NN	I-NP	O
procedure	procedure	NN	I-NP	O
with	with	IN	B-PP	O
horseradish	horseradish	JJ	B-NP	B-DNA
peroxidase-conjugated	peroxidase-conjugated	JJ	I-NP	I-DNA
Fc	Fc	NN	I-NP	I-DNA
fragments	fragment	NNS	I-NP	I-DNA
from	from	IN	B-PP	O
human	human	JJ	B-NP	B-protein
IgG	IgG	NN	I-NP	I-protein
.	.	.	O	O

Neither	Neither	CC	O	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
nor	nor	CC	I-NP	O
animal	animal	JJ	I-NP	O
biotype	biotype	NN	I-NP	O
of	of	IN	B-PP	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
possessed	possess	VBD	B-VP	O
IgG	IgG	NN	B-NP	B-protein
Fc-binding	Fc-binding	JJ	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
strongest	strong	JJS	I-NP	O
positive	positive	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
of	of	IN	B-PP	O
gram-negative	gram-negative	JJ	B-NP	B-protein
species	specie	NNS	I-NP	I-protein
with	with	IN	B-PP	O
the	the	DT	B-NP	O
IgG	IgG	NN	I-NP	B-DNA
Fc	Fc	NN	I-NP	I-DNA
fragments	fragment	NNS	I-NP	I-DNA
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
with	with	IN	B-PP	O
strains	strain	NNS	B-NP	O
of	of	IN	B-PP	O
Prevotella	Prevotella	NN	B-NP	O
intermedia	intermedia	NN	I-NP	O
and	and	CC	O	O
Fusobacterium	Fusobacterium	NN	B-NP	O
nucleatum	nucleatum	NN	I-NP	O
.	.	.	O	O

Among	Among	IN	B-PP	O
the	the	DT	B-NP	O
gram-positive	gram-positive	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
tested	test	VBN	B-VP	O
,	,	,	O	O
Peptostreptococcus	Peptostreptococcus	NNP	B-NP	O
micros	micro	NNS	I-NP	O
,	,	,	O	O
Lactobacillus	Lactobacillus	NN	B-NP	O
spp.	spp.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
several	several	JJ	B-NP	O
species	specie	NNS	I-NP	O
of	of	IN	B-PP	O
streptococci	streptococci	NNS	B-NP	O
possessed	possess	VBD	B-VP	O
IgG	IgG	NN	B-NP	B-protein
Fc-binding	Fc-binding	JJ	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
investigation	investigation	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
oral	oral	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
to	to	TO	B-VP	O
bind	bind	VB	I-VP	O
IgG	IgG	NN	B-NP	B-protein
Fc	Fc	NN	I-NP	I-protein
fragments	fragment	NNS	I-NP	I-protein
was	be	VBD	B-VP	O
demonstrated	demonstrate	VBN	I-VP	O
.	.	.	O	O

This	This	DT	B-NP	O
factor	factor	NN	I-NP	O
represents	represent	VBZ	B-VP	O
a	a	DT	B-NP	O
potential	potential	JJ	I-NP	O
virulence	virulence	NN	I-NP	O
determinant	determinant	NN	I-NP	O
as	as	IN	B-SBAR	O
it	it	PRP	B-NP	O
may	may	MD	B-VP	O
help	help	VB	I-VP	O
pathogenic	pathogenic	JJ	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
escape	escape	VBP	B-VP	O
host	host	NN	B-NP	O
defense	defense	NN	I-NP	O
mechanisms	mechanism	NNS	I-NP	O
.	.	.	O	O

Viable	Viable	JJ	B-NP	O
counts	count	NNS	I-NP	O
and	and	CC	I-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
sulfate-reducing	sulfate-reducing	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavities	cavity	NNS	I-NP	O
of	of	IN	B-PP	O
12	12	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
volunteers	volunteer	NNS	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
these	these	DT	B-NP	O
,	,	,	O	O
10	10	CD	B-NP	O
harboured	harbour	VBD	B-VP	O
viable	viable	JJ	B-NP	O
sulfate-reducing	sulfate-reducing	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
populations	population	NNS	I-NP	O
.	.	.	O	O

Six	Six	CD	B-NP	O
separate	separate	JJ	I-NP	O
sites	site	NNS	I-NP	O
were	be	VBD	B-VP	O
sampled	sample	VBN	I-VP	O
:	:	:	O	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
tongue	tongue	NN	I-NP	O
,	,	,	O	O
anterior	anterior	JJ	B-NP	O
tongue	tongue	NN	I-NP	O
,	,	,	O	O
mid	mid	JJ	B-NP	O
buccal	buccal	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
,	,	,	O	O
vestibular	vestibular	JJ	B-NP	O
mucosa	mucosa	NN	I-NP	O
,	,	,	O	O
supragingival	supragingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
and	and	CC	O	O
subgingival	subgingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
.	.	.	O	O

Sulfate-reducing	Sulfate-reducing	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
occurred	occur	VBD	B-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
areas	area	NNS	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
highest	high	JJS	I-NP	O
incidence	incidence	NN	I-NP	O
in	in	IN	B-PP	O
supragingival	supragingival	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
.	.	.	O	O

Viable	Viable	JJ	B-NP	O
counts	count	NNS	I-NP	O
and	and	CC	O	O
sulfate-reducing	sulfate-reducing	JJ	B-NP	O
activities	activity	NNS	I-NP	O
in	in	IN	B-PP	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
regions	region	NNS	I-NP	O
varied	vary	VBD	B-VP	O
from	from	IN	B-PP	O
0	0	CD	B-NP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
(	(	(	O	O
8	8	CD	B-NP	O
)	)	)	O	O
cfu	cfu	NN	B-NP	O
(	(	(	O	O
g	g	NN	B-NP	O
wet	wet	JJ	I-NP	O
weight	weight	NN	I-NP	O
)	)	)	O	O
-1	-1	CD	B-PP	O
and	and	CC	I-PP	O
from	from	IN	B-PP	O
0	0	CD	B-NP	O
to	to	TO	B-PP	O
50	50	CD	B-NP	O
nmol	nmol	NN	I-NP	O
(	(	(	O	O
g	g	NN	B-NP	O
wet	wet	JJ	I-NP	O
weight	weight	NN	I-NP	O
)	)	)	O	O
-1	-1	CD	B-NP	O
h-1	h-1	NN	I-NP	O
,	,	,	O	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
sulfate-reducing	sulfate-reducing	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
detected	detect	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
,	,	,	O	O
they	they	PRP	B-NP	O
may	may	MD	B-VP	O
potentially	potentially	RB	I-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
terminal	terminal	JJ	B-NP	O
oxidative	oxidative	JJ	I-NP	O
processes	process	NNS	I-NP	O
carried	carry	VBN	B-VP	O
out	out	RP	B-PRT	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
microflora	microflora	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
expression	expression	NN	I-NP	O
of	of	IN	B-PP	O
sialy-Lewis	sialy-Lewis	NN	B-NP	B-protein
(	(	(	O	O
x	x	NN	B-NP	O
)	)	)	O	O
(	(	(	O	O
sLe	sLe	NN	B-NP	O
(	(	(	O	O
x	x	NN	B-NP	O
)	)	)	O	O
;	;	:	O	O
Neu5Ac	Neu5Ac	NN	B-NP	O
alpha	alpha	NN	I-NP	O
2-3	2-3	CD	I-NP	O
Gal	Gal	NNP	I-NP	O
beta	beta	SYM	I-NP	O
1-4	1-4	CD	I-NP	O
)	)	)	O	O
(	(	(	O	O
Fuc	Fuc	NN	B-NP	O
alpha	alpha	NN	I-NP	O
1-3	1-3	NN	I-NP	O
)	)	)	O	O
GlcNAc-R	GlcNAc-R	NN	B-NP	O
)	)	)	O	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
producing	produce	VBG	B-VP	O
infective	infective	JJ	B-NP	O
endocarditis	endocarditis	NN	I-NP	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
whole-cell	whole-cell	JJ	I-NP	O
enzyme	enzyme	NN	I-NP	O
linked	link	VBD	B-VP	O
immunosorbent	immunosorbent	JJ	B-NP	O
assay	assay	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
immunoelectron	immunoelectron	NN	I-NP	O
microscopy	microscopy	NN	I-NP	O
using	use	VBG	B-VP	O
the	the	DT	B-NP	O
well-characterized	well-characterized	JJ	I-NP	O
anti-sLe	anti-sLe	JJ	I-NP	O
(	(	(	O	O
x	x	NN	B-NP	O
)	)	)	I-NP	O
monoclonal	monoclonal	JJ	I-NP	O
antibody	antibody	NN	I-NP	O
SNH-3	SNH-3	NN	I-NP	O
(	(	(	O	O
mAb	mAb	NN	B-NP	O
SNH-3	SNH-3	NN	I-NP	O
;	;	:	O	O
IgM	IgM	NN	B-NP	B-protein
class	class	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

mAb	mAb	NN	B-NP	B-protein
SNH-3	SNH-3	NN	I-NP	I-protein
reacted	react	VBD	B-VP	O
strongly	strongly	RB	B-ADVP	O
with	with	IN	B-PP	O
whole	whole	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
:	:	:	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
sanguis	sanguis	NNP	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mitis	mitis	NNP	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
salivarius	salivarius	NNP	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
intermedius	intermedius	NNP	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
constellatus	constellatus	NNP	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
anginosus	anginosus	NNP	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
pyogenes	pyogene	NNS	I-NP	O
,	,	,	O	O
Actinobacillus	Actinobacillus	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
,	,	,	O	O
Eikenella	Eikenella	NN	B-NP	O
corrodens	corroden	NNS	I-NP	O
and	and	CC	O	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivalis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
negatively	negatively	RB	I-NP	O
stained	stain	VBN	I-NP	O
immuno-electron	immuno-electron	NN	I-NP	O
micrograph	micrograph	NN	I-NP	O
of	of	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
pyogenes	pyogene	NNS	I-NP	O
showed	show	VBD	B-VP	O
many	many	JJ	B-NP	O
reactive	reactive	JJ	I-NP	O
gold	gold	NN	I-NP	O
particles	particle	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
cell	cell	NN	I-NP	O
surface	surface	NN	I-NP	O
.	.	.	O	O

Our	Our	PRP$	B-NP	O
findings	finding	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
the	the	DT	B-NP	O
existence	existence	NN	I-NP	O
of	of	IN	B-PP	O
immunologic	immunologic	JJ	B-NP	O
mimicry	mimicry	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
sLe	sLe	NN	I-NP	O
(	(	(	O	O
x	x	NN	B-NP	O
)	)	)	O	O
oligosaccharide	oligosaccharide	NN	B-NP	O
and	and	CC	O	O
cell	cell	NN	B-NP	B-protein
surface	surface	NN	I-NP	I-protein
antigens	antigen	NNS	I-NP	I-protein
of	of	IN	B-PP	O
many	many	JJ	B-NP	O
species	specie	NNS	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
infective	infective	JJ	B-NP	O
endocarditis	endocarditis	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
propose	propose	VBP	B-VP	O
the	the	DT	B-NP	O
hypothesis	hypothesis	NN	I-NP	O
that	that	IN	B-SBAR	O
if	if	IN	B-SBAR	O
these	these	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
escape	escape	VBP	B-VP	O
their	their	PRP$	B-NP	O
normal	normal	JJ	I-NP	O
habitats	habitat	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
surface	surface	NN	I-NP	B-protein
components	component	NNS	I-NP	I-protein
that	that	WDT	B-NP	O
mimic	mimic	VBP	B-VP	O
the	the	DT	B-NP	O
sLe	sLe	NN	I-NP	O
(	(	(	O	O
x	x	NN	B-NP	O
)	)	)	O	O
oligosaccharide	oligosaccharide	NN	B-NP	O
might	might	MD	B-VP	O
bind	bind	VB	I-VP	O
to	to	TO	B-PP	O
host	host	NN	B-NP	O
antigens	antigen	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
selectin	selectin	NN	I-NP	B-protein
family	family	NN	I-NP	I-protein
which	which	WDT	B-NP	O
could	could	MD	B-VP	O
promote	promote	VB	I-VP	O
binding	binding	NN	B-NP	O
to	to	TO	B-PP	O
endothelial	endothelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
,	,	,	O	O
consequently	consequently	RB	B-ADVP	O
,	,	,	O	O
initiation	initiation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
events	event	NNS	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
infective	infective	JJ	B-NP	O
endocarditis	endocarditis	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
examine	examine	VB	I-VP	O
the	the	DT	B-NP	O
possible	possible	JJ	I-NP	O
implication	implication	NN	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
epithelial	epithelial	JJ	I-NP	O
and	and	CC	I-NP	O
endothelial	endothelial	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
the	the	DT	B-NP	O
pathogenesis	pathogenesis	NN	I-NP	O
of	of	IN	B-PP	O
various	various	JJ	B-NP	O
diseases	disease	NNS	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
oral	oral	JJ	B-NP	O
viridans	viridan	NNS	I-NP	O
streptococci	streptococci	NNS	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
tested	test	VBD	B-VP	O
the	the	DT	B-NP	O
immunomodulatory	immunomodulatory	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
11	11	CD	B-NP	O
representative	representative	JJ	I-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
viridans	viridan	NNS	I-NP	O
streptococci	streptococci	NNS	I-NP	O
on	on	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
epithelial	epithelial	JJ	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
and	and	CC	O	O
endothelial	endothelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

We	We	PRP	B-NP	O
then	then	RB	B-ADVP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
possible	possible	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
major	major	JJ	I-NP	O
adhesins	adhesin	NNS	I-NP	O
from	from	IN	B-PP	O
oral	oral	JJ	B-NP	O
viridans	viridan	NNS	I-NP	O
streptococci	streptococci	NNS	I-NP	O
,	,	,	O	O
protein	protein	NN	B-NP	O
I/II	I/II	NN	I-NP	O
and	and	CC	O	O
rhamnose-glucose	rhamnose-glucose	NN	B-NP	B-protein
polymers	polymer	NNS	I-NP	I-protein
(	(	(	O	O
RGPs	RGP	NNS	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
we	we	PRP	B-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
oral	oral	JJ	B-NP	O
viridans	viridan	NNS	I-NP	O
streptococci	streptococci	NNS	I-NP	O
are	be	VBP	B-VP	O
potent	potent	JJ	B-NP	O
stimulators	stimulator	NNS	I-NP	O
of	of	IN	B-PP	O
interleukin-8	interleukin-8	NN	B-NP	B-protein
(	(	(	O	O
IL-8	IL-8	NN	B-NP	B-protein
)	)	)	O	O
production	production	NN	B-NP	O
from	from	IN	B-PP	O
KB	KB	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
and	and	CC	B-PP	O
of	of	IN	B-PP	O
IL-6	IL-6	NN	B-NP	B-protein
and	and	CC	O	O
IL-8	IL-8	NN	B-NP	B-protein
production	production	NN	I-NP	O
from	from	IN	B-PP	O
endothelial	endothelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
ability	ability	NN	I-NP	O
of	of	IN	B-PP	O
protein	protein	NN	B-NP	O
I/II	I/II	NN	I-NP	O
and	and	CC	O	O
RGPs	RGP	NNS	B-NP	B-protein
to	to	TO	B-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
these	these	DT	B-NP	O
effects	effect	NNS	I-NP	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
examined	examine	VBN	I-VP	O
.	.	.	O	O

Using	Use	VBG	B-VP	O
biotinylated	biotinylate	VBN	B-NP	O
protein	protein	NN	I-NP	O
I/IIf	I/IIf	NN	I-NP	B-protein
and	and	CC	O	O
RGPs	RGP	NNS	B-NP	B-protein
from	from	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
OMZ	OMZ	NNP	B-NP	O
175	175	CD	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
adhesins	adhesin	NNS	I-NP	B-protein
bind	bind	VBP	B-VP	O
to	to	TO	B-PP	O
KB	KB	NN	B-NP	O
and	and	CC	I-NP	O
endothelial	endothelial	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
through	through	IN	B-PP	O
specific	specific	JJ	B-NP	O
interactions	interaction	NNS	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
binding	binding	NN	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
molecules	molecule	NNS	I-NP	O
initiates	initiate	VBZ	B-VP	O
the	the	DT	B-NP	O
release	release	NN	I-NP	O
of	of	IN	B-PP	O
IL-8	IL-8	NN	B-NP	B-protein
from	from	IN	B-PP	O
KB	KB	NN	B-NP	B-cell_line
cells	cell	NNS	I-NP	I-cell_line
and	and	CC	B-PP	O
of	of	IN	B-PP	O
IL-6	IL-6	NN	B-NP	B-protein
and	and	CC	I-NP	O
IL-8	IL-8	NN	I-NP	B-protein
from	from	IN	B-PP	O
endothelial	endothelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
suggest	suggest	VBP	B-VP	O
that	that	IN	B-SBAR	O
protein	protein	NN	B-NP	O
I/IIf	I/IIf	NN	I-NP	B-protein
and	and	CC	O	O
RGPs	RGP	NNS	B-NP	B-protein
play	play	VBP	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
role	role	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
interactions	interaction	NNS	I-NP	O
between	between	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
and	and	CC	O	O
KB	KB	NN	B-NP	O
and	and	CC	O	O
endothelial	endothelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
that	that	DT	B-NP	O
similar	similar	JJ	I-NP	O
cytokine	cytokine	NN	I-NP	B-protein
profiles	profile	NNS	I-NP	O
are	be	VBP	B-VP	O
obtained	obtain	VBN	I-VP	O
when	when	WRB	B-ADVP	O
cells	cell	NNS	B-NP	O
are	be	VBP	B-VP	O
stimulated	stimulate	VBN	I-VP	O
with	with	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
or	or	CC	O	O
surface	surface	NN	B-NP	O
components	component	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
provide	provide	VBP	B-VP	O
evidence	evidence	NN	B-NP	O
that	that	IN	B-SBAR	O
protein	protein	NN	B-NP	O
I/IIf	I/IIf	NN	I-NP	B-protein
binds	bind	VBZ	B-VP	O
to	to	TO	B-PP	O
and	and	CC	O	O
stimulates	stimulate	VBZ	B-VP	O
KB	KB	NN	B-NP	O
and	and	CC	O	O
endothelial	endothelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
through	through	IN	B-PP	O
lectin	lectin	NN	B-NP	B-protein
interactions	interaction	NNS	I-NP	O
that	that	WDT	B-NP	O
N-acetyl	N-acetyl	NN	B-NP	O
neuraminic	neuraminic	JJ	I-NP	O
acid	acid	NN	I-NP	O
(	(	(	O	O
NANA	NANA	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
fucose	fucose	NN	B-NP	O
present	present	JJ	B-ADJP	O
on	on	IN	B-PP	O
cell	cell	NN	B-NP	B-protein
surface	surface	NN	I-NP	I-protein
glycoproteins	glycoprotein	NNS	I-NP	I-protein
may	may	MD	B-VP	O
form	form	VB	I-VP	O
the	the	DT	B-NP	O
recognition	recognition	NN	I-NP	B-DNA
site	site	NN	I-NP	I-DNA
since	since	IN	B-PP	O
binding	binding	NN	B-NP	O
and	and	CC	O	O
cytokine	cytokine	NN	B-NP	B-protein
release	release	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
inhibited	inhibit	VBN	I-VP	O
by	by	IN	B-PP	O
dispase	dispase	NN	B-NP	O
and	and	CC	I-NP	O
periodate	periodate	NN	I-NP	O
treatment	treatment	NN	I-NP	O
of	of	IN	B-PP	O
cells	cell	NNS	B-NP	O
and	and	CC	B-PP	O
by	by	IN	B-PP	O
NANA	NANA	NN	B-NP	B-protein
and	and	CC	I-NP	O
fucose	fucose	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
results	result	NNS	I-NP	O
demonstrate	demonstrate	VBP	B-VP	O
that	that	IN	B-SBAR	O
ora	ora	JJ	B-NP	O
viridans	viridan	NNS	I-NP	O
streptococci	streptococci	NNS	I-NP	O
,	,	,	O	O
probably	probably	RB	B-ADVP	O
by	by	IN	B-PP	O
engaging	engage	VBG	B-VP	O
two	two	CD	B-NP	O
cell	cell	NN	I-NP	B-protein
surface	surface	NN	I-NP	I-protein
adhesins	adhesin	NNS	I-NP	I-protein
,	,	,	O	O
exert	exert	VBP	B-VP	O
immunomodulatory	immunomodulatory	JJ	B-NP	O
effects	effect	NNS	I-NP	O
on	on	IN	B-PP	O
human	human	JJ	B-NP	O
KB	KB	NN	I-NP	O
and	and	CC	O	O
endothelial	endothelial	JJ	B-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
compared	compare	VBD	B-VP	O
the	the	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
effectiveness	effectiveness	NN	I-NP	O
of	of	IN	B-PP	O
nine	nine	CD	B-NP	O
dental	dental	JJ	I-NP	O
materials	material	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
control	control	NN	I-NP	O
agent	agent	NN	I-NP	O
against	against	IN	B-PP	O
21	21	CD	B-NP	O
strains	strain	NNS	I-NP	O
or	or	CC	I-NP	O
species	specie	NNS	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
using	use	VBG	B-VP	O
an	an	DT	B-NP	O
agar	agar	NN	I-NP	O
diffusion	diffusion	NN	I-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
materials	material	NNS	I-NP	O
were	be	VBD	B-VP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Camphorated	Camphorate	VBN	B-NP	O
parachlorophenol	parachlorophenol	NN	I-NP	O
mixed	mix	VBN	B-VP	O
with	with	IN	B-PP	O
calcium	calcium	NN	B-NP	O
hydroxide	hydroxide	NN	I-NP	O
(	(	(	O	O
CPC	CPC	NN	B-NP	B-protein
+	+	CC	O	I-protein
Ca	Ca	NN	B-NP	I-protein
(	(	(	O	I-protein
OH	OH	NN	B-NP	I-protein
)	)	)	O	I-protein
2	2	CD	B-NP	I-protein
)	)	)	O	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

CPC	CPC	NN	B-NP	B-protein
mixed	mix	VBN	B-VP	O
with	with	IN	B-PP	O
zinc	zinc	NN	B-NP	O
oxide	oxide	NN	I-NP	O
(	(	(	O	O
CPC	CPC	NN	B-NP	B-protein
+	+	SYM	O	O
ZnO	ZnO	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Formocresol	Formocresol	NN	B-NP	O
mixed	mix	VBN	B-VP	O
with	with	IN	B-PP	O
zinc	zinc	NN	B-NP	O
oxide	oxide	NN	I-NP	O
and	and	CC	O	O
eugenol	eugenol	NN	B-NP	O
(	(	(	O	O
FC	FC	NN	B-NP	O
+	+	SYM	O	O
ZOE	ZOE	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Chlorhexidine	Chlorhexidine	NN	B-NP	O
mixed	mix	VBN	B-VP	O
with	with	IN	B-PP	O
ZOE	ZOE	NN	B-NP	B-protein
(	(	(	O	O
CHX	CHX	NN	B-NP	O
+	+	SYM	O	O
ZOE	ZOE	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Kri	Kri	NNP	B-NP	O
paste	paste	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

ZOE	ZOE	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Zinc	Zinc	NN	B-NP	O
oxide	oxide	NN	I-NP	O
mixed	mix	VBN	B-VP	O
with	with	IN	B-PP	O
sterile	sterile	JJ	B-NP	O
water	water	NN	I-NP	O
(	(	(	O	O
ZnO	ZnO	NN	B-NP	B-protein
+	+	SYM	O	O
H2O	H2O	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Calcium	Calcium	NN	B-NP	O
hydroxide	hydroxide	NN	I-NP	O
mixed	mix	VBN	B-VP	O
with	with	IN	B-PP	O
sterile	sterile	JJ	B-NP	O
water	water	NN	I-NP	O
(	(	(	O	O
Ca	Ca	NN	B-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
H2O	H2O	NN	I-NP	B-protein
)	)	)	O	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Vitapex	Vitapex	NNP	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Vaseline	Vaseline	NN	B-NP	O
(	(	(	O	O
control	control	NN	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
test	test	NN	I-NP	O
bacteria	bacteria	NNS	I-NP	O
represented	represent	VBD	B-VP	O
species	specie	NNS	B-NP	O
commonly	commonly	RB	B-VP	O
isolated	isolate	VBN	I-VP	O
from	from	IN	B-PP	O
nonvital	nonvital	JJ	B-NP	O
primary	primary	JJ	I-NP	O
and	and	CC	I-NP	O
permanent	permanent	JJ	I-NP	O
tooth	tooth	JJ	I-NP	O
root	root	NN	I-NP	O
canals	canal	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
effectiveness	effectiveness	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
materials	material	NNS	I-NP	O
was	be	VBD	B-VP	O
divided	divide	VBN	I-VP	O
into	into	IN	B-PP	O
five	five	CD	B-NP	O
groups	group	NNS	I-NP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
diameters	diameter	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
zones	zone	NNS	I-NP	O
of	of	IN	B-PP	O
inhibition	inhibition	NN	B-NP	O
against	against	IN	B-PP	O
all	all	DT	B-NP	O
test	test	NN	I-NP	O
bacteria	bacteria	NNS	I-NP	O
and	and	CC	O	O
distribution	distribution	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
data	datum	NNS	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
materials	material	NNS	I-NP	O
except	except	IN	B-PP	O
Vaseline	Vaseline	NNP	B-NP	O
showed	show	VBD	B-VP	O
antimicrobial	antimicrobial	JJ	B-NP	O
activity	activity	NN	I-NP	O
against	against	IN	B-PP	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
21	21	CD	I-NP	O
organisms	organism	NNS	I-NP	O
.	.	.	O	O

Generally	Generally	RB	B-ADVP	O
,	,	,	O	O
all	all	DT	B-NP	O
materials	material	NNS	I-NP	O
inhibited	inhibit	VBD	B-VP	O
gram-negative	gram-negative	JJ	B-NP	O
anaerobic	anaerobic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
more	more	RBR	B-ADVP	O
effectively	effectively	RB	I-ADVP	O
than	than	IN	B-PP	O
aerotolerant	aerotolerant	JJ	B-NP	O
gram-negative	gram-negative	JJ	I-NP	O
or	or	CC	I-NP	O
gram-positive	gram-positive	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

Materials	Material	NNS	B-NP	O
containing	contain	VBG	B-VP	O
CPC	CPC	NN	B-NP	B-protein
or	or	CC	I-NP	O
FC	FC	NN	I-NP	O
(	(	(	O	O
except	except	IN	B-PP	O
Kri	Kri	NNP	B-NP	O
paste	paste	NN	I-NP	O
)	)	)	O	O
produced	produce	VBD	B-VP	O
strong	strong	JJ	B-NP	O
or	or	CC	I-NP	O
medium	medium	JJ	I-NP	O
strong	strong	JJ	I-NP	O
inhibition	inhibition	NN	I-NP	O
against	against	IN	B-PP	O
most	most	JJS	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

CHX	CHX	NN	B-NP	B-protein
+	+	SYM	I-NP	O
ZOE	ZOE	NNP	I-NP	O
,	,	,	O	O
Kri	Kri	NNP	B-NP	O
paste	paste	NN	I-NP	O
,	,	,	O	O
ZnO	ZnO	NN	B-NP	B-protein
+	+	SYM	I-NP	O
H2O	H2O	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
ZOE	ZOE	NN	B-NP	B-protein
inhibited	inhibit	VBD	B-VP	O
all	all	DT	B-NP	O
or	or	CC	O	O
most	most	JJS	B-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	B-PP	O
but	but	CC	I-PP	O
to	to	TO	B-PP	O
lesser	less	JJR	B-NP	O
extent	extent	NN	I-NP	O
than	than	IN	B-PP	O
CPC	CPC	NN	B-NP	B-protein
+	+	SYM	O	O
Ca	Ca	NN	B-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2	2	CD	B-NP	O
,	,	,	O	O
CPC	CPC	NN	B-NP	B-protein
+	+	SYM	B-NP	O
ZnO	ZnO	NN	I-NP	B-protein
,	,	,	O	O
or	or	CC	O	O
FC	FC	NN	B-NP	O
+	+	SYM	B-NP	O
ZOE	ZOE	NN	I-NP	O
.	.	.	O	O

Ca	Ca	NN	B-NP	O
(	(	(	O	O
OH	OH	NN	B-NP	O
)	)	)	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
H2O	H2O	NN	I-NP	O
,	,	,	O	O
Vitapex	Vitapex	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Vaseline	Vaseline	NNP	B-NP	O
generally	generally	RB	B-ADVP	O
were	be	VBD	B-VP	O
nonihibitory	nonihibitory	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
findings	finding	NNS	I-NP	O
should	should	MD	B-VP	O
allow	allow	VB	I-VP	O
a	a	DT	B-NP	O
comparative	comparative	JJ	I-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
antimicrobial	antimicrobial	JJ	B-NP	O
effectiveness	effectiveness	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
made	make	VBN	I-VP	O
of	of	IN	B-PP	O
materials	material	NNS	B-NP	O
commonly	commonly	RB	B-VP	O
used	use	VBN	I-VP	O
in	in	IN	B-PP	O
pulpectomy	pulpectomy	NN	B-NP	O
procedures	procedure	NNS	I-NP	O
with	with	IN	B-PP	O
primary	primary	JJ	B-NP	O
teeth	tooth	NNS	I-NP	O
.	.	.	O	O

Extra	Extra	NNP	B-NP	O
Parotid	Parotid	NNP	I-NP	O
Glycoprotein	Glycoprotein	NN	I-NP	B-protein
(	(	(	O	O
EP-GP	EP-GP	NN	B-NP	B-protein
)	)	)	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
glycoprotein	glycoprotein	NN	I-NP	B-protein
isolated	isolate	VBN	B-VP	O
from	from	IN	B-PP	O
human	human	JJ	B-NP	O
saliva	saliva	NN	I-NP	O
,	,	,	O	O
having	have	VBG	B-VP	O
homologues	homologue	NNS	B-NP	O
in	in	IN	B-PP	O
several	several	JJ	B-NP	O
other	other	JJ	I-NP	O
body	body	NN	I-NP	O
fluids	fluid	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
biological	biological	JJ	I-NP	O
role	role	NN	I-NP	O
of	of	IN	B-PP	O
EP-GP	EP-GP	NN	B-NP	B-protein
and	and	CC	O	O
its	its	PRP$	B-NP	O
homologues	homologue	NNS	I-NP	O
is	be	VBZ	B-VP	O
unknown	unknown	JJ	B-ADJP	O
.	.	.	O	O

Recently	Recently	RB	B-ADVP	O
,	,	,	O	O
EP-GP	EP-GP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
bind	bind	VB	I-VP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
bacterium	bacterium	NN	I-NP	B-protein
Streptococcus	Streptococcus	NNP	I-NP	I-protein
salivarius	salivarius	NN	I-NP	I-protein
HB	HB	NN	I-NP	I-protein
.	.	.	O	O

In	In	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
binding	binding	NN	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
oral	oral	JJ	I-NP	O
microorganisms	microorganism	NNS	I-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
demonstrated	demonstrate	VBN	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
determined	determine	VBN	I-VP	O
whether	whether	IN	B-SBAR	O
binding	binding	NN	B-NP	O
of	of	IN	B-PP	O
EP-GP	EP-GP	NN	B-NP	B-protein
to	to	TO	B-PP	O
bacteria	bacteria	NNS	B-NP	O
occurs	occur	VBZ	B-VP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
other	other	JJ	B-NP	O
EP-GP	EP-GP	NN	I-NP	B-protein
containing	contain	VBG	B-VP	O
body	body	NN	B-NP	O
fluids	fluid	NNS	I-NP	O
.	.	.	O	O

Therefore	Therefore	RB	B-ADVP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
EP-GP	EP-GP	NN	B-NP	B-protein
on	on	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
by	by	IN	B-PP	O
analyzing	analyze	VBG	B-VP	O
oral	oral	JJ	B-NP	O
,	,	,	I-NP	O
skin	skin	NN	I-NP	O
and	and	CC	I-NP	O
ear	ear	JJ	I-NP	O
floras	flora	NNS	I-NP	O
by	by	IN	B-PP	O
confocal	confocal	JJ	B-NP	O
fluoresence	fluoresence	NN	I-NP	O
microscopy	microscopy	NN	I-NP	O
using	use	VBG	B-VP	O
specific	specific	JJ	B-NP	B-protein
antibodies	antibody	NNS	I-NP	I-protein
.	.	.	O	O

About	About	RB	B-NP	O
12	12	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
in	in	FW	I-NP	O
vivo	vivo	FW	I-NP	O
oral	oral	JJ	I-NP	O
flora	flora	NN	I-NP	O
had	have	VBD	B-VP	O
EP-GP	EP-GP	NN	B-NP	B-protein
present	present	JJ	B-ADJP	O
on	on	IN	B-PP	O
their	their	PRP$	B-NP	O
surface	surface	NN	I-NP	O
,	,	,	O	O
while	while	IN	B-SBAR	O
approximately	approximately	RB	B-NP	O
5	5	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
from	from	IN	B-PP	O
ear	ear	NN	B-NP	O
canal	canal	NN	I-NP	O
or	or	CC	I-NP	O
skin	skin	NN	I-NP	O
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
EP-GP	EP-GP	NN	B-NP	B-protein
.	.	.	O	O

IgA	IgA	NN	B-NP	B-protein
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
on	on	IN	B-PP	O
approximately	approximately	RB	B-NP	O
65	65	CD	I-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
salivary	salivary	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
whereas	whereas	IN	O	O
the	the	DT	B-NP	O
high-molecular	high-molecular	JJ	I-NP	O
weight	weight	NN	I-NP	O
mucin	mucin	NN	I-NP	O
(	(	(	O	O
MG1	MG1	NN	B-NP	B-protein
)	)	)	O	O
and	and	CC	O	O
cystatin	cystatin	NN	B-NP	B-DNA
C	C	NN	I-NP	I-DNA
were	be	VBD	B-VP	O
not	not	RB	O	O
detectable	detectable	JJ	B-ADJP	O
on	on	IN	B-PP	O
any	any	DT	B-NP	O
oral	oral	JJ	I-NP	O
bacterium	bacterium	NN	I-NP	O
.	.	.	O	O

Using	Use	VBG	B-VP	O
a	a	DT	B-NP	O
replica-plate	replica-plate	JJ	I-NP	O
assay	assay	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
EP-GP	EP-GP	NN	B-NP	B-protein
binding	binding	NN	I-NP	I-protein
strains	strain	NNS	I-NP	I-protein
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
were	be	VBD	B-VP	O
isolated	isolate	VBN	I-VP	O
and	and	CC	O	O
identified	identify	VBN	B-VP	O
as	as	IN	B-PP	O
Gemella	Gemella	NN	B-NP	O
haemolysans	haemolysan	NNS	I-NP	O
,	,	,	O	O
Gemella	Gemella	NN	B-NP	O
morbillorium	morbillorium	NN	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
acidominimus	acidominimus	NNP	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
oralis	oralis	NNP	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
salivarius	salivarius	NNP	I-NP	O
and	and	CC	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
parasanguis	parasanguis	NNP	I-NP	O
.	.	.	O	O

Bacteria	Bacteria	NNS	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
ear	ear	JJ	I-NP	O
canal	canal	NN	I-NP	O
and	and	CC	I-NP	O
skin	skin	NN	I-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
identified	identify	VBN	I-VP	O
as	as	IN	B-PP	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
hominis	hominis	NNP	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
EP-GP	EP-GP	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
selectively	selectively	RB	I-VP	O
bound	bind	VBN	I-VP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
to	to	TO	B-PP	O
several	several	JJ	B-NP	O
oral	oral	JJ	I-NP	O
and	and	CC	I-NP	O
non-oral	non-oral	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
purpose	purpose	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
the	the	DT	B-NP	O
prevalence	prevalence	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
microbiota	microbiota	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
mucosal	mucosal	JJ	I-NP	O
surfaces	surface	NNS	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
peri-implant	peri-implant	JJ	I-NP	O
pocket	pocket	NN	I-NP	O
in	in	IN	B-PP	O
edentulous	edentulous	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
past	past	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
periodontitis	periodontitis	NN	B-NP	O
.	.	.	O	O

Twenty	Twenty	CD	B-NP	O
edentulous	edentulous	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
wearing	wear	VBG	B-VP	O
dental	dental	JJ	B-NP	O
implants	implant	NNS	I-NP	O
for	for	IN	B-PP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
one	one	CD	I-NP	O
year	year	NN	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
periodontitis	periodontitis	NN	B-NP	O
participated	participate	VBD	B-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

Clinical	Clinical	JJ	B-NP	O
parameters	parameter	NNS	I-NP	O
were	be	VBD	B-VP	O
assessed	assess	VBN	I-VP	O
(	(	(	O	O
plaque	plaque	NN	B-NP	O
,	,	,	O	O
redness	redness	NN	B-NP	O
,	,	,	O	O
swelling	swelling	NN	B-NP	O
,	,	,	O	O
peri-implant	peri-implant	JJ	B-NP	O
probing	probing	NN	I-NP	O
depth	depth	NN	I-NP	O
[	[	(	O	O
PIPD	PIPD	NN	B-NP	O
]	]	)	O	O
,	,	,	O	O
and	and	CC	O	O
bleeding	bleed	VBG	B-VP	O
on	on	IN	B-PP	O
probing	probing	NN	B-NP	O
)	)	)	O	O
and	and	CC	O	O
microbiological	microbiological	JJ	B-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
(	(	(	O	O
oral	oral	JJ	B-NP	O
mucosal	mucosal	JJ	I-NP	O
surfaces	surface	NNS	I-NP	O
,	,	,	O	O
saliva	saliva	NN	B-NP	O
,	,	,	O	O
plaque	plaque	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
peri-implant	peri-implant	JJ	B-NP	O
pocket	pocket	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Based	Base	VBN	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
results	result	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
group	group	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
whole	whole	NN	I-NP	O
showed	show	VBD	B-VP	O
healthy	healthy	JJ	B-NP	O
peri-implant	peri-implant	JJ	I-NP	O
tissues	tissue	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
mean	mean	JJ	I-NP	O
PIPD	PIPD	NN	I-NP	O
of	of	IN	B-PP	O
3.6	3.6	CD	B-NP	O
mm	mm	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
statistically	statistically	RB	I-NP	O
significant	significant	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
PIPD	PIPD	NN	I-NP	O
and	and	CC	O	O
bleeding	bleed	VBG	B-VP	O
upon	upon	IN	B-PP	O
probing	probing	NN	B-NP	O
,	,	,	O	O
plaque	plaque	NN	B-NP	O
scores	score	NNS	I-NP	O
,	,	,	O	O
redness	redness	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
swelling	swelling	NN	B-NP	O
.	.	.	O	O

Actinobacillus	Actinobacillus	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
and	and	CC	O	O
Porphyromonas	Porphyromonas	NN	B-NP	O
gingivalis	gingivali	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
detected	detect	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
subjects	subject	NNS	I-NP	O
harboring	harbor	VBG	B-VP	O
Prevotella	Prevotella	NN	B-NP	O
intermedia	intermedia	NNS	I-NP	O
showed	show	VBD	B-VP	O
presence	presence	NN	B-NP	O
of	of	IN	B-PP	O
PIPD	PIPD	NN	B-NP	O
of	of	IN	B-PP	O
>	>	SYM	B-NP	O
or	or	CC	O	O
=	=	SYM	B-VP	O
5	5	CD	B-NP	O
mm	mm	NN	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
subjects	subject	NNS	I-NP	O
harbored	harbor	VBD	B-VP	O
Peptostreptococcus	Peptostreptococcus	NNP	B-NP	O
spp.	spp.	NNP	I-NP	O
,	,	,	O	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
spp.	spp.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
other	other	JJ	B-NP	O
Prevotella	Prevotella	NN	I-NP	B-protein
species	specie	NNS	I-NP	I-protein
.	.	.	O	O

Actinomyces	Actinomyce	NNS	B-NP	O
odontolyticus	odontolyticus	NN	I-NP	O
,	,	,	O	O
Bacteroides	Bacteroide	NNS	B-NP	O
forsythus	forsythus	RB	B-ADVP	O
,	,	,	O	O
Campylobacter	Campylobacter	NNP	B-NP	O
rectus	rectus	NNP	I-NP	O
,	,	,	O	O
Pseudomonas	Pseudomonas	NNP	B-NP	O
spp.	spp.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
enterobacteria	enterobacteria	NNS	B-NP	O
were	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
less	less	RBR	B-ADVP	O
frequently	frequently	RB	I-ADVP	O
.	.	.	O	O

Three	Three	CD	B-NP	O
subjects	subject	NNS	I-NP	O
showed	show	VBD	B-VP	O
signs	sign	NNS	B-NP	O
of	of	IN	B-PP	O
overt	overt	JJ	B-NP	O
soft	soft	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
inflammation	inflammation	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
harbored	harbor	VBD	B-VP	O
higher	high	JJR	B-NP	O
proportions	proportion	NNS	I-NP	O
of	of	IN	B-PP	O
Peptostreptococcus	Peptostreptococcus	NN	B-NP	B-protein
spp	spp	NN	I-NP	I-protein
.	.	.	O	O

than	than	IN	B-PP	O
the	the	DT	B-NP	O
other	other	JJ	I-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
corroborate	corroborate	VBP	B-VP	O
the	the	DT	B-NP	O
suggestion	suggestion	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
colonization	colonization	NN	B-NP	O
for	for	IN	B-PP	O
dental	dental	JJ	B-NP	O
implants	implant	NNS	I-NP	O
in	in	IN	B-PP	O
edentulous	edentulous	JJ	B-NP	O
patients	patient	NNS	I-NP	O
are	be	VBP	B-VP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
mucous	mucous	JJ	I-NP	O
membranes	membrane	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
microbiota	microbiota	NN	I-NP	O
of	of	IN	B-PP	O
subjects	subject	NNS	B-NP	O
wearing	wear	VBG	B-VP	O
dental	dental	JJ	B-NP	O
implants	implant	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
past	past	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
periodontitis	periodontitis	NN	B-NP	O
are	be	VBP	B-VP	O
composed	compose	VBN	I-VP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
healthy	healthy	JJ	I-NP	O
periodontium	periodontium	NN	I-NP	O
or	or	CC	I-NP	O
gingivitis	gingivitis	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
suggested	suggest	VBN	I-VP	O
that	that	IN	B-SBAR	O
elimination	elimination	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
subgingival	subgingival	JJ	I-NP	O
environment	environment	NN	I-NP	O
by	by	IN	B-PP	O
extraction	extraction	NN	B-NP	O
of	of	IN	B-PP	O
all	all	DT	B-NP	O
natural	natural	JJ	I-NP	O
teeth	teeth	NN	I-NP	O
probably	probably	RB	B-ADVP	O
initiates	initiate	VBZ	B-VP	O
the	the	DT	B-NP	O
disappearance	disappearance	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
periodonta	periodonta	NN	I-NP	O
bacteria	bacteria	NNS	I-NP	O
A.	A.	NN	I-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
and	and	CC	O	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
.	.	.	O	O

Various	Various	JJ	B-NP	O
oral	oral	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
species	specie	NNS	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
inhibit	inhibit	VB	I-VP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
Helicobacter	Helicobacter	NN	B-NP	B-protein
pylori	pylori	NN	I-NP	I-protein
strains	strain	NNS	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
growth	growth	NN	I-NP	O
inhibitory	inhibitory	JJ	I-NP	O
activities	activity	NNS	I-NP	O
of	of	IN	B-PP	O
most	most	JJS	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
adversely	adversely	RB	I-VP	O
affected	affect	VBN	I-VP	O
by	by	IN	B-PP	O
heating	heat	VBG	B-VP	O
at	at	IN	B-PP	O
80	80	CD	B-NP	O
degrees	degree	NNS	I-NP	O
C	C	JJ	B-ADJP	O
for	for	IN	B-PP	O
60	60	CD	B-NP	O
min	min	NN	I-NP	O
or	or	CC	B-PP	O
by	by	IN	B-PP	O
protease	protease	NN	B-NP	B-protein
treatment	treatment	NN	I-NP	O
,	,	,	O	O
indicating	indicate	VBG	B-VP	O
that	that	IN	B-SBAR	O
these	these	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
produce	produce	VBP	B-VP	O
bacteriocin-like	bacteriocin-like	JJ	B-NP	B-protein
inhibitory	inhibitory	JJ	I-NP	I-protein
proteins	protein	NNS	I-NP	I-protein
against	against	IN	B-PP	O
H.	H.	NN	B-NP	O
pylori	pylori	NN	I-NP	O
strains	strain	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
antagonistic	antagonistic	JJ	I-NP	O
effects	effect	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
against	against	IN	B-PP	O
H.	H.	NN	B-NP	O
pylori	pylori	NN	I-NP	O
may	may	MD	B-VP	O
restrain	restrain	VB	I-VP	O
colonization	colonization	NN	B-NP	O
by	by	IN	B-PP	O
this	this	DT	B-NP	O
organism	organism	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

Halitosis	Halitosis	NN	B-NP	O
is	be	VBZ	B-VP	O
most	most	RBS	I-VP	O
often	often	RB	I-VP	O
caused	cause	VBN	I-VP	O
by	by	IN	B-PP	O
oral	oral	JJ	B-NP	O
conditions	condition	NNS	I-NP	O
.	.	.	O	O

Volatile	Volatile	JJ	B-NP	O
sulfur	sulfur	NN	I-NP	O
compounds	compound	NNS	I-NP	O
(	(	(	O	O
VSC	VSC	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
constituting	constitute	VBG	B-VP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
components	component	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
malodor	malodor	NN	I-NP	O
,	,	,	O	O
are	be	VBP	B-VP	O
produced	produce	VBN	I-VP	O
by	by	IN	B-PP	O
anaerobic	anaerobic	JJ	B-NP	O
,	,	,	I-NP	O
gram-negative	gram-negative	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
retained	retain	VBD	B-VP	O
mainly	mainly	RB	B-ADVP	O
in	in	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
pockets	pocket	NNS	I-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
tongue	tongue	NN	I-NP	O
dorsum	dorsum	NN	I-NP	O
.	.	.	O	O

Sulfur-containing	Sulfur-containing	JJ	B-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
serve	serve	VBP	B-VP	O
as	as	IN	B-PP	O
substrate	substrate	NN	B-NP	O
for	for	IN	B-PP	O
these	these	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

VSC	VSC	NNS	B-NP	B-cell_type
have	have	VBP	B-VP	O
also	also	RB	I-VP	O
been	be	VBN	I-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
unfavorable	unfavorable	JJ	B-NP	O
effect	effect	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
tissue	tissue	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
examine	examine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
normal	normal	JJ	B-NP	O
,	,	,	I-NP	O
healthy	healthy	JJ	I-NP	O
individuals	individual	NNS	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
halitosis	halitosis	NN	B-NP	O
were	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
produce	produce	VB	I-VP	O
VSC	VSC	NNP	B-NP	B-cell_type
from	from	IN	B-PP	O
cysteine	cysteine	NN	B-NP	O
,	,	,	O	O
when	when	WRB	B-ADVP	O
applied	apply	VBN	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
mouthrinse	mouthrinse	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
further	further	JJ	I-NP	O
aim	aim	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
investigate	investigate	VB	I-VP	O
and	and	CC	I-VP	O
compare	compare	VB	I-VP	O
the	the	DT	B-NP	O
potential	potential	NN	I-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
Sulfur-containing	Sulfur-containing	JJ	I-NP	O
amino	amino	NN	I-NP	O
acids	acid	NNS	I-NP	O
and	and	CC	O	O
peptides	peptide	NNS	B-NP	O
as	as	IN	B-PP	O
substrates	substrate	NNS	B-NP	O
for	for	IN	B-PP	O
oral	oral	JJ	B-NP	O
VSC	VSC	NN	I-NP	O
production	production	NN	I-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
localize	localize	VB	I-VP	O
the	the	DT	B-NP	O
odor-production	odor-production	NN	I-NP	B-DNA
sites	site	NNS	I-NP	I-DNA
.	.	.	O	O

A	A	DT	B-NP	O
portable	portable	JJ	I-NP	O
sulfide	sulfide	NN	I-NP	O
monitor	monitor	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
for	for	IN	B-PP	O
VSC	VSC	NN	B-NP	O
registration	registration	NN	I-NP	O
.	.	.	O	O

Results	Result	NNS	B-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
all	all	DT	B-NP	O
test	test	NN	I-NP	O
subjects	subject	NNS	I-NP	O
produced	produce	VBD	B-VP	O
high	high	JJ	B-NP	O
oral	oral	JJ	I-NP	O
concentrations	concentration	NNS	I-NP	O
of	of	IN	B-PP	O
VSC	VSC	NN	B-NP	B-protein
upon	upon	IN	B-PP	O
rinses	rinse	NNS	B-NP	O
with	with	IN	B-PP	O
cysteine	cysteine	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
thus	thus	RB	B-ADVP	O
seems	seem	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
major	major	JJ	I-NP	O
substrate	substrate	NN	I-NP	O
for	for	IN	B-PP	O
VSC	VSC	NN	B-NP	B-protein
production	production	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
other	other	JJ	I-NP	O
sulfur-containing	sulfur-containing	JJ	I-NP	O
substrates	substrate	NNS	I-NP	O
had	have	VBD	B-VP	O
much	much	RB	B-NP	O
less	less	JJR	I-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
tongue	tongue	NN	I-NP	O
was	be	VBD	B-VP	O
the	the	DT	B-NP	O
major	major	JJ	I-NP	O
site	site	NN	I-NP	O
for	for	IN	B-PP	O
VSC	VSC	NN	B-NP	B-protein
production	production	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
saliva	saliva	FW	B-NP	O
per	per	FW	I-NP	O
se	se	NN	I-NP	O
caused	cause	VBD	B-VP	O
low	low	JJ	B-NP	O
VSC	VSC	NN	I-NP	O
production	production	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
of	of	IN	B-PP	O
denture	denture	NN	B-NP	O
stomatitis	stomatitis	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
desirable	desirable	JJ	B-ADJP	O
to	to	TO	B-VP	O
inhibit	inhibit	VB	I-VP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
causative	causative	JJ	I-NP	O
organism	organism	NN	I-NP	O
,	,	,	O	O
Candida	Candida	NNP	B-NP	O
albicans	albicans	NNP	I-NP	O
,	,	,	O	O
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
other	other	JJ	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
closely	closely	RB	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

Three	Three	CD	B-NP	O
synthetic	synthetic	JJ	I-NP	O
anti-candidal	anti-candidal	JJ	I-NP	O
chalcones	chalcone	NNS	I-NP	O
were	be	VBD	B-VP	O
characterized	characterize	VBN	I-VP	O
and	and	CC	O	O
compared	compare	VBN	B-VP	O
for	for	IN	B-PP	O
their	their	PRP$	B-NP	O
additional	additional	JJ	I-NP	O
activity	activity	NN	I-NP	O
in	in	IN	B-PP	O
inhibiting	inhibit	VBG	B-VP	O
these	these	DT	B-NP	O
causative	causative	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

Among	Among	IN	B-PP	O
the	the	DT	B-NP	O
tested	test	VBN	I-NP	O
chalcones	chalcone	NNS	I-NP	O
,	,	,	O	O
2,4,2'-trihydroxy-5'-methylchalcone	2,4,2'-trihydroxy-5'-methylchalcone	NN	B-NP	O
showed	show	VBD	B-VP	O
the	the	DT	B-NP	O
highest	high	JJS	I-NP	O
activity	activity	NN	I-NP	O
for	for	IN	B-PP	O
different	different	JJ	B-NP	O
Gram-positive	Gram-positive	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
inhibited	inhibit	VBD	B-VP	O
the	the	DT	B-NP	O
growth	growth	NN	I-NP	O
of	of	IN	B-PP	O
streptococci	streptococci	NNS	B-NP	O
,	,	,	I-NP	O
staphylococci	staphylococci	NNS	I-NP	O
and	and	CC	I-NP	O
lactobacilli	lactobacillus	NNS	I-NP	O
at	at	IN	B-PP	O
25.0-50.0	25.0-50.0	CD	B-NP	O
micrograms/mL	micrograms/mL	NNS	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
lower	low	JJR	B-ADJP	O
than	than	IN	B-PP	O
or	or	CC	O	O
comparable	comparable	JJ	B-ADJP	O
to	to	TO	B-PP	O
its	its	PRP$	B-NP	O
minimum	minimum	JJ	I-NP	O
inhibitory	inhibitory	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
for	for	IN	B-PP	O
candida	candida	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
functioned	function	VBD	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
bactericidal	bactericidal	JJ	I-NP	O
action	action	NN	I-NP	O
and	and	CC	O	O
leaked	leak	VBD	B-VP	O
260	260	CD	B-NP	O
nm-absorbing	nm-absorbing	JJ	I-NP	O
substances	substance	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
streptococcal	streptococcal	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
.	.	.	O	O

The	The	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
activity	activity	NN	I-NP	O
of	of	IN	B-PP	O
2,4,2'-trihydroxy-5'-methylchalcone	2,4,2'-trihydroxy-5'-methylchalcone	NN	B-NP	O
against	against	IN	B-PP	O
both	both	CC	O	O
primary	primary	JJ	B-NP	O
and	and	CC	I-NP	O
secondary	secondary	JJ	I-NP	O
causative	causative	JJ	I-NP	O
agents	agent	NNS	I-NP	O
suggests	suggest	VBZ	B-VP	O
it	it	PRP	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
useful	useful	JJ	B-ADJP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
potent	potent	JJ	I-NP	O
therapeutic	therapeutic	JJ	I-NP	O
agent	agent	NN	I-NP	O
in	in	IN	B-PP	O
denture	denture	NN	B-NP	O
stomatitis	stomatitis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
objective	objective	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
60-day	60-day	JJ	I-NP	O
single-blind	single-blind	JJ	I-NP	O
,	,	,	I-NP	O
parallel	parallel	JJ	I-NP	O
trial	trial	NN	I-NP	O
,	,	,	O	O
using	use	VBG	B-VP	O
150	150	CD	B-NP	O
subjects	subject	NNS	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
the	the	DT	B-NP	O
effect	effect	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
20	20	CD	I-NP	O
%	%	NN	I-NP	O
sodium	sodium	NN	I-NP	O
bicarbonate	bicarbonate	NN	I-NP	O
dentifrice	dentifrice	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
1.5	1.5	CD	I-NP	O
%	%	NN	I-NP	O
hydrogen	hydrogen	NN	I-NP	O
peroxide	peroxide	NN	I-NP	O
solution	solution	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
mouth	mouth	NN	I-NP	O
moisturizer	moisturizer	NN	I-NP	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	O
tissues	tissue	NNS	I-NP	O
and	and	CC	I-NP	O
microflora	microflora	NNS	I-NP	O
.	.	.	O	O

Subjects	Subject	NNS	B-NP	O
were	be	VBD	B-VP	O
randomly	randomly	RB	I-VP	O
assigned	assign	VBN	I-VP	O
to	to	TO	B-PP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
five	five	CD	B-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
treatments	treatment	NNS	I-NP	O
were	be	VBD	B-VP	O
:	:	:	O	O
1	1	LS	B-LST	O
)	)	)	O	O
Sage	Sage	NN	B-NP	O
dentifrice	dentifrice	NN	I-NP	O
(	(	(	O	O
sodium	sodium	NN	B-NP	O
bicarbonate	bicarbonate	NN	I-NP	O
)	)	)	O	O
.	.	.	O	O

Toothette	Toothette	NNP	B-NP	O
Plus	Plus	NNP	I-NP	O
containing	contain	VBG	B-VP	O
baking	bake	VBG	B-NP	O
soda	soda	NN	I-NP	O
saturated	saturate	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
hydrogen	hydrogen	NN	I-NP	O
peroxide	peroxide	NN	I-NP	O
solution	solution	NN	I-NP	O
and	and	CC	I-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
mouth	mouth	NN	I-NP	O
moisturizer	moisturizer	NN	I-NP	O
,	,	,	O	O
2	2	LS	B-LST	O
)	)	)	O	O
Crest	Crest	NN	B-NP	O
dentifrice	dentifrice	NN	I-NP	O
,	,	,	O	O
Toothette	Toothette	NNP	B-NP	O
Plus	Plus	NNP	I-NP	O
containing	contain	VBG	B-VP	O
baking	bake	VBG	B-NP	O
soda	soda	NN	I-NP	O
saturated	saturate	VBN	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
hydrogen	hydrogen	NN	I-NP	O
peroxide	peroxide	NN	I-NP	O
solution	solution	NN	I-NP	O
and	and	CC	I-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
mouth	mouth	NN	I-NP	O
moisturizer	moisturizer	NN	I-NP	O
,	,	,	O	O
3	3	LS	B-LST	O
)	)	)	O	O
Crest	Crest	NN	B-NP	O
dentifrice	dentifrice	NN	I-NP	O
,	,	,	O	O
Toothette	Toothette	NNP	B-NP	O
Plus	Plus	NNP	I-NP	O
containing	contain	VBG	B-VP	O
baking	bake	VBG	B-VP	O
soda	soda	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
control	control	NN	I-NP	O
solution	solution	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
mouth	mouth	NN	I-NP	O
moisturizer	moisturizer	NN	I-NP	O
,	,	,	O	O
4	4	CD	B-NP	O
)	)	)	O	O
Crest	Crest	NN	B-NP	O
dentifrice	dentifrice	NN	I-NP	O
,	,	,	O	O
Toothette	Toothette	NNP	B-NP	O
(	(	(	O	O
without	without	IN	B-PP	O
baking	bake	VBG	B-VP	O
soda	soda	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
saturated	saturate	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
control	control	NN	I-NP	O
solution	solution	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
mouth	mouth	NN	I-NP	O
moisturizer	moisturizer	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
5	5	CD	B-NP	O
)	)	)	O	O
Crest	Crest	NN	B-NP	O
dentifrice	dentifrice	NN	I-NP	O
,	,	,	O	O
Toothette	Toothette	NNP	B-NP	O
saturated	saturate	VBD	B-VP	O
with	with	IN	B-PP	O
1.5	1.5	CD	B-NP	O
%	%	NN	I-NP	O
flavored	flavored	JJ	I-NP	O
H2O2	H2O2	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
mouth	mouth	NN	I-NP	O
moisturizer	moisturizer	NN	I-NP	O
.	.	.	O	O

From	From	IN	B-PP	O
a	a	DT	B-NP	O
subgroup	subgroup	NN	I-NP	O
of	of	IN	B-PP	O
35	35	CD	B-NP	O
patients	patient	NNS	I-NP	O
(	(	(	O	O
seven	seven	CD	B-NP	O
from	from	IN	B-PP	O
each	each	DT	B-NP	O
group	group	NN	I-NP	O
)	)	)	O	O
buccal	buccal	JJ	B-NP	O
smears	smear	NNS	I-NP	O
for	for	IN	B-PP	O
exfoliative	exfoliative	JJ	B-NP	O
cytology	cytology	NN	I-NP	O
were	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
as	as	IN	B-SBAR	O
were	be	VBD	B-VP	O
supragingival	supragingival	JJ	B-NP	O
microbiological	microbiological	JJ	I-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
mesial	mesial	JJ	I-NP	O
aspect	aspect	NN	I-NP	O
of	of	IN	B-PP	O
first	first	JJ	B-NP	O
molars	molar	NNS	I-NP	O
(	(	(	O	O
pooled	pool	VBN	B-VP	O
)	)	)	O	O
.	.	.	O	O

Buccal	Buccal	JJ	B-NP	O
smears	smear	NNS	I-NP	O
were	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
for	for	IN	B-PP	O
signs	sign	NNS	B-NP	O
of	of	IN	B-PP	O
histopathological	histopathological	JJ	B-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Microbiological	Microbiological	JJ	B-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
supra-	supra-	JJ	B-NP	O
and	and	CC	I-NP	O
subgingival	subgingival	JJ	I-NP	O
plaque	plaque	NN	I-NP	O
for	for	IN	B-PP	O
P.	P.	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
P.	P.	NNP	B-NP	O
intermedia	intermedia	NNS	I-NP	O
,	,	,	O	O
A.	A.	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
viscosus	viscosus	NN	I-NP	O
,	,	,	O	O
F.	F.	NNP	B-NP	O
nucleatum	nucleatum	NNP	I-NP	O
,	,	,	O	O
F.	F.	NNP	B-NP	O
sanguis	sanguis	NN	I-NP	O
and	and	CC	I-NP	O
C.	C.	NN	I-NP	O
albicans	albican	NNS	I-NP	O
were	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
.	.	.	O	O

Clinical	Clinical	JJ	B-NP	O
parameters	parameter	NNS	I-NP	O
measured	measure	VBN	B-VP	O
were	be	VBD	B-VP	O
a	a	DT	B-NP	O
stain	stain	NN	I-NP	O
index	index	NN	I-NP	O
(	(	(	O	O
SI	SI	NN	B-NP	O
)	)	)	O	O
,	,	,	O	O
the	the	DT	B-NP	O
modified	modify	VBN	I-NP	O
gingival	gingival	JJ	I-NP	O
index	index	NN	I-NP	O
(	(	(	O	O
MGI	MGI	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
plaque	plaque	NN	I-NP	O
index	index	NN	I-NP	O
(	(	(	O	O
PI	PI	NN	B-NP	B-protein
)	)	)	O	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
adverse	adverse	JJ	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microflora	microflora	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
anaplastic	anaplastic	JJ	I-NP	O
or	or	CC	I-NP	O
other	other	JJ	I-NP	O
pathological	pathological	JJ	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
any	any	DT	B-NP	O
subjects	subject	NNS	I-NP	O
.	.	.	O	O

Clinical	Clinical	JJ	B-NP	O
parameters	parameter	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
statistically	statistically	RB	I-NP	O
significant	significant	JJ	I-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
MGI	MGI	NN	I-NP	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
26.7-29.9	26.7-29.9	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
differences	difference	NNS	I-NP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
groups	group	NNS	I-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
>	>	SYM	O	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
PI	PI	NN	I-NP	B-DNA
showed	show	VBD	B-VP	O
small	small	JJ	B-NP	O
reductions	reduction	NNS	I-NP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
groups	group	NNS	I-NP	O
except	except	IN	B-PP	O
group	group	NN	B-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
differences	difference	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	O	O
statistically	statistically	RB	B-ADJP	O
significant	significant	JJ	I-ADJP	O
from	from	IN	B-PP	O
each	each	DT	B-NP	O
other	other	JJ	I-NP	O
or	or	CC	O	O
baseline	baseline	NN	B-NP	O
(	(	(	O	O
p	p	NN	B-NP	O
>	>	SYM	O	O
0.05	0.05	CD	B-NP	O
)	)	)	O	O
.	.	.	O	O

The	The	DT	B-NP	O
SI	SI	NNP	I-NP	O
revealed	reveal	VBD	B-VP	O
slight	slight	JJ	B-NP	O
increases	increase	NNS	I-NP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
groups	group	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
differences	difference	NNS	I-NP	O
among	among	IN	B-PP	O
the	the	DT	B-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
concluded	conclude	VBN	I-VP	O
that	that	IN	B-SBAR	O
use	use	NN	B-NP	O
of	of	IN	B-PP	O
Sage	Sage	NN	B-NP	O
dentifrice	dentifrice	NN	I-NP	O
,	,	,	O	O
Toothette	Toothette	NNP	B-NP	O
Plus	Plus	NNP	I-NP	O
saturated	saturate	VBD	B-VP	O
with	with	IN	B-PP	O
Perox-A-Mint	Perox-A-Mint	NNP	B-NP	O
and	and	CC	I-NP	O
Sage	Sage	NNP	I-NP	O
Mouth	Mouth	NNP	I-NP	O
Moisturizer	Moisturizer	NNP	I-NP	O
are	be	VBP	B-VP	O
safe	safe	JJ	B-ADJP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
tissues	tissue	NNS	I-NP	O
.	.	.	O	O

Using	Use	VBG	B-VP	O
these	these	DT	B-NP	O
components	component	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
result	result	VB	I-VP	O
in	in	IN	B-PP	O
clinically	clinically	RB	B-NP	O
noticeable	noticeable	JJ	I-NP	O
stain	stain	NN	I-NP	O
formation	formation	NN	I-NP	O
,	,	,	O	O
promote	promote	VBP	B-VP	O
plaque	plaque	NN	B-NP	O
formation	formation	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
produce	produce	VB	B-VP	O
any	any	DT	B-NP	O
significant	significant	JJ	I-NP	O
adverse	adverse	JJ	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
microflora	microflora	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
bactericidal	bactericidal	JJ	I-NP	O
efficacy	efficacy	NN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
types	type	NNS	I-NP	O
of	of	IN	B-PP	O
Listerine	Listerine	NN	B-NP	O
;	;	:	O	O
Listerine	Listerine	NNP	B-NP	O
and	and	CC	I-NP	O
Cool	Cool	NNP	I-NP	O
Mint	Mint	NNP	I-NP	O
Listerine	Listerine	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
povidone	povidone	NN	B-NP	O
iodine	iodine	NN	I-NP	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	O
microorganisms	microorganism	NNS	I-NP	O
,	,	,	O	O
methicillin-resistant	methicillin-resistant	JJ	B-NP	O
Staphylococcus	Staphylococcus	FW	I-NP	O
aureus	aureus	FW	I-NP	O
(	(	(	O	O
MRSA	MRSA	NN	B-NP	B-protein
)	)	)	O	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
pyogenes	pyogene	NNS	I-NP	O
,	,	,	O	O
Helicobacter	Helicobacter	NN	B-NP	O
pylori	pylori	NN	I-NP	O
and	and	CC	I-NP	O
Candida	Candida	NN	I-NP	O
albicans	albican	NNS	I-NP	O
were	be	VBD	B-VP	O
examined	examine	VBN	I-VP	O
.	.	.	O	O

Most	Most	JJS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
were	be	VBD	B-VP	O
killed	kill	VBN	I-VP	O
completely	completely	RB	B-ADVP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
10-sec	10-sec	JJ	I-NP	O
exposure	exposure	NN	I-NP	O
to	to	TO	B-PP	O
Listerine	Listerine	NNP	B-NP	O
or	or	CC	I-NP	O
Cool	Cool	NNP	I-NP	O
Mint	Mint	NNP	I-NP	O
Listerine	Listerine	NNP	I-NP	O
.	.	.	O	O

H.	H.	NN	B-NP	O
pylori	pylori	NN	I-NP	O
,	,	,	O	O
MRSA	MRSA	NN	B-NP	O
and	and	CC	O	O
C.	C.	NN	B-NP	O
albicans	albican	NNS	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
reduced	reduce	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
30-sec	30-sec	JJ	I-NP	O
exposure	exposure	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Listerine	Listerine	JJ	I-NP	O
mouth	mouth	NN	I-NP	O
rinse	rinse	NN	I-NP	O
.	.	.	O	O

Bacteria	Bacteria	NNS	B-NP	O
in	in	IN	B-PP	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
were	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
by	by	IN	B-PP	O
exposure	exposure	NN	B-NP	O
to	to	TO	B-PP	O
Listerine	Listerine	NNP	B-NP	O
,	,	,	O	O
Cool	Cool	NNP	B-NP	O
Mint	Mint	NNP	I-NP	O
Listerine	Listerine	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
povidone	povidone	NN	B-NP	O
iodine	iodine	NN	I-NP	O
for	for	IN	B-PP	O
30	30	CD	B-NP	O
seconds	second	NNS	I-NP	O
.	.	.	O	O

Mouthwashing	Mouthwashe	VBG	B-VP	O
with	with	IN	B-PP	O
Listerine	Listerine	NN	B-NP	O
for	for	IN	B-PP	O
30	30	CD	B-NP	O
seconds	second	NNS	I-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
to	to	TO	B-PP	O
approximately	approximately	RB	B-NP	O
1/100	1/100	CD	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
viable	viable	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
counts	count	NNS	I-NP	O
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
bactericidal	bactericidal	JJ	I-NP	O
effects	effect	NNS	I-NP	O
against	against	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
in	in	IN	B-PP	O
saliva	saliva	NN	B-NP	O
and	and	CC	O	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
that	that	IN	B-SBAR	O
Listerine	Listerine	NNP	B-NP	O
and	and	CC	I-NP	O
Cool	Cool	NNP	I-NP	O
Mint	Mint	NNP	I-NP	O
Listerine	Listerine	NNP	I-NP	O
antiseptic	antiseptic	JJ	B-ADVP	O
are	be	VBP	B-VP	O
useful	useful	JJ	B-ADJP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
cavity	cavity	NN	I-NP	O
as	as	IN	B-PP	O
antiseptic	antiseptic	JJ	B-NP	O
mouth	mouth	NN	I-NP	O
rinses	rinse	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
purpose	purpose	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
if	if	IN	B-SBAR	O
endodontic	endodontic	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
act	act	NN	I-NP	O
in	in	FW	B-ADVP	O
vitro	vitro	FW	I-ADVP	O
on	on	IN	B-PP	O
human	human	JJ	B-NP	B-cell_type
gingival	gingival	JJ	I-NP	I-cell_type
fibroblast	fibroblast	NN	I-NP	I-cell_type
functions	function	NNS	I-NP	O
via	via	IN	B-PP	O
extracellular	extracellular	JJ	B-NP	B-protein
products	product	NNS	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
used	use	VBN	B-VP	O
were	be	VBD	B-VP	O
Prevotella	Prevotella	NNP	B-NP	O
nigrescens	nigrescens	NNP	I-NP	O
,	,	,	O	O
Capnocytophaga	Capnocytophaga	NNP	B-NP	O
ochracea	ochracea	NNP	I-NP	O
,	,	,	O	O
Peptostreptoccocus	Peptostreptoccocus	NNP	B-NP	O
micros	micro	NNS	I-NP	O
and	and	CC	O	O
Actinobacillus	Actinobacillus	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
.	.	.	O	O

Supernatants	Supernatant	NNS	B-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
from	from	IN	B-PP	O
bacterial	bacterial	JJ	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
at	at	IN	B-PP	O
the	the	DT	B-NP	O
beginning	beginning	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
stationary	stationary	JJ	I-NP	O
phase	phase	NN	I-NP	O
when	when	WRB	B-ADVP	O
their	their	PRP$	B-NP	O
density	density	NN	I-NP	O
was	be	VBD	B-VP	O
similar	similar	JJ	B-ADJP	O
.	.	.	O	O

Toxins	Toxin	NNS	B-NP	O
that	that	WDT	B-NP	O
inhibited	inhibit	VBD	B-VP	O
fibroblast	fibroblast	NN	B-NP	O
proliferation	proliferation	NN	I-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
culture	culture	NN	I-NP	O
supernatants	supernatant	NNS	I-NP	O
of	of	IN	B-PP	O
Gram-positive	Gram-positive	JJ	B-NP	O
or	or	CC	I-NP	O
Gram-negative	Gram-negative	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
strains	strain	NNS	I-NP	O
,	,	,	O	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
Prev	Prev	NNP	B-NP	O
.	.	.	I-NP	O
I-bacteria	I-bacteria	NNP	I-NP	O
nigrescens	nigrescens	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
cytotoxicity	cytotoxicity	NN	I-NP	O
of	of	IN	B-PP	O
A.	A.	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
supernatant	supernatant	NN	I-NP	O
was	be	VBD	B-VP	O
about	about	RB	B-NP	O
1000	1000	CD	I-NP	O
fold	fold	RB	B-ADJP	O
higher	high	JJR	I-ADJP	O
than	than	IN	B-PP	O
the	the	DT	B-NP	O
others	other	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
supernatant	supernatant	NN	I-NP	O
diluted	dilute	VBN	B-VP	O
to	to	TO	B-PP	O
1/1000	1/1000	CD	B-NP	O
led	lead	VBD	B-VP	O
to	to	TO	B-PP	O
total	total	JJ	B-NP	O
fibroblast	fibroblast	NN	I-NP	O
growth	growth	NN	I-NP	O
inhibition	inhibition	NN	I-NP	O
whereas	whereas	IN	B-PP	O
only	only	RB	B-NP	O
25	25	CD	I-NP	O
%	%	NN	I-NP	O
growth	growth	NN	I-NP	O
inhibition	inhibition	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
with	with	IN	B-PP	O
Capn	Capn	NNP	B-NP	O
.	.	.	I-NP	O
I-bacteria	I-bacteria	NNP	I-NP	O
ochracea	ochracea	NN	I-NP	O
and	and	CC	I-NP	O
Pept	Pept	NN	I-NP	O
.	.	.	O	O
I-bacteria	I-bacteria	NN	B-NP	B-protein
micros	micro	NNS	I-NP	I-protein
diluted	dilute	VBD	B-VP	O
to	to	TO	B-PP	O
1/10	1/10	CD	B-NP	O
.	.	.	O	O

Bacterial	Bacterial	JJ	B-NP	O
supernatant	supernatant	JJ	I-NP	O
proteolytic	proteolytic	JJ	I-NP	O
activity	activity	NN	I-NP	O
was	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
in	in	IN	B-PP	O
confluent	confluent	JJ	B-NP	B-cell_line
fibroblast	fibroblast	NN	I-NP	I-cell_line
cultures	culture	NNS	I-NP	I-cell_line
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
incubated	incubate	VBN	I-VP	O
for	for	IN	B-PP	O
48	48	CD	B-NP	O
hr	hr	NN	I-NP	O
with	with	IN	B-PP	O
each	each	DT	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
supernatants	supernatant	NNS	I-NP	O
diluted	dilute	VBD	B-VP	O
to	to	TO	B-PP	O
1/2	1/2	CD	B-NP	O
except	except	IN	B-PP	O
for	for	IN	B-PP	O
A.	A.	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
supernatant	supernatant	JJ	B-ADJP	O
diluted	dilute	VBN	B-VP	O
to	to	TO	B-PP	O
1/20	1/20	CD	B-NP	O
.	.	.	O	O

Indirect	Indirect	JJ	B-NP	O
immunofluorescence	immunofluorescence	NN	I-NP	O
studies	study	NNS	I-NP	O
of	of	IN	B-PP	O
extracellular-matrix	extracellular-matrix	JJ	B-NP	B-protein
molecules	molecule	NNS	I-NP	I-protein
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
immunoelectrophoretic	immunoelectrophoretic	JJ	B-NP	O
analysis	analysis	NN	I-NP	O
of	of	IN	B-PP	O
extracts	extract	NNS	B-NP	O
of	of	IN	B-PP	O
whole-cell	whole-cell	JJ	B-NP	O
layers	layer	NNS	I-NP	O
,	,	,	O	O
demonstrated	demonstrate	VBD	B-VP	O
that	that	IN	B-SBAR	O
only	only	RB	B-NP	O
conditioned	condition	VBN	I-NP	O
medium	medium	NN	I-NP	O
of	of	IN	B-PP	O
Prev	Prev	NNP	B-NP	O
.	.	.	I-NP	O
I-bacteria	I-bacteria	NNP	I-NP	O
nigrescens	nigrescens	NNP	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
proteolytic	proteolytic	JJ	I-NP	O
activity	activity	NN	I-NP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
degrading	degrade	VBG	B-VP	O
the	the	DT	B-NP	O
greater	great	JJR	I-NP	O
part	part	NN	I-NP	O
of	of	IN	B-PP	O
type	type	NN	B-NP	B-protein
I	I	CD	I-NP	I-protein
collagen	collagen	NN	I-NP	I-protein
and	and	CC	I-NP	O
fibronectin	fibronectin	NN	I-NP	O
fibres	fibre	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
extracellular	extracellular	JJ	I-NP	O
matrix	matrix	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
growing	grow	VBG	I-VP	O
public	public	JJ	B-NP	O
recognition	recognition	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
health	health	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
symbolized	symbolize	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
theme	theme	NN	I-NP	O
.	.	.	O	O

``	``	``	O	O
Oral	Oral	NNP	B-NP	O
Health	Health	NNP	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
Healthy	Healthy	NNP	I-NP	O
Life	Life	NNP	I-NP	O
''	''	''	O	O
proposed	propose	VBN	B-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
1994	1994	CD	I-NP	O
World	World	NNP	I-NP	O
Health	Health	NNP	I-NP	O
Day	Day	NNP	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
report	report	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
efficacy	efficacy	NN	I-NP	O
of	of	IN	B-PP	O
antimicrobial	antimicrobial	JJ	B-NP	O
mouth	mouth	NN	I-NP	O
rinses	rinse	NNS	I-NP	O
,	,	,	O	O
mainly	mainly	RB	B-NP	O
Listerine	Listerine	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
reviewed	review	VBN	I-VP	O
by	by	IN	B-PP	O
three	three	CD	B-NP	O
investigators	investigator	NNS	I-NP	O
who	who	WP	B-NP	O
are	be	VBP	B-VP	O
working	work	VBG	I-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
microbiologist	microbiologist	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
microbiologist	microbiologist	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
dentist	dentist	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
dental	dental	JJ	I-NP	O
hygienist	hygienist	NN	I-NP	O
participating	participate	VBG	B-VP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
health	health	NN	I-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

Listerine	Listerine	NN	B-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
mouth	mouth	NN	I-NP	O
rinse	rinse	NN	I-NP	O
,	,	,	O	O
completely	completely	RB	B-NP	O
killed	kill	VBN	I-NP	O
microorganisms	microorganism	NNS	I-NP	O
in	in	IN	B-PP	O
10	10	CD	B-NP	O
to	to	TO	I-NP	O
30	30	CD	I-NP	O
seconds	second	NNS	I-NP	O
;	;	:	O	O
the	the	DT	B-NP	O
microbes	microbe	NNS	I-NP	O
includes	include	VBZ	B-VP	O
methicillin-resistant	methicillin-resistant	JJ	B-NP	O
Staphylococcus	Staphylococcus	NNP	I-NP	O
aureus	aureus	NNP	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
pyogenes	pyogene	NNS	I-NP	O
,	,	,	O	O
Helicobacter	Helicobacter	NN	B-NP	O
pylori	pylori	NN	I-NP	O
,	,	,	O	O
Candida	Candida	NNP	B-NP	O
albicans	albicans	NNP	I-NP	O
,	,	,	O	O
Streptococcus	Streptococcus	NNP	B-NP	O
mutans	mutan	NNS	I-NP	O
,	,	,	O	O
Actinomyces	Actinomyces	NNP	B-NP	O
viscosus	viscosus	NNP	I-NP	O
,	,	,	O	O
Porphyromonas	Porphyromonas	NNP	B-NP	O
gingivalis	gingivalis	NNP	I-NP	O
,	,	,	O	O
Prevotella	Prevotella	NNP	B-NP	O
intermedia	intermedia	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Actinobacillus	Actinobacillus	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
.	.	.	O	O

Listerine	Listerine	NN	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
weakly	weakly	RB	B-ADJP	O
effective	effective	JJ	I-ADJP	O
in	in	IN	B-PP	O
inactivating	inactivate	VBG	B-VP	O
human	human	JJ	B-NP	O
immunodeficiency	immunodeficiency	NN	I-NP	O
viruses	virus	NNS	I-NP	O
.	.	.	O	O

Bacteria	Bacteria	NNS	B-NP	O
in	in	IN	B-PP	O
samples	sample	NNS	B-NP	O
collected	collect	VBN	B-VP	O
from	from	IN	B-PP	O
human	human	JJ	B-NP	O
dental	dental	JJ	I-NP	O
plaque	plaque	NN	I-NP	O
and	and	CC	I-NP	O
saliva	saliva	NN	I-NP	O
were	be	VBD	B-VP	O
completely	completely	RB	I-VP	O
killed	kill	VBN	I-VP	O
within	within	IN	B-PP	O
30	30	CD	B-NP	O
seconds	second	NNS	I-NP	O
when	when	WRB	B-ADVP	O
exposed	expose	VBN	B-VP	O
to	to	TO	B-PP	O
Listerine	Listerine	NN	B-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
saliva	saliva	NN	B-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
from	from	IN	B-PP	O
subjects	subject	NNS	B-NP	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
rinsed	rinse	VBN	I-VP	O
their	their	PRP$	B-NP	O
mouths	mouth	NNS	I-NP	O
with	with	IN	B-PP	O
20	20	CD	B-NP	O
ml	ml	NN	I-NP	O
of	of	IN	B-PP	O
Listerine	Listerine	NN	B-NP	O
or	or	CC	O	O
1:50	1:50	CD	B-NP	O
diluted	diluted	JJ	I-NP	O
povidone-iodine	povidone-iodine	NN	I-NP	O
,	,	,	O	O
levels	level	NNS	B-NP	O
of	of	IN	B-PP	O
viable	viable	JJ	B-NP	O
anaerobic	anaerobic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
samples	sample	NNS	I-NP	O
were	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
to	to	TO	B-PP	O
1	1	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
Listerine	Listerine	NN	B-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
for	for	IN	B-PP	O
oral	oral	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
tooth	tooth	JJ	B-NP	O
extraction	extraction	NN	I-NP	O
and	and	CC	O	O
periodontal	periodontal	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
agent	agent	NN	I-NP	O
was	be	VBD	B-VP	O
effective	effective	JJ	B-ADJP	O
in	in	IN	B-PP	O
relieving	relieve	VBG	B-VP	O
toothache	toothache	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
probably	probably	RB	B-ADVP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
antimicrobial	antimicrobial	JJ	I-NP	O
action	action	NN	I-NP	O
of	of	IN	B-PP	O
Listerine	Listerine	NN	B-NP	O
,	,	,	O	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
lowering	lower	VBG	B-VP	O
the	the	DT	B-NP	O
inflammatory	inflammatory	JJ	I-NP	O
response	response	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
host	host	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
antimicrobial	antimicrobial	JJ	B-NP	O
mouth	mouth	NN	I-NP	O
rinse	rinse	NN	I-NP	O
during	during	IN	B-PP	O
dental	dental	JJ	B-NP	O
treatments	treatment	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
endodontic	endodontic	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
proved	prove	VBD	B-VP	O
effective	effective	JJ	B-ADJP	O
for	for	IN	B-PP	O
more	more	RBR	B-NP	O
reliable	reliable	JJ	I-NP	O
infection	infection	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
Japan	Japan	NNP	B-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
are	be	VBP	B-VP	O
an	an	DT	B-NP	O
increasing	increase	VBG	I-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
elderly	elderly	JJ	B-NP	O
and	and	CC	I-NP	O
medically	medically	RB	I-NP	O
compromised	compromise	VBN	I-NP	O
hosts	host	NNS	I-NP	O
who	who	WP	B-NP	O
are	be	VBP	B-VP	O
potentially	potentially	RB	B-ADVP	O
at	at	IN	B-PP	O
risk	risk	NN	B-NP	O
for	for	IN	B-PP	O
developing	develop	VBG	B-VP	O
pneumonia	pneumonia	NN	B-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
silent	silent	JJ	B-NP	O
aspiration	aspiration	NN	I-NP	O
of	of	IN	B-PP	O
microbes	microbe	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
and	and	CC	I-NP	O
throat	throat	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
the	the	DT	B-NP	O
aged	aged	JJ	I-NP	O
with	with	IN	B-PP	O
such	such	JJ	B-NP	O
potential	potential	JJ	I-NP	O
risk	risk	NN	I-NP	O
,	,	,	O	O
using	use	VBG	B-VP	O
of	of	IN	B-PP	O
antimicrobial	antimicrobial	JJ	B-NP	O
mouth	mouth	NN	I-NP	O
rinse	rinse	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
effective	effective	JJ	B-ADJP	O
in	in	IN	B-PP	O
preventing	prevent	VBG	B-VP	O
dental	dental	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
accumulation	accumulation	NN	I-NP	O
when	when	WRB	B-ADVP	O
used	use	VBN	B-VP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
mechanical	mechanical	JJ	I-NP	O
control	control	NN	I-NP	O
of	of	IN	B-PP	O
plaque	plaque	NN	B-NP	O
,	,	,	O	O
since	since	IN	B-SBAR	O
they	they	PRP	B-NP	O
tend	tend	VBP	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
difficulty	difficulty	NN	B-NP	O
in	in	IN	B-PP	O
brushing	brush	VBG	B-VP	O
teeth	tooth	NNS	B-NP	O
by	by	IN	B-PP	O
themselves	themselves	PRP	B-NP	O
.	.	.	O	O

Indeed	Indeed	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
antimicrobial	antimicrobial	JJ	B-NP	O
mouth	mouth	NN	I-NP	O
rinse	rinse	NN	I-NP	O
in	in	IN	B-PP	O
these	these	DT	B-NP	O
elderly	elderly	JJ	I-NP	O
people	people	NNS	I-NP	O
proved	prove	VBD	B-VP	O
useful	useful	JJ	B-ADJP	O
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
in	in	IN	B-PP	O
preventing	prevent	VBG	B-VP	O
bacterial	bacterial	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
,	,	,	O	O
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
in	in	IN	B-PP	O
improving	improve	VBG	B-VP	O
their	their	PRP$	B-NP	O
quality	quality	NN	I-NP	O
of	of	IN	B-PP	O
life	life	NN	B-NP	O
by	by	IN	B-PP	O
preserving	preserve	VBG	B-VP	O
their	their	PRP$	B-NP	O
oral	oral	JJ	I-NP	O
health	health	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	B-cell_type
polymorphonuclear	polymorphonuclear	JJ	I-NP	I-cell_type
granulocytes	granulocyte	NNS	I-NP	I-cell_type
(	(	(	O	O
PMNs	PMN	NNS	B-NP	B-cell_type
)	)	)	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
counts	count	NNS	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
92	92	CD	B-NP	O
children	child	NNS	I-NP	O
(	(	(	O	O
33	33	CD	B-NP	O
girls	girl	NNS	I-NP	O
and	and	CC	O	O
59	59	CD	B-NP	O
boys	boy	NNS	I-NP	O
)	)	)	O	O
,	,	,	O	O
aged	age	VBN	B-ADJP	O
4-15	4-15	CD	B-NP	O
was	be	VBD	B-VP	O
investigated	investigate	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
groups	group	NNS	I-NP	O
of	of	IN	B-PP	O
children	child	NNS	B-NP	O
comprised	comprise	VBD	B-VP	O
44	44	CD	B-NP	O
healthy	healthy	JJ	I-NP	O
individuals	individual	NNS	I-NP	O
and	and	CC	O	O
48	48	CD	B-NP	O
children	child	NNS	I-NP	O
suffering	suffer	VBG	B-VP	O
from	from	IN	B-PP	O
acute	acute	JJ	B-NP	O
lymphoblastic	lymphoblastic	JJ	I-NP	O
leukaemia	leukaemia	NN	I-NP	O
who	who	WP	B-NP	O
were	be	VBD	B-VP	O
given	give	VBN	I-VP	O
intensive	intensive	JJ	B-NP	O
antileukaemic	antileukaemic	JJ	I-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
that	that	IN	B-SBAR	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
PMNs	PMN	NNS	B-NP	B-cell_type
in	in	IN	B-PP	O
blood	blood	NN	B-NP	O
decreased	decrease	VBD	B-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
counts	count	NNS	I-NP	O
of	of	IN	B-PP	O
Streptococcus	Streptococcus	NNP	B-NP	O
spp.	spp.	NNP	I-NP	O
,	,	,	O	O
Staphylococcus	Staphylococcus	NNP	B-NP	O
spp.	spp.	NN	I-NP	O
,	,	,	O	O
mutans	mutan	NNS	B-NP	O
streptococci	streptococci	NNS	I-NP	O
,	,	,	O	O
Lactobacillus	Lactobacillus	NN	B-NP	O
spp.	spp.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Actinomyces	Actinomyces	NNP	B-NP	O
spp	spp	NN	I-NP	O
.	.	.	O	O

in	in	IN	B-PP	O
the	the	DT	B-NP	O
saliva	saliva	NN	I-NP	O
tended	tend	VBD	B-VP	O
to	to	TO	I-VP	O
increase	increase	VB	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
similar	similar	JJ	I-NP	O
reciprocal	reciprocal	JJ	I-NP	O
correlation	correlation	NN	I-NP	O
between	between	IN	B-PP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	B-cell_type
PMNs	PMN	NNS	I-NP	I-cell_type
and	and	CC	O	O
the	the	DT	B-NP	O
counts	count	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
saliva	saliva	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
group	group	NN	I-NP	O
of	of	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
concluded	conclude	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	B-cell_type
PMNs	PMN	NNS	I-NP	I-cell_type
,	,	,	O	O
by	by	IN	B-PP	O
influencing	influence	VBG	B-VP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
PMNs	PMN	NNS	I-NP	B-cell_type
which	which	WDT	B-NP	O
control	control	VBP	B-VP	O
bacteria	bacteria	NNS	B-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
habitat	habitat	NN	I-NP	O
,	,	,	O	O
influence	influence	NN	B-NP	O
also	also	RB	B-ADVP	O
the	the	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
groups	group	NNS	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
there	there	RB	B-ADVP	O
.	.	.	O	O

Bacteriocin	Bacteriocin	NN	B-NP	O
production	production	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
studied	study	VBN	I-VP	O
in	in	IN	B-PP	O
very	very	RB	B-NP	O
few	few	JJ	I-NP	O
anaerobic	anaerobic	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
report	report	NN	I-NP	O
is	be	VBZ	B-VP	O
available	available	JJ	B-ADJP	O
for	for	IN	B-PP	O
Fusobacterium	Fusobacterium	NNP	B-NP	O
species	specie	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
present	present	JJ	I-NP	O
study	study	NN	I-NP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
167	167	CD	B-NP	O
Fusobacterium	Fusobacterium	NN	I-NP	O
isolates	isolate	NNS	I-NP	O
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
for	for	IN	B-PP	O
bacteriocin	bacteriocin	NN	B-NP	O
production	production	NN	I-NP	O
:	:	:	O	O
70	70	CD	B-NP	O
isolates	isolate	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
of	of	IN	B-PP	O
patients	patient	NNS	B-NP	O
with	with	IN	B-PP	O
periodontal	periodontal	JJ	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
47	47	CD	B-NP	O
were	be	VBD	B-VP	O
recovered	recover	VBN	I-VP	O
from	from	IN	B-PP	O
healthy	healthy	JJ	B-NP	O
oral	oral	JJ	I-NP	O
sites	site	NNS	I-NP	O
of	of	IN	B-PP	O
human	human	JJ	B-NP	O
subjects	subject	NNS	I-NP	O
and	and	CC	O	O
50	50	CD	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
of	of	IN	B-PP	O
Callithrix	Callithrix	NN	B-NP	B-protein
penicillata	penicillata	NNS	I-NP	I-protein
.	.	.	O	O

Autoantagonism	Autoantagonism	NN	B-NP	O
and	and	CC	I-NP	O
isoantagonism	isoantagonism	NN	I-NP	O
were	be	VBD	B-VP	O
observed	observe	VBN	I-VP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
bacteriocin-producing	bacteriocin-producing	JJ	I-NP	O
isolates	isolate	NNS	I-NP	O
were	be	VBD	B-VP	O
tested	test	VBN	I-VP	O
against	against	IN	B-PP	O
themselves	themselves	PRP	B-NP	O
.	.	.	O	O

Heteroantagonism	Heteroantagonism	NN	B-NP	O
was	be	VBD	B-VP	O
detected	detect	VBN	I-VP	O
by	by	IN	B-PP	O
testing	test	VBG	B-VP	O
the	the	DT	B-NP	O
Fusobacterium	Fusobacterium	NNP	I-NP	O
isolates	isolate	VBZ	B-VP	O
against	against	IN	B-PP	O
14	14	CD	B-NP	O
reference	reference	NN	I-NP	O
strains	strain	NNS	I-NP	O
and	and	CC	O	O
2	2	CD	B-NP	O
strains	strain	NNS	I-NP	O
of	of	IN	B-PP	O
Actinobacillus	Actinobacillus	NN	B-NP	O
actinomycetemcomitans	actinomycetemcomitan	NNS	I-NP	O
from	from	IN	B-PP	O
our	our	PRP$	B-NP	O
laboratory	laboratory	NN	I-NP	O
collection	collection	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
auto-	auto-	NN	I-NP	O
,	,	,	I-NP	O
iso-	iso-	NN	I-NP	O
and	and	CC	I-NP	O
heteroantagonism	heteroantagonism	NN	I-NP	O
phenomena	phenomenon	NNS	I-NP	O
observed	observe	VBN	B-VP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
comparative	comparative	JJ	I-NP	O
study	study	NN	I-NP	O
suggest	suggest	VBP	B-VP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
ecological	ecological	JJ	I-NP	O
role	role	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
(	(	(	O	O
these	these	DT	O	O
)	)	)	O	O
antagonistic	antagonistic	JJ	B-NP	O
substance	substance	NN	I-NP	O
(	(	(	I-NP	O
s	s	NNS	I-NP	O
)	)	)	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
environment	environment	NN	I-NP	O
.	.	.	O	O

Competitive	Competitive	JJ	B-NP	O
PCR	PCR	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
to	to	TO	B-VP	O
monitor	monitor	VB	I-VP	O
the	the	DT	B-NP	O
survival	survival	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
520-bp	520-bp	JJ	I-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
target	target	NN	I-NP	I-DNA
sequence	sequence	NN	I-NP	I-DNA
from	from	IN	B-PP	O
a	a	DT	B-NP	O
recombinant	recombinant	JJ	I-NP	B-DNA
plasmid	plasmid	NN	I-NP	I-DNA
,	,	,	O	O
pVACMC1	pVACMC1	NN	B-NP	B-protein
,	,	,	O	O
after	after	IN	B-PP	O
admixture	admixture	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
plasmid	plasmid	NN	I-NP	B-DNA
with	with	IN	B-PP	O
freshly	freshly	RB	B-NP	O
sampled	sample	VBN	I-NP	O
human	human	JJ	I-NP	O
saliva	saliva	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
target	target	NN	I-NP	O
remaining	remain	VBG	B-VP	O
amplifiable	amplifiable	JJ	B-ADJP	O
ranged	range	VBD	B-VP	O
from	from	IN	B-PP	O
40	40	CD	B-NP	O
to	to	TO	I-NP	O
65	65	CD	I-NP	O
%	%	NN	I-NP	O
after	after	IN	B-PP	O
10	10	CD	B-NP	O
min	min	NN	I-NP	O
of	of	IN	B-PP	O
exposure	exposure	NN	B-NP	O
to	to	TO	B-PP	O
saliva	saliva	NN	B-NP	O
samples	sample	NNS	I-NP	O
from	from	IN	B-PP	O
five	five	CD	B-NP	O
subjects	subject	NNS	I-NP	O
and	and	CC	B-PP	O
from	from	IN	B-PP	O
6	6	CD	B-NP	O
to	to	TO	I-NP	O
25	25	CD	I-NP	O
%	%	NN	I-NP	O
after	after	IN	B-PP	O
60	60	CD	B-NP	O
min	min	NN	I-NP	O
of	of	IN	B-PP	O
exposure	exposure	NN	B-NP	O
.	.	.	O	O

pVACMC1	pVACMC1	NN	B-NP	O
plasmid	plasmid	NN	I-NP	O
DNA	DNA	NN	I-NP	O
that	that	WDT	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
exposed	expose	VBN	I-VP	O
to	to	TO	B-PP	O
degradation	degradation	NN	B-NP	O
by	by	IN	B-PP	O
fresh	fresh	JJ	B-NP	O
saliva	saliva	NN	I-NP	O
was	be	VBD	B-VP	O
capable	capable	JJ	B-ADJP	O
of	of	IN	B-PP	O
transforming	transform	VBG	B-VP	B-protein
naturally	naturally	RB	B-NP	I-protein
competent	competent	JJ	I-NP	I-protein
Streptococcus	Streptococcus	NNP	I-NP	I-protein
gordonii	gordonii	NNP	I-NP	I-protein
DL1	DL1	NN	I-NP	I-protein
to	to	TO	B-PP	O
erythromycin	erythromycin	NN	B-NP	O
resistance	resistance	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
transforming	transform	VBG	B-VP	O
activity	activity	NN	B-NP	O
decreased	decrease	VBD	B-VP	O
rapidly	rapidly	RB	B-ADVP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
half-life	half-life	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
50	50	CD	I-NP	O
s.	s.	NNS	I-NP	O
S.	S.	NNP	B-NP	O
gordonii	gordonii	NN	I-NP	O
DL1	DL1	NN	I-NP	O
transformants	transformant	NNS	I-NP	O
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
filter-sterilized	filter-sterilized	JJ	B-NP	O
saliva	saliva	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
1-microg/ml	1-microg/ml	JJ	I-NP	O
final	final	JJ	I-NP	O
concentration	concentration	NN	I-NP	O
of	of	IN	B-PP	O
pVACMC1	pVACMC1	NN	B-NP	B-DNA
DNA	DNA	NN	I-NP	I-DNA
.	.	.	O	O

Addition	Addition	NN	B-NP	O
of	of	IN	B-PP	O
filter-sterilized	filter-sterilized	JJ	B-NP	O
saliva	saliva	NN	I-NP	O
instead	instead	RB	B-PP	O
of	of	IN	I-PP	O
heat-inactivated	heat-inactivated	JJ	B-NP	B-cell_line
horse	horse	NN	I-NP	I-cell_line
serum	serum	NN	I-NP	I-cell_line
to	to	TO	B-PP	I-cell_line
S.	S.	NNP	B-NP	I-cell_line
gordonii	gordonii	NN	I-NP	I-cell_line
DL1	DL1	NN	I-NP	I-cell_line
cells	cell	NNS	I-NP	I-cell_line
induced	induce	VBD	B-VP	O
competence	competence	NN	B-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
with	with	IN	B-PP	O
slightly	slightly	RB	B-NP	O
lower	low	JJR	I-NP	O
efficiency	efficiency	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
indicate	indicate	VBP	B-VP	O
that	that	IN	B-SBAR	O
DNA	DNA	NN	B-NP	O
released	release	VBN	B-VP	O
from	from	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
or	or	CC	O	O
food	food	NN	B-NP	O
sources	source	NNS	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
has	have	VBZ	B-VP	O
the	the	DT	B-NP	O
potential	potential	NN	I-NP	O
to	to	TO	B-VP	O
transform	transform	VB	I-VP	O
naturally	naturally	RB	B-NP	O
competent	competent	JJ	I-NP	O
oral	oral	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
further	further	JJ	B-NP	O
investigations	investigation	NNS	I-NP	O
are	be	VBP	B-VP	O
needed	need	VBN	I-VP	O
to	to	TO	B-VP	O
establish	establish	VB	I-VP	O
whether	whether	IN	B-SBAR	O
transformation	transformation	NN	B-NP	O
of	of	IN	B-PP	O
oral	oral	JJ	B-NP	O
bacteria	bacteria	NNS	I-NP	O
can	can	MD	B-VP	O
occur	occur	VB	I-VP	O
at	at	IN	B-PP	O
significant	significant	JJ	B-NP	O
frequencies	frequency	NNS	I-NP	O
in	in	FW	B-ADVP	O
vivo	vivo	FW	I-ADVP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
over	over	IN	B-NP	O
300	300	CD	I-NP	O
species	specie	NNS	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	B-cell_type
forming	form	VBG	B-VP	I-cell_type
populations	population	NNS	B-NP	I-cell_type
of	of	IN	B-PP	O
several	several	JJ	B-NP	O
hundred	hundred	CD	I-NP	O
billion	billion	CD	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
human	human	JJ	I-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
number	number	NN	I-NP	O
of	of	IN	B-PP	O
bacteria	bacteria	NNS	B-NP	O
reaches	reach	VBZ	B-VP	O
a	a	DT	B-NP	O
thousand	thousand	CD	I-NP	O
billion	billion	CD	I-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
mouth	mouth	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
sufficiently	sufficiently	RB	B-ADJP	O
cleaned	clean	VBN	I-ADJP	O
.	.	.	O	O

Using	Use	VBG	B-VP	O
saliva	saliva	NN	B-NP	O
and	and	CC	O	O
gingival	gingival	JJ	B-NP	O
crevicular	crevicular	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
as	as	IN	B-PP	O
their	their	PRP$	B-NP	O
main	main	JJ	I-NP	O
nutrients	nutrient	NNS	I-NP	O
,	,	,	O	O
these	these	DT	B-NP	O
bacteria	bacteria	NNS	I-NP	O
create	create	VBP	B-VP	O
their	their	PRP$	B-NP	O
ecological	ecological	JJ	I-NP	O
niches	niche	NNS	I-NP	O
on	on	IN	B-PP	O
tooth	tooth	JJ	B-NP	O
surfaces	surface	NNS	I-NP	O
,	,	,	O	O
gingival	gingival	JJ	B-NP	O
crevices	crevice	NNS	I-NP	O
,	,	,	O	O
saliva	saliva	NN	B-NP	O
,	,	,	O	O
dorsum	dorsum	NN	B-NP	O
linguae	lingua	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
buccal	buccal	JJ	B-NP	O
and	and	CC	I-NP	O
pharyngeal	pharyngeal	JJ	I-NP	O
mucosa	mucosa	NN	I-NP	O
,	,	,	O	O
threatening	threaten	VBG	B-VP	O
oral	oral	JJ	B-NP	O
and	and	CC	I-NP	O
systemic	systemic	JJ	I-NP	O
health	health	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
known	know	VBN	I-VP	O
that	that	IN	B-SBAR	O
primary	primary	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
bacterial	bacterial	JJ	I-NP	O
infections	infection	NNS	I-NP	O
secondarily	secondarily	RB	B-ADVP	O
cause	cause	VBP	B-VP	O
nephritis	nephritis	NN	B-NP	O
,	,	,	O	O
rheumatoid	rheumatoid	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
dermatitis	dermatitis	NN	B-NP	O
.	.	.	O	O

Further	Further	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
demonstrated	demonstrate	VBN	I-VP	O
in	in	IN	B-PP	O
recent	recent	JJ	B-NP	O
years	year	NNS	I-NP	O
that	that	IN	B-SBAR	O
bacteria	bacteria	NNS	B-NP	O
inhabiting	inhabit	VBG	B-VP	O
the	the	DT	B-NP	O
oral	oral	JJ	I-NP	O
cavity	cavity	NN	I-NP	O
can	can	MD	B-VP	O
cause	cause	VB	I-VP	O
bacterial	bacterial	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
and	and	CC	I-NP	O
endocarditis	endocarditis	NN	I-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
periodontal-disease-associated	periodontal-disease-associated	JJ	I-NP	O
bacteria	bacteria	NNS	I-NP	O
become	become	VBP	B-VP	O
causative	causative	JJ	B-NP	O
agents	agent	NNS	I-NP	O
for	for	IN	B-PP	O
pregnancy	pregnancy	NN	B-NP	O
troubles	trouble	NNS	I-NP	O
and	and	CC	O	O
are	be	VBP	B-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
blood	blood	NN	B-NP	O
circulation	circulation	NN	I-NP	O
problem	problem	NN	I-NP	O
and	and	CC	O	O
coronary	coronary	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Dentistry	Dentistry	NNP	B-NP	O
reviewed	review	VBD	B-VP	O
the	the	DT	B-NP	O
theme	theme	NN	I-NP	O
of	of	IN	B-PP	O
World	World	NNP	B-NP	O
Health	Health	NNP	I-NP	O
Day	Day	NNP	I-NP	O
,	,	,	O	O
Oral	Oral	NNP	B-NP	O
Health	Health	NNP	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
Healthy	Healthy	NNP	I-NP	O
Life	Life	NNP	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
1994	1994	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
8020	8020	CD	I-NP	O
campaign	campaign	NN	I-NP	O
to	to	TO	B-VP	O
promote	promote	VB	I-VP	O
tooth	tooth	JJ	B-NP	O
care	care	NN	I-NP	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
becoming	become	VBG	I-VP	O
established	establish	VBN	I-VP	O
in	in	IN	B-PP	O
Japan	Japan	NNP	B-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
authors	author	NNS	I-NP	O
emphasized	emphasize	VBD	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
achievement	achievement	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
the	the	DT	B-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
dental	dental	JJ	B-NP	O
health	health	NN	I-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
this	this	DT	B-NP	O
article	article	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
explain	explain	VBP	B-VP	O
the	the	DT	B-NP	O
bases	base	NNS	I-NP	O
supporting	support	VBG	B-VP	O
the	the	DT	B-NP	O
concept	concept	NN	I-NP	O
that	that	IN	B-SBAR	O
oral	oral	JJ	B-NP	O
health	health	NN	I-NP	O
care	care	NN	I-NP	O
,	,	,	O	O
primarily	primarily	RB	B-NP	O
mouth	mouth	JJ	I-NP	O
cleaning	cleaning	NN	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
important	important	JJ	B-ADJP	O
for	for	IN	B-PP	O
not	not	RB	B-CONJP	O
only	only	RB	I-CONJP	O
oral	oral	JJ	B-NP	O
disease	disease	NN	I-NP	O
but	but	CC	B-CONJP	O
also	also	RB	I-CONJP	O
a	a	DT	B-NP	O
healthy	healthy	JJ	I-NP	O
life	life	NN	I-NP	O
.	.	.	O	O